data_2kb3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kb3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 106.842 -1.54 . . . . 64.340000000000003 106.842 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.89 126.29 40.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 107.507 -1.294 . . . . 74.109999999999999 107.507 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -81.42 132.74 35.34 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.366 1.079 . . . . 73.329999999999998 113.732 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -118.58 90.57 3.36 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 101.477 -3.527 . . . . 75.230000000000004 101.477 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.21 160.06 18.66 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.104 0.779 . . . . 73.019999999999996 113.104 -167.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.01 -7.16 37.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.133 -0.939 . . . . 74.299999999999997 109.647 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.32 -16.82 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.029 1.122 . . . . 75.299999999999997 114.029 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.5 pp -66.19 -26.68 67.51 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.407 0.622 . . . . 75.549999999999997 110.953 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' N ' HD12 ' A' ' 23' ' ' LEU . 38.4 ttmt -73.97 -39.97 63.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.299 -1.0 . . . . 75.109999999999999 108.299 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.62 -35.61 80.6 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.617 -0.719 . . . . 74.140000000000001 110.076 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -42.36 98.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.983 -0.747 . . . . 71.219999999999999 108.983 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.29 -34.32 77.15 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 73.140000000000001 110.879 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.8 m -69.54 -19.06 63.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.421 0.629 . . . . 71.310000000000002 110.366 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 t -86.85 -16.71 35.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.537 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -59.52 119.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.525 0.679 . . . . 72.310000000000002 110.511 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.88 -78.38 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.167 -1.973 . . . . 63.130000000000003 108.167 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.3 t -116.76 148.41 41.17 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.463 -0.94 . . . . 75.25 108.463 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.95 116.64 26.06 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 106.893 -1.521 . . . . 70.109999999999999 106.893 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.48 140.64 82.98 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.08 1.187 . . . . 75.040000000000006 110.865 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.3 126.2 29.25 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.651 -0.87 . . . . 74.510000000000005 108.651 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 m -131.49 149.87 52.36 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.47 -0.937 . . . . 73.349999999999994 108.47 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -127.11 153.04 46.51 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.422 -0.585 . . . . 71.140000000000001 109.422 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 24.67 4.1 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 120.463 -0.875 . . . . 71.129999999999995 112.134 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.572 -0.529 . . . . 72.120000000000005 109.572 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.39 -2.31 52.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.549 -0.751 . . . . 74.530000000000001 110.998 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.43 -34.48 41.62 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.459 -0.941 . . . . 74.420000000000002 108.459 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.6 mt 56.55 90.96 0.08 OUTLIER Pre-proline 0 N--CA 1.45 -0.426 0 O-C-N 124.774 1.296 . . . . 72.519999999999996 113.006 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 8.3 Cg_endo -53.99 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.462 2.108 . . . . 74.420000000000002 111.888 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.59 15.45 8.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.0 0.429 . . . . 70.319999999999993 110.334 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.07 18.32 76.84 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.833 -0.621 . . . . 65.329999999999998 112.323 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.7 t -138.01 167.01 22.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -150.9 157.65 43.16 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 108.548 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.15 160.0 39.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 121.014 -0.275 . . . . 73.329999999999998 111.458 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -127.24 134.93 50.02 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.526 -0.916 . . . . 74.140000000000001 108.526 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.51 136.75 44.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.502 -0.555 . . . . 75.450000000000003 109.502 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 17.1 t -80.59 117.42 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 106.717 -1.586 . . . . 71.329999999999998 106.717 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 51.2 tptt -90.63 -32.06 16.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.749 0.785 . . . . 72.120000000000005 109.136 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 77.8 ttt180 -151.51 142.35 22.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.52 -2.03 . . . . 74.230000000000004 105.52 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.22 -171.13 27.95 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.594 -1.002 . . . . 70.129999999999995 110.594 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 -50.15 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.386 2.057 . . . . 73.019999999999996 110.889 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.93 24.34 2.81 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.66 1.184 . . . . 72.430000000000007 112.666 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -53.45 131.78 38.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.568 0.699 . . . . 71.25 112.78 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.94 -17.31 45.28 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.359 -0.837 . . . . 74.120000000000005 111.901 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 146.53 23.98 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 122.593 -0.357 . . . . 75.439999999999998 110.435 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -120.26 135.29 55.05 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.926 -0.768 . . . . 74.019999999999996 108.926 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -118.07 140.99 48.95 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.77 -1.196 . . . . 75.219999999999999 107.77 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -110.7 140.96 44.59 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.256 -0.577 . . . . 75.129999999999995 111.576 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.15 104.59 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.316 -0.994 . . . . 73.239999999999995 108.316 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -112.08 -4.86 14.35 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.965 0.888 . . . . 73.420000000000002 109.752 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -108.97 151.78 42.07 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 115.357 -0.838 . . . . 72.150000000000006 109.762 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -64.98 -18.04 61.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.036 2.49 . . . . 71.450000000000003 113.948 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -144.12 122.4 12.28 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.595 -0.691 . . . . 64.409999999999997 109.522 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.2 m -121.95 114.46 21.01 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.302 -0.629 . . . . 71.400000000000006 109.302 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -95.55 137.12 35.06 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.976 -0.452 . . . . 72.310000000000002 109.97 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 135.32 55.03 Favored 'General case' 0 C--O 1.261 1.66 0 CA-C-O 121.313 0.577 . . . . 73.25 111.228 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.04 -161.85 24.41 Favored Glycine 0 C--O 1.251 1.185 0 N-CA-C 109.07 -1.612 . . . . 73.230000000000004 109.07 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 3.9 tmm_? -94.07 118.75 31.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.188 -1.782 . . . . 72.129999999999995 106.188 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.556 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 11.1 t-80 -166.5 139.58 3.19 Favored Pre-proline 0 N--CA 1.401 -2.914 0 N-CA-C 103.705 -2.702 . . . . 74.219999999999999 103.705 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 17.9 Cg_endo -61.89 -29.6 82.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.115 1.21 . . . . 74.010000000000005 111.703 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -105.34 17.84 23.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.335 -0.848 . . . . 63.530000000000001 111.422 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 19.4 p -77.91 128.66 34.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 118.652 -1.219 . . . . 60.219999999999999 110.636 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.28 -30.25 54.19 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.627 0.727 . . . . 73.340000000000003 109.109 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.04 99.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.558 -0.905 . . . . 72.030000000000001 108.558 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -92.42 120.17 32.66 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.849 -0.614 . . . . 72.319999999999993 109.9 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.9 mt -127.56 140.13 52.31 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.797 -1.557 . . . . 64.120000000000005 106.797 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -87.07 116.31 25.04 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.746 -0.835 . . . . 74.140000000000001 108.746 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 84' ' ' THR . 11.0 t70 -87.01 178.66 6.87 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.099 -1.074 . . . . 73.230000000000004 108.099 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.92 -34.18 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 106.873 -1.528 . . . . 72.239999999999995 106.873 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.543 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 7.0 t -114.37 -167.42 1.22 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 104.651 -2.351 . . . . 75.540000000000006 104.651 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.17 101.9 12.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.617 -1.233 . . . . 64.5 109.926 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.8 p -87.98 101.41 13.73 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.987 -0.551 . . . . 72.430000000000007 110.824 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.9 ptt180 -64.32 -34.7 78.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.751 0.786 . . . . 74.140000000000001 109.656 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -147.2 95.88 2.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.957 -1.019 . . . . 74.319999999999993 108.638 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -99.98 -52.54 3.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.769 -1.172 . . . . 73.200000000000003 109.323 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.59 156.2 34.67 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 119.925 -0.71 . . . . 70.430000000000007 111.344 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 9.7 pt-20 -137.84 142.03 40.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.943 -0.571 . . . . 64.310000000000002 109.964 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -105.69 117.48 34.14 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.928 -1.508 . . . . 73.329999999999998 106.928 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.402 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 16.3 mtp180 -109.5 127.98 54.84 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.906 -0.776 . . . . 74.239999999999995 108.906 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.455 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.8 mp -105.86 113.59 43.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.794 -1.188 . . . . 71.140000000000001 107.794 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -126.59 117.45 22.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.648 -0.501 . . . . 73.540000000000006 109.648 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 53.49 37.7 26.32 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.513 1.525 . . . . 73.120000000000005 112.229 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.58 87.51 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-N 115.325 -0.852 . . . . 73.129999999999995 113.02 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.49 143.06 32.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.301 -0.629 . . . . 71.420000000000002 109.301 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.455 ' CD2' HG13 ' A' ' 94' ' ' ILE . 61.9 m-85 -110.45 124.12 51.18 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.891 -0.595 . . . . 72.329999999999998 110.277 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.92 141.07 49.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.327 -0.62 . . . . 75.230000000000004 109.327 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.9 t -102.95 125.36 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 107.545 -1.28 . . . . 71.420000000000002 107.545 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.79 122.12 68.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 N-CA-C 107.375 -1.343 . . . . 75.239999999999995 107.375 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 2.2 t70 -87.63 122.02 30.8 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.978 -1.01 . . . . 75.310000000000002 108.448 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.4 m -116.46 13.7 7.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 115.447 -0.797 . . . . 74.209999999999994 109.73 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.5 -66.07 0.25 Allowed Glycine 0 N--CA 1.412 -2.948 0 CA-C-N 115.084 -0.962 . . . . 72.129999999999995 112.807 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.3 t 60.66 9.61 2.23 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.974 0.91 . . . . 72.409999999999997 111.051 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.44 HD13 ' N ' ' A' ' 108' ' ' ASN . 3.3 pp -65.38 -46.71 79.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.724 1.21 . . . . 74.409999999999997 112.83 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.44 ' N ' HD13 ' A' ' 107' ' ' LEU . 6.8 t30 -92.77 -18.06 23.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.285 -1.006 . . . . 73.310000000000002 108.285 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.39 93.87 1.22 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 106.486 -2.646 . . . . 70.299999999999997 106.486 -169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 5.1 m -76.4 128.7 35.33 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 108.705 -0.85 . . . . 72.299999999999997 108.705 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.514 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 50.0 m-85 -112.19 126.16 54.91 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 106.888 -1.523 . . . . 73.340000000000003 106.888 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.471 ' CG1' ' HG2' ' A' ' 120' ' ' GLN . 3.1 t -123.22 134.76 65.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 N-CA-C 104.358 -2.46 . . . . 73.409999999999997 104.358 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.28 38.23 29.58 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.759 -1.2 . . . . 63.149999999999999 107.759 -169.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 64.36 9.18 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.852 1.427 . . . . 70.219999999999999 114.852 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.0 148.41 67.24 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 119.03 0.832 . . . . 70.230000000000004 110.14 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 110' ' ' THR . 18.1 Cg_endo -60.83 122.68 11.6 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.563 1.509 . . . . 75.040000000000006 110.213 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -146.47 133.13 19.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.019 -0.672 . . . . 74.120000000000005 109.215 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 16.8 m120 -92.84 -28.86 16.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.568 0.699 . . . . 72.409999999999997 111.28 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.44 135.37 26.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.45 -1.685 . . . . 71.319999999999993 106.45 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HG2' ' CG1' ' A' ' 112' ' ' VAL . 7.5 tp60 -140.54 144.68 36.05 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 111.713 0.264 . . . . 75.230000000000004 111.713 -173.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.81 124.57 52.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 103.96 -2.607 . . . . 62.420000000000002 103.96 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 51.4 mtp -87.94 146.33 25.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.42 -0.912 . . . . 62.32 111.946 -171.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.15 156.87 41.09 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.849 -1.537 . . . . 72.340000000000003 106.849 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -71.08 133.69 46.47 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.229 -1.397 . . . . 73.219999999999999 107.229 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.55 57.45 Favored Glycine 0 C--N 1.312 -0.785 0 C-N-CA 120.67 -0.776 . . . . 51.299999999999997 111.778 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.47 139.34 45.7 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.654 -0.869 . . . . 73.450000000000003 108.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -112.08 126.2 54.92 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.749 -1.204 . . . . 71.239999999999995 107.749 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.06 126.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.866 -0.79 . . . . 73.209999999999994 108.866 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 55.4 tp60 -105.0 111.51 24.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.222 -1.029 . . . . 74.120000000000005 108.222 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.93 112.86 42.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.614 -1.624 . . . . 74.099999999999994 106.614 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.63 -126.97 25.31 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 108.906 -1.678 . . . . 65.129999999999995 108.906 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 17.57 20.47 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.431 0.634 . . . . 71.519999999999996 109.738 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -120.62 165.62 14.79 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.078 -0.51 . . . . 75.510000000000005 110.134 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 14.7 ptm180 -137.15 146.62 45.2 Favored 'General case' 0 C--O 1.256 1.431 0 CA-C-O 121.544 0.687 . . . . 65.239999999999995 112.72 -168.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -120.48 139.88 52.23 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.548 -1.278 . . . . 74.329999999999998 107.548 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.74 120.43 62.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 107.919 -1.141 . . . . 73.109999999999999 107.919 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.03 126.61 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.261 -0.644 . . . . 61.32 109.261 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.03 162.13 30.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 123.779 0.832 . . . . 72.019999999999996 109.201 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.53 148.03 45.39 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.103 -1.443 . . . . 72.129999999999995 107.103 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.604 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -77.9 -161.43 16.48 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 121.074 -0.584 . . . . 73.400000000000006 114.356 -171.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.63 143.91 93.33 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.583 2.189 . . . . 74.430000000000007 111.897 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.48 31.93 6.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.091 -1.078 . . . . 73.209999999999994 108.091 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.524 -1.216 . . . . 73.510000000000005 109.689 -177.342 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 105.394 -2.076 . . . . 74.010000000000005 105.394 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.46 115.87 24.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.533 0.683 . . . . 75.319999999999993 109.337 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -119.94 139.86 51.79 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.287 -0.87 . . . . 75.340000000000003 110.432 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -113.22 92.18 3.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.732 -1.581 . . . . 73.040000000000006 106.732 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 22' ' ' LEU . . . -78.21 -173.86 3.42 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.059 -0.973 . . . . 75.120000000000005 112.024 -175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.58 -0.55 1.42 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.117 1.767 . . . . 71.299999999999997 111.683 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 20' ' ' ALA . 4.6 pp -63.98 -17.54 63.39 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.735 1.214 . . . . 64.209999999999994 111.174 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.19 -8.95 35.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.685 0.794 . . . . 75.310000000000002 111.677 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 63.5 tttp -88.93 -23.08 22.78 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.05 -0.407 . . . . 71.430000000000007 111.246 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -59.76 -23.47 63.27 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.419 0.526 . . . . 74.019999999999996 112.419 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.57 -30.63 71.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.85 0.685 . . . . 73.219999999999999 112.85 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 13.8 pt-20 -76.56 -26.05 54.7 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.601 -0.839 . . . . 74.099999999999994 110.796 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -80.16 -26.18 39.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.029 -0.73 . . . . 74.409999999999997 109.029 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 m -77.58 -25.74 50.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.125 -0.943 . . . . 63.140000000000001 110.448 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.5 m -74.74 108.77 7.7 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.369 -0.974 . . . . 71.420000000000002 108.369 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.75 -5.23 12.82 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 109.281 -1.528 . . . . 73.540000000000006 109.281 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -113.8 121.72 44.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.012 -0.736 . . . . 73.209999999999994 109.012 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.59 45.0 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.279 -1.008 . . . . 74.299999999999997 108.279 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.15 142.08 96.89 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.162 1.908 . . . . 73.209999999999994 111.079 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.56 126.01 42.61 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.205 -0.294 . . . . 73.319999999999993 110.205 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 84.96 2.08 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.036 -1.098 . . . . 71.109999999999999 108.036 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -101.6 -36.33 8.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.251 0.548 . . . . 73.209999999999994 111.02 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.73 62.19 0.37 Allowed Glycine 0 C--N 1.305 -1.159 0 C-N-CA 121.013 -0.613 . . . . 71.510000000000005 111.991 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.65 -28.52 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.591 -0.358 . . . . 73.200000000000003 111.257 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -92.75 -5.25 51.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.333 0.494 . . . . 74.230000000000004 112.333 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -80.22 -43.84 20.78 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.118 0.784 . . . . 73.450000000000003 113.118 -168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.0 mt 42.76 65.66 5.05 Favored Pre-proline 0 CA--C 1.557 1.248 0 O-C-N 124.181 0.926 . . . . 72.319999999999993 111.959 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.27 -70.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.461 2.774 . . . . 65.319999999999993 113.979 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.19 7.89 45.65 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.509 -0.476 . . . . 61.210000000000001 110.661 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.54 75.16 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.987 -0.551 . . . . 60.450000000000003 111.769 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -115.18 153.97 29.85 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 123.954 0.902 . . . . 71.239999999999995 111.012 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.34 44.3 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.459 -0.791 . . . . 74.239999999999995 109.974 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.85 160.7 38.08 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.542 -0.754 . . . . 73.030000000000001 109.196 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -121.28 131.88 54.47 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.34 -0.985 . . . . 75.0 108.34 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.57 129.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.32 -0.622 . . . . 74.310000000000002 109.32 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG22 ' ND2' ' A' ' 56' ' ' ASN . 22.4 t -80.19 118.06 27.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.529 -1.656 . . . . 70.420000000000002 106.529 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.985 0.898 . . . . 74.209999999999994 109.667 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.599 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -141.47 148.05 38.85 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.641 -1.244 . . . . 75.420000000000002 107.641 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.43 -179.7 16.85 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 111.093 -0.803 . . . . 73.239999999999995 111.093 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -67.67 -38.11 14.83 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.097 1.865 . . . . 74.430000000000007 110.943 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.442 ' ND2' HG22 ' A' ' 51' ' ' VAL . 4.7 p-10 -96.14 22.63 7.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.392 -0.822 . . . . 71.310000000000002 111.261 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.22 144.02 55.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.326 0.651 . . . . 74.030000000000001 111.342 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.46 33.23 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 111.139 -0.785 . . . . 74.530000000000001 111.139 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 141.93 29.14 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 120.765 0.317 . . . . 70.239999999999995 110.731 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -119.82 138.7 53.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.069 -0.514 . . . . 74.530000000000001 110.276 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.98 133.98 54.82 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.533 -0.543 . . . . 64.319999999999993 109.533 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -96.86 144.53 26.72 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.049 0.218 . . . . 73.209999999999994 110.502 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 69.3 mt -104.5 113.39 26.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -128.52 -3.1 5.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.973 0.416 . . . . 75.549999999999997 111.509 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -107.87 143.14 26.73 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 109.383 -0.599 . . . . 63.229999999999997 109.383 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.94 -25.2 27.01 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.455 2.77 . . . . 73.519999999999996 114.369 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.7 m -143.23 121.96 12.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 110.258 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 24.9 m -117.96 129.26 55.5 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.446 -0.797 . . . . 60.409999999999997 109.768 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 m -100.89 135.67 41.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.459 -0.571 . . . . 72.140000000000001 109.459 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.07 135.43 54.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.054 -0.721 . . . . 65.019999999999996 109.054 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -165.41 34.49 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.974 -1.25 . . . . 75.140000000000001 109.974 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 79.2 ttt180 -91.6 149.16 21.79 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.465 -0.568 . . . . 74.349999999999994 109.465 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 79.03 161.26 0.14 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.552 1.141 . . . . 74.5 110.519 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -72.28 13.1 0.56 Allowed 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.834 2.356 . . . . 74.310000000000002 113.156 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.62 -5.54 59.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.767 0.794 . . . . 75.540000000000006 109.6 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 m -117.57 148.74 41.62 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.75 -1.204 . . . . 72.200000000000003 107.75 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.16 -44.86 83.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.915 0.886 . . . . 71.310000000000002 109.361 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.9 mm -100.17 124.5 53.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.004 -1.11 . . . . 75.420000000000002 108.004 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -88.84 124.35 34.09 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.519 0.512 . . . . 75.420000000000002 111.229 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 6.2 mp -126.3 141.3 51.96 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.751 -1.203 . . . . 74.049999999999997 107.751 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.27 117.43 34.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.34 -1.726 . . . . 64.450000000000003 106.34 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 84' ' ' THR . 9.4 t70 -105.46 173.25 6.39 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.69 -0.687 . . . . 73.549999999999997 109.538 -168.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -82.95 -24.86 8.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.449 -1.315 . . . . 73.120000000000005 107.449 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.2 m -124.56 -173.66 2.84 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.0 -1.852 . . . . 74.209999999999994 106.0 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.67 99.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 120.667 -1.271 . . . . 72.510000000000005 110.157 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 p -83.87 107.47 16.28 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.434 -0.803 . . . . 73.349999999999994 109.837 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -32.36 73.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.643 0.735 . . . . 74.510000000000005 111.006 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -168.9 119.93 0.74 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.668 -2.345 . . . . 74.549999999999997 104.668 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -99.58 -52.04 3.59 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 123.375 0.422 . . . . 75.519999999999996 109.893 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.73 157.81 44.13 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.326 -0.549 . . . . 74.329999999999998 110.155 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.19 132.03 51.86 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.882 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.506 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 4.2 m-85 -105.62 113.75 27.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.72 -1.585 . . . . 73.25 106.72 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -104.15 133.48 49.0 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.4 mt -104.29 113.53 41.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.063 -1.828 . . . . 65.329999999999998 106.063 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -134.47 118.58 17.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.447 -0.575 . . . . 72.109999999999999 109.447 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 54.22 38.04 28.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.161 0.985 . . . . 73.400000000000006 112.039 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.0 -6.92 79.84 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.092 -0.504 . . . . 61.530000000000001 113.702 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.74 149.91 23.99 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.359 -0.608 . . . . 72.540000000000006 109.359 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.97 116.9 28.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 73.450000000000003 108.794 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -112.04 127.28 55.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.202 -0.666 . . . . 70.319999999999993 109.202 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.459 HG23 ' SD ' ' A' ' 122' ' ' MET . 43.6 t -105.5 124.32 60.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.235 -0.654 . . . . 74.219999999999999 109.235 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.4 t -115.01 122.97 70.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 115.779 -0.646 . . . . 73.310000000000002 109.639 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.05 131.4 34.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.216 -0.902 . . . . 73.230000000000004 111.351 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.37 12.74 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.905 -1.043 . . . . 65.019999999999996 108.377 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.14 34.51 5.03 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.994 -1.242 . . . . 74.510000000000005 109.994 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 m -61.9 -11.7 14.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.618 1.167 . . . . 75.219999999999999 111.315 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -71.15 -26.16 62.87 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.055 0.942 . . . . 75.209999999999994 108.94 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.61 -18.68 24.74 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.106 -0.952 . . . . 75.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.94 62.71 1.65 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.702 -0.681 . . . . 72.25 112.644 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -64.5 135.5 56.11 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 124.081 0.952 . . . . 74.099999999999994 112.444 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.14 126.77 44.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.966 -1.124 . . . . 73.329999999999998 107.966 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -107.85 117.32 53.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.764 -1.569 . . . . 72.120000000000005 106.764 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 51.32 49.96 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.128 0.971 . . . . 74.340000000000003 110.276 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 70.68 7.81 6.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.273 1.429 . . . . 72.120000000000005 113.709 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.54 137.82 31.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.451 -0.9 . . . . 75.25 111.228 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.13 123.92 14.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.103 1.869 . . . . 64.239999999999995 108.793 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -151.44 138.49 19.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.124 -1.065 . . . . 64.540000000000006 108.124 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.1 -53.24 3.88 Favored 'General case' 0 C--O 1.199 -1.582 0 C-N-CA 120.73 -0.388 . . . . 75.519999999999996 110.637 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.93 136.53 54.93 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.13 -0.693 . . . . 64.299999999999997 109.13 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 140.43 20.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.383 -0.969 . . . . 75.239999999999995 108.383 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -96.42 114.57 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 105.101 -2.185 . . . . 71.400000000000006 105.101 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 101' ' ' VAL . 79.1 mtp -90.22 145.32 25.1 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 114.414 1.264 . . . . 74.329999999999998 114.414 -166.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -111.59 158.15 19.56 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 63.43 108.677 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 138' ' ' LEU . 24.4 m -58.14 120.9 9.45 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.819 -0.437 . . . . 74.400000000000006 109.819 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.73 1.54 56.34 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.217 -0.992 . . . . 65.299999999999997 112.718 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.98 141.56 28.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.23 -1.026 . . . . 74.129999999999995 108.23 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.24 145.67 49.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.918 0.711 . . . . 74.310000000000002 112.918 -169.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.434 HD12 ' SD ' ' A' ' 122' ' ' MET . 34.5 mt -116.08 132.87 64.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.002 -0.74 . . . . 74.340000000000003 109.002 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -103.63 110.5 22.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.789 -1.93 . . . . 73.010000000000005 105.789 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.0 mt -109.67 105.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.475 -0.935 . . . . 74.040000000000006 108.475 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.51 -107.94 2.3 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.016 -1.634 . . . . 73.319999999999993 109.016 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -119.93 9.04 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 120.808 0.337 . . . . 65.040000000000006 110.12 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.599 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.4 p90 -120.28 146.26 46.26 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.802 0.668 . . . . 72.439999999999998 112.802 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -112.58 132.28 55.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.427 -0.806 . . . . 74.140000000000001 111.467 -167.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.4 139.97 52.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.258 -0.645 . . . . 74.230000000000004 109.258 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.0 130.23 66.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.673 -0.862 . . . . 74.450000000000003 108.673 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -104.27 128.48 52.04 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.124 -0.695 . . . . 75.510000000000005 109.124 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 124' ' ' THR 0.278 0.0 OUTLIER -140.09 135.63 32.76 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 113.109 0.781 . . . . 75.430000000000007 113.109 177.728 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.2 124.97 44.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.281 -1.748 . . . . 74.329999999999998 106.281 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 165.43 -33.7 0.24 Allowed Glycine 0 C--N 1.29 -1.976 0 C-N-CA 118.723 -1.703 . . . . 62.109999999999999 116.468 -171.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 10.2 Cg_endo -53.87 142.16 64.38 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.896 2.848 . . . . 75.310000000000002 114.653 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.49 88.92 1.23 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.831 -2.285 . . . . 74.409999999999997 104.831 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 114.803 -1.089 . . . . 73.030000000000001 108.282 -172.657 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.888 -0.412 . . . . 64.510000000000005 109.888 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.9 115.79 27.85 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 CA-C-O 120.822 0.344 . . . . 73.310000000000002 110.36 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -107.69 120.16 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.729 -0.841 . . . . 75.109999999999999 108.729 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.57 141.26 46.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.688 -0.687 . . . . 73.099999999999994 112.624 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 82.84 -20.93 0.31 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.32 1.848 . . . . 73.120000000000005 113.505 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -80.1 -38.44 31.63 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.422 -0.955 . . . . 62.219999999999999 108.422 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.49 HD11 ' N ' ' A' ' 23' ' ' LEU . 2.2 pp -64.73 -26.62 68.45 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.014 -0.993 . . . . 75.310000000000002 110.792 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.49 ' N ' HD11 ' A' ' 22' ' ' LEU . 50.9 tp -74.85 -39.96 61.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.4 -0.818 . . . . 71.140000000000001 109.232 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.8 -41.41 78.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 74.340000000000003 110.448 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.78 -39.55 80.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.706 -0.679 . . . . 62.140000000000001 110.409 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -59.43 -39.23 82.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 73.150000000000006 110.796 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -63.51 -38.51 91.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.73 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -72.06 -38.77 69.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.961 -0.563 . . . . 61.049999999999997 110.302 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -66.46 -47.01 74.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.956 -0.565 . . . . 64.340000000000003 110.242 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -83.08 98.11 9.14 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.874 0.369 . . . . 70.519999999999996 111.288 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.54 -60.51 0.74 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 108.38 -1.888 . . . . 75.540000000000006 108.38 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 38.2 m -114.37 124.77 52.78 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.866 -1.161 . . . . 73.439999999999998 107.866 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.82 94.52 6.44 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.619 -0.512 . . . . 54.009999999999998 109.619 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 32' ' ' THR . 2.7 Cg_exo -76.25 142.91 24.71 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.575 2.183 . . . . 63.399999999999999 111.962 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.1 154.74 19.93 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.156 -1.053 . . . . 54.399999999999999 108.156 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 m -114.43 144.85 42.65 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.144 0.497 . . . . 74.400000000000006 112.075 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -132.58 144.39 50.36 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.743 -1.576 . . . . 72.310000000000002 106.743 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.13 11.91 32.9 Favored Glycine 0 CA--C 1.49 -1.515 0 N-CA-C 109.891 -1.283 . . . . 73.319999999999993 109.891 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.04 -32.0 16.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.882 -0.785 . . . . 73.530000000000001 108.882 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.09 3.6 38.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.52 -1.218 . . . . 74.25 110.95 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -80.12 -36.34 35.42 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.398 -0.819 . . . . 71.010000000000005 110.566 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 51.15 45.85 3.17 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 123.725 0.641 . . . . 71.109999999999999 112.492 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.99 -52.85 1.04 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.9 1.733 . . . . 71.129999999999995 113.929 -170.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -18.34 40.27 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.946 -0.57 . . . . 54.329999999999998 112.53 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.94 -0.49 82.7 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 120.422 -0.894 . . . . 73.319999999999993 111.814 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 t -118.62 170.02 9.32 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.347 -1.353 . . . . 72.400000000000006 107.347 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . . . -139.65 152.92 47.14 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.598 0.237 . . . . 72.239999999999995 110.463 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -130.05 155.58 45.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.925 -0.58 . . . . 75.299999999999997 109.959 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -119.39 125.15 48.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.911 -1.144 . . . . 72.040000000000006 107.911 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.2 135.18 53.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 115.433 -0.803 . . . . 75.200000000000003 109.791 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.11 117.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 105.171 -2.159 . . . . 60.049999999999997 105.171 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.63 -39.43 22.15 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.323 -1.362 . . . . 73.420000000000002 107.323 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 47.7 ttt180 -160.95 144.21 13.05 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.317 -1.364 . . . . 75.510000000000005 107.317 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.61 -167.69 26.54 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 108.355 -1.898 . . . . 33.020000000000003 108.355 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.1 -47.57 12.16 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.378 2.052 . . . . 73.5 112.184 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.11 22.05 3.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.662 -0.244 . . . . 72.549999999999997 111.198 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.6 134.09 46.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.723 0.638 . . . . 72.409999999999997 112.723 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.18 21.72 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.217 -0.901 . . . . 73.340000000000003 111.829 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 145.76 33.35 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.843 0.354 . . . . 73.230000000000004 110.126 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.85 136.3 22.85 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 110.991 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -121.59 145.24 48.18 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.347 -1.353 . . . . 73.409999999999997 107.347 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 1.4 pt? -110.38 145.53 37.4 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.575 0.226 . . . . 74.040000000000006 110.63 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.75 103.41 5.01 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.101 -1.444 . . . . 72.230000000000004 107.101 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -123.2 7.55 9.14 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.952 -1.499 . . . . 60.399999999999999 106.952 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -137.03 146.1 53.3 Favored Pre-proline 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 74.439999999999998 107.669 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -72.06 -14.36 29.01 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.832 2.355 . . . . 74.319999999999993 114.496 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -140.14 122.37 15.88 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.293 -0.88 . . . . 73.120000000000005 109.479 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 m -131.02 139.08 49.91 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.523 0.729 . . . . 74.340000000000003 111.224 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.15 52.64 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.128 -1.064 . . . . 73.319999999999993 108.128 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.75 135.1 54.69 Favored 'General case' 0 C--O 1.264 1.823 0 CA-C-O 120.996 0.427 . . . . 72.530000000000001 109.94 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.74 -156.17 22.33 Favored Glycine 0 N--CA 1.417 -2.617 0 CA-C-N 115.316 -0.856 . . . . 62.340000000000003 111.119 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.463 ' NH1' ' HA ' ' A' ' 86' ' ' SER . 40.8 ttp180 -88.86 150.61 22.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.308 -0.627 . . . . 75.209999999999994 109.308 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.9 m170 81.53 150.07 0.11 Allowed Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 125.435 1.494 . . . . 74.329999999999998 111.093 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.29 0.86 6.11 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.051 2.501 . . . . 72.439999999999998 111.225 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.63 -26.53 60.82 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 124.722 1.209 . . . . 74.530000000000001 107.754 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -85.84 136.43 33.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.604 -1.258 . . . . 73.439999999999998 107.604 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.64 -46.49 73.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.369 1.068 . . . . 74.150000000000006 109.765 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 mm -102.73 109.4 26.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.588 -1.264 . . . . 72.019999999999996 107.588 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -87.61 115.77 25.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.763 -0.653 . . . . 72.099999999999994 111.196 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.23 127.83 45.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.037 -1.468 . . . . 74.150000000000006 107.037 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.07 117.9 34.98 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.113 -0.635 . . . . 71.019999999999996 110.216 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -150.34 161.52 42.32 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 104.546 -2.39 . . . . 74.219999999999999 104.546 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.3 -39.3 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 118.168 0.44 . . . . 71.209999999999994 111.371 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -101.32 7.35 42.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.72 0.771 . . . . 75.329999999999998 112.308 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.93 121.15 36.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.279 -1.008 . . . . 74.239999999999995 108.279 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.463 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 35.0 m -93.11 -164.54 1.19 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.307 0.855 . . . . 73.329999999999998 113.307 -173.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -55.07 -21.37 12.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.57 2.348 . . . . 71.439999999999998 113.499 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -170.24 116.44 0.52 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.73 -0.841 . . . . 72.430000000000007 108.73 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.48 ' ND1' HG21 ' A' ' 130' ' ' ILE . 9.4 t-160 -100.39 -51.96 3.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.984 -0.747 . . . . 74.150000000000006 108.984 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.14 43.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.454 -0.943 . . . . 73.319999999999993 108.454 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.33 149.64 50.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.536 -0.466 . . . . 72.219999999999999 110.787 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -112.65 113.77 26.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.97 -1.122 . . . . 75.310000000000002 107.97 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -108.78 131.89 54.51 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.264 -1.013 . . . . 75.230000000000004 108.264 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 3.2 mp -106.4 120.05 56.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.685 -1.228 . . . . 74.530000000000001 107.685 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.1 129.95 28.36 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.333 -0.617 . . . . 73.140000000000001 109.333 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.26 35.75 25.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.728 1.211 . . . . 72.519999999999996 110.71 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.17 82.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.473 -0.785 . . . . 74.120000000000005 113.839 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 21.4 mm-40 -100.61 141.56 33.3 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.945 -0.761 . . . . 75.239999999999995 108.945 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -106.82 117.86 35.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.091 -1.078 . . . . 73.109999999999999 108.091 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.02 141.87 51.49 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.065 -0.654 . . . . 72.549999999999997 111.674 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.05 124.82 58.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.443 -0.947 . . . . 74.329999999999998 108.443 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.84 123.38 71.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.382 -0.97 . . . . 74.230000000000004 108.382 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.98 127.64 32.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 73.109999999999999 110.81 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.69 -15.96 9.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.613 0.721 . . . . 75.340000000000003 109.77 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -122.73 57.79 0.63 Allowed Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.479 -1.448 . . . . 72.310000000000002 109.479 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -69.33 5.14 1.39 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.528 0.68 . . . . 64.010000000000005 111.56 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 105' ' ' GLY . 5.8 mp -77.89 -20.9 52.13 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.317 0.647 . . . . 71.349999999999994 109.355 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -87.83 -19.79 26.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 72.519999999999996 110.35 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.04 71.72 0.99 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 112.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.582 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 10.0 m -69.67 130.32 42.05 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.159 -1.052 . . . . 61.530000000000001 108.159 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -108.83 125.9 52.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.429 -0.908 . . . . 75.439999999999998 110.613 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.03 117.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 105.792 -1.929 . . . . 72.219999999999999 105.792 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.88 40.63 30.54 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.042 0.925 . . . . 74.099999999999994 108.849 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 71.86 7.36 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.215 1.932 . . . . 74.099999999999994 116.215 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -115.85 135.96 22.81 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 118.72 0.691 . . . . 74.340000000000003 110.519 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 110' ' ' THR . 32.1 Cg_endo -63.48 148.05 92.81 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.86 2.374 . . . . 75.540000000000006 112.62 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 51.6 mmt-85 -121.55 160.99 23.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 114.335 1.235 . . . . 75.540000000000006 114.335 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -115.8 -51.76 2.65 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 112.943 -1.935 . . . . 72.239999999999995 106.125 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.19 135.66 5.35 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.338 -1.727 . . . . 65.400000000000006 106.338 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.65 145.46 23.47 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.44 -0.504 . . . . 74.319999999999993 110.998 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.37 124.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.309 -2.108 . . . . 72.329999999999998 105.309 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 tpp -89.5 134.48 34.09 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.311 -0.955 . . . . 75.420000000000002 113.481 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -103.69 141.67 35.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.485 -1.234 . . . . 73.019999999999996 110.645 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -61.37 130.22 45.02 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.874 -1.057 . . . . 70.530000000000001 111.451 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.43 58.23 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.911 -0.586 . . . . 73.340000000000003 113.182 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -88.98 154.73 19.99 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 116.866 0.333 . . . . 71.129999999999995 110.864 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.81 133.82 53.03 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.942 0.877 . . . . 60.409999999999997 110.801 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.1 mm -113.68 123.65 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.763 -1.199 . . . . 71.099999999999994 107.763 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -104.71 113.37 26.92 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.189 -0.604 . . . . 74.519999999999996 109.562 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.48 HG21 ' ND1' ' A' ' 89' ' ' HIS . 36.9 mt -109.66 124.39 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 114.806 -1.088 . . . . 74.430000000000007 108.128 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.82 -86.36 1.35 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.866 -1.294 . . . . 62.219999999999999 109.866 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.93 25.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.364 0.602 . . . . 73.340000000000003 110.215 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.4 p90 -141.04 164.08 31.24 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.384 -0.825 . . . . 74.420000000000002 108.897 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -112.55 144.82 41.38 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 114.598 1.333 . . . . 74.129999999999995 114.598 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.06 140.64 49.72 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.22 -1.809 . . . . 72.349999999999994 106.137 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.2 t -111.3 124.76 68.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 109.067 -0.716 . . . . 72.209999999999994 109.067 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -91.46 116.03 28.52 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.614 -1.254 . . . . 70.099999999999994 107.614 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 48' ' ' LEU . 1.8 tm? -128.61 132.46 48.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.931 -1.137 . . . . 73.129999999999995 107.931 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . . . -90.16 118.75 29.93 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.668 -0.813 . . . . 54.450000000000003 110.394 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 125.67 73.35 0.21 Allowed Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.763 -0.653 . . . . 75.230000000000004 112.328 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.61 162.85 40.89 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.979 2.453 . . . . 74.329999999999998 111.343 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.05 48.31 1.23 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.712 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.414 -2.239 0 CA-C-N 115.659 -0.701 . . . . 75.510000000000005 110.517 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 108.871 -0.789 . . . . 52.210000000000001 108.871 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.53 115.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 108.193 -1.04 . . . . 75.040000000000006 108.193 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -115.45 133.32 56.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.669 . . . . 74.420000000000002 109.192 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -86.78 94.41 9.53 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.02 -1.072 . . . . 62.409999999999997 110.392 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.28 -152.07 0.05 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.441 -1.254 . . . . 75.140000000000001 108.934 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.4 7.11 47.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.938 -0.476 . . . . 72.099999999999994 111.191 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.77 -50.46 72.23 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.095 1.517 . . . . 65.420000000000002 115.095 -171.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' O ' ' HG3' ' A' ' 26' ' ' MET . 7.3 tt -72.63 -39.15 67.44 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.473 0.654 . . . . 75.519999999999996 109.365 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -69.72 -32.77 71.51 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.717 -0.674 . . . . 54.549999999999997 110.314 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.51 -42.18 95.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.14 0.576 . . . . 64.420000000000002 110.151 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.01 -30.72 71.32 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 120.083 -0.647 . . . . 74.450000000000003 111.163 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.0 -49.4 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 74.120000000000005 109.785 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -69.84 -27.03 64.51 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.315 -0.857 . . . . 65.319999999999993 112.608 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.433 ' OG ' ' HD2' ' A' ' 114' ' ' ARG . 31.7 p -79.96 -16.75 54.59 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.145 0.497 . . . . 72.0 111.053 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -74.19 106.14 5.71 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 122.151 0.977 . . . . 74.540000000000006 111.095 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.78 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 104.927 -3.269 . . . . 72.439999999999998 104.927 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 m -115.5 121.39 42.55 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.729 -1.952 . . . . 71.109999999999999 105.729 168.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.37 115.46 65.47 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 106.588 -1.634 . . . . 63.310000000000002 106.588 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.84 140.03 93.4 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 121.982 1.788 . . . . 71.299999999999997 112.313 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.85 126.54 29.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.395 -0.82 . . . . 51.219999999999999 110.805 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 124' ' ' THR . 67.9 m -147.44 109.47 4.48 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.836 -1.172 . . . . 71.319999999999993 107.836 172.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -86.82 96.59 10.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 65.230000000000004 112.217 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.11 7.33 0.25 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.783 -0.644 . . . . 63.210000000000001 112.409 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.31 -21.17 24.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.754 0.787 . . . . 64.530000000000001 110.375 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -92.15 -6.73 50.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.711 -1.131 . . . . 71.230000000000004 109.122 178.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -100.04 -42.29 6.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.39 -1.277 . . . . 73.219999999999999 109.624 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 56.12 78.71 0.37 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.602 -0.726 . . . . 64.120000000000005 110.128 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.47 -55.5 0.91 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.131 1.888 . . . . 74.319999999999993 113.153 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.47 -7.38 26.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.932 -0.576 . . . . 73.239999999999995 111.854 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.06 -12.62 11.36 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.213 -0.449 . . . . 50.329999999999998 112.866 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m -124.68 153.42 42.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.762 -1.569 . . . . 74.340000000000003 106.762 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.28 41.13 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.905 0.128 . . . . 62.509999999999998 110.782 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.1 pp -127.6 157.01 41.36 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.803 0.668 . . . . 74.409999999999997 112.803 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.35 138.25 54.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.923 -1.14 . . . . 74.540000000000006 107.923 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.79 135.72 62.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 C-N-CA 120.534 -0.466 . . . . 74.310000000000002 109.906 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -80.81 117.09 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.774 -1.936 . . . . 73.510000000000005 105.774 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -90.21 -34.67 15.72 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.779 -0.646 . . . . 75.340000000000003 109.551 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -148.61 137.56 21.6 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.179 -0.674 . . . . 74.329999999999998 109.179 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.68 -177.86 23.8 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 108.907 -1.677 . . . . 44.310000000000002 108.907 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 72.1 Cg_exo -55.65 -51.18 10.41 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.935 2.423 . . . . 65.450000000000003 112.823 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -91.48 22.75 3.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.302 0.482 . . . . 75.200000000000003 112.302 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.85 143.07 48.71 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.087 0.47 . . . . 73.430000000000007 111.799 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.27 -23.27 32.33 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.301 -0.72 . . . . 55.329999999999998 111.301 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 134.19 34.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 120.93 0.395 . . . . 64.340000000000003 110.459 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -107.38 138.68 43.14 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.919 -1.141 . . . . 75.319999999999993 107.919 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.5 127.52 44.14 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.422 -0.584 . . . . 75.530000000000001 109.422 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 9.2 mp -93.62 137.78 32.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.39 -0.596 . . . . 75.019999999999996 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.95 103.34 13.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.013 -1.477 . . . . 72.319999999999993 107.013 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.99 -15.22 6.92 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.498 -0.774 . . . . 72.129999999999995 111.236 -175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.447 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.2 pt20 -107.32 142.47 25.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 109.648 -0.501 . . . . 74.450000000000003 109.648 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.6 -19.9 19.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.965 3.11 . . . . 72.530000000000001 113.865 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.3 m -147.18 121.66 9.72 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.814 -1.18 . . . . 71.219999999999999 107.814 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 m -120.81 113.83 20.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.378 -1.341 . . . . 74.519999999999996 107.378 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.0 m -92.36 144.04 25.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.822 -0.549 . . . . 73.450000000000003 110.704 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.29 139.02 52.6 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 123.166 0.586 . . . . 72.120000000000005 109.497 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.63 -135.84 5.63 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.893 -1.283 . . . . 74.299999999999997 109.893 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 22.9 ptt85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.077 -1.083 . . . . 75.310000000000002 108.077 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER 144.77 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 127.635 2.374 . . . . 75.239999999999995 108.81 174.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.69 -15.25 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.763 1.642 . . . . 64.430000000000007 110.416 174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -78.81 -24.07 44.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.143 -0.935 . . . . 73.150000000000006 110.444 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 p -84.71 121.32 27.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.615 -0.883 . . . . 75.209999999999994 108.615 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.88 -35.8 74.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 110.677 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.4 98.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.25 -1.389 . . . . 74.409999999999997 107.25 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -92.93 115.11 27.82 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.904 -0.589 . . . . 74.109999999999999 109.632 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.6 mt -111.62 134.38 53.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.519 -1.289 . . . . 72.340000000000003 107.519 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.92 128.35 54.73 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.535 0.683 . . . . 73.299999999999997 110.413 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -148.43 -178.8 6.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.447 -2.057 . . . . 65.129999999999995 105.447 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.53 -24.84 8.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.982 -1.118 . . . . 73.430000000000007 107.982 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.2 m -137.36 90.3 2.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.968 0.89 . . . . 74.140000000000001 110.236 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -101.85 150.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.143 -1.058 . . . . 74.510000000000005 108.143 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.2 m -92.45 146.45 23.67 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.419 -0.956 . . . . 75.420000000000002 108.419 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -17.56 53.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.725 0.774 . . . . 72.400000000000006 111.829 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -140.8 93.87 2.65 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.578 -2.379 . . . . 75.230000000000004 104.578 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -91.96 -53.32 4.32 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.229 0.538 . . . . 73.230000000000004 111.269 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.16 155.92 37.62 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.797 -0.816 . . . . 74.430000000000007 108.797 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.24 135.1 44.76 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.894 -0.594 . . . . 70.010000000000005 109.56 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -104.92 117.22 33.47 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.534 -1.654 . . . . 74.019999999999996 106.534 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -103.67 130.78 51.2 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.588 -0.523 . . . . 72.140000000000001 109.588 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.9 mp -114.31 113.09 42.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.628 -1.619 . . . . 74.329999999999998 106.628 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -138.38 122.78 18.33 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.79 -0.448 . . . . 74.340000000000003 109.79 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 56.3 37.86 29.23 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.796 1.238 . . . . 71.420000000000002 112.891 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.45 13.68 82.34 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.223 -0.899 . . . . 71.099999999999994 113.32 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -116.04 142.38 46.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.579 -0.897 . . . . 65.329999999999998 108.579 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -115.51 117.97 31.85 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.078 -0.712 . . . . 70.400000000000006 109.078 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.03 145.22 48.35 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 111.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 37.0 t -103.51 124.71 57.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.06 -1.459 . . . . 73.329999999999998 107.06 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.95 122.86 70.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.157 -1.423 . . . . 75.219999999999999 107.157 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -104.51 134.54 47.52 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 111.787 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.8 0.5 3.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.6 -0.727 . . . . 75.150000000000006 110.297 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.32 58.9 0.4 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.124 -1.19 . . . . 44.420000000000002 110.124 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -70.33 -8.48 50.83 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.581 0.752 . . . . 72.319999999999993 112.017 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -24.05 58.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.969 0.414 . . . . 75.310000000000002 109.958 174.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -87.34 -17.93 31.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.771 -1.196 . . . . 75.549999999999997 107.771 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.62 56.06 6.27 Favored Glycine 0 CA--C 1.496 -1.128 0 CA-C-N 114.718 -1.128 . . . . 55.299999999999997 113.329 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -63.41 128.71 37.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.853 -0.425 . . . . 75.109999999999999 109.853 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 20.5 m-30 -124.28 139.89 53.48 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 110.03 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.26 121.71 66.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.32 -1.733 . . . . 74.200000000000003 106.32 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.19 39.15 31.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.037 1.335 . . . . 74.450000000000003 108.24 -169.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.433 ' HD2' ' OG ' ' A' ' 29' ' ' SER . 19.0 mtm105 62.62 20.3 11.92 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.055 -1.429 . . . . 71.450000000000003 111.519 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -111.81 136.13 21.17 Favored Pre-proline 0 C--N 1.315 -0.931 0 C-N-CA 122.875 0.47 . . . . 74.239999999999995 110.043 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.17 123.72 13.74 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.663 2.242 . . . . 72.239999999999995 108.664 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 8.9 tpp180 -143.23 142.44 31.4 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 119.167 -1.013 . . . . 75.430000000000007 112.549 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -79.05 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.614 0.766 . . . . 75.25 109.916 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -151.39 136.48 17.45 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.624 -1.25 . . . . 71.230000000000004 107.624 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 52.4 tp60 -153.22 141.68 20.74 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.023 0.202 . . . . 64.409999999999997 111.208 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 58.4 t -66.23 133.03 31.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 106.522 -1.658 . . . . 64.430000000000007 106.522 170.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -87.42 144.65 26.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.205 -1.035 . . . . 74.519999999999996 108.205 -174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -126.77 152.47 46.85 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 113.212 0.819 . . . . 73.400000000000006 113.212 -170.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 36' ' ' SER . 0.7 OUTLIER -59.46 118.15 5.69 Favored 'General case' 0 N--CA 1.403 -2.815 0 C-N-CA 124.758 1.223 . . . . 74.420000000000002 112.563 -176.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.87 -7.03 64.8 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.802 -0.713 . . . . 73.120000000000005 112.62 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -83.09 153.09 25.04 Favored 'General case' 0 C--O 1.252 1.193 0 C-N-CA 120.132 -0.627 . . . . 63.310000000000002 110.678 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.51 131.48 55.2 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.073 -0.967 . . . . 71.030000000000001 110.285 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.2 mt -105.76 115.93 48.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 104.868 -2.271 . . . . 70.420000000000002 104.868 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -104.95 131.67 52.16 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.567 -1.272 . . . . 74.409999999999997 107.567 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.61 103.61 9.15 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 107.858 -1.164 . . . . 74.420000000000002 107.858 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.57 -78.6 0.01 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.095 0.798 . . . . 62.210000000000001 115.095 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -134.05 8.96 3.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.788 1.235 . . . . 74.530000000000001 109.981 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.596 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 49.2 m-85 -102.1 143.19 32.25 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.463 -0.569 . . . . 75.420000000000002 109.463 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -119.55 118.65 31.6 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.158 -1.423 . . . . 73.549999999999997 107.158 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.7 mp -119.16 135.31 54.73 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.992 -0.744 . . . . 73.040000000000006 108.992 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.15 130.85 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.01 -1.107 . . . . 70.340000000000003 108.01 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -95.68 124.87 39.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 110.823 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -129.71 132.34 46.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.311 0.577 . . . . 73.510000000000005 110.531 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.66 118.24 33.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.063 -1.828 . . . . 63.109999999999999 106.063 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.7 0.03 OUTLIER Glycine 0 C--N 1.296 -1.664 0 C-N-CA 118.252 -1.927 . . . . 71.510000000000005 115.428 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.76 141.55 97.06 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 119.977 1.888 . . . . 75.150000000000006 111.179 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.27 79.18 1.68 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.321 -0.992 . . . . 72.409999999999997 108.321 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.389 -3.481 0 CA-C-N 114.627 -1.17 . . . . 74.420000000000002 108.862 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 108.581 -0.896 . . . . 71.519999999999996 108.581 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.83 115.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.592 -0.522 . . . . 75.150000000000006 109.592 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -122.33 137.95 54.68 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.343 -0.614 . . . . 73.140000000000001 109.343 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.09 97.37 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.368 -1.345 . . . . 75.040000000000006 107.368 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 22' ' ' LEU . . . -79.57 -165.84 0.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.312 -0.858 . . . . 65.209999999999994 112.821 -173.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.09 9.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.49 2.316 . . . . 73.329999999999998 114.3 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 20' ' ' ALA . 2.9 pp -56.37 -20.45 19.37 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.06 1.133 . . . . 73.230000000000004 114.06 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.84 -43.87 82.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.722 -0.473 . . . . 72.040000000000006 109.722 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -82.51 -21.16 35.58 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.4 -0.363 . . . . 75.519999999999996 111.621 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 22' ' ' LEU . 5.6 tp10 -56.81 -48.73 77.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.377 -1.342 . . . . 74.420000000000002 107.377 170.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.4 ttp -68.76 -47.89 65.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.555 -1.202 . . . . 72.239999999999995 110.482 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -52.53 -49.79 64.14 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.455 1.102 . . . . 75.140000000000001 111.987 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 t -84.47 -27.82 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.719 0.637 . . . . 75.430000000000007 112.719 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -82.93 -22.29 33.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.434 -0.906 . . . . 64.329999999999998 110.949 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.5 m -72.03 111.46 7.28 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.093 -0.706 . . . . 61.020000000000003 109.093 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.1 -32.89 1.26 Allowed Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 109.56 -1.416 . . . . 73.230000000000004 109.56 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -94.51 120.52 34.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 74.439999999999998 108.705 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.9 111.94 20.34 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.828 -0.804 . . . . 73.319999999999993 108.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.66 141.48 66.58 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 121.949 1.766 . . . . 72.120000000000005 113.118 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.25 162.67 31.17 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.032 -0.985 . . . . 72.25 108.607 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.2 m 61.76 20.02 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.095 0.958 . . . . 65.319999999999993 112.141 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.8 m -90.85 109.94 21.15 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.657 -1.238 . . . . 63.329999999999998 107.657 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.19 53.99 0.6 Allowed Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.051 -1.071 . . . . 52.450000000000003 113.364 -172.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 -6.94 53.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.209 1.004 . . . . 74.409999999999997 109.419 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.45 14.11 0.83 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.583 -1.19 . . . . 72.340000000000003 113.261 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.71 -5.9 23.26 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.838 -0.43 . . . . 73.109999999999999 109.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 68.38 94.82 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.606 0 O-C-N 124.691 1.244 . . . . 71.439999999999998 111.245 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.21 -74.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.672 1.582 . . . . 72.340000000000003 112.519 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.71 6.69 46.8 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.844 -0.535 . . . . 63.100000000000001 111.593 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.01 17.76 75.83 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 116.048 -0.524 . . . . 62.210000000000001 113.293 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -131.99 169.74 15.89 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.753 -1.203 . . . . 70.430000000000007 107.753 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.49 154.45 48.81 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.16 -0.616 . . . . 73.140000000000001 111.034 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.42 161.3 36.7 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 114.954 -1.021 . . . . 75.329999999999998 109.288 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -127.3 139.62 52.76 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.454 -0.573 . . . . 70.409999999999997 109.454 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.8 133.65 65.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.715 -0.846 . . . . 64.400000000000006 108.715 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.55 117.12 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.003 -1.851 . . . . 72.319999999999993 106.003 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -99.86 -31.0 11.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.904 -0.589 . . . . 71.129999999999995 110.745 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -137.43 132.0 32.78 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.96 -0.696 . . . . 72.299999999999997 109.323 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.43 175.11 13.94 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.594 -1.002 . . . . 73.420000000000002 110.594 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.545 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 19.2 Cg_endo -59.82 -39.62 70.77 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.68 2.253 . . . . 71.450000000000003 112.535 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -95.29 22.22 7.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.123 -0.49 . . . . 75.010000000000005 112.087 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.77 57.53 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.037 0.535 . . . . 63.399999999999999 110.889 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.31 -18.32 36.02 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.242 -1.143 . . . . 52.450000000000003 110.242 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.66 131.95 35.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.507 -0.347 . . . . 75.450000000000003 110.281 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -125.74 136.77 53.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.99 -0.744 . . . . 73.310000000000002 108.99 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -131.14 141.14 50.07 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.074 -0.713 . . . . 70.120000000000005 109.074 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.95 143.92 31.22 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.446 -0.576 . . . . 72.340000000000003 109.446 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.0 mt -97.4 118.72 34.51 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.971 0.415 . . . . 75.109999999999999 111.637 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.3 2.77 7.79 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -110.32 148.94 39.42 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-N 115.007 -0.997 . . . . 74.310000000000002 110.361 -174.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 -15.86 27.6 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.981 2.454 . . . . 64.430000000000007 113.446 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 91.8 m -152.84 124.29 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 121.753 -0.592 . . . . 71.540000000000006 110.853 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.9 m -121.41 113.98 20.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.733 -0.84 . . . . 74.349999999999994 108.733 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 88.0 m -88.51 137.77 32.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.983 -0.377 . . . . 61.350000000000001 109.983 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.04 134.89 54.55 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-O 121.415 0.626 . . . . 75.409999999999997 110.349 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.99 -135.87 6.29 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.252 -1.34 . . . . 64.340000000000003 110.019 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.687 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -117.74 124.54 48.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.977 -0.749 . . . . 74.230000000000004 108.977 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.1 151.39 0.11 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 107.801 -1.185 . . . . 74.430000000000007 107.801 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.73 -32.11 47.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.861 1.708 . . . . 71.530000000000001 111.496 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.07 -5.9 59.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.065 0.394 . . . . 74.329999999999998 112.065 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.7 m -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.119 -1.067 . . . . 73.230000000000004 108.119 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.4 -43.01 71.11 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 124.33 1.019 . . . . 74.25 110.58 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.2 pt -106.96 107.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.992 0.901 . . . . 75.400000000000006 110.388 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -95.12 128.77 42.21 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.956 -1.02 . . . . 71.239999999999995 110.009 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.3 mt -111.44 135.43 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.847 -1.909 . . . . 75.329999999999998 105.847 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.69 137.11 52.4 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.001 -0.679 . . . . 72.200000000000003 112.472 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 83' ' ' VAL . 30.2 t70 -160.69 -162.19 0.92 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.158 -1.423 . . . . 74.25 107.158 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.548 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 48.2 t -68.54 -42.88 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 108.906 -0.775 . . . . 75.420000000000002 108.906 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.2 m -156.14 101.09 2.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.776 -0.647 . . . . 74.129999999999995 109.852 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 t -102.9 149.69 7.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 106.589 -1.634 . . . . 74.150000000000006 106.589 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.0 t -68.87 143.49 54.5 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 123.376 0.423 . . . . 73.019999999999996 111.725 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.1 ptt180 -55.86 -28.4 56.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.701 1.2 . . . . 72.510000000000005 110.389 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.95 104.72 2.86 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.805 -1.089 . . . . 74.409999999999997 109.212 169.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -86.86 -51.63 5.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.835 -1.543 . . . . 64.129999999999995 106.835 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.97 159.23 41.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.659 -1.237 . . . . 73.150000000000006 107.659 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 11.6 pt-20 -142.13 154.37 44.83 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.327 0.584 . . . . 71.409999999999997 112.186 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 67' ' ' THR . 4.8 m-85 -104.29 127.83 51.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.204 -1.406 . . . . 72.129999999999995 107.204 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -121.06 125.1 46.43 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.943 -0.762 . . . . 74.430000000000007 108.943 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 94' ' ' ILE . 3.6 mp -113.63 111.59 36.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.539 -1.652 . . . . 72.239999999999995 106.539 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -139.81 129.45 24.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.135 -0.484 . . . . 74.420000000000002 110.481 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.72 36.44 27.25 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.722 1.209 . . . . 63.109999999999999 111.888 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.82 -0.76 87.93 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 113.197 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -101.27 136.72 40.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.182 -0.673 . . . . 74.340000000000003 109.182 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.87 118.04 34.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.222 -1.029 . . . . 72.129999999999995 108.222 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -127.5 146.94 50.33 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.156 -0.617 . . . . 73.439999999999998 109.938 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.57 123.72 68.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.783 -1.192 . . . . 72.430000000000007 107.783 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.7 134.77 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.728 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.83 132.79 38.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.968 -1.864 . . . . 74.420000000000002 105.968 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.96 18.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 112.341 0.496 . . . . 61.530000000000001 112.341 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.79 42.16 0.29 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.376 -1.392 . . . . 54.020000000000003 113.344 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.8 p -87.49 143.63 27.12 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.983 -1.087 . . . . 74.049999999999997 108.365 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.94 -19.77 17.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.299 0.571 . . . . 74.340000000000003 109.475 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -87.31 -19.66 27.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.274 -0.875 . . . . 73.439999999999998 111.207 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.7 120.19 4.41 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.313 -0.946 . . . . 74.129999999999995 114.163 174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.3 m -88.04 132.04 34.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.409 -0.589 . . . . 70.510000000000005 109.409 173.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -119.8 126.42 50.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.919 -0.488 . . . . 75.319999999999993 110.004 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.3 t -111.57 117.17 54.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 106.932 -1.507 . . . . 75.540000000000006 106.932 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 55.08 37.96 29.73 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 125.452 1.501 . . . . 73.040000000000006 110.003 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 67.53 16.08 9.88 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 113.776 -1.556 . . . . 74.420000000000002 112.475 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -103.76 138.48 19.54 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 107.465 -1.309 . . . . 74.230000000000004 107.465 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.49 124.36 14.94 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.097 1.864 . . . . 75.310000000000002 109.034 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -148.17 141.89 25.62 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.915 -0.714 . . . . 74.219999999999999 110.439 -172.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.19 -58.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.129 -1.063 . . . . 75.420000000000002 108.129 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.11 139.19 42.77 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.966 -0.458 . . . . 75.150000000000006 109.784 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.92 143.79 22.91 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.073 -0.714 . . . . 74.299999999999997 109.073 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.72 131.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 107.119 -1.438 . . . . 74.319999999999993 107.119 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 122' ' ' MET . 11.4 mmt -88.97 148.49 23.76 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.889 0.852 . . . . 72.409999999999997 112.671 -170.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.425 ' HG2' ' OD2' ' A' ' 126' ' ' ASP . 18.9 pt20 -119.55 157.07 29.12 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.885 -1.895 . . . . 73.549999999999997 105.885 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 133.55 54.86 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.425 -0.954 . . . . 70.409999999999997 108.425 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.93 0.49 56.22 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.589 -0.815 . . . . 75.120000000000005 112.743 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.425 ' OD2' ' HG2' ' A' ' 123' ' ' GLN . 34.0 m-20 -76.12 141.06 42.05 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.638 0.719 . . . . 74.209999999999994 111.636 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.8 127.79 55.91 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.019 -1.104 . . . . 64.230000000000004 108.019 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.9 mt -107.42 119.54 57.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.091 -1.448 . . . . 73.439999999999998 107.091 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 11.5 tm0? -106.37 117.39 33.91 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.95 -1.5 . . . . 75.230000000000004 106.95 -174.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.02 101.65 12.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.862 -1.162 . . . . 73.239999999999995 107.862 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.14 -73.52 0.13 Allowed Glycine 0 CA--C 1.536 1.405 0 CA-C-O 121.361 0.423 . . . . 72.109999999999999 113.615 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -145.44 16.53 1.49 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.452 1.101 . . . . 74.140000000000001 109.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.545 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 72.4 m-85 -109.38 148.59 30.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.145 -0.934 . . . . 74.409999999999997 109.494 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -128.53 119.78 25.48 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.168 -0.679 . . . . 73.439999999999998 109.168 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.0 mt -106.45 132.72 52.15 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.452 -1.685 . . . . 64.329999999999998 106.452 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.73 120.15 61.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.054 -1.091 . . . . 74.129999999999995 108.054 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -96.43 121.58 38.39 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.67 -0.863 . . . . 75.099999999999994 108.67 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.63 136.8 49.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.809 0.337 . . . . 72.209999999999994 110.296 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.16 119.38 29.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 105.382 -2.081 . . . . 73.349999999999994 105.382 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.26 -132.83 1.87 Allowed Glycine 0 N--CA 1.42 -2.431 0 C-N-CA 119.088 -1.53 . . . . 75.400000000000006 113.342 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.47 162.13 43.52 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.757 2.971 . . . . 73.200000000000003 114.235 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.39 69.79 1.41 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.792 -1.558 . . . . 65.430000000000007 106.792 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 . . . . . 0 N--CA 1.42 -1.974 0 CA-C-N 114.758 -1.11 . . . . 74.430000000000007 111.162 -175.231 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 105.785 -1.931 . . . . 73.019999999999996 105.785 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -89.89 112.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 107.452 -1.314 . . . . 65.010000000000005 107.452 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -125.53 141.35 52.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.616 -0.72 . . . . 74.150000000000006 109.349 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -81.5 112.85 19.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.068 -1.456 . . . . 72.019999999999996 107.068 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . -64.4 -168.44 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 115.317 1.599 . . . . 75.420000000000002 115.317 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.41 2.89 2.02 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.417 1.887 . . . . 70.109999999999999 111.536 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 3.9 pp -57.28 -21.14 32.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.476 1.51 . . . . 62.240000000000002 112.915 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.84 -34.54 78.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.349 0.26 . . . . 74.439999999999998 110.975 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.39 -40.31 8.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.112 -0.699 . . . . 74.109999999999999 109.112 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 13.1 tp10 -65.7 -24.94 67.1 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 114.34 -1.3 . . . . 74.310000000000002 114.016 -172.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.21 -50.36 69.61 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.873 0.761 . . . . 72.109999999999999 112.074 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.6 -31.92 69.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.125 0.488 . . . . 75.510000000000005 110.807 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -71.97 -26.37 62.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.656 -0.702 . . . . 74.049999999999997 110.751 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.52 -40.57 12.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.577 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.4 m -75.42 85.21 2.54 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.679 0.752 . . . . 71.030000000000001 112.402 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.57 26.17 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.132 -0.94 . . . . 53.299999999999997 111.194 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -83.9 123.9 30.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 123.378 0.671 . . . . 73.340000000000003 109.818 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.93 124.18 81.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 106.21 -1.774 . . . . 72.299999999999997 106.21 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.74 141.76 91.95 Favored 'Trans proline' 0 C--O 1.251 1.134 0 C-N-CA 121.939 1.759 . . . . 70.540000000000006 111.909 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.06 141.44 48.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.093 -0.958 . . . . 73.329999999999998 109.463 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.3 t -141.14 112.1 7.19 Favored 'General case' 0 N--CA 1.407 -2.61 0 CA-C-O 121.55 0.691 . . . . 73.420000000000002 109.962 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.09 36.41 0.98 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.687 -1.597 . . . . 73.450000000000003 106.687 174.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . 86.7 25.63 34.75 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.309 -2.316 . . . . 73.329999999999998 107.309 -169.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 139' ' ' ALA . . . -72.29 -47.6 48.76 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.715 -1.243 . . . . 65.319999999999993 113.618 -168.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -80.92 -2.35 47.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.614 0.721 . . . . 74.030000000000001 111.453 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.45 -25.39 20.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.868 -1.06 . . . . 75.409999999999997 108.626 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 57.37 85.49 0.19 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 114.732 -1.122 . . . . 71.400000000000006 111.284 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 45.3 Cg_endo -83.1 -73.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.443 2.095 . . . . 74.200000000000003 114.11 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.11 65.3 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.705 0.632 . . . . 63.240000000000002 112.705 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -11.85 71.02 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 111.083 -0.807 . . . . 64.329999999999998 111.083 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.3 m -114.7 169.84 8.77 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.939 -1.504 . . . . 64.400000000000006 106.939 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 138' ' ' LEU . . . -149.61 157.58 43.38 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.974 -0.38 . . . . 51.240000000000002 109.974 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.19 137.65 54.51 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.366 0.603 . . . . 63.329999999999998 110.324 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 pp -111.11 137.02 49.3 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 109.125 -0.694 . . . . 74.230000000000004 109.125 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.8 135.62 50.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 109.613 -0.514 . . . . 73.049999999999997 109.613 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 16.1 t -80.83 118.15 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.7 -1.222 . . . . 72.239999999999995 107.7 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -88.79 -35.95 16.35 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.182 -0.673 . . . . 73.109999999999999 109.182 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -148.1 141.93 25.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.299 -0.864 . . . . 73.519999999999996 109.282 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.79 174.78 13.57 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.397 -1.081 . . . . 72.140000000000001 110.397 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.541 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.8 Cg_exo -54.65 -44.68 47.26 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.602 2.201 . . . . 74.319999999999993 113.52 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -92.64 22.37 4.77 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.081 -1.012 . . . . 74.120000000000005 113.268 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -54.51 140.5 34.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.812 0.445 . . . . 71.5 112.036 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.37 -16.27 55.36 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.545 -0.622 . . . . 74.530000000000001 111.545 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.33 142.34 27.82 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.086 -0.246 . . . . 73.340000000000003 110.49 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -112.83 135.14 53.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.481 -0.933 . . . . 75.340000000000003 108.481 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.36 133.09 56.17 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.783 -0.451 . . . . 75.340000000000003 109.783 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.95 124.71 47.07 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.892 -0.594 . . . . 73.219999999999999 110.107 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.91 105.24 14.64 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.361 -1.348 . . . . 73.230000000000004 107.361 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -122.35 18.22 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.983 0.897 . . . . 73.319999999999993 109.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -133.17 157.67 77.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 65.329999999999998 109.516 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.59 -26.51 75.9 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.047 2.498 . . . . 62.229999999999997 114.079 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.6 m -147.55 121.8 9.58 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.329 -0.857 . . . . 75.540000000000006 111.182 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.0 m -109.87 135.32 50.94 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.862 -0.608 . . . . 62.109999999999999 109.943 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -106.39 141.52 37.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.69 135.28 54.56 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 109.781 -0.451 . . . . 74.5 109.781 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.89 -164.19 25.52 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.792 -1.323 . . . . 70.109999999999999 109.792 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 86.1 mtt180 -101.43 117.8 35.68 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.123 -1.066 . . . . 73.109999999999999 108.123 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 176.88 153.8 0.4 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.854 -1.906 . . . . 75.239999999999995 105.854 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.07 -15.76 51.1 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.924 1.749 . . . . 74.200000000000003 113.178 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.44 -1.28 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.607 0.595 . . . . 75.219999999999999 112.607 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -85.07 112.52 20.72 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.11 -1.036 . . . . 71.230000000000004 111.154 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.19 -36.95 74.98 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.133 -0.692 . . . . 70.420000000000002 109.133 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -100.66 98.73 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 122.253 1.025 . . . . 71.109999999999999 108.449 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -90.06 122.06 32.7 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.949 -1.023 . . . . 74.099999999999994 108.63 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.6 mt -123.87 122.18 37.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.154 -2.165 . . . . 71.319999999999993 105.154 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -130.67 117.53 19.61 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.198 -0.668 . . . . 72.120000000000005 109.198 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -128.78 -155.91 0.73 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.426 -0.953 . . . . 73.0 108.426 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.9 -41.74 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.24 0.616 . . . . 71.200000000000003 111.377 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -153.99 89.44 1.3 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.617 -0.677 . . . . 72.530000000000001 111.735 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.54 136.29 37.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.983 -0.747 . . . . 64.439999999999998 108.983 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.413 ' HB2' HD22 ' A' ' 107' ' ' LEU . 41.2 t -71.33 161.99 30.17 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 123.843 0.715 . . . . 74.5 111.186 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 27.9 ptt180 -65.4 -38.16 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 122.127 0.965 . . . . 74.420000000000002 109.374 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -136.14 112.96 10.23 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.491 -1.3 . . . . 75.409999999999997 107.491 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.628 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t-80 -99.62 -52.93 3.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.851 -0.613 . . . . 51.420000000000002 109.847 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.69 160.44 37.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.266 -0.574 . . . . 75.25 110.537 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.0 133.97 53.56 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.307 -0.861 . . . . 72.140000000000001 110.628 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -105.69 115.54 30.42 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.417 -1.698 . . . . 72.209999999999994 106.417 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -112.65 133.92 54.44 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.032 -0.667 . . . . 74.319999999999993 110.884 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.474 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.6 mp -104.48 121.13 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.022 -1.103 . . . . 74.409999999999997 108.022 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -123.84 116.64 23.29 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.29 -1.374 . . . . 74.409999999999997 107.29 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.98 37.83 14.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.777 0.831 . . . . 71.549999999999997 112.884 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.51 -2.49 87.38 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.097 -0.501 . . . . 71.519999999999996 114.172 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.81 138.9 39.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.729 0.765 . . . . 74.420000000000002 109.148 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' CD2' HG13 ' A' ' 94' ' ' ILE . 31.5 m-85 -108.52 122.77 47.76 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.61 -0.268 . . . . 72.319999999999993 111.246 -172.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -114.75 139.01 50.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.667 -0.864 . . . . 75.420000000000002 108.667 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.32 123.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.991 -1.115 . . . . 74.140000000000001 107.991 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.72 121.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.169 -1.419 . . . . 63.240000000000002 107.169 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.52 153.94 18.26 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.783 -1.191 . . . . 70.439999999999998 107.783 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 89' ' ' HIS . 18.7 m -78.79 -12.31 13.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 113.379 0.881 . . . . 70.329999999999998 113.379 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.23 17.58 0.02 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 119.086 -1.53 . . . . 54.43 116.019 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p 57.97 26.92 14.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.664 1.586 . . . . 73.450000000000003 111.496 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 86' ' ' SER . 0.0 OUTLIER -65.26 -35.31 80.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.961 -1.472 . . . . 73.299999999999997 112.926 -174.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.628 ' HB2' ' CD2' ' A' ' 89' ' ' HIS . 2.6 m120 -86.76 3.77 43.63 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 110.374 -0.232 . . . . 73.019999999999996 110.374 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.66 49.17 6.26 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.933 -1.267 . . . . 75.0 109.933 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -61.54 129.86 43.14 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 123.496 0.718 . . . . 71.219999999999999 110.977 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.2 125.64 43.97 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.326 -1.731 . . . . 73.540000000000006 106.326 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.14 124.77 61.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 106.694 -1.595 . . . . 65.400000000000006 106.694 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 4.3 t-20 57.81 37.64 27.1 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.543 1.163 . . . . 65.310000000000002 107.884 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.15 18.62 6.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.976 -1.466 . . . . 63.350000000000001 114.23 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -125.04 147.47 57.02 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.407 -0.96 . . . . 74.329999999999998 108.407 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.57 129.43 17.78 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 N-CA-C 108.528 -1.374 . . . . 73.400000000000006 108.528 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.44 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 13.0 tpp180 -148.38 150.19 33.11 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.636 -0.826 . . . . 74.400000000000006 110.143 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -93.81 -55.46 3.23 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.558 -0.534 . . . . 63.329999999999998 109.558 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.68 34.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.808 -0.812 . . . . 72.120000000000005 108.808 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 58.1 tp60 -153.85 143.19 21.5 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 123.145 0.278 . . . . 73.209999999999994 110.71 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.95 128.11 37.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.573 -1.64 . . . . 74.310000000000002 106.573 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 39.4 ttp -90.26 134.88 34.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.402 0.62 . . . . 75.299999999999997 111.357 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -104.07 152.19 22.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.23 -0.895 . . . . 72.5 110.67 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.25 130.71 41.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 C-N-CA 123.646 0.778 . . . . 64.510000000000005 111.979 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -0.44 63.0 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.099 -0.8 . . . . 73.540000000000006 111.099 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 28.3 t70 -89.44 153.65 20.66 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.45 -0.375 . . . . 75.150000000000006 111.565 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -115.92 131.19 57.01 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 121.525 0.679 . . . . 73.409999999999997 112.611 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.09 131.76 61.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 107.659 -1.237 . . . . 71.049999999999997 107.659 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.5 tm0? -109.97 130.74 55.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.727 -1.212 . . . . 62.130000000000003 107.727 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.431 HG22 ' CE1' ' A' ' 89' ' ' HIS . 4.1 mp -130.09 104.03 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.644 -0.873 . . . . 71.219999999999999 108.644 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.55 -96.45 0.18 Allowed Glycine 0 C--O 1.243 0.699 0 C-N-CA 121.052 -0.594 . . . . 73.409999999999997 112.565 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -113.43 -0.55 14.43 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.002 0.43 . . . . 74.239999999999995 110.219 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.541 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 87.1 m-85 -100.19 152.85 19.8 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.291 0.636 . . . . 64.140000000000001 111.479 -175.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -137.09 120.2 16.64 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.995 -1.113 . . . . 74.109999999999999 107.995 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.414 ' CD2' HG23 ' A' ' 51' ' ' VAL . 65.2 mt -105.25 140.39 38.47 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.468 0.707 . . . . 73.340000000000003 109.442 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.33 120.02 61.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.265 -1.754 . . . . 74.129999999999995 106.265 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -97.74 119.63 36.67 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 112.128 0.418 . . . . 71.310000000000002 112.128 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 95.5 mt -129.34 153.91 47.4 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.853 -0.795 . . . . 70.439999999999998 108.853 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 39' ' ' ALA . . . -75.95 162.01 28.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.869 -0.332 . . . . 63.049999999999997 110.927 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.2 168.23 41.88 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.417 -0.81 . . . . 55.420000000000002 112.108 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HB2' ' CG ' ' A' ' 143' ' ' GLU . 12.0 Cg_endo -54.72 145.29 61.0 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 123.768 2.979 . . . . 74.530000000000001 115.455 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 43.39 1.07 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.546 -1.207 . . . . 74.549999999999997 110.384 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 141' ' ' PRO . 2.9 pt-20 . . . . . 0 N--CA 1.413 -2.307 0 C-N-CA 123.651 0.78 . . . . 75.549999999999997 109.385 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.653 -0.499 . . . . 53.340000000000003 109.653 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.0 t -83.24 116.57 27.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.544 -0.539 . . . . 64.349999999999994 109.544 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -123.87 140.12 53.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.73 -0.47 . . . . 74.540000000000006 109.73 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttp85 -96.21 108.53 21.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.114 -1.069 . . . . 75.099999999999994 108.114 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 22' ' ' LEU . . . -77.7 -173.84 3.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.574 -0.739 . . . . 60.130000000000003 110.989 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -72.91 6.83 2.34 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.701 0.8 . . . . 64.310000000000002 111.497 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' H ' ' C ' ' A' ' 20' ' ' ALA . 2.4 pp -57.25 -26.21 60.39 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.222 1.409 . . . . 71.109999999999999 113.942 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.4 tp -72.28 -22.52 61.2 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.87 0.843 . . . . 74.530000000000001 109.616 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.16 -32.53 12.44 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.595 -0.73 . . . . 73.230000000000004 109.572 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -56.93 -38.97 73.64 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.119 -0.492 . . . . 73.120000000000005 111.086 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 ptp -62.4 -25.94 68.21 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 120.792 -0.363 . . . . 71.420000000000002 111.558 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -87.53 -49.65 7.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.948 0.404 . . . . 75.120000000000005 110.077 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -61.21 -41.98 97.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.793 -0.64 . . . . 53.43 111.145 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -82.92 -16.98 45.31 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.881 -0.414 . . . . 74.129999999999995 109.881 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m 67.29 101.75 0.05 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.773 1.229 . . . . 65.109999999999999 113.964 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.58 -141.38 48.02 Favored Glycine 0 CA--C 1.499 -0.963 0 CA-C-N 115.485 -0.779 . . . . 62.009999999999998 112.69 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t -115.77 149.39 38.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.608 -0.516 . . . . 75.0 109.608 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 110.97 40.6 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.323 -0.992 . . . . 73.420000000000002 108.323 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.78 145.2 90.56 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.859 2.373 . . . . 72.019999999999996 113.616 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.23 162.45 13.19 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.904 -0.589 . . . . 71.5 110.102 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 123' ' ' GLN . 18.3 m -94.26 116.0 28.33 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.168 0.509 . . . . 72.340000000000003 110.551 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.2 m -69.38 100.04 1.3 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.551 -0.75 . . . . 73.120000000000005 109.403 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 41' ' ' ASN . . . -152.31 43.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.273 -0.965 . . . . 71.239999999999995 112.993 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.47 -39.83 13.92 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.622 -1.251 . . . . 74.319999999999993 107.622 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.46 -1.81 25.83 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.328 -1.306 . . . . 71.120000000000005 111.387 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.428 ' OD1' ' HA2' ' A' ' 38' ' ' GLY . 11.0 m120 -82.8 -30.55 28.74 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.481 -0.782 . . . . 74.540000000000006 109.29 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt 48.06 81.33 0.26 Allowed Pre-proline 0 C--N 1.345 0.371 0 O-C-N 124.229 0.956 . . . . 72.109999999999999 112.049 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.79 -61.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 111.891 -176.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.67 -12.97 5.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.956 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.83 1.46 85.06 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.087 -1.054 . . . . 64.329999999999998 111.176 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 m -115.02 156.56 24.9 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.23 -1.396 . . . . 61.32 107.23 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -148.11 154.53 40.31 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.708 -0.478 . . . . 73.120000000000005 109.708 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 152.37 44.5 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.92 -0.4 . . . . 73.420000000000002 109.92 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.01 132.46 52.01 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.46 -0.941 . . . . 74.329999999999998 108.46 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 p -108.82 137.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.644 -0.502 . . . . 74.129999999999995 109.644 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' A' ' 135' ' ' LEU . 10.5 t -86.09 118.27 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 107.997 -1.112 . . . . 72.400000000000006 107.997 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -93.42 -31.71 14.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.356 -0.838 . . . . 71.540000000000006 109.953 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -147.11 138.5 24.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.988 -0.745 . . . . 74.450000000000003 108.988 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.06 171.05 12.93 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.155 -1.178 . . . . 72.430000000000007 110.155 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.662 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.1 Cg_exo -54.64 -29.99 63.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.598 2.199 . . . . 63.409999999999997 113.714 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.43 8.47 33.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.502 -0.479 . . . . 72.329999999999998 112.199 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.95 131.61 45.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.86 0.362 . . . . 72.299999999999997 111.515 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -23.94 24.44 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 115.588 -0.733 . . . . 71.120000000000005 112.295 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 152.54 20.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.754 0.277 . . . . 74.329999999999998 110.768 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.75 137.12 48.07 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.764 -0.828 . . . . 72.540000000000006 108.764 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -115.24 139.51 49.88 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.614 -0.513 . . . . 63.130000000000003 109.614 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.3 127.94 42.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.947 -1.131 . . . . 75.439999999999998 107.947 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.75 113.21 26.18 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.485 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.18 3.47 4.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.24 1.019 . . . . 74.230000000000004 108.582 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.41 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.4 pm0 -106.45 137.09 19.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-N 115.056 -0.975 . . . . 74.230000000000004 109.123 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.25 -21.58 67.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.309 2.673 . . . . 71.140000000000001 113.764 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -137.23 122.68 19.55 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.322 -0.622 . . . . 74.540000000000006 109.322 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.0 m -129.89 112.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.91 -0.774 . . . . 72.140000000000001 108.91 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 m -88.53 140.59 29.31 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.394 -0.595 . . . . 71.310000000000002 109.394 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.52 135.2 55.14 Favored 'General case' 0 C--O 1.268 2.039 0 N-CA-C 109.09 -0.707 . . . . 72.219999999999999 109.09 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -136.0 4.81 Favored Glycine 0 N--CA 1.422 -2.298 0 O-C-N 123.916 0.76 . . . . 71.120000000000005 112.833 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.581 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 24.8 mmm180 -118.67 152.94 35.17 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 125.486 1.514 . . . . 72.239999999999995 109.552 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.427 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 27.0 t-80 82.57 142.87 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 125.31 1.444 . . . . 74.319999999999993 109.209 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 9.8 Cg_endo -52.63 -6.77 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 124.14 3.227 . . . . 71.010000000000005 115.538 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.5 -12.89 59.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.353 0.597 . . . . 74.040000000000006 110.086 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -88.19 134.91 33.66 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.358 -0.979 . . . . 52.229999999999997 108.358 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -76.99 -42.2 39.8 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.169 -1.049 . . . . 74.120000000000005 108.169 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.7 mm -97.46 104.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 106.469 -1.678 . . . . 65.329999999999998 106.469 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -87.62 108.81 19.25 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.49 -0.777 . . . . 64.420000000000002 109.431 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 82.3 mt -95.7 141.05 29.65 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.742 -1.577 . . . . 73.530000000000001 106.742 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.581 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 18.3 t70 -103.94 117.46 34.36 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.152 -0.619 . . . . 75.120000000000005 110.499 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -151.22 174.98 12.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.643 -1.243 . . . . 73.409999999999997 107.643 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.48 -34.25 10.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.585 -0.894 . . . . 71.209999999999994 108.585 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.553 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 m -74.61 125.23 28.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.02 -0.991 . . . . 52.310000000000002 109.711 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.5 98.01 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 119.618 -0.833 . . . . 71.129999999999995 109.109 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.413 ' HG ' ' HB2' ' A' ' 89' ' ' HIS . 14.1 t -107.01 90.5 3.32 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.457 -1.312 . . . . 72.540000000000006 107.457 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -57.92 -31.9 67.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.544 -1.207 . . . . 74.409999999999997 111.384 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -145.12 93.43 2.39 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.411 -0.959 . . . . 73.409999999999997 108.411 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.489 ' CE1' HG23 ' A' ' 130' ' ' ILE . 39.7 t-80 -96.58 -53.58 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.704 -0.798 . . . . 73.519999999999996 109.691 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.32 160.62 38.71 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 109.194 -0.669 . . . . 75.0 109.194 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.02 143.94 36.67 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.331 0.586 . . . . 73.450000000000003 110.138 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -104.94 122.16 45.24 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.027 -2.212 . . . . 74.120000000000005 105.027 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -115.81 142.84 46.23 Favored 'General case' 0 C--N 1.273 -2.72 0 C-N-CA 119.618 -0.833 . . . . 73.340000000000003 109.256 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.7 mp -113.95 112.97 42.46 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 104.219 -2.511 . . . . 70.219999999999999 104.219 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.63 122.7 25.1 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.766 -0.457 . . . . 65.439999999999998 109.766 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 56.03 38.0 29.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.146 0.904 . . . . 72.540000000000006 111.571 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.91 -7.84 75.68 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.248 -0.887 . . . . 74.510000000000005 113.925 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -101.79 150.28 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.151 0.475 . . . . 65.25 109.844 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.29 126.4 53.31 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.774 -0.825 . . . . 74.519999999999996 108.774 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.9 147.84 52.59 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.647 0.26 . . . . 65.340000000000003 111.174 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 122' ' ' MET . 25.6 t -112.59 122.69 67.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.942 -1.503 . . . . 74.239999999999995 106.942 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.88 122.33 68.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.198 0.523 . . . . 62.009999999999998 111.147 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.9 136.93 32.75 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 123.787 0.835 . . . . 63.329999999999998 110.553 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.57 5.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.813 -0.63 . . . . 75.219999999999999 110.463 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.78 58.83 0.57 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.99 -0.624 . . . . 62.43 111.835 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -60.03 -11.65 6.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.783 1.233 . . . . 74.400000000000006 112.563 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.4 -20.48 65.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.992 0.917 . . . . 74.420000000000002 110.847 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.66 -5.5 58.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 64.519999999999996 110.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.35 66.15 1.72 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.789 -0.641 . . . . 43.009999999999998 112.178 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 m -73.9 127.44 32.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.079 0.466 . . . . 75.400000000000006 110.844 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -136.62 141.42 43.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 109.827 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.17 119.57 58.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 106.905 -1.517 . . . . 71.140000000000001 106.905 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 127' ' ' GLU . 87.7 m-20 56.58 39.38 29.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.792 0.837 . . . . 63.229999999999997 110.699 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.492 ' HG2' HH11 ' A' ' 114' ' ' ARG . 0.0 OUTLIER 65.32 15.21 9.9 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 113.066 0.765 . . . . 74.329999999999998 113.066 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -112.43 133.99 21.68 Favored Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 123.062 0.545 . . . . 74.5 109.761 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.52 123.28 10.91 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 108.161 -1.515 . . . . 72.239999999999995 108.161 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -153.03 137.3 16.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.716 -1.216 . . . . 75.209999999999994 107.716 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -107.91 -56.53 2.22 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.114 -0.635 . . . . 73.329999999999998 110.657 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.7 132.72 54.38 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.127 -1.064 . . . . 72.400000000000006 108.127 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.61 150.55 26.52 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 112.682 0.623 . . . . 70.409999999999997 112.682 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.61 132.4 33.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 104.926 -2.25 . . . . 71.219999999999999 104.926 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.423 ' HB2' HG21 ' A' ' 101' ' ' VAL . 33.1 ttp -88.97 129.12 35.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.107 -0.637 . . . . 71.239999999999995 109.938 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 36' ' ' SER . 61.9 mt-30 -118.34 156.56 28.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.738 -1.119 . . . . 63.439999999999998 109.133 -173.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -71.21 130.21 40.86 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.463 -0.94 . . . . 74.230000000000004 108.463 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.44 -4.1 56.68 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.788 -0.642 . . . . 44.43 113.057 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.27 137.33 54.63 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 117.952 0.876 . . . . 71.099999999999994 110.444 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 12.6 pt-20 -112.69 126.32 55.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.575 -1.269 . . . . 74.209999999999994 107.575 172.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.98 117.03 54.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.652 0 N-CA-C 107.878 -1.156 . . . . 74.310000000000002 107.878 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -105.33 123.87 48.58 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.553 0.692 . . . . 74.209999999999994 112.111 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.489 HG23 ' CE1' ' A' ' 89' ' ' HIS . 10.3 mm -109.87 101.95 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 105.53 -2.026 . . . . 74.239999999999995 105.53 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 56.34 -98.15 0.06 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 120.789 -0.72 . . . . 72.109999999999999 112.112 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -97.53 -24.0 15.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.808 0.443 . . . . 73.430000000000007 111.34 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.662 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 65.5 m-85 -75.31 148.47 39.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 122.769 0.428 . . . . 72.140000000000001 110.25 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -138.37 120.12 15.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.529 -0.915 . . . . 71.450000000000003 108.529 170.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.7 mm? -103.36 139.86 38.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.68 -0.859 . . . . 74.530000000000001 108.68 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.7 t -116.37 123.2 71.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.24 -1.022 . . . . 73.040000000000006 108.24 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.444 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 94.3 t80 -94.68 129.86 41.4 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.978 -0.555 . . . . 64.120000000000005 111.252 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.93 132.04 53.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.158 -1.053 . . . . 62.310000000000002 108.158 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.42 131.4 53.66 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.45 -0.5 . . . . 63.299999999999997 111.099 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.66 46.29 2.33 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 117.506 1.762 . . . . 55.310000000000002 117.506 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.18 155.67 56.26 Favored 'Trans proline' 0 C--N 1.363 1.336 0 CA-C-N 121.108 2.454 . . . . 74.25 109.718 169.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.69 83.59 0.96 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.253 0.549 . . . . 72.519999999999996 110.426 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.172 -1.418 . . . . 72.430000000000007 107.172 177.272 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 108' ' ' ASN . 16.2 m . . . . . 0 N--CA 1.429 -1.521 0 CA-C-O 121.136 0.493 . . . . 73.340000000000003 112.176 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.15 115.92 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 104.903 -2.258 . . . . 72.430000000000007 104.903 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -81.6 113.59 19.72 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.543 0.687 . . . . 72.530000000000001 110.802 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.92 120.63 42.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.664 -1.236 . . . . 74.120000000000005 107.664 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.49 -178.09 7.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.996 0.427 . . . . 65.0 110.009 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -83.97 -4.47 58.74 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.803 0.811 . . . . 63.0 109.862 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.34 -4.53 58.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.034 -0.985 . . . . 72.129999999999995 111.748 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.59 -33.39 68.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.111 -0.7 . . . . 71.450000000000003 109.111 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -71.81 -22.41 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.518 -0.765 . . . . 70.140000000000001 110.126 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.88 -30.85 40.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.419 -0.585 . . . . 72.150000000000006 109.419 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.415 ' O ' ' HB ' ' A' ' 30' ' ' THR . 32.7 ttm -66.95 -12.11 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.64 1.21 . . . . 71.019999999999996 108.915 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.73 -38.07 8.84 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.899 -1.046 . . . . 74.349999999999994 109.894 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -88.8 -46.38 9.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.905 1.076 . . . . 75.519999999999996 113.905 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -90.17 -20.26 23.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 119.478 -0.889 . . . . 74.349999999999994 112.006 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 26' ' ' MET . 5.7 m -80.53 65.48 5.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.906 0.86 . . . . 64.200000000000003 109.669 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.92 5.4 2.23 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.135 -1.186 . . . . 72.239999999999995 110.135 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -110.66 121.96 46.61 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.134 -1.062 . . . . 73.549999999999997 108.134 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.16 120.96 83.98 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.979 -0.378 . . . . 74.219999999999999 109.979 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.43 150.88 87.39 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.702 2.268 . . . . 70.120000000000005 111.368 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.18 141.66 31.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.38 -0.6 . . . . 72.019999999999996 109.38 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.8 m -80.1 117.57 21.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.92 -0.4 . . . . 72.510000000000005 109.92 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.7 p -82.26 -49.85 9.63 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.903 -0.59 . . . . 72.019999999999996 110.186 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.49 114.58 2.32 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.401 -0.818 . . . . 55.509999999999998 111.894 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.85 -7.79 45.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 120.923 0.392 . . . . 62.039999999999999 110.315 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -5.3 21.11 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.678 1.362 . . . . 75.420000000000002 114.678 -168.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.03 -32.43 18.79 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.373 -0.531 . . . . 73.040000000000006 110.98 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 48.26 68.85 3.12 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 124.079 0.862 . . . . 73.030000000000001 111.069 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.44 -58.25 0.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 125.113 3.875 . . . . 74.109999999999999 114.556 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.31 17.15 4.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.329 -0.989 . . . . 71.219999999999999 108.329 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.77 -12.4 29.19 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 114.623 -1.171 . . . . 73.340000000000003 112.583 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -118.99 164.84 14.88 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.993 -0.373 . . . . 72.430000000000007 109.993 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.25 156.98 40.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.911 -1.515 . . . . 71.420000000000002 106.911 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.43 145.78 51.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.141 0.496 . . . . 74.219999999999999 111.746 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -106.32 142.68 35.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.491 -0.929 . . . . 73.209999999999994 108.491 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.66 132.24 71.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.434 -0.58 . . . . 75.319999999999993 109.434 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.56 118.3 22.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.244 -1.391 . . . . 71.230000000000004 107.244 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -89.79 -34.82 16.02 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.618 -0.719 . . . . 74.299999999999997 110.756 -174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 43.1 ttt180 -137.96 150.95 47.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.275 -1.38 . . . . 74.120000000000005 107.275 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.96 -178.2 16.48 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.471 -0.871 . . . . 61.119999999999997 112.338 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.58 -29.08 13.6 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.889 2.393 . . . . 64.299999999999997 111.782 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -97.08 18.99 13.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.827 -0.624 . . . . 74.409999999999997 110.955 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.35 139.22 58.74 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.415 -0.357 . . . . 74.010000000000005 111.168 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.83 -18.15 50.82 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.644 -0.582 . . . . 71.140000000000001 111.644 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.12 138.78 33.54 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 120.494 0.188 . . . . 72.340000000000003 110.719 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -122.78 145.91 48.0 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.398 -0.593 . . . . 74.150000000000006 109.398 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.28 142.68 47.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.519 -0.919 . . . . 70.530000000000001 108.519 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.29 143.84 26.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.315 0.579 . . . . 74.129999999999995 112.434 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.29 104.78 12.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.451 -0.795 . . . . 75.200000000000003 108.956 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -168.59 61.1 0.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 75.439999999999998 107.473 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -146.8 157.3 47.47 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 113.126 -1.852 . . . . 74.200000000000003 107.473 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.09 -35.52 97.92 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.812 1.675 . . . . 73.230000000000004 112.614 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 m -154.53 122.44 5.89 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.195 0.522 . . . . 74.329999999999998 111.814 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -108.48 116.92 32.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.402 -0.962 . . . . 71.530000000000001 108.402 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 p -90.4 133.02 35.28 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.938 -0.476 . . . . 74.430000000000007 110.851 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.87 134.68 55.16 Favored 'General case' 0 C--O 1.253 1.259 0 N-CA-C 109.631 -0.507 . . . . 75.230000000000004 109.631 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.96 -158.72 31.83 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.733 -1.347 . . . . 73.140000000000001 109.733 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 62.1 ttt180 -95.89 150.52 20.34 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.241 -0.651 . . . . 75.530000000000001 109.241 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 85.05 151.55 0.1 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.331 1.452 . . . . 72.230000000000004 111.881 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 -0.12 3.49 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.68 2.92 . . . . 74.340000000000003 114.97 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.73 -9.93 57.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.566 0.698 . . . . 75.049999999999997 110.285 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 m -90.86 136.94 32.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.02 -1.845 . . . . 61.43 106.02 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.19 -38.57 91.67 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.892 -0.781 . . . . 71.239999999999995 108.892 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.9 mm -98.91 119.46 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.106 -1.442 . . . . 74.030000000000001 107.106 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -90.17 118.01 29.37 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.798 0.332 . . . . 64.409999999999997 111.595 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 5.2 mp -124.98 134.75 52.48 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.757 -1.572 . . . . 75.340000000000003 106.757 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -131.67 123.45 27.83 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.324 -0.551 . . . . 74.319999999999993 111.346 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -149.79 172.79 14.55 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.045 -1.465 . . . . 75.439999999999998 107.045 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.96 -31.19 52.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.165 -0.68 . . . . 75.030000000000001 109.165 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -62.29 121.12 12.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.403 0.621 . . . . 74.400000000000006 110.719 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.34 125.32 39.84 Favored 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.209 -0.905 . . . . 73.420000000000002 109.6 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 m -159.08 106.06 1.78 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.353 0.661 . . . . 70.049999999999997 110.541 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -64.38 -46.0 85.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 120.701 -0.4 . . . . 74.409999999999997 111.635 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -141.3 131.03 24.16 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.494 -1.669 . . . . 73.430000000000007 106.494 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -99.83 -52.18 3.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.806 -0.812 . . . . 71.430000000000007 108.806 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.26 155.29 36.3 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.279 -0.873 . . . . 74.209999999999994 109.167 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.5 135.55 54.68 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 116.001 -0.545 . . . . 73.430000000000007 109.591 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 33.8 m-85 -105.04 113.23 26.7 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.021 -1.844 . . . . 73.230000000000004 106.021 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.35 132.82 53.76 Favored 'General case' 0 C--N 1.269 -2.922 0 N-CA-C 108.279 -1.008 . . . . 74.030000000000001 108.279 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.7 111.9 35.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.072 -2.196 . . . . 75.340000000000003 105.072 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -124.93 118.47 26.34 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.615 -1.175 . . . . 70.400000000000006 109.752 -169.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 53.96 36.9 25.54 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.38 1.072 . . . . 73.510000000000005 111.347 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 0.58 90.27 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.68 -0.691 . . . . 72.030000000000001 113.707 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -102.49 150.27 23.55 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.691 -0.855 . . . . 73.519999999999996 108.691 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -104.51 117.01 33.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.912 -1.144 . . . . 74.140000000000001 107.912 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -124.78 134.75 52.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.5 0.667 . . . . 74.150000000000006 110.845 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.03 124.98 57.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 106.735 -1.58 . . . . 64.540000000000006 106.735 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.38 122.84 70.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 107.042 -1.466 . . . . 61.130000000000003 107.042 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -96.63 144.79 26.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 115.189 -0.914 . . . . 75.049999999999997 109.741 -178.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.03 -9.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.55 -0.46 . . . . 75.109999999999999 112.037 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.45 92.52 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 119.78 -1.2 . . . . 70.329999999999998 112.367 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.1 m -58.23 -22.03 50.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.172 0.589 . . . . 63.130000000000003 111.802 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -18.83 62.03 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.965 0.906 . . . . 74.340000000000003 112.997 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' SER . 6.3 t30 -85.79 -0.55 55.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.786 0.803 . . . . 74.530000000000001 108.855 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.74 44.27 1.82 Allowed Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.521 -0.763 . . . . 73.0 113.059 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m -87.02 126.93 35.06 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.26 -0.645 . . . . 63.329999999999998 109.26 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 69.7 m-85 -137.44 131.62 32.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.839 -0.43 . . . . 75.109999999999999 109.839 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.16 116.36 50.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.058 -2.201 . . . . 73.5 105.058 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 55.96 40.55 30.41 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.065 0.946 . . . . 65.540000000000006 109.729 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.0 8.55 5.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.026 1.33 . . . . 72.150000000000006 113.698 -175.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.6 128.24 27.82 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.752 -0.593 . . . . 72.140000000000001 109.408 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.26 136.27 63.33 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.639 1.559 . . . . 74.409999999999997 108.854 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -151.47 131.95 13.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.461 -0.896 . . . . 74.319999999999993 109.891 -173.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 2.9 t-20 -98.91 -31.41 11.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 122.043 0.925 . . . . 63.32 109.878 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -141.14 135.69 31.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.061 -1.459 . . . . 71.319999999999993 107.061 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -144.71 144.56 31.27 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.016 0.197 . . . . 73.329999999999998 111.492 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 80.6 t -94.49 117.53 38.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 105.092 -2.188 . . . . 74.530000000000001 105.092 171.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 40.6 ttp -89.85 129.27 36.24 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.415 0.626 . . . . 62.530000000000001 111.296 -170.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.58 157.1 43.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.842 -1.072 . . . . 70.439999999999998 109.522 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -62.53 134.19 56.03 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.568 0.543 . . . . 74.109999999999999 109.805 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.05 -8.64 61.12 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.409 -0.901 . . . . 65.310000000000002 111.933 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 140.15 32.5 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.072 0.463 . . . . 71.209999999999994 110.046 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -114.12 134.78 54.65 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.446 -0.797 . . . . 73.010000000000005 109.563 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.3 mt -112.1 118.3 57.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 107.676 -1.231 . . . . 75.510000000000005 107.676 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -104.84 117.05 33.09 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.901 -1.889 . . . . 73.099999999999994 105.901 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.78 103.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.446 -0.797 . . . . 72.530000000000001 109.447 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.45 -84.44 0.44 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.107 -0.951 . . . . 64.200000000000003 112.272 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -125.35 -18.34 5.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.638 0.256 . . . . 72.450000000000003 111.192 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 48.4 p90 -121.14 150.33 41.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 112.924 0.713 . . . . 74.230000000000004 112.924 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 8.2 ptm180 -112.52 142.14 45.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.547 -0.752 . . . . 75.0 112.236 -170.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.2 139.17 54.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.911 -1.514 . . . . 72.329999999999998 106.911 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.42 134.95 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.163 -0.68 . . . . 73.310000000000002 109.163 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -97.43 119.63 36.33 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.777 -0.453 . . . . 65.230000000000004 109.777 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.42 131.14 55.59 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.651 -0.5 . . . . 74.430000000000007 109.651 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.47 135.75 33.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.751 -0.833 . . . . 74.030000000000001 108.751 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.72 163.93 15.6 Favored Glycine 0 N--CA 1.421 -2.329 0 N-CA-C 107.637 -2.185 . . . . 73.329999999999998 107.637 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.86 141.76 72.81 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 CA-C-N 119.725 1.762 . . . . 72.409999999999997 113.167 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -118.67 26.53 9.5 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.559 -1.645 . . . . 70.109999999999999 106.559 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.417 -2.099 0 CA-C-N 113.242 -1.799 . . . . 70.150000000000006 107.693 -178.152 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 108.839 -0.8 . . . . 74.549999999999997 108.839 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -83.11 115.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.453 -0.573 . . . . 71.310000000000002 109.453 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -99.54 105.35 17.23 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.603 -0.888 . . . . 75.109999999999999 108.603 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -126.96 124.92 40.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.58 0.705 . . . . 75.140000000000001 112.851 -176.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.91 -37.56 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.002 1.321 . . . . 64.099999999999994 107.885 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.74 -17.14 0.49 Allowed 'General case' 0 C--O 1.203 -1.367 0 CA-C-N 112.734 -2.03 . . . . 74.219999999999999 114.756 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.1 -41.8 88.98 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 118.156 0.434 . . . . 73.209999999999994 110.818 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.43 -36.28 45.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.569 . . . . 72.349999999999994 109.465 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -60.14 -44.09 95.22 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.11 -0.95 . . . . 61.399999999999999 108.951 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -43.12 64.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.583 -1.19 . . . . 75.019999999999996 111.149 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.15 -36.78 71.16 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.172 0.51 . . . . 74.319999999999993 110.621 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.97 -26.35 68.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.499 -0.773 . . . . 72.319999999999993 110.4 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -98.41 -36.59 9.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.557 -0.292 . . . . 61.329999999999998 111.29 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -75.33 -23.96 57.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.356 0.502 . . . . 70.030000000000001 112.356 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.1 m -66.1 114.87 5.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.332 0.587 . . . . 63.340000000000003 110.689 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.0 -70.23 0.27 Allowed Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.07 -1.612 . . . . 65.430000000000007 109.07 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -115.56 138.36 51.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.168 0.508 . . . . 73.409999999999997 111.638 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.32 154.21 37.57 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.588 -0.893 . . . . 65.0 108.588 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.2 150.97 62.65 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.512 2.141 . . . . 74.310000000000002 111.762 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.14 143.77 25.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.654 0.264 . . . . 63.240000000000002 110.517 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 p -85.15 95.16 9.05 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.865 -0.791 . . . . 61.219999999999999 108.865 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.0 p -84.77 -173.08 4.53 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.781 -0.645 . . . . 62.450000000000003 110.821 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.84 3.99 67.49 Favored Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.024 -1.231 . . . . 63.109999999999999 110.024 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 139' ' ' ALA . . . -68.57 -19.18 64.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.076 -1.062 . . . . 64.430000000000007 110.375 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.1 -5.72 37.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.395 0.617 . . . . 72.140000000000001 111.506 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.89 -12.81 23.0 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.58 -0.896 . . . . 64.120000000000005 108.58 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.87 74.07 0.56 Allowed Pre-proline 0 C--O 1.221 -0.408 0 CA-C-N 114.501 -1.227 . . . . 72.239999999999995 109.268 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.42 -57.92 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.235 1.956 . . . . 73.510000000000005 114.104 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.9 -20.21 20.88 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.961 0.726 . . . . 74.329999999999998 112.961 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.78 -4.62 83.58 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 119.978 -1.106 . . . . 54.439999999999998 111.383 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.8 m -115.48 163.74 15.31 Favored 'General case' 0 C--O 1.254 1.337 0 N-CA-C 107.9 -1.148 . . . . 71.319999999999993 107.9 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.15 158.32 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.405 -0.185 . . . . 74.439999999999998 111.176 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 48' ' ' LEU . 3.7 pp -131.08 137.19 49.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.14 0.495 . . . . 70.150000000000006 110.177 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.442 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.1 pp -117.03 136.84 52.65 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.369 -0.604 . . . . 64.420000000000002 109.369 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.75 130.92 71.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.866 -0.42 . . . . 73.510000000000005 109.866 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 t -79.37 123.12 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.913 -1.143 . . . . 74.310000000000002 107.913 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -99.24 -30.28 12.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.259 0.552 . . . . 72.109999999999999 110.033 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -136.53 127.73 28.07 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.485 -0.561 . . . . 71.329999999999998 109.485 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 136.3 175.64 13.93 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.8 -1.32 . . . . 73.510000000000005 109.8 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.57 -31.66 79.84 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 122.428 2.085 . . . . 74.239999999999995 111.817 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.29 12.78 15.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 75.519999999999996 110.897 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.54 132.18 50.45 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.928 0.394 . . . . 71.200000000000003 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -27.4 14.67 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.553 -1.019 . . . . 74.019999999999996 110.553 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.72 142.63 28.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.695 -0.483 . . . . 72.230000000000004 109.695 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -122.46 137.3 54.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.894 -0.594 . . . . 71.319999999999993 110.632 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.35 145.54 43.98 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.426 -0.953 . . . . 73.120000000000005 108.426 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.37 133.99 50.21 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.251 0.834 . . . . 72.540000000000006 113.251 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.51 104.38 16.4 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.91 -1.885 . . . . 71.019999999999996 105.91 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.59 -0.43 2.16 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.916 0.865 . . . . 50.310000000000002 110.561 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.26 150.81 41.01 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.776 -0.824 . . . . 72.319999999999993 108.776 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.84 -30.17 46.28 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.417 2.745 . . . . 61.549999999999997 113.497 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -146.17 121.78 10.45 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.716 -0.615 . . . . 64.0 110.26 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 m -118.15 114.19 22.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.551 -0.295 . . . . 74.150000000000006 110.739 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m -87.32 130.18 34.72 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 110.275 -0.269 . . . . 74.219999999999999 110.275 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.63 139.68 53.67 Favored 'General case' 0 C--O 1.272 2.247 0 CA-C-O 121.609 0.719 . . . . 73.010000000000005 112.289 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.24 -160.62 31.43 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.27 -1.532 . . . . 74.5 109.27 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -118.87 116.74 27.12 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.214 -1.773 . . . . 70.420000000000002 106.214 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.631 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.7 t-160 166.87 151.0 0.08 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 104.527 -2.397 . . . . 73.109999999999999 104.527 -173.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.631 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 28.1 Cg_endo -64.52 -14.28 43.49 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.246 1.964 . . . . 74.420000000000002 112.281 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.86 -11.15 48.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 112.093 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -72.55 136.65 45.87 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.886 -0.783 . . . . 63.119999999999997 108.886 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.22 -45.07 34.78 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.716 -1.216 . . . . 64.409999999999997 107.716 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -106.32 119.27 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 107.255 -1.387 . . . . 65.200000000000003 107.255 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 81' ' ' ASP . 84.8 t80 -99.28 121.22 40.77 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.851 -0.613 . . . . 74.120000000000005 112.121 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.5 139.88 42.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.278 -2.119 . . . . 74.400000000000006 105.278 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 31.7 t70 -128.05 142.48 51.21 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 110.031 -0.359 . . . . 74.430000000000007 110.031 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -162.37 -161.42 0.73 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.613 -1.625 . . . . 75.310000000000002 106.613 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.92 -36.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.235 0.54 . . . . 73.439999999999998 109.66 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -75.71 152.45 37.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.531 -0.759 . . . . 74.219999999999999 110.521 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.26 99.09 7.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.628 -0.879 . . . . 74.239999999999995 108.628 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -99.07 85.68 3.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.126 -1.065 . . . . 73.319999999999993 108.126 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -55.4 -46.08 76.63 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.601 0.563 . . . . 71.349999999999994 111.933 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -155.62 114.28 3.49 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.623 -1.621 . . . . 72.030000000000001 106.623 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.601 ' ND1' HG22 ' A' ' 130' ' ' ILE . 22.0 t-160 -99.74 -51.88 3.61 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.551 -0.86 . . . . 64.310000000000002 109.731 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.15 158.01 41.19 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.316 -0.554 . . . . 72.329999999999998 110.469 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.447 ' OE1' HG13 ' A' ' 104' ' ' VAL . 11.9 pt-20 -132.16 148.11 52.46 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-O 121.203 0.525 . . . . 63.439999999999998 110.021 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' A' ' 101' ' ' VAL . 54.8 m-85 -105.14 117.01 32.92 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 75.530000000000001 108.114 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -106.29 133.63 50.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.199 -1.038 . . . . 73.409999999999997 108.199 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.8 mt -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.563 -0.532 . . . . 73.340000000000003 109.563 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -138.87 121.02 15.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.297 -0.631 . . . . 74.120000000000005 109.297 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 55.76 38.09 29.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.223 1.009 . . . . 75.140000000000001 112.268 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.23 85.0 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.966 -0.635 . . . . 70.040000000000006 114.007 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -102.32 131.71 48.75 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 117.986 0.893 . . . . 74.439999999999998 109.788 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.99 123.62 48.11 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.936 -1.029 . . . . 74.030000000000001 109.177 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.26 137.48 54.2 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.669 -0.493 . . . . 73.219999999999999 109.669 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.441 HG23 ' CD2' ' A' ' 92' ' ' PHE . 29.2 t -103.58 122.61 56.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.212 -1.403 . . . . 70.219999999999999 107.212 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.95 133.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.923 -1.139 . . . . 74.129999999999995 107.923 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.9 148.96 36.12 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.35 0.595 . . . . 72.219999999999999 110.074 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG13 ' OE1' ' A' ' 91' ' ' GLU . 14.5 m -137.47 27.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.721 -1.214 . . . . 74.400000000000006 107.721 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 156.4 56.86 0.01 OUTLIER Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 113.796 -1.547 . . . . 73.310000000000002 110.41 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t -65.56 11.16 0.07 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.965 1.306 . . . . 62.439999999999998 111.961 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 105' ' ' GLY . 78.4 mt -65.5 -19.88 66.11 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 125.634 1.574 . . . . 74.319999999999993 110.885 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -87.09 -13.54 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.333 -0.394 . . . . 74.549999999999997 110.515 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.01 89.19 1.85 Allowed Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.729 -0.748 . . . . 70.430000000000007 111.253 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -86.6 127.9 34.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.773 -0.825 . . . . 63.310000000000002 108.773 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 81.1 m-85 -136.25 134.06 37.67 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.856 -0.794 . . . . 74.239999999999995 108.856 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.18 117.68 51.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 105.474 -2.047 . . . . 75.450000000000003 105.474 175.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.2 39.11 30.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.676 0.75 . . . . 74.430000000000007 110.172 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 mtm180 69.94 9.02 6.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.954 1.702 . . . . 75.329999999999998 114.851 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -110.24 135.89 20.55 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 110.351 -0.24 . . . . 75.25 110.351 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.02 135.9 12.69 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.728 2.285 . . . . 70.439999999999998 112.07 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -149.64 -177.62 5.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.281 0.562 . . . . 73.319999999999993 110.249 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.85 -31.02 4.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.259 -1.337 . . . . 72.340000000000003 110.057 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.7 137.31 28.1 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.277 -1.009 . . . . 70.349999999999994 108.277 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.5 HE22 ' HA ' ' A' ' 122' ' ' MET . 0.7 OUTLIER -152.44 122.63 7.14 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.277 -0.638 . . . . 73.230000000000004 109.277 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.17 117.56 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 106.963 -1.495 . . . . 71.209999999999994 106.963 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.5 ' HA ' HE22 ' A' ' 120' ' ' GLN . 32.6 ttm -96.87 137.81 35.39 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 114.281 1.215 . . . . 75.129999999999995 114.281 -165.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -114.14 157.25 22.86 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.473 -1.694 . . . . 73.109999999999999 107.745 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.8 t -62.59 133.94 55.63 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.414 0.626 . . . . 65.450000000000003 109.456 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.44 -0.09 56.9 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 121.107 -0.568 . . . . 74.030000000000001 111.887 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -82.38 142.2 32.18 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.932 -0.766 . . . . 72.420000000000002 108.932 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.404 ' CD ' HH21 ' A' ' 134' ' ' ARG . 44.4 mt-10 -113.46 132.63 55.58 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.362 0.601 . . . . 75.510000000000005 110.248 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -107.39 132.82 53.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 54.2 mt-30 -117.63 117.79 30.34 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.268 0.556 . . . . 74.5 109.781 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.601 HG22 ' ND1' ' A' ' 89' ' ' HIS . 48.1 mm -109.75 102.27 13.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.973 -1.491 . . . . 75.340000000000003 106.973 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.94 -78.08 0.21 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.406 -0.677 . . . . 43.140000000000001 111.406 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -141.87 5.37 1.74 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.045 0.45 . . . . 74.430000000000007 111.222 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.2 m-85 -78.9 150.44 32.14 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.223 -0.658 . . . . 55.539999999999999 109.223 176.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 127' ' ' GLU . 13.8 tpt180 -124.72 118.64 26.91 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.411 -1.7 . . . . 74.430000000000007 106.411 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mp -122.29 140.84 52.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.337 -0.986 . . . . 74.450000000000003 108.337 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.07 122.56 65.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.201 -1.407 . . . . 73.019999999999996 107.201 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -99.31 127.29 45.31 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.077 -0.51 . . . . 75.329999999999998 109.957 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.99 155.54 50.59 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.818 -0.808 . . . . 54.450000000000003 108.818 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 141' ' ' PRO . . . -82.61 142.15 31.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.451 -1.685 . . . . 53.340000000000003 106.451 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.44 2.71 Favored Glycine 0 C--N 1.305 -1.192 0 C-N-CA 119.384 -1.389 . . . . 72.209999999999994 113.927 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 139' ' ' ALA . 2.9 Cg_exo -72.79 142.03 34.8 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.974 1.783 . . . . 75.0 109.769 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 179.76 73.71 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.929 0.892 . . . . 73.109999999999999 109.26 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.39 -3.448 0 CA-C-N 114.435 -1.257 . . . . 73.209999999999994 109.413 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.421 -1.883 0 N-CA-C 105.768 -1.938 . . . . 60.439999999999998 105.768 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -81.53 114.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 117.675 -1.61 . . . . 74.310000000000002 108.024 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.673 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 45.1 t80 -99.71 116.24 31.35 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.004 -0.998 . . . . 73.209999999999994 108.857 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -81.15 92.07 6.23 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.796 -0.816 . . . . 73.340000000000003 108.796 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.65 -168.41 2.08 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.975 -1.011 . . . . 73.310000000000002 110.926 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.43 -9.71 13.86 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.34 1.056 . . . . 74.5 111.28 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.86 -19.13 65.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.004 0.922 . . . . 71.450000000000003 110.365 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.0 OUTLIER -59.21 -43.71 92.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.331 -0.989 . . . . 73.430000000000007 108.331 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.535 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 7.8 tmtm? -80.47 -29.3 37.46 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.547 -0.909 . . . . 74.450000000000003 108.547 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.26 -33.9 75.22 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.987 -0.551 . . . . 73.510000000000005 110.705 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 27.5 ptt? -68.57 -21.02 64.55 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.778 -0.369 . . . . 75.239999999999995 110.741 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.04 -33.52 63.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.715 -1.217 . . . . 75.329999999999998 107.715 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -79.94 -14.66 58.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.769 -1.105 . . . . 70.420000000000002 110.884 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 t -67.44 -25.66 66.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.201 -0.666 . . . . 75.150000000000006 109.201 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.92 97.06 5.18 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.883 -1.525 . . . . 74.420000000000002 106.883 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.19 58.91 2.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.379 -1.088 . . . . 64.239999999999995 110.379 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -92.79 149.93 20.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.899 -0.408 . . . . 75.409999999999997 109.899 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.22 101.22 40.97 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.721 -0.474 . . . . 73.230000000000004 109.721 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 69.3 Cg_endo -75.79 143.52 26.74 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.308 2.005 . . . . 72.409999999999997 111.181 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.12 166.8 22.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.335 -0.393 . . . . 71.25 110.724 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 m -67.71 118.82 11.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.168 -0.469 . . . . 72.519999999999996 110.266 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.416 ' HB ' ' OE1' ' A' ' 123' ' ' GLN . 17.8 p -110.93 -161.57 0.76 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.569 0.748 . . . . 64.030000000000001 110.63 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.94 80.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.518 -0.633 . . . . 51.130000000000003 111.518 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.64 -24.51 19.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.927 0.714 . . . . 65.519999999999996 112.927 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.02 0.61 4.33 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.549 1.315 . . . . 73.019999999999996 114.549 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.3 -39.01 15.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.692 -0.855 . . . . 72.420000000000002 108.692 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.7 mt 53.18 80.29 0.3 Allowed Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 123.98 0.912 . . . . 74.239999999999995 111.607 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.79 -67.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 123.649 2.9 . . . . 75.5 114.678 -173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.38 -0.98 3.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.098 0.475 . . . . 73.109999999999999 111.317 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.6 6.98 82.6 Favored Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.384 -0.912 . . . . 71.319999999999993 112.643 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 m -129.46 158.21 39.84 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 108.118 -1.068 . . . . 73.010000000000005 108.118 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.49 41.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.254 -0.276 . . . . 73.349999999999994 110.254 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 139.95 53.4 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.326 0.391 . . . . 74.019999999999996 110.267 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' HD11 ' A' ' 49' ' ' LEU . 4.2 pp -112.42 137.34 50.75 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.69 -0.855 . . . . 75.319999999999993 108.69 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.73 133.34 61.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.195 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.8 t -78.51 117.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 106.113 -1.81 . . . . 62.119999999999997 106.113 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -86.41 -33.99 20.3 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.545 -0.752 . . . . 75.519999999999996 110.527 -172.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 31.3 tpt180 -154.66 139.7 17.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.232 -1.025 . . . . 71.230000000000004 108.232 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.08 -178.93 20.41 Favored Glycine 0 N--CA 1.437 -1.3 0 O-C-N 123.867 0.729 . . . . 74.310000000000002 111.346 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -70.0 -37.11 9.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.341 2.027 . . . . 74.340000000000003 111.513 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 81' ' ' ASP . 5.0 p30 -90.73 18.52 6.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.352 0.596 . . . . 74.239999999999995 111.167 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.65 145.19 54.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.432 0.693 . . . . 75.040000000000006 111.034 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -14.82 37.06 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.243 -1.143 . . . . 64.120000000000005 110.243 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.86 33.56 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 121.08 -0.248 . . . . 74.319999999999993 110.359 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -134.97 139.25 44.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.816 -1.179 . . . . 73.319999999999993 107.816 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.25 123.16 26.39 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 121.311 -0.155 . . . . 72.340000000000003 110.737 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.5 tp -89.63 115.4 26.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.057 -1.461 . . . . 75.439999999999998 107.057 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.81 106.87 16.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.458 0.647 . . . . 74.549999999999997 111.744 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -102.92 15.27 29.87 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.474 -1.306 . . . . 72.310000000000002 107.474 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.446 ' NE2' ' HG1' ' A' ' 68' ' ' THR . 15.7 mt-30 -107.31 141.85 23.83 Favored Pre-proline 0 CA--C 1.468 -2.205 0 CA-C-N 114.714 -1.13 . . . . 73.200000000000003 110.026 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.03 -13.15 28.74 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.973 1.782 . . . . 74.329999999999998 109.375 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.0 m -149.29 125.37 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.281 0.563 . . . . 70.430000000000007 110.67 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.3 m -131.51 139.48 49.29 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.366 -0.976 . . . . 71.219999999999999 108.366 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.24 -0.913 . . . . 70.450000000000003 110.319 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.58 143.41 46.14 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.764 -0.828 . . . . 71.420000000000002 108.764 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.96 -147.07 6.39 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 111.361 -0.696 . . . . 73.439999999999998 111.361 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -90.91 147.9 22.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 122.591 0.357 . . . . 64.239999999999995 110.951 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.46 169.76 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.65 1.18 . . . . 75.310000000000002 112.291 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -73.2 6.66 2.48 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.246 1.964 . . . . 74.409999999999997 111.446 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.93 -37.56 67.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.319 -1.363 . . . . 53.229999999999997 107.319 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -78.74 152.82 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.758 -1.11 . . . . 73.120000000000005 108.264 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' OD2' HG21 ' A' ' 68' ' ' THR . 32.0 t70 -64.67 -41.76 95.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.892 0.377 . . . . 71.129999999999995 111.094 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.0 126.81 67.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.306 -0.998 . . . . 72.099999999999994 108.306 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -88.42 129.63 35.38 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.682 0.614 . . . . 74.310000000000002 110.737 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.7 140.3 52.82 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.39 -1.337 . . . . 75.219999999999999 107.39 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.524 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 30.7 t70 -125.4 118.42 25.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.993 -0.549 . . . . 70.319999999999993 109.611 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.34 -175.45 4.78 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.775 -2.306 . . . . 75.049999999999997 104.775 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.24 -34.84 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.368 -0.975 . . . . 74.230000000000004 108.368 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 m -148.63 114.69 5.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.071 -1.085 . . . . 64.299999999999997 108.071 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.2 t -103.94 152.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.513 -0.551 . . . . 74.140000000000001 109.513 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.8 m -72.65 153.07 41.4 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.572 0.349 . . . . 52.530000000000001 110.47 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -69.26 -29.27 67.14 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.922 0.867 . . . . 73.219999999999999 110.767 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.438 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 24.0 mtp180 -148.78 120.19 7.9 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 101.666 -3.457 . . . . 73.120000000000005 101.666 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.49 ' CE1' HG21 ' A' ' 130' ' ' ILE . 13.4 t60 -99.65 -52.69 3.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.725 -0.79 . . . . 75.420000000000002 110.483 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.01 146.52 25.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.625 -0.88 . . . . 63.350000000000001 108.625 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.517 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 11.0 pt-20 -118.36 129.75 55.61 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.816 -0.629 . . . . 74.540000000000006 109.61 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.498 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 26.7 m-85 -105.26 113.06 26.43 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.302 -2.11 . . . . 74.420000000000002 105.302 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.517 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 26.2 mtp180 -115.25 127.29 55.39 Favored 'General case' 0 C--N 1.262 -3.2 0 N-CA-C 108.46 -0.941 . . . . 75.349999999999994 108.46 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.67 113.02 39.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 106.894 -1.521 . . . . 71.319999999999993 106.894 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -119.65 125.06 47.81 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.812 -1.181 . . . . 70.530000000000001 107.812 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.29 34.97 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.994 0.918 . . . . 75.219999999999999 112.576 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.2 -0.15 89.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.078 -0.582 . . . . 72.400000000000006 113.401 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -102.91 150.51 23.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.28 -1.007 . . . . 74.530000000000001 108.28 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -110.1 117.65 34.29 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 121.306 -0.157 . . . . 63.130000000000003 110.745 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.618 -0.882 . . . . 63.530000000000001 108.618 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.0 123.63 68.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.743 -1.206 . . . . 71.040000000000006 107.743 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.24 130.06 73.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.664 -0.865 . . . . 71.239999999999995 108.664 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.42 130.4 37.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.482 -0.933 . . . . 71.430000000000007 108.482 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 12.85 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-N 115.675 -0.693 . . . . 65.230000000000004 109.322 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -154.83 83.01 0.16 Allowed Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.158 -0.928 . . . . 52.140000000000001 113.375 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.415 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 40.6 m -82.4 15.58 2.43 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.396 . . . . 72.230000000000004 111.176 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.673 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.7 tm? -67.2 -50.48 60.76 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 106.539 -1.652 . . . . 74.219999999999999 106.539 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 26.9 t-20 -104.46 -19.86 13.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.992 -0.744 . . . . 72.439999999999998 108.992 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . 83.99 119.32 0.76 Allowed Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.75 1.06 . . . . 60.310000000000002 115.75 168.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.9 m -87.29 128.4 35.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.793 -0.818 . . . . 74.25 108.793 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.41 142.17 51.49 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.185 -1.043 . . . . 64.099999999999994 108.185 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -124.62 117.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.389 -0.967 . . . . 74.310000000000002 108.389 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 6.8 m-80 50.93 49.03 21.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.798 0.839 . . . . 71.329999999999998 112.993 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 67.21 9.42 6.94 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.481 1.513 . . . . 75.120000000000005 112.303 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -109.97 136.31 20.43 Favored Pre-proline 0 C--N 1.313 -1.004 0 O-C-N 121.936 -0.477 . . . . 65.150000000000006 110.334 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.42 123.81 12.73 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 121.946 1.764 . . . . 64.25 108.652 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -147.41 131.98 17.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.02 -0.733 . . . . 64.549999999999997 109.02 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.79 -35.52 9.02 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.358 0.411 . . . . 75.239999999999995 111.476 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.26 135.26 53.28 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.78 -1.193 . . . . 73.329999999999998 107.78 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -146.88 143.61 28.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.513 0.197 . . . . 72.140000000000001 111.391 -175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 114.03 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 103.181 -2.896 . . . . 70.450000000000003 103.181 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.446 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 30.3 ttm -93.91 130.85 39.84 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.778 -1.169 . . . . 62.210000000000001 111.468 -170.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.416 ' OE1' ' HB ' ' A' ' 37' ' ' THR . 40.3 mt-30 -114.03 157.87 21.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 74.409999999999997 109.675 -170.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.429 ' HB ' ' HB1' ' A' ' 139' ' ' ALA . 14.8 t -63.54 126.57 27.94 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.897 -0.779 . . . . 75.519999999999996 108.897 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.0 -1.66 57.85 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 115.772 -0.649 . . . . 70.349999999999994 111.489 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.8 145.74 34.16 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 107.982 -1.118 . . . . 55.43 107.982 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.93 132.86 55.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.831 -0.433 . . . . 74.219999999999999 109.831 -172.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 mt -107.98 131.59 57.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.044 -0.724 . . . . 73.120000000000005 109.044 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -105.53 115.43 30.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.554 -1.276 . . . . 74.340000000000003 107.554 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.49 HG21 ' CE1' ' A' ' 89' ' ' HIS . 63.4 mt -125.42 116.8 47.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.086 -1.449 . . . . 63.399999999999999 107.086 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.53 -104.29 0.75 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.668 -0.973 . . . . 64.219999999999999 110.668 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -124.61 5.09 8.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.195 0.522 . . . . 72.219999999999999 109.94 176.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 34.2 p90 -111.14 156.58 21.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.985 -175.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.57 136.74 54.7 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.166 0.508 . . . . 74.310000000000002 111.542 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.17 139.62 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.585 -1.265 . . . . 71.510000000000005 107.585 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.7 t -112.13 131.41 63.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.893 -1.151 . . . . 73.129999999999995 107.893 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.446 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 48.7 t80 -103.57 117.02 33.47 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.941 -0.763 . . . . 73.420000000000002 108.941 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.19 131.08 55.8 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.488 -0.56 . . . . 63.329999999999998 109.488 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.429 ' HB1' ' HB ' ' A' ' 124' ' ' THR . . . -111.87 121.93 46.39 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.307 -0.997 . . . . 72.409999999999997 108.307 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.74 -104.89 0.21 Allowed Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.477 -0.868 . . . . 74.409999999999997 111.89 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.19 161.66 45.12 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.004 2.469 . . . . 73.120000000000005 113.596 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.1 24.38 5.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.309 -0.86 . . . . 63.43 109.343 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.435 -1.197 0 C-N-CA 124.961 1.305 . . . . 71.530000000000001 113.462 -176.668 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 105.883 -1.895 . . . . 72.150000000000006 105.883 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 t -85.9 130.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 117.8 0.273 . . . . 74.420000000000002 110.415 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -96.48 131.9 42.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.432 -0.507 . . . . 74.299999999999997 109.64 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.54 91.69 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.69 -0.485 . . . . 74.030000000000001 109.69 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.49 -84.22 0.07 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.122 0.416 . . . . 65.450000000000003 112.122 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.32 -35.48 65.18 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.497 1.119 . . . . 74.209999999999994 112.505 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.8 mt -57.85 -12.29 3.01 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.887 1.275 . . . . 74.230000000000004 113.904 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.4 tp -80.07 -16.32 55.3 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.714 0.405 . . . . 74.040000000000006 111.066 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.85 -39.65 89.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.415 1.265 . . . . 72.150000000000006 114.415 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -72.57 -14.48 61.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.239 0.829 . . . . 75.010000000000005 113.239 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.4 ttp -60.25 -30.69 69.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.367 0.603 . . . . 75.510000000000005 110.376 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.77 -16.74 63.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.367 -0.833 . . . . 72.109999999999999 111.91 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -78.38 -17.95 55.74 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.936 -0.394 . . . . 71.209999999999994 109.936 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.0 m -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.355 0.598 . . . . 73.120000000000005 110.889 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -81.79 111.44 18.03 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 115.523 -0.762 . . . . 65.329999999999998 109.757 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.0 -79.95 0.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.827 -0.701 . . . . 72.340000000000003 113.702 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -105.69 121.36 43.86 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.225 0.536 . . . . 72.420000000000002 111.707 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.61 136.12 28.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.516 -0.92 . . . . 73.530000000000001 108.516 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.42 154.55 73.85 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.319 2.012 . . . . 70.510000000000005 110.199 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.31 169.06 16.51 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 116.32 -0.4 . . . . 73.010000000000005 110.378 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 p -57.03 136.7 56.32 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.069 0.856 . . . . 71.450000000000003 110.411 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 m -118.22 1.7 11.91 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.204 0.526 . . . . 64.200000000000003 111.968 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 15.21 56.36 Favored Glycine 0 CA--C 1.488 -1.624 0 N-CA-C 108.107 -1.997 . . . . 63.109999999999999 108.107 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.13 -8.95 47.3 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.898 -1.651 . . . . 72.439999999999998 109.379 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.22 -11.4 60.77 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.627 1.571 . . . . 74.040000000000006 111.063 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.63 -22.79 43.15 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.832 -1.531 . . . . 70.439999999999998 109.425 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.66 67.58 1.51 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.255 -0.646 . . . . 75.319999999999993 109.255 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.08 -54.56 4.21 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.831 3.021 . . . . 73.430000000000007 114.914 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.14 -15.04 45.15 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.273 0.472 . . . . 74.200000000000003 112.273 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.51 -11.89 70.85 Favored Glycine 0 C--N 1.319 -0.387 0 N-CA-C 110.788 -0.925 . . . . 35.240000000000002 110.788 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.0 m -127.21 162.38 26.32 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.525 -1.658 . . . . 62.229999999999997 106.525 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -141.38 157.32 45.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.253 -0.647 . . . . 75.140000000000001 109.253 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.57 149.08 43.66 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.225 0.536 . . . . 75.219999999999999 111.831 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -111.04 132.24 54.39 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.568 -0.901 . . . . 73.430000000000007 108.568 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.05 134.25 51.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.404 -0.591 . . . . 73.420000000000002 109.404 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.46 117.9 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.835 -1.543 . . . . 73.5 106.835 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -93.53 -30.97 14.73 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.052 -0.522 . . . . 75.010000000000005 111.46 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' CZ ' ' H ' ' A' ' 54' ' ' GLY . 2.7 tpm_? -144.52 141.19 29.34 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.583 -0.447 . . . . 73.430000000000007 109.961 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' H ' ' CZ ' ' A' ' 53' ' ' ARG . . . 128.8 168.1 12.32 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.942 -1.663 . . . . 63.32 108.942 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.4 Cg_exo -55.26 -29.58 67.78 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.46 2.107 . . . . 62.219999999999999 113.438 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -91.7 14.51 15.03 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.529 0.566 . . . . 75.019999999999996 112.529 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.51 143.07 58.18 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.191 0.52 . . . . 72.430000000000007 111.567 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.79 -23.15 34.75 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 115.408 -0.814 . . . . 75.040000000000006 111.243 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.57 149.31 22.2 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.771 0.319 . . . . 64.510000000000005 110.458 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 2.0 ppt_? -123.95 141.14 52.3 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.751 -0.463 . . . . 74.120000000000005 109.751 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -119.24 125.62 49.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.11 -0.7 . . . . 70.109999999999999 109.11 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.8 tp -93.67 136.19 34.2 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 74.0 107.809 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.84 104.7 16.6 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.937 -0.705 . . . . 75.510000000000005 110.09 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -116.46 -9.76 11.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.509 -1.223 . . . . 73.219999999999999 107.707 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.462 ' O ' HD12 ' A' ' 94' ' ' ILE . 15.1 pm0 -106.9 139.81 20.76 Favored Pre-proline 0 N--CA 1.425 -1.688 0 CA-C-N 114.871 -1.059 . . . . 75.519999999999996 109.728 -173.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 31.0 Cg_endo -64.18 -14.52 44.21 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.471 2.78 . . . . 73.129999999999995 114.182 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -148.02 127.55 13.23 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.216 -0.927 . . . . 75.409999999999997 112.015 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 45.7 m -124.15 113.54 18.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.312 -0.996 . . . . 73.25 108.312 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -89.43 134.89 33.89 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.329 -0.619 . . . . 71.340000000000003 109.329 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.5 147.0 44.09 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.514 0.673 . . . . 72.310000000000002 111.585 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -169.78 21.38 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 107.867 -2.093 . . . . 73.040000000000006 107.867 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -115.61 118.34 32.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.78 -1.563 . . . . 73.310000000000002 106.78 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 176.38 162.05 0.46 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 106.381 -1.711 . . . . 75.409999999999997 106.381 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -48.74 -36.64 33.56 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 123.925 3.083 . . . . 74.120000000000005 115.146 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -90.81 16.2 9.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.771 1.026 . . . . 73.409999999999997 113.771 -177.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.4 p -66.05 112.28 3.78 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.167 -0.679 . . . . 62.549999999999997 109.167 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -77.52 -34.67 53.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.415 -0.957 . . . . 64.430000000000007 108.415 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.99 117.95 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.992 -1.484 . . . . 63.130000000000003 106.992 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -95.19 116.93 29.39 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.321 0.582 . . . . 74.420000000000002 110.959 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 2.2 mm? -123.19 139.94 53.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.032 -2.21 . . . . 74.200000000000003 105.032 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 55' ' ' PRO . 4.5 p-10 -79.68 127.15 31.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.903 0.858 . . . . 72.219999999999999 109.533 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.92 146.15 39.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.839 -1.073 . . . . 72.239999999999995 111.648 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.38 -43.27 20.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.478 -0.934 . . . . 75.150000000000006 108.478 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.2 m -133.53 158.0 44.23 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.517 -2.031 . . . . 63.32 105.517 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.97 99.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.773 0.797 . . . . 75.430000000000007 112.754 -165.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -104.14 101.76 11.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.262 -1.335 . . . . 72.420000000000002 107.584 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 6.7 ppt_? -57.16 -31.72 65.67 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.691 0.62 . . . . 75.099999999999994 112.349 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 43.6 ttm180 -159.97 132.51 6.51 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.597 -1.631 . . . . 74.129999999999995 106.597 172.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -98.67 -52.75 3.51 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.644 0.59 . . . . 74.340000000000003 110.456 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 164.6 34.45 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.335 -0.393 . . . . 71.219999999999999 110.605 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.96 130.94 54.04 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.371 -0.974 . . . . 73.230000000000004 108.371 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 9.1 m-85 -105.66 113.47 27.05 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.212 -1.773 . . . . 61.049999999999997 106.212 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -112.21 141.61 45.69 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.37 -0.532 . . . . 74.230000000000004 110.524 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 65' ' ' GLN . 2.5 mp -113.78 112.72 41.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 105.117 -2.179 . . . . 74.400000000000006 105.117 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -131.48 126.55 35.29 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.939 -0.573 . . . . 72.25 109.551 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 55.67 36.21 26.76 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 125.194 1.398 . . . . 74.439999999999998 110.08 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.75 -2.0 75.76 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 115.492 -0.776 . . . . 62.210000000000001 113.685 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.22 150.33 25.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.37 0.585 . . . . 74.120000000000005 109.94 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -106.43 131.51 53.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.55 -0.295 . . . . 75.400000000000006 110.612 -173.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.42 147.21 52.1 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.754 -0.461 . . . . 71.230000000000004 109.754 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.28 123.17 64.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.388 -1.338 . . . . 70.040000000000006 107.388 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.91 122.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.346 0.593 . . . . 73.430000000000007 110.364 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.454 ' CG ' ' HG ' ' A' ' 106' ' ' SER . 4.5 t70 -83.23 137.83 33.86 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.437 -0.801 . . . . 72.299999999999997 109.646 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.6 12.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.488 -0.778 . . . . 72.450000000000003 109.489 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 175.75 79.65 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.286 -0.959 . . . . 73.109999999999999 112.817 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.454 ' HG ' ' CG ' ' A' ' 103' ' ' ASP . 49.2 m -71.37 33.55 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 123.588 0.755 . . . . 70.430000000000007 112.209 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 105' ' ' GLY . 4.3 tt -62.81 -42.34 99.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.545 -0.909 . . . . 74.340000000000003 108.545 -176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -86.42 -4.1 59.11 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.506 -1.225 . . . . 74.230000000000004 109.374 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 88.87 1.01 Allowed Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.992 -0.623 . . . . 71.200000000000003 112.683 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -87.51 127.71 35.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.991 -0.374 . . . . 74.299999999999997 109.991 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.8 m-85 -136.37 141.73 43.71 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 109.968 -0.382 . . . . 73.409999999999997 109.968 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.7 117.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.442 -2.059 . . . . 73.219999999999999 105.442 172.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 56.71 38.65 29.68 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.859 0.837 . . . . 71.420000000000002 110.141 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.487 HH12 ' NH2' ' A' ' 134' ' ' ARG . 75.1 mtm-85 62.79 13.02 6.13 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.339 -1.3 . . . . 74.450000000000003 114.118 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -104.06 130.3 23.64 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.735 -1.58 . . . . 73.430000000000007 106.735 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.13 123.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.586 1.524 . . . . 72.450000000000003 109.701 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -142.18 140.12 32.28 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.69 -1.226 . . . . 74.400000000000006 107.69 -172.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.2 -47.06 4.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.194 0.521 . . . . 73.310000000000002 110.189 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.14 136.47 54.6 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.775 -0.824 . . . . 73.239999999999995 108.775 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -148.49 143.88 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.737 -0.665 . . . . 75.230000000000004 110.454 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.51 114.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 102.967 -2.975 . . . . 72.319999999999993 102.967 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.6 ttp -90.03 129.39 36.35 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.482 0.658 . . . . 74.510000000000005 110.833 -169.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -129.18 157.68 41.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.86 -1.064 . . . . 72.329999999999998 108.807 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -58.92 133.7 56.29 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.883 -0.599 . . . . 74.140000000000001 109.972 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.64 -4.8 56.62 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.586 -0.734 . . . . 74.129999999999995 111.752 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -88.69 140.06 29.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.202 -0.666 . . . . 72.319999999999993 109.202 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -117.07 145.11 43.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.811 -0.811 . . . . 75.319999999999993 108.811 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.0 127.63 72.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.159 -0.682 . . . . 70.540000000000006 109.159 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 44.9 tt0 -104.86 122.08 45.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.209 -1.404 . . . . 74.140000000000001 107.209 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.74 101.75 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.091 -1.818 . . . . 62.509999999999998 106.091 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.48 -110.96 3.06 Favored Glycine 0 C--N 1.306 -1.097 0 C-N-CA 120.864 -0.684 . . . . 72.400000000000006 112.107 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -96.86 -3.52 41.88 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.981 0.513 . . . . 74.439999999999998 110.435 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.579 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.3 m-85 -95.11 139.15 31.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 109.798 -0.445 . . . . 75.120000000000005 109.798 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.487 ' NH2' HH12 ' A' ' 114' ' ' ARG . 81.1 ttt180 -124.81 119.43 28.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.446 -0.946 . . . . 74.200000000000003 108.446 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.7 mt -110.21 138.64 46.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.594 -0.891 . . . . 75.120000000000005 108.594 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.93 120.7 64.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.855 -1.165 . . . . 73.540000000000006 107.855 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 85.6 t80 -97.14 117.77 32.07 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.355 0.409 . . . . 75.329999999999998 110.29 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.16 143.76 49.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.08 0.467 . . . . 73.120000000000005 110.128 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.47 119.81 38.61 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.051 0.453 . . . . 72.409999999999997 110.244 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.46 174.44 40.5 Favored Glycine 0 C--N 1.287 -2.164 0 N-CA-C 109.436 -1.465 . . . . 74.299999999999997 109.436 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.47 141.22 38.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 119.091 1.445 . . . . 73.219999999999999 109.66 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.55 26.67 0.13 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.889 -1.152 . . . . 64.420000000000002 107.889 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.407 -2.589 0 CA-C-N 114.498 -1.228 . . . . 74.420000000000002 108.315 -177.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 121.038 0.447 . . . . 72.010000000000005 111.997 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 115.64 26.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 73.430000000000007 108.649 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -123.12 117.79 26.21 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.637 -0.71 . . . . 74.310000000000002 110.144 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -82.76 101.24 10.78 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.691 -1.966 . . . . 72.510000000000005 105.691 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 108.75 1.71 Allowed 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.489 -0.778 . . . . 61.409999999999997 110.474 -177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.445 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 35.5 t70 -60.1 -24.16 64.41 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.659 0.742 . . . . 70.120000000000005 110.263 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -65.81 -3.81 5.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.645 -1.161 . . . . 74.310000000000002 113.142 178.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.83 -24.62 58.24 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.122 0.487 . . . . 75.109999999999999 111.287 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 21' ' ' ASP . 49.6 mtmt -66.82 -28.95 68.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.836 -0.62 . . . . 74.430000000000007 110.857 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -26.31 62.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.478 -0.328 . . . . 72.340000000000003 110.855 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.3 mtm -65.93 -40.35 91.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.93 -0.767 . . . . 65.450000000000003 108.93 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.91 -40.28 94.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.033 -0.985 . . . . 73.040000000000006 109.557 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 m -73.01 -27.75 61.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.536 -0.756 . . . . 61.119999999999997 111.044 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -74.05 -30.48 62.42 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 109.921 -0.4 . . . . 63.439999999999998 109.921 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 127.88 34.29 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.941 -1.027 . . . . 65.040000000000006 109.341 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.22 -42.69 1.28 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 107.674 -2.17 . . . . 63.539999999999999 107.674 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.6 m -115.77 121.95 43.99 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.474 -1.306 . . . . 72.519999999999996 107.474 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.39 138.52 26.95 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.008 -0.738 . . . . 74.310000000000002 109.008 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.52 142.24 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.701 1.6 . . . . 70.510000000000005 111.468 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.13 126.48 46.38 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.081 -1.081 . . . . 73.319999999999993 108.081 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 123' ' ' GLN . 12.9 m -137.96 110.88 7.71 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.631 -0.507 . . . . 75.400000000000006 109.631 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.6 m -154.18 142.4 20.44 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.733 -1.21 . . . . 74.200000000000003 107.733 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -15.01 3.63 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.114 -1.041 . . . . 52.420000000000002 112.166 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.13 59.04 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.299 -0.63 . . . . 62.0 109.299 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -79.8 3.7 18.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.188 -0.914 . . . . 73.310000000000002 111.671 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.28 -27.89 18.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.085 -0.709 . . . . 75.310000000000002 109.085 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 46.65 77.93 0.43 Allowed Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.331 1.052 . . . . 73.200000000000003 113.665 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -70.22 -61.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.508 1.472 . . . . 71.349999999999994 111.537 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.05 -13.79 18.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 111.567 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.17 17.52 74.04 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.711 -0.955 . . . . 73.430000000000007 110.711 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -150.44 167.08 28.19 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 105.902 -1.888 . . . . 71.409999999999997 105.902 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -152.12 157.9 42.21 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 118.446 0.566 . . . . 63.43 111.278 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -121.2 154.53 36.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.129 0.49 . . . . 74.329999999999998 111.916 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.42 141.37 51.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.966 -0.753 . . . . 73.140000000000001 108.966 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.68 134.36 59.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.891 -0.411 . . . . 70.129999999999995 109.891 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 t -86.63 118.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 108.103 -1.073 . . . . 64.129999999999995 108.103 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -92.27 -32.2 15.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 111.336 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -143.47 136.73 27.97 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.422 -0.511 . . . . 75.319999999999993 110.096 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.86 174.84 13.84 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.2 -1.16 . . . . 63.340000000000003 110.2 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -55.43 -32.05 80.36 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.649 2.233 . . . . 74.200000000000003 112.793 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.44 10.48 25.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.256 0.465 . . . . 73.109999999999999 112.256 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.27 57.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.902 0.319 . . . . 73.409999999999997 111.444 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.16 -16.78 55.19 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.509 -0.636 . . . . 72.030000000000001 111.509 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.63 139.01 31.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.907 0.384 . . . . 73.450000000000003 110.324 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -122.79 134.55 54.42 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.58 118.65 30.73 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.546 -0.297 . . . . 74.319999999999993 110.338 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -87.55 111.76 21.54 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.31 -0.996 . . . . 72.140000000000001 108.31 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -95.0 117.26 29.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.342 0.591 . . . . 73.310000000000002 109.653 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -122.02 14.03 10.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.846 -1.07 . . . . 72.209999999999994 108.835 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -108.47 156.46 38.62 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 64.310000000000002 109.521 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 38.2 Cg_endo -69.18 -20.68 37.25 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.175 1.917 . . . . 71.329999999999998 114.527 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.5 m -153.53 127.17 8.74 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.29 -0.881 . . . . 75.140000000000001 111.858 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -126.25 112.86 16.23 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.979 -1.119 . . . . 74.299999999999997 107.979 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.7 m -89.07 139.18 30.72 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.39 -0.524 . . . . 74.349999999999994 109.624 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.01 135.61 54.85 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.358 0.599 . . . . 64.340000000000003 110.912 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.05 -160.21 33.1 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.731 -2.148 . . . . 61.229999999999997 107.731 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -115.72 116.81 28.7 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 151.43 153.23 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 127.48 2.312 . . . . 73.219999999999999 107.228 177.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.95 -9.97 25.22 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.397 2.065 . . . . 75.099999999999994 111.79 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.52 -17.84 61.17 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.746 0.818 . . . . 75.120000000000005 110.248 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 m -90.07 150.02 22.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.218 -1.401 . . . . 64.150000000000006 107.218 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.31 -45.95 24.56 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.702 -0.851 . . . . 74.430000000000007 108.702 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.8 pt -106.16 130.51 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.086 -1.079 . . . . 75.420000000000002 108.086 174.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -94.26 108.12 20.03 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.954 -0.566 . . . . 74.409999999999997 109.996 -173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.74 116.25 32.33 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.992 -1.485 . . . . 75.140000000000001 106.992 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.03 117.04 13.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.931 0.395 . . . . 73.200000000000003 110.227 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -107.62 165.97 11.03 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.815 -0.63 . . . . 65.109999999999999 109.55 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.55 -28.68 32.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.963 0.887 . . . . 73.239999999999995 108.786 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -111.03 173.93 6.1 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.588 -1.634 . . . . 54.329999999999998 106.588 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.48 96.91 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 N-CA-C 106.018 -1.845 . . . . 63.340000000000003 106.018 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 m -105.13 106.74 17.37 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.65 -0.87 . . . . 75.420000000000002 108.65 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -56.29 -42.04 76.88 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.787 1.032 . . . . 74.5 113.787 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -148.7 129.31 14.05 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.857 -1.164 . . . . 74.409999999999997 107.857 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 4.1 t60 -100.29 -52.19 3.45 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.776 -1.194 . . . . 74.409999999999997 107.776 172.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.15 163.98 38.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.147 -1.057 . . . . 71.310000000000002 108.147 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -138.34 148.42 44.55 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.248 0.547 . . . . 74.230000000000004 110.631 176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -105.29 131.72 52.39 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.18 -1.415 . . . . 74.319999999999993 107.18 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -122.95 130.93 53.44 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 116.319 -0.401 . . . . 71.219999999999999 110.444 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 46.3 mt -116.09 112.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.553 -2.017 . . . . 75.439999999999998 105.553 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -139.83 125.71 19.59 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.731 -0.47 . . . . 73.450000000000003 109.731 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 55.87 38.02 29.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.103 0.961 . . . . 74.230000000000004 112.353 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.52 -0.31 89.26 Favored Glycine 0 C--O 1.223 -0.564 0 C-N-CA 121.16 -0.543 . . . . 62.119999999999997 113.98 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -106.47 136.86 45.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.005 0.402 . . . . 62.039999999999999 110.046 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -107.79 119.51 39.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 72.230000000000004 108.127 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.35 146.64 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.733 -0.604 . . . . 64.150000000000006 112.329 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.04 123.98 58.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.508 -1.664 . . . . 73.0 106.508 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.43 122.38 68.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.419 -0.956 . . . . 64.549999999999997 108.419 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.12 134.58 35.67 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.994 -0.743 . . . . 73.230000000000004 108.994 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.74 9.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.068 0.461 . . . . 72.329999999999998 109.867 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -155.63 57.19 0.39 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 108.727 -1.749 . . . . 71.310000000000002 108.727 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 p -68.7 24.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.376 1.871 . . . . 75.010000000000005 114.349 -172.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 105' ' ' GLY . 78.3 mt -106.35 -26.47 11.48 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 116.431 -0.349 . . . . 74.129999999999995 111.546 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.512 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 2.9 m-20 -86.48 -18.94 30.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.601 -0.84 . . . . 75.400000000000006 111.738 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.98 74.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 119.664 -1.255 . . . . 61.25 113.073 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -87.76 128.56 35.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 110.036 -0.357 . . . . 75.510000000000005 110.036 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -135.53 136.06 40.87 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.658 -0.867 . . . . 74.409999999999997 108.658 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 133.19 60.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.137 -1.431 . . . . 73.540000000000006 107.137 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.52 38.59 29.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.309 1.044 . . . . 74.219999999999999 108.688 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 64.18 14.85 8.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.046 1.498 . . . . 71.219999999999999 115.046 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -124.5 148.66 59.29 Favored Pre-proline 0 C--N 1.308 -1.202 0 C-N-CA 120.204 -0.599 . . . . 73.549999999999997 109.423 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 123.43 13.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.801 1.667 . . . . 74.349999999999994 108.502 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.449 ' CG ' ' HB2' ' A' ' 120' ' ' GLN . 17.4 tpp85 -151.07 135.92 17.32 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.634 -0.827 . . . . 75.109999999999999 109.728 -170.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -96.7 -57.6 2.26 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.712 0.633 . . . . 73.030000000000001 110.552 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 134.04 55.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.834 -1.173 . . . . 73.329999999999998 107.834 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 117' ' ' ARG . 27.7 tp60 -155.08 132.9 11.42 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.226 0.329 . . . . 71.239999999999995 111.228 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.58 130.71 31.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.268 -1.382 . . . . 75.340000000000003 107.268 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.644 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 11.8 ptm -98.87 130.24 45.26 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.103 0.478 . . . . 73.209999999999994 110.183 -174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 2.8 tp60 -113.53 156.16 24.09 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.861 -0.609 . . . . 60.450000000000003 110.257 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.2 m -61.34 123.29 17.35 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 122.31 -0.244 . . . . 71.129999999999995 110.379 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.07 -2.03 56.55 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.812 -0.515 . . . . 64.400000000000006 111.812 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.49 146.0 32.94 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 108.525 -0.917 . . . . 73.150000000000006 108.525 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.45 126.69 51.06 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.915 0.864 . . . . 72.209999999999994 110.654 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.41 131.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-N 114.599 -1.182 . . . . 71.409999999999997 108.02 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -120.63 112.49 18.96 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.868 -1.16 . . . . 73.450000000000003 107.868 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.2 mt -109.66 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.237 -0.892 . . . . 74.239999999999995 109.18 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.19 -89.06 0.41 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.97 -1.252 . . . . 75.420000000000002 109.97 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.439 ' HZ2' ' HB3' ' A' ' 132' ' ' LYS . 7.9 mtpm? -134.47 6.13 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.417 -0.586 . . . . 74.409999999999997 109.417 174.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -84.59 147.77 26.82 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -124.88 120.06 30.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.84 -0.8 . . . . 73.319999999999993 108.84 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.33 138.07 50.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.387 -1.338 . . . . 74.409999999999997 107.387 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.11 127.13 74.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 107.539 -1.282 . . . . 72.150000000000006 107.539 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.644 ' CD1' ' HE2' ' A' ' 122' ' ' MET . 76.7 t80 -95.49 126.95 41.13 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.435 0.459 . . . . 75.209999999999994 111.062 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -127.23 159.92 32.86 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.028 -0.73 . . . . 75.400000000000006 109.028 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.41 38.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.103 -0.703 . . . . 73.420000000000002 109.103 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.491 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.93 155.26 53.55 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.172 -0.537 . . . . 63.049999999999997 112.256 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -71.18 142.85 42.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.466 2.111 . . . . 75.150000000000006 111.52 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.98 65.27 0.8 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.163 -1.421 . . . . 74.109999999999999 107.163 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.607 -1.633 . . . . 71.409999999999997 108.499 -176.82 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 108.602 -0.888 . . . . 72.400000000000006 108.602 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.63 115.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.746 -0.835 . . . . 71.310000000000002 108.746 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -123.82 140.78 52.65 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.697 -0.683 . . . . 75.219999999999999 110.554 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -97.53 95.58 7.73 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.1 -1.074 . . . . 72.430000000000007 108.1 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.82 38.85 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.668 -1.151 . . . . 74.329999999999998 112.069 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.86 2.18 2.16 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.536 1.135 . . . . 75.239999999999995 113.759 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -13.77 59.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 72.540000000000006 112.758 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -69.03 -19.67 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.342 0.592 . . . . 75.400000000000006 109.929 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.09 -22.52 59.47 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.077 -0.51 . . . . 74.109999999999999 110.499 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -77.09 -29.95 55.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.231 0.539 . . . . 74.310000000000002 109.939 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -65.3 -47.47 76.5 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.941 -1.133 . . . . 73.510000000000005 107.941 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.32 -39.86 94.43 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.318 -1.31 . . . . 65.530000000000001 110.251 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 t -60.84 -39.01 87.48 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.786 1.234 . . . . 63.119999999999997 110.884 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.483 ' HB2' ' NH1' ' A' ' 114' ' ' ARG . 31.3 t -81.71 -16.52 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.583 -0.28 . . . . 63.100000000000001 110.512 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 m 71.57 31.63 2.2 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 122.525 1.155 . . . . 71.340000000000003 108.481 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.89 -151.05 19.69 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 115.097 -0.956 . . . . 72.439999999999998 112.04 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -84.78 137.97 32.88 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.144 0.577 . . . . 62.229999999999997 110.433 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.9 115.57 59.43 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 74.129999999999995 108.304 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 142.51 25.99 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.354 2.036 . . . . 74.209999999999994 114.9 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.12 126.51 30.18 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.466 -2.049 . . . . 74.019999999999996 105.466 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 37' ' ' THR . 55.4 p -91.32 -98.43 0.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.253 -0.979 . . . . 63.43 113.445 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -170.34 -169.97 0.89 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.007 1.323 . . . . 71.120000000000005 108.877 -177.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.07 -161.44 31.98 Favored Glycine 1 N--CA 1.386 -4.684 0 N-CA-C 105.961 -2.856 . . . . 72.329999999999998 105.961 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.9 -20.88 20.95 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.887 -1.153 . . . . 73.329999999999998 107.887 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.62 -10.7 59.96 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.193 -1.821 . . . . 71.420000000000002 112.965 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.419 ' O ' HD12 ' A' ' 42' ' ' LEU . 32.4 p-10 -80.39 -33.72 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.377 -0.529 . . . . 73.329999999999998 110.74 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 97' ' ' GLY . 2.1 mm? -128.13 82.92 67.53 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.141 -1.059 . . . . 75.129999999999995 108.141 173.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.48 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 4.0 Cg_exo -77.24 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.173 1.915 . . . . 72.109999999999999 111.758 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 142' ' ' ALA . . . -104.48 -7.05 20.08 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.449 -0.574 . . . . 75.310000000000002 109.449 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.06 43.75 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.386 -1.086 . . . . 71.409999999999997 110.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -126.07 149.27 49.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.376 -1.342 . . . . 74.510000000000005 107.376 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.07 157.75 42.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.606 -0.516 . . . . 61.109999999999999 109.606 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.17 142.18 51.44 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 110.003 -0.369 . . . . 75.530000000000001 110.003 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.7 pp -110.17 139.31 45.46 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.902 -0.777 . . . . 71.420000000000002 108.902 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.56 132.59 68.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 109.538 -0.542 . . . . 73.310000000000002 109.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -81.59 117.45 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.048 -1.464 . . . . 71.329999999999998 107.048 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -85.78 -38.22 18.44 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.489 -0.778 . . . . 71.030000000000001 109.119 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 22.6 tpt180 -148.16 136.9 21.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.2 -1.407 . . . . 75.439999999999998 107.2 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.68 -176.55 26.46 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.681 -0.968 . . . . 75.329999999999998 110.681 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 -45.18 12.01 Favored 'Trans proline' 0 C--N 1.327 -0.572 0 C-N-CA 122.519 2.146 . . . . 73.230000000000004 112.145 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -95.11 23.08 5.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 111.83 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 138.77 46.98 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.32 -0.4 . . . . 74.439999999999998 111.286 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.57 -25.8 23.32 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.878 -0.889 . . . . 73.310000000000002 110.878 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 150.2 21.81 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.033 0.444 . . . . 71.209999999999994 110.19 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -126.45 153.56 44.88 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.221 -1.029 . . . . 75.540000000000006 108.221 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -128.14 130.18 47.69 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.82 -0.807 . . . . 74.209999999999994 108.82 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 tp -95.53 130.8 42.25 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.997 -0.547 . . . . 73.530000000000001 110.197 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -107.31 105.19 15.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.044 -1.095 . . . . 71.040000000000006 108.044 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.42 14.89 6.08 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.847 1.308 . . . . 73.140000000000001 107.709 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -114.43 155.01 46.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 113.825 -1.534 . . . . 63.350000000000001 108.507 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 66.5 Cg_endo -72.79 -14.64 26.9 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.734 2.289 . . . . 74.510000000000005 113.61 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.3 m -153.22 128.94 10.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.562 -0.711 . . . . 71.439999999999998 110.54 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 15.4 m -130.09 126.89 38.67 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.66 -0.496 . . . . 71.439999999999998 109.66 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.0 m -90.55 129.59 36.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.639 -0.874 . . . . 64.310000000000002 108.639 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.02 134.56 55.12 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.364 0.602 . . . . 74.319999999999993 110.66 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.37 -170.09 33.37 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.438 -2.665 . . . . 61.310000000000002 106.438 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -105.96 118.18 35.95 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.946 1.373 . . . . 72.019999999999996 110.396 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 17.7 m170 -172.84 152.02 2.34 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 127.184 2.194 . . . . 65.129999999999995 106.06 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.83 -17.6 28.95 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 121.627 1.552 . . . . 74.430000000000007 108.952 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -76.81 -26.84 54.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.952 -1.476 . . . . 74.150000000000006 110.035 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 45.6 m -67.61 132.25 47.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.707 -0.849 . . . . 64.120000000000005 108.707 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.72 -41.44 95.96 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.08 -0.711 . . . . 73.129999999999995 109.08 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.6 pt -107.64 118.8 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.646 -0.872 . . . . 74.510000000000005 108.646 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.54 109.42 20.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.755 0.788 . . . . 74.430000000000007 110.512 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.16 140.37 49.6 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.438 -1.69 . . . . 71.239999999999995 106.438 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.32 117.67 34.65 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.363 -0.977 . . . . 73.510000000000005 108.363 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -102.62 173.85 6.16 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.927 -1.033 . . . . 74.25 111.956 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -66.14 -30.94 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 124.316 1.047 . . . . 73.430000000000007 108.732 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 m -117.17 163.1 16.8 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 106.899 -1.519 . . . . 63.229999999999997 106.899 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.32 96.92 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 N-CA-C 104.434 -2.432 . . . . 74.219999999999999 104.434 168.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 131.54 39.66 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.494 -0.775 . . . . 71.530000000000001 110.326 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -74.23 -47.59 34.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 123.224 1.488 . . . . 72.450000000000003 107.117 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -149.54 115.55 5.69 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 112.557 -2.11 . . . . 72.430000000000007 107.807 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -99.22 -47.2 5.28 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.735 -0.839 . . . . 73.019999999999996 108.735 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.54 151.51 40.32 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.895 -0.78 . . . . 72.510000000000005 108.895 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.8 134.55 54.41 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.902 -1.147 . . . . 73.310000000000002 107.902 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.7 m-85 -105.2 121.43 43.83 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.257 -1.016 . . . . 74.329999999999998 108.257 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -115.85 123.74 48.93 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.171 -1.048 . . . . 75.109999999999999 108.171 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.41 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.9 mp -104.49 123.15 58.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 106.609 -1.626 . . . . 63.310000000000002 106.609 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -136.87 123.66 21.24 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.986 -1.116 . . . . 72.5 107.986 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 56.13 36.13 26.87 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.605 1.162 . . . . 71.409999999999997 111.102 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.466 ' O ' HD13 ' A' ' 42' ' ' LEU . . . 78.97 -0.32 79.2 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 113.374 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.7 149.7 23.88 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.002 -0.74 . . . . 73.430000000000007 109.002 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.8 117.54 33.11 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.126 -0.488 . . . . 74.450000000000003 110.089 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.78 129.93 55.51 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.152 0.501 . . . . 71.120000000000005 109.658 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.49 124.6 59.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.526 -0.916 . . . . 74.439999999999998 108.526 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.22 137.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.257 -0.646 . . . . 72.549999999999997 109.257 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.81 140.94 30.02 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.64 -0.709 . . . . 64.420000000000002 110.841 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.63 14.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 122.39 1.09 . . . . 74.439999999999998 108.555 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.93 48.48 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.572 -1.411 . . . . 72.109999999999999 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -60.06 -2.6 0.45 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.876 1.67 . . . . 75.230000000000004 113.631 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.14 -26.0 17.62 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.447 -0.575 . . . . 75.430000000000007 109.447 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -94.71 -18.65 21.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 73.219999999999999 111.83 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.92 77.1 1.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.012 -1.089 . . . . 61.109999999999999 112.643 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.1 m -87.02 128.68 35.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.014 0.435 . . . . 75.109999999999999 110.388 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -133.64 127.41 32.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.261 -0.427 . . . . 72.319999999999993 110.516 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.15 137.66 55.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 105.398 -2.075 . . . . 73.519999999999996 105.398 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 57.3 33.77 23.78 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 106.738 -1.579 . . . . 74.099999999999994 106.738 -166.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.483 ' NH1' ' HB2' ' A' ' 29' ' ' SER . 73.6 mtt180 57.94 11.43 1.43 Allowed 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 123.187 0.595 . . . . 71.430000000000007 111.655 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -107.7 144.47 29.36 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 124.388 1.075 . . . . 75.219999999999999 110.248 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.14 123.93 12.26 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.089 1.859 . . . . 74.510000000000005 108.787 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' A' ' 117' ' ' ARG . 3.7 mmp_? -135.82 155.85 49.71 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.667 0.988 . . . . 73.409999999999997 113.667 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -99.2 -41.85 7.31 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.9 -1.5 . . . . 74.129999999999995 107.434 171.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.4 143.61 25.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.52 -1.218 . . . . 72.099999999999994 108.197 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 138.15 19.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.011 -1.107 . . . . 72.329999999999998 108.011 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.73 116.7 40.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 105.412 -2.07 . . . . 75.019999999999996 105.412 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 77.4 mtp -89.75 149.08 22.88 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 114.163 1.172 . . . . 75.430000000000007 114.163 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -112.43 157.38 21.14 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.661 -1.609 . . . . 63.240000000000002 107.778 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.6 t -66.27 127.39 32.01 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.169 -0.613 . . . . 75.219999999999999 109.829 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 0.03 57.32 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.266 -0.734 . . . . 71.439999999999998 111.266 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -82.77 152.27 25.77 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.964 -0.384 . . . . 74.129999999999995 109.964 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -115.71 144.18 44.32 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.263 0.554 . . . . 75.420000000000002 112.237 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.6 mt -117.91 131.88 69.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.442 . . . . 74.420000000000002 107.108 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -117.84 120.55 38.23 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.56 -0.904 . . . . 74.140000000000001 108.56 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.75 114.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.301 -0.863 . . . . 74.540000000000006 108.836 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.0 -80.98 0.57 Allowed Glycine 0 C--O 1.206 -1.594 0 N-CA-C 110.006 -1.238 . . . . 70.200000000000003 110.006 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -154.87 8.28 0.3 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.436 0.294 . . . . 72.299999999999997 111.112 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 31.1 p90 -107.39 160.29 15.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.881 -0.785 . . . . 75.420000000000002 108.881 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -124.76 137.82 54.31 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.234 -0.986 . . . . 74.549999999999997 112.329 -168.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mp -122.32 139.82 53.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.698 -1.223 . . . . 75.209999999999994 107.698 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.12 124.93 69.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.768 -1.197 . . . . 74.239999999999995 107.768 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -98.28 118.26 34.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.188 -0.671 . . . . 75.25 109.188 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.4 mt -122.34 131.67 54.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.972 -0.381 . . . . 75.239999999999995 109.972 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.29 119.57 28.82 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.458 -1.682 . . . . 72.340000000000003 106.458 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.01 -70.66 0.29 Allowed Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.519 -1.324 . . . . 73.099999999999994 115.356 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 43' ' ' PRO . 25.7 Cg_exo -57.74 141.28 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.693 1.595 . . . . 72.120000000000005 114.785 -172.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.459 ' HA ' ' HB1' ' A' ' 44' ' ' ALA . . . -161.84 29.34 0.12 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.011 -2.588 . . . . 71.540000000000006 104.011 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.416 -2.154 0 CA-C-N 112.99 -1.914 . . . . 73.230000000000004 108.31 -169.134 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 110.009 -0.367 . . . . 73.219999999999999 110.009 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 47.1 t -87.17 122.44 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.302 -0.629 . . . . 71.219999999999999 109.302 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -123.66 129.02 50.49 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.872 0.368 . . . . 74.530000000000001 111.855 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -96.55 116.03 28.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.266 -1.753 . . . . 75.129999999999995 106.266 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.36 -166.71 2.63 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.546 -0.862 . . . . 73.239999999999995 113.315 -171.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.16 -14.28 1.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.886 2.074 . . . . 73.040000000000006 115.059 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.66 -23.11 67.15 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.119 -0.363 . . . . 73.439999999999998 111.744 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.19 -22.5 63.9 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.877 0.37 . . . . 72.450000000000003 111.823 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -91.8 -42.04 10.32 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.822 -1.547 . . . . 74.400000000000006 106.822 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -26.37 67.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.642 1.177 . . . . 61.219999999999999 109.397 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.6 tpp -51.75 -26.13 8.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.757 1.223 . . . . 65.209999999999994 112.167 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.49 -38.34 86.94 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 120.725 0.298 . . . . 74.510000000000005 110.472 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -72.91 -34.96 66.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.234 -0.654 . . . . 71.400000000000006 109.234 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 17.9 m -68.81 -30.5 69.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.901 -0.591 . . . . 71.120000000000005 110.065 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.4 m -81.55 107.03 13.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.18 0.514 . . . . 71.099999999999994 110.797 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 179.65 38.69 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 108.997 -1.641 . . . . 54.530000000000001 108.997 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.6 m -74.94 124.16 26.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 117.69 0.745 . . . . 72.099999999999994 109.646 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.45 150.24 38.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 N-CA-C 108.251 -1.018 . . . . 64.219999999999999 108.251 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 125' ' ' GLY . 53.4 Cg_exo -57.18 154.97 31.25 Favored 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.551 2.167 . . . . 72.549999999999997 111.876 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.07 145.67 27.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.695 -0.684 . . . . 74.140000000000001 112.335 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.1 m -116.07 148.3 40.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.122 -1.066 . . . . 75.439999999999998 108.122 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -116.74 -60.68 1.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.931 0.396 . . . . 75.140000000000001 111.384 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.83 -63.55 0.18 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.467 -0.653 . . . . 61.43 111.467 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.56 54.5 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.123 0.487 . . . . 73.409999999999997 110.95 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.52 -5.92 47.62 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.424 -0.807 . . . . 70.140000000000001 111.08 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.09 -42.17 19.54 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.414 -0.812 . . . . 62.420000000000002 110.131 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.32 83.22 60.21 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 109.086 -0.709 . . . . 61.109999999999999 109.086 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.39 -65.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.848 2.365 . . . . 73.150000000000006 112.269 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.13 -16.19 59.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 74.400000000000006 111.012 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.97 -7.44 77.6 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 110.975 -0.85 . . . . 75.340000000000003 110.975 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -120.08 157.08 29.7 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.624 -1.621 . . . . 74.439999999999998 106.624 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.89 156.87 43.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.583 -0.525 . . . . 75.340000000000003 109.583 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.95 140.82 52.57 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.996 0.427 . . . . 72.219999999999999 110.712 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -112.19 140.73 46.65 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 116.288 -0.414 . . . . 74.420000000000002 110.931 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.71 128.08 71.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.45 118.92 26.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.736 -1.209 . . . . 73.409999999999997 107.736 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -83.4 -32.63 26.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.62 0.724 . . . . 74.299999999999997 110.131 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 20.2 tpp180 -154.01 148.81 26.53 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.992 -1.485 . . . . 72.439999999999998 106.992 -177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.28 -174.85 17.86 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 109.722 -1.351 . . . . 73.420000000000002 109.722 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -65.2 -37.95 29.58 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.309 2.006 . . . . 74.329999999999998 111.029 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.61 14.37 11.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.749 -1.114 . . . . 72.109999999999999 110.862 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 129.32 41.55 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.762 0.315 . . . . 63.210000000000001 111.295 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.0 -26.05 24.38 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.95 -0.568 . . . . 73.239999999999995 112.188 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.81 144.77 29.9 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.839 0.352 . . . . 54.329999999999998 110.133 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -123.69 137.54 54.69 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.992 -0.744 . . . . 75.340000000000003 108.992 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.04 130.56 52.76 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.705 -0.48 . . . . 72.219999999999999 109.705 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.75 128.4 36.67 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.644 -1.243 . . . . 75.340000000000003 107.644 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.414 HD22 HG23 ' A' ' 68' ' ' THR . 26.6 mt -106.78 123.95 48.89 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.057 -1.09 . . . . 73.409999999999997 108.057 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -136.57 1.11 2.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.688 0.996 . . . . 64.450000000000003 113.688 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.535 ' O ' HD11 ' A' ' 94' ' ' ILE . 3.8 pt20 -107.24 152.88 41.33 Favored Pre-proline 0 C--O 1.211 -0.961 0 C-N-CA 119.556 -0.857 . . . . 74.510000000000005 110.13 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 8.8 Cg_endo -52.2 -21.56 13.32 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 124.088 3.192 . . . . 74.310000000000002 114.996 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.7 m -142.51 121.66 12.97 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.723 -0.473 . . . . 75.349999999999994 109.723 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.414 HG23 HD22 ' A' ' 63' ' ' LEU . 67.9 m -129.3 113.27 14.78 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.162 -0.681 . . . . 73.409999999999997 109.162 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -94.28 143.1 26.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.707 -0.797 . . . . 74.420000000000002 109.811 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.16 135.02 54.73 Favored 'General case' 0 C--O 1.279 2.644 0 C-N-CA 122.63 0.372 . . . . 64.319999999999993 111.516 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.22 -142.12 10.24 Favored Glycine 0 N--CA 1.435 -1.401 0 O-C-N 124.759 1.287 . . . . 65.439999999999998 111.882 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 86' ' ' SER . 17.9 mmt85 -88.04 154.74 20.24 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.615 1.966 . . . . 74.530000000000001 110.272 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.9 m170 89.17 130.06 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.718 1.607 . . . . 63.240000000000002 111.057 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.21 -3.22 8.27 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.818 2.345 . . . . 75.230000000000004 113.283 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.56 -25.3 60.31 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.888 -0.782 . . . . 75.109999999999999 108.888 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.9 m -78.55 143.62 36.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.335 -1.357 . . . . 61.539999999999999 107.335 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.44 -45.72 68.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.78 0.324 . . . . 74.010000000000005 111.142 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.3 pt -107.45 109.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 121.859 0.838 . . . . 74.319999999999993 111.032 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -87.86 115.81 25.59 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.514 -1.221 . . . . 74.109999999999999 110.652 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.21 139.98 49.79 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.1 -1.815 . . . . 72.540000000000006 106.1 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -92.2 117.05 29.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.474 -1.29 . . . . 71.140000000000001 110.197 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 171.69 7.82 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 110.24 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.93 -29.38 17.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.343 1.057 . . . . 71.530000000000001 109.76 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.3 t -131.26 -163.17 1.29 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.484 -0.932 . . . . 74.450000000000003 108.484 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -84.05 97.33 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.791 0.805 . . . . 75.230000000000004 109.008 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 16.4 t -95.9 77.83 3.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.879 -1.526 . . . . 75.219999999999999 106.879 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -56.68 -44.48 81.48 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 112.825 0.676 . . . . 74.329999999999998 112.825 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -163.42 97.3 0.88 Allowed 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.108 -1.812 . . . . 75.209999999999994 106.108 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 23.7 t-160 -92.77 -52.04 4.8 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.883 -0.727 . . . . 75.109999999999999 109.483 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -128.25 150.14 50.17 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 118.986 -1.086 . . . . 74.239999999999995 110.246 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.36 134.46 36.0 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.97 -0.752 . . . . 74.430000000000007 108.97 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -104.27 120.31 40.89 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.43 -1.693 . . . . 75.129999999999995 106.43 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -110.19 133.75 52.91 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.61 -1.256 . . . . 72.319999999999993 107.61 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.535 HD11 ' O ' ' A' ' 65' ' ' GLN . 1.9 mp -103.6 113.47 40.52 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 105.64 -1.985 . . . . 72.420000000000002 105.64 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -130.0 122.52 28.61 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.36 -1.291 . . . . 72.129999999999995 108.19 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 56.54 36.86 28.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.937 0.895 . . . . 71.349999999999994 110.786 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.44 1.69 77.01 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.218 -0.447 . . . . 73.150000000000006 113.873 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.23 152.78 29.34 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.852 0.461 . . . . 75.510000000000005 110.337 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -102.2 117.92 35.79 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.22 0.533 . . . . 74.430000000000007 110.483 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -114.89 131.85 56.72 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.078 -1.082 . . . . 74.200000000000003 108.078 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 48.0 t -103.55 124.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.817 -0.809 . . . . 72.25 108.817 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.71 129.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 115.586 -0.734 . . . . 75.329999999999998 109.247 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.0 121.9 23.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.495 -1.669 . . . . 64.230000000000004 106.495 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.43 12.42 7.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.032 0.444 . . . . 75.420000000000002 110.853 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . 169.65 83.35 0.05 OUTLIER Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.595 -1.002 . . . . 73.040000000000006 110.595 -178.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.8 m -60.63 100.44 0.11 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 122.832 0.453 . . . . 64.319999999999993 110.735 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 tp -73.68 -52.31 13.72 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.988 -1.115 . . . . 74.420000000000002 107.988 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -121.44 -19.15 7.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.092 0.949 . . . . 65.030000000000001 108.613 170.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.08 130.41 3.74 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 108.446 -1.862 . . . . 72.409999999999997 108.446 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 56.3 m -81.73 130.18 34.97 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 117.13 0.465 . . . . 73.230000000000004 109.984 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.426 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 98.1 m-85 -105.43 126.24 51.89 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.29 -0.633 . . . . 72.099999999999994 109.29 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.57 122.82 67.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 105.642 -1.984 . . . . 73.420000000000002 105.642 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 56.67 39.65 29.64 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.49 1.138 . . . . 71.040000000000006 108.155 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER 62.5 8.69 3.0 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.267 1.827 . . . . 73.409999999999997 113.44 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.28 134.53 20.44 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.949 -0.76 . . . . 75.540000000000006 108.949 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.8 123.01 12.36 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 121.977 1.784 . . . . 74.400000000000006 109.737 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -145.33 148.71 33.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.959 -0.756 . . . . 75.409999999999997 108.959 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -95.1 -70.16 0.72 Allowed 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.158 -0.682 . . . . 73.340000000000003 109.158 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -124.53 134.47 52.99 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 119.715 -0.794 . . . . 63.329999999999998 109.835 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -155.19 147.04 23.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.095 -0.502 . . . . 74.239999999999995 110.832 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.24 132.12 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.698 -1.593 . . . . 74.549999999999997 106.698 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.2 tpp -90.15 148.79 22.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 112.963 0.727 . . . . 73.340000000000003 112.963 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.2 156.35 28.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.774 -1.103 . . . . 73.219999999999999 108.996 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.7 t -79.56 129.36 34.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.79 0.805 . . . . 73.5 111.252 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.525 ' O ' ' HD2' ' A' ' 34' ' ' PRO . . . 98.95 -2.84 58.37 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 115.485 -0.779 . . . . 73.219999999999999 111.82 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.97 153.25 21.18 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.403 -0.592 . . . . 70.230000000000004 109.403 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.03 132.18 56.73 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.692 0.758 . . . . 74.25 112.077 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.9 mt -111.16 126.37 68.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.444 -1.317 . . . . 73.010000000000005 107.444 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 25.9 tt0 -106.41 114.99 29.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.53 0.681 . . . . 71.319999999999993 110.62 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mm -110.61 133.69 55.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.026 -1.443 . . . . 74.409999999999997 108.09 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.88 -93.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.375 -1.09 . . . . 65.5 110.375 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -140.03 9.06 2.32 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.563 0.345 . . . . 74.019999999999996 110.941 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.0 p90 -131.7 152.53 50.81 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.033 -0.417 . . . . 73.209999999999994 111.775 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -112.83 146.15 39.39 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 114.126 1.158 . . . . 74.439999999999998 114.126 -174.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mp -114.55 141.79 47.28 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.285 -1.78 . . . . 74.230000000000004 107.454 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -109.4 121.57 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.888 -1.523 . . . . 75.409999999999997 106.888 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -91.65 116.22 28.69 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.681 -0.69 . . . . 75.200000000000003 109.944 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.84 147.93 37.53 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.687 -0.486 . . . . 75.450000000000003 109.687 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.03 142.41 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.776 -0.453 . . . . 73.150000000000006 109.776 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.3 136.53 47.8 Favored Glycine 0 N--CA 1.441 -1.013 0 O-C-N 123.914 0.759 . . . . 72.129999999999995 112.496 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.19 162.46 35.78 Favored 'Trans proline' 0 C--O 1.251 1.156 0 C-N-CA 123.192 2.595 . . . . 75.430000000000007 112.357 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.5 46.02 0.61 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.96 0.886 . . . . 74.129999999999995 110.883 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.421 -1.326 . . . . 73.299999999999997 107.421 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 108.483 -0.932 . . . . 75.230000000000004 108.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.648 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 91.2 t -83.56 122.91 38.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.071 -0.344 . . . . 74.209999999999994 110.071 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -115.39 139.91 49.6 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.248 0.547 . . . . 75.420000000000002 110.369 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -88.3 118.23 27.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.421 -0.809 . . . . 75.239999999999995 109.594 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.84 169.81 14.13 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.547 -0.752 . . . . 61.219999999999999 110.311 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.19 8.21 24.92 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.989 1.716 . . . . 71.510000000000005 112.145 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -4.78 1.3 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.604 1.162 . . . . 75.109999999999999 113.861 -175.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.47 -40.31 86.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.285 0.634 . . . . 74.409999999999997 109.32 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -64.97 -27.71 69.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.78 -0.645 . . . . 74.219999999999999 111.323 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.46 ' HB3' HE22 ' A' ' 129' ' ' GLN . 72.5 mm-40 -69.07 -48.73 61.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.45 -0.341 . . . . 72.019999999999996 110.931 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 ptp -68.74 -17.98 64.14 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.721 0.296 . . . . 73.230000000000004 110.996 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.97 -50.17 4.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 112.079 0.4 . . . . 72.230000000000004 112.079 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 m -102.05 -27.61 12.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.565 1.321 . . . . 74.430000000000007 114.565 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -76.2 -21.67 56.19 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.287 -1.005 . . . . 74.430000000000007 108.287 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -70.58 119.57 14.93 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.655 -1.157 . . . . 70.409999999999997 108.429 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.06 -37.25 0.53 Allowed Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 106.909 -2.476 . . . . 55.009999999999998 106.909 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -77.81 122.12 25.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.431 -0.951 . . . . 64.010000000000005 108.431 173.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.64 155.57 62.08 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 116.32 -0.4 . . . . 72.25 109.965 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.03 158.33 21.83 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.95 2.433 . . . . 73.219999999999999 111.669 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.48 156.93 25.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.811 -0.44 . . . . 74.420000000000002 109.811 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -118.26 134.56 54.92 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 108.744 -0.836 . . . . 74.230000000000004 108.744 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.2 p -144.44 162.45 36.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.793 -1.188 . . . . 75.310000000000002 107.793 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.89 18.14 56.29 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.402 -1.079 . . . . 61.399999999999999 110.402 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.1 11.3 23.57 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.396 0.679 . . . . 75.219999999999999 111.179 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.26 3.64 5.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.392 0.677 . . . . 71.420000000000002 112.279 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.04 -16.72 18.58 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.223 -1.029 . . . . 75.329999999999998 108.223 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.34 85.68 0.18 Allowed Pre-proline 0 C--O 1.222 -0.37 0 CA-C-N 115.048 -0.978 . . . . 74.319999999999993 111.101 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.23 -54.04 4.94 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.923 2.415 . . . . 73.200000000000003 113.166 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.46 0.76 51.35 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.251 -0.432 . . . . 63.409999999999997 111.108 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 10.8 70.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 116.344 -0.389 . . . . 70.129999999999995 112.928 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 m -124.13 149.45 46.23 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.476 -0.565 . . . . 71.140000000000001 109.476 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.26 157.41 44.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.802 -1.184 . . . . 71.439999999999998 107.802 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.54 155.34 50.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.43 -0.508 . . . . 75.400000000000006 111.328 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 pp -119.79 134.53 55.2 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.927 -0.578 . . . . 74.420000000000002 109.812 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.09 132.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.121 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 HG23 ' ND2' ' A' ' 56' ' ' ASN . 21.8 t -83.55 118.39 30.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.199 -1.037 . . . . 74.430000000000007 108.199 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.74 -31.62 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.554 0.693 . . . . 74.540000000000006 110.338 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.638 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 64.6 ttt180 -137.8 136.63 37.41 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.894 -1.15 . . . . 74.109999999999999 107.894 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.27 176.91 15.97 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 110.195 -1.162 . . . . 64.0 110.195 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.68 -32.89 18.0 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 122.268 1.979 . . . . 74.420000000000002 110.986 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.481 ' ND2' HG23 ' A' ' 51' ' ' VAL . 4.2 p-10 -99.67 23.32 9.71 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.959 -1.019 . . . . 74.439999999999998 110.561 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.43 57.6 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.071 -0.513 . . . . 71.129999999999995 110.718 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.94 -18.28 50.16 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.856 -0.898 . . . . 41.299999999999997 110.856 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 147.42 25.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.76 0.314 . . . . 73.349999999999994 110.328 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -124.42 139.23 54.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.937 -1.134 . . . . 74.530000000000001 107.937 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.78 134.7 54.92 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.032 -1.099 . . . . 73.430000000000007 108.032 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tt -104.29 128.59 52.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.64 0.734 . . . . 73.310000000000002 110.703 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 76.1 mt -103.54 107.55 18.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.642 -0.708 . . . . 75.040000000000006 109.768 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -146.64 17.24 1.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.781 1.277 . . . . 73.219999999999999 107.87 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.493 ' NE2' ' HA ' ' A' ' 63' ' ' LEU . 3.3 pm0 -118.12 149.87 46.44 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.294 -1.321 . . . . 74.430000000000007 109.536 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.2 Cg_exo -55.25 -30.66 72.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.148 2.566 . . . . 73.409999999999997 114.453 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 m -149.45 131.68 15.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.686 -0.805 . . . . 75.510000000000005 111.062 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 m -133.81 114.08 12.98 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.298 -0.63 . . . . 75.109999999999999 109.298 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -88.6 132.53 34.51 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.703 -0.851 . . . . 73.329999999999998 108.703 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 140.54 49.83 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 120.915 0.388 . . . . 71.209999999999994 111.257 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.45 -160.42 30.94 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 107.719 -2.152 . . . . 63.530000000000001 107.719 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 35.9 ttp180 -119.31 117.71 29.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.162 0.981 . . . . 75.340000000000003 110.348 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 0.5 OUTLIER 161.54 158.79 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 104.094 -2.558 . . . . 74.129999999999995 104.094 173.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 18.9 Cg_endo -64.54 -9.91 22.32 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 121.969 1.78 . . . . 74.140000000000001 112.229 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.51 -10.98 58.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.645 -0.707 . . . . 75.450000000000003 110.197 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 m -87.25 143.88 27.07 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 106.526 -1.657 . . . . 74.239999999999995 106.526 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.1 -42.78 36.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.849 0.833 . . . . 74.319999999999993 109.883 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.79 132.51 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 107.372 -1.344 . . . . 75.200000000000003 107.372 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -94.02 117.18 29.75 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.401 0.62 . . . . 75.209999999999994 111.913 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.4 140.28 49.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.032 -2.211 . . . . 75.239999999999995 105.032 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.41 116.22 28.67 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.277 -1.369 . . . . 64.209999999999994 109.17 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.456 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 15.6 t0 -96.21 167.03 11.45 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.46 -0.791 . . . . 74.430000000000007 109.244 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.76 -30.64 29.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.044 0.449 . . . . 71.239999999999995 109.934 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -137.64 -152.81 0.45 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.257 -0.645 . . . . 72.549999999999997 109.257 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.54 98.37 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.554 0.693 . . . . 74.040000000000006 109.941 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.2 m -124.07 84.87 2.33 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.316 -1.364 . . . . 72.120000000000005 107.316 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -62.28 -44.61 96.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.04 -0.982 . . . . 74.310000000000002 111.533 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -118.78 110.93 17.82 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.003 -1.11 . . . . 71.200000000000003 108.003 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.51 ' ND1' HG23 ' A' ' 130' ' ' ILE . 11.1 t-160 -100.22 -50.79 3.84 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.592 -1.262 . . . . 72.239999999999995 107.592 171.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.11 148.85 37.29 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.286 -1.005 . . . . 74.030000000000001 108.286 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -123.83 134.88 53.52 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.469 0.652 . . . . 71.430000000000007 110.043 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.26 124.73 50.03 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.836 -1.172 . . . . 74.420000000000002 107.836 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -115.22 127.58 55.6 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.477 -0.935 . . . . 72.230000000000004 108.477 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -121.35 113.19 38.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.351 -1.351 . . . . 75.340000000000003 107.351 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -136.3 131.02 33.81 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.817 -0.438 . . . . 63.399999999999999 109.817 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 55.67 37.05 28.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.059 0.944 . . . . 64.140000000000001 111.804 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.09 3.97 90.59 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.23 -0.895 . . . . 74.010000000000005 113.461 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -109.0 139.14 44.28 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.552 -0.536 . . . . 74.340000000000003 109.552 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -114.94 122.02 44.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.697 -0.683 . . . . 73.540000000000006 110.139 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.62 146.04 48.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.765 -0.457 . . . . 71.140000000000001 109.765 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.96 124.26 70.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.784 -1.191 . . . . 72.209999999999994 107.784 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.11 124.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.786 -0.82 . . . . 71.430000000000007 108.786 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -81.78 121.86 26.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.272 -1.01 . . . . 74.420000000000002 108.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 m -117.04 -11.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.955 -0.566 . . . . 73.340000000000003 110.876 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.35 46.9 1.1 Allowed Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 108.406 -1.878 . . . . 62.520000000000003 108.406 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.8 p -65.61 -3.16 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.773 1.229 . . . . 71.340000000000003 113.389 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.93 -26.65 59.77 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.045 -0.724 . . . . 73.400000000000006 109.045 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.648 ' OD1' ' HA ' ' A' ' 17' ' ' VAL . 94.3 m-20 -105.62 -21.72 13.13 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.77 -0.826 . . . . 74.310000000000002 108.77 174.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.07 119.27 0.27 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.122 -0.944 . . . . 73.329999999999998 114.03 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.4 m -87.07 138.27 31.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.048 -1.093 . . . . 74.299999999999997 108.048 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 84.8 m-85 -119.13 129.16 54.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.946 -0.39 . . . . 75.430000000000007 109.946 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.9 t -114.92 120.58 64.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.532 -1.655 . . . . 72.129999999999995 106.532 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 56.27 37.96 29.33 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.564 1.146 . . . . 74.329999999999998 110.967 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 mtm-85 66.19 19.68 11.1 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 114.222 -1.354 . . . . 74.340000000000003 112.74 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.51 133.19 23.03 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.24 -1.022 . . . . 73.430000000000007 108.24 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.51 123.6 11.0 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.57 1.513 . . . . 74.329999999999998 109.401 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -144.93 138.69 27.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.199 -1.037 . . . . 75.5 108.199 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -86.3 -37.73 18.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.13 0.49 . . . . 75.239999999999995 110.422 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.63 136.28 25.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.12 -1.067 . . . . 75.450000000000003 108.12 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.19 143.09 25.71 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 65.439999999999998 108.43 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -88.23 126.18 41.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.473 -2.047 . . . . 74.0 105.473 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.6 tpt -87.99 130.71 34.88 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 113.394 0.887 . . . . 73.540000000000006 113.394 -164.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.495 ' HB3' ' OD2' ' A' ' 126' ' ' ASP . 16.3 tt0 -107.72 141.9 38.55 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.38 1.472 . . . . 73.129999999999995 109.525 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -67.03 133.53 50.1 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.046 -0.724 . . . . 75.409999999999997 109.046 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.25 -2.71 56.5 Favored Glycine 0 C--O 1.252 1.269 0 N-CA-C 111.456 -0.658 . . . . 72.340000000000003 111.456 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 123' ' ' GLN . 96.7 m-20 -82.47 151.38 26.55 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.384 0.612 . . . . 73.349999999999994 110.402 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -112.32 131.54 55.46 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.516 -0.765 . . . . 75.530000000000001 109.718 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 21.2 mt -107.64 131.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 106.594 -1.632 . . . . 73.439999999999998 106.594 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.46 HE22 ' HB3' ' A' ' 25' ' ' GLU . 31.0 tt0 -112.6 118.24 34.53 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.251 -1.018 . . . . 73.140000000000001 108.251 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.51 HG23 ' ND1' ' A' ' 89' ' ' HIS . 43.7 mm -109.1 104.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.779 -1.1 . . . . 74.319999999999993 108.137 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.4 -83.95 0.64 Allowed Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.31 -0.859 . . . . 65.439999999999998 111.225 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -133.82 -12.89 2.57 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.114 0.566 . . . . 74.510000000000005 110.296 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.638 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.317 42.7 p90 -99.0 170.34 8.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 114.29 1.218 . . . . 64.099999999999994 114.29 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -118.46 126.07 51.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.604 . . . . 75.400000000000006 111.393 -164.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.09 140.23 52.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.066 -1.087 . . . . 73.099999999999994 108.066 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.3 t -115.35 127.51 72.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.253 -0.647 . . . . 75.5 109.253 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -98.33 121.28 40.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.956 -0.757 . . . . 75.450000000000003 108.956 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -140.49 160.63 39.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 110.553 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.72 127.29 32.4 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.525 -1.287 . . . . 74.450000000000003 107.525 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.13 -122.47 1.13 Allowed Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 115.423 -0.808 . . . . 70.349999999999994 113.2 -172.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 157.69 55.75 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.085 1.857 . . . . 74.420000000000002 114.273 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.75 20.97 11.62 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.408 -2.071 . . . . 71.230000000000004 105.408 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 112.803 -1.998 . . . . 75.310000000000002 108.836 -176.051 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 107.226 -1.398 . . . . 63.43 107.226 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.1 t -81.92 115.16 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.785 0.802 . . . . 74.109999999999999 108.914 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 29.8 p90 -119.43 142.18 48.46 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.83 -1.077 . . . . 75.530000000000001 110.469 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -125.93 90.62 3.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.406 0.622 . . . . 71.329999999999998 110.616 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.24 -84.42 0.15 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.723 -0.671 . . . . 75.519999999999996 110.419 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.06 -11.47 59.91 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.621 -0.718 . . . . 72.409999999999997 109.797 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 89.8 mt -64.31 -15.83 61.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.012 -0.995 . . . . 74.219999999999999 111.784 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -45.78 90.32 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.302 -0.629 . . . . 74.340000000000003 109.302 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -86.04 -33.57 20.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 109.68 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 4.6 tp10 -59.11 -33.14 70.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.418 -0.81 . . . . 73.519999999999996 110.414 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 42.3 tpp -59.47 -49.55 77.37 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.527 -0.306 . . . . 74.540000000000006 111.585 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.46 -29.49 67.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.107 0.48 . . . . 75.540000000000006 110.927 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -73.89 -25.77 60.2 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.588 0.709 . . . . 74.120000000000005 110.583 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.457 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 8.2 t -89.71 -15.73 31.9 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.468 -0.787 . . . . 73.109999999999999 110.625 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 m -62.69 101.57 0.26 Allowed 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.384 0.611 . . . . 74.239999999999995 110.59 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.69 -146.66 15.64 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.652 -1.379 . . . . 71.109999999999999 109.652 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.455 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 54.3 m -116.43 134.25 55.08 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.277 0.539 . . . . 72.450000000000003 110.686 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.18 94.65 5.81 Favored Pre-proline 0 C--O 1.246 0.872 0 N-CA-C 109.651 -0.5 . . . . 61.520000000000003 109.651 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 32' ' ' THR . 4.0 Cg_exo -76.39 160.71 35.37 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.343 2.696 . . . . 70.109999999999999 112.818 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.82 168.84 17.66 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.48 -0.934 . . . . 73.129999999999995 108.48 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 m -117.0 158.57 23.9 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.797 -0.445 . . . . 72.420000000000002 109.797 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -92.51 154.89 18.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.454 -0.943 . . . . 75.120000000000005 108.454 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.01 -29.44 1.0 Allowed Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.671 -0.776 . . . . 65.519999999999996 111.551 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.93 80.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.727 -0.472 . . . . 73.430000000000007 109.727 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.83 -6.44 41.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.613 -0.721 . . . . 74.420000000000002 111.854 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.3 -19.95 20.22 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.873 -1.158 . . . . 65.25 107.873 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.8 mt 58.91 88.0 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 113.97 -1.468 . . . . 73.219999999999999 111.391 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.44 -58.89 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.487 2.124 . . . . 74.25 110.097 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 0.89 7.59 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.585 -0.734 . . . . 72.540000000000006 109.138 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.15 85.99 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.117 -0.947 . . . . 64.140000000000001 111.419 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -134.85 165.56 25.02 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.082 -1.451 . . . . 65.409999999999997 107.082 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 158.87 43.1 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.256 -0.646 . . . . 73.439999999999998 109.256 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.41 157.8 35.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.444 -0.206 . . . . 74.019999999999996 110.444 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.15 139.01 54.25 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.204 -1.036 . . . . 75.010000000000005 108.204 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -118.65 137.26 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 120.791 0.329 . . . . 73.25 110.136 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.83 118.22 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 106.404 -1.702 . . . . 73.310000000000002 106.404 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -94.91 -31.62 13.59 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.695 -0.684 . . . . 74.340000000000003 109.918 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -145.83 137.78 25.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.933 -0.766 . . . . 73.25 108.933 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' HE2' ' A' ' 132' ' ' LYS . . . 133.29 178.74 15.76 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.457 -1.057 . . . . 72.340000000000003 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 85.4 Cg_exo -55.3 -40.49 85.35 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.684 2.256 . . . . 73.400000000000006 112.154 177.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -90.36 16.31 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.512 -0.313 . . . . 73.019999999999996 111.593 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.96 132.7 54.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.919 0.39 . . . . 75.450000000000003 111.197 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -19.77 32.0 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.576 -0.738 . . . . 72.120000000000005 111.635 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 131.74 34.28 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.946 0.403 . . . . 73.310000000000002 110.625 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -113.3 139.15 49.08 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.107 -1.071 . . . . 75.329999999999998 108.107 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -126.68 128.07 46.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.747 -0.835 . . . . 71.120000000000005 108.747 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -88.23 130.03 35.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 74.209999999999994 110.528 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 103.86 12.46 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.087 -1.079 . . . . 75.349999999999994 108.087 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -121.46 -5.62 9.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.375 1.083 . . . . 72.409999999999997 108.545 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -107.95 142.14 24.62 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 114.128 -1.396 . . . . 74.409999999999997 110.487 -175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.79 -32.0 93.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.524 2.816 . . . . 75.310000000000002 112.942 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -143.6 122.04 12.41 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 109.251 -0.648 . . . . 75.239999999999995 109.251 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.41 HG22 HG12 ' A' ' 78' ' ' ILE . 21.0 m -114.54 113.92 25.07 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.844 -1.169 . . . . 74.340000000000003 107.844 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.3 p -89.8 138.43 31.49 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 111.65 0.241 . . . . 73.129999999999995 111.65 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.51 55.75 Favored 'General case' 0 C--O 1.267 2.025 0 N-CA-C 109.14 -0.689 . . . . 74.030000000000001 109.14 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.49 -145.39 11.33 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.022 -0.99 . . . . 43.32 110.723 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' C ' ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -105.84 151.81 24.05 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 122.994 0.518 . . . . 73.230000000000004 111.909 -177.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t-80 76.75 143.39 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.93 1.292 . . . . 75.319999999999993 110.407 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 88.0 Cg_exo -48.28 -6.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 124.846 3.697 . . . . 74.209999999999994 116.688 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.83 -24.63 59.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.662 -0.866 . . . . 74.200000000000003 108.662 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.422 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 19.4 m -92.07 115.37 28.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 106.56 -1.644 . . . . 75.310000000000002 106.56 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.53 -36.25 77.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.941 -0.572 . . . . 73.219999999999999 111.409 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 68' ' ' THR . 42.3 mm -106.7 99.56 8.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.016 -1.105 . . . . 72.109999999999999 108.016 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -93.36 110.3 21.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.727 -0.67 . . . . 74.450000000000003 109.901 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 87.0 mt -116.64 122.5 44.76 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.34 -1.356 . . . . 74.510000000000005 107.34 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.11 117.08 29.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.662 -0.815 . . . . 61.109999999999999 109.896 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 132' ' ' LYS . 10.0 t70 -120.62 -165.11 1.16 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.385 -0.968 . . . . 75.450000000000003 108.385 -173.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.41 -35.51 19.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.403 -0.962 . . . . 75.430000000000007 108.403 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.421 ' HB ' ' CE1' ' A' ' 18' ' ' PHE . 83.2 m -145.63 99.44 3.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.261 -1.015 . . . . 74.450000000000003 108.261 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG21 ' H ' ' A' ' 82' ' ' ASP . 7.1 t -88.78 131.48 36.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.677 -0.49 . . . . 72.409999999999997 109.677 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -79.25 157.78 27.71 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.785 -0.643 . . . . 72.519999999999996 110.304 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -62.76 -45.86 90.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 74.430000000000007 109.68 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -147.25 99.55 3.16 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 103.784 -2.673 . . . . 74.439999999999998 103.784 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.508 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 5.1 t60 -79.32 -50.26 11.15 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.915 -1.513 . . . . 71.340000000000003 106.915 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.25 163.02 40.74 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.468 -1.242 . . . . 44.43 109.539 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.49 141.38 48.76 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 109.076 -0.712 . . . . 72.420000000000002 109.076 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.83 114.08 28.08 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.712 -1.959 . . . . 71.540000000000006 105.712 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -109.95 127.5 54.8 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-N 114.736 -1.12 . . . . 74.219999999999999 110.488 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 94' ' ' ILE . 3.0 mp -109.04 112.12 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 104.099 -2.556 . . . . 73.319999999999993 104.099 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -135.48 121.09 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.225 -0.657 . . . . 62.240000000000002 109.225 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 56.53 37.85 29.16 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.379 1.05 . . . . 61.200000000000003 110.687 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.47 88.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.359 -0.837 . . . . 73.019999999999996 113.469 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.48 141.31 36.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.912 -0.774 . . . . 75.219999999999999 108.912 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -111.4 117.01 31.9 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.222 -0.658 . . . . 74.430000000000007 109.222 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 146.2 52.29 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.793 0.33 . . . . 75.230000000000004 111.775 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.79 123.37 57.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.18 -1.785 . . . . 74.439999999999998 106.18 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.1 t -119.15 126.51 75.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.103 -0.703 . . . . 63.32 109.103 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -81.05 123.54 28.45 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.197 -1.409 . . . . 73.340000000000003 107.197 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.38 14.55 7.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-O 121.049 0.452 . . . . 64.120000000000005 111.244 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.492 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . -108.9 -30.68 3.62 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.41 -1.076 . . . . 73.349999999999994 110.41 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.3 p 67.43 -52.86 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.55 2.34 . . . . 73.230000000000004 113.56 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.31 -20.43 60.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.902 0.382 . . . . 74.510000000000005 111.037 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.508 ' OD1' ' HA ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -87.28 -20.25 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.227 1.195 . . . . 74.349999999999994 114.227 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.06 87.0 0.04 OUTLIER Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.344 0.897 . . . . 64.109999999999999 115.344 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.9 m -79.51 137.59 37.24 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 73.430000000000007 108.787 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.508 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 30.1 m-85 -113.06 126.87 55.95 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.539 -0.465 . . . . 73.310000000000002 109.97 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.45 135.93 55.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 105.006 -2.22 . . . . 73.140000000000001 105.006 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m120 53.47 34.74 18.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 75.409999999999997 107.601 -165.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 29' ' ' SER . 37.9 mtm180 57.92 12.76 1.85 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.025 1.12 . . . . 74.200000000000003 114.025 -175.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -104.27 134.17 19.83 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.84 -0.8 . . . . 73.510000000000005 108.84 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.04 123.49 12.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.12 1.88 . . . . 73.129999999999995 111.657 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -140.62 165.39 27.59 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 116.079 -0.509 . . . . 74.209999999999994 110.825 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -103.91 -36.74 7.68 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.282 -1.007 . . . . 72.140000000000001 108.282 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.24 134.85 17.44 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.63 -1.248 . . . . 63.149999999999999 107.63 173.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.31 143.63 22.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.137 -0.69 . . . . 73.349999999999994 109.137 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.75 125.63 34.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.605 -0.887 . . . . 73.219999999999999 108.605 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -90.06 130.27 36.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 64.420000000000002 110.19 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -113.79 156.41 23.9 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.128 -0.942 . . . . 74.329999999999998 109.717 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.3 t -67.53 124.64 23.79 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 121.387 0.613 . . . . 75.019999999999996 109.565 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.09 57.56 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.909 -0.877 . . . . 72.450000000000003 110.909 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -79.92 151.84 29.89 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.77 125.91 50.68 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.024 -0.732 . . . . 74.310000000000002 109.024 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -109.33 129.55 63.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 106.846 -1.538 . . . . 73.519999999999996 106.846 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 54.8 tp60 -110.05 123.22 49.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.274 -1.01 . . . . 73.319999999999993 108.274 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.4 mt -128.77 104.17 10.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.782 -1.192 . . . . 65.120000000000005 107.782 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.21 -117.21 8.25 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.4 -1.48 . . . . 55.310000000000002 109.4 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.445 ' HG3' ' OD2' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -106.46 5.75 29.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.289 0.566 . . . . 75.319999999999993 110.894 175.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.59 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 69.6 m-85 -85.37 133.21 34.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.676 -0.693 . . . . 75.129999999999995 111.091 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -110.8 119.22 38.39 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.187 -2.153 . . . . 75.219999999999999 105.187 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 mt -114.87 139.85 49.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.018 -0.734 . . . . 74.109999999999999 109.018 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.21 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.309 -0.997 . . . . 62.340000000000003 108.309 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.75 127.72 38.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.283 -0.636 . . . . 64.299999999999997 109.283 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.61 130.78 42.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.229 0.538 . . . . 74.400000000000006 110.582 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.96 122.79 44.13 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.575 -0.898 . . . . 74.019999999999996 108.575 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.0 -144.17 3.87 Favored Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.282 -1.437 . . . . 62.43 113.088 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.83 146.7 60.52 Favored 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.681 2.921 . . . . 74.219999999999999 113.157 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 179.66 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.992 1.317 . . . . 74.340000000000003 108.526 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 107.462 -1.31 . . . . 74.150000000000006 107.462 -176.065 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.434 -1.246 0 CA-C-O 121.281 0.562 . . . . 75.109999999999999 112.091 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 58.6 t -93.85 115.7 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.553 -2.017 . . . . 73.129999999999995 105.553 170.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -108.04 127.5 53.83 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.152 -1.019 . . . . 75.0 111.544 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -106.96 101.91 11.31 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 109.468 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.56 166.21 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.928 -0.578 . . . . 64.209999999999994 111.539 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.08 -6.99 19.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.136 1.374 . . . . 74.230000000000004 112.25 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.64 -25.42 60.12 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.51 0.93 . . . . 61.520000000000003 113.51 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 88.4 mt -81.47 -28.59 34.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 111.806 0.299 . . . . 74.150000000000006 111.806 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -53.95 -45.43 71.3 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.883 0.873 . . . . 73.200000000000003 111.878 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 26' ' ' MET . 8.0 pt-20 -70.19 -37.02 75.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.823 0.344 . . . . 72.150000000000006 111.888 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.425 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 22.9 ptp -79.79 -27.36 40.36 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 112.596 0.591 . . . . 75.420000000000002 112.596 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 48.3 mt-10 -58.4 -49.46 77.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.974 0.352 . . . . 72.400000000000006 111.18 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -68.74 -26.41 65.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.632 -0.713 . . . . 74.25 110.878 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.7 t -88.17 -22.74 23.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.655 -0.702 . . . . 73.540000000000006 110.409 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.3 m -97.31 105.87 18.09 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.64 0.733 . . . . 71.430000000000007 112.097 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.9 -29.13 0.76 Allowed Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.287 -1.525 . . . . 73.049999999999997 109.287 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -116.11 148.99 39.71 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.77 -0.826 . . . . 74.310000000000002 108.77 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.47 138.92 20.68 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.652 -1.61 . . . . 72.510000000000005 106.652 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.25 142.52 91.83 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.125 1.884 . . . . 64.349999999999994 112.784 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.36 149.49 51.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.079 -0.712 . . . . 64.450000000000003 109.079 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -129.23 139.56 51.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.797 0.332 . . . . 70.420000000000002 110.624 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 m -79.34 115.07 18.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 71.329999999999998 108.036 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.16 8.2 22.05 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 110.622 -0.991 . . . . 64.519999999999996 110.622 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.09 87.67 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 123.514 0.725 . . . . 70.409999999999997 111.75 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.89 1.9 56.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.054 -0.521 . . . . 75.430000000000007 111.532 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -33.39 12.0 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.433 -1.321 . . . . 75.400000000000006 107.433 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.4 mm? 59.73 84.06 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 108.17 -1.048 . . . . 70.310000000000002 108.17 -173.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 6.8 Cg_endo -42.7 -61.85 0.5 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.593 3.529 . . . . 74.140000000000001 115.328 -168.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -13.77 40.69 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.201 -0.599 . . . . 74.209999999999994 112.151 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.22 -4.86 77.89 Favored Glycine 0 C--N 1.317 -0.5 0 C-N-CA 121.111 -0.566 . . . . 72.109999999999999 112.253 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.7 m -133.93 163.65 29.04 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.922 -0.769 . . . . 74.120000000000005 108.922 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.39 150.81 36.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.367 -0.605 . . . . 74.409999999999997 109.367 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.51 148.57 44.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.067 -0.515 . . . . 73.340000000000003 110.556 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -105.32 133.9 49.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.637 -0.875 . . . . 65.019999999999996 108.637 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.4 128.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.584 -0.895 . . . . 75.030000000000001 108.584 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.1 t -77.18 118.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.593 -1.632 . . . . 65.099999999999994 106.593 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -89.73 -33.92 16.4 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.231 0.539 . . . . 73.430000000000007 109.666 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 2.2 tpm_? -144.79 136.95 26.06 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.989 -1.115 . . . . 71.430000000000007 107.989 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.17 -171.45 25.64 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 109.442 -1.463 . . . . 52.119999999999997 109.442 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.32 -43.64 5.81 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.522 2.148 . . . . 75.319999999999993 111.067 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.16 22.7 5.63 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.308 -0.86 . . . . 70.230000000000004 112.005 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.49 129.78 42.2 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.979 0.419 . . . . 74.430000000000007 111.069 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.97 -21.46 29.49 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.684 -0.689 . . . . 74.299999999999997 111.379 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.03 29.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.725 0.298 . . . . 72.420000000000002 110.224 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -128.8 139.05 52.36 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.721 -0.844 . . . . 75.349999999999994 108.721 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.09 131.12 53.81 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.981 -0.748 . . . . 73.310000000000002 108.981 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.3 tp -89.55 126.82 35.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.983 -0.377 . . . . 73.030000000000001 109.983 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -82.58 103.99 12.52 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.175 -0.676 . . . . 73.450000000000003 109.175 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -126.65 5.28 6.76 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 123.006 1.384 . . . . 71.140000000000001 108.061 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.81 149.75 39.4 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 114.197 -1.365 . . . . 72.420000000000002 108.792 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.99 -16.04 32.44 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.615 2.21 . . . . 71.219999999999999 113.036 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 90.3 m -154.58 128.85 9.01 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.05 -0.722 . . . . 74.299999999999997 109.05 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 20.5 m -118.58 121.38 40.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 m -96.28 130.24 43.42 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.609 -0.515 . . . . 65.540000000000006 109.609 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.04 139.4 53.35 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 116.414 -0.357 . . . . 73.120000000000005 110.19 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.37 -161.0 30.97 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.217 -1.553 . . . . 75.040000000000006 109.217 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 16.7 ttp180 -119.45 116.99 27.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 118.116 0.958 . . . . 74.349999999999994 109.544 176.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER 152.94 156.74 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 104.621 -2.363 . . . . 72.430000000000007 104.621 176.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.85 -9.29 15.98 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.443 2.096 . . . . 73.340000000000003 113.258 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.07 -18.45 60.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.461 . . . . 75.019999999999996 110.728 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 m -98.02 123.58 42.1 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 116.134 -0.485 . . . . 71.109999999999999 109.722 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.19 -42.74 96.54 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.521 -0.918 . . . . 75.450000000000003 108.521 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.52 104.74 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 106.444 -1.687 . . . . 61.25 106.444 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 72' ' ' ARG . 59.6 t80 -88.03 113.93 24.15 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.671 -0.695 . . . . 74.319999999999993 109.149 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 2.8 mm? -110.36 113.4 26.03 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.489 -0.93 . . . . 73.530000000000001 108.489 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 29.2 t70 -79.11 118.32 20.97 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.025 0.44 . . . . 72.319999999999993 110.745 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -133.08 178.0 7.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.259 -1.015 . . . . 64.549999999999997 108.259 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.07 -28.99 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 124.084 0.954 . . . . 75.140000000000001 109.247 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.401 ' HB ' HD22 ' A' ' 108' ' ' ASN . 0.7 OUTLIER -104.11 152.98 21.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.716 -0.675 . . . . 74.129999999999995 110.52 -174.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -92.19 97.46 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.698 -0.853 . . . . 74.109999999999999 108.698 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -99.81 87.83 3.63 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.595 -0.891 . . . . 64.319999999999993 108.595 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -66.92 -28.97 68.74 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.655 -0.702 . . . . 72.319999999999993 112.513 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -145.29 91.28 2.11 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.125 -1.805 . . . . 73.129999999999995 106.125 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 31.3 t60 -100.63 -52.81 3.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.053 -1.059 . . . . 71.430000000000007 112.075 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.17 141.93 46.01 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.48 -0.763 . . . . 74.310000000000002 109.158 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -122.58 129.41 51.89 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.304 -0.999 . . . . 61.210000000000001 108.304 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 67' ' ' THR . 7.7 m-85 -105.2 117.83 35.0 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.403 -1.703 . . . . 64.219999999999999 106.403 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -109.75 119.23 38.71 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.643 -0.873 . . . . 75.040000000000006 108.643 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 94' ' ' ILE . 3.3 mp -111.96 113.29 43.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.684 -1.598 . . . . 74.420000000000002 106.684 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -138.92 123.89 18.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.943 -0.391 . . . . 72.030000000000001 109.943 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.39 36.8 26.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.413 1.085 . . . . 75.409999999999997 112.128 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 3.53 90.45 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.977 -0.63 . . . . 71.310000000000002 113.19 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -100.89 131.23 46.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.475 -0.935 . . . . 70.239999999999995 108.475 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -108.13 116.42 31.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.324 -0.991 . . . . 71.310000000000002 108.324 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -123.6 126.16 46.14 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.335 -0.616 . . . . 74.209999999999994 109.335 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.41 123.13 56.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.511 -1.292 . . . . 74.329999999999998 107.511 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.48 138.04 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 115.586 -0.733 . . . . 54.100000000000001 110.648 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 106.141 -1.8 . . . . 73.219999999999999 106.141 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.0 m -92.41 17.07 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.756 0.65 . . . . 74.510000000000005 112.756 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.26 47.28 4.72 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 107.728 -2.149 . . . . 53.409999999999997 107.728 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.7 m -79.28 175.98 10.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.467 -0.866 . . . . 70.120000000000005 112.654 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 2.3 mm? -101.72 -28.17 12.62 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.578 0.955 . . . . 64.019999999999996 113.578 -171.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -86.61 -20.47 27.82 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 118.518 -1.273 . . . . 75.140000000000001 111.127 -173.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.79 100.13 2.29 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 119.337 -1.411 . . . . 75.209999999999994 112.615 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 m -87.41 129.13 35.15 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.52 -0.918 . . . . 53.0 108.52 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 20.4 m-85 -127.96 126.7 41.92 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.969 -1.123 . . . . 74.319999999999993 107.969 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -111.7 131.84 61.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.129 -1.434 . . . . 74.540000000000006 107.129 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.661 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 17.4 m120 57.78 38.29 27.32 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.608 0.763 . . . . 73.109999999999999 110.187 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.76 14.46 7.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.966 1.307 . . . . 75.209999999999994 113.211 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.64 145.24 37.11 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 122.351 -0.218 . . . . 74.519999999999996 110.523 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.09 123.55 13.42 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.607 1.538 . . . . 72.310000000000002 108.431 171.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -139.5 145.85 39.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.828 -1.175 . . . . 72.430000000000007 107.828 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -103.31 -44.04 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.934 -0.306 . . . . 75.209999999999994 110.85 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.14 24.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.007 -1.108 . . . . 72.329999999999998 108.007 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -150.26 134.59 17.21 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.783 -0.367 . . . . 74.200000000000003 111.264 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.6 t -78.9 114.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 104.584 -2.376 . . . . 74.040000000000006 104.584 170.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 80.3 mtp -97.09 144.59 26.8 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.721 1.008 . . . . 74.409999999999997 113.721 -172.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.526 ' HG3' ' OD2' ' A' ' 126' ' ' ASP . 4.8 pp0? -119.73 157.84 27.74 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.0 -1.455 . . . . 74.120000000000005 108.328 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.3 p -58.83 126.87 29.46 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 123.508 0.723 . . . . 72.319999999999993 111.62 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.56 -5.53 54.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.927 -0.579 . . . . 71.340000000000003 113.327 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' A' ' 123' ' ' GLN . 73.3 m-20 -76.81 143.91 39.47 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 117.799 0.799 . . . . 73.129999999999995 109.337 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.661 ' OE1' ' HA ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -112.57 145.44 40.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.045 0.45 . . . . 75.409999999999997 111.412 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 41.1 mt -116.71 126.91 74.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.579 -0.897 . . . . 74.040000000000006 108.579 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 24.3 tp60 -104.81 113.45 27.05 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 104.941 -2.244 . . . . 75.420000000000002 104.941 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 62.8 mt -109.28 103.87 16.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.91 -1.144 . . . . 72.200000000000003 107.91 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.16 -98.84 0.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 CA-C-N 115.206 -0.906 . . . . 63.520000000000003 111.266 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -119.44 2.67 11.28 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.937 1.088 . . . . 72.510000000000005 113.937 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.25 25.4 p90 -131.23 168.97 16.6 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.549 -0.719 . . . . 72.340000000000003 112.19 176.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -129.22 138.96 52.0 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 113.037 0.754 . . . . 74.439999999999998 113.037 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.87 139.79 53.19 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.682 -1.599 . . . . 74.450000000000003 106.682 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.63 140.2 40.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 109.42 -0.585 . . . . 73.209999999999994 109.42 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -92.9 115.5 28.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.048 -0.723 . . . . 73.299999999999997 109.048 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.06 159.95 22.96 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.121 0.486 . . . . 75.230000000000004 111.691 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.77 131.46 39.81 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.84 -0.8 . . . . 74.439999999999998 108.84 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.06 143.0 15.92 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.309 -0.948 . . . . 73.340000000000003 110.922 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -59.24 156.0 37.38 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.592 2.194 . . . . 62.450000000000003 111.567 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.83 61.22 6.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.313 1.054 . . . . 74.239999999999995 109.451 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.292 -1.919 0 CA-C-N 113.107 -1.861 . . . . 74.530000000000001 109.846 -179.983 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.223 -1.399 . . . . 71.120000000000005 107.223 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.61 134.56 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 120.952 0.406 . . . . 72.010000000000005 111.304 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -123.18 141.35 52.07 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.111 -1.07 . . . . 73.319999999999993 108.111 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -83.78 137.29 33.8 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.275 -0.57 . . . . 74.409999999999997 109.808 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.93 151.19 23.45 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.411 -0.588 . . . . 64.409999999999997 109.411 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.08 2.76 56.08 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.844 0.831 . . . . 73.340000000000003 110.869 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.485 HD13 ' CZ ' ' A' ' 111' ' ' TYR . 1.9 pp -58.95 -17.45 24.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.274 1.213 . . . . 74.329999999999998 114.274 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 22' ' ' LEU . 2.2 pt? -70.25 -7.71 44.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.215 0.531 . . . . 75.400000000000006 111.765 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -80.41 -28.47 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.562 -0.903 . . . . 73.340000000000003 108.562 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.54 -22.05 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.005 -1.109 . . . . 74.310000000000002 108.005 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.5 ttp -53.95 -49.54 68.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 75.439999999999998 111.175 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -9.96 58.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.065 0.459 . . . . 72.109999999999999 111.844 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -78.64 -39.26 37.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.435 -0.802 . . . . 72.230000000000004 110.112 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -87.13 -17.79 31.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.694 0.627 . . . . 64.200000000000003 112.694 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.1 m -72.61 114.0 10.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.48 -0.563 . . . . 74.200000000000003 109.48 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.6 -59.32 0.2 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.485 -1.046 . . . . 61.420000000000002 110.485 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.7 p -114.85 121.33 42.93 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.914 -0.314 . . . . 71.239999999999995 110.509 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.86 53.0 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 109.208 -0.664 . . . . 43.0 109.208 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.64 156.56 60.82 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 121.81 1.674 . . . . 72.239999999999995 108.805 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.17 124.65 21.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.87 -1.159 . . . . 53.240000000000002 107.87 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 124' ' ' THR . 10.3 m -98.78 -10.84 22.49 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.879 -0.6 . . . . 75.349999999999994 112.205 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -73.47 147.48 44.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.545 -0.752 . . . . 75.329999999999998 109.987 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 -15.08 7.72 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.327 -1.109 . . . . 63.119999999999997 110.327 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.03 68.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.198 0.523 . . . . 64.230000000000004 111.322 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 41' ' ' ASN . 11.6 pt-20 -70.81 -22.13 62.38 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.255 -0.884 . . . . 74.319999999999993 112.15 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 m-20 -96.21 -13.84 23.17 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.83 -0.433 . . . . 73.420000000000002 109.83 -175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt 55.05 66.62 3.8 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 114.98 -1.009 . . . . 75.109999999999999 110.634 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.65 -55.79 2.48 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.274 2.649 . . . . 65.239999999999995 113.569 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.72 -20.52 42.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.895 -0.593 . . . . 64.140000000000001 111.752 -176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -5.44 77.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.555 -0.831 . . . . 65.319999999999993 111.903 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -152.86 161.0 43.1 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.637 -1.246 . . . . 51.210000000000001 107.637 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.44 157.52 44.0 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.521 -0.548 . . . . 73.409999999999997 109.521 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pp -137.45 155.78 48.93 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 111.905 0.335 . . . . 75.310000000000002 111.905 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -116.22 133.67 55.77 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.001 -1.111 . . . . 71.25 108.001 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.11 133.86 51.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.57 -0.9 . . . . 73.040000000000006 108.57 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.27 118.69 31.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.765 -1.568 . . . . 75.099999999999994 106.765 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -83.26 -31.83 26.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.636 -0.711 . . . . 73.109999999999999 110.302 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -160.42 150.66 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.937 -1.505 . . . . 73.109999999999999 106.937 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.65 -167.72 17.96 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 110.217 -1.153 . . . . 62.509999999999998 110.217 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.58 -49.86 9.42 Favored 'Trans proline' 0 N--CA 1.479 0.668 0 C-N-CA 122.802 2.334 . . . . 73.239999999999995 112.257 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.6 22.54 3.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.227 -0.442 . . . . 72.150000000000006 112.045 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.23 128.73 38.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.859 0.362 . . . . 74.400000000000006 111.346 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.71 40.28 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.626 -0.715 . . . . 73.099999999999994 111.528 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 156.91 18.02 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.999 0.428 . . . . 74.209999999999994 110.155 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 139.49 30.87 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.792 -0.64 . . . . 75.310000000000002 109.564 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.39 134.05 55.46 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.2 -0.667 . . . . 73.010000000000005 109.2 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -90.79 143.77 26.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.024 -0.732 . . . . 64.299999999999997 109.024 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -111.43 110.7 21.27 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.013 0.375 . . . . 73.439999999999998 112.013 -174.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -138.35 59.56 1.64 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.849 -1.537 . . . . 65.340000000000003 106.849 168.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -146.35 140.89 15.79 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 112.884 -1.962 . . . . 75.0 107.544 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.36 -22.11 71.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.271 1.98 . . . . 73.329999999999998 113.679 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -148.79 122.23 9.08 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.539 -0.726 . . . . 73.420000000000002 111.677 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 m -113.21 113.84 25.9 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.176 -1.416 . . . . 74.540000000000006 107.176 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.7 m -94.17 138.51 32.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.089 -0.645 . . . . 72.239999999999995 109.582 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 134.76 55.01 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 109.62 -0.511 . . . . 74.430000000000007 109.62 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.26 -119.1 0.9 Allowed Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.159 -0.928 . . . . 75.420000000000002 111.687 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -118.89 152.46 36.26 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.706 0.402 . . . . 72.530000000000001 110.825 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.1 m170 90.37 151.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 125.77 1.628 . . . . 73.430000000000007 111.057 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.48 -5.71 16.69 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.02 2.48 . . . . 73.439999999999998 111.799 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.68 -26.25 60.64 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.214 -1.032 . . . . 75.310000000000002 108.214 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -83.68 122.21 28.31 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.309 -1.367 . . . . 75.430000000000007 107.309 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.02 -32.38 74.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.317 0.579 . . . . 72.340000000000003 110.902 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tp -119.41 113.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-O 121.679 0.752 . . . . 75.129999999999995 109.137 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -88.01 138.18 31.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.977 -1.011 . . . . 73.239999999999995 110.542 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.5 mt -123.82 138.76 54.44 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.29 -0.633 . . . . 64.239999999999995 109.29 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.82 127.55 38.87 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.997 -1.112 . . . . 73.450000000000003 107.997 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 83' ' ' VAL . 16.8 t70 -149.56 -161.4 1.34 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.839 -1.911 . . . . 72.219999999999999 105.839 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.413 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 46.7 t -62.61 -36.51 75.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.791 0.805 . . . . 74.310000000000002 109.665 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.0 m -149.51 125.78 10.78 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.93 -1.137 . . . . 75.519999999999996 107.93 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.59 135.23 43.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.825 -0.435 . . . . 74.319999999999993 109.825 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 159.84 27.95 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.793 -0.447 . . . . 75.420000000000002 109.793 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -57.66 -46.39 84.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.333 0.653 . . . . 63.439999999999998 110.534 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -146.34 109.72 4.76 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 103.755 -2.683 . . . . 74.450000000000003 103.755 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -90.25 -52.11 5.1 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.551 0.691 . . . . 73.530000000000001 109.611 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.59 156.05 41.3 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.59 -0.732 . . . . 74.120000000000005 109.049 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.487 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 10.0 pt-20 -134.59 134.19 41.02 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.306 0.574 . . . . 74.510000000000005 109.564 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -104.95 112.89 26.18 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.126 -2.175 . . . . 75.430000000000007 105.126 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.487 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 23.5 mtp180 -108.44 135.99 48.82 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.828 -0.624 . . . . 75.230000000000004 110.423 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.415 HG13 ' CD1' ' A' ' 99' ' ' PHE . 1.8 mp -103.59 111.68 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.664 0 N-CA-C 102.283 -3.229 . . . . 74.5 102.283 173.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -129.12 116.56 19.43 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.93 -0.767 . . . . 65.540000000000006 108.93 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 51.04 37.56 18.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.873 1.269 . . . . 75.439999999999998 111.822 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.3 -1.96 87.49 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.013 -0.54 . . . . 72.340000000000003 113.578 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.39 145.71 29.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.279 -1.008 . . . . 73.340000000000003 108.279 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.415 ' CD1' HG13 ' A' ' 94' ' ' ILE . 92.2 m-85 -104.7 117.94 35.33 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.223 -1.399 . . . . 64.319999999999993 107.223 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -129.49 130.75 46.24 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.319 0.58 . . . . 74.099999999999994 111.185 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.52 122.62 56.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.889 -1.152 . . . . 73.409999999999997 107.889 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.48 132.7 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 116.187 -0.461 . . . . 65.439999999999998 110.834 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -80.27 134.64 36.11 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.157 -1.423 . . . . 75.329999999999998 107.157 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.07 13.56 2.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.438 0.637 . . . . 73.019999999999996 111.226 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.89 74.85 0.09 OUTLIER Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.108 -1.197 . . . . 64.219999999999999 110.108 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 63.4 m -64.63 75.38 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.779 1.029 . . . . 73.329999999999998 113.779 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.81 -47.99 9.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.848 -1.538 . . . . 72.519999999999996 106.848 170.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -105.86 -20.0 13.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.966 -1.47 . . . . 75.019999999999996 108.631 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.72 99.33 0.04 OUTLIER Glycine 0 C--O 1.21 -1.385 0 N-CA-C 108.29 -1.924 . . . . 73.049999999999997 108.29 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.2 m -60.14 132.44 53.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.868 0.842 . . . . 74.200000000000003 112.904 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 83.4 m-85 -101.86 126.69 48.8 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 115.367 -0.833 . . . . 75.239999999999995 108.777 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.52 137.91 53.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.498 -1.667 . . . . 73.150000000000006 106.498 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 57.62 38.15 27.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.402 0.681 . . . . 71.109999999999999 109.693 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 59.4 26.13 14.98 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.825 -1.08 . . . . 75.5 111.923 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.8 153.0 71.67 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.585 0.354 . . . . 73.400000000000006 110.366 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.62 129.55 31.44 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.348 2.032 . . . . 74.239999999999995 109.671 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -140.42 165.5 27.24 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.768 -0.456 . . . . 75.209999999999994 109.768 -173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.91 -41.53 1.81 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.363 -0.606 . . . . 75.299999999999997 109.363 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.29 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.655 -1.239 . . . . 73.349999999999994 107.655 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -153.11 133.61 13.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 121.124 -0.23 . . . . 72.329999999999998 111.57 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.2 t -81.56 115.6 24.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 104.658 -2.349 . . . . 74.530000000000001 104.658 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.6 ptm -90.46 149.87 22.05 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.736 0.779 . . . . 75.439999999999998 112.694 -169.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 72.2 mt-30 -107.57 157.84 17.72 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.46 -1.246 . . . . 72.25 108.617 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' SER . 11.5 t -70.66 130.83 42.8 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.912 -0.715 . . . . 73.219999999999999 109.597 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.2 55.67 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 110.96 -0.856 . . . . 71.400000000000006 110.96 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 10.8 t0 -69.57 144.63 53.0 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 108.995 -0.743 . . . . 74.329999999999998 108.995 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.64 126.37 47.51 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.068 0.461 . . . . 74.239999999999995 109.875 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 70.9 mt -110.08 115.6 50.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.793 -1.094 . . . . 72.129999999999995 108.867 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.4 ' HG2' HD21 ' A' ' 22' ' ' LEU . 54.1 tt0 -105.22 123.62 48.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.584 -0.524 . . . . 65.239999999999995 109.584 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.71 129.19 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.428 0.691 . . . . 72.239999999999995 109.846 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.52 -86.4 1.46 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 109.837 -1.305 . . . . 62.009999999999998 109.837 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB2' ' HZ3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -155.94 14.32 0.34 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.288 0.635 . . . . 74.420000000000002 109.461 171.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -130.64 170.13 14.71 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.189 -0.671 . . . . 75.329999999999998 109.189 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -137.76 150.09 46.96 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.896 1.443 . . . . 74.129999999999995 114.896 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 mt -102.77 134.55 45.98 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.195 -1.78 . . . . 70.120000000000005 106.195 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.6 t -111.97 124.09 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.391 -0.966 . . . . 73.409999999999997 108.391 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -98.9 126.15 44.49 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 122.244 0.217 . . . . 74.329999999999998 110.918 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -133.81 147.48 51.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.42 -0.585 . . . . 71.510000000000005 109.42 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.59 118.69 18.7 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.621 -2.362 . . . . 73.310000000000002 104.621 169.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.04 -82.48 0.59 Allowed Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 118.502 -1.809 . . . . 54.130000000000003 113.959 -169.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.92 142.36 47.04 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 121.599 1.532 . . . . 74.540000000000006 113.859 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.48 36.7 1.67 Allowed 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 104.223 -2.51 . . . . 73.129999999999995 104.223 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.428 -1.545 0 CA-C-N 112.345 -2.207 . . . . 71.109999999999999 109.806 -171.027 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.488 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 20.0 m . . . . . 0 N--CA 1.435 -1.208 0 N-CA-C 108.552 -0.907 . . . . 65.0 108.552 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.27 115.57 29.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.01 -0.737 . . . . 74.010000000000005 109.01 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 62.2 t80 -111.89 127.44 55.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.177 -1.046 . . . . 74.450000000000003 108.177 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -126.44 137.06 53.37 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.158 -0.682 . . . . 75.519999999999996 109.158 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 22' ' ' LEU . . . -142.65 161.75 37.25 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.039 0.447 . . . . 75.409999999999997 110.751 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.02 7.45 0.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.118 1.367 . . . . 74.510000000000005 112.893 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.41 ' H ' ' C ' ' A' ' 20' ' ' ALA . 4.6 pp -58.05 -34.5 70.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.865 0.866 . . . . 73.549999999999997 111.284 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.53 -19.69 63.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.552 0.575 . . . . 62.340000000000003 112.552 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.11 -22.96 21.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.195 -0.668 . . . . 75.25 109.195 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -98.3 -42.9 7.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.397 -0.819 . . . . 65.349999999999994 113.045 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -68.25 -1.34 6.0 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.268 0.84 . . . . 74.209999999999994 113.268 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.65 -28.59 63.87 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.173 0.989 . . . . 74.230000000000004 111.128 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -63.56 -45.43 90.53 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.21 1.004 . . . . 71.230000000000004 111.378 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.2 p -79.39 -19.34 50.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.51 -0.768 . . . . 75.310000000000002 112.566 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -88.23 78.39 8.06 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 121.856 0.836 . . . . 74.510000000000005 110.141 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.79 -105.14 1.28 Allowed Glycine 0 CA--C 1.485 -1.825 0 N-CA-C 109.107 -1.597 . . . . 75.329999999999998 109.107 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 m -99.88 118.52 36.5 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.173 -1.417 . . . . 75.310000000000002 107.173 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.57 114.24 18.06 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.84 157.28 39.32 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.46 1.44 . . . . 72.120000000000005 110.517 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 125.72 31.12 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.927 -1.508 . . . . 71.299999999999997 106.927 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 15.8 m -71.0 113.93 8.54 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.229 0.538 . . . . 74.519999999999996 111.023 -175.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.7 p -98.7 140.69 32.53 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.337 -0.392 . . . . 75.109999999999999 110.306 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.01 -25.28 0.55 Allowed Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.694 -0.563 . . . . 53.310000000000002 111.694 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.89 58.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.989 0.423 . . . . 72.439999999999998 110.203 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -24.66 63.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 73.439999999999998 109.202 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.8 -13.75 47.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.776 -1.102 . . . . 73.519999999999996 109.835 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.4 mt 63.97 91.02 0.08 OUTLIER Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 115.142 -0.935 . . . . 74.340000000000003 111.174 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.87 -69.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.147 2.565 . . . . 72.319999999999993 113.975 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.07 16.38 1.07 Allowed 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.503 -0.479 . . . . 75.129999999999995 110.817 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.71 -12.4 56.77 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 120.839 -0.696 . . . . 73.439999999999998 111.617 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -137.37 151.88 49.07 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.231 -1.396 . . . . 53.329999999999998 107.231 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.44 157.19 40.85 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.072 -1.455 . . . . 33.32 107.072 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.24 156.75 38.03 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.341 0.591 . . . . 72.409999999999997 112.559 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.84 139.24 49.91 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.684 -1.228 . . . . 75.430000000000007 107.684 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 133.96 61.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.661 -0.496 . . . . 74.209999999999994 109.661 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.5 t -75.4 118.46 21.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.602 -0.888 . . . . 74.319999999999993 108.602 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -84.01 -43.4 15.19 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.034 -0.985 . . . . 73.420000000000002 108.722 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 57.4 ttt180 -144.7 133.55 22.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.468 -0.787 . . . . 73.310000000000002 109.231 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.13 174.8 23.12 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 109.109 -1.596 . . . . 73.129999999999995 109.109 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.65 -21.67 38.85 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.485 2.123 . . . . 74.519999999999996 111.187 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 80' ' ' LEU . 18.2 p-10 -100.9 21.98 12.83 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.093 0.957 . . . . 74.219999999999999 110.64 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -59.86 141.63 55.03 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.658 0.383 . . . . 70.129999999999995 111.797 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.65 -7.93 74.28 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.846 -0.692 . . . . 75.530000000000001 112.08 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.11 126.72 31.44 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 110.151 -0.314 . . . . 74.25 110.151 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -116.22 136.66 52.81 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.585 -0.895 . . . . 74.129999999999995 108.585 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -130.73 116.32 17.85 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.577 -0.527 . . . . 71.340000000000003 109.577 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.95 118.46 24.03 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.608 -0.886 . . . . 74.239999999999995 108.608 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.2 mt -87.42 125.2 34.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.83 0.348 . . . . 74.409999999999997 110.894 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -138.03 -0.61 2.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.313 -0.858 . . . . 75.040000000000006 109.825 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.52 150.34 39.98 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.132 -0.486 . . . . 62.399999999999999 111.085 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 37.7 Cg_exo -65.17 -20.87 62.95 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.365 2.71 . . . . 72.140000000000001 114.078 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.7 m -145.68 122.54 11.28 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.272 0.558 . . . . 73.349999999999994 110.21 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.6 m -123.64 113.4 18.61 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.764 -1.199 . . . . 73.239999999999995 107.764 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.6 m -94.08 138.73 31.82 Favored 'General case' 0 C--O 1.255 1.393 0 O-C-N 121.594 -0.691 . . . . 71.099999999999994 111.038 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 135.39 54.63 Favored 'General case' 0 C--O 1.262 1.717 0 CA-C-O 121.655 0.741 . . . . 64.109999999999999 110.802 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.55 29.28 Favored Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 105.782 -2.927 . . . . 73.0 105.782 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 15.2 ptt180 -119.18 121.01 38.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 117.711 -1.596 . . . . 64.349999999999994 109.311 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -167.1 163.39 10.35 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 106.001 -1.851 . . . . 74.209999999999994 106.001 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.58 -46.19 34.97 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.706 2.271 . . . . 70.310000000000002 113.856 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.75 20.5 5.52 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.692 0.627 . . . . 73.409999999999997 112.692 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -58.91 116.28 3.68 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.46 -0.571 . . . . 64.450000000000003 109.46 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.27 -38.97 41.47 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.721 -1.214 . . . . 70.340000000000003 107.721 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.26 121.85 57.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.126 -1.064 . . . . 74.430000000000007 108.126 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -87.95 124.76 34.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 110.065 -0.346 . . . . 75.099999999999994 110.065 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 80.0 mt -127.2 140.92 51.91 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.323 -0.991 . . . . 75.400000000000006 108.323 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -130.59 140.65 50.44 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.434 -0.58 . . . . 74.129999999999995 109.434 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -163.34 178.34 8.21 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.387 -1.709 . . . . 75.329999999999998 106.387 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 -35.19 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 107.943 -1.132 . . . . 65.439999999999998 107.943 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 m -142.0 99.84 3.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.672 0.748 . . . . 74.120000000000005 109.939 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -98.6 137.38 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.471 -1.307 . . . . 64.430000000000007 107.471 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 23.0 t -73.57 150.72 41.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.114 -1.069 . . . . 73.310000000000002 108.114 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.1 ptt180 -61.59 -45.95 91.92 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -135.21 113.86 11.75 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.413 -1.329 . . . . 75.140000000000001 107.413 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -99.29 -51.82 3.7 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.705 -0.85 . . . . 74.239999999999995 108.705 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.65 163.65 39.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.229 -0.656 . . . . 74.239999999999995 109.229 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.8 147.93 45.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.498 0.666 . . . . 74.209999999999994 109.883 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -104.76 133.31 49.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.184 -1.413 . . . . 75.0 107.184 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -118.1 121.78 41.44 Favored 'General case' 0 C--N 1.268 -2.964 0 CA-C-N 115.608 -0.724 . . . . 72.099999999999994 109.414 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 59.3 mt -121.14 111.39 31.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.655 -1.609 . . . . 75.120000000000005 106.655 176.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -139.24 125.7 20.42 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.643 -0.423 . . . . 75.129999999999995 110.413 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.58 40.25 31.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.015 0.926 . . . . 70.329999999999998 112.486 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 -1.67 87.53 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.032 -0.531 . . . . 53.140000000000001 113.807 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -101.04 140.97 34.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.227 -0.657 . . . . 74.230000000000004 109.227 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -119.34 117.8 29.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.112 -1.07 . . . . 74.129999999999995 108.112 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -126.45 144.89 50.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.854 -0.424 . . . . 75.109999999999999 109.854 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.98 122.13 66.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 105.244 -2.132 . . . . 72.549999999999997 105.244 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.61 131.88 71.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 120.652 -0.419 . . . . 73.510000000000005 110.157 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.463 ' CG ' ' HG ' ' A' ' 106' ' ' SER . 11.3 t70 -80.12 140.97 36.19 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.422 -0.955 . . . . 75.239999999999995 108.422 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.2 9.89 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.637 0.256 . . . . 64.310000000000002 110.731 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.37 77.85 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.013 -0.613 . . . . 72.219999999999999 112.053 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.463 ' HG ' ' CG ' ' A' ' 103' ' ' ASP . 23.7 m -64.6 86.76 0.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.826 0.45 . . . . 71.099999999999994 111.124 178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 9.8 tt -91.36 -49.91 6.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 119.137 -1.025 . . . . 75.120000000000005 108.435 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.61 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 1.0 OUTLIER -92.81 -19.02 22.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.156 -0.683 . . . . 55.119999999999997 109.156 -178.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.68 114.86 3.77 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.836 -0.62 . . . . 74.349999999999994 112.367 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.2 m -87.3 129.65 34.91 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 122.211 -0.582 . . . . 74.540000000000006 110.469 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 82.3 m-85 -134.9 126.0 27.84 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.077 -1.083 . . . . 74.049999999999997 108.077 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.5 t -131.14 133.98 61.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.854 -1.536 . . . . 72.519999999999996 106.854 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 54.01 40.71 31.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.306 1.051 . . . . 73.420000000000002 109.404 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 66.76 9.23 6.56 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.946 1.699 . . . . 71.400000000000006 112.424 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 49.5 mm-40 -104.57 127.66 28.5 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 112.472 0.545 . . . . 75.420000000000002 112.472 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -63.7 123.44 12.02 Favored 'Trans proline' 0 C--N 1.36 1.139 0 N-CA-C 106.242 -2.253 . . . . 74.209999999999994 106.242 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.483 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 11.8 tpt180 -146.99 154.89 41.77 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.791 -1.564 . . . . 72.409999999999997 111.797 -167.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -107.67 -37.93 6.02 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.806 -0.812 . . . . 74.120000000000005 108.806 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.2 135.21 32.16 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.265 -0.574 . . . . 72.310000000000002 109.667 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 54.3 tp60 -152.12 143.68 23.49 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 110.268 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.13 131.6 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 107.72 -1.215 . . . . 73.5 107.72 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 43.7 ttp -89.25 128.54 35.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.359 -0.978 . . . . 71.329999999999998 108.359 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 36' ' ' SER . 9.3 pt20 -130.37 142.8 50.51 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.299 -0.864 . . . . 74.519999999999996 111.382 -173.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.7 t -74.31 134.25 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 64.319999999999993 111.229 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.11 59.75 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.241 -0.89 . . . . 54.5 111.163 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -89.63 154.67 19.79 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.565 -0.318 . . . . 74.019999999999996 111.198 -177.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.3 127.86 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.663 0.744 . . . . 74.099999999999994 109.797 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.28 119.81 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 N-CA-C 107.369 -1.345 . . . . 73.409999999999997 107.369 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 47.3 tt0 -104.86 120.92 42.57 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 115.106 -0.952 . . . . 74.099999999999994 108.476 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.7 mt -109.36 102.98 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 105.914 -1.884 . . . . 72.239999999999995 105.914 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.61 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 67.45 -107.55 2.08 Favored Glycine 0 N--CA 1.411 -3.01 0 CA-C-N 114.48 -1.236 . . . . 72.329999999999998 111.639 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -118.22 11.0 13.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.408 0.521 . . . . 75.329999999999998 112.408 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 27.2 p90 -125.06 157.87 35.18 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.883 -0.414 . . . . 74.0 109.883 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -129.36 142.07 50.91 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 114.51 1.3 . . . . 75.219999999999999 114.51 -169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.35 138.52 54.37 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.591 -1.633 . . . . 75.109999999999999 106.591 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -112.48 138.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.833 -1.173 . . . . 74.329999999999998 107.833 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -101.61 116.13 32.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.175 -0.676 . . . . 72.329999999999998 109.175 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.12 154.64 48.09 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.408 0.623 . . . . 72.209999999999994 110.545 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.51 126.4 30.85 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.538 -1.653 . . . . 72.549999999999997 106.538 168.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.77 -111.42 3.57 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.587 -0.816 . . . . 62.140000000000001 111.497 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -69.14 142.87 51.93 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.114 1.876 . . . . 74.319999999999993 111.787 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.25 18.08 19.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.648 -0.871 . . . . 73.329999999999998 108.648 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.424 -1.745 0 C-N-CA 125.305 1.442 . . . . 73.409999999999997 110.001 -179.137 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 105.671 -1.974 . . . . 72.439999999999998 105.671 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 57.8 t -81.31 114.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 119.679 -0.808 . . . . 75.040000000000006 108.854 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -118.86 140.22 50.33 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 109.241 -0.651 . . . . 75.299999999999997 109.241 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -132.75 138.66 47.27 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.953 -1.128 . . . . 74.230000000000004 107.953 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.39 172.73 12.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.075 0.768 . . . . 63.32 113.075 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.82 -3.12 26.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.905 1.282 . . . . 74.409999999999997 110.976 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.36 -25.81 60.03 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.88 0.872 . . . . 75.409999999999997 112.784 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.72 -28.36 68.36 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 121.044 0.45 . . . . 73.010000000000005 110.982 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -67.26 -44.75 78.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 74.340000000000003 109.96 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -76.1 -31.92 58.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.883 -0.599 . . . . 74.349999999999994 110.096 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.29 -30.41 64.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 75.219999999999999 110.819 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.08 -49.43 75.88 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.984 0.513 . . . . 75.409999999999997 110.633 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -77.81 -19.81 54.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.101 0.56 . . . . 72.030000000000001 111.553 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -82.97 -17.11 44.66 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.702 -0.481 . . . . 62.109999999999999 109.702 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.556 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 39.9 m -109.12 103.99 13.09 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 121.207 0.527 . . . . 62.43 111.169 -176.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.88 -52.69 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 111.389 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -104.94 142.5 34.66 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.259 -0.645 . . . . 72.310000000000002 109.259 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.93 153.0 84.81 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.16 -1.052 . . . . 62.520000000000003 108.16 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.14 142.23 96.97 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.047 1.831 . . . . 75.010000000000005 112.831 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.49 131.71 41.92 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.527 -0.545 . . . . 72.120000000000005 109.527 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -125.07 -168.35 1.81 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.371 0.605 . . . . 71.319999999999993 109.969 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -106.97 5.81 28.53 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.526 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 43.48 3.79 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.22 -1.552 . . . . 62.240000000000002 109.22 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.4 -3.67 59.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.392 0.615 . . . . 64.140000000000001 110.967 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.82 2.1 3.72 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 124.167 0.987 . . . . 64.040000000000006 112.726 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -83.17 -19.59 36.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.269 -1.011 . . . . 74.549999999999997 108.269 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt 57.44 79.47 0.32 Allowed Pre-proline 0 C--N 1.345 0.394 0 CA-C-N 114.46 -1.245 . . . . 70.430000000000007 111.937 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.68 -62.48 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.483 2.122 . . . . 65.310000000000002 112.162 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.72 -2.28 35.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.953 0.406 . . . . 73.010000000000005 111.644 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.68 79.85 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.871 -0.681 . . . . 61.100000000000001 113.163 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 m -147.37 164.21 34.0 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.474 -0.565 . . . . 61.329999999999998 109.474 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.82 157.35 45.87 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.884 -1.154 . . . . 51.109999999999999 107.884 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -123.46 152.69 41.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 118.388 0.54 . . . . 72.420000000000002 111.593 -175.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD13 HD22 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -116.88 143.19 45.99 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.673 -1.232 . . . . 74.150000000000006 107.673 173.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.88 133.38 61.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 121.093 -0.243 . . . . 74.530000000000001 110.496 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.3 116.88 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 104.792 -2.299 . . . . 64.430000000000007 104.792 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -89.87 -31.87 17.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.752 -0.658 . . . . 61.229999999999997 109.595 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -152.89 137.0 16.42 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.924 -0.58 . . . . 74.209999999999994 109.566 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.41 172.23 13.13 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 109.21 -1.556 . . . . 74.230000000000004 109.21 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.537 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 77.9 Cg_exo -55.28 -29.67 68.36 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 122.73 2.287 . . . . 75.430000000000007 113.926 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.28 18.12 21.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 120.326 -0.549 . . . . 74.310000000000002 110.399 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.86 143.58 41.94 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.107 0.48 . . . . 63.530000000000001 112.195 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.85 -14.28 57.47 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.359 -1.096 . . . . 61.219999999999999 110.359 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.79 122.12 21.04 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.289 -0.456 . . . . 62.530000000000001 109.847 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -133.4 134.97 44.34 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.551 -1.277 . . . . 74.420000000000002 107.551 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -137.26 145.38 43.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.288 -0.634 . . . . 74.310000000000002 109.288 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.1 tp -93.17 127.23 38.64 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.493 0.496 . . . . 74.450000000000003 109.717 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 49' ' ' LEU . 2.4 mm? -97.6 107.3 19.77 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.197 0.522 . . . . 74.049999999999997 111.368 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.24 19.19 1.09 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.054 -1.832 . . . . 74.230000000000004 106.054 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.459 ' NE2' ' HG1' ' A' ' 68' ' ' THR . 16.0 pt20 -107.21 142.14 24.44 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 113.971 -1.468 . . . . 73.409999999999997 107.931 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 27.9 Cg_endo -64.94 -19.19 63.88 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.251 1.967 . . . . 75.219999999999999 113.955 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -149.5 129.99 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.231 -0.587 . . . . 72.510000000000005 111.58 -176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.459 ' HG1' ' NE2' ' A' ' 65' ' ' GLN . 29.9 m -132.9 113.51 12.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.337 -1.357 . . . . 74.349999999999994 107.337 172.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -92.88 138.03 31.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.757 -0.46 . . . . 73.299999999999997 109.757 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 136.93 53.33 Favored 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.329 0.393 . . . . 72.329999999999998 110.082 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.57 -153.37 24.99 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.572 -1.411 . . . . 75.230000000000004 109.572 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 64.1 ttt-85 -118.51 118.06 30.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.637 -1.986 . . . . 73.340000000000003 105.637 175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' CD2' ' H ' ' A' ' 75' ' ' GLU . 5.2 t-160 177.92 139.25 0.24 Allowed Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.955 -1.498 . . . . 73.439999999999998 106.955 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.6 -30.53 36.69 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.529 1.486 . . . . 73.230000000000004 111.978 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.486 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 8.4 mm-40 -88.96 4.51 47.89 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.222 0.823 . . . . 54.439999999999998 113.222 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.6 p -89.99 115.84 27.58 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 119.082 -1.047 . . . . 72.230000000000004 108.879 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.9 -34.87 73.76 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.485 0.491 . . . . 75.140000000000001 110.831 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.5 pt -114.36 111.8 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.222 -1.029 . . . . 75.25 108.222 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -94.01 121.12 35.16 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.994 -1.003 . . . . 75.019999999999996 110.774 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.29 119.4 33.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.849 -1.167 . . . . 74.450000000000003 107.849 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.74 124.77 41.77 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.799 0.296 . . . . 75.430000000000007 111.799 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.418 ' OD2' HG21 ' A' ' 83' ' ' VAL . 16.9 t70 177.5 -145.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 103.877 -2.638 . . . . 63.0 103.877 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG21 ' OD2' ' A' ' 82' ' ' ASP . 48.5 t -57.43 -23.56 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.914 0.779 . . . . 73.420000000000002 111.004 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 m -76.59 81.59 3.26 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.688 0.756 . . . . 75.329999999999998 110.108 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.08 105.85 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.148 -1.056 . . . . 74.430000000000007 108.148 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.3 m -163.57 136.28 5.29 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.767 -1.568 . . . . 74.420000000000002 106.767 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 17.1 ptt180 -64.28 -25.56 68.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.817 0.698 . . . . 73.420000000000002 111.629 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -145.21 128.25 16.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.776 -0.824 . . . . 75.209999999999994 108.776 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 110' ' ' THR . 30.0 t-80 -99.88 -52.78 3.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.324 -1.362 . . . . 75.150000000000006 107.324 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.01 164.91 36.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.681 -1.145 . . . . 52.329999999999998 108.271 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.85 139.45 52.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.708 -0.478 . . . . 72.209999999999994 109.708 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -108.04 125.3 51.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.946 -1.502 . . . . 74.409999999999997 106.946 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.99 131.7 56.86 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.925 -0.768 . . . . 74.420000000000002 108.925 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.8 mp -115.25 112.27 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.411 -1.329 . . . . 61.32 107.411 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -138.93 125.49 20.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 110.724 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.77 37.97 29.51 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.851 0.86 . . . . 74.150000000000006 112.677 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 1.77 90.22 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.972 -0.558 . . . . 51.329999999999998 113.544 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -110.61 131.64 54.88 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.458 -0.571 . . . . 75.109999999999999 109.458 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -104.66 117.56 34.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.869 -1.16 . . . . 71.0 107.869 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.97 130.92 56.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.183 0.516 . . . . 61.140000000000001 110.412 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.44 122.6 61.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.64 -1.245 . . . . 71.549999999999997 107.64 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.93 124.0 71.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.426 -0.583 . . . . 64.329999999999998 109.426 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.62 140.36 40.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.8 -1.185 . . . . 55.219999999999999 107.8 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.8 m -100.41 -13.71 8.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.947 -0.701 . . . . 74.209999999999994 111.923 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 179.65 95.29 0.1 OUTLIER Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.505 -1.038 . . . . 64.030000000000001 110.505 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -64.96 14.48 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.681 1.592 . . . . 75.430000000000007 114.291 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 6.0 mp -70.87 -37.92 73.09 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.897 -1.149 . . . . 73.439999999999998 107.897 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.3 -20.15 22.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.47 -0.786 . . . . 74.450000000000003 110.326 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.39 94.87 0.22 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.556 -0.747 . . . . 62.109999999999999 114.58 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.467 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 58.1 m -80.98 130.16 34.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.284 -0.635 . . . . 74.019999999999996 109.284 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.36 125.69 54.54 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.643 -1.243 . . . . 74.329999999999998 107.643 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.0 t -133.1 136.86 54.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.165 -1.421 . . . . 74.420000000000002 107.165 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.33 39.25 30.74 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.367 1.467 . . . . 75.209999999999994 108.257 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.556 ' NH1' ' HA ' ' A' ' 30' ' ' THR . 34.2 mtm105 63.81 20.47 12.23 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.655 -1.611 . . . . 72.209999999999994 115.279 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.51 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 41.4 mt-10 -136.02 153.42 76.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.298 -0.63 . . . . 73.420000000000002 109.298 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.2 123.72 13.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.251 1.967 . . . . 71.319999999999993 108.925 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.51 ' NH2' ' HB2' ' A' ' 115' ' ' GLU . 18.3 tpp180 -135.96 139.99 43.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.253 -0.579 . . . . 75.25 109.869 -170.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -98.84 -37.57 9.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.477 0.656 . . . . 75.120000000000005 110.525 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.04 136.96 18.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.258 -1.386 . . . . 72.239999999999995 107.258 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.485 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 55.5 tp60 -152.58 136.02 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.176 0.435 . . . . 72.519999999999996 112.176 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.35 117.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 104.676 -2.342 . . . . 72.230000000000004 104.676 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.443 ' SD ' HD11 ' A' ' 128' ' ' ILE . 43.5 ttp -88.05 130.71 34.91 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.664 0.745 . . . . 75.400000000000006 111.458 -168.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.27 156.44 16.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.081 -1.418 . . . . 74.140000000000001 109.151 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.0 t -70.56 130.81 42.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.932 -1.136 . . . . 71.040000000000006 107.932 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.3 57.73 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 120.565 -0.826 . . . . 72.319999999999993 111.158 -177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.43 141.06 50.28 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 109.326 -0.62 . . . . 54.219999999999999 109.326 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.47 125.7 54.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.496 -0.557 . . . . 72.140000000000001 109.496 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.443 HD11 ' SD ' ' A' ' 122' ' ' MET . 68.3 mt -108.21 131.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.302 -1.37 . . . . 72.219999999999999 107.302 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -119.92 123.0 42.49 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 121.378 0.609 . . . . 75.019999999999996 109.654 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.6 mt -113.9 102.31 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.301 -1.74 . . . . 75.329999999999998 106.301 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.71 -111.86 4.43 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 109.933 -1.267 . . . . 54.450000000000003 109.933 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -103.58 -4.67 23.58 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 117.406 0.603 . . . . 74.510000000000005 110.428 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.537 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.9 m-85 -73.22 130.5 40.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.401 -0.592 . . . . 73.239999999999995 109.401 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -112.01 119.41 38.37 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.628 -1.249 . . . . 75.230000000000004 107.628 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.3 134.3 54.96 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.582 -1.266 . . . . 73.230000000000004 107.582 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.71 131.53 69.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 108.746 -0.835 . . . . 75.340000000000003 108.746 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.31 122.56 43.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.572 -0.529 . . . . 73.349999999999994 109.572 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' O ' HD11 ' A' ' 48' ' ' LEU . 3.9 mp -128.72 137.19 51.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 110.162 -0.31 . . . . 73.310000000000002 110.162 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.57 135.48 33.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.986 -0.746 . . . . 74.230000000000004 108.986 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.2 88.07 1.81 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.788 -0.925 . . . . 74.150000000000006 110.788 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.64 161.86 39.7 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.215 2.61 . . . . 64.540000000000006 112.459 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.43 53.73 0.88 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.196 -1.038 . . . . 73.510000000000005 108.196 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.026 -0.988 . . . . 73.340000000000003 109.216 -175.583 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 109.451 -0.574 . . . . 73.150000000000006 109.451 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 107' ' ' LEU . 93.7 t -113.64 117.45 55.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 119.63 -0.224 . . . . 72.209999999999994 110.692 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 83' ' ' VAL . 47.8 p90 -123.12 127.25 48.44 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.085 -0.646 . . . . 72.430000000000007 109.454 171.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -106.9 92.13 3.96 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.924 -1.139 . . . . 71.25 107.924 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 -154.99 0.56 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.233 -0.894 . . . . 73.420000000000002 112.169 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.65 -3.21 6.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.388 1.475 . . . . 73.209999999999994 112.032 -172.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.82 -25.04 60.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.132 0.973 . . . . 74.530000000000001 111.713 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.31 -24.33 65.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.302 0.572 . . . . 74.430000000000007 111.304 177.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -88.56 -29.79 19.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.839 -0.8 . . . . 75.319999999999993 108.839 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -56.57 -44.77 81.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 53.420000000000002 110.794 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.496 ' HE1' ' CE2' ' A' ' 111' ' ' TYR . 21.3 ptp -83.99 2.76 37.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.614 -0.721 . . . . 73.099999999999994 111.556 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -91.88 -49.66 6.13 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.209 -1.034 . . . . 75.219999999999999 108.209 176.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.2 m -61.0 -42.85 99.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.29 -0.868 . . . . 72.400000000000006 111.986 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -77.4 -33.56 55.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.902 0.382 . . . . 62.299999999999997 110.293 177.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m 74.44 -54.8 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.122 1.369 . . . . 64.319999999999993 111.21 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.34 -163.8 10.58 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 109.935 -1.266 . . . . 63.009999999999998 109.935 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 113' ' ' ASN . 97.8 m -104.6 138.36 41.06 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 117.054 0.427 . . . . 71.329999999999998 110.288 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.34 121.45 66.46 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 108.367 -0.975 . . . . 75.530000000000001 108.367 176.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -59.48 152.28 62.73 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 122.93 2.42 . . . . 73.230000000000004 113.02 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 166.43 16.17 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.36 -0.836 . . . . 65.040000000000006 109.127 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -66.05 122.74 18.09 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.231 0.539 . . . . 72.150000000000006 111.189 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 m -54.67 133.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.445 -1.252 . . . . 71.530000000000001 109.904 177.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 41' ' ' ASN . . . 129.78 -28.18 3.99 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 108.826 -1.71 . . . . 71.439999999999998 108.826 -174.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.5 65.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.695 0.76 . . . . 74.150000000000006 110.328 178.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 7.86 4.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.008 0.909 . . . . 71.5 112.576 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.7 m120 -79.54 -16.69 55.52 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.506 -1.224 . . . . 63.119999999999997 110.269 173.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 50.96 68.62 3.2 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 123.987 0.804 . . . . 71.010000000000005 112.819 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.03 -56.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.528 2.152 . . . . 74.140000000000001 113.648 -175.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -23.31 33.43 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.019 0.377 . . . . 72.540000000000006 112.019 -177.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.93 79.7 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 120.351 -0.928 . . . . 71.519999999999996 111.182 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.1 m -115.12 157.19 23.94 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.125 -1.065 . . . . 73.040000000000006 108.125 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.59 157.3 46.04 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.548 -0.538 . . . . 71.319999999999993 109.548 -177.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.04 160.26 38.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.744 0.652 . . . . 75.140000000000001 109.317 -177.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -128.69 141.22 51.4 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 120.158 -0.617 . . . . 75.310000000000002 109.846 175.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.86 139.67 38.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.432 -0.804 . . . . 75.319999999999993 109.809 -176.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.0 118.37 28.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.204 -1.036 . . . . 72.230000000000004 108.204 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -85.15 -34.79 22.05 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.169 -0.923 . . . . 75.099999999999994 109.858 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 29.2 tpt180 -151.68 144.91 24.67 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.52 -1.659 . . . . 74.310000000000002 106.52 -177.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.62 -171.05 22.48 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.508 -0.853 . . . . 74.329999999999998 111.551 179.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.67 -33.06 8.75 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.204 1.936 . . . . 72.519999999999996 109.932 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.77 11.81 21.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.058 -1.428 . . . . 74.540000000000006 110.109 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.56 42.36 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.298 0.571 . . . . 54.240000000000002 112.109 -175.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.91 -19.27 47.37 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 115.225 -0.898 . . . . 74.329999999999998 111.712 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.74 156.84 19.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.958 -0.386 . . . . 74.430000000000007 109.958 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -139.46 155.15 47.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.752 -1.203 . . . . 73.439999999999998 107.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -147.78 143.3 27.42 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.608 -0.516 . . . . 75.510000000000005 109.608 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -108.62 144.75 35.93 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.526 0.516 . . . . 74.430000000000007 110.285 -177.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.15 105.06 11.14 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.703 -0.681 . . . . 74.340000000000003 110.175 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.93 -15.93 11.17 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.312 1.045 . . . . 65.340000000000003 109.344 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.471 ' NE2' ' HG1' ' A' ' 68' ' ' THR . 7.3 pm0 -107.34 153.23 41.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 114.4 -1.273 . . . . 72.319999999999993 110.117 -174.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -63.17 -29.32 73.9 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.897 2.398 . . . . 74.340000000000003 113.743 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 67.2 m -150.47 122.67 8.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.084 0.469 . . . . 70.510000000000005 111.287 -177.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.471 ' HG1' ' NE2' ' A' ' 65' ' ' GLN . 11.8 m -112.6 114.24 26.78 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.163 -0.68 . . . . 74.439999999999998 109.163 178.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -90.75 133.87 34.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.39 -0.967 . . . . 72.200000000000003 108.39 175.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -128.03 135.4 49.82 Favored 'General case' 0 C--O 1.267 2.019 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 111.404 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.41 -153.62 25.01 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 114.579 -1.192 . . . . 72.310000000000002 111.174 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 22.0 tpp85 -79.4 151.82 30.72 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.977 1.311 . . . . 75.010000000000005 108.676 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 14.9 m170 92.39 127.89 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 125.904 1.682 . . . . 74.420000000000002 110.619 -175.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.85 2.97 4.8 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.347 2.032 . . . . 54.25 112.522 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 12.9 pt-20 -80.2 -25.19 39.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.252 -1.018 . . . . 72.310000000000002 108.252 175.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -73.01 132.04 42.9 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.7 -1.222 . . . . 74.340000000000003 107.7 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -54.74 -39.53 68.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.698 0.629 . . . . 71.200000000000003 112.698 -174.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.4 mm -119.58 124.69 73.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.34 108.06 20.22 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.266 0.555 . . . . 74.010000000000005 110.604 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.62 117.6 32.72 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.953 -2.24 . . . . 62.420000000000002 104.953 176.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.48 116.76 18.32 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.387 -0.925 . . . . 74.329999999999998 111.954 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.73 161.4 14.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.755 -0.657 . . . . 73.230000000000004 109.457 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.413 ' HB ' ' CE2' ' A' ' 18' ' ' PHE . 98.6 t -67.95 -36.25 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.328 0.585 . . . . 73.239999999999995 109.914 178.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 p -116.44 -171.29 1.98 Allowed 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.791 -0.641 . . . . 71.140000000000001 110.479 -176.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.31 96.58 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.452 -0.944 . . . . 75.230000000000004 108.452 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.9 m -129.44 85.69 2.34 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.929 -1.508 . . . . 51.25 106.929 174.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 20.0 ptt180 -77.31 -45.88 24.78 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 74.109999999999999 110.117 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -106.21 93.4 4.59 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.534 -1.284 . . . . 73.200000000000003 107.534 172.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -99.65 -53.27 3.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.094 -1.076 . . . . 75.319999999999993 108.094 174.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.9 143.76 31.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.744 -0.782 . . . . 73.340000000000003 111.474 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -122.35 135.54 54.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.29 -0.868 . . . . 64.430000000000007 109.58 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 67' ' ' THR . 35.6 m-85 -104.2 113.62 27.29 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.572 -1.64 . . . . 65.099999999999994 106.572 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.24 123.88 51.1 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.865 -0.791 . . . . 72.319999999999993 108.865 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' N ' HD11 ' A' ' 94' ' ' ILE . 2.6 mp -104.02 115.13 45.39 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 N-CA-C 106.82 -1.548 . . . . 74.329999999999998 106.82 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -131.53 120.56 23.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.58 -0.526 . . . . 73.319999999999993 109.58 -177.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 48.22 48.23 18.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.556 1.143 . . . . 73.540000000000006 113.586 -177.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.07 -6.46 62.93 Favored Glycine 0 N--CA 1.462 0.427 0 CA-C-N 116.015 -0.539 . . . . 74.099999999999994 114.414 176.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -103.05 143.56 32.43 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.276 -0.639 . . . . 71.209999999999994 109.276 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -104.8 116.76 32.57 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.871 -0.788 . . . . 72.439999999999998 108.871 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.0 126.28 55.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.434 -0.951 . . . . 73.109999999999999 108.434 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' HB ' ' HE1' ' A' ' 122' ' ' MET . 59.7 t -107.77 123.97 63.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 118.662 -1.215 . . . . 71.540000000000006 107.787 173.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.17 123.38 67.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.044 -1.465 . . . . 71.510000000000005 107.044 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.4 ' CG ' ' HG1' ' A' ' 110' ' ' THR . 1.1 t70 -107.53 136.47 47.26 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.94 -1.027 . . . . 75.510000000000005 109.991 -178.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -116.75 0.1 8.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.946 -0.57 . . . . 73.019999999999996 110.616 177.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.08 34.64 4.86 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 121.151 -0.547 . . . . 63.140000000000001 112.049 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -51.62 -34.42 37.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.876 1.27 . . . . 71.430000000000007 111.177 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 17' ' ' VAL . 4.6 mp -67.34 -23.92 65.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.063 -0.971 . . . . 75.25 111.16 -178.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.95 -18.64 30.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.586 0.708 . . . . 75.430000000000007 109.704 -175.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.22 0.43 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 119.103 -1.522 . . . . 71.230000000000004 113.93 175.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.4 ' HG1' ' CG ' ' A' ' 103' ' ' ASP . 3.8 m -77.79 129.14 35.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.871 -0.789 . . . . 42.310000000000002 108.871 172.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.496 ' CE2' ' HE1' ' A' ' 26' ' ' MET . 96.7 m-85 -135.11 144.55 47.2 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.897 -0.321 . . . . 73.219999999999999 110.189 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.18 117.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.594 -1.632 . . . . 75.310000000000002 106.594 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.416 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 93.9 m-20 56.91 45.75 20.82 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.734 0.646 . . . . 64.420000000000002 110.062 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.04 8.95 2.81 Favored 'General case' 0 CA--C 1.569 1.701 0 C-N-CA 125.731 1.612 . . . . 74.400000000000006 113.809 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -114.11 136.85 22.24 Favored Pre-proline 0 C--N 1.31 -1.134 0 O-C-N 121.341 -0.85 . . . . 65.420000000000002 110.342 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -68.05 138.17 43.08 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 122.025 1.817 . . . . 75.209999999999994 111.211 177.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -142.19 164.6 29.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.082 -0.508 . . . . 73.310000000000002 111.025 -177.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -117.37 -37.6 3.48 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.489 1.118 . . . . 70.239999999999995 108.258 176.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.01 139.95 26.48 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.283 -1.377 . . . . 73.510000000000005 107.283 175.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.49 130.33 11.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.432 -0.581 . . . . 64.219999999999999 109.432 -177.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.8 t -83.41 118.29 30.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.999 -1.482 . . . . 75.409999999999997 106.999 174.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.41 ' HE1' ' HB ' ' A' ' 101' ' ' VAL . 22.8 mmt -88.82 144.93 25.9 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.725 0.774 . . . . 63.5 112.944 -167.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.58 155.91 45.04 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.946 -1.479 . . . . 75.319999999999993 107.26 -177.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 t -62.57 134.38 56.29 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.339 0.59 . . . . 75.349999999999994 111.336 -176.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.32 -7.47 56.46 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.06 -0.973 . . . . 71.400000000000006 113.535 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.79 152.14 24.81 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 119.002 -1.079 . . . . 75.439999999999998 111.709 175.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.21 129.15 51.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.381 -1.281 . . . . 73.230000000000004 110.187 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt -108.1 131.91 57.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.198 -1.408 . . . . 74.230000000000004 107.198 -177.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -104.35 122.48 45.54 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.312 -0.996 . . . . 74.349999999999994 108.312 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 135' ' ' LEU . 2.3 mp -109.22 104.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 106.602 -1.629 . . . . 74.540000000000006 106.602 178.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.05 -107.81 2.21 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.248 -1.141 . . . . 73.120000000000005 110.248 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -110.77 6.86 21.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.849 0.325 . . . . 75.019999999999996 111.673 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 44.1 p90 -123.49 157.63 33.1 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.542 0.941 . . . . 74.219999999999999 113.542 -177.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -116.05 136.61 52.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.347 -0.388 . . . . 74.230000000000004 111.329 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.439 HD12 HD11 ' A' ' 130' ' ' ILE . 9.6 mp -123.45 139.72 53.74 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.191 0.997 . . . . 74.319999999999993 108.337 175.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.45 126.82 69.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.574 -0.528 . . . . 75.420000000000002 109.574 -178.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -88.32 127.74 35.48 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.657 -0.868 . . . . 72.310000000000002 108.657 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.44 143.72 50.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.577 0.703 . . . . 75.340000000000003 111.238 -176.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.2 121.92 45.5 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.489 -0.93 . . . . 60.229999999999997 108.489 176.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 132.27 82.23 0.22 Allowed Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.72 -1.352 . . . . 53.219999999999999 109.72 -177.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.98 162.38 29.42 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.276 2.65 . . . . 54.450000000000003 112.719 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.89 -1.17 56.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.198 0.999 . . . . 74.230000000000004 110.929 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.271 -2.838 0 N-CA-C 103.627 -2.731 . . . . 70.230000000000004 103.627 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 107' ' ' LEU . 36.1 t . . . . . 0 N--CA 1.424 -1.773 0 N-CA-C 108.785 -0.82 . . . . 64.420000000000002 108.785 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -85.56 115.13 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.283 -1.377 . . . . 72.439999999999998 107.283 177.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.459 ' CE2' ' HG ' ' A' ' 107' ' ' LEU . 40.3 p90 -114.79 142.53 46.4 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 120.813 0.34 . . . . 74.319999999999993 110.55 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -80.78 95.93 6.81 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.74 -1.208 . . . . 73.420000000000002 107.74 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -81.3 -178.71 7.04 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.421 -0.809 . . . . 73.25 112.26 -175.187 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.42 4.44 4.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 114.326 1.232 . . . . 71.409999999999997 114.326 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -82.83 -16.75 46.5 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.879 -0.513 . . . . 74.450000000000003 111.553 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 2.6 pp -70.01 -1.14 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.118 1.525 . . . . 75.140000000000001 115.118 -173.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -102.73 -22.5 13.92 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.574 -0.451 . . . . 71.209999999999994 111.257 177.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' OE2' ' HD3' ' A' ' 114' ' ' ARG . 30.8 tt0 -72.68 -23.6 60.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.703 -0.399 . . . . 74.310000000000002 111.829 -172.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.445 ' O ' ' HB3' ' A' ' 29' ' ' SER . 52.6 ttp -62.33 -47.52 83.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.327 -0.397 . . . . 51.32 110.196 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.42 -22.58 23.66 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.505 -0.316 . . . . 70.319999999999993 110.963 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.6 t -62.29 -27.44 69.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.186 0.993 . . . . 70.519999999999996 108.532 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 26' ' ' MET . 40.0 t -65.38 -39.14 91.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.311 -1.313 . . . . 74.310000000000002 110.593 175.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 m 69.46 -7.08 0.89 Allowed 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 124.879 1.271 . . . . 71.329999999999998 111.418 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 165.64 96.23 0.11 Allowed Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.668 -1.773 . . . . 72.340000000000003 108.668 -179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 92.0 m -72.84 121.02 19.28 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.869 0.842 . . . . 64.219999999999999 110.772 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.13 106.16 19.9 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 114.803 -1.09 . . . . 73.329999999999998 109.042 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -61.16 142.96 98.38 Favored 'Trans proline' 0 C--O 1.263 1.74 0 C-N-CA 121.551 1.501 . . . . 73.420000000000002 109.202 173.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.47 125.72 27.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.939 -0.573 . . . . 72.239999999999995 110.342 -177.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.5 m -84.33 92.7 8.07 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.657 -0.868 . . . . 72.049999999999997 108.657 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 m -102.55 155.62 18.16 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.875 -1.157 . . . . 72.239999999999995 107.875 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.7 25.57 7.3 Favored Glycine 0 CA--C 1.499 -0.947 0 N-CA-C 111.05 -0.82 . . . . 74.219999999999999 111.05 -175.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.93 5.18 49.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.987 -0.607 . . . . 74.140000000000001 110.202 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.23 -3.35 13.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.373 1.069 . . . . 65.549999999999997 113.393 -175.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.86 -2.81 31.1 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.233 -1.025 . . . . 73.430000000000007 108.233 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.9 82.83 0.22 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.185 -0.916 . . . . 74.120000000000005 110.95 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.03 -59.72 0.74 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.235 2.623 . . . . 73.409999999999997 114.257 -175.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.13 -4.08 59.09 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.227 0.454 . . . . 75.109999999999999 112.227 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 9.61 86.82 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.709 -0.758 . . . . 71.030000000000001 111.478 -177.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 m -145.86 169.22 19.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.884 -1.524 . . . . 73.230000000000004 106.884 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.77 157.23 43.63 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.414 0.446 . . . . 75.409999999999997 109.916 -178.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -133.26 153.32 51.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.8 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.419 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.5 pp -110.86 135.02 52.03 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.573 176.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.75 135.2 55.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.394 -0.595 . . . . 72.219999999999999 109.394 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.26 117.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.361 -1.718 . . . . 74.120000000000005 106.361 176.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.53 -31.95 16.53 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.527 -0.761 . . . . 73.200000000000003 109.683 -175.641 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -148.19 141.02 24.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.399 -0.963 . . . . 75.310000000000002 108.399 -178.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.5 174.14 13.22 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.793 -0.923 . . . . 62.420000000000002 110.793 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 76.6 Cg_exo -54.68 -43.28 60.52 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.83 2.353 . . . . 65.040000000000006 112.402 177.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -93.11 21.88 5.5 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.792 1.034 . . . . 73.439999999999998 113.792 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.75 137.26 44.9 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.735 0.302 . . . . 73.310000000000002 111.14 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.6 -18.95 40.18 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.144 -0.783 . . . . 65.319999999999993 111.144 -177.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.23 143.06 29.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.53 -0.544 . . . . 74.129999999999995 109.53 177.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -135.2 135.58 41.11 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.505 -0.924 . . . . 75.219999999999999 108.505 179.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -128.42 129.67 46.51 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.511 -0.552 . . . . 73.409999999999997 109.511 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -92.13 139.07 31.0 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.286 -0.635 . . . . 74.319999999999993 109.286 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.31 104.38 15.09 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.941 -0.763 . . . . 70.530000000000001 108.941 -179.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -124.37 -2.77 7.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.564 -1.198 . . . . 61.409999999999997 108.957 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pm0 -107.73 143.76 27.93 Favored Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-N 115.184 -0.916 . . . . 74.319999999999993 109.392 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -68.37 -16.28 43.28 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.777 2.318 . . . . 71.040000000000006 113.445 -178.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -150.1 128.05 11.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.727 -0.608 . . . . 74.239999999999995 109.495 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 10.6 m -123.7 119.38 29.63 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 p -87.5 137.12 32.61 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 110.208 -0.293 . . . . 70.540000000000006 110.208 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.02 148.3 51.86 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.329 0.585 . . . . 71.450000000000003 110.787 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.23 28.31 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 108.612 -1.795 . . . . 65.349999999999994 108.612 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -119.15 117.66 29.27 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.653 -1.61 . . . . 72.430000000000007 106.653 175.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 171.45 162.14 0.24 Allowed Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 126.077 1.751 . . . . 74.219999999999999 106.623 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.87 -28.66 75.72 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.373 2.049 . . . . 74.340000000000003 114.22 -176.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.14 4.52 48.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.719 0.637 . . . . 71.450000000000003 112.719 -174.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 m -67.9 117.54 9.92 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 73.439999999999998 109.407 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.94 -39.27 84.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.201 -1.037 . . . . 72.239999999999995 108.201 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.429 HG12 ' CG2' ' A' ' 68' ' ' THR . 47.5 mm -112.65 110.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.196 -1.779 . . . . 64.420000000000002 106.196 169.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.4 129.45 39.53 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.991 -0.549 . . . . 75.319999999999993 110.74 -176.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 1.7 mm? -124.58 129.78 51.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.254 -2.128 . . . . 71.019999999999996 105.254 175.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -101.31 116.66 33.31 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.589 -0.844 . . . . 54.520000000000003 109.782 177.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.03 -160.11 0.95 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.312 -1.366 . . . . 74.239999999999995 107.312 -178.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.79 -27.99 17.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.65 0.611 . . . . 74.439999999999998 112.65 -174.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.1 m -139.42 148.83 43.33 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.209 -0.932 . . . . 70.400000000000006 111.844 -175.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -74.56 148.88 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.029 . . . . 73.409999999999997 110.189 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -142.28 113.69 7.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.19 -1.041 . . . . 74.25 108.19 177.624 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -56.63 -25.3 52.91 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.148 0.795 . . . . 73.329999999999998 113.148 -177.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -172.99 99.02 0.13 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.286 -1.376 . . . . 72.319999999999993 107.286 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 27.0 t-80 -84.56 -52.53 6.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.425 0.631 . . . . 72.439999999999998 109.698 -177.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.42 41.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.754 -0.832 . . . . 72.420000000000002 108.754 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.65 143.98 43.76 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.553 -0.536 . . . . 54.43 109.553 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 83.3 m-85 -104.78 125.32 50.73 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.381 -1.711 . . . . 73.319999999999993 106.381 178.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -113.43 119.11 36.48 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 106.795 -1.557 . . . . 73.439999999999998 106.795 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 3.4 mp -114.65 111.88 37.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.541 -1.651 . . . . 75.430000000000007 106.541 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -135.29 128.9 32.68 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.786 -1.19 . . . . 65.340000000000003 107.786 -177.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 55.45 37.98 29.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.882 0.873 . . . . 75.010000000000005 112.035 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.37 1.45 90.43 Favored Glycine 0 C--O 1.238 0.402 0 CA-C-N 115.974 -0.557 . . . . 52.520000000000003 113.911 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 20.2 mm-40 -102.11 131.74 48.42 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.782 -0.451 . . . . 65.239999999999995 109.782 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -107.48 118.59 37.13 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.211 -1.404 . . . . 72.439999999999998 107.211 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.17 142.79 51.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.251 -0.579 . . . . 71.209999999999994 110.303 178.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -106.63 123.61 61.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.586 -1.265 . . . . 74.430000000000007 107.586 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.3 121.21 65.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.138 -0.69 . . . . 74.230000000000004 109.138 175.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -83.14 131.65 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.459 -0.941 . . . . 74.519999999999996 108.459 173.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.74 -14.46 4.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 123.457 0.473 . . . . 72.209999999999994 110.645 178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . -156.28 84.48 0.14 Allowed Glycine 0 N--CA 1.419 -2.454 0 C-N-CA 120.816 -0.707 . . . . 72.409999999999997 112.768 -178.444 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -69.7 83.09 0.44 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.11 0.481 . . . . 73.209999999999994 109.975 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 16' ' ' SER . 12.4 tp -77.17 -49.31 15.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.675 -1.232 . . . . 74.25 107.675 174.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -102.37 -19.17 15.08 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.296 -1.774 . . . . 73.219999999999999 110.049 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 108.82 3.31 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.873 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.6 m -87.38 130.43 34.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.464 0.174 . . . . 74.329999999999998 111.24 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.417 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 5.6 m-30 -127.97 132.24 49.21 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.147 0.979 . . . . 74.340000000000003 109.068 175.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.75 127.74 75.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.842 -1.54 . . . . 75.140000000000001 106.842 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 56.85 36.49 27.8 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.031 1.332 . . . . 73.040000000000006 109.185 -169.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.48 ' HD3' ' OE2' ' A' ' 25' ' ' GLU 0.274 44.0 ttp180 57.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.576 1.948 0 C-N-CA 125.716 1.607 . . . . 75.310000000000002 113.059 -177.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.23 147.87 36.84 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.71 -1.219 . . . . 72.450000000000003 107.71 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.72 123.16 12.14 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.703 1.602 . . . . 71.340000000000003 110.24 177.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -161.11 136.89 8.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.707 -1.22 . . . . 75.230000000000004 107.707 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -100.56 -53.75 3.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 123.364 0.415 . . . . 75.239999999999995 109.959 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.604 -0.887 . . . . 65.420000000000002 108.604 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -154.77 140.22 17.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.315 -0.402 . . . . 74.430000000000007 110.699 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.6 t -76.06 124.54 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 105.756 -1.942 . . . . 74.109999999999999 105.756 168.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 128' ' ' ILE . 36.6 ttp -89.81 141.19 28.86 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.485 -169.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 11.0 pt20 -115.1 156.99 24.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 124.557 1.143 . . . . 73.099999999999994 109.815 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -69.92 130.26 41.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 74.540000000000006 107.692 173.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.02 56.5 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 119.963 -1.113 . . . . 54.340000000000003 110.351 -174.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 6.3 t70 -76.21 137.53 40.06 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.27 -1.381 . . . . 74.450000000000003 107.27 178.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.6 124.28 45.95 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.354 0.597 . . . . 73.299999999999997 109.765 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.428 HD13 ' SD ' ' A' ' 122' ' ' MET . 37.3 mt -108.16 131.69 57.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.53 -0.915 . . . . 65.120000000000005 108.53 -172.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 7.2 tp60 -115.52 119.04 34.88 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.345 -0.613 . . . . 74.420000000000002 109.345 -176.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.19 102.83 9.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 106.48 -1.674 . . . . 74.349999999999994 106.48 176.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.89 -103.66 0.06 OUTLIER Glycine 0 N--CA 1.475 1.24 0 O-C-N 123.74 0.65 . . . . 75.349999999999994 114.134 -175.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -106.59 2.03 25.73 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.106 -0.547 . . . . 75.329999999999998 111.903 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.593 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 89.3 m-85 -96.32 135.39 38.23 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.219 -1.4 . . . . 73.409999999999997 107.219 173.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -131.76 120.17 22.31 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.029 -1.1 . . . . 74.409999999999997 108.029 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.37 136.59 48.55 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.416 -0.587 . . . . 73.400000000000006 109.416 -176.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.95 120.17 64.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.219 -1.4 . . . . 75.340000000000003 107.219 175.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -98.27 117.15 32.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 110.147 -0.316 . . . . 74.209999999999994 110.147 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.37 143.88 47.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.182 0.515 . . . . 74.200000000000003 111.187 -177.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.97 119.64 34.83 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.759 -1.571 . . . . 64.510000000000005 106.759 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.39 153.24 19.81 Favored Glycine 0 N--CA 1.426 -1.969 0 C-N-CA 118.866 -1.635 . . . . 72.0 112.697 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.67 164.13 36.71 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 123.687 2.925 . . . . 72.409999999999997 111.524 175.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 84.31 69.22 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 125.213 1.405 . . . . 73.430000000000007 111.989 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 105.264 -2.125 . . . . 62.329999999999998 105.264 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.548 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 44.9 t . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.204 -0.295 . . . . 74.230000000000004 110.204 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.38 118.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.789 -0.449 . . . . 74.230000000000004 109.789 -178.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -124.04 140.73 52.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.384 -0.371 . . . . 74.299999999999997 111.16 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -94.51 139.59 30.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.239 -0.437 . . . . 74.019999999999996 111.232 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -128.46 -164.2 1.36 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 7.6 p-10 -68.08 -3.23 9.65 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.929 0.871 . . . . 73.209999999999994 111.2 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.7 mt -57.25 -31.99 66.1 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 125.89 1.676 . . . . 73.019999999999996 111.502 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 1.6 pp -68.39 -1.38 6.32 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.224 1.564 . . . . 73.219999999999999 115.224 -175.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 63.2 pttt -81.25 -5.71 58.07 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.847 -0.533 . . . . 72.319999999999993 111.599 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -48.9 31.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 116.112 1.893 . . . . 74.109999999999999 116.112 -175.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.7 ttm -62.26 -46.86 86.93 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.942 0.401 . . . . 74.530000000000001 111.658 -176.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.28 -28.25 61.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.318 0.58 . . . . 72.129999999999995 110.303 -178.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -80.51 -11.63 59.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.924 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -71.33 -24.41 62.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.756 -0.831 . . . . 54.539999999999999 108.756 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -76.08 93.74 3.36 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.305 -1.369 . . . . 75.129999999999995 107.305 171.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.78 50.32 0.85 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 106.901 -2.48 . . . . 51.32 106.901 -169.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -67.17 148.39 51.86 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.853 1.261 . . . . 71.510000000000005 112.118 -173.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 150.38 37.8 Favored Pre-proline 0 C--N 1.312 -1.028 0 N-CA-C 108.501 -0.925 . . . . 51.009999999999998 108.501 177.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.98 146.42 96.31 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.418 2.079 . . . . 74.129999999999995 113.24 -177.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.72 159.22 17.19 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 71.219999999999999 108.484 175.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.3 t -98.92 178.12 5.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.489 -0.56 . . . . 73.040000000000006 109.489 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.553 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 12.9 t -156.4 33.56 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.792 -1.929 . . . . 73.140000000000001 105.792 176.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' O ' HG22 ' A' ' 124' ' ' THR . . . -103.56 35.45 5.02 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 114.827 -1.079 . . . . 72.040000000000006 113.072 -173.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.82 -33.93 15.49 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.396 -0.964 . . . . 63.039999999999999 108.396 174.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.28 12.65 1.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.934 -1.485 . . . . 71.209999999999994 112.346 -177.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.08 -42.02 24.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.24 -0.282 . . . . 74.140000000000001 110.24 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt 35.94 76.07 0.46 Allowed Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 124.766 1.291 . . . . 74.530000000000001 114.241 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.35 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.437 1.425 . . . . 73.329999999999998 111.112 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.06 -8.44 20.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.147 0.499 . . . . 74.129999999999995 110.954 178.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -6.22 80.15 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.401 -0.904 . . . . 75.439999999999998 111.925 -179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -114.49 162.79 16.24 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.94 -1.874 . . . . 72.439999999999998 105.94 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -153.15 157.14 39.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 118.137 0.426 . . . . 73.519999999999996 110.51 -178.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 143.72 44.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.14 0.422 . . . . 74.140000000000001 112.14 -178.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -116.55 138.54 51.32 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.402 -0.592 . . . . 74.329999999999998 109.402 176.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.68 132.5 57.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 123.64 0.587 . . . . 72.329999999999998 109.573 -176.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.72 118.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.724 -1.584 . . . . 63.340000000000003 106.724 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.91 -38.96 18.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.411 0.624 . . . . 73.349999999999994 110.34 -175.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -147.54 140.7 25.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.325 -1.361 . . . . 65.019999999999996 107.325 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.94 -177.14 19.12 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 111.475 -0.65 . . . . 73.349999999999994 111.475 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.23 -36.9 86.37 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 122.772 2.315 . . . . 75.019999999999996 111.863 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.75 14.55 18.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.808 -0.633 . . . . 70.239999999999995 111.419 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.49 134.39 56.64 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.776 0.658 . . . . 73.409999999999997 112.776 -176.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -21.09 44.37 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.786 -0.643 . . . . 64.439999999999998 111.876 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 155.03 19.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.766 0.317 . . . . 75.340000000000003 110.47 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.14 144.54 51.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.107 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -117.82 138.53 52.02 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.221 -1.029 . . . . 71.200000000000003 108.221 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.11 127.01 56.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.917 0.865 . . . . 74.549999999999997 110.795 -175.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.45 114.77 26.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.822 -1.081 . . . . 74.530000000000001 108.436 179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -134.33 4.27 3.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.296 1.046 . . . . 74.349999999999994 109.193 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -121.49 143.3 37.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.978 -1.01 . . . . 73.049999999999997 110.724 -175.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 53.7 Cg_exo -55.19 -24.39 41.26 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.746 2.964 . . . . 75.420000000000002 114.699 -178.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -144.27 121.54 11.57 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.474 -0.766 . . . . 74.540000000000006 110.722 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.3 m -129.7 119.88 24.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.9 -0.778 . . . . 74.040000000000006 108.9 -178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 140.25 29.72 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.508 0.594 . . . . 74.409999999999997 111.275 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.05 135.5 55.18 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 109.549 -0.538 . . . . 71.340000000000003 109.549 178.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.36 -161.34 25.69 Favored Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 115.65 -0.705 . . . . 72.510000000000005 111.385 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -103.83 142.16 34.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.062 -1.459 . . . . 74.239999999999995 107.062 -177.554 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 75' ' ' GLU . 90.4 m-70 80.58 145.84 0.1 OUTLIER Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 125.414 1.486 . . . . 74.400000000000006 110.092 -176.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -66.5 17.4 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.601 2.867 . . . . 74.340000000000003 114.341 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 73' ' ' HIS . 10.4 mm-40 -77.37 -28.77 53.02 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.313 -1.366 . . . . 73.430000000000007 107.313 177.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -96.1 153.0 18.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.919 -1.037 . . . . 61.409999999999997 109.658 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.18 -47.19 78.78 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.56 0.744 . . . . 74.219999999999999 110.463 -178.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.8 mm -98.98 109.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.026 -1.102 . . . . 74.030000000000001 108.026 178.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -87.68 115.6 25.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.115 0.483 . . . . 74.420000000000002 110.577 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 70.8 mt -126.74 140.42 52.4 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.491 -1.67 . . . . 72.430000000000007 106.491 176.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -96.52 117.11 30.24 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.246 -0.982 . . . . 74.530000000000001 109.661 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 46.1 t0 -117.38 -179.88 3.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.779 -0.646 . . . . 75.349999999999994 109.36 -171.492 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.03 -46.44 96.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 123.757 0.823 . . . . 75.109999999999999 111.694 -176.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -128.27 -173.1 2.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.463 -0.94 . . . . 74.150000000000006 108.463 -178.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.37 97.5 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 108.825 -0.806 . . . . 74.430000000000007 108.825 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.6 m -89.74 84.89 6.31 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 108.525 -0.917 . . . . 74.109999999999999 108.525 177.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -71.82 -36.98 70.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.97 -1.468 . . . . 75.120000000000005 112.091 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 31.2 mmm180 -133.71 85.86 2.24 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.241 -1.022 . . . . 73.349999999999994 108.241 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -101.55 -55.65 2.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.193 -0.603 . . . . 61.420000000000002 110.952 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.76 164.59 31.42 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.077 0.465 . . . . 62.409999999999997 111.046 -176.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.66 141.49 37.01 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.397 0.617 . . . . 75.049999999999997 110.148 173.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -104.25 117.4 34.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.781 -1.562 . . . . 63.119999999999997 106.781 -178.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -117.37 128.46 55.05 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-N 115.445 -0.798 . . . . 74.120000000000005 109.256 -175.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -115.52 112.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 105.907 -1.886 . . . . 72.519999999999996 105.907 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -138.52 125.48 21.22 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.893 -0.323 . . . . 70.420000000000002 111.255 -175.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 51.56 49.9 19.94 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.978 1.424 . . . . 72.0 114.098 173.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 114.877 -1.056 . . . . 73.510000000000005 115.382 173.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -127.6 146.99 50.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 118.277 1.038 . . . . 74.230000000000004 111.026 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.33 119.6 39.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.485 -1.302 . . . . 75.5 107.485 -176.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.55 128.46 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.525 0.679 . . . . 71.349999999999994 111.353 -176.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.9 t -103.82 124.51 58.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.506 -1.294 . . . . 75.150000000000006 107.506 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 20.8 m -118.51 123.37 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 121.588 0.709 . . . . 75.329999999999998 110.836 176.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.29 121.6 25.3 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.447 -1.686 . . . . 74.010000000000005 106.447 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -111.84 -8.72 11.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.175 0.512 . . . . 72.530000000000001 111.349 -174.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -147.28 90.97 0.15 Allowed Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.17 -1.572 . . . . 52.25 109.17 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 m -79.22 74.09 5.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.559 0.695 . . . . 71.129999999999995 110.989 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.6 pt? -104.77 -44.36 4.87 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.328 -0.851 . . . . 75.200000000000003 108.786 175.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -101.16 -21.78 14.85 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.461 -1.245 . . . . 71.510000000000005 107.897 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.49 116.41 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.309 -0.86 . . . . 73.409999999999997 111.774 -177.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 m -75.82 128.51 35.29 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.794 -0.817 . . . . 71.540000000000006 108.794 176.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 22' ' ' LEU . 6.4 m-85 -115.24 126.34 54.42 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.616 -0.513 . . . . 74.349999999999994 109.616 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.6 127.87 62.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.408 -1.33 . . . . 75.200000000000003 107.408 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 57.05 46.58 18.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.637 1.208 . . . . 75.109999999999999 108.385 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 62.69 8.56 3.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.534 -1.667 . . . . 75.0 114.471 -177.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.43 132.66 23.45 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 113.231 0.826 . . . . 74.5 113.231 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 52.7 Cg_endo -78.13 123.19 6.04 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.0 1.8 . . . . 73.129999999999995 108.369 173.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -150.34 158.05 43.73 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.173 -1.047 . . . . 72.430000000000007 108.173 -176.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 15.7 m120 -92.95 -40.8 10.37 Favored 'General case' 0 C--O 1.206 -1.192 0 C-N-CA 120.003 -0.679 . . . . 72.430000000000007 112.77 -176.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.02 134.46 55.29 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.206 -1.405 . . . . 62.200000000000003 107.206 174.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -151.92 143.44 23.49 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 120.837 -0.345 . . . . 74.430000000000007 111.309 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -82.41 124.34 39.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.15 -1.426 . . . . 61.219999999999999 107.15 173.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.3 ttp -92.5 129.25 38.49 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 74.340000000000003 108.347 -177.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.553 ' OE1' ' HA ' ' A' ' 37' ' ' THR . 26.3 mt-30 -129.8 151.02 50.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.121 -0.696 . . . . 73.150000000000006 109.121 -172.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 38' ' ' GLY . 13.7 t -62.42 132.75 53.59 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.394 0.616 . . . . 63.210000000000001 110.058 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.28 -12.08 61.82 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.774 -0.648 . . . . 72.5 112.584 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.74 151.96 25.95 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.025 0.441 . . . . 74.239999999999995 111.819 178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -112.23 144.53 41.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.371 -0.832 . . . . 74.540000000000006 109.73 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.43 131.63 67.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.008 -1.108 . . . . 71.420000000000002 108.008 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -117.41 130.51 56.53 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.428 -0.509 . . . . 63.210000000000001 110.163 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.43 107.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 106.29 -1.744 . . . . 74.239999999999995 106.29 175.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.82 -108.53 2.27 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.127 -0.488 . . . . 74.299999999999997 113.323 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.99 -1.2 32.35 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.741 -0.23 . . . . 75.010000000000005 111.504 -175.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 38.1 p90 -124.71 146.39 49.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.992 1.108 . . . . 74.400000000000006 113.992 -173.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -118.18 132.18 56.34 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.117 -0.947 . . . . 75.219999999999999 111.288 -172.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.39 140.66 52.43 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 124.142 0.977 . . . . 73.019999999999996 108.875 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.04 130.39 67.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.705 -0.85 . . . . 74.510000000000005 108.705 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -94.06 133.07 37.91 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.976 -0.557 . . . . 64.519999999999996 111.221 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.29 155.57 39.98 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.906 -0.776 . . . . 75.510000000000005 108.906 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.42 148.66 38.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.034 -0.728 . . . . 63.219999999999999 109.034 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.496 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -75.58 136.56 20.26 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.781 -0.724 . . . . 73.439999999999998 112.019 -178.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.52 153.89 72.06 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.259 2.64 . . . . 72.310000000000002 112.27 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.61 65.56 0.8 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.791 -0.64 . . . . 63.43 111.516 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.414 -2.225 0 N-CA-C 107.944 -1.132 . . . . 75.349999999999994 107.944 173.183 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 105.504 -2.036 . . . . 73.439999999999998 105.504 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 93.4 t -82.78 114.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.853 -0.739 . . . . 74.5 109.321 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -123.3 120.41 32.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.51 -0.768 . . . . 75.329999999999998 110.778 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.92 93.02 3.04 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.155 -2.165 . . . . 74.299999999999997 105.155 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.64 9.52 22.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.467 0.914 . . . . 70.549999999999997 113.467 -168.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -107.24 8.17 29.77 Favored 'General case' 0 C--O 1.182 -2.498 0 C-N-CA 118.909 -1.116 . . . . 74.420000000000002 112.581 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.83 -32.4 63.54 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.111 -0.993 . . . . 70.430000000000007 113.374 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.1 tp -68.05 -37.69 81.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.33 0.586 . . . . 75.329999999999998 110.289 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -91.08 -25.18 19.76 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.126 -0.359 . . . . 71.420000000000002 111.343 -177.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -44.31 93.08 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.163 -1.421 . . . . 72.340000000000003 107.163 174.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.3 mtt -62.27 -35.4 78.86 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.33 -0.396 . . . . 74.420000000000002 111.468 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.85 -44.46 80.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.741 0.781 . . . . 75.040000000000006 109.221 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -72.92 -10.44 59.8 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.086 -178.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -65.42 -17.19 64.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.577 0.227 . . . . 42.109999999999999 110.94 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -57.43 116.95 3.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.437 -0.949 . . . . 75.230000000000004 108.437 174.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.15 119.74 18.5 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.335 -0.848 . . . . 74.239999999999995 115.079 -173.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -116.68 149.49 39.71 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.513 -1.292 . . . . 75.439999999999998 107.513 173.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.01 127.49 92.86 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.994 -0.373 . . . . 72.209999999999994 109.994 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.02 142.58 88.32 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.134 1.889 . . . . 75.239999999999995 110.61 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.69 168.13 9.34 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.505 -0.316 . . . . 72.549999999999997 110.289 -174.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.4 t -174.88 -168.28 0.34 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.903 -1.518 . . . . 75.549999999999997 106.903 177.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t 174.45 -29.81 0.0 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.803 0.841 . . . . 71.340000000000003 109.906 178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.34 63.3 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.901 -1.143 . . . . 64.019999999999996 112.661 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.34 -45.9 18.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.037 -0.727 . . . . 70.239999999999995 109.037 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.15 4.7 22.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.409 -0.814 . . . . 72.420000000000002 110.651 -178.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -89.88 -28.18 19.4 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.664 -1.153 . . . . 74.439999999999998 108.16 177.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.4 mt 56.34 80.05 0.31 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 114.739 -1.119 . . . . 61.130000000000003 110.626 -177.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.76 -63.71 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 122.743 2.295 . . . . 71.209999999999994 113.406 -175.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.8 14.03 7.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.212 0.529 . . . . 55.210000000000001 110.588 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.28 -9.07 62.1 Favored Glycine 0 C--O 1.215 -1.087 0 C-N-CA 121.127 -0.558 . . . . 71.340000000000003 113.378 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -115.35 153.98 30.02 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 122.351 -0.499 . . . . 61.539999999999999 109.779 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -145.91 157.51 43.89 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.073 -0.714 . . . . 73.239999999999995 109.073 -177.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.76 161.49 37.07 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.831 -0.347 . . . . 74.420000000000002 111.137 -179.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.6 147.36 52.52 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.745 -0.465 . . . . 71.209999999999994 109.745 177.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.04 132.09 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.12 -0.696 . . . . 71.230000000000004 109.12 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.25 117.92 26.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.167 -1.42 . . . . 74.430000000000007 107.167 176.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.62 -34.0 18.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.747 -0.381 . . . . 75.209999999999994 110.636 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -146.82 133.43 19.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.431 -0.581 . . . . 74.420000000000002 109.431 -178.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.43 171.88 17.0 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 107.304 -2.318 . . . . 64.439999999999998 107.304 -177.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.581 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 52.3 Cg_exo -57.61 -31.89 92.97 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.234 1.956 . . . . 75.310000000000002 111.273 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -93.94 20.33 7.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.375 -0.829 . . . . 74.239999999999995 111.274 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 138.54 58.4 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.645 0.26 . . . . 73.329999999999998 110.654 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.92 63.16 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.737 -0.665 . . . . 73.0 111.715 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.33 135.9 33.35 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.698 0.285 . . . . 72.310000000000002 110.446 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.03 134.53 54.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.316 -1.365 . . . . 73.209999999999994 107.316 177.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -128.49 144.9 51.22 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.351 -1.352 . . . . 73.219999999999999 107.351 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -116.66 143.18 45.95 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.528 -0.869 . . . . 74.530000000000001 111.951 -177.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.37 105.01 16.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.116 -1.809 . . . . 64.409999999999997 106.116 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -127.37 12.33 7.0 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.487 1.137 . . . . 64.340000000000003 109.761 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.66 153.81 47.38 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.029 -1.1 . . . . 71.329999999999998 108.029 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.3 -21.25 71.74 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.378 2.052 . . . . 73.519999999999996 113.713 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.7 m -136.93 121.7 18.65 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 121.893 -0.505 . . . . 64.150000000000006 110.514 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.8 m -129.59 118.18 21.59 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.179 -0.674 . . . . 75.340000000000003 109.179 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 p -86.86 150.8 23.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.802 -0.561 . . . . 71.129999999999995 110.841 -178.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.3 135.24 48.51 Favored 'General case' 0 C--O 1.264 1.851 0 CA-C-O 121.049 0.452 . . . . 74.25 112.035 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.93 -138.66 6.35 Favored Glycine 0 N--CA 1.422 -2.3 0 CA-C-N 114.796 -1.093 . . . . 62.409999999999997 110.891 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 56.2 ttt180 -118.87 151.57 37.87 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.506 -1.294 . . . . 74.530000000000001 107.506 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 34.9 m170 89.3 164.5 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.967 0 C-N-CA 125.234 1.414 . . . . 75.230000000000004 111.323 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.15 -2.61 8.32 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.018 2.479 . . . . 71.349999999999994 111.009 174.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.24 -22.37 60.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.951 -1.022 . . . . 75.319999999999993 108.36 175.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 m -112.2 130.02 56.06 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.23 -0.895 . . . . 74.030000000000001 109.417 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -77.37 -33.87 55.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.474 0.654 . . . . 73.329999999999998 109.652 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.9 mm -91.71 101.03 12.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 105.558 -2.016 . . . . 65.109999999999999 105.558 173.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -87.79 113.98 23.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.52 0.676 . . . . 73.0 112.237 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.0 mt -119.87 127.42 52.71 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.878 -1.897 . . . . 74.230000000000004 105.878 175.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -106.21 117.06 33.06 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.83 -0.748 . . . . 71.510000000000005 109.613 -176.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -119.85 177.56 4.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.033 -0.985 . . . . 73.439999999999998 109.071 -175.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.38 -35.76 68.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 107.913 -1.143 . . . . 74.439999999999998 107.913 176.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.9 m -97.96 151.32 20.41 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.81 -1.086 . . . . 74.120000000000005 108.778 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -90.51 98.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 118.686 -1.206 . . . . 73.239999999999995 110.408 175.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -87.03 78.42 8.96 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.677 -1.231 . . . . 73.140000000000001 107.677 172.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -57.43 -23.82 51.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 112.083 -176.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -172.79 97.7 0.13 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.605 -0.887 . . . . 75.129999999999995 108.605 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 2.3 t-160 -99.34 -52.12 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.942 -1.132 . . . . 72.409999999999997 107.942 176.222 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.81 155.44 41.09 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.987 -0.551 . . . . 74.340000000000003 110.844 -174.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.49 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 34.0 tt0 -131.05 129.15 41.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.566 -1.642 . . . . 74.530000000000001 106.566 176.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -105.27 122.2 45.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.622 -1.621 . . . . 74.150000000000006 106.622 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' HD3' ' OE2' ' A' ' 91' ' ' GLU . 21.3 mtm180 -125.07 145.91 49.7 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.635 0.731 . . . . 71.310000000000002 110.635 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.403 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.1 mp -103.98 111.41 33.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 102.856 -3.016 . . . . 74.150000000000006 102.856 175.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -138.73 118.45 13.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.038 -0.528 . . . . 72.329999999999998 110.829 -169.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 53.48 37.8 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.454 1.102 . . . . 72.510000000000005 112.272 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.06 87.52 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 113.515 178.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.98 150.12 26.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.387 -0.598 . . . . 73.230000000000004 109.387 -179.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.403 ' CD2' HG13 ' A' ' 94' ' ' ILE . 94.1 m-85 -104.59 116.19 31.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.257 -1.757 . . . . 70.25 106.257 174.151 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.14 135.31 54.3 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.206 0.527 . . . . 75.219999999999999 111.51 -174.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.42 120.65 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 104.815 -2.291 . . . . 73.430000000000007 104.815 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.03 131.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 N-CA-C 108.35 -0.982 . . . . 72.349999999999994 108.35 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.597 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.8 p30 -97.8 157.94 15.79 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 117.65 -1.62 . . . . 74.030000000000001 112.123 176.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -129.96 23.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.067 -1.827 . . . . 75.420000000000002 106.067 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.99 62.92 0.52 Allowed Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.752 -1.567 . . . . 74.040000000000006 110.11 -176.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -70.97 -7.01 43.1 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 122.802 0.441 . . . . 72.310000000000002 111.485 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 mt -75.19 -40.94 58.93 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.318 -0.253 . . . . 74.519999999999996 110.318 -178.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 94.3 m-20 -85.8 -20.56 29.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 119.799 -0.76 . . . . 74.310000000000002 110.25 -176.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.17 109.85 0.42 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.302 -0.951 . . . . 71.5 113.525 174.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -85.38 130.36 34.61 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.456 -0.942 . . . . 61.399999999999999 108.456 174.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -120.0 134.31 55.28 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.076 -0.712 . . . . 74.519999999999996 109.076 179.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.8 t -129.87 120.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.928 -1.508 . . . . 73.129999999999995 106.928 175.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.37 39.82 28.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.645 0.736 . . . . 73.430000000000007 109.777 -173.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 62.07 14.87 6.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 113.589 -1.641 . . . . 73.329999999999998 113.736 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -103.53 123.41 41.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 107.684 -1.228 . . . . 72.209999999999994 107.684 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.37 123.87 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.321 2.014 . . . . 74.420000000000002 110.786 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -141.33 162.31 35.79 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 110.593 -179.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.597 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 18.4 m120 -113.81 -29.84 6.95 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.595 -1.184 . . . . 73.409999999999997 109.533 176.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.31 134.7 36.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.617 -1.623 . . . . 72.0 106.617 172.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -153.46 138.45 17.24 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.458 -0.497 . . . . 71.239999999999995 111.826 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.6 t -84.86 122.52 38.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.401 -1.333 . . . . 75.540000000000006 107.401 171.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.444 ' HE3' ' CD1' ' A' ' 137' ' ' PHE . 13.6 ptm -90.25 130.53 36.36 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.961 -0.563 . . . . 71.430000000000007 111.099 -173.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -101.8 156.2 17.66 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.299 -0.63 . . . . 74.420000000000002 109.299 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.3 t -67.17 126.71 30.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 61.439999999999998 108.677 175.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.91 -6.66 58.62 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.725 -0.67 . . . . 75.430000000000007 112.747 -175.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.23 151.76 29.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.27 0.535 . . . . 71.219999999999999 111.184 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -112.39 127.48 56.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.45 0.643 . . . . 75.439999999999998 110.423 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.94 122.34 68.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.041 -1.096 . . . . 72.420000000000002 108.041 -177.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 39.0 mt-30 -108.02 131.11 54.92 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 113.101 0.778 . . . . 72.230000000000004 113.101 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.468 HG23 ' ND1' ' A' ' 89' ' ' HIS . 3.3 mp -117.35 103.24 14.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.478 -1.675 . . . . 74.439999999999998 106.478 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -65.6 1.29 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-O 121.279 0.377 . . . . 64.439999999999998 112.842 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -157.72 5.71 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.151 0.98 . . . . 74.400000000000006 110.847 173.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 68.0 m-85 -91.18 124.54 35.47 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.894 -1.15 . . . . 75.120000000000005 107.894 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -111.57 118.8 36.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.927 0.87 . . . . 75.530000000000001 110.932 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.29 133.74 52.08 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.475 -1.693 . . . . 75.409999999999997 107.413 -178.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.25 129.09 67.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.862 -1.162 . . . . 72.519999999999996 107.862 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.444 ' CD1' ' HE3' ' A' ' 122' ' ' MET . 80.5 t80 -88.56 134.03 33.99 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.53 -0.759 . . . . 74.450000000000003 109.484 -176.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.75 161.23 33.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.139 0.495 . . . . 75.209999999999994 109.846 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.56 132.06 43.3 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.701 -1.592 . . . . 73.430000000000007 106.701 174.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.43 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -80.11 -163.74 28.59 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 115.739 1.055 . . . . 63.299999999999997 115.739 -169.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.36 145.3 47.84 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 123.001 2.467 . . . . 74.420000000000002 112.424 -177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.42 65.86 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.494 -1.298 . . . . 71.420000000000002 107.494 175.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--N 1.295 -1.782 0 CA-C-N 114.288 -1.324 . . . . 72.230000000000004 109.388 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.9 t -83.72 124.57 39.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.82 -0.807 . . . . 73.329999999999998 108.82 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.46 105.91 13.01 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.627 -1.249 . . . . 73.319999999999993 107.627 -178.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -89.1 95.88 10.5 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.638 -0.71 . . . . 74.340000000000003 110.203 -178.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.69 157.89 23.59 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.139 -0.937 . . . . 75.319999999999993 108.508 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.01 3.6 16.78 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.097 0.475 . . . . 75.310000000000002 112.066 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.42 ' CD1' ' HH ' ' A' ' 111' ' ' TYR . 3.9 pp -65.88 -23.02 66.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.492 1.293 . . . . 72.299999999999997 114.492 -174.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.36 -26.96 63.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.913 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -66.66 -29.46 69.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 74.129999999999995 110.997 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.55 -48.64 76.66 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.535 0.522 . . . . 75.239999999999995 111.744 -175.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -76.78 -18.05 58.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.313 0.578 . . . . 74.420000000000002 110.868 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -81.6 -34.35 31.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.136 -1.061 . . . . 64.219999999999999 108.136 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 t -72.59 -45.24 60.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.974 -0.557 . . . . 75.209999999999994 110.21 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 p -80.75 -17.35 51.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.253 -0.43 . . . . 73.420000000000002 111.993 -177.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 67.07 73.89 0.34 Allowed 'General case' 0 C--O 1.25 1.1 0 CA-C-O 122.088 0.946 . . . . 73.310000000000002 110.228 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.62 124.68 34.34 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 113.695 -1.593 . . . . 71.25 113.926 -176.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -94.68 137.76 33.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.356 -0.609 . . . . 73.409999999999997 109.356 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.61 98.97 43.0 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 109.63 -0.507 . . . . 63.409999999999997 109.63 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 143.08 27.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.027 1.818 . . . . 73.450000000000003 110.946 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 126.0 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.944 -1.132 . . . . 71.349999999999994 107.944 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -112.28 156.83 21.76 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.288 -0.634 . . . . 75.120000000000005 109.288 -177.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.23 160.83 32.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.807 -0.812 . . . . 72.430000000000007 108.807 -177.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.53 -7.12 24.46 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.647 -1.381 . . . . 62.200000000000003 109.647 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' HB3' ' H ' ' A' ' 124' ' ' THR . . . -73.8 -39.78 63.85 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.721 -0.74 . . . . 73.209999999999994 109.979 -177.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.51 -5.08 59.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.466 -1.243 . . . . 75.120000000000005 110.432 -177.144 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -86.63 -29.89 22.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.931 -0.577 . . . . 72.040000000000006 110.119 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 53.41 69.21 2.38 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 124.158 0.911 . . . . 73.400000000000006 110.384 -177.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.15 -65.97 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.181 2.587 . . . . 72.420000000000002 113.819 -173.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 140' ' ' GLY . . . -102.22 -0.37 33.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.611 -0.436 . . . . 74.239999999999995 111.467 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.9 -5.14 77.14 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.079 -0.581 . . . . 53.119999999999997 113.606 178.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.1 m -115.22 157.67 23.38 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 110.0 -0.371 . . . . 61.439999999999998 110.0 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -142.59 139.93 31.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.308 -0.406 . . . . 74.540000000000006 110.161 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.46 150.61 32.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.927 0.394 . . . . 72.019999999999996 111.782 -178.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.36 134.25 53.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.262 -0.644 . . . . 74.120000000000005 109.262 177.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.02 133.36 56.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.042 -0.526 . . . . 73.120000000000005 110.222 -178.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.535 HG23 ' ND2' ' A' ' 56' ' ' ASN . 24.8 t -76.54 117.54 21.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.732 -1.581 . . . . 72.5 106.732 177.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -90.35 -31.98 16.67 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.323 0.582 . . . . 75.549999999999997 110.164 -173.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -142.5 144.27 32.91 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.91 -1.885 . . . . 75.120000000000005 105.91 -176.974 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' HD3' ' A' ' 53' ' ' ARG . . . 134.2 169.52 12.05 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 110.175 -1.17 . . . . 72.099999999999994 110.175 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.55 -31.81 87.53 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.309 2.006 . . . . 73.209999999999994 112.042 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.535 ' ND2' HG23 ' A' ' 51' ' ' VAL . 4.5 p-10 -101.35 22.68 12.14 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.363 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.95 143.91 55.8 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.995 0.426 . . . . 74.329999999999998 111.357 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.23 -13.58 60.07 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.002 -0.839 . . . . 63.009999999999998 111.002 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 128.66 36.49 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.32 -0.622 . . . . 64.519999999999996 109.32 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -110.73 135.31 51.51 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.036 -0.727 . . . . 75.439999999999998 109.036 176.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.294 -1.002 . . . . 73.310000000000002 108.294 -179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.98 144.48 26.24 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.614 -0.434 . . . . 73.340000000000003 109.846 177.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 3.4 mm? -74.77 118.4 17.69 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.91 -0.774 . . . . 75.019999999999996 108.91 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.98 -29.03 4.33 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 111.825 0.306 . . . . 73.409999999999997 111.825 -174.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.455 ' O ' HD11 ' A' ' 94' ' ' ILE . 3.0 pt20 -118.69 151.96 50.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 112.97 0.73 . . . . 71.510000000000005 112.97 -177.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.76 -25.65 27.59 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 124.306 3.337 . . . . 72.430000000000007 114.202 -179.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.3 m -135.21 119.8 18.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.722 -1.214 . . . . 63.130000000000003 107.722 175.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.4 m -115.5 114.28 24.8 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.7 -0.852 . . . . 73.349999999999994 108.7 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.5 p -86.52 135.65 33.37 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 122.138 -0.351 . . . . 71.409999999999997 111.344 -176.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.15 134.68 55.06 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-N 116.019 -0.537 . . . . 54.409999999999997 111.492 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.43 -163.95 28.42 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 108.709 -1.756 . . . . 75.329999999999998 108.709 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -112.8 119.23 37.3 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.09 -1.818 . . . . 75.540000000000006 106.09 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.617 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 4.5 t-160 -174.33 155.29 2.18 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 104.861 -2.274 . . . . 74.219999999999999 104.861 -173.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.617 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 55.8 Cg_endo -75.66 -18.57 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-N 120.507 1.217 . . . . 74.25 110.799 175.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.21 -3.47 55.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.411 -0.813 . . . . 63.140000000000001 112.321 -176.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.452 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 56.1 p -80.38 143.09 33.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.87 -0.732 . . . . 73.209999999999994 110.24 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.64 -39.0 67.54 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.557 -0.457 . . . . 74.540000000000006 110.388 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.14 135.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.051 -0.722 . . . . 72.400000000000006 109.051 176.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -96.14 117.84 31.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.251 0.548 . . . . 75.540000000000006 110.152 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -125.9 140.23 52.82 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.659 -1.978 . . . . 73.310000000000002 105.659 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.12 117.29 29.9 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.056 -0.658 . . . . 60.399999999999999 109.267 -176.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.18 173.44 6.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.684 -0.858 . . . . 63.32 108.684 -174.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.32 -29.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.436 -0.95 . . . . 74.329999999999998 108.436 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -128.35 -165.26 1.47 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.591 -1.263 . . . . 75.120000000000005 107.591 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.06 98.17 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.683 -0.807 . . . . 61.439999999999998 109.896 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.1 m -87.4 73.85 9.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 122.0 0.905 . . . . 75.239999999999995 110.275 175.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -69.87 -40.37 75.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.198 -1.365 . . . . 75.420000000000002 112.618 -179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -135.65 73.76 1.48 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.47 -0.937 . . . . 73.150000000000006 108.47 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -100.45 -53.5 3.09 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.374 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.78 162.54 40.54 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 119.763 -0.775 . . . . 73.150000000000006 111.082 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.12 146.04 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.291 173.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -104.87 119.19 38.4 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.55 -2.019 . . . . 74.450000000000003 105.55 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -109.07 132.88 53.69 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.688 -0.687 . . . . 74.540000000000006 109.257 -172.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 63' ' ' LEU . 57.9 mt -125.93 123.98 65.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.393 -0.821 . . . . 73.409999999999997 108.905 -173.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.91 118.24 18.67 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.479 -0.488 . . . . 75.319999999999993 111.537 174.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.44 37.82 29.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.908 0.883 . . . . 70.430000000000007 111.905 175.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.02 82.4 Favored Glycine 0 C--O 1.222 -0.632 0 CA-C-N 115.642 -0.708 . . . . 51.329999999999998 113.859 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 35.2 mt-10 -101.53 130.58 47.85 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.048 -1.464 . . . . 74.340000000000003 107.048 175.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.2 124.47 52.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.829 -0.434 . . . . 75.239999999999995 109.829 -174.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.88 148.78 52.69 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 120.763 0.316 . . . . 71.409999999999997 111.064 177.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.48 123.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 106.681 -1.6 . . . . 74.329999999999998 106.681 177.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.36 122.97 69.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.606 -0.516 . . . . 74.319999999999993 109.606 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.49 129.42 34.5 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.67 -1.233 . . . . 74.319999999999993 107.67 172.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.57 23.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 120.796 -0.362 . . . . 71.120000000000005 111.369 -176.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.27 -38.07 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 118.418 -1.849 . . . . 64.099999999999994 114.218 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 61.2 30.84 19.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.931 0.872 . . . . 73.420000000000002 109.268 -174.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.99 -49.21 75.59 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 113.931 -1.486 . . . . 75.209999999999994 111.083 -174.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -106.96 -19.4 13.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.772 -1.171 . . . . 74.420000000000002 109.084 178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.17 101.86 2.72 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.385 -1.086 . . . . 72.510000000000005 110.385 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 m -87.8 129.41 35.2 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.362 0.601 . . . . 72.049999999999997 110.652 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 73.3 m-85 -116.01 126.82 54.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.307 -0.997 . . . . 72.439999999999998 108.307 175.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 t -120.9 126.91 75.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 105.443 -2.058 . . . . 75.400000000000006 105.443 176.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 55.46 38.73 30.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.182 -1.414 . . . . 73.349999999999994 107.182 -169.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' HD3' ' NH1' ' A' ' 134' ' ' ARG . 22.1 mtm105 63.39 8.99 3.79 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 114.035 -1.439 . . . . 74.030000000000001 114.461 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.45 135.67 19.29 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.035 -0.728 . . . . 72.420000000000002 109.035 176.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.9 122.94 11.15 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 121.735 1.623 . . . . 73.200000000000003 108.651 177.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.485 ' CD ' ' HB2' ' A' ' 120' ' ' GLN . 26.1 ttm-85 -152.37 169.56 22.25 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.773 -0.771 . . . . 73.230000000000004 110.164 -170.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -104.76 -68.65 0.84 Allowed 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.533 0.521 . . . . 72.329999999999998 110.458 174.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.69 54.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.042 -0.411 . . . . 73.120000000000005 110.68 -174.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.485 ' HB2' ' CD ' ' A' ' 117' ' ' ARG . 57.1 tp60 -153.63 137.88 16.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.944 -0.571 . . . . 63.299999999999997 111.111 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 82.8 t -65.93 133.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.379 -1.711 . . . . 64.540000000000006 106.379 169.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 42.2 ttm -87.33 129.55 34.97 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.674 -0.861 . . . . 75.129999999999995 108.674 -170.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -114.09 149.29 35.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.001 -0.74 . . . . 74.099999999999994 109.001 -177.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 39' ' ' ALA . 14.6 t -73.52 130.58 40.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 109.272 -0.64 . . . . 75.450000000000003 109.272 -179.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.24 -0.13 57.15 Favored Glycine 0 C--O 1.241 0.535 0 N-CA-C 111.464 -0.654 . . . . 70.439999999999998 111.464 -176.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.51 148.23 35.4 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 108.953 -0.758 . . . . 74.530000000000001 108.953 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.7 124.93 53.06 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.528 -0.915 . . . . 61.039999999999999 108.528 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -108.42 113.08 42.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 106.821 -1.548 . . . . 73.319999999999993 106.821 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 64.6 tt0 -108.22 126.37 52.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.144 0.497 . . . . 75.540000000000006 109.679 -176.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.82 108.36 25.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.607 -1.257 . . . . 72.409999999999997 107.607 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.37 -105.11 1.49 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.594 -1.402 . . . . 41.200000000000003 109.594 -175.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -116.07 -13.64 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.197 -0.601 . . . . 73.430000000000007 111.764 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -98.92 140.75 32.61 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.386 -0.926 . . . . 70.400000000000006 110.63 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.514 ' NH1' ' HD3' ' A' ' 114' ' ' ARG . 19.5 ptp180 -112.58 144.14 42.56 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 112.667 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.63 139.76 49.37 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.983 -1.858 . . . . 75.109999999999999 105.983 174.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -111.79 128.39 68.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.127 -1.064 . . . . 72.129999999999995 108.127 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.463 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 80.4 t80 -94.41 122.11 36.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.984 0.421 . . . . 71.319999999999993 110.982 -178.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.73 159.1 26.07 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.462 0.649 . . . . 73.230000000000004 110.142 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.38 124.44 27.13 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.676 -1.231 . . . . 73.120000000000005 107.676 173.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.454 ' O ' ' HB1' ' A' ' 44' ' ' ALA . . . -75.84 142.16 28.32 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.932 -0.651 . . . . 71.230000000000004 112.19 -175.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.45 162.79 41.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.14 2.56 . . . . 75.040000000000006 111.991 176.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.62 44.17 0.96 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.594 0.711 . . . . 75.400000000000006 109.902 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 106.679 -1.6 . . . . 74.310000000000002 106.679 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.427 -1.595 0 N-CA-C 107.815 -1.18 . . . . 71.140000000000001 107.815 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.78 115.31 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.869 -1.16 . . . . 72.140000000000001 107.869 178.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.38 131.87 45.09 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.248 -1.019 . . . . 72.349999999999994 108.248 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -129.24 105.3 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.173 0.511 . . . . 74.120000000000005 110.496 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.49 140.75 48.48 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.751 -0.833 . . . . 71.510000000000005 108.751 178.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.52 2.04 34.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.66 0.245 . . . . 53.420000000000002 111.66 -176.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -63.92 -10.48 21.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.99 1.107 . . . . 73.310000000000002 113.99 -179.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.37 -12.76 61.93 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 122.153 0.978 . . . . 73.540000000000006 110.976 176.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.5 -20.53 66.38 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 126.016 1.727 . . . . 74.510000000000005 109.813 177.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HA ' ' OG ' ' A' ' 28' ' ' SER . 11.7 tp10 -59.18 -18.47 36.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.508 -0.769 . . . . 72.129999999999995 111.979 -176.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -57.84 -41.49 82.46 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.18 -0.325 . . . . 71.209999999999994 110.745 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.26 -22.16 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.992 0.368 . . . . 74.299999999999997 111.992 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 25' ' ' GLU . 6.7 p -81.02 -36.07 31.07 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.965 -0.694 . . . . 75.439999999999998 111.473 177.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.3 m -79.94 -48.42 13.43 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.607 -0.837 . . . . 73.340000000000003 110.757 177.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.1 m 47.58 -76.89 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.122 1.897 . . . . 73.010000000000005 116.122 -178.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.03 65.9 2.57 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 114.563 0.585 . . . . 74.430000000000007 114.563 -172.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.1 m -116.07 123.62 48.38 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.389 -1.338 . . . . 74.420000000000002 107.389 172.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.25 109.57 51.57 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.471 -0.491 . . . . 74.439999999999998 110.672 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.79 142.83 99.22 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.666 2.244 . . . . 72.299999999999997 110.301 174.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.49 126.35 32.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.25 -0.432 . . . . 54.119999999999997 111.233 -176.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 p -96.2 80.38 3.24 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.478 0.656 . . . . 74.040000000000006 110.001 178.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.8 t -89.51 -27.63 20.18 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.687 -0.688 . . . . 63.140000000000001 110.463 -178.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.99 55.23 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.543 -0.837 . . . . 74.519999999999996 112.55 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.91 -39.96 79.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 109.769 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.46 -11.96 60.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.92 . . . . 71.230000000000004 111.492 -178.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -97.1 -12.36 23.24 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.269 -0.641 . . . . 64.340000000000003 109.269 -175.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 mt 59.73 83.63 0.21 Allowed Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 124.722 1.264 . . . . 72.230000000000004 108.599 -176.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -33.98 -59.29 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.094 1 C-N-CA 125.703 4.269 . . . . 74.200000000000003 115.767 -166.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.58 10.71 3.72 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.743 0.782 . . . . 70.040000000000006 109.687 179.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.48 -12.46 46.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.1 -0.8 . . . . 75.209999999999994 111.1 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -138.9 151.52 47.01 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.056 -1.831 . . . . 65.019999999999996 106.056 177.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 137' ' ' PHE . . . -152.92 158.55 42.27 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.794 -0.817 . . . . 75.239999999999995 108.794 -177.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -120.86 149.67 42.24 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.237 -0.585 . . . . 72.239999999999995 111.965 -175.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -114.99 139.55 49.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.773 -0.825 . . . . 75.030000000000001 108.773 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.19 135.93 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.422 -0.354 . . . . 74.430000000000007 110.384 -177.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -82.79 118.12 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.026 -1.472 . . . . 75.519999999999996 107.026 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -95.96 -31.34 13.13 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.062 -0.972 . . . . 73.349999999999994 110.408 -174.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -143.12 137.68 29.29 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.153 -0.684 . . . . 73.310000000000002 109.153 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.44 175.14 13.88 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.816 -1.314 . . . . 34.229999999999997 109.816 -179.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 78.4 Cg_exo -55.62 -37.69 95.0 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 74.299999999999997 112.807 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -96.69 22.77 7.71 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.564 0.579 . . . . 72.209999999999994 112.564 -178.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.02 137.38 58.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.928 0.394 . . . . 63.43 110.416 177.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.55 -18.03 41.91 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 111.023 -0.831 . . . . 72.120000000000005 111.023 -178.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.29 139.6 30.33 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 110.126 -0.324 . . . . 71.299999999999997 110.126 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -128.22 137.76 52.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 73.319999999999993 108.724 178.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -125.18 138.39 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.999 -0.741 . . . . 72.430000000000007 108.999 -178.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -96.91 134.02 40.79 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.105 0.479 . . . . 72.409999999999997 109.713 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.6 mt -97.95 105.21 17.32 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.277 -0.42 . . . . 73.430000000000007 110.219 -178.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -130.55 5.55 4.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.774 0.797 . . . . 63.350000000000001 109.578 176.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -107.84 141.46 23.13 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 115.109 -0.95 . . . . 74.310000000000002 110.709 -177.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.1 Cg_exo -57.41 -27.55 76.39 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.364 2.71 . . . . 65.25 113.745 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -137.03 123.5 20.82 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.299 -0.63 . . . . 71.200000000000003 109.299 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 26.3 m -123.47 120.76 33.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.463 -0.94 . . . . 74.010000000000005 108.463 178.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.467 HG21 HH11 ' A' ' 88' ' ' ARG . 74.6 m -94.49 131.06 40.59 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 112.06 0.392 . . . . 75.099999999999994 112.06 -176.353 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.89 135.49 54.89 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.292 0.568 . . . . 75.25 110.556 178.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.09 -159.74 25.2 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.465 -1.454 . . . . 72.109999999999999 109.465 179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -101.69 117.75 35.53 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.724 -1.213 . . . . 71.030000000000001 107.724 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -175.88 148.2 0.94 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 105.558 -2.016 . . . . 74.230000000000004 105.558 -175.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.57 -40.47 65.41 Favored 'Trans proline' 0 C--O 1.221 -0.358 0 C-N-CA 122.041 1.827 . . . . 73.219999999999999 111.801 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.07 19.37 7.97 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.514 0.931 . . . . 73.140000000000001 113.514 -178.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m -66.61 122.99 18.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.303 -0.559 . . . . 65.129999999999995 109.796 174.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.11 -38.47 66.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.289 -1.375 . . . . 62.450000000000003 107.289 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.1 mm -108.75 98.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.791 -1.929 . . . . 74.349999999999994 105.791 173.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -91.03 120.2 31.82 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.951 -0.568 . . . . 75.349999999999994 109.857 -176.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.71 138.54 52.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.4 -0.963 . . . . 73.299999999999997 108.4 -179.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.37 116.49 32.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.519 -1.66 . . . . 64.439999999999998 106.519 176.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -105.96 -173.32 2.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.182 0.438 . . . . 74.310000000000002 112.182 -171.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.72 -32.61 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.24 0.616 . . . . 75.040000000000006 111.328 -174.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.405 ' CG2' ' HG ' ' A' ' 107' ' ' LEU . 6.1 t -123.89 -152.81 0.53 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 105.723 -1.955 . . . . 74.109999999999999 105.723 -178.013 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.85 95.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.644 -1.623 . . . . 72.25 109.387 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -92.34 85.59 5.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.179 -1.045 . . . . 71.239999999999995 108.179 176.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.439 ' NH1' ' HB2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -57.28 -27.69 62.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.976 -1.465 . . . . 74.420000000000002 112.458 -177.644 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.578 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 20.3 mmm180 -154.87 111.33 3.24 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 104.498 -2.408 . . . . 72.439999999999998 104.498 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 12.2 t60 -100.4 -52.77 3.28 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 117.667 -1.613 . . . . 75.219999999999999 109.901 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.49 151.69 36.8 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.1 -0.704 . . . . 73.319999999999993 109.1 -177.167 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -118.42 129.43 55.4 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.694 -1.965 . . . . 62.130000000000003 105.694 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.555 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.5 m-85 -105.98 113.45 27.0 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.969 -1.493 . . . . 73.040000000000006 106.969 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -107.74 131.94 53.9 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.545 -0.539 . . . . 74.310000000000002 109.545 -177.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -118.92 113.28 41.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 106.684 -1.599 . . . . 72.230000000000004 106.684 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.93 121.41 20.49 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.129 -0.693 . . . . 75.299999999999997 109.129 -177.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 56.81 37.58 28.89 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.098 1.359 . . . . 64.439999999999998 110.244 -179.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.06 89.33 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.087 -0.961 . . . . 71.140000000000001 113.855 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.08 131.75 46.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.641 0.72 . . . . 72.209999999999994 109.217 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -106.2 118.1 35.74 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.857 0.723 . . . . 75.030000000000001 110.256 -174.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.87 142.48 51.09 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.569 -0.53 . . . . 74.120000000000005 109.569 177.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.407 HG21 ' CD2' ' A' ' 92' ' ' PHE . 42.0 t -114.4 123.5 70.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.74 -1.207 . . . . 74.540000000000006 107.74 177.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.07 132.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.049 0.452 . . . . 75.25 110.287 177.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -77.04 127.46 32.72 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.288 -1.004 . . . . 71.239999999999995 108.288 177.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.51 16.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.602 -0.888 . . . . 74.299999999999997 108.602 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -174.8 81.12 0.07 OUTLIER Glycine 0 N--CA 1.418 -2.556 0 CA-C-N 115.273 -0.876 . . . . 74.019999999999996 111.934 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -77.57 42.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.687 1.232 . . . . 74.430000000000007 109.053 178.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 105' ' ' GLY . 23.4 tp -95.23 -28.51 14.99 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.782 -1.099 . . . . 75.140000000000001 110.627 -176.153 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.532 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 50.8 t30 -109.47 -19.82 13.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.354 -0.98 . . . . 75.120000000000005 108.354 173.197 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.404 ' N ' ' HE1' ' A' ' 89' ' ' HIS . . . 100.0 109.24 3.05 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.78 -0.645 . . . . 64.310000000000002 113.39 174.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.0 m -87.29 128.99 35.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.464 -0.569 . . . . 71.230000000000004 109.464 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -135.54 136.61 41.29 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.85 -0.796 . . . . 75.400000000000006 108.85 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.0 t -128.34 130.85 69.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.989 -1.856 . . . . 73.519999999999996 105.989 175.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.84 37.28 28.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.137 0.898 . . . . 75.519999999999996 108.747 -175.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 63.12 16.92 9.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 71.349999999999994 113.031 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.64 137.08 23.89 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 110.007 -0.368 . . . . 71.209999999999994 110.007 178.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.12 124.85 16.11 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.957 2.438 . . . . 75.540000000000006 112.112 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -126.66 159.29 34.06 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.24 0.543 . . . . 73.200000000000003 111.793 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.12 -29.0 3.36 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.288 -1.323 . . . . 73.230000000000004 108.145 177.118 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.65 136.91 18.6 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.515 -1.291 . . . . 65.230000000000004 107.515 174.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.38 141.94 20.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.27 -0.641 . . . . 75.420000000000002 109.27 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.65 122.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.676 -1.602 . . . . 71.230000000000004 106.676 174.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.468 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 44.3 ttp -89.6 130.44 35.91 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.328 0.585 . . . . 71.120000000000005 112.288 -168.836 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.531 ' HB2' ' OD1' ' A' ' 126' ' ' ASP . 16.7 mt-30 -120.05 152.18 37.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.053 -0.976 . . . . 75.239999999999995 108.92 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.2 p -73.21 133.81 44.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 123.522 0.729 . . . . 74.019999999999996 110.569 178.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.69 61.57 Favored Glycine 0 C--N 1.309 -0.93 0 N-CA-C 111.452 -0.659 . . . . 42.340000000000003 111.452 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 123' ' ' GLN . 3.0 m-20 -85.11 153.98 22.34 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.242 0.617 . . . . 73.099999999999994 111.437 178.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.02 130.67 55.5 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-N 115.256 -0.883 . . . . 71.140000000000001 109.515 -176.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.5 mt -114.69 132.21 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.091 -1.077 . . . . 75.299999999999997 108.091 177.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -119.73 122.9 42.47 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 108.656 -0.868 . . . . 75.420000000000002 108.656 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 89' ' ' HIS . 66.3 mt -117.32 102.28 13.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.211 -1.403 . . . . 55.439999999999998 107.211 178.249 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.74 -108.39 1.53 Allowed Glycine 0 C--N 1.309 -0.961 0 N-CA-C 110.926 -0.87 . . . . 72.109999999999999 110.926 -173.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -103.4 4.7 36.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.644 0.259 . . . . 74.420000000000002 110.684 178.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.574 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 78.0 m-85 -87.63 158.55 18.84 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.569 0.7 . . . . 70.530000000000001 111.285 179.298 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -133.43 123.13 24.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.971 -1.013 . . . . 74.239999999999995 108.763 174.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.76 125.39 41.67 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.994 -1.484 . . . . 73.140000000000001 106.994 177.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.03 129.05 68.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.089 -1.449 . . . . 73.209999999999994 107.089 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 47' ' ' ALA . 22.0 t80 -88.4 116.55 26.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.784 -0.821 . . . . 71.530000000000001 108.784 -178.387 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp -108.47 147.03 32.26 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.172 -0.677 . . . . 75.219999999999999 109.172 -173.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.33 131.24 40.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.474 -0.33 . . . . 72.420000000000002 111.207 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.29 132.56 11.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.602 -1.799 . . . . 74.200000000000003 108.602 175.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.08 148.68 92.71 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.132 1.888 . . . . 75.150000000000006 112.287 -177.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.25 69.9 10.51 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 106.775 -1.565 . . . . 63.229999999999997 106.775 178.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--N 1.266 -3.058 0 CA-C-N 112.03 -2.35 . . . . 72.430000000000007 106.338 -178.875 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.424 -1.752 0 N-CA-C 106.121 -1.807 . . . . 75.140000000000001 106.121 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -82.09 122.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.985 -0.746 . . . . 72.439999999999998 108.985 -178.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 14.8 t80 -86.95 105.41 17.09 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.097 -0.705 . . . . 72.319999999999993 109.097 -176.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -122.62 120.04 32.56 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.365 -0.606 . . . . 75.540000000000006 109.365 177.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.27 -160.68 0.86 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.188 -0.915 . . . . 63.350000000000001 108.976 -173.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -50.6 -22.16 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.266 1.426 . . . . 74.219999999999999 113.774 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 23' ' ' LEU . 3.9 pp -56.69 -30.83 63.84 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.256 0.835 . . . . 72.430000000000007 113.256 -178.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -89.39 0.08 57.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.469 0.914 . . . . 74.129999999999995 113.469 -177.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.23 -46.75 3.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.708 0.765 . . . . 73.329999999999998 110.45 176.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -69.36 -31.19 69.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.489 -1.232 . . . . 70.299999999999997 112.379 -174.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -56.42 -38.92 72.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.525 1.306 . . . . 74.310000000000002 114.525 -174.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.3 -35.62 35.5 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.0 0.429 . . . . 74.540000000000006 110.85 -176.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 m -68.1 -31.88 71.8 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.646 0.736 . . . . 73.109999999999999 110.825 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 p -83.03 -16.0 48.83 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 112.215 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 m -57.61 142.86 43.34 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.924 -0.769 . . . . 75.400000000000006 108.924 177.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.7 -52.03 0.84 Allowed Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.957 -1.257 . . . . 55.509999999999998 109.957 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 m -79.89 119.64 23.03 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.135 -1.431 . . . . 71.040000000000006 107.135 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.28 144.87 53.44 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 120.768 -0.373 . . . . 73.299999999999997 111.756 -174.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' OD1' ' A' ' 113' ' ' ASN . 42.1 Cg_exo -62.46 149.83 89.52 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.941 2.428 . . . . 73.230000000000004 110.916 172.601 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.834 0.35 . . . . 71.200000000000003 110.214 -178.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 m -77.55 90.08 3.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.776 -0.824 . . . . 61.130000000000003 108.776 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -94.55 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.371 0.508 . . . . 73.040000000000006 112.371 -177.04 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.34 57.88 0.64 Allowed Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.364 -0.694 . . . . 74.239999999999995 111.364 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB1' ' H ' ' A' ' 124' ' ' THR . . . -92.85 -47.05 7.23 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.555 0.693 . . . . 73.409999999999997 110.722 176.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.32 -0.49 6.34 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.361 -1.29 . . . . 73.450000000000003 114.466 -170.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -86.19 -28.47 23.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.089 -0.708 . . . . 72.310000000000002 109.089 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt 49.03 76.61 0.53 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.749 1.22 . . . . 73.299999999999997 111.747 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.503 ' HG2' ' O ' ' A' ' 140' ' ' GLY . 26.6 Cg_endo -87.41 -74.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.152 1.901 . . . . 74.540000000000006 114.344 -175.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.83 -32.63 67.73 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.151 0.501 . . . . 73.400000000000006 112.297 -176.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 7.7 82.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.183 -1.008 . . . . 64.230000000000004 110.763 -176.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 m -132.81 167.04 20.89 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.553 -1.647 . . . . 74.099999999999994 106.553 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 157.1 43.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.149 0.431 . . . . 75.010000000000005 110.127 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.16 137.51 51.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.288 0.566 . . . . 72.010000000000005 110.348 178.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 49' ' ' LEU . 4.2 pp -108.7 137.05 47.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 109.036 -0.728 . . . . 73.120000000000005 109.036 178.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -113.56 128.85 70.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 121.119 0.485 . . . . 73.140000000000001 110.03 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.46 HG21 ' ND2' ' A' ' 56' ' ' ASN . 38.4 t -83.75 118.09 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 106.99 -1.485 . . . . 74.530000000000001 106.99 178.237 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -95.05 -31.71 13.46 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.411 -0.813 . . . . 74.230000000000004 109.719 -174.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -141.35 138.41 33.05 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.753 -0.658 . . . . 75.450000000000003 109.259 176.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.68 169.29 13.18 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.72 -1.752 . . . . 75.209999999999994 108.72 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.98 -41.99 69.22 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.027 1.818 . . . . 73.340000000000003 111.634 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.46 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.1 p-10 -91.67 22.71 3.93 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.223 0.453 . . . . 73.010000000000005 112.223 178.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.21 55.57 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 123.22 0.608 . . . . 62.109999999999999 111.222 177.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.21 -19.42 43.12 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.487 -1.045 . . . . 74.530000000000001 110.487 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.36 144.37 26.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.407 -0.397 . . . . 72.340000000000003 110.28 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -119.67 134.87 55.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.273 -1.01 . . . . 72.510000000000005 108.273 176.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -117.12 125.07 50.67 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.972 -0.381 . . . . 73.239999999999995 109.972 -176.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.5 124.18 34.28 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.479 -0.782 . . . . 74.0 109.368 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.02 104.82 15.99 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.383 -1.71 . . . . 75.109999999999999 106.383 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.05 -21.3 12.68 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 112.157 -173.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.16 154.44 40.45 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 120.329 -0.548 . . . . 74.109999999999999 110.923 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 75.5 Cg_exo -52.56 -25.98 27.48 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.609 2.873 . . . . 71.409999999999997 114.021 -178.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 m -140.94 120.1 12.9 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.568 -0.853 . . . . 74.319999999999993 109.809 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 49.6 m -116.43 114.39 24.17 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 109.057 -0.719 . . . . 73.420000000000002 109.057 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.2 136.4 32.94 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.88 -0.415 . . . . 74.239999999999995 109.88 178.163 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.58 134.71 54.89 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.34 0.59 . . . . 73.219999999999999 110.723 -177.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.37 178.01 15.39 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.284 -1.527 . . . . 74.329999999999998 109.284 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 43.6 ttt180 -85.49 117.67 24.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.222 -0.659 . . . . 75.140000000000001 109.222 178.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.75 145.9 0.31 Allowed Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 107.658 -1.238 . . . . 73.010000000000005 107.658 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -61.24 -15.72 41.93 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.236 2.624 . . . . 73.439999999999998 113.851 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.92 6.24 33.47 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.546 0.212 . . . . 74.230000000000004 111.194 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.9 m -100.56 125.2 46.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.625 -0.509 . . . . 74.299999999999997 109.625 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.1 -48.54 73.32 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.046 -0.524 . . . . 73.420000000000002 110.956 -178.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.15 130.18 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.895 -0.722 . . . . 72.540000000000006 110.715 -179.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.02 143.0 48.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.282 0.563 . . . . 63.049999999999997 111.417 -178.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.7 mt -106.44 140.42 39.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.06 -1.459 . . . . 70.140000000000001 107.06 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HZ ' ' A' ' 133' ' ' PHE . 20.5 t70 -91.45 116.45 28.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.533 -1.654 . . . . 64.510000000000005 106.533 177.266 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 84' ' ' THR . 12.4 t0 -116.04 164.39 14.51 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.155 -0.683 . . . . 75.310000000000002 109.155 -169.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.26 -31.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.702 -1.222 . . . . 61.340000000000003 107.702 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 27.3 m -115.42 170.94 8.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.794 -1.558 . . . . 74.120000000000005 106.794 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.5 98.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.051 -1.031 . . . . 74.310000000000002 111.437 -177.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -97.1 91.7 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.479 -0.782 . . . . 74.409999999999997 110.227 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 17.8 ptt180 -81.47 -45.22 16.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.527 0.936 . . . . 74.140000000000001 113.527 -176.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.418 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 5.6 tpt180 -126.73 87.7 2.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.712 -1.588 . . . . 75.230000000000004 106.712 -176.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -100.2 -52.36 3.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.844 -0.616 . . . . 75.450000000000003 112.253 -174.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.44 162.99 37.9 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.953 -0.699 . . . . 73.319999999999993 111.428 -175.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.44 133.78 36.99 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.361 -0.836 . . . . 65.109999999999999 109.109 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -112.28 122.3 47.33 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.939 -0.763 . . . . 63.539999999999999 108.939 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.44 119.51 39.02 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.497 -0.557 . . . . 72.329999999999998 109.497 175.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -107.1 111.77 37.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.534 -2.395 . . . . 71.420000000000002 104.534 176.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -135.74 117.66 15.24 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 120.141 -0.624 . . . . 75.010000000000005 110.258 -174.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 51.7 39.82 26.13 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.76 1.224 . . . . 74.519999999999996 111.775 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -5.61 84.33 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 115.282 -0.872 . . . . 43.329999999999998 114.677 178.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.5 150.02 23.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.907 0.854 . . . . 73.219999999999999 109.102 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.94 117.46 24.84 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.692 -0.403 . . . . 74.230000000000004 110.959 -172.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -109.6 127.13 54.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.249 -1.019 . . . . 74.140000000000001 108.249 177.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.85 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.538 -0.912 . . . . 75.319999999999993 108.538 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.01 131.39 72.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.976 -0.556 . . . . 75.129999999999995 110.444 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.46 131.11 34.45 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.394 -0.965 . . . . 54.350000000000001 108.394 174.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.35 11.38 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 116.302 -0.408 . . . . 70.400000000000006 111.074 -177.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -165.1 59.88 0.25 Allowed Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.535 -1.317 . . . . 75.150000000000006 112.954 -178.464 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.6 t -80.78 75.13 7.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.736 0.779 . . . . 71.409999999999997 109.677 177.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.86 -21.99 13.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.832 -1.544 . . . . 75.239999999999995 106.832 170.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.426 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 3.2 m-20 -102.83 3.17 36.39 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.342 -1.299 . . . . 75.230000000000004 110.868 -177.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.76 77.29 1.13 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.936 -0.575 . . . . 55.100000000000001 113.051 178.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -86.92 128.9 35.06 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.203 -0.666 . . . . 74.400000000000006 109.203 176.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -135.68 140.2 44.28 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.881 0.372 . . . . 74.109999999999999 110.245 177.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.46 119.7 60.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 105.841 -1.911 . . . . 75.140000000000001 105.841 175.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.449 ' OD1' ' HD2' ' A' ' 34' ' ' PRO . 0.7 OUTLIER 57.38 36.82 27.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.293 -1.003 . . . . 75.150000000000006 108.293 -171.896 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 60.7 14.32 4.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.26 1.424 . . . . 74.200000000000003 112.979 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.06 142.48 25.12 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 124.089 0.956 . . . . 73.129999999999995 109.205 176.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.06 122.97 10.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.7 1.6 . . . . 64.239999999999995 109.569 178.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -146.36 140.04 26.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.091 -1.078 . . . . 73.400000000000006 108.091 -175.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.8 -41.42 8.85 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.237 -0.283 . . . . 71.099999999999994 110.237 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.39 136.84 33.53 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.822 -0.807 . . . . 75.329999999999998 108.822 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 141.91 21.9 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.731 -0.84 . . . . 74.349999999999994 108.731 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.85 114.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 106.261 -1.755 . . . . 72.430000000000007 106.261 175.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 38.0 ttm -94.37 148.84 21.82 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.383 0.883 . . . . 65.099999999999994 113.383 -166.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -125.66 158.34 35.0 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.829 1.252 . . . . 61.020000000000003 111.113 -172.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.424 ' H ' ' HB1' ' A' ' 39' ' ' ALA . 10.6 m -58.38 124.27 18.97 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.294 0.637 . . . . 72.430000000000007 110.192 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.61 -9.45 60.53 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.908 -0.587 . . . . 72.340000000000003 112.051 178.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.52 151.21 44.09 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 108.708 -0.849 . . . . 75.120000000000005 108.708 -179.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.3 137.66 54.47 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.798 0.808 . . . . 64.299999999999997 112.124 -175.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.95 126.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 105.844 -1.91 . . . . 74.5 105.844 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -108.95 128.68 55.15 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.179 -1.785 . . . . 74.030000000000001 106.179 178.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 133' ' ' PHE . 66.6 mt -131.56 138.32 53.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 N-CA-C 103.825 -2.657 . . . . 75.430000000000007 103.825 -177.238 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -36.19 99.46 0.01 OUTLIER Glycine 0 CA--C 1.548 2.153 0 N-CA-C 115.912 1.125 . . . . 64.030000000000001 115.912 -177.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt 77.51 14.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.609 1.564 . . . . 73.319999999999993 112.929 178.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.53 ' HB2' ' HB ' ' A' ' 130' ' ' ILE . 55.8 m-85 -123.56 150.64 43.81 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 125.295 1.438 . . . . 74.439999999999998 109.355 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -137.15 119.83 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.316 -1.735 . . . . 74.120000000000005 106.316 175.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 mp -122.9 136.13 54.75 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.94 -0.393 . . . . 60.530000000000001 109.94 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.68 130.16 68.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.509 -0.923 . . . . 64.420000000000002 108.509 179.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -95.93 131.88 41.83 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.106 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -131.45 136.86 48.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.88 -0.785 . . . . 64.030000000000001 108.88 177.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.05 33.04 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.433 -0.951 . . . . 63.509999999999998 108.433 175.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 43' ' ' PRO . . . -59.94 130.64 49.7 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.7 -0.96 . . . . 64.319999999999993 110.7 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.11 160.34 13.14 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.345 2.697 . . . . 71.310000000000002 113.585 -175.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.19 48.58 1.01 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.713 1.205 . . . . 71.010000000000005 111.406 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.406 -2.662 0 CA-C-N 114.643 -1.162 . . . . 62.219999999999999 108.017 176.339 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 108.475 -0.935 . . . . 73.420000000000002 108.475 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -83.79 117.22 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.179 -0.675 . . . . 71.349999999999994 109.179 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.72 140.18 29.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.292 0.568 . . . . 72.430000000000007 110.968 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -84.59 120.65 26.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.686 -2.338 . . . . 74.430000000000007 104.686 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.79 80.91 2.09 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.286 0.565 . . . . 73.420000000000002 111.538 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.15 -23.18 33.06 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.661 -0.866 . . . . 62.399999999999999 108.661 177.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 pp -63.33 -5.95 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.088 1.355 . . . . 74.530000000000001 113.592 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.6 -28.75 70.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.048 0.539 . . . . 73.340000000000003 109.811 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.96 -10.32 58.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.794 -0.639 . . . . 74.439999999999998 111.048 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -99.77 -41.73 7.14 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.119 0.485 . . . . 73.299999999999997 111.368 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -84.47 -3.42 58.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.931 0.396 . . . . 72.129999999999995 111.755 -176.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -61.9 -41.9 98.44 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.102 0.561 . . . . 72.530000000000001 111.57 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -78.49 -13.15 59.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.086 0.47 . . . . 75.150000000000006 111.126 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -86.59 -24.8 25.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.598 -1.26 . . . . 74.329999999999998 107.598 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.1 m -66.92 107.38 2.2 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.32 -0.855 . . . . 72.140000000000001 110.68 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.91 177.82 40.27 Favored Glycine 0 N--CA 1.404 -3.462 0 N-CA-C 107.32 -2.312 . . . . 41.409999999999997 107.32 178.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 m -75.2 120.62 20.95 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 117.686 0.743 . . . . 63.25 110.346 -177.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.21 92.01 45.01 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 106.673 -1.602 . . . . 65.439999999999998 106.673 174.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.89 142.54 69.52 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.753 2.302 . . . . 51.530000000000001 113.036 -174.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.49 162.74 18.82 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.784 -1.191 . . . . 54.43 107.784 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -77.95 126.77 31.34 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.529 -0.468 . . . . 72.140000000000001 110.342 -176.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 p -67.12 146.52 54.18 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.706 -0.679 . . . . 74.010000000000005 110.055 178.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 116.51 -8.75 17.36 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 108.375 -1.89 . . . . 71.030000000000001 108.375 -174.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.11 66.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.183 -1.009 . . . . 65.109999999999999 110.231 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.31 1.82 47.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.425 -0.807 . . . . 65.120000000000005 110.627 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.53 7.7 17.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.036 -0.529 . . . . 73.239999999999995 110.209 -175.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 69.74 89.91 0.09 OUTLIER Pre-proline 0 CA--C 1.512 -0.482 0 C-N-CA 124.309 1.044 . . . . 73.310000000000002 109.61 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.69 -26.3 28.06 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.674 2.25 . . . . 73.409999999999997 112.184 -175.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.39 -27.99 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.837 -1.529 . . . . 75.310000000000002 110.229 -178.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.43 69.64 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.1 -1.2 . . . . 53.310000000000002 110.1 -177.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.8 t -131.06 158.13 41.19 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.052 -1.462 . . . . 72.230000000000004 107.052 176.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.97 40.93 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.743 -0.836 . . . . 64.310000000000002 108.743 -175.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 pp -133.13 151.56 51.99 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.899 0.381 . . . . 74.030000000000001 110.385 178.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 pp -113.52 132.18 55.79 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.006 -1.109 . . . . 74.540000000000006 108.006 175.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.81 132.06 68.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 109.906 -178.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 15.3 t -86.64 117.86 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.363 -1.347 . . . . 63.200000000000003 107.363 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.42 -33.02 12.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.033 0.444 . . . . 73.349999999999994 110.817 -179.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 13.7 tpt180 -137.85 139.61 40.01 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.476 -1.305 . . . . 73.400000000000006 107.476 -176.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.25 176.17 14.25 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.013 -0.835 . . . . 64.109999999999999 111.013 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.5 -35.23 39.73 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.614 2.209 . . . . 75.299999999999997 112.089 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -97.49 22.31 9.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.04 0.536 . . . . 72.209999999999994 111.139 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -62.94 141.31 58.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.997 0.427 . . . . 73.400000000000006 111.793 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.99 -13.87 57.38 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.046 -0.822 . . . . 71.329999999999998 111.046 -177.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.64 142.98 27.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.898 0.38 . . . . 61.119999999999997 110.371 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -131.17 136.43 48.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.573 -0.899 . . . . 75.140000000000001 108.573 177.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -130.51 139.22 50.5 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.984 -0.747 . . . . 70.209999999999994 108.984 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.06 143.64 32.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.407 0.622 . . . . 72.030000000000001 112.114 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.04 103.36 15.44 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.496 -0.927 . . . . 70.219999999999999 108.496 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -133.18 8.61 4.03 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.902 1.334 . . . . 74.310000000000002 107.621 178.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.454 ' O ' HD11 ' A' ' 94' ' ' ILE . 4.0 pt20 -113.23 156.93 42.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 113.437 -1.71 . . . . 62.299999999999997 109.092 -174.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.99 -32.42 94.97 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.466 2.111 . . . . 74.219999999999999 112.451 178.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 97.7 m -153.92 129.67 10.09 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 122.095 -0.378 . . . . 74.120000000000005 111.138 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 19.8 m -103.29 113.5 27.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.775 -1.565 . . . . 65.140000000000001 106.775 174.449 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -91.77 132.95 36.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.445 -0.576 . . . . 62.140000000000001 109.445 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.86 134.26 55.28 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 109.905 -0.405 . . . . 73.439999999999998 109.905 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.85 -132.45 2.83 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.108 -0.797 . . . . 75.329999999999998 111.108 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 86' ' ' SER . 9.9 mmm180 -118.54 151.28 38.16 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 123.029 0.532 . . . . 72.439999999999998 110.719 -175.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.8 m80 80.3 152.73 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 124.913 1.285 . . . . 72.239999999999995 112.628 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.45 -18.87 26.72 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.978 3.118 . . . . 71.310000000000002 115.6 -175.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.52 -23.2 60.98 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.236 0.471 . . . . 74.549999999999997 110.708 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m -78.18 119.72 21.97 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 105.706 -1.961 . . . . 74.120000000000005 105.706 172.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.44 -49.18 78.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.957 -0.565 . . . . 75.310000000000002 111.399 -173.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.5 pt -107.28 123.23 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 C-N-CA 120.12 -0.632 . . . . 71.120000000000005 109.685 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.89 124.02 33.24 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 109.044 -0.725 . . . . 72.0 109.044 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 mt -121.2 140.44 52.02 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.293 -2.114 . . . . 71.400000000000006 105.293 178.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -102.21 116.31 32.38 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.101 -1.814 . . . . 72.439999999999998 106.101 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -88.53 176.77 7.01 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.615 -1.175 . . . . 72.519999999999996 112.837 -171.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.401 ' C ' ' HG1' ' A' ' 84' ' ' THR . 32.2 t -79.73 -32.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.229 1.014 . . . . 70.230000000000004 108.505 -177.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 83' ' ' VAL . 99.4 m -150.14 153.67 36.74 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.074 -2.565 . . . . 64.409999999999997 104.074 175.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.416 HG12 ' HG3' ' A' ' 72' ' ' ARG . 50.0 t -70.67 112.47 5.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.655 1.217 . . . . 75.5 113.375 -162.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 23.2 m -111.27 107.18 16.38 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 113.259 -1.792 . . . . 75.219999999999999 108.0 177.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -55.84 -45.69 78.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.422 -0.808 . . . . 73.530000000000001 112.03 -175.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -137.3 119.88 16.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.322 -2.103 . . . . 75.219999999999999 105.322 171.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -89.76 -52.91 4.75 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.205 -1.035 . . . . 73.310000000000002 108.205 178.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.2 34.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.83 -0.623 . . . . 42.5 109.567 -177.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.71 145.92 52.06 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.241 0.543 . . . . 73.329999999999998 111.04 171.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 101' ' ' VAL . 9.4 m-85 -104.45 113.22 26.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.351 -1.722 . . . . 75.230000000000004 106.351 -177.319 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -106.67 120.72 42.73 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.649 -0.871 . . . . 74.239999999999995 108.649 -176.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 65' ' ' GLN . 3.1 mp -104.42 111.58 34.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 105.109 -2.182 . . . . 75.319999999999993 105.109 179.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -139.38 130.56 26.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 110.083 -0.34 . . . . 73.140000000000001 110.083 -177.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 55.87 36.67 27.73 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 122.293 1.044 . . . . 73.209999999999994 110.533 175.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 0.86 81.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.11 -0.95 . . . . 63.240000000000002 113.652 179.057 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -101.45 133.75 45.6 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.413 -0.958 . . . . 62.039999999999999 108.413 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -104.9 116.09 31.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.521 -1.288 . . . . 73.340000000000003 107.521 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.33 134.28 48.86 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.99 0.424 . . . . 74.040000000000006 110.504 -178.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 92' ' ' PHE . 39.0 t -102.49 124.08 56.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.496 -1.298 . . . . 74.120000000000005 107.496 175.071 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.62 123.09 68.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.825 0.821 . . . . 72.25 109.325 176.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -100.48 140.63 34.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.651 -1.159 . . . . 74.5 111.952 -174.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.33 1.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.809 . . . . 72.319999999999993 109.946 171.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.7 40.15 2.52 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 121.358 -0.449 . . . . 63.43 113.092 -173.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.8 m -55.73 -19.62 11.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 73.450000000000003 111.903 178.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.271 0.628 . . . . 65.239999999999995 111.293 -178.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -86.99 -17.91 31.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.695 0.759 . . . . 75.519999999999996 109.287 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.37 76.23 1.12 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.324 -0.853 . . . . 53.340000000000003 113.213 175.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 m -86.69 126.67 34.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.758 -0.46 . . . . 73.109999999999999 109.758 175.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -136.79 136.44 38.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 110.033 -0.358 . . . . 71.409999999999997 110.033 178.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.65 121.11 63.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.798 -1.556 . . . . 74.519999999999996 106.798 174.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.31 44.67 27.01 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.334 1.053 . . . . 72.340000000000003 110.111 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.8 9.35 5.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.375 1.47 . . . . 74.120000000000005 114.587 -177.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -120.07 135.54 24.42 Favored Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.982 -0.687 . . . . 73.430000000000007 109.894 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.54 137.2 67.81 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.544 2.162 . . . . 75.340000000000003 111.55 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -134.43 159.42 41.13 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.304 0.573 . . . . 75.409999999999997 111.705 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.65 -34.65 3.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.344 -1.298 . . . . 73.0 108.761 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.78 27.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.694 -1.595 . . . . 73.409999999999997 106.694 174.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -147.61 122.21 9.82 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.856 -0.338 . . . . 71.519999999999996 111.214 -176.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.59 114.13 26.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.465 -2.05 . . . . 73.040000000000006 105.465 173.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 128' ' ' ILE . 73.6 mtp -93.34 147.19 23.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 115.268 1.581 . . . . 74.540000000000006 115.268 -168.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -112.06 152.11 28.58 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.935 -1.484 . . . . 74.040000000000006 107.653 175.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -66.55 133.52 50.5 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.337 0.589 . . . . 74.030000000000001 111.385 -178.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.39 -2.14 56.13 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.584 -0.735 . . . . 43.329999999999998 112.392 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.94 153.52 20.97 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 117.032 0.416 . . . . 74.329999999999998 109.931 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.32 145.82 42.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.011 0.745 . . . . 63.030000000000001 113.011 -172.192 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.471 HD11 ' SD ' ' A' ' 122' ' ' MET . 60.4 mt -120.23 132.05 70.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.537 -0.912 . . . . 73.109999999999999 108.537 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -116.35 122.01 43.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.89 -1.152 . . . . 75.230000000000004 107.89 175.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.6 105.05 18.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.422 -0.955 . . . . 74.319999999999993 108.422 -178.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.25 -86.29 0.5 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 108.986 -1.646 . . . . 64.329999999999998 108.986 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -140.35 -2.86 1.39 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.535 -0.333 . . . . 75.530000000000001 111.425 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.254 50.5 p90 -95.04 164.11 13.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.202 -0.999 . . . . 74.030000000000001 111.529 -179.758 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -120.0 126.61 51.26 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 113.07 0.766 . . . . 74.219999999999999 113.07 -165.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.7 mt -121.96 140.13 52.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.984 -1.117 . . . . 75.140000000000001 107.984 175.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.05 137.46 55.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.602 -0.888 . . . . 73.239999999999995 108.602 176.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -105.69 114.83 29.23 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.146 0.579 . . . . 73.450000000000003 109.69 -177.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -127.7 159.18 35.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.817 -0.438 . . . . 71.510000000000005 109.817 -178.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.85 123.53 25.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.577 -1.638 . . . . 62.420000000000002 106.577 171.081 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.72 -89.5 1.35 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.093 -1.051 . . . . 63.340000000000003 114.934 -170.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.68 152.55 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.333 2.022 . . . . 70.040000000000006 112.821 -177.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.45 20.24 11.9 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.072 -1.085 . . . . 74.439999999999998 108.072 178.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-N 114.312 -1.313 . . . . 73.0 108.375 -178.425 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 106.638 -1.615 . . . . 74.450000000000003 106.638 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.78 115.71 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.679 -1.23 . . . . 70.340000000000003 107.679 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.18 139.81 30.1 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.427 -0.806 . . . . 62.340000000000003 109.942 -174.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -81.64 132.0 35.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.582 -0.896 . . . . 73.329999999999998 108.582 177.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.59 66.58 9.73 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.28 0.562 . . . . 73.219999999999999 112.465 -175.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.92 -18.25 58.41 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 107.841 -1.17 . . . . 73.540000000000006 107.841 174.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -62.12 -12.92 22.13 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 114.841 -1.072 . . . . 74.230000000000004 112.862 177.031 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.91 -30.54 69.89 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 121.358 0.599 . . . . 73.530000000000001 109.536 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.47 -33.74 76.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 125.008 1.323 . . . . 75.209999999999994 108.989 178.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 -49.0 10.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.279 -0.873 . . . . 74.530000000000001 109.081 177.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.3 tpp -56.88 -32.65 66.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.824 1.25 . . . . 71.409999999999997 112.031 -176.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 30.0 tt0 -62.78 -32.13 73.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.756 0.312 . . . . 73.120000000000005 111.554 -178.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -69.61 -32.2 70.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.097 -0.705 . . . . 75.239999999999995 109.097 179.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -84.26 -16.65 42.42 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.039 0.935 . . . . 71.329999999999998 111.513 -179.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.406 ' OG1' ' HA ' ' A' ' 27' ' ' GLU . 61.6 m -59.59 124.91 21.61 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 112.615 0.598 . . . . 74.439999999999998 112.615 -175.122 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.71 -144.25 8.45 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 109.036 -1.626 . . . . 64.040000000000006 109.036 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 p -115.52 139.79 49.74 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 117.446 0.623 . . . . 73.099999999999994 109.56 174.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . . . -127.12 122.26 23.04 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 120.607 -0.437 . . . . 44.219999999999999 109.831 177.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.37 156.95 60.53 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 123.146 2.564 . . . . 75.010000000000005 112.513 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.65 158.78 35.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.567 -0.901 . . . . 73.349999999999994 108.567 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.3 m -81.26 105.62 12.6 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.382 -0.969 . . . . 62.43 108.382 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 m -70.23 78.25 0.52 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.148 0.975 . . . . 73.5 111.641 -176.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 25.98 0.14 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 109.641 -1.383 . . . . 70.400000000000006 109.641 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.1 72.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.169 -0.515 . . . . 74.310000000000002 110.134 -177.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.21 4.13 51.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.707 -0.679 . . . . 73.349999999999994 111.056 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -84.6 -42.24 15.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.964 -1.125 . . . . 75.329999999999998 107.964 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt 50.88 68.74 3.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.728 -1.124 . . . . 74.019999999999996 111.22 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.56 -65.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.38 2.054 . . . . 75.340000000000003 113.482 -175.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -15.82 60.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.815 0.302 . . . . 65.239999999999995 111.815 -177.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -2.85 72.74 Favored Glycine 0 N--CA 1.46 0.271 0 N-CA-C 111.746 -0.542 . . . . 54.140000000000001 111.746 -178.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -150.77 169.59 21.29 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.616 -1.624 . . . . 73.409999999999997 106.616 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.59 44.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 118.06 0.391 . . . . 74.530000000000001 111.1 -173.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.42 157.73 36.13 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.4 0.438 . . . . 73.430000000000007 110.715 177.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.78 151.2 50.77 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.117 -0.697 . . . . 71.340000000000003 109.117 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.71 134.69 66.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 110.027 -0.36 . . . . 75.329999999999998 110.027 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.83 118.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.17 -1.419 . . . . 73.430000000000007 107.17 177.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -91.0 -32.95 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.939 0.4 . . . . 72.219999999999999 110.159 -177.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 tpm_? -137.81 132.63 32.92 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.647 -0.421 . . . . 73.510000000000005 110.085 -179.16 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.15 173.01 17.96 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.991 -1.644 . . . . 74.109999999999999 108.991 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -59.55 -35.42 95.64 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.584 2.189 . . . . 74.129999999999995 112.725 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -100.5 22.15 12.18 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.595 -0.442 . . . . 64.109999999999999 112.187 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.6 138.71 57.64 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.752 178.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.03 -19.24 32.89 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.268 -0.733 . . . . 74.209999999999994 111.268 -177.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.96 144.01 26.78 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 110.138 -0.319 . . . . 62.149999999999999 110.138 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.73 156.75 18.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.9 -0.778 . . . . 73.099999999999994 108.9 178.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CG ' HG21 ' A' ' 78' ' ' ILE . 98.3 m-85 -138.0 144.44 41.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.335 -1.358 . . . . 75.329999999999998 107.335 175.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.7 135.1 54.97 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.156 -0.683 . . . . 74.540000000000006 109.156 -178.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.46 104.36 10.02 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.87 -0.789 . . . . 75.510000000000005 108.87 179.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.93 -21.37 11.61 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.827 -0.624 . . . . 72.430000000000007 111.351 -177.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.58 144.86 30.12 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.001 -0.545 . . . . 74.219999999999999 110.983 -173.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.32 -19.85 36.9 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.745 2.963 . . . . 73.200000000000003 113.901 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.8 m -141.74 121.23 13.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.997 -0.742 . . . . 71.310000000000002 108.997 175.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.8 m -120.06 133.13 55.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.253 -0.647 . . . . 61.329999999999998 109.253 -177.321 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.2 m -105.66 143.83 33.26 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.901 -0.407 . . . . 73.299999999999997 109.901 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.07 134.91 54.54 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.042 -0.725 . . . . 73.129999999999995 109.042 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.79 -146.64 18.57 Favored Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 109.113 -1.595 . . . . 70.510000000000005 109.113 -179.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -119.67 118.65 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.614 -1.234 . . . . 71.400000000000006 111.497 174.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.556 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 47.5 m-70 -167.55 142.14 3.09 Favored Pre-proline 0 C--N 1.277 -2.557 0 C-N-CA 126.832 2.053 . . . . 75.519999999999996 105.564 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.57 -21.95 73.44 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.611 2.207 . . . . 73.120000000000005 114.733 -175.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.432 ' OE2' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -105.79 5.19 30.62 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.259 0.466 . . . . 75.319999999999993 112.259 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 73.3 m -80.98 140.27 35.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.494 -0.482 . . . . 71.219999999999999 109.826 178.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.08 -49.89 14.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 111.121 -173.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.462 HG21 ' CG ' ' A' ' 61' ' ' PHE . 43.9 pt -100.37 103.47 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.289 1.043 . . . . 75.030000000000001 111.015 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -88.1 132.44 34.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.378 -1.283 . . . . 75.140000000000001 108.965 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.48 136.36 51.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.029 -1.471 . . . . 74.040000000000006 107.029 176.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.38 139.37 50.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.235 -0.654 . . . . 75.310000000000002 109.235 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -166.4 -174.56 2.91 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.079 -2.193 . . . . 73.239999999999995 105.079 178.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.45 -24.35 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.806 -1.553 . . . . 73.209999999999994 106.806 175.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -78.96 96.19 5.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.505 -1.294 . . . . 72.319999999999993 107.505 176.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.56 135.59 35.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.17 0.509 . . . . 74.319999999999993 112.315 -173.023 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.9 t -134.52 142.36 46.99 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.625 -2.361 . . . . 72.299999999999997 104.625 173.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -62.55 -46.07 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.296 0.57 . . . . 75.040000000000006 109.742 -178.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.412 ' CZ ' HG22 ' A' ' 104' ' ' VAL . 16.8 ptt180 -151.42 151.06 31.16 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.348 -1.352 . . . . 73.120000000000005 107.348 170.068 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -100.67 -52.33 3.36 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.613 0.571 . . . . 74.519999999999996 112.186 -176.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.03 164.79 36.49 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.314 -0.555 . . . . 71.230000000000004 110.462 -172.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.21 132.0 45.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.598 -0.728 . . . . 75.219999999999999 109.248 173.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 68.3 m-85 -106.11 123.76 48.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.646 -0.872 . . . . 65.230000000000004 108.646 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -106.12 127.08 52.95 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.465 -0.494 . . . . 75.209999999999994 109.728 173.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.15 114.41 46.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.563 -1.643 . . . . 73.329999999999998 106.563 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -136.84 118.93 15.41 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 120.685 -0.406 . . . . 74.5 110.205 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 55.87 40.64 30.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.602 1.161 . . . . 71.25 111.396 177.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.45 -8.53 74.29 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.464 -1.244 . . . . 44.439999999999998 114.116 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.49 135.78 42.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.882 0.841 . . . . 75.019999999999996 110.17 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -104.94 128.35 53.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.77 -1.105 . . . . 70.439999999999998 108.183 -176.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.46 137.13 49.65 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.127 0.489 . . . . 75.099999999999994 110.39 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.33 125.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.729 -0.841 . . . . 71.5 108.729 -177.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -116.66 126.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.834 -1.173 . . . . 73.129999999999995 107.834 174.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.21 134.09 35.56 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.898 -0.779 . . . . 72.230000000000004 108.898 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 88' ' ' ARG . 15.5 m -138.21 15.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.862 0.839 . . . . 74.319999999999993 109.509 179.168 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -155.48 70.66 0.27 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 110.472 -1.051 . . . . 73.140000000000001 110.472 -176.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -72.42 27.53 0.05 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.63 0.772 . . . . 72.120000000000005 112.49 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 105' ' ' GLY . 3.0 tm? -82.96 -47.07 12.16 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 105.716 -1.957 . . . . 73.310000000000002 105.716 174.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.98 -19.93 19.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.285 -0.966 . . . . 74.540000000000006 109.55 176.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.77 129.7 0.12 Allowed Glycine 0 C--N 1.343 0.944 0 O-C-N 123.957 0.786 . . . . 72.219999999999999 112.352 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.2 m -82.96 127.8 33.87 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.481 -1.288 . . . . 73.319999999999993 109.116 174.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -130.06 126.29 37.28 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.564 -1.272 . . . . 73.010000000000005 107.564 175.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.47 119.24 59.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.097 -1.446 . . . . 72.140000000000001 107.097 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 33' ' ' ALA . 36.2 t-20 54.61 40.84 32.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.133 0.968 . . . . 71.030000000000001 109.063 -178.172 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 71.53 10.9 6.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.1 -1.409 . . . . 73.549999999999997 113.036 175.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.35 129.53 24.91 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 75.209999999999994 109.629 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.09 126.66 16.86 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.907 2.405 . . . . 73.400000000000006 110.782 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.17 162.77 23.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.958 0.885 . . . . 72.420000000000002 113.228 -176.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -133.0 -38.33 0.97 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.886 -1.961 . . . . 64.420000000000002 107.306 178.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.68 136.64 27.56 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.908 -2.256 . . . . 64.450000000000003 104.908 171.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -152.9 126.04 8.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.123 -0.631 . . . . 73.109999999999999 110.148 179.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.22 119.69 27.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.006 -1.479 . . . . 74.129999999999995 107.006 174.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.0 ttt -87.01 140.06 29.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.595 0.712 . . . . 72.530000000000001 112.032 -162.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -128.97 155.96 44.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.564 -1.198 . . . . 64.150000000000006 111.581 -176.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.5 t -80.03 135.27 36.32 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.452 1.101 . . . . 71.25 113.406 -173.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.57 -20.46 48.19 Favored Glycine 0 CA--C 1.499 -0.937 0 CA-C-N 115.851 -0.613 . . . . 63.210000000000001 112.238 177.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.76 151.95 37.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 122.903 0.481 . . . . 74.319999999999993 109.74 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 147.6 35.05 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.462 0.649 . . . . 74.140000000000001 110.896 -178.718 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -105.7 124.83 61.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 106.58 -1.637 . . . . 72.129999999999995 106.58 -176.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -110.18 126.39 54.05 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.632 -1.988 . . . . 75.120000000000005 105.632 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.31 102.49 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.15 -1.056 . . . . 74.430000000000007 108.15 -176.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.14 -84.18 0.02 OUTLIER Glycine 0 CA--C 1.536 1.38 0 CA-C-O 121.39 0.439 . . . . 53.25 113.077 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -131.82 8.91 4.52 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.491 0.716 . . . . 75.409999999999997 110.209 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -102.37 151.89 21.74 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.513 -0.767 . . . . 51.119999999999997 109.633 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 124.47 21.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.921 -0.581 . . . . 75.349999999999994 109.895 170.358 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.57 141.22 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.922 -1.14 . . . . 73.430000000000007 107.922 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.3 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.627 -0.879 . . . . 74.219999999999999 108.627 -178.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -102.23 126.95 49.36 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.732 0.645 . . . . 74.310000000000002 110.003 -176.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -140.0 131.06 26.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.887 0.851 . . . . 75.340000000000003 111.895 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.95 118.25 35.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.986 -1.487 . . . . 63.520000000000003 106.986 176.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.04 -71.02 0.06 OUTLIER Glycine 0 C--N 1.295 -1.708 0 C-N-CA 118.279 -1.915 . . . . 65.340000000000003 114.639 -176.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.89 142.31 97.23 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.357 2.038 . . . . 71.540000000000006 113.179 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.83 76.51 1.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.636 -1.165 . . . . 74.5 108.166 -178.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 114.024 -1.444 . . . . 73.019999999999996 108.114 -178.592 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.435 -1.201 0 N-CA-C 109.889 -0.411 . . . . 72.219999999999999 109.889 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -97.57 114.53 35.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 107.451 -1.315 . . . . 74.409999999999997 107.451 177.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.45 138.6 34.65 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.033 -0.667 . . . . 63.549999999999997 112.307 -177.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.34 91.1 7.53 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.363 -2.458 . . . . 70.230000000000004 104.363 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.5 168.08 9.73 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.213 -1.358 . . . . 55.020000000000003 112.779 -166.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.92 -1.42 56.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.235 -1.348 . . . . 61.210000000000001 109.172 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB2' ' HH ' ' A' ' 111' ' ' TYR . 3.8 pp -63.65 -14.7 54.36 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.295 -0.866 . . . . 74.239999999999995 112.478 -178.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.69 -19.61 64.38 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.897 0.38 . . . . 72.430000000000007 111.077 175.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -84.02 -38.77 20.47 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.779 -1.193 . . . . 74.5 107.779 173.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -57.47 -34.54 69.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.983 -1.008 . . . . 75.140000000000001 109.986 176.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.53 -49.17 70.9 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.435 1.094 . . . . 72.239999999999995 111.551 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.29 -36.05 76.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.659 0.266 . . . . 73.319999999999993 110.528 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -62.16 -37.47 85.33 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.638 -0.71 . . . . 62.509999999999998 110.8 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -86.27 -17.03 35.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.22 0.452 . . . . 63.32 112.22 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.0 m -63.71 125.34 23.98 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.345 -0.613 . . . . 75.209999999999994 109.345 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.87 3.4 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 108.311 -1.916 . . . . 74.319999999999993 108.311 -171.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.8 t -101.75 140.05 36.57 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.576 -0.812 . . . . 73.450000000000003 108.994 -179.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.27 80.02 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 107.418 -1.326 . . . . 74.310000000000002 107.418 174.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 38.2 Cg_exo -62.29 142.01 89.73 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.315 1.343 . . . . 64.340000000000003 109.68 176.652 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.28 124.58 44.48 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.072 -0.651 . . . . 41.119999999999997 109.459 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 124' ' ' THR . 73.4 m -165.2 143.79 6.39 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 72.519999999999996 109.531 -179.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -118.62 8.94 12.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.684 0.754 . . . . 75.019999999999996 109.775 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.28 65.8 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 107.008 -2.437 . . . . 73.540000000000006 107.008 -177.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.498 ' HB1' ' OE1' ' A' ' 123' ' ' GLN . . . -57.02 -47.56 80.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.972 -1.114 . . . . 73.519999999999996 113.151 -165.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -104.44 3.57 32.31 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 120.742 -0.383 . . . . 72.219999999999999 111.255 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.01 -44.51 9.28 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.39 -0.924 . . . . 72.319999999999993 112.03 -171.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 36.51 69.23 1.29 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 124.2 0.938 . . . . 75.040000000000006 111.18 -175.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.9 -70.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 125.265 3.977 . . . . 64.439999999999998 116.804 -167.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.28 -5.72 58.19 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.444 -0.502 . . . . 72.219999999999999 112.299 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -4.77 64.34 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.96 -0.638 . . . . 53.439999999999998 112.267 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.3 m -114.79 153.37 30.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.335 -1.728 . . . . 63.310000000000002 106.335 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 156.83 40.02 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.286 -0.566 . . . . 73.109999999999999 112.235 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.5 161.09 35.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.922 -1.036 . . . . 74.299999999999997 109.743 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -130.9 135.14 47.41 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.196 -0.668 . . . . 75.409999999999997 109.196 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -116.2 133.56 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.06 0.457 . . . . 74.120000000000005 110.61 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.0 t -78.82 118.62 26.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.667 -1.234 . . . . 72.319999999999993 107.667 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -90.86 -31.12 16.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 110.428 -176.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 26.2 tpt180 -143.34 145.7 32.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.109 -1.071 . . . . 74.540000000000006 108.109 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.46 178.12 15.18 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 111.305 -0.718 . . . . 71.510000000000005 111.305 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HG2' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -61.42 -31.28 88.15 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.696 2.264 . . . . 73.530000000000001 112.303 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -97.09 21.22 10.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.996 0.369 . . . . 74.049999999999997 111.996 177.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.23 45.39 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 120.814 0.34 . . . . 61.25 110.761 179.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.04 -13.07 52.63 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 111.45 -0.66 . . . . 65.120000000000005 111.45 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 145.24 25.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.777 0.322 . . . . 35.340000000000003 110.197 178.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -125.62 147.54 49.28 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.08 -1.082 . . . . 74.319999999999993 108.08 177.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.85 144.89 51.79 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.749 -1.204 . . . . 64.040000000000006 107.749 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -111.74 134.04 53.57 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.753 0.311 . . . . 74.109999999999999 110.861 -177.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.4 mt -93.44 104.96 17.07 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.493 -0.558 . . . . 74.340000000000003 109.493 -178.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -121.29 -12.42 8.64 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.83 0.824 . . . . 52.329999999999998 110.809 -179.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -106.96 144.86 29.94 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 115.712 -0.677 . . . . 74.329999999999998 110.644 -175.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.05 -29.51 45.22 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.763 2.975 . . . . 74.129999999999995 113.434 -178.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -140.62 121.98 14.98 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.73 -0.606 . . . . 74.209999999999994 109.75 179.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -118.0 139.54 51.04 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.227 -1.397 . . . . 63.299999999999997 107.227 178.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.4 m -115.39 141.9 47.41 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.79 . . . . 74.010000000000005 110.222 -178.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.49 135.42 54.78 Favored 'General case' 0 C--O 1.256 1.446 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.761 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.01 -144.91 12.72 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.666 -1.374 . . . . 70.299999999999997 109.666 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -119.95 118.29 30.32 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.663 -0.495 . . . . 70.329999999999998 109.663 176.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.8 p80 169.74 163.02 0.2 Allowed Pre-proline 0 C--N 1.315 -0.925 0 C-N-CA 126.812 2.045 . . . . 73.230000000000004 107.811 174.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.54 -25.43 75.65 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.237 1.958 . . . . 65.540000000000006 113.043 -178.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -86.64 -4.9 59.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.653 -0.249 . . . . 72.329999999999998 111.481 -178.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -71.29 107.57 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.366 -0.605 . . . . 64.019999999999996 109.366 178.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.0 -32.01 56.89 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.581 -1.266 . . . . 73.319999999999993 107.581 175.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.68 100.85 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.305 -2.109 . . . . 64.299999999999997 105.305 173.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.72 118.32 36.6 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.76 -0.376 . . . . 72.450000000000003 110.737 -175.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -123.06 122.3 38.15 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.71 -1.218 . . . . 75.299999999999997 107.71 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 55' ' ' PRO . 24.8 t70 -130.71 132.24 45.25 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.603 -0.888 . . . . 64.420000000000002 108.603 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -141.58 175.17 9.9 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.677 -1.601 . . . . 74.5 106.677 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -60.12 -32.19 49.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.577 -1.268 . . . . 64.219999999999999 107.577 174.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.1 m -74.88 114.59 13.52 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.691 -1.225 . . . . 72.0 107.691 173.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.57 125.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.226 0.536 . . . . 73.140000000000001 110.53 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.1 m -145.13 103.12 3.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.162 -0.681 . . . . 70.150000000000006 109.162 177.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -80.68 -45.68 16.77 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 119.604 -0.839 . . . . 73.340000000000003 111.488 179.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -118.88 99.67 6.9 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.313 -0.625 . . . . 74.409999999999997 109.313 177.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.43 ' CE1' HG13 ' A' ' 130' ' ' ILE . 44.4 t-80 -100.32 -52.66 3.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.301 -0.96 . . . . 73.519999999999996 111.325 177.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.59 163.57 39.2 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.03 -0.668 . . . . 71.140000000000001 111.913 -175.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.78 137.4 54.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.952 -1.129 . . . . 74.109999999999999 107.952 176.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -105.83 113.58 27.22 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.739 -1.578 . . . . 65.439999999999998 106.739 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -111.13 136.54 50.03 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.832 -0.432 . . . . 74.5 109.832 -175.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.472 HD12 ' CD2' ' A' ' 99' ' ' PHE . 17.9 mm -107.97 113.52 44.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.628 -1.99 . . . . 74.430000000000007 105.628 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -135.96 122.84 21.26 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.511 -0.476 . . . . 72.340000000000003 110.51 -177.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 56.37 37.16 28.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.265 1.426 . . . . 75.25 110.403 179.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.5 -0.72 87.53 Favored Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.13 -0.941 . . . . 54.340000000000003 113.215 177.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.85 145.72 29.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.458 -0.941 . . . . 74.150000000000006 108.458 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 94' ' ' ILE . 50.3 m-85 -105.11 127.12 52.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.289 -1.375 . . . . 73.030000000000001 107.289 -177.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -130.29 147.39 52.0 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.886 -0.509 . . . . 74.129999999999995 110.23 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -113.53 123.68 69.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.636 -1.246 . . . . 73.140000000000001 107.636 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.3 121.87 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.419 0.628 . . . . 74.010000000000005 109.608 175.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.84 138.21 35.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.77 -0.65 . . . . 72.430000000000007 110.612 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.22 12.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.679 -0.691 . . . . 74.549999999999997 109.517 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.7 -63.4 0.12 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 119.91 -1.138 . . . . 72.219999999999999 112.981 -177.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 t 62.23 9.55 3.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.723 1.209 . . . . 75.310000000000002 111.205 -177.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 108' ' ' ASN . 2.6 pt? -75.98 -46.02 31.77 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 124.017 0.927 . . . . 74.129999999999995 112.577 -173.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.401 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 34.2 t-20 -89.74 -18.46 26.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 75.140000000000001 109.735 -171.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.79 86.19 1.77 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.516 -1.034 . . . . 74.310000000000002 110.516 -177.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 m -80.63 129.81 34.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.027 0.441 . . . . 71.430000000000007 110.323 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 51.3 m-85 -131.02 136.07 48.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.741 -0.663 . . . . 72.209999999999994 110.585 178.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.66 123.32 49.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 105.935 -1.876 . . . . 64.129999999999995 105.935 174.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 57.34 37.76 28.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.44 1.096 . . . . 73.409999999999997 108.867 -176.914 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.3 mtm-85 66.68 12.29 8.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.56 -1.2 . . . . 74.140000000000001 113.702 178.142 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -114.57 142.94 29.0 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 108.871 -0.789 . . . . 71.540000000000006 108.871 174.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.54 123.17 11.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.716 1.611 . . . . 73.200000000000003 108.73 172.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -157.3 136.89 12.18 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.166 -1.42 . . . . 73.209999999999994 107.166 -176.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -93.66 -49.27 5.95 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.062 -0.655 . . . . 72.109999999999999 110.56 -178.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.2 134.22 55.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.612 -0.835 . . . . 74.239999999999995 109.151 177.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -154.4 144.92 22.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.97 -0.559 . . . . 74.340000000000003 110.808 -178.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.78 125.55 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.265 -1.754 . . . . 75.439999999999998 106.265 172.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.7 ttp -98.38 129.87 45.03 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.212 0.529 . . . . 73.109999999999999 110.191 -173.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.498 ' OE1' ' HB1' ' A' ' 39' ' ' ALA . 69.5 mt-30 -117.7 156.23 28.6 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.8 -1.185 . . . . 74.519999999999996 107.8 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.9 t -62.62 133.74 55.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.95 0.722 . . . . 73.129999999999995 112.95 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.43 56.16 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.699 -0.682 . . . . 44.409999999999997 112.588 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -88.67 153.01 21.45 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 109.63 -0.507 . . . . 71.340000000000003 109.63 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -120.6 127.18 51.87 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.002 0.905 . . . . 75.109999999999999 111.836 -176.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.27 129.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.175 -1.046 . . . . 74.299999999999997 108.175 -177.142 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.0 tt0 -118.77 132.25 56.13 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.651 -177.425 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.43 HG13 ' CE1' ' A' ' 89' ' ' HIS . 2.9 mp -108.69 103.46 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.884 -1.895 . . . . 74.219999999999999 105.884 178.179 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.06 -93.54 0.33 Allowed Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 115.476 -0.784 . . . . 75.049999999999997 112.807 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.0 3.85 9.35 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.156 0.428 . . . . 72.209999999999994 112.156 -175.149 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.5 p90 -131.61 141.9 49.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.647 -0.658 . . . . 74.25 111.605 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -122.63 149.55 43.85 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 114.606 1.336 . . . . 74.0 114.606 -171.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.0 mp -117.39 140.92 48.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.654 -1.612 . . . . 72.319999999999993 107.634 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.4 t -111.13 131.41 62.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.341 -0.985 . . . . 74.400000000000006 108.341 178.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -95.4 121.9 37.56 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.221 -0.9 . . . . 75.019999999999996 110.932 -175.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.16 133.42 51.58 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.192 0.52 . . . . 74.239999999999995 109.943 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 148.62 27.29 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.781 -0.822 . . . . 72.109999999999999 108.781 175.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 129.88 24.07 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.361 -1.096 . . . . 72.340000000000003 110.361 178.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.67 162.61 38.57 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.945 2.43 . . . . 63.130000000000003 111.459 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.34 51.96 0.9 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.028 0.918 . . . . 75.409999999999997 110.769 -178.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 105.507 -2.034 . . . . 74.319999999999993 105.507 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 108.424 -0.954 . . . . 71.340000000000003 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -150.1 -43.92 0.13 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.86 0.362 . . . . 72.349999999999994 110.365 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.72 165.25 23.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.365 -0.38 . . . . 72.400000000000006 110.433 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -72.27 114.44 10.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.449 -0.945 . . . . 74.319999999999993 108.449 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.83 100.12 3.38 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.785 0.802 . . . . 75.200000000000003 111.252 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.21 -150.62 22.6 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 107.847 -2.101 . . . . 72.5 107.847 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -122.75 108.57 32.91 Favored Pre-proline 0 C--N 1.293 -1.882 0 CA-C-N 118.22 1.01 . . . . 72.430000000000007 111.738 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.33 131.41 20.38 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 107.426 -1.798 . . . . 73.030000000000001 107.426 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -79.5 123.12 84.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 121.185 -0.206 . . . . 71.329999999999998 111.221 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.11 135.39 34.5 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.372 2.048 . . . . 71.510000000000005 110.115 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -125.69 137.7 53.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t -110.1 121.64 63.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.13 -1.433 . . . . 75.019999999999996 107.13 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -158.98 157.94 32.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.613 -1.254 . . . . 75.400000000000006 107.613 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 m -104.46 115.87 31.12 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 73.019999999999996 110.847 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . 0.588 ' O2P' ' HG2' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -89.17 135.55 33.5 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.842 -1.54 . . . . 64.340000000000003 106.842 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.89 126.29 40.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 107.507 -1.294 . . . . 74.109999999999999 107.507 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -81.42 132.74 35.34 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.366 1.079 . . . . 73.329999999999998 113.732 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -118.58 90.57 3.36 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 101.477 -3.527 . . . . 75.230000000000004 101.477 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.21 160.06 18.66 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.104 0.779 . . . . 73.019999999999996 113.104 -167.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.01 -7.16 37.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.133 -0.939 . . . . 74.299999999999997 109.647 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.32 -16.82 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.029 1.122 . . . . 75.299999999999997 114.029 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.5 pp -66.19 -26.68 67.51 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.407 0.622 . . . . 75.549999999999997 110.953 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' N ' HD12 ' A' ' 23' ' ' LEU . 38.4 ttmt -73.97 -39.97 63.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.299 -1.0 . . . . 75.109999999999999 108.299 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.62 -35.61 80.6 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.617 -0.719 . . . . 74.140000000000001 110.076 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -42.36 98.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.983 -0.747 . . . . 71.219999999999999 108.983 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.29 -34.32 77.15 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 73.140000000000001 110.879 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.8 m -69.54 -19.06 63.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.421 0.629 . . . . 71.310000000000002 110.366 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 t -86.85 -16.71 35.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.537 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -59.52 119.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.525 0.679 . . . . 72.310000000000002 110.511 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.88 -78.38 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.167 -1.973 . . . . 63.130000000000003 108.167 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.3 t -116.76 148.41 41.17 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.463 -0.94 . . . . 75.25 108.463 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.95 116.64 26.06 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 106.893 -1.521 . . . . 70.109999999999999 106.893 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.48 140.64 82.98 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.08 1.187 . . . . 75.040000000000006 110.865 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.3 126.2 29.25 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.651 -0.87 . . . . 74.510000000000005 108.651 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 m -131.49 149.87 52.36 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.47 -0.937 . . . . 73.349999999999994 108.47 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -127.11 153.04 46.51 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.422 -0.585 . . . . 71.140000000000001 109.422 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 24.67 4.1 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 120.463 -0.875 . . . . 71.129999999999995 112.134 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.572 -0.529 . . . . 72.120000000000005 109.572 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.39 -2.31 52.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.549 -0.751 . . . . 74.530000000000001 110.998 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.43 -34.48 41.62 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.459 -0.941 . . . . 74.420000000000002 108.459 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.6 mt 56.55 90.96 0.08 OUTLIER Pre-proline 0 N--CA 1.45 -0.426 0 O-C-N 124.774 1.296 . . . . 72.519999999999996 113.006 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 8.3 Cg_endo -53.99 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.462 2.108 . . . . 74.420000000000002 111.888 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.59 15.45 8.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.0 0.429 . . . . 70.319999999999993 110.334 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.07 18.32 76.84 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.833 -0.621 . . . . 65.329999999999998 112.323 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.7 t -138.01 167.01 22.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.604 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -150.9 157.65 43.16 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 108.548 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.15 160.0 39.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 121.014 -0.275 . . . . 73.329999999999998 111.458 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -127.24 134.93 50.02 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.526 -0.916 . . . . 74.140000000000001 108.526 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.51 136.75 44.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.502 -0.555 . . . . 75.450000000000003 109.502 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 17.1 t -80.59 117.42 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 106.717 -1.586 . . . . 71.329999999999998 106.717 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 51.2 tptt -90.63 -32.06 16.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.749 0.785 . . . . 72.120000000000005 109.136 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.606 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 77.8 ttt180 -151.51 142.35 22.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.52 -2.03 . . . . 74.230000000000004 105.52 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.22 -171.13 27.95 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.594 -1.002 . . . . 70.129999999999995 110.594 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 -50.15 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.386 2.057 . . . . 73.019999999999996 110.889 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.93 24.34 2.81 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.66 1.184 . . . . 72.430000000000007 112.666 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -53.45 131.78 38.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.568 0.699 . . . . 71.25 112.78 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.94 -17.31 45.28 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.359 -0.837 . . . . 74.120000000000005 111.901 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 146.53 23.98 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 122.593 -0.357 . . . . 75.439999999999998 110.435 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -120.26 135.29 55.05 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.926 -0.768 . . . . 74.019999999999996 108.926 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -118.07 140.99 48.95 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.77 -1.196 . . . . 75.219999999999999 107.77 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -110.7 140.96 44.59 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.256 -0.577 . . . . 75.129999999999995 111.576 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.15 104.59 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.316 -0.994 . . . . 73.239999999999995 108.316 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -112.08 -4.86 14.35 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.965 0.888 . . . . 73.420000000000002 109.752 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -108.97 151.78 42.07 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 115.357 -0.838 . . . . 72.150000000000006 109.762 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -64.98 -18.04 61.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.036 2.49 . . . . 71.450000000000003 113.948 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -144.12 122.4 12.28 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.595 -0.691 . . . . 64.409999999999997 109.522 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.2 m -121.95 114.46 21.01 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.302 -0.629 . . . . 71.400000000000006 109.302 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -95.55 137.12 35.06 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.976 -0.452 . . . . 72.310000000000002 109.97 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 135.32 55.03 Favored 'General case' 0 C--O 1.261 1.66 0 CA-C-O 121.313 0.577 . . . . 73.25 111.228 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.04 -161.85 24.41 Favored Glycine 0 C--O 1.251 1.185 0 N-CA-C 109.07 -1.612 . . . . 73.230000000000004 109.07 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 3.9 tmm_? -94.07 118.75 31.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.188 -1.782 . . . . 72.129999999999995 106.188 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.556 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 11.1 t-80 -166.5 139.58 3.19 Favored Pre-proline 0 N--CA 1.401 -2.914 0 N-CA-C 103.705 -2.702 . . . . 74.219999999999999 103.705 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.556 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 17.9 Cg_endo -61.89 -29.6 82.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.115 1.21 . . . . 74.010000000000005 111.703 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -105.34 17.84 23.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.335 -0.848 . . . . 63.530000000000001 111.422 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 19.4 p -77.91 128.66 34.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 118.652 -1.219 . . . . 60.219999999999999 110.636 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.28 -30.25 54.19 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.627 0.727 . . . . 73.340000000000003 109.109 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.04 99.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.558 -0.905 . . . . 72.030000000000001 108.558 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -92.42 120.17 32.66 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.849 -0.614 . . . . 72.319999999999993 109.9 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.9 mt -127.56 140.13 52.31 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.797 -1.557 . . . . 64.120000000000005 106.797 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -87.07 116.31 25.04 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.746 -0.835 . . . . 74.140000000000001 108.746 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 84' ' ' THR . 11.0 t70 -87.01 178.66 6.87 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.099 -1.074 . . . . 73.230000000000004 108.099 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.92 -34.18 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 106.873 -1.528 . . . . 72.239999999999995 106.873 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.543 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 7.0 t -114.37 -167.42 1.22 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 104.651 -2.351 . . . . 75.540000000000006 104.651 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.17 101.9 12.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.617 -1.233 . . . . 64.5 109.926 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.8 p -87.98 101.41 13.73 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.987 -0.551 . . . . 72.430000000000007 110.824 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.588 ' HG2' ' O2P' ' A' ' 15' ' ' TPO . 15.9 ptt180 -64.32 -34.7 78.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.751 0.786 . . . . 74.140000000000001 109.656 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -147.2 95.88 2.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.957 -1.019 . . . . 74.319999999999993 108.638 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -99.98 -52.54 3.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.769 -1.172 . . . . 73.200000000000003 109.323 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.59 156.2 34.67 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 119.925 -0.71 . . . . 70.430000000000007 111.344 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 9.7 pt-20 -137.84 142.03 40.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.943 -0.571 . . . . 64.310000000000002 109.964 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -105.69 117.48 34.14 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.928 -1.508 . . . . 73.329999999999998 106.928 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.402 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 16.3 mtp180 -109.5 127.98 54.84 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.906 -0.776 . . . . 74.239999999999995 108.906 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.455 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.8 mp -105.86 113.59 43.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.794 -1.188 . . . . 71.140000000000001 107.794 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -126.59 117.45 22.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.648 -0.501 . . . . 73.540000000000006 109.648 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 53.49 37.7 26.32 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.513 1.525 . . . . 73.120000000000005 112.229 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.58 87.51 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-N 115.325 -0.852 . . . . 73.129999999999995 113.02 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.49 143.06 32.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.301 -0.629 . . . . 71.420000000000002 109.301 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.455 ' CD2' HG13 ' A' ' 94' ' ' ILE . 61.9 m-85 -110.45 124.12 51.18 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.891 -0.595 . . . . 72.329999999999998 110.277 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.92 141.07 49.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.327 -0.62 . . . . 75.230000000000004 109.327 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.9 t -102.95 125.36 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 107.545 -1.28 . . . . 71.420000000000002 107.545 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.79 122.12 68.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 N-CA-C 107.375 -1.343 . . . . 75.239999999999995 107.375 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 2.2 t70 -87.63 122.02 30.8 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.978 -1.01 . . . . 75.310000000000002 108.448 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.4 m -116.46 13.7 7.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 115.447 -0.797 . . . . 74.209999999999994 109.73 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.5 -66.07 0.25 Allowed Glycine 0 N--CA 1.412 -2.948 0 CA-C-N 115.084 -0.962 . . . . 72.129999999999995 112.807 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.3 t 60.66 9.61 2.23 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.974 0.91 . . . . 72.409999999999997 111.051 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.44 HD13 ' N ' ' A' ' 108' ' ' ASN . 3.3 pp -65.38 -46.71 79.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.724 1.21 . . . . 74.409999999999997 112.83 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.44 ' N ' HD13 ' A' ' 107' ' ' LEU . 6.8 t30 -92.77 -18.06 23.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.285 -1.006 . . . . 73.310000000000002 108.285 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.39 93.87 1.22 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 106.486 -2.646 . . . . 70.299999999999997 106.486 -169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 5.1 m -76.4 128.7 35.33 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 108.705 -0.85 . . . . 72.299999999999997 108.705 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.514 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 50.0 m-85 -112.19 126.16 54.91 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 106.888 -1.523 . . . . 73.340000000000003 106.888 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.471 ' CG1' ' HG2' ' A' ' 120' ' ' GLN . 3.1 t -123.22 134.76 65.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 N-CA-C 104.358 -2.46 . . . . 73.409999999999997 104.358 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.28 38.23 29.58 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.759 -1.2 . . . . 63.149999999999999 107.759 -169.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 64.36 9.18 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.852 1.427 . . . . 70.219999999999999 114.852 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.0 148.41 67.24 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 119.03 0.832 . . . . 70.230000000000004 110.14 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 110' ' ' THR . 18.1 Cg_endo -60.83 122.68 11.6 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.563 1.509 . . . . 75.040000000000006 110.213 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -146.47 133.13 19.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.019 -0.672 . . . . 74.120000000000005 109.215 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 16.8 m120 -92.84 -28.86 16.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.568 0.699 . . . . 72.409999999999997 111.28 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.44 135.37 26.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.45 -1.685 . . . . 71.319999999999993 106.45 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HG2' ' CG1' ' A' ' 112' ' ' VAL . 7.5 tp60 -140.54 144.68 36.05 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 111.713 0.264 . . . . 75.230000000000004 111.713 -173.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.81 124.57 52.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 103.96 -2.607 . . . . 62.420000000000002 103.96 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 51.4 mtp -87.94 146.33 25.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.42 -0.912 . . . . 62.32 111.946 -171.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.15 156.87 41.09 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.849 -1.537 . . . . 72.340000000000003 106.849 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -71.08 133.69 46.47 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.229 -1.397 . . . . 73.219999999999999 107.229 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.55 57.45 Favored Glycine 0 C--N 1.312 -0.785 0 C-N-CA 120.67 -0.776 . . . . 51.299999999999997 111.778 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.47 139.34 45.7 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.654 -0.869 . . . . 73.450000000000003 108.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -112.08 126.2 54.92 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.749 -1.204 . . . . 71.239999999999995 107.749 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.06 126.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.866 -0.79 . . . . 73.209999999999994 108.866 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 55.4 tp60 -105.0 111.51 24.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.222 -1.029 . . . . 74.120000000000005 108.222 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.93 112.86 42.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.614 -1.624 . . . . 74.099999999999994 106.614 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.63 -126.97 25.31 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 108.906 -1.678 . . . . 65.129999999999995 108.906 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 17.57 20.47 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.431 0.634 . . . . 71.519999999999996 109.738 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -120.62 165.62 14.79 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.078 -0.51 . . . . 75.510000000000005 110.134 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 14.7 ptm180 -137.15 146.62 45.2 Favored 'General case' 0 C--O 1.256 1.431 0 CA-C-O 121.544 0.687 . . . . 65.239999999999995 112.72 -168.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -120.48 139.88 52.23 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.548 -1.278 . . . . 74.329999999999998 107.548 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.74 120.43 62.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 107.919 -1.141 . . . . 73.109999999999999 107.919 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.03 126.61 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.261 -0.644 . . . . 61.32 109.261 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.03 162.13 30.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 123.779 0.832 . . . . 72.019999999999996 109.201 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.53 148.03 45.39 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.103 -1.443 . . . . 72.129999999999995 107.103 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.604 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -77.9 -161.43 16.48 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 121.074 -0.584 . . . . 73.400000000000006 114.356 -171.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.63 143.91 93.33 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.583 2.189 . . . . 74.430000000000007 111.897 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.48 31.93 6.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.091 -1.078 . . . . 73.209999999999994 108.091 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.524 -1.216 . . . . 73.510000000000005 109.689 -177.342 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 108.399 -0.963 . . . . 73.219999999999999 108.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.2 t -168.59 171.51 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.319 -1.363 . . . . 75.420000000000002 107.319 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.92 114.26 13.18 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.108 -0.701 . . . . 64.439999999999998 109.108 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -87.05 151.86 22.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.044 -0.526 . . . . 74.040000000000006 109.942 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -108.23 167.15 10.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.54 -0.541 . . . . 64.230000000000004 109.54 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.53 -162.72 26.19 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 109.684 -1.366 . . . . 63.43 109.684 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.8 m -79.75 128.26 75.01 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 72.200000000000003 109.553 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.9 154.18 46.05 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 123.591 2.861 . . . . 54.420000000000002 111.356 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -78.19 119.35 77.02 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 116.405 -0.362 . . . . 74.530000000000001 110.61 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.45 140.59 82.82 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.478 2.785 . . . . 72.340000000000003 113.201 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 19.6 pt20 -94.09 161.11 14.41 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.853 -1.536 . . . . 75.310000000000002 106.853 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.74 123.72 70.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.058 -0.657 . . . . 71.129999999999995 110.023 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -151.29 138.39 19.19 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.914 -1.884 . . . . 74.349999999999994 105.914 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.7 m -94.97 128.72 42.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.612 0.244 . . . . 71.109999999999999 110.86 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . 0.54 ' O2P' ' HA ' ' A' ' 86' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -88.2 152.58 21.88 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.394 -2.076 . . . . 74.010000000000005 105.394 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.46 115.87 24.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.533 0.683 . . . . 75.319999999999993 109.337 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -119.94 139.86 51.79 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.287 -0.87 . . . . 75.340000000000003 110.432 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -113.22 92.18 3.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.732 -1.581 . . . . 73.040000000000006 106.732 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 22' ' ' LEU . . . -78.21 -173.86 3.42 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.059 -0.973 . . . . 75.120000000000005 112.024 -175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.58 -0.55 1.42 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.117 1.767 . . . . 71.299999999999997 111.683 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 20' ' ' ALA . 4.6 pp -63.98 -17.54 63.39 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.735 1.214 . . . . 64.209999999999994 111.174 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.19 -8.95 35.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.685 0.794 . . . . 75.310000000000002 111.677 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 63.5 tttp -88.93 -23.08 22.78 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.05 -0.407 . . . . 71.430000000000007 111.246 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -59.76 -23.47 63.27 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.419 0.526 . . . . 74.019999999999996 112.419 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.57 -30.63 71.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.85 0.685 . . . . 73.219999999999999 112.85 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 13.8 pt-20 -76.56 -26.05 54.7 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.601 -0.839 . . . . 74.099999999999994 110.796 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -80.16 -26.18 39.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.029 -0.73 . . . . 74.409999999999997 109.029 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 m -77.58 -25.74 50.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.125 -0.943 . . . . 63.140000000000001 110.448 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.5 m -74.74 108.77 7.7 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.369 -0.974 . . . . 71.420000000000002 108.369 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.75 -5.23 12.82 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 109.281 -1.528 . . . . 73.540000000000006 109.281 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -113.8 121.72 44.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.012 -0.736 . . . . 73.209999999999994 109.012 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.59 45.0 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.279 -1.008 . . . . 74.299999999999997 108.279 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.15 142.08 96.89 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.162 1.908 . . . . 73.209999999999994 111.079 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.56 126.01 42.61 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.205 -0.294 . . . . 73.319999999999993 110.205 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 84.96 2.08 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.036 -1.098 . . . . 71.109999999999999 108.036 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -101.6 -36.33 8.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.251 0.548 . . . . 73.209999999999994 111.02 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.73 62.19 0.37 Allowed Glycine 0 C--N 1.305 -1.159 0 C-N-CA 121.013 -0.613 . . . . 71.510000000000005 111.991 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.65 -28.52 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.591 -0.358 . . . . 73.200000000000003 111.257 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -92.75 -5.25 51.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.333 0.494 . . . . 74.230000000000004 112.333 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -80.22 -43.84 20.78 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.118 0.784 . . . . 73.450000000000003 113.118 -168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.0 mt 42.76 65.66 5.05 Favored Pre-proline 0 CA--C 1.557 1.248 0 O-C-N 124.181 0.926 . . . . 72.319999999999993 111.959 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.27 -70.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.461 2.774 . . . . 65.319999999999993 113.979 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.19 7.89 45.65 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.509 -0.476 . . . . 61.210000000000001 110.661 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.54 75.16 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.987 -0.551 . . . . 60.450000000000003 111.769 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -115.18 153.97 29.85 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 123.954 0.902 . . . . 71.239999999999995 111.012 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.34 44.3 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.459 -0.791 . . . . 74.239999999999995 109.974 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.85 160.7 38.08 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.542 -0.754 . . . . 73.030000000000001 109.196 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -121.28 131.88 54.47 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.34 -0.985 . . . . 75.0 108.34 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.57 129.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.32 -0.622 . . . . 74.310000000000002 109.32 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG22 ' ND2' ' A' ' 56' ' ' ASN . 22.4 t -80.19 118.06 27.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.529 -1.656 . . . . 70.420000000000002 106.529 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.985 0.898 . . . . 74.209999999999994 109.667 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.599 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -141.47 148.05 38.85 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.641 -1.244 . . . . 75.420000000000002 107.641 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.43 -179.7 16.85 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 111.093 -0.803 . . . . 73.239999999999995 111.093 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -67.67 -38.11 14.83 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.097 1.865 . . . . 74.430000000000007 110.943 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.442 ' ND2' HG22 ' A' ' 51' ' ' VAL . 4.7 p-10 -96.14 22.63 7.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.392 -0.822 . . . . 71.310000000000002 111.261 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.22 144.02 55.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.326 0.651 . . . . 74.030000000000001 111.342 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.46 33.23 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 111.139 -0.785 . . . . 74.530000000000001 111.139 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 141.93 29.14 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 120.765 0.317 . . . . 70.239999999999995 110.731 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -119.82 138.7 53.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.069 -0.514 . . . . 74.530000000000001 110.276 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.98 133.98 54.82 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.533 -0.543 . . . . 64.319999999999993 109.533 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -96.86 144.53 26.72 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.049 0.218 . . . . 73.209999999999994 110.502 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 69.3 mt -104.5 113.39 26.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -128.52 -3.1 5.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.973 0.416 . . . . 75.549999999999997 111.509 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -107.87 143.14 26.73 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 109.383 -0.599 . . . . 63.229999999999997 109.383 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.94 -25.2 27.01 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.455 2.77 . . . . 73.519999999999996 114.369 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.7 m -143.23 121.96 12.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 110.258 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 24.9 m -117.96 129.26 55.5 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.446 -0.797 . . . . 60.409999999999997 109.768 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 m -100.89 135.67 41.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.459 -0.571 . . . . 72.140000000000001 109.459 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.07 135.43 54.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.054 -0.721 . . . . 65.019999999999996 109.054 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -165.41 34.49 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.974 -1.25 . . . . 75.140000000000001 109.974 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 79.2 ttt180 -91.6 149.16 21.79 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.465 -0.568 . . . . 74.349999999999994 109.465 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 79.03 161.26 0.14 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.552 1.141 . . . . 74.5 110.519 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -72.28 13.1 0.56 Allowed 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.834 2.356 . . . . 74.310000000000002 113.156 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.62 -5.54 59.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.767 0.794 . . . . 75.540000000000006 109.6 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 m -117.57 148.74 41.62 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.75 -1.204 . . . . 72.200000000000003 107.75 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.16 -44.86 83.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.915 0.886 . . . . 71.310000000000002 109.361 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.9 mm -100.17 124.5 53.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.004 -1.11 . . . . 75.420000000000002 108.004 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -88.84 124.35 34.09 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.519 0.512 . . . . 75.420000000000002 111.229 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 6.2 mp -126.3 141.3 51.96 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.751 -1.203 . . . . 74.049999999999997 107.751 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.27 117.43 34.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.34 -1.726 . . . . 64.450000000000003 106.34 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 84' ' ' THR . 9.4 t70 -105.46 173.25 6.39 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.69 -0.687 . . . . 73.549999999999997 109.538 -168.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -82.95 -24.86 8.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.449 -1.315 . . . . 73.120000000000005 107.449 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.2 m -124.56 -173.66 2.84 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.0 -1.852 . . . . 74.209999999999994 106.0 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.67 99.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 120.667 -1.271 . . . . 72.510000000000005 110.157 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.54 ' HA ' ' O2P' ' A' ' 15' ' ' TPO . 1.9 p -83.87 107.47 16.28 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.434 -0.803 . . . . 73.349999999999994 109.837 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -64.43 -32.36 73.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.643 0.735 . . . . 74.510000000000005 111.006 -176.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -168.9 119.93 0.74 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.668 -2.345 . . . . 74.549999999999997 104.668 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -99.58 -52.04 3.59 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 123.375 0.422 . . . . 75.519999999999996 109.893 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.73 157.81 44.13 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.326 -0.549 . . . . 74.329999999999998 110.155 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.19 132.03 51.86 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.882 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.506 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 4.2 m-85 -105.62 113.75 27.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.72 -1.585 . . . . 73.25 106.72 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -104.15 133.48 49.0 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.4 mt -104.29 113.53 41.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.063 -1.828 . . . . 65.329999999999998 106.063 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -134.47 118.58 17.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.447 -0.575 . . . . 72.109999999999999 109.447 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 54.22 38.04 28.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.161 0.985 . . . . 73.400000000000006 112.039 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.0 -6.92 79.84 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.092 -0.504 . . . . 61.530000000000001 113.702 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.74 149.91 23.99 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.359 -0.608 . . . . 72.540000000000006 109.359 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.97 116.9 28.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 73.450000000000003 108.794 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -112.04 127.28 55.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.202 -0.666 . . . . 70.319999999999993 109.202 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.459 HG23 ' SD ' ' A' ' 122' ' ' MET . 43.6 t -105.5 124.32 60.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.235 -0.654 . . . . 74.219999999999999 109.235 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.4 t -115.01 122.97 70.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 115.779 -0.646 . . . . 73.310000000000002 109.639 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.05 131.4 34.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.216 -0.902 . . . . 73.230000000000004 111.351 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.37 12.74 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.905 -1.043 . . . . 65.019999999999996 108.377 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.14 34.51 5.03 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.994 -1.242 . . . . 74.510000000000005 109.994 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 m -61.9 -11.7 14.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.618 1.167 . . . . 75.219999999999999 111.315 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -71.15 -26.16 62.87 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.055 0.942 . . . . 75.209999999999994 108.94 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.61 -18.68 24.74 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.106 -0.952 . . . . 75.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.94 62.71 1.65 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.702 -0.681 . . . . 72.25 112.644 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -64.5 135.5 56.11 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 124.081 0.952 . . . . 74.099999999999994 112.444 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.14 126.77 44.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.966 -1.124 . . . . 73.329999999999998 107.966 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -107.85 117.32 53.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.764 -1.569 . . . . 72.120000000000005 106.764 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 51.32 49.96 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.128 0.971 . . . . 74.340000000000003 110.276 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 70.68 7.81 6.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.273 1.429 . . . . 72.120000000000005 113.709 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.54 137.82 31.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.451 -0.9 . . . . 75.25 111.228 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.13 123.92 14.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.103 1.869 . . . . 64.239999999999995 108.793 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -151.44 138.49 19.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.124 -1.065 . . . . 64.540000000000006 108.124 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.1 -53.24 3.88 Favored 'General case' 0 C--O 1.199 -1.582 0 C-N-CA 120.73 -0.388 . . . . 75.519999999999996 110.637 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.93 136.53 54.93 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.13 -0.693 . . . . 64.299999999999997 109.13 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 140.43 20.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.383 -0.969 . . . . 75.239999999999995 108.383 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -96.42 114.57 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 105.101 -2.185 . . . . 71.400000000000006 105.101 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 101' ' ' VAL . 79.1 mtp -90.22 145.32 25.1 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 114.414 1.264 . . . . 74.329999999999998 114.414 -166.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -111.59 158.15 19.56 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 63.43 108.677 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 138' ' ' LEU . 24.4 m -58.14 120.9 9.45 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.819 -0.437 . . . . 74.400000000000006 109.819 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.73 1.54 56.34 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.217 -0.992 . . . . 65.299999999999997 112.718 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.98 141.56 28.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.23 -1.026 . . . . 74.129999999999995 108.23 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.24 145.67 49.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.918 0.711 . . . . 74.310000000000002 112.918 -169.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.434 HD12 ' SD ' ' A' ' 122' ' ' MET . 34.5 mt -116.08 132.87 64.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.002 -0.74 . . . . 74.340000000000003 109.002 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -103.63 110.5 22.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.789 -1.93 . . . . 73.010000000000005 105.789 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.0 mt -109.67 105.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.475 -0.935 . . . . 74.040000000000006 108.475 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.51 -107.94 2.3 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.016 -1.634 . . . . 73.319999999999993 109.016 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -119.93 9.04 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 120.808 0.337 . . . . 65.040000000000006 110.12 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.599 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.4 p90 -120.28 146.26 46.26 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.802 0.668 . . . . 72.439999999999998 112.802 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -112.58 132.28 55.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.427 -0.806 . . . . 74.140000000000001 111.467 -167.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.4 139.97 52.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.258 -0.645 . . . . 74.230000000000004 109.258 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.0 130.23 66.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.673 -0.862 . . . . 74.450000000000003 108.673 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -104.27 128.48 52.04 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.124 -0.695 . . . . 75.510000000000005 109.124 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 124' ' ' THR 0.278 0.0 OUTLIER -140.09 135.63 32.76 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 113.109 0.781 . . . . 75.430000000000007 113.109 177.728 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.2 124.97 44.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.281 -1.748 . . . . 74.329999999999998 106.281 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 165.43 -33.7 0.24 Allowed Glycine 0 C--N 1.29 -1.976 0 C-N-CA 118.723 -1.703 . . . . 62.109999999999999 116.468 -171.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 10.2 Cg_endo -53.87 142.16 64.38 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.896 2.848 . . . . 75.310000000000002 114.653 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.49 88.92 1.23 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.831 -2.285 . . . . 74.409999999999997 104.831 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 114.803 -1.089 . . . . 73.030000000000001 108.282 -172.657 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' H3 ' HD11 ' A' ' 62' ' ' LEU . 65.2 mtt . . . . . 0 CA--C 1.503 -0.862 0 N-CA-C 108.828 -0.804 . . . . 72.239999999999995 108.828 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 6.2 p -154.98 132.4 11.17 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.581 -0.896 . . . . 72.120000000000005 108.581 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.2 -70.73 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.441 -0.578 . . . . 72.519999999999996 109.441 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -147.47 130.4 16.23 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 107.568 -1.271 . . . . 61.409999999999997 107.568 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.417 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 3.5 t-20 -65.31 115.23 5.38 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.115 0.884 . . . . 75.420000000000002 109.257 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.13 98.97 2.28 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 115.663 -0.698 . . . . 61.450000000000003 114.296 -174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -114.61 107.98 50.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 107.479 -1.304 . . . . 73.340000000000003 107.479 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.75 144.09 99.51 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.825 2.35 . . . . 74.450000000000003 113.272 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.51 149.46 71.79 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.114 -0.948 . . . . 74.439999999999998 109.39 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -50.84 112.05 0.68 Allowed 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.61 2.873 . . . . 65.129999999999995 113.133 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -147.78 144.58 28.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.027 -1.101 . . . . 63.0 108.027 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.46 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 41.8 t -111.82 127.38 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 120.976 0.417 . . . . 72.129999999999995 111.378 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.0 164.42 28.03 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.52 -0.919 . . . . 73.409999999999997 108.52 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -99.54 126.96 45.6 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.644 -0.873 . . . . 72.319999999999993 108.644 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -93.49 149.17 21.44 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.098 -0.501 . . . . 64.510000000000005 109.888 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.9 115.79 27.85 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 CA-C-O 120.822 0.344 . . . . 73.310000000000002 110.36 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -107.69 120.16 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.729 -0.841 . . . . 75.109999999999999 108.729 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.57 141.26 46.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.688 -0.687 . . . . 73.099999999999994 112.624 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 82.84 -20.93 0.31 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.32 1.848 . . . . 73.120000000000005 113.505 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -80.1 -38.44 31.63 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.422 -0.955 . . . . 62.219999999999999 108.422 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.49 HD11 ' N ' ' A' ' 23' ' ' LEU . 2.2 pp -64.73 -26.62 68.45 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.014 -0.993 . . . . 75.310000000000002 110.792 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.49 ' N ' HD11 ' A' ' 22' ' ' LEU . 50.9 tp -74.85 -39.96 61.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.4 -0.818 . . . . 71.140000000000001 109.232 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.8 -41.41 78.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 74.340000000000003 110.448 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.78 -39.55 80.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.706 -0.679 . . . . 62.140000000000001 110.409 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -59.43 -39.23 82.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 73.150000000000006 110.796 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -63.51 -38.51 91.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.73 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -72.06 -38.77 69.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.961 -0.563 . . . . 61.049999999999997 110.302 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -66.46 -47.01 74.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.956 -0.565 . . . . 64.340000000000003 110.242 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -83.08 98.11 9.14 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.874 0.369 . . . . 70.519999999999996 111.288 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.54 -60.51 0.74 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 108.38 -1.888 . . . . 75.540000000000006 108.38 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 38.2 m -114.37 124.77 52.78 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.866 -1.161 . . . . 73.439999999999998 107.866 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.82 94.52 6.44 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.619 -0.512 . . . . 54.009999999999998 109.619 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 32' ' ' THR . 2.7 Cg_exo -76.25 142.91 24.71 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.575 2.183 . . . . 63.399999999999999 111.962 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.1 154.74 19.93 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.156 -1.053 . . . . 54.399999999999999 108.156 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 m -114.43 144.85 42.65 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.144 0.497 . . . . 74.400000000000006 112.075 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -132.58 144.39 50.36 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.743 -1.576 . . . . 72.310000000000002 106.743 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.13 11.91 32.9 Favored Glycine 0 CA--C 1.49 -1.515 0 N-CA-C 109.891 -1.283 . . . . 73.319999999999993 109.891 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.04 -32.0 16.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.882 -0.785 . . . . 73.530000000000001 108.882 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.09 3.6 38.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.52 -1.218 . . . . 74.25 110.95 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -80.12 -36.34 35.42 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.398 -0.819 . . . . 71.010000000000005 110.566 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 51.15 45.85 3.17 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 123.725 0.641 . . . . 71.109999999999999 112.492 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.99 -52.85 1.04 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.9 1.733 . . . . 71.129999999999995 113.929 -170.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -18.34 40.27 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.946 -0.57 . . . . 54.329999999999998 112.53 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.94 -0.49 82.7 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 120.422 -0.894 . . . . 73.319999999999993 111.814 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 t -118.62 170.02 9.32 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.347 -1.353 . . . . 72.400000000000006 107.347 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . . . -139.65 152.92 47.14 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.598 0.237 . . . . 72.239999999999995 110.463 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -130.05 155.58 45.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.925 -0.58 . . . . 75.299999999999997 109.959 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -119.39 125.15 48.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.911 -1.144 . . . . 72.040000000000006 107.911 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.2 135.18 53.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 115.433 -0.803 . . . . 75.200000000000003 109.791 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.11 117.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 105.171 -2.159 . . . . 60.049999999999997 105.171 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.63 -39.43 22.15 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.323 -1.362 . . . . 73.420000000000002 107.323 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 47.7 ttt180 -160.95 144.21 13.05 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.317 -1.364 . . . . 75.510000000000005 107.317 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.61 -167.69 26.54 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 108.355 -1.898 . . . . 33.020000000000003 108.355 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.1 -47.57 12.16 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.378 2.052 . . . . 73.5 112.184 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.11 22.05 3.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.662 -0.244 . . . . 72.549999999999997 111.198 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.6 134.09 46.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.723 0.638 . . . . 72.409999999999997 112.723 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.18 21.72 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.217 -0.901 . . . . 73.340000000000003 111.829 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 145.76 33.35 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.843 0.354 . . . . 73.230000000000004 110.126 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.85 136.3 22.85 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 110.991 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -121.59 145.24 48.18 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.347 -1.353 . . . . 73.409999999999997 107.347 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 1.4 pt? -110.38 145.53 37.4 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.575 0.226 . . . . 74.040000000000006 110.63 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.75 103.41 5.01 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.101 -1.444 . . . . 72.230000000000004 107.101 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 16.0 t70 -123.2 7.55 9.14 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.952 -1.499 . . . . 60.399999999999999 106.952 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -137.03 146.1 53.3 Favored Pre-proline 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 74.439999999999998 107.669 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -72.06 -14.36 29.01 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.832 2.355 . . . . 74.319999999999993 114.496 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -140.14 122.37 15.88 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.293 -0.88 . . . . 73.120000000000005 109.479 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 m -131.02 139.08 49.91 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.523 0.729 . . . . 74.340000000000003 111.224 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.15 52.64 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.128 -1.064 . . . . 73.319999999999993 108.128 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.75 135.1 54.69 Favored 'General case' 0 C--O 1.264 1.823 0 CA-C-O 120.996 0.427 . . . . 72.530000000000001 109.94 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.74 -156.17 22.33 Favored Glycine 0 N--CA 1.417 -2.617 0 CA-C-N 115.316 -0.856 . . . . 62.340000000000003 111.119 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.463 ' NH1' ' HA ' ' A' ' 86' ' ' SER . 40.8 ttp180 -88.86 150.61 22.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.308 -0.627 . . . . 75.209999999999994 109.308 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.9 m170 81.53 150.07 0.11 Allowed Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 125.435 1.494 . . . . 74.329999999999998 111.093 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.29 0.86 6.11 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.051 2.501 . . . . 72.439999999999998 111.225 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.63 -26.53 60.82 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 124.722 1.209 . . . . 74.530000000000001 107.754 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -85.84 136.43 33.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.604 -1.258 . . . . 73.439999999999998 107.604 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' A' ' 5' ' ' ASN . 17.0 t70 -54.64 -46.49 73.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.369 1.068 . . . . 74.150000000000006 109.765 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 mm -102.73 109.4 26.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.588 -1.264 . . . . 72.019999999999996 107.588 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -87.61 115.77 25.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.763 -0.653 . . . . 72.099999999999994 111.196 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.23 127.83 45.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.037 -1.468 . . . . 74.150000000000006 107.037 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.07 117.9 34.98 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.113 -0.635 . . . . 71.019999999999996 110.216 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -150.34 161.52 42.32 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 104.546 -2.39 . . . . 74.219999999999999 104.546 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.3 -39.3 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 118.168 0.44 . . . . 71.209999999999994 111.371 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -101.32 7.35 42.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.72 0.771 . . . . 75.329999999999998 112.308 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.93 121.15 36.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.279 -1.008 . . . . 74.239999999999995 108.279 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.463 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 35.0 m -93.11 -164.54 1.19 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.307 0.855 . . . . 73.329999999999998 113.307 -173.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' NH1' ' HA ' ' A' ' 12' ' ' VAL . 21.3 ptt180 -55.07 -21.37 12.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.57 2.348 . . . . 71.439999999999998 113.499 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -170.24 116.44 0.52 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.73 -0.841 . . . . 72.430000000000007 108.73 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.48 ' ND1' HG21 ' A' ' 130' ' ' ILE . 9.4 t-160 -100.39 -51.96 3.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.984 -0.747 . . . . 74.150000000000006 108.984 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.14 43.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.454 -0.943 . . . . 73.319999999999993 108.454 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.33 149.64 50.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.536 -0.466 . . . . 72.219999999999999 110.787 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -112.65 113.77 26.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.97 -1.122 . . . . 75.310000000000002 107.97 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -108.78 131.89 54.51 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.264 -1.013 . . . . 75.230000000000004 108.264 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 3.2 mp -106.4 120.05 56.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.685 -1.228 . . . . 74.530000000000001 107.685 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.1 129.95 28.36 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.333 -0.617 . . . . 73.140000000000001 109.333 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.26 35.75 25.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.728 1.211 . . . . 72.519999999999996 110.71 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.17 82.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.473 -0.785 . . . . 74.120000000000005 113.839 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 21.4 mm-40 -100.61 141.56 33.3 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.945 -0.761 . . . . 75.239999999999995 108.945 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -106.82 117.86 35.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.091 -1.078 . . . . 73.109999999999999 108.091 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.02 141.87 51.49 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.065 -0.654 . . . . 72.549999999999997 111.674 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.05 124.82 58.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.443 -0.947 . . . . 74.329999999999998 108.443 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.84 123.38 71.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.382 -0.97 . . . . 74.230000000000004 108.382 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.98 127.64 32.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 73.109999999999999 110.81 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.69 -15.96 9.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.613 0.721 . . . . 75.340000000000003 109.77 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -122.73 57.79 0.63 Allowed Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.479 -1.448 . . . . 72.310000000000002 109.479 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -69.33 5.14 1.39 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.528 0.68 . . . . 64.010000000000005 111.56 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 105' ' ' GLY . 5.8 mp -77.89 -20.9 52.13 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.317 0.647 . . . . 71.349999999999994 109.355 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -87.83 -19.79 26.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 72.519999999999996 110.35 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.04 71.72 0.99 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 112.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.582 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 10.0 m -69.67 130.32 42.05 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.159 -1.052 . . . . 61.530000000000001 108.159 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -108.83 125.9 52.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.429 -0.908 . . . . 75.439999999999998 110.613 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.03 117.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 105.792 -1.929 . . . . 72.219999999999999 105.792 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.88 40.63 30.54 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.042 0.925 . . . . 74.099999999999994 108.849 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 71.86 7.36 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.215 1.932 . . . . 74.099999999999994 116.215 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -115.85 135.96 22.81 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 118.72 0.691 . . . . 74.340000000000003 110.519 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 110' ' ' THR . 32.1 Cg_endo -63.48 148.05 92.81 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.86 2.374 . . . . 75.540000000000006 112.62 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 51.6 mmt-85 -121.55 160.99 23.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 114.335 1.235 . . . . 75.540000000000006 114.335 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -115.8 -51.76 2.65 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 112.943 -1.935 . . . . 72.239999999999995 106.125 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.19 135.66 5.35 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.338 -1.727 . . . . 65.400000000000006 106.338 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.65 145.46 23.47 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.44 -0.504 . . . . 74.319999999999993 110.998 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.37 124.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.309 -2.108 . . . . 72.329999999999998 105.309 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 tpp -89.5 134.48 34.09 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.311 -0.955 . . . . 75.420000000000002 113.481 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -103.69 141.67 35.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.485 -1.234 . . . . 73.019999999999996 110.645 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -61.37 130.22 45.02 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.874 -1.057 . . . . 70.530000000000001 111.451 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.43 58.23 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.911 -0.586 . . . . 73.340000000000003 113.182 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -88.98 154.73 19.99 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 116.866 0.333 . . . . 71.129999999999995 110.864 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.81 133.82 53.03 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.942 0.877 . . . . 60.409999999999997 110.801 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.1 mm -113.68 123.65 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.763 -1.199 . . . . 71.099999999999994 107.763 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -104.71 113.37 26.92 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.189 -0.604 . . . . 74.519999999999996 109.562 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.48 HG21 ' ND1' ' A' ' 89' ' ' HIS . 36.9 mt -109.66 124.39 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 114.806 -1.088 . . . . 74.430000000000007 108.128 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.82 -86.36 1.35 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.866 -1.294 . . . . 62.219999999999999 109.866 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.93 25.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.364 0.602 . . . . 73.340000000000003 110.215 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.4 p90 -141.04 164.08 31.24 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.384 -0.825 . . . . 74.420000000000002 108.897 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -112.55 144.82 41.38 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 114.598 1.333 . . . . 74.129999999999995 114.598 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.06 140.64 49.72 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.22 -1.809 . . . . 72.349999999999994 106.137 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.2 t -111.3 124.76 68.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 109.067 -0.716 . . . . 72.209999999999994 109.067 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -91.46 116.03 28.52 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.614 -1.254 . . . . 70.099999999999994 107.614 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 48' ' ' LEU . 1.8 tm? -128.61 132.46 48.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.931 -1.137 . . . . 73.129999999999995 107.931 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . . . -90.16 118.75 29.93 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.668 -0.813 . . . . 54.450000000000003 110.394 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 125.67 73.35 0.21 Allowed Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.763 -0.653 . . . . 75.230000000000004 112.328 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.61 162.85 40.89 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.979 2.453 . . . . 74.329999999999998 111.343 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.05 48.31 1.23 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.712 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.414 -2.239 0 CA-C-N 115.659 -0.701 . . . . 75.510000000000005 110.517 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 108.016 -1.105 . . . . 72.129999999999995 108.016 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p 50.88 27.33 3.08 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.753 0.821 . . . . 73.010000000000005 112.895 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -107.71 121.12 44.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.786 -1.19 . . . . 75.239999999999995 107.786 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -98.88 132.12 44.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.357 -0.838 . . . . 72.439999999999998 109.783 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.05 129.96 40.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.26 -0.645 . . . . 72.209999999999994 109.26 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.08 40.75 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 116.021 -0.536 . . . . 54.520000000000003 112.074 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.0 m -79.83 118.08 70.63 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 109.561 -0.533 . . . . 74.430000000000007 109.561 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.31 132.11 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.146 1.897 . . . . 65.430000000000007 111.029 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.08 118.07 59.98 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 109.608 -0.515 . . . . 71.439999999999998 109.608 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.04 157.11 30.51 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.664 2.243 . . . . 74.010000000000005 112.178 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -122.21 132.2 54.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.051 -0.722 . . . . 74.420000000000002 109.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.19 121.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.713 -0.847 . . . . 73.209999999999994 108.713 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.477 ' OE1' ' HD3' ' A' ' 87' ' ' ARG . 43.2 mt-10 -130.21 167.98 17.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.662 -1.977 . . . . 73.420000000000002 105.662 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 m -70.4 108.63 4.34 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.737 0.78 . . . . 73.219999999999999 111.854 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.3 t -89.41 146.49 24.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.871 -0.789 . . . . 52.210000000000001 108.871 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.53 115.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 108.193 -1.04 . . . . 75.040000000000006 108.193 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -115.45 133.32 56.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.669 . . . . 74.420000000000002 109.192 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -86.78 94.41 9.53 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.02 -1.072 . . . . 62.409999999999997 110.392 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.28 -152.07 0.05 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.441 -1.254 . . . . 75.140000000000001 108.934 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.4 7.11 47.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.938 -0.476 . . . . 72.099999999999994 111.191 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.77 -50.46 72.23 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.095 1.517 . . . . 65.420000000000002 115.095 -171.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' O ' ' HG3' ' A' ' 26' ' ' MET . 7.3 tt -72.63 -39.15 67.44 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.473 0.654 . . . . 75.519999999999996 109.365 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -69.72 -32.77 71.51 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.717 -0.674 . . . . 54.549999999999997 110.314 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.51 -42.18 95.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.14 0.576 . . . . 64.420000000000002 110.151 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.01 -30.72 71.32 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 120.083 -0.647 . . . . 74.450000000000003 111.163 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.0 -49.4 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 74.120000000000005 109.785 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -69.84 -27.03 64.51 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.315 -0.857 . . . . 65.319999999999993 112.608 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.433 ' OG ' ' HD2' ' A' ' 114' ' ' ARG . 31.7 p -79.96 -16.75 54.59 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.145 0.497 . . . . 72.0 111.053 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -74.19 106.14 5.71 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 122.151 0.977 . . . . 74.540000000000006 111.095 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.78 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 104.927 -3.269 . . . . 72.439999999999998 104.927 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 m -115.5 121.39 42.55 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.729 -1.952 . . . . 71.109999999999999 105.729 168.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.37 115.46 65.47 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 106.588 -1.634 . . . . 63.310000000000002 106.588 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.84 140.03 93.4 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 121.982 1.788 . . . . 71.299999999999997 112.313 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.85 126.54 29.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.395 -0.82 . . . . 51.219999999999999 110.805 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 124' ' ' THR . 67.9 m -147.44 109.47 4.48 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.836 -1.172 . . . . 71.319999999999993 107.836 172.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -86.82 96.59 10.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 65.230000000000004 112.217 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.11 7.33 0.25 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.783 -0.644 . . . . 63.210000000000001 112.409 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.31 -21.17 24.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.754 0.787 . . . . 64.530000000000001 110.375 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -92.15 -6.73 50.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.711 -1.131 . . . . 71.230000000000004 109.122 178.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -100.04 -42.29 6.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.39 -1.277 . . . . 73.219999999999999 109.624 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 56.12 78.71 0.37 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.602 -0.726 . . . . 64.120000000000005 110.128 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.47 -55.5 0.91 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.131 1.888 . . . . 74.319999999999993 113.153 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.47 -7.38 26.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.932 -0.576 . . . . 73.239999999999995 111.854 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.06 -12.62 11.36 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.213 -0.449 . . . . 50.329999999999998 112.866 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m -124.68 153.42 42.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.762 -1.569 . . . . 74.340000000000003 106.762 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.28 41.13 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.905 0.128 . . . . 62.509999999999998 110.782 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.1 pp -127.6 157.01 41.36 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.803 0.668 . . . . 74.409999999999997 112.803 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -121.35 138.25 54.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.923 -1.14 . . . . 74.540000000000006 107.923 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.79 135.72 62.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 C-N-CA 120.534 -0.466 . . . . 74.310000000000002 109.906 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -80.81 117.09 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.774 -1.936 . . . . 73.510000000000005 105.774 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -90.21 -34.67 15.72 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.779 -0.646 . . . . 75.340000000000003 109.551 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -148.61 137.56 21.6 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.179 -0.674 . . . . 74.329999999999998 109.179 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.68 -177.86 23.8 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 108.907 -1.677 . . . . 44.310000000000002 108.907 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 72.1 Cg_exo -55.65 -51.18 10.41 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.935 2.423 . . . . 65.450000000000003 112.823 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -91.48 22.75 3.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.302 0.482 . . . . 75.200000000000003 112.302 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.85 143.07 48.71 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.087 0.47 . . . . 73.430000000000007 111.799 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.27 -23.27 32.33 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.301 -0.72 . . . . 55.329999999999998 111.301 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 134.19 34.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 120.93 0.395 . . . . 64.340000000000003 110.459 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -107.38 138.68 43.14 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.919 -1.141 . . . . 75.319999999999993 107.919 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.5 127.52 44.14 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.422 -0.584 . . . . 75.530000000000001 109.422 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 9.2 mp -93.62 137.78 32.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.39 -0.596 . . . . 75.019999999999996 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.95 103.34 13.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.013 -1.477 . . . . 72.319999999999993 107.013 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.99 -15.22 6.92 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.498 -0.774 . . . . 72.129999999999995 111.236 -175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.447 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.2 pt20 -107.32 142.47 25.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 109.648 -0.501 . . . . 74.450000000000003 109.648 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.6 -19.9 19.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.965 3.11 . . . . 72.530000000000001 113.865 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.3 m -147.18 121.66 9.72 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.814 -1.18 . . . . 71.219999999999999 107.814 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 m -120.81 113.83 20.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.378 -1.341 . . . . 74.519999999999996 107.378 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.0 m -92.36 144.04 25.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.822 -0.549 . . . . 73.450000000000003 110.704 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.29 139.02 52.6 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 123.166 0.586 . . . . 72.120000000000005 109.497 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.63 -135.84 5.63 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.893 -1.283 . . . . 74.299999999999997 109.893 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 22.9 ptt85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.077 -1.083 . . . . 75.310000000000002 108.077 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER 144.77 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 127.635 2.374 . . . . 75.239999999999995 108.81 174.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.69 -15.25 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.763 1.642 . . . . 64.430000000000007 110.416 174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -78.81 -24.07 44.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.143 -0.935 . . . . 73.150000000000006 110.444 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 p -84.71 121.32 27.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.615 -0.883 . . . . 75.209999999999994 108.615 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.88 -35.8 74.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 110.677 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.4 98.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.25 -1.389 . . . . 74.409999999999997 107.25 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -92.93 115.11 27.82 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.904 -0.589 . . . . 74.109999999999999 109.632 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.6 mt -111.62 134.38 53.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.519 -1.289 . . . . 72.340000000000003 107.519 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.92 128.35 54.73 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.535 0.683 . . . . 73.299999999999997 110.413 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -148.43 -178.8 6.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.447 -2.057 . . . . 65.129999999999995 105.447 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.53 -24.84 8.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.982 -1.118 . . . . 73.430000000000007 107.982 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.2 m -137.36 90.3 2.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.968 0.89 . . . . 74.140000000000001 110.236 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -101.85 150.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.143 -1.058 . . . . 74.510000000000005 108.143 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.2 m -92.45 146.45 23.67 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.419 -0.956 . . . . 75.420000000000002 108.419 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.477 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -79.61 -17.56 53.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.725 0.774 . . . . 72.400000000000006 111.829 -177.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -140.8 93.87 2.65 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.578 -2.379 . . . . 75.230000000000004 104.578 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -91.96 -53.32 4.32 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.229 0.538 . . . . 73.230000000000004 111.269 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.16 155.92 37.62 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.797 -0.816 . . . . 74.430000000000007 108.797 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.24 135.1 44.76 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.894 -0.594 . . . . 70.010000000000005 109.56 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -104.92 117.22 33.47 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.534 -1.654 . . . . 74.019999999999996 106.534 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -103.67 130.78 51.2 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.588 -0.523 . . . . 72.140000000000001 109.588 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.9 mp -114.31 113.09 42.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.628 -1.619 . . . . 74.329999999999998 106.628 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -138.38 122.78 18.33 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.79 -0.448 . . . . 74.340000000000003 109.79 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 56.3 37.86 29.23 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.796 1.238 . . . . 71.420000000000002 112.891 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.45 13.68 82.34 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.223 -0.899 . . . . 71.099999999999994 113.32 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -116.04 142.38 46.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.579 -0.897 . . . . 65.329999999999998 108.579 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -115.51 117.97 31.85 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.078 -0.712 . . . . 70.400000000000006 109.078 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.03 145.22 48.35 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 111.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 37.0 t -103.51 124.71 57.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.06 -1.459 . . . . 73.329999999999998 107.06 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.95 122.86 70.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.157 -1.423 . . . . 75.219999999999999 107.157 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -104.51 134.54 47.52 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 111.787 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.8 0.5 3.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.6 -0.727 . . . . 75.150000000000006 110.297 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.32 58.9 0.4 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.124 -1.19 . . . . 44.420000000000002 110.124 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -70.33 -8.48 50.83 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.581 0.752 . . . . 72.319999999999993 112.017 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -24.05 58.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.969 0.414 . . . . 75.310000000000002 109.958 174.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -87.34 -17.93 31.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.771 -1.196 . . . . 75.549999999999997 107.771 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.62 56.06 6.27 Favored Glycine 0 CA--C 1.496 -1.128 0 CA-C-N 114.718 -1.128 . . . . 55.299999999999997 113.329 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -63.41 128.71 37.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.853 -0.425 . . . . 75.109999999999999 109.853 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 20.5 m-30 -124.28 139.89 53.48 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 110.03 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.26 121.71 66.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.32 -1.733 . . . . 74.200000000000003 106.32 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.19 39.15 31.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.037 1.335 . . . . 74.450000000000003 108.24 -169.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.433 ' HD2' ' OG ' ' A' ' 29' ' ' SER . 19.0 mtm105 62.62 20.3 11.92 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.055 -1.429 . . . . 71.450000000000003 111.519 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -111.81 136.13 21.17 Favored Pre-proline 0 C--N 1.315 -0.931 0 C-N-CA 122.875 0.47 . . . . 74.239999999999995 110.043 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.17 123.72 13.74 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.663 2.242 . . . . 72.239999999999995 108.664 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 8.9 tpp180 -143.23 142.44 31.4 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 119.167 -1.013 . . . . 75.430000000000007 112.549 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -79.05 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.614 0.766 . . . . 75.25 109.916 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -151.39 136.48 17.45 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.624 -1.25 . . . . 71.230000000000004 107.624 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 121' ' ' VAL . 52.4 tp60 -153.22 141.68 20.74 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.023 0.202 . . . . 64.409999999999997 111.208 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 58.4 t -66.23 133.03 31.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 106.522 -1.658 . . . . 64.430000000000007 106.522 170.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -87.42 144.65 26.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.205 -1.035 . . . . 74.519999999999996 108.205 -174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -126.77 152.47 46.85 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 113.212 0.819 . . . . 73.400000000000006 113.212 -170.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 36' ' ' SER . 0.7 OUTLIER -59.46 118.15 5.69 Favored 'General case' 0 N--CA 1.403 -2.815 0 C-N-CA 124.758 1.223 . . . . 74.420000000000002 112.563 -176.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.87 -7.03 64.8 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.802 -0.713 . . . . 73.120000000000005 112.62 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -83.09 153.09 25.04 Favored 'General case' 0 C--O 1.252 1.193 0 C-N-CA 120.132 -0.627 . . . . 63.310000000000002 110.678 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.51 131.48 55.2 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.073 -0.967 . . . . 71.030000000000001 110.285 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.2 mt -105.76 115.93 48.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 104.868 -2.271 . . . . 70.420000000000002 104.868 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -104.95 131.67 52.16 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.567 -1.272 . . . . 74.409999999999997 107.567 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.61 103.61 9.15 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 107.858 -1.164 . . . . 74.420000000000002 107.858 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.57 -78.6 0.01 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.095 0.798 . . . . 62.210000000000001 115.095 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -134.05 8.96 3.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.788 1.235 . . . . 74.530000000000001 109.981 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.596 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 49.2 m-85 -102.1 143.19 32.25 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.463 -0.569 . . . . 75.420000000000002 109.463 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -119.55 118.65 31.6 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.158 -1.423 . . . . 73.549999999999997 107.158 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.7 mp -119.16 135.31 54.73 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.992 -0.744 . . . . 73.040000000000006 108.992 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.15 130.85 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.01 -1.107 . . . . 70.340000000000003 108.01 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -95.68 124.87 39.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 110.823 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -129.71 132.34 46.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.311 0.577 . . . . 73.510000000000005 110.531 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.66 118.24 33.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.063 -1.828 . . . . 63.109999999999999 106.063 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.7 0.03 OUTLIER Glycine 0 C--N 1.296 -1.664 0 C-N-CA 118.252 -1.927 . . . . 71.510000000000005 115.428 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.76 141.55 97.06 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 119.977 1.888 . . . . 75.150000000000006 111.179 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.27 79.18 1.68 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.321 -0.992 . . . . 72.409999999999997 108.321 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.389 -3.481 0 CA-C-N 114.627 -1.17 . . . . 74.420000000000002 108.862 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 108.957 -0.757 . . . . 75.420000000000002 108.957 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -84.99 78.5 9.9 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.457 0.646 . . . . 75.200000000000003 109.416 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -80.72 -55.75 4.62 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.794 -1.187 . . . . 74.219999999999999 107.794 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 58.1 t30 64.7 94.77 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.446 1.498 . . . . 74.230000000000004 111.721 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -140.81 -53.23 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.469 0.652 . . . . 64.140000000000001 109.324 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.26 59.33 0.1 Allowed Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.804 -0.918 . . . . 74.329999999999998 110.804 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 m -79.68 111.31 20.22 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.234 -1.395 . . . . 72.109999999999999 107.234 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.6 131.56 10.46 Favored 'Trans proline' 0 N--CA 1.428 -2.355 0 C-N-CA 121.22 1.28 . . . . 71.019999999999996 112.076 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -117.99 141.02 28.59 Favored Pre-proline 0 C--N 1.283 -2.305 0 N-CA-C 107.497 -1.298 . . . . 72.510000000000005 107.497 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.24 143.97 79.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.931 1.754 . . . . 75.219999999999999 110.993 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -91.95 144.68 25.22 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.873 -1.529 . . . . 73.219999999999999 106.873 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.09 133.27 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.697 -0.853 . . . . 73.439999999999998 108.697 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.34 146.96 33.98 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.803 -1.09 . . . . 71.230000000000004 108.526 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -105.57 124.8 50.16 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.802 -1.925 . . . . 63.43 105.802 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -88.91 133.23 34.37 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.581 -0.896 . . . . 71.519999999999996 108.581 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.83 115.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.592 -0.522 . . . . 75.150000000000006 109.592 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -122.33 137.95 54.68 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.343 -0.614 . . . . 73.140000000000001 109.343 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.09 97.37 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.368 -1.345 . . . . 75.040000000000006 107.368 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 22' ' ' LEU . . . -79.57 -165.84 0.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.312 -0.858 . . . . 65.209999999999994 112.821 -173.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.09 9.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.49 2.316 . . . . 73.329999999999998 114.3 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 20' ' ' ALA . 2.9 pp -56.37 -20.45 19.37 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.06 1.133 . . . . 73.230000000000004 114.06 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.84 -43.87 82.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.722 -0.473 . . . . 72.040000000000006 109.722 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -82.51 -21.16 35.58 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.4 -0.363 . . . . 75.519999999999996 111.621 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 22' ' ' LEU . 5.6 tp10 -56.81 -48.73 77.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.377 -1.342 . . . . 74.420000000000002 107.377 170.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.4 ttp -68.76 -47.89 65.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.555 -1.202 . . . . 72.239999999999995 110.482 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -52.53 -49.79 64.14 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.455 1.102 . . . . 75.140000000000001 111.987 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 t -84.47 -27.82 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.719 0.637 . . . . 75.430000000000007 112.719 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -82.93 -22.29 33.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.434 -0.906 . . . . 64.329999999999998 110.949 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.5 m -72.03 111.46 7.28 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.093 -0.706 . . . . 61.020000000000003 109.093 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.1 -32.89 1.26 Allowed Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 109.56 -1.416 . . . . 73.230000000000004 109.56 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -94.51 120.52 34.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 74.439999999999998 108.705 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.9 111.94 20.34 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.828 -0.804 . . . . 73.319999999999993 108.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.66 141.48 66.58 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 121.949 1.766 . . . . 72.120000000000005 113.118 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.25 162.67 31.17 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.032 -0.985 . . . . 72.25 108.607 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.2 m 61.76 20.02 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.095 0.958 . . . . 65.319999999999993 112.141 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.8 m -90.85 109.94 21.15 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.657 -1.238 . . . . 63.329999999999998 107.657 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.19 53.99 0.6 Allowed Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.051 -1.071 . . . . 52.450000000000003 113.364 -172.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 -6.94 53.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.209 1.004 . . . . 74.409999999999997 109.419 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.45 14.11 0.83 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.583 -1.19 . . . . 72.340000000000003 113.261 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.71 -5.9 23.26 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.838 -0.43 . . . . 73.109999999999999 109.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 68.38 94.82 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.606 0 O-C-N 124.691 1.244 . . . . 71.439999999999998 111.245 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.21 -74.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.672 1.582 . . . . 72.340000000000003 112.519 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.71 6.69 46.8 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.844 -0.535 . . . . 63.100000000000001 111.593 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.01 17.76 75.83 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 116.048 -0.524 . . . . 62.210000000000001 113.293 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -131.99 169.74 15.89 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.753 -1.203 . . . . 70.430000000000007 107.753 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.49 154.45 48.81 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.16 -0.616 . . . . 73.140000000000001 111.034 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.42 161.3 36.7 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 114.954 -1.021 . . . . 75.329999999999998 109.288 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -127.3 139.62 52.76 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.454 -0.573 . . . . 70.409999999999997 109.454 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.8 133.65 65.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.715 -0.846 . . . . 64.400000000000006 108.715 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.55 117.12 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.003 -1.851 . . . . 72.319999999999993 106.003 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -99.86 -31.0 11.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.904 -0.589 . . . . 71.129999999999995 110.745 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -137.43 132.0 32.78 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.96 -0.696 . . . . 72.299999999999997 109.323 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.43 175.11 13.94 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.594 -1.002 . . . . 73.420000000000002 110.594 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.545 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 19.2 Cg_endo -59.82 -39.62 70.77 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.68 2.253 . . . . 71.450000000000003 112.535 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -95.29 22.22 7.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.123 -0.49 . . . . 75.010000000000005 112.087 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.77 57.53 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.037 0.535 . . . . 63.399999999999999 110.889 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.31 -18.32 36.02 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.242 -1.143 . . . . 52.450000000000003 110.242 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.66 131.95 35.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.507 -0.347 . . . . 75.450000000000003 110.281 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -125.74 136.77 53.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.99 -0.744 . . . . 73.310000000000002 108.99 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -131.14 141.14 50.07 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.074 -0.713 . . . . 70.120000000000005 109.074 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.95 143.92 31.22 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.446 -0.576 . . . . 72.340000000000003 109.446 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.0 mt -97.4 118.72 34.51 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.971 0.415 . . . . 75.109999999999999 111.637 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.3 2.77 7.79 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -110.32 148.94 39.42 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-N 115.007 -0.997 . . . . 74.310000000000002 110.361 -174.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 -15.86 27.6 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.981 2.454 . . . . 64.430000000000007 113.446 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 91.8 m -152.84 124.29 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 121.753 -0.592 . . . . 71.540000000000006 110.853 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.9 m -121.41 113.98 20.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.733 -0.84 . . . . 74.349999999999994 108.733 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 88.0 m -88.51 137.77 32.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.983 -0.377 . . . . 61.350000000000001 109.983 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.04 134.89 54.55 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-O 121.415 0.626 . . . . 75.409999999999997 110.349 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.99 -135.87 6.29 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.252 -1.34 . . . . 64.340000000000003 110.019 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.687 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -117.74 124.54 48.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.977 -0.749 . . . . 74.230000000000004 108.977 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.1 151.39 0.11 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 107.801 -1.185 . . . . 74.430000000000007 107.801 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.73 -32.11 47.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.861 1.708 . . . . 71.530000000000001 111.496 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.07 -5.9 59.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.065 0.394 . . . . 74.329999999999998 112.065 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.7 m -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.119 -1.067 . . . . 73.230000000000004 108.119 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.4 -43.01 71.11 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 124.33 1.019 . . . . 74.25 110.58 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.2 pt -106.96 107.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.992 0.901 . . . . 75.400000000000006 110.388 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -95.12 128.77 42.21 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.956 -1.02 . . . . 71.239999999999995 110.009 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.3 mt -111.44 135.43 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.847 -1.909 . . . . 75.329999999999998 105.847 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.69 137.11 52.4 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.001 -0.679 . . . . 72.200000000000003 112.472 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 83' ' ' VAL . 30.2 t70 -160.69 -162.19 0.92 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.158 -1.423 . . . . 74.25 107.158 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.548 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 48.2 t -68.54 -42.88 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 108.906 -0.775 . . . . 75.420000000000002 108.906 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.2 m -156.14 101.09 2.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.776 -0.647 . . . . 74.129999999999995 109.852 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 t -102.9 149.69 7.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 106.589 -1.634 . . . . 74.150000000000006 106.589 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.0 t -68.87 143.49 54.5 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 123.376 0.423 . . . . 73.019999999999996 111.725 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.1 ptt180 -55.86 -28.4 56.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.701 1.2 . . . . 72.510000000000005 110.389 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.95 104.72 2.86 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.805 -1.089 . . . . 74.409999999999997 109.212 169.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -86.86 -51.63 5.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.835 -1.543 . . . . 64.129999999999995 106.835 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.97 159.23 41.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.659 -1.237 . . . . 73.150000000000006 107.659 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 11.6 pt-20 -142.13 154.37 44.83 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.327 0.584 . . . . 71.409999999999997 112.186 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 67' ' ' THR . 4.8 m-85 -104.29 127.83 51.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.204 -1.406 . . . . 72.129999999999995 107.204 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -121.06 125.1 46.43 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.943 -0.762 . . . . 74.430000000000007 108.943 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 94' ' ' ILE . 3.6 mp -113.63 111.59 36.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.539 -1.652 . . . . 72.239999999999995 106.539 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -139.81 129.45 24.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.135 -0.484 . . . . 74.420000000000002 110.481 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.72 36.44 27.25 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.722 1.209 . . . . 63.109999999999999 111.888 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.82 -0.76 87.93 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 113.197 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -101.27 136.72 40.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.182 -0.673 . . . . 74.340000000000003 109.182 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.87 118.04 34.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.222 -1.029 . . . . 72.129999999999995 108.222 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -127.5 146.94 50.33 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.156 -0.617 . . . . 73.439999999999998 109.938 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.57 123.72 68.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.783 -1.192 . . . . 72.430000000000007 107.783 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.7 134.77 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.728 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.83 132.79 38.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.968 -1.864 . . . . 74.420000000000002 105.968 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.96 18.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 112.341 0.496 . . . . 61.530000000000001 112.341 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.79 42.16 0.29 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.376 -1.392 . . . . 54.020000000000003 113.344 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.8 p -87.49 143.63 27.12 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.983 -1.087 . . . . 74.049999999999997 108.365 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.94 -19.77 17.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.299 0.571 . . . . 74.340000000000003 109.475 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -87.31 -19.66 27.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.274 -0.875 . . . . 73.439999999999998 111.207 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.7 120.19 4.41 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.313 -0.946 . . . . 74.129999999999995 114.163 174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.3 m -88.04 132.04 34.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.409 -0.589 . . . . 70.510000000000005 109.409 173.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -119.8 126.42 50.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.919 -0.488 . . . . 75.319999999999993 110.004 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.3 t -111.57 117.17 54.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 106.932 -1.507 . . . . 75.540000000000006 106.932 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 55.08 37.96 29.73 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 125.452 1.501 . . . . 73.040000000000006 110.003 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 67.53 16.08 9.88 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 113.776 -1.556 . . . . 74.420000000000002 112.475 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -103.76 138.48 19.54 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 107.465 -1.309 . . . . 74.230000000000004 107.465 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.49 124.36 14.94 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.097 1.864 . . . . 75.310000000000002 109.034 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -148.17 141.89 25.62 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.915 -0.714 . . . . 74.219999999999999 110.439 -172.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.19 -58.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.129 -1.063 . . . . 75.420000000000002 108.129 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.11 139.19 42.77 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.966 -0.458 . . . . 75.150000000000006 109.784 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.92 143.79 22.91 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.073 -0.714 . . . . 74.299999999999997 109.073 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.72 131.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 107.119 -1.438 . . . . 74.319999999999993 107.119 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 122' ' ' MET . 11.4 mmt -88.97 148.49 23.76 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.889 0.852 . . . . 72.409999999999997 112.671 -170.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.425 ' HG2' ' OD2' ' A' ' 126' ' ' ASP . 18.9 pt20 -119.55 157.07 29.12 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.885 -1.895 . . . . 73.549999999999997 105.885 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 133.55 54.86 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.425 -0.954 . . . . 70.409999999999997 108.425 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.93 0.49 56.22 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.589 -0.815 . . . . 75.120000000000005 112.743 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.425 ' OD2' ' HG2' ' A' ' 123' ' ' GLN . 34.0 m-20 -76.12 141.06 42.05 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.638 0.719 . . . . 74.209999999999994 111.636 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.8 127.79 55.91 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.019 -1.104 . . . . 64.230000000000004 108.019 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.9 mt -107.42 119.54 57.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.091 -1.448 . . . . 73.439999999999998 107.091 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 11.5 tm0? -106.37 117.39 33.91 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.95 -1.5 . . . . 75.230000000000004 106.95 -174.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.02 101.65 12.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.862 -1.162 . . . . 73.239999999999995 107.862 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.14 -73.52 0.13 Allowed Glycine 0 CA--C 1.536 1.405 0 CA-C-O 121.361 0.423 . . . . 72.109999999999999 113.615 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -145.44 16.53 1.49 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.452 1.101 . . . . 74.140000000000001 109.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.545 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 72.4 m-85 -109.38 148.59 30.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.145 -0.934 . . . . 74.409999999999997 109.494 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -128.53 119.78 25.48 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.168 -0.679 . . . . 73.439999999999998 109.168 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.0 mt -106.45 132.72 52.15 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.452 -1.685 . . . . 64.329999999999998 106.452 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.73 120.15 61.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.054 -1.091 . . . . 74.129999999999995 108.054 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -96.43 121.58 38.39 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.67 -0.863 . . . . 75.099999999999994 108.67 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.63 136.8 49.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.809 0.337 . . . . 72.209999999999994 110.296 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.16 119.38 29.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 105.382 -2.081 . . . . 73.349999999999994 105.382 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.26 -132.83 1.87 Allowed Glycine 0 N--CA 1.42 -2.431 0 C-N-CA 119.088 -1.53 . . . . 75.400000000000006 113.342 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.47 162.13 43.52 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.757 2.971 . . . . 73.200000000000003 114.235 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.39 69.79 1.41 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.792 -1.558 . . . . 65.430000000000007 106.792 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 . . . . . 0 N--CA 1.42 -1.974 0 CA-C-N 114.758 -1.11 . . . . 74.430000000000007 111.162 -175.231 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 CA--C 1.512 -0.483 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 110.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 t -144.73 90.94 2.11 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.232 -1.766 . . . . 64.540000000000006 106.232 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -147.03 136.26 22.58 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.374 -0.972 . . . . 71.510000000000005 108.374 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -88.2 169.41 11.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.861 0.362 . . . . 74.219999999999999 110.727 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -90.08 114.47 26.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.854 -0.795 . . . . 74.019999999999996 108.854 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.35 -49.04 54.77 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 109.402 -1.479 . . . . 63.020000000000003 109.402 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 m -116.12 108.5 45.97 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 107.312 -1.366 . . . . 70.340000000000003 107.312 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.75 143.32 73.6 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.487 2.124 . . . . 63.340000000000003 112.787 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.29 127.69 60.33 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.642 -0.708 . . . . 75.019999999999996 111.481 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.92 91.9 1.07 Allowed 'Trans proline' 0 N--CA 1.427 -2.415 0 C-N-CA 121.711 1.607 . . . . 73.0 110.446 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -91.75 143.79 26.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.232 -1.349 . . . . 75.439999999999998 107.703 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -107.99 137.47 39.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.434 0.635 . . . . 72.239999999999995 110.57 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.28 155.88 41.24 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 105.129 -2.174 . . . . 72.430000000000007 105.129 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -70.51 109.85 5.05 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 113.292 0.849 . . . . 75.530000000000001 113.292 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . 0.416 HG22 ' HG ' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -135.87 147.9 48.4 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.785 -1.931 . . . . 73.019999999999996 105.785 172.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -89.89 112.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 107.452 -1.314 . . . . 65.010000000000005 107.452 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -125.53 141.35 52.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.616 -0.72 . . . . 74.150000000000006 109.349 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -81.5 112.85 19.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.068 -1.456 . . . . 72.019999999999996 107.068 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . -64.4 -168.44 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 115.317 1.599 . . . . 75.420000000000002 115.317 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.41 2.89 2.02 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.417 1.887 . . . . 70.109999999999999 111.536 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 3.9 pp -57.28 -21.14 32.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.476 1.51 . . . . 62.240000000000002 112.915 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.84 -34.54 78.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.349 0.26 . . . . 74.439999999999998 110.975 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.39 -40.31 8.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.112 -0.699 . . . . 74.109999999999999 109.112 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 13.1 tp10 -65.7 -24.94 67.1 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 114.34 -1.3 . . . . 74.310000000000002 114.016 -172.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.21 -50.36 69.61 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.873 0.761 . . . . 72.109999999999999 112.074 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.6 -31.92 69.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.125 0.488 . . . . 75.510000000000005 110.807 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -71.97 -26.37 62.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.656 -0.702 . . . . 74.049999999999997 110.751 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.52 -40.57 12.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.577 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.4 m -75.42 85.21 2.54 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.679 0.752 . . . . 71.030000000000001 112.402 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.57 26.17 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.132 -0.94 . . . . 53.299999999999997 111.194 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -83.9 123.9 30.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 123.378 0.671 . . . . 73.340000000000003 109.818 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.93 124.18 81.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 106.21 -1.774 . . . . 72.299999999999997 106.21 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.74 141.76 91.95 Favored 'Trans proline' 0 C--O 1.251 1.134 0 C-N-CA 121.939 1.759 . . . . 70.540000000000006 111.909 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.06 141.44 48.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.093 -0.958 . . . . 73.329999999999998 109.463 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.3 t -141.14 112.1 7.19 Favored 'General case' 0 N--CA 1.407 -2.61 0 CA-C-O 121.55 0.691 . . . . 73.420000000000002 109.962 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.09 36.41 0.98 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.687 -1.597 . . . . 73.450000000000003 106.687 174.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . 86.7 25.63 34.75 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.309 -2.316 . . . . 73.329999999999998 107.309 -169.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 139' ' ' ALA . . . -72.29 -47.6 48.76 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.715 -1.243 . . . . 65.319999999999993 113.618 -168.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -80.92 -2.35 47.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.614 0.721 . . . . 74.030000000000001 111.453 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.45 -25.39 20.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.868 -1.06 . . . . 75.409999999999997 108.626 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 57.37 85.49 0.19 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 114.732 -1.122 . . . . 71.400000000000006 111.284 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 45.3 Cg_endo -83.1 -73.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.443 2.095 . . . . 74.200000000000003 114.11 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.11 65.3 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.705 0.632 . . . . 63.240000000000002 112.705 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -11.85 71.02 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 111.083 -0.807 . . . . 64.329999999999998 111.083 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.3 m -114.7 169.84 8.77 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.939 -1.504 . . . . 64.400000000000006 106.939 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 138' ' ' LEU . . . -149.61 157.58 43.38 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.974 -0.38 . . . . 51.240000000000002 109.974 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.19 137.65 54.51 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.366 0.603 . . . . 63.329999999999998 110.324 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 pp -111.11 137.02 49.3 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 109.125 -0.694 . . . . 74.230000000000004 109.125 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.8 135.62 50.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 109.613 -0.514 . . . . 73.049999999999997 109.613 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 16.1 t -80.83 118.15 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.7 -1.222 . . . . 72.239999999999995 107.7 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -88.79 -35.95 16.35 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.182 -0.673 . . . . 73.109999999999999 109.182 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -148.1 141.93 25.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.299 -0.864 . . . . 73.519999999999996 109.282 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.79 174.78 13.57 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.397 -1.081 . . . . 72.140000000000001 110.397 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.541 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.8 Cg_exo -54.65 -44.68 47.26 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.602 2.201 . . . . 74.319999999999993 113.52 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -92.64 22.37 4.77 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.081 -1.012 . . . . 74.120000000000005 113.268 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -54.51 140.5 34.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.812 0.445 . . . . 71.5 112.036 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.37 -16.27 55.36 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.545 -0.622 . . . . 74.530000000000001 111.545 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.33 142.34 27.82 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.086 -0.246 . . . . 73.340000000000003 110.49 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -112.83 135.14 53.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.481 -0.933 . . . . 75.340000000000003 108.481 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.36 133.09 56.17 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.783 -0.451 . . . . 75.340000000000003 109.783 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.95 124.71 47.07 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.892 -0.594 . . . . 73.219999999999999 110.107 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.91 105.24 14.64 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.361 -1.348 . . . . 73.230000000000004 107.361 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -122.35 18.22 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.983 0.897 . . . . 73.319999999999993 109.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -133.17 157.67 77.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 65.329999999999998 109.516 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.59 -26.51 75.9 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.047 2.498 . . . . 62.229999999999997 114.079 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.6 m -147.55 121.8 9.58 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.329 -0.857 . . . . 75.540000000000006 111.182 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.0 m -109.87 135.32 50.94 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.862 -0.608 . . . . 62.109999999999999 109.943 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -106.39 141.52 37.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.69 135.28 54.56 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 109.781 -0.451 . . . . 74.5 109.781 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.89 -164.19 25.52 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.792 -1.323 . . . . 70.109999999999999 109.792 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 86.1 mtt180 -101.43 117.8 35.68 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.123 -1.066 . . . . 73.109999999999999 108.123 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 176.88 153.8 0.4 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.854 -1.906 . . . . 75.239999999999995 105.854 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.07 -15.76 51.1 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.924 1.749 . . . . 74.200000000000003 113.178 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.44 -1.28 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.607 0.595 . . . . 75.219999999999999 112.607 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -85.07 112.52 20.72 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.11 -1.036 . . . . 71.230000000000004 111.154 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.19 -36.95 74.98 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.133 -0.692 . . . . 70.420000000000002 109.133 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -100.66 98.73 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 122.253 1.025 . . . . 71.109999999999999 108.449 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -90.06 122.06 32.7 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.949 -1.023 . . . . 74.099999999999994 108.63 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.6 mt -123.87 122.18 37.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.154 -2.165 . . . . 71.319999999999993 105.154 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -130.67 117.53 19.61 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.198 -0.668 . . . . 72.120000000000005 109.198 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -128.78 -155.91 0.73 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.426 -0.953 . . . . 73.0 108.426 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.9 -41.74 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.24 0.616 . . . . 71.200000000000003 111.377 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -153.99 89.44 1.3 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.617 -0.677 . . . . 72.530000000000001 111.735 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.54 136.29 37.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.983 -0.747 . . . . 64.439999999999998 108.983 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.413 ' HB2' HD22 ' A' ' 107' ' ' LEU . 41.2 t -71.33 161.99 30.17 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 123.843 0.715 . . . . 74.5 111.186 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 27.9 ptt180 -65.4 -38.16 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 122.127 0.965 . . . . 74.420000000000002 109.374 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -136.14 112.96 10.23 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.491 -1.3 . . . . 75.409999999999997 107.491 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.628 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t-80 -99.62 -52.93 3.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.851 -0.613 . . . . 51.420000000000002 109.847 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.69 160.44 37.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.266 -0.574 . . . . 75.25 110.537 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.0 133.97 53.56 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.307 -0.861 . . . . 72.140000000000001 110.628 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -105.69 115.54 30.42 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.417 -1.698 . . . . 72.209999999999994 106.417 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -112.65 133.92 54.44 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.032 -0.667 . . . . 74.319999999999993 110.884 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.474 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.6 mp -104.48 121.13 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.022 -1.103 . . . . 74.409999999999997 108.022 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -123.84 116.64 23.29 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.29 -1.374 . . . . 74.409999999999997 107.29 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.98 37.83 14.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.777 0.831 . . . . 71.549999999999997 112.884 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.51 -2.49 87.38 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.097 -0.501 . . . . 71.519999999999996 114.172 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.81 138.9 39.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.729 0.765 . . . . 74.420000000000002 109.148 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' CD2' HG13 ' A' ' 94' ' ' ILE . 31.5 m-85 -108.52 122.77 47.76 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.61 -0.268 . . . . 72.319999999999993 111.246 -172.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -114.75 139.01 50.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.667 -0.864 . . . . 75.420000000000002 108.667 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.32 123.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.991 -1.115 . . . . 74.140000000000001 107.991 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.72 121.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.169 -1.419 . . . . 63.240000000000002 107.169 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.52 153.94 18.26 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.783 -1.191 . . . . 70.439999999999998 107.783 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 89' ' ' HIS . 18.7 m -78.79 -12.31 13.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 113.379 0.881 . . . . 70.329999999999998 113.379 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.23 17.58 0.02 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 119.086 -1.53 . . . . 54.43 116.019 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p 57.97 26.92 14.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.664 1.586 . . . . 73.450000000000003 111.496 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 15' ' ' TPO . 0.0 OUTLIER -65.26 -35.31 80.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.961 -1.472 . . . . 73.299999999999997 112.926 -174.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.628 ' HB2' ' CD2' ' A' ' 89' ' ' HIS . 2.6 m120 -86.76 3.77 43.63 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 110.374 -0.232 . . . . 73.019999999999996 110.374 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.66 49.17 6.26 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.933 -1.267 . . . . 75.0 109.933 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -61.54 129.86 43.14 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 123.496 0.718 . . . . 71.219999999999999 110.977 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.2 125.64 43.97 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.326 -1.731 . . . . 73.540000000000006 106.326 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.14 124.77 61.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 106.694 -1.595 . . . . 65.400000000000006 106.694 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 4.3 t-20 57.81 37.64 27.1 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.543 1.163 . . . . 65.310000000000002 107.884 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.15 18.62 6.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.976 -1.466 . . . . 63.350000000000001 114.23 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -125.04 147.47 57.02 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.407 -0.96 . . . . 74.329999999999998 108.407 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.57 129.43 17.78 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 N-CA-C 108.528 -1.374 . . . . 73.400000000000006 108.528 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.44 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 13.0 tpp180 -148.38 150.19 33.11 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.636 -0.826 . . . . 74.400000000000006 110.143 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -93.81 -55.46 3.23 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.558 -0.534 . . . . 63.329999999999998 109.558 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.68 34.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.808 -0.812 . . . . 72.120000000000005 108.808 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 58.1 tp60 -153.85 143.19 21.5 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 123.145 0.278 . . . . 73.209999999999994 110.71 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.95 128.11 37.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.573 -1.64 . . . . 74.310000000000002 106.573 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 39.4 ttp -90.26 134.88 34.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.402 0.62 . . . . 75.299999999999997 111.357 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -104.07 152.19 22.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.23 -0.895 . . . . 72.5 110.67 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.25 130.71 41.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 C-N-CA 123.646 0.778 . . . . 64.510000000000005 111.979 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -0.44 63.0 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.099 -0.8 . . . . 73.540000000000006 111.099 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 28.3 t70 -89.44 153.65 20.66 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.45 -0.375 . . . . 75.150000000000006 111.565 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -115.92 131.19 57.01 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 121.525 0.679 . . . . 73.409999999999997 112.611 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.09 131.76 61.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 107.659 -1.237 . . . . 71.049999999999997 107.659 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.5 tm0? -109.97 130.74 55.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.727 -1.212 . . . . 62.130000000000003 107.727 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.431 HG22 ' CE1' ' A' ' 89' ' ' HIS . 4.1 mp -130.09 104.03 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.644 -0.873 . . . . 71.219999999999999 108.644 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.55 -96.45 0.18 Allowed Glycine 0 C--O 1.243 0.699 0 C-N-CA 121.052 -0.594 . . . . 73.409999999999997 112.565 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -113.43 -0.55 14.43 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.002 0.43 . . . . 74.239999999999995 110.219 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.541 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 87.1 m-85 -100.19 152.85 19.8 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.291 0.636 . . . . 64.140000000000001 111.479 -175.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -137.09 120.2 16.64 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.995 -1.113 . . . . 74.109999999999999 107.995 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.414 ' CD2' HG23 ' A' ' 51' ' ' VAL . 65.2 mt -105.25 140.39 38.47 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.468 0.707 . . . . 73.340000000000003 109.442 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.33 120.02 61.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.265 -1.754 . . . . 74.129999999999995 106.265 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -97.74 119.63 36.67 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 112.128 0.418 . . . . 71.310000000000002 112.128 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 95.5 mt -129.34 153.91 47.4 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.853 -0.795 . . . . 70.439999999999998 108.853 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 39' ' ' ALA . . . -75.95 162.01 28.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.869 -0.332 . . . . 63.049999999999997 110.927 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.2 168.23 41.88 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.417 -0.81 . . . . 55.420000000000002 112.108 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HB2' ' CG ' ' A' ' 143' ' ' GLU . 12.0 Cg_endo -54.72 145.29 61.0 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 123.768 2.979 . . . . 74.530000000000001 115.455 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 43.39 1.07 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.546 -1.207 . . . . 74.549999999999997 110.384 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 141' ' ' PRO . 2.9 pt-20 . . . . . 0 N--CA 1.413 -2.307 0 C-N-CA 123.651 0.78 . . . . 75.549999999999997 109.385 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.5 -0.966 0 N-CA-C 107.938 -1.134 . . . . 75.439999999999998 107.938 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.1 m 70.66 -64.36 0.37 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 124.153 0.981 . . . . 73.430000000000007 110.368 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 56.2 29.95 15.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 72.019999999999996 113.577 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -150.28 137.48 19.52 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.451 -0.795 . . . . 65.200000000000003 109.15 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -88.26 94.68 9.91 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.72 -0.844 . . . . 72.209999999999994 108.72 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.47 -58.11 2.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.083 -1.207 . . . . 71.310000000000002 110.083 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.5 m -111.9 108.5 55.6 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-N 115.393 -0.404 . . . . 61.299999999999997 110.867 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.08 136.77 18.65 Favored 'Trans proline' 0 C--O 1.256 1.386 0 N-CA-C 108.157 -1.516 . . . . 73.430000000000007 108.157 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.84 133.46 62.01 Favored Pre-proline 0 C--N 1.315 -0.896 0 C-N-CA 120.482 -0.487 . . . . 64.420000000000002 111.39 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.48 118.6 5.71 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 122.243 1.962 . . . . 74.010000000000005 112.433 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 26.5 mm-40 -112.69 139.87 47.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.406 -2.072 . . . . 74.430000000000007 105.406 174.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.24 133.54 54.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 119.819 -0.752 . . . . 72.109999999999999 112.764 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.11 150.22 21.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.384 -1.339 . . . . 74.230000000000004 107.384 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -90.35 130.3 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.023 0.439 . . . . 73.530000000000001 110.92 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.5 m -89.92 152.6 21.15 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.653 -0.499 . . . . 53.340000000000003 109.653 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.0 t -83.24 116.57 27.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.544 -0.539 . . . . 64.349999999999994 109.544 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -123.87 140.12 53.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.73 -0.47 . . . . 74.540000000000006 109.73 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttp85 -96.21 108.53 21.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.114 -1.069 . . . . 75.099999999999994 108.114 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 22' ' ' LEU . . . -77.7 -173.84 3.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.574 -0.739 . . . . 60.130000000000003 110.989 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -72.91 6.83 2.34 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.701 0.8 . . . . 64.310000000000002 111.497 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' H ' ' C ' ' A' ' 20' ' ' ALA . 2.4 pp -57.25 -26.21 60.39 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.222 1.409 . . . . 71.109999999999999 113.942 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.4 tp -72.28 -22.52 61.2 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.87 0.843 . . . . 74.530000000000001 109.616 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.16 -32.53 12.44 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.595 -0.73 . . . . 73.230000000000004 109.572 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -56.93 -38.97 73.64 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.119 -0.492 . . . . 73.120000000000005 111.086 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 ptp -62.4 -25.94 68.21 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 120.792 -0.363 . . . . 71.420000000000002 111.558 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -87.53 -49.65 7.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.948 0.404 . . . . 75.120000000000005 110.077 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -61.21 -41.98 97.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.793 -0.64 . . . . 53.43 111.145 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -82.92 -16.98 45.31 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.881 -0.414 . . . . 74.129999999999995 109.881 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m 67.29 101.75 0.05 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.773 1.229 . . . . 65.109999999999999 113.964 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.58 -141.38 48.02 Favored Glycine 0 CA--C 1.499 -0.963 0 CA-C-N 115.485 -0.779 . . . . 62.009999999999998 112.69 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t -115.77 149.39 38.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.608 -0.516 . . . . 75.0 109.608 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 110.97 40.6 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.323 -0.992 . . . . 73.420000000000002 108.323 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.78 145.2 90.56 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.859 2.373 . . . . 72.019999999999996 113.616 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.23 162.45 13.19 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.904 -0.589 . . . . 71.5 110.102 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 123' ' ' GLN . 18.3 m -94.26 116.0 28.33 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.168 0.509 . . . . 72.340000000000003 110.551 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.2 m -69.38 100.04 1.3 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.551 -0.75 . . . . 73.120000000000005 109.403 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 41' ' ' ASN . . . -152.31 43.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.273 -0.965 . . . . 71.239999999999995 112.993 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.47 -39.83 13.92 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.622 -1.251 . . . . 74.319999999999993 107.622 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.46 -1.81 25.83 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.328 -1.306 . . . . 71.120000000000005 111.387 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' OD1' ' HA2' ' A' ' 38' ' ' GLY . 11.0 m120 -82.8 -30.55 28.74 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.481 -0.782 . . . . 74.540000000000006 109.29 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt 48.06 81.33 0.26 Allowed Pre-proline 0 C--N 1.345 0.371 0 O-C-N 124.229 0.956 . . . . 72.109999999999999 112.049 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.79 -61.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 111.891 -176.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.67 -12.97 5.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.956 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.83 1.46 85.06 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.087 -1.054 . . . . 64.329999999999998 111.176 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 m -115.02 156.56 24.9 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.23 -1.396 . . . . 61.32 107.23 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -148.11 154.53 40.31 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.708 -0.478 . . . . 73.120000000000005 109.708 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 152.37 44.5 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.92 -0.4 . . . . 73.420000000000002 109.92 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.01 132.46 52.01 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.46 -0.941 . . . . 74.329999999999998 108.46 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 p -108.82 137.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.644 -0.502 . . . . 74.129999999999995 109.644 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' A' ' 135' ' ' LEU . 10.5 t -86.09 118.27 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 107.997 -1.112 . . . . 72.400000000000006 107.997 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -93.42 -31.71 14.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.356 -0.838 . . . . 71.540000000000006 109.953 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -147.11 138.5 24.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.988 -0.745 . . . . 74.450000000000003 108.988 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.06 171.05 12.93 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.155 -1.178 . . . . 72.430000000000007 110.155 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.662 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.1 Cg_exo -54.64 -29.99 63.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.598 2.199 . . . . 63.409999999999997 113.714 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.43 8.47 33.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.502 -0.479 . . . . 72.329999999999998 112.199 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.95 131.61 45.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.86 0.362 . . . . 72.299999999999997 111.515 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -23.94 24.44 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 115.588 -0.733 . . . . 71.120000000000005 112.295 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 152.54 20.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.754 0.277 . . . . 74.329999999999998 110.768 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.75 137.12 48.07 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.764 -0.828 . . . . 72.540000000000006 108.764 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -115.24 139.51 49.88 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.614 -0.513 . . . . 63.130000000000003 109.614 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.3 127.94 42.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.947 -1.131 . . . . 75.439999999999998 107.947 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.75 113.21 26.18 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.485 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.18 3.47 4.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.24 1.019 . . . . 74.230000000000004 108.582 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.41 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.4 pm0 -106.45 137.09 19.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-N 115.056 -0.975 . . . . 74.230000000000004 109.123 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.25 -21.58 67.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.309 2.673 . . . . 71.140000000000001 113.764 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -137.23 122.68 19.55 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.322 -0.622 . . . . 74.540000000000006 109.322 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.0 m -129.89 112.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.91 -0.774 . . . . 72.140000000000001 108.91 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 m -88.53 140.59 29.31 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.394 -0.595 . . . . 71.310000000000002 109.394 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.52 135.2 55.14 Favored 'General case' 0 C--O 1.268 2.039 0 N-CA-C 109.09 -0.707 . . . . 72.219999999999999 109.09 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -136.0 4.81 Favored Glycine 0 N--CA 1.422 -2.298 0 O-C-N 123.916 0.76 . . . . 71.120000000000005 112.833 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.581 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 24.8 mmm180 -118.67 152.94 35.17 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 125.486 1.514 . . . . 72.239999999999995 109.552 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.427 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 27.0 t-80 82.57 142.87 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 125.31 1.444 . . . . 74.319999999999993 109.209 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 9.8 Cg_endo -52.63 -6.77 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 124.14 3.227 . . . . 71.010000000000005 115.538 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.5 -12.89 59.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.353 0.597 . . . . 74.040000000000006 110.086 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -88.19 134.91 33.66 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.358 -0.979 . . . . 52.229999999999997 108.358 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -76.99 -42.2 39.8 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.169 -1.049 . . . . 74.120000000000005 108.169 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.7 mm -97.46 104.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 106.469 -1.678 . . . . 65.329999999999998 106.469 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -87.62 108.81 19.25 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.49 -0.777 . . . . 64.420000000000002 109.431 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 82.3 mt -95.7 141.05 29.65 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.742 -1.577 . . . . 73.530000000000001 106.742 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.581 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 18.3 t70 -103.94 117.46 34.36 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.152 -0.619 . . . . 75.120000000000005 110.499 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -151.22 174.98 12.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.643 -1.243 . . . . 73.409999999999997 107.643 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.48 -34.25 10.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.585 -0.894 . . . . 71.209999999999994 108.585 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.553 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 m -74.61 125.23 28.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.02 -0.991 . . . . 52.310000000000002 109.711 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.5 98.01 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 119.618 -0.833 . . . . 71.129999999999995 109.109 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.413 ' HG ' ' HB2' ' A' ' 89' ' ' HIS . 14.1 t -107.01 90.5 3.32 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.457 -1.312 . . . . 72.540000000000006 107.457 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 11' ' ' GLN . 20.7 ptt180 -57.92 -31.9 67.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.544 -1.207 . . . . 74.409999999999997 111.384 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -145.12 93.43 2.39 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.411 -0.959 . . . . 73.409999999999997 108.411 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.489 ' CE1' HG23 ' A' ' 130' ' ' ILE . 39.7 t-80 -96.58 -53.58 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.704 -0.798 . . . . 73.519999999999996 109.691 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.32 160.62 38.71 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 109.194 -0.669 . . . . 75.0 109.194 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.02 143.94 36.67 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.331 0.586 . . . . 73.450000000000003 110.138 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -104.94 122.16 45.24 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.027 -2.212 . . . . 74.120000000000005 105.027 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -115.81 142.84 46.23 Favored 'General case' 0 C--N 1.273 -2.72 0 C-N-CA 119.618 -0.833 . . . . 73.340000000000003 109.256 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.7 mp -113.95 112.97 42.46 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 104.219 -2.511 . . . . 70.219999999999999 104.219 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.63 122.7 25.1 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.766 -0.457 . . . . 65.439999999999998 109.766 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 56.03 38.0 29.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.146 0.904 . . . . 72.540000000000006 111.571 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.91 -7.84 75.68 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.248 -0.887 . . . . 74.510000000000005 113.925 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -101.79 150.28 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.151 0.475 . . . . 65.25 109.844 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.29 126.4 53.31 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.774 -0.825 . . . . 74.519999999999996 108.774 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.9 147.84 52.59 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.647 0.26 . . . . 65.340000000000003 111.174 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 122' ' ' MET . 25.6 t -112.59 122.69 67.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.942 -1.503 . . . . 74.239999999999995 106.942 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.88 122.33 68.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.198 0.523 . . . . 62.009999999999998 111.147 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.9 136.93 32.75 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 123.787 0.835 . . . . 63.329999999999998 110.553 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.57 5.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.813 -0.63 . . . . 75.219999999999999 110.463 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.78 58.83 0.57 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.99 -0.624 . . . . 62.43 111.835 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -60.03 -11.65 6.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.783 1.233 . . . . 74.400000000000006 112.563 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.4 -20.48 65.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.992 0.917 . . . . 74.420000000000002 110.847 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.66 -5.5 58.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 64.519999999999996 110.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.35 66.15 1.72 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.789 -0.641 . . . . 43.009999999999998 112.178 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 m -73.9 127.44 32.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.079 0.466 . . . . 75.400000000000006 110.844 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -136.62 141.42 43.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 109.827 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.17 119.57 58.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 106.905 -1.517 . . . . 71.140000000000001 106.905 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 127' ' ' GLU . 87.7 m-20 56.58 39.38 29.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.792 0.837 . . . . 63.229999999999997 110.699 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.492 ' HG2' HH11 ' A' ' 114' ' ' ARG . 0.0 OUTLIER 65.32 15.21 9.9 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 113.066 0.765 . . . . 74.329999999999998 113.066 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -112.43 133.99 21.68 Favored Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 123.062 0.545 . . . . 74.5 109.761 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.52 123.28 10.91 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 108.161 -1.515 . . . . 72.239999999999995 108.161 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -153.03 137.3 16.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.716 -1.216 . . . . 75.209999999999994 107.716 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -107.91 -56.53 2.22 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.114 -0.635 . . . . 73.329999999999998 110.657 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.7 132.72 54.38 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.127 -1.064 . . . . 72.400000000000006 108.127 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.61 150.55 26.52 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 112.682 0.623 . . . . 70.409999999999997 112.682 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.61 132.4 33.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 104.926 -2.25 . . . . 71.219999999999999 104.926 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.423 ' HB2' HG21 ' A' ' 101' ' ' VAL . 33.1 ttp -88.97 129.12 35.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.107 -0.637 . . . . 71.239999999999995 109.938 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 36' ' ' SER . 61.9 mt-30 -118.34 156.56 28.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.738 -1.119 . . . . 63.439999999999998 109.133 -173.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -71.21 130.21 40.86 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.463 -0.94 . . . . 74.230000000000004 108.463 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.44 -4.1 56.68 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.788 -0.642 . . . . 44.43 113.057 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.27 137.33 54.63 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 117.952 0.876 . . . . 71.099999999999994 110.444 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 12.6 pt-20 -112.69 126.32 55.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.575 -1.269 . . . . 74.209999999999994 107.575 172.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.98 117.03 54.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.652 0 N-CA-C 107.878 -1.156 . . . . 74.310000000000002 107.878 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -105.33 123.87 48.58 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.553 0.692 . . . . 74.209999999999994 112.111 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.489 HG23 ' CE1' ' A' ' 89' ' ' HIS . 10.3 mm -109.87 101.95 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 105.53 -2.026 . . . . 74.239999999999995 105.53 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 56.34 -98.15 0.06 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 120.789 -0.72 . . . . 72.109999999999999 112.112 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -97.53 -24.0 15.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.808 0.443 . . . . 73.430000000000007 111.34 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.662 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 65.5 m-85 -75.31 148.47 39.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 122.769 0.428 . . . . 72.140000000000001 110.25 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -138.37 120.12 15.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.529 -0.915 . . . . 71.450000000000003 108.529 170.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.7 mm? -103.36 139.86 38.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.68 -0.859 . . . . 74.530000000000001 108.68 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.7 t -116.37 123.2 71.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.24 -1.022 . . . . 73.040000000000006 108.24 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.444 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 94.3 t80 -94.68 129.86 41.4 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.978 -0.555 . . . . 64.120000000000005 111.252 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.93 132.04 53.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.158 -1.053 . . . . 62.310000000000002 108.158 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.42 131.4 53.66 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.45 -0.5 . . . . 63.299999999999997 111.099 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.66 46.29 2.33 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 117.506 1.762 . . . . 55.310000000000002 117.506 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.18 155.67 56.26 Favored 'Trans proline' 0 C--N 1.363 1.336 0 CA-C-N 121.108 2.454 . . . . 74.25 109.718 169.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.69 83.59 0.96 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.253 0.549 . . . . 72.519999999999996 110.426 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.172 -1.418 . . . . 72.430000000000007 107.172 177.272 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 108.489 -0.93 . . . . 74.129999999999995 108.489 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.3 m -150.17 160.74 43.45 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.475 -0.565 . . . . 74.340000000000003 109.475 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.72 99.71 11.02 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.583 0.552 . . . . 71.409999999999997 110.32 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.78 91.61 7.56 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.798 0.809 . . . . 72.519999999999996 108.936 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -118.68 152.12 36.7 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.411 -1.268 . . . . 75.219999999999999 108.575 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.52 98.88 0.3 Allowed Glycine 0 N--CA 1.437 -1.292 0 O-C-N 123.649 0.593 . . . . 71.340000000000003 111.863 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.9 m -82.48 128.82 65.42 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.089 -0.708 . . . . 70.239999999999995 109.089 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 132.28 50.84 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.288 1.992 . . . . 65.430000000000007 110.696 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -89.93 148.61 40.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.427 -0.582 . . . . 73.299999999999997 109.427 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.91 153.67 49.45 Favored 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.364 2.043 . . . . 64.400000000000006 111.025 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -91.84 167.53 12.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.43 -0.952 . . . . 73.400000000000006 108.43 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.92 132.83 54.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.432 0.634 . . . . 72.129999999999995 111.239 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 10.0 tp10 -158.18 154.36 27.23 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.274 -2.121 . . . . 73.25 105.274 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -70.66 134.75 47.82 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.784 1.031 . . . . 74.030000000000001 113.784 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 108' ' ' ASN . 16.2 m -99.04 152.39 19.88 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.136 0.493 . . . . 73.340000000000003 112.176 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.15 115.92 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 104.903 -2.258 . . . . 72.430000000000007 104.903 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -81.6 113.59 19.72 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.543 0.687 . . . . 72.530000000000001 110.802 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.92 120.63 42.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.664 -1.236 . . . . 74.120000000000005 107.664 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.49 -178.09 7.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.996 0.427 . . . . 65.0 110.009 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -83.97 -4.47 58.74 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.803 0.811 . . . . 63.0 109.862 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.34 -4.53 58.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.034 -0.985 . . . . 72.129999999999995 111.748 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.59 -33.39 68.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.111 -0.7 . . . . 71.450000000000003 109.111 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -71.81 -22.41 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.518 -0.765 . . . . 70.140000000000001 110.126 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.88 -30.85 40.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.419 -0.585 . . . . 72.150000000000006 109.419 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.415 ' O ' ' HB ' ' A' ' 30' ' ' THR . 32.7 ttm -66.95 -12.11 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.64 1.21 . . . . 71.019999999999996 108.915 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.73 -38.07 8.84 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.899 -1.046 . . . . 74.349999999999994 109.894 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -88.8 -46.38 9.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.905 1.076 . . . . 75.519999999999996 113.905 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -90.17 -20.26 23.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 119.478 -0.889 . . . . 74.349999999999994 112.006 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 26' ' ' MET . 5.7 m -80.53 65.48 5.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.906 0.86 . . . . 64.200000000000003 109.669 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.92 5.4 2.23 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.135 -1.186 . . . . 72.239999999999995 110.135 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -110.66 121.96 46.61 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.134 -1.062 . . . . 73.549999999999997 108.134 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.16 120.96 83.98 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.979 -0.378 . . . . 74.219999999999999 109.979 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.43 150.88 87.39 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.702 2.268 . . . . 70.120000000000005 111.368 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.18 141.66 31.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.38 -0.6 . . . . 72.019999999999996 109.38 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.8 m -80.1 117.57 21.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.92 -0.4 . . . . 72.510000000000005 109.92 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.7 p -82.26 -49.85 9.63 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.903 -0.59 . . . . 72.019999999999996 110.186 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.49 114.58 2.32 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.401 -0.818 . . . . 55.509999999999998 111.894 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.85 -7.79 45.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 120.923 0.392 . . . . 62.039999999999999 110.315 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -5.3 21.11 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.678 1.362 . . . . 75.420000000000002 114.678 -168.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.03 -32.43 18.79 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.373 -0.531 . . . . 73.040000000000006 110.98 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 48.26 68.85 3.12 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 124.079 0.862 . . . . 73.030000000000001 111.069 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.44 -58.25 0.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 125.113 3.875 . . . . 74.109999999999999 114.556 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.31 17.15 4.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.329 -0.989 . . . . 71.219999999999999 108.329 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.77 -12.4 29.19 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 114.623 -1.171 . . . . 73.340000000000003 112.583 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -118.99 164.84 14.88 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.993 -0.373 . . . . 72.430000000000007 109.993 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.25 156.98 40.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.911 -1.515 . . . . 71.420000000000002 106.911 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.43 145.78 51.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.141 0.496 . . . . 74.219999999999999 111.746 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -106.32 142.68 35.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.491 -0.929 . . . . 73.209999999999994 108.491 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.66 132.24 71.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.434 -0.58 . . . . 75.319999999999993 109.434 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.56 118.3 22.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.244 -1.391 . . . . 71.230000000000004 107.244 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -89.79 -34.82 16.02 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.618 -0.719 . . . . 74.299999999999997 110.756 -174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 43.1 ttt180 -137.96 150.95 47.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.275 -1.38 . . . . 74.120000000000005 107.275 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.96 -178.2 16.48 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.471 -0.871 . . . . 61.119999999999997 112.338 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.58 -29.08 13.6 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.889 2.393 . . . . 64.299999999999997 111.782 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -97.08 18.99 13.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.827 -0.624 . . . . 74.409999999999997 110.955 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.35 139.22 58.74 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.415 -0.357 . . . . 74.010000000000005 111.168 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.83 -18.15 50.82 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.644 -0.582 . . . . 71.140000000000001 111.644 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.12 138.78 33.54 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 120.494 0.188 . . . . 72.340000000000003 110.719 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -122.78 145.91 48.0 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.398 -0.593 . . . . 74.150000000000006 109.398 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.28 142.68 47.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.519 -0.919 . . . . 70.530000000000001 108.519 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.29 143.84 26.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.315 0.579 . . . . 74.129999999999995 112.434 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.29 104.78 12.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.451 -0.795 . . . . 75.200000000000003 108.956 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -168.59 61.1 0.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 75.439999999999998 107.473 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -146.8 157.3 47.47 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 113.126 -1.852 . . . . 74.200000000000003 107.473 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.09 -35.52 97.92 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.812 1.675 . . . . 73.230000000000004 112.614 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 m -154.53 122.44 5.89 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.195 0.522 . . . . 74.329999999999998 111.814 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -108.48 116.92 32.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.402 -0.962 . . . . 71.530000000000001 108.402 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 p -90.4 133.02 35.28 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.938 -0.476 . . . . 74.430000000000007 110.851 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.87 134.68 55.16 Favored 'General case' 0 C--O 1.253 1.259 0 N-CA-C 109.631 -0.507 . . . . 75.230000000000004 109.631 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.96 -158.72 31.83 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.733 -1.347 . . . . 73.140000000000001 109.733 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 62.1 ttt180 -95.89 150.52 20.34 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.241 -0.651 . . . . 75.530000000000001 109.241 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 85.05 151.55 0.1 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.331 1.452 . . . . 72.230000000000004 111.881 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 -0.12 3.49 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.68 2.92 . . . . 74.340000000000003 114.97 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.73 -9.93 57.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.566 0.698 . . . . 75.049999999999997 110.285 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 m -90.86 136.94 32.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.02 -1.845 . . . . 61.43 106.02 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.19 -38.57 91.67 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.892 -0.781 . . . . 71.239999999999995 108.892 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.9 mm -98.91 119.46 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.106 -1.442 . . . . 74.030000000000001 107.106 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -90.17 118.01 29.37 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.798 0.332 . . . . 64.409999999999997 111.595 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 5.2 mp -124.98 134.75 52.48 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.757 -1.572 . . . . 75.340000000000003 106.757 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -131.67 123.45 27.83 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.324 -0.551 . . . . 74.319999999999993 111.346 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -149.79 172.79 14.55 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.045 -1.465 . . . . 75.439999999999998 107.045 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.96 -31.19 52.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.165 -0.68 . . . . 75.030000000000001 109.165 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -62.29 121.12 12.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.403 0.621 . . . . 74.400000000000006 110.719 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.34 125.32 39.84 Favored 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.209 -0.905 . . . . 73.420000000000002 109.6 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 m -159.08 106.06 1.78 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.353 0.661 . . . . 70.049999999999997 110.541 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' A' ' 13' ' ' GLU . 27.7 ptt180 -64.38 -46.0 85.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 120.701 -0.4 . . . . 74.409999999999997 111.635 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -141.3 131.03 24.16 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.494 -1.669 . . . . 73.430000000000007 106.494 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -99.83 -52.18 3.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.806 -0.812 . . . . 71.430000000000007 108.806 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.26 155.29 36.3 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.279 -0.873 . . . . 74.209999999999994 109.167 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.5 135.55 54.68 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 116.001 -0.545 . . . . 73.430000000000007 109.591 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 33.8 m-85 -105.04 113.23 26.7 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.021 -1.844 . . . . 73.230000000000004 106.021 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.35 132.82 53.76 Favored 'General case' 0 C--N 1.269 -2.922 0 N-CA-C 108.279 -1.008 . . . . 74.030000000000001 108.279 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.7 111.9 35.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.072 -2.196 . . . . 75.340000000000003 105.072 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -124.93 118.47 26.34 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.615 -1.175 . . . . 70.400000000000006 109.752 -169.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 53.96 36.9 25.54 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.38 1.072 . . . . 73.510000000000005 111.347 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 0.58 90.27 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.68 -0.691 . . . . 72.030000000000001 113.707 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -102.49 150.27 23.55 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.691 -0.855 . . . . 73.519999999999996 108.691 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -104.51 117.01 33.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.912 -1.144 . . . . 74.140000000000001 107.912 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -124.78 134.75 52.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.5 0.667 . . . . 74.150000000000006 110.845 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.03 124.98 57.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 106.735 -1.58 . . . . 64.540000000000006 106.735 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.38 122.84 70.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 107.042 -1.466 . . . . 61.130000000000003 107.042 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -96.63 144.79 26.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 115.189 -0.914 . . . . 75.049999999999997 109.741 -178.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.03 -9.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.55 -0.46 . . . . 75.109999999999999 112.037 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.45 92.52 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 119.78 -1.2 . . . . 70.329999999999998 112.367 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.1 m -58.23 -22.03 50.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.172 0.589 . . . . 63.130000000000003 111.802 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -18.83 62.03 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.965 0.906 . . . . 74.340000000000003 112.997 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' SER . 6.3 t30 -85.79 -0.55 55.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.786 0.803 . . . . 74.530000000000001 108.855 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.74 44.27 1.82 Allowed Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.521 -0.763 . . . . 73.0 113.059 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m -87.02 126.93 35.06 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.26 -0.645 . . . . 63.329999999999998 109.26 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 69.7 m-85 -137.44 131.62 32.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.839 -0.43 . . . . 75.109999999999999 109.839 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.16 116.36 50.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.058 -2.201 . . . . 73.5 105.058 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 55.96 40.55 30.41 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.065 0.946 . . . . 65.540000000000006 109.729 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.0 8.55 5.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.026 1.33 . . . . 72.150000000000006 113.698 -175.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.6 128.24 27.82 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.752 -0.593 . . . . 72.140000000000001 109.408 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.26 136.27 63.33 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.639 1.559 . . . . 74.409999999999997 108.854 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 -151.47 131.95 13.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.461 -0.896 . . . . 74.319999999999993 109.891 -173.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 2.9 t-20 -98.91 -31.41 11.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 122.043 0.925 . . . . 63.32 109.878 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -141.14 135.69 31.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.061 -1.459 . . . . 71.319999999999993 107.061 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -144.71 144.56 31.27 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.016 0.197 . . . . 73.329999999999998 111.492 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 80.6 t -94.49 117.53 38.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 105.092 -2.188 . . . . 74.530000000000001 105.092 171.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 40.6 ttp -89.85 129.27 36.24 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.415 0.626 . . . . 62.530000000000001 111.296 -170.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.58 157.1 43.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.842 -1.072 . . . . 70.439999999999998 109.522 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -62.53 134.19 56.03 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.568 0.543 . . . . 74.109999999999999 109.805 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.05 -8.64 61.12 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.409 -0.901 . . . . 65.310000000000002 111.933 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 140.15 32.5 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.072 0.463 . . . . 71.209999999999994 110.046 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -114.12 134.78 54.65 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.446 -0.797 . . . . 73.010000000000005 109.563 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.3 mt -112.1 118.3 57.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 107.676 -1.231 . . . . 75.510000000000005 107.676 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -104.84 117.05 33.09 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.901 -1.889 . . . . 73.099999999999994 105.901 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.78 103.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.446 -0.797 . . . . 72.530000000000001 109.447 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.45 -84.44 0.44 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.107 -0.951 . . . . 64.200000000000003 112.272 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -125.35 -18.34 5.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.638 0.256 . . . . 72.450000000000003 111.192 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 48.4 p90 -121.14 150.33 41.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 112.924 0.713 . . . . 74.230000000000004 112.924 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 8.2 ptm180 -112.52 142.14 45.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.547 -0.752 . . . . 75.0 112.236 -170.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.2 139.17 54.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.911 -1.514 . . . . 72.329999999999998 106.911 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.42 134.95 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.163 -0.68 . . . . 73.310000000000002 109.163 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -97.43 119.63 36.33 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.777 -0.453 . . . . 65.230000000000004 109.777 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.42 131.14 55.59 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.651 -0.5 . . . . 74.430000000000007 109.651 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.47 135.75 33.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.751 -0.833 . . . . 74.030000000000001 108.751 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.72 163.93 15.6 Favored Glycine 0 N--CA 1.421 -2.329 0 N-CA-C 107.637 -2.185 . . . . 73.329999999999998 107.637 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.86 141.76 72.81 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 CA-C-N 119.725 1.762 . . . . 72.409999999999997 113.167 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -118.67 26.53 9.5 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.559 -1.645 . . . . 70.109999999999999 106.559 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.417 -2.099 0 CA-C-N 113.242 -1.799 . . . . 70.150000000000006 107.693 -178.152 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 109.945 -0.391 . . . . 74.450000000000003 109.945 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -120.95 94.28 4.3 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.687 -0.633 . . . . 64.219999999999999 111.564 -173.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -89.47 68.78 7.9 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.577 1.18 . . . . 73.129999999999995 108.051 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.59 156.04 44.85 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.127 -1.397 . . . . 65.420000000000002 108.336 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -82.77 82.59 8.03 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.844 0.831 . . . . 61.219999999999999 108.82 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.39 -71.57 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 106.024 -2.83 . . . . 75.430000000000007 106.024 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.0 m -114.5 106.25 52.69 Favored Pre-proline 0 N--CA 1.416 -2.162 0 N-CA-C 106.503 -1.666 . . . . 74.430000000000007 106.503 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.73 132.37 9.74 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.641 1.561 . . . . 75.239999999999995 110.296 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.44 147.53 39.82 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.31 -1.367 . . . . 74.25 107.31 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.45 137.19 25.59 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.341 2.027 . . . . 74.530000000000001 108.937 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.91 132.76 35.14 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.27 -0.972 . . . . 62.039999999999999 110.092 -169.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 51.0 t -108.24 121.04 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.719 -1.585 . . . . 75.530000000000001 106.719 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -127.09 132.93 50.52 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.699 -1.223 . . . . 73.310000000000002 107.699 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -81.19 113.17 19.16 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.131 -1.433 . . . . 64.340000000000003 107.131 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . 0.464 ' O ' ' HB3' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 m -92.95 152.39 19.37 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.839 -0.8 . . . . 74.549999999999997 108.839 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -83.11 115.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.453 -0.573 . . . . 71.310000000000002 109.453 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -99.54 105.35 17.23 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.603 -0.888 . . . . 75.109999999999999 108.603 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -126.96 124.92 40.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.58 0.705 . . . . 75.140000000000001 112.851 -176.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.91 -37.56 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.002 1.321 . . . . 64.099999999999994 107.885 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.74 -17.14 0.49 Allowed 'General case' 0 C--O 1.203 -1.367 0 CA-C-N 112.734 -2.03 . . . . 74.219999999999999 114.756 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.1 -41.8 88.98 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 118.156 0.434 . . . . 73.209999999999994 110.818 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.43 -36.28 45.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.569 . . . . 72.349999999999994 109.465 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -60.14 -44.09 95.22 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.11 -0.95 . . . . 61.399999999999999 108.951 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -43.12 64.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.583 -1.19 . . . . 75.019999999999996 111.149 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.15 -36.78 71.16 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.172 0.51 . . . . 74.319999999999993 110.621 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.97 -26.35 68.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.499 -0.773 . . . . 72.319999999999993 110.4 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -98.41 -36.59 9.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.557 -0.292 . . . . 61.329999999999998 111.29 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -75.33 -23.96 57.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.356 0.502 . . . . 70.030000000000001 112.356 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.1 m -66.1 114.87 5.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.332 0.587 . . . . 63.340000000000003 110.689 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.0 -70.23 0.27 Allowed Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.07 -1.612 . . . . 65.430000000000007 109.07 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -115.56 138.36 51.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.168 0.508 . . . . 73.409999999999997 111.638 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.32 154.21 37.57 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.588 -0.893 . . . . 65.0 108.588 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.2 150.97 62.65 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.512 2.141 . . . . 74.310000000000002 111.762 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.14 143.77 25.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.654 0.264 . . . . 63.240000000000002 110.517 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 p -85.15 95.16 9.05 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.865 -0.791 . . . . 61.219999999999999 108.865 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.0 p -84.77 -173.08 4.53 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.781 -0.645 . . . . 62.450000000000003 110.821 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.84 3.99 67.49 Favored Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.024 -1.231 . . . . 63.109999999999999 110.024 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 139' ' ' ALA . . . -68.57 -19.18 64.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.076 -1.062 . . . . 64.430000000000007 110.375 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.1 -5.72 37.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.395 0.617 . . . . 72.140000000000001 111.506 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.89 -12.81 23.0 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.58 -0.896 . . . . 64.120000000000005 108.58 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.87 74.07 0.56 Allowed Pre-proline 0 C--O 1.221 -0.408 0 CA-C-N 114.501 -1.227 . . . . 72.239999999999995 109.268 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.42 -57.92 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.235 1.956 . . . . 73.510000000000005 114.104 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.9 -20.21 20.88 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.961 0.726 . . . . 74.329999999999998 112.961 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.78 -4.62 83.58 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 119.978 -1.106 . . . . 54.439999999999998 111.383 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.8 m -115.48 163.74 15.31 Favored 'General case' 0 C--O 1.254 1.337 0 N-CA-C 107.9 -1.148 . . . . 71.319999999999993 107.9 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.15 158.32 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.405 -0.185 . . . . 74.439999999999998 111.176 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 48' ' ' LEU . 3.7 pp -131.08 137.19 49.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.14 0.495 . . . . 70.150000000000006 110.177 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.442 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.1 pp -117.03 136.84 52.65 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.369 -0.604 . . . . 64.420000000000002 109.369 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.75 130.92 71.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.866 -0.42 . . . . 73.510000000000005 109.866 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 t -79.37 123.12 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.913 -1.143 . . . . 74.310000000000002 107.913 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -99.24 -30.28 12.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.259 0.552 . . . . 72.109999999999999 110.033 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -136.53 127.73 28.07 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.485 -0.561 . . . . 71.329999999999998 109.485 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 136.3 175.64 13.93 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.8 -1.32 . . . . 73.510000000000005 109.8 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.57 -31.66 79.84 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 122.428 2.085 . . . . 74.239999999999995 111.817 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.29 12.78 15.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 75.519999999999996 110.897 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.54 132.18 50.45 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.928 0.394 . . . . 71.200000000000003 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -27.4 14.67 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.553 -1.019 . . . . 74.019999999999996 110.553 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.72 142.63 28.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.695 -0.483 . . . . 72.230000000000004 109.695 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -122.46 137.3 54.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.894 -0.594 . . . . 71.319999999999993 110.632 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.35 145.54 43.98 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.426 -0.953 . . . . 73.120000000000005 108.426 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.37 133.99 50.21 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.251 0.834 . . . . 72.540000000000006 113.251 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.51 104.38 16.4 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.91 -1.885 . . . . 71.019999999999996 105.91 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.59 -0.43 2.16 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.916 0.865 . . . . 50.310000000000002 110.561 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.26 150.81 41.01 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.776 -0.824 . . . . 72.319999999999993 108.776 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.84 -30.17 46.28 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.417 2.745 . . . . 61.549999999999997 113.497 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -146.17 121.78 10.45 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.716 -0.615 . . . . 64.0 110.26 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 m -118.15 114.19 22.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.551 -0.295 . . . . 74.150000000000006 110.739 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m -87.32 130.18 34.72 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 110.275 -0.269 . . . . 74.219999999999999 110.275 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.63 139.68 53.67 Favored 'General case' 0 C--O 1.272 2.247 0 CA-C-O 121.609 0.719 . . . . 73.010000000000005 112.289 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.24 -160.62 31.43 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.27 -1.532 . . . . 74.5 109.27 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -118.87 116.74 27.12 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.214 -1.773 . . . . 70.420000000000002 106.214 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.631 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.7 t-160 166.87 151.0 0.08 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 104.527 -2.397 . . . . 73.109999999999999 104.527 -173.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.631 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 28.1 Cg_endo -64.52 -14.28 43.49 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.246 1.964 . . . . 74.420000000000002 112.281 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.86 -11.15 48.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 112.093 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -72.55 136.65 45.87 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.886 -0.783 . . . . 63.119999999999997 108.886 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.22 -45.07 34.78 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.716 -1.216 . . . . 64.409999999999997 107.716 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -106.32 119.27 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 107.255 -1.387 . . . . 65.200000000000003 107.255 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 81' ' ' ASP . 84.8 t80 -99.28 121.22 40.77 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.851 -0.613 . . . . 74.120000000000005 112.121 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.5 139.88 42.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.278 -2.119 . . . . 74.400000000000006 105.278 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 31.7 t70 -128.05 142.48 51.21 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 110.031 -0.359 . . . . 74.430000000000007 110.031 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -162.37 -161.42 0.73 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.613 -1.625 . . . . 75.310000000000002 106.613 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.92 -36.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.235 0.54 . . . . 73.439999999999998 109.66 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -75.71 152.45 37.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.531 -0.759 . . . . 74.219999999999999 110.521 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.26 99.09 7.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.628 -0.879 . . . . 74.239999999999995 108.628 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -99.07 85.68 3.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.126 -1.065 . . . . 73.319999999999993 108.126 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 12' ' ' VAL . 16.4 ptt180 -55.4 -46.08 76.63 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.601 0.563 . . . . 71.349999999999994 111.933 -173.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -155.62 114.28 3.49 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.623 -1.621 . . . . 72.030000000000001 106.623 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.601 ' ND1' HG22 ' A' ' 130' ' ' ILE . 22.0 t-160 -99.74 -51.88 3.61 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.551 -0.86 . . . . 64.310000000000002 109.731 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.15 158.01 41.19 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.316 -0.554 . . . . 72.329999999999998 110.469 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' OE1' HG13 ' A' ' 104' ' ' VAL . 11.9 pt-20 -132.16 148.11 52.46 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-O 121.203 0.525 . . . . 63.439999999999998 110.021 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' A' ' 101' ' ' VAL . 54.8 m-85 -105.14 117.01 32.92 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 75.530000000000001 108.114 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -106.29 133.63 50.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.199 -1.038 . . . . 73.409999999999997 108.199 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.8 mt -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.563 -0.532 . . . . 73.340000000000003 109.563 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -138.87 121.02 15.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.297 -0.631 . . . . 74.120000000000005 109.297 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 55.76 38.09 29.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.223 1.009 . . . . 75.140000000000001 112.268 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.23 85.0 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.966 -0.635 . . . . 70.040000000000006 114.007 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -102.32 131.71 48.75 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 117.986 0.893 . . . . 74.439999999999998 109.788 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.99 123.62 48.11 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.936 -1.029 . . . . 74.030000000000001 109.177 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.26 137.48 54.2 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.669 -0.493 . . . . 73.219999999999999 109.669 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.441 HG23 ' CD2' ' A' ' 92' ' ' PHE . 29.2 t -103.58 122.61 56.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.212 -1.403 . . . . 70.219999999999999 107.212 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.95 133.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.923 -1.139 . . . . 74.129999999999995 107.923 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.9 148.96 36.12 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.35 0.595 . . . . 72.219999999999999 110.074 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG13 ' OE1' ' A' ' 91' ' ' GLU . 14.5 m -137.47 27.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.721 -1.214 . . . . 74.400000000000006 107.721 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 156.4 56.86 0.01 OUTLIER Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 113.796 -1.547 . . . . 73.310000000000002 110.41 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t -65.56 11.16 0.07 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.965 1.306 . . . . 62.439999999999998 111.961 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 105' ' ' GLY . 78.4 mt -65.5 -19.88 66.11 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 125.634 1.574 . . . . 74.319999999999993 110.885 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -87.09 -13.54 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.333 -0.394 . . . . 74.549999999999997 110.515 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.01 89.19 1.85 Allowed Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.729 -0.748 . . . . 70.430000000000007 111.253 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -86.6 127.9 34.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.773 -0.825 . . . . 63.310000000000002 108.773 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 81.1 m-85 -136.25 134.06 37.67 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.856 -0.794 . . . . 74.239999999999995 108.856 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.18 117.68 51.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 105.474 -2.047 . . . . 75.450000000000003 105.474 175.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.2 39.11 30.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.676 0.75 . . . . 74.430000000000007 110.172 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 mtm180 69.94 9.02 6.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.954 1.702 . . . . 75.329999999999998 114.851 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -110.24 135.89 20.55 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 110.351 -0.24 . . . . 75.25 110.351 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.02 135.9 12.69 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.728 2.285 . . . . 70.439999999999998 112.07 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -149.64 -177.62 5.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.281 0.562 . . . . 73.319999999999993 110.249 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.85 -31.02 4.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.259 -1.337 . . . . 72.340000000000003 110.057 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.7 137.31 28.1 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.277 -1.009 . . . . 70.349999999999994 108.277 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.5 HE22 ' HA ' ' A' ' 122' ' ' MET . 0.7 OUTLIER -152.44 122.63 7.14 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.277 -0.638 . . . . 73.230000000000004 109.277 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.17 117.56 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 106.963 -1.495 . . . . 71.209999999999994 106.963 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.5 ' HA ' HE22 ' A' ' 120' ' ' GLN . 32.6 ttm -96.87 137.81 35.39 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 114.281 1.215 . . . . 75.129999999999995 114.281 -165.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -114.14 157.25 22.86 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.473 -1.694 . . . . 73.109999999999999 107.745 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.8 t -62.59 133.94 55.63 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.414 0.626 . . . . 65.450000000000003 109.456 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.44 -0.09 56.9 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 121.107 -0.568 . . . . 74.030000000000001 111.887 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -82.38 142.2 32.18 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.932 -0.766 . . . . 72.420000000000002 108.932 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' CD ' HH21 ' A' ' 134' ' ' ARG . 44.4 mt-10 -113.46 132.63 55.58 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.362 0.601 . . . . 75.510000000000005 110.248 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -107.39 132.82 53.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 54.2 mt-30 -117.63 117.79 30.34 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.268 0.556 . . . . 74.5 109.781 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.601 HG22 ' ND1' ' A' ' 89' ' ' HIS . 48.1 mm -109.75 102.27 13.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.973 -1.491 . . . . 75.340000000000003 106.973 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.94 -78.08 0.21 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.406 -0.677 . . . . 43.140000000000001 111.406 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -141.87 5.37 1.74 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.045 0.45 . . . . 74.430000000000007 111.222 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.2 m-85 -78.9 150.44 32.14 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.223 -0.658 . . . . 55.539999999999999 109.223 176.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 127' ' ' GLU . 13.8 tpt180 -124.72 118.64 26.91 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.411 -1.7 . . . . 74.430000000000007 106.411 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mp -122.29 140.84 52.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.337 -0.986 . . . . 74.450000000000003 108.337 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.07 122.56 65.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.201 -1.407 . . . . 73.019999999999996 107.201 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -99.31 127.29 45.31 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.077 -0.51 . . . . 75.329999999999998 109.957 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.99 155.54 50.59 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.818 -0.808 . . . . 54.450000000000003 108.818 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 141' ' ' PRO . . . -82.61 142.15 31.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.451 -1.685 . . . . 53.340000000000003 106.451 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.44 2.71 Favored Glycine 0 C--N 1.305 -1.192 0 C-N-CA 119.384 -1.389 . . . . 72.209999999999994 113.927 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 139' ' ' ALA . 2.9 Cg_exo -72.79 142.03 34.8 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.974 1.783 . . . . 75.0 109.769 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 179.76 73.71 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.929 0.892 . . . . 73.109999999999999 109.26 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.39 -3.448 0 CA-C-N 114.435 -1.257 . . . . 73.209999999999994 109.413 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 111.24 0.089 . . . . 65.510000000000005 111.24 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.2 t -178.07 -173.79 0.39 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.817 -1.92 . . . . 73.439999999999998 105.817 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.46 168.02 12.97 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 109.875 -0.417 . . . . 72.209999999999994 109.875 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -74.37 127.74 33.77 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.859 -0.793 . . . . 64.400000000000006 108.859 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -122.44 154.13 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.983 0.42 . . . . 75.140000000000001 112.049 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.92 -147.0 8.3 Favored Glycine 0 N--CA 1.425 -2.076 0 CA-C-N 115.115 -0.948 . . . . 75.439999999999998 111.925 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.541 ' HB ' ' NH1' ' A' ' 93' ' ' ARG . 14.9 t -125.67 151.55 70.84 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.647 -0.871 . . . . 73.120000000000005 108.647 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.49 151.18 39.0 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 122.507 2.138 . . . . 72.510000000000005 110.234 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.39 139.34 59.65 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-O 121.058 0.456 . . . . 74.409999999999997 111.629 -171.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.83 135.3 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.39 3.393 . . . . 52.329999999999998 117.3 -170.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -124.91 132.75 53.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 104.51 -2.404 . . . . 73.019999999999996 104.51 170.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.91 132.8 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.82 0.819 . . . . 72.230000000000004 110.971 -172.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' HB3' ' HG2' ' A' ' 87' ' ' ARG . 8.7 tp10 -148.02 159.99 43.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 104.898 -2.26 . . . . 73.099999999999994 104.898 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -85.97 125.33 33.3 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.669 0.618 . . . . 73.420000000000002 112.669 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . 0.51 ' O2P' ' HG3' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -100.0 155.35 17.75 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 105.768 -1.938 . . . . 60.439999999999998 105.768 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -81.53 114.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 117.675 -1.61 . . . . 74.310000000000002 108.024 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.673 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 45.1 t80 -99.71 116.24 31.35 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.004 -0.998 . . . . 73.209999999999994 108.857 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -81.15 92.07 6.23 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.796 -0.816 . . . . 73.340000000000003 108.796 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.65 -168.41 2.08 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.975 -1.011 . . . . 73.310000000000002 110.926 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.43 -9.71 13.86 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.34 1.056 . . . . 74.5 111.28 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.86 -19.13 65.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.004 0.922 . . . . 71.450000000000003 110.365 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.0 OUTLIER -59.21 -43.71 92.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.331 -0.989 . . . . 73.430000000000007 108.331 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.535 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 7.8 tmtm? -80.47 -29.3 37.46 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.547 -0.909 . . . . 74.450000000000003 108.547 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.26 -33.9 75.22 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.987 -0.551 . . . . 73.510000000000005 110.705 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 27.5 ptt? -68.57 -21.02 64.55 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.778 -0.369 . . . . 75.239999999999995 110.741 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.04 -33.52 63.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.715 -1.217 . . . . 75.329999999999998 107.715 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -79.94 -14.66 58.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.769 -1.105 . . . . 70.420000000000002 110.884 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 t -67.44 -25.66 66.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.201 -0.666 . . . . 75.150000000000006 109.201 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.92 97.06 5.18 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.883 -1.525 . . . . 74.420000000000002 106.883 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.19 58.91 2.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.379 -1.088 . . . . 64.239999999999995 110.379 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -92.79 149.93 20.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.899 -0.408 . . . . 75.409999999999997 109.899 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.22 101.22 40.97 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.721 -0.474 . . . . 73.230000000000004 109.721 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 69.3 Cg_endo -75.79 143.52 26.74 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.308 2.005 . . . . 72.409999999999997 111.181 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.12 166.8 22.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.335 -0.393 . . . . 71.25 110.724 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 m -67.71 118.82 11.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.168 -0.469 . . . . 72.519999999999996 110.266 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.416 ' HB ' ' OE1' ' A' ' 123' ' ' GLN . 17.8 p -110.93 -161.57 0.76 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.569 0.748 . . . . 64.030000000000001 110.63 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.94 80.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.518 -0.633 . . . . 51.130000000000003 111.518 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.64 -24.51 19.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.927 0.714 . . . . 65.519999999999996 112.927 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.02 0.61 4.33 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.549 1.315 . . . . 73.019999999999996 114.549 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.3 -39.01 15.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.692 -0.855 . . . . 72.420000000000002 108.692 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.7 mt 53.18 80.29 0.3 Allowed Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 123.98 0.912 . . . . 74.239999999999995 111.607 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.79 -67.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 123.649 2.9 . . . . 75.5 114.678 -173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.38 -0.98 3.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.098 0.475 . . . . 73.109999999999999 111.317 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.6 6.98 82.6 Favored Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.384 -0.912 . . . . 71.319999999999993 112.643 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 m -129.46 158.21 39.84 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 108.118 -1.068 . . . . 73.010000000000005 108.118 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.49 41.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.254 -0.276 . . . . 73.349999999999994 110.254 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 139.95 53.4 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.326 0.391 . . . . 74.019999999999996 110.267 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' HD11 ' A' ' 49' ' ' LEU . 4.2 pp -112.42 137.34 50.75 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.69 -0.855 . . . . 75.319999999999993 108.69 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.73 133.34 61.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.195 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.8 t -78.51 117.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 106.113 -1.81 . . . . 62.119999999999997 106.113 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -86.41 -33.99 20.3 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.545 -0.752 . . . . 75.519999999999996 110.527 -172.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 31.3 tpt180 -154.66 139.7 17.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.232 -1.025 . . . . 71.230000000000004 108.232 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.08 -178.93 20.41 Favored Glycine 0 N--CA 1.437 -1.3 0 O-C-N 123.867 0.729 . . . . 74.310000000000002 111.346 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -70.0 -37.11 9.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.341 2.027 . . . . 74.340000000000003 111.513 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 81' ' ' ASP . 5.0 p30 -90.73 18.52 6.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.352 0.596 . . . . 74.239999999999995 111.167 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.65 145.19 54.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.432 0.693 . . . . 75.040000000000006 111.034 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -14.82 37.06 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.243 -1.143 . . . . 64.120000000000005 110.243 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.86 33.56 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 121.08 -0.248 . . . . 74.319999999999993 110.359 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -134.97 139.25 44.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.816 -1.179 . . . . 73.319999999999993 107.816 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.25 123.16 26.39 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 121.311 -0.155 . . . . 72.340000000000003 110.737 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.5 tp -89.63 115.4 26.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.057 -1.461 . . . . 75.439999999999998 107.057 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.81 106.87 16.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.458 0.647 . . . . 74.549999999999997 111.744 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -102.92 15.27 29.87 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.474 -1.306 . . . . 72.310000000000002 107.474 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.446 ' NE2' ' HG1' ' A' ' 68' ' ' THR . 15.7 mt-30 -107.31 141.85 23.83 Favored Pre-proline 0 CA--C 1.468 -2.205 0 CA-C-N 114.714 -1.13 . . . . 73.200000000000003 110.026 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.03 -13.15 28.74 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.973 1.782 . . . . 74.329999999999998 109.375 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.0 m -149.29 125.37 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.281 0.563 . . . . 70.430000000000007 110.67 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.3 m -131.51 139.48 49.29 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.366 -0.976 . . . . 71.219999999999999 108.366 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.24 -0.913 . . . . 70.450000000000003 110.319 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.58 143.41 46.14 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.764 -0.828 . . . . 71.420000000000002 108.764 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.96 -147.07 6.39 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 111.361 -0.696 . . . . 73.439999999999998 111.361 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -90.91 147.9 22.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 122.591 0.357 . . . . 64.239999999999995 110.951 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.46 169.76 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.65 1.18 . . . . 75.310000000000002 112.291 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -73.2 6.66 2.48 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.246 1.964 . . . . 74.409999999999997 111.446 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.93 -37.56 67.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.319 -1.363 . . . . 53.229999999999997 107.319 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -78.74 152.82 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.758 -1.11 . . . . 73.120000000000005 108.264 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' OD2' HG21 ' A' ' 68' ' ' THR . 32.0 t70 -64.67 -41.76 95.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.892 0.377 . . . . 71.129999999999995 111.094 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.0 126.81 67.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.306 -0.998 . . . . 72.099999999999994 108.306 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -88.42 129.63 35.38 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.682 0.614 . . . . 74.310000000000002 110.737 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.7 140.3 52.82 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.39 -1.337 . . . . 75.219999999999999 107.39 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.524 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 30.7 t70 -125.4 118.42 25.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.993 -0.549 . . . . 70.319999999999993 109.611 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.34 -175.45 4.78 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.775 -2.306 . . . . 75.049999999999997 104.775 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.24 -34.84 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.368 -0.975 . . . . 74.230000000000004 108.368 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 m -148.63 114.69 5.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.071 -1.085 . . . . 64.299999999999997 108.071 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.2 t -103.94 152.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.513 -0.551 . . . . 74.140000000000001 109.513 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.8 m -72.65 153.07 41.4 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.572 0.349 . . . . 52.530000000000001 110.47 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' HG3' ' O2P' ' A' ' 15' ' ' TPO . 5.4 ppt_? -69.26 -29.27 67.14 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.922 0.867 . . . . 73.219999999999999 110.767 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.438 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 24.0 mtp180 -148.78 120.19 7.9 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 101.666 -3.457 . . . . 73.120000000000005 101.666 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.49 ' CE1' HG21 ' A' ' 130' ' ' ILE . 13.4 t60 -99.65 -52.69 3.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.725 -0.79 . . . . 75.420000000000002 110.483 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.01 146.52 25.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.625 -0.88 . . . . 63.350000000000001 108.625 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.517 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 11.0 pt-20 -118.36 129.75 55.61 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.816 -0.629 . . . . 74.540000000000006 109.61 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.498 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 26.7 m-85 -105.26 113.06 26.43 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.302 -2.11 . . . . 74.420000000000002 105.302 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.541 ' NH1' ' HB ' ' A' ' 7' ' ' THR . 26.2 mtp180 -115.25 127.29 55.39 Favored 'General case' 0 C--N 1.262 -3.2 0 N-CA-C 108.46 -0.941 . . . . 75.349999999999994 108.46 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.67 113.02 39.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 106.894 -1.521 . . . . 71.319999999999993 106.894 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -119.65 125.06 47.81 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.812 -1.181 . . . . 70.530000000000001 107.812 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.29 34.97 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.994 0.918 . . . . 75.219999999999999 112.576 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.2 -0.15 89.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.078 -0.582 . . . . 72.400000000000006 113.401 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -102.91 150.51 23.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.28 -1.007 . . . . 74.530000000000001 108.28 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -110.1 117.65 34.29 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 121.306 -0.157 . . . . 63.130000000000003 110.745 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.618 -0.882 . . . . 63.530000000000001 108.618 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.0 123.63 68.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.743 -1.206 . . . . 71.040000000000006 107.743 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.24 130.06 73.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.664 -0.865 . . . . 71.239999999999995 108.664 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.42 130.4 37.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.482 -0.933 . . . . 71.430000000000007 108.482 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 12.85 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-N 115.675 -0.693 . . . . 65.230000000000004 109.322 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -154.83 83.01 0.16 Allowed Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.158 -0.928 . . . . 52.140000000000001 113.375 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.415 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 40.6 m -82.4 15.58 2.43 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.396 . . . . 72.230000000000004 111.176 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.673 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.7 tm? -67.2 -50.48 60.76 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 106.539 -1.652 . . . . 74.219999999999999 106.539 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.414 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 26.9 t-20 -104.46 -19.86 13.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.992 -0.744 . . . . 72.439999999999998 108.992 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . 83.99 119.32 0.76 Allowed Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.75 1.06 . . . . 60.310000000000002 115.75 168.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.9 m -87.29 128.4 35.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.793 -0.818 . . . . 74.25 108.793 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.41 142.17 51.49 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.185 -1.043 . . . . 64.099999999999994 108.185 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -124.62 117.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.389 -0.967 . . . . 74.310000000000002 108.389 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 6.8 m-80 50.93 49.03 21.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.798 0.839 . . . . 71.329999999999998 112.993 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 67.21 9.42 6.94 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.481 1.513 . . . . 75.120000000000005 112.303 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -109.97 136.31 20.43 Favored Pre-proline 0 C--N 1.313 -1.004 0 O-C-N 121.936 -0.477 . . . . 65.150000000000006 110.334 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.42 123.81 12.73 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 121.946 1.764 . . . . 64.25 108.652 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -147.41 131.98 17.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.02 -0.733 . . . . 64.549999999999997 109.02 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.79 -35.52 9.02 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.358 0.411 . . . . 75.239999999999995 111.476 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.26 135.26 53.28 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.78 -1.193 . . . . 73.329999999999998 107.78 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -146.88 143.61 28.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.513 0.197 . . . . 72.140000000000001 111.391 -175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 114.03 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 103.181 -2.896 . . . . 70.450000000000003 103.181 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.446 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 30.3 ttm -93.91 130.85 39.84 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.778 -1.169 . . . . 62.210000000000001 111.468 -170.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.416 ' OE1' ' HB ' ' A' ' 37' ' ' THR . 40.3 mt-30 -114.03 157.87 21.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 74.409999999999997 109.675 -170.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.429 ' HB ' ' HB1' ' A' ' 139' ' ' ALA . 14.8 t -63.54 126.57 27.94 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.897 -0.779 . . . . 75.519999999999996 108.897 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.0 -1.66 57.85 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 115.772 -0.649 . . . . 70.349999999999994 111.489 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.8 145.74 34.16 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 107.982 -1.118 . . . . 55.43 107.982 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.93 132.86 55.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.831 -0.433 . . . . 74.219999999999999 109.831 -172.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 mt -107.98 131.59 57.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.044 -0.724 . . . . 73.120000000000005 109.044 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -105.53 115.43 30.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.554 -1.276 . . . . 74.340000000000003 107.554 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.49 HG21 ' CE1' ' A' ' 89' ' ' HIS . 63.4 mt -125.42 116.8 47.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.086 -1.449 . . . . 63.399999999999999 107.086 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.53 -104.29 0.75 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.668 -0.973 . . . . 64.219999999999999 110.668 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -124.61 5.09 8.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.195 0.522 . . . . 72.219999999999999 109.94 176.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 34.2 p90 -111.14 156.58 21.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.985 -175.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.57 136.74 54.7 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.166 0.508 . . . . 74.310000000000002 111.542 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.17 139.62 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.585 -1.265 . . . . 71.510000000000005 107.585 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.7 t -112.13 131.41 63.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.893 -1.151 . . . . 73.129999999999995 107.893 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.446 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 48.7 t80 -103.57 117.02 33.47 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.941 -0.763 . . . . 73.420000000000002 108.941 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.19 131.08 55.8 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.488 -0.56 . . . . 63.329999999999998 109.488 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.429 ' HB1' ' HB ' ' A' ' 124' ' ' THR . . . -111.87 121.93 46.39 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.307 -0.997 . . . . 72.409999999999997 108.307 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.74 -104.89 0.21 Allowed Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.477 -0.868 . . . . 74.409999999999997 111.89 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.19 161.66 45.12 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.004 2.469 . . . . 73.120000000000005 113.596 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.1 24.38 5.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.309 -0.86 . . . . 63.43 109.343 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.435 -1.197 0 C-N-CA 124.961 1.305 . . . . 71.530000000000001 113.462 -176.668 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 108.0 -1.111 . . . . 70.109999999999999 108.0 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -106.17 -179.13 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.956 -1.128 . . . . 55.219999999999999 107.956 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -150.91 147.93 27.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.248 -1.019 . . . . 72.299999999999997 108.248 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -82.08 127.83 33.5 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.341 0.497 . . . . 73.129999999999995 112.341 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -85.48 109.94 18.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.397 -0.964 . . . . 75.329999999999998 108.397 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.02 -127.2 3.65 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 110.883 -0.887 . . . . 61.229999999999997 110.883 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -96.51 112.11 59.06 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.709 -0.848 . . . . 73.219999999999999 108.709 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.71 147.81 92.42 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.905 2.404 . . . . 73.409999999999997 113.051 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -79.34 131.89 64.22 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.153 -0.93 . . . . 75.230000000000004 109.878 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.89 154.9 23.16 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.996 1.798 . . . . 75.329999999999998 110.32 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -92.71 152.86 19.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.997 -0.742 . . . . 73.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.66 121.18 66.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.504 -0.554 . . . . 71.530000000000001 109.504 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -146.89 169.33 19.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.977 0.911 . . . . 70.140000000000001 110.917 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -77.49 122.22 24.93 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.596 0.591 . . . . 73.109999999999999 112.596 -174.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -131.94 137.53 47.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.883 -1.895 . . . . 72.150000000000006 105.883 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 t -85.9 130.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 117.8 0.273 . . . . 74.420000000000002 110.415 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -96.48 131.9 42.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.432 -0.507 . . . . 74.299999999999997 109.64 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.54 91.69 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.69 -0.485 . . . . 74.030000000000001 109.69 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.49 -84.22 0.07 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.122 0.416 . . . . 65.450000000000003 112.122 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.32 -35.48 65.18 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.497 1.119 . . . . 74.209999999999994 112.505 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.8 mt -57.85 -12.29 3.01 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.887 1.275 . . . . 74.230000000000004 113.904 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.4 tp -80.07 -16.32 55.3 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.714 0.405 . . . . 74.040000000000006 111.066 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.85 -39.65 89.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.415 1.265 . . . . 72.150000000000006 114.415 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -72.57 -14.48 61.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.239 0.829 . . . . 75.010000000000005 113.239 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.4 ttp -60.25 -30.69 69.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.367 0.603 . . . . 75.510000000000005 110.376 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.77 -16.74 63.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.367 -0.833 . . . . 72.109999999999999 111.91 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -78.38 -17.95 55.74 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.936 -0.394 . . . . 71.209999999999994 109.936 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.0 m -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.355 0.598 . . . . 73.120000000000005 110.889 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -81.79 111.44 18.03 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 115.523 -0.762 . . . . 65.329999999999998 109.757 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.0 -79.95 0.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.827 -0.701 . . . . 72.340000000000003 113.702 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -105.69 121.36 43.86 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.225 0.536 . . . . 72.420000000000002 111.707 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.61 136.12 28.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.516 -0.92 . . . . 73.530000000000001 108.516 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.42 154.55 73.85 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.319 2.012 . . . . 70.510000000000005 110.199 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.31 169.06 16.51 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 116.32 -0.4 . . . . 73.010000000000005 110.378 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 p -57.03 136.7 56.32 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.069 0.856 . . . . 71.450000000000003 110.411 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 m -118.22 1.7 11.91 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.204 0.526 . . . . 64.200000000000003 111.968 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 15.21 56.36 Favored Glycine 0 CA--C 1.488 -1.624 0 N-CA-C 108.107 -1.997 . . . . 63.109999999999999 108.107 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.13 -8.95 47.3 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.898 -1.651 . . . . 72.439999999999998 109.379 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.22 -11.4 60.77 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.627 1.571 . . . . 74.040000000000006 111.063 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.63 -22.79 43.15 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.832 -1.531 . . . . 70.439999999999998 109.425 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.66 67.58 1.51 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.255 -0.646 . . . . 75.319999999999993 109.255 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.08 -54.56 4.21 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.831 3.021 . . . . 73.430000000000007 114.914 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.14 -15.04 45.15 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.273 0.472 . . . . 74.200000000000003 112.273 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.51 -11.89 70.85 Favored Glycine 0 C--N 1.319 -0.387 0 N-CA-C 110.788 -0.925 . . . . 35.240000000000002 110.788 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.0 m -127.21 162.38 26.32 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.525 -1.658 . . . . 62.229999999999997 106.525 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -141.38 157.32 45.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.253 -0.647 . . . . 75.140000000000001 109.253 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.57 149.08 43.66 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.225 0.536 . . . . 75.219999999999999 111.831 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -111.04 132.24 54.39 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.568 -0.901 . . . . 73.430000000000007 108.568 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.05 134.25 51.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.404 -0.591 . . . . 73.420000000000002 109.404 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.46 117.9 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.835 -1.543 . . . . 73.5 106.835 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -93.53 -30.97 14.73 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.052 -0.522 . . . . 75.010000000000005 111.46 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' CZ ' ' H ' ' A' ' 54' ' ' GLY . 2.7 tpm_? -144.52 141.19 29.34 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.583 -0.447 . . . . 73.430000000000007 109.961 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' H ' ' CZ ' ' A' ' 53' ' ' ARG . . . 128.8 168.1 12.32 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.942 -1.663 . . . . 63.32 108.942 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.4 Cg_exo -55.26 -29.58 67.78 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.46 2.107 . . . . 62.219999999999999 113.438 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -91.7 14.51 15.03 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.529 0.566 . . . . 75.019999999999996 112.529 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.51 143.07 58.18 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.191 0.52 . . . . 72.430000000000007 111.567 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.79 -23.15 34.75 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 115.408 -0.814 . . . . 75.040000000000006 111.243 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.57 149.31 22.2 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.771 0.319 . . . . 64.510000000000005 110.458 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 2.0 ppt_? -123.95 141.14 52.3 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.751 -0.463 . . . . 74.120000000000005 109.751 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -119.24 125.62 49.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.11 -0.7 . . . . 70.109999999999999 109.11 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.8 tp -93.67 136.19 34.2 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 74.0 107.809 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.84 104.7 16.6 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.937 -0.705 . . . . 75.510000000000005 110.09 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -116.46 -9.76 11.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.509 -1.223 . . . . 73.219999999999999 107.707 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' O ' HD12 ' A' ' 94' ' ' ILE . 15.1 pm0 -106.9 139.81 20.76 Favored Pre-proline 0 N--CA 1.425 -1.688 0 CA-C-N 114.871 -1.059 . . . . 75.519999999999996 109.728 -173.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 31.0 Cg_endo -64.18 -14.52 44.21 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.471 2.78 . . . . 73.129999999999995 114.182 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -148.02 127.55 13.23 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.216 -0.927 . . . . 75.409999999999997 112.015 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 45.7 m -124.15 113.54 18.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.312 -0.996 . . . . 73.25 108.312 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -89.43 134.89 33.89 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.329 -0.619 . . . . 71.340000000000003 109.329 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.5 147.0 44.09 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.514 0.673 . . . . 72.310000000000002 111.585 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -169.78 21.38 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 107.867 -2.093 . . . . 73.040000000000006 107.867 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -115.61 118.34 32.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.78 -1.563 . . . . 73.310000000000002 106.78 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 176.38 162.05 0.46 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 106.381 -1.711 . . . . 75.409999999999997 106.381 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -48.74 -36.64 33.56 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 123.925 3.083 . . . . 74.120000000000005 115.146 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -90.81 16.2 9.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.771 1.026 . . . . 73.409999999999997 113.771 -177.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.4 p -66.05 112.28 3.78 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.167 -0.679 . . . . 62.549999999999997 109.167 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -77.52 -34.67 53.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.415 -0.957 . . . . 64.430000000000007 108.415 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.99 117.95 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.992 -1.484 . . . . 63.130000000000003 106.992 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -95.19 116.93 29.39 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.321 0.582 . . . . 74.420000000000002 110.959 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 2.2 mm? -123.19 139.94 53.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.032 -2.21 . . . . 74.200000000000003 105.032 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 55' ' ' PRO . 4.5 p-10 -79.68 127.15 31.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.903 0.858 . . . . 72.219999999999999 109.533 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.92 146.15 39.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.839 -1.073 . . . . 72.239999999999995 111.648 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.38 -43.27 20.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.478 -0.934 . . . . 75.150000000000006 108.478 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.2 m -133.53 158.0 44.23 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.517 -2.031 . . . . 63.32 105.517 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.97 99.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.773 0.797 . . . . 75.430000000000007 112.754 -165.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -104.14 101.76 11.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.262 -1.335 . . . . 72.420000000000002 107.584 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 6.7 ppt_? -57.16 -31.72 65.67 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.691 0.62 . . . . 75.099999999999994 112.349 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 43.6 ttm180 -159.97 132.51 6.51 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.597 -1.631 . . . . 74.129999999999995 106.597 172.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -98.67 -52.75 3.51 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.644 0.59 . . . . 74.340000000000003 110.456 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 164.6 34.45 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.335 -0.393 . . . . 71.219999999999999 110.605 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.96 130.94 54.04 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.371 -0.974 . . . . 73.230000000000004 108.371 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 9.1 m-85 -105.66 113.47 27.05 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.212 -1.773 . . . . 61.049999999999997 106.212 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -112.21 141.61 45.69 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.37 -0.532 . . . . 74.230000000000004 110.524 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 65' ' ' GLN . 2.5 mp -113.78 112.72 41.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 105.117 -2.179 . . . . 74.400000000000006 105.117 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -131.48 126.55 35.29 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.939 -0.573 . . . . 72.25 109.551 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 55.67 36.21 26.76 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 125.194 1.398 . . . . 74.439999999999998 110.08 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.75 -2.0 75.76 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 115.492 -0.776 . . . . 62.210000000000001 113.685 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.22 150.33 25.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.37 0.585 . . . . 74.120000000000005 109.94 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -106.43 131.51 53.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.55 -0.295 . . . . 75.400000000000006 110.612 -173.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.42 147.21 52.1 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.754 -0.461 . . . . 71.230000000000004 109.754 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.28 123.17 64.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.388 -1.338 . . . . 70.040000000000006 107.388 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.91 122.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.346 0.593 . . . . 73.430000000000007 110.364 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.454 ' CG ' ' HG ' ' A' ' 106' ' ' SER . 4.5 t70 -83.23 137.83 33.86 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.437 -0.801 . . . . 72.299999999999997 109.646 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.6 12.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.488 -0.778 . . . . 72.450000000000003 109.489 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 175.75 79.65 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.286 -0.959 . . . . 73.109999999999999 112.817 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.454 ' HG ' ' CG ' ' A' ' 103' ' ' ASP . 49.2 m -71.37 33.55 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 123.588 0.755 . . . . 70.430000000000007 112.209 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 105' ' ' GLY . 4.3 tt -62.81 -42.34 99.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.545 -0.909 . . . . 74.340000000000003 108.545 -176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -86.42 -4.1 59.11 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.506 -1.225 . . . . 74.230000000000004 109.374 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 88.87 1.01 Allowed Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.992 -0.623 . . . . 71.200000000000003 112.683 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -87.51 127.71 35.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.991 -0.374 . . . . 74.299999999999997 109.991 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.8 m-85 -136.37 141.73 43.71 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 109.968 -0.382 . . . . 73.409999999999997 109.968 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.7 117.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.442 -2.059 . . . . 73.219999999999999 105.442 172.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 56.71 38.65 29.68 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.859 0.837 . . . . 71.420000000000002 110.141 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.487 HH12 ' NH2' ' A' ' 134' ' ' ARG . 75.1 mtm-85 62.79 13.02 6.13 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.339 -1.3 . . . . 74.450000000000003 114.118 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -104.06 130.3 23.64 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.735 -1.58 . . . . 73.430000000000007 106.735 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.13 123.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.586 1.524 . . . . 72.450000000000003 109.701 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -142.18 140.12 32.28 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.69 -1.226 . . . . 74.400000000000006 107.69 -172.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.2 -47.06 4.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.194 0.521 . . . . 73.310000000000002 110.189 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.14 136.47 54.6 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.775 -0.824 . . . . 73.239999999999995 108.775 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -148.49 143.88 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.737 -0.665 . . . . 75.230000000000004 110.454 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.51 114.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 102.967 -2.975 . . . . 72.319999999999993 102.967 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.6 ttp -90.03 129.39 36.35 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.482 0.658 . . . . 74.510000000000005 110.833 -169.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -129.18 157.68 41.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.86 -1.064 . . . . 72.329999999999998 108.807 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -58.92 133.7 56.29 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.883 -0.599 . . . . 74.140000000000001 109.972 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.64 -4.8 56.62 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.586 -0.734 . . . . 74.129999999999995 111.752 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -88.69 140.06 29.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.202 -0.666 . . . . 72.319999999999993 109.202 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -117.07 145.11 43.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.811 -0.811 . . . . 75.319999999999993 108.811 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.0 127.63 72.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.159 -0.682 . . . . 70.540000000000006 109.159 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 44.9 tt0 -104.86 122.08 45.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.209 -1.404 . . . . 74.140000000000001 107.209 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.74 101.75 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.091 -1.818 . . . . 62.509999999999998 106.091 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.48 -110.96 3.06 Favored Glycine 0 C--N 1.306 -1.097 0 C-N-CA 120.864 -0.684 . . . . 72.400000000000006 112.107 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -96.86 -3.52 41.88 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.981 0.513 . . . . 74.439999999999998 110.435 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.579 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.3 m-85 -95.11 139.15 31.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 109.798 -0.445 . . . . 75.120000000000005 109.798 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.487 ' NH2' HH12 ' A' ' 114' ' ' ARG . 81.1 ttt180 -124.81 119.43 28.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.446 -0.946 . . . . 74.200000000000003 108.446 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.7 mt -110.21 138.64 46.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.594 -0.891 . . . . 75.120000000000005 108.594 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.93 120.7 64.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.855 -1.165 . . . . 73.540000000000006 107.855 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 85.6 t80 -97.14 117.77 32.07 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.355 0.409 . . . . 75.329999999999998 110.29 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.16 143.76 49.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.08 0.467 . . . . 73.120000000000005 110.128 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.47 119.81 38.61 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.051 0.453 . . . . 72.409999999999997 110.244 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.46 174.44 40.5 Favored Glycine 0 C--N 1.287 -2.164 0 N-CA-C 109.436 -1.465 . . . . 74.299999999999997 109.436 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.47 141.22 38.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 119.091 1.445 . . . . 73.219999999999999 109.66 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.55 26.67 0.13 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.889 -1.152 . . . . 64.420000000000002 107.889 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.407 -2.589 0 CA-C-N 114.498 -1.228 . . . . 74.420000000000002 108.315 -177.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 107.176 -1.416 . . . . 75.430000000000007 107.176 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 m -70.55 137.28 49.99 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 109.311 -0.626 . . . . 72.540000000000006 109.311 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -145.7 152.89 40.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.22 -1.03 . . . . 65.420000000000002 108.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -157.69 141.86 16.08 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.885 -1.154 . . . . 70.209999999999994 107.885 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -76.69 87.17 3.33 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.891 0.853 . . . . 74.549999999999997 111.001 178.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.23 -7.67 79.55 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.107 -1.197 . . . . 61.130000000000003 110.107 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -79.59 118.6 73.33 Favored Pre-proline 0 N--CA 1.417 -2.091 0 C-N-CA 123.904 0.882 . . . . 64.129999999999995 108.903 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.9 150.85 55.97 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.453 1.435 . . . . 74.519999999999996 109.021 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -78.19 123.12 86.02 Favored Pre-proline 0 C--N 1.309 -1.162 0 C-N-CA 120.119 -0.632 . . . . 74.329999999999998 109.426 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.61 132.36 23.4 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.844 1.696 . . . . 72.099999999999994 109.958 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -91.32 145.16 24.87 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.31 132.31 55.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.372 0.605 . . . . 71.400000000000006 109.558 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -140.76 155.86 46.32 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.486 -1.672 . . . . 72.219999999999999 106.486 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -70.29 127.11 31.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.335 0.865 . . . . 74.430000000000007 113.335 -171.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -90.34 146.57 24.08 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.038 0.447 . . . . 72.010000000000005 111.997 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 115.64 26.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 73.430000000000007 108.649 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -123.12 117.79 26.21 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.637 -0.71 . . . . 74.310000000000002 110.144 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -82.76 101.24 10.78 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.691 -1.966 . . . . 72.510000000000005 105.691 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 108.75 1.71 Allowed 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.489 -0.778 . . . . 61.409999999999997 110.474 -177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 35.5 t70 -60.1 -24.16 64.41 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.659 0.742 . . . . 70.120000000000005 110.263 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -65.81 -3.81 5.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.645 -1.161 . . . . 74.310000000000002 113.142 178.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.83 -24.62 58.24 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.122 0.487 . . . . 75.109999999999999 111.287 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 21' ' ' ASP . 49.6 mtmt -66.82 -28.95 68.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.836 -0.62 . . . . 74.430000000000007 110.857 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -26.31 62.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.478 -0.328 . . . . 72.340000000000003 110.855 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.3 mtm -65.93 -40.35 91.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.93 -0.767 . . . . 65.450000000000003 108.93 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.91 -40.28 94.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.033 -0.985 . . . . 73.040000000000006 109.557 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 m -73.01 -27.75 61.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.536 -0.756 . . . . 61.119999999999997 111.044 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -74.05 -30.48 62.42 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 109.921 -0.4 . . . . 63.439999999999998 109.921 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 127.88 34.29 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.941 -1.027 . . . . 65.040000000000006 109.341 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.22 -42.69 1.28 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 107.674 -2.17 . . . . 63.539999999999999 107.674 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.6 m -115.77 121.95 43.99 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.474 -1.306 . . . . 72.519999999999996 107.474 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.39 138.52 26.95 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.008 -0.738 . . . . 74.310000000000002 109.008 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.52 142.24 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.701 1.6 . . . . 70.510000000000005 111.468 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.13 126.48 46.38 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.081 -1.081 . . . . 73.319999999999993 108.081 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 123' ' ' GLN . 12.9 m -137.96 110.88 7.71 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.631 -0.507 . . . . 75.400000000000006 109.631 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.6 m -154.18 142.4 20.44 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.733 -1.21 . . . . 74.200000000000003 107.733 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -15.01 3.63 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.114 -1.041 . . . . 52.420000000000002 112.166 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.13 59.04 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.299 -0.63 . . . . 62.0 109.299 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -79.8 3.7 18.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.188 -0.914 . . . . 73.310000000000002 111.671 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.28 -27.89 18.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.085 -0.709 . . . . 75.310000000000002 109.085 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 46.65 77.93 0.43 Allowed Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.331 1.052 . . . . 73.200000000000003 113.665 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -70.22 -61.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.508 1.472 . . . . 71.349999999999994 111.537 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.05 -13.79 18.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 111.567 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.17 17.52 74.04 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.711 -0.955 . . . . 73.430000000000007 110.711 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -150.44 167.08 28.19 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 105.902 -1.888 . . . . 71.409999999999997 105.902 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -152.12 157.9 42.21 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 118.446 0.566 . . . . 63.43 111.278 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -121.2 154.53 36.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.129 0.49 . . . . 74.329999999999998 111.916 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.42 141.37 51.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.966 -0.753 . . . . 73.140000000000001 108.966 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.68 134.36 59.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.891 -0.411 . . . . 70.129999999999995 109.891 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 t -86.63 118.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 108.103 -1.073 . . . . 64.129999999999995 108.103 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -92.27 -32.2 15.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 111.336 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -143.47 136.73 27.97 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.422 -0.511 . . . . 75.319999999999993 110.096 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.86 174.84 13.84 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.2 -1.16 . . . . 63.340000000000003 110.2 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -55.43 -32.05 80.36 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.649 2.233 . . . . 74.200000000000003 112.793 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.44 10.48 25.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.256 0.465 . . . . 73.109999999999999 112.256 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.27 57.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.902 0.319 . . . . 73.409999999999997 111.444 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.16 -16.78 55.19 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.509 -0.636 . . . . 72.030000000000001 111.509 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.63 139.01 31.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.907 0.384 . . . . 73.450000000000003 110.324 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -122.79 134.55 54.42 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.58 118.65 30.73 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.546 -0.297 . . . . 74.319999999999993 110.338 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -87.55 111.76 21.54 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.31 -0.996 . . . . 72.140000000000001 108.31 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -95.0 117.26 29.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.342 0.591 . . . . 73.310000000000002 109.653 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -122.02 14.03 10.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.846 -1.07 . . . . 72.209999999999994 108.835 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -108.47 156.46 38.62 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 64.310000000000002 109.521 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 38.2 Cg_endo -69.18 -20.68 37.25 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.175 1.917 . . . . 71.329999999999998 114.527 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.5 m -153.53 127.17 8.74 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.29 -0.881 . . . . 75.140000000000001 111.858 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -126.25 112.86 16.23 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.979 -1.119 . . . . 74.299999999999997 107.979 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.7 m -89.07 139.18 30.72 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.39 -0.524 . . . . 74.349999999999994 109.624 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.01 135.61 54.85 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.358 0.599 . . . . 64.340000000000003 110.912 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.05 -160.21 33.1 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.731 -2.148 . . . . 61.229999999999997 107.731 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -115.72 116.81 28.7 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 151.43 153.23 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 127.48 2.312 . . . . 73.219999999999999 107.228 177.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.95 -9.97 25.22 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.397 2.065 . . . . 75.099999999999994 111.79 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.52 -17.84 61.17 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.746 0.818 . . . . 75.120000000000005 110.248 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 m -90.07 150.02 22.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.218 -1.401 . . . . 64.150000000000006 107.218 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.31 -45.95 24.56 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.702 -0.851 . . . . 74.430000000000007 108.702 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.8 pt -106.16 130.51 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.086 -1.079 . . . . 75.420000000000002 108.086 174.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -94.26 108.12 20.03 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.954 -0.566 . . . . 74.409999999999997 109.996 -173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.74 116.25 32.33 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.992 -1.485 . . . . 75.140000000000001 106.992 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.03 117.04 13.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.931 0.395 . . . . 73.200000000000003 110.227 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -107.62 165.97 11.03 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.815 -0.63 . . . . 65.109999999999999 109.55 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.55 -28.68 32.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.963 0.887 . . . . 73.239999999999995 108.786 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -111.03 173.93 6.1 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.588 -1.634 . . . . 54.329999999999998 106.588 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.48 96.91 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 N-CA-C 106.018 -1.845 . . . . 63.340000000000003 106.018 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 m -105.13 106.74 17.37 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.65 -0.87 . . . . 75.420000000000002 108.65 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -56.29 -42.04 76.88 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.787 1.032 . . . . 74.5 113.787 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -148.7 129.31 14.05 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.857 -1.164 . . . . 74.409999999999997 107.857 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 4.1 t60 -100.29 -52.19 3.45 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.776 -1.194 . . . . 74.409999999999997 107.776 172.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.15 163.98 38.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.147 -1.057 . . . . 71.310000000000002 108.147 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -138.34 148.42 44.55 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.248 0.547 . . . . 74.230000000000004 110.631 176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -105.29 131.72 52.39 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.18 -1.415 . . . . 74.319999999999993 107.18 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -122.95 130.93 53.44 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 116.319 -0.401 . . . . 71.219999999999999 110.444 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 46.3 mt -116.09 112.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.553 -2.017 . . . . 75.439999999999998 105.553 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -139.83 125.71 19.59 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.731 -0.47 . . . . 73.450000000000003 109.731 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 55.87 38.02 29.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.103 0.961 . . . . 74.230000000000004 112.353 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.52 -0.31 89.26 Favored Glycine 0 C--O 1.223 -0.564 0 C-N-CA 121.16 -0.543 . . . . 62.119999999999997 113.98 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -106.47 136.86 45.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.005 0.402 . . . . 62.039999999999999 110.046 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -107.79 119.51 39.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 72.230000000000004 108.127 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.35 146.64 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.733 -0.604 . . . . 64.150000000000006 112.329 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.04 123.98 58.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.508 -1.664 . . . . 73.0 106.508 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.43 122.38 68.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.419 -0.956 . . . . 64.549999999999997 108.419 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.12 134.58 35.67 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.994 -0.743 . . . . 73.230000000000004 108.994 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.74 9.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.068 0.461 . . . . 72.329999999999998 109.867 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -155.63 57.19 0.39 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 108.727 -1.749 . . . . 71.310000000000002 108.727 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 p -68.7 24.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.376 1.871 . . . . 75.010000000000005 114.349 -172.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 105' ' ' GLY . 78.3 mt -106.35 -26.47 11.48 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 116.431 -0.349 . . . . 74.129999999999995 111.546 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.512 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 2.9 m-20 -86.48 -18.94 30.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.601 -0.84 . . . . 75.400000000000006 111.738 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.98 74.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 119.664 -1.255 . . . . 61.25 113.073 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -87.76 128.56 35.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 110.036 -0.357 . . . . 75.510000000000005 110.036 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -135.53 136.06 40.87 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.658 -0.867 . . . . 74.409999999999997 108.658 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 133.19 60.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.137 -1.431 . . . . 73.540000000000006 107.137 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.52 38.59 29.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.309 1.044 . . . . 74.219999999999999 108.688 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 64.18 14.85 8.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.046 1.498 . . . . 71.219999999999999 115.046 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -124.5 148.66 59.29 Favored Pre-proline 0 C--N 1.308 -1.202 0 C-N-CA 120.204 -0.599 . . . . 73.549999999999997 109.423 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 123.43 13.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.801 1.667 . . . . 74.349999999999994 108.502 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.449 ' CG ' ' HB2' ' A' ' 120' ' ' GLN . 17.4 tpp85 -151.07 135.92 17.32 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.634 -0.827 . . . . 75.109999999999999 109.728 -170.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -96.7 -57.6 2.26 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.712 0.633 . . . . 73.030000000000001 110.552 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 134.04 55.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.834 -1.173 . . . . 73.329999999999998 107.834 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 117' ' ' ARG . 27.7 tp60 -155.08 132.9 11.42 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.226 0.329 . . . . 71.239999999999995 111.228 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.58 130.71 31.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.268 -1.382 . . . . 75.340000000000003 107.268 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.644 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 11.8 ptm -98.87 130.24 45.26 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.103 0.478 . . . . 73.209999999999994 110.183 -174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 2.8 tp60 -113.53 156.16 24.09 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.861 -0.609 . . . . 60.450000000000003 110.257 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.2 m -61.34 123.29 17.35 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 122.31 -0.244 . . . . 71.129999999999995 110.379 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.07 -2.03 56.55 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.812 -0.515 . . . . 64.400000000000006 111.812 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.49 146.0 32.94 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 108.525 -0.917 . . . . 73.150000000000006 108.525 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.45 126.69 51.06 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.915 0.864 . . . . 72.209999999999994 110.654 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.41 131.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-N 114.599 -1.182 . . . . 71.409999999999997 108.02 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -120.63 112.49 18.96 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.868 -1.16 . . . . 73.450000000000003 107.868 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.2 mt -109.66 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.237 -0.892 . . . . 74.239999999999995 109.18 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.19 -89.06 0.41 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.97 -1.252 . . . . 75.420000000000002 109.97 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.439 ' HZ2' ' HB3' ' A' ' 132' ' ' LYS . 7.9 mtpm? -134.47 6.13 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.417 -0.586 . . . . 74.409999999999997 109.417 174.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -84.59 147.77 26.82 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -124.88 120.06 30.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.84 -0.8 . . . . 73.319999999999993 108.84 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.33 138.07 50.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.387 -1.338 . . . . 74.409999999999997 107.387 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.11 127.13 74.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 107.539 -1.282 . . . . 72.150000000000006 107.539 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.644 ' CD1' ' HE2' ' A' ' 122' ' ' MET . 76.7 t80 -95.49 126.95 41.13 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.435 0.459 . . . . 75.209999999999994 111.062 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -127.23 159.92 32.86 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.028 -0.73 . . . . 75.400000000000006 109.028 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.41 38.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.103 -0.703 . . . . 73.420000000000002 109.103 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.491 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.93 155.26 53.55 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.172 -0.537 . . . . 63.049999999999997 112.256 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -71.18 142.85 42.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.466 2.111 . . . . 75.150000000000006 111.52 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.98 65.27 0.8 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.163 -1.421 . . . . 74.109999999999999 107.163 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.607 -1.633 . . . . 71.409999999999997 108.499 -176.82 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.682 0.277 . . . . 75.340000000000003 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -72.68 82.3 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 115.314 1.598 . . . . 74.230000000000004 115.314 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -95.48 105.66 17.65 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.554 -1.647 . . . . 64.329999999999998 106.554 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -62.96 100.47 0.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.698 0.999 . . . . 72.329999999999998 113.698 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.36 155.81 36.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.055 -0.975 . . . . 75.109999999999999 110.011 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 167.22 30.84 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.392 -1.083 . . . . 72.450000000000003 110.392 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -105.18 108.35 61.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 117.196 0.498 . . . . 75.140000000000001 110.767 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.44 150.6 52.32 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.617 2.211 . . . . 73.340000000000003 112.576 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -79.44 119.68 77.79 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.361 -0.978 . . . . 71.409999999999997 108.361 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.98 160.01 43.77 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.225 1.95 . . . . 74.400000000000006 112.287 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -91.66 162.57 14.44 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.095 -1.817 . . . . 64.329999999999998 106.095 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.6 t -108.22 121.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 119.326 -0.949 . . . . 72.420000000000002 109.694 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.65 138.42 32.5 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.319 -0.993 . . . . 74.200000000000003 108.319 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -76.48 133.31 39.83 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.83 0.706 . . . . 75.120000000000005 109.976 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.1 m -89.41 152.92 21.23 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.602 -0.888 . . . . 72.400000000000006 108.602 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.63 115.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.746 -0.835 . . . . 71.310000000000002 108.746 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -123.82 140.78 52.65 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.697 -0.683 . . . . 75.219999999999999 110.554 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -97.53 95.58 7.73 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.1 -1.074 . . . . 72.430000000000007 108.1 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.82 38.85 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.668 -1.151 . . . . 74.329999999999998 112.069 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.86 2.18 2.16 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.536 1.135 . . . . 75.239999999999995 113.759 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -13.77 59.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 72.540000000000006 112.758 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -69.03 -19.67 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.342 0.592 . . . . 75.400000000000006 109.929 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.09 -22.52 59.47 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.077 -0.51 . . . . 74.109999999999999 110.499 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -77.09 -29.95 55.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.231 0.539 . . . . 74.310000000000002 109.939 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -65.3 -47.47 76.5 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.941 -1.133 . . . . 73.510000000000005 107.941 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.32 -39.86 94.43 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.318 -1.31 . . . . 65.530000000000001 110.251 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 t -60.84 -39.01 87.48 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.786 1.234 . . . . 63.119999999999997 110.884 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.483 ' HB2' ' NH1' ' A' ' 114' ' ' ARG . 31.3 t -81.71 -16.52 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.583 -0.28 . . . . 63.100000000000001 110.512 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 m 71.57 31.63 2.2 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 122.525 1.155 . . . . 71.340000000000003 108.481 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.89 -151.05 19.69 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 115.097 -0.956 . . . . 72.439999999999998 112.04 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -84.78 137.97 32.88 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.144 0.577 . . . . 62.229999999999997 110.433 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.9 115.57 59.43 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 74.129999999999995 108.304 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 142.51 25.99 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.354 2.036 . . . . 74.209999999999994 114.9 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.12 126.51 30.18 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.466 -2.049 . . . . 74.019999999999996 105.466 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 37' ' ' THR . 55.4 p -91.32 -98.43 0.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.253 -0.979 . . . . 63.43 113.445 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -170.34 -169.97 0.89 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.007 1.323 . . . . 71.120000000000005 108.877 -177.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.07 -161.44 31.98 Favored Glycine 1 N--CA 1.386 -4.684 0 N-CA-C 105.961 -2.856 . . . . 72.329999999999998 105.961 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.9 -20.88 20.95 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.887 -1.153 . . . . 73.329999999999998 107.887 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.62 -10.7 59.96 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.193 -1.821 . . . . 71.420000000000002 112.965 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.419 ' O ' HD12 ' A' ' 42' ' ' LEU . 32.4 p-10 -80.39 -33.72 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.377 -0.529 . . . . 73.329999999999998 110.74 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 97' ' ' GLY . 2.1 mm? -128.13 82.92 67.53 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.141 -1.059 . . . . 75.129999999999995 108.141 173.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.48 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 4.0 Cg_exo -77.24 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.173 1.915 . . . . 72.109999999999999 111.758 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 142' ' ' ALA . . . -104.48 -7.05 20.08 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.449 -0.574 . . . . 75.310000000000002 109.449 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.06 43.75 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.386 -1.086 . . . . 71.409999999999997 110.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -126.07 149.27 49.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.376 -1.342 . . . . 74.510000000000005 107.376 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.07 157.75 42.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.606 -0.516 . . . . 61.109999999999999 109.606 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.17 142.18 51.44 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 110.003 -0.369 . . . . 75.530000000000001 110.003 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.7 pp -110.17 139.31 45.46 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.902 -0.777 . . . . 71.420000000000002 108.902 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.56 132.59 68.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 109.538 -0.542 . . . . 73.310000000000002 109.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -81.59 117.45 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.048 -1.464 . . . . 71.329999999999998 107.048 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -85.78 -38.22 18.44 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.489 -0.778 . . . . 71.030000000000001 109.119 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 22.6 tpt180 -148.16 136.9 21.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.2 -1.407 . . . . 75.439999999999998 107.2 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.68 -176.55 26.46 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.681 -0.968 . . . . 75.329999999999998 110.681 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 -45.18 12.01 Favored 'Trans proline' 0 C--N 1.327 -0.572 0 C-N-CA 122.519 2.146 . . . . 73.230000000000004 112.145 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -95.11 23.08 5.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 111.83 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 138.77 46.98 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.32 -0.4 . . . . 74.439999999999998 111.286 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.57 -25.8 23.32 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.878 -0.889 . . . . 73.310000000000002 110.878 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 150.2 21.81 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.033 0.444 . . . . 71.209999999999994 110.19 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -126.45 153.56 44.88 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.221 -1.029 . . . . 75.540000000000006 108.221 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -128.14 130.18 47.69 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.82 -0.807 . . . . 74.209999999999994 108.82 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 tp -95.53 130.8 42.25 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.997 -0.547 . . . . 73.530000000000001 110.197 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -107.31 105.19 15.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.044 -1.095 . . . . 71.040000000000006 108.044 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.42 14.89 6.08 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.847 1.308 . . . . 73.140000000000001 107.709 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -114.43 155.01 46.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 113.825 -1.534 . . . . 63.350000000000001 108.507 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 66.5 Cg_endo -72.79 -14.64 26.9 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.734 2.289 . . . . 74.510000000000005 113.61 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.3 m -153.22 128.94 10.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.562 -0.711 . . . . 71.439999999999998 110.54 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 15.4 m -130.09 126.89 38.67 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.66 -0.496 . . . . 71.439999999999998 109.66 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.0 m -90.55 129.59 36.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.639 -0.874 . . . . 64.310000000000002 108.639 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.02 134.56 55.12 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.364 0.602 . . . . 74.319999999999993 110.66 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.37 -170.09 33.37 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.438 -2.665 . . . . 61.310000000000002 106.438 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -105.96 118.18 35.95 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.946 1.373 . . . . 72.019999999999996 110.396 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 17.7 m170 -172.84 152.02 2.34 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 127.184 2.194 . . . . 65.129999999999995 106.06 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.83 -17.6 28.95 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 121.627 1.552 . . . . 74.430000000000007 108.952 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -76.81 -26.84 54.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.952 -1.476 . . . . 74.150000000000006 110.035 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 45.6 m -67.61 132.25 47.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.707 -0.849 . . . . 64.120000000000005 108.707 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.72 -41.44 95.96 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.08 -0.711 . . . . 73.129999999999995 109.08 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.6 pt -107.64 118.8 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.646 -0.872 . . . . 74.510000000000005 108.646 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.54 109.42 20.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.755 0.788 . . . . 74.430000000000007 110.512 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.16 140.37 49.6 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.438 -1.69 . . . . 71.239999999999995 106.438 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.32 117.67 34.65 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.363 -0.977 . . . . 73.510000000000005 108.363 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -102.62 173.85 6.16 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.927 -1.033 . . . . 74.25 111.956 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -66.14 -30.94 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 124.316 1.047 . . . . 73.430000000000007 108.732 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 m -117.17 163.1 16.8 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 106.899 -1.519 . . . . 63.229999999999997 106.899 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.32 96.92 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 N-CA-C 104.434 -2.432 . . . . 74.219999999999999 104.434 168.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 131.54 39.66 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.494 -0.775 . . . . 71.530000000000001 110.326 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -74.23 -47.59 34.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 123.224 1.488 . . . . 72.450000000000003 107.117 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -149.54 115.55 5.69 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 112.557 -2.11 . . . . 72.430000000000007 107.807 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -99.22 -47.2 5.28 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.735 -0.839 . . . . 73.019999999999996 108.735 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.54 151.51 40.32 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.895 -0.78 . . . . 72.510000000000005 108.895 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.8 134.55 54.41 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.902 -1.147 . . . . 73.310000000000002 107.902 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.439 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.7 m-85 -105.2 121.43 43.83 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.257 -1.016 . . . . 74.329999999999998 108.257 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -115.85 123.74 48.93 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.171 -1.048 . . . . 75.109999999999999 108.171 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.41 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.9 mp -104.49 123.15 58.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 106.609 -1.626 . . . . 63.310000000000002 106.609 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -136.87 123.66 21.24 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.986 -1.116 . . . . 72.5 107.986 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 56.13 36.13 26.87 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.605 1.162 . . . . 71.409999999999997 111.102 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.466 ' O ' HD13 ' A' ' 42' ' ' LEU . . . 78.97 -0.32 79.2 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 113.374 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.7 149.7 23.88 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.002 -0.74 . . . . 73.430000000000007 109.002 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.8 117.54 33.11 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.126 -0.488 . . . . 74.450000000000003 110.089 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.78 129.93 55.51 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.152 0.501 . . . . 71.120000000000005 109.658 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.49 124.6 59.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.526 -0.916 . . . . 74.439999999999998 108.526 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.22 137.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.257 -0.646 . . . . 72.549999999999997 109.257 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.81 140.94 30.02 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.64 -0.709 . . . . 64.420000000000002 110.841 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.63 14.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 122.39 1.09 . . . . 74.439999999999998 108.555 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.93 48.48 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.572 -1.411 . . . . 72.109999999999999 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -60.06 -2.6 0.45 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.876 1.67 . . . . 75.230000000000004 113.631 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.14 -26.0 17.62 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.447 -0.575 . . . . 75.430000000000007 109.447 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -94.71 -18.65 21.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 73.219999999999999 111.83 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.92 77.1 1.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.012 -1.089 . . . . 61.109999999999999 112.643 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.1 m -87.02 128.68 35.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.014 0.435 . . . . 75.109999999999999 110.388 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -133.64 127.41 32.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.261 -0.427 . . . . 72.319999999999993 110.516 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.15 137.66 55.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 105.398 -2.075 . . . . 73.519999999999996 105.398 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 57.3 33.77 23.78 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 106.738 -1.579 . . . . 74.099999999999994 106.738 -166.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.483 ' NH1' ' HB2' ' A' ' 29' ' ' SER . 73.6 mtt180 57.94 11.43 1.43 Allowed 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 123.187 0.595 . . . . 71.430000000000007 111.655 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -107.7 144.47 29.36 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 124.388 1.075 . . . . 75.219999999999999 110.248 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.14 123.93 12.26 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.089 1.859 . . . . 74.510000000000005 108.787 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' A' ' 117' ' ' ARG . 3.7 mmp_? -135.82 155.85 49.71 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.667 0.988 . . . . 73.409999999999997 113.667 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -99.2 -41.85 7.31 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.9 -1.5 . . . . 74.129999999999995 107.434 171.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.4 143.61 25.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.52 -1.218 . . . . 72.099999999999994 108.197 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 138.15 19.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.011 -1.107 . . . . 72.329999999999998 108.011 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.73 116.7 40.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 105.412 -2.07 . . . . 75.019999999999996 105.412 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 77.4 mtp -89.75 149.08 22.88 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 114.163 1.172 . . . . 75.430000000000007 114.163 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -112.43 157.38 21.14 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.661 -1.609 . . . . 63.240000000000002 107.778 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.6 t -66.27 127.39 32.01 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.169 -0.613 . . . . 75.219999999999999 109.829 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 0.03 57.32 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.266 -0.734 . . . . 71.439999999999998 111.266 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -82.77 152.27 25.77 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.964 -0.384 . . . . 74.129999999999995 109.964 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -115.71 144.18 44.32 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.263 0.554 . . . . 75.420000000000002 112.237 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.6 mt -117.91 131.88 69.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.442 . . . . 74.420000000000002 107.108 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -117.84 120.55 38.23 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.56 -0.904 . . . . 74.140000000000001 108.56 175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.75 114.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.301 -0.863 . . . . 74.540000000000006 108.836 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.0 -80.98 0.57 Allowed Glycine 0 C--O 1.206 -1.594 0 N-CA-C 110.006 -1.238 . . . . 70.200000000000003 110.006 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -154.87 8.28 0.3 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.436 0.294 . . . . 72.299999999999997 111.112 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 31.1 p90 -107.39 160.29 15.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.881 -0.785 . . . . 75.420000000000002 108.881 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -124.76 137.82 54.31 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.234 -0.986 . . . . 74.549999999999997 112.329 -168.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mp -122.32 139.82 53.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.698 -1.223 . . . . 75.209999999999994 107.698 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.12 124.93 69.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.768 -1.197 . . . . 74.239999999999995 107.768 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -98.28 118.26 34.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.188 -0.671 . . . . 75.25 109.188 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.4 mt -122.34 131.67 54.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.972 -0.381 . . . . 75.239999999999995 109.972 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.29 119.57 28.82 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.458 -1.682 . . . . 72.340000000000003 106.458 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.01 -70.66 0.29 Allowed Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.519 -1.324 . . . . 73.099999999999994 115.356 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 43' ' ' PRO . 25.7 Cg_exo -57.74 141.28 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.693 1.595 . . . . 72.120000000000005 114.785 -172.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.459 ' HA ' ' HB1' ' A' ' 44' ' ' ALA . . . -161.84 29.34 0.12 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.011 -2.588 . . . . 71.540000000000006 104.011 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.416 -2.154 0 CA-C-N 112.99 -1.914 . . . . 73.230000000000004 108.31 -169.134 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 121.423 0.63 . . . . 61.420000000000002 111.543 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -92.76 11.92 25.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.672 0.749 . . . . 74.239999999999995 109.078 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.32 158.83 16.44 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 125.308 1.443 . . . . 74.230000000000004 110.823 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -79.69 -178.39 6.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.213 -0.448 . . . . 74.040000000000006 111.306 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.8 94.32 8.68 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.203 0.525 . . . . 71.219999999999999 111.092 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.51 36.31 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.967 -1.253 . . . . 72.129999999999995 109.967 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.8 p -99.38 113.22 64.69 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 119.824 -0.75 . . . . 65.019999999999996 111.551 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.16 132.63 37.25 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 N-CA-C 106.311 -2.227 . . . . 62.149999999999999 106.311 167.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.37 140.49 56.34 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 119.818 -0.753 . . . . 63.420000000000002 110.564 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -67.8 92.38 0.37 Allowed 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 121.915 1.744 . . . . 73.150000000000006 111.976 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -119.58 149.89 41.2 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.418 -1.327 . . . . 65.530000000000001 107.418 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 t -109.07 121.65 62.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.076 -1.453 . . . . 71.150000000000006 107.076 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -119.16 169.3 10.06 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.884 -1.154 . . . . 73.219999999999999 107.884 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -67.87 109.61 3.48 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.762 0.791 . . . . 61.329999999999998 111.761 -170.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -124.92 120.82 32.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.009 -0.367 . . . . 73.219999999999999 110.009 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 47.1 t -87.17 122.44 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.302 -0.629 . . . . 71.219999999999999 109.302 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -123.66 129.02 50.49 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.872 0.368 . . . . 74.530000000000001 111.855 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -96.55 116.03 28.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.266 -1.753 . . . . 75.129999999999995 106.266 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.36 -166.71 2.63 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.546 -0.862 . . . . 73.239999999999995 113.315 -171.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.16 -14.28 1.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.886 2.074 . . . . 73.040000000000006 115.059 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.66 -23.11 67.15 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.119 -0.363 . . . . 73.439999999999998 111.744 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.19 -22.5 63.9 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.877 0.37 . . . . 72.450000000000003 111.823 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -91.8 -42.04 10.32 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.822 -1.547 . . . . 74.400000000000006 106.822 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -26.37 67.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.642 1.177 . . . . 61.219999999999999 109.397 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.6 tpp -51.75 -26.13 8.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.757 1.223 . . . . 65.209999999999994 112.167 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.49 -38.34 86.94 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 120.725 0.298 . . . . 74.510000000000005 110.472 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -72.91 -34.96 66.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.234 -0.654 . . . . 71.400000000000006 109.234 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 17.9 m -68.81 -30.5 69.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.901 -0.591 . . . . 71.120000000000005 110.065 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.4 m -81.55 107.03 13.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.18 0.514 . . . . 71.099999999999994 110.797 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 179.65 38.69 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 108.997 -1.641 . . . . 54.530000000000001 108.997 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.6 m -74.94 124.16 26.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 117.69 0.745 . . . . 72.099999999999994 109.646 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.45 150.24 38.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 N-CA-C 108.251 -1.018 . . . . 64.219999999999999 108.251 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 125' ' ' GLY . 53.4 Cg_exo -57.18 154.97 31.25 Favored 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.551 2.167 . . . . 72.549999999999997 111.876 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.07 145.67 27.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.695 -0.684 . . . . 74.140000000000001 112.335 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.1 m -116.07 148.3 40.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.122 -1.066 . . . . 75.439999999999998 108.122 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -116.74 -60.68 1.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.931 0.396 . . . . 75.140000000000001 111.384 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.83 -63.55 0.18 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.467 -0.653 . . . . 61.43 111.467 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.56 54.5 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.123 0.487 . . . . 73.409999999999997 110.95 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.52 -5.92 47.62 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.424 -0.807 . . . . 70.140000000000001 111.08 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.09 -42.17 19.54 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.414 -0.812 . . . . 62.420000000000002 110.131 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.32 83.22 60.21 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 109.086 -0.709 . . . . 61.109999999999999 109.086 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.39 -65.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.848 2.365 . . . . 73.150000000000006 112.269 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.13 -16.19 59.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 74.400000000000006 111.012 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.97 -7.44 77.6 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 110.975 -0.85 . . . . 75.340000000000003 110.975 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -120.08 157.08 29.7 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.624 -1.621 . . . . 74.439999999999998 106.624 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.89 156.87 43.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.583 -0.525 . . . . 75.340000000000003 109.583 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.95 140.82 52.57 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.996 0.427 . . . . 72.219999999999999 110.712 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pp -112.19 140.73 46.65 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 116.288 -0.414 . . . . 74.420000000000002 110.931 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.71 128.08 71.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.45 118.92 26.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.736 -1.209 . . . . 73.409999999999997 107.736 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -83.4 -32.63 26.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.62 0.724 . . . . 74.299999999999997 110.131 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.592 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 20.2 tpp180 -154.01 148.81 26.53 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.992 -1.485 . . . . 72.439999999999998 106.992 -177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.28 -174.85 17.86 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 109.722 -1.351 . . . . 73.420000000000002 109.722 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -65.2 -37.95 29.58 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.309 2.006 . . . . 74.329999999999998 111.029 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.61 14.37 11.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.749 -1.114 . . . . 72.109999999999999 110.862 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 129.32 41.55 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.762 0.315 . . . . 63.210000000000001 111.295 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.0 -26.05 24.38 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.95 -0.568 . . . . 73.239999999999995 112.188 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.81 144.77 29.9 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.839 0.352 . . . . 54.329999999999998 110.133 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -123.69 137.54 54.69 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.992 -0.744 . . . . 75.340000000000003 108.992 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.04 130.56 52.76 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.705 -0.48 . . . . 72.219999999999999 109.705 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.75 128.4 36.67 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.644 -1.243 . . . . 75.340000000000003 107.644 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.414 HD22 HG23 ' A' ' 68' ' ' THR . 26.6 mt -106.78 123.95 48.89 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.057 -1.09 . . . . 73.409999999999997 108.057 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -136.57 1.11 2.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.688 0.996 . . . . 64.450000000000003 113.688 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.535 ' O ' HD11 ' A' ' 94' ' ' ILE . 3.8 pt20 -107.24 152.88 41.33 Favored Pre-proline 0 C--O 1.211 -0.961 0 C-N-CA 119.556 -0.857 . . . . 74.510000000000005 110.13 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 8.8 Cg_endo -52.2 -21.56 13.32 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 124.088 3.192 . . . . 74.310000000000002 114.996 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.7 m -142.51 121.66 12.97 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.723 -0.473 . . . . 75.349999999999994 109.723 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.414 HG23 HD22 ' A' ' 63' ' ' LEU . 67.9 m -129.3 113.27 14.78 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.162 -0.681 . . . . 73.409999999999997 109.162 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -94.28 143.1 26.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.707 -0.797 . . . . 74.420000000000002 109.811 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.16 135.02 54.73 Favored 'General case' 0 C--O 1.279 2.644 0 C-N-CA 122.63 0.372 . . . . 64.319999999999993 111.516 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.22 -142.12 10.24 Favored Glycine 0 N--CA 1.435 -1.401 0 O-C-N 124.759 1.287 . . . . 65.439999999999998 111.882 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 86' ' ' SER . 17.9 mmt85 -88.04 154.74 20.24 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.615 1.966 . . . . 74.530000000000001 110.272 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 22.9 m170 89.17 130.06 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.718 1.607 . . . . 63.240000000000002 111.057 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.21 -3.22 8.27 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.818 2.345 . . . . 75.230000000000004 113.283 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.56 -25.3 60.31 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.888 -0.782 . . . . 75.109999999999999 108.888 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.9 m -78.55 143.62 36.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.335 -1.357 . . . . 61.539999999999999 107.335 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.44 -45.72 68.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.78 0.324 . . . . 74.010000000000005 111.142 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.3 pt -107.45 109.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 121.859 0.838 . . . . 74.319999999999993 111.032 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -87.86 115.81 25.59 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.514 -1.221 . . . . 74.109999999999999 110.652 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.21 139.98 49.79 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.1 -1.815 . . . . 72.540000000000006 106.1 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -92.2 117.05 29.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.474 -1.29 . . . . 71.140000000000001 110.197 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 171.69 7.82 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 110.24 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.93 -29.38 17.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.343 1.057 . . . . 71.530000000000001 109.76 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.3 t -131.26 -163.17 1.29 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.484 -0.932 . . . . 74.450000000000003 108.484 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -84.05 97.33 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.791 0.805 . . . . 75.230000000000004 109.008 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 16.4 t -95.9 77.83 3.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.879 -1.526 . . . . 75.219999999999999 106.879 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -56.68 -44.48 81.48 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 112.825 0.676 . . . . 74.329999999999998 112.825 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -163.42 97.3 0.88 Allowed 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.108 -1.812 . . . . 75.209999999999994 106.108 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 23.7 t-160 -92.77 -52.04 4.8 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.883 -0.727 . . . . 75.109999999999999 109.483 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -128.25 150.14 50.17 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 118.986 -1.086 . . . . 74.239999999999995 110.246 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.36 134.46 36.0 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.97 -0.752 . . . . 74.430000000000007 108.97 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -104.27 120.31 40.89 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.43 -1.693 . . . . 75.129999999999995 106.43 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -110.19 133.75 52.91 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.61 -1.256 . . . . 72.319999999999993 107.61 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.535 HD11 ' O ' ' A' ' 65' ' ' GLN . 1.9 mp -103.6 113.47 40.52 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 105.64 -1.985 . . . . 72.420000000000002 105.64 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -130.0 122.52 28.61 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.36 -1.291 . . . . 72.129999999999995 108.19 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 56.54 36.86 28.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.937 0.895 . . . . 71.349999999999994 110.786 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.44 1.69 77.01 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.218 -0.447 . . . . 73.150000000000006 113.873 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.23 152.78 29.34 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.852 0.461 . . . . 75.510000000000005 110.337 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -102.2 117.92 35.79 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.22 0.533 . . . . 74.430000000000007 110.483 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -114.89 131.85 56.72 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.078 -1.082 . . . . 74.200000000000003 108.078 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 48.0 t -103.55 124.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.817 -0.809 . . . . 72.25 108.817 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.71 129.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 115.586 -0.734 . . . . 75.329999999999998 109.247 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.0 121.9 23.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.495 -1.669 . . . . 64.230000000000004 106.495 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.43 12.42 7.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.032 0.444 . . . . 75.420000000000002 110.853 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . 169.65 83.35 0.05 OUTLIER Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.595 -1.002 . . . . 73.040000000000006 110.595 -178.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.8 m -60.63 100.44 0.11 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 122.832 0.453 . . . . 64.319999999999993 110.735 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 tp -73.68 -52.31 13.72 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.988 -1.115 . . . . 74.420000000000002 107.988 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -121.44 -19.15 7.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.092 0.949 . . . . 65.030000000000001 108.613 170.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.08 130.41 3.74 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 108.446 -1.862 . . . . 72.409999999999997 108.446 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 56.3 m -81.73 130.18 34.97 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 117.13 0.465 . . . . 73.230000000000004 109.984 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.426 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 98.1 m-85 -105.43 126.24 51.89 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.29 -0.633 . . . . 72.099999999999994 109.29 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.57 122.82 67.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 105.642 -1.984 . . . . 73.420000000000002 105.642 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 56.67 39.65 29.64 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.49 1.138 . . . . 71.040000000000006 108.155 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER 62.5 8.69 3.0 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.267 1.827 . . . . 73.409999999999997 113.44 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.28 134.53 20.44 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.949 -0.76 . . . . 75.540000000000006 108.949 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.8 123.01 12.36 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 121.977 1.784 . . . . 74.400000000000006 109.737 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -145.33 148.71 33.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.959 -0.756 . . . . 75.409999999999997 108.959 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -95.1 -70.16 0.72 Allowed 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.158 -0.682 . . . . 73.340000000000003 109.158 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -124.53 134.47 52.99 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 119.715 -0.794 . . . . 63.329999999999998 109.835 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -155.19 147.04 23.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.095 -0.502 . . . . 74.239999999999995 110.832 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.24 132.12 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.698 -1.593 . . . . 74.549999999999997 106.698 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.2 tpp -90.15 148.79 22.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 112.963 0.727 . . . . 73.340000000000003 112.963 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.2 156.35 28.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.774 -1.103 . . . . 73.219999999999999 108.996 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.7 t -79.56 129.36 34.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.79 0.805 . . . . 73.5 111.252 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.525 ' O ' ' HD2' ' A' ' 34' ' ' PRO . . . 98.95 -2.84 58.37 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 115.485 -0.779 . . . . 73.219999999999999 111.82 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.97 153.25 21.18 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.403 -0.592 . . . . 70.230000000000004 109.403 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.03 132.18 56.73 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.692 0.758 . . . . 74.25 112.077 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.9 mt -111.16 126.37 68.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.444 -1.317 . . . . 73.010000000000005 107.444 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 25.9 tt0 -106.41 114.99 29.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.53 0.681 . . . . 71.319999999999993 110.62 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mm -110.61 133.69 55.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.026 -1.443 . . . . 74.409999999999997 108.09 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.88 -93.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.375 -1.09 . . . . 65.5 110.375 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -140.03 9.06 2.32 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.563 0.345 . . . . 74.019999999999996 110.941 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.0 p90 -131.7 152.53 50.81 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.033 -0.417 . . . . 73.209999999999994 111.775 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -112.83 146.15 39.39 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 114.126 1.158 . . . . 74.439999999999998 114.126 -174.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mp -114.55 141.79 47.28 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.285 -1.78 . . . . 74.230000000000004 107.454 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -109.4 121.57 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.888 -1.523 . . . . 75.409999999999997 106.888 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -91.65 116.22 28.69 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.681 -0.69 . . . . 75.200000000000003 109.944 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.84 147.93 37.53 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.687 -0.486 . . . . 75.450000000000003 109.687 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.03 142.41 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.776 -0.453 . . . . 73.150000000000006 109.776 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.3 136.53 47.8 Favored Glycine 0 N--CA 1.441 -1.013 0 O-C-N 123.914 0.759 . . . . 72.129999999999995 112.496 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.19 162.46 35.78 Favored 'Trans proline' 0 C--O 1.251 1.156 0 C-N-CA 123.192 2.595 . . . . 75.430000000000007 112.357 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.5 46.02 0.61 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.96 0.886 . . . . 74.129999999999995 110.883 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.421 -1.326 . . . . 73.299999999999997 107.421 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 114.141 1.163 . . . . 73.209999999999994 114.141 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 p -125.98 17.0 7.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.187 -1.783 . . . . 75.340000000000003 106.187 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.75 17.12 24.72 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 112.952 -1.931 . . . . 73.200000000000003 110.267 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.36 135.88 36.84 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.86 -1.163 . . . . 74.420000000000002 107.86 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -53.49 113.37 1.14 Allowed 'General case' 0 C--O 1.248 1.016 0 O-C-N 123.9 0.75 . . . . 74.329999999999998 111.05 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.6 68.46 2.98 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.734 -0.666 . . . . 64.219999999999999 112.77 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -85.69 127.73 61.63 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 108.557 -0.905 . . . . 73.329999999999998 108.557 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.42 132.02 36.5 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.836 1.691 . . . . 73.450000000000003 108.986 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -115.62 128.83 25.63 Favored Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-N 116.233 -0.439 . . . . 74.010000000000005 111.761 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.4 108.02 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.148 1.899 . . . . 75.109999999999999 109.008 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -131.16 164.05 26.35 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.158 -1.053 . . . . 73.349999999999994 108.158 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.39 120.27 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.914 -1.884 . . . . 72.099999999999994 105.914 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -125.65 148.36 49.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.613 -1.995 . . . . 75.230000000000004 105.613 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -131.59 109.2 10.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.019 -1.073 . . . . 74.120000000000005 113.113 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -88.69 132.68 34.49 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.483 -0.932 . . . . 75.230000000000004 108.483 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.648 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 91.2 t -83.56 122.91 38.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.071 -0.344 . . . . 74.209999999999994 110.071 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -115.39 139.91 49.6 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.248 0.547 . . . . 75.420000000000002 110.369 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -88.3 118.23 27.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.421 -0.809 . . . . 75.239999999999995 109.594 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.84 169.81 14.13 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.547 -0.752 . . . . 61.219999999999999 110.311 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.19 8.21 24.92 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.989 1.716 . . . . 71.510000000000005 112.145 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -4.78 1.3 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.604 1.162 . . . . 75.109999999999999 113.861 -175.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.47 -40.31 86.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.285 0.634 . . . . 74.409999999999997 109.32 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -64.97 -27.71 69.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.78 -0.645 . . . . 74.219999999999999 111.323 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' HB3' HE22 ' A' ' 129' ' ' GLN . 72.5 mm-40 -69.07 -48.73 61.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.45 -0.341 . . . . 72.019999999999996 110.931 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 ptp -68.74 -17.98 64.14 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.721 0.296 . . . . 73.230000000000004 110.996 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.97 -50.17 4.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 112.079 0.4 . . . . 72.230000000000004 112.079 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 m -102.05 -27.61 12.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.565 1.321 . . . . 74.430000000000007 114.565 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -76.2 -21.67 56.19 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.287 -1.005 . . . . 74.430000000000007 108.287 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -70.58 119.57 14.93 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.655 -1.157 . . . . 70.409999999999997 108.429 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.06 -37.25 0.53 Allowed Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 106.909 -2.476 . . . . 55.009999999999998 106.909 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -77.81 122.12 25.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.431 -0.951 . . . . 64.010000000000005 108.431 173.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.64 155.57 62.08 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 116.32 -0.4 . . . . 72.25 109.965 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.03 158.33 21.83 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.95 2.433 . . . . 73.219999999999999 111.669 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.48 156.93 25.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.811 -0.44 . . . . 74.420000000000002 109.811 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -118.26 134.56 54.92 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 108.744 -0.836 . . . . 74.230000000000004 108.744 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.2 p -144.44 162.45 36.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.793 -1.188 . . . . 75.310000000000002 107.793 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.89 18.14 56.29 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.402 -1.079 . . . . 61.399999999999999 110.402 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.1 11.3 23.57 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.396 0.679 . . . . 75.219999999999999 111.179 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.26 3.64 5.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.392 0.677 . . . . 71.420000000000002 112.279 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.04 -16.72 18.58 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.223 -1.029 . . . . 75.329999999999998 108.223 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 58.34 85.68 0.18 Allowed Pre-proline 0 C--O 1.222 -0.37 0 CA-C-N 115.048 -0.978 . . . . 74.319999999999993 111.101 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.23 -54.04 4.94 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.923 2.415 . . . . 73.200000000000003 113.166 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.46 0.76 51.35 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.251 -0.432 . . . . 63.409999999999997 111.108 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 10.8 70.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 116.344 -0.389 . . . . 70.129999999999995 112.928 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 m -124.13 149.45 46.23 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.476 -0.565 . . . . 71.140000000000001 109.476 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.26 157.41 44.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.802 -1.184 . . . . 71.439999999999998 107.802 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.54 155.34 50.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.43 -0.508 . . . . 75.400000000000006 111.328 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 pp -119.79 134.53 55.2 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.927 -0.578 . . . . 74.420000000000002 109.812 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.09 132.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.121 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 HG23 ' ND2' ' A' ' 56' ' ' ASN . 21.8 t -83.55 118.39 30.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.199 -1.037 . . . . 74.430000000000007 108.199 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.74 -31.62 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.554 0.693 . . . . 74.540000000000006 110.338 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.638 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 64.6 ttt180 -137.8 136.63 37.41 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.894 -1.15 . . . . 74.109999999999999 107.894 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.27 176.91 15.97 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 110.195 -1.162 . . . . 64.0 110.195 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.68 -32.89 18.0 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 122.268 1.979 . . . . 74.420000000000002 110.986 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.481 ' ND2' HG23 ' A' ' 51' ' ' VAL . 4.2 p-10 -99.67 23.32 9.71 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.959 -1.019 . . . . 74.439999999999998 110.561 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.43 57.6 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.071 -0.513 . . . . 71.129999999999995 110.718 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.94 -18.28 50.16 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.856 -0.898 . . . . 41.299999999999997 110.856 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 147.42 25.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.76 0.314 . . . . 73.349999999999994 110.328 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -124.42 139.23 54.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.937 -1.134 . . . . 74.530000000000001 107.937 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.78 134.7 54.92 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.032 -1.099 . . . . 73.430000000000007 108.032 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tt -104.29 128.59 52.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.64 0.734 . . . . 73.310000000000002 110.703 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 76.1 mt -103.54 107.55 18.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.642 -0.708 . . . . 75.040000000000006 109.768 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -146.64 17.24 1.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.781 1.277 . . . . 73.219999999999999 107.87 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.493 ' NE2' ' HA ' ' A' ' 63' ' ' LEU . 3.3 pm0 -118.12 149.87 46.44 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.294 -1.321 . . . . 74.430000000000007 109.536 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.2 Cg_exo -55.25 -30.66 72.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.148 2.566 . . . . 73.409999999999997 114.453 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 m -149.45 131.68 15.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.686 -0.805 . . . . 75.510000000000005 111.062 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 m -133.81 114.08 12.98 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.298 -0.63 . . . . 75.109999999999999 109.298 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -88.6 132.53 34.51 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.703 -0.851 . . . . 73.329999999999998 108.703 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 140.54 49.83 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 120.915 0.388 . . . . 71.209999999999994 111.257 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.45 -160.42 30.94 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 107.719 -2.152 . . . . 63.530000000000001 107.719 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 35.9 ttp180 -119.31 117.71 29.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.162 0.981 . . . . 75.340000000000003 110.348 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 0.5 OUTLIER 161.54 158.79 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 104.094 -2.558 . . . . 74.129999999999995 104.094 173.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 18.9 Cg_endo -64.54 -9.91 22.32 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 121.969 1.78 . . . . 74.140000000000001 112.229 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.51 -10.98 58.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.645 -0.707 . . . . 75.450000000000003 110.197 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 m -87.25 143.88 27.07 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 106.526 -1.657 . . . . 74.239999999999995 106.526 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.1 -42.78 36.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.849 0.833 . . . . 74.319999999999993 109.883 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.79 132.51 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 107.372 -1.344 . . . . 75.200000000000003 107.372 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -94.02 117.18 29.75 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.401 0.62 . . . . 75.209999999999994 111.913 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.4 140.28 49.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.032 -2.211 . . . . 75.239999999999995 105.032 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.41 116.22 28.67 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.277 -1.369 . . . . 64.209999999999994 109.17 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.456 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 15.6 t0 -96.21 167.03 11.45 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.46 -0.791 . . . . 74.430000000000007 109.244 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.76 -30.64 29.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.044 0.449 . . . . 71.239999999999995 109.934 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -137.64 -152.81 0.45 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.257 -0.645 . . . . 72.549999999999997 109.257 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.54 98.37 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.554 0.693 . . . . 74.040000000000006 109.941 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.2 m -124.07 84.87 2.33 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.316 -1.364 . . . . 72.120000000000005 107.316 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -62.28 -44.61 96.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.04 -0.982 . . . . 74.310000000000002 111.533 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -118.78 110.93 17.82 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.003 -1.11 . . . . 71.200000000000003 108.003 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.51 ' ND1' HG23 ' A' ' 130' ' ' ILE . 11.1 t-160 -100.22 -50.79 3.84 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.592 -1.262 . . . . 72.239999999999995 107.592 171.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.11 148.85 37.29 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.286 -1.005 . . . . 74.030000000000001 108.286 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -123.83 134.88 53.52 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.469 0.652 . . . . 71.430000000000007 110.043 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.26 124.73 50.03 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.836 -1.172 . . . . 74.420000000000002 107.836 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -115.22 127.58 55.6 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.477 -0.935 . . . . 72.230000000000004 108.477 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -121.35 113.19 38.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.351 -1.351 . . . . 75.340000000000003 107.351 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -136.3 131.02 33.81 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.817 -0.438 . . . . 63.399999999999999 109.817 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 55.67 37.05 28.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.059 0.944 . . . . 64.140000000000001 111.804 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.09 3.97 90.59 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.23 -0.895 . . . . 74.010000000000005 113.461 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -109.0 139.14 44.28 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.552 -0.536 . . . . 74.340000000000003 109.552 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -114.94 122.02 44.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.697 -0.683 . . . . 73.540000000000006 110.139 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.62 146.04 48.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.765 -0.457 . . . . 71.140000000000001 109.765 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.96 124.26 70.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.784 -1.191 . . . . 72.209999999999994 107.784 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.11 124.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.786 -0.82 . . . . 71.430000000000007 108.786 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -81.78 121.86 26.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.272 -1.01 . . . . 74.420000000000002 108.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 m -117.04 -11.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.955 -0.566 . . . . 73.340000000000003 110.876 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.35 46.9 1.1 Allowed Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 108.406 -1.878 . . . . 62.520000000000003 108.406 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.8 p -65.61 -3.16 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.773 1.229 . . . . 71.340000000000003 113.389 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.93 -26.65 59.77 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.045 -0.724 . . . . 73.400000000000006 109.045 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.648 ' OD1' ' HA ' ' A' ' 17' ' ' VAL . 94.3 m-20 -105.62 -21.72 13.13 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.77 -0.826 . . . . 74.310000000000002 108.77 174.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.07 119.27 0.27 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.122 -0.944 . . . . 73.329999999999998 114.03 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.4 m -87.07 138.27 31.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.048 -1.093 . . . . 74.299999999999997 108.048 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 84.8 m-85 -119.13 129.16 54.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.946 -0.39 . . . . 75.430000000000007 109.946 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.9 t -114.92 120.58 64.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.532 -1.655 . . . . 72.129999999999995 106.532 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 56.27 37.96 29.33 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.564 1.146 . . . . 74.329999999999998 110.967 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 mtm-85 66.19 19.68 11.1 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 114.222 -1.354 . . . . 74.340000000000003 112.74 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.51 133.19 23.03 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.24 -1.022 . . . . 73.430000000000007 108.24 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.51 123.6 11.0 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.57 1.513 . . . . 74.329999999999998 109.401 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -144.93 138.69 27.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.199 -1.037 . . . . 75.5 108.199 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -86.3 -37.73 18.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.13 0.49 . . . . 75.239999999999995 110.422 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.63 136.28 25.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.12 -1.067 . . . . 75.450000000000003 108.12 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.19 143.09 25.71 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 65.439999999999998 108.43 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -88.23 126.18 41.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.473 -2.047 . . . . 74.0 105.473 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.6 tpt -87.99 130.71 34.88 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 113.394 0.887 . . . . 73.540000000000006 113.394 -164.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.495 ' HB3' ' OD2' ' A' ' 126' ' ' ASP . 16.3 tt0 -107.72 141.9 38.55 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.38 1.472 . . . . 73.129999999999995 109.525 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -67.03 133.53 50.1 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.046 -0.724 . . . . 75.409999999999997 109.046 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.25 -2.71 56.5 Favored Glycine 0 C--O 1.252 1.269 0 N-CA-C 111.456 -0.658 . . . . 72.340000000000003 111.456 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 123' ' ' GLN . 96.7 m-20 -82.47 151.38 26.55 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.384 0.612 . . . . 73.349999999999994 110.402 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -112.32 131.54 55.46 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.516 -0.765 . . . . 75.530000000000001 109.718 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 21.2 mt -107.64 131.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 106.594 -1.632 . . . . 73.439999999999998 106.594 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.46 HE22 ' HB3' ' A' ' 25' ' ' GLU . 31.0 tt0 -112.6 118.24 34.53 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.251 -1.018 . . . . 73.140000000000001 108.251 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.51 HG23 ' ND1' ' A' ' 89' ' ' HIS . 43.7 mm -109.1 104.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.779 -1.1 . . . . 74.319999999999993 108.137 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.4 -83.95 0.64 Allowed Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.31 -0.859 . . . . 65.439999999999998 111.225 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -133.82 -12.89 2.57 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.114 0.566 . . . . 74.510000000000005 110.296 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.638 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.317 42.7 p90 -99.0 170.34 8.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 114.29 1.218 . . . . 64.099999999999994 114.29 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -118.46 126.07 51.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.604 . . . . 75.400000000000006 111.393 -164.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.09 140.23 52.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.066 -1.087 . . . . 73.099999999999994 108.066 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.3 t -115.35 127.51 72.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.253 -0.647 . . . . 75.5 109.253 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -98.33 121.28 40.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.956 -0.757 . . . . 75.450000000000003 108.956 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -140.49 160.63 39.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 110.553 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.72 127.29 32.4 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.525 -1.287 . . . . 74.450000000000003 107.525 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.13 -122.47 1.13 Allowed Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 115.423 -0.808 . . . . 70.349999999999994 113.2 -172.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 157.69 55.75 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.085 1.857 . . . . 74.420000000000002 114.273 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.75 20.97 11.62 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.408 -2.071 . . . . 71.230000000000004 105.408 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 112.803 -1.998 . . . . 75.310000000000002 108.836 -176.051 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 109.138 -0.69 . . . . 72.209999999999994 109.138 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -67.08 123.23 19.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.764 0.653 . . . . 55.119999999999997 112.764 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -109.51 160.1 16.51 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.04 -1.837 . . . . 64.209999999999994 106.04 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -57.19 118.73 5.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.087 0.858 . . . . 54.340000000000003 110.564 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -143.38 155.68 44.48 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.224 -1.399 . . . . 75.409999999999997 107.224 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.38 132.76 52.71 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.281 -1.128 . . . . 72.219999999999999 110.281 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 124.3 85.04 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 120.461 -0.496 . . . . 72.450000000000003 110.911 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.87 143.46 45.57 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.229 1.953 . . . . 70.129999999999995 109.089 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 136.65 52.31 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.601 -0.518 . . . . 74.209999999999994 109.601 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.45 142.52 95.62 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.816 2.344 . . . . 64.129999999999995 113.832 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -91.79 139.82 30.3 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.79 -1.096 . . . . 75.129999999999995 108.383 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.36 121.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.075 0.464 . . . . 75.349999999999994 110.343 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' OE2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -135.32 158.26 44.82 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.817 -1.549 . . . . 63.299999999999997 106.817 175.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 m -116.24 134.03 55.36 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 119.906 -0.718 . . . . 74.430000000000007 109.064 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . 0.54 ' O2P' ' HG2' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -101.86 154.16 19.18 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.786 -1.552 . . . . 63.43 107.226 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.1 t -81.92 115.16 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.785 0.802 . . . . 74.109999999999999 108.914 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 29.8 p90 -119.43 142.18 48.46 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.83 -1.077 . . . . 75.530000000000001 110.469 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -125.93 90.62 3.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.406 0.622 . . . . 71.329999999999998 110.616 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.24 -84.42 0.15 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.723 -0.671 . . . . 75.519999999999996 110.419 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.06 -11.47 59.91 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.621 -0.718 . . . . 72.409999999999997 109.797 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 89.8 mt -64.31 -15.83 61.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.012 -0.995 . . . . 74.219999999999999 111.784 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -45.78 90.32 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.302 -0.629 . . . . 74.340000000000003 109.302 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -86.04 -33.57 20.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 109.68 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 4.6 tp10 -59.11 -33.14 70.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.418 -0.81 . . . . 73.519999999999996 110.414 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 42.3 tpp -59.47 -49.55 77.37 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.527 -0.306 . . . . 74.540000000000006 111.585 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.46 -29.49 67.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.107 0.48 . . . . 75.540000000000006 110.927 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -73.89 -25.77 60.2 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.588 0.709 . . . . 74.120000000000005 110.583 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.457 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 8.2 t -89.71 -15.73 31.9 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.468 -0.787 . . . . 73.109999999999999 110.625 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 m -62.69 101.57 0.26 Allowed 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.384 0.611 . . . . 74.239999999999995 110.59 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.69 -146.66 15.64 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.652 -1.379 . . . . 71.109999999999999 109.652 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 54.3 m -116.43 134.25 55.08 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.277 0.539 . . . . 72.450000000000003 110.686 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.18 94.65 5.81 Favored Pre-proline 0 C--O 1.246 0.872 0 N-CA-C 109.651 -0.5 . . . . 61.520000000000003 109.651 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 32' ' ' THR . 4.0 Cg_exo -76.39 160.71 35.37 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.343 2.696 . . . . 70.109999999999999 112.818 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.82 168.84 17.66 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.48 -0.934 . . . . 73.129999999999995 108.48 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 m -117.0 158.57 23.9 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.797 -0.445 . . . . 72.420000000000002 109.797 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -92.51 154.89 18.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.454 -0.943 . . . . 75.120000000000005 108.454 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.01 -29.44 1.0 Allowed Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.671 -0.776 . . . . 65.519999999999996 111.551 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.93 80.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.727 -0.472 . . . . 73.430000000000007 109.727 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.83 -6.44 41.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.613 -0.721 . . . . 74.420000000000002 111.854 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.3 -19.95 20.22 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.873 -1.158 . . . . 65.25 107.873 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.8 mt 58.91 88.0 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 113.97 -1.468 . . . . 73.219999999999999 111.391 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.44 -58.89 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.487 2.124 . . . . 74.25 110.097 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 0.89 7.59 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.585 -0.734 . . . . 72.540000000000006 109.138 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.15 85.99 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.117 -0.947 . . . . 64.140000000000001 111.419 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -134.85 165.56 25.02 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.082 -1.451 . . . . 65.409999999999997 107.082 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 158.87 43.1 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.256 -0.646 . . . . 73.439999999999998 109.256 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.41 157.8 35.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.444 -0.206 . . . . 74.019999999999996 110.444 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.15 139.01 54.25 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.204 -1.036 . . . . 75.010000000000005 108.204 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -118.65 137.26 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 120.791 0.329 . . . . 73.25 110.136 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.83 118.22 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 106.404 -1.702 . . . . 73.310000000000002 106.404 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -94.91 -31.62 13.59 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.695 -0.684 . . . . 74.340000000000003 109.918 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -145.83 137.78 25.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.933 -0.766 . . . . 73.25 108.933 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' HE2' ' A' ' 132' ' ' LYS . . . 133.29 178.74 15.76 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.457 -1.057 . . . . 72.340000000000003 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 85.4 Cg_exo -55.3 -40.49 85.35 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.684 2.256 . . . . 73.400000000000006 112.154 177.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -90.36 16.31 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.512 -0.313 . . . . 73.019999999999996 111.593 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.96 132.7 54.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.919 0.39 . . . . 75.450000000000003 111.197 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -19.77 32.0 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.576 -0.738 . . . . 72.120000000000005 111.635 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 131.74 34.28 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.946 0.403 . . . . 73.310000000000002 110.625 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -113.3 139.15 49.08 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.107 -1.071 . . . . 75.329999999999998 108.107 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -126.68 128.07 46.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.747 -0.835 . . . . 71.120000000000005 108.747 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -88.23 130.03 35.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 74.209999999999994 110.528 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 103.86 12.46 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.087 -1.079 . . . . 75.349999999999994 108.087 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -121.46 -5.62 9.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.375 1.083 . . . . 72.409999999999997 108.545 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -107.95 142.14 24.62 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 114.128 -1.396 . . . . 74.409999999999997 110.487 -175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.79 -32.0 93.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.524 2.816 . . . . 75.310000000000002 112.942 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -143.6 122.04 12.41 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 109.251 -0.648 . . . . 75.239999999999995 109.251 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.41 HG22 HG12 ' A' ' 78' ' ' ILE . 21.0 m -114.54 113.92 25.07 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.844 -1.169 . . . . 74.340000000000003 107.844 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.3 p -89.8 138.43 31.49 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 111.65 0.241 . . . . 73.129999999999995 111.65 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.51 55.75 Favored 'General case' 0 C--O 1.267 2.025 0 N-CA-C 109.14 -0.689 . . . . 74.030000000000001 109.14 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.49 -145.39 11.33 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.022 -0.99 . . . . 43.32 110.723 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' C ' ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -105.84 151.81 24.05 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 122.994 0.518 . . . . 73.230000000000004 111.909 -177.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t-80 76.75 143.39 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.93 1.292 . . . . 75.319999999999993 110.407 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 88.0 Cg_exo -48.28 -6.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 124.846 3.697 . . . . 74.209999999999994 116.688 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.83 -24.63 59.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.662 -0.866 . . . . 74.200000000000003 108.662 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.422 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 19.4 m -92.07 115.37 28.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 106.56 -1.644 . . . . 75.310000000000002 106.56 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.53 -36.25 77.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.941 -0.572 . . . . 73.219999999999999 111.409 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 68' ' ' THR . 42.3 mm -106.7 99.56 8.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.016 -1.105 . . . . 72.109999999999999 108.016 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -93.36 110.3 21.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.727 -0.67 . . . . 74.450000000000003 109.901 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 87.0 mt -116.64 122.5 44.76 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.34 -1.356 . . . . 74.510000000000005 107.34 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.11 117.08 29.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.662 -0.815 . . . . 61.109999999999999 109.896 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 132' ' ' LYS . 10.0 t70 -120.62 -165.11 1.16 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.385 -0.968 . . . . 75.450000000000003 108.385 -173.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.41 -35.51 19.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.403 -0.962 . . . . 75.430000000000007 108.403 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.421 ' HB ' ' CE1' ' A' ' 18' ' ' PHE . 83.2 m -145.63 99.44 3.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.261 -1.015 . . . . 74.450000000000003 108.261 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG21 ' H ' ' A' ' 82' ' ' ASP . 7.1 t -88.78 131.48 36.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.677 -0.49 . . . . 72.409999999999997 109.677 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -79.25 157.78 27.71 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.785 -0.643 . . . . 72.519999999999996 110.304 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.54 ' HG2' ' O2P' ' A' ' 15' ' ' TPO . 18.4 ptp180 -62.76 -45.86 90.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 74.430000000000007 109.68 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -147.25 99.55 3.16 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 103.784 -2.673 . . . . 74.439999999999998 103.784 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.508 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 5.1 t60 -79.32 -50.26 11.15 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.915 -1.513 . . . . 71.340000000000003 106.915 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.25 163.02 40.74 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.468 -1.242 . . . . 44.43 109.539 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.49 141.38 48.76 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 109.076 -0.712 . . . . 72.420000000000002 109.076 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.83 114.08 28.08 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.712 -1.959 . . . . 71.540000000000006 105.712 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -109.95 127.5 54.8 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-N 114.736 -1.12 . . . . 74.219999999999999 110.488 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 94' ' ' ILE . 3.0 mp -109.04 112.12 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 104.099 -2.556 . . . . 73.319999999999993 104.099 176.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -135.48 121.09 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.225 -0.657 . . . . 62.240000000000002 109.225 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 56.53 37.85 29.16 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.379 1.05 . . . . 61.200000000000003 110.687 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.47 88.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.359 -0.837 . . . . 73.019999999999996 113.469 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.48 141.31 36.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.912 -0.774 . . . . 75.219999999999999 108.912 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -111.4 117.01 31.9 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.222 -0.658 . . . . 74.430000000000007 109.222 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 146.2 52.29 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.793 0.33 . . . . 75.230000000000004 111.775 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.79 123.37 57.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.18 -1.785 . . . . 74.439999999999998 106.18 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.1 t -119.15 126.51 75.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.103 -0.703 . . . . 63.32 109.103 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -81.05 123.54 28.45 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.197 -1.409 . . . . 73.340000000000003 107.197 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.38 14.55 7.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-O 121.049 0.452 . . . . 64.120000000000005 111.244 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.492 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . -108.9 -30.68 3.62 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.41 -1.076 . . . . 73.349999999999994 110.41 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.3 p 67.43 -52.86 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.55 2.34 . . . . 73.230000000000004 113.56 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.31 -20.43 60.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.902 0.382 . . . . 74.510000000000005 111.037 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.508 ' OD1' ' HA ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -87.28 -20.25 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.227 1.195 . . . . 74.349999999999994 114.227 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.06 87.0 0.04 OUTLIER Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.344 0.897 . . . . 64.109999999999999 115.344 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.9 m -79.51 137.59 37.24 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 73.430000000000007 108.787 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.508 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 30.1 m-85 -113.06 126.87 55.95 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.539 -0.465 . . . . 73.310000000000002 109.97 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.45 135.93 55.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 105.006 -2.22 . . . . 73.140000000000001 105.006 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m120 53.47 34.74 18.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 75.409999999999997 107.601 -165.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 29' ' ' SER . 37.9 mtm180 57.92 12.76 1.85 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.025 1.12 . . . . 74.200000000000003 114.025 -175.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -104.27 134.17 19.83 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.84 -0.8 . . . . 73.510000000000005 108.84 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.04 123.49 12.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.12 1.88 . . . . 73.129999999999995 111.657 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -140.62 165.39 27.59 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 116.079 -0.509 . . . . 74.209999999999994 110.825 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -103.91 -36.74 7.68 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.282 -1.007 . . . . 72.140000000000001 108.282 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.24 134.85 17.44 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.63 -1.248 . . . . 63.149999999999999 107.63 173.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.31 143.63 22.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.137 -0.69 . . . . 73.349999999999994 109.137 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.75 125.63 34.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.605 -0.887 . . . . 73.219999999999999 108.605 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -90.06 130.27 36.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 64.420000000000002 110.19 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -113.79 156.41 23.9 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.128 -0.942 . . . . 74.329999999999998 109.717 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.3 t -67.53 124.64 23.79 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 121.387 0.613 . . . . 75.019999999999996 109.565 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.09 57.56 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.909 -0.877 . . . . 72.450000000000003 110.909 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -79.92 151.84 29.89 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.77 125.91 50.68 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.024 -0.732 . . . . 74.310000000000002 109.024 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -109.33 129.55 63.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 106.846 -1.538 . . . . 73.519999999999996 106.846 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 54.8 tp60 -110.05 123.22 49.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.274 -1.01 . . . . 73.319999999999993 108.274 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.4 mt -128.77 104.17 10.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.782 -1.192 . . . . 65.120000000000005 107.782 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.21 -117.21 8.25 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.4 -1.48 . . . . 55.310000000000002 109.4 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.445 ' HG3' ' OD2' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -106.46 5.75 29.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.289 0.566 . . . . 75.319999999999993 110.894 175.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.59 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 69.6 m-85 -85.37 133.21 34.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.676 -0.693 . . . . 75.129999999999995 111.091 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -110.8 119.22 38.39 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.187 -2.153 . . . . 75.219999999999999 105.187 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 mt -114.87 139.85 49.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.018 -0.734 . . . . 74.109999999999999 109.018 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.21 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.309 -0.997 . . . . 62.340000000000003 108.309 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.75 127.72 38.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.283 -0.636 . . . . 64.299999999999997 109.283 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.61 130.78 42.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.229 0.538 . . . . 74.400000000000006 110.582 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.96 122.79 44.13 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.575 -0.898 . . . . 74.019999999999996 108.575 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.0 -144.17 3.87 Favored Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.282 -1.437 . . . . 62.43 113.088 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.83 146.7 60.52 Favored 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.681 2.921 . . . . 74.219999999999999 113.157 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 179.66 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.992 1.317 . . . . 74.340000000000003 108.526 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 107.462 -1.31 . . . . 74.150000000000006 107.462 -176.065 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 C--O 1.245 0.866 0 CA-C-O 121.006 0.431 . . . . 74.219999999999999 110.008 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -63.71 127.78 32.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.174 -0.921 . . . . 74.409999999999997 111.267 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -88.0 -177.03 5.66 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.515 -0.766 . . . . 75.200000000000003 110.353 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.65 99.8 2.65 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 113.32 0.859 . . . . 75.420000000000002 113.32 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -90.0 98.4 11.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.957 -1.868 . . . . 73.329999999999998 105.957 169.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 -167.52 31.27 Favored Glycine 0 N--CA 1.416 -2.681 0 C-N-CA 120.558 -0.829 . . . . 70.439999999999998 112.266 -175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.8 m -125.06 123.78 25.4 Favored Pre-proline 0 C--N 1.283 -2.317 0 N-CA-C 107.259 -1.386 . . . . 74.329999999999998 107.259 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.28 150.01 52.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.13 1.887 . . . . 74.150000000000006 110.939 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.64 120.5 81.65 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.883 -0.784 . . . . 61.049999999999997 108.883 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -54.05 102.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.553 2.836 . . . . 74.200000000000003 113.877 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -103.63 168.49 9.11 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.203 -2.147 . . . . 75.349999999999994 105.203 172.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.4 119.32 55.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 106.74 -1.578 . . . . 71.109999999999999 106.74 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -159.42 148.01 17.85 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 103.96 -2.608 . . . . 71.420000000000002 103.96 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -123.57 129.12 50.71 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.298 -0.63 . . . . 73.209999999999994 109.298 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -88.74 144.2 26.42 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 112.091 -172.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 58.6 t -93.85 115.7 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.553 -2.017 . . . . 73.129999999999995 105.553 170.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -108.04 127.5 53.83 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.152 -1.019 . . . . 75.0 111.544 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -106.96 101.91 11.31 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 109.468 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.56 166.21 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.928 -0.578 . . . . 64.209999999999994 111.539 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.08 -6.99 19.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.136 1.374 . . . . 74.230000000000004 112.25 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.64 -25.42 60.12 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.51 0.93 . . . . 61.520000000000003 113.51 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 88.4 mt -81.47 -28.59 34.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 111.806 0.299 . . . . 74.150000000000006 111.806 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -53.95 -45.43 71.3 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.883 0.873 . . . . 73.200000000000003 111.878 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 26' ' ' MET . 8.0 pt-20 -70.19 -37.02 75.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.823 0.344 . . . . 72.150000000000006 111.888 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.425 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 22.9 ptp -79.79 -27.36 40.36 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 112.596 0.591 . . . . 75.420000000000002 112.596 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 48.3 mt-10 -58.4 -49.46 77.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.974 0.352 . . . . 72.400000000000006 111.18 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -68.74 -26.41 65.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.632 -0.713 . . . . 74.25 110.878 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.7 t -88.17 -22.74 23.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.655 -0.702 . . . . 73.540000000000006 110.409 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.3 m -97.31 105.87 18.09 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.64 0.733 . . . . 71.430000000000007 112.097 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.9 -29.13 0.76 Allowed Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.287 -1.525 . . . . 73.049999999999997 109.287 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -116.11 148.99 39.71 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.77 -0.826 . . . . 74.310000000000002 108.77 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.47 138.92 20.68 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.652 -1.61 . . . . 72.510000000000005 106.652 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.25 142.52 91.83 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.125 1.884 . . . . 64.349999999999994 112.784 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.36 149.49 51.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.079 -0.712 . . . . 64.450000000000003 109.079 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -129.23 139.56 51.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.797 0.332 . . . . 70.420000000000002 110.624 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 m -79.34 115.07 18.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 71.329999999999998 108.036 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.16 8.2 22.05 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 110.622 -0.991 . . . . 64.519999999999996 110.622 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.09 87.67 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 123.514 0.725 . . . . 70.409999999999997 111.75 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.89 1.9 56.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.054 -0.521 . . . . 75.430000000000007 111.532 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -33.39 12.0 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.433 -1.321 . . . . 75.400000000000006 107.433 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.4 mm? 59.73 84.06 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 108.17 -1.048 . . . . 70.310000000000002 108.17 -173.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 6.8 Cg_endo -42.7 -61.85 0.5 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.593 3.529 . . . . 74.140000000000001 115.328 -168.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -13.77 40.69 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.201 -0.599 . . . . 74.209999999999994 112.151 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.22 -4.86 77.89 Favored Glycine 0 C--N 1.317 -0.5 0 C-N-CA 121.111 -0.566 . . . . 72.109999999999999 112.253 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.7 m -133.93 163.65 29.04 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.922 -0.769 . . . . 74.120000000000005 108.922 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.39 150.81 36.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.367 -0.605 . . . . 74.409999999999997 109.367 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.51 148.57 44.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.067 -0.515 . . . . 73.340000000000003 110.556 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -105.32 133.9 49.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.637 -0.875 . . . . 65.019999999999996 108.637 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.4 128.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.584 -0.895 . . . . 75.030000000000001 108.584 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.1 t -77.18 118.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.593 -1.632 . . . . 65.099999999999994 106.593 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -89.73 -33.92 16.4 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.231 0.539 . . . . 73.430000000000007 109.666 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 2.2 tpm_? -144.79 136.95 26.06 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.989 -1.115 . . . . 71.430000000000007 107.989 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.17 -171.45 25.64 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 109.442 -1.463 . . . . 52.119999999999997 109.442 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.32 -43.64 5.81 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.522 2.148 . . . . 75.319999999999993 111.067 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.16 22.7 5.63 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.308 -0.86 . . . . 70.230000000000004 112.005 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.49 129.78 42.2 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.979 0.419 . . . . 74.430000000000007 111.069 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.97 -21.46 29.49 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.684 -0.689 . . . . 74.299999999999997 111.379 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.03 29.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.725 0.298 . . . . 72.420000000000002 110.224 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -128.8 139.05 52.36 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.721 -0.844 . . . . 75.349999999999994 108.721 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.09 131.12 53.81 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.981 -0.748 . . . . 73.310000000000002 108.981 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.3 tp -89.55 126.82 35.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.983 -0.377 . . . . 73.030000000000001 109.983 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -82.58 103.99 12.52 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.175 -0.676 . . . . 73.450000000000003 109.175 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -126.65 5.28 6.76 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 123.006 1.384 . . . . 71.140000000000001 108.061 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.81 149.75 39.4 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 114.197 -1.365 . . . . 72.420000000000002 108.792 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.99 -16.04 32.44 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.615 2.21 . . . . 71.219999999999999 113.036 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 90.3 m -154.58 128.85 9.01 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.05 -0.722 . . . . 74.299999999999997 109.05 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 20.5 m -118.58 121.38 40.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 m -96.28 130.24 43.42 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.609 -0.515 . . . . 65.540000000000006 109.609 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.04 139.4 53.35 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 116.414 -0.357 . . . . 73.120000000000005 110.19 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.37 -161.0 30.97 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.217 -1.553 . . . . 75.040000000000006 109.217 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 16.7 ttp180 -119.45 116.99 27.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 118.116 0.958 . . . . 74.349999999999994 109.544 176.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER 152.94 156.74 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 104.621 -2.363 . . . . 72.430000000000007 104.621 176.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.85 -9.29 15.98 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.443 2.096 . . . . 73.340000000000003 113.258 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.07 -18.45 60.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.461 . . . . 75.019999999999996 110.728 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 m -98.02 123.58 42.1 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 116.134 -0.485 . . . . 71.109999999999999 109.722 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.19 -42.74 96.54 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.521 -0.918 . . . . 75.450000000000003 108.521 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.52 104.74 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 106.444 -1.687 . . . . 61.25 106.444 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 72' ' ' ARG . 59.6 t80 -88.03 113.93 24.15 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.671 -0.695 . . . . 74.319999999999993 109.149 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 2.8 mm? -110.36 113.4 26.03 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.489 -0.93 . . . . 73.530000000000001 108.489 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 29.2 t70 -79.11 118.32 20.97 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.025 0.44 . . . . 72.319999999999993 110.745 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -133.08 178.0 7.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.259 -1.015 . . . . 64.549999999999997 108.259 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.07 -28.99 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 124.084 0.954 . . . . 75.140000000000001 109.247 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.401 ' HB ' HD22 ' A' ' 108' ' ' ASN . 0.7 OUTLIER -104.11 152.98 21.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.716 -0.675 . . . . 74.129999999999995 110.52 -174.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -92.19 97.46 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.698 -0.853 . . . . 74.109999999999999 108.698 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -99.81 87.83 3.63 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.595 -0.891 . . . . 64.319999999999993 108.595 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -66.92 -28.97 68.74 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.655 -0.702 . . . . 72.319999999999993 112.513 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -145.29 91.28 2.11 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.125 -1.805 . . . . 73.129999999999995 106.125 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 31.3 t60 -100.63 -52.81 3.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.053 -1.059 . . . . 71.430000000000007 112.075 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.17 141.93 46.01 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.48 -0.763 . . . . 74.310000000000002 109.158 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -122.58 129.41 51.89 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.304 -0.999 . . . . 61.210000000000001 108.304 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 67' ' ' THR . 7.7 m-85 -105.2 117.83 35.0 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.403 -1.703 . . . . 64.219999999999999 106.403 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -109.75 119.23 38.71 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.643 -0.873 . . . . 75.040000000000006 108.643 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 94' ' ' ILE . 3.3 mp -111.96 113.29 43.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.684 -1.598 . . . . 74.420000000000002 106.684 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -138.92 123.89 18.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.943 -0.391 . . . . 72.030000000000001 109.943 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.39 36.8 26.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.413 1.085 . . . . 75.409999999999997 112.128 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 3.53 90.45 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.977 -0.63 . . . . 71.310000000000002 113.19 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -100.89 131.23 46.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.475 -0.935 . . . . 70.239999999999995 108.475 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -108.13 116.42 31.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.324 -0.991 . . . . 71.310000000000002 108.324 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -123.6 126.16 46.14 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.335 -0.616 . . . . 74.209999999999994 109.335 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.41 123.13 56.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.511 -1.292 . . . . 74.329999999999998 107.511 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.48 138.04 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 115.586 -0.733 . . . . 54.100000000000001 110.648 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 106.141 -1.8 . . . . 73.219999999999999 106.141 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.0 m -92.41 17.07 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.756 0.65 . . . . 74.510000000000005 112.756 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.26 47.28 4.72 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 107.728 -2.149 . . . . 53.409999999999997 107.728 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.7 m -79.28 175.98 10.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.467 -0.866 . . . . 70.120000000000005 112.654 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 2.3 mm? -101.72 -28.17 12.62 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.578 0.955 . . . . 64.019999999999996 113.578 -171.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -86.61 -20.47 27.82 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 118.518 -1.273 . . . . 75.140000000000001 111.127 -173.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.79 100.13 2.29 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 119.337 -1.411 . . . . 75.209999999999994 112.615 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 m -87.41 129.13 35.15 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.52 -0.918 . . . . 53.0 108.52 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 20.4 m-85 -127.96 126.7 41.92 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.969 -1.123 . . . . 74.319999999999993 107.969 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -111.7 131.84 61.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.129 -1.434 . . . . 74.540000000000006 107.129 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.661 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 17.4 m120 57.78 38.29 27.32 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.608 0.763 . . . . 73.109999999999999 110.187 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.76 14.46 7.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.966 1.307 . . . . 75.209999999999994 113.211 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.64 145.24 37.11 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 122.351 -0.218 . . . . 74.519999999999996 110.523 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.09 123.55 13.42 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.607 1.538 . . . . 72.310000000000002 108.431 171.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -139.5 145.85 39.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.828 -1.175 . . . . 72.430000000000007 107.828 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -103.31 -44.04 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.934 -0.306 . . . . 75.209999999999994 110.85 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.14 24.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.007 -1.108 . . . . 72.329999999999998 108.007 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -150.26 134.59 17.21 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.783 -0.367 . . . . 74.200000000000003 111.264 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.6 t -78.9 114.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 104.584 -2.376 . . . . 74.040000000000006 104.584 170.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 80.3 mtp -97.09 144.59 26.8 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.721 1.008 . . . . 74.409999999999997 113.721 -172.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.526 ' HG3' ' OD2' ' A' ' 126' ' ' ASP . 4.8 pp0? -119.73 157.84 27.74 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.0 -1.455 . . . . 74.120000000000005 108.328 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.3 p -58.83 126.87 29.46 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 123.508 0.723 . . . . 72.319999999999993 111.62 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.56 -5.53 54.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.927 -0.579 . . . . 71.340000000000003 113.327 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' A' ' 123' ' ' GLN . 73.3 m-20 -76.81 143.91 39.47 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 117.799 0.799 . . . . 73.129999999999995 109.337 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.661 ' OE1' ' HA ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -112.57 145.44 40.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.045 0.45 . . . . 75.409999999999997 111.412 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 41.1 mt -116.71 126.91 74.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.579 -0.897 . . . . 74.040000000000006 108.579 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 24.3 tp60 -104.81 113.45 27.05 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 104.941 -2.244 . . . . 75.420000000000002 104.941 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 62.8 mt -109.28 103.87 16.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.91 -1.144 . . . . 72.200000000000003 107.91 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.16 -98.84 0.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 CA-C-N 115.206 -0.906 . . . . 63.520000000000003 111.266 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -119.44 2.67 11.28 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.937 1.088 . . . . 72.510000000000005 113.937 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.25 25.4 p90 -131.23 168.97 16.6 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.549 -0.719 . . . . 72.340000000000003 112.19 176.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -129.22 138.96 52.0 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 113.037 0.754 . . . . 74.439999999999998 113.037 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.87 139.79 53.19 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.682 -1.599 . . . . 74.450000000000003 106.682 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.63 140.2 40.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 109.42 -0.585 . . . . 73.209999999999994 109.42 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -92.9 115.5 28.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.048 -0.723 . . . . 73.299999999999997 109.048 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.06 159.95 22.96 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.121 0.486 . . . . 75.230000000000004 111.691 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.77 131.46 39.81 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.84 -0.8 . . . . 74.439999999999998 108.84 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.06 143.0 15.92 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.309 -0.948 . . . . 73.340000000000003 110.922 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -59.24 156.0 37.38 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.592 2.194 . . . . 62.450000000000003 111.567 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.83 61.22 6.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.313 1.054 . . . . 74.239999999999995 109.451 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.292 -1.919 0 CA-C-N 113.107 -1.861 . . . . 74.530000000000001 109.846 -179.983 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 108.811 -0.811 . . . . 65.409999999999997 108.811 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m 76.6 4.24 3.51 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.212 1.405 . . . . 70.530000000000001 110.386 -172.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.75 121.9 44.97 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.817 -1.083 . . . . 74.310000000000002 109.504 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -147.93 179.53 7.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.37 -1.344 . . . . 73.400000000000006 107.37 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 65' ' ' GLN . 21.3 m120 -137.97 140.55 40.28 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 120.755 -0.378 . . . . 73.109999999999999 111.244 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.61 98.7 1.29 Allowed Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 107.089 -2.404 . . . . 60.539999999999999 107.089 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -78.75 144.26 64.24 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-O 120.434 0.159 . . . . 73.340000000000003 110.915 -170.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 143.09 99.6 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.528 2.152 . . . . 72.349999999999994 109.144 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.18 140.55 57.12 Favored Pre-proline 0 C--N 1.291 -1.944 0 C-N-CA 119.928 -0.709 . . . . 73.150000000000006 110.68 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.29 103.5 0.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.272 1.982 . . . . 71.099999999999994 110.178 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -92.18 156.41 17.35 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.893 -1.521 . . . . 75.239999999999995 106.893 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.2 t -108.05 121.05 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.102 -0.703 . . . . 74.329999999999998 109.102 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -158.53 132.21 7.63 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.863 -1.162 . . . . 75.420000000000002 107.863 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -75.64 134.1 40.7 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.087 -1.079 . . . . 74.420000000000002 108.087 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -88.65 120.53 30.13 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.223 -1.399 . . . . 71.120000000000005 107.223 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.61 134.56 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 120.952 0.406 . . . . 72.010000000000005 111.304 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -123.18 141.35 52.07 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.111 -1.07 . . . . 73.319999999999993 108.111 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -83.78 137.29 33.8 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.275 -0.57 . . . . 74.409999999999997 109.808 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.93 151.19 23.45 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.411 -0.588 . . . . 64.409999999999997 109.411 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.08 2.76 56.08 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.844 0.831 . . . . 73.340000000000003 110.869 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.485 HD13 ' CZ ' ' A' ' 111' ' ' TYR . 1.9 pp -58.95 -17.45 24.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.274 1.213 . . . . 74.329999999999998 114.274 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 22' ' ' LEU . 2.2 pt? -70.25 -7.71 44.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.215 0.531 . . . . 75.400000000000006 111.765 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -80.41 -28.47 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.562 -0.903 . . . . 73.340000000000003 108.562 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.54 -22.05 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.005 -1.109 . . . . 74.310000000000002 108.005 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.5 ttp -53.95 -49.54 68.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 75.439999999999998 111.175 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -9.96 58.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.065 0.459 . . . . 72.109999999999999 111.844 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -78.64 -39.26 37.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.435 -0.802 . . . . 72.230000000000004 110.112 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -87.13 -17.79 31.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.694 0.627 . . . . 64.200000000000003 112.694 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.1 m -72.61 114.0 10.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.48 -0.563 . . . . 74.200000000000003 109.48 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.6 -59.32 0.2 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.485 -1.046 . . . . 61.420000000000002 110.485 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.7 p -114.85 121.33 42.93 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.914 -0.314 . . . . 71.239999999999995 110.509 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.86 53.0 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 109.208 -0.664 . . . . 43.0 109.208 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.64 156.56 60.82 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 121.81 1.674 . . . . 72.239999999999995 108.805 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.17 124.65 21.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.87 -1.159 . . . . 53.240000000000002 107.87 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 124' ' ' THR . 10.3 m -98.78 -10.84 22.49 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.879 -0.6 . . . . 75.349999999999994 112.205 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -73.47 147.48 44.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.545 -0.752 . . . . 75.329999999999998 109.987 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 -15.08 7.72 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.327 -1.109 . . . . 63.119999999999997 110.327 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.03 68.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.198 0.523 . . . . 64.230000000000004 111.322 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 41' ' ' ASN . 11.6 pt-20 -70.81 -22.13 62.38 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.255 -0.884 . . . . 74.319999999999993 112.15 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 m-20 -96.21 -13.84 23.17 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.83 -0.433 . . . . 73.420000000000002 109.83 -175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt 55.05 66.62 3.8 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 114.98 -1.009 . . . . 75.109999999999999 110.634 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.65 -55.79 2.48 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.274 2.649 . . . . 65.239999999999995 113.569 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.72 -20.52 42.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.895 -0.593 . . . . 64.140000000000001 111.752 -176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -5.44 77.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.555 -0.831 . . . . 65.319999999999993 111.903 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -152.86 161.0 43.1 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.637 -1.246 . . . . 51.210000000000001 107.637 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.44 157.52 44.0 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.521 -0.548 . . . . 73.409999999999997 109.521 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pp -137.45 155.78 48.93 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 111.905 0.335 . . . . 75.310000000000002 111.905 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -116.22 133.67 55.77 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.001 -1.111 . . . . 71.25 108.001 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.11 133.86 51.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.57 -0.9 . . . . 73.040000000000006 108.57 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.27 118.69 31.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.765 -1.568 . . . . 75.099999999999994 106.765 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -83.26 -31.83 26.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.636 -0.711 . . . . 73.109999999999999 110.302 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -160.42 150.66 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.937 -1.505 . . . . 73.109999999999999 106.937 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.65 -167.72 17.96 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 110.217 -1.153 . . . . 62.509999999999998 110.217 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.58 -49.86 9.42 Favored 'Trans proline' 0 N--CA 1.479 0.668 0 C-N-CA 122.802 2.334 . . . . 73.239999999999995 112.257 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.6 22.54 3.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.227 -0.442 . . . . 72.150000000000006 112.045 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.23 128.73 38.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.859 0.362 . . . . 74.400000000000006 111.346 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.71 40.28 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.626 -0.715 . . . . 73.099999999999994 111.528 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 156.91 18.02 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.999 0.428 . . . . 74.209999999999994 110.155 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 139.49 30.87 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.792 -0.64 . . . . 75.310000000000002 109.564 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.39 134.05 55.46 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.2 -0.667 . . . . 73.010000000000005 109.2 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -90.79 143.77 26.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.024 -0.732 . . . . 64.299999999999997 109.024 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -111.43 110.7 21.27 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.013 0.375 . . . . 73.439999999999998 112.013 -174.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -138.35 59.56 1.64 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.849 -1.537 . . . . 65.340000000000003 106.849 168.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.409 ' HB2' ' OD1' ' A' ' 5' ' ' ASN . 19.7 pt20 -146.35 140.89 15.79 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 112.884 -1.962 . . . . 75.0 107.544 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.36 -22.11 71.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.271 1.98 . . . . 73.329999999999998 113.679 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -148.79 122.23 9.08 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.539 -0.726 . . . . 73.420000000000002 111.677 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 m -113.21 113.84 25.9 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.176 -1.416 . . . . 74.540000000000006 107.176 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.7 m -94.17 138.51 32.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.089 -0.645 . . . . 72.239999999999995 109.582 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 134.76 55.01 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 109.62 -0.511 . . . . 74.430000000000007 109.62 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.26 -119.1 0.9 Allowed Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.159 -0.928 . . . . 75.420000000000002 111.687 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -118.89 152.46 36.26 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.706 0.402 . . . . 72.530000000000001 110.825 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.1 m170 90.37 151.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 125.77 1.628 . . . . 73.430000000000007 111.057 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.48 -5.71 16.69 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.02 2.48 . . . . 73.439999999999998 111.799 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.68 -26.25 60.64 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.214 -1.032 . . . . 75.310000000000002 108.214 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -83.68 122.21 28.31 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.309 -1.367 . . . . 75.430000000000007 107.309 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.02 -32.38 74.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.317 0.579 . . . . 72.340000000000003 110.902 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tp -119.41 113.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-O 121.679 0.752 . . . . 75.129999999999995 109.137 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -88.01 138.18 31.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.977 -1.011 . . . . 73.239999999999995 110.542 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.5 mt -123.82 138.76 54.44 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.29 -0.633 . . . . 64.239999999999995 109.29 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.82 127.55 38.87 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.997 -1.112 . . . . 73.450000000000003 107.997 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 83' ' ' VAL . 16.8 t70 -149.56 -161.4 1.34 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.839 -1.911 . . . . 72.219999999999999 105.839 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.413 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 46.7 t -62.61 -36.51 75.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.791 0.805 . . . . 74.310000000000002 109.665 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.0 m -149.51 125.78 10.78 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.93 -1.137 . . . . 75.519999999999996 107.93 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.59 135.23 43.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.825 -0.435 . . . . 74.319999999999993 109.825 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 159.84 27.95 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.793 -0.447 . . . . 75.420000000000002 109.793 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -57.66 -46.39 84.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.333 0.653 . . . . 63.439999999999998 110.534 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -146.34 109.72 4.76 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 103.755 -2.683 . . . . 74.450000000000003 103.755 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -90.25 -52.11 5.1 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.551 0.691 . . . . 73.530000000000001 109.611 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.59 156.05 41.3 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.59 -0.732 . . . . 74.120000000000005 109.049 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.487 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 10.0 pt-20 -134.59 134.19 41.02 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.306 0.574 . . . . 74.510000000000005 109.564 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -104.95 112.89 26.18 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.126 -2.175 . . . . 75.430000000000007 105.126 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.487 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 23.5 mtp180 -108.44 135.99 48.82 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.828 -0.624 . . . . 75.230000000000004 110.423 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.415 HG13 ' CD1' ' A' ' 99' ' ' PHE . 1.8 mp -103.59 111.68 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.664 0 N-CA-C 102.283 -3.229 . . . . 74.5 102.283 173.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -129.12 116.56 19.43 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.93 -0.767 . . . . 65.540000000000006 108.93 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 51.04 37.56 18.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.873 1.269 . . . . 75.439999999999998 111.822 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.3 -1.96 87.49 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.013 -0.54 . . . . 72.340000000000003 113.578 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.39 145.71 29.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.279 -1.008 . . . . 73.340000000000003 108.279 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.415 ' CD1' HG13 ' A' ' 94' ' ' ILE . 92.2 m-85 -104.7 117.94 35.33 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.223 -1.399 . . . . 64.319999999999993 107.223 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -129.49 130.75 46.24 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.319 0.58 . . . . 74.099999999999994 111.185 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.52 122.62 56.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.889 -1.152 . . . . 73.409999999999997 107.889 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.48 132.7 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 116.187 -0.461 . . . . 65.439999999999998 110.834 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -80.27 134.64 36.11 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.157 -1.423 . . . . 75.329999999999998 107.157 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.07 13.56 2.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.438 0.637 . . . . 73.019999999999996 111.226 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.89 74.85 0.09 OUTLIER Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.108 -1.197 . . . . 64.219999999999999 110.108 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 63.4 m -64.63 75.38 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.779 1.029 . . . . 73.329999999999998 113.779 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.81 -47.99 9.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.848 -1.538 . . . . 72.519999999999996 106.848 170.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -105.86 -20.0 13.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.966 -1.47 . . . . 75.019999999999996 108.631 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.72 99.33 0.04 OUTLIER Glycine 0 C--O 1.21 -1.385 0 N-CA-C 108.29 -1.924 . . . . 73.049999999999997 108.29 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.2 m -60.14 132.44 53.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.868 0.842 . . . . 74.200000000000003 112.904 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 83.4 m-85 -101.86 126.69 48.8 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 115.367 -0.833 . . . . 75.239999999999995 108.777 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.52 137.91 53.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.498 -1.667 . . . . 73.150000000000006 106.498 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 57.62 38.15 27.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.402 0.681 . . . . 71.109999999999999 109.693 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 59.4 26.13 14.98 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.825 -1.08 . . . . 75.5 111.923 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.8 153.0 71.67 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.585 0.354 . . . . 73.400000000000006 110.366 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.62 129.55 31.44 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.348 2.032 . . . . 74.239999999999995 109.671 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -140.42 165.5 27.24 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.768 -0.456 . . . . 75.209999999999994 109.768 -173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.91 -41.53 1.81 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.363 -0.606 . . . . 75.299999999999997 109.363 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.29 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.655 -1.239 . . . . 73.349999999999994 107.655 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -153.11 133.61 13.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 121.124 -0.23 . . . . 72.329999999999998 111.57 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.2 t -81.56 115.6 24.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 104.658 -2.349 . . . . 74.530000000000001 104.658 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.6 ptm -90.46 149.87 22.05 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.736 0.779 . . . . 75.439999999999998 112.694 -169.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 72.2 mt-30 -107.57 157.84 17.72 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.46 -1.246 . . . . 72.25 108.617 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' SER . 11.5 t -70.66 130.83 42.8 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.912 -0.715 . . . . 73.219999999999999 109.597 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.2 55.67 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 110.96 -0.856 . . . . 71.400000000000006 110.96 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 10.8 t0 -69.57 144.63 53.0 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 108.995 -0.743 . . . . 74.329999999999998 108.995 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.64 126.37 47.51 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.068 0.461 . . . . 74.239999999999995 109.875 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 70.9 mt -110.08 115.6 50.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.793 -1.094 . . . . 72.129999999999995 108.867 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.4 ' HG2' HD21 ' A' ' 22' ' ' LEU . 54.1 tt0 -105.22 123.62 48.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.584 -0.524 . . . . 65.239999999999995 109.584 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.71 129.19 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.428 0.691 . . . . 72.239999999999995 109.846 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.52 -86.4 1.46 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 109.837 -1.305 . . . . 62.009999999999998 109.837 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB2' ' HZ3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -155.94 14.32 0.34 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.288 0.635 . . . . 74.420000000000002 109.461 171.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -130.64 170.13 14.71 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.189 -0.671 . . . . 75.329999999999998 109.189 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -137.76 150.09 46.96 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.896 1.443 . . . . 74.129999999999995 114.896 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 mt -102.77 134.55 45.98 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.195 -1.78 . . . . 70.120000000000005 106.195 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.6 t -111.97 124.09 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.391 -0.966 . . . . 73.409999999999997 108.391 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -98.9 126.15 44.49 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 122.244 0.217 . . . . 74.329999999999998 110.918 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -133.81 147.48 51.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.42 -0.585 . . . . 71.510000000000005 109.42 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.59 118.69 18.7 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.621 -2.362 . . . . 73.310000000000002 104.621 169.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.04 -82.48 0.59 Allowed Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 118.502 -1.809 . . . . 54.130000000000003 113.959 -169.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.92 142.36 47.04 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 121.599 1.532 . . . . 74.540000000000006 113.859 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.48 36.7 1.67 Allowed 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 104.223 -2.51 . . . . 73.129999999999995 104.223 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.428 -1.545 0 CA-C-N 112.345 -2.207 . . . . 71.109999999999999 109.806 -171.027 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.398 -0.593 . . . . 71.299999999999997 109.398 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -64.89 140.25 58.85 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 112.287 0.477 . . . . 62.140000000000001 112.287 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -104.79 111.0 23.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.656 -0.702 . . . . 75.420000000000002 111.063 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.62 143.77 48.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.976 -1.49 . . . . 74.299999999999997 106.976 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.12 133.99 49.06 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.303 -0.258 . . . . 74.099999999999994 110.303 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.93 120.99 24.38 Favored Glycine 0 N--CA 1.44 -1.058 0 O-C-N 123.813 0.695 . . . . 71.120000000000005 111.836 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -90.85 134.82 29.68 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 109.416 -0.587 . . . . 71.310000000000002 109.416 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.54 132.52 11.11 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.054 1.836 . . . . 73.310000000000002 111.32 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -80.32 127.97 74.5 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.26 -0.644 . . . . 75.129999999999995 109.26 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.71 134.55 47.82 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.373 2.049 . . . . 74.430000000000007 110.983 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.44 132.42 36.8 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.445 -0.946 . . . . 63.109999999999999 108.445 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.9 t -108.36 120.86 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 105.915 -1.883 . . . . 73.310000000000002 105.915 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.571 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 6.0 tp10 -127.53 132.89 49.85 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 107.342 -1.355 . . . . 73.510000000000005 107.342 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.538 ' HB ' ' NH2' ' A' ' 87' ' ' ARG . 22.3 m -84.52 121.97 28.35 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.039 -1.097 . . . . 72.010000000000005 108.039 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . 0.502 ' O2P' ' HB3' ' A' ' 13' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.488 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 20.0 m -100.21 152.3 20.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.552 -0.907 . . . . 65.0 108.552 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.27 115.57 29.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.01 -0.737 . . . . 74.010000000000005 109.01 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 62.2 t80 -111.89 127.44 55.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.177 -1.046 . . . . 74.450000000000003 108.177 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -126.44 137.06 53.37 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.158 -0.682 . . . . 75.519999999999996 109.158 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 22' ' ' LEU . . . -142.65 161.75 37.25 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.039 0.447 . . . . 75.409999999999997 110.751 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.02 7.45 0.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.118 1.367 . . . . 74.510000000000005 112.893 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.41 ' H ' ' C ' ' A' ' 20' ' ' ALA . 4.6 pp -58.05 -34.5 70.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.865 0.866 . . . . 73.549999999999997 111.284 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.53 -19.69 63.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.552 0.575 . . . . 62.340000000000003 112.552 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.11 -22.96 21.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.195 -0.668 . . . . 75.25 109.195 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -98.3 -42.9 7.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.397 -0.819 . . . . 65.349999999999994 113.045 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -68.25 -1.34 6.0 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.268 0.84 . . . . 74.209999999999994 113.268 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.65 -28.59 63.87 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.173 0.989 . . . . 74.230000000000004 111.128 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -63.56 -45.43 90.53 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.21 1.004 . . . . 71.230000000000004 111.378 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.2 p -79.39 -19.34 50.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.51 -0.768 . . . . 75.310000000000002 112.566 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -88.23 78.39 8.06 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 121.856 0.836 . . . . 74.510000000000005 110.141 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.79 -105.14 1.28 Allowed Glycine 0 CA--C 1.485 -1.825 0 N-CA-C 109.107 -1.597 . . . . 75.329999999999998 109.107 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 m -99.88 118.52 36.5 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.173 -1.417 . . . . 75.310000000000002 107.173 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.57 114.24 18.06 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.84 157.28 39.32 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.46 1.44 . . . . 72.120000000000005 110.517 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 125.72 31.12 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.927 -1.508 . . . . 71.299999999999997 106.927 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 15.8 m -71.0 113.93 8.54 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.229 0.538 . . . . 74.519999999999996 111.023 -175.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.7 p -98.7 140.69 32.53 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.337 -0.392 . . . . 75.109999999999999 110.306 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.01 -25.28 0.55 Allowed Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.694 -0.563 . . . . 53.310000000000002 111.694 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.89 58.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.989 0.423 . . . . 72.439999999999998 110.203 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -24.66 63.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 73.439999999999998 109.202 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.8 -13.75 47.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.776 -1.102 . . . . 73.519999999999996 109.835 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.4 mt 63.97 91.02 0.08 OUTLIER Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 115.142 -0.935 . . . . 74.340000000000003 111.174 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.87 -69.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.147 2.565 . . . . 72.319999999999993 113.975 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.07 16.38 1.07 Allowed 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.503 -0.479 . . . . 75.129999999999995 110.817 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.71 -12.4 56.77 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 120.839 -0.696 . . . . 73.439999999999998 111.617 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -137.37 151.88 49.07 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.231 -1.396 . . . . 53.329999999999998 107.231 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.44 157.19 40.85 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.072 -1.455 . . . . 33.32 107.072 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.24 156.75 38.03 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.341 0.591 . . . . 72.409999999999997 112.559 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.84 139.24 49.91 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.684 -1.228 . . . . 75.430000000000007 107.684 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 133.96 61.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.661 -0.496 . . . . 74.209999999999994 109.661 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.5 t -75.4 118.46 21.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.602 -0.888 . . . . 74.319999999999993 108.602 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -84.01 -43.4 15.19 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.034 -0.985 . . . . 73.420000000000002 108.722 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 57.4 ttt180 -144.7 133.55 22.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.468 -0.787 . . . . 73.310000000000002 109.231 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.13 174.8 23.12 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 109.109 -1.596 . . . . 73.129999999999995 109.109 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.65 -21.67 38.85 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.485 2.123 . . . . 74.519999999999996 111.187 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 80' ' ' LEU . 18.2 p-10 -100.9 21.98 12.83 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.093 0.957 . . . . 74.219999999999999 110.64 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -59.86 141.63 55.03 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.658 0.383 . . . . 70.129999999999995 111.797 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.65 -7.93 74.28 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.846 -0.692 . . . . 75.530000000000001 112.08 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.11 126.72 31.44 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 110.151 -0.314 . . . . 74.25 110.151 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -116.22 136.66 52.81 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.585 -0.895 . . . . 74.129999999999995 108.585 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -130.73 116.32 17.85 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.577 -0.527 . . . . 71.340000000000003 109.577 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.95 118.46 24.03 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.608 -0.886 . . . . 74.239999999999995 108.608 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.2 mt -87.42 125.2 34.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.83 0.348 . . . . 74.409999999999997 110.894 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -138.03 -0.61 2.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.313 -0.858 . . . . 75.040000000000006 109.825 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.52 150.34 39.98 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.132 -0.486 . . . . 62.399999999999999 111.085 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 37.7 Cg_exo -65.17 -20.87 62.95 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.365 2.71 . . . . 72.140000000000001 114.078 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.7 m -145.68 122.54 11.28 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.272 0.558 . . . . 73.349999999999994 110.21 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.6 m -123.64 113.4 18.61 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.764 -1.199 . . . . 73.239999999999995 107.764 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.6 m -94.08 138.73 31.82 Favored 'General case' 0 C--O 1.255 1.393 0 O-C-N 121.594 -0.691 . . . . 71.099999999999994 111.038 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 135.39 54.63 Favored 'General case' 0 C--O 1.262 1.717 0 CA-C-O 121.655 0.741 . . . . 64.109999999999999 110.802 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.55 29.28 Favored Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 105.782 -2.927 . . . . 73.0 105.782 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 15.2 ptt180 -119.18 121.01 38.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 117.711 -1.596 . . . . 64.349999999999994 109.311 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -167.1 163.39 10.35 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 106.001 -1.851 . . . . 74.209999999999994 106.001 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.58 -46.19 34.97 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.706 2.271 . . . . 70.310000000000002 113.856 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.75 20.5 5.52 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.692 0.627 . . . . 73.409999999999997 112.692 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -58.91 116.28 3.68 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.46 -0.571 . . . . 64.450000000000003 109.46 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.27 -38.97 41.47 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.721 -1.214 . . . . 70.340000000000003 107.721 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.4 mm -105.26 121.85 57.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.126 -1.064 . . . . 74.430000000000007 108.126 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -87.95 124.76 34.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 110.065 -0.346 . . . . 75.099999999999994 110.065 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 80.0 mt -127.2 140.92 51.91 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.323 -0.991 . . . . 75.400000000000006 108.323 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -130.59 140.65 50.44 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.434 -0.58 . . . . 74.129999999999995 109.434 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -163.34 178.34 8.21 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.387 -1.709 . . . . 75.329999999999998 106.387 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 -35.19 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 107.943 -1.132 . . . . 65.439999999999998 107.943 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 m -142.0 99.84 3.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.672 0.748 . . . . 74.120000000000005 109.939 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -98.6 137.38 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.471 -1.307 . . . . 64.430000000000007 107.471 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 23.0 t -73.57 150.72 41.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.114 -1.069 . . . . 73.310000000000002 108.114 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.538 ' NH2' ' HB ' ' A' ' 14' ' ' THR . 10.1 ptt180 -61.59 -45.95 91.92 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 40.2 mtp-105 -135.21 113.86 11.75 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.413 -1.329 . . . . 75.140000000000001 107.413 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -99.29 -51.82 3.7 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.705 -0.85 . . . . 74.239999999999995 108.705 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.65 163.65 39.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.229 -0.656 . . . . 74.239999999999995 109.229 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.8 147.93 45.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.498 0.666 . . . . 74.209999999999994 109.883 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -104.76 133.31 49.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.184 -1.413 . . . . 75.0 107.184 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -118.1 121.78 41.44 Favored 'General case' 0 C--N 1.268 -2.964 0 CA-C-N 115.608 -0.724 . . . . 72.099999999999994 109.414 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 59.3 mt -121.14 111.39 31.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.655 -1.609 . . . . 75.120000000000005 106.655 176.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -139.24 125.7 20.42 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.643 -0.423 . . . . 75.129999999999995 110.413 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.58 40.25 31.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.015 0.926 . . . . 70.329999999999998 112.486 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 -1.67 87.53 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.032 -0.531 . . . . 53.140000000000001 113.807 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -101.04 140.97 34.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.227 -0.657 . . . . 74.230000000000004 109.227 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -119.34 117.8 29.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.112 -1.07 . . . . 74.129999999999995 108.112 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -126.45 144.89 50.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.854 -0.424 . . . . 75.109999999999999 109.854 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.98 122.13 66.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 105.244 -2.132 . . . . 72.549999999999997 105.244 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.61 131.88 71.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 120.652 -0.419 . . . . 73.510000000000005 110.157 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.463 ' CG ' ' HG ' ' A' ' 106' ' ' SER . 11.3 t70 -80.12 140.97 36.19 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.422 -0.955 . . . . 75.239999999999995 108.422 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.2 9.89 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.637 0.256 . . . . 64.310000000000002 110.731 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.37 77.85 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.013 -0.613 . . . . 72.219999999999999 112.053 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.463 ' HG ' ' CG ' ' A' ' 103' ' ' ASP . 23.7 m -64.6 86.76 0.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.826 0.45 . . . . 71.099999999999994 111.124 178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 9.8 tt -91.36 -49.91 6.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 119.137 -1.025 . . . . 75.120000000000005 108.435 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.61 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 1.0 OUTLIER -92.81 -19.02 22.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.156 -0.683 . . . . 55.119999999999997 109.156 -178.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.68 114.86 3.77 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.836 -0.62 . . . . 74.349999999999994 112.367 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.2 m -87.3 129.65 34.91 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 122.211 -0.582 . . . . 74.540000000000006 110.469 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 82.3 m-85 -134.9 126.0 27.84 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.077 -1.083 . . . . 74.049999999999997 108.077 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.5 t -131.14 133.98 61.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.854 -1.536 . . . . 72.519999999999996 106.854 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 54.01 40.71 31.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.306 1.051 . . . . 73.420000000000002 109.404 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 66.76 9.23 6.56 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.946 1.699 . . . . 71.400000000000006 112.424 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 49.5 mm-40 -104.57 127.66 28.5 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 112.472 0.545 . . . . 75.420000000000002 112.472 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -63.7 123.44 12.02 Favored 'Trans proline' 0 C--N 1.36 1.139 0 N-CA-C 106.242 -2.253 . . . . 74.209999999999994 106.242 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.483 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 11.8 tpt180 -146.99 154.89 41.77 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.791 -1.564 . . . . 72.409999999999997 111.797 -167.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -107.67 -37.93 6.02 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.806 -0.812 . . . . 74.120000000000005 108.806 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.2 135.21 32.16 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.265 -0.574 . . . . 72.310000000000002 109.667 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 54.3 tp60 -152.12 143.68 23.49 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 110.268 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.13 131.6 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 107.72 -1.215 . . . . 73.5 107.72 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 43.7 ttp -89.25 128.54 35.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.359 -0.978 . . . . 71.329999999999998 108.359 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 36' ' ' SER . 9.3 pt20 -130.37 142.8 50.51 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.299 -0.864 . . . . 74.519999999999996 111.382 -173.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.7 t -74.31 134.25 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 64.319999999999993 111.229 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.11 59.75 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.241 -0.89 . . . . 54.5 111.163 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -89.63 154.67 19.79 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.565 -0.318 . . . . 74.019999999999996 111.198 -177.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.3 127.86 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.663 0.744 . . . . 74.099999999999994 109.797 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.28 119.81 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 N-CA-C 107.369 -1.345 . . . . 73.409999999999997 107.369 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 47.3 tt0 -104.86 120.92 42.57 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 115.106 -0.952 . . . . 74.099999999999994 108.476 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.7 mt -109.36 102.98 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 105.914 -1.884 . . . . 72.239999999999995 105.914 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.61 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 67.45 -107.55 2.08 Favored Glycine 0 N--CA 1.411 -3.01 0 CA-C-N 114.48 -1.236 . . . . 72.329999999999998 111.639 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -118.22 11.0 13.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.408 0.521 . . . . 75.329999999999998 112.408 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 27.2 p90 -125.06 157.87 35.18 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.883 -0.414 . . . . 74.0 109.883 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -129.36 142.07 50.91 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 114.51 1.3 . . . . 75.219999999999999 114.51 -169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.35 138.52 54.37 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.591 -1.633 . . . . 75.109999999999999 106.591 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -112.48 138.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.833 -1.173 . . . . 74.329999999999998 107.833 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -101.61 116.13 32.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.175 -0.676 . . . . 72.329999999999998 109.175 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.12 154.64 48.09 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.408 0.623 . . . . 72.209999999999994 110.545 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.51 126.4 30.85 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.538 -1.653 . . . . 72.549999999999997 106.538 168.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.77 -111.42 3.57 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.587 -0.816 . . . . 62.140000000000001 111.497 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -69.14 142.87 51.93 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.114 1.876 . . . . 74.319999999999993 111.787 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.25 18.08 19.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.648 -0.871 . . . . 73.329999999999998 108.648 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.424 -1.745 0 C-N-CA 125.305 1.442 . . . . 73.409999999999997 110.001 -179.137 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 107.11 -1.441 . . . . 55.200000000000003 107.11 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -79.02 134.99 36.76 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.124 -0.63 . . . . 61.0 110.085 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.95 100.31 12.81 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.661 -1.607 . . . . 73.349999999999994 106.661 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -89.68 113.97 25.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.965 -1.016 . . . . 71.239999999999995 113.303 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 p30 179.7 -167.89 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.688 -2.338 . . . . 74.030000000000001 104.688 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.62 -157.96 30.37 Favored Glycine 0 CA--C 1.48 -2.142 0 C-N-CA 118.967 -1.587 . . . . 73.0 112.566 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 t -112.21 108.97 54.61 Favored Pre-proline 0 N--CA 1.417 -2.116 0 N-CA-C 107.653 -1.24 . . . . 74.230000000000004 107.653 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.58 131.31 25.76 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.845 1.697 . . . . 75.329999999999998 111.371 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.74 115.51 63.2 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 106.128 -1.804 . . . . 72.510000000000005 106.128 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 24.3 Cg_endo -92.07 -161.94 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.049 2.499 . . . . 75.230000000000004 114.05 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -92.94 134.9 34.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.145 -1.428 . . . . 55.439999999999998 107.145 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.491 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 54.7 t -109.12 120.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 C-N-CA 119.035 -1.066 . . . . 74.409999999999997 110.273 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.47 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 50.1 mt-10 -128.77 140.96 51.47 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.075 -1.083 . . . . 72.25 108.075 175.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -70.35 134.36 47.83 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.877 1.271 . . . . 72.450000000000003 113.812 -168.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.3 t -125.46 155.34 40.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.671 -1.974 . . . . 72.439999999999998 105.671 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 57.8 t -81.31 114.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 119.679 -0.808 . . . . 75.040000000000006 108.854 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -118.86 140.22 50.33 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 109.241 -0.651 . . . . 75.299999999999997 109.241 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -132.75 138.66 47.27 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.953 -1.128 . . . . 74.230000000000004 107.953 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.39 172.73 12.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.075 0.768 . . . . 63.32 113.075 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.82 -3.12 26.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.905 1.282 . . . . 74.409999999999997 110.976 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.36 -25.81 60.03 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.88 0.872 . . . . 75.409999999999997 112.784 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.72 -28.36 68.36 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 121.044 0.45 . . . . 73.010000000000005 110.982 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -67.26 -44.75 78.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 74.340000000000003 109.96 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -76.1 -31.92 58.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.883 -0.599 . . . . 74.349999999999994 110.096 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.29 -30.41 64.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 75.219999999999999 110.819 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.08 -49.43 75.88 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.984 0.513 . . . . 75.409999999999997 110.633 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -77.81 -19.81 54.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.101 0.56 . . . . 72.030000000000001 111.553 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -82.97 -17.11 44.66 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.702 -0.481 . . . . 62.109999999999999 109.702 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.556 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 39.9 m -109.12 103.99 13.09 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 121.207 0.527 . . . . 62.43 111.169 -176.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.88 -52.69 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 111.389 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -104.94 142.5 34.66 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.259 -0.645 . . . . 72.310000000000002 109.259 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.93 153.0 84.81 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.16 -1.052 . . . . 62.520000000000003 108.16 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.14 142.23 96.97 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.047 1.831 . . . . 75.010000000000005 112.831 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.49 131.71 41.92 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.527 -0.545 . . . . 72.120000000000005 109.527 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -125.07 -168.35 1.81 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.371 0.605 . . . . 71.319999999999993 109.969 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -106.97 5.81 28.53 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.526 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 43.48 3.79 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.22 -1.552 . . . . 62.240000000000002 109.22 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.4 -3.67 59.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.392 0.615 . . . . 64.140000000000001 110.967 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.82 2.1 3.72 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 124.167 0.987 . . . . 64.040000000000006 112.726 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -83.17 -19.59 36.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.269 -1.011 . . . . 74.549999999999997 108.269 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt 57.44 79.47 0.32 Allowed Pre-proline 0 C--N 1.345 0.394 0 CA-C-N 114.46 -1.245 . . . . 70.430000000000007 111.937 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.68 -62.48 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.483 2.122 . . . . 65.310000000000002 112.162 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.72 -2.28 35.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.953 0.406 . . . . 73.010000000000005 111.644 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.68 79.85 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.871 -0.681 . . . . 61.100000000000001 113.163 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 m -147.37 164.21 34.0 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.474 -0.565 . . . . 61.329999999999998 109.474 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.82 157.35 45.87 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.884 -1.154 . . . . 51.109999999999999 107.884 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -123.46 152.69 41.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 118.388 0.54 . . . . 72.420000000000002 111.593 -175.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD13 HD22 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -116.88 143.19 45.99 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.673 -1.232 . . . . 74.150000000000006 107.673 173.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.88 133.38 61.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 121.093 -0.243 . . . . 74.530000000000001 110.496 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.3 116.88 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 104.792 -2.299 . . . . 64.430000000000007 104.792 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -89.87 -31.87 17.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.752 -0.658 . . . . 61.229999999999997 109.595 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -152.89 137.0 16.42 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.924 -0.58 . . . . 74.209999999999994 109.566 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.41 172.23 13.13 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 109.21 -1.556 . . . . 74.230000000000004 109.21 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.537 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 77.9 Cg_exo -55.28 -29.67 68.36 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 122.73 2.287 . . . . 75.430000000000007 113.926 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.28 18.12 21.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 120.326 -0.549 . . . . 74.310000000000002 110.399 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.86 143.58 41.94 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.107 0.48 . . . . 63.530000000000001 112.195 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.85 -14.28 57.47 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.359 -1.096 . . . . 61.219999999999999 110.359 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.79 122.12 21.04 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.289 -0.456 . . . . 62.530000000000001 109.847 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -133.4 134.97 44.34 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.551 -1.277 . . . . 74.420000000000002 107.551 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -137.26 145.38 43.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.288 -0.634 . . . . 74.310000000000002 109.288 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.1 tp -93.17 127.23 38.64 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.493 0.496 . . . . 74.450000000000003 109.717 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 49' ' ' LEU . 2.4 mm? -97.6 107.3 19.77 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.197 0.522 . . . . 74.049999999999997 111.368 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.24 19.19 1.09 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.054 -1.832 . . . . 74.230000000000004 106.054 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.459 ' NE2' ' HG1' ' A' ' 68' ' ' THR . 16.0 pt20 -107.21 142.14 24.44 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 113.971 -1.468 . . . . 73.409999999999997 107.931 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 27.9 Cg_endo -64.94 -19.19 63.88 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.251 1.967 . . . . 75.219999999999999 113.955 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -149.5 129.99 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.231 -0.587 . . . . 72.510000000000005 111.58 -176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.459 ' HG1' ' NE2' ' A' ' 65' ' ' GLN . 29.9 m -132.9 113.51 12.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.337 -1.357 . . . . 74.349999999999994 107.337 172.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -92.88 138.03 31.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.757 -0.46 . . . . 73.299999999999997 109.757 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 136.93 53.33 Favored 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.329 0.393 . . . . 72.329999999999998 110.082 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.57 -153.37 24.99 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.572 -1.411 . . . . 75.230000000000004 109.572 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 64.1 ttt-85 -118.51 118.06 30.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.637 -1.986 . . . . 73.340000000000003 105.637 175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' CD2' ' H ' ' A' ' 75' ' ' GLU . 5.2 t-160 177.92 139.25 0.24 Allowed Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.955 -1.498 . . . . 73.439999999999998 106.955 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.6 -30.53 36.69 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.529 1.486 . . . . 73.230000000000004 111.978 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.486 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 8.4 mm-40 -88.96 4.51 47.89 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.222 0.823 . . . . 54.439999999999998 113.222 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.6 p -89.99 115.84 27.58 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 119.082 -1.047 . . . . 72.230000000000004 108.879 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.9 -34.87 73.76 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.485 0.491 . . . . 75.140000000000001 110.831 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.5 pt -114.36 111.8 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.222 -1.029 . . . . 75.25 108.222 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -94.01 121.12 35.16 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.994 -1.003 . . . . 75.019999999999996 110.774 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.29 119.4 33.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.849 -1.167 . . . . 74.450000000000003 107.849 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.74 124.77 41.77 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.799 0.296 . . . . 75.430000000000007 111.799 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.418 ' OD2' HG21 ' A' ' 83' ' ' VAL . 16.9 t70 177.5 -145.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 103.877 -2.638 . . . . 63.0 103.877 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG21 ' OD2' ' A' ' 82' ' ' ASP . 48.5 t -57.43 -23.56 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.914 0.779 . . . . 73.420000000000002 111.004 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 m -76.59 81.59 3.26 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.688 0.756 . . . . 75.329999999999998 110.108 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.08 105.85 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.148 -1.056 . . . . 74.430000000000007 108.148 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.3 m -163.57 136.28 5.29 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.767 -1.568 . . . . 74.420000000000002 106.767 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 17.1 ptt180 -64.28 -25.56 68.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.817 0.698 . . . . 73.420000000000002 111.629 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -145.21 128.25 16.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.776 -0.824 . . . . 75.209999999999994 108.776 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 110' ' ' THR . 30.0 t-80 -99.88 -52.78 3.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.324 -1.362 . . . . 75.150000000000006 107.324 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.01 164.91 36.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.681 -1.145 . . . . 52.329999999999998 108.271 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.85 139.45 52.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.708 -0.478 . . . . 72.209999999999994 109.708 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -108.04 125.3 51.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.946 -1.502 . . . . 74.409999999999997 106.946 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.99 131.7 56.86 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.925 -0.768 . . . . 74.420000000000002 108.925 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.8 mp -115.25 112.27 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.411 -1.329 . . . . 61.32 107.411 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -138.93 125.49 20.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 110.724 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.77 37.97 29.51 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.851 0.86 . . . . 74.150000000000006 112.677 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 1.77 90.22 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.972 -0.558 . . . . 51.329999999999998 113.544 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -110.61 131.64 54.88 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.458 -0.571 . . . . 75.109999999999999 109.458 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -104.66 117.56 34.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.869 -1.16 . . . . 71.0 107.869 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.97 130.92 56.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.183 0.516 . . . . 61.140000000000001 110.412 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.44 122.6 61.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.64 -1.245 . . . . 71.549999999999997 107.64 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.93 124.0 71.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.426 -0.583 . . . . 64.329999999999998 109.426 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.62 140.36 40.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.8 -1.185 . . . . 55.219999999999999 107.8 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.8 m -100.41 -13.71 8.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.947 -0.701 . . . . 74.209999999999994 111.923 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 179.65 95.29 0.1 OUTLIER Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.505 -1.038 . . . . 64.030000000000001 110.505 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -64.96 14.48 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.681 1.592 . . . . 75.430000000000007 114.291 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 6.0 mp -70.87 -37.92 73.09 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.897 -1.149 . . . . 73.439999999999998 107.897 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.3 -20.15 22.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.47 -0.786 . . . . 74.450000000000003 110.326 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.39 94.87 0.22 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.556 -0.747 . . . . 62.109999999999999 114.58 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.467 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 58.1 m -80.98 130.16 34.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.284 -0.635 . . . . 74.019999999999996 109.284 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.36 125.69 54.54 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.643 -1.243 . . . . 74.329999999999998 107.643 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.0 t -133.1 136.86 54.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.165 -1.421 . . . . 74.420000000000002 107.165 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.33 39.25 30.74 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.367 1.467 . . . . 75.209999999999994 108.257 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.556 ' NH1' ' HA ' ' A' ' 30' ' ' THR . 34.2 mtm105 63.81 20.47 12.23 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.655 -1.611 . . . . 72.209999999999994 115.279 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.51 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 41.4 mt-10 -136.02 153.42 76.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.298 -0.63 . . . . 73.420000000000002 109.298 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.2 123.72 13.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.251 1.967 . . . . 71.319999999999993 108.925 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.51 ' NH2' ' HB2' ' A' ' 115' ' ' GLU . 18.3 tpp180 -135.96 139.99 43.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.253 -0.579 . . . . 75.25 109.869 -170.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -98.84 -37.57 9.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.477 0.656 . . . . 75.120000000000005 110.525 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.04 136.96 18.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.258 -1.386 . . . . 72.239999999999995 107.258 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.485 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 55.5 tp60 -152.58 136.02 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.176 0.435 . . . . 72.519999999999996 112.176 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.35 117.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 104.676 -2.342 . . . . 72.230000000000004 104.676 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.443 ' SD ' HD11 ' A' ' 128' ' ' ILE . 43.5 ttp -88.05 130.71 34.91 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.664 0.745 . . . . 75.400000000000006 111.458 -168.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.27 156.44 16.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.081 -1.418 . . . . 74.140000000000001 109.151 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.0 t -70.56 130.81 42.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.932 -1.136 . . . . 71.040000000000006 107.932 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.3 57.73 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 120.565 -0.826 . . . . 72.319999999999993 111.158 -177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.43 141.06 50.28 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 109.326 -0.62 . . . . 54.219999999999999 109.326 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.47 125.7 54.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.496 -0.557 . . . . 72.140000000000001 109.496 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.443 HD11 ' SD ' ' A' ' 122' ' ' MET . 68.3 mt -108.21 131.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.302 -1.37 . . . . 72.219999999999999 107.302 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -119.92 123.0 42.49 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 121.378 0.609 . . . . 75.019999999999996 109.654 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.6 mt -113.9 102.31 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.301 -1.74 . . . . 75.329999999999998 106.301 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.71 -111.86 4.43 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 109.933 -1.267 . . . . 54.450000000000003 109.933 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -103.58 -4.67 23.58 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 117.406 0.603 . . . . 74.510000000000005 110.428 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.537 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.9 m-85 -73.22 130.5 40.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.401 -0.592 . . . . 73.239999999999995 109.401 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -112.01 119.41 38.37 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.628 -1.249 . . . . 75.230000000000004 107.628 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.3 134.3 54.96 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.582 -1.266 . . . . 73.230000000000004 107.582 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.71 131.53 69.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 108.746 -0.835 . . . . 75.340000000000003 108.746 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.31 122.56 43.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.572 -0.529 . . . . 73.349999999999994 109.572 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' O ' HD11 ' A' ' 48' ' ' LEU . 3.9 mp -128.72 137.19 51.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 110.162 -0.31 . . . . 73.310000000000002 110.162 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.57 135.48 33.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.986 -0.746 . . . . 74.230000000000004 108.986 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.2 88.07 1.81 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.788 -0.925 . . . . 74.150000000000006 110.788 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.64 161.86 39.7 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.215 2.61 . . . . 64.540000000000006 112.459 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.43 53.73 0.88 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.196 -1.038 . . . . 73.510000000000005 108.196 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.026 -0.988 . . . . 73.340000000000003 109.216 -175.583 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 C--O 1.245 0.864 0 CA-C-O 121.247 0.546 . . . . 75.420000000000002 109.986 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 m -128.33 174.87 8.93 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.434 -0.803 . . . . 74.120000000000005 109.521 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -83.05 161.24 21.75 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 108.961 -0.755 . . . . 74.329999999999998 108.961 176.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -112.92 150.99 31.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.563 -0.902 . . . . 75.439999999999998 108.563 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -121.46 16.38 11.29 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.565 -1.643 . . . . 74.219999999999999 106.565 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.02 -36.18 90.47 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.036 -1.438 . . . . 71.540000000000006 109.874 177.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 m -110.02 106.73 58.46 Favored Pre-proline 0 N--CA 1.414 -2.243 0 N-CA-C 108.689 -0.856 . . . . 63.219999999999999 108.689 172.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 148.72 19.65 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.902 1.735 . . . . 73.349999999999994 108.496 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -113.88 113.76 46.95 Favored Pre-proline 0 N--CA 1.422 -1.844 0 C-N-CA 117.588 -1.645 . . . . 75.319999999999993 110.823 176.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -105.31 173.87 0.13 Allowed 'Trans proline' 0 N--CA 1.42 -2.795 0 C-N-CA 122.978 2.452 . . . . 74.340000000000003 110.313 172.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -128.88 166.19 19.57 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.576 -0.898 . . . . 73.109999999999999 108.576 175.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.24 120.07 57.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 101.361 -3.57 . . . . 73.519999999999996 101.361 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 13.0 tp10 -124.31 156.24 37.3 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.101 0.778 . . . . 73.319999999999993 113.101 -161.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.4 m -131.07 107.29 8.95 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.9 0.857 . . . . 73.439999999999998 109.718 178.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -105.47 152.49 22.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.451 -0.574 . . . . 73.150000000000006 109.451 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 107' ' ' LEU . 93.7 t -113.64 117.45 55.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 119.63 -0.224 . . . . 72.209999999999994 110.692 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 83' ' ' VAL . 47.8 p90 -123.12 127.25 48.44 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.085 -0.646 . . . . 72.430000000000007 109.454 171.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -106.9 92.13 3.96 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.924 -1.139 . . . . 71.25 107.924 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 -154.99 0.56 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.233 -0.894 . . . . 73.420000000000002 112.169 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.65 -3.21 6.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.388 1.475 . . . . 73.209999999999994 112.032 -172.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.82 -25.04 60.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.132 0.973 . . . . 74.530000000000001 111.713 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.31 -24.33 65.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.302 0.572 . . . . 74.430000000000007 111.304 177.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -88.56 -29.79 19.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.839 -0.8 . . . . 75.319999999999993 108.839 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -56.57 -44.77 81.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 53.420000000000002 110.794 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.496 ' HE1' ' CE2' ' A' ' 111' ' ' TYR . 21.3 ptp -83.99 2.76 37.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.614 -0.721 . . . . 73.099999999999994 111.556 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -91.88 -49.66 6.13 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.209 -1.034 . . . . 75.219999999999999 108.209 176.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.2 m -61.0 -42.85 99.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.29 -0.868 . . . . 72.400000000000006 111.986 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -77.4 -33.56 55.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.902 0.382 . . . . 62.299999999999997 110.293 177.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m 74.44 -54.8 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.122 1.369 . . . . 64.319999999999993 111.21 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.34 -163.8 10.58 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 109.935 -1.266 . . . . 63.009999999999998 109.935 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 113' ' ' ASN . 97.8 m -104.6 138.36 41.06 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 117.054 0.427 . . . . 71.329999999999998 110.288 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.34 121.45 66.46 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 108.367 -0.975 . . . . 75.530000000000001 108.367 176.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -59.48 152.28 62.73 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 122.93 2.42 . . . . 73.230000000000004 113.02 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 166.43 16.17 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.36 -0.836 . . . . 65.040000000000006 109.127 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -66.05 122.74 18.09 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.231 0.539 . . . . 72.150000000000006 111.189 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 m -54.67 133.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.445 -1.252 . . . . 71.530000000000001 109.904 177.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 41' ' ' ASN . . . 129.78 -28.18 3.99 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 108.826 -1.71 . . . . 71.439999999999998 108.826 -174.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.5 65.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.695 0.76 . . . . 74.150000000000006 110.328 178.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 7.86 4.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.008 0.909 . . . . 71.5 112.576 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.7 m120 -79.54 -16.69 55.52 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.506 -1.224 . . . . 63.119999999999997 110.269 173.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 50.96 68.62 3.2 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 123.987 0.804 . . . . 71.010000000000005 112.819 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.03 -56.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.528 2.152 . . . . 74.140000000000001 113.648 -175.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -23.31 33.43 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.019 0.377 . . . . 72.540000000000006 112.019 -177.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.93 79.7 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 120.351 -0.928 . . . . 71.519999999999996 111.182 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.1 m -115.12 157.19 23.94 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.125 -1.065 . . . . 73.040000000000006 108.125 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.59 157.3 46.04 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.548 -0.538 . . . . 71.319999999999993 109.548 -177.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.04 160.26 38.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.744 0.652 . . . . 75.140000000000001 109.317 -177.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -128.69 141.22 51.4 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 120.158 -0.617 . . . . 75.310000000000002 109.846 175.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.86 139.67 38.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.432 -0.804 . . . . 75.319999999999993 109.809 -176.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.0 118.37 28.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.204 -1.036 . . . . 72.230000000000004 108.204 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -85.15 -34.79 22.05 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.169 -0.923 . . . . 75.099999999999994 109.858 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 29.2 tpt180 -151.68 144.91 24.67 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.52 -1.659 . . . . 74.310000000000002 106.52 -177.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.62 -171.05 22.48 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.508 -0.853 . . . . 74.329999999999998 111.551 179.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.67 -33.06 8.75 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.204 1.936 . . . . 72.519999999999996 109.932 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.77 11.81 21.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.058 -1.428 . . . . 74.540000000000006 110.109 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.56 42.36 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.298 0.571 . . . . 54.240000000000002 112.109 -175.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.91 -19.27 47.37 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 115.225 -0.898 . . . . 74.329999999999998 111.712 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.74 156.84 19.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.958 -0.386 . . . . 74.430000000000007 109.958 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -139.46 155.15 47.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.752 -1.203 . . . . 73.439999999999998 107.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -147.78 143.3 27.42 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.608 -0.516 . . . . 75.510000000000005 109.608 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -108.62 144.75 35.93 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.526 0.516 . . . . 74.430000000000007 110.285 -177.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.15 105.06 11.14 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.703 -0.681 . . . . 74.340000000000003 110.175 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.93 -15.93 11.17 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.312 1.045 . . . . 65.340000000000003 109.344 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.471 ' NE2' ' HG1' ' A' ' 68' ' ' THR . 7.3 pm0 -107.34 153.23 41.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 114.4 -1.273 . . . . 72.319999999999993 110.117 -174.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -63.17 -29.32 73.9 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.897 2.398 . . . . 74.340000000000003 113.743 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 67.2 m -150.47 122.67 8.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.084 0.469 . . . . 70.510000000000005 111.287 -177.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.471 ' HG1' ' NE2' ' A' ' 65' ' ' GLN . 11.8 m -112.6 114.24 26.78 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.163 -0.68 . . . . 74.439999999999998 109.163 178.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -90.75 133.87 34.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.39 -0.967 . . . . 72.200000000000003 108.39 175.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -128.03 135.4 49.82 Favored 'General case' 0 C--O 1.267 2.019 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 111.404 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.41 -153.62 25.01 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 114.579 -1.192 . . . . 72.310000000000002 111.174 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 22.0 tpp85 -79.4 151.82 30.72 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.977 1.311 . . . . 75.010000000000005 108.676 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 14.9 m170 92.39 127.89 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 125.904 1.682 . . . . 74.420000000000002 110.619 -175.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.85 2.97 4.8 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.347 2.032 . . . . 54.25 112.522 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 12.9 pt-20 -80.2 -25.19 39.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.252 -1.018 . . . . 72.310000000000002 108.252 175.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -73.01 132.04 42.9 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.7 -1.222 . . . . 74.340000000000003 107.7 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -54.74 -39.53 68.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.698 0.629 . . . . 71.200000000000003 112.698 -174.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.4 mm -119.58 124.69 73.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.34 108.06 20.22 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.266 0.555 . . . . 74.010000000000005 110.604 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.62 117.6 32.72 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.953 -2.24 . . . . 62.420000000000002 104.953 176.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.48 116.76 18.32 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.387 -0.925 . . . . 74.329999999999998 111.954 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.73 161.4 14.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.755 -0.657 . . . . 73.230000000000004 109.457 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.413 ' HB ' ' CE2' ' A' ' 18' ' ' PHE . 98.6 t -67.95 -36.25 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.328 0.585 . . . . 73.239999999999995 109.914 178.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 p -116.44 -171.29 1.98 Allowed 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.791 -0.641 . . . . 71.140000000000001 110.479 -176.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.31 96.58 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.452 -0.944 . . . . 75.230000000000004 108.452 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.9 m -129.44 85.69 2.34 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.929 -1.508 . . . . 51.25 106.929 174.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.445 ' NH2' ' HA ' ' A' ' 13' ' ' GLU . 20.0 ptt180 -77.31 -45.88 24.78 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 74.109999999999999 110.117 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -106.21 93.4 4.59 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.534 -1.284 . . . . 73.200000000000003 107.534 172.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -99.65 -53.27 3.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.094 -1.076 . . . . 75.319999999999993 108.094 174.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.9 143.76 31.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.744 -0.782 . . . . 73.340000000000003 111.474 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -122.35 135.54 54.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.29 -0.868 . . . . 64.430000000000007 109.58 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 67' ' ' THR . 35.6 m-85 -104.2 113.62 27.29 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.572 -1.64 . . . . 65.099999999999994 106.572 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.24 123.88 51.1 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.865 -0.791 . . . . 72.319999999999993 108.865 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' N ' HD11 ' A' ' 94' ' ' ILE . 2.6 mp -104.02 115.13 45.39 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 N-CA-C 106.82 -1.548 . . . . 74.329999999999998 106.82 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -131.53 120.56 23.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.58 -0.526 . . . . 73.319999999999993 109.58 -177.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 48.22 48.23 18.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.556 1.143 . . . . 73.540000000000006 113.586 -177.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.07 -6.46 62.93 Favored Glycine 0 N--CA 1.462 0.427 0 CA-C-N 116.015 -0.539 . . . . 74.099999999999994 114.414 176.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -103.05 143.56 32.43 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.276 -0.639 . . . . 71.209999999999994 109.276 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -104.8 116.76 32.57 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.871 -0.788 . . . . 72.439999999999998 108.871 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.0 126.28 55.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.434 -0.951 . . . . 73.109999999999999 108.434 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' HB ' ' HE1' ' A' ' 122' ' ' MET . 59.7 t -107.77 123.97 63.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 118.662 -1.215 . . . . 71.540000000000006 107.787 173.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.17 123.38 67.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.044 -1.465 . . . . 71.510000000000005 107.044 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.4 ' CG ' ' HG1' ' A' ' 110' ' ' THR . 1.1 t70 -107.53 136.47 47.26 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.94 -1.027 . . . . 75.510000000000005 109.991 -178.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -116.75 0.1 8.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.946 -0.57 . . . . 73.019999999999996 110.616 177.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.08 34.64 4.86 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 121.151 -0.547 . . . . 63.140000000000001 112.049 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -51.62 -34.42 37.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.876 1.27 . . . . 71.430000000000007 111.177 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 17' ' ' VAL . 4.6 mp -67.34 -23.92 65.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.063 -0.971 . . . . 75.25 111.16 -178.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.95 -18.64 30.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.586 0.708 . . . . 75.430000000000007 109.704 -175.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.22 0.43 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 119.103 -1.522 . . . . 71.230000000000004 113.93 175.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.4 ' HG1' ' CG ' ' A' ' 103' ' ' ASP . 3.8 m -77.79 129.14 35.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.871 -0.789 . . . . 42.310000000000002 108.871 172.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.496 ' CE2' ' HE1' ' A' ' 26' ' ' MET . 96.7 m-85 -135.11 144.55 47.2 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.897 -0.321 . . . . 73.219999999999999 110.189 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.18 117.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.594 -1.632 . . . . 75.310000000000002 106.594 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.416 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 93.9 m-20 56.91 45.75 20.82 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.734 0.646 . . . . 64.420000000000002 110.062 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.04 8.95 2.81 Favored 'General case' 0 CA--C 1.569 1.701 0 C-N-CA 125.731 1.612 . . . . 74.400000000000006 113.809 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -114.11 136.85 22.24 Favored Pre-proline 0 C--N 1.31 -1.134 0 O-C-N 121.341 -0.85 . . . . 65.420000000000002 110.342 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -68.05 138.17 43.08 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 122.025 1.817 . . . . 75.209999999999994 111.211 177.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -142.19 164.6 29.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.082 -0.508 . . . . 73.310000000000002 111.025 -177.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -117.37 -37.6 3.48 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.489 1.118 . . . . 70.239999999999995 108.258 176.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.01 139.95 26.48 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.283 -1.377 . . . . 73.510000000000005 107.283 175.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.49 130.33 11.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.432 -0.581 . . . . 64.219999999999999 109.432 -177.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.8 t -83.41 118.29 30.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.999 -1.482 . . . . 75.409999999999997 106.999 174.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.41 ' HE1' ' HB ' ' A' ' 101' ' ' VAL . 22.8 mmt -88.82 144.93 25.9 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.725 0.774 . . . . 63.5 112.944 -167.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.58 155.91 45.04 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.946 -1.479 . . . . 75.319999999999993 107.26 -177.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 t -62.57 134.38 56.29 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.339 0.59 . . . . 75.349999999999994 111.336 -176.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.32 -7.47 56.46 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.06 -0.973 . . . . 71.400000000000006 113.535 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.79 152.14 24.81 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 119.002 -1.079 . . . . 75.439999999999998 111.709 175.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.21 129.15 51.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.381 -1.281 . . . . 73.230000000000004 110.187 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt -108.1 131.91 57.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.198 -1.408 . . . . 74.230000000000004 107.198 -177.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -104.35 122.48 45.54 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.312 -0.996 . . . . 74.349999999999994 108.312 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 135' ' ' LEU . 2.3 mp -109.22 104.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 106.602 -1.629 . . . . 74.540000000000006 106.602 178.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.05 -107.81 2.21 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.248 -1.141 . . . . 73.120000000000005 110.248 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -110.77 6.86 21.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.849 0.325 . . . . 75.019999999999996 111.673 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 44.1 p90 -123.49 157.63 33.1 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.542 0.941 . . . . 74.219999999999999 113.542 -177.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -116.05 136.61 52.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.347 -0.388 . . . . 74.230000000000004 111.329 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.439 HD12 HD11 ' A' ' 130' ' ' ILE . 9.6 mp -123.45 139.72 53.74 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.191 0.997 . . . . 74.319999999999993 108.337 175.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.45 126.82 69.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.574 -0.528 . . . . 75.420000000000002 109.574 -178.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -88.32 127.74 35.48 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.657 -0.868 . . . . 72.310000000000002 108.657 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.44 143.72 50.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.577 0.703 . . . . 75.340000000000003 111.238 -176.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.2 121.92 45.5 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.489 -0.93 . . . . 60.229999999999997 108.489 176.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 132.27 82.23 0.22 Allowed Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.72 -1.352 . . . . 53.219999999999999 109.72 -177.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.98 162.38 29.42 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.276 2.65 . . . . 54.450000000000003 112.719 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.89 -1.17 56.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.198 0.999 . . . . 74.230000000000004 110.929 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.271 -2.838 0 N-CA-C 103.627 -2.731 . . . . 70.230000000000004 103.627 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 109.129 -0.693 . . . . 75.129999999999995 109.129 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.7 m -130.44 134.76 47.35 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.321 -0.251 . . . . 62.409999999999997 110.321 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.18 157.89 22.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.198 -0.667 . . . . 72.310000000000002 109.198 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.57 141.18 58.52 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.919 0.488 . . . . 71.310000000000002 111.776 -175.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.16 134.67 39.87 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 122.563 0.345 . . . . 71.329999999999998 110.221 178.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.37 147.71 50.15 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.125 -0.79 . . . . 64.519999999999996 111.125 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 m -90.85 119.56 68.91 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 109.979 -0.378 . . . . 72.439999999999998 109.979 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.6 140.93 84.14 Favored 'Trans proline' 0 C--O 1.253 1.236 0 C-N-CA 123.011 2.474 . . . . 74.129999999999995 112.513 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -90.16 128.12 50.75 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-N 116.071 -0.513 . . . . 73.120000000000005 110.573 178.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.0 -166.37 0.19 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.053 . . . . 71.140000000000001 108.966 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.436 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 97.0 mt-30 -109.46 166.51 10.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.632 -0.877 . . . . 55.100000000000001 108.632 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.75 125.68 65.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.201 -1.037 . . . . 73.430000000000007 108.201 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -158.83 132.33 7.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.252 -0.431 . . . . 64.129999999999995 110.561 -173.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -75.59 133.13 41.0 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.733 -1.951 . . . . 75.209999999999994 105.733 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 107' ' ' LEU . 36.1 t -89.46 123.06 33.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.996 -1.002 . . . . 64.420000000000002 108.785 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -85.56 115.13 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.283 -1.377 . . . . 72.439999999999998 107.283 177.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.459 ' CE2' ' HG ' ' A' ' 107' ' ' LEU . 40.3 p90 -114.79 142.53 46.4 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 120.813 0.34 . . . . 74.319999999999993 110.55 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -80.78 95.93 6.81 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.74 -1.208 . . . . 73.420000000000002 107.74 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -81.3 -178.71 7.04 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.421 -0.809 . . . . 73.25 112.26 -175.187 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.42 4.44 4.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 114.326 1.232 . . . . 71.409999999999997 114.326 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -82.83 -16.75 46.5 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.879 -0.513 . . . . 74.450000000000003 111.553 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 2.6 pp -70.01 -1.14 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.118 1.525 . . . . 75.140000000000001 115.118 -173.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -102.73 -22.5 13.92 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.574 -0.451 . . . . 71.209999999999994 111.257 177.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' OE2' ' HD3' ' A' ' 114' ' ' ARG . 30.8 tt0 -72.68 -23.6 60.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.703 -0.399 . . . . 74.310000000000002 111.829 -172.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.445 ' O ' ' HB3' ' A' ' 29' ' ' SER . 52.6 ttp -62.33 -47.52 83.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.327 -0.397 . . . . 51.32 110.196 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.42 -22.58 23.66 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.505 -0.316 . . . . 70.319999999999993 110.963 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.6 t -62.29 -27.44 69.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.186 0.993 . . . . 70.519999999999996 108.532 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 26' ' ' MET . 40.0 t -65.38 -39.14 91.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.311 -1.313 . . . . 74.310000000000002 110.593 175.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 m 69.46 -7.08 0.89 Allowed 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 124.879 1.271 . . . . 71.329999999999998 111.418 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' SER . . . 165.64 96.23 0.11 Allowed Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.668 -1.773 . . . . 72.340000000000003 108.668 -179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 92.0 m -72.84 121.02 19.28 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.869 0.842 . . . . 64.219999999999999 110.772 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.13 106.16 19.9 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 114.803 -1.09 . . . . 73.329999999999998 109.042 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -61.16 142.96 98.38 Favored 'Trans proline' 0 C--O 1.263 1.74 0 C-N-CA 121.551 1.501 . . . . 73.420000000000002 109.202 173.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.47 125.72 27.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.939 -0.573 . . . . 72.239999999999995 110.342 -177.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.5 m -84.33 92.7 8.07 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.657 -0.868 . . . . 72.049999999999997 108.657 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 m -102.55 155.62 18.16 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.875 -1.157 . . . . 72.239999999999995 107.875 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.7 25.57 7.3 Favored Glycine 0 CA--C 1.499 -0.947 0 N-CA-C 111.05 -0.82 . . . . 74.219999999999999 111.05 -175.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.93 5.18 49.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.987 -0.607 . . . . 74.140000000000001 110.202 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.23 -3.35 13.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.373 1.069 . . . . 65.549999999999997 113.393 -175.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.86 -2.81 31.1 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.233 -1.025 . . . . 73.430000000000007 108.233 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.9 82.83 0.22 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.185 -0.916 . . . . 74.120000000000005 110.95 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.03 -59.72 0.74 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.235 2.623 . . . . 73.409999999999997 114.257 -175.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.13 -4.08 59.09 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.227 0.454 . . . . 75.109999999999999 112.227 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 9.61 86.82 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.709 -0.758 . . . . 71.030000000000001 111.478 -177.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 m -145.86 169.22 19.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.884 -1.524 . . . . 73.230000000000004 106.884 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.77 157.23 43.63 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.414 0.446 . . . . 75.409999999999997 109.916 -178.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -133.26 153.32 51.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.8 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.419 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.5 pp -110.86 135.02 52.03 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.573 176.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.75 135.2 55.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.394 -0.595 . . . . 72.219999999999999 109.394 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.26 117.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.361 -1.718 . . . . 74.120000000000005 106.361 176.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.53 -31.95 16.53 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.527 -0.761 . . . . 73.200000000000003 109.683 -175.641 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -148.19 141.02 24.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.399 -0.963 . . . . 75.310000000000002 108.399 -178.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.5 174.14 13.22 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.793 -0.923 . . . . 62.420000000000002 110.793 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 76.6 Cg_exo -54.68 -43.28 60.52 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.83 2.353 . . . . 65.040000000000006 112.402 177.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -93.11 21.88 5.5 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.792 1.034 . . . . 73.439999999999998 113.792 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.75 137.26 44.9 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.735 0.302 . . . . 73.310000000000002 111.14 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.6 -18.95 40.18 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.144 -0.783 . . . . 65.319999999999993 111.144 -177.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.23 143.06 29.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.53 -0.544 . . . . 74.129999999999995 109.53 177.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -135.2 135.58 41.11 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.505 -0.924 . . . . 75.219999999999999 108.505 179.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -128.42 129.67 46.51 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.511 -0.552 . . . . 73.409999999999997 109.511 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -92.13 139.07 31.0 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.286 -0.635 . . . . 74.319999999999993 109.286 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.31 104.38 15.09 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.941 -0.763 . . . . 70.530000000000001 108.941 -179.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -124.37 -2.77 7.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.564 -1.198 . . . . 61.409999999999997 108.957 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pm0 -107.73 143.76 27.93 Favored Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-N 115.184 -0.916 . . . . 74.319999999999993 109.392 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -68.37 -16.28 43.28 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.777 2.318 . . . . 71.040000000000006 113.445 -178.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -150.1 128.05 11.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.727 -0.608 . . . . 74.239999999999995 109.495 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 10.6 m -123.7 119.38 29.63 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 p -87.5 137.12 32.61 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 110.208 -0.293 . . . . 70.540000000000006 110.208 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.02 148.3 51.86 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.329 0.585 . . . . 71.450000000000003 110.787 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.23 28.31 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 108.612 -1.795 . . . . 65.349999999999994 108.612 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -119.15 117.66 29.27 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.653 -1.61 . . . . 72.430000000000007 106.653 175.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 171.45 162.14 0.24 Allowed Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 126.077 1.751 . . . . 74.219999999999999 106.623 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.87 -28.66 75.72 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.373 2.049 . . . . 74.340000000000003 114.22 -176.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.14 4.52 48.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.719 0.637 . . . . 71.450000000000003 112.719 -174.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 m -67.9 117.54 9.92 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 73.439999999999998 109.407 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.94 -39.27 84.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.201 -1.037 . . . . 72.239999999999995 108.201 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.429 HG12 ' CG2' ' A' ' 68' ' ' THR . 47.5 mm -112.65 110.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.196 -1.779 . . . . 64.420000000000002 106.196 169.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.4 129.45 39.53 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.991 -0.549 . . . . 75.319999999999993 110.74 -176.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 1.7 mm? -124.58 129.78 51.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.254 -2.128 . . . . 71.019999999999996 105.254 175.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -101.31 116.66 33.31 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.589 -0.844 . . . . 54.520000000000003 109.782 177.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.03 -160.11 0.95 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.312 -1.366 . . . . 74.239999999999995 107.312 -178.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.79 -27.99 17.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.65 0.611 . . . . 74.439999999999998 112.65 -174.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.1 m -139.42 148.83 43.33 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.209 -0.932 . . . . 70.400000000000006 111.844 -175.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -74.56 148.88 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.029 . . . . 73.409999999999997 110.189 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB3' HD21 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -142.28 113.69 7.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.19 -1.041 . . . . 74.25 108.19 177.624 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 11' ' ' GLN . 22.3 ptt180 -56.63 -25.3 52.91 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.148 0.795 . . . . 73.329999999999998 113.148 -177.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -172.99 99.02 0.13 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.286 -1.376 . . . . 72.319999999999993 107.286 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 27.0 t-80 -84.56 -52.53 6.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.425 0.631 . . . . 72.439999999999998 109.698 -177.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.42 41.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.754 -0.832 . . . . 72.420000000000002 108.754 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.65 143.98 43.76 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.553 -0.536 . . . . 54.43 109.553 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 83.3 m-85 -104.78 125.32 50.73 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.381 -1.711 . . . . 73.319999999999993 106.381 178.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -113.43 119.11 36.48 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 106.795 -1.557 . . . . 73.439999999999998 106.795 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 3.4 mp -114.65 111.88 37.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.541 -1.651 . . . . 75.430000000000007 106.541 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -135.29 128.9 32.68 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.786 -1.19 . . . . 65.340000000000003 107.786 -177.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 55.45 37.98 29.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.882 0.873 . . . . 75.010000000000005 112.035 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.37 1.45 90.43 Favored Glycine 0 C--O 1.238 0.402 0 CA-C-N 115.974 -0.557 . . . . 52.520000000000003 113.911 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 20.2 mm-40 -102.11 131.74 48.42 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.782 -0.451 . . . . 65.239999999999995 109.782 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -107.48 118.59 37.13 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.211 -1.404 . . . . 72.439999999999998 107.211 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.17 142.79 51.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.251 -0.579 . . . . 71.209999999999994 110.303 178.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -106.63 123.61 61.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.586 -1.265 . . . . 74.430000000000007 107.586 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.3 121.21 65.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.138 -0.69 . . . . 74.230000000000004 109.138 175.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -83.14 131.65 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.459 -0.941 . . . . 74.519999999999996 108.459 173.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.74 -14.46 4.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 123.457 0.473 . . . . 72.209999999999994 110.645 178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . -156.28 84.48 0.14 Allowed Glycine 0 N--CA 1.419 -2.454 0 C-N-CA 120.816 -0.707 . . . . 72.409999999999997 112.768 -178.444 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -69.7 83.09 0.44 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.11 0.481 . . . . 73.209999999999994 109.975 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 16' ' ' SER . 12.4 tp -77.17 -49.31 15.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.675 -1.232 . . . . 74.25 107.675 174.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -102.37 -19.17 15.08 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.296 -1.774 . . . . 73.219999999999999 110.049 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 108.82 3.31 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.873 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.6 m -87.38 130.43 34.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.464 0.174 . . . . 74.329999999999998 111.24 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.417 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 5.6 m-30 -127.97 132.24 49.21 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.147 0.979 . . . . 74.340000000000003 109.068 175.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.75 127.74 75.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.842 -1.54 . . . . 75.140000000000001 106.842 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 56.85 36.49 27.8 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.031 1.332 . . . . 73.040000000000006 109.185 -169.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.48 ' HD3' ' OE2' ' A' ' 25' ' ' GLU 0.274 44.0 ttp180 57.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.576 1.948 0 C-N-CA 125.716 1.607 . . . . 75.310000000000002 113.059 -177.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.23 147.87 36.84 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.71 -1.219 . . . . 72.450000000000003 107.71 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.72 123.16 12.14 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.703 1.602 . . . . 71.340000000000003 110.24 177.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -161.11 136.89 8.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.707 -1.22 . . . . 75.230000000000004 107.707 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -100.56 -53.75 3.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 123.364 0.415 . . . . 75.239999999999995 109.959 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.604 -0.887 . . . . 65.420000000000002 108.604 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -154.77 140.22 17.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.315 -0.402 . . . . 74.430000000000007 110.699 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.6 t -76.06 124.54 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 105.756 -1.942 . . . . 74.109999999999999 105.756 168.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 128' ' ' ILE . 36.6 ttp -89.81 141.19 28.86 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.485 -169.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 11.0 pt20 -115.1 156.99 24.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 124.557 1.143 . . . . 73.099999999999994 109.815 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -69.92 130.26 41.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 74.540000000000006 107.692 173.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.02 56.5 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 119.963 -1.113 . . . . 54.340000000000003 110.351 -174.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 6.3 t70 -76.21 137.53 40.06 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.27 -1.381 . . . . 74.450000000000003 107.27 178.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.6 124.28 45.95 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.354 0.597 . . . . 73.299999999999997 109.765 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.428 HD13 ' SD ' ' A' ' 122' ' ' MET . 37.3 mt -108.16 131.69 57.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.53 -0.915 . . . . 65.120000000000005 108.53 -172.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 7.2 tp60 -115.52 119.04 34.88 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.345 -0.613 . . . . 74.420000000000002 109.345 -176.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.19 102.83 9.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 106.48 -1.674 . . . . 74.349999999999994 106.48 176.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.89 -103.66 0.06 OUTLIER Glycine 0 N--CA 1.475 1.24 0 O-C-N 123.74 0.65 . . . . 75.349999999999994 114.134 -175.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -106.59 2.03 25.73 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.106 -0.547 . . . . 75.329999999999998 111.903 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.593 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 89.3 m-85 -96.32 135.39 38.23 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.219 -1.4 . . . . 73.409999999999997 107.219 173.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -131.76 120.17 22.31 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.029 -1.1 . . . . 74.409999999999997 108.029 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.37 136.59 48.55 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.416 -0.587 . . . . 73.400000000000006 109.416 -176.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.95 120.17 64.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.219 -1.4 . . . . 75.340000000000003 107.219 175.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -98.27 117.15 32.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 110.147 -0.316 . . . . 74.209999999999994 110.147 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.37 143.88 47.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.182 0.515 . . . . 74.200000000000003 111.187 -177.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.97 119.64 34.83 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.759 -1.571 . . . . 64.510000000000005 106.759 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.39 153.24 19.81 Favored Glycine 0 N--CA 1.426 -1.969 0 C-N-CA 118.866 -1.635 . . . . 72.0 112.697 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.67 164.13 36.71 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 123.687 2.925 . . . . 72.409999999999997 111.524 175.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 84.31 69.22 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 125.213 1.405 . . . . 73.430000000000007 111.989 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 105.264 -2.125 . . . . 62.329999999999998 105.264 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 C--O 1.245 0.828 0 N-CA-C 109.471 -0.566 . . . . 74.430000000000007 109.471 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -85.33 115.83 23.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.911 -1.885 . . . . 72.140000000000001 105.911 173.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -99.38 163.5 12.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.929 0.395 . . . . 65.010000000000005 110.906 -173.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.49 124.49 21.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.641 -0.709 . . . . 73.329999999999998 110.955 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -102.74 91.45 4.18 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.65 0.738 . . . . 71.150000000000006 110.438 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.94 -46.9 4.06 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.483 -0.865 . . . . 63.399999999999999 110.982 177.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 m -104.93 109.59 63.38 Favored Pre-proline 0 C--N 1.31 -1.132 0 O-C-N 122.6 -0.353 . . . . 72.349999999999994 110.742 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.3 140.48 30.62 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 N-CA-C 107.956 -1.594 . . . . 74.109999999999999 107.956 172.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -79.13 123.06 84.97 Favored Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.97 -0.692 . . . . 62.030000000000001 109.905 -176.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.2 106.09 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.567 2.178 . . . . 64.109999999999999 112.754 -176.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.8 131.83 9.03 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.801 -1.185 . . . . 75.239999999999995 107.801 177.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.6 120.53 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.762 -1.57 . . . . 73.230000000000004 106.762 173.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.72 131.44 54.42 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 115.414 -0.812 . . . . 72.140000000000001 109.473 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.2 m -77.56 120.41 22.49 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.532 -0.758 . . . . 73.140000000000001 109.661 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . 0.476 HG21 ' HB3' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.548 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 44.9 t -89.31 117.84 28.55 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.21 -0.306 . . . . 74.230000000000004 110.204 -177.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.38 118.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.789 -0.449 . . . . 74.230000000000004 109.789 -178.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -124.04 140.73 52.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.384 -0.371 . . . . 74.299999999999997 111.16 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -94.51 139.59 30.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.239 -0.437 . . . . 74.019999999999996 111.232 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -128.46 -164.2 1.36 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 7.6 p-10 -68.08 -3.23 9.65 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.929 0.871 . . . . 73.209999999999994 111.2 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.7 mt -57.25 -31.99 66.1 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 125.89 1.676 . . . . 73.019999999999996 111.502 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 1.6 pp -68.39 -1.38 6.32 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.224 1.564 . . . . 73.219999999999999 115.224 -175.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 63.2 pttt -81.25 -5.71 58.07 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.847 -0.533 . . . . 72.319999999999993 111.599 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -48.9 31.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 116.112 1.893 . . . . 74.109999999999999 116.112 -175.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.7 ttm -62.26 -46.86 86.93 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.942 0.401 . . . . 74.530000000000001 111.658 -176.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.28 -28.25 61.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.318 0.58 . . . . 72.129999999999995 110.303 -178.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -80.51 -11.63 59.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.924 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -71.33 -24.41 62.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.756 -0.831 . . . . 54.539999999999999 108.756 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -76.08 93.74 3.36 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.305 -1.369 . . . . 75.129999999999995 107.305 171.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.78 50.32 0.85 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 106.901 -2.48 . . . . 51.32 106.901 -169.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -67.17 148.39 51.86 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.853 1.261 . . . . 71.510000000000005 112.118 -173.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 150.38 37.8 Favored Pre-proline 0 C--N 1.312 -1.028 0 N-CA-C 108.501 -0.925 . . . . 51.009999999999998 108.501 177.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.98 146.42 96.31 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.418 2.079 . . . . 74.129999999999995 113.24 -177.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.72 159.22 17.19 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 71.219999999999999 108.484 175.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.3 t -98.92 178.12 5.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.489 -0.56 . . . . 73.040000000000006 109.489 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.553 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 12.9 t -156.4 33.56 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.792 -1.929 . . . . 73.140000000000001 105.792 176.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' O ' HG22 ' A' ' 124' ' ' THR . . . -103.56 35.45 5.02 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 114.827 -1.079 . . . . 72.040000000000006 113.072 -173.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.82 -33.93 15.49 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.396 -0.964 . . . . 63.039999999999999 108.396 174.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.28 12.65 1.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.934 -1.485 . . . . 71.209999999999994 112.346 -177.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.08 -42.02 24.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.24 -0.282 . . . . 74.140000000000001 110.24 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt 35.94 76.07 0.46 Allowed Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 124.766 1.291 . . . . 74.530000000000001 114.241 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.35 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.437 1.425 . . . . 73.329999999999998 111.112 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.06 -8.44 20.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.147 0.499 . . . . 74.129999999999995 110.954 178.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -6.22 80.15 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.401 -0.904 . . . . 75.439999999999998 111.925 -179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -114.49 162.79 16.24 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.94 -1.874 . . . . 72.439999999999998 105.94 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -153.15 157.14 39.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 118.137 0.426 . . . . 73.519999999999996 110.51 -178.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 143.72 44.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.14 0.422 . . . . 74.140000000000001 112.14 -178.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -116.55 138.54 51.32 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.402 -0.592 . . . . 74.329999999999998 109.402 176.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.68 132.5 57.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 123.64 0.587 . . . . 72.329999999999998 109.573 -176.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.72 118.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.724 -1.584 . . . . 63.340000000000003 106.724 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.91 -38.96 18.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.411 0.624 . . . . 73.349999999999994 110.34 -175.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -147.54 140.7 25.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.325 -1.361 . . . . 65.019999999999996 107.325 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.94 -177.14 19.12 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 111.475 -0.65 . . . . 73.349999999999994 111.475 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.23 -36.9 86.37 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 122.772 2.315 . . . . 75.019999999999996 111.863 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.75 14.55 18.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.808 -0.633 . . . . 70.239999999999995 111.419 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.49 134.39 56.64 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.776 0.658 . . . . 73.409999999999997 112.776 -176.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -21.09 44.37 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.786 -0.643 . . . . 64.439999999999998 111.876 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 155.03 19.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.766 0.317 . . . . 75.340000000000003 110.47 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.14 144.54 51.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.107 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -117.82 138.53 52.02 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.221 -1.029 . . . . 71.200000000000003 108.221 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.11 127.01 56.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.917 0.865 . . . . 74.549999999999997 110.795 -175.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.45 114.77 26.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.822 -1.081 . . . . 74.530000000000001 108.436 179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -134.33 4.27 3.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.296 1.046 . . . . 74.349999999999994 109.193 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -121.49 143.3 37.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.978 -1.01 . . . . 73.049999999999997 110.724 -175.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 53.7 Cg_exo -55.19 -24.39 41.26 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.746 2.964 . . . . 75.420000000000002 114.699 -178.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -144.27 121.54 11.57 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.474 -0.766 . . . . 74.540000000000006 110.722 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.3 m -129.7 119.88 24.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.9 -0.778 . . . . 74.040000000000006 108.9 -178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 140.25 29.72 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.508 0.594 . . . . 74.409999999999997 111.275 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.05 135.5 55.18 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 109.549 -0.538 . . . . 71.340000000000003 109.549 178.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.36 -161.34 25.69 Favored Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 115.65 -0.705 . . . . 72.510000000000005 111.385 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -103.83 142.16 34.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.062 -1.459 . . . . 74.239999999999995 107.062 -177.554 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 75' ' ' GLU . 90.4 m-70 80.58 145.84 0.1 OUTLIER Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 125.414 1.486 . . . . 74.400000000000006 110.092 -176.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -66.5 17.4 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.601 2.867 . . . . 74.340000000000003 114.341 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 73' ' ' HIS . 10.4 mm-40 -77.37 -28.77 53.02 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.313 -1.366 . . . . 73.430000000000007 107.313 177.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -96.1 153.0 18.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.919 -1.037 . . . . 61.409999999999997 109.658 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.18 -47.19 78.78 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.56 0.744 . . . . 74.219999999999999 110.463 -178.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.8 mm -98.98 109.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.026 -1.102 . . . . 74.030000000000001 108.026 178.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -87.68 115.6 25.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.115 0.483 . . . . 74.420000000000002 110.577 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 70.8 mt -126.74 140.42 52.4 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.491 -1.67 . . . . 72.430000000000007 106.491 176.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -96.52 117.11 30.24 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.246 -0.982 . . . . 74.530000000000001 109.661 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 46.1 t0 -117.38 -179.88 3.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.779 -0.646 . . . . 75.349999999999994 109.36 -171.492 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.03 -46.44 96.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 123.757 0.823 . . . . 75.109999999999999 111.694 -176.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -128.27 -173.1 2.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.463 -0.94 . . . . 74.150000000000006 108.463 -178.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.37 97.5 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 108.825 -0.806 . . . . 74.430000000000007 108.825 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.6 m -89.74 84.89 6.31 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 108.525 -0.917 . . . . 74.109999999999999 108.525 177.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -71.82 -36.98 70.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.97 -1.468 . . . . 75.120000000000005 112.091 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.583 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 31.2 mmm180 -133.71 85.86 2.24 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.241 -1.022 . . . . 73.349999999999994 108.241 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -101.55 -55.65 2.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.193 -0.603 . . . . 61.420000000000002 110.952 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.76 164.59 31.42 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.077 0.465 . . . . 62.409999999999997 111.046 -176.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.66 141.49 37.01 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.397 0.617 . . . . 75.049999999999997 110.148 173.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -104.25 117.4 34.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.781 -1.562 . . . . 63.119999999999997 106.781 -178.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -117.37 128.46 55.05 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-N 115.445 -0.798 . . . . 74.120000000000005 109.256 -175.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -115.52 112.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 105.907 -1.886 . . . . 72.519999999999996 105.907 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -138.52 125.48 21.22 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.893 -0.323 . . . . 70.420000000000002 111.255 -175.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 51.56 49.9 19.94 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.978 1.424 . . . . 72.0 114.098 173.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 114.877 -1.056 . . . . 73.510000000000005 115.382 173.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -127.6 146.99 50.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 118.277 1.038 . . . . 74.230000000000004 111.026 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.33 119.6 39.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.485 -1.302 . . . . 75.5 107.485 -176.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.55 128.46 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.525 0.679 . . . . 71.349999999999994 111.353 -176.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.9 t -103.82 124.51 58.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.506 -1.294 . . . . 75.150000000000006 107.506 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 20.8 m -118.51 123.37 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 121.588 0.709 . . . . 75.329999999999998 110.836 176.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.29 121.6 25.3 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.447 -1.686 . . . . 74.010000000000005 106.447 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -111.84 -8.72 11.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.175 0.512 . . . . 72.530000000000001 111.349 -174.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -147.28 90.97 0.15 Allowed Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.17 -1.572 . . . . 52.25 109.17 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 m -79.22 74.09 5.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.559 0.695 . . . . 71.129999999999995 110.989 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.6 pt? -104.77 -44.36 4.87 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.328 -0.851 . . . . 75.200000000000003 108.786 175.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -101.16 -21.78 14.85 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.461 -1.245 . . . . 71.510000000000005 107.897 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.49 116.41 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.309 -0.86 . . . . 73.409999999999997 111.774 -177.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 m -75.82 128.51 35.29 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.794 -0.817 . . . . 71.540000000000006 108.794 176.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 22' ' ' LEU . 6.4 m-85 -115.24 126.34 54.42 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.616 -0.513 . . . . 74.349999999999994 109.616 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.6 127.87 62.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.408 -1.33 . . . . 75.200000000000003 107.408 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 57.05 46.58 18.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.637 1.208 . . . . 75.109999999999999 108.385 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 62.69 8.56 3.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.534 -1.667 . . . . 75.0 114.471 -177.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.43 132.66 23.45 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 113.231 0.826 . . . . 74.5 113.231 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 52.7 Cg_endo -78.13 123.19 6.04 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.0 1.8 . . . . 73.129999999999995 108.369 173.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -150.34 158.05 43.73 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.173 -1.047 . . . . 72.430000000000007 108.173 -176.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 15.7 m120 -92.95 -40.8 10.37 Favored 'General case' 0 C--O 1.206 -1.192 0 C-N-CA 120.003 -0.679 . . . . 72.430000000000007 112.77 -176.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.02 134.46 55.29 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.206 -1.405 . . . . 62.200000000000003 107.206 174.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -151.92 143.44 23.49 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 120.837 -0.345 . . . . 74.430000000000007 111.309 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -82.41 124.34 39.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.15 -1.426 . . . . 61.219999999999999 107.15 173.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.3 ttp -92.5 129.25 38.49 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 74.340000000000003 108.347 -177.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.553 ' OE1' ' HA ' ' A' ' 37' ' ' THR . 26.3 mt-30 -129.8 151.02 50.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.121 -0.696 . . . . 73.150000000000006 109.121 -172.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 38' ' ' GLY . 13.7 t -62.42 132.75 53.59 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.394 0.616 . . . . 63.210000000000001 110.058 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.28 -12.08 61.82 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.774 -0.648 . . . . 72.5 112.584 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.74 151.96 25.95 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.025 0.441 . . . . 74.239999999999995 111.819 178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -112.23 144.53 41.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.371 -0.832 . . . . 74.540000000000006 109.73 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.43 131.63 67.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.008 -1.108 . . . . 71.420000000000002 108.008 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -117.41 130.51 56.53 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.428 -0.509 . . . . 63.210000000000001 110.163 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.43 107.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 106.29 -1.744 . . . . 74.239999999999995 106.29 175.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.82 -108.53 2.27 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.127 -0.488 . . . . 74.299999999999997 113.323 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.99 -1.2 32.35 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.741 -0.23 . . . . 75.010000000000005 111.504 -175.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 38.1 p90 -124.71 146.39 49.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.992 1.108 . . . . 74.400000000000006 113.992 -173.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -118.18 132.18 56.34 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.117 -0.947 . . . . 75.219999999999999 111.288 -172.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.39 140.66 52.43 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 124.142 0.977 . . . . 73.019999999999996 108.875 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.04 130.39 67.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.705 -0.85 . . . . 74.510000000000005 108.705 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -94.06 133.07 37.91 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.976 -0.557 . . . . 64.519999999999996 111.221 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.29 155.57 39.98 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.906 -0.776 . . . . 75.510000000000005 108.906 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.42 148.66 38.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.034 -0.728 . . . . 63.219999999999999 109.034 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.496 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -75.58 136.56 20.26 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.781 -0.724 . . . . 73.439999999999998 112.019 -178.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.52 153.89 72.06 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.259 2.64 . . . . 72.310000000000002 112.27 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.61 65.56 0.8 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.791 -0.64 . . . . 63.43 111.516 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.414 -2.225 0 N-CA-C 107.944 -1.132 . . . . 75.349999999999994 107.944 173.183 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 108.736 -0.839 . . . . 74.230000000000004 108.736 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -84.52 136.45 33.8 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.872 -0.603 . . . . 74.049999999999997 111.678 -174.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.18 102.32 8.44 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.321 -0.854 . . . . 71.409999999999997 109.436 177.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -129.18 142.25 50.92 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.206 -1.776 . . . . 73.329999999999998 106.206 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.26 171.3 15.62 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.853 -0.425 . . . . 74.230000000000004 109.853 -177.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.97 -70.75 1.13 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.193 -0.527 . . . . 75.510000000000005 112.629 -178.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.0 m -129.32 111.07 17.99 Favored Pre-proline 0 C--N 1.287 -2.116 0 O-C-N 122.546 -0.385 . . . . 74.5 110.308 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.49 131.69 25.3 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.546 1.498 . . . . 74.040000000000006 109.148 173.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.88 149.79 40.9 Favored Pre-proline 0 C--N 1.29 -2.009 0 N-CA-C 108.803 -0.814 . . . . 75.510000000000005 108.803 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.51 122.06 7.26 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 122.174 1.916 . . . . 70.099999999999994 107.965 170.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -91.28 132.95 35.81 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.131 0.967 . . . . 74.430000000000007 112.349 -168.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.3 121.02 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.935 -1.876 . . . . 75.519999999999996 105.935 177.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.84 154.52 25.02 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 108.311 -0.996 . . . . 74.310000000000002 108.311 -177.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -70.27 113.14 7.14 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 123.623 0.769 . . . . 74.230000000000004 112.373 -173.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -96.81 152.95 18.18 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.504 -2.036 . . . . 73.439999999999998 105.504 172.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 93.4 t -82.78 114.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.853 -0.739 . . . . 74.5 109.321 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -123.3 120.41 32.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.51 -0.768 . . . . 75.329999999999998 110.778 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.92 93.02 3.04 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.155 -2.165 . . . . 74.299999999999997 105.155 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.64 9.52 22.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.467 0.914 . . . . 70.549999999999997 113.467 -168.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -107.24 8.17 29.77 Favored 'General case' 0 C--O 1.182 -2.498 0 C-N-CA 118.909 -1.116 . . . . 74.420000000000002 112.581 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.83 -32.4 63.54 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.111 -0.993 . . . . 70.430000000000007 113.374 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.1 tp -68.05 -37.69 81.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.33 0.586 . . . . 75.329999999999998 110.289 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -91.08 -25.18 19.76 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.126 -0.359 . . . . 71.420000000000002 111.343 -177.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -44.31 93.08 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.163 -1.421 . . . . 72.340000000000003 107.163 174.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.3 mtt -62.27 -35.4 78.86 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.33 -0.396 . . . . 74.420000000000002 111.468 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.85 -44.46 80.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.741 0.781 . . . . 75.040000000000006 109.221 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -72.92 -10.44 59.8 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.086 -178.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -65.42 -17.19 64.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.577 0.227 . . . . 42.109999999999999 110.94 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -57.43 116.95 3.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.437 -0.949 . . . . 75.230000000000004 108.437 174.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.15 119.74 18.5 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.335 -0.848 . . . . 74.239999999999995 115.079 -173.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -116.68 149.49 39.71 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.513 -1.292 . . . . 75.439999999999998 107.513 173.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.01 127.49 92.86 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.994 -0.373 . . . . 72.209999999999994 109.994 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.02 142.58 88.32 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.134 1.889 . . . . 75.239999999999995 110.61 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.69 168.13 9.34 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.505 -0.316 . . . . 72.549999999999997 110.289 -174.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.4 t -174.88 -168.28 0.34 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.903 -1.518 . . . . 75.549999999999997 106.903 177.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t 174.45 -29.81 0.0 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.803 0.841 . . . . 71.340000000000003 109.906 178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.34 63.3 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.901 -1.143 . . . . 64.019999999999996 112.661 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.34 -45.9 18.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.037 -0.727 . . . . 70.239999999999995 109.037 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.15 4.7 22.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.409 -0.814 . . . . 72.420000000000002 110.651 -178.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -89.88 -28.18 19.4 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.664 -1.153 . . . . 74.439999999999998 108.16 177.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.4 mt 56.34 80.05 0.31 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 114.739 -1.119 . . . . 61.130000000000003 110.626 -177.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.76 -63.71 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 122.743 2.295 . . . . 71.209999999999994 113.406 -175.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.8 14.03 7.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.212 0.529 . . . . 55.210000000000001 110.588 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.28 -9.07 62.1 Favored Glycine 0 C--O 1.215 -1.087 0 C-N-CA 121.127 -0.558 . . . . 71.340000000000003 113.378 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -115.35 153.98 30.02 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 122.351 -0.499 . . . . 61.539999999999999 109.779 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -145.91 157.51 43.89 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.073 -0.714 . . . . 73.239999999999995 109.073 -177.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.76 161.49 37.07 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.831 -0.347 . . . . 74.420000000000002 111.137 -179.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.6 147.36 52.52 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.745 -0.465 . . . . 71.209999999999994 109.745 177.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.04 132.09 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.12 -0.696 . . . . 71.230000000000004 109.12 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.25 117.92 26.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.167 -1.42 . . . . 74.430000000000007 107.167 176.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.62 -34.0 18.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.747 -0.381 . . . . 75.209999999999994 110.636 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -146.82 133.43 19.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.431 -0.581 . . . . 74.420000000000002 109.431 -178.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.43 171.88 17.0 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 107.304 -2.318 . . . . 64.439999999999998 107.304 -177.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.581 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 52.3 Cg_exo -57.61 -31.89 92.97 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.234 1.956 . . . . 75.310000000000002 111.273 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -93.94 20.33 7.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.375 -0.829 . . . . 74.239999999999995 111.274 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 138.54 58.4 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.645 0.26 . . . . 73.329999999999998 110.654 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.92 63.16 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.737 -0.665 . . . . 73.0 111.715 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.33 135.9 33.35 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.698 0.285 . . . . 72.310000000000002 110.446 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.03 134.53 54.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.316 -1.365 . . . . 73.209999999999994 107.316 177.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -128.49 144.9 51.22 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.351 -1.352 . . . . 73.219999999999999 107.351 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -116.66 143.18 45.95 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.528 -0.869 . . . . 74.530000000000001 111.951 -177.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.37 105.01 16.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.116 -1.809 . . . . 64.409999999999997 106.116 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -127.37 12.33 7.0 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.487 1.137 . . . . 64.340000000000003 109.761 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.66 153.81 47.38 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.029 -1.1 . . . . 71.329999999999998 108.029 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.3 -21.25 71.74 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.378 2.052 . . . . 73.519999999999996 113.713 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.7 m -136.93 121.7 18.65 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 121.893 -0.505 . . . . 64.150000000000006 110.514 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.8 m -129.59 118.18 21.59 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.179 -0.674 . . . . 75.340000000000003 109.179 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 p -86.86 150.8 23.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.802 -0.561 . . . . 71.129999999999995 110.841 -178.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.3 135.24 48.51 Favored 'General case' 0 C--O 1.264 1.851 0 CA-C-O 121.049 0.452 . . . . 74.25 112.035 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.93 -138.66 6.35 Favored Glycine 0 N--CA 1.422 -2.3 0 CA-C-N 114.796 -1.093 . . . . 62.409999999999997 110.891 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 56.2 ttt180 -118.87 151.57 37.87 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.506 -1.294 . . . . 74.530000000000001 107.506 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 34.9 m170 89.3 164.5 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.967 0 C-N-CA 125.234 1.414 . . . . 75.230000000000004 111.323 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.15 -2.61 8.32 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.018 2.479 . . . . 71.349999999999994 111.009 174.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.24 -22.37 60.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.951 -1.022 . . . . 75.319999999999993 108.36 175.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 m -112.2 130.02 56.06 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.23 -0.895 . . . . 74.030000000000001 109.417 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -77.37 -33.87 55.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.474 0.654 . . . . 73.329999999999998 109.652 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.9 mm -91.71 101.03 12.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 105.558 -2.016 . . . . 65.109999999999999 105.558 173.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -87.79 113.98 23.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.52 0.676 . . . . 73.0 112.237 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.0 mt -119.87 127.42 52.71 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.878 -1.897 . . . . 74.230000000000004 105.878 175.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -106.21 117.06 33.06 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.83 -0.748 . . . . 71.510000000000005 109.613 -176.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -119.85 177.56 4.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.033 -0.985 . . . . 73.439999999999998 109.071 -175.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.38 -35.76 68.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 107.913 -1.143 . . . . 74.439999999999998 107.913 176.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.9 m -97.96 151.32 20.41 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.81 -1.086 . . . . 74.120000000000005 108.778 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -90.51 98.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 118.686 -1.206 . . . . 73.239999999999995 110.408 175.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -87.03 78.42 8.96 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.677 -1.231 . . . . 73.140000000000001 107.677 172.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -57.43 -23.82 51.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 112.083 -176.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -172.79 97.7 0.13 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.605 -0.887 . . . . 75.129999999999995 108.605 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 2.3 t-160 -99.34 -52.12 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.942 -1.132 . . . . 72.409999999999997 107.942 176.222 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.81 155.44 41.09 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.987 -0.551 . . . . 74.340000000000003 110.844 -174.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.49 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 34.0 tt0 -131.05 129.15 41.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.566 -1.642 . . . . 74.530000000000001 106.566 176.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -105.27 122.2 45.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.622 -1.621 . . . . 74.150000000000006 106.622 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' HD3' ' OE2' ' A' ' 91' ' ' GLU . 21.3 mtm180 -125.07 145.91 49.7 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.635 0.731 . . . . 71.310000000000002 110.635 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.403 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.1 mp -103.98 111.41 33.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 102.856 -3.016 . . . . 74.150000000000006 102.856 175.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -138.73 118.45 13.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.038 -0.528 . . . . 72.329999999999998 110.829 -169.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 53.48 37.8 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.454 1.102 . . . . 72.510000000000005 112.272 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.06 87.52 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 113.515 178.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.98 150.12 26.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.387 -0.598 . . . . 73.230000000000004 109.387 -179.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.403 ' CD2' HG13 ' A' ' 94' ' ' ILE . 94.1 m-85 -104.59 116.19 31.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.257 -1.757 . . . . 70.25 106.257 174.151 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.14 135.31 54.3 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.206 0.527 . . . . 75.219999999999999 111.51 -174.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.42 120.65 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 104.815 -2.291 . . . . 73.430000000000007 104.815 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.03 131.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 N-CA-C 108.35 -0.982 . . . . 72.349999999999994 108.35 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.597 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.8 p30 -97.8 157.94 15.79 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 117.65 -1.62 . . . . 74.030000000000001 112.123 176.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -129.96 23.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.067 -1.827 . . . . 75.420000000000002 106.067 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.99 62.92 0.52 Allowed Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.752 -1.567 . . . . 74.040000000000006 110.11 -176.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -70.97 -7.01 43.1 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 122.802 0.441 . . . . 72.310000000000002 111.485 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 mt -75.19 -40.94 58.93 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.318 -0.253 . . . . 74.519999999999996 110.318 -178.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 94.3 m-20 -85.8 -20.56 29.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 119.799 -0.76 . . . . 74.310000000000002 110.25 -176.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.17 109.85 0.42 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.302 -0.951 . . . . 71.5 113.525 174.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -85.38 130.36 34.61 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.456 -0.942 . . . . 61.399999999999999 108.456 174.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -120.0 134.31 55.28 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.076 -0.712 . . . . 74.519999999999996 109.076 179.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.8 t -129.87 120.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.928 -1.508 . . . . 73.129999999999995 106.928 175.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.37 39.82 28.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.645 0.736 . . . . 73.430000000000007 109.777 -173.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 62.07 14.87 6.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 113.589 -1.641 . . . . 73.329999999999998 113.736 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -103.53 123.41 41.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 107.684 -1.228 . . . . 72.209999999999994 107.684 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.37 123.87 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.321 2.014 . . . . 74.420000000000002 110.786 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -141.33 162.31 35.79 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 110.593 -179.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.597 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 18.4 m120 -113.81 -29.84 6.95 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.595 -1.184 . . . . 73.409999999999997 109.533 176.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.31 134.7 36.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.617 -1.623 . . . . 72.0 106.617 172.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -153.46 138.45 17.24 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.458 -0.497 . . . . 71.239999999999995 111.826 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.6 t -84.86 122.52 38.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.401 -1.333 . . . . 75.540000000000006 107.401 171.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.444 ' HE3' ' CD1' ' A' ' 137' ' ' PHE . 13.6 ptm -90.25 130.53 36.36 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.961 -0.563 . . . . 71.430000000000007 111.099 -173.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -101.8 156.2 17.66 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.299 -0.63 . . . . 74.420000000000002 109.299 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.3 t -67.17 126.71 30.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 61.439999999999998 108.677 175.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.91 -6.66 58.62 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.725 -0.67 . . . . 75.430000000000007 112.747 -175.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.23 151.76 29.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.27 0.535 . . . . 71.219999999999999 111.184 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -112.39 127.48 56.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.45 0.643 . . . . 75.439999999999998 110.423 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.94 122.34 68.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.041 -1.096 . . . . 72.420000000000002 108.041 -177.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 39.0 mt-30 -108.02 131.11 54.92 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 113.101 0.778 . . . . 72.230000000000004 113.101 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.468 HG23 ' ND1' ' A' ' 89' ' ' HIS . 3.3 mp -117.35 103.24 14.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.478 -1.675 . . . . 74.439999999999998 106.478 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -65.6 1.29 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-O 121.279 0.377 . . . . 64.439999999999998 112.842 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -157.72 5.71 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.151 0.98 . . . . 74.400000000000006 110.847 173.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 68.0 m-85 -91.18 124.54 35.47 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.894 -1.15 . . . . 75.120000000000005 107.894 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -111.57 118.8 36.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.927 0.87 . . . . 75.530000000000001 110.932 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.29 133.74 52.08 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.475 -1.693 . . . . 75.409999999999997 107.413 -178.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.25 129.09 67.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.862 -1.162 . . . . 72.519999999999996 107.862 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.444 ' CD1' ' HE3' ' A' ' 122' ' ' MET . 80.5 t80 -88.56 134.03 33.99 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.53 -0.759 . . . . 74.450000000000003 109.484 -176.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.75 161.23 33.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.139 0.495 . . . . 75.209999999999994 109.846 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.56 132.06 43.3 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.701 -1.592 . . . . 73.430000000000007 106.701 174.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.43 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -80.11 -163.74 28.59 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 115.739 1.055 . . . . 63.299999999999997 115.739 -169.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.36 145.3 47.84 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 123.001 2.467 . . . . 74.420000000000002 112.424 -177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.42 65.86 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.494 -1.298 . . . . 71.420000000000002 107.494 175.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--N 1.295 -1.782 0 CA-C-N 114.288 -1.324 . . . . 72.230000000000004 109.388 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.886 0 CA-C-O 121.42 0.629 . . . . 75.400000000000006 111.795 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -140.07 85.11 2.0 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.44 -1.318 . . . . 73.329999999999998 107.44 176.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -96.13 152.61 18.39 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.077 -0.712 . . . . 53.119999999999997 109.077 179.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.99 131.02 55.66 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.248 0.547 . . . . 75.430000000000007 111.775 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -150.12 154.02 37.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.592 -2.373 . . . . 71.329999999999998 104.592 174.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.77 -114.38 1.49 Allowed Glycine 0 N--CA 1.423 -2.169 0 C-N-CA 118.867 -1.635 . . . . 74.349999999999994 113.06 -176.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 m -81.22 131.77 58.13 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.308 -0.446 . . . . 70.129999999999995 111.171 -174.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.93 145.79 95.96 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.061 1.841 . . . . 71.099999999999994 108.152 169.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.87 124.22 84.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 120.279 -0.568 . . . . 75.150000000000006 110.721 -173.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.89 104.31 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.096 2.531 . . . . 74.409999999999997 110.859 177.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -100.16 154.33 18.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.292 -1.003 . . . . 74.510000000000005 108.292 178.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.1 t -108.22 131.57 58.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.543 0.687 . . . . 63.009999999999998 110.418 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.27 168.92 24.38 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.104 -2.924 . . . . 71.340000000000003 103.104 176.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.619 ' HB ' ' NH2' ' A' ' 87' ' ' ARG . 33.8 m -70.52 109.01 4.58 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.251 1.024 . . . . 75.400000000000006 109.854 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.4 m -117.65 143.76 45.85 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 178.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.9 t -83.72 124.57 39.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.82 -0.807 . . . . 73.329999999999998 108.82 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.46 105.91 13.01 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.627 -1.249 . . . . 73.319999999999993 107.627 -178.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -89.1 95.88 10.5 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.638 -0.71 . . . . 74.340000000000003 110.203 -178.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.69 157.89 23.59 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.139 -0.937 . . . . 75.319999999999993 108.508 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.01 3.6 16.78 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.097 0.475 . . . . 75.310000000000002 112.066 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.42 ' CD1' ' HH ' ' A' ' 111' ' ' TYR . 3.9 pp -65.88 -23.02 66.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.492 1.293 . . . . 72.299999999999997 114.492 -174.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.36 -26.96 63.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.913 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -66.66 -29.46 69.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 74.129999999999995 110.997 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.55 -48.64 76.66 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.535 0.522 . . . . 75.239999999999995 111.744 -175.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -76.78 -18.05 58.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.313 0.578 . . . . 74.420000000000002 110.868 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -81.6 -34.35 31.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.136 -1.061 . . . . 64.219999999999999 108.136 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 t -72.59 -45.24 60.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.974 -0.557 . . . . 75.209999999999994 110.21 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 p -80.75 -17.35 51.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.253 -0.43 . . . . 73.420000000000002 111.993 -177.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 67.07 73.89 0.34 Allowed 'General case' 0 C--O 1.25 1.1 0 CA-C-O 122.088 0.946 . . . . 73.310000000000002 110.228 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.62 124.68 34.34 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 113.695 -1.593 . . . . 71.25 113.926 -176.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -94.68 137.76 33.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.356 -0.609 . . . . 73.409999999999997 109.356 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.61 98.97 43.0 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 109.63 -0.507 . . . . 63.409999999999997 109.63 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 143.08 27.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.027 1.818 . . . . 73.450000000000003 110.946 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 126.0 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.944 -1.132 . . . . 71.349999999999994 107.944 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -112.28 156.83 21.76 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.288 -0.634 . . . . 75.120000000000005 109.288 -177.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.23 160.83 32.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.807 -0.812 . . . . 72.430000000000007 108.807 -177.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.53 -7.12 24.46 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.647 -1.381 . . . . 62.200000000000003 109.647 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' HB3' ' H ' ' A' ' 124' ' ' THR . . . -73.8 -39.78 63.85 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.721 -0.74 . . . . 73.209999999999994 109.979 -177.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.51 -5.08 59.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.466 -1.243 . . . . 75.120000000000005 110.432 -177.144 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -86.63 -29.89 22.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.931 -0.577 . . . . 72.040000000000006 110.119 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 53.41 69.21 2.38 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 124.158 0.911 . . . . 73.400000000000006 110.384 -177.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.15 -65.97 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.181 2.587 . . . . 72.420000000000002 113.819 -173.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 140' ' ' GLY . . . -102.22 -0.37 33.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.611 -0.436 . . . . 74.239999999999995 111.467 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.9 -5.14 77.14 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.079 -0.581 . . . . 53.119999999999997 113.606 178.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.1 m -115.22 157.67 23.38 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 110.0 -0.371 . . . . 61.439999999999998 110.0 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -142.59 139.93 31.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.308 -0.406 . . . . 74.540000000000006 110.161 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.46 150.61 32.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.927 0.394 . . . . 72.019999999999996 111.782 -178.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.36 134.25 53.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.262 -0.644 . . . . 74.120000000000005 109.262 177.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.02 133.36 56.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.042 -0.526 . . . . 73.120000000000005 110.222 -178.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.535 HG23 ' ND2' ' A' ' 56' ' ' ASN . 24.8 t -76.54 117.54 21.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.732 -1.581 . . . . 72.5 106.732 177.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -90.35 -31.98 16.67 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.323 0.582 . . . . 75.549999999999997 110.164 -173.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -142.5 144.27 32.91 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.91 -1.885 . . . . 75.120000000000005 105.91 -176.974 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' HD3' ' A' ' 53' ' ' ARG . . . 134.2 169.52 12.05 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 110.175 -1.17 . . . . 72.099999999999994 110.175 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.55 -31.81 87.53 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.309 2.006 . . . . 73.209999999999994 112.042 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.535 ' ND2' HG23 ' A' ' 51' ' ' VAL . 4.5 p-10 -101.35 22.68 12.14 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.363 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.95 143.91 55.8 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.995 0.426 . . . . 74.329999999999998 111.357 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.23 -13.58 60.07 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.002 -0.839 . . . . 63.009999999999998 111.002 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 128.66 36.49 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.32 -0.622 . . . . 64.519999999999996 109.32 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -110.73 135.31 51.51 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.036 -0.727 . . . . 75.439999999999998 109.036 176.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.294 -1.002 . . . . 73.310000000000002 108.294 -179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.98 144.48 26.24 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.614 -0.434 . . . . 73.340000000000003 109.846 177.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 3.4 mm? -74.77 118.4 17.69 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.91 -0.774 . . . . 75.019999999999996 108.91 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.98 -29.03 4.33 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 111.825 0.306 . . . . 73.409999999999997 111.825 -174.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.455 ' O ' HD11 ' A' ' 94' ' ' ILE . 3.0 pt20 -118.69 151.96 50.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 112.97 0.73 . . . . 71.510000000000005 112.97 -177.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.76 -25.65 27.59 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 124.306 3.337 . . . . 72.430000000000007 114.202 -179.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.3 m -135.21 119.8 18.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.722 -1.214 . . . . 63.130000000000003 107.722 175.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.4 m -115.5 114.28 24.8 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.7 -0.852 . . . . 73.349999999999994 108.7 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.5 p -86.52 135.65 33.37 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 122.138 -0.351 . . . . 71.409999999999997 111.344 -176.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.15 134.68 55.06 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-N 116.019 -0.537 . . . . 54.409999999999997 111.492 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.43 -163.95 28.42 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 108.709 -1.756 . . . . 75.329999999999998 108.709 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -112.8 119.23 37.3 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.09 -1.818 . . . . 75.540000000000006 106.09 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.617 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 4.5 t-160 -174.33 155.29 2.18 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 104.861 -2.274 . . . . 74.219999999999999 104.861 -173.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.617 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 55.8 Cg_endo -75.66 -18.57 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-N 120.507 1.217 . . . . 74.25 110.799 175.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.21 -3.47 55.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.411 -0.813 . . . . 63.140000000000001 112.321 -176.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.452 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 56.1 p -80.38 143.09 33.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.87 -0.732 . . . . 73.209999999999994 110.24 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.64 -39.0 67.54 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.557 -0.457 . . . . 74.540000000000006 110.388 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.14 135.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.051 -0.722 . . . . 72.400000000000006 109.051 176.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -96.14 117.84 31.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.251 0.548 . . . . 75.540000000000006 110.152 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -125.9 140.23 52.82 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.659 -1.978 . . . . 73.310000000000002 105.659 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.12 117.29 29.9 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.056 -0.658 . . . . 60.399999999999999 109.267 -176.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.18 173.44 6.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.684 -0.858 . . . . 63.32 108.684 -174.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.32 -29.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.436 -0.95 . . . . 74.329999999999998 108.436 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -128.35 -165.26 1.47 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.591 -1.263 . . . . 75.120000000000005 107.591 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.06 98.17 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.683 -0.807 . . . . 61.439999999999998 109.896 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.1 m -87.4 73.85 9.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 122.0 0.905 . . . . 75.239999999999995 110.275 175.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' NH2' ' HB ' ' A' ' 14' ' ' THR . 8.5 ptt180 -69.87 -40.37 75.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.198 -1.365 . . . . 75.420000000000002 112.618 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -135.65 73.76 1.48 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.47 -0.937 . . . . 73.150000000000006 108.47 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -100.45 -53.5 3.09 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.374 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.78 162.54 40.54 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 119.763 -0.775 . . . . 73.150000000000006 111.082 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.12 146.04 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.291 173.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -104.87 119.19 38.4 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.55 -2.019 . . . . 74.450000000000003 105.55 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -109.07 132.88 53.69 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.688 -0.687 . . . . 74.540000000000006 109.257 -172.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 63' ' ' LEU . 57.9 mt -125.93 123.98 65.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.393 -0.821 . . . . 73.409999999999997 108.905 -173.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.91 118.24 18.67 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.479 -0.488 . . . . 75.319999999999993 111.537 174.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.44 37.82 29.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.908 0.883 . . . . 70.430000000000007 111.905 175.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.02 82.4 Favored Glycine 0 C--O 1.222 -0.632 0 CA-C-N 115.642 -0.708 . . . . 51.329999999999998 113.859 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 35.2 mt-10 -101.53 130.58 47.85 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.048 -1.464 . . . . 74.340000000000003 107.048 175.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.2 124.47 52.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.829 -0.434 . . . . 75.239999999999995 109.829 -174.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.88 148.78 52.69 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 120.763 0.316 . . . . 71.409999999999997 111.064 177.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.48 123.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 106.681 -1.6 . . . . 74.329999999999998 106.681 177.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.36 122.97 69.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.606 -0.516 . . . . 74.319999999999993 109.606 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.49 129.42 34.5 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.67 -1.233 . . . . 74.319999999999993 107.67 172.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.57 23.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 120.796 -0.362 . . . . 71.120000000000005 111.369 -176.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.27 -38.07 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 118.418 -1.849 . . . . 64.099999999999994 114.218 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 61.2 30.84 19.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.931 0.872 . . . . 73.420000000000002 109.268 -174.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.99 -49.21 75.59 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 113.931 -1.486 . . . . 75.209999999999994 111.083 -174.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -106.96 -19.4 13.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.772 -1.171 . . . . 74.420000000000002 109.084 178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.17 101.86 2.72 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.385 -1.086 . . . . 72.510000000000005 110.385 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 m -87.8 129.41 35.2 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.362 0.601 . . . . 72.049999999999997 110.652 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 73.3 m-85 -116.01 126.82 54.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.307 -0.997 . . . . 72.439999999999998 108.307 175.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 t -120.9 126.91 75.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 105.443 -2.058 . . . . 75.400000000000006 105.443 176.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 55.46 38.73 30.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.182 -1.414 . . . . 73.349999999999994 107.182 -169.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' HD3' ' NH1' ' A' ' 134' ' ' ARG . 22.1 mtm105 63.39 8.99 3.79 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 114.035 -1.439 . . . . 74.030000000000001 114.461 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.45 135.67 19.29 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.035 -0.728 . . . . 72.420000000000002 109.035 176.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.9 122.94 11.15 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 121.735 1.623 . . . . 73.200000000000003 108.651 177.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.485 ' CD ' ' HB2' ' A' ' 120' ' ' GLN . 26.1 ttm-85 -152.37 169.56 22.25 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.773 -0.771 . . . . 73.230000000000004 110.164 -170.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -104.76 -68.65 0.84 Allowed 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.533 0.521 . . . . 72.329999999999998 110.458 174.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.69 54.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.042 -0.411 . . . . 73.120000000000005 110.68 -174.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.485 ' HB2' ' CD ' ' A' ' 117' ' ' ARG . 57.1 tp60 -153.63 137.88 16.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.944 -0.571 . . . . 63.299999999999997 111.111 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 82.8 t -65.93 133.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.379 -1.711 . . . . 64.540000000000006 106.379 169.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 42.2 ttm -87.33 129.55 34.97 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.674 -0.861 . . . . 75.129999999999995 108.674 -170.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -114.09 149.29 35.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.001 -0.74 . . . . 74.099999999999994 109.001 -177.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 39' ' ' ALA . 14.6 t -73.52 130.58 40.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 109.272 -0.64 . . . . 75.450000000000003 109.272 -179.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.24 -0.13 57.15 Favored Glycine 0 C--O 1.241 0.535 0 N-CA-C 111.464 -0.654 . . . . 70.439999999999998 111.464 -176.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.51 148.23 35.4 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 108.953 -0.758 . . . . 74.530000000000001 108.953 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.7 124.93 53.06 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.528 -0.915 . . . . 61.039999999999999 108.528 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -108.42 113.08 42.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 106.821 -1.548 . . . . 73.319999999999993 106.821 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 64.6 tt0 -108.22 126.37 52.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.144 0.497 . . . . 75.540000000000006 109.679 -176.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.82 108.36 25.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.607 -1.257 . . . . 72.409999999999997 107.607 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.37 -105.11 1.49 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.594 -1.402 . . . . 41.200000000000003 109.594 -175.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -116.07 -13.64 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.197 -0.601 . . . . 73.430000000000007 111.764 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -98.92 140.75 32.61 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.386 -0.926 . . . . 70.400000000000006 110.63 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.514 ' NH1' ' HD3' ' A' ' 114' ' ' ARG . 19.5 ptp180 -112.58 144.14 42.56 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 112.667 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.63 139.76 49.37 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.983 -1.858 . . . . 75.109999999999999 105.983 174.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -111.79 128.39 68.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.127 -1.064 . . . . 72.129999999999995 108.127 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.463 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 80.4 t80 -94.41 122.11 36.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.984 0.421 . . . . 71.319999999999993 110.982 -178.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.73 159.1 26.07 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.462 0.649 . . . . 73.230000000000004 110.142 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.38 124.44 27.13 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.676 -1.231 . . . . 73.120000000000005 107.676 173.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.454 ' O ' ' HB1' ' A' ' 44' ' ' ALA . . . -75.84 142.16 28.32 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.932 -0.651 . . . . 71.230000000000004 112.19 -175.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.45 162.79 41.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.14 2.56 . . . . 75.040000000000006 111.991 176.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.62 44.17 0.96 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.594 0.711 . . . . 75.400000000000006 109.902 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 106.679 -1.6 . . . . 74.310000000000002 106.679 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.477 0.18 . . . . 71.329999999999998 110.991 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.8 t -112.55 116.83 30.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.808 -0.557 . . . . 74.25 110.026 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -129.11 145.54 51.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.157 -1.423 . . . . 72.340000000000003 107.157 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -138.23 152.05 48.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.133 0.492 . . . . 44.530000000000001 110.983 -178.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.62 22.0 10.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.645 -0.707 . . . . 70.430000000000007 110.779 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.15 -19.04 77.72 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.322 -0.711 . . . . 63.119999999999997 111.322 178.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -78.88 119.41 77.15 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 122.9 0.48 . . . . 74.420000000000002 109.771 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.24 132.54 21.15 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.379 2.053 . . . . 73.109999999999999 112.261 -177.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.81 144.87 49.01 Favored Pre-proline 0 N--CA 1.417 -2.099 0 N-CA-C 107.124 -1.436 . . . . 73.510000000000005 107.124 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.06 -179.15 0.15 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 123.054 2.503 . . . . 70.099999999999994 114.129 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -90.35 138.19 31.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.371 -1.344 . . . . 74.430000000000007 107.371 -178.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.5 t -111.4 121.5 64.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.254 -0.647 . . . . 75.540000000000006 109.254 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -114.91 168.33 10.0 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.407 -0.815 . . . . 73.439999999999998 108.99 178.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -68.9 127.85 34.6 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 124.059 0.849 . . . . 73.049999999999997 110.608 -174.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m -103.28 154.5 19.29 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.815 -1.18 . . . . 71.140000000000001 107.815 175.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.78 115.31 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.869 -1.16 . . . . 72.140000000000001 107.869 178.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.38 131.87 45.09 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.248 -1.019 . . . . 72.349999999999994 108.248 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -129.24 105.3 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.173 0.511 . . . . 74.120000000000005 110.496 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.49 140.75 48.48 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.751 -0.833 . . . . 71.510000000000005 108.751 178.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.52 2.04 34.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.66 0.245 . . . . 53.420000000000002 111.66 -176.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -63.92 -10.48 21.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.99 1.107 . . . . 73.310000000000002 113.99 -179.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.37 -12.76 61.93 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 122.153 0.978 . . . . 73.540000000000006 110.976 176.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.5 -20.53 66.38 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 126.016 1.727 . . . . 74.510000000000005 109.813 177.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HA ' ' OG ' ' A' ' 28' ' ' SER . 11.7 tp10 -59.18 -18.47 36.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.508 -0.769 . . . . 72.129999999999995 111.979 -176.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -57.84 -41.49 82.46 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.18 -0.325 . . . . 71.209999999999994 110.745 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.26 -22.16 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.992 0.368 . . . . 74.299999999999997 111.992 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 25' ' ' GLU . 6.7 p -81.02 -36.07 31.07 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.965 -0.694 . . . . 75.439999999999998 111.473 177.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.3 m -79.94 -48.42 13.43 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.607 -0.837 . . . . 73.340000000000003 110.757 177.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.1 m 47.58 -76.89 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.122 1.897 . . . . 73.010000000000005 116.122 -178.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.03 65.9 2.57 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 114.563 0.585 . . . . 74.430000000000007 114.563 -172.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.1 m -116.07 123.62 48.38 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.389 -1.338 . . . . 74.420000000000002 107.389 172.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.25 109.57 51.57 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.471 -0.491 . . . . 74.439999999999998 110.672 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.79 142.83 99.22 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.666 2.244 . . . . 72.299999999999997 110.301 174.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.49 126.35 32.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.25 -0.432 . . . . 54.119999999999997 111.233 -176.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 p -96.2 80.38 3.24 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.478 0.656 . . . . 74.040000000000006 110.001 178.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.8 t -89.51 -27.63 20.18 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.687 -0.688 . . . . 63.140000000000001 110.463 -178.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.99 55.23 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.543 -0.837 . . . . 74.519999999999996 112.55 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.91 -39.96 79.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 109.769 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.46 -11.96 60.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.92 . . . . 71.230000000000004 111.492 -178.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -97.1 -12.36 23.24 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.269 -0.641 . . . . 64.340000000000003 109.269 -175.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 mt 59.73 83.63 0.21 Allowed Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 124.722 1.264 . . . . 72.230000000000004 108.599 -176.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -33.98 -59.29 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.094 1 C-N-CA 125.703 4.269 . . . . 74.200000000000003 115.767 -166.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.58 10.71 3.72 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.743 0.782 . . . . 70.040000000000006 109.687 179.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.48 -12.46 46.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.1 -0.8 . . . . 75.209999999999994 111.1 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -138.9 151.52 47.01 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.056 -1.831 . . . . 65.019999999999996 106.056 177.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 137' ' ' PHE . . . -152.92 158.55 42.27 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.794 -0.817 . . . . 75.239999999999995 108.794 -177.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -120.86 149.67 42.24 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.237 -0.585 . . . . 72.239999999999995 111.965 -175.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -114.99 139.55 49.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.773 -0.825 . . . . 75.030000000000001 108.773 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.19 135.93 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.422 -0.354 . . . . 74.430000000000007 110.384 -177.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -82.79 118.12 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.026 -1.472 . . . . 75.519999999999996 107.026 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -95.96 -31.34 13.13 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.062 -0.972 . . . . 73.349999999999994 110.408 -174.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -143.12 137.68 29.29 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.153 -0.684 . . . . 73.310000000000002 109.153 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.44 175.14 13.88 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.816 -1.314 . . . . 34.229999999999997 109.816 -179.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 78.4 Cg_exo -55.62 -37.69 95.0 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 74.299999999999997 112.807 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -96.69 22.77 7.71 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.564 0.579 . . . . 72.209999999999994 112.564 -178.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.02 137.38 58.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.928 0.394 . . . . 63.43 110.416 177.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.55 -18.03 41.91 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 111.023 -0.831 . . . . 72.120000000000005 111.023 -178.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.29 139.6 30.33 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 110.126 -0.324 . . . . 71.299999999999997 110.126 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -128.22 137.76 52.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 73.319999999999993 108.724 178.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -125.18 138.39 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.999 -0.741 . . . . 72.430000000000007 108.999 -178.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -96.91 134.02 40.79 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.105 0.479 . . . . 72.409999999999997 109.713 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.6 mt -97.95 105.21 17.32 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.277 -0.42 . . . . 73.430000000000007 110.219 -178.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -130.55 5.55 4.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.774 0.797 . . . . 63.350000000000001 109.578 176.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -107.84 141.46 23.13 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 115.109 -0.95 . . . . 74.310000000000002 110.709 -177.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.1 Cg_exo -57.41 -27.55 76.39 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.364 2.71 . . . . 65.25 113.745 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -137.03 123.5 20.82 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.299 -0.63 . . . . 71.200000000000003 109.299 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 26.3 m -123.47 120.76 33.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.463 -0.94 . . . . 74.010000000000005 108.463 178.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.467 HG21 HH11 ' A' ' 88' ' ' ARG . 74.6 m -94.49 131.06 40.59 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 112.06 0.392 . . . . 75.099999999999994 112.06 -176.353 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.89 135.49 54.89 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.292 0.568 . . . . 75.25 110.556 178.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.09 -159.74 25.2 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.465 -1.454 . . . . 72.109999999999999 109.465 179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -101.69 117.75 35.53 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.724 -1.213 . . . . 71.030000000000001 107.724 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -175.88 148.2 0.94 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 105.558 -2.016 . . . . 74.230000000000004 105.558 -175.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.57 -40.47 65.41 Favored 'Trans proline' 0 C--O 1.221 -0.358 0 C-N-CA 122.041 1.827 . . . . 73.219999999999999 111.801 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.07 19.37 7.97 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.514 0.931 . . . . 73.140000000000001 113.514 -178.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m -66.61 122.99 18.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.303 -0.559 . . . . 65.129999999999995 109.796 174.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.11 -38.47 66.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.289 -1.375 . . . . 62.450000000000003 107.289 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.1 mm -108.75 98.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.791 -1.929 . . . . 74.349999999999994 105.791 173.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -91.03 120.2 31.82 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.951 -0.568 . . . . 75.349999999999994 109.857 -176.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.71 138.54 52.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.4 -0.963 . . . . 73.299999999999997 108.4 -179.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.37 116.49 32.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.519 -1.66 . . . . 64.439999999999998 106.519 176.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -105.96 -173.32 2.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.182 0.438 . . . . 74.310000000000002 112.182 -171.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.72 -32.61 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.24 0.616 . . . . 75.040000000000006 111.328 -174.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.405 ' CG2' ' HG ' ' A' ' 107' ' ' LEU . 6.1 t -123.89 -152.81 0.53 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 105.723 -1.955 . . . . 74.109999999999999 105.723 -178.013 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.85 95.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.644 -1.623 . . . . 72.25 109.387 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -92.34 85.59 5.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.179 -1.045 . . . . 71.239999999999995 108.179 176.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.439 ' NH1' ' HB2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -57.28 -27.69 62.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.976 -1.465 . . . . 74.420000000000002 112.458 -177.644 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.578 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 20.3 mmm180 -154.87 111.33 3.24 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 104.498 -2.408 . . . . 72.439999999999998 104.498 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 12.2 t60 -100.4 -52.77 3.28 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 117.667 -1.613 . . . . 75.219999999999999 109.901 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.49 151.69 36.8 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.1 -0.704 . . . . 73.319999999999993 109.1 -177.167 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -118.42 129.43 55.4 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.694 -1.965 . . . . 62.130000000000003 105.694 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.555 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.5 m-85 -105.98 113.45 27.0 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.969 -1.493 . . . . 73.040000000000006 106.969 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -107.74 131.94 53.9 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.545 -0.539 . . . . 74.310000000000002 109.545 -177.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -118.92 113.28 41.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 106.684 -1.599 . . . . 72.230000000000004 106.684 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.93 121.41 20.49 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.129 -0.693 . . . . 75.299999999999997 109.129 -177.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 56.81 37.58 28.89 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.098 1.359 . . . . 64.439999999999998 110.244 -179.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.06 89.33 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.087 -0.961 . . . . 71.140000000000001 113.855 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.08 131.75 46.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.641 0.72 . . . . 72.209999999999994 109.217 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -106.2 118.1 35.74 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.857 0.723 . . . . 75.030000000000001 110.256 -174.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.87 142.48 51.09 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.569 -0.53 . . . . 74.120000000000005 109.569 177.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.407 HG21 ' CD2' ' A' ' 92' ' ' PHE . 42.0 t -114.4 123.5 70.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.74 -1.207 . . . . 74.540000000000006 107.74 177.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.07 132.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.049 0.452 . . . . 75.25 110.287 177.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -77.04 127.46 32.72 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.288 -1.004 . . . . 71.239999999999995 108.288 177.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.51 16.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.602 -0.888 . . . . 74.299999999999997 108.602 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -174.8 81.12 0.07 OUTLIER Glycine 0 N--CA 1.418 -2.556 0 CA-C-N 115.273 -0.876 . . . . 74.019999999999996 111.934 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -77.57 42.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.687 1.232 . . . . 74.430000000000007 109.053 178.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 105' ' ' GLY . 23.4 tp -95.23 -28.51 14.99 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.782 -1.099 . . . . 75.140000000000001 110.627 -176.153 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.532 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 50.8 t30 -109.47 -19.82 13.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.354 -0.98 . . . . 75.120000000000005 108.354 173.197 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.404 ' N ' ' HE1' ' A' ' 89' ' ' HIS . . . 100.0 109.24 3.05 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.78 -0.645 . . . . 64.310000000000002 113.39 174.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.0 m -87.29 128.99 35.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.464 -0.569 . . . . 71.230000000000004 109.464 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -135.54 136.61 41.29 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.85 -0.796 . . . . 75.400000000000006 108.85 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.0 t -128.34 130.85 69.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.989 -1.856 . . . . 73.519999999999996 105.989 175.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.84 37.28 28.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.137 0.898 . . . . 75.519999999999996 108.747 -175.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 63.12 16.92 9.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 71.349999999999994 113.031 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.64 137.08 23.89 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 110.007 -0.368 . . . . 71.209999999999994 110.007 178.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.12 124.85 16.11 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.957 2.438 . . . . 75.540000000000006 112.112 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -126.66 159.29 34.06 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.24 0.543 . . . . 73.200000000000003 111.793 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.12 -29.0 3.36 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.288 -1.323 . . . . 73.230000000000004 108.145 177.118 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.65 136.91 18.6 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.515 -1.291 . . . . 65.230000000000004 107.515 174.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.38 141.94 20.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.27 -0.641 . . . . 75.420000000000002 109.27 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.65 122.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.676 -1.602 . . . . 71.230000000000004 106.676 174.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.468 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 44.3 ttp -89.6 130.44 35.91 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.328 0.585 . . . . 71.120000000000005 112.288 -168.836 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.531 ' HB2' ' OD1' ' A' ' 126' ' ' ASP . 16.7 mt-30 -120.05 152.18 37.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.053 -0.976 . . . . 75.239999999999995 108.92 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.2 p -73.21 133.81 44.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 123.522 0.729 . . . . 74.019999999999996 110.569 178.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.69 61.57 Favored Glycine 0 C--N 1.309 -0.93 0 N-CA-C 111.452 -0.659 . . . . 42.340000000000003 111.452 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 123' ' ' GLN . 3.0 m-20 -85.11 153.98 22.34 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.242 0.617 . . . . 73.099999999999994 111.437 178.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.02 130.67 55.5 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-N 115.256 -0.883 . . . . 71.140000000000001 109.515 -176.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.5 mt -114.69 132.21 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.091 -1.077 . . . . 75.299999999999997 108.091 177.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -119.73 122.9 42.47 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 108.656 -0.868 . . . . 75.420000000000002 108.656 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.455 HG22 ' CE1' ' A' ' 89' ' ' HIS . 66.3 mt -117.32 102.28 13.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.211 -1.403 . . . . 55.439999999999998 107.211 178.249 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.74 -108.39 1.53 Allowed Glycine 0 C--N 1.309 -0.961 0 N-CA-C 110.926 -0.87 . . . . 72.109999999999999 110.926 -173.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -103.4 4.7 36.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.644 0.259 . . . . 74.420000000000002 110.684 178.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.574 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 78.0 m-85 -87.63 158.55 18.84 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.569 0.7 . . . . 70.530000000000001 111.285 179.298 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -133.43 123.13 24.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.971 -1.013 . . . . 74.239999999999995 108.763 174.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.76 125.39 41.67 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.994 -1.484 . . . . 73.140000000000001 106.994 177.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.03 129.05 68.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.089 -1.449 . . . . 73.209999999999994 107.089 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 47' ' ' ALA . 22.0 t80 -88.4 116.55 26.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.784 -0.821 . . . . 71.530000000000001 108.784 -178.387 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp -108.47 147.03 32.26 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.172 -0.677 . . . . 75.219999999999999 109.172 -173.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.33 131.24 40.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.474 -0.33 . . . . 72.420000000000002 111.207 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.29 132.56 11.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.602 -1.799 . . . . 74.200000000000003 108.602 175.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.08 148.68 92.71 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.132 1.888 . . . . 75.150000000000006 112.287 -177.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.25 69.9 10.51 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 106.775 -1.565 . . . . 63.229999999999997 106.775 178.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--N 1.266 -3.058 0 CA-C-N 112.03 -2.35 . . . . 72.430000000000007 106.338 -178.875 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 109.099 -0.704 . . . . 72.439999999999998 109.099 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -139.4 25.27 2.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.328 -1.36 . . . . 72.310000000000002 107.328 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.46 145.69 32.17 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 113.767 -1.56 . . . . 73.140000000000001 110.722 -175.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -91.41 153.34 19.93 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.037 -1.097 . . . . 71.340000000000003 108.037 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.19 47.62 1.53 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.035 0.922 . . . . 73.099999999999994 108.631 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -29.76 32.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.138 -1.185 . . . . 74.430000000000007 110.138 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.5 m -129.76 107.87 17.0 Favored Pre-proline 0 N--CA 1.419 -2.018 0 CA-C-O 121.296 0.569 . . . . 71.109999999999999 109.888 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.28 154.38 71.48 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 124.01 3.14 . . . . 71.109999999999999 111.299 176.04 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -76.14 120.62 82.45 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.39 -1.337 . . . . 75.430000000000007 107.39 178.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.15 125.47 17.64 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 123.184 2.589 . . . . 72.099999999999994 113.032 -173.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -92.87 132.45 37.01 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 107.181 -1.414 . . . . 74.299999999999997 107.181 176.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.38 121.81 66.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 120.096 -0.642 . . . . 75.450000000000003 109.786 -178.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -103.59 132.66 49.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.288 -1.745 . . . . 74.319999999999993 106.288 174.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.455 ' O ' ' HB ' ' A' ' 85' ' ' VAL . 21.5 m -80.8 126.47 31.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 120.438 0.161 . . . . 73.299999999999997 111.293 -173.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -99.29 152.75 19.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.121 -1.807 . . . . 75.140000000000001 106.121 170.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -82.09 122.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.985 -0.746 . . . . 72.439999999999998 108.985 -178.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 14.8 t80 -86.95 105.41 17.09 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.097 -0.705 . . . . 72.319999999999993 109.097 -176.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -122.62 120.04 32.56 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.365 -0.606 . . . . 75.540000000000006 109.365 177.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.27 -160.68 0.86 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.188 -0.915 . . . . 63.350000000000001 108.976 -173.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -50.6 -22.16 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.266 1.426 . . . . 74.219999999999999 113.774 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 23' ' ' LEU . 3.9 pp -56.69 -30.83 63.84 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.256 0.835 . . . . 72.430000000000007 113.256 -178.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -89.39 0.08 57.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.469 0.914 . . . . 74.129999999999995 113.469 -177.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.23 -46.75 3.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.708 0.765 . . . . 73.329999999999998 110.45 176.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -69.36 -31.19 69.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.489 -1.232 . . . . 70.299999999999997 112.379 -174.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -56.42 -38.92 72.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.525 1.306 . . . . 74.310000000000002 114.525 -174.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.3 -35.62 35.5 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.0 0.429 . . . . 74.540000000000006 110.85 -176.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 m -68.1 -31.88 71.8 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.646 0.736 . . . . 73.109999999999999 110.825 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 p -83.03 -16.0 48.83 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 112.215 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 m -57.61 142.86 43.34 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.924 -0.769 . . . . 75.400000000000006 108.924 177.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.7 -52.03 0.84 Allowed Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.957 -1.257 . . . . 55.509999999999998 109.957 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 m -79.89 119.64 23.03 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.135 -1.431 . . . . 71.040000000000006 107.135 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.28 144.87 53.44 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 120.768 -0.373 . . . . 73.299999999999997 111.756 -174.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' OD1' ' A' ' 113' ' ' ASN . 42.1 Cg_exo -62.46 149.83 89.52 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.941 2.428 . . . . 73.230000000000004 110.916 172.601 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.834 0.35 . . . . 71.200000000000003 110.214 -178.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 m -77.55 90.08 3.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.776 -0.824 . . . . 61.130000000000003 108.776 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -94.55 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.371 0.508 . . . . 73.040000000000006 112.371 -177.04 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.34 57.88 0.64 Allowed Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.364 -0.694 . . . . 74.239999999999995 111.364 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB1' ' H ' ' A' ' 124' ' ' THR . . . -92.85 -47.05 7.23 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.555 0.693 . . . . 73.409999999999997 110.722 176.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.32 -0.49 6.34 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.361 -1.29 . . . . 73.450000000000003 114.466 -170.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -86.19 -28.47 23.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.089 -0.708 . . . . 72.310000000000002 109.089 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt 49.03 76.61 0.53 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.749 1.22 . . . . 73.299999999999997 111.747 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.503 ' HG2' ' O ' ' A' ' 140' ' ' GLY . 26.6 Cg_endo -87.41 -74.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.152 1.901 . . . . 74.540000000000006 114.344 -175.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.83 -32.63 67.73 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.151 0.501 . . . . 73.400000000000006 112.297 -176.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 7.7 82.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.183 -1.008 . . . . 64.230000000000004 110.763 -176.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 m -132.81 167.04 20.89 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.553 -1.647 . . . . 74.099999999999994 106.553 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 157.1 43.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.149 0.431 . . . . 75.010000000000005 110.127 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.16 137.51 51.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.288 0.566 . . . . 72.010000000000005 110.348 178.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 49' ' ' LEU . 4.2 pp -108.7 137.05 47.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 109.036 -0.728 . . . . 73.120000000000005 109.036 178.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -113.56 128.85 70.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 121.119 0.485 . . . . 73.140000000000001 110.03 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG21 ' ND2' ' A' ' 56' ' ' ASN . 38.4 t -83.75 118.09 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 106.99 -1.485 . . . . 74.530000000000001 106.99 178.237 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -95.05 -31.71 13.46 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.411 -0.813 . . . . 74.230000000000004 109.719 -174.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -141.35 138.41 33.05 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.753 -0.658 . . . . 75.450000000000003 109.259 176.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.68 169.29 13.18 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.72 -1.752 . . . . 75.209999999999994 108.72 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.98 -41.99 69.22 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.027 1.818 . . . . 73.340000000000003 111.634 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.46 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.1 p-10 -91.67 22.71 3.93 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.223 0.453 . . . . 73.010000000000005 112.223 178.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.21 55.57 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 123.22 0.608 . . . . 62.109999999999999 111.222 177.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.21 -19.42 43.12 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.487 -1.045 . . . . 74.530000000000001 110.487 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.36 144.37 26.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.407 -0.397 . . . . 72.340000000000003 110.28 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -119.67 134.87 55.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.273 -1.01 . . . . 72.510000000000005 108.273 176.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -117.12 125.07 50.67 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.972 -0.381 . . . . 73.239999999999995 109.972 -176.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.5 124.18 34.28 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.479 -0.782 . . . . 74.0 109.368 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.02 104.82 15.99 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.383 -1.71 . . . . 75.109999999999999 106.383 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.05 -21.3 12.68 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 112.157 -173.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.16 154.44 40.45 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 120.329 -0.548 . . . . 74.109999999999999 110.923 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 75.5 Cg_exo -52.56 -25.98 27.48 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.609 2.873 . . . . 71.409999999999997 114.021 -178.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 m -140.94 120.1 12.9 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.568 -0.853 . . . . 74.319999999999993 109.809 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 49.6 m -116.43 114.39 24.17 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 109.057 -0.719 . . . . 73.420000000000002 109.057 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.2 136.4 32.94 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.88 -0.415 . . . . 74.239999999999995 109.88 178.163 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.58 134.71 54.89 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.34 0.59 . . . . 73.219999999999999 110.723 -177.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.37 178.01 15.39 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.284 -1.527 . . . . 74.329999999999998 109.284 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 43.6 ttt180 -85.49 117.67 24.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.222 -0.659 . . . . 75.140000000000001 109.222 178.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.75 145.9 0.31 Allowed Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 107.658 -1.238 . . . . 73.010000000000005 107.658 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -61.24 -15.72 41.93 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.236 2.624 . . . . 73.439999999999998 113.851 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.92 6.24 33.47 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.546 0.212 . . . . 74.230000000000004 111.194 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.9 m -100.56 125.2 46.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.625 -0.509 . . . . 74.299999999999997 109.625 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.1 -48.54 73.32 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.046 -0.524 . . . . 73.420000000000002 110.956 -178.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.15 130.18 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.895 -0.722 . . . . 72.540000000000006 110.715 -179.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.02 143.0 48.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.282 0.563 . . . . 63.049999999999997 111.417 -178.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.7 mt -106.44 140.42 39.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.06 -1.459 . . . . 70.140000000000001 107.06 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HZ ' ' A' ' 133' ' ' PHE . 20.5 t70 -91.45 116.45 28.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.533 -1.654 . . . . 64.510000000000005 106.533 177.266 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 84' ' ' THR . 12.4 t0 -116.04 164.39 14.51 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.155 -0.683 . . . . 75.310000000000002 109.155 -169.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.26 -31.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.702 -1.222 . . . . 61.340000000000003 107.702 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 27.3 m -115.42 170.94 8.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.794 -1.558 . . . . 74.120000000000005 106.794 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 14' ' ' THR . 61.4 t -92.5 98.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.051 -1.031 . . . . 74.310000000000002 111.437 -177.574 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -97.1 91.7 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.479 -0.782 . . . . 74.409999999999997 110.227 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 17.8 ptt180 -81.47 -45.22 16.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.527 0.936 . . . . 74.140000000000001 113.527 -176.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.418 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 5.6 tpt180 -126.73 87.7 2.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.712 -1.588 . . . . 75.230000000000004 106.712 -176.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -100.2 -52.36 3.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.844 -0.616 . . . . 75.450000000000003 112.253 -174.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.44 162.99 37.9 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.953 -0.699 . . . . 73.319999999999993 111.428 -175.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.44 133.78 36.99 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.361 -0.836 . . . . 65.109999999999999 109.109 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -112.28 122.3 47.33 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.939 -0.763 . . . . 63.539999999999999 108.939 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.44 119.51 39.02 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.497 -0.557 . . . . 72.329999999999998 109.497 175.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -107.1 111.77 37.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.534 -2.395 . . . . 71.420000000000002 104.534 176.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -135.74 117.66 15.24 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 120.141 -0.624 . . . . 75.010000000000005 110.258 -174.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 51.7 39.82 26.13 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.76 1.224 . . . . 74.519999999999996 111.775 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -5.61 84.33 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 115.282 -0.872 . . . . 43.329999999999998 114.677 178.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.5 150.02 23.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.907 0.854 . . . . 73.219999999999999 109.102 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.94 117.46 24.84 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.692 -0.403 . . . . 74.230000000000004 110.959 -172.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -109.6 127.13 54.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.249 -1.019 . . . . 74.140000000000001 108.249 177.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.85 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.538 -0.912 . . . . 75.319999999999993 108.538 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.01 131.39 72.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.976 -0.556 . . . . 75.129999999999995 110.444 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.46 131.11 34.45 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.394 -0.965 . . . . 54.350000000000001 108.394 174.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.35 11.38 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 116.302 -0.408 . . . . 70.400000000000006 111.074 -177.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -165.1 59.88 0.25 Allowed Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.535 -1.317 . . . . 75.150000000000006 112.954 -178.464 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.6 t -80.78 75.13 7.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.736 0.779 . . . . 71.409999999999997 109.677 177.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.86 -21.99 13.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.832 -1.544 . . . . 75.239999999999995 106.832 170.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.426 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 3.2 m-20 -102.83 3.17 36.39 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.342 -1.299 . . . . 75.230000000000004 110.868 -177.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.76 77.29 1.13 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.936 -0.575 . . . . 55.100000000000001 113.051 178.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -86.92 128.9 35.06 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.203 -0.666 . . . . 74.400000000000006 109.203 176.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -135.68 140.2 44.28 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.881 0.372 . . . . 74.109999999999999 110.245 177.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.46 119.7 60.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 105.841 -1.911 . . . . 75.140000000000001 105.841 175.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.449 ' OD1' ' HD2' ' A' ' 34' ' ' PRO . 0.7 OUTLIER 57.38 36.82 27.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.293 -1.003 . . . . 75.150000000000006 108.293 -171.896 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 60.7 14.32 4.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.26 1.424 . . . . 74.200000000000003 112.979 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.06 142.48 25.12 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 124.089 0.956 . . . . 73.129999999999995 109.205 176.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.06 122.97 10.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.7 1.6 . . . . 64.239999999999995 109.569 178.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -146.36 140.04 26.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.091 -1.078 . . . . 73.400000000000006 108.091 -175.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.8 -41.42 8.85 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.237 -0.283 . . . . 71.099999999999994 110.237 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.39 136.84 33.53 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.822 -0.807 . . . . 75.329999999999998 108.822 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 141.91 21.9 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.731 -0.84 . . . . 74.349999999999994 108.731 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.85 114.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 106.261 -1.755 . . . . 72.430000000000007 106.261 175.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 38.0 ttm -94.37 148.84 21.82 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.383 0.883 . . . . 65.099999999999994 113.383 -166.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -125.66 158.34 35.0 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.829 1.252 . . . . 61.020000000000003 111.113 -172.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.424 ' H ' ' HB1' ' A' ' 39' ' ' ALA . 10.6 m -58.38 124.27 18.97 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.294 0.637 . . . . 72.430000000000007 110.192 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.61 -9.45 60.53 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.908 -0.587 . . . . 72.340000000000003 112.051 178.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.52 151.21 44.09 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 108.708 -0.849 . . . . 75.120000000000005 108.708 -179.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.3 137.66 54.47 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.798 0.808 . . . . 64.299999999999997 112.124 -175.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.95 126.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 105.844 -1.91 . . . . 74.5 105.844 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -108.95 128.68 55.15 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.179 -1.785 . . . . 74.030000000000001 106.179 178.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 133' ' ' PHE . 66.6 mt -131.56 138.32 53.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 N-CA-C 103.825 -2.657 . . . . 75.430000000000007 103.825 -177.238 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -36.19 99.46 0.01 OUTLIER Glycine 0 CA--C 1.548 2.153 0 N-CA-C 115.912 1.125 . . . . 64.030000000000001 115.912 -177.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt 77.51 14.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.609 1.564 . . . . 73.319999999999993 112.929 178.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.53 ' HB2' ' HB ' ' A' ' 130' ' ' ILE . 55.8 m-85 -123.56 150.64 43.81 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 125.295 1.438 . . . . 74.439999999999998 109.355 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -137.15 119.83 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.316 -1.735 . . . . 74.120000000000005 106.316 175.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 mp -122.9 136.13 54.75 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.94 -0.393 . . . . 60.530000000000001 109.94 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.68 130.16 68.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.509 -0.923 . . . . 64.420000000000002 108.509 179.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -95.93 131.88 41.83 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.106 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -131.45 136.86 48.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.88 -0.785 . . . . 64.030000000000001 108.88 177.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.05 33.04 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.433 -0.951 . . . . 63.509999999999998 108.433 175.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 43' ' ' PRO . . . -59.94 130.64 49.7 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.7 -0.96 . . . . 64.319999999999993 110.7 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.11 160.34 13.14 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.345 2.697 . . . . 71.310000000000002 113.585 -175.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.19 48.58 1.01 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.713 1.205 . . . . 71.010000000000005 111.406 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.406 -2.662 0 CA-C-N 114.643 -1.162 . . . . 62.219999999999999 108.017 176.339 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.494 -1.188 0 N-CA-C 108.697 -0.853 . . . . 74.319999999999993 108.697 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -72.85 101.97 3.29 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 123.338 0.399 . . . . 74.439999999999998 110.014 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -97.03 148.45 22.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.83 -0.433 . . . . 73.150000000000006 109.83 177.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -88.2 99.56 12.3 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.43 -0.581 . . . . 75.200000000000003 109.43 178.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -101.8 136.45 41.61 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.108 -0.496 . . . . 65.230000000000004 110.399 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . 121.83 -18.74 8.52 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.687 -0.768 . . . . 73.030000000000001 113.016 176.163 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 m -98.96 108.45 49.31 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 117.116 0.458 . . . . 65.319999999999993 110.742 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 2.4 Cg_endo -78.83 148.76 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.226 1.951 . . . . 74.140000000000001 109.928 176.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.67 133.11 63.18 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 107.883 -1.155 . . . . 74.129999999999995 107.883 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.73 136.05 44.16 Favored 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 121.96 1.773 . . . . 72.010000000000005 111.743 -179.025 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -110.51 140.93 44.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.811 0.338 . . . . 74.310000000000002 110.379 -179.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.5 t -120.42 123.52 70.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.664 -0.865 . . . . 74.420000000000002 108.664 176.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -148.09 148.24 30.42 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 106.476 -1.676 . . . . 72.510000000000005 106.476 -178.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.7 m -89.58 128.76 36.07 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 123.445 0.465 . . . . 60.130000000000003 110.674 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -87.82 138.89 31.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 108.475 -0.935 . . . . 73.420000000000002 108.475 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -83.79 117.22 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.179 -0.675 . . . . 71.349999999999994 109.179 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.72 140.18 29.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.292 0.568 . . . . 72.430000000000007 110.968 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -84.59 120.65 26.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.686 -2.338 . . . . 74.430000000000007 104.686 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.79 80.91 2.09 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.286 0.565 . . . . 73.420000000000002 111.538 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.15 -23.18 33.06 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.661 -0.866 . . . . 62.399999999999999 108.661 177.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 pp -63.33 -5.95 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.088 1.355 . . . . 74.530000000000001 113.592 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.6 -28.75 70.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.048 0.539 . . . . 73.340000000000003 109.811 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.96 -10.32 58.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.794 -0.639 . . . . 74.439999999999998 111.048 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -99.77 -41.73 7.14 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.119 0.485 . . . . 73.299999999999997 111.368 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -84.47 -3.42 58.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.931 0.396 . . . . 72.129999999999995 111.755 -176.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -61.9 -41.9 98.44 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.102 0.561 . . . . 72.530000000000001 111.57 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -78.49 -13.15 59.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.086 0.47 . . . . 75.150000000000006 111.126 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -86.59 -24.8 25.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.598 -1.26 . . . . 74.329999999999998 107.598 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.1 m -66.92 107.38 2.2 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.32 -0.855 . . . . 72.140000000000001 110.68 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.91 177.82 40.27 Favored Glycine 0 N--CA 1.404 -3.462 0 N-CA-C 107.32 -2.312 . . . . 41.409999999999997 107.32 178.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 m -75.2 120.62 20.95 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 117.686 0.743 . . . . 63.25 110.346 -177.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.21 92.01 45.01 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 106.673 -1.602 . . . . 65.439999999999998 106.673 174.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.89 142.54 69.52 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.753 2.302 . . . . 51.530000000000001 113.036 -174.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.49 162.74 18.82 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.784 -1.191 . . . . 54.43 107.784 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -77.95 126.77 31.34 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.529 -0.468 . . . . 72.140000000000001 110.342 -176.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 p -67.12 146.52 54.18 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.706 -0.679 . . . . 74.010000000000005 110.055 178.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 116.51 -8.75 17.36 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 108.375 -1.89 . . . . 71.030000000000001 108.375 -174.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.11 66.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.183 -1.009 . . . . 65.109999999999999 110.231 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.31 1.82 47.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.425 -0.807 . . . . 65.120000000000005 110.627 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.53 7.7 17.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.036 -0.529 . . . . 73.239999999999995 110.209 -175.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 69.74 89.91 0.09 OUTLIER Pre-proline 0 CA--C 1.512 -0.482 0 C-N-CA 124.309 1.044 . . . . 73.310000000000002 109.61 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.69 -26.3 28.06 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.674 2.25 . . . . 73.409999999999997 112.184 -175.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.39 -27.99 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.837 -1.529 . . . . 75.310000000000002 110.229 -178.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.43 69.64 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.1 -1.2 . . . . 53.310000000000002 110.1 -177.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.8 t -131.06 158.13 41.19 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.052 -1.462 . . . . 72.230000000000004 107.052 176.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.97 40.93 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.743 -0.836 . . . . 64.310000000000002 108.743 -175.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 pp -133.13 151.56 51.99 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.899 0.381 . . . . 74.030000000000001 110.385 178.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 pp -113.52 132.18 55.79 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.006 -1.109 . . . . 74.540000000000006 108.006 175.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.81 132.06 68.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 109.906 -178.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 15.3 t -86.64 117.86 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.363 -1.347 . . . . 63.200000000000003 107.363 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.42 -33.02 12.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.033 0.444 . . . . 73.349999999999994 110.817 -179.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 13.7 tpt180 -137.85 139.61 40.01 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.476 -1.305 . . . . 73.400000000000006 107.476 -176.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.25 176.17 14.25 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.013 -0.835 . . . . 64.109999999999999 111.013 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.5 -35.23 39.73 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.614 2.209 . . . . 75.299999999999997 112.089 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -97.49 22.31 9.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.04 0.536 . . . . 72.209999999999994 111.139 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -62.94 141.31 58.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.997 0.427 . . . . 73.400000000000006 111.793 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.99 -13.87 57.38 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.046 -0.822 . . . . 71.329999999999998 111.046 -177.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.64 142.98 27.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.898 0.38 . . . . 61.119999999999997 110.371 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -131.17 136.43 48.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.573 -0.899 . . . . 75.140000000000001 108.573 177.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -130.51 139.22 50.5 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.984 -0.747 . . . . 70.209999999999994 108.984 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.06 143.64 32.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.407 0.622 . . . . 72.030000000000001 112.114 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.3 mp -94.04 103.36 15.44 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.496 -0.927 . . . . 70.219999999999999 108.496 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -133.18 8.61 4.03 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.902 1.334 . . . . 74.310000000000002 107.621 178.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.454 ' O ' HD11 ' A' ' 94' ' ' ILE . 4.0 pt20 -113.23 156.93 42.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 113.437 -1.71 . . . . 62.299999999999997 109.092 -174.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.99 -32.42 94.97 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.466 2.111 . . . . 74.219999999999999 112.451 178.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 97.7 m -153.92 129.67 10.09 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 122.095 -0.378 . . . . 74.120000000000005 111.138 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 19.8 m -103.29 113.5 27.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.775 -1.565 . . . . 65.140000000000001 106.775 174.449 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -91.77 132.95 36.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.445 -0.576 . . . . 62.140000000000001 109.445 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.86 134.26 55.28 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 109.905 -0.405 . . . . 73.439999999999998 109.905 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.85 -132.45 2.83 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.108 -0.797 . . . . 75.329999999999998 111.108 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 86' ' ' SER . 9.9 mmm180 -118.54 151.28 38.16 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 123.029 0.532 . . . . 72.439999999999998 110.719 -175.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.8 m80 80.3 152.73 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 124.913 1.285 . . . . 72.239999999999995 112.628 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.45 -18.87 26.72 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.978 3.118 . . . . 71.310000000000002 115.6 -175.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.52 -23.2 60.98 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.236 0.471 . . . . 74.549999999999997 110.708 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m -78.18 119.72 21.97 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 105.706 -1.961 . . . . 74.120000000000005 105.706 172.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.44 -49.18 78.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.957 -0.565 . . . . 75.310000000000002 111.399 -173.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.5 pt -107.28 123.23 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 C-N-CA 120.12 -0.632 . . . . 71.120000000000005 109.685 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.89 124.02 33.24 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 109.044 -0.725 . . . . 72.0 109.044 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 mt -121.2 140.44 52.02 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.293 -2.114 . . . . 71.400000000000006 105.293 178.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -102.21 116.31 32.38 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.101 -1.814 . . . . 72.439999999999998 106.101 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -88.53 176.77 7.01 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.615 -1.175 . . . . 72.519999999999996 112.837 -171.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.401 ' C ' ' HG1' ' A' ' 84' ' ' THR . 32.2 t -79.73 -32.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.229 1.014 . . . . 70.230000000000004 108.505 -177.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 83' ' ' VAL . 99.4 m -150.14 153.67 36.74 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.074 -2.565 . . . . 64.409999999999997 104.074 175.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.416 HG12 ' HG3' ' A' ' 72' ' ' ARG . 50.0 t -70.67 112.47 5.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.655 1.217 . . . . 75.5 113.375 -162.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 23.2 m -111.27 107.18 16.38 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 113.259 -1.792 . . . . 75.219999999999999 108.0 177.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -55.84 -45.69 78.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.422 -0.808 . . . . 73.530000000000001 112.03 -175.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -137.3 119.88 16.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.322 -2.103 . . . . 75.219999999999999 105.322 171.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -89.76 -52.91 4.75 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.205 -1.035 . . . . 73.310000000000002 108.205 178.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.2 34.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.83 -0.623 . . . . 42.5 109.567 -177.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.71 145.92 52.06 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.241 0.543 . . . . 73.329999999999998 111.04 171.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 101' ' ' VAL . 9.4 m-85 -104.45 113.22 26.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.351 -1.722 . . . . 75.230000000000004 106.351 -177.319 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -106.67 120.72 42.73 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.649 -0.871 . . . . 74.239999999999995 108.649 -176.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 65' ' ' GLN . 3.1 mp -104.42 111.58 34.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 105.109 -2.182 . . . . 75.319999999999993 105.109 179.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -139.38 130.56 26.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 110.083 -0.34 . . . . 73.140000000000001 110.083 -177.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 55.87 36.67 27.73 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 122.293 1.044 . . . . 73.209999999999994 110.533 175.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 0.86 81.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.11 -0.95 . . . . 63.240000000000002 113.652 179.057 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -101.45 133.75 45.6 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.413 -0.958 . . . . 62.039999999999999 108.413 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -104.9 116.09 31.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.521 -1.288 . . . . 73.340000000000003 107.521 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.33 134.28 48.86 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.99 0.424 . . . . 74.040000000000006 110.504 -178.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 92' ' ' PHE . 39.0 t -102.49 124.08 56.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.496 -1.298 . . . . 74.120000000000005 107.496 175.071 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.62 123.09 68.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.825 0.821 . . . . 72.25 109.325 176.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -100.48 140.63 34.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.651 -1.159 . . . . 74.5 111.952 -174.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.33 1.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.809 . . . . 72.319999999999993 109.946 171.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.7 40.15 2.52 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 121.358 -0.449 . . . . 63.43 113.092 -173.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.8 m -55.73 -19.62 11.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 73.450000000000003 111.903 178.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.271 0.628 . . . . 65.239999999999995 111.293 -178.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -86.99 -17.91 31.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.695 0.759 . . . . 75.519999999999996 109.287 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.37 76.23 1.12 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.324 -0.853 . . . . 53.340000000000003 113.213 175.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 m -86.69 126.67 34.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.758 -0.46 . . . . 73.109999999999999 109.758 175.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -136.79 136.44 38.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 110.033 -0.358 . . . . 71.409999999999997 110.033 178.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.65 121.11 63.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.798 -1.556 . . . . 74.519999999999996 106.798 174.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.31 44.67 27.01 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.334 1.053 . . . . 72.340000000000003 110.111 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.8 9.35 5.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.375 1.47 . . . . 74.120000000000005 114.587 -177.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -120.07 135.54 24.42 Favored Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.982 -0.687 . . . . 73.430000000000007 109.894 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.54 137.2 67.81 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.544 2.162 . . . . 75.340000000000003 111.55 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -134.43 159.42 41.13 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.304 0.573 . . . . 75.409999999999997 111.705 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.65 -34.65 3.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.344 -1.298 . . . . 73.0 108.761 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.78 27.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.694 -1.595 . . . . 73.409999999999997 106.694 174.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -147.61 122.21 9.82 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.856 -0.338 . . . . 71.519999999999996 111.214 -176.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.59 114.13 26.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.465 -2.05 . . . . 73.040000000000006 105.465 173.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 128' ' ' ILE . 73.6 mtp -93.34 147.19 23.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 115.268 1.581 . . . . 74.540000000000006 115.268 -168.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -112.06 152.11 28.58 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.935 -1.484 . . . . 74.040000000000006 107.653 175.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -66.55 133.52 50.5 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.337 0.589 . . . . 74.030000000000001 111.385 -178.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.39 -2.14 56.13 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.584 -0.735 . . . . 43.329999999999998 112.392 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.94 153.52 20.97 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 117.032 0.416 . . . . 74.329999999999998 109.931 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.32 145.82 42.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.011 0.745 . . . . 63.030000000000001 113.011 -172.192 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.471 HD11 ' SD ' ' A' ' 122' ' ' MET . 60.4 mt -120.23 132.05 70.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.537 -0.912 . . . . 73.109999999999999 108.537 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -116.35 122.01 43.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.89 -1.152 . . . . 75.230000000000004 107.89 175.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.6 105.05 18.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.422 -0.955 . . . . 74.319999999999993 108.422 -178.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.25 -86.29 0.5 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 108.986 -1.646 . . . . 64.329999999999998 108.986 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -140.35 -2.86 1.39 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.535 -0.333 . . . . 75.530000000000001 111.425 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.254 50.5 p90 -95.04 164.11 13.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.202 -0.999 . . . . 74.030000000000001 111.529 -179.758 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -120.0 126.61 51.26 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 113.07 0.766 . . . . 74.219999999999999 113.07 -165.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.7 mt -121.96 140.13 52.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.984 -1.117 . . . . 75.140000000000001 107.984 175.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.05 137.46 55.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.602 -0.888 . . . . 73.239999999999995 108.602 176.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -105.69 114.83 29.23 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.146 0.579 . . . . 73.450000000000003 109.69 -177.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -127.7 159.18 35.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.817 -0.438 . . . . 71.510000000000005 109.817 -178.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.85 123.53 25.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.577 -1.638 . . . . 62.420000000000002 106.577 171.081 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.72 -89.5 1.35 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.093 -1.051 . . . . 63.340000000000003 114.934 -170.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.68 152.55 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.333 2.022 . . . . 70.040000000000006 112.821 -177.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.45 20.24 11.9 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.072 -1.085 . . . . 74.439999999999998 108.072 178.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-N 114.312 -1.313 . . . . 73.0 108.375 -178.425 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 108.9 -0.778 . . . . 75.230000000000004 108.9 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -116.24 132.82 56.56 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.878 -0.786 . . . . 74.439999999999998 108.878 178.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.67 88.52 3.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.153 -1.054 . . . . 75.329999999999998 108.153 177.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -87.68 83.09 7.23 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.637 -1.165 . . . . 74.349999999999994 109.036 -178.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -71.31 141.86 50.46 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.848 -1.069 . . . . 74.230000000000004 110.104 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.26 120.1 11.39 Favored Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.305 -0.718 . . . . 72.439999999999998 111.305 178.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 t -89.17 112.7 52.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 112.3 0.482 . . . . 74.349999999999994 112.3 -176.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.2 149.72 22.29 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.603 2.202 . . . . 74.209999999999994 110.368 173.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -105.52 125.88 32.25 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.409 -0.589 . . . . 73.209999999999994 109.409 177.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.56 152.22 78.61 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 123.0 2.466 . . . . 74.019999999999996 114.071 -175.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.64 163.58 14.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.792 -1.095 . . . . 74.329999999999998 108.187 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.7 t -127.67 137.8 56.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.45 -0.945 . . . . 71.329999999999998 108.45 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.429 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -119.73 168.29 11.21 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 120.93 0.395 . . . . 72.5 111.319 -179.079 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 m -70.2 112.43 6.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 122.006 0.907 . . . . 74.430000000000007 110.929 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -88.97 149.72 23.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.638 -1.615 . . . . 74.450000000000003 106.638 175.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.78 115.71 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.679 -1.23 . . . . 70.340000000000003 107.679 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.18 139.81 30.1 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.427 -0.806 . . . . 62.340000000000003 109.942 -174.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -81.64 132.0 35.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.582 -0.896 . . . . 73.329999999999998 108.582 177.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.59 66.58 9.73 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.28 0.562 . . . . 73.219999999999999 112.465 -175.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.92 -18.25 58.41 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 107.841 -1.17 . . . . 73.540000000000006 107.841 174.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -62.12 -12.92 22.13 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 114.841 -1.072 . . . . 74.230000000000004 112.862 177.031 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.91 -30.54 69.89 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 121.358 0.599 . . . . 73.530000000000001 109.536 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.47 -33.74 76.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 125.008 1.323 . . . . 75.209999999999994 108.989 178.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 -49.0 10.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.279 -0.873 . . . . 74.530000000000001 109.081 177.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.3 tpp -56.88 -32.65 66.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.824 1.25 . . . . 71.409999999999997 112.031 -176.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 30.0 tt0 -62.78 -32.13 73.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.756 0.312 . . . . 73.120000000000005 111.554 -178.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -69.61 -32.2 70.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.097 -0.705 . . . . 75.239999999999995 109.097 179.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -84.26 -16.65 42.42 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.039 0.935 . . . . 71.329999999999998 111.513 -179.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.406 ' OG1' ' HA ' ' A' ' 27' ' ' GLU . 61.6 m -59.59 124.91 21.61 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 112.615 0.598 . . . . 74.439999999999998 112.615 -175.122 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.71 -144.25 8.45 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 109.036 -1.626 . . . . 64.040000000000006 109.036 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 p -115.52 139.79 49.74 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 117.446 0.623 . . . . 73.099999999999994 109.56 174.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . . . -127.12 122.26 23.04 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 120.607 -0.437 . . . . 44.219999999999999 109.831 177.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.37 156.95 60.53 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 123.146 2.564 . . . . 75.010000000000005 112.513 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.65 158.78 35.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.567 -0.901 . . . . 73.349999999999994 108.567 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.3 m -81.26 105.62 12.6 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.382 -0.969 . . . . 62.43 108.382 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 m -70.23 78.25 0.52 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.148 0.975 . . . . 73.5 111.641 -176.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 25.98 0.14 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 109.641 -1.383 . . . . 70.400000000000006 109.641 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.1 72.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.169 -0.515 . . . . 74.310000000000002 110.134 -177.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.21 4.13 51.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.707 -0.679 . . . . 73.349999999999994 111.056 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -84.6 -42.24 15.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.964 -1.125 . . . . 75.329999999999998 107.964 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt 50.88 68.74 3.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.728 -1.124 . . . . 74.019999999999996 111.22 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.56 -65.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.38 2.054 . . . . 75.340000000000003 113.482 -175.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -15.82 60.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.815 0.302 . . . . 65.239999999999995 111.815 -177.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -2.85 72.74 Favored Glycine 0 N--CA 1.46 0.271 0 N-CA-C 111.746 -0.542 . . . . 54.140000000000001 111.746 -178.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -150.77 169.59 21.29 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.616 -1.624 . . . . 73.409999999999997 106.616 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.59 44.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 118.06 0.391 . . . . 74.530000000000001 111.1 -173.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.42 157.73 36.13 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.4 0.438 . . . . 73.430000000000007 110.715 177.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.78 151.2 50.77 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.117 -0.697 . . . . 71.340000000000003 109.117 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.71 134.69 66.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 110.027 -0.36 . . . . 75.329999999999998 110.027 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.83 118.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.17 -1.419 . . . . 73.430000000000007 107.17 177.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -91.0 -32.95 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.939 0.4 . . . . 72.219999999999999 110.159 -177.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 tpm_? -137.81 132.63 32.92 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.647 -0.421 . . . . 73.510000000000005 110.085 -179.16 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.15 173.01 17.96 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.991 -1.644 . . . . 74.109999999999999 108.991 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -59.55 -35.42 95.64 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.584 2.189 . . . . 74.129999999999995 112.725 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -100.5 22.15 12.18 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.595 -0.442 . . . . 64.109999999999999 112.187 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.6 138.71 57.64 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.752 178.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.03 -19.24 32.89 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.268 -0.733 . . . . 74.209999999999994 111.268 -177.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.96 144.01 26.78 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 110.138 -0.319 . . . . 62.149999999999999 110.138 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.73 156.75 18.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.9 -0.778 . . . . 73.099999999999994 108.9 178.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CG ' HG21 ' A' ' 78' ' ' ILE . 98.3 m-85 -138.0 144.44 41.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.335 -1.358 . . . . 75.329999999999998 107.335 175.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.7 135.1 54.97 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.156 -0.683 . . . . 74.540000000000006 109.156 -178.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.46 104.36 10.02 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.87 -0.789 . . . . 75.510000000000005 108.87 179.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.93 -21.37 11.61 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.827 -0.624 . . . . 72.430000000000007 111.351 -177.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.58 144.86 30.12 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.001 -0.545 . . . . 74.219999999999999 110.983 -173.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.32 -19.85 36.9 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.745 2.963 . . . . 73.200000000000003 113.901 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.8 m -141.74 121.23 13.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.997 -0.742 . . . . 71.310000000000002 108.997 175.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.8 m -120.06 133.13 55.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.253 -0.647 . . . . 61.329999999999998 109.253 -177.321 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.2 m -105.66 143.83 33.26 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.901 -0.407 . . . . 73.299999999999997 109.901 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.07 134.91 54.54 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.042 -0.725 . . . . 73.129999999999995 109.042 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.79 -146.64 18.57 Favored Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 109.113 -1.595 . . . . 70.510000000000005 109.113 -179.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -119.67 118.65 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.614 -1.234 . . . . 71.400000000000006 111.497 174.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.556 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 47.5 m-70 -167.55 142.14 3.09 Favored Pre-proline 0 C--N 1.277 -2.557 0 C-N-CA 126.832 2.053 . . . . 75.519999999999996 105.564 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.57 -21.95 73.44 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.611 2.207 . . . . 73.120000000000005 114.733 -175.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' OE2' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -105.79 5.19 30.62 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.259 0.466 . . . . 75.319999999999993 112.259 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 73.3 m -80.98 140.27 35.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.494 -0.482 . . . . 71.219999999999999 109.826 178.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.08 -49.89 14.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 111.121 -173.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.462 HG21 ' CG ' ' A' ' 61' ' ' PHE . 43.9 pt -100.37 103.47 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.289 1.043 . . . . 75.030000000000001 111.015 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -88.1 132.44 34.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.378 -1.283 . . . . 75.140000000000001 108.965 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.48 136.36 51.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.029 -1.471 . . . . 74.040000000000006 107.029 176.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.38 139.37 50.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.235 -0.654 . . . . 75.310000000000002 109.235 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -166.4 -174.56 2.91 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.079 -2.193 . . . . 73.239999999999995 105.079 178.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.45 -24.35 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.806 -1.553 . . . . 73.209999999999994 106.806 175.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -78.96 96.19 5.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.505 -1.294 . . . . 72.319999999999993 107.505 176.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.56 135.59 35.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.17 0.509 . . . . 74.319999999999993 112.315 -173.023 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.9 t -134.52 142.36 46.99 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.625 -2.361 . . . . 72.299999999999997 104.625 173.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' HD2' ' HB3' ' A' ' 13' ' ' GLU . 12.4 ptp180 -62.55 -46.07 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.296 0.57 . . . . 75.040000000000006 109.742 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.412 ' CZ ' HG22 ' A' ' 104' ' ' VAL . 16.8 ptt180 -151.42 151.06 31.16 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.348 -1.352 . . . . 73.120000000000005 107.348 170.068 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -100.67 -52.33 3.36 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.613 0.571 . . . . 74.519999999999996 112.186 -176.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.03 164.79 36.49 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.314 -0.555 . . . . 71.230000000000004 110.462 -172.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.21 132.0 45.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.598 -0.728 . . . . 75.219999999999999 109.248 173.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 68.3 m-85 -106.11 123.76 48.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.646 -0.872 . . . . 65.230000000000004 108.646 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -106.12 127.08 52.95 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.465 -0.494 . . . . 75.209999999999994 109.728 173.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.15 114.41 46.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.563 -1.643 . . . . 73.329999999999998 106.563 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -136.84 118.93 15.41 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 120.685 -0.406 . . . . 74.5 110.205 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 55.87 40.64 30.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.602 1.161 . . . . 71.25 111.396 177.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.45 -8.53 74.29 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.464 -1.244 . . . . 44.439999999999998 114.116 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.49 135.78 42.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.882 0.841 . . . . 75.019999999999996 110.17 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -104.94 128.35 53.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.77 -1.105 . . . . 70.439999999999998 108.183 -176.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.46 137.13 49.65 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.127 0.489 . . . . 75.099999999999994 110.39 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.33 125.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.729 -0.841 . . . . 71.5 108.729 -177.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -116.66 126.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.834 -1.173 . . . . 73.129999999999995 107.834 174.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.21 134.09 35.56 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.898 -0.779 . . . . 72.230000000000004 108.898 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 88' ' ' ARG . 15.5 m -138.21 15.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.862 0.839 . . . . 74.319999999999993 109.509 179.168 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -155.48 70.66 0.27 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 110.472 -1.051 . . . . 73.140000000000001 110.472 -176.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -72.42 27.53 0.05 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.63 0.772 . . . . 72.120000000000005 112.49 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 105' ' ' GLY . 3.0 tm? -82.96 -47.07 12.16 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 105.716 -1.957 . . . . 73.310000000000002 105.716 174.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.98 -19.93 19.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.285 -0.966 . . . . 74.540000000000006 109.55 176.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.77 129.7 0.12 Allowed Glycine 0 C--N 1.343 0.944 0 O-C-N 123.957 0.786 . . . . 72.219999999999999 112.352 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.2 m -82.96 127.8 33.87 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.481 -1.288 . . . . 73.319999999999993 109.116 174.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -130.06 126.29 37.28 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.564 -1.272 . . . . 73.010000000000005 107.564 175.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.47 119.24 59.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.097 -1.446 . . . . 72.140000000000001 107.097 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 33' ' ' ALA . 36.2 t-20 54.61 40.84 32.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.133 0.968 . . . . 71.030000000000001 109.063 -178.172 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 71.53 10.9 6.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.1 -1.409 . . . . 73.549999999999997 113.036 175.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.35 129.53 24.91 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 75.209999999999994 109.629 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.09 126.66 16.86 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.907 2.405 . . . . 73.400000000000006 110.782 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.17 162.77 23.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.958 0.885 . . . . 72.420000000000002 113.228 -176.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -133.0 -38.33 0.97 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.886 -1.961 . . . . 64.420000000000002 107.306 178.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.68 136.64 27.56 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.908 -2.256 . . . . 64.450000000000003 104.908 171.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -152.9 126.04 8.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.123 -0.631 . . . . 73.109999999999999 110.148 179.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.22 119.69 27.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.006 -1.479 . . . . 74.129999999999995 107.006 174.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.0 ttt -87.01 140.06 29.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.595 0.712 . . . . 72.530000000000001 112.032 -162.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -128.97 155.96 44.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.564 -1.198 . . . . 64.150000000000006 111.581 -176.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.5 t -80.03 135.27 36.32 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.452 1.101 . . . . 71.25 113.406 -173.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.57 -20.46 48.19 Favored Glycine 0 CA--C 1.499 -0.937 0 CA-C-N 115.851 -0.613 . . . . 63.210000000000001 112.238 177.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.76 151.95 37.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 122.903 0.481 . . . . 74.319999999999993 109.74 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 147.6 35.05 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.462 0.649 . . . . 74.140000000000001 110.896 -178.718 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -105.7 124.83 61.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 106.58 -1.637 . . . . 72.129999999999995 106.58 -176.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -110.18 126.39 54.05 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.632 -1.988 . . . . 75.120000000000005 105.632 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.31 102.49 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.15 -1.056 . . . . 74.430000000000007 108.15 -176.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.14 -84.18 0.02 OUTLIER Glycine 0 CA--C 1.536 1.38 0 CA-C-O 121.39 0.439 . . . . 53.25 113.077 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -131.82 8.91 4.52 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.491 0.716 . . . . 75.409999999999997 110.209 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -102.37 151.89 21.74 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.513 -0.767 . . . . 51.119999999999997 109.633 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 124.47 21.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.921 -0.581 . . . . 75.349999999999994 109.895 170.358 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.57 141.22 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.922 -1.14 . . . . 73.430000000000007 107.922 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.3 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.627 -0.879 . . . . 74.219999999999999 108.627 -178.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -102.23 126.95 49.36 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.732 0.645 . . . . 74.310000000000002 110.003 -176.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -140.0 131.06 26.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.887 0.851 . . . . 75.340000000000003 111.895 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.95 118.25 35.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.986 -1.487 . . . . 63.520000000000003 106.986 176.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.04 -71.02 0.06 OUTLIER Glycine 0 C--N 1.295 -1.708 0 C-N-CA 118.279 -1.915 . . . . 65.340000000000003 114.639 -176.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.89 142.31 97.23 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.357 2.038 . . . . 71.540000000000006 113.179 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.83 76.51 1.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.636 -1.165 . . . . 74.5 108.166 -178.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 114.024 -1.444 . . . . 73.019999999999996 108.114 -178.592 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 109.061 -0.718 . . . . 73.040000000000006 109.061 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -110.95 156.26 21.48 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.13 -0.357 . . . . 75.430000000000007 110.174 -178.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -85.09 173.29 10.59 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 71.299999999999997 108.734 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -114.63 106.73 14.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.725 -0.472 . . . . 54.030000000000001 109.725 179.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -131.29 143.44 50.54 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.519 -0.919 . . . . 72.019999999999996 108.519 177.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.26 -69.17 1.28 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.812 -1.185 . . . . 65.040000000000006 110.216 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 p -97.87 130.77 28.09 Favored Pre-proline 0 C--N 1.291 -1.942 0 N-CA-C 109.764 -0.458 . . . . 72.439999999999998 109.764 178.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.24 131.32 21.71 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.104 1.202 . . . . 74.439999999999998 109.669 175.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -102.03 116.88 62.55 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.011 -1.107 . . . . 73.209999999999994 108.011 177.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.87 156.3 13.52 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.052 1.835 . . . . 73.040000000000006 112.483 -177.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.7 153.44 18.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.716 -1.957 . . . . 72.430000000000007 105.716 172.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.01 121.17 59.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.269 -1.382 . . . . 74.109999999999999 107.269 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 8.3 tp10 -125.85 166.19 17.31 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.98 -1.489 . . . . 75.340000000000003 106.98 -175.346 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -69.62 133.65 47.83 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 124.266 1.027 . . . . 73.319999999999993 112.888 -172.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -107.87 108.53 19.74 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.889 -0.411 . . . . 72.219999999999999 109.889 178.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -97.57 114.53 35.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 107.451 -1.315 . . . . 74.409999999999997 107.451 177.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -97.45 138.6 34.65 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.033 -0.667 . . . . 63.549999999999997 112.307 -177.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.34 91.1 7.53 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.363 -2.458 . . . . 70.230000000000004 104.363 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.5 168.08 9.73 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.213 -1.358 . . . . 55.020000000000003 112.779 -166.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.92 -1.42 56.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.235 -1.348 . . . . 61.210000000000001 109.172 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB2' ' HH ' ' A' ' 111' ' ' TYR . 3.8 pp -63.65 -14.7 54.36 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.295 -0.866 . . . . 74.239999999999995 112.478 -178.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.69 -19.61 64.38 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.897 0.38 . . . . 72.430000000000007 111.077 175.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -84.02 -38.77 20.47 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.779 -1.193 . . . . 74.5 107.779 173.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -57.47 -34.54 69.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.983 -1.008 . . . . 75.140000000000001 109.986 176.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.53 -49.17 70.9 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.435 1.094 . . . . 72.239999999999995 111.551 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.29 -36.05 76.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.659 0.266 . . . . 73.319999999999993 110.528 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -62.16 -37.47 85.33 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.638 -0.71 . . . . 62.509999999999998 110.8 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -86.27 -17.03 35.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.22 0.452 . . . . 63.32 112.22 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.0 m -63.71 125.34 23.98 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.345 -0.613 . . . . 75.209999999999994 109.345 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.87 3.4 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 108.311 -1.916 . . . . 74.319999999999993 108.311 -171.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.8 t -101.75 140.05 36.57 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.576 -0.812 . . . . 73.450000000000003 108.994 -179.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.27 80.02 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 107.418 -1.326 . . . . 74.310000000000002 107.418 174.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 38.2 Cg_exo -62.29 142.01 89.73 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.315 1.343 . . . . 64.340000000000003 109.68 176.652 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.28 124.58 44.48 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.072 -0.651 . . . . 41.119999999999997 109.459 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 124' ' ' THR . 73.4 m -165.2 143.79 6.39 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 72.519999999999996 109.531 -179.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -118.62 8.94 12.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.684 0.754 . . . . 75.019999999999996 109.775 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.28 65.8 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 107.008 -2.437 . . . . 73.540000000000006 107.008 -177.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.498 ' HB1' ' OE1' ' A' ' 123' ' ' GLN . . . -57.02 -47.56 80.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.972 -1.114 . . . . 73.519999999999996 113.151 -165.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -104.44 3.57 32.31 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 120.742 -0.383 . . . . 72.219999999999999 111.255 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.01 -44.51 9.28 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.39 -0.924 . . . . 72.319999999999993 112.03 -171.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 36.51 69.23 1.29 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 124.2 0.938 . . . . 75.040000000000006 111.18 -175.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.9 -70.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 125.265 3.977 . . . . 64.439999999999998 116.804 -167.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.28 -5.72 58.19 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.444 -0.502 . . . . 72.219999999999999 112.299 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -4.77 64.34 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.96 -0.638 . . . . 53.439999999999998 112.267 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.3 m -114.79 153.37 30.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.335 -1.728 . . . . 63.310000000000002 106.335 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 156.83 40.02 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.286 -0.566 . . . . 73.109999999999999 112.235 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.5 161.09 35.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.922 -1.036 . . . . 74.299999999999997 109.743 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -130.9 135.14 47.41 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.196 -0.668 . . . . 75.409999999999997 109.196 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -116.2 133.56 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.06 0.457 . . . . 74.120000000000005 110.61 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.0 t -78.82 118.62 26.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.667 -1.234 . . . . 72.319999999999993 107.667 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -90.86 -31.12 16.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 110.428 -176.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 26.2 tpt180 -143.34 145.7 32.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.109 -1.071 . . . . 74.540000000000006 108.109 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.46 178.12 15.18 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 111.305 -0.718 . . . . 71.510000000000005 111.305 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HG2' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -61.42 -31.28 88.15 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.696 2.264 . . . . 73.530000000000001 112.303 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -97.09 21.22 10.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.996 0.369 . . . . 74.049999999999997 111.996 177.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.23 45.39 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 120.814 0.34 . . . . 61.25 110.761 179.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.04 -13.07 52.63 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 111.45 -0.66 . . . . 65.120000000000005 111.45 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 145.24 25.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.777 0.322 . . . . 35.340000000000003 110.197 178.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -125.62 147.54 49.28 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.08 -1.082 . . . . 74.319999999999993 108.08 177.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.85 144.89 51.79 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.749 -1.204 . . . . 64.040000000000006 107.749 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -111.74 134.04 53.57 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.753 0.311 . . . . 74.109999999999999 110.861 -177.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.4 mt -93.44 104.96 17.07 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.493 -0.558 . . . . 74.340000000000003 109.493 -178.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -121.29 -12.42 8.64 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.83 0.824 . . . . 52.329999999999998 110.809 -179.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -106.96 144.86 29.94 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 115.712 -0.677 . . . . 74.329999999999998 110.644 -175.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.05 -29.51 45.22 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.763 2.975 . . . . 74.129999999999995 113.434 -178.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -140.62 121.98 14.98 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.73 -0.606 . . . . 74.209999999999994 109.75 179.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -118.0 139.54 51.04 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.227 -1.397 . . . . 63.299999999999997 107.227 178.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.4 m -115.39 141.9 47.41 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.79 . . . . 74.010000000000005 110.222 -178.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.49 135.42 54.78 Favored 'General case' 0 C--O 1.256 1.446 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.761 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.01 -144.91 12.72 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.666 -1.374 . . . . 70.299999999999997 109.666 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -119.95 118.29 30.32 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.663 -0.495 . . . . 70.329999999999998 109.663 176.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.8 p80 169.74 163.02 0.2 Allowed Pre-proline 0 C--N 1.315 -0.925 0 C-N-CA 126.812 2.045 . . . . 73.230000000000004 107.811 174.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.54 -25.43 75.65 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.237 1.958 . . . . 65.540000000000006 113.043 -178.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -86.64 -4.9 59.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.653 -0.249 . . . . 72.329999999999998 111.481 -178.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -71.29 107.57 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.366 -0.605 . . . . 64.019999999999996 109.366 178.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.0 -32.01 56.89 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.581 -1.266 . . . . 73.319999999999993 107.581 175.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.68 100.85 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.305 -2.109 . . . . 64.299999999999997 105.305 173.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.72 118.32 36.6 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.76 -0.376 . . . . 72.450000000000003 110.737 -175.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -123.06 122.3 38.15 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.71 -1.218 . . . . 75.299999999999997 107.71 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 55' ' ' PRO . 24.8 t70 -130.71 132.24 45.25 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.603 -0.888 . . . . 64.420000000000002 108.603 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -141.58 175.17 9.9 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.677 -1.601 . . . . 74.5 106.677 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -60.12 -32.19 49.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.577 -1.268 . . . . 64.219999999999999 107.577 174.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.1 m -74.88 114.59 13.52 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.691 -1.225 . . . . 72.0 107.691 173.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.57 125.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.226 0.536 . . . . 73.140000000000001 110.53 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.1 m -145.13 103.12 3.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.162 -0.681 . . . . 70.150000000000006 109.162 177.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' HD3' ' H ' ' A' ' 13' ' ' GLU . 18.1 ptt180 -80.68 -45.68 16.77 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 119.604 -0.839 . . . . 73.340000000000003 111.488 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -118.88 99.67 6.9 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.313 -0.625 . . . . 74.409999999999997 109.313 177.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.43 ' CE1' HG13 ' A' ' 130' ' ' ILE . 44.4 t-80 -100.32 -52.66 3.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.301 -0.96 . . . . 73.519999999999996 111.325 177.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.59 163.57 39.2 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.03 -0.668 . . . . 71.140000000000001 111.913 -175.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.78 137.4 54.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.952 -1.129 . . . . 74.109999999999999 107.952 176.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -105.83 113.58 27.22 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.739 -1.578 . . . . 65.439999999999998 106.739 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -111.13 136.54 50.03 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.832 -0.432 . . . . 74.5 109.832 -175.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.472 HD12 ' CD2' ' A' ' 99' ' ' PHE . 17.9 mm -107.97 113.52 44.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.628 -1.99 . . . . 74.430000000000007 105.628 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -135.96 122.84 21.26 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.511 -0.476 . . . . 72.340000000000003 110.51 -177.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 56.37 37.16 28.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.265 1.426 . . . . 75.25 110.403 179.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.5 -0.72 87.53 Favored Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.13 -0.941 . . . . 54.340000000000003 113.215 177.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.85 145.72 29.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.458 -0.941 . . . . 74.150000000000006 108.458 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 94' ' ' ILE . 50.3 m-85 -105.11 127.12 52.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.289 -1.375 . . . . 73.030000000000001 107.289 -177.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -130.29 147.39 52.0 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.886 -0.509 . . . . 74.129999999999995 110.23 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -113.53 123.68 69.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.636 -1.246 . . . . 73.140000000000001 107.636 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.3 121.87 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.419 0.628 . . . . 74.010000000000005 109.608 175.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.84 138.21 35.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.77 -0.65 . . . . 72.430000000000007 110.612 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.22 12.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.679 -0.691 . . . . 74.549999999999997 109.517 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.7 -63.4 0.12 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 119.91 -1.138 . . . . 72.219999999999999 112.981 -177.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 t 62.23 9.55 3.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.723 1.209 . . . . 75.310000000000002 111.205 -177.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 108' ' ' ASN . 2.6 pt? -75.98 -46.02 31.77 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 124.017 0.927 . . . . 74.129999999999995 112.577 -173.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.401 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 34.2 t-20 -89.74 -18.46 26.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 75.140000000000001 109.735 -171.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.79 86.19 1.77 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.516 -1.034 . . . . 74.310000000000002 110.516 -177.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 m -80.63 129.81 34.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.027 0.441 . . . . 71.430000000000007 110.323 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 51.3 m-85 -131.02 136.07 48.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.741 -0.663 . . . . 72.209999999999994 110.585 178.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.66 123.32 49.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 105.935 -1.876 . . . . 64.129999999999995 105.935 174.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 57.34 37.76 28.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.44 1.096 . . . . 73.409999999999997 108.867 -176.914 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.3 mtm-85 66.68 12.29 8.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.56 -1.2 . . . . 74.140000000000001 113.702 178.142 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -114.57 142.94 29.0 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 108.871 -0.789 . . . . 71.540000000000006 108.871 174.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.54 123.17 11.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.716 1.611 . . . . 73.200000000000003 108.73 172.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -157.3 136.89 12.18 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.166 -1.42 . . . . 73.209999999999994 107.166 -176.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -93.66 -49.27 5.95 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.062 -0.655 . . . . 72.109999999999999 110.56 -178.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.2 134.22 55.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.612 -0.835 . . . . 74.239999999999995 109.151 177.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -154.4 144.92 22.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.97 -0.559 . . . . 74.340000000000003 110.808 -178.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.78 125.55 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.265 -1.754 . . . . 75.439999999999998 106.265 172.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.7 ttp -98.38 129.87 45.03 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.212 0.529 . . . . 73.109999999999999 110.191 -173.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.498 ' OE1' ' HB1' ' A' ' 39' ' ' ALA . 69.5 mt-30 -117.7 156.23 28.6 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.8 -1.185 . . . . 74.519999999999996 107.8 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.9 t -62.62 133.74 55.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.95 0.722 . . . . 73.129999999999995 112.95 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.43 56.16 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.699 -0.682 . . . . 44.409999999999997 112.588 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -88.67 153.01 21.45 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 109.63 -0.507 . . . . 71.340000000000003 109.63 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -120.6 127.18 51.87 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.002 0.905 . . . . 75.109999999999999 111.836 -176.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.27 129.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.175 -1.046 . . . . 74.299999999999997 108.175 -177.142 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.0 tt0 -118.77 132.25 56.13 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.651 -177.425 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.43 HG13 ' CE1' ' A' ' 89' ' ' HIS . 2.9 mp -108.69 103.46 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.884 -1.895 . . . . 74.219999999999999 105.884 178.179 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.06 -93.54 0.33 Allowed Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 115.476 -0.784 . . . . 75.049999999999997 112.807 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.0 3.85 9.35 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.156 0.428 . . . . 72.209999999999994 112.156 -175.149 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.5 p90 -131.61 141.9 49.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.647 -0.658 . . . . 74.25 111.605 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -122.63 149.55 43.85 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 114.606 1.336 . . . . 74.0 114.606 -171.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.0 mp -117.39 140.92 48.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.654 -1.612 . . . . 72.319999999999993 107.634 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.4 t -111.13 131.41 62.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.341 -0.985 . . . . 74.400000000000006 108.341 178.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -95.4 121.9 37.56 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.221 -0.9 . . . . 75.019999999999996 110.932 -175.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.16 133.42 51.58 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.192 0.52 . . . . 74.239999999999995 109.943 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 148.62 27.29 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.781 -0.822 . . . . 72.109999999999999 108.781 175.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 129.88 24.07 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.361 -1.096 . . . . 72.340000000000003 110.361 178.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.67 162.61 38.57 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.945 2.43 . . . . 63.130000000000003 111.459 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.34 51.96 0.9 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.028 0.918 . . . . 75.409999999999997 110.769 -178.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 105.507 -2.034 . . . . 74.319999999999993 105.507 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 106.842 -1.54 . . . . 64.340000000000003 106.842 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.89 126.29 40.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 107.507 -1.294 . . . . 73.030000000000001 107.507 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -81.42 132.74 35.34 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.366 1.079 . . . . 72.310000000000002 113.732 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -118.58 90.57 3.36 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 101.477 -3.527 . . . . 63.439999999999998 101.477 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.21 160.06 18.66 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.104 0.779 . . . . 71.099999999999994 113.104 -167.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.01 -7.16 37.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.133 -0.939 . . . . 74.299999999999997 109.647 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.32 -16.82 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.029 1.122 . . . . 75.299999999999997 114.029 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.5 pp -66.19 -26.68 67.51 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.407 0.622 . . . . 74.329999999999998 110.953 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' HD12 ' A' ' 23' ' ' LEU . 38.4 ttmt -73.97 -39.97 63.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.299 -1.0 . . . . 71.140000000000001 108.299 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.62 -35.61 80.6 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.617 -0.719 . . . . 74.140000000000001 110.076 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -42.36 98.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.983 -0.747 . . . . 71.219999999999999 108.983 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.29 -34.32 77.15 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 73.140000000000001 110.879 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.8 m -69.54 -19.06 63.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.421 0.629 . . . . 71.310000000000002 110.366 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 t -86.85 -16.71 35.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.537 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -59.52 119.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.525 0.679 . . . . 64.439999999999998 110.511 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.88 -78.38 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.167 -1.973 . . . . 61.43 108.167 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.3 t -116.76 148.41 41.17 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.463 -0.94 . . . . 74.310000000000002 108.463 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.95 116.64 26.06 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 106.893 -1.521 . . . . 45.420000000000002 106.893 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.48 140.64 82.98 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.08 1.187 . . . . 75.010000000000005 110.865 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.3 126.2 29.25 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.651 -0.87 . . . . 74.510000000000005 108.651 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 m -131.49 149.87 52.36 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.47 -0.937 . . . . 54.119999999999997 108.47 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -127.11 153.04 46.51 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.422 -0.585 . . . . 71.140000000000001 109.422 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 24.67 4.1 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 120.463 -0.875 . . . . 71.129999999999995 112.134 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.572 -0.529 . . . . 71.219999999999999 109.572 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.39 -2.31 52.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.549 -0.751 . . . . 72.409999999999997 110.998 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.43 -34.48 41.62 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.459 -0.941 . . . . 64.219999999999999 108.459 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.6 mt 56.55 90.96 0.08 OUTLIER Pre-proline 0 N--CA 1.45 -0.426 0 O-C-N 124.774 1.296 . . . . 72.519999999999996 113.006 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 8.3 Cg_endo -53.99 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.462 2.108 . . . . 71.409999999999997 111.888 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.59 15.45 8.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.0 0.429 . . . . 70.319999999999993 110.334 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.07 18.32 76.84 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.833 -0.621 . . . . 54.520000000000003 112.323 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.7 t -138.01 167.01 22.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -150.9 157.65 43.16 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.295 1.038 . . . . 73.200000000000003 108.548 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.15 160.0 39.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 121.014 -0.275 . . . . 70.310000000000002 111.458 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -127.24 134.93 50.02 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.526 -0.916 . . . . 65.439999999999998 108.526 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.51 136.75 44.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.502 -0.555 . . . . 61.539999999999999 109.502 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 17.1 t -80.59 117.42 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 106.717 -1.586 . . . . 51.130000000000003 106.717 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 51.2 tptt -90.63 -32.06 16.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.749 0.785 . . . . 64.409999999999997 109.136 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 77.8 ttt180 -151.51 142.35 22.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.52 -2.03 . . . . 61.409999999999997 105.52 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.22 -171.13 27.95 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.594 -1.002 . . . . 70.129999999999995 110.594 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 -50.15 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.386 2.057 . . . . 54.32 110.889 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 HD23 ' A' ' 80' ' ' LEU . 2.7 p30 -90.93 24.34 2.81 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.66 1.184 . . . . 44.549999999999997 112.666 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -53.45 131.78 38.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.568 0.699 . . . . 71.25 112.78 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.94 -17.31 45.28 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.359 -0.837 . . . . 74.120000000000005 111.901 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 146.53 23.98 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 122.593 -0.357 . . . . 75.439999999999998 110.435 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -120.26 135.29 55.05 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.926 -0.768 . . . . 72.010000000000005 108.926 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -118.07 140.99 48.95 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.77 -1.196 . . . . 75.219999999999999 107.77 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.1 pt? -110.7 140.96 44.59 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.256 -0.577 . . . . 64.340000000000003 111.576 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.4 HD23 HD11 ' A' ' 94' ' ' ILE . 4.6 mp -91.15 104.59 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.316 -0.994 . . . . 73.239999999999995 108.316 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -112.08 -4.86 14.35 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.965 0.888 . . . . 72.230000000000004 109.752 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -108.97 151.78 42.07 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 115.357 -0.838 . . . . 70.409999999999997 109.762 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 30.9 Cg_exo -64.98 -18.04 61.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.036 2.49 . . . . 64.239999999999995 113.948 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -144.12 122.4 12.28 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.595 -0.691 . . . . 64.150000000000006 109.522 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 77' ' ' ASP . 19.2 m -121.95 114.46 21.01 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.302 -0.629 . . . . 71.400000000000006 109.302 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -95.55 137.12 35.06 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.976 -0.452 . . . . 72.310000000000002 109.97 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 135.32 55.03 Favored 'General case' 0 C--O 1.261 1.66 0 CA-C-O 121.313 0.577 . . . . 73.25 111.228 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.04 -161.85 24.41 Favored Glycine 0 C--O 1.251 1.185 0 N-CA-C 109.07 -1.612 . . . . 60.229999999999997 109.07 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.418 ' HE ' HG11 ' A' ' 85' ' ' VAL . 3.9 tmm_? -94.07 118.75 31.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.188 -1.782 . . . . 63.119999999999997 106.188 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 76' ' ' SER . 40.1 t60 -166.5 139.58 3.19 Favored Pre-proline 0 N--CA 1.401 -2.914 0 N-CA-C 103.705 -2.702 . . . . 74.209999999999994 103.705 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.89 -29.6 82.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.115 1.21 . . . . 74.010000000000005 111.703 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -105.34 17.84 23.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.335 -0.848 . . . . 63.009999999999998 111.422 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 19.4 p -77.91 128.66 34.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 118.652 -1.219 . . . . 60.219999999999999 110.636 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' A' ' 68' ' ' THR . 12.3 t70 -77.28 -30.25 54.19 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.627 0.727 . . . . 70.5 109.109 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.04 99.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.558 -0.905 . . . . 72.030000000000001 108.558 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -92.42 120.17 32.66 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.849 -0.614 . . . . 72.319999999999993 109.9 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.405 HD23 HD21 ' A' ' 56' ' ' ASN . 77.9 mt -127.56 140.13 52.31 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.797 -1.557 . . . . 62.340000000000003 106.797 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -87.07 116.31 25.04 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.746 -0.835 . . . . 74.140000000000001 108.746 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 84' ' ' THR . 11.0 t70 -87.01 178.66 6.87 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.099 -1.074 . . . . 73.230000000000004 108.099 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.92 -34.18 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 106.873 -1.528 . . . . 72.239999999999995 106.873 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 7.0 t -114.37 -167.42 1.22 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 104.651 -2.351 . . . . 75.349999999999994 104.651 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG11 ' HE ' ' A' ' 72' ' ' ARG . 61.2 t -104.17 101.9 12.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.617 -1.233 . . . . 61.149999999999999 109.926 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.8 p -87.98 101.41 13.73 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.987 -0.551 . . . . 70.319999999999993 110.824 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.9 ptt180 -64.32 -34.7 78.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.751 0.786 . . . . 73.319999999999993 109.656 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -147.2 95.88 2.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.957 -1.019 . . . . 71.239999999999995 108.638 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -99.98 -52.54 3.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.769 -1.172 . . . . 73.200000000000003 109.323 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.59 156.2 34.67 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 119.925 -0.71 . . . . 70.430000000000007 111.344 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 9.7 pt-20 -137.84 142.03 40.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.943 -0.571 . . . . 64.310000000000002 109.964 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -105.69 117.48 34.14 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.928 -1.508 . . . . 73.319999999999993 106.928 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 16.3 mtp180 -109.5 127.98 54.84 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.906 -0.776 . . . . 71.140000000000001 108.906 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 mp -105.86 113.59 43.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.794 -1.188 . . . . 43.229999999999997 107.794 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -126.59 117.45 22.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.648 -0.501 . . . . 71.230000000000004 109.648 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 53.49 37.7 26.32 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.513 1.525 . . . . 72.140000000000001 112.229 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.58 87.51 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-N 115.325 -0.852 . . . . 71.400000000000006 113.02 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.49 143.06 32.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.301 -0.629 . . . . 71.219999999999999 109.301 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' CD2' HG13 ' A' ' 94' ' ' ILE . 61.9 m-85 -110.45 124.12 51.18 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.891 -0.595 . . . . 72.329999999999998 110.277 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.92 141.07 49.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.327 -0.62 . . . . 75.230000000000004 109.327 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.45 HG23 ' HG2' ' A' ' 122' ' ' MET . 17.9 t -102.95 125.36 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 107.545 -1.28 . . . . 71.420000000000002 107.545 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.79 122.12 68.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 N-CA-C 107.375 -1.343 . . . . 75.239999999999995 107.375 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 2.2 t70 -87.63 122.02 30.8 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.978 -1.01 . . . . 75.310000000000002 108.448 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.4 m -116.46 13.7 7.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 115.447 -0.797 . . . . 74.209999999999994 109.73 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.5 -66.07 0.25 Allowed Glycine 0 N--CA 1.412 -2.948 0 CA-C-N 115.084 -0.962 . . . . 72.129999999999995 112.807 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.3 t 60.66 9.61 2.23 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.974 0.91 . . . . 55.229999999999997 111.051 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 108' ' ' ASN . 3.3 pp -65.38 -46.71 79.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.724 1.21 . . . . 63.299999999999997 112.83 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.446 ' N ' HD12 ' A' ' 107' ' ' LEU . 6.8 t30 -92.77 -18.06 23.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.285 -1.006 . . . . 70.040000000000006 108.285 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.39 93.87 1.22 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 106.486 -2.646 . . . . 70.299999999999997 106.486 -169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 5.1 m -76.4 128.7 35.33 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 108.705 -0.85 . . . . 72.299999999999997 108.705 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 50.0 m-85 -112.19 126.16 54.91 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 106.888 -1.523 . . . . 73.340000000000003 106.888 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 120' ' ' GLN . 3.1 t -123.22 134.76 65.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 N-CA-C 104.358 -2.46 . . . . 73.409999999999997 104.358 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.28 38.23 29.58 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.759 -1.2 . . . . 63.149999999999999 107.759 -169.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 64.36 9.18 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.852 1.427 . . . . 70.219999999999999 114.852 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.0 148.41 67.24 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 119.03 0.832 . . . . 61.450000000000003 110.14 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 110' ' ' THR . 18.1 Cg_endo -60.83 122.68 11.6 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.563 1.509 . . . . 73.230000000000004 110.213 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -146.47 133.13 19.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.019 -0.672 . . . . 74.120000000000005 109.215 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 16.8 m120 -92.84 -28.86 16.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.568 0.699 . . . . 72.120000000000005 111.28 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.44 135.37 26.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.45 -1.685 . . . . 71.319999999999993 106.45 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.487 ' HG2' ' CG1' ' A' ' 112' ' ' VAL . 7.5 tp60 -140.54 144.68 36.05 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 111.713 0.264 . . . . 75.230000000000004 111.713 -173.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.81 124.57 52.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 103.96 -2.607 . . . . 52.399999999999999 103.96 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.45 ' HG2' HG23 ' A' ' 101' ' ' VAL . 51.4 mtp -87.94 146.33 25.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.42 -0.912 . . . . 61.450000000000003 111.946 -171.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.15 156.87 41.09 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.849 -1.537 . . . . 71.340000000000003 106.849 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -71.08 133.69 46.47 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.229 -1.397 . . . . 65.099999999999994 107.229 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.55 57.45 Favored Glycine 0 C--N 1.312 -0.785 0 C-N-CA 120.67 -0.776 . . . . 51.299999999999997 111.778 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.47 139.34 45.7 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.654 -0.869 . . . . 71.209999999999994 108.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -112.08 126.2 54.92 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.749 -1.204 . . . . 70.510000000000005 107.749 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.06 126.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.866 -0.79 . . . . 73.209999999999994 108.866 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 55.4 tp60 -105.0 111.51 24.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.222 -1.029 . . . . 72.540000000000006 108.222 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.93 112.86 42.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.614 -1.624 . . . . 74.099999999999994 106.614 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.63 -126.97 25.31 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 108.906 -1.678 . . . . 62.109999999999999 108.906 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 17.57 20.47 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.431 0.634 . . . . 71.519999999999996 109.738 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.616 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -120.62 165.62 14.79 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.078 -0.51 . . . . 72.319999999999993 110.134 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 14.7 ptm180 -137.15 146.62 45.2 Favored 'General case' 0 C--O 1.256 1.431 0 CA-C-O 121.544 0.687 . . . . 65.239999999999995 112.72 -168.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -120.48 139.88 52.23 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.548 -1.278 . . . . 53.420000000000002 107.548 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.74 120.43 62.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 107.919 -1.141 . . . . 73.109999999999999 107.919 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.03 126.61 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.261 -0.644 . . . . 61.32 109.261 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.03 162.13 30.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 123.779 0.832 . . . . 72.019999999999996 109.201 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.53 148.03 45.39 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.103 -1.443 . . . . 72.129999999999995 107.103 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.617 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -77.9 -161.43 16.48 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 121.074 -0.584 . . . . 64.200000000000003 114.356 -171.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.63 143.91 93.33 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.583 2.189 . . . . 74.430000000000007 111.897 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.48 31.93 6.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.091 -1.078 . . . . 72.310000000000002 108.091 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.524 -1.216 . . . . 63.229999999999997 109.689 -177.342 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 105.394 -2.076 . . . . 74.010000000000005 105.394 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.46 115.87 24.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.533 0.683 . . . . 73.019999999999996 109.337 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -119.94 139.86 51.79 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.287 -0.87 . . . . 75.340000000000003 110.432 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -113.22 92.18 3.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.732 -1.581 . . . . 72.319999999999993 106.732 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.21 -173.86 3.42 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.059 -0.973 . . . . 72.019999999999996 112.024 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.58 -0.55 1.42 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.117 1.767 . . . . 71.299999999999997 111.683 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.98 -17.54 63.39 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.735 1.214 . . . . 64.209999999999994 111.174 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.19 -8.95 35.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.685 0.794 . . . . 72.340000000000003 111.677 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 63.5 tttp -88.93 -23.08 22.78 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.05 -0.407 . . . . 63.229999999999997 111.246 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -59.76 -23.47 63.27 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.419 0.526 . . . . 74.019999999999996 112.419 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.57 -30.63 71.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.85 0.685 . . . . 54.450000000000003 112.85 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 13.8 pt-20 -76.56 -26.05 54.7 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.601 -0.839 . . . . 72.120000000000005 110.796 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -80.16 -26.18 39.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.029 -0.73 . . . . 74.409999999999997 109.029 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 m -77.58 -25.74 50.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.125 -0.943 . . . . 63.030000000000001 110.448 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.5 m -74.74 108.77 7.7 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.369 -0.974 . . . . 71.420000000000002 108.369 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.75 -5.23 12.82 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 109.281 -1.528 . . . . 61.0 109.281 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -113.8 121.72 44.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.012 -0.736 . . . . 73.150000000000006 109.012 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.59 45.0 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.279 -1.008 . . . . 73.310000000000002 108.279 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.15 142.08 96.89 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.162 1.908 . . . . 73.209999999999994 111.079 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.56 126.01 42.61 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.205 -0.294 . . . . 71.120000000000005 110.205 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 84.96 2.08 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.036 -1.098 . . . . 62.409999999999997 108.036 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -101.6 -36.33 8.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.251 0.548 . . . . 72.200000000000003 111.02 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.73 62.19 0.37 Allowed Glycine 0 C--N 1.305 -1.159 0 C-N-CA 121.013 -0.613 . . . . 61.340000000000003 111.991 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 123' ' ' GLN . . . -90.65 -28.52 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.591 -0.358 . . . . 61.420000000000002 111.257 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -92.75 -5.25 51.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.333 0.494 . . . . 72.420000000000002 112.333 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -80.22 -43.84 20.78 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.118 0.784 . . . . 73.030000000000001 113.118 -168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.0 mt 42.76 65.66 5.05 Favored Pre-proline 0 CA--C 1.557 1.248 0 O-C-N 124.181 0.926 . . . . 63.530000000000001 111.959 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.27 -70.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.461 2.774 . . . . 63.520000000000003 113.979 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.19 7.89 45.65 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.509 -0.476 . . . . 61.149999999999999 110.661 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.54 75.16 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.987 -0.551 . . . . 54.509999999999998 111.769 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -115.18 153.97 29.85 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 123.954 0.902 . . . . 71.239999999999995 111.012 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.34 44.3 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.459 -0.791 . . . . 74.239999999999995 109.974 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.85 160.7 38.08 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.542 -0.754 . . . . 72.430000000000007 109.196 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 pt? -121.28 131.88 54.47 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.34 -0.985 . . . . 75.0 108.34 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.57 129.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.32 -0.622 . . . . 74.310000000000002 109.32 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG21 ' ND2' ' A' ' 56' ' ' ASN . 22.4 t -80.19 118.06 27.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.529 -1.656 . . . . 70.420000000000002 106.529 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.985 0.898 . . . . 64.230000000000004 109.667 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -141.47 148.05 38.85 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.641 -1.244 . . . . 75.420000000000002 107.641 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.43 -179.7 16.85 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 111.093 -0.803 . . . . 73.239999999999995 111.093 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -67.67 -38.11 14.83 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.097 1.865 . . . . 74.430000000000007 110.943 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.452 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.7 p-10 -96.14 22.63 7.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.392 -0.822 . . . . 71.310000000000002 111.261 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.22 144.02 55.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.326 0.651 . . . . 74.030000000000001 111.342 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.46 33.23 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 111.139 -0.785 . . . . 63.149999999999999 111.139 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 141.93 29.14 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 120.765 0.317 . . . . 70.239999999999995 110.731 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -119.82 138.7 53.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.069 -0.514 . . . . 72.120000000000005 110.276 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.98 133.98 54.82 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.533 -0.543 . . . . 64.239999999999995 109.533 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.5 pt? -96.86 144.53 26.72 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.049 0.218 . . . . 60.399999999999999 110.502 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB3' HD11 ' A' ' 94' ' ' ILE . 69.3 mt -104.5 113.39 26.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -128.52 -3.1 5.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.973 0.416 . . . . 75.549999999999997 111.509 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -107.87 143.14 26.73 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 109.383 -0.599 . . . . 63.229999999999997 109.383 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.94 -25.2 27.01 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.455 2.77 . . . . 73.519999999999996 114.369 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.7 m -143.23 121.96 12.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 110.258 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 24.9 m -117.96 129.26 55.5 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.446 -0.797 . . . . 43.25 109.768 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 m -100.89 135.67 41.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.459 -0.571 . . . . 65.25 109.459 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.07 135.43 54.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.054 -0.721 . . . . 65.019999999999996 109.054 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -165.41 34.49 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.974 -1.25 . . . . 75.140000000000001 109.974 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 79.2 ttt180 -91.6 149.16 21.79 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.465 -0.568 . . . . 74.349999999999994 109.465 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 79.03 161.26 0.14 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.552 1.141 . . . . 63.350000000000001 110.519 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -72.28 13.1 0.56 Allowed 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.834 2.356 . . . . 74.310000000000002 113.156 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.62 -5.54 59.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.767 0.794 . . . . 75.540000000000006 109.6 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 m -117.57 148.74 41.62 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.75 -1.204 . . . . 70.25 107.75 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.16 -44.86 83.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.915 0.886 . . . . 40.340000000000003 109.361 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.9 mm -100.17 124.5 53.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.004 -1.11 . . . . 71.420000000000002 108.004 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -88.84 124.35 34.09 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.519 0.512 . . . . 75.420000000000002 111.229 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 6.2 mp -126.3 141.3 51.96 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.751 -1.203 . . . . 74.049999999999997 107.751 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.27 117.43 34.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.34 -1.726 . . . . 64.450000000000003 106.34 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 84' ' ' THR . 9.4 t70 -105.46 173.25 6.39 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.69 -0.687 . . . . 73.549999999999997 109.538 -168.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -82.95 -24.86 8.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.449 -1.315 . . . . 52.439999999999998 107.449 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.2 m -124.56 -173.66 2.84 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.0 -1.852 . . . . 74.209999999999994 106.0 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 84' ' ' THR . 89.3 t -102.67 99.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 120.667 -1.271 . . . . 72.129999999999995 110.157 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 p -83.87 107.47 16.28 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.434 -0.803 . . . . 73.349999999999994 109.837 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -32.36 73.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.643 0.735 . . . . 74.510000000000005 111.006 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -168.9 119.93 0.74 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.668 -2.345 . . . . 74.549999999999997 104.668 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -99.58 -52.04 3.59 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 123.375 0.422 . . . . 74.230000000000004 109.893 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.73 157.81 44.13 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.326 -0.549 . . . . 72.519999999999996 110.155 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.19 132.03 51.86 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.882 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 4.2 m-85 -105.62 113.75 27.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.72 -1.585 . . . . 73.25 106.72 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.404 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 84.8 mtt180 -104.15 133.48 49.0 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 63' ' ' LEU . 50.4 mt -104.29 113.53 41.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.063 -1.828 . . . . 62.130000000000003 106.063 176.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -134.47 118.58 17.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.447 -0.575 . . . . 70.310000000000002 109.447 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 54.22 38.04 28.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.161 0.985 . . . . 70.299999999999997 112.039 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.0 -6.92 79.84 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.092 -0.504 . . . . 61.530000000000001 113.702 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.74 149.91 23.99 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.359 -0.608 . . . . 52.240000000000002 109.359 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.97 116.9 28.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 72.129999999999995 108.794 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 93' ' ' ARG . 10.4 pt-20 -112.04 127.28 55.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.202 -0.666 . . . . 61.399999999999999 109.202 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.458 HG21 ' SD ' ' A' ' 122' ' ' MET . 43.6 t -105.5 124.32 60.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.235 -0.654 . . . . 74.219999999999999 109.235 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.4 t -115.01 122.97 70.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 115.779 -0.646 . . . . 73.310000000000002 109.639 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.05 131.4 34.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.216 -0.902 . . . . 72.030000000000001 111.351 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.37 12.74 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.905 -1.043 . . . . 53.240000000000002 108.377 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.14 34.51 5.03 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.994 -1.242 . . . . 74.510000000000005 109.994 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 m -61.9 -11.7 14.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.618 1.167 . . . . 75.219999999999999 111.315 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 107' ' ' LEU . 1.7 mm? -71.15 -26.16 62.87 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.055 0.942 . . . . 61.420000000000002 108.94 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.61 -18.68 24.74 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.106 -0.952 . . . . 75.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.94 62.71 1.65 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.702 -0.681 . . . . 72.25 112.644 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -64.5 135.5 56.11 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 124.081 0.952 . . . . 55.5 112.444 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.14 126.77 44.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.966 -1.124 . . . . 72.420000000000002 107.966 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -107.85 117.32 53.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.764 -1.569 . . . . 72.120000000000005 106.764 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 51.32 49.96 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.128 0.971 . . . . 74.340000000000003 110.276 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 70.68 7.81 6.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.273 1.429 . . . . 72.030000000000001 113.709 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.54 137.82 31.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.451 -0.9 . . . . 50.329999999999998 111.228 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.13 123.92 14.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.103 1.869 . . . . 63.140000000000001 108.793 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -151.44 138.49 19.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.124 -1.065 . . . . 64.540000000000006 108.124 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.1 -53.24 3.88 Favored 'General case' 0 C--O 1.199 -1.582 0 C-N-CA 120.73 -0.388 . . . . 64.109999999999999 110.637 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.93 136.53 54.93 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.13 -0.693 . . . . 64.299999999999997 109.13 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 140.43 20.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.383 -0.969 . . . . 75.239999999999995 108.383 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -96.42 114.57 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 105.101 -2.185 . . . . 42.140000000000001 105.101 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.458 ' SD ' HG21 ' A' ' 101' ' ' VAL . 79.1 mtp -90.22 145.32 25.1 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 114.414 1.264 . . . . 74.329999999999998 114.414 -166.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.446 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 76.1 mt-30 -111.59 158.15 19.56 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 63.43 108.677 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 138' ' ' LEU . 24.4 m -58.14 120.9 9.45 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.819 -0.437 . . . . 74.400000000000006 109.819 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.73 1.54 56.34 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.217 -0.992 . . . . 62.119999999999997 112.718 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.98 141.56 28.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.23 -1.026 . . . . 74.129999999999995 108.23 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.24 145.67 49.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.918 0.711 . . . . 74.239999999999995 112.918 -169.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.442 HD11 ' SD ' ' A' ' 122' ' ' MET . 34.5 mt -116.08 132.87 64.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.002 -0.74 . . . . 74.340000000000003 109.002 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -103.63 110.5 22.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.789 -1.93 . . . . 73.010000000000005 105.789 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.0 mt -109.67 105.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.475 -0.935 . . . . 74.040000000000006 108.475 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.51 -107.94 2.3 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.016 -1.634 . . . . 73.319999999999993 109.016 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -119.93 9.04 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 120.808 0.337 . . . . 63.310000000000002 110.12 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.4 p90 -120.28 146.26 46.26 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.802 0.668 . . . . 64.340000000000003 112.802 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 53' ' ' ARG . 47.9 ttt180 -112.58 132.28 55.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.427 -0.806 . . . . 74.140000000000001 111.467 -167.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.4 139.97 52.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.258 -0.645 . . . . 63.340000000000003 109.258 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.0 130.23 66.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.673 -0.862 . . . . 72.140000000000001 108.673 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -104.27 128.48 52.04 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.124 -0.695 . . . . 75.510000000000005 109.124 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB2' HG23 ' A' ' 124' ' ' THR 0.278 0.0 OUTLIER -140.09 135.63 32.76 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 113.109 0.781 . . . . 75.430000000000007 113.109 177.728 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.2 124.97 44.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.281 -1.748 . . . . 63.100000000000001 106.281 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 165.43 -33.7 0.24 Allowed Glycine 0 C--N 1.29 -1.976 0 C-N-CA 118.723 -1.703 . . . . 13.51 116.468 -171.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 10.2 Cg_endo -53.87 142.16 64.38 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.896 2.848 . . . . 62.32 114.653 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.49 88.92 1.23 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.831 -2.285 . . . . 73.430000000000007 104.831 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 114.803 -1.089 . . . . 73.030000000000001 108.282 -172.657 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.888 -0.412 . . . . 61.119999999999997 109.888 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.9 115.79 27.85 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 CA-C-O 120.822 0.344 . . . . 73.310000000000002 110.36 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -107.69 120.16 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.729 -0.841 . . . . 75.109999999999999 108.729 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.57 141.26 46.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.688 -0.687 . . . . 64.430000000000007 112.624 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 82.84 -20.93 0.31 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.32 1.848 . . . . 72.530000000000001 113.505 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -80.1 -38.44 31.63 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.422 -0.955 . . . . 52.009999999999998 108.422 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 23' ' ' LEU . 2.2 pp -64.73 -26.62 68.45 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.014 -0.993 . . . . 75.310000000000002 110.792 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 22' ' ' LEU . 50.9 tp -74.85 -39.96 61.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.4 -0.818 . . . . 63.240000000000002 109.232 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.8 -41.41 78.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 73.140000000000001 110.448 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.78 -39.55 80.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.706 -0.679 . . . . 62.020000000000003 110.409 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -59.43 -39.23 82.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 73.129999999999995 110.796 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -63.51 -38.51 91.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.73 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -72.06 -38.77 69.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.961 -0.563 . . . . 61.049999999999997 110.302 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -66.46 -47.01 74.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.956 -0.565 . . . . 64.340000000000003 110.242 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -83.08 98.11 9.14 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.874 0.369 . . . . 52.130000000000003 111.288 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.54 -60.51 0.74 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 108.38 -1.888 . . . . 75.540000000000006 108.38 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.514 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 38.2 m -114.37 124.77 52.78 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.866 -1.161 . . . . 73.439999999999998 107.866 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.82 94.52 6.44 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.619 -0.512 . . . . 51.420000000000002 109.619 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 32' ' ' THR . 2.7 Cg_exo -76.25 142.91 24.71 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.575 2.183 . . . . 63.399999999999999 111.962 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.1 154.74 19.93 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.156 -1.053 . . . . 54.399999999999999 108.156 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 m -114.43 144.85 42.65 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.144 0.497 . . . . 74.400000000000006 112.075 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -132.58 144.39 50.36 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.743 -1.576 . . . . 72.310000000000002 106.743 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.13 11.91 32.9 Favored Glycine 0 CA--C 1.49 -1.515 0 N-CA-C 109.891 -1.283 . . . . 73.319999999999993 109.891 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.04 -32.0 16.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.882 -0.785 . . . . 73.530000000000001 108.882 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -85.09 3.6 38.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.52 -1.218 . . . . 73.219999999999999 110.95 -177.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -80.12 -36.34 35.42 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.398 -0.819 . . . . 71.010000000000005 110.566 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 51.15 45.85 3.17 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 123.725 0.641 . . . . 71.109999999999999 112.492 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.99 -52.85 1.04 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.9 1.733 . . . . 65.209999999999994 113.929 -170.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -18.34 40.27 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.946 -0.57 . . . . 54.329999999999998 112.53 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.94 -0.49 82.7 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 120.422 -0.894 . . . . 73.319999999999993 111.814 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 t -118.62 170.02 9.32 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.347 -1.353 . . . . 63.020000000000003 107.347 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . . . -139.65 152.92 47.14 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.598 0.237 . . . . 72.239999999999995 110.463 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -130.05 155.58 45.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.925 -0.58 . . . . 75.299999999999997 109.959 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.5 pt? -119.39 125.15 48.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.911 -1.144 . . . . 65.340000000000003 107.911 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.2 135.18 53.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 115.433 -0.803 . . . . 75.200000000000003 109.791 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.11 117.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 105.171 -2.159 . . . . 50.229999999999997 105.171 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.63 -39.43 22.15 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.323 -1.362 . . . . 73.420000000000002 107.323 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 47.7 ttt180 -160.95 144.21 13.05 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.317 -1.364 . . . . 73.150000000000006 107.317 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.61 -167.69 26.54 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 108.355 -1.898 . . . . 31.140000000000001 108.355 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.1 -47.57 12.16 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.378 2.052 . . . . 73.5 112.184 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.11 22.05 3.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.662 -0.244 . . . . 72.549999999999997 111.198 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.6 134.09 46.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.723 0.638 . . . . 72.409999999999997 112.723 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.18 21.72 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.217 -0.901 . . . . 73.340000000000003 111.829 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 145.76 33.35 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.843 0.354 . . . . 73.230000000000004 110.126 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.85 136.3 22.85 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 110.991 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -121.59 145.24 48.18 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.347 -1.353 . . . . 73.409999999999997 107.347 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 1.4 pt? -110.38 145.53 37.4 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.575 0.226 . . . . 74.040000000000006 110.63 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.75 103.41 5.01 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.101 -1.444 . . . . 71.25 107.101 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -123.2 7.55 9.14 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.952 -1.499 . . . . 60.240000000000002 106.952 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -137.03 146.1 53.3 Favored Pre-proline 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 74.439999999999998 107.669 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 14.0 Cg_exo -72.06 -14.36 29.01 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.832 2.355 . . . . 74.319999999999993 114.496 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -140.14 122.37 15.88 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.293 -0.88 . . . . 73.120000000000005 109.479 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.2 m -131.02 139.08 49.91 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.523 0.729 . . . . 55.240000000000002 111.224 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.15 52.64 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.128 -1.064 . . . . 73.319999999999993 108.128 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.75 135.1 54.69 Favored 'General case' 0 C--O 1.264 1.823 0 CA-C-O 120.996 0.427 . . . . 71.239999999999995 109.94 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.74 -156.17 22.33 Favored Glycine 0 N--CA 1.417 -2.617 0 CA-C-N 115.316 -0.856 . . . . 62.130000000000003 111.119 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.505 ' NH1' ' HA ' ' A' ' 86' ' ' SER . 40.8 ttp180 -88.86 150.61 22.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.308 -0.627 . . . . 75.209999999999994 109.308 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.9 m170 81.53 150.07 0.11 Allowed Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 125.435 1.494 . . . . 64.120000000000005 111.093 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.29 0.86 6.11 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.051 2.501 . . . . 70.219999999999999 111.225 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.63 -26.53 60.82 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 124.722 1.209 . . . . 74.530000000000001 107.754 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -85.84 136.43 33.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.604 -1.258 . . . . 73.439999999999998 107.604 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.64 -46.49 73.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.369 1.068 . . . . 74.150000000000006 109.765 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 mm -102.73 109.4 26.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.588 -1.264 . . . . 72.019999999999996 107.588 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -87.61 115.77 25.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.763 -0.653 . . . . 64.219999999999999 111.196 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.23 127.83 45.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.037 -1.468 . . . . 65.319999999999993 107.037 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.07 117.9 34.98 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.113 -0.635 . . . . 71.019999999999996 110.216 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 85' ' ' VAL . 12.2 t70 -150.34 161.52 42.32 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 104.546 -2.39 . . . . 74.219999999999999 104.546 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.3 -39.3 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 118.168 0.44 . . . . 52.530000000000001 111.371 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -101.32 7.35 42.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.72 0.771 . . . . 75.109999999999999 112.308 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 82' ' ' ASP . 69.2 t -85.93 121.15 36.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.279 -1.008 . . . . 72.329999999999998 108.279 173.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.505 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 35.0 m -93.11 -164.54 1.19 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.307 0.855 . . . . 63.039999999999999 113.307 -173.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -55.07 -21.37 12.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.57 2.348 . . . . 71.439999999999998 113.499 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -170.24 116.44 0.52 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.73 -0.841 . . . . 70.530000000000001 108.73 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.491 ' ND1' HG23 ' A' ' 130' ' ' ILE . 9.4 t-160 -100.39 -51.96 3.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.984 -0.747 . . . . 74.150000000000006 108.984 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.14 43.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.454 -0.943 . . . . 44.119999999999997 108.454 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.33 149.64 50.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.536 -0.466 . . . . 72.209999999999994 110.787 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.471 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 21.9 m-85 -112.65 113.77 26.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.97 -1.122 . . . . 70.430000000000007 107.97 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -108.78 131.89 54.51 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.264 -1.013 . . . . 75.230000000000004 108.264 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -106.4 120.05 56.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.685 -1.228 . . . . 73.409999999999997 107.685 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.1 129.95 28.36 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.333 -0.617 . . . . 71.0 109.333 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.26 35.75 25.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.728 1.211 . . . . 65.200000000000003 110.71 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.17 82.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.473 -0.785 . . . . 71.209999999999994 113.839 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -100.61 141.56 33.3 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.945 -0.761 . . . . 75.239999999999995 108.945 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -106.82 117.86 35.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.091 -1.078 . . . . 72.099999999999994 108.091 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.02 141.87 51.49 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.065 -0.654 . . . . 72.549999999999997 111.674 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.05 124.82 58.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.443 -0.947 . . . . 73.019999999999996 108.443 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.84 123.38 71.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.382 -0.97 . . . . 74.230000000000004 108.382 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.98 127.64 32.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 71.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.69 -15.96 9.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.613 0.721 . . . . 75.340000000000003 109.77 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.73 57.79 0.63 Allowed Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.479 -1.448 . . . . 64.140000000000001 109.479 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -69.33 5.14 1.39 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.528 0.68 . . . . 54.240000000000002 111.56 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.89 -20.9 52.13 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.317 0.647 . . . . 70.219999999999999 109.355 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -87.83 -19.79 26.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 62.100000000000001 110.35 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.04 71.72 0.99 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 112.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 10.0 m -69.67 130.32 42.05 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.159 -1.052 . . . . 51.119999999999997 108.159 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -108.83 125.9 52.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.429 -0.908 . . . . 62.229999999999997 110.613 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.03 117.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 105.792 -1.929 . . . . 72.219999999999999 105.792 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.88 40.63 30.54 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.042 0.925 . . . . 74.099999999999994 108.849 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 71.86 7.36 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.215 1.932 . . . . 74.099999999999994 116.215 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -115.85 135.96 22.81 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 118.72 0.691 . . . . 74.230000000000004 110.519 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 110' ' ' THR . 32.1 Cg_endo -63.48 148.05 92.81 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.86 2.374 . . . . 75.540000000000006 112.62 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 51.6 mmt-85 -121.55 160.99 23.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 114.335 1.235 . . . . 75.540000000000006 114.335 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -115.8 -51.76 2.65 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 112.943 -1.935 . . . . 60.240000000000002 106.125 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.19 135.66 5.35 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.338 -1.727 . . . . 65.400000000000006 106.338 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.65 145.46 23.47 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.44 -0.504 . . . . 74.319999999999993 110.998 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.37 124.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.309 -2.108 . . . . 72.109999999999999 105.309 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 tpp -89.5 134.48 34.09 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.311 -0.955 . . . . 75.420000000000002 113.481 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -103.69 141.67 35.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.485 -1.234 . . . . 44.009999999999998 110.645 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -61.37 130.22 45.02 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.874 -1.057 . . . . 70.530000000000001 111.451 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.43 58.23 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.911 -0.586 . . . . 73.340000000000003 113.182 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -88.98 154.73 19.99 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 116.866 0.333 . . . . 62.229999999999997 110.864 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.81 133.82 53.03 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.942 0.877 . . . . 54.240000000000002 110.801 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.1 mm -113.68 123.65 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.763 -1.199 . . . . 71.099999999999994 107.763 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -104.71 113.37 26.92 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.189 -0.604 . . . . 74.519999999999996 109.562 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.491 HG23 ' ND1' ' A' ' 89' ' ' HIS . 36.9 mt -109.66 124.39 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 114.806 -1.088 . . . . 74.430000000000007 108.128 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.82 -86.36 1.35 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.866 -1.294 . . . . 62.219999999999999 109.866 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.93 25.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.364 0.602 . . . . 73.340000000000003 110.215 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.4 p90 -141.04 164.08 31.24 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.384 -0.825 . . . . 74.420000000000002 108.897 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -112.55 144.82 41.38 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 114.598 1.333 . . . . 74.129999999999995 114.598 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.06 140.64 49.72 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.22 -1.809 . . . . 72.349999999999994 106.137 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.2 t -111.3 124.76 68.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 109.067 -0.716 . . . . 72.209999999999994 109.067 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -91.46 116.03 28.52 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.614 -1.254 . . . . 70.099999999999994 107.614 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.8 tm? -128.61 132.46 48.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.931 -1.137 . . . . 63.310000000000002 107.931 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . . . -90.16 118.75 29.93 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.668 -0.813 . . . . 54.32 110.394 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 125.67 73.35 0.21 Allowed Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.763 -0.653 . . . . 34.219999999999999 112.328 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.61 162.85 40.89 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.979 2.453 . . . . 71.0 111.343 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.05 48.31 1.23 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.712 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.414 -2.239 0 CA-C-N 115.659 -0.701 . . . . 61.140000000000001 110.517 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 108.871 -0.789 . . . . 52.210000000000001 108.871 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.53 115.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 108.193 -1.04 . . . . 72.140000000000001 108.193 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -115.45 133.32 56.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.669 . . . . 74.420000000000002 109.192 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -86.78 94.41 9.53 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.02 -1.072 . . . . 62.409999999999997 110.392 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.28 -152.07 0.05 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.441 -1.254 . . . . 43.219999999999999 108.934 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.4 7.11 47.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.938 -0.476 . . . . 71.450000000000003 111.191 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.77 -50.46 72.23 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.095 1.517 . . . . 62.229999999999997 115.095 -171.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 26' ' ' MET . 7.3 tt -72.63 -39.15 67.44 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.473 0.654 . . . . 75.519999999999996 109.365 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -69.72 -32.77 71.51 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.717 -0.674 . . . . 53.329999999999998 110.314 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.51 -42.18 95.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.14 0.576 . . . . 62.329999999999998 110.151 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.01 -30.72 71.32 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 120.083 -0.647 . . . . 74.450000000000003 111.163 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.0 -49.4 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 74.120000000000005 109.785 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -69.84 -27.03 64.51 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.315 -0.857 . . . . 53.130000000000003 112.608 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.442 ' OG ' ' HD2' ' A' ' 114' ' ' ARG . 31.7 p -79.96 -16.75 54.59 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.145 0.497 . . . . 65.140000000000001 111.053 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -74.19 106.14 5.71 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 122.151 0.977 . . . . 74.540000000000006 111.095 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.78 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 104.927 -3.269 . . . . 72.439999999999998 104.927 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 m -115.5 121.39 42.55 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.729 -1.952 . . . . 64.219999999999999 105.729 168.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.37 115.46 65.47 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 106.588 -1.634 . . . . 63.310000000000002 106.588 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.84 140.03 93.4 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 121.982 1.788 . . . . 71.209999999999994 112.313 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.85 126.54 29.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.395 -0.82 . . . . 45.240000000000002 110.805 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 124' ' ' THR . 67.9 m -147.44 109.47 4.48 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.836 -1.172 . . . . 51.340000000000003 107.836 172.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -86.82 96.59 10.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 62.119999999999997 112.217 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.11 7.33 0.25 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.783 -0.644 . . . . 63.210000000000001 112.409 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.417 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -88.31 -21.17 24.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.754 0.787 . . . . 55.210000000000001 110.375 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -92.15 -6.73 50.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.711 -1.131 . . . . 71.230000000000004 109.122 178.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -100.04 -42.29 6.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.39 -1.277 . . . . 73.219999999999999 109.624 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 56.12 78.71 0.37 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.602 -0.726 . . . . 63.100000000000001 110.128 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.47 -55.5 0.91 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.131 1.888 . . . . 74.319999999999993 113.153 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.47 -7.38 26.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.932 -0.576 . . . . 73.239999999999995 111.854 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.06 -12.62 11.36 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.213 -0.449 . . . . 50.329999999999998 112.866 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m -124.68 153.42 42.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.762 -1.569 . . . . 54.43 106.762 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.28 41.13 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.905 0.128 . . . . 43.219999999999999 110.782 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.1 pp -127.6 157.01 41.36 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.803 0.668 . . . . 71.219999999999999 112.803 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 49' ' ' LEU . 3.4 pp -121.35 138.25 54.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.923 -1.14 . . . . 54.149999999999999 107.923 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.79 135.72 62.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 C-N-CA 120.534 -0.466 . . . . 71.030000000000001 109.906 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -80.81 117.09 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.774 -1.936 . . . . 63.039999999999999 105.774 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -90.21 -34.67 15.72 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.779 -0.646 . . . . 70.120000000000005 109.551 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -148.61 137.56 21.6 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.179 -0.674 . . . . 74.329999999999998 109.179 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.68 -177.86 23.8 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 108.907 -1.677 . . . . 44.310000000000002 108.907 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 72.1 Cg_exo -55.65 -51.18 10.41 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.935 2.423 . . . . 14.35 112.823 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -91.48 22.75 3.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.302 0.482 . . . . 55.509999999999998 112.302 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.85 143.07 48.71 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.087 0.47 . . . . 62.310000000000002 111.799 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.27 -23.27 32.33 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.301 -0.72 . . . . 55.329999999999998 111.301 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 134.19 34.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 120.93 0.395 . . . . 54.009999999999998 110.459 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -107.38 138.68 43.14 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.919 -1.141 . . . . 75.319999999999993 107.919 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.5 127.52 44.14 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.422 -0.584 . . . . 75.530000000000001 109.422 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 9.2 mp -93.62 137.78 32.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.39 -0.596 . . . . 74.420000000000002 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.95 103.34 13.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.013 -1.477 . . . . 62.310000000000002 107.013 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.99 -15.22 6.92 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.498 -0.774 . . . . 72.129999999999995 111.236 -175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.2 pt20 -107.32 142.47 25.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 109.648 -0.501 . . . . 74.450000000000003 109.648 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.6 -19.9 19.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.965 3.11 . . . . 72.530000000000001 113.865 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.3 m -147.18 121.66 9.72 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.814 -1.18 . . . . 71.219999999999999 107.814 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 77' ' ' ASP . 9.3 m -120.81 113.83 20.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.378 -1.341 . . . . 70.120000000000005 107.378 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.0 m -92.36 144.04 25.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.822 -0.549 . . . . 65.530000000000001 110.704 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.29 139.02 52.6 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 123.166 0.586 . . . . 62.530000000000001 109.497 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.63 -135.84 5.63 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.893 -1.283 . . . . 74.299999999999997 109.893 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 22.9 ptt85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.077 -1.083 . . . . 75.310000000000002 108.077 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER 144.77 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 127.635 2.374 . . . . 75.239999999999995 108.81 174.252 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.69 -15.25 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.763 1.642 . . . . 64.430000000000007 110.416 174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -78.81 -24.07 44.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.143 -0.935 . . . . 73.150000000000006 110.444 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 p -84.71 121.32 27.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.615 -0.883 . . . . 63.509999999999998 108.615 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 68' ' ' THR . 36.3 t70 -69.88 -35.8 74.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 110.677 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.4 98.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.25 -1.389 . . . . 71.120000000000005 107.25 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -92.93 115.11 27.82 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.904 -0.589 . . . . 74.109999999999999 109.632 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.6 mt -111.62 134.38 53.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.519 -1.289 . . . . 52.020000000000003 107.519 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.92 128.35 54.73 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.535 0.683 . . . . 73.200000000000003 110.413 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -148.43 -178.8 6.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.447 -2.057 . . . . 65.129999999999995 105.447 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.53 -24.84 8.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.982 -1.118 . . . . 55.149999999999999 107.982 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.2 m -137.36 90.3 2.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.968 0.89 . . . . 74.019999999999996 110.236 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -101.85 150.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.143 -1.058 . . . . 64.129999999999995 108.143 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 89' ' ' HIS . 54.2 m -92.45 146.45 23.67 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.419 -0.956 . . . . 75.150000000000006 108.419 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -17.56 53.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.725 0.774 . . . . 71.120000000000005 111.829 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -140.8 93.87 2.65 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.578 -2.379 . . . . 72.319999999999993 104.578 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 26.3 t-80 -91.96 -53.32 4.32 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.229 0.538 . . . . 71.340000000000003 111.269 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.16 155.92 37.62 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.797 -0.816 . . . . 74.430000000000007 108.797 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.24 135.1 44.76 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.894 -0.594 . . . . 70.010000000000005 109.56 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -104.92 117.22 33.47 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.534 -1.654 . . . . 74.019999999999996 106.534 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -103.67 130.78 51.2 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.588 -0.523 . . . . 64.140000000000001 109.588 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.9 mp -114.31 113.09 42.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.628 -1.619 . . . . 70.540000000000006 106.628 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -138.38 122.78 18.33 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.79 -0.448 . . . . 74.340000000000003 109.79 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 56.3 37.86 29.23 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.796 1.238 . . . . 64.329999999999998 112.891 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.45 13.68 82.34 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.223 -0.899 . . . . 45.229999999999997 113.32 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -116.04 142.38 46.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.579 -0.897 . . . . 64.120000000000005 108.579 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -115.51 117.97 31.85 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.078 -0.712 . . . . 70.400000000000006 109.078 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.03 145.22 48.35 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 111.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 37.0 t -103.51 124.71 57.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.06 -1.459 . . . . 73.329999999999998 107.06 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.95 122.86 70.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.157 -1.423 . . . . 60.310000000000002 107.157 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -104.51 134.54 47.52 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 111.787 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.8 0.5 3.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.6 -0.727 . . . . 62.229999999999997 110.297 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.32 58.9 0.4 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.124 -1.19 . . . . 44.420000000000002 110.124 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -70.33 -8.48 50.83 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.581 0.752 . . . . 72.319999999999993 112.017 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -24.05 58.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.969 0.414 . . . . 71.140000000000001 109.958 174.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -87.34 -17.93 31.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.771 -1.196 . . . . 75.549999999999997 107.771 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.62 56.06 6.27 Favored Glycine 0 CA--C 1.496 -1.128 0 CA-C-N 114.718 -1.128 . . . . 45.450000000000003 113.329 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -63.41 128.71 37.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.853 -0.425 . . . . 74.319999999999993 109.853 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 20.5 m-30 -124.28 139.89 53.48 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 110.03 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.26 121.71 66.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.32 -1.733 . . . . 61.149999999999999 106.32 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.19 39.15 31.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.037 1.335 . . . . 41.210000000000001 108.24 -169.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.442 ' HD2' ' OG ' ' A' ' 29' ' ' SER . 19.0 mtm105 62.62 20.3 11.92 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.055 -1.429 . . . . 70.019999999999996 111.519 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -111.81 136.13 21.17 Favored Pre-proline 0 C--N 1.315 -0.931 0 C-N-CA 122.875 0.47 . . . . 73.230000000000004 110.043 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.17 123.72 13.74 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.663 2.242 . . . . 72.239999999999995 108.664 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.537 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 8.9 tpp180 -143.23 142.44 31.4 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 119.167 -1.013 . . . . 73.519999999999996 112.549 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -79.05 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.614 0.766 . . . . 75.25 109.916 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -151.39 136.48 17.45 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.624 -1.25 . . . . 71.230000000000004 107.624 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.537 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 52.4 tp60 -153.22 141.68 20.74 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.023 0.202 . . . . 61.340000000000003 111.208 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 58.4 t -66.23 133.03 31.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 106.522 -1.658 . . . . 64.239999999999995 106.522 170.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -87.42 144.65 26.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.205 -1.035 . . . . 71.219999999999999 108.205 -174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.456 ' HG2' ' HB3' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -126.77 152.47 46.85 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 113.212 0.819 . . . . 70.319999999999993 113.212 -170.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 36' ' ' SER . 0.7 OUTLIER -59.46 118.15 5.69 Favored 'General case' 0 N--CA 1.403 -2.815 0 C-N-CA 124.758 1.223 . . . . 51.310000000000002 112.563 -176.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.87 -7.03 64.8 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.802 -0.713 . . . . 73.120000000000005 112.62 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -83.09 153.09 25.04 Favored 'General case' 0 C--O 1.252 1.193 0 C-N-CA 120.132 -0.627 . . . . 63.310000000000002 110.678 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.51 131.48 55.2 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.073 -0.967 . . . . 61.409999999999997 110.285 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.2 mt -105.76 115.93 48.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 104.868 -2.271 . . . . 53.43 104.868 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -104.95 131.67 52.16 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.567 -1.272 . . . . 74.409999999999997 107.567 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.408 HD13 HD13 ' A' ' 135' ' ' LEU . 4.0 mp -129.61 103.61 9.15 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 107.858 -1.164 . . . . 74.140000000000001 107.858 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.57 -78.6 0.01 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.095 0.798 . . . . 41.420000000000002 115.095 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -134.05 8.96 3.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.788 1.235 . . . . 74.530000000000001 109.981 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.603 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 49.2 m-85 -102.1 143.19 32.25 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.463 -0.569 . . . . 75.420000000000002 109.463 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -119.55 118.65 31.6 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.158 -1.423 . . . . 65.340000000000003 107.158 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 130' ' ' ILE . 9.7 mp -119.16 135.31 54.73 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.992 -0.744 . . . . 63.32 108.992 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.15 130.85 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.01 -1.107 . . . . 70.340000000000003 108.01 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -95.68 124.87 39.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.828 0.347 . . . . 53.539999999999999 110.823 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -129.71 132.34 46.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.311 0.577 . . . . 73.510000000000005 110.531 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.66 118.24 33.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.063 -1.828 . . . . 31.41 106.063 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.7 0.03 OUTLIER Glycine 0 C--N 1.296 -1.664 0 C-N-CA 118.252 -1.927 . . . . 44.329999999999998 115.428 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.76 141.55 97.06 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 119.977 1.888 . . . . 75.150000000000006 111.179 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.27 79.18 1.68 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.321 -0.992 . . . . 72.409999999999997 108.321 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.389 -3.481 0 CA-C-N 114.627 -1.17 . . . . 72.0 108.862 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 108.581 -0.896 . . . . 64.049999999999997 108.581 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.83 115.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.592 -0.522 . . . . 70.140000000000001 109.592 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -122.33 137.95 54.68 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.343 -0.614 . . . . 73.140000000000001 109.343 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.09 97.37 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.368 -1.345 . . . . 75.040000000000006 107.368 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.57 -165.84 0.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.312 -0.858 . . . . 63.039999999999999 112.821 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.09 9.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.49 2.316 . . . . 73.329999999999998 114.3 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 2.9 pp -56.37 -20.45 19.37 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.06 1.133 . . . . 73.230000000000004 114.06 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.84 -43.87 82.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.722 -0.473 . . . . 71.329999999999998 109.722 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 27' ' ' GLU . 66.0 mttm -82.51 -21.16 35.58 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.4 -0.363 . . . . 64.219999999999999 111.621 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 5.6 tp10 -56.81 -48.73 77.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.377 -1.342 . . . . 74.420000000000002 107.377 170.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.4 ttp -68.76 -47.89 65.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.555 -1.202 . . . . 65.329999999999998 110.482 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 24' ' ' LYS . 31.2 tt0 -52.53 -49.79 64.14 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.455 1.102 . . . . 41.119999999999997 111.987 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 t -84.47 -27.82 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.719 0.637 . . . . 75.430000000000007 112.719 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -82.93 -22.29 33.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.434 -0.906 . . . . 54.43 110.949 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.5 m -72.03 111.46 7.28 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.093 -0.706 . . . . 61.020000000000003 109.093 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.1 -32.89 1.26 Allowed Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 109.56 -1.416 . . . . 73.230000000000004 109.56 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -94.51 120.52 34.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 73.329999999999998 108.705 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.9 111.94 20.34 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.828 -0.804 . . . . 64.530000000000001 108.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.66 141.48 66.58 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 121.949 1.766 . . . . 51.119999999999997 113.118 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.25 162.67 31.17 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.032 -0.985 . . . . 72.25 108.607 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.2 m 61.76 20.02 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.095 0.958 . . . . 43.009999999999998 112.141 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.8 m -90.85 109.94 21.15 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.657 -1.238 . . . . 61.32 107.657 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.19 53.99 0.6 Allowed Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.051 -1.071 . . . . 52.450000000000003 113.364 -172.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 -6.94 53.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.209 1.004 . . . . 64.450000000000003 109.419 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.45 14.11 0.83 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.583 -1.19 . . . . 70.329999999999998 113.261 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.71 -5.9 23.26 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.838 -0.43 . . . . 73.109999999999999 109.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 68.38 94.82 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.606 0 O-C-N 124.691 1.244 . . . . 71.129999999999995 111.245 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.21 -74.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.672 1.582 . . . . 64.329999999999998 112.519 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.71 6.69 46.8 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.844 -0.535 . . . . 53.240000000000002 111.593 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.01 17.76 75.83 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 116.048 -0.524 . . . . 62.210000000000001 113.293 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -131.99 169.74 15.89 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.753 -1.203 . . . . 61.43 107.753 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.49 154.45 48.81 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.16 -0.616 . . . . 65.530000000000001 111.034 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.42 161.3 36.7 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 114.954 -1.021 . . . . 63.210000000000001 109.288 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.476 HD11 HG21 ' A' ' 78' ' ' ILE . 4.2 pp -127.3 139.62 52.76 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.454 -0.573 . . . . 63.0 109.454 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.8 133.65 65.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.715 -0.846 . . . . 64.340000000000003 108.715 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.55 117.12 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.003 -1.851 . . . . 64.150000000000006 106.003 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -99.86 -31.0 11.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.904 -0.589 . . . . 64.200000000000003 110.745 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -137.43 132.0 32.78 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.96 -0.696 . . . . 71.040000000000006 109.323 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.43 175.11 13.94 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.594 -1.002 . . . . 64.549999999999997 110.594 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.539 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 19.2 Cg_endo -59.82 -39.62 70.77 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.68 2.253 . . . . 71.450000000000003 112.535 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -95.29 22.22 7.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.123 -0.49 . . . . 72.409999999999997 112.087 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.77 57.53 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.037 0.535 . . . . 63.340000000000003 110.889 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.31 -18.32 36.02 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.242 -1.143 . . . . 43.049999999999997 110.242 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.66 131.95 35.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.507 -0.347 . . . . 75.450000000000003 110.281 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -125.74 136.77 53.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.99 -0.744 . . . . 73.299999999999997 108.99 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -131.14 141.14 50.07 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.074 -0.713 . . . . 70.120000000000005 109.074 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -101.95 143.92 31.22 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.446 -0.576 . . . . 71.400000000000006 109.446 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.0 mt -97.4 118.72 34.51 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.971 0.415 . . . . 62.0 111.637 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.3 2.77 7.79 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -110.32 148.94 39.42 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-N 115.007 -0.997 . . . . 61.32 110.361 -174.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 -15.86 27.6 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.981 2.454 . . . . 64.310000000000002 113.446 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 91.8 m -152.84 124.29 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 121.753 -0.592 . . . . 71.540000000000006 110.853 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 77' ' ' ASP . 25.9 m -121.41 113.98 20.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.733 -0.84 . . . . 74.349999999999994 108.733 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 88.0 m -88.51 137.77 32.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.983 -0.377 . . . . 50.310000000000002 109.983 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.04 134.89 54.55 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-O 121.415 0.626 . . . . 75.409999999999997 110.349 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.99 -135.87 6.29 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.252 -1.34 . . . . 52.520000000000003 110.019 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -117.74 124.54 48.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.977 -0.749 . . . . 63.100000000000001 108.977 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.1 151.39 0.11 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 107.801 -1.185 . . . . 74.310000000000002 107.801 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.73 -32.11 47.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.861 1.708 . . . . 55.340000000000003 111.496 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.07 -5.9 59.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.065 0.394 . . . . 74.329999999999998 112.065 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.7 m -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.119 -1.067 . . . . 62.119999999999997 108.119 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 68' ' ' THR . 10.9 t70 -54.4 -43.01 71.11 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 124.33 1.019 . . . . 61.549999999999997 110.58 -175.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.476 HG21 HD11 ' A' ' 49' ' ' LEU . 29.2 pt -106.96 107.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.992 0.901 . . . . 74.030000000000001 110.388 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -95.12 128.77 42.21 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.956 -1.02 . . . . 71.239999999999995 110.009 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.3 mt -111.44 135.43 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.847 -1.909 . . . . 75.329999999999998 105.847 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.69 137.11 52.4 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.001 -0.679 . . . . 72.200000000000003 112.472 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 83' ' ' VAL . 30.2 t70 -160.69 -162.19 0.92 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.158 -1.423 . . . . 74.25 107.158 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.515 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 48.2 t -68.54 -42.88 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 108.906 -0.775 . . . . 62.310000000000002 108.906 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.2 m -156.14 101.09 2.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.776 -0.647 . . . . 73.209999999999994 109.852 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 t -102.9 149.69 7.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 106.589 -1.634 . . . . 73.319999999999993 106.589 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.0 t -68.87 143.49 54.5 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 123.376 0.423 . . . . 52.210000000000001 111.725 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.1 ptt180 -55.86 -28.4 56.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.701 1.2 . . . . 71.430000000000007 110.389 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.95 104.72 2.86 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.805 -1.089 . . . . 74.409999999999997 109.212 169.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -86.86 -51.63 5.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.835 -1.543 . . . . 64.129999999999995 106.835 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.97 159.23 41.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.659 -1.237 . . . . 63.109999999999999 107.659 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 11.6 pt-20 -142.13 154.37 44.83 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.327 0.584 . . . . 71.409999999999997 112.186 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 67' ' ' THR . 4.8 m-85 -104.29 127.83 51.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.204 -1.406 . . . . 44.350000000000001 107.204 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -121.06 125.1 46.43 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.943 -0.762 . . . . 74.430000000000007 108.943 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.63 111.59 36.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.539 -1.652 . . . . 72.239999999999995 106.539 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -139.81 129.45 24.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.135 -0.484 . . . . 72.420000000000002 110.481 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.72 36.44 27.25 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.722 1.209 . . . . 63.109999999999999 111.888 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.82 -0.76 87.93 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 113.197 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -101.27 136.72 40.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.182 -0.673 . . . . 74.340000000000003 109.182 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.87 118.04 34.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.222 -1.029 . . . . 72.129999999999995 108.222 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -127.5 146.94 50.33 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.156 -0.617 . . . . 73.439999999999998 109.938 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.57 123.72 68.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.783 -1.192 . . . . 72.409999999999997 107.783 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.7 134.77 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.728 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.83 132.79 38.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.968 -1.864 . . . . 74.420000000000002 105.968 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.96 18.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 112.341 0.496 . . . . 54.509999999999998 112.341 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.79 42.16 0.29 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.376 -1.392 . . . . 54.020000000000003 113.344 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.8 p -87.49 143.63 27.12 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.983 -1.087 . . . . 74.049999999999997 108.365 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.94 -19.77 17.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.299 0.571 . . . . 52.329999999999998 109.475 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -87.31 -19.66 27.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.274 -0.875 . . . . 50.030000000000001 111.207 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.7 120.19 4.41 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.313 -0.946 . . . . 74.129999999999995 114.163 174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.3 m -88.04 132.04 34.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.409 -0.589 . . . . 70.510000000000005 109.409 173.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -119.8 126.42 50.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.919 -0.488 . . . . 64.329999999999998 110.004 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.3 t -111.57 117.17 54.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 106.932 -1.507 . . . . 75.540000000000006 106.932 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 55.08 37.96 29.73 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 125.452 1.501 . . . . 44.340000000000003 110.003 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 67.53 16.08 9.88 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 113.776 -1.556 . . . . 72.230000000000004 112.475 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -103.76 138.48 19.54 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 107.465 -1.309 . . . . 74.230000000000004 107.465 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.49 124.36 14.94 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.097 1.864 . . . . 75.310000000000002 109.034 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -148.17 141.89 25.62 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.915 -0.714 . . . . 74.219999999999999 110.439 -172.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.19 -58.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.129 -1.063 . . . . 75.420000000000002 108.129 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.11 139.19 42.77 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.966 -0.458 . . . . 73.340000000000003 109.784 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.92 143.79 22.91 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.073 -0.714 . . . . 74.299999999999997 109.073 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.72 131.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 107.119 -1.438 . . . . 55.299999999999997 107.119 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.4 mmt -88.97 148.49 23.76 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.889 0.852 . . . . 72.409999999999997 112.671 -170.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 126' ' ' ASP . 18.9 pt20 -119.55 157.07 29.12 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.885 -1.895 . . . . 73.549999999999997 105.885 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 133.55 54.86 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.425 -0.954 . . . . 64.519999999999996 108.425 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.93 0.49 56.22 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.589 -0.815 . . . . 64.120000000000005 112.743 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.438 ' OD2' ' HG2' ' A' ' 123' ' ' GLN . 34.0 m-20 -76.12 141.06 42.05 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.638 0.719 . . . . 74.209999999999994 111.636 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.8 127.79 55.91 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.019 -1.104 . . . . 64.230000000000004 108.019 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.9 mt -107.42 119.54 57.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.091 -1.448 . . . . 73.439999999999998 107.091 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 11.5 tm0? -106.37 117.39 33.91 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.95 -1.5 . . . . 71.540000000000006 106.95 -174.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.02 101.65 12.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.862 -1.162 . . . . 73.239999999999995 107.862 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.14 -73.52 0.13 Allowed Glycine 0 CA--C 1.536 1.405 0 CA-C-O 121.361 0.423 . . . . 63.43 113.615 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -145.44 16.53 1.49 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.452 1.101 . . . . 64.239999999999995 109.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.539 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 72.4 m-85 -109.38 148.59 30.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.145 -0.934 . . . . 74.409999999999997 109.494 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -128.53 119.78 25.48 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.168 -0.679 . . . . 54.030000000000001 109.168 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.0 mt -106.45 132.72 52.15 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.452 -1.685 . . . . 60.009999999999998 106.452 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.73 120.15 61.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.054 -1.091 . . . . 64.430000000000007 108.054 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -96.43 121.58 38.39 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.67 -0.863 . . . . 75.099999999999994 108.67 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.63 136.8 49.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.809 0.337 . . . . 61.240000000000002 110.296 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.16 119.38 29.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 105.382 -2.081 . . . . 53.450000000000003 105.382 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.26 -132.83 1.87 Allowed Glycine 0 N--CA 1.42 -2.431 0 C-N-CA 119.088 -1.53 . . . . 75.400000000000006 113.342 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.47 162.13 43.52 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.757 2.971 . . . . 64.099999999999994 114.235 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.39 69.79 1.41 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.792 -1.558 . . . . 65.430000000000007 106.792 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 . . . . . 0 N--CA 1.42 -1.974 0 CA-C-N 114.758 -1.11 . . . . 74.430000000000007 111.162 -175.231 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 105.785 -1.931 . . . . 63.329999999999998 105.785 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -89.89 112.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 107.452 -1.314 . . . . 54.119999999999997 107.452 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -125.53 141.35 52.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.616 -0.72 . . . . 74.150000000000006 109.349 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -81.5 112.85 19.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.068 -1.456 . . . . 72.019999999999996 107.068 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . -64.4 -168.44 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 115.317 1.599 . . . . 72.329999999999998 115.317 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.41 2.89 2.02 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.417 1.887 . . . . 70.109999999999999 111.536 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 3.9 pp -57.28 -21.14 32.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.476 1.51 . . . . 61.340000000000003 112.915 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.84 -34.54 78.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.349 0.26 . . . . 73.439999999999998 110.975 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.39 -40.31 8.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.112 -0.699 . . . . 74.109999999999999 109.112 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 13.1 tp10 -65.7 -24.94 67.1 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 114.34 -1.3 . . . . 74.310000000000002 114.016 -172.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.21 -50.36 69.61 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.873 0.761 . . . . 54.140000000000001 112.074 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.6 -31.92 69.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.125 0.488 . . . . 64.519999999999996 110.807 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -71.97 -26.37 62.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.656 -0.702 . . . . 74.049999999999997 110.751 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.52 -40.57 12.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.104 -0.498 . . . . 62.43 110.577 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.4 m -75.42 85.21 2.54 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.679 0.752 . . . . 61.200000000000003 112.402 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.57 26.17 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.132 -0.94 . . . . 53.299999999999997 111.194 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -83.9 123.9 30.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 123.378 0.671 . . . . 73.340000000000003 109.818 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.93 124.18 81.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 106.21 -1.774 . . . . 72.299999999999997 106.21 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.74 141.76 91.95 Favored 'Trans proline' 0 C--O 1.251 1.134 0 C-N-CA 121.939 1.759 . . . . 70.540000000000006 111.909 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.06 141.44 48.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.093 -0.958 . . . . 51.140000000000001 109.463 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.3 t -141.14 112.1 7.19 Favored 'General case' 0 N--CA 1.407 -2.61 0 CA-C-O 121.55 0.691 . . . . 73.420000000000002 109.962 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.09 36.41 0.98 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.687 -1.597 . . . . 73.450000000000003 106.687 174.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . 86.7 25.63 34.75 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.309 -2.316 . . . . 73.329999999999998 107.309 -169.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 139' ' ' ALA . . . -72.29 -47.6 48.76 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.715 -1.243 . . . . 65.319999999999993 113.618 -168.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -80.92 -2.35 47.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.614 0.721 . . . . 74.030000000000001 111.453 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.45 -25.39 20.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.868 -1.06 . . . . 74.450000000000003 108.626 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 57.37 85.49 0.19 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 114.732 -1.122 . . . . 71.400000000000006 111.284 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 45.3 Cg_endo -83.1 -73.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.443 2.095 . . . . 74.200000000000003 114.11 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.11 65.3 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.705 0.632 . . . . 63.240000000000002 112.705 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -11.85 71.02 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 111.083 -0.807 . . . . 63.109999999999999 111.083 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.3 m -114.7 169.84 8.77 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.939 -1.504 . . . . 64.400000000000006 106.939 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -149.61 157.58 43.38 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.974 -0.38 . . . . 51.240000000000002 109.974 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.404 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.19 137.65 54.51 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.366 0.603 . . . . 62.340000000000003 110.324 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.3 pp -111.11 137.02 49.3 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 109.125 -0.694 . . . . 74.230000000000004 109.125 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.8 135.62 50.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 109.613 -0.514 . . . . 64.540000000000006 109.613 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 16.1 t -80.83 118.15 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.7 -1.222 . . . . 71.109999999999999 107.7 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -88.79 -35.95 16.35 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.182 -0.673 . . . . 73.109999999999999 109.182 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HD2' ' OE1' ' A' ' 25' ' ' GLU . 39.7 ttm180 -148.1 141.93 25.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.299 -0.864 . . . . 72.530000000000001 109.282 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.79 174.78 13.57 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.397 -1.081 . . . . 64.349999999999994 110.397 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.537 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.8 Cg_exo -54.65 -44.68 47.26 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.602 2.201 . . . . 73.25 113.52 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.477 HD21 HD23 ' A' ' 80' ' ' LEU . 33.6 p30 -92.64 22.37 4.77 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.081 -1.012 . . . . 70.109999999999999 113.268 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -54.51 140.5 34.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.812 0.445 . . . . 54.119999999999997 112.036 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.37 -16.27 55.36 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.545 -0.622 . . . . 53.039999999999999 111.545 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.33 142.34 27.82 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.086 -0.246 . . . . 73.340000000000003 110.49 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -112.83 135.14 53.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.481 -0.933 . . . . 75.340000000000003 108.481 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.36 133.09 56.17 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.783 -0.451 . . . . 72.230000000000004 109.783 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.95 124.71 47.07 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.892 -0.594 . . . . 73.219999999999999 110.107 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.91 105.24 14.64 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.361 -1.348 . . . . 61.119999999999997 107.361 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -122.35 18.22 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.983 0.897 . . . . 73.319999999999993 109.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -133.17 157.67 77.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 61.130000000000003 109.516 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.59 -26.51 75.9 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.047 2.498 . . . . 62.229999999999997 114.079 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.6 m -147.55 121.8 9.58 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.329 -0.857 . . . . 75.540000000000006 111.182 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 77' ' ' ASP . 56.0 m -109.87 135.32 50.94 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.862 -0.608 . . . . 50.439999999999998 109.943 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -106.39 141.52 37.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.69 135.28 54.56 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 109.781 -0.451 . . . . 74.5 109.781 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.89 -164.19 25.52 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.792 -1.323 . . . . 70.109999999999999 109.792 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 86.1 mtt180 -101.43 117.8 35.68 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.123 -1.066 . . . . 73.109999999999999 108.123 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 176.88 153.8 0.4 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.854 -1.906 . . . . 74.409999999999997 105.854 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.07 -15.76 51.1 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.924 1.749 . . . . 74.200000000000003 113.178 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.44 -1.28 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.607 0.595 . . . . 75.219999999999999 112.607 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -85.07 112.52 20.72 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.11 -1.036 . . . . 71.230000000000004 111.154 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.453 ' HB3' HG23 ' A' ' 68' ' ' THR . 37.9 t70 -70.19 -36.95 74.98 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.133 -0.692 . . . . 70.420000000000002 109.133 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -100.66 98.73 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 122.253 1.025 . . . . 61.43 108.449 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -90.06 122.06 32.7 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.949 -1.023 . . . . 74.099999999999994 108.63 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.477 HD23 HD21 ' A' ' 56' ' ' ASN . 59.6 mt -123.87 122.18 37.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.154 -2.165 . . . . 71.319999999999993 105.154 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -130.67 117.53 19.61 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.198 -0.668 . . . . 60.130000000000003 109.198 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.0 p30 -128.78 -155.91 0.73 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.426 -0.953 . . . . 73.0 108.426 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.9 -41.74 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.24 0.616 . . . . 62.530000000000001 111.377 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -153.99 89.44 1.3 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.617 -0.677 . . . . 72.530000000000001 111.735 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 82' ' ' ASP . 85.4 t -103.54 136.29 37.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.983 -0.747 . . . . 62.439999999999998 108.983 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.526 ' HB2' HD21 ' A' ' 107' ' ' LEU . 41.2 t -71.33 161.99 30.17 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 123.843 0.715 . . . . 72.420000000000002 111.186 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 27.9 ptt180 -65.4 -38.16 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 122.127 0.965 . . . . 74.420000000000002 109.374 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -136.14 112.96 10.23 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.491 -1.3 . . . . 52.509999999999998 107.491 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t-80 -99.62 -52.93 3.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.851 -0.613 . . . . 51.420000000000002 109.847 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.69 160.44 37.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.266 -0.574 . . . . 43.340000000000003 110.537 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.0 133.97 53.56 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.307 -0.861 . . . . 72.140000000000001 110.628 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -105.69 115.54 30.42 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.417 -1.698 . . . . 61.100000000000001 106.417 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -112.65 133.92 54.44 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.032 -0.667 . . . . 70.319999999999993 110.884 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.6 mp -104.48 121.13 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.022 -1.103 . . . . 74.409999999999997 108.022 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -123.84 116.64 23.29 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.29 -1.374 . . . . 71.319999999999993 107.29 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.98 37.83 14.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.777 0.831 . . . . 71.319999999999993 112.884 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.51 -2.49 87.38 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.097 -0.501 . . . . 44.439999999999998 114.172 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.81 138.9 39.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.729 0.765 . . . . 74.420000000000002 109.148 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD2' HG13 ' A' ' 94' ' ' ILE . 31.5 m-85 -108.52 122.77 47.76 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.61 -0.268 . . . . 72.319999999999993 111.246 -172.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -114.75 139.01 50.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.667 -0.864 . . . . 55.549999999999997 108.667 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.413 HG23 ' HB2' ' A' ' 122' ' ' MET . 43.4 t -109.32 123.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.991 -1.115 . . . . 74.140000000000001 107.991 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.72 121.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.169 -1.419 . . . . 60.439999999999998 107.169 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.52 153.94 18.26 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.783 -1.191 . . . . 51.5 107.783 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 89' ' ' HIS . 18.7 m -78.79 -12.31 13.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 113.379 0.881 . . . . 65.019999999999996 113.379 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.23 17.58 0.02 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 119.086 -1.53 . . . . 54.43 116.019 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p 57.97 26.92 14.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.664 1.586 . . . . 73.450000000000003 111.496 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 86' ' ' SER . 0.0 OUTLIER -65.26 -35.31 80.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.961 -1.472 . . . . 64.439999999999998 112.926 -174.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.635 ' HB2' ' CD2' ' A' ' 89' ' ' HIS . 2.6 m120 -86.76 3.77 43.63 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 110.374 -0.232 . . . . 73.019999999999996 110.374 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.66 49.17 6.26 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.933 -1.267 . . . . 75.0 109.933 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -61.54 129.86 43.14 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 123.496 0.718 . . . . 51.219999999999999 110.977 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.406 ' CB ' ' HB3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -125.2 125.64 43.97 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.326 -1.731 . . . . 73.439999999999998 106.326 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.14 124.77 61.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 106.694 -1.595 . . . . 65.400000000000006 106.694 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.435 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 4.3 t-20 57.81 37.64 27.1 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.543 1.163 . . . . 65.310000000000002 107.884 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.15 18.62 6.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.976 -1.466 . . . . 63.350000000000001 114.23 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -125.04 147.47 57.02 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.407 -0.96 . . . . 74.329999999999998 108.407 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.57 129.43 17.78 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 N-CA-C 108.528 -1.374 . . . . 73.400000000000006 108.528 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.563 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 13.0 tpp180 -148.38 150.19 33.11 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.636 -0.826 . . . . 64.329999999999998 110.143 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -93.81 -55.46 3.23 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.558 -0.534 . . . . 60.439999999999998 109.558 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.68 34.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.808 -0.812 . . . . 61.049999999999997 108.808 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.563 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 58.1 tp60 -153.85 143.19 21.5 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 123.145 0.278 . . . . 52.229999999999997 110.71 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.95 128.11 37.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.573 -1.64 . . . . 71.329999999999998 106.573 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.413 ' HB2' HG23 ' A' ' 101' ' ' VAL . 39.4 ttp -90.26 134.88 34.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.402 0.62 . . . . 75.299999999999997 111.357 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.411 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 12.7 pt20 -104.07 152.19 22.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.23 -0.895 . . . . 72.5 110.67 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.25 130.71 41.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 C-N-CA 123.646 0.778 . . . . 54.140000000000001 111.979 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -0.44 63.0 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.099 -0.8 . . . . 73.540000000000006 111.099 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 28.3 t70 -89.44 153.65 20.66 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.45 -0.375 . . . . 74.340000000000003 111.565 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -115.92 131.19 57.01 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 121.525 0.679 . . . . 73.409999999999997 112.611 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.09 131.76 61.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 107.659 -1.237 . . . . 71.049999999999997 107.659 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 111' ' ' TYR . 16.5 tm0? -109.97 130.74 55.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.727 -1.212 . . . . 62.130000000000003 107.727 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 89' ' ' HIS . 4.1 mp -130.09 104.03 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.644 -0.873 . . . . 64.439999999999998 108.644 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.55 -96.45 0.18 Allowed Glycine 0 C--O 1.243 0.699 0 C-N-CA 121.052 -0.594 . . . . 73.409999999999997 112.565 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -113.43 -0.55 14.43 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.002 0.43 . . . . 73.409999999999997 110.219 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.537 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 87.1 m-85 -100.19 152.85 19.8 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.291 0.636 . . . . 64.140000000000001 111.479 -175.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -137.09 120.2 16.64 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.995 -1.113 . . . . 74.109999999999999 107.995 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.427 ' CD2' HG22 ' A' ' 51' ' ' VAL . 65.2 mt -105.25 140.39 38.47 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.468 0.707 . . . . 63.299999999999997 109.442 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.33 120.02 61.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.265 -1.754 . . . . 74.129999999999995 106.265 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -97.74 119.63 36.67 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 112.128 0.418 . . . . 65.239999999999995 112.128 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.422 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 95.5 mt -129.34 153.91 47.4 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.853 -0.795 . . . . 61.299999999999997 108.853 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 39' ' ' ALA . . . -75.95 162.01 28.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.869 -0.332 . . . . 55.119999999999997 110.927 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.2 168.23 41.88 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.417 -0.81 . . . . 51.229999999999997 112.108 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.522 ' HB2' ' HG2' ' A' ' 143' ' ' GLU . 12.0 Cg_endo -54.72 145.29 61.0 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 123.768 2.979 . . . . 74.530000000000001 115.455 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 43.39 1.07 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.546 -1.207 . . . . 74.549999999999997 110.384 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 141' ' ' PRO . 2.9 pt-20 . . . . . 0 N--CA 1.413 -2.307 0 C-N-CA 123.651 0.78 . . . . 75.549999999999997 109.385 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.653 -0.499 . . . . 53.229999999999997 109.653 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.482 HG22 HD12 ' A' ' 107' ' ' LEU . 57.0 t -83.24 116.57 27.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.544 -0.539 . . . . 64.349999999999994 109.544 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -123.87 140.12 53.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.73 -0.47 . . . . 72.510000000000005 109.73 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttp85 -96.21 108.53 21.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.114 -1.069 . . . . 63.229999999999997 108.114 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 -173.84 3.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.574 -0.739 . . . . 60.130000000000003 110.989 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -72.91 6.83 2.34 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.701 0.8 . . . . 64.310000000000002 111.497 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.25 -26.21 60.39 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.222 1.409 . . . . 53.310000000000002 113.942 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.4 tp -72.28 -22.52 61.2 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.87 0.843 . . . . 74.530000000000001 109.616 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.16 -32.53 12.44 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.595 -0.73 . . . . 72.420000000000002 109.572 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -56.93 -38.97 73.64 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.119 -0.492 . . . . 73.120000000000005 111.086 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 ptp -62.4 -25.94 68.21 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 120.792 -0.363 . . . . 71.420000000000002 111.558 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -87.53 -49.65 7.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.948 0.404 . . . . 75.120000000000005 110.077 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -61.21 -41.98 97.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.793 -0.64 . . . . 53.43 111.145 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -82.92 -16.98 45.31 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.881 -0.414 . . . . 74.129999999999995 109.881 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m 67.29 101.75 0.05 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.773 1.229 . . . . 53.229999999999997 113.964 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.58 -141.38 48.02 Favored Glycine 0 CA--C 1.499 -0.963 0 CA-C-N 115.485 -0.779 . . . . 33.039999999999999 112.69 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t -115.77 149.39 38.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.608 -0.516 . . . . 75.0 109.608 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 110.97 40.6 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.323 -0.992 . . . . 43.020000000000003 108.323 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.78 145.2 90.56 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.859 2.373 . . . . 70.420000000000002 113.616 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.23 162.45 13.19 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.904 -0.589 . . . . 70.450000000000003 110.102 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 123' ' ' GLN . 18.3 m -94.26 116.0 28.33 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.168 0.509 . . . . 63.109999999999999 110.551 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.2 m -69.38 100.04 1.3 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.551 -0.75 . . . . 73.120000000000005 109.403 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' OD1' ' A' ' 41' ' ' ASN . . . -152.31 43.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.273 -0.965 . . . . 55.119999999999997 112.993 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.47 -39.83 13.92 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.622 -1.251 . . . . 74.319999999999993 107.622 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.46 -1.81 25.83 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.328 -1.306 . . . . 65.109999999999999 111.387 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.443 ' OD1' ' HA2' ' A' ' 38' ' ' GLY . 11.0 m120 -82.8 -30.55 28.74 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.481 -0.782 . . . . 72.409999999999997 109.29 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt 48.06 81.33 0.26 Allowed Pre-proline 0 C--N 1.345 0.371 0 O-C-N 124.229 0.956 . . . . 42.200000000000003 112.049 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HB2' ' HA3' ' A' ' 140' ' ' GLY . 6.9 Cg_exo -68.79 -61.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 111.891 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.67 -12.97 5.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.956 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.83 1.46 85.06 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.087 -1.054 . . . . 64.329999999999998 111.176 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 6.8 m -115.02 156.56 24.9 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.23 -1.396 . . . . 61.32 107.23 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -148.11 154.53 40.31 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.708 -0.478 . . . . 71.530000000000001 109.708 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 152.37 44.5 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.92 -0.4 . . . . 54.039999999999999 109.92 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.01 132.46 52.01 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.46 -0.941 . . . . 70.530000000000001 108.46 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 p -108.82 137.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.644 -0.502 . . . . 74.129999999999995 109.644 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 135' ' ' LEU . 10.5 t -86.09 118.27 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 107.997 -1.112 . . . . 71.319999999999993 107.997 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 55.3 tttp -93.42 -31.71 14.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.356 -0.838 . . . . 64.299999999999997 109.953 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.419 ' HB3' ' HG2' ' A' ' 134' ' ' ARG . 19.5 tpp180 -147.11 138.5 24.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.988 -0.745 . . . . 71.329999999999998 108.988 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.06 171.05 12.93 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.155 -1.178 . . . . 71.219999999999999 110.155 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.67 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.1 Cg_exo -54.64 -29.99 63.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.598 2.199 . . . . 63.409999999999997 113.714 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.43 8.47 33.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.502 -0.479 . . . . 72.329999999999998 112.199 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.95 131.61 45.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.86 0.362 . . . . 62.539999999999999 111.515 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -23.94 24.44 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 115.588 -0.733 . . . . 52.509999999999998 112.295 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 152.54 20.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.754 0.277 . . . . 73.420000000000002 110.768 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.75 137.12 48.07 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.764 -0.828 . . . . 71.439999999999998 108.764 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -115.24 139.51 49.88 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.614 -0.513 . . . . 62.229999999999997 109.614 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.3 127.94 42.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.947 -1.131 . . . . 71.510000000000005 107.947 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.75 113.21 26.18 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.485 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.18 3.47 4.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.24 1.019 . . . . 74.230000000000004 108.582 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.4 pm0 -106.45 137.09 19.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-N 115.056 -0.975 . . . . 65.219999999999999 109.123 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.25 -21.58 67.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.309 2.673 . . . . 71.140000000000001 113.764 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -137.23 122.68 19.55 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.322 -0.622 . . . . 74.540000000000006 109.322 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.0 m -129.89 112.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.91 -0.774 . . . . 52.299999999999997 108.91 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 m -88.53 140.59 29.31 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.394 -0.595 . . . . 71.310000000000002 109.394 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.52 135.2 55.14 Favored 'General case' 0 C--O 1.268 2.039 0 N-CA-C 109.09 -0.707 . . . . 64.099999999999994 109.09 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -136.0 4.81 Favored Glycine 0 N--CA 1.422 -2.298 0 O-C-N 123.916 0.76 . . . . 71.120000000000005 112.833 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 24.8 mmm180 -118.67 152.94 35.17 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 125.486 1.514 . . . . 72.239999999999995 109.552 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.428 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 27.0 t-80 82.57 142.87 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 125.31 1.444 . . . . 74.319999999999993 109.209 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 9.8 Cg_endo -52.63 -6.77 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 124.14 3.227 . . . . 54.240000000000002 115.538 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.5 -12.89 59.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.353 0.597 . . . . 74.040000000000006 110.086 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -88.19 134.91 33.66 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.358 -0.979 . . . . 41.200000000000003 108.358 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -76.99 -42.2 39.8 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.169 -1.049 . . . . 74.120000000000005 108.169 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.7 mm -97.46 104.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 106.469 -1.678 . . . . 54.130000000000003 106.469 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -87.62 108.81 19.25 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.49 -0.777 . . . . 64.420000000000002 109.431 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 82.3 mt -95.7 141.05 29.65 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.742 -1.577 . . . . 73.530000000000001 106.742 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.591 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 18.3 t70 -103.94 117.46 34.36 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.152 -0.619 . . . . 75.120000000000005 110.499 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -151.22 174.98 12.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.643 -1.243 . . . . 73.409999999999997 107.643 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.48 -34.25 10.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.585 -0.894 . . . . 70.040000000000006 108.585 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.569 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 m -74.61 125.23 28.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.02 -0.991 . . . . 52.310000000000002 109.711 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.5 98.01 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 119.618 -0.833 . . . . 71.129999999999995 109.109 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 t -107.01 90.5 3.32 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.457 -1.312 . . . . 72.540000000000006 107.457 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -57.92 -31.9 67.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.544 -1.207 . . . . 74.409999999999997 111.384 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -145.12 93.43 2.39 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.411 -0.959 . . . . 71.439999999999998 108.411 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.496 ' CE1' HG23 ' A' ' 130' ' ' ILE . 39.7 t-80 -96.58 -53.58 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.704 -0.798 . . . . 73.519999999999996 109.691 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.32 160.62 38.71 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 109.194 -0.669 . . . . 63.119999999999997 109.194 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.02 143.94 36.67 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.331 0.586 . . . . 73.450000000000003 110.138 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -104.94 122.16 45.24 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.027 -2.212 . . . . 74.120000000000005 105.027 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -115.81 142.84 46.23 Favored 'General case' 0 C--N 1.273 -2.72 0 C-N-CA 119.618 -0.833 . . . . 73.340000000000003 109.256 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.7 mp -113.95 112.97 42.46 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 104.219 -2.511 . . . . 53.130000000000003 104.219 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.63 122.7 25.1 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.766 -0.457 . . . . 63.32 109.766 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 56.03 38.0 29.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.146 0.904 . . . . 72.540000000000006 111.571 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.91 -7.84 75.68 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.248 -0.887 . . . . 52.200000000000003 113.925 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -101.79 150.28 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.151 0.475 . . . . 65.25 109.844 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.29 126.4 53.31 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.774 -0.825 . . . . 73.140000000000001 108.774 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.9 147.84 52.59 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.647 0.26 . . . . 65.340000000000003 111.174 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 122' ' ' MET . 25.6 t -112.59 122.69 67.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.942 -1.503 . . . . 73.120000000000005 106.942 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.88 122.33 68.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.198 0.523 . . . . 61.219999999999999 111.147 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.9 136.93 32.75 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 123.787 0.835 . . . . 63.329999999999998 110.553 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.57 5.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.813 -0.63 . . . . 64.319999999999993 110.463 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.78 58.83 0.57 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.99 -0.624 . . . . 60.229999999999997 111.835 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -60.03 -11.65 6.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.783 1.233 . . . . 70.0 112.563 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 107' ' ' LEU . 1.2 mm? -67.4 -20.48 65.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.992 0.917 . . . . 74.420000000000002 110.847 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.66 -5.5 58.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 53.020000000000003 110.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.35 66.15 1.72 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.789 -0.641 . . . . 31.0 112.178 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 m -73.9 127.44 32.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.079 0.466 . . . . 53.32 110.844 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -136.62 141.42 43.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 109.827 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.17 119.57 58.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 106.905 -1.517 . . . . 71.140000000000001 106.905 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.457 ' OD1' ' HG2' ' A' ' 127' ' ' GLU . 87.7 m-20 56.58 39.38 29.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.792 0.837 . . . . 63.229999999999997 110.699 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 114' ' ' ARG . 0.0 OUTLIER 65.32 15.21 9.9 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 113.066 0.765 . . . . 72.530000000000001 113.066 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -112.43 133.99 21.68 Favored Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 123.062 0.545 . . . . 60.009999999999998 109.761 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.52 123.28 10.91 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 108.161 -1.515 . . . . 72.239999999999995 108.161 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -153.03 137.3 16.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.716 -1.216 . . . . 72.450000000000003 107.716 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -107.91 -56.53 2.22 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.114 -0.635 . . . . 53.119999999999997 110.657 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.7 132.72 54.38 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.127 -1.064 . . . . 72.400000000000006 108.127 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.61 150.55 26.52 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 112.682 0.623 . . . . 62.409999999999997 112.682 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.61 132.4 33.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 104.926 -2.25 . . . . 51.43 104.926 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 101' ' ' VAL . 33.1 ttp -88.97 129.12 35.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.107 -0.637 . . . . 62.530000000000001 109.938 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 36' ' ' SER . 61.9 mt-30 -118.34 156.56 28.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.738 -1.119 . . . . 63.439999999999998 109.133 -173.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -71.21 130.21 40.86 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.463 -0.94 . . . . 74.230000000000004 108.463 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.44 -4.1 56.68 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.788 -0.642 . . . . 44.43 113.057 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.27 137.33 54.63 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 117.952 0.876 . . . . 64.530000000000001 110.444 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 12.6 pt-20 -112.69 126.32 55.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.575 -1.269 . . . . 74.209999999999994 107.575 172.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.98 117.03 54.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.652 0 N-CA-C 107.878 -1.156 . . . . 74.310000000000002 107.878 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -105.33 123.87 48.58 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.553 0.692 . . . . 74.019999999999996 112.111 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.496 HG23 ' CE1' ' A' ' 89' ' ' HIS . 10.3 mm -109.87 101.95 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 105.53 -2.026 . . . . 63.539999999999999 105.53 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 56.34 -98.15 0.06 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 120.789 -0.72 . . . . 72.109999999999999 112.112 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -97.53 -24.0 15.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.808 0.443 . . . . 62.130000000000003 111.34 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.67 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 65.5 m-85 -75.31 148.47 39.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 122.769 0.428 . . . . 72.140000000000001 110.25 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 8.7 ptm180 -138.37 120.12 15.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.529 -0.915 . . . . 63.200000000000003 108.529 170.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.7 mm? -103.36 139.86 38.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.68 -0.859 . . . . 74.530000000000001 108.68 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.7 t -116.37 123.2 71.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.24 -1.022 . . . . 60.299999999999997 108.24 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.461 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 94.3 t80 -94.68 129.86 41.4 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.978 -0.555 . . . . 61.32 111.252 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.93 132.04 53.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.158 -1.053 . . . . 62.310000000000002 108.158 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.42 131.4 53.66 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.45 -0.5 . . . . 53.299999999999997 111.099 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 43' ' ' PRO . . . 97.66 46.29 2.33 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 117.506 1.762 . . . . 55.310000000000002 117.506 175.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 46' ' ' SER . 39.6 Cg_endo -72.18 155.67 56.26 Favored 'Trans proline' 0 C--N 1.363 1.336 0 CA-C-N 121.108 2.454 . . . . 43.439999999999998 109.718 169.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.69 83.59 0.96 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.253 0.549 . . . . 71.140000000000001 110.426 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.172 -1.418 . . . . 72.430000000000007 107.172 177.272 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 108' ' ' ASN . 16.2 m . . . . . 0 N--CA 1.429 -1.521 0 CA-C-O 121.136 0.493 . . . . 64.420000000000002 112.176 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.15 115.92 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 104.903 -2.258 . . . . 32.520000000000003 104.903 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -81.6 113.59 19.72 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.543 0.687 . . . . 72.530000000000001 110.802 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.92 120.63 42.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.664 -1.236 . . . . 74.120000000000005 107.664 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.49 -178.09 7.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.996 0.427 . . . . 65.0 110.009 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -83.97 -4.47 58.74 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.803 0.811 . . . . 63.0 109.862 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.34 -4.53 58.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.034 -0.985 . . . . 60.329999999999998 111.748 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.59 -33.39 68.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.111 -0.7 . . . . 71.450000000000003 109.111 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -71.81 -22.41 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.518 -0.765 . . . . 65.299999999999997 110.126 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.88 -30.85 40.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.419 -0.585 . . . . 72.150000000000006 109.419 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 30' ' ' THR . 32.7 ttm -66.95 -12.11 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.64 1.21 . . . . 71.019999999999996 108.915 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.73 -38.07 8.84 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.899 -1.046 . . . . 74.349999999999994 109.894 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -88.8 -46.38 9.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.905 1.076 . . . . 75.519999999999996 113.905 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -90.17 -20.26 23.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 119.478 -0.889 . . . . 74.349999999999994 112.006 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 115' ' ' GLU . 5.7 m -80.53 65.48 5.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.906 0.86 . . . . 64.200000000000003 109.669 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.92 5.4 2.23 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.135 -1.186 . . . . 54.43 110.135 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -110.66 121.96 46.61 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.134 -1.062 . . . . 40.240000000000002 108.134 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.16 120.96 83.98 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.979 -0.378 . . . . 55.149999999999999 109.979 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.43 150.88 87.39 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.702 2.268 . . . . 70.120000000000005 111.368 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.18 141.66 31.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.38 -0.6 . . . . 72.019999999999996 109.38 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.8 m -80.1 117.57 21.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.92 -0.4 . . . . 72.510000000000005 109.92 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.7 p -82.26 -49.85 9.63 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.903 -0.59 . . . . 72.019999999999996 110.186 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.49 114.58 2.32 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.401 -0.818 . . . . 55.509999999999998 111.894 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.85 -7.79 45.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 120.923 0.392 . . . . 62.039999999999999 110.315 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -5.3 21.11 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.678 1.362 . . . . 52.210000000000001 114.678 -168.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.03 -32.43 18.79 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.373 -0.531 . . . . 73.040000000000006 110.98 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 48.26 68.85 3.12 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 124.079 0.862 . . . . 61.119999999999997 111.069 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.44 -58.25 0.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 125.113 3.875 . . . . 74.109999999999999 114.556 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.31 17.15 4.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.329 -0.989 . . . . 54.219999999999999 108.329 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.77 -12.4 29.19 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 114.623 -1.171 . . . . 73.340000000000003 112.583 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -118.99 164.84 14.88 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.993 -0.373 . . . . 72.430000000000007 109.993 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.25 156.98 40.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.911 -1.515 . . . . 61.149999999999999 106.911 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.43 145.78 51.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.141 0.496 . . . . 73.409999999999997 111.746 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -106.32 142.68 35.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.491 -0.929 . . . . 62.32 108.491 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.66 132.24 71.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.434 -0.58 . . . . 61.229999999999997 109.434 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.56 118.3 22.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.244 -1.391 . . . . 71.230000000000004 107.244 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -89.79 -34.82 16.02 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.618 -0.719 . . . . 64.299999999999997 110.756 -174.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 43.1 ttt180 -137.96 150.95 47.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.275 -1.38 . . . . 74.120000000000005 107.275 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.96 -178.2 16.48 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.471 -0.871 . . . . 42.100000000000001 112.338 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.58 -29.08 13.6 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.889 2.393 . . . . 64.299999999999997 111.782 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -97.08 18.99 13.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.827 -0.624 . . . . 74.310000000000002 110.955 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.35 139.22 58.74 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.415 -0.357 . . . . 74.010000000000005 111.168 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.83 -18.15 50.82 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.644 -0.582 . . . . 71.140000000000001 111.644 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.12 138.78 33.54 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 120.494 0.188 . . . . 63.25 110.719 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -122.78 145.91 48.0 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.398 -0.593 . . . . 72.129999999999995 109.398 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.28 142.68 47.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.519 -0.919 . . . . 62.100000000000001 108.519 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.29 143.84 26.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.315 0.579 . . . . 51.149999999999999 112.434 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.29 104.78 12.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.451 -0.795 . . . . 53.329999999999998 108.956 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -168.59 61.1 0.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 61.310000000000002 107.473 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -146.8 157.3 47.47 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 113.126 -1.852 . . . . 74.200000000000003 107.473 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.09 -35.52 97.92 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.812 1.675 . . . . 62.32 112.614 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 m -154.53 122.44 5.89 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.195 0.522 . . . . 73.219999999999999 111.814 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -108.48 116.92 32.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.402 -0.962 . . . . 71.530000000000001 108.402 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 p -90.4 133.02 35.28 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.938 -0.476 . . . . 74.430000000000007 110.851 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.87 134.68 55.16 Favored 'General case' 0 C--O 1.253 1.259 0 N-CA-C 109.631 -0.507 . . . . 75.230000000000004 109.631 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.96 -158.72 31.83 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.733 -1.347 . . . . 52.109999999999999 109.733 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 62.1 ttt180 -95.89 150.52 20.34 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.241 -0.651 . . . . 75.530000000000001 109.241 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 85.05 151.55 0.1 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.331 1.452 . . . . 72.230000000000004 111.881 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 -0.12 3.49 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.68 2.92 . . . . 61.43 114.97 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.73 -9.93 57.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.566 0.698 . . . . 74.439999999999998 110.285 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 m -90.86 136.94 32.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.02 -1.845 . . . . 60.020000000000003 106.02 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.19 -38.57 91.67 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.892 -0.781 . . . . 62.25 108.892 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.9 mm -98.91 119.46 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.106 -1.442 . . . . 73.219999999999999 107.106 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -90.17 118.01 29.37 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.798 0.332 . . . . 61.530000000000001 111.595 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 5.2 mp -124.98 134.75 52.48 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.757 -1.572 . . . . 74.230000000000004 106.757 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -131.67 123.45 27.83 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.324 -0.551 . . . . 74.319999999999993 111.346 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -149.79 172.79 14.55 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.045 -1.465 . . . . 75.439999999999998 107.045 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.96 -31.19 52.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.165 -0.68 . . . . 75.030000000000001 109.165 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -62.29 121.12 12.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.403 0.621 . . . . 74.400000000000006 110.719 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.34 125.32 39.84 Favored 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.209 -0.905 . . . . 51.200000000000003 109.6 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 m -159.08 106.06 1.78 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.353 0.661 . . . . 70.049999999999997 110.541 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -64.38 -46.0 85.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 120.701 -0.4 . . . . 72.140000000000001 111.635 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -141.3 131.03 24.16 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.494 -1.669 . . . . 73.430000000000007 106.494 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -99.83 -52.18 3.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.806 -0.812 . . . . 71.430000000000007 108.806 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.26 155.29 36.3 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.279 -0.873 . . . . 74.209999999999994 109.167 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.5 135.55 54.68 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 116.001 -0.545 . . . . 65.019999999999996 109.591 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 33.8 m-85 -105.04 113.23 26.7 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.021 -1.844 . . . . 71.310000000000002 106.021 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.35 132.82 53.76 Favored 'General case' 0 C--N 1.269 -2.922 0 N-CA-C 108.279 -1.008 . . . . 63.350000000000001 108.279 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.7 111.9 35.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.072 -2.196 . . . . 63.210000000000001 105.072 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -124.93 118.47 26.34 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.615 -1.175 . . . . 70.400000000000006 109.752 -169.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 53.96 36.9 25.54 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.38 1.072 . . . . 50.439999999999998 111.347 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 0.58 90.27 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.68 -0.691 . . . . 62.240000000000002 113.707 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -102.49 150.27 23.55 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.691 -0.855 . . . . 73.519999999999996 108.691 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -104.51 117.01 33.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.912 -1.144 . . . . 63.5 107.912 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -124.78 134.75 52.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.5 0.667 . . . . 74.150000000000006 110.845 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 120' ' ' GLN . 24.0 t -103.03 124.98 57.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 106.735 -1.58 . . . . 64.540000000000006 106.735 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.38 122.84 70.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 107.042 -1.466 . . . . 61.130000000000003 107.042 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -96.63 144.79 26.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 115.189 -0.914 . . . . 71.239999999999995 109.741 -178.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.03 -9.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.55 -0.46 . . . . 75.109999999999999 112.037 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.45 92.52 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 119.78 -1.2 . . . . 51.409999999999997 112.367 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.1 m -58.23 -22.03 50.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.172 0.589 . . . . 63.130000000000003 111.802 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.557 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -62.12 -18.83 62.03 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.965 0.906 . . . . 73.430000000000007 112.997 177.024 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' SER . 15.4 t-20 -85.79 -0.55 55.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.786 0.803 . . . . 70.420000000000002 108.855 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.74 44.27 1.82 Allowed Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.521 -0.763 . . . . 73.0 113.059 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m -87.02 126.93 35.06 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.26 -0.645 . . . . 41.409999999999997 109.26 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 69.7 m-85 -137.44 131.62 32.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.839 -0.43 . . . . 71.420000000000002 109.839 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.16 116.36 50.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.058 -2.201 . . . . 73.5 105.058 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.5 m120 55.96 40.55 30.41 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.065 0.946 . . . . 65.540000000000006 109.729 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.0 8.55 5.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.026 1.33 . . . . 62.210000000000001 113.698 -175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 30' ' ' THR . 37.2 mt-10 -103.6 128.24 27.82 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.752 -0.593 . . . . 72.140000000000001 109.408 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.26 136.27 63.33 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.639 1.559 . . . . 63.32 108.854 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.435 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 14.2 tpp85 -151.47 131.95 13.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.461 -0.896 . . . . 74.129999999999995 109.891 -173.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 2.9 t-20 -98.91 -31.41 11.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 122.043 0.925 . . . . 50.109999999999999 109.878 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -141.14 135.69 31.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.061 -1.459 . . . . 65.099999999999994 107.061 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.435 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 8.1 tp60 -144.71 144.56 31.27 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.016 0.197 . . . . 65.140000000000001 111.492 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 80.6 t -94.49 117.53 38.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 105.092 -2.188 . . . . 60.109999999999999 105.092 171.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.423 ' HB2' HG23 ' A' ' 101' ' ' VAL . 40.6 ttp -89.85 129.27 36.24 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.415 0.626 . . . . 52.130000000000003 111.296 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.58 157.1 43.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.842 -1.072 . . . . 70.439999999999998 109.522 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -62.53 134.19 56.03 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.568 0.543 . . . . 74.109999999999999 109.805 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.05 -8.64 61.12 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.409 -0.901 . . . . 65.310000000000002 111.933 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 140.15 32.5 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.072 0.463 . . . . 71.209999999999994 110.046 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -114.12 134.78 54.65 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.446 -0.797 . . . . 73.010000000000005 109.563 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.3 mt -112.1 118.3 57.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 107.676 -1.231 . . . . 72.010000000000005 107.676 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.572 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -104.84 117.05 33.09 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.901 -1.889 . . . . 73.099999999999994 105.901 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.78 103.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.446 -0.797 . . . . 72.530000000000001 109.447 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.45 -84.44 0.44 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.107 -0.951 . . . . 40.140000000000001 112.272 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -125.35 -18.34 5.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.638 0.256 . . . . 64.129999999999995 111.192 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 48.4 p90 -121.14 150.33 41.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 112.924 0.713 . . . . 74.109999999999999 112.924 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 8.2 ptm180 -112.52 142.14 45.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.547 -0.752 . . . . 73.209999999999994 112.236 -170.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.2 139.17 54.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.911 -1.514 . . . . 63.229999999999997 106.911 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.42 134.95 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.163 -0.68 . . . . 64.140000000000001 109.163 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -97.43 119.63 36.33 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.777 -0.453 . . . . 65.230000000000004 109.777 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.42 131.14 55.59 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.651 -0.5 . . . . 74.430000000000007 109.651 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.47 135.75 33.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.751 -0.833 . . . . 70.239999999999995 108.751 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.72 163.93 15.6 Favored Glycine 0 N--CA 1.421 -2.329 0 N-CA-C 107.637 -2.185 . . . . 54.43 107.637 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.86 141.76 72.81 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 CA-C-N 119.725 1.762 . . . . 63.130000000000003 113.167 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -118.67 26.53 9.5 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.559 -1.645 . . . . 63.219999999999999 106.559 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.417 -2.099 0 CA-C-N 113.242 -1.799 . . . . 70.150000000000006 107.693 -178.152 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 108.839 -0.8 . . . . 72.010000000000005 108.839 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -83.11 115.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.453 -0.573 . . . . 62.399999999999999 109.453 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -99.54 105.35 17.23 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.603 -0.888 . . . . 70.409999999999997 108.603 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -126.96 124.92 40.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.58 0.705 . . . . 75.140000000000001 112.851 -176.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.91 -37.56 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.002 1.321 . . . . 64.099999999999994 107.885 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.74 -17.14 0.49 Allowed 'General case' 0 C--O 1.203 -1.367 0 CA-C-N 112.734 -2.03 . . . . 74.219999999999999 114.756 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.1 -41.8 88.98 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 118.156 0.434 . . . . 72.120000000000005 110.818 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.43 -36.28 45.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.569 . . . . 72.349999999999994 109.465 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -60.14 -44.09 95.22 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.11 -0.95 . . . . 51.229999999999997 108.951 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -43.12 64.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.583 -1.19 . . . . 75.019999999999996 111.149 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.15 -36.78 71.16 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.172 0.51 . . . . 60.310000000000002 110.621 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.97 -26.35 68.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.499 -0.773 . . . . 72.319999999999993 110.4 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -98.41 -36.59 9.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.557 -0.292 . . . . 54.229999999999997 111.29 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -75.33 -23.96 57.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.356 0.502 . . . . 70.030000000000001 112.356 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.1 m -66.1 114.87 5.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.332 0.587 . . . . 63.340000000000003 110.689 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.0 -70.23 0.27 Allowed Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.07 -1.612 . . . . 65.430000000000007 109.07 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -115.56 138.36 51.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.168 0.508 . . . . 65.129999999999995 111.638 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.32 154.21 37.57 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.588 -0.893 . . . . 65.0 108.588 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.2 150.97 62.65 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.512 2.141 . . . . 65.409999999999997 111.762 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.14 143.77 25.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.654 0.264 . . . . 62.030000000000001 110.517 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 p -85.15 95.16 9.05 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.865 -0.791 . . . . 52.039999999999999 108.865 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.0 p -84.77 -173.08 4.53 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.781 -0.645 . . . . 60.43 110.821 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.84 3.99 67.49 Favored Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.024 -1.231 . . . . 25.449999999999999 110.024 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 139' ' ' ALA . . . -68.57 -19.18 64.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.076 -1.062 . . . . 64.430000000000007 110.375 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.1 -5.72 37.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.395 0.617 . . . . 70.140000000000001 111.506 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.89 -12.81 23.0 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.58 -0.896 . . . . 64.120000000000005 108.58 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.87 74.07 0.56 Allowed Pre-proline 0 C--O 1.221 -0.408 0 CA-C-N 114.501 -1.227 . . . . 71.299999999999997 109.268 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.42 -57.92 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.235 1.956 . . . . 73.510000000000005 114.104 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.9 -20.21 20.88 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.961 0.726 . . . . 62.530000000000001 112.961 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.78 -4.62 83.58 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 119.978 -1.106 . . . . 53.0 111.383 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.8 m -115.48 163.74 15.31 Favored 'General case' 0 C--O 1.254 1.337 0 N-CA-C 107.9 -1.148 . . . . 71.319999999999993 107.9 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.15 158.32 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.405 -0.185 . . . . 32.340000000000003 111.176 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 48' ' ' LEU . 3.7 pp -131.08 137.19 49.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.14 0.495 . . . . 53.210000000000001 110.177 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.1 pp -117.03 136.84 52.65 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.369 -0.604 . . . . 64.420000000000002 109.369 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.75 130.92 71.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.866 -0.42 . . . . 70.400000000000006 109.866 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 t -79.37 123.12 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.913 -1.143 . . . . 61.43 107.913 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -99.24 -30.28 12.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.259 0.552 . . . . 63.350000000000001 110.033 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -136.53 127.73 28.07 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.485 -0.561 . . . . 64.329999999999998 109.485 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 136.3 175.64 13.93 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.8 -1.32 . . . . 70.219999999999999 109.8 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.57 -31.66 79.84 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 122.428 2.085 . . . . 74.239999999999995 111.817 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.29 12.78 15.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 75.519999999999996 110.897 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.54 132.18 50.45 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.928 0.394 . . . . 61.43 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -27.4 14.67 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.553 -1.019 . . . . 74.019999999999996 110.553 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.72 142.63 28.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.695 -0.483 . . . . 72.230000000000004 109.695 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.4 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 3.0 ppt_? -122.46 137.3 54.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.894 -0.594 . . . . 65.129999999999995 110.632 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.35 145.54 43.98 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.426 -0.953 . . . . 71.209999999999994 108.426 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -106.37 133.99 50.21 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.251 0.834 . . . . 62.240000000000002 113.251 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 94' ' ' ILE . 1.9 mm? -97.51 104.38 16.4 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.91 -1.885 . . . . 64.519999999999996 105.91 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.59 -0.43 2.16 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.916 0.865 . . . . 50.310000000000002 110.561 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -108.26 150.81 41.01 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.776 -0.824 . . . . 72.319999999999993 108.776 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.84 -30.17 46.28 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.417 2.745 . . . . 61.549999999999997 113.497 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -146.17 121.78 10.45 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.716 -0.615 . . . . 61.539999999999999 110.26 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 m -118.15 114.19 22.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.551 -0.295 . . . . 52.210000000000001 110.739 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m -87.32 130.18 34.72 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 110.275 -0.269 . . . . 43.240000000000002 110.275 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.63 139.68 53.67 Favored 'General case' 0 C--O 1.272 2.247 0 CA-C-O 121.609 0.719 . . . . 73.010000000000005 112.289 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.24 -160.62 31.43 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.27 -1.532 . . . . 74.5 109.27 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -118.87 116.74 27.12 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.214 -1.773 . . . . 63.140000000000001 106.214 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.435 ' ND1' ' HD2' ' A' ' 74' ' ' PRO . 2.3 t60 166.87 151.0 0.08 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 104.527 -2.397 . . . . 72.099999999999994 104.527 -173.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HD2' ' ND1' ' A' ' 73' ' ' HIS . 28.1 Cg_endo -64.52 -14.28 43.49 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.246 1.964 . . . . 74.420000000000002 112.281 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.86 -11.15 48.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 112.093 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -72.55 136.65 45.87 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.886 -0.783 . . . . 63.119999999999997 108.886 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.22 -45.07 34.78 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.716 -1.216 . . . . 64.409999999999997 107.716 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -106.32 119.27 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 107.255 -1.387 . . . . 44.329999999999998 107.255 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 81' ' ' ASP . 84.8 t80 -99.28 121.22 40.77 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.851 -0.613 . . . . 62.130000000000003 112.121 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.5 139.88 42.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.278 -2.119 . . . . 74.400000000000006 105.278 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 31.7 t70 -128.05 142.48 51.21 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 110.031 -0.359 . . . . 74.430000000000007 110.031 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -162.37 -161.42 0.73 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.613 -1.625 . . . . 75.310000000000002 106.613 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.92 -36.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.235 0.54 . . . . 73.439999999999998 109.66 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -75.71 152.45 37.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.531 -0.759 . . . . 74.219999999999999 110.521 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.26 99.09 7.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.628 -0.879 . . . . 74.239999999999995 108.628 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -99.07 85.68 3.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.126 -1.065 . . . . 63.25 108.126 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -55.4 -46.08 76.63 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.601 0.563 . . . . 71.349999999999994 111.933 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -155.62 114.28 3.49 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.623 -1.621 . . . . 72.030000000000001 106.623 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.611 ' ND1' HG23 ' A' ' 130' ' ' ILE . 22.0 t-160 -99.74 -51.88 3.61 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.551 -0.86 . . . . 64.310000000000002 109.731 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.15 158.01 41.19 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.316 -0.554 . . . . 72.329999999999998 110.469 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' OE1' HG11 ' A' ' 104' ' ' VAL . 11.9 pt-20 -132.16 148.11 52.46 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-O 121.203 0.525 . . . . 54.340000000000003 110.021 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CD2' HG22 ' A' ' 101' ' ' VAL . 54.8 m-85 -105.14 117.01 32.92 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 75.530000000000001 108.114 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -106.29 133.63 50.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.199 -1.038 . . . . 63.130000000000003 108.199 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 63' ' ' LEU . 23.8 mt -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.563 -0.532 . . . . 73.340000000000003 109.563 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -138.87 121.02 15.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.297 -0.631 . . . . 74.120000000000005 109.297 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 55.76 38.09 29.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.223 1.009 . . . . 75.140000000000001 112.268 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.23 85.0 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.966 -0.635 . . . . 44.350000000000001 114.007 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -102.32 131.71 48.75 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 117.986 0.893 . . . . 74.439999999999998 109.788 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.99 123.62 48.11 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.936 -1.029 . . . . 65.230000000000004 109.177 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.26 137.48 54.2 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.669 -0.493 . . . . 65.340000000000003 109.669 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.451 HG22 ' CD2' ' A' ' 92' ' ' PHE . 29.2 t -103.58 122.61 56.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.212 -1.403 . . . . 65.299999999999997 107.212 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.95 133.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.923 -1.139 . . . . 63.450000000000003 107.923 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.9 148.96 36.12 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.35 0.595 . . . . 72.219999999999999 110.074 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.445 HG11 ' OE1' ' A' ' 91' ' ' GLU . 14.5 m -137.47 27.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.721 -1.214 . . . . 74.400000000000006 107.721 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 156.4 56.86 0.01 OUTLIER Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 113.796 -1.547 . . . . 73.310000000000002 110.41 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t -65.56 11.16 0.07 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.965 1.306 . . . . 61.140000000000001 111.961 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 105' ' ' GLY . 78.4 mt -65.5 -19.88 66.11 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 125.634 1.574 . . . . 64.349999999999994 110.885 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -87.09 -13.54 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.333 -0.394 . . . . 74.549999999999997 110.515 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.01 89.19 1.85 Allowed Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.729 -0.748 . . . . 70.430000000000007 111.253 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -86.6 127.9 34.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.773 -0.825 . . . . 63.310000000000002 108.773 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 81.1 m-85 -136.25 134.06 37.67 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.856 -0.794 . . . . 74.239999999999995 108.856 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.18 117.68 51.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 105.474 -2.047 . . . . 72.239999999999995 105.474 175.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.2 39.11 30.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.676 0.75 . . . . 74.430000000000007 110.172 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 mtm180 69.94 9.02 6.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.954 1.702 . . . . 65.519999999999996 114.851 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -110.24 135.89 20.55 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 110.351 -0.24 . . . . 75.040000000000006 110.351 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.02 135.9 12.69 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.728 2.285 . . . . 70.439999999999998 112.07 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -149.64 -177.62 5.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.281 0.562 . . . . 73.319999999999993 110.249 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.85 -31.02 4.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.259 -1.337 . . . . 72.340000000000003 110.057 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.7 137.31 28.1 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.277 -1.009 . . . . 32.25 108.277 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -152.44 122.63 7.14 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.277 -0.638 . . . . 55.450000000000003 109.277 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.17 117.56 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 106.963 -1.495 . . . . 71.209999999999994 106.963 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 32.6 ttm -96.87 137.81 35.39 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 114.281 1.215 . . . . 75.129999999999995 114.281 -165.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -114.14 157.25 22.86 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.473 -1.694 . . . . 54.439999999999998 107.745 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.8 t -62.59 133.94 55.63 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.414 0.626 . . . . 65.450000000000003 109.456 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.44 -0.09 56.9 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 121.107 -0.568 . . . . 74.030000000000001 111.887 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -82.38 142.2 32.18 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.932 -0.766 . . . . 72.420000000000002 108.932 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 134' ' ' ARG . 44.4 mt-10 -113.46 132.63 55.58 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.362 0.601 . . . . 75.510000000000005 110.248 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -107.39 132.82 53.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 111' ' ' TYR . 54.2 mt-30 -117.63 117.79 30.34 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.268 0.556 . . . . 61.240000000000002 109.781 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.611 HG23 ' ND1' ' A' ' 89' ' ' HIS . 48.1 mm -109.75 102.27 13.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.973 -1.491 . . . . 70.129999999999995 106.973 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.94 -78.08 0.21 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.406 -0.677 . . . . 43.140000000000001 111.406 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -141.87 5.37 1.74 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.045 0.45 . . . . 72.310000000000002 111.222 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.2 m-85 -78.9 150.44 32.14 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.223 -0.658 . . . . 54.32 109.223 176.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 127' ' ' GLU . 13.8 tpt180 -124.72 118.64 26.91 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.411 -1.7 . . . . 74.430000000000007 106.411 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.43 HD23 HD13 ' A' ' 49' ' ' LEU . 3.8 mp -122.29 140.84 52.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.337 -0.986 . . . . 74.450000000000003 108.337 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.07 122.56 65.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.201 -1.407 . . . . 73.019999999999996 107.201 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -99.31 127.29 45.31 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.077 -0.51 . . . . 75.329999999999998 109.957 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.99 155.54 50.59 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.818 -0.808 . . . . 45.539999999999999 108.818 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.489 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . . . -82.61 142.15 31.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.451 -1.685 . . . . 50.32 106.451 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.44 2.71 Favored Glycine 0 C--N 1.305 -1.192 0 C-N-CA 119.384 -1.389 . . . . 72.209999999999994 113.927 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 139' ' ' ALA . 2.9 Cg_exo -72.79 142.03 34.8 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.974 1.783 . . . . 75.0 109.769 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 179.76 73.71 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.929 0.892 . . . . 73.109999999999999 109.26 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.39 -3.448 0 CA-C-N 114.435 -1.257 . . . . 62.310000000000002 109.413 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.421 -1.883 0 N-CA-C 105.768 -1.938 . . . . 51.25 105.768 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -81.53 114.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 117.675 -1.61 . . . . 74.310000000000002 108.024 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.682 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 45.1 t80 -99.71 116.24 31.35 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.004 -0.998 . . . . 73.209999999999994 108.857 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -81.15 92.07 6.23 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.796 -0.816 . . . . 73.140000000000001 108.796 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.65 -168.41 2.08 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.975 -1.011 . . . . 73.310000000000002 110.926 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.43 -9.71 13.86 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.34 1.056 . . . . 74.5 111.28 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.86 -19.13 65.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.004 0.922 . . . . 71.450000000000003 110.365 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.0 OUTLIER -59.21 -43.71 92.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.331 -0.989 . . . . 73.430000000000007 108.331 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.536 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 7.8 tmtm? -80.47 -29.3 37.46 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.547 -0.909 . . . . 74.450000000000003 108.547 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 129' ' ' GLN . 6.6 tp10 -68.26 -33.9 75.22 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.987 -0.551 . . . . 73.510000000000005 110.705 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 27.5 ptt? -68.57 -21.02 64.55 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.778 -0.369 . . . . 52.240000000000002 110.741 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.04 -33.52 63.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.715 -1.217 . . . . 71.219999999999999 107.715 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -79.94 -14.66 58.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.769 -1.105 . . . . 63.340000000000003 110.884 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 t -67.44 -25.66 66.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.201 -0.666 . . . . 72.140000000000001 109.201 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.92 97.06 5.18 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.883 -1.525 . . . . 72.409999999999997 106.883 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.19 58.91 2.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.379 -1.088 . . . . 64.239999999999995 110.379 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -92.79 149.93 20.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.899 -0.408 . . . . 74.420000000000002 109.899 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.22 101.22 40.97 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.721 -0.474 . . . . 51.109999999999999 109.721 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.549 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 69.3 Cg_endo -75.79 143.52 26.74 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.308 2.005 . . . . 72.409999999999997 111.181 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.12 166.8 22.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.335 -0.393 . . . . 71.25 110.724 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 m -67.71 118.82 11.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.168 -0.469 . . . . 62.210000000000001 110.266 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 124' ' ' THR . 17.8 p -110.93 -161.57 0.76 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.569 0.748 . . . . 64.030000000000001 110.63 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.94 80.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.518 -0.633 . . . . 23.219999999999999 111.518 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.64 -24.51 19.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.927 0.714 . . . . 65.519999999999996 112.927 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.02 0.61 4.33 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.549 1.315 . . . . 73.019999999999996 114.549 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.3 -39.01 15.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.692 -0.855 . . . . 72.420000000000002 108.692 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 90.7 mt 53.18 80.29 0.3 Allowed Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 123.98 0.912 . . . . 72.519999999999996 111.607 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 10.8 Cg_endo -52.79 -67.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 123.649 2.9 . . . . 75.5 114.678 -173.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.38 -0.98 3.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.098 0.475 . . . . 64.510000000000005 111.317 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.6 6.98 82.6 Favored Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.384 -0.912 . . . . 63.409999999999997 112.643 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 m -129.46 158.21 39.84 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 108.118 -1.068 . . . . 71.25 108.118 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.49 41.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.254 -0.276 . . . . 73.349999999999994 110.254 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.442 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.71 139.95 53.4 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.326 0.391 . . . . 74.019999999999996 110.267 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -112.42 137.34 50.75 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.69 -0.855 . . . . 75.319999999999993 108.69 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.73 133.34 61.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.195 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.8 t -78.51 117.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 106.113 -1.81 . . . . 55.439999999999998 106.113 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -86.41 -33.99 20.3 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.545 -0.752 . . . . 73.319999999999993 110.527 -172.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 31.3 tpt180 -154.66 139.7 17.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.232 -1.025 . . . . 71.230000000000004 108.232 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.08 -178.93 20.41 Favored Glycine 0 N--CA 1.437 -1.3 0 O-C-N 123.867 0.729 . . . . 72.430000000000007 111.346 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -70.0 -37.11 9.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.341 2.027 . . . . 74.340000000000003 111.513 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 81' ' ' ASP . 5.0 p30 -90.73 18.52 6.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.352 0.596 . . . . 74.239999999999995 111.167 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.65 145.19 54.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.432 0.693 . . . . 75.040000000000006 111.034 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -14.82 37.06 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.243 -1.143 . . . . 52.240000000000002 110.243 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.86 33.56 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 121.08 -0.248 . . . . 72.150000000000006 110.359 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -134.97 139.25 44.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.816 -1.179 . . . . 73.239999999999995 107.816 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.25 123.16 26.39 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 121.311 -0.155 . . . . 72.340000000000003 110.737 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.5 tp -89.63 115.4 26.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.057 -1.461 . . . . 63.310000000000002 107.057 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.81 106.87 16.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.458 0.647 . . . . 63.310000000000002 111.744 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -102.92 15.27 29.87 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.474 -1.306 . . . . 72.310000000000002 107.474 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 15.7 mt-30 -107.31 141.85 23.83 Favored Pre-proline 0 CA--C 1.468 -2.205 0 CA-C-N 114.714 -1.13 . . . . 73.200000000000003 110.026 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 16.5 Cg_exo -72.03 -13.15 28.74 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.973 1.782 . . . . 74.329999999999998 109.375 169.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.0 m -149.29 125.37 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.281 0.563 . . . . 61.229999999999997 110.67 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.3 m -131.51 139.48 49.29 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.366 -0.976 . . . . 64.209999999999994 108.366 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.24 -0.913 . . . . 70.450000000000003 110.319 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.58 143.41 46.14 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.764 -0.828 . . . . 63.149999999999999 108.764 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.96 -147.07 6.39 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 111.361 -0.696 . . . . 73.439999999999998 111.361 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -90.91 147.9 22.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 122.591 0.357 . . . . 64.239999999999995 110.951 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.46 169.76 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.65 1.18 . . . . 75.310000000000002 112.291 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -73.2 6.66 2.48 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.246 1.964 . . . . 74.409999999999997 111.446 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.93 -37.56 67.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.319 -1.363 . . . . 53.229999999999997 107.319 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -78.74 152.82 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.758 -1.11 . . . . 73.120000000000005 108.264 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' OD2' HG23 ' A' ' 68' ' ' THR . 32.0 t70 -64.67 -41.76 95.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.892 0.377 . . . . 71.129999999999995 111.094 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.0 126.81 67.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.306 -0.998 . . . . 72.099999999999994 108.306 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -88.42 129.63 35.38 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.682 0.614 . . . . 74.310000000000002 110.737 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.7 140.3 52.82 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.39 -1.337 . . . . 75.219999999999999 107.39 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.584 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 30.7 t70 -125.4 118.42 25.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.993 -0.549 . . . . 62.149999999999999 109.611 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.34 -175.45 4.78 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.775 -2.306 . . . . 75.049999999999997 104.775 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.24 -34.84 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.368 -0.975 . . . . 74.219999999999999 108.368 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 107' ' ' LEU . 8.2 m -148.63 114.69 5.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.071 -1.085 . . . . 64.299999999999997 108.071 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.2 t -103.94 152.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.513 -0.551 . . . . 44.450000000000003 109.513 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.8 m -72.65 153.07 41.4 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.572 0.349 . . . . 52.530000000000001 110.47 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -69.26 -29.27 67.14 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.922 0.867 . . . . 72.140000000000001 110.767 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 24.0 mtp180 -148.78 120.19 7.9 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 101.666 -3.457 . . . . 72.340000000000003 101.666 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.498 ' CE1' HG23 ' A' ' 130' ' ' ILE . 13.4 t60 -99.65 -52.69 3.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.725 -0.79 . . . . 75.420000000000002 110.483 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.01 146.52 25.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.625 -0.88 . . . . 63.350000000000001 108.625 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 11.0 pt-20 -118.36 129.75 55.61 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.816 -0.629 . . . . 74.540000000000006 109.61 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 26.7 m-85 -105.26 113.06 26.43 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.302 -2.11 . . . . 74.420000000000002 105.302 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 26.2 mtp180 -115.25 127.29 55.39 Favored 'General case' 0 C--N 1.262 -3.2 0 N-CA-C 108.46 -0.941 . . . . 74.420000000000002 108.46 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.7 mp -103.67 113.02 39.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 106.894 -1.521 . . . . 63.149999999999999 106.894 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -119.65 125.06 47.81 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.812 -1.181 . . . . 70.530000000000001 107.812 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.29 34.97 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.994 0.918 . . . . 75.219999999999999 112.576 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.2 -0.15 89.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.078 -0.582 . . . . 64.519999999999996 113.401 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -102.91 150.51 23.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.28 -1.007 . . . . 74.530000000000001 108.28 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -110.1 117.65 34.29 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 121.306 -0.157 . . . . 63.130000000000003 110.745 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.618 -0.882 . . . . 63.530000000000001 108.618 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.0 123.63 68.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.743 -1.206 . . . . 42.439999999999998 107.743 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.24 130.06 73.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.664 -0.865 . . . . 62.340000000000003 108.664 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.42 130.4 37.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.482 -0.933 . . . . 71.430000000000007 108.482 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 12.85 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-N 115.675 -0.693 . . . . 63.420000000000002 109.322 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -154.83 83.01 0.16 Allowed Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.158 -0.928 . . . . 43.25 113.375 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 40.6 m -82.4 15.58 2.43 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.396 . . . . 72.230000000000004 111.176 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.7 tm? -67.2 -50.48 60.76 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 106.539 -1.652 . . . . 74.219999999999999 106.539 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 26.9 t-20 -104.46 -19.86 13.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.992 -0.744 . . . . 72.439999999999998 108.992 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . 83.99 119.32 0.76 Allowed Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.75 1.06 . . . . 52.130000000000003 115.75 168.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.9 m -87.29 128.4 35.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.793 -0.818 . . . . 74.25 108.793 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.41 142.17 51.49 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.185 -1.043 . . . . 64.099999999999994 108.185 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -124.62 117.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.389 -0.967 . . . . 74.310000000000002 108.389 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.549 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 6.8 m-80 50.93 49.03 21.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.798 0.839 . . . . 71.120000000000005 112.993 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 67.21 9.42 6.94 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.481 1.513 . . . . 75.120000000000005 112.303 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -109.97 136.31 20.43 Favored Pre-proline 0 C--N 1.313 -1.004 0 O-C-N 121.936 -0.477 . . . . 65.150000000000006 110.334 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.42 123.81 12.73 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 121.946 1.764 . . . . 40.5 108.652 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -147.41 131.98 17.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.02 -0.733 . . . . 64.549999999999997 109.02 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.79 -35.52 9.02 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.358 0.411 . . . . 75.239999999999995 111.476 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.26 135.26 53.28 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.78 -1.193 . . . . 50.43 107.78 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -146.88 143.61 28.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.513 0.197 . . . . 72.140000000000001 111.391 -175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 114.03 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 103.181 -2.896 . . . . 45.399999999999999 103.181 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.452 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 30.3 ttm -93.91 130.85 39.84 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.778 -1.169 . . . . 55.200000000000003 111.468 -170.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.41 ' OE1' ' HB ' ' A' ' 37' ' ' THR . 40.3 mt-30 -114.03 157.87 21.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 74.409999999999997 109.675 -170.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 14.8 t -63.54 126.57 27.94 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.897 -0.779 . . . . 73.140000000000001 108.897 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.0 -1.66 57.85 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 115.772 -0.649 . . . . 60.32 111.489 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.8 145.74 34.16 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 107.982 -1.118 . . . . 51.109999999999999 107.982 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' H ' ' ND2' ' A' ' 113' ' ' ASN . 36.7 mt-10 -119.93 132.86 55.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.831 -0.433 . . . . 73.019999999999996 109.831 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 mt -107.98 131.59 57.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.044 -0.724 . . . . 53.119999999999997 109.044 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.403 ' HG2' ' HG2' ' A' ' 25' ' ' GLU . 52.3 tp60 -105.53 115.43 30.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.554 -1.276 . . . . 71.140000000000001 107.554 175.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.498 HG23 ' CE1' ' A' ' 89' ' ' HIS . 63.4 mt -125.42 116.8 47.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.086 -1.449 . . . . 60.119999999999997 107.086 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.53 -104.29 0.75 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.668 -0.973 . . . . 62.32 110.668 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.503 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -124.61 5.09 8.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.195 0.522 . . . . 72.219999999999999 109.94 176.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 34.2 p90 -111.14 156.58 21.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.985 -175.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.57 136.74 54.7 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.166 0.508 . . . . 74.310000000000002 111.542 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.17 139.62 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.585 -1.265 . . . . 71.420000000000002 107.585 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.7 t -112.13 131.41 63.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.893 -1.151 . . . . 62.229999999999997 107.893 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 48.7 t80 -103.57 117.02 33.47 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.941 -0.763 . . . . 72.120000000000005 108.941 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.19 131.08 55.8 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.488 -0.56 . . . . 61.409999999999997 109.488 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -111.87 121.93 46.39 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.307 -0.997 . . . . 72.409999999999997 108.307 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.74 -104.89 0.21 Allowed Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.477 -0.868 . . . . 74.409999999999997 111.89 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.19 161.66 45.12 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.004 2.469 . . . . 61.409999999999997 113.596 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.1 24.38 5.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.309 -0.86 . . . . 63.43 109.343 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.435 -1.197 0 C-N-CA 124.961 1.305 . . . . 71.530000000000001 113.462 -176.668 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 105.883 -1.895 . . . . 72.150000000000006 105.883 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 t -85.9 130.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 117.8 0.273 . . . . 74.140000000000001 110.415 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -96.48 131.9 42.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.432 -0.507 . . . . 74.299999999999997 109.64 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.54 91.69 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.69 -0.485 . . . . 74.030000000000001 109.69 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.49 -84.22 0.07 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.122 0.416 . . . . 22.149999999999999 112.122 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.32 -35.48 65.18 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.497 1.119 . . . . 74.209999999999994 112.505 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.8 mt -57.85 -12.29 3.01 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.887 1.275 . . . . 74.230000000000004 113.904 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.4 tp -80.07 -16.32 55.3 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.714 0.405 . . . . 73.120000000000005 111.066 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.85 -39.65 89.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.415 1.265 . . . . 62.219999999999999 114.415 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -72.57 -14.48 61.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.239 0.829 . . . . 75.010000000000005 113.239 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.4 ttp -60.25 -30.69 69.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.367 0.603 . . . . 71.310000000000002 110.376 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.77 -16.74 63.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.367 -0.833 . . . . 53.310000000000002 111.91 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -78.38 -17.95 55.74 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.936 -0.394 . . . . 71.209999999999994 109.936 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.0 m -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.355 0.598 . . . . 73.120000000000005 110.889 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -81.79 111.44 18.03 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 115.523 -0.762 . . . . 65.329999999999998 109.757 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.0 -79.95 0.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.827 -0.701 . . . . 62.009999999999998 113.702 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -105.69 121.36 43.86 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.225 0.536 . . . . 71.129999999999995 111.707 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.61 136.12 28.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.516 -0.92 . . . . 71.239999999999995 108.516 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.42 154.55 73.85 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.319 2.012 . . . . 70.420000000000002 110.199 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.31 169.06 16.51 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 116.32 -0.4 . . . . 73.010000000000005 110.378 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 p -57.03 136.7 56.32 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.069 0.856 . . . . 71.019999999999996 110.411 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 m -118.22 1.7 11.91 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.204 0.526 . . . . 64.010000000000005 111.968 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 15.21 56.36 Favored Glycine 0 CA--C 1.488 -1.624 0 N-CA-C 108.107 -1.997 . . . . 63.109999999999999 108.107 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.13 -8.95 47.3 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.898 -1.651 . . . . 72.439999999999998 109.379 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.22 -11.4 60.77 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.627 1.571 . . . . 74.040000000000006 111.063 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.63 -22.79 43.15 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.832 -1.531 . . . . 70.439999999999998 109.425 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.66 67.58 1.51 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.255 -0.646 . . . . 54.329999999999998 109.255 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.08 -54.56 4.21 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.831 3.021 . . . . 73.430000000000007 114.914 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.14 -15.04 45.15 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.273 0.472 . . . . 64.019999999999996 112.273 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.51 -11.89 70.85 Favored Glycine 0 C--N 1.319 -0.387 0 N-CA-C 110.788 -0.925 . . . . 24.550000000000001 110.788 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.0 m -127.21 162.38 26.32 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.525 -1.658 . . . . 62.229999999999997 106.525 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -141.38 157.32 45.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.253 -0.647 . . . . 70.140000000000001 109.253 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -121.57 149.08 43.66 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.225 0.536 . . . . 74.310000000000002 111.831 -175.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -111.04 132.24 54.39 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.568 -0.901 . . . . 73.340000000000003 108.568 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.05 134.25 51.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.404 -0.591 . . . . 73.420000000000002 109.404 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.46 117.9 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.835 -1.543 . . . . 73.5 106.835 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -93.53 -30.97 14.73 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.052 -0.522 . . . . 72.420000000000002 111.46 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' CZ ' ' H ' ' A' ' 54' ' ' GLY . 2.7 tpm_? -144.52 141.19 29.34 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.583 -0.447 . . . . 73.430000000000007 109.961 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.458 ' H ' ' CZ ' ' A' ' 53' ' ' ARG . . . 128.8 168.1 12.32 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.942 -1.663 . . . . 63.32 108.942 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.4 Cg_exo -55.26 -29.58 67.78 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.46 2.107 . . . . 54.5 113.438 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -91.7 14.51 15.03 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.529 0.566 . . . . 71.219999999999999 112.529 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.51 143.07 58.18 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.191 0.52 . . . . 54.520000000000003 111.567 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.79 -23.15 34.75 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 115.408 -0.814 . . . . 72.409999999999997 111.243 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.57 149.31 22.2 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.771 0.319 . . . . 32.25 110.458 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 2.0 ppt_? -123.95 141.14 52.3 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.751 -0.463 . . . . 72.219999999999999 109.751 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -119.24 125.62 49.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.11 -0.7 . . . . 70.109999999999999 109.11 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.8 tp -93.67 136.19 34.2 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 74.0 107.809 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.84 104.7 16.6 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.937 -0.705 . . . . 71.019999999999996 110.09 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -116.46 -9.76 11.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.509 -1.223 . . . . 73.219999999999999 107.707 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 94' ' ' ILE . 15.1 pm0 -106.9 139.81 20.76 Favored Pre-proline 0 N--CA 1.425 -1.688 0 CA-C-N 114.871 -1.059 . . . . 74.010000000000005 109.728 -173.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 31.0 Cg_endo -64.18 -14.52 44.21 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.471 2.78 . . . . 73.129999999999995 114.182 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -148.02 127.55 13.23 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.216 -0.927 . . . . 74.030000000000001 112.015 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 45.7 m -124.15 113.54 18.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.312 -0.996 . . . . 73.239999999999995 108.312 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -89.43 134.89 33.89 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.329 -0.619 . . . . 64.230000000000004 109.329 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.5 147.0 44.09 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.514 0.673 . . . . 62.310000000000002 111.585 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -169.78 21.38 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 107.867 -2.093 . . . . 73.040000000000006 107.867 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -115.61 118.34 32.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.78 -1.563 . . . . 73.310000000000002 106.78 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 44.6 p-80 176.38 162.05 0.46 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 106.381 -1.711 . . . . 75.409999999999997 106.381 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 8.3 Cg_endo -48.74 -36.64 33.56 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 123.925 3.083 . . . . 74.120000000000005 115.146 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -90.81 16.2 9.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.771 1.026 . . . . 73.409999999999997 113.771 -177.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.4 p -66.05 112.28 3.78 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.167 -0.679 . . . . 62.549999999999997 109.167 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 68' ' ' THR . 27.3 t0 -77.52 -34.67 53.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.415 -0.957 . . . . 64.430000000000007 108.415 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.99 117.95 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.992 -1.484 . . . . 52.240000000000002 106.992 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -95.19 116.93 29.39 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.321 0.582 . . . . 61.140000000000001 110.959 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 2.2 mm? -123.19 139.94 53.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.032 -2.21 . . . . 74.200000000000003 105.032 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 55' ' ' PRO . 4.5 p-10 -79.68 127.15 31.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.903 0.858 . . . . 72.219999999999999 109.533 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.92 146.15 39.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.839 -1.073 . . . . 63.350000000000001 111.648 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.38 -43.27 20.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.478 -0.934 . . . . 75.150000000000006 108.478 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.405 ' HB ' ' CD2' ' A' ' 107' ' ' LEU . 45.2 m -133.53 158.0 44.23 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.517 -2.031 . . . . 63.32 105.517 176.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.97 99.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.773 0.797 . . . . 75.430000000000007 112.754 -165.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -104.14 101.76 11.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.262 -1.335 . . . . 71.109999999999999 107.584 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 6.7 ppt_? -57.16 -31.72 65.67 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.691 0.62 . . . . 75.099999999999994 112.349 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 43.6 ttm180 -159.97 132.51 6.51 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.597 -1.631 . . . . 71.510000000000005 106.597 172.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -98.67 -52.75 3.51 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.644 0.59 . . . . 74.340000000000003 110.456 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 164.6 34.45 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.335 -0.393 . . . . 71.219999999999999 110.605 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.96 130.94 54.04 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.371 -0.974 . . . . 61.450000000000003 108.371 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 9.1 m-85 -105.66 113.47 27.05 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.212 -1.773 . . . . 55.420000000000002 106.212 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -112.21 141.61 45.69 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.37 -0.532 . . . . 64.329999999999998 110.524 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.5 mp -113.78 112.72 41.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 105.117 -2.179 . . . . 65.150000000000006 105.117 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -131.48 126.55 35.29 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.939 -0.573 . . . . 72.25 109.551 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 55.67 36.21 26.76 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 125.194 1.398 . . . . 65.140000000000001 110.08 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.75 -2.0 75.76 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 115.492 -0.776 . . . . 61.32 113.685 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.22 150.33 25.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.37 0.585 . . . . 73.530000000000001 109.94 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.401 ' CD2' HG13 ' A' ' 94' ' ' ILE . 49.8 m-85 -106.43 131.51 53.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.55 -0.295 . . . . 75.400000000000006 110.612 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.42 147.21 52.1 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.754 -0.461 . . . . 71.230000000000004 109.754 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.28 123.17 64.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.388 -1.338 . . . . 50.130000000000003 107.388 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.91 122.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.346 0.593 . . . . 73.430000000000007 110.364 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -83.23 137.83 33.86 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.437 -0.801 . . . . 72.299999999999997 109.646 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.6 12.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.488 -0.778 . . . . 71.219999999999999 109.489 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.75 79.65 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.286 -0.959 . . . . 73.109999999999999 112.817 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -71.37 33.55 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 123.588 0.755 . . . . 55.420000000000002 112.209 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.405 ' CD2' ' HB ' ' A' ' 84' ' ' THR . 4.3 tt -62.81 -42.34 99.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.545 -0.909 . . . . 60.43 108.545 -176.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -86.42 -4.1 59.11 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.506 -1.225 . . . . 74.230000000000004 109.374 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 88.87 1.01 Allowed Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.992 -0.623 . . . . 71.200000000000003 112.683 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -87.51 127.71 35.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.991 -0.374 . . . . 74.200000000000003 109.991 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.8 m-85 -136.37 141.73 43.71 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 109.968 -0.382 . . . . 70.230000000000004 109.968 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.7 117.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.442 -2.059 . . . . 72.25 105.442 172.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 56.71 38.65 29.68 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.859 0.837 . . . . 71.120000000000005 110.141 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.486 HH12 ' NH2' ' A' ' 134' ' ' ARG . 75.1 mtm-85 62.79 13.02 6.13 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.339 -1.3 . . . . 74.140000000000001 114.118 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -104.06 130.3 23.64 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.735 -1.58 . . . . 73.430000000000007 106.735 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.13 123.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.586 1.524 . . . . 72.450000000000003 109.701 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -142.18 140.12 32.28 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.69 -1.226 . . . . 71.519999999999996 107.69 -172.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.2 -47.06 4.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.194 0.521 . . . . 73.310000000000002 110.189 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.14 136.47 54.6 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.775 -0.824 . . . . 73.239999999999995 108.775 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -148.49 143.88 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.737 -0.665 . . . . 74.549999999999997 110.454 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.51 114.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 102.967 -2.975 . . . . 72.319999999999993 102.967 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.6 ttp -90.03 129.39 36.35 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.482 0.658 . . . . 74.409999999999997 110.833 -169.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -129.18 157.68 41.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.86 -1.064 . . . . 62.009999999999998 108.807 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -58.92 133.7 56.29 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.883 -0.599 . . . . 61.25 109.972 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.64 -4.8 56.62 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.586 -0.734 . . . . 74.129999999999995 111.752 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -88.69 140.06 29.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.202 -0.666 . . . . 54.539999999999999 109.202 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -117.07 145.11 43.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.811 -0.811 . . . . 74.540000000000006 108.811 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.0 127.63 72.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.159 -0.682 . . . . 70.540000000000006 109.159 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 44.9 tt0 -104.86 122.08 45.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.209 -1.404 . . . . 74.140000000000001 107.209 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.74 101.75 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.091 -1.818 . . . . 62.509999999999998 106.091 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.48 -110.96 3.06 Favored Glycine 0 C--N 1.306 -1.097 0 C-N-CA 120.864 -0.684 . . . . 51.219999999999999 112.107 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -96.86 -3.52 41.88 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.981 0.513 . . . . 51.450000000000003 110.435 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.587 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.3 m-85 -95.11 139.15 31.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 109.798 -0.445 . . . . 72.109999999999999 109.798 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.486 ' NH2' HH12 ' A' ' 114' ' ' ARG . 81.1 ttt180 -124.81 119.43 28.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.446 -0.946 . . . . 74.200000000000003 108.446 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.7 mt -110.21 138.64 46.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.594 -0.891 . . . . 75.120000000000005 108.594 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.93 120.7 64.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.855 -1.165 . . . . 73.540000000000006 107.855 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 85.6 t80 -97.14 117.77 32.07 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.355 0.409 . . . . 75.329999999999998 110.29 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.16 143.76 49.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.08 0.467 . . . . 73.120000000000005 110.128 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.47 119.81 38.61 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.051 0.453 . . . . 72.409999999999997 110.244 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.46 174.44 40.5 Favored Glycine 0 C--N 1.287 -2.164 0 N-CA-C 109.436 -1.465 . . . . 34.420000000000002 109.436 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.47 141.22 38.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 119.091 1.445 . . . . 61.210000000000001 109.66 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.55 26.67 0.13 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.889 -1.152 . . . . 64.420000000000002 107.889 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.407 -2.589 0 CA-C-N 114.498 -1.228 . . . . 74.420000000000002 108.315 -177.493 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 121.038 0.447 . . . . 72.010000000000005 111.997 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 115.64 26.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 72.120000000000005 108.649 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -123.12 117.79 26.21 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.637 -0.71 . . . . 74.310000000000002 110.144 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -82.76 101.24 10.78 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.691 -1.966 . . . . 72.510000000000005 105.691 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 108.75 1.71 Allowed 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.489 -0.778 . . . . 53.200000000000003 110.474 -177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 35.5 t70 -60.1 -24.16 64.41 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.659 0.742 . . . . 70.120000000000005 110.263 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -65.81 -3.81 5.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.645 -1.161 . . . . 74.310000000000002 113.142 178.114 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.83 -24.62 58.24 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.122 0.487 . . . . 65.450000000000003 111.287 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 21' ' ' ASP . 49.6 mtmt -66.82 -28.95 68.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.836 -0.62 . . . . 74.430000000000007 110.857 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -26.31 62.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.478 -0.328 . . . . 61.210000000000001 110.855 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.3 mtm -65.93 -40.35 91.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.93 -0.767 . . . . 64.439999999999998 108.93 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.91 -40.28 94.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.033 -0.985 . . . . 73.040000000000006 109.557 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 m -73.01 -27.75 61.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.536 -0.756 . . . . 61.119999999999997 111.044 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -74.05 -30.48 62.42 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 109.921 -0.4 . . . . 63.439999999999998 109.921 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 127.88 34.29 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.941 -1.027 . . . . 61.539999999999999 109.341 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.22 -42.69 1.28 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 107.674 -2.17 . . . . 63.539999999999999 107.674 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.6 m -115.77 121.95 43.99 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.474 -1.306 . . . . 72.519999999999996 107.474 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -90.39 138.52 26.95 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.008 -0.738 . . . . 74.310000000000002 109.008 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 7.9 Cg_exo -73.52 142.24 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.701 1.6 . . . . 45.039999999999999 111.468 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.13 126.48 46.38 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.081 -1.081 . . . . 73.319999999999993 108.081 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 123' ' ' GLN . 12.9 m -137.96 110.88 7.71 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.631 -0.507 . . . . 75.400000000000006 109.631 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.6 m -154.18 142.4 20.44 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.733 -1.21 . . . . 74.200000000000003 107.733 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -15.01 3.63 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.114 -1.041 . . . . 52.420000000000002 112.166 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.13 59.04 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.299 -0.63 . . . . 61.530000000000001 109.299 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -79.8 3.7 18.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.188 -0.914 . . . . 73.310000000000002 111.671 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.28 -27.89 18.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.085 -0.709 . . . . 75.310000000000002 109.085 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 46.65 77.93 0.43 Allowed Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.331 1.052 . . . . 62.539999999999999 113.665 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -70.22 -61.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.508 1.472 . . . . 71.349999999999994 111.537 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.05 -13.79 18.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 111.567 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.17 17.52 74.04 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.711 -0.955 . . . . 73.430000000000007 110.711 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -150.44 167.08 28.19 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 105.902 -1.888 . . . . 25.120000000000001 105.902 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -152.12 157.9 42.21 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 118.446 0.566 . . . . 63.420000000000002 111.278 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -121.2 154.53 36.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.129 0.49 . . . . 63.340000000000003 111.916 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.42 141.37 51.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.966 -0.753 . . . . 63.399999999999999 108.966 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.68 134.36 59.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.891 -0.411 . . . . 64.299999999999997 109.891 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 t -86.63 118.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 108.103 -1.073 . . . . 63.340000000000003 108.103 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -92.27 -32.2 15.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 111.336 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -143.47 136.73 27.97 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.422 -0.511 . . . . 75.319999999999993 110.096 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.86 174.84 13.84 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.2 -1.16 . . . . 63.340000000000003 110.2 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -55.43 -32.05 80.36 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.649 2.233 . . . . 74.200000000000003 112.793 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.44 10.48 25.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.256 0.465 . . . . 73.109999999999999 112.256 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.27 57.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.902 0.319 . . . . 70.420000000000002 111.444 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.16 -16.78 55.19 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.509 -0.636 . . . . 32.439999999999998 111.509 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.63 139.01 31.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.907 0.384 . . . . 54.200000000000003 110.324 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -122.79 134.55 54.42 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.58 118.65 30.73 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.546 -0.297 . . . . 74.319999999999993 110.338 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -87.55 111.76 21.54 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.31 -0.996 . . . . 72.140000000000001 108.31 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -95.0 117.26 29.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.342 0.591 . . . . 73.310000000000002 109.653 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -122.02 14.03 10.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.846 -1.07 . . . . 72.209999999999994 108.835 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -108.47 156.46 38.62 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 64.310000000000002 109.521 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 38.2 Cg_endo -69.18 -20.68 37.25 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.175 1.917 . . . . 65.230000000000004 114.527 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.5 m -153.53 127.17 8.74 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.29 -0.881 . . . . 75.140000000000001 111.858 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -126.25 112.86 16.23 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.979 -1.119 . . . . 74.299999999999997 107.979 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 77.7 m -89.07 139.18 30.72 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.39 -0.524 . . . . 73.400000000000006 109.624 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.01 135.61 54.85 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.358 0.599 . . . . 60.32 110.912 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.05 -160.21 33.1 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.731 -2.148 . . . . 61.229999999999997 107.731 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -115.72 116.81 28.7 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 151.43 153.23 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 127.48 2.312 . . . . 61.409999999999997 107.228 177.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.95 -9.97 25.22 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.397 2.065 . . . . 75.099999999999994 111.79 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.52 -17.84 61.17 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.746 0.818 . . . . 62.350000000000001 110.248 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 m -90.07 150.02 22.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.218 -1.401 . . . . 62.200000000000003 107.218 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.31 -45.95 24.56 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.702 -0.851 . . . . 74.430000000000007 108.702 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.8 pt -106.16 130.51 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.086 -1.079 . . . . 75.420000000000002 108.086 174.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -94.26 108.12 20.03 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.954 -0.566 . . . . 74.409999999999997 109.996 -173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.74 116.25 32.33 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.992 -1.485 . . . . 72.450000000000003 106.992 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.03 117.04 13.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.931 0.395 . . . . 73.200000000000003 110.227 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -107.62 165.97 11.03 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.815 -0.63 . . . . 65.109999999999999 109.55 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.55 -28.68 32.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.963 0.887 . . . . 73.239999999999995 108.786 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -111.03 173.93 6.1 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.588 -1.634 . . . . 54.329999999999998 106.588 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.48 96.91 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 N-CA-C 106.018 -1.845 . . . . 63.340000000000003 106.018 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 m -105.13 106.74 17.37 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.65 -0.87 . . . . 75.420000000000002 108.65 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -56.29 -42.04 76.88 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.787 1.032 . . . . 74.5 113.787 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -148.7 129.31 14.05 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.857 -1.164 . . . . 73.129999999999995 107.857 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 4.1 t60 -100.29 -52.19 3.45 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.776 -1.194 . . . . 73.030000000000001 107.776 172.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.15 163.98 38.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.147 -1.057 . . . . 71.310000000000002 108.147 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 12.7 pt-20 -138.34 148.42 44.55 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.248 0.547 . . . . 74.230000000000004 110.631 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -105.29 131.72 52.39 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.18 -1.415 . . . . 71.439999999999998 107.18 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -122.95 130.93 53.44 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 116.319 -0.401 . . . . 60.509999999999998 110.444 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 46.3 mt -116.09 112.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.553 -2.017 . . . . 33.43 105.553 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -139.83 125.71 19.59 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.731 -0.47 . . . . 73.450000000000003 109.731 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 55.87 38.02 29.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.103 0.961 . . . . 73.239999999999995 112.353 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.52 -0.31 89.26 Favored Glycine 0 C--O 1.223 -0.564 0 C-N-CA 121.16 -0.543 . . . . 30.140000000000001 113.98 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -106.47 136.86 45.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.005 0.402 . . . . 55.210000000000001 110.046 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -107.79 119.51 39.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 71.010000000000005 108.127 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.35 146.64 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.733 -0.604 . . . . 62.299999999999997 112.329 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.04 123.98 58.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.508 -1.664 . . . . 61.130000000000003 106.508 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.43 122.38 68.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.419 -0.956 . . . . 51.310000000000002 108.419 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.12 134.58 35.67 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.994 -0.743 . . . . 73.230000000000004 108.994 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.74 9.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.068 0.461 . . . . 54.439999999999998 109.867 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.63 57.19 0.39 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 108.727 -1.749 . . . . 71.310000000000002 108.727 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 p -68.7 24.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.376 1.871 . . . . 74.400000000000006 114.349 -172.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -106.35 -26.47 11.48 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 116.431 -0.349 . . . . 74.129999999999995 111.546 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.537 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 2.9 m-20 -86.48 -18.94 30.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.601 -0.84 . . . . 73.340000000000003 111.738 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.98 74.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 119.664 -1.255 . . . . 55.149999999999999 113.073 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -87.76 128.56 35.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 110.036 -0.357 . . . . 75.510000000000005 110.036 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.0 m-85 -135.53 136.06 40.87 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.658 -0.867 . . . . 72.25 108.658 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 133.19 60.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.137 -1.431 . . . . 70.319999999999993 107.137 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.52 38.59 29.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.309 1.044 . . . . 74.129999999999995 108.688 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 64.18 14.85 8.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.046 1.498 . . . . 63.119999999999997 115.046 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -124.5 148.66 59.29 Favored Pre-proline 0 C--N 1.308 -1.202 0 C-N-CA 120.204 -0.599 . . . . 63.0 109.423 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 123.43 13.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.801 1.667 . . . . 74.349999999999994 108.502 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 120' ' ' GLN . 17.4 tpp85 -151.07 135.92 17.32 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.634 -0.827 . . . . 75.109999999999999 109.728 -170.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -96.7 -57.6 2.26 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.712 0.633 . . . . 61.219999999999999 110.552 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 134.04 55.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.834 -1.173 . . . . 64.150000000000006 107.834 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HB2' ' CG ' ' A' ' 117' ' ' ARG . 27.7 tp60 -155.08 132.9 11.42 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.226 0.329 . . . . 65.099999999999994 111.228 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.58 130.71 31.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.268 -1.382 . . . . 75.340000000000003 107.268 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.8 ptm -98.87 130.24 45.26 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.103 0.478 . . . . 70.450000000000003 110.183 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 2.8 tp60 -113.53 156.16 24.09 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.861 -0.609 . . . . 45.409999999999997 110.257 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 138' ' ' LEU . 45.2 m -61.34 123.29 17.35 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 122.31 -0.244 . . . . 63.520000000000003 110.379 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.07 -2.03 56.55 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.812 -0.515 . . . . 61.329999999999998 111.812 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.49 146.0 32.94 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 108.525 -0.917 . . . . 64.109999999999999 108.525 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.45 126.69 51.06 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.915 0.864 . . . . 65.329999999999998 110.654 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.41 131.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-N 114.599 -1.182 . . . . 65.219999999999999 108.02 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.2 tt0 -120.63 112.49 18.96 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.868 -1.16 . . . . 73.450000000000003 107.868 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.2 mt -109.66 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.237 -0.892 . . . . 73.439999999999998 109.18 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.19 -89.06 0.41 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.97 -1.252 . . . . 75.420000000000002 109.97 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -134.47 6.13 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.417 -0.586 . . . . 74.409999999999997 109.417 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.1 m-85 -84.59 147.77 26.82 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -124.88 120.06 30.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.84 -0.8 . . . . 73.319999999999993 108.84 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.33 138.07 50.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.387 -1.338 . . . . 64.109999999999999 107.387 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.11 127.13 74.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 107.539 -1.282 . . . . 72.150000000000006 107.539 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -95.49 126.95 41.13 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.435 0.459 . . . . 75.209999999999994 111.062 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HA ' HG23 ' A' ' 124' ' ' THR . 2.9 mm? -127.23 159.92 32.86 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.028 -0.73 . . . . 75.400000000000006 109.028 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.41 38.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.103 -0.703 . . . . 73.420000000000002 109.103 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.93 155.26 53.55 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.172 -0.537 . . . . 63.049999999999997 112.256 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -71.18 142.85 42.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.466 2.111 . . . . 75.150000000000006 111.52 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.98 65.27 0.8 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.163 -1.421 . . . . 74.109999999999999 107.163 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.607 -1.633 . . . . 65.540000000000006 108.499 -176.82 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 108.602 -0.888 . . . . 72.400000000000006 108.602 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.63 115.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.746 -0.835 . . . . 64.120000000000005 108.746 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -123.82 140.78 52.65 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.697 -0.683 . . . . 75.219999999999999 110.554 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -97.53 95.58 7.73 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.1 -1.074 . . . . 72.430000000000007 108.1 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.82 38.85 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.668 -1.151 . . . . 74.120000000000005 112.069 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.86 2.18 2.16 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.536 1.135 . . . . 75.219999999999999 113.759 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -13.77 59.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 72.230000000000004 112.758 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -69.03 -19.67 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.342 0.592 . . . . 62.32 109.929 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.09 -22.52 59.47 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.077 -0.51 . . . . 74.099999999999994 110.499 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -77.09 -29.95 55.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.231 0.539 . . . . 61.539999999999999 109.939 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -65.3 -47.47 76.5 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.941 -1.133 . . . . 73.510000000000005 107.941 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.32 -39.86 94.43 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.318 -1.31 . . . . 61.009999999999998 110.251 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 t -60.84 -39.01 87.48 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.786 1.234 . . . . 63.119999999999997 110.884 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB2' ' NH1' ' A' ' 114' ' ' ARG . 31.3 t -81.71 -16.52 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.583 -0.28 . . . . 63.100000000000001 110.512 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 m 71.57 31.63 2.2 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 122.525 1.155 . . . . 71.340000000000003 108.481 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.89 -151.05 19.69 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 115.097 -0.956 . . . . 70.150000000000006 112.04 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -84.78 137.97 32.88 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.144 0.577 . . . . 42.240000000000002 110.433 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.9 115.57 59.43 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 73.140000000000001 108.304 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 142.51 25.99 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.354 2.036 . . . . 74.209999999999994 114.9 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.12 126.51 30.18 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.466 -2.049 . . . . 61.310000000000002 105.466 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' THR . 55.4 p -91.32 -98.43 0.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.253 -0.979 . . . . 63.43 113.445 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -170.34 -169.97 0.89 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.007 1.323 . . . . 71.120000000000005 108.877 -177.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.07 -161.44 31.98 Favored Glycine 1 N--CA 1.386 -4.684 0 N-CA-C 105.961 -2.856 . . . . 54.009999999999998 105.961 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.9 -20.88 20.95 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.887 -1.153 . . . . 73.329999999999998 107.887 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.62 -10.7 59.96 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.193 -1.821 . . . . 64.129999999999995 112.965 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.428 ' O ' HD13 ' A' ' 42' ' ' LEU . 32.4 p-10 -80.39 -33.72 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.377 -0.529 . . . . 73.329999999999998 110.74 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 97' ' ' GLY . 2.1 mm? -128.13 82.92 67.53 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.141 -1.059 . . . . 71.239999999999995 108.141 173.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 4.0 Cg_exo -77.24 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.173 1.915 . . . . 72.109999999999999 111.758 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 142' ' ' ALA . . . -104.48 -7.05 20.08 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.449 -0.574 . . . . 75.310000000000002 109.449 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.06 43.75 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.386 -1.086 . . . . 71.409999999999997 110.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -126.07 149.27 49.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.376 -1.342 . . . . 74.510000000000005 107.376 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.07 157.75 42.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.606 -0.516 . . . . 61.109999999999999 109.606 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.17 142.18 51.44 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 110.003 -0.369 . . . . 70.030000000000001 110.003 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.476 HD13 HD23 ' A' ' 135' ' ' LEU . 3.7 pp -110.17 139.31 45.46 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.902 -0.777 . . . . 71.319999999999993 108.902 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.56 132.59 68.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 109.538 -0.542 . . . . 73.310000000000002 109.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -81.59 117.45 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.048 -1.464 . . . . 43.240000000000002 107.048 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -85.78 -38.22 18.44 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.489 -0.778 . . . . 64.439999999999998 109.119 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 22.6 tpt180 -148.16 136.9 21.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.2 -1.407 . . . . 75.439999999999998 107.2 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.68 -176.55 26.46 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.681 -0.968 . . . . 43.530000000000001 110.681 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 -45.18 12.01 Favored 'Trans proline' 0 C--N 1.327 -0.572 0 C-N-CA 122.519 2.146 . . . . 73.230000000000004 112.145 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -95.11 23.08 5.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 111.83 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 138.77 46.98 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.32 -0.4 . . . . 71.310000000000002 111.286 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.57 -25.8 23.32 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.878 -0.889 . . . . 45.5 110.878 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 150.2 21.81 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.033 0.444 . . . . 41.530000000000001 110.19 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -126.45 153.56 44.88 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.221 -1.029 . . . . 70.310000000000002 108.221 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -128.14 130.18 47.69 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.82 -0.807 . . . . 72.439999999999998 108.82 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 tp -95.53 130.8 42.25 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.997 -0.547 . . . . 73.530000000000001 110.197 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -107.31 105.19 15.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.044 -1.095 . . . . 65.010000000000005 108.044 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.42 14.89 6.08 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.847 1.308 . . . . 63.310000000000002 107.709 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -114.43 155.01 46.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 113.825 -1.534 . . . . 61.229999999999997 108.507 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 66.5 Cg_endo -72.79 -14.64 26.9 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.734 2.289 . . . . 73.329999999999998 113.61 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 95.3 m -153.22 128.94 10.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.562 -0.711 . . . . 71.340000000000003 110.54 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 15.4 m -130.09 126.89 38.67 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.66 -0.496 . . . . 71.439999999999998 109.66 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.0 m -90.55 129.59 36.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.639 -0.874 . . . . 64.310000000000002 108.639 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.02 134.56 55.12 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.364 0.602 . . . . 55.119999999999997 110.66 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.37 -170.09 33.37 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.438 -2.665 . . . . 61.310000000000002 106.438 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -105.96 118.18 35.95 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.946 1.373 . . . . 71.340000000000003 110.396 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.414 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 17.7 m170 -172.84 152.02 2.34 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 127.184 2.194 . . . . 65.129999999999995 106.06 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.83 -17.6 28.95 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 121.627 1.552 . . . . 64.219999999999999 108.952 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 73' ' ' HIS . 8.7 mm-40 -76.81 -26.84 54.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.952 -1.476 . . . . 74.150000000000006 110.035 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 45.6 m -67.61 132.25 47.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.707 -0.849 . . . . 64.120000000000005 108.707 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.72 -41.44 95.96 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.08 -0.711 . . . . 60.420000000000002 109.08 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.6 pt -107.64 118.8 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.646 -0.872 . . . . 73.219999999999999 108.646 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.54 109.42 20.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.755 0.788 . . . . 74.430000000000007 110.512 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.16 140.37 49.6 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.438 -1.69 . . . . 71.239999999999995 106.438 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.32 117.67 34.65 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.363 -0.977 . . . . 73.510000000000005 108.363 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -102.62 173.85 6.16 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.927 -1.033 . . . . 71.209999999999994 111.956 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -66.14 -30.94 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 124.316 1.047 . . . . 71.010000000000005 108.732 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 m -117.17 163.1 16.8 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 106.899 -1.519 . . . . 52.229999999999997 106.899 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.32 96.92 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 N-CA-C 104.434 -2.432 . . . . 74.219999999999999 104.434 168.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 131.54 39.66 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.494 -0.775 . . . . 71.530000000000001 110.326 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 87' ' ' ARG . 36.9 mtt180 -74.23 -47.59 34.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 123.224 1.488 . . . . 72.450000000000003 107.117 -175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -149.54 115.55 5.69 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 112.557 -2.11 . . . . 72.430000000000007 107.807 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -99.22 -47.2 5.28 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.735 -0.839 . . . . 65.230000000000004 108.735 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.54 151.51 40.32 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.895 -0.78 . . . . 60.200000000000003 108.895 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.8 134.55 54.41 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.902 -1.147 . . . . 52.409999999999997 107.902 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.7 m-85 -105.2 121.43 43.83 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.257 -1.016 . . . . 74.010000000000005 108.257 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -115.85 123.74 48.93 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.171 -1.048 . . . . 63.299999999999997 108.171 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.9 mp -104.49 123.15 58.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 106.609 -1.626 . . . . 63.310000000000002 106.609 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -136.87 123.66 21.24 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.986 -1.116 . . . . 72.5 107.986 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 56.13 36.13 26.87 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.605 1.162 . . . . 71.409999999999997 111.102 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' HD12 ' A' ' 42' ' ' LEU . . . 78.97 -0.32 79.2 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 113.374 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.7 149.7 23.88 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.002 -0.74 . . . . 73.430000000000007 109.002 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.8 117.54 33.11 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.126 -0.488 . . . . 63.219999999999999 110.089 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.78 129.93 55.51 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.152 0.501 . . . . 71.120000000000005 109.658 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.49 124.6 59.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.526 -0.916 . . . . 63.509999999999998 108.526 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.22 137.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.257 -0.646 . . . . 62.030000000000001 109.257 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.81 140.94 30.02 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.64 -0.709 . . . . 64.420000000000002 110.841 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.63 14.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 122.39 1.09 . . . . 74.439999999999998 108.555 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.93 48.48 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.572 -1.411 . . . . 72.109999999999999 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -60.06 -2.6 0.45 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.876 1.67 . . . . 75.230000000000004 113.631 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.14 -26.0 17.62 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.447 -0.575 . . . . 75.430000000000007 109.447 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -94.71 -18.65 21.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 73.219999999999999 111.83 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.92 77.1 1.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.012 -1.089 . . . . 61.109999999999999 112.643 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.1 m -87.02 128.68 35.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.014 0.435 . . . . 75.109999999999999 110.388 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 35.9 m-85 -133.64 127.41 32.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.261 -0.427 . . . . 72.319999999999993 110.516 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.15 137.66 55.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 105.398 -2.075 . . . . 64.230000000000004 105.398 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 57.3 33.77 23.78 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 106.738 -1.579 . . . . 64.239999999999995 106.738 -166.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.496 ' NH1' ' HB2' ' A' ' 29' ' ' SER . 73.6 mtt180 57.94 11.43 1.43 Allowed 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 123.187 0.595 . . . . 63.340000000000003 111.655 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -107.7 144.47 29.36 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 124.388 1.075 . . . . 75.219999999999999 110.248 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.14 123.93 12.26 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.089 1.859 . . . . 64.209999999999994 108.787 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 117' ' ' ARG . 3.7 mmp_? -135.82 155.85 49.71 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.667 0.988 . . . . 73.150000000000006 113.667 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -99.2 -41.85 7.31 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.9 -1.5 . . . . 62.219999999999999 107.434 171.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.4 143.61 25.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.52 -1.218 . . . . 71.310000000000002 108.197 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 138.15 19.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.011 -1.107 . . . . 54.509999999999998 108.011 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.73 116.7 40.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 105.412 -2.07 . . . . 75.019999999999996 105.412 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 77.4 mtp -89.75 149.08 22.88 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 114.163 1.172 . . . . 64.129999999999995 114.163 -168.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -112.43 157.38 21.14 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.661 -1.609 . . . . 61.420000000000002 107.778 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.6 t -66.27 127.39 32.01 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.169 -0.613 . . . . 73.129999999999995 109.829 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 0.03 57.32 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.266 -0.734 . . . . 71.439999999999998 111.266 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -82.77 152.27 25.77 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.964 -0.384 . . . . 72.019999999999996 109.964 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -115.71 144.18 44.32 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.263 0.554 . . . . 75.420000000000002 112.237 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.6 mt -117.91 131.88 69.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.442 . . . . 74.420000000000002 107.108 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 111' ' ' TYR . 54.9 mt-30 -117.84 120.55 38.23 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.56 -0.904 . . . . 73.319999999999993 108.56 175.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.75 114.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.301 -0.863 . . . . 70.010000000000005 108.836 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.0 -80.98 0.57 Allowed Glycine 0 C--O 1.206 -1.594 0 N-CA-C 110.006 -1.238 . . . . 35.130000000000003 110.006 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -154.87 8.28 0.3 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.436 0.294 . . . . 72.299999999999997 111.112 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 31.1 p90 -107.39 160.29 15.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.881 -0.785 . . . . 62.43 108.881 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -124.76 137.82 54.31 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.234 -0.986 . . . . 64.120000000000005 112.329 -168.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.476 HD23 HD13 ' A' ' 49' ' ' LEU . 3.0 mp -122.32 139.82 53.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.698 -1.223 . . . . 75.209999999999994 107.698 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.12 124.93 69.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.768 -1.197 . . . . 55.32 107.768 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -98.28 118.26 34.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.188 -0.671 . . . . 75.25 109.188 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.4 mt -122.34 131.67 54.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.972 -0.381 . . . . 75.239999999999995 109.972 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.29 119.57 28.82 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.458 -1.682 . . . . 72.219999999999999 106.458 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.01 -70.66 0.29 Allowed Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.519 -1.324 . . . . 73.099999999999994 115.356 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 43' ' ' PRO . 25.7 Cg_exo -57.74 141.28 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.693 1.595 . . . . 71.25 114.785 -172.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . . . -161.84 29.34 0.12 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.011 -2.588 . . . . 71.540000000000006 104.011 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.416 -2.154 0 CA-C-N 112.99 -1.914 . . . . 41.140000000000001 108.31 -169.134 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 110.009 -0.367 . . . . 73.219999999999999 110.009 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 47.1 t -87.17 122.44 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.302 -0.629 . . . . 61.539999999999999 109.302 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -123.66 129.02 50.49 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.872 0.368 . . . . 74.530000000000001 111.855 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -96.55 116.03 28.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.266 -1.753 . . . . 75.129999999999995 106.266 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.36 -166.71 2.63 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.546 -0.862 . . . . 73.239999999999995 113.315 -171.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.16 -14.28 1.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.886 2.074 . . . . 73.040000000000006 115.059 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 22' ' ' LEU . 1.8 pt? -64.66 -23.11 67.15 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.119 -0.363 . . . . 73.439999999999998 111.744 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.19 -22.5 63.9 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.877 0.37 . . . . 72.450000000000003 111.823 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -91.8 -42.04 10.32 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.822 -1.547 . . . . 74.400000000000006 106.822 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -26.37 67.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.642 1.177 . . . . 54.32 109.397 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.6 tpp -51.75 -26.13 8.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.757 1.223 . . . . 65.209999999999994 112.167 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.49 -38.34 86.94 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 120.725 0.298 . . . . 61.340000000000003 110.472 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -72.91 -34.96 66.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.234 -0.654 . . . . 64.439999999999998 109.234 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.45 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 17.9 m -68.81 -30.5 69.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.901 -0.591 . . . . 71.120000000000005 110.065 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.4 m -81.55 107.03 13.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.18 0.514 . . . . 54.420000000000002 110.797 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 179.65 38.69 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 108.997 -1.641 . . . . 44.439999999999998 108.997 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.6 m -74.94 124.16 26.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 117.69 0.745 . . . . 72.099999999999994 109.646 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.45 150.24 38.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 N-CA-C 108.251 -1.018 . . . . 53.210000000000001 108.251 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 125' ' ' GLY . 53.4 Cg_exo -57.18 154.97 31.25 Favored 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.551 2.167 . . . . 52.310000000000002 111.876 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.07 145.67 27.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.695 -0.684 . . . . 33.310000000000002 112.335 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.426 ' HB3' HD21 ' A' ' 41' ' ' ASN . 66.1 m -116.07 148.3 40.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.122 -1.066 . . . . 75.439999999999998 108.122 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -116.74 -60.68 1.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.931 0.396 . . . . 75.140000000000001 111.384 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.83 -63.55 0.18 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.467 -0.653 . . . . 50.009999999999998 111.467 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.56 54.5 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.123 0.487 . . . . 73.409999999999997 110.95 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.52 -5.92 47.62 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.424 -0.807 . . . . 63.219999999999999 111.08 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 36' ' ' SER . 3.1 m-20 -82.09 -42.17 19.54 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.414 -0.812 . . . . 62.420000000000002 110.131 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.32 83.22 60.21 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 109.086 -0.709 . . . . 54.119999999999997 109.086 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.39 -65.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.848 2.365 . . . . 73.150000000000006 112.269 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.13 -16.19 59.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 71.230000000000004 111.012 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.97 -7.44 77.6 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 110.975 -0.85 . . . . 75.340000000000003 110.975 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -120.08 157.08 29.7 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.624 -1.621 . . . . 74.439999999999998 106.624 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.89 156.87 43.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.583 -0.525 . . . . 72.25 109.583 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.95 140.82 52.57 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.996 0.427 . . . . 72.219999999999999 110.712 -178.303 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.417 HD13 HD23 ' A' ' 135' ' ' LEU . 1.5 pp -112.19 140.73 46.65 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 116.288 -0.414 . . . . 74.420000000000002 110.931 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.71 128.08 71.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.45 118.92 26.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.736 -1.209 . . . . 73.409999999999997 107.736 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -83.4 -32.63 26.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.62 0.724 . . . . 74.299999999999997 110.131 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 20.2 tpp180 -154.01 148.81 26.53 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.992 -1.485 . . . . 72.439999999999998 106.992 -177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.28 -174.85 17.86 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 109.722 -1.351 . . . . 61.520000000000003 109.722 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -65.2 -37.95 29.58 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.309 2.006 . . . . 64.230000000000004 111.029 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.61 14.37 11.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.749 -1.114 . . . . 72.109999999999999 110.862 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 129.32 41.55 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.762 0.315 . . . . 63.210000000000001 111.295 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.0 -26.05 24.38 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.95 -0.568 . . . . 54.229999999999997 112.188 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.81 144.77 29.9 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.839 0.352 . . . . 53.130000000000003 110.133 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -123.69 137.54 54.69 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.992 -0.744 . . . . 73.219999999999999 108.992 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.04 130.56 52.76 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.705 -0.48 . . . . 72.140000000000001 109.705 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.75 128.4 36.67 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.644 -1.243 . . . . 75.340000000000003 107.644 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.731 HD22 HG21 ' A' ' 68' ' ' THR . 26.6 mt -106.78 123.95 48.89 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.057 -1.09 . . . . 61.409999999999997 108.057 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -136.57 1.11 2.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.688 0.996 . . . . 64.450000000000003 113.688 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.545 ' O ' HD13 ' A' ' 94' ' ' ILE . 28.1 pt20 -107.24 152.88 41.33 Favored Pre-proline 0 C--O 1.211 -0.961 0 C-N-CA 119.556 -0.857 . . . . 74.510000000000005 110.13 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 8.8 Cg_endo -52.2 -21.56 13.32 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 124.088 3.192 . . . . 74.310000000000002 114.996 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.7 m -142.51 121.66 12.97 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.723 -0.473 . . . . 71.420000000000002 109.723 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.731 HG21 HD22 ' A' ' 63' ' ' LEU . 67.9 m -129.3 113.27 14.78 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.162 -0.681 . . . . 73.409999999999997 109.162 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -94.28 143.1 26.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.707 -0.797 . . . . 74.420000000000002 109.811 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.16 135.02 54.73 Favored 'General case' 0 C--O 1.279 2.644 0 C-N-CA 122.63 0.372 . . . . 52.420000000000002 111.516 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.22 -142.12 10.24 Favored Glycine 0 N--CA 1.435 -1.401 0 O-C-N 124.759 1.287 . . . . 60.340000000000003 111.882 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 86' ' ' SER . 17.9 mmt85 -88.04 154.74 20.24 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.615 1.966 . . . . 62.299999999999997 110.272 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.433 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 22.9 m170 89.17 130.06 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.718 1.607 . . . . 63.240000000000002 111.057 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.21 -3.22 8.27 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.818 2.345 . . . . 75.230000000000004 113.283 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 13.2 pt-20 -73.56 -25.3 60.31 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.888 -0.782 . . . . 75.109999999999999 108.888 173.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.9 m -78.55 143.62 36.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.335 -1.357 . . . . 61.039999999999999 107.335 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' A' ' 68' ' ' THR . 30.0 t70 -69.44 -45.72 68.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.78 0.324 . . . . 74.010000000000005 111.142 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.3 pt -107.45 109.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 121.859 0.838 . . . . 72.120000000000005 111.032 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -87.86 115.81 25.59 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.514 -1.221 . . . . 71.329999999999998 110.652 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.21 139.98 49.79 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.1 -1.815 . . . . 72.540000000000006 106.1 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -92.2 117.05 29.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.474 -1.29 . . . . 52.240000000000002 110.197 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 171.69 7.82 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 110.24 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.93 -29.38 17.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.343 1.057 . . . . 64.109999999999999 109.76 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.3 t -131.26 -163.17 1.29 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.484 -0.932 . . . . 74.450000000000003 108.484 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -84.05 97.33 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.791 0.805 . . . . 65.450000000000003 109.008 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 16.4 t -95.9 77.83 3.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.879 -1.526 . . . . 64.329999999999998 106.879 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -56.68 -44.48 81.48 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 112.825 0.676 . . . . 74.329999999999998 112.825 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -163.42 97.3 0.88 Allowed 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.108 -1.812 . . . . 75.209999999999994 106.108 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 23.7 t-160 -92.77 -52.04 4.8 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.883 -0.727 . . . . 75.109999999999999 109.483 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -128.25 150.14 50.17 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 118.986 -1.086 . . . . 74.239999999999995 110.246 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.36 134.46 36.0 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.97 -0.752 . . . . 74.430000000000007 108.97 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 30.0 m-85 -104.27 120.31 40.89 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.43 -1.693 . . . . 54.229999999999997 106.43 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -110.19 133.75 52.91 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.61 -1.256 . . . . 72.310000000000002 107.61 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 1.9 mp -103.6 113.47 40.52 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 105.64 -1.985 . . . . 65.530000000000001 105.64 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -130.0 122.52 28.61 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.36 -1.291 . . . . 65.310000000000002 108.19 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 56.54 36.86 28.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.937 0.895 . . . . 71.349999999999994 110.786 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.44 1.69 77.01 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.218 -0.447 . . . . 71.430000000000007 113.873 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.23 152.78 29.34 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.852 0.461 . . . . 75.510000000000005 110.337 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -102.2 117.92 35.79 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.22 0.533 . . . . 73.349999999999994 110.483 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -114.89 131.85 56.72 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.078 -1.082 . . . . 72.010000000000005 108.078 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 48.0 t -103.55 124.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.817 -0.809 . . . . 65.239999999999995 108.817 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.71 129.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 115.586 -0.734 . . . . 75.329999999999998 109.247 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.0 121.9 23.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.495 -1.669 . . . . 53.229999999999997 106.495 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.43 12.42 7.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.032 0.444 . . . . 75.420000000000002 110.853 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . 169.65 83.35 0.05 OUTLIER Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.595 -1.002 . . . . 72.049999999999997 110.595 -178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.8 m -60.63 100.44 0.11 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 122.832 0.453 . . . . 64.319999999999993 110.735 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 tp -73.68 -52.31 13.72 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.988 -1.115 . . . . 74.019999999999996 107.988 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -121.44 -19.15 7.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.092 0.949 . . . . 55.130000000000003 108.613 170.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.08 130.41 3.74 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 108.446 -1.862 . . . . 72.409999999999997 108.446 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 56.3 m -81.73 130.18 34.97 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 117.13 0.465 . . . . 73.230000000000004 109.984 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 98.1 m-85 -105.43 126.24 51.89 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.29 -0.633 . . . . 70.299999999999997 109.29 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.57 122.82 67.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 105.642 -1.984 . . . . 73.420000000000002 105.642 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 56.67 39.65 29.64 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.49 1.138 . . . . 61.420000000000002 108.155 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER 62.5 8.69 3.0 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.267 1.827 . . . . 73.409999999999997 113.44 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.28 134.53 20.44 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.949 -0.76 . . . . 75.540000000000006 108.949 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.8 123.01 12.36 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 121.977 1.784 . . . . 74.400000000000006 109.737 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -145.33 148.71 33.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.959 -0.756 . . . . 63.020000000000003 108.959 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -95.1 -70.16 0.72 Allowed 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.158 -0.682 . . . . 73.340000000000003 109.158 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -124.53 134.47 52.99 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 119.715 -0.794 . . . . 32.450000000000003 109.835 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -155.19 147.04 23.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.095 -0.502 . . . . 74.239999999999995 110.832 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.24 132.12 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.698 -1.593 . . . . 74.549999999999997 106.698 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.2 tpp -90.15 148.79 22.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 112.963 0.727 . . . . 73.150000000000006 112.963 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.2 156.35 28.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.774 -1.103 . . . . 62.509999999999998 108.996 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.7 t -79.56 129.36 34.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.79 0.805 . . . . 64.329999999999998 111.252 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.546 ' O ' ' HD2' ' A' ' 34' ' ' PRO . . . 98.95 -2.84 58.37 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 115.485 -0.779 . . . . 54.030000000000001 111.82 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.97 153.25 21.18 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.403 -0.592 . . . . 70.230000000000004 109.403 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.03 132.18 56.73 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.692 0.758 . . . . 74.25 112.077 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.9 mt -111.16 126.37 68.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.444 -1.317 . . . . 51.130000000000003 107.444 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' ARG . 25.9 tt0 -106.41 114.99 29.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.53 0.681 . . . . 61.420000000000002 110.62 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mm -110.61 133.69 55.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.026 -1.443 . . . . 71.209999999999994 108.09 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.88 -93.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.375 -1.09 . . . . 65.5 110.375 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -140.03 9.06 2.32 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.563 0.345 . . . . 61.5 110.941 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.608 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.0 p90 -131.7 152.53 50.81 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.033 -0.417 . . . . 60.340000000000003 111.775 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -112.83 146.15 39.39 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 114.126 1.158 . . . . 74.439999999999998 114.126 -174.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 49' ' ' LEU . 4.4 mp -114.55 141.79 47.28 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.285 -1.78 . . . . 74.230000000000004 107.454 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -109.4 121.57 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.888 -1.523 . . . . 75.409999999999997 106.888 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -91.65 116.22 28.69 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.681 -0.69 . . . . 75.200000000000003 109.944 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.84 147.93 37.53 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.687 -0.486 . . . . 75.140000000000001 109.687 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.03 142.41 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.776 -0.453 . . . . 71.510000000000005 109.776 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.3 136.53 47.8 Favored Glycine 0 N--CA 1.441 -1.013 0 O-C-N 123.914 0.759 . . . . 63.030000000000001 112.496 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.19 162.46 35.78 Favored 'Trans proline' 0 C--O 1.251 1.156 0 C-N-CA 123.192 2.595 . . . . 61.130000000000003 112.357 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.5 46.02 0.61 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.96 0.886 . . . . 73.510000000000005 110.883 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.421 -1.326 . . . . 73.299999999999997 107.421 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 108.483 -0.932 . . . . 72.329999999999998 108.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 91.2 t -83.56 122.91 38.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.071 -0.344 . . . . 74.209999999999994 110.071 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -115.39 139.91 49.6 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.248 0.547 . . . . 75.420000000000002 110.369 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -88.3 118.23 27.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.421 -0.809 . . . . 74.340000000000003 109.594 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -128.84 169.81 14.13 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.547 -0.752 . . . . 52.439999999999998 110.311 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.19 8.21 24.92 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.989 1.716 . . . . 71.510000000000005 112.145 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -61.28 -4.78 1.3 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.604 1.162 . . . . 75.109999999999999 113.861 -175.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.47 -40.31 86.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.285 0.634 . . . . 64.040000000000006 109.32 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -64.97 -27.71 69.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.78 -0.645 . . . . 73.430000000000007 111.323 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -69.07 -48.73 61.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.45 -0.341 . . . . 72.019999999999996 110.931 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 ptp -68.74 -17.98 64.14 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.721 0.296 . . . . 73.230000000000004 110.996 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.97 -50.17 4.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 112.079 0.4 . . . . 61.109999999999999 112.079 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 m -102.05 -27.61 12.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.565 1.321 . . . . 74.430000000000007 114.565 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -76.2 -21.67 56.19 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.287 -1.005 . . . . 63.039999999999999 108.287 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -70.58 119.57 14.93 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.655 -1.157 . . . . 62.43 108.429 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.06 -37.25 0.53 Allowed Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 106.909 -2.476 . . . . 55.009999999999998 106.909 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -77.81 122.12 25.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.431 -0.951 . . . . 44.200000000000003 108.431 173.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.64 155.57 62.08 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 116.32 -0.4 . . . . 72.25 109.965 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.03 158.33 21.83 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.95 2.433 . . . . 72.230000000000004 111.669 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.48 156.93 25.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.811 -0.44 . . . . 74.420000000000002 109.811 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -118.26 134.56 54.92 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 108.744 -0.836 . . . . 74.230000000000004 108.744 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.2 p -144.44 162.45 36.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.793 -1.188 . . . . 75.310000000000002 107.793 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.89 18.14 56.29 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.402 -1.079 . . . . 45.420000000000002 110.402 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.1 11.3 23.57 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.396 0.679 . . . . 74.340000000000003 111.179 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.26 3.64 5.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.392 0.677 . . . . 71.420000000000002 112.279 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.04 -16.72 18.58 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.223 -1.029 . . . . 75.329999999999998 108.223 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.2 mm? 58.34 85.68 0.18 Allowed Pre-proline 0 C--O 1.222 -0.37 0 CA-C-N 115.048 -0.978 . . . . 73.409999999999997 111.101 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 18.9 Cg_endo -55.23 -54.04 4.94 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.923 2.415 . . . . 73.200000000000003 113.166 -174.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.46 0.76 51.35 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.251 -0.432 . . . . 61.25 111.108 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 10.8 70.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 116.344 -0.389 . . . . 52.439999999999998 112.928 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 m -124.13 149.45 46.23 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.476 -0.565 . . . . 71.140000000000001 109.476 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.26 157.41 44.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.802 -1.184 . . . . 71.439999999999998 107.802 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.54 155.34 50.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.43 -0.508 . . . . 75.400000000000006 111.328 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.3 pp -119.79 134.53 55.2 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.927 -0.578 . . . . 72.510000000000005 109.812 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.09 132.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.121 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG21 ' ND2' ' A' ' 56' ' ' ASN . 21.8 t -83.55 118.39 30.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.199 -1.037 . . . . 71.420000000000002 108.199 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.74 -31.62 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.554 0.693 . . . . 74.540000000000006 110.338 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 64.6 ttt180 -137.8 136.63 37.41 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.894 -1.15 . . . . 74.109999999999999 107.894 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.27 176.91 15.97 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 110.195 -1.162 . . . . 44.240000000000002 110.195 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.68 -32.89 18.0 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 122.268 1.979 . . . . 72.299999999999997 110.986 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.49 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.2 p-10 -99.67 23.32 9.71 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.959 -1.019 . . . . 71.530000000000001 110.561 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.43 57.6 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.071 -0.513 . . . . 64.120000000000005 110.718 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.94 -18.28 50.16 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.856 -0.898 . . . . 41.299999999999997 110.856 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 147.42 25.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.76 0.314 . . . . 73.349999999999994 110.328 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 60' ' ' ARG . 5.7 ptp180 -124.42 139.23 54.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.937 -1.134 . . . . 74.530000000000001 107.937 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.78 134.7 54.92 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.032 -1.099 . . . . 73.430000000000007 108.032 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tt -104.29 128.59 52.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.64 0.734 . . . . 63.130000000000003 110.703 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 76.1 mt -103.54 107.55 18.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.642 -0.708 . . . . 64.120000000000005 109.768 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -146.64 17.24 1.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.781 1.277 . . . . 60.030000000000001 107.87 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 63' ' ' LEU . 3.3 pm0 -118.12 149.87 46.44 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.294 -1.321 . . . . 74.430000000000007 109.536 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.2 Cg_exo -55.25 -30.66 72.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.148 2.566 . . . . 72.019999999999996 114.453 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 m -149.45 131.68 15.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.686 -0.805 . . . . 63.030000000000001 111.062 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 m -133.81 114.08 12.98 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.298 -0.63 . . . . 75.109999999999999 109.298 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -88.6 132.53 34.51 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.703 -0.851 . . . . 62.140000000000001 108.703 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 140.54 49.83 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 120.915 0.388 . . . . 52.219999999999999 111.257 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.45 -160.42 30.94 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 107.719 -2.152 . . . . 63.530000000000001 107.719 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 35.9 ttp180 -119.31 117.71 29.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.162 0.981 . . . . 75.340000000000003 110.348 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 0.5 OUTLIER 161.54 158.79 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 104.094 -2.558 . . . . 73.349999999999994 104.094 173.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 18.9 Cg_endo -64.54 -9.91 22.32 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 121.969 1.78 . . . . 74.140000000000001 112.229 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.51 -10.98 58.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.645 -0.707 . . . . 35.450000000000003 110.197 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 m -87.25 143.88 27.07 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 106.526 -1.657 . . . . 74.239999999999995 106.526 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.1 -42.78 36.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.849 0.833 . . . . 74.319999999999993 109.883 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.79 132.51 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 107.372 -1.344 . . . . 53.420000000000002 107.372 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -94.02 117.18 29.75 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.401 0.62 . . . . 61.039999999999999 111.913 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.4 140.28 49.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.032 -2.211 . . . . 75.239999999999995 105.032 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 26.7 t70 -91.41 116.22 28.67 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.277 -1.369 . . . . 64.209999999999994 109.17 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.454 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 15.6 t0 -96.21 167.03 11.45 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.46 -0.791 . . . . 74.430000000000007 109.244 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.76 -30.64 29.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.044 0.449 . . . . 71.239999999999995 109.934 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -137.64 -152.81 0.45 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.257 -0.645 . . . . 63.530000000000001 109.257 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.54 98.37 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.554 0.693 . . . . 74.040000000000006 109.941 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.2 m -124.07 84.87 2.33 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.316 -1.364 . . . . 64.530000000000001 107.316 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -62.28 -44.61 96.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.04 -0.982 . . . . 72.510000000000005 111.533 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -118.78 110.93 17.82 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.003 -1.11 . . . . 53.439999999999998 108.003 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.52 ' ND1' HG23 ' A' ' 130' ' ' ILE . 11.1 t-160 -100.22 -50.79 3.84 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.592 -1.262 . . . . 72.239999999999995 107.592 171.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.11 148.85 37.29 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.286 -1.005 . . . . 74.030000000000001 108.286 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -123.83 134.88 53.52 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.469 0.652 . . . . 64.530000000000001 110.043 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.26 124.73 50.03 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.836 -1.172 . . . . 74.420000000000002 107.836 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -115.22 127.58 55.6 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.477 -0.935 . . . . 65.430000000000007 108.477 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -121.35 113.19 38.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.351 -1.351 . . . . 74.25 107.351 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -136.3 131.02 33.81 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.817 -0.438 . . . . 63.399999999999999 109.817 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 55.67 37.05 28.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.059 0.944 . . . . 64.140000000000001 111.804 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.09 3.97 90.59 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.23 -0.895 . . . . 71.140000000000001 113.461 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -109.0 139.14 44.28 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.552 -0.536 . . . . 73.25 109.552 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -114.94 122.02 44.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.697 -0.683 . . . . 73.540000000000006 110.139 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.62 146.04 48.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.765 -0.457 . . . . 70.230000000000004 109.765 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.96 124.26 70.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.784 -1.191 . . . . 71.400000000000006 107.784 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.11 124.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.786 -0.82 . . . . 65.409999999999997 108.786 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -81.78 121.86 26.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.272 -1.01 . . . . 64.120000000000005 108.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 m -117.04 -11.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.955 -0.566 . . . . 62.439999999999998 110.876 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.35 46.9 1.1 Allowed Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 108.406 -1.878 . . . . 51.229999999999997 108.406 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.8 p -65.61 -3.16 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.773 1.229 . . . . 71.340000000000003 113.389 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.93 -26.65 59.77 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.045 -0.724 . . . . 40.450000000000003 109.045 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 17' ' ' VAL . 94.3 m-20 -105.62 -21.72 13.13 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.77 -0.826 . . . . 71.239999999999995 108.77 174.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.07 119.27 0.27 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.122 -0.944 . . . . 62.329999999999998 114.03 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.4 m -87.07 138.27 31.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.048 -1.093 . . . . 52.130000000000003 108.048 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 84.8 m-85 -119.13 129.16 54.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.946 -0.39 . . . . 75.430000000000007 109.946 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.9 t -114.92 120.58 64.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.532 -1.655 . . . . 72.129999999999995 106.532 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 56.27 37.96 29.33 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.564 1.146 . . . . 74.329999999999998 110.967 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 mtm-85 66.19 19.68 11.1 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 114.222 -1.354 . . . . 74.340000000000003 112.74 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.51 133.19 23.03 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.24 -1.022 . . . . 73.430000000000007 108.24 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.51 123.6 11.0 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.57 1.513 . . . . 64.430000000000007 109.401 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -144.93 138.69 27.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.199 -1.037 . . . . 75.5 108.199 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -86.3 -37.73 18.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.13 0.49 . . . . 75.239999999999995 110.422 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.63 136.28 25.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.12 -1.067 . . . . 72.120000000000005 108.12 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.19 143.09 25.71 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 63.229999999999997 108.43 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -88.23 126.18 41.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.473 -2.047 . . . . 64.340000000000003 105.473 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.41 ' HE2' HG12 ' A' ' 128' ' ' ILE . 6.6 tpt -87.99 130.71 34.88 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 113.394 0.887 . . . . 73.540000000000006 113.394 -164.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.498 ' HB3' ' OD2' ' A' ' 126' ' ' ASP . 16.3 tt0 -107.72 141.9 38.55 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.38 1.472 . . . . 65.120000000000005 109.525 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -67.03 133.53 50.1 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.046 -0.724 . . . . 75.409999999999997 109.046 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.25 -2.71 56.5 Favored Glycine 0 C--O 1.252 1.269 0 N-CA-C 111.456 -0.658 . . . . 62.43 111.456 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 123' ' ' GLN . 96.7 m-20 -82.47 151.38 26.55 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.384 0.612 . . . . 61.299999999999997 110.402 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -112.32 131.54 55.46 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.516 -0.765 . . . . 75.530000000000001 109.718 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.41 HG12 ' HE2' ' A' ' 122' ' ' MET . 21.2 mt -107.64 131.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 106.594 -1.632 . . . . 73.439999999999998 106.594 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 26.2 tt0 -112.6 118.24 34.53 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.251 -1.018 . . . . 73.140000000000001 108.251 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.52 HG23 ' ND1' ' A' ' 89' ' ' HIS . 43.7 mm -109.1 104.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.779 -1.1 . . . . 72.450000000000003 108.137 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.4 -83.95 0.64 Allowed Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.31 -0.859 . . . . 63.049999999999997 111.225 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -133.82 -12.89 2.57 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.114 0.566 . . . . 73.310000000000002 110.296 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.648 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.317 42.7 p90 -99.0 170.34 8.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 114.29 1.218 . . . . 64.099999999999994 114.29 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -118.46 126.07 51.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.604 . . . . 52.219999999999999 111.393 -164.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.09 140.23 52.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.066 -1.087 . . . . 72.010000000000005 108.066 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.3 t -115.35 127.51 72.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.253 -0.647 . . . . 72.140000000000001 109.253 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -98.33 121.28 40.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.956 -0.757 . . . . 75.450000000000003 108.956 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -140.49 160.63 39.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 110.553 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.72 127.29 32.4 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.525 -1.287 . . . . 74.450000000000003 107.525 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.13 -122.47 1.13 Allowed Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 115.423 -0.808 . . . . 70.349999999999994 113.2 -172.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 157.69 55.75 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.085 1.857 . . . . 74.420000000000002 114.273 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.75 20.97 11.62 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.408 -2.071 . . . . 71.230000000000004 105.408 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 112.803 -1.998 . . . . 75.209999999999994 108.836 -176.051 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 107.226 -1.398 . . . . 34.210000000000001 107.226 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.1 t -81.92 115.16 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.785 0.802 . . . . 73.219999999999999 108.914 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 29.8 p90 -119.43 142.18 48.46 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.83 -1.077 . . . . 75.530000000000001 110.469 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -125.93 90.62 3.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.406 0.622 . . . . 71.329999999999998 110.616 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.24 -84.42 0.15 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.723 -0.671 . . . . 75.519999999999996 110.419 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.06 -11.47 59.91 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.621 -0.718 . . . . 72.409999999999997 109.797 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 89.8 mt -64.31 -15.83 61.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.012 -0.995 . . . . 71.299999999999997 111.784 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -45.78 90.32 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.302 -0.629 . . . . 74.340000000000003 109.302 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -86.04 -33.57 20.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 109.68 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 4.6 tp10 -59.11 -33.14 70.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.418 -0.81 . . . . 73.519999999999996 110.414 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 42.3 tpp -59.47 -49.55 77.37 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.527 -0.306 . . . . 54.229999999999997 111.585 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.46 -29.49 67.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.107 0.48 . . . . 75.540000000000006 110.927 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -73.89 -25.77 60.2 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.588 0.709 . . . . 73.450000000000003 110.583 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.482 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 8.2 t -89.71 -15.73 31.9 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.468 -0.787 . . . . 73.109999999999999 110.625 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 m -62.69 101.57 0.26 Allowed 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.384 0.611 . . . . 60.009999999999998 110.59 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.69 -146.66 15.64 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.652 -1.379 . . . . 71.109999999999999 109.652 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 54.3 m -116.43 134.25 55.08 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.277 0.539 . . . . 72.450000000000003 110.686 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.18 94.65 5.81 Favored Pre-proline 0 C--O 1.246 0.872 0 N-CA-C 109.651 -0.5 . . . . 61.520000000000003 109.651 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 32' ' ' THR . 4.0 Cg_exo -76.39 160.71 35.37 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.343 2.696 . . . . 70.109999999999999 112.818 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.82 168.84 17.66 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.48 -0.934 . . . . 73.129999999999995 108.48 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 m -117.0 158.57 23.9 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.797 -0.445 . . . . 72.420000000000002 109.797 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -92.51 154.89 18.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.454 -0.943 . . . . 72.409999999999997 108.454 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.01 -29.44 1.0 Allowed Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.671 -0.776 . . . . 65.519999999999996 111.551 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.93 80.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.727 -0.472 . . . . 73.430000000000007 109.727 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.83 -6.44 41.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.613 -0.721 . . . . 74.239999999999995 111.854 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.3 -19.95 20.22 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.873 -1.158 . . . . 62.229999999999997 107.873 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.8 mt 58.91 88.0 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 113.97 -1.468 . . . . 73.140000000000001 111.391 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.44 -58.89 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.487 2.124 . . . . 74.25 110.097 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 0.89 7.59 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.585 -0.734 . . . . 43.210000000000001 109.138 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.15 85.99 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.117 -0.947 . . . . 64.140000000000001 111.419 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 15.0 m -134.85 165.56 25.02 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.082 -1.451 . . . . 65.409999999999997 107.082 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 158.87 43.1 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.256 -0.646 . . . . 62.030000000000001 109.256 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -125.41 157.8 35.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.444 -0.206 . . . . 73.310000000000002 110.444 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.15 139.01 54.25 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.204 -1.036 . . . . 75.010000000000005 108.204 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -118.65 137.26 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 120.791 0.329 . . . . 64.209999999999994 110.136 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.83 118.22 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 106.404 -1.702 . . . . 54.310000000000002 106.404 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -94.91 -31.62 13.59 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.695 -0.684 . . . . 71.25 109.918 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -145.83 137.78 25.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.933 -0.766 . . . . 54.030000000000001 108.933 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 132' ' ' LYS . . . 133.29 178.74 15.76 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.457 -1.057 . . . . 51.140000000000001 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 85.4 Cg_exo -55.3 -40.49 85.35 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.684 2.256 . . . . 73.400000000000006 112.154 177.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -90.36 16.31 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.512 -0.313 . . . . 73.019999999999996 111.593 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.96 132.7 54.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.919 0.39 . . . . 71.430000000000007 111.197 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -19.77 32.0 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.576 -0.738 . . . . 71.340000000000003 111.635 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 131.74 34.28 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.946 0.403 . . . . 71.349999999999994 110.625 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -113.3 139.15 49.08 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.107 -1.071 . . . . 51.299999999999997 108.107 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -126.68 128.07 46.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.747 -0.835 . . . . 71.120000000000005 108.747 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.4 pt? -88.23 130.03 35.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 74.129999999999995 110.528 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 103.86 12.46 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.087 -1.079 . . . . 70.450000000000003 108.087 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -121.46 -5.62 9.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.375 1.083 . . . . 72.409999999999997 108.545 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 5.9 pm0 -107.95 142.14 24.62 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 114.128 -1.396 . . . . 65.409999999999997 110.487 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' GLN . 50.2 Cg_exo -57.79 -32.0 93.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.524 2.816 . . . . 75.310000000000002 112.942 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -143.6 122.04 12.41 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 109.251 -0.648 . . . . 60.329999999999998 109.251 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.486 HG22 HG12 ' A' ' 78' ' ' ILE . 21.0 m -114.54 113.92 25.07 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.844 -1.169 . . . . 73.109999999999999 107.844 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.3 p -89.8 138.43 31.49 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 111.65 0.241 . . . . 73.129999999999995 111.65 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.51 55.75 Favored 'General case' 0 C--O 1.267 2.025 0 N-CA-C 109.14 -0.689 . . . . 74.030000000000001 109.14 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.49 -145.39 11.33 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.022 -0.99 . . . . 25.129999999999999 110.723 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.516 ' C ' ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -105.84 151.81 24.05 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 122.994 0.518 . . . . 54.240000000000002 111.909 -177.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.583 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t-80 76.75 143.39 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.93 1.292 . . . . 75.319999999999993 110.407 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 88.0 Cg_exo -48.28 -6.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 124.846 3.697 . . . . 74.209999999999994 116.688 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.83 -24.63 59.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.662 -0.866 . . . . 74.200000000000003 108.662 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.424 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 19.4 m -92.07 115.37 28.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 106.56 -1.644 . . . . 75.310000000000002 106.56 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.53 -36.25 77.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.941 -0.572 . . . . 73.030000000000001 111.409 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.486 HG12 HG22 ' A' ' 68' ' ' THR . 42.3 mm -106.7 99.56 8.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.016 -1.105 . . . . 72.109999999999999 108.016 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -93.36 110.3 21.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.727 -0.67 . . . . 63.329999999999998 109.901 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 87.0 mt -116.64 122.5 44.76 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.34 -1.356 . . . . 71.349999999999994 107.34 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.11 117.08 29.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.662 -0.815 . . . . 61.109999999999999 109.896 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.486 ' H ' HG22 ' A' ' 85' ' ' VAL . 10.0 t70 -120.62 -165.11 1.16 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.385 -0.968 . . . . 61.32 108.385 -173.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.41 -35.51 19.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.403 -0.962 . . . . 75.430000000000007 108.403 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 18' ' ' PHE . 83.2 m -145.63 99.44 3.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.261 -1.015 . . . . 74.450000000000003 108.261 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 82' ' ' ASP . 7.1 t -88.78 131.48 36.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.677 -0.49 . . . . 72.400000000000006 109.677 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -79.25 157.78 27.71 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.785 -0.643 . . . . 72.519999999999996 110.304 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -62.76 -45.86 90.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 72.540000000000006 109.68 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -147.25 99.55 3.16 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 103.784 -2.673 . . . . 62.409999999999997 103.784 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 5.1 t60 -79.32 -50.26 11.15 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.915 -1.513 . . . . 70.239999999999995 106.915 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.25 163.02 40.74 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.468 -1.242 . . . . 31.129999999999999 109.539 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.49 141.38 48.76 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 109.076 -0.712 . . . . 72.420000000000002 109.076 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.83 114.08 28.08 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.712 -1.959 . . . . 70.209999999999994 105.712 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 95' ' ' ASN . 35.0 mtp85 -109.95 127.5 54.8 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-N 114.736 -1.12 . . . . 74.219999999999999 110.488 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.04 112.12 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 104.099 -2.556 . . . . 50.399999999999999 104.099 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 93' ' ' ARG . 17.8 m120 -135.48 121.09 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.225 -0.657 . . . . 62.240000000000002 109.225 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 56.53 37.85 29.16 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.379 1.05 . . . . 54.409999999999997 110.687 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.47 88.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.359 -0.837 . . . . 73.019999999999996 113.469 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.48 141.31 36.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.912 -0.774 . . . . 73.450000000000003 108.912 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 84.0 m-85 -111.4 117.01 31.9 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.222 -0.658 . . . . 74.430000000000007 109.222 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 146.2 52.29 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.793 0.33 . . . . 75.230000000000004 111.775 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 23.5 t -103.79 123.37 57.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.18 -1.785 . . . . 74.439999999999998 106.18 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.1 t -119.15 126.51 75.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.103 -0.703 . . . . 45.409999999999997 109.103 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -81.05 123.54 28.45 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.197 -1.409 . . . . 73.340000000000003 107.197 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.38 14.55 7.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-O 121.049 0.452 . . . . 55.420000000000002 111.244 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.498 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . -108.9 -30.68 3.62 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.41 -1.076 . . . . 63.100000000000001 110.41 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.3 p 67.43 -52.86 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.55 2.34 . . . . 73.230000000000004 113.56 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.31 -20.43 60.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.902 0.382 . . . . 74.510000000000005 111.037 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -87.28 -20.25 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.227 1.195 . . . . 73.120000000000005 114.227 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.429 ' N ' HD22 ' A' ' 108' ' ' ASN . . . 62.06 87.0 0.04 OUTLIER Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.344 0.897 . . . . 64.109999999999999 115.344 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.9 m -79.51 137.59 37.24 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 64.140000000000001 108.787 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 30.1 m-85 -113.06 126.87 55.95 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.539 -0.465 . . . . 73.310000000000002 109.97 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.45 135.93 55.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 105.006 -2.22 . . . . 73.140000000000001 105.006 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 53.47 34.74 18.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 75.409999999999997 107.601 -165.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 29' ' ' SER . 37.9 mtm180 57.92 12.76 1.85 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.025 1.12 . . . . 74.200000000000003 114.025 -175.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -104.27 134.17 19.83 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.84 -0.8 . . . . 73.510000000000005 108.84 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.04 123.49 12.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.12 1.88 . . . . 73.129999999999995 111.657 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -140.62 165.39 27.59 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 116.079 -0.509 . . . . 64.140000000000001 110.825 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -103.91 -36.74 7.68 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.282 -1.007 . . . . 72.140000000000001 108.282 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -150.24 134.85 17.44 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.63 -1.248 . . . . 62.439999999999998 107.63 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.31 143.63 22.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.137 -0.69 . . . . 73.349999999999994 109.137 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.75 125.63 34.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.605 -0.887 . . . . 73.219999999999999 108.605 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.448 ' HE3' ' HB3' ' A' ' 99' ' ' PHE . 22.2 ptt? -90.06 130.27 36.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 62.25 110.19 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -113.79 156.41 23.9 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.128 -0.942 . . . . 74.329999999999998 109.717 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.3 t -67.53 124.64 23.79 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 121.387 0.613 . . . . 75.019999999999996 109.565 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.09 57.56 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.909 -0.877 . . . . 72.450000000000003 110.909 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -79.92 151.84 29.89 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.77 125.91 50.68 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.024 -0.732 . . . . 74.310000000000002 109.024 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -109.33 129.55 63.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 106.846 -1.538 . . . . 63.450000000000003 106.846 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 54.8 tp60 -110.05 123.22 49.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.274 -1.01 . . . . 70.209999999999994 108.274 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.4 mt -128.77 104.17 10.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.782 -1.192 . . . . 65.120000000000005 107.782 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.21 -117.21 8.25 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.4 -1.48 . . . . 55.310000000000002 109.4 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -106.46 5.75 29.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.289 0.566 . . . . 72.319999999999993 110.894 175.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.588 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 69.6 m-85 -85.37 133.21 34.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.676 -0.693 . . . . 75.129999999999995 111.091 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -110.8 119.22 38.39 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.187 -2.153 . . . . 75.219999999999999 105.187 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 mt -114.87 139.85 49.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.018 -0.734 . . . . 64.439999999999998 109.018 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.21 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.309 -0.997 . . . . 62.340000000000003 108.309 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.75 127.72 38.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.283 -0.636 . . . . 64.299999999999997 109.283 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.61 130.78 42.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.229 0.538 . . . . 74.400000000000006 110.582 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.96 122.79 44.13 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.575 -0.898 . . . . 31.440000000000001 108.575 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.0 -144.17 3.87 Favored Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.282 -1.437 . . . . 62.43 113.088 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.83 146.7 60.52 Favored 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.681 2.921 . . . . 70.209999999999994 113.157 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 46' ' ' SER . . . 179.66 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.992 1.317 . . . . 33.219999999999999 108.526 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 107.462 -1.31 . . . . 61.509999999999998 107.462 -176.065 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.434 -1.246 0 CA-C-O 121.281 0.562 . . . . 75.109999999999999 112.091 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 58.6 t -93.85 115.7 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.553 -2.017 . . . . 52.25 105.553 170.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -108.04 127.5 53.83 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.152 -1.019 . . . . 75.0 111.544 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -106.96 101.91 11.31 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 109.468 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.56 166.21 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.928 -0.578 . . . . 64.0 111.539 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.08 -6.99 19.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.136 1.374 . . . . 74.230000000000004 112.25 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.64 -25.42 60.12 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.51 0.93 . . . . 60.149999999999999 113.51 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 88.4 mt -81.47 -28.59 34.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 111.806 0.299 . . . . 70.439999999999998 111.806 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -53.95 -45.43 71.3 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.883 0.873 . . . . 71.540000000000006 111.878 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 26' ' ' MET . 8.0 pt-20 -70.19 -37.02 75.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.823 0.344 . . . . 72.150000000000006 111.888 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.43 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 22.9 ptp -79.79 -27.36 40.36 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 112.596 0.591 . . . . 75.420000000000002 112.596 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 48.3 mt-10 -58.4 -49.46 77.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.974 0.352 . . . . 72.400000000000006 111.18 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -68.74 -26.41 65.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.632 -0.713 . . . . 74.25 110.878 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.7 t -88.17 -22.74 23.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.655 -0.702 . . . . 73.540000000000006 110.409 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.3 m -97.31 105.87 18.09 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.64 0.733 . . . . 70.239999999999995 112.097 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.9 -29.13 0.76 Allowed Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.287 -1.525 . . . . 73.049999999999997 109.287 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -116.11 148.99 39.71 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.77 -0.826 . . . . 74.310000000000002 108.77 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.47 138.92 20.68 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.652 -1.61 . . . . 64.5 106.652 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.25 142.52 91.83 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.125 1.884 . . . . 64.349999999999994 112.784 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.36 149.49 51.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.079 -0.712 . . . . 64.450000000000003 109.079 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -129.23 139.56 51.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.797 0.332 . . . . 70.420000000000002 110.624 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 m -79.34 115.07 18.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 64.109999999999999 108.036 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.16 8.2 22.05 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 110.622 -0.991 . . . . 53.140000000000001 110.622 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.09 87.67 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 123.514 0.725 . . . . 70.409999999999997 111.75 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.89 1.9 56.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.054 -0.521 . . . . 75.430000000000007 111.532 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -33.39 12.0 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.433 -1.321 . . . . 75.400000000000006 107.433 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.4 mm? 59.73 84.06 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 108.17 -1.048 . . . . 53.310000000000002 108.17 -173.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 6.8 Cg_endo -42.7 -61.85 0.5 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.593 3.529 . . . . 74.140000000000001 115.328 -168.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -13.77 40.69 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.201 -0.599 . . . . 74.209999999999994 112.151 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.22 -4.86 77.89 Favored Glycine 0 C--N 1.317 -0.5 0 C-N-CA 121.111 -0.566 . . . . 72.109999999999999 112.253 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB3' HD11 ' A' ' 62' ' ' LEU . 32.7 m -133.93 163.65 29.04 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.922 -0.769 . . . . 73.5 108.922 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.39 150.81 36.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.367 -0.605 . . . . 64.049999999999997 109.367 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.51 148.57 44.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.067 -0.515 . . . . 73.140000000000001 110.556 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.6 pt? -105.32 133.9 49.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.637 -0.875 . . . . 65.019999999999996 108.637 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.4 128.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.584 -0.895 . . . . 74.099999999999994 108.584 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.1 t -77.18 118.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.593 -1.632 . . . . 64.329999999999998 106.593 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -89.73 -33.92 16.4 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.231 0.539 . . . . 73.430000000000007 109.666 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 2.2 tpm_? -144.79 136.95 26.06 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.989 -1.115 . . . . 71.430000000000007 107.989 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.17 -171.45 25.64 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 109.442 -1.463 . . . . 15.529999999999999 109.442 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 15.6 Cg_exo -67.32 -43.64 5.81 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.522 2.148 . . . . 61.109999999999999 111.067 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.16 22.7 5.63 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.308 -0.86 . . . . 63.340000000000003 112.005 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.49 129.78 42.2 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.979 0.419 . . . . 62.100000000000001 111.069 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.97 -21.46 29.49 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.684 -0.689 . . . . 74.299999999999997 111.379 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.03 29.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.725 0.298 . . . . 72.420000000000002 110.224 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -128.8 139.05 52.36 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.721 -0.844 . . . . 61.25 108.721 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.09 131.12 53.81 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.981 -0.748 . . . . 73.310000000000002 108.981 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 46' ' ' SER . 56.3 tp -89.55 126.82 35.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.983 -0.377 . . . . 65.230000000000004 109.983 -177.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.421 HD23 HD11 ' A' ' 94' ' ' ILE . 5.2 mp -82.58 103.99 12.52 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -126.65 5.28 6.76 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 123.006 1.384 . . . . 71.140000000000001 108.061 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.81 149.75 39.4 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 114.197 -1.365 . . . . 64.25 108.792 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.99 -16.04 32.44 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.615 2.21 . . . . 71.219999999999999 113.036 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 90.3 m -154.58 128.85 9.01 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.05 -0.722 . . . . 74.299999999999997 109.05 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 20.5 m -118.58 121.38 40.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 m -96.28 130.24 43.42 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.609 -0.515 . . . . 65.540000000000006 109.609 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.04 139.4 53.35 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 116.414 -0.357 . . . . 73.120000000000005 110.19 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.37 -161.0 30.97 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.217 -1.553 . . . . 51.439999999999998 109.217 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 16.7 ttp180 -119.45 116.99 27.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 118.116 0.958 . . . . 72.030000000000001 109.544 176.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER 152.94 156.74 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 104.621 -2.363 . . . . 62.310000000000002 104.621 176.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.85 -9.29 15.98 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.443 2.096 . . . . 73.340000000000003 113.258 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.07 -18.45 60.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.461 . . . . 75.019999999999996 110.728 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 m -98.02 123.58 42.1 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 116.134 -0.485 . . . . 71.109999999999999 109.722 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.19 -42.74 96.54 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.521 -0.918 . . . . 74.519999999999996 108.521 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.52 104.74 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 106.444 -1.687 . . . . 60.219999999999999 106.444 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 72' ' ' ARG . 59.6 t80 -88.03 113.93 24.15 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.671 -0.695 . . . . 72.030000000000001 109.149 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 2.8 mm? -110.36 113.4 26.03 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.489 -0.93 . . . . 63.130000000000003 108.489 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 29.2 t70 -79.11 118.32 20.97 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.025 0.44 . . . . 72.319999999999993 110.745 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -133.08 178.0 7.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.259 -1.015 . . . . 64.549999999999997 108.259 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.07 -28.99 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 124.084 0.954 . . . . 71.200000000000003 109.247 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.441 ' HB ' HD21 ' A' ' 108' ' ' ASN . 0.7 OUTLIER -104.11 152.98 21.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.716 -0.675 . . . . 74.129999999999995 110.52 -174.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -92.19 97.46 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.698 -0.853 . . . . 73.519999999999996 108.698 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -99.81 87.83 3.63 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.595 -0.891 . . . . 63.140000000000001 108.595 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -66.92 -28.97 68.74 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.655 -0.702 . . . . 62.229999999999997 112.513 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -145.29 91.28 2.11 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.125 -1.805 . . . . 73.120000000000005 106.125 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 31.3 t60 -100.63 -52.81 3.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.053 -1.059 . . . . 71.430000000000007 112.075 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.17 141.93 46.01 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.48 -0.763 . . . . 72.510000000000005 109.158 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -122.58 129.41 51.89 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.304 -0.999 . . . . 61.210000000000001 108.304 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 67' ' ' THR . 7.7 m-85 -105.2 117.83 35.0 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.403 -1.703 . . . . 64.219999999999999 106.403 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -109.75 119.23 38.71 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.643 -0.873 . . . . 75.040000000000006 108.643 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.421 HD11 HD23 ' A' ' 63' ' ' LEU . 3.3 mp -111.96 113.29 43.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.684 -1.598 . . . . 74.329999999999998 106.684 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -138.92 123.89 18.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.943 -0.391 . . . . 62.420000000000002 109.943 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.39 36.8 26.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.413 1.085 . . . . 75.409999999999997 112.128 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 3.53 90.45 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.977 -0.63 . . . . 71.310000000000002 113.19 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -100.89 131.23 46.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.475 -0.935 . . . . 70.239999999999995 108.475 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -108.13 116.42 31.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.324 -0.991 . . . . 71.310000000000002 108.324 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 121' ' ' VAL . 41.9 mt-10 -123.6 126.16 46.14 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.335 -0.616 . . . . 73.239999999999995 109.335 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.41 123.13 56.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.511 -1.292 . . . . 72.239999999999995 107.511 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.48 138.04 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 115.586 -0.733 . . . . 54.100000000000001 110.648 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 106.141 -1.8 . . . . 73.219999999999999 106.141 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.0 m -92.41 17.07 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.756 0.65 . . . . 74.510000000000005 112.756 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.26 47.28 4.72 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 107.728 -2.149 . . . . 53.409999999999997 107.728 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.7 m -79.28 175.98 10.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.467 -0.866 . . . . 62.229999999999997 112.654 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 2.3 mm? -101.72 -28.17 12.62 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.578 0.955 . . . . 64.019999999999996 113.578 -171.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -86.61 -20.47 27.82 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 118.518 -1.273 . . . . 75.140000000000001 111.127 -173.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.79 100.13 2.29 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 119.337 -1.411 . . . . 75.209999999999994 112.615 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 m -87.41 129.13 35.15 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.52 -0.918 . . . . 53.0 108.52 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 20.4 m-85 -127.96 126.7 41.92 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.969 -1.123 . . . . 74.319999999999993 107.969 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -111.7 131.84 61.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.129 -1.434 . . . . 74.540000000000006 107.129 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.675 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 17.4 m120 57.78 38.29 27.32 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.608 0.763 . . . . 73.109999999999999 110.187 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.76 14.46 7.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.966 1.307 . . . . 64.319999999999993 113.211 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.64 145.24 37.11 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 122.351 -0.218 . . . . 73.450000000000003 110.523 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.09 123.55 13.42 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.607 1.538 . . . . 65.400000000000006 108.431 171.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -139.5 145.85 39.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.828 -1.175 . . . . 72.430000000000007 107.828 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -103.31 -44.04 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.934 -0.306 . . . . 75.209999999999994 110.85 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.14 24.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.007 -1.108 . . . . 70.219999999999999 108.007 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -150.26 134.59 17.21 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.783 -0.367 . . . . 74.200000000000003 111.264 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 100' ' ' GLU . 48.6 t -78.9 114.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 104.584 -2.376 . . . . 74.040000000000006 104.584 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.47 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 80.3 mtp -97.09 144.59 26.8 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.721 1.008 . . . . 73.25 113.721 -172.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.531 ' HG3' ' OD2' ' A' ' 126' ' ' ASP . 4.8 pp0? -119.73 157.84 27.74 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.0 -1.455 . . . . 74.120000000000005 108.328 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.3 p -58.83 126.87 29.46 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 123.508 0.723 . . . . 72.319999999999993 111.62 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.56 -5.53 54.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.927 -0.579 . . . . 71.340000000000003 113.327 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.531 ' OD2' ' HG3' ' A' ' 123' ' ' GLN . 73.3 m-20 -76.81 143.91 39.47 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 117.799 0.799 . . . . 73.129999999999995 109.337 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.675 ' OE1' ' HA ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -112.57 145.44 40.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.045 0.45 . . . . 72.310000000000002 111.412 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 41.1 mt -116.71 126.91 74.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.579 -0.897 . . . . 72.530000000000001 108.579 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 24.3 tp60 -104.81 113.45 27.05 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 104.941 -2.244 . . . . 75.420000000000002 104.941 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 62.8 mt -109.28 103.87 16.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.91 -1.144 . . . . 63.329999999999998 107.91 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.16 -98.84 0.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 CA-C-N 115.206 -0.906 . . . . 55.340000000000003 111.266 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -119.44 2.67 11.28 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.937 1.088 . . . . 53.109999999999999 113.937 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.25 25.4 p90 -131.23 168.97 16.6 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.549 -0.719 . . . . 72.340000000000003 112.19 176.251 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -129.22 138.96 52.0 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 113.037 0.754 . . . . 74.439999999999998 113.037 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.87 139.79 53.19 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.682 -1.599 . . . . 73.510000000000005 106.682 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.63 140.2 40.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 109.42 -0.585 . . . . 73.209999999999994 109.42 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -92.9 115.5 28.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.048 -0.723 . . . . 72.129999999999995 109.048 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.06 159.95 22.96 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.121 0.486 . . . . 74.010000000000005 111.691 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.77 131.46 39.81 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.84 -0.8 . . . . 74.439999999999998 108.84 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.06 143.0 15.92 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.309 -0.948 . . . . 73.340000000000003 110.922 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -59.24 156.0 37.38 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.592 2.194 . . . . 61.350000000000001 111.567 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.83 61.22 6.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.313 1.054 . . . . 63.329999999999998 109.451 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.292 -1.919 0 CA-C-N 113.107 -1.861 . . . . 74.530000000000001 109.846 -179.983 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.223 -1.399 . . . . 62.200000000000003 107.223 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.61 134.56 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 120.952 0.406 . . . . 65.209999999999994 111.304 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -123.18 141.35 52.07 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.111 -1.07 . . . . 73.319999999999993 108.111 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -83.78 137.29 33.8 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.275 -0.57 . . . . 73.140000000000001 109.808 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.93 151.19 23.45 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.411 -0.588 . . . . 62.200000000000003 109.411 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.08 2.76 56.08 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.844 0.831 . . . . 73.340000000000003 110.869 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 111' ' ' TYR . 1.9 pp -58.95 -17.45 24.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.274 1.213 . . . . 74.329999999999998 114.274 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 22' ' ' LEU . 2.2 pt? -70.25 -7.71 44.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 111.765 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -80.41 -28.47 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.562 -0.903 . . . . 73.340000000000003 108.562 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.54 -22.05 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.005 -1.109 . . . . 72.209999999999994 108.005 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.5 ttp -53.95 -49.54 68.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 63.020000000000003 111.175 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -9.96 58.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.065 0.459 . . . . 72.109999999999999 111.844 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -78.64 -39.26 37.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.435 -0.802 . . . . 61.140000000000001 110.112 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -87.13 -17.79 31.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.694 0.627 . . . . 62.340000000000003 112.694 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.1 m -72.61 114.0 10.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.48 -0.563 . . . . 55.399999999999999 109.48 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.6 -59.32 0.2 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.485 -1.046 . . . . 41.530000000000001 110.485 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.7 p -114.85 121.33 42.93 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.914 -0.314 . . . . 53.020000000000003 110.509 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.86 53.0 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 109.208 -0.664 . . . . 32.020000000000003 109.208 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.64 156.56 60.82 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 121.81 1.674 . . . . 72.239999999999995 108.805 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.17 124.65 21.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.87 -1.159 . . . . 52.030000000000001 107.87 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' THR . 10.3 m -98.78 -10.84 22.49 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.879 -0.6 . . . . 55.329999999999998 112.205 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -73.47 147.48 44.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.545 -0.752 . . . . 74.450000000000003 109.987 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 -15.08 7.72 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.327 -1.109 . . . . 53.240000000000002 110.327 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.03 68.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.198 0.523 . . . . 51.109999999999999 111.322 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 41' ' ' ASN . 11.6 pt-20 -70.81 -22.13 62.38 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.255 -0.884 . . . . 74.319999999999993 112.15 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.511 ' OD1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 m-20 -96.21 -13.84 23.17 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.83 -0.433 . . . . 73.420000000000002 109.83 -175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt 55.05 66.62 3.8 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 114.98 -1.009 . . . . 72.420000000000002 110.634 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.65 -55.79 2.48 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.274 2.649 . . . . 65.239999999999995 113.569 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.72 -20.52 42.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.895 -0.593 . . . . 64.140000000000001 111.752 -176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -5.44 77.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.555 -0.831 . . . . 65.319999999999993 111.903 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -152.86 161.0 43.1 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.637 -1.246 . . . . 40.439999999999998 107.637 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.44 157.52 44.0 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.521 -0.548 . . . . 73.409999999999997 109.521 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pp -137.45 155.78 48.93 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 111.905 0.335 . . . . 75.310000000000002 111.905 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD22 HD21 ' A' ' 63' ' ' LEU . 2.4 pt? -116.22 133.67 55.77 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.001 -1.111 . . . . 71.25 108.001 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.11 133.86 51.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.57 -0.9 . . . . 73.040000000000006 108.57 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.27 118.69 31.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.765 -1.568 . . . . 75.099999999999994 106.765 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -83.26 -31.83 26.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.636 -0.711 . . . . 64.540000000000006 110.302 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -160.42 150.66 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.937 -1.505 . . . . 72.010000000000005 106.937 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.65 -167.72 17.96 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 110.217 -1.153 . . . . 62.509999999999998 110.217 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.58 -49.86 9.42 Favored 'Trans proline' 0 N--CA 1.479 0.668 0 C-N-CA 122.802 2.334 . . . . 73.239999999999995 112.257 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.6 22.54 3.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.227 -0.442 . . . . 72.150000000000006 112.045 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.23 128.73 38.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.859 0.362 . . . . 61.409999999999997 111.346 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.71 40.28 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.626 -0.715 . . . . 52.240000000000002 111.528 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 156.91 18.02 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.999 0.428 . . . . 74.209999999999994 110.155 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 139.49 30.87 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.792 -0.64 . . . . 75.310000000000002 109.564 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.39 134.05 55.46 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.2 -0.667 . . . . 73.010000000000005 109.2 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.4 pt? -90.79 143.77 26.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.024 -0.732 . . . . 64.299999999999997 109.024 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 49' ' ' LEU . 1.5 mm? -111.43 110.7 21.27 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.013 0.375 . . . . 53.020000000000003 112.013 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -138.35 59.56 1.64 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.849 -1.537 . . . . 65.340000000000003 106.849 168.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -146.35 140.89 15.79 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 112.884 -1.962 . . . . 75.0 107.544 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.36 -22.11 71.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.271 1.98 . . . . 71.450000000000003 113.679 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -148.79 122.23 9.08 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.539 -0.726 . . . . 73.420000000000002 111.677 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 m -113.21 113.84 25.9 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.176 -1.416 . . . . 74.540000000000006 107.176 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.7 m -94.17 138.51 32.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.089 -0.645 . . . . 72.239999999999995 109.582 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 134.76 55.01 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 109.62 -0.511 . . . . 74.430000000000007 109.62 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.26 -119.1 0.9 Allowed Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.159 -0.928 . . . . 75.420000000000002 111.687 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -118.89 152.46 36.26 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.706 0.402 . . . . 72.519999999999996 110.825 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.1 m170 90.37 151.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 125.77 1.628 . . . . 71.129999999999995 111.057 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.48 -5.71 16.69 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.02 2.48 . . . . 71.319999999999993 111.799 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.68 -26.25 60.64 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.214 -1.032 . . . . 75.310000000000002 108.214 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -83.68 122.21 28.31 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.309 -1.367 . . . . 75.430000000000007 107.309 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.02 -32.38 74.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.317 0.579 . . . . 45.119999999999997 110.902 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tp -119.41 113.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-O 121.679 0.752 . . . . 33.210000000000001 109.137 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -88.01 138.18 31.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.977 -1.011 . . . . 73.239999999999995 110.542 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.5 mt -123.82 138.76 54.44 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.29 -0.633 . . . . 64.239999999999995 109.29 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.82 127.55 38.87 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.997 -1.112 . . . . 64.230000000000004 107.997 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.56 -161.4 1.34 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.839 -1.911 . . . . 72.219999999999999 105.839 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.61 -36.51 75.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.791 0.805 . . . . 72.200000000000003 109.665 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.0 m -149.51 125.78 10.78 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.93 -1.137 . . . . 75.519999999999996 107.93 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.59 135.23 43.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.825 -0.435 . . . . 74.319999999999993 109.825 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 159.84 27.95 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.793 -0.447 . . . . 72.129999999999995 109.793 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -57.66 -46.39 84.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.333 0.653 . . . . 62.140000000000001 110.534 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -146.34 109.72 4.76 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 103.755 -2.683 . . . . 71.230000000000004 103.755 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -90.25 -52.11 5.1 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.551 0.691 . . . . 73.530000000000001 109.611 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.59 156.05 41.3 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.59 -0.732 . . . . 74.120000000000005 109.049 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.492 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 10.0 pt-20 -134.59 134.19 41.02 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.306 0.574 . . . . 52.420000000000002 109.564 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -104.95 112.89 26.18 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.126 -2.175 . . . . 72.120000000000005 105.126 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 23.5 mtp180 -108.44 135.99 48.82 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.828 -0.624 . . . . 75.230000000000004 110.423 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' A' ' 99' ' ' PHE . 1.8 mp -103.59 111.68 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.664 0 N-CA-C 102.283 -3.229 . . . . 74.5 102.283 173.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -129.12 116.56 19.43 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.93 -0.767 . . . . 64.040000000000006 108.93 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 51.04 37.56 18.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.873 1.269 . . . . 73.519999999999996 111.822 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.3 -1.96 87.49 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.013 -0.54 . . . . 43.210000000000001 113.578 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.39 145.71 29.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.279 -1.008 . . . . 63.130000000000003 108.279 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 92.2 m-85 -104.7 117.94 35.33 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.223 -1.399 . . . . 64.319999999999993 107.223 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -129.49 130.75 46.24 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.319 0.58 . . . . 74.099999999999994 111.185 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.52 122.62 56.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.889 -1.152 . . . . 73.409999999999997 107.889 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.48 132.7 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 116.187 -0.461 . . . . 65.439999999999998 110.834 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -80.27 134.64 36.11 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.157 -1.423 . . . . 75.329999999999998 107.157 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.07 13.56 2.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.438 0.637 . . . . 73.019999999999996 111.226 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.89 74.85 0.09 OUTLIER Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.108 -1.197 . . . . 64.219999999999999 110.108 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 63.4 m -64.63 75.38 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.779 1.029 . . . . 73.329999999999998 113.779 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.81 -47.99 9.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.848 -1.538 . . . . 64.329999999999998 106.848 170.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -105.86 -20.0 13.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.966 -1.47 . . . . 63.409999999999997 108.631 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.72 99.33 0.04 OUTLIER Glycine 0 C--O 1.21 -1.385 0 N-CA-C 108.29 -1.924 . . . . 73.049999999999997 108.29 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.2 m -60.14 132.44 53.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.868 0.842 . . . . 61.240000000000002 112.904 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 83.4 m-85 -101.86 126.69 48.8 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 115.367 -0.833 . . . . 74.200000000000003 108.777 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.52 137.91 53.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.498 -1.667 . . . . 73.150000000000006 106.498 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 57.62 38.15 27.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.402 0.681 . . . . 64.209999999999994 109.693 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 59.4 26.13 14.98 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.825 -1.08 . . . . 75.5 111.923 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.8 153.0 71.67 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.585 0.354 . . . . 64.340000000000003 110.366 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.62 129.55 31.44 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.348 2.032 . . . . 73.340000000000003 109.671 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 20.2 tpp180 -140.42 165.5 27.24 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.768 -0.456 . . . . 73.140000000000001 109.768 -173.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.91 -41.53 1.81 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.363 -0.606 . . . . 75.299999999999997 109.363 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.29 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.655 -1.239 . . . . 73.349999999999994 107.655 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.422 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 59.4 tp60 -153.11 133.61 13.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 121.124 -0.23 . . . . 72.329999999999998 111.57 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.2 t -81.56 115.6 24.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 104.658 -2.349 . . . . 74.530000000000001 104.658 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.6 ptm -90.46 149.87 22.05 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.736 0.779 . . . . 75.439999999999998 112.694 -169.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 72.2 mt-30 -107.57 157.84 17.72 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.46 -1.246 . . . . 63.25 108.617 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 36' ' ' SER . 11.5 t -70.66 130.83 42.8 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.912 -0.715 . . . . 73.219999999999999 109.597 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.2 55.67 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 110.96 -0.856 . . . . 71.400000000000006 110.96 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 10.8 t0 -69.57 144.63 53.0 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 108.995 -0.743 . . . . 74.329999999999998 108.995 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.64 126.37 47.51 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.068 0.461 . . . . 74.239999999999995 109.875 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 70.9 mt -110.08 115.6 50.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.793 -1.094 . . . . 71.219999999999999 108.867 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.442 ' HG2' HD22 ' A' ' 22' ' ' LEU . 54.1 tt0 -105.22 123.62 48.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.584 -0.524 . . . . 65.150000000000006 109.584 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.71 129.19 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.428 0.691 . . . . 72.239999999999995 109.846 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.52 -86.4 1.46 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 109.837 -1.305 . . . . 62.009999999999998 109.837 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.94 14.32 0.34 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.288 0.635 . . . . 72.310000000000002 109.461 171.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -130.64 170.13 14.71 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.189 -0.671 . . . . 70.310000000000002 109.189 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -137.76 150.09 46.96 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.896 1.443 . . . . 72.150000000000006 114.896 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 mt -102.77 134.55 45.98 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.195 -1.78 . . . . 70.120000000000005 106.195 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.6 t -111.97 124.09 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.391 -0.966 . . . . 73.409999999999997 108.391 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -98.9 126.15 44.49 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 122.244 0.217 . . . . 74.329999999999998 110.918 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -133.81 147.48 51.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.42 -0.585 . . . . 71.510000000000005 109.42 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.59 118.69 18.7 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.621 -2.362 . . . . 73.310000000000002 104.621 169.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.04 -82.48 0.59 Allowed Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 118.502 -1.809 . . . . 43.520000000000003 113.959 -169.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.92 142.36 47.04 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 121.599 1.532 . . . . 64.140000000000001 113.859 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.48 36.7 1.67 Allowed 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 104.223 -2.51 . . . . 65.099999999999994 104.223 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.428 -1.545 0 CA-C-N 112.345 -2.207 . . . . 71.109999999999999 109.806 -171.027 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 20.0 m . . . . . 0 N--CA 1.435 -1.208 0 N-CA-C 108.552 -0.907 . . . . 44.329999999999998 108.552 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.27 115.57 29.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.01 -0.737 . . . . 53.5 109.01 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 62.2 t80 -111.89 127.44 55.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.177 -1.046 . . . . 70.120000000000005 108.177 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -126.44 137.06 53.37 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.158 -0.682 . . . . 75.519999999999996 109.158 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' HB3' HD23 ' A' ' 22' ' ' LEU . . . -142.65 161.75 37.25 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.039 0.447 . . . . 75.409999999999997 110.751 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.02 7.45 0.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.118 1.367 . . . . 64.049999999999997 112.893 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 20' ' ' ALA . 4.6 pp -58.05 -34.5 70.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.865 0.866 . . . . 73.549999999999997 111.284 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.53 -19.69 63.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.552 0.575 . . . . 53.210000000000001 112.552 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.11 -22.96 21.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.195 -0.668 . . . . 74.239999999999995 109.195 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -98.3 -42.9 7.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.397 -0.819 . . . . 65.349999999999994 113.045 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -68.25 -1.34 6.0 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.268 0.84 . . . . 72.120000000000005 113.268 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.65 -28.59 63.87 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.173 0.989 . . . . 61.130000000000003 111.128 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -63.56 -45.43 90.53 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.21 1.004 . . . . 71.230000000000004 111.378 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.2 p -79.39 -19.34 50.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.51 -0.768 . . . . 75.310000000000002 112.566 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -88.23 78.39 8.06 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 121.856 0.836 . . . . 71.25 110.141 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.79 -105.14 1.28 Allowed Glycine 0 CA--C 1.485 -1.825 0 N-CA-C 109.107 -1.597 . . . . 74.129999999999995 109.107 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 m -99.88 118.52 36.5 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.173 -1.417 . . . . 73.439999999999998 107.173 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.57 114.24 18.06 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.84 157.28 39.32 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.46 1.44 . . . . 62.539999999999999 110.517 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 125.72 31.12 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.927 -1.508 . . . . 71.299999999999997 106.927 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 15.8 m -71.0 113.93 8.54 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.229 0.538 . . . . 74.519999999999996 111.023 -175.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.7 p -98.7 140.69 32.53 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.337 -0.392 . . . . 71.319999999999993 110.306 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.01 -25.28 0.55 Allowed Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.694 -0.563 . . . . 53.310000000000002 111.694 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.89 58.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.989 0.423 . . . . 35.310000000000002 110.203 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -69.93 -24.66 63.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 65.340000000000003 109.202 -179.368 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.8 -13.75 47.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.776 -1.102 . . . . 71.299999999999997 109.835 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.4 mt 63.97 91.02 0.08 OUTLIER Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 115.142 -0.935 . . . . 63.439999999999998 111.174 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 10.3 Cg_endo -52.87 -69.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.147 2.565 . . . . 71.219999999999999 113.975 -176.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.07 16.38 1.07 Allowed 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.503 -0.479 . . . . 61.409999999999997 110.817 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.71 -12.4 56.77 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 120.839 -0.696 . . . . 73.439999999999998 111.617 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -137.37 151.88 49.07 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.231 -1.396 . . . . 53.329999999999998 107.231 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.44 157.19 40.85 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.072 -1.455 . . . . 31.32 107.072 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.24 156.75 38.03 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.341 0.591 . . . . 72.409999999999997 112.559 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.84 139.24 49.91 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.684 -1.228 . . . . 63.32 107.684 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 133.96 61.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.661 -0.496 . . . . 74.209999999999994 109.661 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.5 t -75.4 118.46 21.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.602 -0.888 . . . . 74.319999999999993 108.602 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -84.01 -43.4 15.19 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.034 -0.985 . . . . 73.420000000000002 108.722 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 57.4 ttt180 -144.7 133.55 22.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.468 -0.787 . . . . 73.310000000000002 109.231 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.13 174.8 23.12 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 109.109 -1.596 . . . . 63.210000000000001 109.109 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.65 -21.67 38.85 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.485 2.123 . . . . 74.519999999999996 111.187 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 80' ' ' LEU . 18.2 p-10 -100.9 21.98 12.83 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.093 0.957 . . . . 74.219999999999999 110.64 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -59.86 141.63 55.03 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.658 0.383 . . . . 62.420000000000002 111.797 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.65 -7.93 74.28 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.846 -0.692 . . . . 75.530000000000001 112.08 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.11 126.72 31.44 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 110.151 -0.314 . . . . 24.010000000000002 110.151 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -116.22 136.66 52.81 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.585 -0.895 . . . . 74.129999999999995 108.585 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -130.73 116.32 17.85 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.577 -0.527 . . . . 71.340000000000003 109.577 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.95 118.46 24.03 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.608 -0.886 . . . . 54.450000000000003 108.608 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.2 mt -87.42 125.2 34.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.83 0.348 . . . . 74.409999999999997 110.894 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -138.03 -0.61 2.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.313 -0.858 . . . . 63.119999999999997 109.825 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -107.52 150.34 39.98 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.132 -0.486 . . . . 61.530000000000001 111.085 -175.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 37.7 Cg_exo -65.17 -20.87 62.95 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.365 2.71 . . . . 61.130000000000003 114.078 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.7 m -145.68 122.54 11.28 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.272 0.558 . . . . 55.409999999999997 110.21 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.41 HG22 HG12 ' A' ' 78' ' ' ILE . 7.6 m -123.64 113.4 18.61 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.764 -1.199 . . . . 73.239999999999995 107.764 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.6 m -94.08 138.73 31.82 Favored 'General case' 0 C--O 1.255 1.393 0 O-C-N 121.594 -0.691 . . . . 71.099999999999994 111.038 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 135.39 54.63 Favored 'General case' 0 C--O 1.262 1.717 0 CA-C-O 121.655 0.741 . . . . 64.109999999999999 110.802 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.55 29.28 Favored Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 105.782 -2.927 . . . . 53.310000000000002 105.782 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 15.2 ptt180 -119.18 121.01 38.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 117.711 -1.596 . . . . 64.349999999999994 109.311 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -167.1 163.39 10.35 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 106.001 -1.851 . . . . 74.209999999999994 106.001 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.58 -46.19 34.97 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.706 2.271 . . . . 70.310000000000002 113.856 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.75 20.5 5.52 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.692 0.627 . . . . 72.329999999999998 112.692 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -58.91 116.28 3.68 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.46 -0.571 . . . . 64.450000000000003 109.46 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.27 -38.97 41.47 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.721 -1.214 . . . . 70.340000000000003 107.721 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 68' ' ' THR . 44.4 mm -105.26 121.85 57.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.126 -1.064 . . . . 74.430000000000007 108.126 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -87.95 124.76 34.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 110.065 -0.346 . . . . 73.510000000000005 110.065 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 80.0 mt -127.2 140.92 51.91 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.323 -0.991 . . . . 73.140000000000001 108.323 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -130.59 140.65 50.44 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.434 -0.58 . . . . 74.129999999999995 109.434 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -163.34 178.34 8.21 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.387 -1.709 . . . . 75.329999999999998 106.387 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 -35.19 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 107.943 -1.132 . . . . 44.0 107.943 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 m -142.0 99.84 3.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.672 0.748 . . . . 45.030000000000001 109.939 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -98.6 137.38 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.471 -1.307 . . . . 64.430000000000007 107.471 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 23.0 t -73.57 150.72 41.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.114 -1.069 . . . . 62.009999999999998 108.114 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.1 ptt180 -61.59 -45.95 91.92 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -135.21 113.86 11.75 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.413 -1.329 . . . . 75.140000000000001 107.413 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -99.29 -51.82 3.7 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.705 -0.85 . . . . 74.239999999999995 108.705 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.65 163.65 39.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.229 -0.656 . . . . 62.509999999999998 109.229 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.8 147.93 45.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.498 0.666 . . . . 64.349999999999994 109.883 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -104.76 133.31 49.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.184 -1.413 . . . . 62.140000000000001 107.184 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 8.5 mtp180 -118.1 121.78 41.44 Favored 'General case' 0 C--N 1.268 -2.964 0 CA-C-N 115.608 -0.724 . . . . 71.439999999999998 109.414 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 59.3 mt -121.14 111.39 31.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.655 -1.609 . . . . 75.120000000000005 106.655 176.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -139.24 125.7 20.42 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.643 -0.423 . . . . 71.409999999999997 110.413 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.58 40.25 31.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.015 0.926 . . . . 55.350000000000001 112.486 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 -1.67 87.53 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.032 -0.531 . . . . 32.140000000000001 113.807 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -101.04 140.97 34.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.227 -0.657 . . . . 44.340000000000003 109.227 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -119.34 117.8 29.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.112 -1.07 . . . . 62.240000000000002 108.112 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -126.45 144.89 50.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.854 -0.424 . . . . 54.329999999999998 109.854 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 122' ' ' MET . 25.1 t -112.98 122.13 66.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 105.244 -2.132 . . . . 72.549999999999997 105.244 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.61 131.88 71.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 120.652 -0.419 . . . . 73.030000000000001 110.157 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.12 140.97 36.19 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.422 -0.955 . . . . 61.329999999999998 108.422 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.2 9.89 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.637 0.256 . . . . 64.310000000000002 110.731 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.37 77.85 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.013 -0.613 . . . . 54.539999999999999 112.053 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 m -64.6 86.76 0.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.826 0.45 . . . . 62.030000000000001 111.124 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 9.8 tt -91.36 -49.91 6.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 119.137 -1.025 . . . . 75.120000000000005 108.435 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.63 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 1.0 OUTLIER -92.81 -19.02 22.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.156 -0.683 . . . . 55.119999999999997 109.156 -178.438 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.68 114.86 3.77 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.836 -0.62 . . . . 74.349999999999994 112.367 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.2 m -87.3 129.65 34.91 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 122.211 -0.582 . . . . 74.540000000000006 110.469 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.506 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 82.3 m-85 -134.9 126.0 27.84 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.077 -1.083 . . . . 74.049999999999997 108.077 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.5 t -131.14 133.98 61.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.854 -1.536 . . . . 72.519999999999996 106.854 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 54.01 40.71 31.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.306 1.051 . . . . 73.420000000000002 109.404 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 66.76 9.23 6.56 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.946 1.699 . . . . 71.400000000000006 112.424 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 49.5 mm-40 -104.57 127.66 28.5 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 112.472 0.545 . . . . 75.420000000000002 112.472 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -63.7 123.44 12.02 Favored 'Trans proline' 0 C--N 1.36 1.139 0 N-CA-C 106.242 -2.253 . . . . 74.209999999999994 106.242 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 11.8 tpt180 -146.99 154.89 41.77 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.791 -1.564 . . . . 72.409999999999997 111.797 -167.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -107.67 -37.93 6.02 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.806 -0.812 . . . . 73.230000000000004 108.806 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.2 135.21 32.16 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.265 -0.574 . . . . 64.439999999999998 109.667 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.567 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 54.3 tp60 -152.12 143.68 23.49 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.194 -0.457 . . . . 72.150000000000006 110.268 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.13 131.6 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 107.72 -1.215 . . . . 71.230000000000004 107.72 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.411 ' HB2' HG23 ' A' ' 101' ' ' VAL . 43.7 ttp -89.25 128.54 35.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.359 -0.978 . . . . 60.32 108.359 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 9.3 pt20 -130.37 142.8 50.51 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.299 -0.864 . . . . 71.349999999999994 111.382 -173.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.7 t -74.31 134.25 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 62.420000000000002 111.229 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.11 59.75 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.241 -0.89 . . . . 54.5 111.163 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -89.63 154.67 19.79 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.565 -0.318 . . . . 74.019999999999996 111.198 -177.059 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.3 127.86 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.663 0.744 . . . . 74.099999999999994 109.797 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.28 119.81 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 N-CA-C 107.369 -1.345 . . . . 73.409999999999997 107.369 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 47.3 tt0 -104.86 120.92 42.57 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 115.106 -0.952 . . . . 74.099999999999994 108.476 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.7 mt -109.36 102.98 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 105.914 -1.884 . . . . 72.239999999999995 105.914 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.63 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 67.45 -107.55 2.08 Favored Glycine 0 N--CA 1.411 -3.01 0 CA-C-N 114.48 -1.236 . . . . 55.299999999999997 111.639 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -118.22 11.0 13.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.408 0.521 . . . . 75.329999999999998 112.408 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 27.2 p90 -125.06 157.87 35.18 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.883 -0.414 . . . . 70.109999999999999 109.883 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -129.36 142.07 50.91 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 114.51 1.3 . . . . 75.219999999999999 114.51 -169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.35 138.52 54.37 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.591 -1.633 . . . . 75.109999999999999 106.591 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -112.48 138.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.833 -1.173 . . . . 72.120000000000005 107.833 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -101.61 116.13 32.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.175 -0.676 . . . . 72.329999999999998 109.175 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.12 154.64 48.09 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.408 0.623 . . . . 71.129999999999995 110.545 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.51 126.4 30.85 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.538 -1.653 . . . . 53.409999999999997 106.538 168.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 141' ' ' PRO . . . -103.77 -111.42 3.57 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.587 -0.816 . . . . 53.439999999999998 111.497 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 140' ' ' GLY . 10.8 Cg_exo -69.14 142.87 51.93 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.114 1.876 . . . . 62.439999999999998 111.787 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.25 18.08 19.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.648 -0.871 . . . . 53.030000000000001 108.648 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.424 -1.745 0 C-N-CA 125.305 1.442 . . . . 73.109999999999999 110.001 -179.137 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 105.671 -1.974 . . . . 65.329999999999998 105.671 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 57.8 t -81.31 114.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 119.679 -0.808 . . . . 72.409999999999997 108.854 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -118.86 140.22 50.33 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 109.241 -0.651 . . . . 74.239999999999995 109.241 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -132.75 138.66 47.27 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.953 -1.128 . . . . 74.230000000000004 107.953 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.39 172.73 12.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.075 0.768 . . . . 63.200000000000003 113.075 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.82 -3.12 26.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.905 1.282 . . . . 71.310000000000002 110.976 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 23' ' ' LEU . 4.0 pp -57.36 -25.81 60.03 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.88 0.872 . . . . 61.450000000000003 112.784 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 22' ' ' LEU . 94.7 mt -66.72 -28.36 68.36 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 121.044 0.45 . . . . 50.130000000000003 110.982 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -67.26 -44.75 78.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 74.340000000000003 109.96 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -76.1 -31.92 58.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.883 -0.599 . . . . 74.349999999999994 110.096 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.29 -30.41 64.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 75.219999999999999 110.819 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.08 -49.43 75.88 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.984 0.513 . . . . 52.219999999999999 110.633 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -77.81 -19.81 54.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.101 0.56 . . . . 72.030000000000001 111.553 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -82.97 -17.11 44.66 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.702 -0.481 . . . . 62.109999999999999 109.702 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.554 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 39.9 m -109.12 103.99 13.09 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 121.207 0.527 . . . . 60.240000000000002 111.169 -176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.88 -52.69 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 111.389 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -104.94 142.5 34.66 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.259 -0.645 . . . . 72.310000000000002 109.259 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.93 153.0 84.81 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.16 -1.052 . . . . 53.130000000000003 108.16 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.14 142.23 96.97 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.047 1.831 . . . . 71.129999999999995 112.831 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.49 131.71 41.92 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.527 -0.545 . . . . 55.219999999999999 109.527 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -125.07 -168.35 1.81 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.371 0.605 . . . . 71.319999999999993 109.969 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -106.97 5.81 28.53 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.526 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 43.48 3.79 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.22 -1.552 . . . . 62.240000000000002 109.22 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.4 -3.67 59.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.392 0.615 . . . . 64.140000000000001 110.967 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.82 2.1 3.72 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 124.167 0.987 . . . . 64.040000000000006 112.726 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -83.17 -19.59 36.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.269 -1.011 . . . . 72.329999999999998 108.269 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt 57.44 79.47 0.32 Allowed Pre-proline 0 C--N 1.345 0.394 0 CA-C-N 114.46 -1.245 . . . . 52.520000000000003 111.937 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.68 -62.48 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.483 2.122 . . . . 54.32 112.162 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.72 -2.28 35.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.953 0.406 . . . . 63.200000000000003 111.644 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.68 79.85 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.871 -0.681 . . . . 13.1 113.163 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 m -147.37 164.21 34.0 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.474 -0.565 . . . . 55.350000000000001 109.474 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.82 157.35 45.87 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.884 -1.154 . . . . 44.509999999999998 107.884 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -123.46 152.69 41.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 118.388 0.54 . . . . 72.420000000000002 111.593 -175.248 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.583 HD12 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -116.88 143.19 45.99 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.673 -1.232 . . . . 73.510000000000005 107.673 173.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.88 133.38 61.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 121.093 -0.243 . . . . 74.530000000000001 110.496 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.3 116.88 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 104.792 -2.299 . . . . 64.430000000000007 104.792 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -89.87 -31.87 17.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.752 -0.658 . . . . 54.200000000000003 109.595 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -152.89 137.0 16.42 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.924 -0.58 . . . . 74.209999999999994 109.566 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.41 172.23 13.13 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 109.21 -1.556 . . . . 74.219999999999999 109.21 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.538 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 77.9 Cg_exo -55.28 -29.67 68.36 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 122.73 2.287 . . . . 52.009999999999998 113.926 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.28 18.12 21.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 120.326 -0.549 . . . . 72.439999999999998 110.399 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.86 143.58 41.94 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.107 0.48 . . . . 63.530000000000001 112.195 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.85 -14.28 57.47 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.359 -1.096 . . . . 61.219999999999999 110.359 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.79 122.12 21.04 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.289 -0.456 . . . . 61.520000000000003 109.847 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -133.4 134.97 44.34 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.551 -1.277 . . . . 74.420000000000002 107.551 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -137.26 145.38 43.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.288 -0.634 . . . . 74.310000000000002 109.288 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.1 tp -93.17 127.23 38.64 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.493 0.496 . . . . 73.129999999999995 109.717 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.583 HD21 HD12 ' A' ' 49' ' ' LEU . 2.4 mm? -97.6 107.3 19.77 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.197 0.522 . . . . 74.049999999999997 111.368 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.24 19.19 1.09 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.054 -1.832 . . . . 73.150000000000006 106.054 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.466 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 16.0 pt20 -107.21 142.14 24.44 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 113.971 -1.468 . . . . 72.040000000000006 107.931 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 27.9 Cg_endo -64.94 -19.19 63.88 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.251 1.967 . . . . 75.219999999999999 113.955 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -149.5 129.99 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.231 -0.587 . . . . 72.510000000000005 111.58 -176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.9 m -132.9 113.51 12.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.337 -1.357 . . . . 72.209999999999994 107.337 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -92.88 138.03 31.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.757 -0.46 . . . . 73.239999999999995 109.757 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 136.93 53.33 Favored 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.329 0.393 . . . . 70.439999999999998 110.082 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.57 -153.37 24.99 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.572 -1.411 . . . . 75.230000000000004 109.572 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 64.1 ttt-85 -118.51 118.06 30.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.637 -1.986 . . . . 73.340000000000003 105.637 175.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t-80 177.92 139.25 0.24 Allowed Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.955 -1.498 . . . . 73.200000000000003 106.955 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.6 -30.53 36.69 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.529 1.486 . . . . 63.329999999999998 111.978 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -88.96 4.51 47.89 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.222 0.823 . . . . 54.439999999999998 113.222 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.6 p -89.99 115.84 27.58 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 119.082 -1.047 . . . . 72.230000000000004 108.879 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.9 -34.87 73.76 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.485 0.491 . . . . 75.140000000000001 110.831 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.5 pt -114.36 111.8 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.222 -1.029 . . . . 73.439999999999998 108.222 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -94.01 121.12 35.16 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.994 -1.003 . . . . 73.420000000000002 110.774 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.29 119.4 33.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.849 -1.167 . . . . 71.129999999999995 107.849 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.74 124.77 41.77 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.799 0.296 . . . . 74.329999999999998 111.799 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD2' HG23 ' A' ' 83' ' ' VAL . 16.9 t70 177.5 -145.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 103.877 -2.638 . . . . 63.0 103.877 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.424 HG23 ' OD2' ' A' ' 82' ' ' ASP . 48.5 t -57.43 -23.56 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.914 0.779 . . . . 63.219999999999999 111.004 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 m -76.59 81.59 3.26 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.688 0.756 . . . . 75.329999999999998 110.108 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.08 105.85 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.148 -1.056 . . . . 70.439999999999998 108.148 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.3 m -163.57 136.28 5.29 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.767 -1.568 . . . . 72.219999999999999 106.767 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 17.1 ptt180 -64.28 -25.56 68.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.817 0.698 . . . . 73.349999999999994 111.629 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' HG21 ' A' ' 104' ' ' VAL . 45.3 mtt-85 -145.21 128.25 16.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.776 -0.824 . . . . 73.420000000000002 108.776 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 110' ' ' THR . 30.0 t-80 -99.88 -52.78 3.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.324 -1.362 . . . . 75.150000000000006 107.324 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.01 164.91 36.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.681 -1.145 . . . . 51.409999999999997 108.271 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.85 139.45 52.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.708 -0.478 . . . . 72.049999999999997 109.708 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -108.04 125.3 51.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.946 -1.502 . . . . 71.400000000000006 106.946 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.99 131.7 56.86 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.925 -0.768 . . . . 74.420000000000002 108.925 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.8 mp -115.25 112.27 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.411 -1.329 . . . . 61.109999999999999 107.411 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -138.93 125.49 20.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 110.724 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.77 37.97 29.51 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.851 0.86 . . . . 74.150000000000006 112.677 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 1.77 90.22 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.972 -0.558 . . . . 51.329999999999998 113.544 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -110.61 131.64 54.88 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.458 -0.571 . . . . 74.409999999999997 109.458 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -104.66 117.56 34.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.869 -1.16 . . . . 64.109999999999999 107.869 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.97 130.92 56.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.183 0.516 . . . . 61.140000000000001 110.412 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.44 122.6 61.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.64 -1.245 . . . . 61.229999999999997 107.64 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.93 124.0 71.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.426 -0.583 . . . . 64.329999999999998 109.426 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.62 140.36 40.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.8 -1.185 . . . . 55.219999999999999 107.8 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 88' ' ' ARG . 18.8 m -100.41 -13.71 8.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.947 -0.701 . . . . 71.439999999999998 111.923 -175.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.65 95.29 0.1 OUTLIER Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.505 -1.038 . . . . 64.030000000000001 110.505 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -64.96 14.48 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.681 1.592 . . . . 75.430000000000007 114.291 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 6.0 mp -70.87 -37.92 73.09 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.897 -1.149 . . . . 61.409999999999997 107.897 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.3 -20.15 22.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.47 -0.786 . . . . 74.120000000000005 110.326 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.39 94.87 0.22 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.556 -0.747 . . . . 61.32 114.58 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 58.1 m -80.98 130.16 34.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.284 -0.635 . . . . 74.019999999999996 109.284 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.36 125.69 54.54 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.643 -1.243 . . . . 74.329999999999998 107.643 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.0 t -133.1 136.86 54.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.165 -1.421 . . . . 74.420000000000002 107.165 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.33 39.25 30.74 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.367 1.467 . . . . 75.209999999999994 108.257 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' A' ' 30' ' ' THR . 34.2 mtm105 63.81 20.47 12.23 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.655 -1.611 . . . . 71.5 115.279 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.513 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 41.4 mt-10 -136.02 153.42 76.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.298 -0.63 . . . . 73.420000000000002 109.298 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.2 123.72 13.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.251 1.967 . . . . 63.030000000000001 108.925 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.626 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 18.3 tpp180 -135.96 139.99 43.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.253 -0.579 . . . . 70.400000000000006 109.869 -170.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -98.84 -37.57 9.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.477 0.656 . . . . 75.120000000000005 110.525 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.04 136.96 18.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.258 -1.386 . . . . 70.040000000000006 107.258 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.626 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 55.5 tp60 -152.58 136.02 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.176 0.435 . . . . 72.519999999999996 112.176 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.35 117.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 104.676 -2.342 . . . . 72.230000000000004 104.676 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.452 ' SD ' HD11 ' A' ' 128' ' ' ILE . 43.5 ttp -88.05 130.71 34.91 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.664 0.745 . . . . 75.400000000000006 111.458 -168.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.27 156.44 16.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.081 -1.418 . . . . 74.140000000000001 109.151 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.0 t -70.56 130.81 42.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.932 -1.136 . . . . 64.329999999999998 107.932 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.3 57.73 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 120.565 -0.826 . . . . 72.319999999999993 111.158 -177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.43 141.06 50.28 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 109.326 -0.62 . . . . 54.219999999999999 109.326 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.47 125.7 54.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.496 -0.557 . . . . 72.140000000000001 109.496 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.452 HD11 ' SD ' ' A' ' 122' ' ' MET . 68.3 mt -108.21 131.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.302 -1.37 . . . . 72.219999999999999 107.302 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -119.92 123.0 42.49 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 121.378 0.609 . . . . 75.019999999999996 109.654 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.6 mt -113.9 102.31 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.301 -1.74 . . . . 74.510000000000005 106.301 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.71 -111.86 4.43 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 109.933 -1.267 . . . . 41.509999999999998 109.933 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' A' ' 82' ' ' ASP . 65.9 pttt -103.58 -4.67 23.58 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 117.406 0.603 . . . . 74.510000000000005 110.428 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.538 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.9 m-85 -73.22 130.5 40.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.401 -0.592 . . . . 73.239999999999995 109.401 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -112.01 119.41 38.37 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.628 -1.249 . . . . 75.040000000000006 107.628 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.3 134.3 54.96 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.582 -1.266 . . . . 72.519999999999996 107.582 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.71 131.53 69.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 108.746 -0.835 . . . . 73.530000000000001 108.746 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.31 122.56 43.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.572 -0.529 . . . . 73.349999999999994 109.572 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 48' ' ' LEU . 3.9 mp -128.72 137.19 51.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 110.162 -0.31 . . . . 73.310000000000002 110.162 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.57 135.48 33.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.986 -0.746 . . . . 74.230000000000004 108.986 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.2 88.07 1.81 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.788 -0.925 . . . . 74.150000000000006 110.788 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' ' 48' ' ' LEU . 21.2 Cg_exo -66.64 161.86 39.7 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.215 2.61 . . . . 64.540000000000006 112.459 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.43 53.73 0.88 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.196 -1.038 . . . . 72.310000000000002 108.196 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.026 -0.988 . . . . 72.450000000000003 109.216 -175.583 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 109.451 -0.574 . . . . 73.150000000000006 109.451 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 107' ' ' LEU . 93.7 t -113.64 117.45 55.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 119.63 -0.224 . . . . 62.130000000000003 110.692 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 83' ' ' VAL . 47.8 p90 -123.12 127.25 48.44 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.085 -0.646 . . . . 72.430000000000007 109.454 171.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 19' ' ' ARG . 28.5 mtp180 -106.9 92.13 3.96 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.924 -1.139 . . . . 71.25 107.924 176.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 -154.99 0.56 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.233 -0.894 . . . . 63.0 112.169 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.65 -3.21 6.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.388 1.475 . . . . 73.209999999999994 112.032 -172.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.82 -25.04 60.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.132 0.973 . . . . 74.530000000000001 111.713 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.8 pp -67.31 -24.33 65.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.302 0.572 . . . . 74.219999999999999 111.304 177.52 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 23' ' ' LEU . 34.9 ttmt -88.56 -29.79 19.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.839 -0.8 . . . . 75.319999999999993 108.839 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -56.57 -44.77 81.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 42.420000000000002 110.794 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.3 ptp -83.99 2.76 37.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.614 -0.721 . . . . 73.099999999999994 111.556 -179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -91.88 -49.66 6.13 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.209 -1.034 . . . . 75.219999999999999 108.209 176.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.2 m -61.0 -42.85 99.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.29 -0.868 . . . . 51.439999999999998 111.986 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -77.4 -33.56 55.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.902 0.382 . . . . 50.340000000000003 110.293 177.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m 74.44 -54.8 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.122 1.369 . . . . 64.319999999999993 111.21 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.34 -163.8 10.58 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 109.935 -1.266 . . . . 23.149999999999999 109.935 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 113' ' ' ASN . 97.8 m -104.6 138.36 41.06 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 117.054 0.427 . . . . 71.329999999999998 110.288 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.34 121.45 66.46 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 108.367 -0.975 . . . . 61.240000000000002 108.367 176.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -59.48 152.28 62.73 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 122.93 2.42 . . . . 71.140000000000001 113.02 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 166.43 16.17 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.36 -0.836 . . . . 55.399999999999999 109.127 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -66.05 122.74 18.09 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.231 0.539 . . . . 63.210000000000001 111.189 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 m -54.67 133.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.445 -1.252 . . . . 71.530000000000001 109.904 177.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 41' ' ' ASN . . . 129.78 -28.18 3.99 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 108.826 -1.71 . . . . 71.439999999999998 108.826 -174.316 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.5 65.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.695 0.76 . . . . 74.150000000000006 110.328 178.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 7.86 4.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.008 0.909 . . . . 71.5 112.576 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.7 m120 -79.54 -16.69 55.52 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.506 -1.224 . . . . 63.119999999999997 110.269 173.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 50.96 68.62 3.2 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 123.987 0.804 . . . . 71.010000000000005 112.819 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.03 -56.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.528 2.152 . . . . 74.140000000000001 113.648 -175.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -23.31 33.43 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.019 0.377 . . . . 72.540000000000006 112.019 -177.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.93 79.7 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 120.351 -0.928 . . . . 53.530000000000001 111.182 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.1 m -115.12 157.19 23.94 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.125 -1.065 . . . . 54.340000000000003 108.125 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.59 157.3 46.04 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.548 -0.538 . . . . 63.149999999999999 109.548 -177.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -134.04 160.26 38.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.744 0.652 . . . . 71.329999999999998 109.317 -177.136 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -128.69 141.22 51.4 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 120.158 -0.617 . . . . 53.329999999999998 109.846 175.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.86 139.67 38.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.432 -0.804 . . . . 62.219999999999999 109.809 -176.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 20.7 t -81.0 118.37 28.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.204 -1.036 . . . . 63.43 108.204 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -85.15 -34.79 22.05 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.169 -0.923 . . . . 75.099999999999994 109.858 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.627 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 29.2 tpt180 -151.68 144.91 24.67 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.52 -1.659 . . . . 73.109999999999999 106.52 -177.311 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.62 -171.05 22.48 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.508 -0.853 . . . . 52.229999999999997 111.551 179.219 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.67 -33.06 8.75 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.204 1.936 . . . . 72.519999999999996 109.932 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.77 11.81 21.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.058 -1.428 . . . . 74.540000000000006 110.109 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.56 42.36 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.298 0.571 . . . . 24.34 112.109 -175.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.91 -19.27 47.37 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 115.225 -0.898 . . . . 73.420000000000002 111.712 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.74 156.84 19.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.958 -0.386 . . . . 65.150000000000006 109.958 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -139.46 155.15 47.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.752 -1.203 . . . . 73.439999999999998 107.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -147.78 143.3 27.42 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.608 -0.516 . . . . 75.510000000000005 109.608 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.3 pt? -108.62 144.75 35.93 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.526 0.516 . . . . 74.430000000000007 110.285 -177.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.15 105.06 11.14 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.703 -0.681 . . . . 70.340000000000003 110.175 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.93 -15.93 11.17 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.312 1.045 . . . . 65.340000000000003 109.344 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -107.34 153.23 41.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 114.4 -1.273 . . . . 72.319999999999993 110.117 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -63.17 -29.32 73.9 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.897 2.398 . . . . 73.409999999999997 113.743 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 67.2 m -150.47 122.67 8.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.084 0.469 . . . . 70.510000000000005 111.287 -177.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.8 m -112.6 114.24 26.78 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.163 -0.68 . . . . 74.439999999999998 109.163 178.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -90.75 133.87 34.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.39 -0.967 . . . . 72.200000000000003 108.39 175.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -128.03 135.4 49.82 Favored 'General case' 0 C--O 1.267 2.019 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 111.404 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.41 -153.62 25.01 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 114.579 -1.192 . . . . 72.310000000000002 111.174 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 22.0 tpp85 -79.4 151.82 30.72 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.977 1.311 . . . . 74.219999999999999 108.676 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 14.9 m170 92.39 127.89 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 125.904 1.682 . . . . 74.420000000000002 110.619 -175.105 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.85 2.97 4.8 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.347 2.032 . . . . 54.25 112.522 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 12.9 pt-20 -80.2 -25.19 39.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.252 -1.018 . . . . 72.310000000000002 108.252 175.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -73.01 132.04 42.9 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.7 -1.222 . . . . 74.219999999999999 107.7 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -54.74 -39.53 68.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.698 0.629 . . . . 44.119999999999997 112.698 -174.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.4 mm -119.58 124.69 73.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.34 108.06 20.22 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.266 0.555 . . . . 60.530000000000001 110.604 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.62 117.6 32.72 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.953 -2.24 . . . . 62.420000000000002 104.953 176.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.48 116.76 18.32 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.387 -0.925 . . . . 74.329999999999998 111.954 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.73 161.4 14.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.755 -0.657 . . . . 62.020000000000003 109.457 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 18' ' ' PHE . 98.6 t -67.95 -36.25 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.328 0.585 . . . . 64.310000000000002 109.914 178.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 p -116.44 -171.29 1.98 Allowed 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.791 -0.641 . . . . 71.140000000000001 110.479 -176.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.31 96.58 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.452 -0.944 . . . . 75.230000000000004 108.452 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.9 m -129.44 85.69 2.34 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.929 -1.508 . . . . 34.100000000000001 106.929 174.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 20.0 ptt180 -77.31 -45.88 24.78 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 74.109999999999999 110.117 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -106.21 93.4 4.59 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.534 -1.284 . . . . 63.340000000000003 107.534 172.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -99.65 -53.27 3.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.094 -1.076 . . . . 75.319999999999993 108.094 174.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.9 143.76 31.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.744 -0.782 . . . . 71.549999999999997 111.474 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -122.35 135.54 54.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.29 -0.868 . . . . 64.430000000000007 109.58 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 35.6 m-85 -104.2 113.62 27.29 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.572 -1.64 . . . . 65.099999999999994 106.572 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.24 123.88 51.1 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.865 -0.791 . . . . 64.310000000000002 108.865 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 94' ' ' ILE . 2.6 mp -104.02 115.13 45.39 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 N-CA-C 106.82 -1.548 . . . . 74.329999999999998 106.82 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -131.53 120.56 23.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.58 -0.526 . . . . 50.130000000000003 109.58 -177.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 48.22 48.23 18.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.556 1.143 . . . . 73.540000000000006 113.586 -177.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.07 -6.46 62.93 Favored Glycine 0 N--CA 1.462 0.427 0 CA-C-N 116.015 -0.539 . . . . 61.240000000000002 114.414 176.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -103.05 143.56 32.43 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.276 -0.639 . . . . 71.209999999999994 109.276 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -104.8 116.76 32.57 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.871 -0.788 . . . . 72.439999999999998 108.871 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.0 126.28 55.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.434 -0.951 . . . . 73.109999999999999 108.434 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.77 123.97 63.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 118.662 -1.215 . . . . 43.409999999999997 107.787 173.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.17 123.38 67.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.044 -1.465 . . . . 71.25 107.044 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.53 136.47 47.26 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.94 -1.027 . . . . 72.430000000000007 109.991 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -116.75 0.1 8.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.946 -0.57 . . . . 64.310000000000002 110.616 177.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.08 34.64 4.86 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 121.151 -0.547 . . . . 63.140000000000001 112.049 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -51.62 -34.42 37.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.876 1.27 . . . . 61.219999999999999 111.177 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 107' ' ' LEU . 4.6 mp -67.34 -23.92 65.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.063 -0.971 . . . . 54.409999999999997 111.16 -178.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.95 -18.64 30.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.586 0.708 . . . . 75.430000000000007 109.704 -175.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.22 0.43 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 119.103 -1.522 . . . . 71.230000000000004 113.93 175.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.8 m -77.79 129.14 35.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.871 -0.789 . . . . 42.310000000000002 108.871 172.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.11 144.55 47.2 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.897 -0.321 . . . . 64.319999999999993 110.189 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.18 117.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.594 -1.632 . . . . 71.510000000000005 106.594 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.422 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 93.9 m-20 56.91 45.75 20.82 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.734 0.646 . . . . 54.32 110.062 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.04 8.95 2.81 Favored 'General case' 0 CA--C 1.569 1.701 0 C-N-CA 125.731 1.612 . . . . 73.409999999999997 113.809 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -114.11 136.85 22.24 Favored Pre-proline 0 C--N 1.31 -1.134 0 O-C-N 121.341 -0.85 . . . . 65.420000000000002 110.342 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -68.05 138.17 43.08 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 122.025 1.817 . . . . 70.420000000000002 111.211 177.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -142.19 164.6 29.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.082 -0.508 . . . . 62.310000000000002 111.025 -177.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -117.37 -37.6 3.48 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.489 1.118 . . . . 70.239999999999995 108.258 176.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.01 139.95 26.48 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.283 -1.377 . . . . 73.510000000000005 107.283 175.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 0.0 OUTLIER -152.49 130.33 11.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.432 -0.581 . . . . 64.219999999999999 109.432 -177.864 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.8 t -83.41 118.29 30.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.999 -1.482 . . . . 65.349999999999994 106.999 174.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.443 ' HE2' ' HB3' ' A' ' 120' ' ' GLN . 22.8 mmt -88.82 144.93 25.9 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.725 0.774 . . . . 63.5 112.944 -167.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.58 155.91 45.04 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.946 -1.479 . . . . 75.319999999999993 107.26 -177.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 t -62.57 134.38 56.29 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.339 0.59 . . . . 71.310000000000002 111.336 -176.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.32 -7.47 56.46 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.06 -0.973 . . . . 71.400000000000006 113.535 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.79 152.14 24.81 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 119.002 -1.079 . . . . 75.439999999999998 111.709 175.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.21 129.15 51.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.381 -1.281 . . . . 71.25 110.187 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt -108.1 131.91 57.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.198 -1.408 . . . . 74.230000000000004 107.198 -177.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -104.35 122.48 45.54 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.312 -0.996 . . . . 71.420000000000002 108.312 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 135' ' ' LEU . 2.3 mp -109.22 104.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 106.602 -1.629 . . . . 53.530000000000001 106.602 178.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.05 -107.81 2.21 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.248 -1.141 . . . . 73.120000000000005 110.248 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -110.77 6.86 21.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.849 0.325 . . . . 70.340000000000003 111.673 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.627 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 44.1 p90 -123.49 157.63 33.1 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.542 0.941 . . . . 74.219999999999999 113.542 -177.013 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -116.05 136.61 52.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.347 -0.388 . . . . 64.120000000000005 111.329 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 130' ' ' ILE . 9.6 mp -123.45 139.72 53.74 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.191 0.997 . . . . 64.230000000000004 108.337 175.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.45 126.82 69.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.574 -0.528 . . . . 62.210000000000001 109.574 -178.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -88.32 127.74 35.48 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.657 -0.868 . . . . 71.140000000000001 108.657 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.44 143.72 50.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.577 0.703 . . . . 72.120000000000005 111.238 -176.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.2 121.92 45.5 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.489 -0.93 . . . . 60.229999999999997 108.489 176.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 132.27 82.23 0.22 Allowed Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.72 -1.352 . . . . 53.219999999999999 109.72 -177.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.98 162.38 29.42 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.276 2.65 . . . . 54.219999999999999 112.719 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.89 -1.17 56.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.198 0.999 . . . . 63.240000000000002 110.929 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.271 -2.838 0 N-CA-C 103.627 -2.731 . . . . 62.009999999999998 103.627 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.509 ' O ' HD12 ' A' ' 107' ' ' LEU . 36.1 t . . . . . 0 N--CA 1.424 -1.773 0 N-CA-C 108.785 -0.82 . . . . 64.420000000000002 108.785 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -85.56 115.13 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.283 -1.377 . . . . 72.439999999999998 107.283 177.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.472 ' CE2' ' HG ' ' A' ' 107' ' ' LEU . 40.3 p90 -114.79 142.53 46.4 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 120.813 0.34 . . . . 74.319999999999993 110.55 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -80.78 95.93 6.81 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.74 -1.208 . . . . 73.420000000000002 107.74 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -81.3 -178.71 7.04 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.421 -0.809 . . . . 73.230000000000004 112.26 -175.187 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.42 4.44 4.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 114.326 1.232 . . . . 64.420000000000002 114.326 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 22' ' ' LEU . 2.5 pt? -82.83 -16.75 46.5 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.879 -0.513 . . . . 74.450000000000003 111.553 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 2.6 pp -70.01 -1.14 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.118 1.525 . . . . 75.140000000000001 115.118 -173.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -102.73 -22.5 13.92 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.574 -0.451 . . . . 60.229999999999997 111.257 177.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 114' ' ' ARG . 30.8 tt0 -72.68 -23.6 60.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.703 -0.399 . . . . 74.310000000000002 111.829 -172.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' SER . 52.6 ttp -62.33 -47.52 83.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.327 -0.397 . . . . 51.25 110.196 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.42 -22.58 23.66 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.505 -0.316 . . . . 70.319999999999993 110.963 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.6 t -62.29 -27.44 69.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.186 0.993 . . . . 65.540000000000006 108.532 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 26' ' ' MET . 40.0 t -65.38 -39.14 91.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.311 -1.313 . . . . 62.299999999999997 110.593 175.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 m 69.46 -7.08 0.89 Allowed 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 124.879 1.271 . . . . 71.329999999999998 111.418 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.64 96.23 0.11 Allowed Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.668 -1.773 . . . . 72.340000000000003 108.668 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 92.0 m -72.84 121.02 19.28 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.869 0.842 . . . . 62.200000000000003 110.772 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.13 106.16 19.9 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 114.803 -1.09 . . . . 73.329999999999998 109.042 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -61.16 142.96 98.38 Favored 'Trans proline' 0 C--O 1.263 1.74 0 C-N-CA 121.551 1.501 . . . . 60.240000000000002 109.202 173.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.47 125.72 27.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.939 -0.573 . . . . 63.329999999999998 110.342 -177.39 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.5 m -84.33 92.7 8.07 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.657 -0.868 . . . . 61.549999999999997 108.657 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 m -102.55 155.62 18.16 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.875 -1.157 . . . . 72.239999999999995 107.875 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.7 25.57 7.3 Favored Glycine 0 CA--C 1.499 -0.947 0 N-CA-C 111.05 -0.82 . . . . 74.219999999999999 111.05 -175.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.93 5.18 49.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.987 -0.607 . . . . 74.140000000000001 110.202 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.23 -3.35 13.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.373 1.069 . . . . 65.409999999999997 113.393 -175.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.86 -2.81 31.1 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.233 -1.025 . . . . 73.430000000000007 108.233 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.9 82.83 0.22 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.185 -0.916 . . . . 71.329999999999998 110.95 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.03 -59.72 0.74 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.235 2.623 . . . . 73.409999999999997 114.257 -175.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.13 -4.08 59.09 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.227 0.454 . . . . 51.229999999999997 112.227 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 9.61 86.82 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.709 -0.758 . . . . 71.0 111.478 -177.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 m -145.86 169.22 19.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.884 -1.524 . . . . 73.230000000000004 106.884 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.77 157.23 43.63 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.414 0.446 . . . . 75.409999999999997 109.916 -178.134 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -133.26 153.32 51.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.056 0.455 . . . . 72.439999999999998 110.8 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.5 pp -110.86 135.02 52.03 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.573 176.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.75 135.2 55.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.394 -0.595 . . . . 72.219999999999999 109.394 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.26 117.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.361 -1.718 . . . . 65.400000000000006 106.361 176.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.53 -31.95 16.53 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.527 -0.761 . . . . 73.200000000000003 109.683 -175.641 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -148.19 141.02 24.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.399 -0.963 . . . . 72.439999999999998 108.399 -178.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.5 174.14 13.22 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.793 -0.923 . . . . 62.420000000000002 110.793 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.592 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 76.6 Cg_exo -54.68 -43.28 60.52 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.83 2.353 . . . . 65.040000000000006 112.402 177.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -93.11 21.88 5.5 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.792 1.034 . . . . 73.439999999999998 113.792 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.75 137.26 44.9 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.735 0.302 . . . . 52.109999999999999 111.14 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.6 -18.95 40.18 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.144 -0.783 . . . . 65.319999999999993 111.144 -177.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.23 143.06 29.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.53 -0.544 . . . . 74.129999999999995 109.53 177.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -135.2 135.58 41.11 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.505 -0.924 . . . . 75.219999999999999 108.505 179.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -128.42 129.67 46.51 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.511 -0.552 . . . . 73.409999999999997 109.511 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.7 pt? -92.13 139.07 31.0 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.286 -0.635 . . . . 74.319999999999993 109.286 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.31 104.38 15.09 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.941 -0.763 . . . . 61.310000000000002 108.941 -179.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -124.37 -2.77 7.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.564 -1.198 . . . . 53.119999999999997 108.957 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 8.8 pm0 -107.73 143.76 27.93 Favored Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-N 115.184 -0.916 . . . . 74.319999999999993 109.392 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 65' ' ' GLN . 21.2 Cg_exo -68.37 -16.28 43.28 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.777 2.318 . . . . 70.319999999999993 113.445 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -150.1 128.05 11.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.727 -0.608 . . . . 74.239999999999995 109.495 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 10.6 m -123.7 119.38 29.63 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 p -87.5 137.12 32.61 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 110.208 -0.293 . . . . 70.540000000000006 110.208 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.02 148.3 51.86 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.329 0.585 . . . . 62.420000000000002 110.787 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.23 28.31 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 108.612 -1.795 . . . . 65.349999999999994 108.612 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -119.15 117.66 29.27 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.653 -1.61 . . . . 44.409999999999997 106.653 175.967 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 171.45 162.14 0.24 Allowed Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 126.077 1.751 . . . . 74.219999999999999 106.623 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.87 -28.66 75.72 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.373 2.049 . . . . 74.340000000000003 114.22 -176.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.14 4.52 48.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.719 0.637 . . . . 62.240000000000002 112.719 -174.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 m -67.9 117.54 9.92 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 73.439999999999998 109.407 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.94 -39.27 84.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.201 -1.037 . . . . 72.239999999999995 108.201 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.455 HG12 ' CG2' ' A' ' 68' ' ' THR . 47.5 mm -112.65 110.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.196 -1.779 . . . . 62.219999999999999 106.196 169.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.4 129.45 39.53 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.991 -0.549 . . . . 75.319999999999993 110.74 -176.194 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 1.7 mm? -124.58 129.78 51.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.254 -2.128 . . . . 71.019999999999996 105.254 175.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -101.31 116.66 33.31 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.589 -0.844 . . . . 54.520000000000003 109.782 177.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.03 -160.11 0.95 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.312 -1.366 . . . . 74.239999999999995 107.312 -178.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.79 -27.99 17.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.65 0.611 . . . . 55.140000000000001 112.65 -174.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.1 m -139.42 148.83 43.33 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.209 -0.932 . . . . 64.439999999999998 111.844 -175.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -74.56 148.88 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.029 . . . . 73.299999999999997 110.189 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.491 ' HB3' HD22 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -142.28 113.69 7.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.19 -1.041 . . . . 74.25 108.19 177.624 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -56.63 -25.3 52.91 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.148 0.795 . . . . 73.329999999999998 113.148 -177.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.416 ' HG2' HG21 ' A' ' 104' ' ' VAL . 34.5 ttt180 -172.99 99.02 0.13 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.286 -1.376 . . . . 63.229999999999997 107.286 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 27.0 t-80 -84.56 -52.53 6.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.425 0.631 . . . . 72.439999999999998 109.698 -177.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.42 41.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.754 -0.832 . . . . 62.5 108.754 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.65 143.98 43.76 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.553 -0.536 . . . . 54.43 109.553 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 83.3 m-85 -104.78 125.32 50.73 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.381 -1.711 . . . . 73.319999999999993 106.381 178.487 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -113.43 119.11 36.48 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 106.795 -1.557 . . . . 73.439999999999998 106.795 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 3.4 mp -114.65 111.88 37.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.541 -1.651 . . . . 70.340000000000003 106.541 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -135.29 128.9 32.68 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.786 -1.19 . . . . 65.340000000000003 107.786 -177.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 55.45 37.98 29.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.882 0.873 . . . . 61.130000000000003 112.035 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.37 1.45 90.43 Favored Glycine 0 C--O 1.238 0.402 0 CA-C-N 115.974 -0.557 . . . . 52.520000000000003 113.911 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 20.2 mm-40 -102.11 131.74 48.42 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.782 -0.451 . . . . 65.239999999999995 109.782 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -107.48 118.59 37.13 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.211 -1.404 . . . . 72.439999999999998 107.211 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.17 142.79 51.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.251 -0.579 . . . . 52.329999999999998 110.303 178.527 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -106.63 123.61 61.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.586 -1.265 . . . . 54.420000000000002 107.586 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.3 121.21 65.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.138 -0.69 . . . . 61.340000000000003 109.138 175.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -83.14 131.65 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.459 -0.941 . . . . 74.519999999999996 108.459 173.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.416 HG21 ' HG2' ' A' ' 88' ' ' ARG . 34.6 m -124.74 -14.46 4.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 123.457 0.473 . . . . 72.209999999999994 110.645 178.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . -156.28 84.48 0.14 Allowed Glycine 0 N--CA 1.419 -2.454 0 C-N-CA 120.816 -0.707 . . . . 54.219999999999999 112.768 -178.444 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -69.7 83.09 0.44 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.11 0.481 . . . . 73.209999999999994 109.975 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 16' ' ' SER . 12.4 tp -77.17 -49.31 15.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.675 -1.232 . . . . 74.25 107.675 174.025 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -102.37 -19.17 15.08 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.296 -1.774 . . . . 52.149999999999999 110.049 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 108.82 3.31 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.873 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.6 m -87.38 130.43 34.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.464 0.174 . . . . 55.329999999999998 111.24 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 5.6 m-30 -127.97 132.24 49.21 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.147 0.979 . . . . 74.340000000000003 109.068 175.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.75 127.74 75.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.842 -1.54 . . . . 75.140000000000001 106.842 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 56.85 36.49 27.8 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.031 1.332 . . . . 73.040000000000006 109.185 -169.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.493 ' HD3' ' OE2' ' A' ' 25' ' ' GLU 0.274 44.0 ttp180 57.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.576 1.948 0 C-N-CA 125.716 1.607 . . . . 75.310000000000002 113.059 -177.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.23 147.87 36.84 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.71 -1.219 . . . . 72.450000000000003 107.71 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.72 123.16 12.14 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.703 1.602 . . . . 61.119999999999997 110.24 177.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -161.11 136.89 8.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.707 -1.22 . . . . 75.230000000000004 107.707 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -100.56 -53.75 3.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 123.364 0.415 . . . . 75.239999999999995 109.959 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.604 -0.887 . . . . 65.420000000000002 108.604 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -154.77 140.22 17.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.315 -0.402 . . . . 72.400000000000006 110.699 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.6 t -76.06 124.54 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 105.756 -1.942 . . . . 71.299999999999997 105.756 168.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.436 ' SD ' HD11 ' A' ' 128' ' ' ILE . 36.6 ttp -89.81 141.19 28.86 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.485 -169.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 11.0 pt20 -115.1 156.99 24.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 124.557 1.143 . . . . 73.099999999999994 109.815 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -69.92 130.26 41.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 74.340000000000003 107.692 173.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.02 56.5 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 119.963 -1.113 . . . . 54.340000000000003 110.351 -174.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 6.3 t70 -76.21 137.53 40.06 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.27 -1.381 . . . . 74.209999999999994 107.27 178.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.6 124.28 45.95 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.354 0.597 . . . . 73.299999999999997 109.765 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.436 HD11 ' SD ' ' A' ' 122' ' ' MET . 37.3 mt -108.16 131.69 57.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.53 -0.915 . . . . 62.210000000000001 108.53 -172.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 7.2 tp60 -115.52 119.04 34.88 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.345 -0.613 . . . . 53.140000000000001 109.345 -176.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.19 102.83 9.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 106.48 -1.674 . . . . 64.340000000000003 106.48 176.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.89 -103.66 0.06 OUTLIER Glycine 0 N--CA 1.475 1.24 0 O-C-N 123.74 0.65 . . . . 75.349999999999994 114.134 -175.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -106.59 2.03 25.73 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.106 -0.547 . . . . 73.109999999999999 111.903 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 89.3 m-85 -96.32 135.39 38.23 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.219 -1.4 . . . . 73.099999999999994 107.219 173.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -131.76 120.17 22.31 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.029 -1.1 . . . . 74.409999999999997 108.029 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.37 136.59 48.55 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.416 -0.587 . . . . 73.400000000000006 109.416 -176.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.95 120.17 64.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.219 -1.4 . . . . 72.239999999999995 107.219 175.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -98.27 117.15 32.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 110.147 -0.316 . . . . 73.510000000000005 110.147 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.37 143.88 47.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.182 0.515 . . . . 61.200000000000003 111.187 -177.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.97 119.64 34.83 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.759 -1.571 . . . . 63.210000000000001 106.759 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.39 153.24 19.81 Favored Glycine 0 N--CA 1.426 -1.969 0 C-N-CA 118.866 -1.635 . . . . 72.0 112.697 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.67 164.13 36.71 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 123.687 2.925 . . . . 72.409999999999997 111.524 175.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 84.31 69.22 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 125.213 1.405 . . . . 73.430000000000007 111.989 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 105.264 -2.125 . . . . 54.119999999999997 105.264 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 44.9 t . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.204 -0.295 . . . . 63.350000000000001 110.204 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.38 118.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.789 -0.449 . . . . 63.340000000000003 109.789 -178.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -124.04 140.73 52.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.384 -0.371 . . . . 74.299999999999997 111.16 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -94.51 139.59 30.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.239 -0.437 . . . . 74.019999999999996 111.232 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -128.46 -164.2 1.36 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 7.6 p-10 -68.08 -3.23 9.65 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.929 0.871 . . . . 73.209999999999994 111.2 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.7 mt -57.25 -31.99 66.1 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 125.89 1.676 . . . . 73.019999999999996 111.502 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 1.6 pp -68.39 -1.38 6.32 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.224 1.564 . . . . 64.099999999999994 115.224 -175.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 63.2 pttt -81.25 -5.71 58.07 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.847 -0.533 . . . . 71.319999999999993 111.599 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -48.9 31.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 116.112 1.893 . . . . 70.430000000000007 116.112 -175.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.7 ttm -62.26 -46.86 86.93 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.942 0.401 . . . . 62.240000000000002 111.658 -176.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.28 -28.25 61.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.318 0.58 . . . . 45.409999999999997 110.303 -178.248 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -80.51 -11.63 59.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.114 -0.494 . . . . 61.439999999999998 110.924 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -71.33 -24.41 62.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.756 -0.831 . . . . 54.539999999999999 108.756 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -76.08 93.74 3.36 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.305 -1.369 . . . . 72.310000000000002 107.305 171.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.78 50.32 0.85 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 106.901 -2.48 . . . . 51.32 106.901 -169.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -67.17 148.39 51.86 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.853 1.261 . . . . 71.510000000000005 112.118 -173.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 150.38 37.8 Favored Pre-proline 0 C--N 1.312 -1.028 0 N-CA-C 108.501 -0.925 . . . . 51.009999999999998 108.501 177.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.98 146.42 96.31 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.418 2.079 . . . . 74.129999999999995 113.24 -177.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.72 159.22 17.19 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 71.219999999999999 108.484 175.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.3 t -98.92 178.12 5.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.489 -0.56 . . . . 73.040000000000006 109.489 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.506 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 12.9 t -156.4 33.56 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.792 -1.929 . . . . 72.420000000000002 105.792 176.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 124' ' ' THR . . . -103.56 35.45 5.02 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 114.827 -1.079 . . . . 62.409999999999997 113.072 -173.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 123' ' ' GLN . . . -90.82 -33.93 15.49 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.396 -0.964 . . . . 63.039999999999999 108.396 174.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.28 12.65 1.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.934 -1.485 . . . . 71.209999999999994 112.346 -177.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.08 -42.02 24.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.24 -0.282 . . . . 72.400000000000006 110.24 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt 35.94 76.07 0.46 Allowed Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 124.766 1.291 . . . . 74.530000000000001 114.241 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.35 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.437 1.425 . . . . 44.100000000000001 111.112 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.06 -8.44 20.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.147 0.499 . . . . 64.329999999999998 110.954 178.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -6.22 80.15 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.401 -0.904 . . . . 75.439999999999998 111.925 -179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -114.49 162.79 16.24 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.94 -1.874 . . . . 71.400000000000006 105.94 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -153.15 157.14 39.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 118.137 0.426 . . . . 73.519999999999996 110.51 -178.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 143.72 44.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.14 0.422 . . . . 74.140000000000001 112.14 -178.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 pt? -116.55 138.54 51.32 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.402 -0.592 . . . . 71.140000000000001 109.402 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.68 132.5 57.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 123.64 0.587 . . . . 72.329999999999998 109.573 -176.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.72 118.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.724 -1.584 . . . . 63.340000000000003 106.724 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.91 -38.96 18.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.411 0.624 . . . . 73.040000000000006 110.34 -175.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -147.54 140.7 25.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.325 -1.361 . . . . 65.019999999999996 107.325 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.94 -177.14 19.12 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 111.475 -0.65 . . . . 73.349999999999994 111.475 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.23 -36.9 86.37 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 122.772 2.315 . . . . 62.009999999999998 111.863 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.75 14.55 18.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.808 -0.633 . . . . 70.239999999999995 111.419 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.49 134.39 56.64 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.776 0.658 . . . . 61.119999999999997 112.776 -176.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -21.09 44.37 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.786 -0.643 . . . . 64.439999999999998 111.876 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 155.03 19.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.766 0.317 . . . . 73.040000000000006 110.47 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.14 144.54 51.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.107 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -117.82 138.53 52.02 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.221 -1.029 . . . . 63.219999999999999 108.221 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.11 127.01 56.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.917 0.865 . . . . 74.549999999999997 110.795 -175.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 49' ' ' LEU . 2.2 mm? -95.45 114.77 26.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.822 -1.081 . . . . 73.519999999999996 108.436 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -134.33 4.27 3.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.296 1.046 . . . . 74.349999999999994 109.193 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -121.49 143.3 37.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.978 -1.01 . . . . 72.299999999999997 110.724 -175.083 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 53.7 Cg_exo -55.19 -24.39 41.26 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.746 2.964 . . . . 75.420000000000002 114.699 -178.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -144.27 121.54 11.57 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.474 -0.766 . . . . 63.210000000000001 110.722 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.3 m -129.7 119.88 24.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.9 -0.778 . . . . 74.040000000000006 108.9 -178.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 140.25 29.72 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.508 0.594 . . . . 73.209999999999994 111.275 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.05 135.5 55.18 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 109.549 -0.538 . . . . 71.340000000000003 109.549 178.079 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.36 -161.34 25.69 Favored Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 115.65 -0.705 . . . . 42.130000000000003 111.385 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.541 ' HG2' ' H ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -103.83 142.16 34.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.062 -1.459 . . . . 74.239999999999995 107.062 -177.554 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.463 ' CD2' ' HD2' ' A' ' 72' ' ' ARG . 90.4 m-70 80.58 145.84 0.1 OUTLIER Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 125.414 1.486 . . . . 74.400000000000006 110.092 -176.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -66.5 17.4 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.601 2.867 . . . . 51.109999999999999 114.341 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 73' ' ' HIS . 10.4 mm-40 -77.37 -28.77 53.02 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.313 -1.366 . . . . 65.420000000000002 107.313 177.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -96.1 153.0 18.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.919 -1.037 . . . . 61.409999999999997 109.658 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.18 -47.19 78.78 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.56 0.744 . . . . 64.400000000000006 110.463 -178.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.8 mm -98.98 109.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.026 -1.102 . . . . 74.030000000000001 108.026 178.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -87.68 115.6 25.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.115 0.483 . . . . 74.420000000000002 110.577 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 70.8 mt -126.74 140.42 52.4 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.491 -1.67 . . . . 72.430000000000007 106.491 176.623 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -96.52 117.11 30.24 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.246 -0.982 . . . . 74.530000000000001 109.661 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.541 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 46.1 t0 -117.38 -179.88 3.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.779 -0.646 . . . . 70.109999999999999 109.36 -171.492 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.03 -46.44 96.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 123.757 0.823 . . . . 74.439999999999998 111.694 -176.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -128.27 -173.1 2.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.463 -0.94 . . . . 72.209999999999994 108.463 -178.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.37 97.5 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 108.825 -0.806 . . . . 54.420000000000002 108.825 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.6 m -89.74 84.89 6.31 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 108.525 -0.917 . . . . 55.210000000000001 108.525 177.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -71.82 -36.98 70.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.97 -1.468 . . . . 75.120000000000005 112.091 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.588 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 31.2 mmm180 -133.71 85.86 2.24 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.241 -1.022 . . . . 71.319999999999993 108.241 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -101.55 -55.65 2.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.193 -0.603 . . . . 61.420000000000002 110.952 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.76 164.59 31.42 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.077 0.465 . . . . 62.409999999999997 111.046 -176.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.66 141.49 37.01 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.397 0.617 . . . . 75.049999999999997 110.148 173.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -104.25 117.4 34.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.781 -1.562 . . . . 63.119999999999997 106.781 -178.464 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -117.37 128.46 55.05 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-N 115.445 -0.798 . . . . 74.040000000000006 109.256 -175.348 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -115.52 112.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 105.907 -1.886 . . . . 63.109999999999999 105.907 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -138.52 125.48 21.22 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.893 -0.323 . . . . 70.420000000000002 111.255 -175.353 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 51.56 49.9 19.94 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.978 1.424 . . . . 72.0 114.098 173.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 114.877 -1.056 . . . . 73.510000000000005 115.382 173.252 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -127.6 146.99 50.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 118.277 1.038 . . . . 74.230000000000004 111.026 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.33 119.6 39.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.485 -1.302 . . . . 75.5 107.485 -176.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.55 128.46 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.525 0.679 . . . . 70.549999999999997 111.353 -176.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 122' ' ' MET . 32.9 t -103.82 124.51 58.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.506 -1.294 . . . . 63.32 107.506 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 20.8 m -118.51 123.37 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 121.588 0.709 . . . . 71.140000000000001 110.836 176.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.29 121.6 25.3 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.447 -1.686 . . . . 73.209999999999994 106.447 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -111.84 -8.72 11.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.175 0.512 . . . . 72.530000000000001 111.349 -174.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -147.28 90.97 0.15 Allowed Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.17 -1.572 . . . . 51.200000000000003 109.17 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 m -79.22 74.09 5.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.559 0.695 . . . . 71.129999999999995 110.989 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.6 pt? -104.77 -44.36 4.87 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.328 -0.851 . . . . 75.200000000000003 108.786 175.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.408 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 45.7 t-20 -101.16 -21.78 14.85 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.461 -1.245 . . . . 71.510000000000005 107.897 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.49 116.41 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.309 -0.86 . . . . 73.409999999999997 111.774 -177.166 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 25.2 m -75.82 128.51 35.29 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.794 -0.817 . . . . 71.540000000000006 108.794 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 22' ' ' LEU . 6.4 m-85 -115.24 126.34 54.42 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.616 -0.513 . . . . 71.140000000000001 109.616 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.6 127.87 62.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.408 -1.33 . . . . 75.200000000000003 107.408 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 57.05 46.58 18.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.637 1.208 . . . . 72.120000000000005 108.385 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 62.69 8.56 3.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.534 -1.667 . . . . 75.0 114.471 -177.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.43 132.66 23.45 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 113.231 0.826 . . . . 64.219999999999999 113.231 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 52.7 Cg_endo -78.13 123.19 6.04 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.0 1.8 . . . . 73.129999999999995 108.369 173.278 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -150.34 158.05 43.73 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.173 -1.047 . . . . 71.239999999999995 108.173 -176.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 15.7 m120 -92.95 -40.8 10.37 Favored 'General case' 0 C--O 1.206 -1.192 0 C-N-CA 120.003 -0.679 . . . . 72.430000000000007 112.77 -176.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.02 134.46 55.29 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.206 -1.405 . . . . 62.200000000000003 107.206 174.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -151.92 143.44 23.49 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 120.837 -0.345 . . . . 74.430000000000007 111.309 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -82.41 124.34 39.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.15 -1.426 . . . . 61.009999999999998 107.15 173.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.438 ' HB2' HG23 ' A' ' 101' ' ' VAL . 47.3 ttp -92.5 129.25 38.49 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 62.420000000000002 108.347 -177.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' A' ' 37' ' ' THR . 26.3 mt-30 -129.8 151.02 50.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.121 -0.696 . . . . 61.030000000000001 109.121 -172.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 38' ' ' GLY . 13.7 t -62.42 132.75 53.59 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.394 0.616 . . . . 63.210000000000001 110.058 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.28 -12.08 61.82 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.774 -0.648 . . . . 72.5 112.584 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.74 151.96 25.95 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.025 0.441 . . . . 74.239999999999995 111.819 178.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -112.23 144.53 41.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.371 -0.832 . . . . 74.540000000000006 109.73 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.43 131.63 67.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.008 -1.108 . . . . 70.310000000000002 108.008 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -117.41 130.51 56.53 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.428 -0.509 . . . . 63.210000000000001 110.163 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.43 107.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 106.29 -1.744 . . . . 72.450000000000003 106.29 175.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.82 -108.53 2.27 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.127 -0.488 . . . . 70.549999999999997 113.323 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.99 -1.2 32.35 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.741 -0.23 . . . . 75.010000000000005 111.504 -175.016 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 38.1 p90 -124.71 146.39 49.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.992 1.108 . . . . 74.400000000000006 113.992 -173.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -118.18 132.18 56.34 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.117 -0.947 . . . . 74.25 111.288 -172.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.39 140.66 52.43 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 124.142 0.977 . . . . 73.019999999999996 108.875 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.04 130.39 67.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.705 -0.85 . . . . 73.310000000000002 108.705 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -94.06 133.07 37.91 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.976 -0.557 . . . . 63.219999999999999 111.221 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.29 155.57 39.98 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.906 -0.776 . . . . 75.319999999999993 108.906 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.42 148.66 38.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.034 -0.728 . . . . 55.109999999999999 109.034 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.5 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -75.58 136.56 20.26 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.781 -0.724 . . . . 65.129999999999995 112.019 -178.146 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.52 153.89 72.06 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.259 2.64 . . . . 53.030000000000001 112.27 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.61 65.56 0.8 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.791 -0.64 . . . . 62.439999999999998 111.516 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.414 -2.225 0 N-CA-C 107.944 -1.132 . . . . 75.349999999999994 107.944 173.183 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 105.504 -2.036 . . . . 73.439999999999998 105.504 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.467 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 93.4 t -82.78 114.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.853 -0.739 . . . . 73.200000000000003 109.321 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -123.3 120.41 32.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.51 -0.768 . . . . 75.329999999999998 110.778 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.92 93.02 3.04 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.155 -2.165 . . . . 71.329999999999998 105.155 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.64 9.52 22.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.467 0.914 . . . . 70.549999999999997 113.467 -168.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -107.24 8.17 29.77 Favored 'General case' 0 C--O 1.182 -2.498 0 C-N-CA 118.909 -1.116 . . . . 74.420000000000002 112.581 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.83 -32.4 63.54 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.111 -0.993 . . . . 70.430000000000007 113.374 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.1 tp -68.05 -37.69 81.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.33 0.586 . . . . 75.329999999999998 110.289 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -91.08 -25.18 19.76 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.126 -0.359 . . . . 55.200000000000003 111.343 -177.181 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -44.31 93.08 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.163 -1.421 . . . . 65.519999999999996 107.163 174.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.3 mtt -62.27 -35.4 78.86 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.33 -0.396 . . . . 65.420000000000002 111.468 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.85 -44.46 80.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.741 0.781 . . . . 75.040000000000006 109.221 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -72.92 -10.44 59.8 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.086 -178.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -65.42 -17.19 64.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.577 0.227 . . . . 32.219999999999999 110.94 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -57.43 116.95 3.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.437 -0.949 . . . . 74.25 108.437 174.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.15 119.74 18.5 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.335 -0.848 . . . . 61.310000000000002 115.079 -173.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -116.68 149.49 39.71 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.513 -1.292 . . . . 64.310000000000002 107.513 173.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.01 127.49 92.86 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.994 -0.373 . . . . 55.149999999999999 109.994 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.02 142.58 88.32 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.134 1.889 . . . . 75.239999999999995 110.61 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . . . -103.69 168.13 9.34 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.505 -0.316 . . . . 72.549999999999997 110.289 -174.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.477 ' HA ' HG23 ' A' ' 124' ' ' THR . 14.4 t -174.88 -168.28 0.34 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.903 -1.518 . . . . 72.510000000000005 106.903 177.226 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 36' ' ' SER . 15.3 t 174.45 -29.81 0.0 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.803 0.841 . . . . 71.340000000000003 109.906 178.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.34 63.3 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.901 -1.143 . . . . 64.019999999999996 112.661 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 124' ' ' THR . . . -79.34 -45.9 18.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.037 -0.727 . . . . 70.239999999999995 109.037 179.202 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.15 4.7 22.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.409 -0.814 . . . . 72.400000000000006 110.651 -178.002 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -89.88 -28.18 19.4 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.664 -1.153 . . . . 51.130000000000003 108.16 177.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.4 mt 56.34 80.05 0.31 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 114.739 -1.119 . . . . 53.530000000000001 110.626 -177.463 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.76 -63.71 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 122.743 2.295 . . . . 71.209999999999994 113.406 -175.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.8 14.03 7.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.212 0.529 . . . . 55.210000000000001 110.588 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.28 -9.07 62.1 Favored Glycine 0 C--O 1.215 -1.087 0 C-N-CA 121.127 -0.558 . . . . 71.019999999999996 113.378 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -115.35 153.98 30.02 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 122.351 -0.499 . . . . 51.520000000000003 109.779 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -145.91 157.51 43.89 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.073 -0.714 . . . . 42.329999999999998 109.073 -177.169 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HG ' ' HA2' ' A' ' 140' ' ' GLY . 3.9 pp -138.76 161.49 37.07 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.831 -0.347 . . . . 62.539999999999999 111.137 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.6 147.36 52.52 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.745 -0.465 . . . . 71.209999999999994 109.745 177.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.04 132.09 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.12 -0.696 . . . . 71.230000000000004 109.12 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG22 ' HG ' ' A' ' 135' ' ' LEU . 25.5 t -80.25 117.92 26.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.167 -1.42 . . . . 74.430000000000007 107.167 176.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.62 -34.0 18.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.747 -0.381 . . . . 75.209999999999994 110.636 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -146.82 133.43 19.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.431 -0.581 . . . . 70.299999999999997 109.431 -178.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.43 171.88 17.0 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 107.304 -2.318 . . . . 40.049999999999997 107.304 -177.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 52.3 Cg_exo -57.61 -31.89 92.97 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.234 1.956 . . . . 50.149999999999999 111.273 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -93.94 20.33 7.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.375 -0.829 . . . . 74.239999999999995 111.274 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 138.54 58.4 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.645 0.26 . . . . 54.109999999999999 110.654 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.92 63.16 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.737 -0.665 . . . . 73.0 111.715 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.33 135.9 33.35 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.698 0.285 . . . . 45.520000000000003 110.446 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.03 134.53 54.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.316 -1.365 . . . . 71.120000000000005 107.316 177.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -128.49 144.9 51.22 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.351 -1.352 . . . . 64.409999999999997 107.351 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.2 pt? -116.66 143.18 45.95 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.528 -0.869 . . . . 74.530000000000001 111.951 -177.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HB3' HD11 ' A' ' 94' ' ' ILE . 2.8 mm? -87.37 105.01 16.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.116 -1.809 . . . . 64.409999999999997 106.116 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -127.37 12.33 7.0 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.487 1.137 . . . . 64.340000000000003 109.761 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.66 153.81 47.38 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.029 -1.1 . . . . 71.329999999999998 108.029 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.3 -21.25 71.74 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.378 2.052 . . . . 72.150000000000006 113.713 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.7 m -136.93 121.7 18.65 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 121.893 -0.505 . . . . 64.150000000000006 110.514 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 77' ' ' ASP . 45.8 m -129.59 118.18 21.59 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.179 -0.674 . . . . 52.32 109.179 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 p -86.86 150.8 23.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.802 -0.561 . . . . 54.32 110.841 -178.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.3 135.24 48.51 Favored 'General case' 0 C--O 1.264 1.851 0 CA-C-O 121.049 0.452 . . . . 70.209999999999994 112.035 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.93 -138.66 6.35 Favored Glycine 0 N--CA 1.422 -2.3 0 CA-C-N 114.796 -1.093 . . . . 62.409999999999997 110.891 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 56.2 ttt180 -118.87 151.57 37.87 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.506 -1.294 . . . . 74.530000000000001 107.506 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 34.9 m170 89.3 164.5 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.967 0 C-N-CA 125.234 1.414 . . . . 75.230000000000004 111.323 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.15 -2.61 8.32 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.018 2.479 . . . . 71.349999999999994 111.009 174.146 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.24 -22.37 60.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.951 -1.022 . . . . 75.319999999999993 108.36 175.281 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 m -112.2 130.02 56.06 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.23 -0.895 . . . . 74.030000000000001 109.417 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.418 ' HB3' HG23 ' A' ' 68' ' ' THR . 20.0 t70 -77.37 -33.87 55.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.474 0.654 . . . . 73.329999999999998 109.652 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.9 mm -91.71 101.03 12.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 105.558 -2.016 . . . . 64.239999999999995 105.558 173.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -87.79 113.98 23.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.52 0.676 . . . . 71.230000000000004 112.237 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.0 mt -119.87 127.42 52.71 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.878 -1.897 . . . . 72.349999999999994 105.878 175.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -106.21 117.06 33.06 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.83 -0.748 . . . . 54.240000000000002 109.613 -176.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -119.85 177.56 4.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.033 -0.985 . . . . 72.530000000000001 109.071 -175.091 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.38 -35.76 68.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 107.913 -1.143 . . . . 74.439999999999998 107.913 176.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.9 m -97.96 151.32 20.41 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.81 -1.086 . . . . 72.129999999999995 108.778 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 81.8 t -90.51 98.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 118.686 -1.206 . . . . 73.239999999999995 110.408 175.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -87.03 78.42 8.96 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.677 -1.231 . . . . 63.109999999999999 107.677 172.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -57.43 -23.82 51.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 112.083 -176.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -172.79 97.7 0.13 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.605 -0.887 . . . . 75.129999999999995 108.605 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.503 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 2.3 t-160 -99.34 -52.12 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.942 -1.132 . . . . 72.409999999999997 107.942 176.222 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.81 155.44 41.09 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.987 -0.551 . . . . 72.519999999999996 110.844 -174.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.488 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 34.0 tt0 -131.05 129.15 41.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.566 -1.642 . . . . 74.530000000000001 106.566 176.188 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -105.27 122.2 45.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.622 -1.621 . . . . 63.509999999999998 106.622 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD3' ' OE2' ' A' ' 91' ' ' GLU . 21.3 mtm180 -125.07 145.91 49.7 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.635 0.731 . . . . 62.020000000000003 110.635 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 63' ' ' LEU . 2.1 mp -103.98 111.41 33.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 102.856 -3.016 . . . . 74.019999999999996 102.856 175.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -138.73 118.45 13.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.038 -0.528 . . . . 72.329999999999998 110.829 -169.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 53.48 37.8 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.454 1.102 . . . . 72.510000000000005 112.272 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.06 87.52 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 113.515 178.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.98 150.12 26.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.387 -0.598 . . . . 73.230000000000004 109.387 -179.44 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.415 ' CD2' HG13 ' A' ' 94' ' ' ILE . 94.1 m-85 -104.59 116.19 31.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.257 -1.757 . . . . 70.25 106.257 174.151 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.14 135.31 54.3 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.206 0.527 . . . . 55.539999999999999 111.51 -174.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.42 120.65 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 104.815 -2.291 . . . . 65.120000000000005 104.815 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.03 131.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 N-CA-C 108.35 -0.982 . . . . 72.349999999999994 108.35 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.616 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.8 p30 -97.8 157.94 15.79 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 117.65 -1.62 . . . . 74.030000000000001 112.123 176.005 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -129.96 23.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.067 -1.827 . . . . 74.349999999999994 106.067 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.99 62.92 0.52 Allowed Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.752 -1.567 . . . . 74.040000000000006 110.11 -176.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -70.97 -7.01 43.1 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 122.802 0.441 . . . . 71.099999999999994 111.485 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HB3' HG22 ' A' ' 17' ' ' VAL . 49.5 mt -75.19 -40.94 58.93 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.318 -0.253 . . . . 71.400000000000006 110.318 -178.411 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 94.3 m-20 -85.8 -20.56 29.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 119.799 -0.76 . . . . 72.25 110.25 -176.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.17 109.85 0.42 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.302 -0.951 . . . . 52.210000000000001 113.525 174.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -85.38 130.36 34.61 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.456 -0.942 . . . . 44.119999999999997 108.456 174.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 72.0 m-85 -120.0 134.31 55.28 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.076 -0.712 . . . . 74.519999999999996 109.076 179.003 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.8 t -129.87 120.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.928 -1.508 . . . . 73.129999999999995 106.928 175.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.37 39.82 28.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.645 0.736 . . . . 73.430000000000007 109.777 -173.358 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 62.07 14.87 6.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 113.589 -1.641 . . . . 73.329999999999998 113.736 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -103.53 123.41 41.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 107.684 -1.228 . . . . 72.209999999999994 107.684 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.37 123.87 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.321 2.014 . . . . 74.420000000000002 110.786 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -141.33 162.31 35.79 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 120.887 0.375 . . . . 73.140000000000001 110.593 -179.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.616 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 18.4 m120 -113.81 -29.84 6.95 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.595 -1.184 . . . . 73.409999999999997 109.533 176.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.31 134.7 36.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.617 -1.623 . . . . 71.219999999999999 106.617 172.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -153.46 138.45 17.24 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.458 -0.497 . . . . 65.450000000000003 111.826 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.6 t -84.86 122.52 38.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.401 -1.333 . . . . 75.540000000000006 107.401 171.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 ptm -90.25 130.53 36.36 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.961 -0.563 . . . . 64.439999999999998 111.099 -173.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -101.8 156.2 17.66 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.299 -0.63 . . . . 74.219999999999999 109.299 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 36' ' ' SER . 6.3 t -67.17 126.71 30.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 61.399999999999999 108.677 175.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 35' ' ' ALA . . . 99.91 -6.66 58.62 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.725 -0.67 . . . . 75.430000000000007 112.747 -175.115 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.23 151.76 29.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.27 0.535 . . . . 71.219999999999999 111.184 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -112.39 127.48 56.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.45 0.643 . . . . 75.439999999999998 110.423 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.94 122.34 68.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.041 -1.096 . . . . 72.239999999999995 108.041 -177.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 39.0 mt-30 -108.02 131.11 54.92 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 113.101 0.778 . . . . 72.230000000000004 113.101 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.477 HG23 ' ND1' ' A' ' 89' ' ' HIS . 3.3 mp -117.35 103.24 14.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.478 -1.675 . . . . 70.120000000000005 106.478 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -65.6 1.29 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-O 121.279 0.377 . . . . 64.439999999999998 112.842 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -157.72 5.71 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.151 0.98 . . . . 74.400000000000006 110.847 173.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 68.0 m-85 -91.18 124.54 35.47 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.894 -1.15 . . . . 75.120000000000005 107.894 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -111.57 118.8 36.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.927 0.87 . . . . 75.239999999999995 110.932 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' A' ' 51' ' ' VAL . 5.8 mp -108.29 133.74 52.08 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.475 -1.693 . . . . 75.409999999999997 107.413 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.25 129.09 67.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.862 -1.162 . . . . 72.519999999999996 107.862 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -88.56 134.03 33.99 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.53 -0.759 . . . . 74.450000000000003 109.484 -176.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.75 161.23 33.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.139 0.495 . . . . 75.209999999999994 109.846 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.56 132.06 43.3 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.701 -1.592 . . . . 73.430000000000007 106.701 174.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -80.11 -163.74 28.59 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 115.739 1.055 . . . . 63.299999999999997 115.739 -169.131 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.36 145.3 47.84 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 123.001 2.467 . . . . 73.409999999999997 112.424 -177.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.42 65.86 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.494 -1.298 . . . . 71.420000000000002 107.494 175.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--N 1.295 -1.782 0 CA-C-N 114.288 -1.324 . . . . 72.230000000000004 109.388 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.9 t -83.72 124.57 39.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.82 -0.807 . . . . 71.400000000000006 108.82 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 43.9 t80 -81.46 105.91 13.01 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.627 -1.249 . . . . 72.209999999999994 107.627 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -89.1 95.88 10.5 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.638 -0.71 . . . . 65.450000000000003 110.203 -178.164 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.69 157.89 23.59 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.139 -0.937 . . . . 71.239999999999995 108.508 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.01 3.6 16.78 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.097 0.475 . . . . 71.209999999999994 112.066 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.88 -23.02 66.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.492 1.293 . . . . 64.230000000000004 114.492 -174.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.36 -26.96 63.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.913 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -66.66 -29.46 69.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 74.129999999999995 110.997 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.55 -48.64 76.66 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.535 0.522 . . . . 75.239999999999995 111.744 -175.428 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -76.78 -18.05 58.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.313 0.578 . . . . 73.310000000000002 110.868 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -81.6 -34.35 31.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.136 -1.061 . . . . 64.209999999999994 108.136 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 t -72.59 -45.24 60.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.974 -0.557 . . . . 34.32 110.21 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 p -80.75 -17.35 51.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.253 -0.43 . . . . 73.420000000000002 111.993 -177.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 67.07 73.89 0.34 Allowed 'General case' 0 C--O 1.25 1.1 0 CA-C-O 122.088 0.946 . . . . 73.310000000000002 110.228 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.62 124.68 34.34 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 113.695 -1.593 . . . . 71.25 113.926 -176.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -94.68 137.76 33.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.356 -0.609 . . . . 73.409999999999997 109.356 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.61 98.97 43.0 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 109.63 -0.507 . . . . 61.219999999999999 109.63 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 143.08 27.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.027 1.818 . . . . 73.450000000000003 110.946 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 126.0 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.944 -1.132 . . . . 71.349999999999994 107.944 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -112.28 156.83 21.76 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.288 -0.634 . . . . 75.120000000000005 109.288 -177.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.23 160.83 32.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.807 -0.812 . . . . 72.109999999999999 108.807 -177.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.53 -7.12 24.46 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.647 -1.381 . . . . 51.130000000000003 109.647 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -73.8 -39.78 63.85 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.721 -0.74 . . . . 64.040000000000006 109.979 -177.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -86.51 -5.08 59.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.466 -1.243 . . . . 75.120000000000005 110.432 -177.144 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -86.63 -29.89 22.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.931 -0.577 . . . . 72.040000000000006 110.119 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 53.41 69.21 2.38 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 124.158 0.911 . . . . 73.400000000000006 110.384 -177.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.15 -65.97 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.181 2.587 . . . . 65.200000000000003 113.819 -173.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . -102.22 -0.37 33.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.611 -0.436 . . . . 74.239999999999995 111.467 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.9 -5.14 77.14 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.079 -0.581 . . . . 53.119999999999997 113.606 178.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.1 m -115.22 157.67 23.38 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 110.0 -0.371 . . . . 61.439999999999998 110.0 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -142.59 139.93 31.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.308 -0.406 . . . . 45.25 110.161 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.46 150.61 32.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.927 0.394 . . . . 54.530000000000001 111.782 -178.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.1 pt? -124.36 134.25 53.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.262 -0.644 . . . . 74.120000000000005 109.262 177.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.7 p -111.02 133.36 56.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.042 -0.526 . . . . 62.399999999999999 110.222 -178.347 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 ' ND2' ' A' ' 56' ' ' ASN . 24.8 t -76.54 117.54 21.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.732 -1.581 . . . . 72.5 106.732 177.01 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -90.35 -31.98 16.67 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.323 0.582 . . . . 50.229999999999997 110.164 -173.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -142.5 144.27 32.91 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.91 -1.885 . . . . 61.240000000000002 105.91 -176.974 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 53' ' ' ARG . . . 134.2 169.52 12.05 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 110.175 -1.17 . . . . 72.099999999999994 110.175 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.55 -31.81 87.53 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.309 2.006 . . . . 73.209999999999994 112.042 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.548 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.5 p-10 -101.35 22.68 12.14 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.363 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.95 143.91 55.8 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.995 0.426 . . . . 72.140000000000001 111.357 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.23 -13.58 60.07 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.002 -0.839 . . . . 50.450000000000003 111.002 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 128.66 36.49 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.32 -0.622 . . . . 43.399999999999999 109.32 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 23.2 ptt180 -110.73 135.31 51.51 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.036 -0.727 . . . . 74.219999999999999 109.036 176.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' HD23 ' A' ' 49' ' ' LEU . 95.8 m-85 -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.294 -1.002 . . . . 71.120000000000005 108.294 -179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.98 144.48 26.24 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.614 -0.434 . . . . 73.340000000000003 109.846 177.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 3.4 mm? -74.77 118.4 17.69 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.91 -0.774 . . . . 62.340000000000003 108.91 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.98 -29.03 4.33 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 111.825 0.306 . . . . 71.519999999999996 111.825 -174.133 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.471 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.0 pt20 -118.69 151.96 50.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 112.97 0.73 . . . . 71.510000000000005 112.97 -177.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 76.1 Cg_exo -52.76 -25.65 27.59 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 124.306 3.337 . . . . 71.400000000000006 114.202 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.3 m -135.21 119.8 18.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.722 -1.214 . . . . 41.399999999999999 107.722 175.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.4 m -115.5 114.28 24.8 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.7 -0.852 . . . . 73.349999999999994 108.7 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.5 p -86.52 135.65 33.37 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 122.138 -0.351 . . . . 71.409999999999997 111.344 -176.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.15 134.68 55.06 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-N 116.019 -0.537 . . . . 23.440000000000001 111.492 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.43 -163.95 28.42 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 108.709 -1.756 . . . . 71.299999999999997 108.709 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -112.8 119.23 37.3 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.09 -1.818 . . . . 73.530000000000001 106.09 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.641 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 4.5 t-160 -174.33 155.29 2.18 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 104.861 -2.274 . . . . 74.219999999999999 104.861 -173.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.641 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 55.8 Cg_endo -75.66 -18.57 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-N 120.507 1.217 . . . . 53.210000000000001 110.799 175.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.21 -3.47 55.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.411 -0.813 . . . . 54.25 112.321 -176.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.468 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 56.1 p -80.38 143.09 33.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.87 -0.732 . . . . 73.120000000000005 110.24 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.64 -39.0 67.54 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.557 -0.457 . . . . 74.540000000000006 110.388 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.14 135.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.051 -0.722 . . . . 61.119999999999997 109.051 176.24 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -96.14 117.84 31.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.251 0.548 . . . . 71.409999999999997 110.152 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -125.9 140.23 52.82 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.659 -1.978 . . . . 72.409999999999997 105.659 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.12 117.29 29.9 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.056 -0.658 . . . . 43.420000000000002 109.267 -176.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.18 173.44 6.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.684 -0.858 . . . . 63.32 108.684 -174.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.32 -29.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.436 -0.95 . . . . 65.120000000000005 108.436 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -128.35 -165.26 1.47 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.591 -1.263 . . . . 74.510000000000005 107.591 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.06 98.17 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.683 -0.807 . . . . 53.140000000000001 109.896 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 107' ' ' LEU . 70.1 m -87.4 73.85 9.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 122.0 0.905 . . . . 75.239999999999995 110.275 175.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -69.87 -40.37 75.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.198 -1.365 . . . . 73.120000000000005 112.618 -179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -135.65 73.76 1.48 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.47 -0.937 . . . . 72.239999999999995 108.47 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -100.45 -53.5 3.09 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.374 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.78 162.54 40.54 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 119.763 -0.775 . . . . 64.439999999999998 111.082 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.12 146.04 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.291 173.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -104.87 119.19 38.4 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.55 -2.019 . . . . 74.450000000000003 105.55 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -109.07 132.88 53.69 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.688 -0.687 . . . . 74.540000000000006 109.257 -172.404 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 63' ' ' LEU . 57.9 mt -125.93 123.98 65.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.393 -0.821 . . . . 64.299999999999997 108.905 -173.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.91 118.24 18.67 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.479 -0.488 . . . . 63.210000000000001 111.537 174.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.44 37.82 29.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.908 0.883 . . . . 70.430000000000007 111.905 175.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.02 82.4 Favored Glycine 0 C--O 1.222 -0.632 0 CA-C-N 115.642 -0.708 . . . . 51.329999999999998 113.859 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 35.2 mt-10 -101.53 130.58 47.85 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.048 -1.464 . . . . 74.340000000000003 107.048 175.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.2 124.47 52.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.829 -0.434 . . . . 71.420000000000002 109.829 -174.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.88 148.78 52.69 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 120.763 0.316 . . . . 71.409999999999997 111.064 177.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.48 123.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 106.681 -1.6 . . . . 74.329999999999998 106.681 177.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.36 122.97 69.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.606 -0.516 . . . . 74.319999999999993 109.606 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 6.6 t70 -80.49 129.42 34.5 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.67 -1.233 . . . . 74.319999999999993 107.67 172.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.57 23.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 120.796 -0.362 . . . . 70.299999999999997 111.369 -176.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.27 -38.07 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 118.418 -1.849 . . . . 61.020000000000003 114.218 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 61.2 30.84 19.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.931 0.872 . . . . 73.420000000000002 109.268 -174.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 86' ' ' SER . 6.4 tt -62.99 -49.21 75.59 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 113.931 -1.486 . . . . 75.209999999999994 111.083 -174.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 37.6 t-20 -106.96 -19.4 13.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.772 -1.171 . . . . 63.299999999999997 109.084 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.17 101.86 2.72 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.385 -1.086 . . . . 62.530000000000001 110.385 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 m -87.8 129.41 35.2 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.362 0.601 . . . . 72.049999999999997 110.652 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 73.3 m-85 -116.01 126.82 54.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.307 -0.997 . . . . 61.020000000000003 108.307 175.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 t -120.9 126.91 75.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 105.443 -2.058 . . . . 75.400000000000006 105.443 176.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 55.46 38.73 30.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.182 -1.414 . . . . 73.349999999999994 107.182 -169.395 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.522 ' HD3' ' NH1' ' A' ' 134' ' ' ARG . 22.1 mtm105 63.39 8.99 3.79 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 114.035 -1.439 . . . . 74.030000000000001 114.461 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.45 135.67 19.29 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.035 -0.728 . . . . 71.019999999999996 109.035 176.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.9 122.94 11.15 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 121.735 1.623 . . . . 73.200000000000003 108.651 177.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.637 ' HD2' ' HB2' ' A' ' 120' ' ' GLN . 26.1 ttm-85 -152.37 169.56 22.25 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.773 -0.771 . . . . 63.009999999999998 110.164 -170.124 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 27.3 t-20 -104.76 -68.65 0.84 Allowed 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.533 0.521 . . . . 72.129999999999995 110.458 174.579 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.69 54.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.042 -0.411 . . . . 35.399999999999999 110.68 -174.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.637 ' HB2' ' HD2' ' A' ' 117' ' ' ARG . 57.1 tp60 -153.63 137.88 16.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.944 -0.571 . . . . 63.299999999999997 111.111 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 82.8 t -65.93 133.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.379 -1.711 . . . . 62.539999999999999 106.379 169.074 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 42.2 ttm -87.33 129.55 34.97 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.674 -0.861 . . . . 75.129999999999995 108.674 -170.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -114.09 149.29 35.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.001 -0.74 . . . . 72.530000000000001 109.001 -177.254 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.476 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 14.6 t -73.52 130.58 40.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 109.272 -0.64 . . . . 75.450000000000003 109.272 -179.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.24 -0.13 57.15 Favored Glycine 0 C--O 1.241 0.535 0 N-CA-C 111.464 -0.654 . . . . 65.409999999999997 111.464 -176.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.51 148.23 35.4 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 108.953 -0.758 . . . . 74.530000000000001 108.953 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.7 124.93 53.06 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.528 -0.915 . . . . 61.039999999999999 108.528 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -108.42 113.08 42.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 106.821 -1.548 . . . . 73.319999999999993 106.821 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 64.6 tt0 -108.22 126.37 52.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.144 0.497 . . . . 72.540000000000006 109.679 -176.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.82 108.36 25.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.607 -1.257 . . . . 71.519999999999996 107.607 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.37 -105.11 1.49 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.594 -1.402 . . . . 41.200000000000003 109.594 -175.129 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -116.07 -13.64 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.197 -0.601 . . . . 60.32 111.764 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -98.92 140.75 32.61 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.386 -0.926 . . . . 70.400000000000006 110.63 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.522 ' NH1' ' HD3' ' A' ' 114' ' ' ARG . 19.5 ptp180 -112.58 144.14 42.56 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 112.667 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.63 139.76 49.37 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.983 -1.858 . . . . 74.140000000000001 105.983 174.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -111.79 128.39 68.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.127 -1.064 . . . . 72.129999999999995 108.127 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.478 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 80.4 t80 -94.41 122.11 36.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.984 0.421 . . . . 71.319999999999993 110.982 -178.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.73 159.1 26.07 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.462 0.649 . . . . 63.450000000000003 110.142 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.38 124.44 27.13 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.676 -1.231 . . . . 73.120000000000005 107.676 173.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 44' ' ' ALA . . . -75.84 142.16 28.32 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.932 -0.651 . . . . 71.230000000000004 112.19 -175.304 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.45 162.79 41.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.14 2.56 . . . . 52.32 111.991 176.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.62 44.17 0.96 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.594 0.711 . . . . 75.400000000000006 109.902 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 106.679 -1.6 . . . . 74.109999999999999 106.679 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.427 -1.595 0 N-CA-C 107.815 -1.18 . . . . 62.210000000000001 107.815 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.78 115.31 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.869 -1.16 . . . . 72.140000000000001 107.869 178.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.38 131.87 45.09 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.248 -1.019 . . . . 64.310000000000002 108.248 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -129.24 105.3 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.173 0.511 . . . . 74.120000000000005 110.496 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.49 140.75 48.48 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.751 -0.833 . . . . 71.510000000000005 108.751 178.502 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.52 2.04 34.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.66 0.245 . . . . 43.399999999999999 111.66 -176.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -63.92 -10.48 21.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.99 1.107 . . . . 73.310000000000002 113.99 -179.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.37 -12.76 61.93 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 122.153 0.978 . . . . 73.540000000000006 110.976 176.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 36.5 ttmt -65.5 -20.53 66.38 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 126.016 1.727 . . . . 72.439999999999998 109.813 177.196 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.525 ' HA ' ' OG ' ' A' ' 28' ' ' SER . 11.7 tp10 -59.18 -18.47 36.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.508 -0.769 . . . . 72.129999999999995 111.979 -176.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -57.84 -41.49 82.46 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.18 -0.325 . . . . 71.209999999999994 110.745 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.26 -22.16 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.992 0.368 . . . . 74.299999999999997 111.992 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 25' ' ' GLU . 6.7 p -81.02 -36.07 31.07 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.965 -0.694 . . . . 75.439999999999998 111.473 177.3 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.3 m -79.94 -48.42 13.43 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.607 -0.837 . . . . 52.399999999999999 110.757 177.069 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.1 m 47.58 -76.89 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.122 1.897 . . . . 72.450000000000003 116.122 -178.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.03 65.9 2.57 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 114.563 0.585 . . . . 74.430000000000007 114.563 -172.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.1 m -116.07 123.62 48.38 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.389 -1.338 . . . . 74.420000000000002 107.389 172.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.25 109.57 51.57 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.471 -0.491 . . . . 73.439999999999998 110.672 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.79 142.83 99.22 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.666 2.244 . . . . 72.299999999999997 110.301 174.281 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.49 126.35 32.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.25 -0.432 . . . . 54.119999999999997 111.233 -176.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 p -96.2 80.38 3.24 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.478 0.656 . . . . 71.010000000000005 110.001 178.326 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.8 t -89.51 -27.63 20.18 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.687 -0.688 . . . . 43.409999999999997 110.463 -178.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.99 55.23 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.543 -0.837 . . . . 62.32 112.55 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.91 -39.96 79.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 109.769 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.46 -11.96 60.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.92 . . . . 71.230000000000004 111.492 -178.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -97.1 -12.36 23.24 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.269 -0.641 . . . . 63.310000000000002 109.269 -175.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 mt 59.73 83.63 0.21 Allowed Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 124.722 1.264 . . . . 65.200000000000003 108.599 -176.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -33.98 -59.29 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.094 1 C-N-CA 125.703 4.269 . . . . 72.540000000000006 115.767 -166.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.58 10.71 3.72 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.743 0.782 . . . . 70.040000000000006 109.687 179.094 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.48 -12.46 46.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.1 -0.8 . . . . 75.209999999999994 111.1 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -138.9 151.52 47.01 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.056 -1.831 . . . . 61.43 106.056 177.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -152.92 158.55 42.27 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.794 -0.817 . . . . 75.239999999999995 108.794 -177.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -120.86 149.67 42.24 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.237 -0.585 . . . . 72.239999999999995 111.965 -175.225 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 49' ' ' LEU . 2.1 pt? -114.99 139.55 49.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.773 -0.825 . . . . 62.130000000000003 108.773 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.19 135.93 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.422 -0.354 . . . . 62.350000000000001 110.384 -177.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -82.79 118.12 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.026 -1.472 . . . . 63.420000000000002 107.026 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -95.96 -31.34 13.13 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.062 -0.972 . . . . 73.349999999999994 110.408 -174.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -143.12 137.68 29.29 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.153 -0.684 . . . . 73.310000000000002 109.153 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.44 175.14 13.88 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.816 -1.314 . . . . 34.229999999999997 109.816 -179.385 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 78.4 Cg_exo -55.62 -37.69 95.0 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 74.299999999999997 112.807 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -96.69 22.77 7.71 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.564 0.579 . . . . 72.209999999999994 112.564 -178.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.02 137.38 58.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.928 0.394 . . . . 63.43 110.416 177.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.55 -18.03 41.91 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 111.023 -0.831 . . . . 72.120000000000005 111.023 -178.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.29 139.6 30.33 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 110.126 -0.324 . . . . 54.520000000000003 110.126 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -128.22 137.76 52.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 73.319999999999993 108.724 178.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.41 ' O ' HD23 ' A' ' 49' ' ' LEU . 92.5 m-85 -125.18 138.39 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.999 -0.741 . . . . 72.319999999999993 108.999 -178.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -96.91 134.02 40.79 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.105 0.479 . . . . 62.420000000000002 109.713 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' HE22 ' A' ' 65' ' ' GLN . 67.6 mt -97.95 105.21 17.32 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.277 -0.42 . . . . 73.430000000000007 110.219 -178.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -130.55 5.55 4.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.774 0.797 . . . . 63.350000000000001 109.578 176.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 3.7 pm0 -107.84 141.46 23.13 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 115.109 -0.95 . . . . 74.310000000000002 110.709 -177.224 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.1 Cg_exo -57.41 -27.55 76.39 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.364 2.71 . . . . 63.520000000000003 113.745 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -137.03 123.5 20.82 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.299 -0.63 . . . . 71.200000000000003 109.299 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 26.3 m -123.47 120.76 33.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.463 -0.94 . . . . 74.010000000000005 108.463 178.285 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.519 HG23 HH11 ' A' ' 88' ' ' ARG . 74.6 m -94.49 131.06 40.59 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 112.06 0.392 . . . . 75.099999999999994 112.06 -176.353 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.89 135.49 54.89 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.292 0.568 . . . . 41.149999999999999 110.556 178.173 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.09 -159.74 25.2 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.465 -1.454 . . . . 72.109999999999999 109.465 179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -101.69 117.75 35.53 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.724 -1.213 . . . . 60.409999999999997 107.724 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -175.88 148.2 0.94 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 105.558 -2.016 . . . . 74.230000000000004 105.558 -175.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.57 -40.47 65.41 Favored 'Trans proline' 0 C--O 1.221 -0.358 0 C-N-CA 122.041 1.827 . . . . 73.120000000000005 111.801 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.07 19.37 7.97 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.514 0.931 . . . . 71.120000000000005 113.514 -178.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m -66.61 122.99 18.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.303 -0.559 . . . . 64.109999999999999 109.796 174.03 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.11 -38.47 66.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.289 -1.375 . . . . 62.450000000000003 107.289 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.1 mm -108.75 98.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.791 -1.929 . . . . 64.010000000000005 105.791 173.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -91.03 120.2 31.82 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.951 -0.568 . . . . 72.439999999999998 109.857 -176.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.71 138.54 52.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.4 -0.963 . . . . 73.299999999999997 108.4 -179.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.37 116.49 32.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.519 -1.66 . . . . 63.119999999999997 106.519 176.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -105.96 -173.32 2.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.182 0.438 . . . . 73.25 112.182 -171.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.72 -32.61 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.24 0.616 . . . . 75.040000000000006 111.328 -174.553 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.405 ' CG2' ' HG ' ' A' ' 107' ' ' LEU . 6.1 t -123.89 -152.81 0.53 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 105.723 -1.955 . . . . 74.109999999999999 105.723 -178.013 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.85 95.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.644 -1.623 . . . . 72.25 109.387 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -92.34 85.59 5.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.179 -1.045 . . . . 64.540000000000006 108.179 176.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.452 ' NH1' ' HB2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -57.28 -27.69 62.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.976 -1.465 . . . . 53.049999999999997 112.458 -177.644 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.588 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 20.3 mmm180 -154.87 111.33 3.24 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 104.498 -2.408 . . . . 71.319999999999993 104.498 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 12.2 t60 -100.4 -52.77 3.28 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 117.667 -1.613 . . . . 73.150000000000006 109.901 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.49 151.69 36.8 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.1 -0.704 . . . . 73.200000000000003 109.1 -177.167 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -118.42 129.43 55.4 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.694 -1.965 . . . . 62.130000000000003 105.694 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.5 m-85 -105.98 113.45 27.0 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.969 -1.493 . . . . 72.420000000000002 106.969 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -107.74 131.94 53.9 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.545 -0.539 . . . . 74.310000000000002 109.545 -177.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -118.92 113.28 41.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 106.684 -1.599 . . . . 70.109999999999999 106.684 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.93 121.41 20.49 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.129 -0.693 . . . . 75.299999999999997 109.129 -177.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 56.81 37.58 28.89 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.098 1.359 . . . . 64.439999999999998 110.244 -179.705 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.06 89.33 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.087 -0.961 . . . . 62.149999999999999 113.855 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.08 131.75 46.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.641 0.72 . . . . 72.209999999999994 109.217 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -106.2 118.1 35.74 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.857 0.723 . . . . 75.030000000000001 110.256 -174.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.87 142.48 51.09 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.569 -0.53 . . . . 54.119999999999997 109.569 177.202 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 122' ' ' MET . 42.0 t -114.4 123.5 70.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.74 -1.207 . . . . 74.049999999999997 107.74 177.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.07 132.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.049 0.452 . . . . 62.520000000000003 110.287 177.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -77.04 127.46 32.72 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.288 -1.004 . . . . 71.239999999999995 108.288 177.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.51 16.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.602 -0.888 . . . . 74.299999999999997 108.602 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -174.8 81.12 0.07 OUTLIER Glycine 0 N--CA 1.418 -2.556 0 CA-C-N 115.273 -0.876 . . . . 74.019999999999996 111.934 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -77.57 42.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.687 1.232 . . . . 55.109999999999999 109.053 178.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.405 ' HG ' ' CG2' ' A' ' 84' ' ' THR . 23.4 tp -95.23 -28.51 14.99 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.782 -1.099 . . . . 51.240000000000002 110.627 -176.153 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 50.8 t30 -109.47 -19.82 13.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.354 -0.98 . . . . 75.120000000000005 108.354 173.197 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 109.24 3.05 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.78 -0.645 . . . . 21.23 113.39 174.452 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.0 m -87.29 128.99 35.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.464 -0.569 . . . . 61.140000000000001 109.464 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 85.3 m-85 -135.54 136.61 41.29 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.85 -0.796 . . . . 74.019999999999996 108.85 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.0 t -128.34 130.85 69.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.989 -1.856 . . . . 73.519999999999996 105.989 175.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.84 37.28 28.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.137 0.898 . . . . 74.239999999999995 108.747 -175.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 63.12 16.92 9.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 65.340000000000003 113.031 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.64 137.08 23.89 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 110.007 -0.368 . . . . 71.150000000000006 110.007 178.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.12 124.85 16.11 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.957 2.438 . . . . 75.540000000000006 112.112 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -126.66 159.29 34.06 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.24 0.543 . . . . 73.200000000000003 111.793 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.12 -29.0 3.36 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.288 -1.323 . . . . 53.299999999999997 108.145 177.118 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.65 136.91 18.6 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.515 -1.291 . . . . 52.020000000000003 107.515 174.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.38 141.94 20.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.27 -0.641 . . . . 75.420000000000002 109.27 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.65 122.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.676 -1.602 . . . . 71.230000000000004 106.676 174.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.48 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 44.3 ttp -89.6 130.44 35.91 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.328 0.585 . . . . 53.299999999999997 112.288 -168.836 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.546 ' HB2' ' OD1' ' A' ' 126' ' ' ASP . 16.7 mt-30 -120.05 152.18 37.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.053 -0.976 . . . . 74.120000000000005 108.92 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.2 p -73.21 133.81 44.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 123.522 0.729 . . . . 74.019999999999996 110.569 178.44 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.69 61.57 Favored Glycine 0 C--N 1.309 -0.93 0 N-CA-C 111.452 -0.659 . . . . 42.340000000000003 111.452 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 123' ' ' GLN . 3.0 m-20 -85.11 153.98 22.34 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.242 0.617 . . . . 73.099999999999994 111.437 178.41 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.02 130.67 55.5 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-N 115.256 -0.883 . . . . 71.140000000000001 109.515 -176.325 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.5 mt -114.69 132.21 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.091 -1.077 . . . . 74.120000000000005 108.091 177.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 43.9 tt0 -119.73 122.9 42.47 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 108.656 -0.868 . . . . 75.420000000000002 108.656 178.453 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 89' ' ' HIS . 66.3 mt -117.32 102.28 13.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.211 -1.403 . . . . 50.149999999999999 107.211 178.249 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.74 -108.39 1.53 Allowed Glycine 0 C--N 1.309 -0.961 0 N-CA-C 110.926 -0.87 . . . . 72.109999999999999 110.926 -173.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -103.4 4.7 36.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.644 0.259 . . . . 55.100000000000001 110.684 178.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.588 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 78.0 m-85 -87.63 158.55 18.84 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.569 0.7 . . . . 70.310000000000002 111.285 179.298 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -133.43 123.13 24.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.971 -1.013 . . . . 74.239999999999995 108.763 174.466 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.76 125.39 41.67 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.994 -1.484 . . . . 65.109999999999999 106.994 177.542 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.03 129.05 68.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.089 -1.449 . . . . 72.329999999999998 107.089 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 22.0 t80 -88.4 116.55 26.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.784 -0.821 . . . . 71.530000000000001 108.784 -178.387 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp -108.47 147.03 32.26 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.172 -0.677 . . . . 73.200000000000003 109.172 -173.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.33 131.24 40.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.474 -0.33 . . . . 62.43 111.207 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.29 132.56 11.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.602 -1.799 . . . . 74.120000000000005 108.602 175.165 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.08 148.68 92.71 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.132 1.888 . . . . 75.150000000000006 112.287 -177.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.25 69.9 10.51 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 106.775 -1.565 . . . . 63.229999999999997 106.775 178.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--N 1.266 -3.058 0 CA-C-N 112.03 -2.35 . . . . 45.520000000000003 106.338 -178.875 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.424 -1.752 0 N-CA-C 106.121 -1.807 . . . . 75.140000000000001 106.121 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -82.09 122.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.985 -0.746 . . . . 55.130000000000003 108.985 -178.181 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.587 ' HD2' ' HG1' ' A' ' 84' ' ' THR . 14.8 t80 -86.95 105.41 17.09 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.097 -0.705 . . . . 64.340000000000003 109.097 -176.563 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -122.62 120.04 32.56 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.365 -0.606 . . . . 74.310000000000002 109.365 177.037 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.27 -160.68 0.86 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.188 -0.915 . . . . 62.210000000000001 108.976 -173.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -50.6 -22.16 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.266 1.426 . . . . 63.030000000000001 113.774 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 23' ' ' LEU . 3.9 pp -56.69 -30.83 63.84 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.256 0.835 . . . . 70.010000000000005 113.256 -178.024 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -89.39 0.08 57.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.469 0.914 . . . . 74.129999999999995 113.469 -177.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.23 -46.75 3.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.708 0.765 . . . . 73.329999999999998 110.45 176.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -69.36 -31.19 69.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.489 -1.232 . . . . 70.299999999999997 112.379 -174.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -56.42 -38.92 72.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.525 1.306 . . . . 74.310000000000002 114.525 -174.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.3 -35.62 35.5 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.0 0.429 . . . . 74.540000000000006 110.85 -176.318 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 m -68.1 -31.88 71.8 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.646 0.736 . . . . 54.130000000000003 110.825 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 p -83.03 -16.0 48.83 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 112.215 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 m -57.61 142.86 43.34 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.924 -0.769 . . . . 75.400000000000006 108.924 177.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.7 -52.03 0.84 Allowed Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.957 -1.257 . . . . 34.030000000000001 109.957 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 m -79.89 119.64 23.03 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.135 -1.431 . . . . 51.32 107.135 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -128.28 144.87 53.44 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 120.768 -0.373 . . . . 70.109999999999999 111.756 -174.442 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.608 ' HD2' ' ND2' ' A' ' 113' ' ' ASN . 42.1 Cg_exo -62.46 149.83 89.52 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.941 2.428 . . . . 54.219999999999999 110.916 172.601 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.834 0.35 . . . . 71.019999999999996 110.214 -178.141 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 m -77.55 90.08 3.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.776 -0.824 . . . . 52.310000000000002 108.776 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -94.55 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.371 0.508 . . . . 65.439999999999998 112.371 -177.04 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.34 57.88 0.64 Allowed Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.364 -0.694 . . . . 72.310000000000002 111.364 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -92.85 -47.05 7.23 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.555 0.693 . . . . 64.219999999999999 110.722 176.524 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.32 -0.49 6.34 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.361 -1.29 . . . . 70.150000000000006 114.466 -170.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -86.19 -28.47 23.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.089 -0.708 . . . . 72.310000000000002 109.089 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt 49.03 76.61 0.53 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.749 1.22 . . . . 51.5 111.747 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.512 ' HG2' ' O ' ' A' ' 140' ' ' GLY . 26.6 Cg_endo -87.41 -74.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.152 1.901 . . . . 61.439999999999998 114.344 -175.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.83 -32.63 67.73 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.151 0.501 . . . . 72.439999999999998 112.297 -176.421 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 7.7 82.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.183 -1.008 . . . . 64.230000000000004 110.763 -176.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 m -132.81 167.04 20.89 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.553 -1.647 . . . . 74.099999999999994 106.553 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 157.1 43.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.149 0.431 . . . . 70.140000000000001 110.127 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.16 137.51 51.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.288 0.566 . . . . 60.539999999999999 110.348 178.71 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.419 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -108.7 137.05 47.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 109.036 -0.728 . . . . 71.340000000000003 109.036 178.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -113.56 128.85 70.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 121.119 0.485 . . . . 73.140000000000001 110.03 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.468 HG21 ' ND2' ' A' ' 56' ' ' ASN . 38.4 t -83.75 118.09 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 106.99 -1.485 . . . . 73.420000000000002 106.99 178.237 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -95.05 -31.71 13.46 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.411 -0.813 . . . . 62.310000000000002 109.719 -174.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -141.35 138.41 33.05 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.753 -0.658 . . . . 72.439999999999998 109.259 176.194 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.68 169.29 13.18 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.72 -1.752 . . . . 64.519999999999996 108.72 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.98 -41.99 69.22 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.027 1.818 . . . . 72.519999999999996 111.634 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.468 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.1 p-10 -91.67 22.71 3.93 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.223 0.453 . . . . 73.010000000000005 112.223 178.518 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.21 55.57 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 123.22 0.608 . . . . 62.109999999999999 111.222 177.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.21 -19.42 43.12 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.487 -1.045 . . . . 74.530000000000001 110.487 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.36 144.37 26.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.407 -0.397 . . . . 72.340000000000003 110.28 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -119.67 134.87 55.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.273 -1.01 . . . . 71.230000000000004 108.273 176.25 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.463 ' HB3' HG21 ' A' ' 78' ' ' ILE . 93.9 m-85 -117.12 125.07 50.67 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.972 -0.381 . . . . 72.040000000000006 109.972 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.5 124.18 34.28 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.479 -0.782 . . . . 71.430000000000007 109.368 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.02 104.82 15.99 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.383 -1.71 . . . . 60.039999999999999 106.383 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.05 -21.3 12.68 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.149 -0.478 . . . . 64.109999999999999 112.157 -173.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -107.16 154.44 40.45 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 120.329 -0.548 . . . . 52.340000000000003 110.923 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 75.5 Cg_exo -52.56 -25.98 27.48 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.609 2.873 . . . . 71.409999999999997 114.021 -178.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 m -140.94 120.1 12.9 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.568 -0.853 . . . . 65.120000000000005 109.809 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 77' ' ' ASP . 49.6 m -116.43 114.39 24.17 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 109.057 -0.719 . . . . 73.049999999999997 109.057 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -87.2 136.4 32.94 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.88 -0.415 . . . . 51.539999999999999 109.88 178.163 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.58 134.71 54.89 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.34 0.59 . . . . 61.140000000000001 110.723 -177.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.37 178.01 15.39 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.284 -1.527 . . . . 43.25 109.284 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 43.6 ttt180 -85.49 117.67 24.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.222 -0.659 . . . . 74.299999999999997 109.222 178.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.75 145.9 0.31 Allowed Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 107.658 -1.238 . . . . 73.010000000000005 107.658 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -61.24 -15.72 41.93 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.236 2.624 . . . . 71.340000000000003 113.851 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.92 6.24 33.47 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.546 0.212 . . . . 74.230000000000004 111.194 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 40.9 m -100.56 125.2 46.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.625 -0.509 . . . . 74.299999999999997 109.625 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB3' HG23 ' A' ' 68' ' ' THR . 19.0 t70 -65.1 -48.54 73.32 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.046 -0.524 . . . . 73.420000000000002 110.956 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 61' ' ' PHE . 2.3 pp -116.15 130.18 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.895 -0.722 . . . . 72.540000000000006 110.715 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.02 143.0 48.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.282 0.563 . . . . 60.109999999999999 111.417 -178.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.7 mt -106.44 140.42 39.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.06 -1.459 . . . . 70.140000000000001 107.06 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HZ ' ' A' ' 133' ' ' PHE . 20.5 t70 -91.45 116.45 28.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.533 -1.654 . . . . 64.510000000000005 106.533 177.266 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' THR . 12.4 t0 -116.04 164.39 14.51 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.155 -0.683 . . . . 64.329999999999998 109.155 -169.304 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.26 -31.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.702 -1.222 . . . . 35.25 107.702 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.587 ' HG1' ' HD2' ' A' ' 18' ' ' PHE . 27.3 m -115.42 170.94 8.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.794 -1.558 . . . . 74.120000000000005 106.794 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.5 98.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.051 -1.031 . . . . 71.239999999999995 111.437 -177.574 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -97.1 91.7 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.479 -0.782 . . . . 44.420000000000002 110.227 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 17.8 ptt180 -81.47 -45.22 16.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.527 0.936 . . . . 65.519999999999996 113.527 -176.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.428 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 5.6 tpt180 -126.73 87.7 2.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.712 -1.588 . . . . 75.230000000000004 106.712 -176.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -100.2 -52.36 3.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.844 -0.616 . . . . 75.450000000000003 112.253 -174.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.44 162.99 37.9 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.953 -0.699 . . . . 51.109999999999999 111.428 -175.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.44 133.78 36.99 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.361 -0.836 . . . . 65.109999999999999 109.109 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -112.28 122.3 47.33 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.939 -0.763 . . . . 63.539999999999999 108.939 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.44 119.51 39.02 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.497 -0.557 . . . . 72.329999999999998 109.497 175.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -107.1 111.77 37.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.534 -2.395 . . . . 70.409999999999997 104.534 176.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -135.74 117.66 15.24 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 120.141 -0.624 . . . . 74.230000000000004 110.258 -174.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 51.7 39.82 26.13 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.76 1.224 . . . . 74.519999999999996 111.775 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -5.61 84.33 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 115.282 -0.872 . . . . 43.329999999999998 114.677 178.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.5 150.02 23.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.907 0.854 . . . . 63.210000000000001 109.102 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.94 117.46 24.84 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.692 -0.403 . . . . 62.329999999999998 110.959 -172.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -109.6 127.13 54.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.249 -1.019 . . . . 74.140000000000001 108.249 177.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.85 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.538 -0.912 . . . . 74.510000000000005 108.538 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.01 131.39 72.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.976 -0.556 . . . . 72.239999999999995 110.444 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.46 131.11 34.45 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.394 -0.965 . . . . 54.350000000000001 108.394 174.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.35 11.38 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 116.302 -0.408 . . . . 64.510000000000005 111.074 -177.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -165.1 59.88 0.25 Allowed Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.535 -1.317 . . . . 64.5 112.954 -178.464 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.6 t -80.78 75.13 7.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.736 0.779 . . . . 71.219999999999999 109.677 177.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.86 -21.99 13.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.832 -1.544 . . . . 75.239999999999995 106.832 170.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 3.2 m-20 -102.83 3.17 36.39 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.342 -1.299 . . . . 75.230000000000004 110.868 -177.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.76 77.29 1.13 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.936 -0.575 . . . . 55.100000000000001 113.051 178.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -86.92 128.9 35.06 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.203 -0.666 . . . . 42.350000000000001 109.203 176.036 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -135.68 140.2 44.28 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.881 0.372 . . . . 64.019999999999996 110.245 177.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.46 119.7 60.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 105.841 -1.911 . . . . 71.519999999999996 105.841 175.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.608 ' ND2' ' HD2' ' A' ' 34' ' ' PRO . 2.9 m-20 57.38 36.82 27.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.293 -1.003 . . . . 75.109999999999999 108.293 -171.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 60.7 14.32 4.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.26 1.424 . . . . 70.430000000000007 112.979 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.06 142.48 25.12 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 124.089 0.956 . . . . 71.219999999999999 109.205 176.983 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.06 122.97 10.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.7 1.6 . . . . 64.239999999999995 109.569 178.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -146.36 140.04 26.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.091 -1.078 . . . . 73.400000000000006 108.091 -175.027 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.8 -41.42 8.85 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.237 -0.283 . . . . 71.099999999999994 110.237 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.39 136.84 33.53 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.822 -0.807 . . . . 75.329999999999998 108.822 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 141.91 21.9 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.731 -0.84 . . . . 61.32 108.731 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.85 114.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 106.261 -1.755 . . . . 72.430000000000007 106.261 175.139 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 38.0 ttm -94.37 148.84 21.82 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.383 0.883 . . . . 65.099999999999994 113.383 -166.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -125.66 158.34 35.0 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.829 1.252 . . . . 55.240000000000002 111.113 -172.396 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 10.6 m -58.38 124.27 18.97 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.294 0.637 . . . . 55.140000000000001 110.192 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.61 -9.45 60.53 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.908 -0.587 . . . . 71.019999999999996 112.051 178.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.52 151.21 44.09 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 108.708 -0.849 . . . . 75.120000000000005 108.708 -179.416 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.3 137.66 54.47 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.798 0.808 . . . . 63.119999999999997 112.124 -175.148 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.95 126.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 105.844 -1.91 . . . . 43.119999999999997 105.844 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -108.95 128.68 55.15 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.179 -1.785 . . . . 73.209999999999994 106.179 178.154 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 133' ' ' PHE . 66.6 mt -131.56 138.32 53.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 N-CA-C 103.825 -2.657 . . . . 71.150000000000006 103.825 -177.238 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -36.19 99.46 0.01 OUTLIER Glycine 0 CA--C 1.548 2.153 0 N-CA-C 115.912 1.125 . . . . 64.030000000000001 115.912 -177.416 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt 77.51 14.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.609 1.564 . . . . 73.319999999999993 112.929 178.331 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 130' ' ' ILE . 55.8 m-85 -123.56 150.64 43.81 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 125.295 1.438 . . . . 74.439999999999998 109.355 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 134' ' ' ARG . 15.6 mmm-85 -137.15 119.83 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.316 -1.735 . . . . 74.120000000000005 106.316 175.128 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 mp -122.9 136.13 54.75 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.94 -0.393 . . . . 60.530000000000001 109.94 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.68 130.16 68.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.509 -0.923 . . . . 64.420000000000002 108.509 179.424 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -95.93 131.88 41.83 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.106 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -131.45 136.86 48.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.88 -0.785 . . . . 64.030000000000001 108.88 177.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.05 33.04 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.433 -0.951 . . . . 63.509999999999998 108.433 175.479 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' PRO . . . -59.94 130.64 49.7 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.7 -0.96 . . . . 55.210000000000001 110.7 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.11 160.34 13.14 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.345 2.697 . . . . 71.219999999999999 113.585 -175.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.19 48.58 1.01 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.713 1.205 . . . . 71.010000000000005 111.406 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.406 -2.662 0 CA-C-N 114.643 -1.162 . . . . 62.219999999999999 108.017 176.339 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 108.475 -0.935 . . . . 73.420000000000002 108.475 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -83.79 117.22 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.179 -0.675 . . . . 61.149999999999999 109.179 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.72 140.18 29.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.292 0.568 . . . . 72.200000000000003 110.968 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -84.59 120.65 26.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.686 -2.338 . . . . 65.140000000000001 104.686 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.79 80.91 2.09 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.286 0.565 . . . . 73.420000000000002 111.538 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.15 -23.18 33.06 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.661 -0.866 . . . . 62.399999999999999 108.661 177.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 pp -63.33 -5.95 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.088 1.355 . . . . 71.109999999999999 113.592 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.6 -28.75 70.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.048 0.539 . . . . 72.420000000000002 109.811 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.96 -10.32 58.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.794 -0.639 . . . . 72.400000000000006 111.048 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -99.77 -41.73 7.14 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.119 0.485 . . . . 54.409999999999997 111.368 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -84.47 -3.42 58.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.931 0.396 . . . . 63.119999999999997 111.755 -176.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -61.9 -41.9 98.44 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.102 0.561 . . . . 72.530000000000001 111.57 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -78.49 -13.15 59.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.086 0.47 . . . . 75.150000000000006 111.126 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -86.59 -24.8 25.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.598 -1.26 . . . . 74.329999999999998 107.598 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.1 m -66.92 107.38 2.2 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.32 -0.855 . . . . 64.299999999999997 110.68 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.91 177.82 40.27 Favored Glycine 0 N--CA 1.404 -3.462 0 N-CA-C 107.32 -2.312 . . . . 40.100000000000001 107.32 178.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 m -75.2 120.62 20.95 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 117.686 0.743 . . . . 63.25 110.346 -177.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.21 92.01 45.01 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 106.673 -1.602 . . . . 65.439999999999998 106.673 174.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.89 142.54 69.52 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.753 2.302 . . . . 51.530000000000001 113.036 -174.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.49 162.74 18.82 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.784 -1.191 . . . . 30.329999999999998 107.784 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -77.95 126.77 31.34 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.529 -0.468 . . . . 63.130000000000003 110.342 -176.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 p -67.12 146.52 54.18 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.706 -0.679 . . . . 63.340000000000003 110.055 178.162 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 116.51 -8.75 17.36 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 108.375 -1.89 . . . . 71.030000000000001 108.375 -174.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.11 66.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.183 -1.009 . . . . 65.109999999999999 110.231 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.31 1.82 47.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.425 -0.807 . . . . 64.239999999999995 110.627 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.53 7.7 17.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.036 -0.529 . . . . 73.239999999999995 110.209 -175.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 69.74 89.91 0.09 OUTLIER Pre-proline 0 CA--C 1.512 -0.482 0 C-N-CA 124.309 1.044 . . . . 73.310000000000002 109.61 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.69 -26.3 28.06 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.674 2.25 . . . . 73.409999999999997 112.184 -175.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.39 -27.99 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.837 -1.529 . . . . 75.310000000000002 110.229 -178.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.43 69.64 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.1 -1.2 . . . . 53.310000000000002 110.1 -177.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.8 t -131.06 158.13 41.19 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.052 -1.462 . . . . 63.210000000000001 107.052 176.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.97 40.93 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.743 -0.836 . . . . 64.310000000000002 108.743 -175.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 pp -133.13 151.56 51.99 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.899 0.381 . . . . 60.149999999999999 110.385 178.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.3 pp -113.52 132.18 55.79 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.006 -1.109 . . . . 74.540000000000006 108.006 175.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.81 132.06 68.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 109.906 -178.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 15.3 t -86.64 117.86 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.363 -1.347 . . . . 63.200000000000003 107.363 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.42 -33.02 12.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.033 0.444 . . . . 72.319999999999993 110.817 -179.094 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 13.7 tpt180 -137.85 139.61 40.01 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.476 -1.305 . . . . 65.310000000000002 107.476 -176.129 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.25 176.17 14.25 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.013 -0.835 . . . . 33.119999999999997 111.013 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.5 -35.23 39.73 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.614 2.209 . . . . 62.340000000000003 112.089 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -97.49 22.31 9.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.04 0.536 . . . . 65.450000000000003 111.139 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -62.94 141.31 58.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.997 0.427 . . . . 54.25 111.793 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.99 -13.87 57.38 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.046 -0.822 . . . . 71.329999999999998 111.046 -177.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.64 142.98 27.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.898 0.38 . . . . 55.0 110.371 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -131.17 136.43 48.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.573 -0.899 . . . . 75.019999999999996 108.573 177.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -130.51 139.22 50.5 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.984 -0.747 . . . . 62.439999999999998 108.984 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.06 143.64 32.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.407 0.622 . . . . 72.019999999999996 112.114 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.436 HD23 HD11 ' A' ' 94' ' ' ILE . 5.3 mp -94.04 103.36 15.44 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.496 -0.927 . . . . 70.030000000000001 108.496 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -133.18 8.61 4.03 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.902 1.334 . . . . 62.409999999999997 107.621 178.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.458 ' O ' HD13 ' A' ' 94' ' ' ILE . 4.0 pt20 -113.23 156.93 42.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 113.437 -1.71 . . . . 62.299999999999997 109.092 -174.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.99 -32.42 94.97 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.466 2.111 . . . . 74.219999999999999 112.451 178.061 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 97.7 m -153.92 129.67 10.09 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 122.095 -0.378 . . . . 74.120000000000005 111.138 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 19.8 m -103.29 113.5 27.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.775 -1.565 . . . . 65.140000000000001 106.775 174.449 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -91.77 132.95 36.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.445 -0.576 . . . . 62.140000000000001 109.445 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.86 134.26 55.28 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 109.905 -0.405 . . . . 73.439999999999998 109.905 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.85 -132.45 2.83 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.108 -0.797 . . . . 75.329999999999998 111.108 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 86' ' ' SER . 9.9 mmm180 -118.54 151.28 38.16 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 123.029 0.532 . . . . 54.439999999999998 110.719 -175.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.8 m80 80.3 152.73 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 124.913 1.285 . . . . 72.239999999999995 112.628 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.45 -18.87 26.72 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.978 3.118 . . . . 71.310000000000002 115.6 -175.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.52 -23.2 60.98 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.236 0.471 . . . . 74.549999999999997 110.708 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m -78.18 119.72 21.97 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 105.706 -1.961 . . . . 53.020000000000003 105.706 172.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.44 -49.18 78.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.957 -0.565 . . . . 75.310000000000002 111.399 -173.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.5 pt -107.28 123.23 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 C-N-CA 120.12 -0.632 . . . . 61.130000000000003 109.685 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.89 124.02 33.24 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 109.044 -0.725 . . . . 72.0 109.044 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 mt -121.2 140.44 52.02 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.293 -2.114 . . . . 63.350000000000001 105.293 178.338 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -102.21 116.31 32.38 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.101 -1.814 . . . . 72.439999999999998 106.101 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -88.53 176.77 7.01 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.615 -1.175 . . . . 72.519999999999996 112.837 -171.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.73 -32.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.229 1.014 . . . . 70.230000000000004 108.505 -177.71 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.4 m -150.14 153.67 36.74 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.074 -2.565 . . . . 54.43 104.074 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 72' ' ' ARG . 50.0 t -70.67 112.47 5.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.655 1.217 . . . . 62.43 113.375 -162.702 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.557 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 23.2 m -111.27 107.18 16.38 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 113.259 -1.792 . . . . 75.219999999999999 108.0 177.294 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -55.84 -45.69 78.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.422 -0.808 . . . . 65.120000000000005 112.03 -175.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -137.3 119.88 16.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.322 -2.103 . . . . 70.310000000000002 105.322 171.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -89.76 -52.91 4.75 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.205 -1.035 . . . . 73.310000000000002 108.205 178.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.2 34.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.83 -0.623 . . . . 33.450000000000003 109.567 -177.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.71 145.92 52.06 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.241 0.543 . . . . 52.020000000000003 111.04 171.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 101' ' ' VAL . 9.4 m-85 -104.45 113.22 26.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.351 -1.722 . . . . 74.329999999999998 106.351 -177.319 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -106.67 120.72 42.73 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.649 -0.871 . . . . 74.239999999999995 108.649 -176.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 65' ' ' GLN . 3.1 mp -104.42 111.58 34.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 105.109 -2.182 . . . . 74.299999999999997 105.109 179.109 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -139.38 130.56 26.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 110.083 -0.34 . . . . 73.140000000000001 110.083 -177.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 55.87 36.67 27.73 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 122.293 1.044 . . . . 73.209999999999994 110.533 175.538 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 0.86 81.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.11 -0.95 . . . . 62.240000000000002 113.652 179.057 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -101.45 133.75 45.6 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.413 -0.958 . . . . 54.340000000000003 108.413 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -104.9 116.09 31.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.521 -1.288 . . . . 73.340000000000003 107.521 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.33 134.28 48.86 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.99 0.424 . . . . 74.040000000000006 110.504 -178.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 92' ' ' PHE . 39.0 t -102.49 124.08 56.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.496 -1.298 . . . . 74.120000000000005 107.496 175.071 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.62 123.09 68.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.825 0.821 . . . . 72.25 109.325 176.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -100.48 140.63 34.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.651 -1.159 . . . . 71.510000000000005 111.952 -174.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.33 1.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.809 . . . . 72.319999999999993 109.946 171.513 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.7 40.15 2.52 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 121.358 -0.449 . . . . 63.43 113.092 -173.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.8 m -55.73 -19.62 11.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 73.450000000000003 111.903 178.491 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.448 ' H ' HD22 ' A' ' 107' ' ' LEU . 2.4 mm? -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.271 0.628 . . . . 45.329999999999998 111.293 -178.111 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -86.99 -17.91 31.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.695 0.759 . . . . 75.519999999999996 109.287 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.37 76.23 1.12 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.324 -0.853 . . . . 53.340000000000003 113.213 175.539 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 m -86.69 126.67 34.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.758 -0.46 . . . . 73.109999999999999 109.758 175.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -136.79 136.44 38.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 110.033 -0.358 . . . . 71.409999999999997 110.033 178.178 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.429 HG11 ' HG2' ' A' ' 120' ' ' GLN . 58.8 t -121.65 121.11 63.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.798 -1.556 . . . . 73.140000000000001 106.798 174.596 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.31 44.67 27.01 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.334 1.053 . . . . 71.129999999999995 110.111 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.8 9.35 5.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.375 1.47 . . . . 74.120000000000005 114.587 -177.48 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -120.07 135.54 24.42 Favored Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.982 -0.687 . . . . 73.430000000000007 109.894 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.54 137.2 67.81 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.544 2.162 . . . . 75.340000000000003 111.55 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -134.43 159.42 41.13 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.304 0.573 . . . . 74.239999999999995 111.705 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -123.65 -34.65 3.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.344 -1.298 . . . . 73.0 108.761 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.78 27.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.694 -1.595 . . . . 73.319999999999993 106.694 174.345 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.429 ' HG2' HG11 ' A' ' 112' ' ' VAL . 56.5 tp60 -147.61 122.21 9.82 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.856 -0.338 . . . . 71.430000000000007 111.214 -176.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.59 114.13 26.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.465 -2.05 . . . . 73.040000000000006 105.465 173.097 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.482 ' SD ' HD11 ' A' ' 128' ' ' ILE . 73.6 mtp -93.34 147.19 23.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 115.268 1.581 . . . . 60.119999999999997 115.268 -168.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -112.06 152.11 28.58 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.935 -1.484 . . . . 74.040000000000006 107.653 175.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -66.55 133.52 50.5 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.337 0.589 . . . . 63.130000000000003 111.385 -178.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.39 -2.14 56.13 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.584 -0.735 . . . . 42.329999999999998 112.392 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.94 153.52 20.97 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 117.032 0.416 . . . . 72.519999999999996 109.931 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.32 145.82 42.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.011 0.745 . . . . 63.030000000000001 113.011 -172.192 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.482 HD11 ' SD ' ' A' ' 122' ' ' MET . 60.4 mt -120.23 132.05 70.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.537 -0.912 . . . . 52.329999999999998 108.537 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -116.35 122.01 43.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.89 -1.152 . . . . 75.230000000000004 107.89 175.323 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.6 105.05 18.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.422 -0.955 . . . . 74.319999999999993 108.422 -178.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.25 -86.29 0.5 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 108.986 -1.646 . . . . 43.329999999999998 108.986 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -140.35 -2.86 1.39 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.535 -0.333 . . . . 75.530000000000001 111.425 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.254 50.5 p90 -95.04 164.11 13.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.202 -0.999 . . . . 74.030000000000001 111.529 -179.758 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -120.0 126.61 51.26 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 113.07 0.766 . . . . 74.219999999999999 113.07 -165.149 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.7 mt -121.96 140.13 52.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.984 -1.117 . . . . 75.140000000000001 107.984 175.149 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.05 137.46 55.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.602 -0.888 . . . . 63.049999999999997 108.602 176.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -105.69 114.83 29.23 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.146 0.579 . . . . 73.450000000000003 109.69 -177.286 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -127.7 159.18 35.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.817 -0.438 . . . . 71.510000000000005 109.817 -178.135 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.85 123.53 25.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.577 -1.638 . . . . 44.450000000000003 106.577 171.081 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.72 -89.5 1.35 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.093 -1.051 . . . . 63.340000000000003 114.934 -170.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.68 152.55 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.333 2.022 . . . . 62.119999999999997 112.821 -177.51 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.45 20.24 11.9 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.072 -1.085 . . . . 64.129999999999995 108.072 178.402 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-N 114.312 -1.313 . . . . 73.0 108.375 -178.425 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 106.638 -1.615 . . . . 74.420000000000002 106.638 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.78 115.71 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.679 -1.23 . . . . 70.340000000000003 107.679 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.18 139.81 30.1 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.427 -0.806 . . . . 62.340000000000003 109.942 -174.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -81.64 132.0 35.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.582 -0.896 . . . . 73.329999999999998 108.582 177.498 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.59 66.58 9.73 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.28 0.562 . . . . 64.129999999999995 112.465 -175.445 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.92 -18.25 58.41 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 107.841 -1.17 . . . . 64.349999999999994 107.841 174.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -62.12 -12.92 22.13 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 114.841 -1.072 . . . . 74.230000000000004 112.862 177.031 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.91 -30.54 69.89 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 121.358 0.599 . . . . 73.530000000000001 109.536 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.47 -33.74 76.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 125.008 1.323 . . . . 72.150000000000006 108.989 178.409 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 -49.0 10.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.279 -0.873 . . . . 74.530000000000001 109.081 177.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.3 tpp -56.88 -32.65 66.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.824 1.25 . . . . 71.409999999999997 112.031 -176.262 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 30.0 tt0 -62.78 -32.13 73.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.756 0.312 . . . . 73.120000000000005 111.554 -178.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -69.61 -32.2 70.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.097 -0.705 . . . . 73.230000000000004 109.097 179.23 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -84.26 -16.65 42.42 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.039 0.935 . . . . 71.329999999999998 111.513 -179.486 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 27' ' ' GLU . 61.6 m -59.59 124.91 21.61 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 112.615 0.598 . . . . 65.319999999999993 112.615 -175.122 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.71 -144.25 8.45 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 109.036 -1.626 . . . . 64.040000000000006 109.036 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 p -115.52 139.79 49.74 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 117.446 0.623 . . . . 73.099999999999994 109.56 174.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . . . -127.12 122.26 23.04 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 120.607 -0.437 . . . . 44.219999999999999 109.831 177.924 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.37 156.95 60.53 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 123.146 2.564 . . . . 71.329999999999998 112.513 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.65 158.78 35.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.567 -0.901 . . . . 73.349999999999994 108.567 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.3 m -81.26 105.62 12.6 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.382 -0.969 . . . . 62.43 108.382 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 m -70.23 78.25 0.52 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.148 0.975 . . . . 73.019999999999996 111.641 -176.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 25.98 0.14 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 109.641 -1.383 . . . . 70.400000000000006 109.641 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.1 72.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.169 -0.515 . . . . 74.099999999999994 110.134 -177.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.21 4.13 51.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.707 -0.679 . . . . 65.019999999999996 111.056 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -84.6 -42.24 15.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.964 -1.125 . . . . 75.329999999999998 107.964 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt 50.88 68.74 3.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.728 -1.124 . . . . 64.299999999999997 111.22 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.417 ' HG2' ' HA2' ' A' ' 140' ' ' GLY . 30.7 Cg_endo -65.56 -65.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.38 2.054 . . . . 73.239999999999995 113.482 -175.648 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -15.82 60.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.815 0.302 . . . . 54.149999999999999 111.815 -177.491 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -2.85 72.74 Favored Glycine 0 N--CA 1.46 0.271 0 N-CA-C 111.746 -0.542 . . . . 54.140000000000001 111.746 -178.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -150.77 169.59 21.29 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.616 -1.624 . . . . 73.409999999999997 106.616 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.59 44.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 118.06 0.391 . . . . 74.530000000000001 111.1 -173.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.42 157.73 36.13 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.4 0.438 . . . . 65.349999999999994 110.715 177.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.78 151.2 50.77 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.117 -0.697 . . . . 71.340000000000003 109.117 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.71 134.69 66.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 110.027 -0.36 . . . . 63.520000000000003 110.027 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.83 118.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.17 -1.419 . . . . 70.140000000000001 107.17 177.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -91.0 -32.95 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.939 0.4 . . . . 70.129999999999995 110.159 -177.162 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 tpm_? -137.81 132.63 32.92 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.647 -0.421 . . . . 73.510000000000005 110.085 -179.16 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.15 173.01 17.96 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.991 -1.644 . . . . 55.399999999999999 108.991 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -59.55 -35.42 95.64 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.584 2.189 . . . . 74.129999999999995 112.725 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -100.5 22.15 12.18 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.595 -0.442 . . . . 63.520000000000003 112.187 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.6 138.71 57.64 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.752 178.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.03 -19.24 32.89 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.268 -0.733 . . . . 74.209999999999994 111.268 -177.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.96 144.01 26.78 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 110.138 -0.319 . . . . 50.520000000000003 110.138 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.73 156.75 18.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.9 -0.778 . . . . 73.099999999999994 108.9 178.045 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.471 ' CG ' HG22 ' A' ' 78' ' ' ILE . 98.3 m-85 -138.0 144.44 41.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.335 -1.358 . . . . 75.019999999999996 107.335 175.844 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.7 135.1 54.97 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.156 -0.683 . . . . 74.230000000000004 109.156 -178.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.46 104.36 10.02 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.87 -0.789 . . . . 61.299999999999997 108.87 179.222 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.93 -21.37 11.61 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.827 -0.624 . . . . 72.430000000000007 111.351 -177.341 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.58 144.86 30.12 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.001 -0.545 . . . . 74.219999999999999 110.983 -173.73 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.32 -19.85 36.9 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.745 2.963 . . . . 73.129999999999995 113.901 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.8 m -141.74 121.23 13.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.997 -0.742 . . . . 71.310000000000002 108.997 175.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.8 m -120.06 133.13 55.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.253 -0.647 . . . . 55.210000000000001 109.253 -177.321 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.2 m -105.66 143.83 33.26 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.901 -0.407 . . . . 73.299999999999997 109.901 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.07 134.91 54.54 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.042 -0.725 . . . . 73.129999999999995 109.042 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . 133.79 -146.64 18.57 Favored Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 109.113 -1.595 . . . . 70.510000000000005 109.113 -179.113 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -119.67 118.65 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.614 -1.234 . . . . 53.219999999999999 111.497 174.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.581 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 47.5 m-70 -167.55 142.14 3.09 Favored Pre-proline 0 C--N 1.277 -2.557 0 C-N-CA 126.832 2.053 . . . . 73.430000000000007 105.564 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.57 -21.95 73.44 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.611 2.207 . . . . 71.439999999999998 114.733 -175.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.429 ' OE2' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -105.79 5.19 30.62 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.259 0.466 . . . . 32.219999999999999 112.259 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.581 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 73.3 m -80.98 140.27 35.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.494 -0.482 . . . . 71.219999999999999 109.826 178.532 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.08 -49.89 14.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 111.121 -173.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.471 HG22 ' CG ' ' A' ' 61' ' ' PHE . 43.9 pt -100.37 103.47 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.289 1.043 . . . . 75.030000000000001 111.015 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -88.1 132.44 34.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.378 -1.283 . . . . 72.340000000000003 108.965 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.48 136.36 51.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.029 -1.471 . . . . 54.43 107.029 176.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.38 139.37 50.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.235 -0.654 . . . . 75.310000000000002 109.235 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -166.4 -174.56 2.91 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.079 -2.193 . . . . 73.239999999999995 105.079 178.025 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.45 -24.35 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.806 -1.553 . . . . 73.209999999999994 106.806 175.055 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -78.96 96.19 5.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.505 -1.294 . . . . 72.319999999999993 107.505 176.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.56 135.59 35.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.17 0.509 . . . . 40.140000000000001 112.315 -173.023 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.9 t -134.52 142.36 46.99 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.625 -2.361 . . . . 70.120000000000005 104.625 173.578 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -62.55 -46.07 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.296 0.57 . . . . 71.340000000000003 109.742 -178.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 16.8 ptt180 -151.42 151.06 31.16 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.348 -1.352 . . . . 61.229999999999997 107.348 170.068 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -100.67 -52.33 3.36 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.613 0.571 . . . . 74.519999999999996 112.186 -176.463 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.03 164.79 36.49 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.314 -0.555 . . . . 63.140000000000001 110.462 -172.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.21 132.0 45.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.598 -0.728 . . . . 65.040000000000006 109.248 173.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.405 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 68.3 m-85 -106.11 123.76 48.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.646 -0.872 . . . . 63.399999999999999 108.646 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -106.12 127.08 52.95 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.465 -0.494 . . . . 71.310000000000002 109.728 173.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.15 114.41 46.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.563 -1.643 . . . . 72.439999999999998 106.563 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -136.84 118.93 15.41 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 120.685 -0.406 . . . . 74.5 110.205 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 55.87 40.64 30.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.602 1.161 . . . . 71.25 111.396 177.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.45 -8.53 74.29 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.464 -1.244 . . . . 35.450000000000003 114.116 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.49 135.78 42.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.882 0.841 . . . . 75.019999999999996 110.17 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 37.9 m-85 -104.94 128.35 53.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.77 -1.105 . . . . 65.310000000000002 108.183 -176.441 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.46 137.13 49.65 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.127 0.489 . . . . 75.099999999999994 110.39 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.33 125.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.729 -0.841 . . . . 71.5 108.729 -177.46 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -116.66 126.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.834 -1.173 . . . . 73.129999999999995 107.834 174.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.21 134.09 35.56 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.898 -0.779 . . . . 72.230000000000004 108.898 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG21 ' CZ ' ' A' ' 88' ' ' ARG . 15.5 m -138.21 15.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.862 0.839 . . . . 74.319999999999993 109.509 179.168 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -155.48 70.66 0.27 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 110.472 -1.051 . . . . 62.539999999999999 110.472 -176.28 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -72.42 27.53 0.05 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.63 0.772 . . . . 64.430000000000007 112.49 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 105' ' ' GLY . 3.0 tm? -82.96 -47.07 12.16 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 105.716 -1.957 . . . . 62.409999999999997 105.716 174.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.98 -19.93 19.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.285 -0.966 . . . . 62.43 109.55 176.709 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.77 129.7 0.12 Allowed Glycine 0 C--N 1.343 0.944 0 O-C-N 123.957 0.786 . . . . 53.43 112.352 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.2 m -82.96 127.8 33.87 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.481 -1.288 . . . . 73.319999999999993 109.116 174.301 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -130.06 126.29 37.28 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.564 -1.272 . . . . 73.010000000000005 107.564 175.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.47 119.24 59.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.097 -1.446 . . . . 72.140000000000001 107.097 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 33' ' ' ALA . 36.2 t-20 54.61 40.84 32.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.133 0.968 . . . . 71.030000000000001 109.063 -178.172 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 71.53 10.9 6.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.1 -1.409 . . . . 73.549999999999997 113.036 175.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.35 129.53 24.91 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 71.129999999999995 109.629 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.09 126.66 16.86 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.907 2.405 . . . . 61.420000000000002 110.782 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.17 162.77 23.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.958 0.885 . . . . 65.209999999999994 113.228 -176.092 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -133.0 -38.33 0.97 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.886 -1.961 . . . . 60.32 107.306 178.08 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.68 136.64 27.56 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.908 -2.256 . . . . 64.209999999999994 104.908 171.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -152.9 126.04 8.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.123 -0.631 . . . . 73.109999999999999 110.148 179.416 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.22 119.69 27.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.006 -1.479 . . . . 62.009999999999998 107.006 174.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.464 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 11.0 ttt -87.01 140.06 29.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.595 0.712 . . . . 72.530000000000001 112.032 -162.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -128.97 155.96 44.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.564 -1.198 . . . . 64.150000000000006 111.581 -176.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.5 t -80.03 135.27 36.32 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.452 1.101 . . . . 71.25 113.406 -173.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.57 -20.46 48.19 Favored Glycine 0 CA--C 1.499 -0.937 0 CA-C-N 115.851 -0.613 . . . . 54.32 112.238 177.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.76 151.95 37.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 122.903 0.481 . . . . 74.319999999999993 109.74 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 147.6 35.05 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.462 0.649 . . . . 54.140000000000001 110.896 -178.718 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -105.7 124.83 61.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 106.58 -1.637 . . . . 72.129999999999995 106.58 -176.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -110.18 126.39 54.05 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.632 -1.988 . . . . 75.120000000000005 105.632 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.31 102.49 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.15 -1.056 . . . . 63.130000000000003 108.15 -176.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.14 -84.18 0.02 OUTLIER Glycine 0 CA--C 1.536 1.38 0 CA-C-O 121.39 0.439 . . . . 53.25 113.077 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -131.82 8.91 4.52 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.491 0.716 . . . . 75.409999999999997 110.209 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -102.37 151.89 21.74 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.513 -0.767 . . . . 45.140000000000001 109.633 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 124.47 21.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.921 -0.581 . . . . 73.209999999999994 109.895 170.358 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.57 141.22 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.922 -1.14 . . . . 73.430000000000007 107.922 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.3 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.627 -0.879 . . . . 74.219999999999999 108.627 -178.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -102.23 126.95 49.36 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.732 0.645 . . . . 74.140000000000001 110.003 -176.762 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -140.0 131.06 26.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.887 0.851 . . . . 73.140000000000001 111.895 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.95 118.25 35.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.986 -1.487 . . . . 63.520000000000003 106.986 176.259 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 43' ' ' PRO . . . -177.04 -71.02 0.06 OUTLIER Glycine 0 C--N 1.295 -1.708 0 C-N-CA 118.279 -1.915 . . . . 65.340000000000003 114.639 -176.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.89 142.31 97.23 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.357 2.038 . . . . 71.540000000000006 113.179 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.83 76.51 1.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.636 -1.165 . . . . 62.350000000000001 108.166 -178.157 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 114.024 -1.444 . . . . 64.200000000000003 108.114 -178.592 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.435 -1.201 0 N-CA-C 109.889 -0.411 . . . . 72.219999999999999 109.889 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -97.57 114.53 35.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 107.451 -1.315 . . . . 74.409999999999997 107.451 177.097 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.456 ' CE2' HG23 ' A' ' 84' ' ' THR . 22.7 m-85 -97.45 138.6 34.65 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.033 -0.667 . . . . 63.549999999999997 112.307 -177.499 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.34 91.1 7.53 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.363 -2.458 . . . . 70.230000000000004 104.363 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . . . -101.5 168.08 9.73 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.213 -1.358 . . . . 55.020000000000003 112.779 -166.881 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.92 -1.42 56.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.235 -1.348 . . . . 61.210000000000001 109.172 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' ' 20' ' ' ALA . 3.8 pp -63.65 -14.7 54.36 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.295 -0.866 . . . . 74.239999999999995 112.478 -178.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.69 -19.61 64.38 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.897 0.38 . . . . 72.25 111.077 175.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -84.02 -38.77 20.47 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.779 -1.193 . . . . 74.5 107.779 173.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -57.47 -34.54 69.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.983 -1.008 . . . . 72.329999999999998 109.986 176.356 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.53 -49.17 70.9 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.435 1.094 . . . . 72.239999999999995 111.551 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.29 -36.05 76.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.659 0.266 . . . . 73.319999999999993 110.528 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -62.16 -37.47 85.33 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.638 -0.71 . . . . 62.509999999999998 110.8 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -86.27 -17.03 35.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.22 0.452 . . . . 63.32 112.22 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.0 m -63.71 125.34 23.98 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.345 -0.613 . . . . 71.430000000000007 109.345 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.87 3.4 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 108.311 -1.916 . . . . 74.319999999999993 108.311 -171.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.8 t -101.75 140.05 36.57 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.576 -0.812 . . . . 73.450000000000003 108.994 -179.079 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.27 80.02 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 107.418 -1.326 . . . . 74.310000000000002 107.418 174.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.487 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 38.2 Cg_exo -62.29 142.01 89.73 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.315 1.343 . . . . 53.340000000000003 109.68 176.652 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.28 124.58 44.48 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.072 -0.651 . . . . 23.420000000000002 109.459 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 124' ' ' THR . 73.4 m -165.2 143.79 6.39 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 71.209999999999994 109.531 -179.23 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -118.62 8.94 12.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.684 0.754 . . . . 62.420000000000002 109.775 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.28 65.8 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 107.008 -2.437 . . . . 73.540000000000006 107.008 -177.507 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' OE1' ' A' ' 123' ' ' GLN . . . -57.02 -47.56 80.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.972 -1.114 . . . . 51.130000000000003 113.151 -165.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -104.44 3.57 32.31 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 120.742 -0.383 . . . . 72.219999999999999 111.255 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.01 -44.51 9.28 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.39 -0.924 . . . . 72.319999999999993 112.03 -171.481 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 36.51 69.23 1.29 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 124.2 0.938 . . . . 75.040000000000006 111.18 -175.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.9 -70.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 125.265 3.977 . . . . 64.439999999999998 116.804 -167.505 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.28 -5.72 58.19 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.444 -0.502 . . . . 72.219999999999999 112.299 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -4.77 64.34 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.96 -0.638 . . . . 53.439999999999998 112.267 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.3 m -114.79 153.37 30.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.335 -1.728 . . . . 61.229999999999997 106.335 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 156.83 40.02 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.286 -0.566 . . . . 71.0 112.235 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.5 161.09 35.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.922 -1.036 . . . . 44.520000000000003 109.743 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -130.9 135.14 47.41 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.196 -0.668 . . . . 64.310000000000002 109.196 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -116.2 133.56 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.06 0.457 . . . . 74.120000000000005 110.61 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 14.0 t -78.82 118.62 26.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.667 -1.234 . . . . 33.100000000000001 107.667 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 136' ' ' VAL . 32.2 mmmt -90.86 -31.12 16.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 110.428 -176.2 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 26.2 tpt180 -143.34 145.7 32.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.109 -1.071 . . . . 74.540000000000006 108.109 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.46 178.12 15.18 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 111.305 -0.718 . . . . 42.149999999999999 111.305 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -61.42 -31.28 88.15 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.696 2.264 . . . . 73.530000000000001 112.303 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -97.09 21.22 10.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.996 0.369 . . . . 54.130000000000003 111.996 177.102 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.23 45.39 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 120.814 0.34 . . . . 54.119999999999997 110.761 179.114 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.04 -13.07 52.63 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 111.45 -0.66 . . . . 65.120000000000005 111.45 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 145.24 25.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.777 0.322 . . . . 34.329999999999998 110.197 178.758 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -125.62 147.54 49.28 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.08 -1.082 . . . . 70.329999999999998 108.08 177.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.85 144.89 51.79 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.749 -1.204 . . . . 64.040000000000006 107.749 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.0 pt? -111.74 134.04 53.57 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.753 0.311 . . . . 73.209999999999994 110.861 -177.107 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.4 mt -93.44 104.96 17.07 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.493 -0.558 . . . . 70.230000000000004 109.493 -178.797 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -121.29 -12.42 8.64 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.83 0.824 . . . . 52.329999999999998 110.809 -179.336 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -106.96 144.86 29.94 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 115.712 -0.677 . . . . 72.150000000000006 110.644 -175.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.05 -29.51 45.22 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.763 2.975 . . . . 74.129999999999995 113.434 -178.326 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -140.62 121.98 14.98 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.73 -0.606 . . . . 74.209999999999994 109.75 179.01 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -118.0 139.54 51.04 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.227 -1.397 . . . . 63.299999999999997 107.227 178.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.4 m -115.39 141.9 47.41 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.79 . . . . 65.349999999999994 110.222 -178.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.49 135.42 54.78 Favored 'General case' 0 C--O 1.256 1.446 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.761 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.01 -144.91 12.72 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.666 -1.374 . . . . 70.299999999999997 109.666 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 58.2 ttt-85 -119.95 118.29 30.32 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.663 -0.495 . . . . 65.099999999999994 109.663 176.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 75' ' ' GLU . 8.8 p80 169.74 163.02 0.2 Allowed Pre-proline 0 C--N 1.315 -0.925 0 C-N-CA 126.812 2.045 . . . . 73.230000000000004 107.811 174.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.54 -25.43 75.65 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.237 1.958 . . . . 44.210000000000001 113.043 -178.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 20.3 mp0 -86.64 -4.9 59.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.653 -0.249 . . . . 64.519999999999996 111.481 -178.397 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -71.29 107.57 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.366 -0.605 . . . . 63.549999999999997 109.366 178.035 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.0 -32.01 56.89 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.581 -1.266 . . . . 71.450000000000003 107.581 175.294 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.68 100.85 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.305 -2.109 . . . . 63.109999999999999 105.305 173.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.72 118.32 36.6 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.76 -0.376 . . . . 72.450000000000003 110.737 -175.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -123.06 122.3 38.15 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.71 -1.218 . . . . 41.350000000000001 107.71 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 55' ' ' PRO . 24.8 t70 -130.71 132.24 45.25 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.603 -0.888 . . . . 54.409999999999997 108.603 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -141.58 175.17 9.9 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.677 -1.601 . . . . 51.25 106.677 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -60.12 -32.19 49.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.577 -1.268 . . . . 64.219999999999999 107.577 174.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.456 HG23 ' CE2' ' A' ' 18' ' ' PHE . 13.1 m -74.88 114.59 13.52 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.691 -1.225 . . . . 72.0 107.691 173.282 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.57 125.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.226 0.536 . . . . 73.140000000000001 110.53 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.1 m -145.13 103.12 3.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.162 -0.681 . . . . 70.150000000000006 109.162 177.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 18.1 ptt180 -80.68 -45.68 16.77 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 119.604 -0.839 . . . . 73.340000000000003 111.488 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -118.88 99.67 6.9 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.313 -0.625 . . . . 74.0 109.313 177.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.442 ' CE1' HG13 ' A' ' 130' ' ' ILE . 44.4 t-80 -100.32 -52.66 3.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.301 -0.96 . . . . 73.519999999999996 111.325 177.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.59 163.57 39.2 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.03 -0.668 . . . . 45.020000000000003 111.913 -175.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.78 137.4 54.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.952 -1.129 . . . . 74.109999999999999 107.952 176.323 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -105.83 113.58 27.22 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.739 -1.578 . . . . 65.439999999999998 106.739 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -111.13 136.54 50.03 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.832 -0.432 . . . . 74.5 109.832 -175.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' A' ' 99' ' ' PHE . 17.9 mm -107.97 113.52 44.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.628 -1.99 . . . . 71.239999999999995 105.628 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -135.96 122.84 21.26 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.511 -0.476 . . . . 65.409999999999997 110.51 -177.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 56.37 37.16 28.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.265 1.426 . . . . 54.130000000000003 110.403 179.232 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.5 -0.72 87.53 Favored Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.13 -0.941 . . . . 31.02 113.215 177.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.85 145.72 29.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.458 -0.941 . . . . 74.150000000000006 108.458 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD2' HD12 ' A' ' 94' ' ' ILE . 50.3 m-85 -105.11 127.12 52.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.289 -1.375 . . . . 73.030000000000001 107.289 -177.503 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -130.29 147.39 52.0 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.886 -0.509 . . . . 74.129999999999995 110.23 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -113.53 123.68 69.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.636 -1.246 . . . . 53.009999999999998 107.636 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.3 121.87 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.419 0.628 . . . . 71.420000000000002 109.608 175.19 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.448 ' HB2' HG21 ' A' ' 110' ' ' THR . 3.5 t70 -81.84 138.21 35.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.77 -0.65 . . . . 72.430000000000007 110.612 178.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.22 12.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.679 -0.691 . . . . 72.409999999999997 109.517 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.7 -63.4 0.12 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 119.91 -1.138 . . . . 61.039999999999999 112.981 -177.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 t 62.23 9.55 3.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.723 1.209 . . . . 43.329999999999998 111.205 -177.609 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.6 pt? -75.98 -46.02 31.77 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 124.017 0.927 . . . . 65.230000000000004 112.577 -173.544 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.445 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 34.2 t-20 -89.74 -18.46 26.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 75.140000000000001 109.735 -171.091 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.79 86.19 1.77 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.516 -1.034 . . . . 72.230000000000004 110.516 -177.438 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 103' ' ' ASP . 8.4 m -80.63 129.81 34.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.027 0.441 . . . . 64.230000000000004 110.323 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 51.3 m-85 -131.02 136.07 48.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.741 -0.663 . . . . 71.319999999999993 110.585 178.529 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.66 123.32 49.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 105.935 -1.876 . . . . 43.310000000000002 105.935 174.135 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 57.34 37.76 28.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.44 1.096 . . . . 73.409999999999997 108.867 -176.914 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.3 mtm-85 66.68 12.29 8.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.56 -1.2 . . . . 74.140000000000001 113.702 178.142 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -114.57 142.94 29.0 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 108.871 -0.789 . . . . 71.540000000000006 108.871 174.57 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 110' ' ' THR . 26.1 Cg_exo -63.54 123.17 11.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.716 1.611 . . . . 73.200000000000003 108.73 172.721 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -157.3 136.89 12.18 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.166 -1.42 . . . . 73.209999999999994 107.166 -176.566 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -93.66 -49.27 5.95 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.062 -0.655 . . . . 72.109999999999999 110.56 -178.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.2 134.22 55.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.612 -0.835 . . . . 74.239999999999995 109.151 177.061 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -154.4 144.92 22.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.97 -0.559 . . . . 74.340000000000003 110.808 -178.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.78 125.55 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.265 -1.754 . . . . 72.420000000000002 106.265 172.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.7 ttp -98.38 129.87 45.03 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.212 0.529 . . . . 62.119999999999997 110.191 -173.218 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.492 ' OE1' ' HB1' ' A' ' 39' ' ' ALA . 69.5 mt-30 -117.7 156.23 28.6 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.8 -1.185 . . . . 62.210000000000001 107.8 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.9 t -62.62 133.74 55.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.95 0.722 . . . . 73.129999999999995 112.95 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.43 56.16 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.699 -0.682 . . . . 44.409999999999997 112.588 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -88.67 153.01 21.45 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 109.63 -0.507 . . . . 71.340000000000003 109.63 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -120.6 127.18 51.87 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.002 0.905 . . . . 53.0 111.836 -176.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.27 129.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 -177.142 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.0 tt0 -118.77 132.25 56.13 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.651 -177.425 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.442 HG13 ' CE1' ' A' ' 89' ' ' HIS . 2.9 mp -108.69 103.46 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.884 -1.895 . . . . 74.219999999999999 105.884 178.179 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.06 -93.54 0.33 Allowed Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 115.476 -0.784 . . . . 75.049999999999997 112.807 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.0 3.85 9.35 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.156 0.428 . . . . 63.5 112.156 -175.149 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.5 p90 -131.61 141.9 49.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.647 -0.658 . . . . 74.25 111.605 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 12.1 ptp180 -122.63 149.55 43.85 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 114.606 1.336 . . . . 73.409999999999997 114.606 -171.375 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 51' ' ' VAL . 6.0 mp -117.39 140.92 48.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.654 -1.612 . . . . 72.319999999999993 107.634 178.093 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.435 HG23 ' HG3' ' A' ' 52' ' ' LYS . 87.4 t -111.13 131.41 62.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.341 -0.985 . . . . 73.409999999999997 108.341 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -95.4 121.9 37.56 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.221 -0.9 . . . . 75.019999999999996 110.932 -175.657 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.16 133.42 51.58 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.192 0.52 . . . . 52.539999999999999 109.943 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 148.62 27.29 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.781 -0.822 . . . . 54.450000000000003 108.781 175.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 129.88 24.07 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.361 -1.096 . . . . 72.340000000000003 110.361 178.639 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.67 162.61 38.57 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.945 2.43 . . . . 63.130000000000003 111.459 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.34 51.96 0.9 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.028 0.918 . . . . 62.020000000000003 110.769 -178.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 105.507 -2.034 . . . . 54.210000000000001 105.507 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 108.424 -0.954 . . . . 45.149999999999999 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -150.1 -43.92 0.13 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.86 0.362 . . . . 64.299999999999997 110.365 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.72 165.25 23.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.365 -0.38 . . . . 72.400000000000006 110.433 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -72.27 114.44 10.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.449 -0.945 . . . . 74.319999999999993 108.449 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -73.83 100.12 3.38 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.785 0.802 . . . . 75.200000000000003 111.252 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.21 -150.62 22.6 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 107.847 -2.101 . . . . 72.5 107.847 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -122.75 108.57 32.91 Favored Pre-proline 0 C--N 1.293 -1.882 0 CA-C-N 118.22 1.01 . . . . 72.430000000000007 111.738 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.33 131.41 20.38 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 107.426 -1.798 . . . . 65.310000000000002 107.426 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -79.5 123.12 84.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 121.185 -0.206 . . . . 64.439999999999998 111.221 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.11 135.39 34.5 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.372 2.048 . . . . 71.510000000000005 110.115 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -125.69 137.7 53.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t -110.1 121.64 63.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.13 -1.433 . . . . 75.019999999999996 107.13 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -158.98 157.94 32.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.613 -1.254 . . . . 74.349999999999994 107.613 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 m -104.46 115.87 31.12 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 73.019999999999996 110.847 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.602 ' O2P' ' HG2' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -89.17 135.55 33.5 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.842 -1.54 . . . . 64.340000000000003 106.842 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.89 126.29 40.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 107.507 -1.294 . . . . 73.030000000000001 107.507 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -81.42 132.74 35.34 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.366 1.079 . . . . 72.310000000000002 113.732 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -118.58 90.57 3.36 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 101.477 -3.527 . . . . 63.439999999999998 101.477 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.21 160.06 18.66 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.104 0.779 . . . . 71.099999999999994 113.104 -167.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.01 -7.16 37.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.133 -0.939 . . . . 74.299999999999997 109.647 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.32 -16.82 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.029 1.122 . . . . 75.299999999999997 114.029 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.5 pp -66.19 -26.68 67.51 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.407 0.622 . . . . 74.329999999999998 110.953 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' HD12 ' A' ' 23' ' ' LEU . 38.4 ttmt -73.97 -39.97 63.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.299 -1.0 . . . . 71.140000000000001 108.299 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.62 -35.61 80.6 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.617 -0.719 . . . . 74.140000000000001 110.076 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -42.36 98.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.983 -0.747 . . . . 71.219999999999999 108.983 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.29 -34.32 77.15 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 73.140000000000001 110.879 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.8 m -69.54 -19.06 63.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.421 0.629 . . . . 71.310000000000002 110.366 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 t -86.85 -16.71 35.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.537 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -59.52 119.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.525 0.679 . . . . 64.439999999999998 110.511 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.88 -78.38 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.167 -1.973 . . . . 61.43 108.167 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.3 t -116.76 148.41 41.17 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.463 -0.94 . . . . 74.310000000000002 108.463 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.95 116.64 26.06 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 106.893 -1.521 . . . . 45.420000000000002 106.893 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.48 140.64 82.98 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.08 1.187 . . . . 75.010000000000005 110.865 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.3 126.2 29.25 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.651 -0.87 . . . . 74.510000000000005 108.651 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 m -131.49 149.87 52.36 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.47 -0.937 . . . . 54.119999999999997 108.47 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -127.11 153.04 46.51 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.422 -0.585 . . . . 71.140000000000001 109.422 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 24.67 4.1 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 120.463 -0.875 . . . . 71.129999999999995 112.134 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.572 -0.529 . . . . 71.219999999999999 109.572 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.39 -2.31 52.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.549 -0.751 . . . . 72.409999999999997 110.998 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.43 -34.48 41.62 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.459 -0.941 . . . . 64.219999999999999 108.459 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.6 mt 56.55 90.96 0.08 OUTLIER Pre-proline 0 N--CA 1.45 -0.426 0 O-C-N 124.774 1.296 . . . . 72.519999999999996 113.006 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 8.3 Cg_endo -53.99 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.462 2.108 . . . . 71.409999999999997 111.888 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.59 15.45 8.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.0 0.429 . . . . 70.319999999999993 110.334 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.07 18.32 76.84 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.833 -0.621 . . . . 54.520000000000003 112.323 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.7 t -138.01 167.01 22.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -150.9 157.65 43.16 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.295 1.038 . . . . 73.200000000000003 108.548 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.15 160.0 39.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 121.014 -0.275 . . . . 70.310000000000002 111.458 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -127.24 134.93 50.02 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.526 -0.916 . . . . 65.439999999999998 108.526 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.51 136.75 44.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.502 -0.555 . . . . 61.539999999999999 109.502 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 17.1 t -80.59 117.42 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 106.717 -1.586 . . . . 51.130000000000003 106.717 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 51.2 tptt -90.63 -32.06 16.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.749 0.785 . . . . 64.409999999999997 109.136 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 77.8 ttt180 -151.51 142.35 22.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.52 -2.03 . . . . 61.409999999999997 105.52 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.22 -171.13 27.95 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.594 -1.002 . . . . 70.129999999999995 110.594 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 -50.15 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.386 2.057 . . . . 54.32 110.889 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 HD23 ' A' ' 80' ' ' LEU . 2.7 p30 -90.93 24.34 2.81 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.66 1.184 . . . . 44.549999999999997 112.666 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -53.45 131.78 38.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.568 0.699 . . . . 71.25 112.78 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.94 -17.31 45.28 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.359 -0.837 . . . . 74.120000000000005 111.901 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 146.53 23.98 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 122.593 -0.357 . . . . 75.439999999999998 110.435 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -120.26 135.29 55.05 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.926 -0.768 . . . . 72.010000000000005 108.926 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -118.07 140.99 48.95 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.77 -1.196 . . . . 75.219999999999999 107.77 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.1 pt? -110.7 140.96 44.59 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.256 -0.577 . . . . 64.340000000000003 111.576 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.4 HD23 HD11 ' A' ' 94' ' ' ILE . 4.6 mp -91.15 104.59 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.316 -0.994 . . . . 73.239999999999995 108.316 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -112.08 -4.86 14.35 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.965 0.888 . . . . 72.230000000000004 109.752 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -108.97 151.78 42.07 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 115.357 -0.838 . . . . 70.409999999999997 109.762 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 30.9 Cg_exo -64.98 -18.04 61.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.036 2.49 . . . . 64.239999999999995 113.948 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -144.12 122.4 12.28 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.595 -0.691 . . . . 64.150000000000006 109.522 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 77' ' ' ASP . 19.2 m -121.95 114.46 21.01 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.302 -0.629 . . . . 71.400000000000006 109.302 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -95.55 137.12 35.06 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.976 -0.452 . . . . 72.310000000000002 109.97 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 135.32 55.03 Favored 'General case' 0 C--O 1.261 1.66 0 CA-C-O 121.313 0.577 . . . . 73.25 111.228 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.04 -161.85 24.41 Favored Glycine 0 C--O 1.251 1.185 0 N-CA-C 109.07 -1.612 . . . . 60.229999999999997 109.07 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.418 ' HE ' HG11 ' A' ' 85' ' ' VAL . 3.9 tmm_? -94.07 118.75 31.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.188 -1.782 . . . . 63.119999999999997 106.188 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.552 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 11.1 t-80 -166.5 139.58 3.19 Favored Pre-proline 0 N--CA 1.401 -2.914 0 N-CA-C 103.705 -2.702 . . . . 74.209999999999994 103.705 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.552 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 17.9 Cg_endo -61.89 -29.6 82.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.115 1.21 . . . . 74.010000000000005 111.703 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -105.34 17.84 23.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.335 -0.848 . . . . 63.009999999999998 111.422 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 19.4 p -77.91 128.66 34.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 118.652 -1.219 . . . . 60.219999999999999 110.636 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' A' ' 68' ' ' THR . 12.3 t70 -77.28 -30.25 54.19 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.627 0.727 . . . . 70.5 109.109 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.04 99.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.558 -0.905 . . . . 72.030000000000001 108.558 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -92.42 120.17 32.66 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.849 -0.614 . . . . 72.319999999999993 109.9 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.405 HD23 HD21 ' A' ' 56' ' ' ASN . 77.9 mt -127.56 140.13 52.31 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.797 -1.557 . . . . 62.340000000000003 106.797 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -87.07 116.31 25.04 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.746 -0.835 . . . . 74.140000000000001 108.746 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 84' ' ' THR . 11.0 t70 -87.01 178.66 6.87 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.099 -1.074 . . . . 73.230000000000004 108.099 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.92 -34.18 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 106.873 -1.528 . . . . 72.239999999999995 106.873 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 7.0 t -114.37 -167.42 1.22 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 104.651 -2.351 . . . . 75.349999999999994 104.651 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG11 ' HE ' ' A' ' 72' ' ' ARG . 61.2 t -104.17 101.9 12.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.617 -1.233 . . . . 61.149999999999999 109.926 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.8 p -87.98 101.41 13.73 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.987 -0.551 . . . . 70.319999999999993 110.824 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.602 ' HG2' ' O2P' ' A' ' 15' ' ' TPO . 15.9 ptt180 -64.32 -34.7 78.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.751 0.786 . . . . 73.319999999999993 109.656 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -147.2 95.88 2.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.957 -1.019 . . . . 71.239999999999995 108.638 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -99.98 -52.54 3.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.769 -1.172 . . . . 73.200000000000003 109.323 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.59 156.2 34.67 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 119.925 -0.71 . . . . 70.430000000000007 111.344 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 9.7 pt-20 -137.84 142.03 40.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.943 -0.571 . . . . 64.310000000000002 109.964 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -105.69 117.48 34.14 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.928 -1.508 . . . . 73.319999999999993 106.928 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 16.3 mtp180 -109.5 127.98 54.84 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.906 -0.776 . . . . 71.140000000000001 108.906 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 mp -105.86 113.59 43.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.794 -1.188 . . . . 43.229999999999997 107.794 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -126.59 117.45 22.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.648 -0.501 . . . . 71.230000000000004 109.648 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 53.49 37.7 26.32 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.513 1.525 . . . . 72.140000000000001 112.229 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.58 87.51 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-N 115.325 -0.852 . . . . 71.400000000000006 113.02 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.49 143.06 32.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.301 -0.629 . . . . 71.219999999999999 109.301 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' CD2' HG13 ' A' ' 94' ' ' ILE . 61.9 m-85 -110.45 124.12 51.18 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.891 -0.595 . . . . 72.329999999999998 110.277 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.92 141.07 49.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.327 -0.62 . . . . 75.230000000000004 109.327 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.45 HG23 ' HG2' ' A' ' 122' ' ' MET . 17.9 t -102.95 125.36 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 107.545 -1.28 . . . . 71.420000000000002 107.545 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.79 122.12 68.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 N-CA-C 107.375 -1.343 . . . . 75.239999999999995 107.375 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 2.2 t70 -87.63 122.02 30.8 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.978 -1.01 . . . . 75.310000000000002 108.448 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.4 m -116.46 13.7 7.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 115.447 -0.797 . . . . 74.209999999999994 109.73 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.5 -66.07 0.25 Allowed Glycine 0 N--CA 1.412 -2.948 0 CA-C-N 115.084 -0.962 . . . . 72.129999999999995 112.807 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.3 t 60.66 9.61 2.23 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.974 0.91 . . . . 55.229999999999997 111.051 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 108' ' ' ASN . 3.3 pp -65.38 -46.71 79.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.724 1.21 . . . . 63.299999999999997 112.83 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.446 ' N ' HD12 ' A' ' 107' ' ' LEU . 6.8 t30 -92.77 -18.06 23.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.285 -1.006 . . . . 70.040000000000006 108.285 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.39 93.87 1.22 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 106.486 -2.646 . . . . 70.299999999999997 106.486 -169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 5.1 m -76.4 128.7 35.33 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 108.705 -0.85 . . . . 72.299999999999997 108.705 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 50.0 m-85 -112.19 126.16 54.91 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 106.888 -1.523 . . . . 73.340000000000003 106.888 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 120' ' ' GLN . 3.1 t -123.22 134.76 65.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 N-CA-C 104.358 -2.46 . . . . 73.409999999999997 104.358 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.28 38.23 29.58 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.759 -1.2 . . . . 63.149999999999999 107.759 -169.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 64.36 9.18 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.852 1.427 . . . . 70.219999999999999 114.852 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.0 148.41 67.24 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 119.03 0.832 . . . . 61.450000000000003 110.14 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 110' ' ' THR . 18.1 Cg_endo -60.83 122.68 11.6 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.563 1.509 . . . . 73.230000000000004 110.213 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -146.47 133.13 19.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.019 -0.672 . . . . 74.120000000000005 109.215 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 16.8 m120 -92.84 -28.86 16.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.568 0.699 . . . . 72.120000000000005 111.28 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.44 135.37 26.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.45 -1.685 . . . . 71.319999999999993 106.45 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.487 ' HG2' ' CG1' ' A' ' 112' ' ' VAL . 7.5 tp60 -140.54 144.68 36.05 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 111.713 0.264 . . . . 75.230000000000004 111.713 -173.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.81 124.57 52.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 103.96 -2.607 . . . . 52.399999999999999 103.96 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.45 ' HG2' HG23 ' A' ' 101' ' ' VAL . 51.4 mtp -87.94 146.33 25.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.42 -0.912 . . . . 61.450000000000003 111.946 -171.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.15 156.87 41.09 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.849 -1.537 . . . . 71.340000000000003 106.849 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -71.08 133.69 46.47 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.229 -1.397 . . . . 65.099999999999994 107.229 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.55 57.45 Favored Glycine 0 C--N 1.312 -0.785 0 C-N-CA 120.67 -0.776 . . . . 51.299999999999997 111.778 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.47 139.34 45.7 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.654 -0.869 . . . . 71.209999999999994 108.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -112.08 126.2 54.92 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.749 -1.204 . . . . 70.510000000000005 107.749 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.06 126.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.866 -0.79 . . . . 73.209999999999994 108.866 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 55.4 tp60 -105.0 111.51 24.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.222 -1.029 . . . . 72.540000000000006 108.222 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.93 112.86 42.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.614 -1.624 . . . . 74.099999999999994 106.614 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.63 -126.97 25.31 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 108.906 -1.678 . . . . 62.109999999999999 108.906 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 17.57 20.47 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.431 0.634 . . . . 71.519999999999996 109.738 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.616 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -120.62 165.62 14.79 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.078 -0.51 . . . . 72.319999999999993 110.134 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 14.7 ptm180 -137.15 146.62 45.2 Favored 'General case' 0 C--O 1.256 1.431 0 CA-C-O 121.544 0.687 . . . . 65.239999999999995 112.72 -168.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -120.48 139.88 52.23 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.548 -1.278 . . . . 53.420000000000002 107.548 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.74 120.43 62.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 107.919 -1.141 . . . . 73.109999999999999 107.919 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.03 126.61 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.261 -0.644 . . . . 61.32 109.261 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.03 162.13 30.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 123.779 0.832 . . . . 72.019999999999996 109.201 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.53 148.03 45.39 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.103 -1.443 . . . . 72.129999999999995 107.103 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.617 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -77.9 -161.43 16.48 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 121.074 -0.584 . . . . 64.200000000000003 114.356 -171.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.63 143.91 93.33 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.583 2.189 . . . . 74.430000000000007 111.897 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.48 31.93 6.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.091 -1.078 . . . . 72.310000000000002 108.091 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.524 -1.216 . . . . 63.229999999999997 109.689 -177.342 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 108.399 -0.963 . . . . 73.219999999999999 108.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.2 t -168.59 171.51 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.319 -1.363 . . . . 74.409999999999997 107.319 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.92 114.26 13.18 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.108 -0.701 . . . . 64.439999999999998 109.108 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -87.05 151.86 22.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.044 -0.526 . . . . 74.040000000000006 109.942 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -108.23 167.15 10.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.54 -0.541 . . . . 63.340000000000003 109.54 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.53 -162.72 26.19 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 109.684 -1.366 . . . . 63.43 109.684 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 23.8 m -79.75 128.26 75.01 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 71.150000000000006 109.553 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 7' ' ' THR . 18.9 Cg_endo -58.9 154.18 46.05 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 123.591 2.861 . . . . 54.420000000000002 111.356 175.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -78.19 119.35 77.02 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 116.405 -0.362 . . . . 63.409999999999997 110.61 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.45 140.59 82.82 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.478 2.785 . . . . 72.340000000000003 113.201 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' A' ' 11' ' ' GLN . 19.6 pt20 -94.09 161.11 14.41 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.853 -1.536 . . . . 75.310000000000002 106.853 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.74 123.72 70.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.058 -0.657 . . . . 70.299999999999997 110.023 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -151.29 138.39 19.19 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.914 -1.884 . . . . 74.349999999999994 105.914 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.7 m -94.97 128.72 42.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.612 0.244 . . . . 71.109999999999999 110.86 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.565 ' O2P' ' HA ' ' A' ' 86' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -88.2 152.58 21.88 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.394 -2.076 . . . . 74.010000000000005 105.394 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.46 115.87 24.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.533 0.683 . . . . 73.019999999999996 109.337 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -119.94 139.86 51.79 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.287 -0.87 . . . . 75.340000000000003 110.432 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -113.22 92.18 3.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.732 -1.581 . . . . 72.319999999999993 106.732 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.21 -173.86 3.42 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.059 -0.973 . . . . 72.019999999999996 112.024 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.58 -0.55 1.42 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.117 1.767 . . . . 71.299999999999997 111.683 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.98 -17.54 63.39 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.735 1.214 . . . . 64.209999999999994 111.174 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.19 -8.95 35.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.685 0.794 . . . . 72.340000000000003 111.677 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 63.5 tttp -88.93 -23.08 22.78 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.05 -0.407 . . . . 63.229999999999997 111.246 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -59.76 -23.47 63.27 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.419 0.526 . . . . 74.019999999999996 112.419 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.57 -30.63 71.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.85 0.685 . . . . 54.450000000000003 112.85 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 13.8 pt-20 -76.56 -26.05 54.7 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.601 -0.839 . . . . 72.120000000000005 110.796 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -80.16 -26.18 39.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.029 -0.73 . . . . 74.409999999999997 109.029 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 m -77.58 -25.74 50.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.125 -0.943 . . . . 63.030000000000001 110.448 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.5 m -74.74 108.77 7.7 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.369 -0.974 . . . . 71.420000000000002 108.369 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.75 -5.23 12.82 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 109.281 -1.528 . . . . 61.0 109.281 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -113.8 121.72 44.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.012 -0.736 . . . . 73.150000000000006 109.012 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.59 45.0 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.279 -1.008 . . . . 73.310000000000002 108.279 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.15 142.08 96.89 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.162 1.908 . . . . 73.209999999999994 111.079 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.56 126.01 42.61 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.205 -0.294 . . . . 71.120000000000005 110.205 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 84.96 2.08 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.036 -1.098 . . . . 62.409999999999997 108.036 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -101.6 -36.33 8.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.251 0.548 . . . . 72.200000000000003 111.02 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.73 62.19 0.37 Allowed Glycine 0 C--N 1.305 -1.159 0 C-N-CA 121.013 -0.613 . . . . 61.340000000000003 111.991 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 123' ' ' GLN . . . -90.65 -28.52 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.591 -0.358 . . . . 61.420000000000002 111.257 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -92.75 -5.25 51.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.333 0.494 . . . . 72.420000000000002 112.333 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -80.22 -43.84 20.78 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.118 0.784 . . . . 73.030000000000001 113.118 -168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.0 mt 42.76 65.66 5.05 Favored Pre-proline 0 CA--C 1.557 1.248 0 O-C-N 124.181 0.926 . . . . 63.530000000000001 111.959 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.27 -70.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.461 2.774 . . . . 63.520000000000003 113.979 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.19 7.89 45.65 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.509 -0.476 . . . . 61.149999999999999 110.661 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.54 75.16 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.987 -0.551 . . . . 54.509999999999998 111.769 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -115.18 153.97 29.85 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 123.954 0.902 . . . . 71.239999999999995 111.012 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.34 44.3 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.459 -0.791 . . . . 74.239999999999995 109.974 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.85 160.7 38.08 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.542 -0.754 . . . . 72.430000000000007 109.196 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 pt? -121.28 131.88 54.47 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.34 -0.985 . . . . 75.0 108.34 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.57 129.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.32 -0.622 . . . . 74.310000000000002 109.32 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG21 ' ND2' ' A' ' 56' ' ' ASN . 22.4 t -80.19 118.06 27.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.529 -1.656 . . . . 70.420000000000002 106.529 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.985 0.898 . . . . 64.230000000000004 109.667 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -141.47 148.05 38.85 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.641 -1.244 . . . . 75.420000000000002 107.641 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.43 -179.7 16.85 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 111.093 -0.803 . . . . 73.239999999999995 111.093 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -67.67 -38.11 14.83 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.097 1.865 . . . . 74.430000000000007 110.943 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.7 p-10 -96.14 22.63 7.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.392 -0.822 . . . . 71.310000000000002 111.261 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.22 144.02 55.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.326 0.651 . . . . 74.030000000000001 111.342 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.46 33.23 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 111.139 -0.785 . . . . 63.149999999999999 111.139 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 141.93 29.14 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 120.765 0.317 . . . . 70.239999999999995 110.731 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -119.82 138.7 53.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.069 -0.514 . . . . 72.120000000000005 110.276 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.98 133.98 54.82 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.533 -0.543 . . . . 64.239999999999995 109.533 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.5 pt? -96.86 144.53 26.72 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.049 0.218 . . . . 60.399999999999999 110.502 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB3' HD11 ' A' ' 94' ' ' ILE . 69.3 mt -104.5 113.39 26.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -128.52 -3.1 5.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.973 0.416 . . . . 75.549999999999997 111.509 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -107.87 143.14 26.73 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 109.383 -0.599 . . . . 63.229999999999997 109.383 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.94 -25.2 27.01 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.455 2.77 . . . . 73.519999999999996 114.369 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.7 m -143.23 121.96 12.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 110.258 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 24.9 m -117.96 129.26 55.5 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.446 -0.797 . . . . 43.25 109.768 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 m -100.89 135.67 41.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.459 -0.571 . . . . 65.25 109.459 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.07 135.43 54.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.054 -0.721 . . . . 65.019999999999996 109.054 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -165.41 34.49 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.974 -1.25 . . . . 75.140000000000001 109.974 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 79.2 ttt180 -91.6 149.16 21.79 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.465 -0.568 . . . . 74.349999999999994 109.465 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 79.03 161.26 0.14 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.552 1.141 . . . . 63.350000000000001 110.519 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -72.28 13.1 0.56 Allowed 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.834 2.356 . . . . 74.310000000000002 113.156 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.62 -5.54 59.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.767 0.794 . . . . 75.540000000000006 109.6 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 m -117.57 148.74 41.62 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.75 -1.204 . . . . 70.25 107.75 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.16 -44.86 83.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.915 0.886 . . . . 40.340000000000003 109.361 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.9 mm -100.17 124.5 53.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.004 -1.11 . . . . 71.420000000000002 108.004 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -88.84 124.35 34.09 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.519 0.512 . . . . 75.420000000000002 111.229 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 6.2 mp -126.3 141.3 51.96 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.751 -1.203 . . . . 74.049999999999997 107.751 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.27 117.43 34.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.34 -1.726 . . . . 64.450000000000003 106.34 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 84' ' ' THR . 9.4 t70 -105.46 173.25 6.39 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.69 -0.687 . . . . 73.549999999999997 109.538 -168.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -82.95 -24.86 8.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.449 -1.315 . . . . 52.439999999999998 107.449 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.2 m -124.56 -173.66 2.84 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.0 -1.852 . . . . 74.209999999999994 106.0 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 84' ' ' THR . 89.3 t -102.67 99.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 120.667 -1.271 . . . . 72.129999999999995 110.157 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.565 ' HA ' ' O2P' ' A' ' 15' ' ' TPO . 1.9 p -83.87 107.47 16.28 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.434 -0.803 . . . . 73.349999999999994 109.837 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.404 ' HD2' ' O2P' ' A' ' 15' ' ' TPO . 0.1 OUTLIER -64.43 -32.36 73.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.643 0.735 . . . . 74.510000000000005 111.006 -176.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -168.9 119.93 0.74 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.668 -2.345 . . . . 74.549999999999997 104.668 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -99.58 -52.04 3.59 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 123.375 0.422 . . . . 74.230000000000004 109.893 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.73 157.81 44.13 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.326 -0.549 . . . . 72.519999999999996 110.155 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.19 132.03 51.86 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.882 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 4.2 m-85 -105.62 113.75 27.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.72 -1.585 . . . . 73.25 106.72 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.404 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 84.8 mtt180 -104.15 133.48 49.0 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 63' ' ' LEU . 50.4 mt -104.29 113.53 41.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.063 -1.828 . . . . 62.130000000000003 106.063 176.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -134.47 118.58 17.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.447 -0.575 . . . . 70.310000000000002 109.447 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 54.22 38.04 28.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.161 0.985 . . . . 70.299999999999997 112.039 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.0 -6.92 79.84 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.092 -0.504 . . . . 61.530000000000001 113.702 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.74 149.91 23.99 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.359 -0.608 . . . . 52.240000000000002 109.359 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.97 116.9 28.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 72.129999999999995 108.794 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 93' ' ' ARG . 10.4 pt-20 -112.04 127.28 55.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.202 -0.666 . . . . 61.399999999999999 109.202 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.458 HG21 ' SD ' ' A' ' 122' ' ' MET . 43.6 t -105.5 124.32 60.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.235 -0.654 . . . . 74.219999999999999 109.235 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.4 t -115.01 122.97 70.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 115.779 -0.646 . . . . 73.310000000000002 109.639 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.05 131.4 34.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.216 -0.902 . . . . 72.030000000000001 111.351 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.37 12.74 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.905 -1.043 . . . . 53.240000000000002 108.377 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.14 34.51 5.03 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.994 -1.242 . . . . 74.510000000000005 109.994 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 m -61.9 -11.7 14.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.618 1.167 . . . . 75.219999999999999 111.315 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 107' ' ' LEU . 1.7 mm? -71.15 -26.16 62.87 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.055 0.942 . . . . 61.420000000000002 108.94 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.61 -18.68 24.74 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.106 -0.952 . . . . 75.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.94 62.71 1.65 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.702 -0.681 . . . . 72.25 112.644 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -64.5 135.5 56.11 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 124.081 0.952 . . . . 55.5 112.444 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.14 126.77 44.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.966 -1.124 . . . . 72.420000000000002 107.966 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -107.85 117.32 53.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.764 -1.569 . . . . 72.120000000000005 106.764 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 51.32 49.96 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.128 0.971 . . . . 74.340000000000003 110.276 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 70.68 7.81 6.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.273 1.429 . . . . 72.030000000000001 113.709 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.54 137.82 31.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.451 -0.9 . . . . 50.329999999999998 111.228 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.13 123.92 14.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.103 1.869 . . . . 63.140000000000001 108.793 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -151.44 138.49 19.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.124 -1.065 . . . . 64.540000000000006 108.124 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.1 -53.24 3.88 Favored 'General case' 0 C--O 1.199 -1.582 0 C-N-CA 120.73 -0.388 . . . . 64.109999999999999 110.637 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.93 136.53 54.93 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.13 -0.693 . . . . 64.299999999999997 109.13 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 140.43 20.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.383 -0.969 . . . . 75.239999999999995 108.383 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -96.42 114.57 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 105.101 -2.185 . . . . 42.140000000000001 105.101 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.458 ' SD ' HG21 ' A' ' 101' ' ' VAL . 79.1 mtp -90.22 145.32 25.1 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 114.414 1.264 . . . . 74.329999999999998 114.414 -166.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.446 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 76.1 mt-30 -111.59 158.15 19.56 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 63.43 108.677 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 138' ' ' LEU . 24.4 m -58.14 120.9 9.45 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.819 -0.437 . . . . 74.400000000000006 109.819 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.73 1.54 56.34 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.217 -0.992 . . . . 62.119999999999997 112.718 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.98 141.56 28.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.23 -1.026 . . . . 74.129999999999995 108.23 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.24 145.67 49.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.918 0.711 . . . . 74.239999999999995 112.918 -169.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.442 HD11 ' SD ' ' A' ' 122' ' ' MET . 34.5 mt -116.08 132.87 64.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.002 -0.74 . . . . 74.340000000000003 109.002 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -103.63 110.5 22.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.789 -1.93 . . . . 73.010000000000005 105.789 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.0 mt -109.67 105.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.475 -0.935 . . . . 74.040000000000006 108.475 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.51 -107.94 2.3 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.016 -1.634 . . . . 73.319999999999993 109.016 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -119.93 9.04 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 120.808 0.337 . . . . 63.310000000000002 110.12 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.4 p90 -120.28 146.26 46.26 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.802 0.668 . . . . 64.340000000000003 112.802 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 53' ' ' ARG . 47.9 ttt180 -112.58 132.28 55.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.427 -0.806 . . . . 74.140000000000001 111.467 -167.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.4 139.97 52.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.258 -0.645 . . . . 63.340000000000003 109.258 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.0 130.23 66.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.673 -0.862 . . . . 72.140000000000001 108.673 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -104.27 128.48 52.04 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.124 -0.695 . . . . 75.510000000000005 109.124 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB2' HG23 ' A' ' 124' ' ' THR 0.278 0.0 OUTLIER -140.09 135.63 32.76 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 113.109 0.781 . . . . 75.430000000000007 113.109 177.728 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.2 124.97 44.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.281 -1.748 . . . . 63.100000000000001 106.281 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 165.43 -33.7 0.24 Allowed Glycine 0 C--N 1.29 -1.976 0 C-N-CA 118.723 -1.703 . . . . 13.51 116.468 -171.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 10.2 Cg_endo -53.87 142.16 64.38 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.896 2.848 . . . . 62.32 114.653 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.49 88.92 1.23 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.831 -2.285 . . . . 73.430000000000007 104.831 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 114.803 -1.089 . . . . 73.030000000000001 108.282 -172.657 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' H3 ' HD11 ' A' ' 62' ' ' LEU . 65.2 mtt . . . . . 0 CA--C 1.503 -0.862 0 N-CA-C 108.828 -0.804 . . . . 60.030000000000001 108.828 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 6.2 p -154.98 132.4 11.17 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.581 -0.896 . . . . 72.120000000000005 108.581 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.2 -70.73 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.441 -0.578 . . . . 72.519999999999996 109.441 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -147.47 130.4 16.23 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 107.568 -1.271 . . . . 42.049999999999997 107.568 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.432 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 3.5 t-20 -65.31 115.23 5.38 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.115 0.884 . . . . 73.439999999999998 109.257 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.13 98.97 2.28 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 115.663 -0.698 . . . . 61.450000000000003 114.296 -174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -114.61 107.98 50.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 107.479 -1.304 . . . . 73.340000000000003 107.479 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.75 144.09 99.51 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.825 2.35 . . . . 74.450000000000003 113.272 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.51 149.46 71.79 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.114 -0.948 . . . . 72.310000000000002 109.39 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -50.84 112.05 0.68 Allowed 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.61 2.873 . . . . 62.43 113.133 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -147.78 144.58 28.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.027 -1.101 . . . . 44.43 108.027 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 41.8 t -111.82 127.38 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 120.976 0.417 . . . . 71.319999999999993 111.378 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.0 164.42 28.03 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.52 -0.919 . . . . 73.209999999999994 108.52 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -99.54 126.96 45.6 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.644 -0.873 . . . . 71.219999999999999 108.644 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -93.49 149.17 21.44 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.098 -0.501 . . . . 61.119999999999997 109.888 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.9 115.79 27.85 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 CA-C-O 120.822 0.344 . . . . 73.310000000000002 110.36 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -107.69 120.16 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.729 -0.841 . . . . 75.109999999999999 108.729 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.57 141.26 46.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.688 -0.687 . . . . 64.430000000000007 112.624 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 82.84 -20.93 0.31 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.32 1.848 . . . . 72.530000000000001 113.505 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -80.1 -38.44 31.63 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.422 -0.955 . . . . 52.009999999999998 108.422 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 23' ' ' LEU . 2.2 pp -64.73 -26.62 68.45 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.014 -0.993 . . . . 75.310000000000002 110.792 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 22' ' ' LEU . 50.9 tp -74.85 -39.96 61.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.4 -0.818 . . . . 63.240000000000002 109.232 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.8 -41.41 78.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 73.140000000000001 110.448 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.78 -39.55 80.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.706 -0.679 . . . . 62.020000000000003 110.409 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -59.43 -39.23 82.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 73.129999999999995 110.796 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -63.51 -38.51 91.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.73 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -72.06 -38.77 69.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.961 -0.563 . . . . 61.049999999999997 110.302 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -66.46 -47.01 74.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.956 -0.565 . . . . 64.340000000000003 110.242 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -83.08 98.11 9.14 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.874 0.369 . . . . 52.130000000000003 111.288 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.54 -60.51 0.74 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 108.38 -1.888 . . . . 75.540000000000006 108.38 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.514 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 38.2 m -114.37 124.77 52.78 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.866 -1.161 . . . . 73.439999999999998 107.866 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.82 94.52 6.44 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.619 -0.512 . . . . 51.420000000000002 109.619 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 32' ' ' THR . 2.7 Cg_exo -76.25 142.91 24.71 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.575 2.183 . . . . 63.399999999999999 111.962 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.1 154.74 19.93 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.156 -1.053 . . . . 54.399999999999999 108.156 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 m -114.43 144.85 42.65 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.144 0.497 . . . . 74.400000000000006 112.075 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -132.58 144.39 50.36 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.743 -1.576 . . . . 72.310000000000002 106.743 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.13 11.91 32.9 Favored Glycine 0 CA--C 1.49 -1.515 0 N-CA-C 109.891 -1.283 . . . . 73.319999999999993 109.891 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.04 -32.0 16.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.882 -0.785 . . . . 73.530000000000001 108.882 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -85.09 3.6 38.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.52 -1.218 . . . . 73.219999999999999 110.95 -177.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -80.12 -36.34 35.42 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.398 -0.819 . . . . 71.010000000000005 110.566 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 51.15 45.85 3.17 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 123.725 0.641 . . . . 71.109999999999999 112.492 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.99 -52.85 1.04 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.9 1.733 . . . . 65.209999999999994 113.929 -170.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -18.34 40.27 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.946 -0.57 . . . . 54.329999999999998 112.53 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.94 -0.49 82.7 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 120.422 -0.894 . . . . 73.319999999999993 111.814 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 t -118.62 170.02 9.32 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.347 -1.353 . . . . 63.020000000000003 107.347 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . . . -139.65 152.92 47.14 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.598 0.237 . . . . 72.239999999999995 110.463 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -130.05 155.58 45.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.925 -0.58 . . . . 75.299999999999997 109.959 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.5 pt? -119.39 125.15 48.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.911 -1.144 . . . . 65.340000000000003 107.911 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.2 135.18 53.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 115.433 -0.803 . . . . 75.200000000000003 109.791 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.11 117.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 105.171 -2.159 . . . . 50.229999999999997 105.171 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.63 -39.43 22.15 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.323 -1.362 . . . . 73.420000000000002 107.323 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 47.7 ttt180 -160.95 144.21 13.05 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.317 -1.364 . . . . 73.150000000000006 107.317 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.61 -167.69 26.54 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 108.355 -1.898 . . . . 31.140000000000001 108.355 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.1 -47.57 12.16 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.378 2.052 . . . . 73.5 112.184 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.11 22.05 3.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.662 -0.244 . . . . 72.549999999999997 111.198 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.6 134.09 46.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.723 0.638 . . . . 72.409999999999997 112.723 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.18 21.72 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.217 -0.901 . . . . 73.340000000000003 111.829 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 145.76 33.35 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.843 0.354 . . . . 73.230000000000004 110.126 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.85 136.3 22.85 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 110.991 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -121.59 145.24 48.18 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.347 -1.353 . . . . 73.409999999999997 107.347 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 1.4 pt? -110.38 145.53 37.4 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.575 0.226 . . . . 74.040000000000006 110.63 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.75 103.41 5.01 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.101 -1.444 . . . . 71.25 107.101 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 16.0 t70 -123.2 7.55 9.14 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.952 -1.499 . . . . 60.240000000000002 106.952 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -137.03 146.1 53.3 Favored Pre-proline 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 74.439999999999998 107.669 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 14.0 Cg_exo -72.06 -14.36 29.01 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.832 2.355 . . . . 74.319999999999993 114.496 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -140.14 122.37 15.88 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.293 -0.88 . . . . 73.120000000000005 109.479 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.2 m -131.02 139.08 49.91 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.523 0.729 . . . . 55.240000000000002 111.224 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.15 52.64 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.128 -1.064 . . . . 73.319999999999993 108.128 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.75 135.1 54.69 Favored 'General case' 0 C--O 1.264 1.823 0 CA-C-O 120.996 0.427 . . . . 71.239999999999995 109.94 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.74 -156.17 22.33 Favored Glycine 0 N--CA 1.417 -2.617 0 CA-C-N 115.316 -0.856 . . . . 62.130000000000003 111.119 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.505 ' NH1' ' HA ' ' A' ' 86' ' ' SER . 40.8 ttp180 -88.86 150.61 22.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.308 -0.627 . . . . 75.209999999999994 109.308 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.9 m170 81.53 150.07 0.11 Allowed Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 125.435 1.494 . . . . 64.120000000000005 111.093 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.29 0.86 6.11 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.051 2.501 . . . . 70.219999999999999 111.225 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.63 -26.53 60.82 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 124.722 1.209 . . . . 74.530000000000001 107.754 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -85.84 136.43 33.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.604 -1.258 . . . . 73.439999999999998 107.604 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' A' ' 5' ' ' ASN . 17.0 t70 -54.64 -46.49 73.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.369 1.068 . . . . 74.150000000000006 109.765 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 mm -102.73 109.4 26.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.588 -1.264 . . . . 72.019999999999996 107.588 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -87.61 115.77 25.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.763 -0.653 . . . . 64.219999999999999 111.196 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.23 127.83 45.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.037 -1.468 . . . . 65.319999999999993 107.037 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.07 117.9 34.98 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.113 -0.635 . . . . 71.019999999999996 110.216 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 85' ' ' VAL . 12.2 t70 -150.34 161.52 42.32 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 104.546 -2.39 . . . . 74.219999999999999 104.546 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.3 -39.3 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 118.168 0.44 . . . . 52.530000000000001 111.371 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -101.32 7.35 42.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.72 0.771 . . . . 75.109999999999999 112.308 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 82' ' ' ASP . 69.2 t -85.93 121.15 36.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.279 -1.008 . . . . 72.329999999999998 108.279 173.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.505 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 35.0 m -93.11 -164.54 1.19 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.307 0.855 . . . . 63.039999999999999 113.307 -173.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.471 ' NH1' ' HA ' ' A' ' 12' ' ' VAL . 21.3 ptt180 -55.07 -21.37 12.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.57 2.348 . . . . 71.439999999999998 113.499 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -170.24 116.44 0.52 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.73 -0.841 . . . . 70.530000000000001 108.73 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.491 ' ND1' HG23 ' A' ' 130' ' ' ILE . 9.4 t-160 -100.39 -51.96 3.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.984 -0.747 . . . . 74.150000000000006 108.984 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.14 43.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.454 -0.943 . . . . 44.119999999999997 108.454 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.33 149.64 50.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.536 -0.466 . . . . 72.209999999999994 110.787 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.471 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 21.9 m-85 -112.65 113.77 26.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.97 -1.122 . . . . 70.430000000000007 107.97 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -108.78 131.89 54.51 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.264 -1.013 . . . . 75.230000000000004 108.264 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -106.4 120.05 56.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.685 -1.228 . . . . 73.409999999999997 107.685 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.1 129.95 28.36 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.333 -0.617 . . . . 71.0 109.333 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.26 35.75 25.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.728 1.211 . . . . 65.200000000000003 110.71 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.17 82.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.473 -0.785 . . . . 71.209999999999994 113.839 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -100.61 141.56 33.3 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.945 -0.761 . . . . 75.239999999999995 108.945 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -106.82 117.86 35.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.091 -1.078 . . . . 72.099999999999994 108.091 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.02 141.87 51.49 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.065 -0.654 . . . . 72.549999999999997 111.674 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.05 124.82 58.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.443 -0.947 . . . . 73.019999999999996 108.443 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.84 123.38 71.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.382 -0.97 . . . . 74.230000000000004 108.382 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.98 127.64 32.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 71.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.69 -15.96 9.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.613 0.721 . . . . 75.340000000000003 109.77 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.73 57.79 0.63 Allowed Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.479 -1.448 . . . . 64.140000000000001 109.479 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -69.33 5.14 1.39 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.528 0.68 . . . . 54.240000000000002 111.56 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.89 -20.9 52.13 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.317 0.647 . . . . 70.219999999999999 109.355 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -87.83 -19.79 26.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 62.100000000000001 110.35 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.04 71.72 0.99 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 112.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 10.0 m -69.67 130.32 42.05 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.159 -1.052 . . . . 51.119999999999997 108.159 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -108.83 125.9 52.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.429 -0.908 . . . . 62.229999999999997 110.613 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.03 117.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 105.792 -1.929 . . . . 72.219999999999999 105.792 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.88 40.63 30.54 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.042 0.925 . . . . 74.099999999999994 108.849 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 71.86 7.36 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.215 1.932 . . . . 74.099999999999994 116.215 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -115.85 135.96 22.81 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 118.72 0.691 . . . . 74.230000000000004 110.519 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 110' ' ' THR . 32.1 Cg_endo -63.48 148.05 92.81 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.86 2.374 . . . . 75.540000000000006 112.62 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 51.6 mmt-85 -121.55 160.99 23.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 114.335 1.235 . . . . 75.540000000000006 114.335 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -115.8 -51.76 2.65 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 112.943 -1.935 . . . . 60.240000000000002 106.125 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.19 135.66 5.35 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.338 -1.727 . . . . 65.400000000000006 106.338 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.65 145.46 23.47 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.44 -0.504 . . . . 74.319999999999993 110.998 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.37 124.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.309 -2.108 . . . . 72.109999999999999 105.309 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 tpp -89.5 134.48 34.09 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.311 -0.955 . . . . 75.420000000000002 113.481 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -103.69 141.67 35.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.485 -1.234 . . . . 44.009999999999998 110.645 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -61.37 130.22 45.02 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.874 -1.057 . . . . 70.530000000000001 111.451 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.43 58.23 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.911 -0.586 . . . . 73.340000000000003 113.182 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -88.98 154.73 19.99 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 116.866 0.333 . . . . 62.229999999999997 110.864 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.81 133.82 53.03 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.942 0.877 . . . . 54.240000000000002 110.801 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.1 mm -113.68 123.65 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.763 -1.199 . . . . 71.099999999999994 107.763 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -104.71 113.37 26.92 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.189 -0.604 . . . . 74.519999999999996 109.562 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.491 HG23 ' ND1' ' A' ' 89' ' ' HIS . 36.9 mt -109.66 124.39 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 114.806 -1.088 . . . . 74.430000000000007 108.128 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.82 -86.36 1.35 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.866 -1.294 . . . . 62.219999999999999 109.866 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.93 25.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.364 0.602 . . . . 73.340000000000003 110.215 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.4 p90 -141.04 164.08 31.24 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.384 -0.825 . . . . 74.420000000000002 108.897 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -112.55 144.82 41.38 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 114.598 1.333 . . . . 74.129999999999995 114.598 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.06 140.64 49.72 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.22 -1.809 . . . . 72.349999999999994 106.137 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.2 t -111.3 124.76 68.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 109.067 -0.716 . . . . 72.209999999999994 109.067 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -91.46 116.03 28.52 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.614 -1.254 . . . . 70.099999999999994 107.614 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.8 tm? -128.61 132.46 48.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.931 -1.137 . . . . 63.310000000000002 107.931 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . . . -90.16 118.75 29.93 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.668 -0.813 . . . . 54.32 110.394 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 125.67 73.35 0.21 Allowed Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.763 -0.653 . . . . 34.219999999999999 112.328 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.61 162.85 40.89 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.979 2.453 . . . . 71.0 111.343 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.05 48.31 1.23 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.712 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.414 -2.239 0 CA-C-N 115.659 -0.701 . . . . 61.140000000000001 110.517 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 108.016 -1.105 . . . . 71.230000000000004 108.016 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p 50.88 27.33 3.08 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.753 0.821 . . . . 63.340000000000003 112.895 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -107.71 121.12 44.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.786 -1.19 . . . . 75.239999999999995 107.786 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -98.88 132.12 44.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.357 -0.838 . . . . 72.439999999999998 109.783 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.05 129.96 40.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.26 -0.645 . . . . 64.319999999999993 109.26 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.08 40.75 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 116.021 -0.536 . . . . 53.539999999999999 112.074 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.0 m -79.83 118.08 70.63 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 109.561 -0.533 . . . . 73.349999999999994 109.561 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.31 132.11 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.146 1.897 . . . . 65.430000000000007 111.029 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.08 118.07 59.98 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 109.608 -0.515 . . . . 53.229999999999997 109.608 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.04 157.11 30.51 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.664 2.243 . . . . 74.010000000000005 112.178 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -122.21 132.2 54.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.051 -0.722 . . . . 61.229999999999997 109.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.19 121.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.713 -0.847 . . . . 73.209999999999994 108.713 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' OE1' ' HD3' ' A' ' 87' ' ' ARG . 43.2 mt-10 -130.21 167.98 17.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.662 -1.977 . . . . 73.420000000000002 105.662 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 m -70.4 108.63 4.34 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.737 0.78 . . . . 72.230000000000004 111.854 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.3 t -89.41 146.49 24.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.871 -0.789 . . . . 52.210000000000001 108.871 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.53 115.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 108.193 -1.04 . . . . 72.140000000000001 108.193 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -115.45 133.32 56.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.669 . . . . 74.420000000000002 109.192 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -86.78 94.41 9.53 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.02 -1.072 . . . . 62.409999999999997 110.392 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.28 -152.07 0.05 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.441 -1.254 . . . . 43.219999999999999 108.934 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.4 7.11 47.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.938 -0.476 . . . . 71.450000000000003 111.191 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.77 -50.46 72.23 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.095 1.517 . . . . 62.229999999999997 115.095 -171.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 26' ' ' MET . 7.3 tt -72.63 -39.15 67.44 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.473 0.654 . . . . 75.519999999999996 109.365 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -69.72 -32.77 71.51 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.717 -0.674 . . . . 53.329999999999998 110.314 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.51 -42.18 95.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.14 0.576 . . . . 62.329999999999998 110.151 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.01 -30.72 71.32 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 120.083 -0.647 . . . . 74.450000000000003 111.163 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.0 -49.4 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 74.120000000000005 109.785 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -69.84 -27.03 64.51 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.315 -0.857 . . . . 53.130000000000003 112.608 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.442 ' OG ' ' HD2' ' A' ' 114' ' ' ARG . 31.7 p -79.96 -16.75 54.59 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.145 0.497 . . . . 65.140000000000001 111.053 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -74.19 106.14 5.71 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 122.151 0.977 . . . . 74.540000000000006 111.095 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.78 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 104.927 -3.269 . . . . 72.439999999999998 104.927 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 m -115.5 121.39 42.55 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.729 -1.952 . . . . 64.219999999999999 105.729 168.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.37 115.46 65.47 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 106.588 -1.634 . . . . 63.310000000000002 106.588 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.84 140.03 93.4 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 121.982 1.788 . . . . 71.209999999999994 112.313 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.85 126.54 29.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.395 -0.82 . . . . 45.240000000000002 110.805 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 124' ' ' THR . 67.9 m -147.44 109.47 4.48 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.836 -1.172 . . . . 51.340000000000003 107.836 172.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -86.82 96.59 10.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 62.119999999999997 112.217 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.11 7.33 0.25 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.783 -0.644 . . . . 63.210000000000001 112.409 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.417 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -88.31 -21.17 24.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.754 0.787 . . . . 55.210000000000001 110.375 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -92.15 -6.73 50.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.711 -1.131 . . . . 71.230000000000004 109.122 178.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -100.04 -42.29 6.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.39 -1.277 . . . . 73.219999999999999 109.624 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 56.12 78.71 0.37 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.602 -0.726 . . . . 63.100000000000001 110.128 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.47 -55.5 0.91 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.131 1.888 . . . . 74.319999999999993 113.153 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.47 -7.38 26.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.932 -0.576 . . . . 73.239999999999995 111.854 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.06 -12.62 11.36 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.213 -0.449 . . . . 50.329999999999998 112.866 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m -124.68 153.42 42.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.762 -1.569 . . . . 54.43 106.762 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.28 41.13 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.905 0.128 . . . . 43.219999999999999 110.782 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.1 pp -127.6 157.01 41.36 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.803 0.668 . . . . 71.219999999999999 112.803 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 49' ' ' LEU . 3.4 pp -121.35 138.25 54.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.923 -1.14 . . . . 54.149999999999999 107.923 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.79 135.72 62.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 C-N-CA 120.534 -0.466 . . . . 71.030000000000001 109.906 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -80.81 117.09 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.774 -1.936 . . . . 63.039999999999999 105.774 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -90.21 -34.67 15.72 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.779 -0.646 . . . . 70.120000000000005 109.551 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -148.61 137.56 21.6 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.179 -0.674 . . . . 74.329999999999998 109.179 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.68 -177.86 23.8 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 108.907 -1.677 . . . . 44.310000000000002 108.907 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 72.1 Cg_exo -55.65 -51.18 10.41 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.935 2.423 . . . . 14.35 112.823 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -91.48 22.75 3.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.302 0.482 . . . . 55.509999999999998 112.302 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.85 143.07 48.71 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.087 0.47 . . . . 62.310000000000002 111.799 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.27 -23.27 32.33 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.301 -0.72 . . . . 55.329999999999998 111.301 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 134.19 34.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 120.93 0.395 . . . . 54.009999999999998 110.459 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -107.38 138.68 43.14 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.919 -1.141 . . . . 75.319999999999993 107.919 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.5 127.52 44.14 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.422 -0.584 . . . . 75.530000000000001 109.422 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 9.2 mp -93.62 137.78 32.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.39 -0.596 . . . . 74.420000000000002 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.95 103.34 13.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.013 -1.477 . . . . 62.310000000000002 107.013 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.99 -15.22 6.92 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.498 -0.774 . . . . 72.129999999999995 111.236 -175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.2 pt20 -107.32 142.47 25.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 109.648 -0.501 . . . . 74.450000000000003 109.648 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.6 -19.9 19.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.965 3.11 . . . . 72.530000000000001 113.865 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.3 m -147.18 121.66 9.72 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.814 -1.18 . . . . 71.219999999999999 107.814 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 77' ' ' ASP . 9.3 m -120.81 113.83 20.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.378 -1.341 . . . . 70.120000000000005 107.378 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.0 m -92.36 144.04 25.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.822 -0.549 . . . . 65.530000000000001 110.704 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.29 139.02 52.6 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 123.166 0.586 . . . . 62.530000000000001 109.497 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.63 -135.84 5.63 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.893 -1.283 . . . . 74.299999999999997 109.893 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 22.9 ptt85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.077 -1.083 . . . . 75.310000000000002 108.077 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER 144.77 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 127.635 2.374 . . . . 75.239999999999995 108.81 174.252 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.69 -15.25 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.763 1.642 . . . . 64.430000000000007 110.416 174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -78.81 -24.07 44.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.143 -0.935 . . . . 73.150000000000006 110.444 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 p -84.71 121.32 27.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.615 -0.883 . . . . 63.509999999999998 108.615 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 68' ' ' THR . 36.3 t70 -69.88 -35.8 74.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 110.677 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.4 98.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.25 -1.389 . . . . 71.120000000000005 107.25 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -92.93 115.11 27.82 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.904 -0.589 . . . . 74.109999999999999 109.632 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.6 mt -111.62 134.38 53.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.519 -1.289 . . . . 52.020000000000003 107.519 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.92 128.35 54.73 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.535 0.683 . . . . 73.200000000000003 110.413 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -148.43 -178.8 6.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.447 -2.057 . . . . 65.129999999999995 105.447 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.53 -24.84 8.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.982 -1.118 . . . . 55.149999999999999 107.982 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.2 m -137.36 90.3 2.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.968 0.89 . . . . 74.019999999999996 110.236 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -101.85 150.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.143 -1.058 . . . . 64.129999999999995 108.143 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 89' ' ' HIS . 54.2 m -92.45 146.45 23.67 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.419 -0.956 . . . . 75.150000000000006 108.419 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -79.61 -17.56 53.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.725 0.774 . . . . 71.120000000000005 111.829 -177.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -140.8 93.87 2.65 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.578 -2.379 . . . . 72.319999999999993 104.578 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 26.3 t-80 -91.96 -53.32 4.32 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.229 0.538 . . . . 71.340000000000003 111.269 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.16 155.92 37.62 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.797 -0.816 . . . . 74.430000000000007 108.797 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.24 135.1 44.76 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.894 -0.594 . . . . 70.010000000000005 109.56 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -104.92 117.22 33.47 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.534 -1.654 . . . . 74.019999999999996 106.534 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -103.67 130.78 51.2 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.588 -0.523 . . . . 64.140000000000001 109.588 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.9 mp -114.31 113.09 42.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.628 -1.619 . . . . 70.540000000000006 106.628 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -138.38 122.78 18.33 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.79 -0.448 . . . . 74.340000000000003 109.79 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 56.3 37.86 29.23 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.796 1.238 . . . . 64.329999999999998 112.891 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.45 13.68 82.34 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.223 -0.899 . . . . 45.229999999999997 113.32 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -116.04 142.38 46.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.579 -0.897 . . . . 64.120000000000005 108.579 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -115.51 117.97 31.85 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.078 -0.712 . . . . 70.400000000000006 109.078 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.03 145.22 48.35 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 111.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 37.0 t -103.51 124.71 57.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.06 -1.459 . . . . 73.329999999999998 107.06 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.95 122.86 70.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.157 -1.423 . . . . 60.310000000000002 107.157 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -104.51 134.54 47.52 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 111.787 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.8 0.5 3.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.6 -0.727 . . . . 62.229999999999997 110.297 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.32 58.9 0.4 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.124 -1.19 . . . . 44.420000000000002 110.124 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -70.33 -8.48 50.83 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.581 0.752 . . . . 72.319999999999993 112.017 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -24.05 58.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.969 0.414 . . . . 71.140000000000001 109.958 174.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -87.34 -17.93 31.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.771 -1.196 . . . . 75.549999999999997 107.771 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.62 56.06 6.27 Favored Glycine 0 CA--C 1.496 -1.128 0 CA-C-N 114.718 -1.128 . . . . 45.450000000000003 113.329 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -63.41 128.71 37.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.853 -0.425 . . . . 74.319999999999993 109.853 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 20.5 m-30 -124.28 139.89 53.48 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 110.03 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.26 121.71 66.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.32 -1.733 . . . . 61.149999999999999 106.32 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.19 39.15 31.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.037 1.335 . . . . 41.210000000000001 108.24 -169.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.442 ' HD2' ' OG ' ' A' ' 29' ' ' SER . 19.0 mtm105 62.62 20.3 11.92 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.055 -1.429 . . . . 70.019999999999996 111.519 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -111.81 136.13 21.17 Favored Pre-proline 0 C--N 1.315 -0.931 0 C-N-CA 122.875 0.47 . . . . 73.230000000000004 110.043 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.17 123.72 13.74 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.663 2.242 . . . . 72.239999999999995 108.664 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.537 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 8.9 tpp180 -143.23 142.44 31.4 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 119.167 -1.013 . . . . 73.519999999999996 112.549 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -79.05 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.614 0.766 . . . . 75.25 109.916 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -151.39 136.48 17.45 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.624 -1.25 . . . . 71.230000000000004 107.624 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.537 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 52.4 tp60 -153.22 141.68 20.74 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.023 0.202 . . . . 61.340000000000003 111.208 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 58.4 t -66.23 133.03 31.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 106.522 -1.658 . . . . 64.239999999999995 106.522 170.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -87.42 144.65 26.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.205 -1.035 . . . . 71.219999999999999 108.205 -174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.456 ' HG2' ' HB3' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -126.77 152.47 46.85 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 113.212 0.819 . . . . 70.319999999999993 113.212 -170.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 36' ' ' SER . 0.7 OUTLIER -59.46 118.15 5.69 Favored 'General case' 0 N--CA 1.403 -2.815 0 C-N-CA 124.758 1.223 . . . . 51.310000000000002 112.563 -176.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.87 -7.03 64.8 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.802 -0.713 . . . . 73.120000000000005 112.62 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -83.09 153.09 25.04 Favored 'General case' 0 C--O 1.252 1.193 0 C-N-CA 120.132 -0.627 . . . . 63.310000000000002 110.678 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.51 131.48 55.2 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.073 -0.967 . . . . 61.409999999999997 110.285 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.2 mt -105.76 115.93 48.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 104.868 -2.271 . . . . 53.43 104.868 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -104.95 131.67 52.16 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.567 -1.272 . . . . 74.409999999999997 107.567 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.408 HD13 HD13 ' A' ' 135' ' ' LEU . 4.0 mp -129.61 103.61 9.15 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 107.858 -1.164 . . . . 74.140000000000001 107.858 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.57 -78.6 0.01 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.095 0.798 . . . . 41.420000000000002 115.095 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -134.05 8.96 3.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.788 1.235 . . . . 74.530000000000001 109.981 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.603 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 49.2 m-85 -102.1 143.19 32.25 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.463 -0.569 . . . . 75.420000000000002 109.463 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -119.55 118.65 31.6 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.158 -1.423 . . . . 65.340000000000003 107.158 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 130' ' ' ILE . 9.7 mp -119.16 135.31 54.73 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.992 -0.744 . . . . 63.32 108.992 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.15 130.85 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.01 -1.107 . . . . 70.340000000000003 108.01 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -95.68 124.87 39.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.828 0.347 . . . . 53.539999999999999 110.823 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -129.71 132.34 46.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.311 0.577 . . . . 73.510000000000005 110.531 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.66 118.24 33.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.063 -1.828 . . . . 31.41 106.063 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.7 0.03 OUTLIER Glycine 0 C--N 1.296 -1.664 0 C-N-CA 118.252 -1.927 . . . . 44.329999999999998 115.428 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.76 141.55 97.06 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 119.977 1.888 . . . . 75.150000000000006 111.179 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.27 79.18 1.68 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.321 -0.992 . . . . 72.409999999999997 108.321 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.389 -3.481 0 CA-C-N 114.627 -1.17 . . . . 72.0 108.862 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 108.957 -0.757 . . . . 60.439999999999998 108.957 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -84.99 78.5 9.9 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.457 0.646 . . . . 75.200000000000003 109.416 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -80.72 -55.75 4.62 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.794 -1.187 . . . . 74.219999999999999 107.794 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 58.1 t30 64.7 94.77 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.446 1.498 . . . . 74.230000000000004 111.721 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -140.81 -53.23 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.469 0.652 . . . . 62.549999999999997 109.324 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.26 59.33 0.1 Allowed Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.804 -0.918 . . . . 74.329999999999998 110.804 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 m -79.68 111.31 20.22 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.234 -1.395 . . . . 72.109999999999999 107.234 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.6 131.56 10.46 Favored 'Trans proline' 0 N--CA 1.428 -2.355 0 C-N-CA 121.22 1.28 . . . . 65.25 112.076 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -117.99 141.02 28.59 Favored Pre-proline 0 C--N 1.283 -2.305 0 N-CA-C 107.497 -1.298 . . . . 72.510000000000005 107.497 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.24 143.97 79.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.931 1.754 . . . . 71.409999999999997 110.993 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -91.95 144.68 25.22 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.873 -1.529 . . . . 73.219999999999999 106.873 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.09 133.27 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.697 -0.853 . . . . 73.439999999999998 108.697 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.34 146.96 33.98 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.803 -1.09 . . . . 64.230000000000004 108.526 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -105.57 124.8 50.16 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.802 -1.925 . . . . 42.340000000000003 105.802 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -88.91 133.23 34.37 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.581 -0.896 . . . . 64.049999999999997 108.581 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.83 115.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.592 -0.522 . . . . 70.140000000000001 109.592 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -122.33 137.95 54.68 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.343 -0.614 . . . . 73.140000000000001 109.343 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.09 97.37 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.368 -1.345 . . . . 75.040000000000006 107.368 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.57 -165.84 0.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.312 -0.858 . . . . 63.039999999999999 112.821 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.09 9.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.49 2.316 . . . . 73.329999999999998 114.3 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 2.9 pp -56.37 -20.45 19.37 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.06 1.133 . . . . 73.230000000000004 114.06 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.84 -43.87 82.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.722 -0.473 . . . . 71.329999999999998 109.722 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 27' ' ' GLU . 66.0 mttm -82.51 -21.16 35.58 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.4 -0.363 . . . . 64.219999999999999 111.621 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 5.6 tp10 -56.81 -48.73 77.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.377 -1.342 . . . . 74.420000000000002 107.377 170.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.4 ttp -68.76 -47.89 65.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.555 -1.202 . . . . 65.329999999999998 110.482 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 24' ' ' LYS . 31.2 tt0 -52.53 -49.79 64.14 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.455 1.102 . . . . 41.119999999999997 111.987 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 t -84.47 -27.82 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.719 0.637 . . . . 75.430000000000007 112.719 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -82.93 -22.29 33.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.434 -0.906 . . . . 54.43 110.949 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.5 m -72.03 111.46 7.28 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.093 -0.706 . . . . 61.020000000000003 109.093 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.1 -32.89 1.26 Allowed Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 109.56 -1.416 . . . . 73.230000000000004 109.56 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -94.51 120.52 34.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 73.329999999999998 108.705 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.9 111.94 20.34 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.828 -0.804 . . . . 64.530000000000001 108.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.66 141.48 66.58 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 121.949 1.766 . . . . 51.119999999999997 113.118 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.25 162.67 31.17 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.032 -0.985 . . . . 72.25 108.607 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.2 m 61.76 20.02 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.095 0.958 . . . . 43.009999999999998 112.141 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.8 m -90.85 109.94 21.15 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.657 -1.238 . . . . 61.32 107.657 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.19 53.99 0.6 Allowed Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.051 -1.071 . . . . 52.450000000000003 113.364 -172.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 -6.94 53.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.209 1.004 . . . . 64.450000000000003 109.419 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.45 14.11 0.83 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.583 -1.19 . . . . 70.329999999999998 113.261 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.71 -5.9 23.26 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.838 -0.43 . . . . 73.109999999999999 109.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 68.38 94.82 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.606 0 O-C-N 124.691 1.244 . . . . 71.129999999999995 111.245 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.21 -74.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.672 1.582 . . . . 64.329999999999998 112.519 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.71 6.69 46.8 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.844 -0.535 . . . . 53.240000000000002 111.593 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.01 17.76 75.83 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 116.048 -0.524 . . . . 62.210000000000001 113.293 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -131.99 169.74 15.89 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.753 -1.203 . . . . 61.43 107.753 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.49 154.45 48.81 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.16 -0.616 . . . . 65.530000000000001 111.034 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.42 161.3 36.7 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 114.954 -1.021 . . . . 63.210000000000001 109.288 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.476 HD11 HG21 ' A' ' 78' ' ' ILE . 4.2 pp -127.3 139.62 52.76 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.454 -0.573 . . . . 63.0 109.454 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.8 133.65 65.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.715 -0.846 . . . . 64.340000000000003 108.715 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.55 117.12 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.003 -1.851 . . . . 64.150000000000006 106.003 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -99.86 -31.0 11.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.904 -0.589 . . . . 64.200000000000003 110.745 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -137.43 132.0 32.78 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.96 -0.696 . . . . 71.040000000000006 109.323 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.43 175.11 13.94 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.594 -1.002 . . . . 64.549999999999997 110.594 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.539 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 19.2 Cg_endo -59.82 -39.62 70.77 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.68 2.253 . . . . 71.450000000000003 112.535 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -95.29 22.22 7.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.123 -0.49 . . . . 72.409999999999997 112.087 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.77 57.53 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.037 0.535 . . . . 63.340000000000003 110.889 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.31 -18.32 36.02 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.242 -1.143 . . . . 43.049999999999997 110.242 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.66 131.95 35.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.507 -0.347 . . . . 75.450000000000003 110.281 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -125.74 136.77 53.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.99 -0.744 . . . . 73.299999999999997 108.99 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -131.14 141.14 50.07 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.074 -0.713 . . . . 70.120000000000005 109.074 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -101.95 143.92 31.22 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.446 -0.576 . . . . 71.400000000000006 109.446 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.0 mt -97.4 118.72 34.51 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.971 0.415 . . . . 62.0 111.637 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.3 2.77 7.79 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -110.32 148.94 39.42 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-N 115.007 -0.997 . . . . 61.32 110.361 -174.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 -15.86 27.6 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.981 2.454 . . . . 64.310000000000002 113.446 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 91.8 m -152.84 124.29 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 121.753 -0.592 . . . . 71.540000000000006 110.853 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 77' ' ' ASP . 25.9 m -121.41 113.98 20.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.733 -0.84 . . . . 74.349999999999994 108.733 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 88.0 m -88.51 137.77 32.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.983 -0.377 . . . . 50.310000000000002 109.983 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.04 134.89 54.55 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-O 121.415 0.626 . . . . 75.409999999999997 110.349 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.99 -135.87 6.29 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.252 -1.34 . . . . 52.520000000000003 110.019 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -117.74 124.54 48.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.977 -0.749 . . . . 63.100000000000001 108.977 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.1 151.39 0.11 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 107.801 -1.185 . . . . 74.310000000000002 107.801 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.73 -32.11 47.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.861 1.708 . . . . 55.340000000000003 111.496 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.07 -5.9 59.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.065 0.394 . . . . 74.329999999999998 112.065 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.7 m -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.119 -1.067 . . . . 62.119999999999997 108.119 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 68' ' ' THR . 10.9 t70 -54.4 -43.01 71.11 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 124.33 1.019 . . . . 61.549999999999997 110.58 -175.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.476 HG21 HD11 ' A' ' 49' ' ' LEU . 29.2 pt -106.96 107.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.992 0.901 . . . . 74.030000000000001 110.388 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -95.12 128.77 42.21 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.956 -1.02 . . . . 71.239999999999995 110.009 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.3 mt -111.44 135.43 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.847 -1.909 . . . . 75.329999999999998 105.847 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.69 137.11 52.4 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.001 -0.679 . . . . 72.200000000000003 112.472 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 83' ' ' VAL . 30.2 t70 -160.69 -162.19 0.92 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.158 -1.423 . . . . 74.25 107.158 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.515 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 48.2 t -68.54 -42.88 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 108.906 -0.775 . . . . 62.310000000000002 108.906 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.2 m -156.14 101.09 2.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.776 -0.647 . . . . 73.209999999999994 109.852 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 t -102.9 149.69 7.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 106.589 -1.634 . . . . 73.319999999999993 106.589 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.0 t -68.87 143.49 54.5 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 123.376 0.423 . . . . 52.210000000000001 111.725 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.1 ptt180 -55.86 -28.4 56.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.701 1.2 . . . . 71.430000000000007 110.389 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.95 104.72 2.86 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.805 -1.089 . . . . 74.409999999999997 109.212 169.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -86.86 -51.63 5.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.835 -1.543 . . . . 64.129999999999995 106.835 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.97 159.23 41.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.659 -1.237 . . . . 63.109999999999999 107.659 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 11.6 pt-20 -142.13 154.37 44.83 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.327 0.584 . . . . 71.409999999999997 112.186 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 67' ' ' THR . 4.8 m-85 -104.29 127.83 51.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.204 -1.406 . . . . 44.350000000000001 107.204 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -121.06 125.1 46.43 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.943 -0.762 . . . . 74.430000000000007 108.943 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.63 111.59 36.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.539 -1.652 . . . . 72.239999999999995 106.539 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -139.81 129.45 24.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.135 -0.484 . . . . 72.420000000000002 110.481 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.72 36.44 27.25 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.722 1.209 . . . . 63.109999999999999 111.888 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.82 -0.76 87.93 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 113.197 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -101.27 136.72 40.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.182 -0.673 . . . . 74.340000000000003 109.182 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.87 118.04 34.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.222 -1.029 . . . . 72.129999999999995 108.222 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -127.5 146.94 50.33 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.156 -0.617 . . . . 73.439999999999998 109.938 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.57 123.72 68.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.783 -1.192 . . . . 72.409999999999997 107.783 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.7 134.77 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.728 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.83 132.79 38.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.968 -1.864 . . . . 74.420000000000002 105.968 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.96 18.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 112.341 0.496 . . . . 54.509999999999998 112.341 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.79 42.16 0.29 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.376 -1.392 . . . . 54.020000000000003 113.344 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.8 p -87.49 143.63 27.12 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.983 -1.087 . . . . 74.049999999999997 108.365 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.94 -19.77 17.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.299 0.571 . . . . 52.329999999999998 109.475 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -87.31 -19.66 27.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.274 -0.875 . . . . 50.030000000000001 111.207 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.7 120.19 4.41 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.313 -0.946 . . . . 74.129999999999995 114.163 174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.3 m -88.04 132.04 34.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.409 -0.589 . . . . 70.510000000000005 109.409 173.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -119.8 126.42 50.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.919 -0.488 . . . . 64.329999999999998 110.004 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.3 t -111.57 117.17 54.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 106.932 -1.507 . . . . 75.540000000000006 106.932 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 55.08 37.96 29.73 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 125.452 1.501 . . . . 44.340000000000003 110.003 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 67.53 16.08 9.88 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 113.776 -1.556 . . . . 72.230000000000004 112.475 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -103.76 138.48 19.54 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 107.465 -1.309 . . . . 74.230000000000004 107.465 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.49 124.36 14.94 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.097 1.864 . . . . 75.310000000000002 109.034 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -148.17 141.89 25.62 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.915 -0.714 . . . . 74.219999999999999 110.439 -172.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.19 -58.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.129 -1.063 . . . . 75.420000000000002 108.129 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.11 139.19 42.77 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.966 -0.458 . . . . 73.340000000000003 109.784 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.92 143.79 22.91 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.073 -0.714 . . . . 74.299999999999997 109.073 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.72 131.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 107.119 -1.438 . . . . 55.299999999999997 107.119 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.4 mmt -88.97 148.49 23.76 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.889 0.852 . . . . 72.409999999999997 112.671 -170.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 126' ' ' ASP . 18.9 pt20 -119.55 157.07 29.12 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.885 -1.895 . . . . 73.549999999999997 105.885 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 133.55 54.86 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.425 -0.954 . . . . 64.519999999999996 108.425 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.93 0.49 56.22 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.589 -0.815 . . . . 64.120000000000005 112.743 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.438 ' OD2' ' HG2' ' A' ' 123' ' ' GLN . 34.0 m-20 -76.12 141.06 42.05 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.638 0.719 . . . . 74.209999999999994 111.636 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.8 127.79 55.91 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.019 -1.104 . . . . 64.230000000000004 108.019 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.9 mt -107.42 119.54 57.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.091 -1.448 . . . . 73.439999999999998 107.091 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 11.5 tm0? -106.37 117.39 33.91 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.95 -1.5 . . . . 71.540000000000006 106.95 -174.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.02 101.65 12.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.862 -1.162 . . . . 73.239999999999995 107.862 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.14 -73.52 0.13 Allowed Glycine 0 CA--C 1.536 1.405 0 CA-C-O 121.361 0.423 . . . . 63.43 113.615 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -145.44 16.53 1.49 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.452 1.101 . . . . 64.239999999999995 109.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.539 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 72.4 m-85 -109.38 148.59 30.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.145 -0.934 . . . . 74.409999999999997 109.494 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -128.53 119.78 25.48 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.168 -0.679 . . . . 54.030000000000001 109.168 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.0 mt -106.45 132.72 52.15 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.452 -1.685 . . . . 60.009999999999998 106.452 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.73 120.15 61.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.054 -1.091 . . . . 64.430000000000007 108.054 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -96.43 121.58 38.39 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.67 -0.863 . . . . 75.099999999999994 108.67 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.63 136.8 49.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.809 0.337 . . . . 61.240000000000002 110.296 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.16 119.38 29.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 105.382 -2.081 . . . . 53.450000000000003 105.382 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.26 -132.83 1.87 Allowed Glycine 0 N--CA 1.42 -2.431 0 C-N-CA 119.088 -1.53 . . . . 75.400000000000006 113.342 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.47 162.13 43.52 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.757 2.971 . . . . 64.099999999999994 114.235 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.39 69.79 1.41 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.792 -1.558 . . . . 65.430000000000007 106.792 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 . . . . . 0 N--CA 1.42 -1.974 0 CA-C-N 114.758 -1.11 . . . . 74.430000000000007 111.162 -175.231 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 CA--C 1.512 -0.483 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 110.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 t -144.73 90.94 2.11 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.232 -1.766 . . . . 64.540000000000006 106.232 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -147.03 136.26 22.58 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.374 -0.972 . . . . 52.009999999999998 108.374 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -88.2 169.41 11.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.861 0.362 . . . . 74.219999999999999 110.727 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -90.08 114.47 26.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.854 -0.795 . . . . 74.019999999999996 108.854 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.35 -49.04 54.77 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 109.402 -1.479 . . . . 63.020000000000003 109.402 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 m -116.12 108.5 45.97 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 107.312 -1.366 . . . . 62.32 107.312 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.75 143.32 73.6 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.487 2.124 . . . . 62.399999999999999 112.787 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.29 127.69 60.33 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.642 -0.708 . . . . 75.019999999999996 111.481 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.92 91.9 1.07 Allowed 'Trans proline' 0 N--CA 1.427 -2.415 0 C-N-CA 121.711 1.607 . . . . 73.0 110.446 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -91.75 143.79 26.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.232 -1.349 . . . . 75.439999999999998 107.703 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -107.99 137.47 39.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.434 0.635 . . . . 72.239999999999995 110.57 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.28 155.88 41.24 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 105.129 -2.174 . . . . 72.430000000000007 105.129 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -70.51 109.85 5.05 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 113.292 0.849 . . . . 45.340000000000003 113.292 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.49 HG22 ' HG ' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -135.87 147.9 48.4 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.785 -1.931 . . . . 63.329999999999998 105.785 172.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -89.89 112.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 107.452 -1.314 . . . . 54.119999999999997 107.452 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -125.53 141.35 52.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.616 -0.72 . . . . 74.150000000000006 109.349 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -81.5 112.85 19.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.068 -1.456 . . . . 72.019999999999996 107.068 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . -64.4 -168.44 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 115.317 1.599 . . . . 72.329999999999998 115.317 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.41 2.89 2.02 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.417 1.887 . . . . 70.109999999999999 111.536 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 3.9 pp -57.28 -21.14 32.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.476 1.51 . . . . 61.340000000000003 112.915 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.84 -34.54 78.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.349 0.26 . . . . 73.439999999999998 110.975 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.39 -40.31 8.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.112 -0.699 . . . . 74.109999999999999 109.112 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 13.1 tp10 -65.7 -24.94 67.1 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 114.34 -1.3 . . . . 74.310000000000002 114.016 -172.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.21 -50.36 69.61 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.873 0.761 . . . . 54.140000000000001 112.074 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.6 -31.92 69.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.125 0.488 . . . . 64.519999999999996 110.807 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -71.97 -26.37 62.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.656 -0.702 . . . . 74.049999999999997 110.751 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.52 -40.57 12.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.104 -0.498 . . . . 62.43 110.577 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.4 m -75.42 85.21 2.54 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.679 0.752 . . . . 61.200000000000003 112.402 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.57 26.17 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.132 -0.94 . . . . 53.299999999999997 111.194 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -83.9 123.9 30.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 123.378 0.671 . . . . 73.340000000000003 109.818 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.93 124.18 81.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 106.21 -1.774 . . . . 72.299999999999997 106.21 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.74 141.76 91.95 Favored 'Trans proline' 0 C--O 1.251 1.134 0 C-N-CA 121.939 1.759 . . . . 70.540000000000006 111.909 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.06 141.44 48.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.093 -0.958 . . . . 51.140000000000001 109.463 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.3 t -141.14 112.1 7.19 Favored 'General case' 0 N--CA 1.407 -2.61 0 CA-C-O 121.55 0.691 . . . . 73.420000000000002 109.962 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.09 36.41 0.98 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.687 -1.597 . . . . 73.450000000000003 106.687 174.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . 86.7 25.63 34.75 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.309 -2.316 . . . . 73.329999999999998 107.309 -169.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 139' ' ' ALA . . . -72.29 -47.6 48.76 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.715 -1.243 . . . . 65.319999999999993 113.618 -168.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -80.92 -2.35 47.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.614 0.721 . . . . 74.030000000000001 111.453 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.45 -25.39 20.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.868 -1.06 . . . . 74.450000000000003 108.626 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 57.37 85.49 0.19 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 114.732 -1.122 . . . . 71.400000000000006 111.284 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 45.3 Cg_endo -83.1 -73.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.443 2.095 . . . . 74.200000000000003 114.11 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.11 65.3 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.705 0.632 . . . . 63.240000000000002 112.705 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -11.85 71.02 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 111.083 -0.807 . . . . 63.109999999999999 111.083 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.3 m -114.7 169.84 8.77 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.939 -1.504 . . . . 64.400000000000006 106.939 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -149.61 157.58 43.38 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.974 -0.38 . . . . 51.240000000000002 109.974 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.404 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.19 137.65 54.51 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.366 0.603 . . . . 62.340000000000003 110.324 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.3 pp -111.11 137.02 49.3 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 109.125 -0.694 . . . . 74.230000000000004 109.125 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.8 135.62 50.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 109.613 -0.514 . . . . 64.540000000000006 109.613 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 16.1 t -80.83 118.15 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.7 -1.222 . . . . 71.109999999999999 107.7 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -88.79 -35.95 16.35 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.182 -0.673 . . . . 73.109999999999999 109.182 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HD2' ' OE1' ' A' ' 25' ' ' GLU . 39.7 ttm180 -148.1 141.93 25.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.299 -0.864 . . . . 72.530000000000001 109.282 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.79 174.78 13.57 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.397 -1.081 . . . . 64.349999999999994 110.397 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.537 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.8 Cg_exo -54.65 -44.68 47.26 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.602 2.201 . . . . 73.25 113.52 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.477 HD21 HD23 ' A' ' 80' ' ' LEU . 33.6 p30 -92.64 22.37 4.77 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.081 -1.012 . . . . 70.109999999999999 113.268 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -54.51 140.5 34.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.812 0.445 . . . . 54.119999999999997 112.036 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.37 -16.27 55.36 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.545 -0.622 . . . . 53.039999999999999 111.545 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.33 142.34 27.82 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.086 -0.246 . . . . 73.340000000000003 110.49 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -112.83 135.14 53.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.481 -0.933 . . . . 75.340000000000003 108.481 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.36 133.09 56.17 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.783 -0.451 . . . . 72.230000000000004 109.783 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.95 124.71 47.07 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.892 -0.594 . . . . 73.219999999999999 110.107 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.91 105.24 14.64 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.361 -1.348 . . . . 61.119999999999997 107.361 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -122.35 18.22 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.983 0.897 . . . . 73.319999999999993 109.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -133.17 157.67 77.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 61.130000000000003 109.516 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.59 -26.51 75.9 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.047 2.498 . . . . 62.229999999999997 114.079 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.6 m -147.55 121.8 9.58 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.329 -0.857 . . . . 75.540000000000006 111.182 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 77' ' ' ASP . 56.0 m -109.87 135.32 50.94 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.862 -0.608 . . . . 50.439999999999998 109.943 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -106.39 141.52 37.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.69 135.28 54.56 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 109.781 -0.451 . . . . 74.5 109.781 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.89 -164.19 25.52 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.792 -1.323 . . . . 70.109999999999999 109.792 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 86.1 mtt180 -101.43 117.8 35.68 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.123 -1.066 . . . . 73.109999999999999 108.123 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 176.88 153.8 0.4 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.854 -1.906 . . . . 74.409999999999997 105.854 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.07 -15.76 51.1 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.924 1.749 . . . . 74.200000000000003 113.178 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.44 -1.28 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.607 0.595 . . . . 75.219999999999999 112.607 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -85.07 112.52 20.72 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.11 -1.036 . . . . 71.230000000000004 111.154 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.453 ' HB3' HG23 ' A' ' 68' ' ' THR . 37.9 t70 -70.19 -36.95 74.98 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.133 -0.692 . . . . 70.420000000000002 109.133 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -100.66 98.73 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 122.253 1.025 . . . . 61.43 108.449 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -90.06 122.06 32.7 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.949 -1.023 . . . . 74.099999999999994 108.63 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.477 HD23 HD21 ' A' ' 56' ' ' ASN . 59.6 mt -123.87 122.18 37.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.154 -2.165 . . . . 71.319999999999993 105.154 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -130.67 117.53 19.61 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.198 -0.668 . . . . 60.130000000000003 109.198 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.0 p30 -128.78 -155.91 0.73 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.426 -0.953 . . . . 73.0 108.426 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.9 -41.74 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.24 0.616 . . . . 62.530000000000001 111.377 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -153.99 89.44 1.3 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.617 -0.677 . . . . 72.530000000000001 111.735 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 82' ' ' ASP . 85.4 t -103.54 136.29 37.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.983 -0.747 . . . . 62.439999999999998 108.983 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.526 ' HB2' HD21 ' A' ' 107' ' ' LEU . 41.2 t -71.33 161.99 30.17 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 123.843 0.715 . . . . 72.420000000000002 111.186 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 27.9 ptt180 -65.4 -38.16 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 122.127 0.965 . . . . 74.420000000000002 109.374 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -136.14 112.96 10.23 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.491 -1.3 . . . . 52.509999999999998 107.491 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t-80 -99.62 -52.93 3.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.851 -0.613 . . . . 51.420000000000002 109.847 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.69 160.44 37.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.266 -0.574 . . . . 43.340000000000003 110.537 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.0 133.97 53.56 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.307 -0.861 . . . . 72.140000000000001 110.628 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -105.69 115.54 30.42 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.417 -1.698 . . . . 61.100000000000001 106.417 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -112.65 133.92 54.44 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.032 -0.667 . . . . 70.319999999999993 110.884 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.6 mp -104.48 121.13 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.022 -1.103 . . . . 74.409999999999997 108.022 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -123.84 116.64 23.29 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.29 -1.374 . . . . 71.319999999999993 107.29 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.98 37.83 14.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.777 0.831 . . . . 71.319999999999993 112.884 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.51 -2.49 87.38 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.097 -0.501 . . . . 44.439999999999998 114.172 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.81 138.9 39.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.729 0.765 . . . . 74.420000000000002 109.148 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD2' HG13 ' A' ' 94' ' ' ILE . 31.5 m-85 -108.52 122.77 47.76 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.61 -0.268 . . . . 72.319999999999993 111.246 -172.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -114.75 139.01 50.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.667 -0.864 . . . . 55.549999999999997 108.667 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.413 HG23 ' HB2' ' A' ' 122' ' ' MET . 43.4 t -109.32 123.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.991 -1.115 . . . . 74.140000000000001 107.991 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.72 121.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.169 -1.419 . . . . 60.439999999999998 107.169 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.52 153.94 18.26 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.783 -1.191 . . . . 51.5 107.783 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 89' ' ' HIS . 18.7 m -78.79 -12.31 13.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 113.379 0.881 . . . . 65.019999999999996 113.379 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.23 17.58 0.02 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 119.086 -1.53 . . . . 54.43 116.019 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p 57.97 26.92 14.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.664 1.586 . . . . 73.450000000000003 111.496 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 86' ' ' SER . 0.0 OUTLIER -65.26 -35.31 80.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.961 -1.472 . . . . 64.439999999999998 112.926 -174.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.635 ' HB2' ' CD2' ' A' ' 89' ' ' HIS . 2.6 m120 -86.76 3.77 43.63 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 110.374 -0.232 . . . . 73.019999999999996 110.374 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.66 49.17 6.26 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.933 -1.267 . . . . 75.0 109.933 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -61.54 129.86 43.14 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 123.496 0.718 . . . . 51.219999999999999 110.977 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.406 ' CB ' ' HB3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -125.2 125.64 43.97 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.326 -1.731 . . . . 73.439999999999998 106.326 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.14 124.77 61.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 106.694 -1.595 . . . . 65.400000000000006 106.694 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.435 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 4.3 t-20 57.81 37.64 27.1 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.543 1.163 . . . . 65.310000000000002 107.884 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.15 18.62 6.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.976 -1.466 . . . . 63.350000000000001 114.23 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -125.04 147.47 57.02 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.407 -0.96 . . . . 74.329999999999998 108.407 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.57 129.43 17.78 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 N-CA-C 108.528 -1.374 . . . . 73.400000000000006 108.528 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.563 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 13.0 tpp180 -148.38 150.19 33.11 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.636 -0.826 . . . . 64.329999999999998 110.143 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -93.81 -55.46 3.23 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.558 -0.534 . . . . 60.439999999999998 109.558 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.68 34.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.808 -0.812 . . . . 61.049999999999997 108.808 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.563 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 58.1 tp60 -153.85 143.19 21.5 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 123.145 0.278 . . . . 52.229999999999997 110.71 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.95 128.11 37.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.573 -1.64 . . . . 71.329999999999998 106.573 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.413 ' HB2' HG23 ' A' ' 101' ' ' VAL . 39.4 ttp -90.26 134.88 34.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.402 0.62 . . . . 75.299999999999997 111.357 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.411 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 12.7 pt20 -104.07 152.19 22.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.23 -0.895 . . . . 72.5 110.67 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.25 130.71 41.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 C-N-CA 123.646 0.778 . . . . 54.140000000000001 111.979 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -0.44 63.0 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.099 -0.8 . . . . 73.540000000000006 111.099 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 28.3 t70 -89.44 153.65 20.66 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.45 -0.375 . . . . 74.340000000000003 111.565 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -115.92 131.19 57.01 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 121.525 0.679 . . . . 73.409999999999997 112.611 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.09 131.76 61.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 107.659 -1.237 . . . . 71.049999999999997 107.659 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 111' ' ' TYR . 16.5 tm0? -109.97 130.74 55.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.727 -1.212 . . . . 62.130000000000003 107.727 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 89' ' ' HIS . 4.1 mp -130.09 104.03 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.644 -0.873 . . . . 64.439999999999998 108.644 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.55 -96.45 0.18 Allowed Glycine 0 C--O 1.243 0.699 0 C-N-CA 121.052 -0.594 . . . . 73.409999999999997 112.565 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -113.43 -0.55 14.43 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.002 0.43 . . . . 73.409999999999997 110.219 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.537 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 87.1 m-85 -100.19 152.85 19.8 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.291 0.636 . . . . 64.140000000000001 111.479 -175.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -137.09 120.2 16.64 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.995 -1.113 . . . . 74.109999999999999 107.995 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.427 ' CD2' HG22 ' A' ' 51' ' ' VAL . 65.2 mt -105.25 140.39 38.47 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.468 0.707 . . . . 63.299999999999997 109.442 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.33 120.02 61.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.265 -1.754 . . . . 74.129999999999995 106.265 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -97.74 119.63 36.67 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 112.128 0.418 . . . . 65.239999999999995 112.128 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.422 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 95.5 mt -129.34 153.91 47.4 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.853 -0.795 . . . . 61.299999999999997 108.853 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 39' ' ' ALA . . . -75.95 162.01 28.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.869 -0.332 . . . . 55.119999999999997 110.927 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.2 168.23 41.88 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.417 -0.81 . . . . 51.229999999999997 112.108 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.522 ' HB2' ' HG2' ' A' ' 143' ' ' GLU . 12.0 Cg_endo -54.72 145.29 61.0 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 123.768 2.979 . . . . 74.530000000000001 115.455 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 43.39 1.07 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.546 -1.207 . . . . 74.549999999999997 110.384 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 141' ' ' PRO . 2.9 pt-20 . . . . . 0 N--CA 1.413 -2.307 0 C-N-CA 123.651 0.78 . . . . 75.549999999999997 109.385 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.5 -0.966 0 N-CA-C 107.938 -1.134 . . . . 71.040000000000006 107.938 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.1 m 70.66 -64.36 0.37 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 124.153 0.981 . . . . 65.420000000000002 110.368 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 56.2 29.95 15.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 63.009999999999998 113.577 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -150.28 137.48 19.52 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.451 -0.795 . . . . 65.200000000000003 109.15 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -88.26 94.68 9.91 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.72 -0.844 . . . . 51.520000000000003 108.72 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.47 -58.11 2.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.083 -1.207 . . . . 71.310000000000002 110.083 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.5 m -111.9 108.5 55.6 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-N 115.393 -0.404 . . . . 52.119999999999997 110.867 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.08 136.77 18.65 Favored 'Trans proline' 0 C--O 1.256 1.386 0 N-CA-C 108.157 -1.516 . . . . 73.109999999999999 108.157 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.84 133.46 62.01 Favored Pre-proline 0 C--N 1.315 -0.896 0 C-N-CA 120.482 -0.487 . . . . 63.229999999999997 111.39 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.48 118.6 5.71 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 122.243 1.962 . . . . 73.019999999999996 112.433 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.475 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 26.5 mm-40 -112.69 139.87 47.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.406 -2.072 . . . . 61.310000000000002 105.406 174.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.24 133.54 54.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 119.819 -0.752 . . . . 72.109999999999999 112.764 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.11 150.22 21.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.384 -1.339 . . . . 54.210000000000001 107.384 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -90.35 130.3 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.023 0.439 . . . . 61.039999999999999 110.92 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.5 m -89.92 152.6 21.15 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.653 -0.499 . . . . 53.229999999999997 109.653 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG22 HD12 ' A' ' 107' ' ' LEU . 57.0 t -83.24 116.57 27.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.544 -0.539 . . . . 64.349999999999994 109.544 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -123.87 140.12 53.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.73 -0.47 . . . . 72.510000000000005 109.73 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttp85 -96.21 108.53 21.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.114 -1.069 . . . . 63.229999999999997 108.114 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 -173.84 3.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.574 -0.739 . . . . 60.130000000000003 110.989 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -72.91 6.83 2.34 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.701 0.8 . . . . 64.310000000000002 111.497 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.25 -26.21 60.39 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.222 1.409 . . . . 53.310000000000002 113.942 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.4 tp -72.28 -22.52 61.2 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.87 0.843 . . . . 74.530000000000001 109.616 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.16 -32.53 12.44 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.595 -0.73 . . . . 72.420000000000002 109.572 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -56.93 -38.97 73.64 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.119 -0.492 . . . . 73.120000000000005 111.086 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 ptp -62.4 -25.94 68.21 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 120.792 -0.363 . . . . 71.420000000000002 111.558 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -87.53 -49.65 7.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.948 0.404 . . . . 75.120000000000005 110.077 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -61.21 -41.98 97.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.793 -0.64 . . . . 53.43 111.145 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -82.92 -16.98 45.31 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.881 -0.414 . . . . 74.129999999999995 109.881 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m 67.29 101.75 0.05 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.773 1.229 . . . . 53.229999999999997 113.964 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.58 -141.38 48.02 Favored Glycine 0 CA--C 1.499 -0.963 0 CA-C-N 115.485 -0.779 . . . . 33.039999999999999 112.69 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t -115.77 149.39 38.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.608 -0.516 . . . . 75.0 109.608 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 110.97 40.6 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.323 -0.992 . . . . 43.020000000000003 108.323 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.78 145.2 90.56 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.859 2.373 . . . . 70.420000000000002 113.616 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.23 162.45 13.19 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.904 -0.589 . . . . 70.450000000000003 110.102 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 123' ' ' GLN . 18.3 m -94.26 116.0 28.33 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.168 0.509 . . . . 63.109999999999999 110.551 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.2 m -69.38 100.04 1.3 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.551 -0.75 . . . . 73.120000000000005 109.403 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' OD1' ' A' ' 41' ' ' ASN . . . -152.31 43.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.273 -0.965 . . . . 55.119999999999997 112.993 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.47 -39.83 13.92 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.622 -1.251 . . . . 74.319999999999993 107.622 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.46 -1.81 25.83 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.328 -1.306 . . . . 65.109999999999999 111.387 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.443 ' OD1' ' HA2' ' A' ' 38' ' ' GLY . 11.0 m120 -82.8 -30.55 28.74 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.481 -0.782 . . . . 72.409999999999997 109.29 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt 48.06 81.33 0.26 Allowed Pre-proline 0 C--N 1.345 0.371 0 O-C-N 124.229 0.956 . . . . 42.200000000000003 112.049 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HB2' ' HA3' ' A' ' 140' ' ' GLY . 6.9 Cg_exo -68.79 -61.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 111.891 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.67 -12.97 5.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.956 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.83 1.46 85.06 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.087 -1.054 . . . . 64.329999999999998 111.176 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 6.8 m -115.02 156.56 24.9 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.23 -1.396 . . . . 61.32 107.23 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -148.11 154.53 40.31 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.708 -0.478 . . . . 71.530000000000001 109.708 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 152.37 44.5 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.92 -0.4 . . . . 54.039999999999999 109.92 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.01 132.46 52.01 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.46 -0.941 . . . . 70.530000000000001 108.46 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 p -108.82 137.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.644 -0.502 . . . . 74.129999999999995 109.644 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 135' ' ' LEU . 10.5 t -86.09 118.27 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 107.997 -1.112 . . . . 71.319999999999993 107.997 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 55.3 tttp -93.42 -31.71 14.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.356 -0.838 . . . . 64.299999999999997 109.953 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.419 ' HB3' ' HG2' ' A' ' 134' ' ' ARG . 19.5 tpp180 -147.11 138.5 24.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.988 -0.745 . . . . 71.329999999999998 108.988 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.06 171.05 12.93 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.155 -1.178 . . . . 71.219999999999999 110.155 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.67 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.1 Cg_exo -54.64 -29.99 63.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.598 2.199 . . . . 63.409999999999997 113.714 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.43 8.47 33.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.502 -0.479 . . . . 72.329999999999998 112.199 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.95 131.61 45.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.86 0.362 . . . . 62.539999999999999 111.515 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -23.94 24.44 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 115.588 -0.733 . . . . 52.509999999999998 112.295 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 152.54 20.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.754 0.277 . . . . 73.420000000000002 110.768 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.75 137.12 48.07 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.764 -0.828 . . . . 71.439999999999998 108.764 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -115.24 139.51 49.88 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.614 -0.513 . . . . 62.229999999999997 109.614 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.3 127.94 42.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.947 -1.131 . . . . 71.510000000000005 107.947 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.75 113.21 26.18 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.485 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.18 3.47 4.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.24 1.019 . . . . 74.230000000000004 108.582 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.4 pm0 -106.45 137.09 19.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-N 115.056 -0.975 . . . . 65.219999999999999 109.123 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.25 -21.58 67.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.309 2.673 . . . . 71.140000000000001 113.764 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -137.23 122.68 19.55 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.322 -0.622 . . . . 74.540000000000006 109.322 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.0 m -129.89 112.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.91 -0.774 . . . . 52.299999999999997 108.91 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 m -88.53 140.59 29.31 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.394 -0.595 . . . . 71.310000000000002 109.394 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.52 135.2 55.14 Favored 'General case' 0 C--O 1.268 2.039 0 N-CA-C 109.09 -0.707 . . . . 64.099999999999994 109.09 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -136.0 4.81 Favored Glycine 0 N--CA 1.422 -2.298 0 O-C-N 123.916 0.76 . . . . 71.120000000000005 112.833 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 24.8 mmm180 -118.67 152.94 35.17 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 125.486 1.514 . . . . 72.239999999999995 109.552 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.428 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 27.0 t-80 82.57 142.87 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 125.31 1.444 . . . . 74.319999999999993 109.209 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 9.8 Cg_endo -52.63 -6.77 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 124.14 3.227 . . . . 54.240000000000002 115.538 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.5 -12.89 59.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.353 0.597 . . . . 74.040000000000006 110.086 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -88.19 134.91 33.66 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.358 -0.979 . . . . 41.200000000000003 108.358 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -76.99 -42.2 39.8 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.169 -1.049 . . . . 74.120000000000005 108.169 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.7 mm -97.46 104.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 106.469 -1.678 . . . . 54.130000000000003 106.469 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -87.62 108.81 19.25 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.49 -0.777 . . . . 64.420000000000002 109.431 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 82.3 mt -95.7 141.05 29.65 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.742 -1.577 . . . . 73.530000000000001 106.742 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.591 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 18.3 t70 -103.94 117.46 34.36 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.152 -0.619 . . . . 75.120000000000005 110.499 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -151.22 174.98 12.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.643 -1.243 . . . . 73.409999999999997 107.643 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.48 -34.25 10.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.585 -0.894 . . . . 70.040000000000006 108.585 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.569 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 m -74.61 125.23 28.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.02 -0.991 . . . . 52.310000000000002 109.711 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.5 98.01 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 119.618 -0.833 . . . . 71.129999999999995 109.109 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 t -107.01 90.5 3.32 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.457 -1.312 . . . . 72.540000000000006 107.457 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 11' ' ' GLN . 20.7 ptt180 -57.92 -31.9 67.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.544 -1.207 . . . . 74.409999999999997 111.384 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -145.12 93.43 2.39 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.411 -0.959 . . . . 71.439999999999998 108.411 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.496 ' CE1' HG23 ' A' ' 130' ' ' ILE . 39.7 t-80 -96.58 -53.58 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.704 -0.798 . . . . 73.519999999999996 109.691 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.32 160.62 38.71 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 109.194 -0.669 . . . . 63.119999999999997 109.194 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.02 143.94 36.67 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.331 0.586 . . . . 73.450000000000003 110.138 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -104.94 122.16 45.24 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.027 -2.212 . . . . 74.120000000000005 105.027 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -115.81 142.84 46.23 Favored 'General case' 0 C--N 1.273 -2.72 0 C-N-CA 119.618 -0.833 . . . . 73.340000000000003 109.256 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.7 mp -113.95 112.97 42.46 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 104.219 -2.511 . . . . 53.130000000000003 104.219 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.63 122.7 25.1 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.766 -0.457 . . . . 63.32 109.766 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 56.03 38.0 29.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.146 0.904 . . . . 72.540000000000006 111.571 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.91 -7.84 75.68 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.248 -0.887 . . . . 52.200000000000003 113.925 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -101.79 150.28 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.151 0.475 . . . . 65.25 109.844 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.29 126.4 53.31 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.774 -0.825 . . . . 73.140000000000001 108.774 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.9 147.84 52.59 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.647 0.26 . . . . 65.340000000000003 111.174 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 122' ' ' MET . 25.6 t -112.59 122.69 67.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.942 -1.503 . . . . 73.120000000000005 106.942 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.88 122.33 68.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.198 0.523 . . . . 61.219999999999999 111.147 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.9 136.93 32.75 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 123.787 0.835 . . . . 63.329999999999998 110.553 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.57 5.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.813 -0.63 . . . . 64.319999999999993 110.463 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.78 58.83 0.57 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.99 -0.624 . . . . 60.229999999999997 111.835 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -60.03 -11.65 6.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.783 1.233 . . . . 70.0 112.563 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 107' ' ' LEU . 1.2 mm? -67.4 -20.48 65.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.992 0.917 . . . . 74.420000000000002 110.847 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.66 -5.5 58.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 53.020000000000003 110.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.35 66.15 1.72 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.789 -0.641 . . . . 31.0 112.178 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 m -73.9 127.44 32.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.079 0.466 . . . . 53.32 110.844 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -136.62 141.42 43.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 109.827 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.17 119.57 58.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 106.905 -1.517 . . . . 71.140000000000001 106.905 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.457 ' OD1' ' HG2' ' A' ' 127' ' ' GLU . 87.7 m-20 56.58 39.38 29.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.792 0.837 . . . . 63.229999999999997 110.699 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 114' ' ' ARG . 0.0 OUTLIER 65.32 15.21 9.9 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 113.066 0.765 . . . . 72.530000000000001 113.066 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -112.43 133.99 21.68 Favored Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 123.062 0.545 . . . . 60.009999999999998 109.761 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.52 123.28 10.91 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 108.161 -1.515 . . . . 72.239999999999995 108.161 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -153.03 137.3 16.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.716 -1.216 . . . . 72.450000000000003 107.716 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -107.91 -56.53 2.22 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.114 -0.635 . . . . 53.119999999999997 110.657 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.7 132.72 54.38 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.127 -1.064 . . . . 72.400000000000006 108.127 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.61 150.55 26.52 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 112.682 0.623 . . . . 62.409999999999997 112.682 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.61 132.4 33.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 104.926 -2.25 . . . . 51.43 104.926 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 101' ' ' VAL . 33.1 ttp -88.97 129.12 35.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.107 -0.637 . . . . 62.530000000000001 109.938 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 36' ' ' SER . 61.9 mt-30 -118.34 156.56 28.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.738 -1.119 . . . . 63.439999999999998 109.133 -173.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -71.21 130.21 40.86 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.463 -0.94 . . . . 74.230000000000004 108.463 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.44 -4.1 56.68 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.788 -0.642 . . . . 44.43 113.057 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.27 137.33 54.63 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 117.952 0.876 . . . . 64.530000000000001 110.444 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 12.6 pt-20 -112.69 126.32 55.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.575 -1.269 . . . . 74.209999999999994 107.575 172.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.98 117.03 54.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.652 0 N-CA-C 107.878 -1.156 . . . . 74.310000000000002 107.878 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -105.33 123.87 48.58 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.553 0.692 . . . . 74.019999999999996 112.111 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.496 HG23 ' CE1' ' A' ' 89' ' ' HIS . 10.3 mm -109.87 101.95 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 105.53 -2.026 . . . . 63.539999999999999 105.53 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 56.34 -98.15 0.06 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 120.789 -0.72 . . . . 72.109999999999999 112.112 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -97.53 -24.0 15.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.808 0.443 . . . . 62.130000000000003 111.34 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.67 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 65.5 m-85 -75.31 148.47 39.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 122.769 0.428 . . . . 72.140000000000001 110.25 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 8.7 ptm180 -138.37 120.12 15.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.529 -0.915 . . . . 63.200000000000003 108.529 170.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.7 mm? -103.36 139.86 38.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.68 -0.859 . . . . 74.530000000000001 108.68 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.7 t -116.37 123.2 71.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.24 -1.022 . . . . 60.299999999999997 108.24 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.461 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 94.3 t80 -94.68 129.86 41.4 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.978 -0.555 . . . . 61.32 111.252 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.93 132.04 53.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.158 -1.053 . . . . 62.310000000000002 108.158 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.42 131.4 53.66 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.45 -0.5 . . . . 53.299999999999997 111.099 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 43' ' ' PRO . . . 97.66 46.29 2.33 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 117.506 1.762 . . . . 55.310000000000002 117.506 175.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 46' ' ' SER . 39.6 Cg_endo -72.18 155.67 56.26 Favored 'Trans proline' 0 C--N 1.363 1.336 0 CA-C-N 121.108 2.454 . . . . 43.439999999999998 109.718 169.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.69 83.59 0.96 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.253 0.549 . . . . 71.140000000000001 110.426 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.172 -1.418 . . . . 72.430000000000007 107.172 177.272 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 108.489 -0.93 . . . . 74.129999999999995 108.489 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.3 m -150.17 160.74 43.45 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.475 -0.565 . . . . 74.340000000000003 109.475 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.72 99.71 11.02 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.583 0.552 . . . . 61.340000000000003 110.32 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.78 91.61 7.56 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.798 0.809 . . . . 72.519999999999996 108.936 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -118.68 152.12 36.7 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.411 -1.268 . . . . 72.530000000000001 108.575 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.52 98.88 0.3 Allowed Glycine 0 N--CA 1.437 -1.292 0 O-C-N 123.649 0.593 . . . . 71.340000000000003 111.863 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.9 m -82.48 128.82 65.42 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.089 -0.708 . . . . 70.239999999999995 109.089 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 132.28 50.84 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.288 1.992 . . . . 64.109999999999999 110.696 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -89.93 148.61 40.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.427 -0.582 . . . . 73.299999999999997 109.427 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.91 153.67 49.45 Favored 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.364 2.043 . . . . 64.400000000000006 111.025 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -91.84 167.53 12.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.43 -0.952 . . . . 65.140000000000001 108.43 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.92 132.83 54.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.432 0.634 . . . . 72.129999999999995 111.239 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 10.0 tp10 -158.18 154.36 27.23 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.274 -2.121 . . . . 64.329999999999998 105.274 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -70.66 134.75 47.82 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.784 1.031 . . . . 70.120000000000005 113.784 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 108' ' ' ASN . 16.2 m -99.04 152.39 19.88 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.136 0.493 . . . . 64.420000000000002 112.176 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.15 115.92 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 104.903 -2.258 . . . . 32.520000000000003 104.903 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -81.6 113.59 19.72 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.543 0.687 . . . . 72.530000000000001 110.802 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.92 120.63 42.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.664 -1.236 . . . . 74.120000000000005 107.664 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.49 -178.09 7.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.996 0.427 . . . . 65.0 110.009 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -83.97 -4.47 58.74 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.803 0.811 . . . . 63.0 109.862 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.34 -4.53 58.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.034 -0.985 . . . . 60.329999999999998 111.748 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.59 -33.39 68.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.111 -0.7 . . . . 71.450000000000003 109.111 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -71.81 -22.41 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.518 -0.765 . . . . 65.299999999999997 110.126 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.88 -30.85 40.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.419 -0.585 . . . . 72.150000000000006 109.419 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 30' ' ' THR . 32.7 ttm -66.95 -12.11 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.64 1.21 . . . . 71.019999999999996 108.915 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.73 -38.07 8.84 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.899 -1.046 . . . . 74.349999999999994 109.894 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -88.8 -46.38 9.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.905 1.076 . . . . 75.519999999999996 113.905 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -90.17 -20.26 23.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 119.478 -0.889 . . . . 74.349999999999994 112.006 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 115' ' ' GLU . 5.7 m -80.53 65.48 5.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.906 0.86 . . . . 64.200000000000003 109.669 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.92 5.4 2.23 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.135 -1.186 . . . . 54.43 110.135 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -110.66 121.96 46.61 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.134 -1.062 . . . . 40.240000000000002 108.134 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.16 120.96 83.98 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.979 -0.378 . . . . 55.149999999999999 109.979 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.43 150.88 87.39 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.702 2.268 . . . . 70.120000000000005 111.368 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.18 141.66 31.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.38 -0.6 . . . . 72.019999999999996 109.38 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.8 m -80.1 117.57 21.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.92 -0.4 . . . . 72.510000000000005 109.92 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.7 p -82.26 -49.85 9.63 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.903 -0.59 . . . . 72.019999999999996 110.186 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.49 114.58 2.32 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.401 -0.818 . . . . 55.509999999999998 111.894 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.85 -7.79 45.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 120.923 0.392 . . . . 62.039999999999999 110.315 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -5.3 21.11 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.678 1.362 . . . . 52.210000000000001 114.678 -168.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.03 -32.43 18.79 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.373 -0.531 . . . . 73.040000000000006 110.98 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 48.26 68.85 3.12 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 124.079 0.862 . . . . 61.119999999999997 111.069 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.44 -58.25 0.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 125.113 3.875 . . . . 74.109999999999999 114.556 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.31 17.15 4.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.329 -0.989 . . . . 54.219999999999999 108.329 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.77 -12.4 29.19 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 114.623 -1.171 . . . . 73.340000000000003 112.583 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -118.99 164.84 14.88 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.993 -0.373 . . . . 72.430000000000007 109.993 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.25 156.98 40.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.911 -1.515 . . . . 61.149999999999999 106.911 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.43 145.78 51.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.141 0.496 . . . . 73.409999999999997 111.746 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -106.32 142.68 35.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.491 -0.929 . . . . 62.32 108.491 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.66 132.24 71.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.434 -0.58 . . . . 61.229999999999997 109.434 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.56 118.3 22.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.244 -1.391 . . . . 71.230000000000004 107.244 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -89.79 -34.82 16.02 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.618 -0.719 . . . . 64.299999999999997 110.756 -174.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 43.1 ttt180 -137.96 150.95 47.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.275 -1.38 . . . . 74.120000000000005 107.275 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.96 -178.2 16.48 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.471 -0.871 . . . . 42.100000000000001 112.338 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.58 -29.08 13.6 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.889 2.393 . . . . 64.299999999999997 111.782 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -97.08 18.99 13.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.827 -0.624 . . . . 74.310000000000002 110.955 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.35 139.22 58.74 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.415 -0.357 . . . . 74.010000000000005 111.168 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.83 -18.15 50.82 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.644 -0.582 . . . . 71.140000000000001 111.644 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.12 138.78 33.54 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 120.494 0.188 . . . . 63.25 110.719 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -122.78 145.91 48.0 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.398 -0.593 . . . . 72.129999999999995 109.398 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.28 142.68 47.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.519 -0.919 . . . . 62.100000000000001 108.519 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.29 143.84 26.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.315 0.579 . . . . 51.149999999999999 112.434 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.29 104.78 12.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.451 -0.795 . . . . 53.329999999999998 108.956 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -168.59 61.1 0.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 61.310000000000002 107.473 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -146.8 157.3 47.47 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 113.126 -1.852 . . . . 74.200000000000003 107.473 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.09 -35.52 97.92 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.812 1.675 . . . . 62.32 112.614 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 m -154.53 122.44 5.89 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.195 0.522 . . . . 73.219999999999999 111.814 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -108.48 116.92 32.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.402 -0.962 . . . . 71.530000000000001 108.402 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 p -90.4 133.02 35.28 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.938 -0.476 . . . . 74.430000000000007 110.851 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.87 134.68 55.16 Favored 'General case' 0 C--O 1.253 1.259 0 N-CA-C 109.631 -0.507 . . . . 75.230000000000004 109.631 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.96 -158.72 31.83 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.733 -1.347 . . . . 52.109999999999999 109.733 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 62.1 ttt180 -95.89 150.52 20.34 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.241 -0.651 . . . . 75.530000000000001 109.241 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 85.05 151.55 0.1 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.331 1.452 . . . . 72.230000000000004 111.881 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 -0.12 3.49 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.68 2.92 . . . . 61.43 114.97 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.73 -9.93 57.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.566 0.698 . . . . 74.439999999999998 110.285 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 m -90.86 136.94 32.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.02 -1.845 . . . . 60.020000000000003 106.02 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.19 -38.57 91.67 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.892 -0.781 . . . . 62.25 108.892 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.9 mm -98.91 119.46 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.106 -1.442 . . . . 73.219999999999999 107.106 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -90.17 118.01 29.37 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.798 0.332 . . . . 61.530000000000001 111.595 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 5.2 mp -124.98 134.75 52.48 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.757 -1.572 . . . . 74.230000000000004 106.757 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -131.67 123.45 27.83 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.324 -0.551 . . . . 74.319999999999993 111.346 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -149.79 172.79 14.55 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.045 -1.465 . . . . 75.439999999999998 107.045 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.96 -31.19 52.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.165 -0.68 . . . . 75.030000000000001 109.165 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -62.29 121.12 12.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.403 0.621 . . . . 74.400000000000006 110.719 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.34 125.32 39.84 Favored 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.209 -0.905 . . . . 51.200000000000003 109.6 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 m -159.08 106.06 1.78 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.353 0.661 . . . . 70.049999999999997 110.541 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' A' ' 13' ' ' GLU . 27.7 ptt180 -64.38 -46.0 85.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 120.701 -0.4 . . . . 72.140000000000001 111.635 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -141.3 131.03 24.16 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.494 -1.669 . . . . 73.430000000000007 106.494 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -99.83 -52.18 3.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.806 -0.812 . . . . 71.430000000000007 108.806 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.26 155.29 36.3 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.279 -0.873 . . . . 74.209999999999994 109.167 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.5 135.55 54.68 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 116.001 -0.545 . . . . 65.019999999999996 109.591 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 33.8 m-85 -105.04 113.23 26.7 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.021 -1.844 . . . . 71.310000000000002 106.021 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.35 132.82 53.76 Favored 'General case' 0 C--N 1.269 -2.922 0 N-CA-C 108.279 -1.008 . . . . 63.350000000000001 108.279 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.7 111.9 35.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.072 -2.196 . . . . 63.210000000000001 105.072 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -124.93 118.47 26.34 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.615 -1.175 . . . . 70.400000000000006 109.752 -169.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 53.96 36.9 25.54 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.38 1.072 . . . . 50.439999999999998 111.347 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 0.58 90.27 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.68 -0.691 . . . . 62.240000000000002 113.707 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -102.49 150.27 23.55 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.691 -0.855 . . . . 73.519999999999996 108.691 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -104.51 117.01 33.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.912 -1.144 . . . . 63.5 107.912 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -124.78 134.75 52.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.5 0.667 . . . . 74.150000000000006 110.845 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 120' ' ' GLN . 24.0 t -103.03 124.98 57.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 106.735 -1.58 . . . . 64.540000000000006 106.735 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.38 122.84 70.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 107.042 -1.466 . . . . 61.130000000000003 107.042 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -96.63 144.79 26.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 115.189 -0.914 . . . . 71.239999999999995 109.741 -178.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.03 -9.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.55 -0.46 . . . . 75.109999999999999 112.037 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.45 92.52 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 119.78 -1.2 . . . . 51.409999999999997 112.367 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.1 m -58.23 -22.03 50.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.172 0.589 . . . . 63.130000000000003 111.802 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.557 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -62.12 -18.83 62.03 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.965 0.906 . . . . 73.430000000000007 112.997 177.024 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' SER . 6.3 t30 -85.79 -0.55 55.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.786 0.803 . . . . 70.420000000000002 108.855 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.74 44.27 1.82 Allowed Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.521 -0.763 . . . . 73.0 113.059 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m -87.02 126.93 35.06 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.26 -0.645 . . . . 41.409999999999997 109.26 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 69.7 m-85 -137.44 131.62 32.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.839 -0.43 . . . . 71.420000000000002 109.839 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.16 116.36 50.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.058 -2.201 . . . . 73.5 105.058 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.5 m120 55.96 40.55 30.41 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.065 0.946 . . . . 65.540000000000006 109.729 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.0 8.55 5.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.026 1.33 . . . . 62.210000000000001 113.698 -175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 30' ' ' THR . 37.2 mt-10 -103.6 128.24 27.82 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.752 -0.593 . . . . 72.140000000000001 109.408 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.26 136.27 63.33 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.639 1.559 . . . . 63.32 108.854 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.435 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 14.2 tpp85 -151.47 131.95 13.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.461 -0.896 . . . . 74.129999999999995 109.891 -173.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 2.9 t-20 -98.91 -31.41 11.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 122.043 0.925 . . . . 50.109999999999999 109.878 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -141.14 135.69 31.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.061 -1.459 . . . . 65.099999999999994 107.061 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.435 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 8.1 tp60 -144.71 144.56 31.27 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.016 0.197 . . . . 65.140000000000001 111.492 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 80.6 t -94.49 117.53 38.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 105.092 -2.188 . . . . 60.109999999999999 105.092 171.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.423 ' HB2' HG23 ' A' ' 101' ' ' VAL . 40.6 ttp -89.85 129.27 36.24 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.415 0.626 . . . . 52.130000000000003 111.296 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.58 157.1 43.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.842 -1.072 . . . . 70.439999999999998 109.522 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -62.53 134.19 56.03 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.568 0.543 . . . . 74.109999999999999 109.805 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.05 -8.64 61.12 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.409 -0.901 . . . . 65.310000000000002 111.933 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 140.15 32.5 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.072 0.463 . . . . 71.209999999999994 110.046 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -114.12 134.78 54.65 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.446 -0.797 . . . . 73.010000000000005 109.563 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.3 mt -112.1 118.3 57.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 107.676 -1.231 . . . . 72.010000000000005 107.676 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.572 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -104.84 117.05 33.09 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.901 -1.889 . . . . 73.099999999999994 105.901 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.78 103.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.446 -0.797 . . . . 72.530000000000001 109.447 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.45 -84.44 0.44 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.107 -0.951 . . . . 40.140000000000001 112.272 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -125.35 -18.34 5.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.638 0.256 . . . . 64.129999999999995 111.192 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 48.4 p90 -121.14 150.33 41.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 112.924 0.713 . . . . 74.109999999999999 112.924 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 8.2 ptm180 -112.52 142.14 45.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.547 -0.752 . . . . 73.209999999999994 112.236 -170.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.2 139.17 54.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.911 -1.514 . . . . 63.229999999999997 106.911 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.42 134.95 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.163 -0.68 . . . . 64.140000000000001 109.163 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -97.43 119.63 36.33 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.777 -0.453 . . . . 65.230000000000004 109.777 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.42 131.14 55.59 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.651 -0.5 . . . . 74.430000000000007 109.651 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.47 135.75 33.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.751 -0.833 . . . . 70.239999999999995 108.751 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.72 163.93 15.6 Favored Glycine 0 N--CA 1.421 -2.329 0 N-CA-C 107.637 -2.185 . . . . 54.43 107.637 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.86 141.76 72.81 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 CA-C-N 119.725 1.762 . . . . 63.130000000000003 113.167 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -118.67 26.53 9.5 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.559 -1.645 . . . . 63.219999999999999 106.559 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.417 -2.099 0 CA-C-N 113.242 -1.799 . . . . 70.150000000000006 107.693 -178.152 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 109.945 -0.391 . . . . 72.099999999999994 109.945 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -120.95 94.28 4.3 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.687 -0.633 . . . . 54.140000000000001 111.564 -173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -89.47 68.78 7.9 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.577 1.18 . . . . 73.129999999999995 108.051 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.59 156.04 44.85 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.127 -1.397 . . . . 65.420000000000002 108.336 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -82.77 82.59 8.03 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.844 0.831 . . . . 52.420000000000002 108.82 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.39 -71.57 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 106.024 -2.83 . . . . 75.430000000000007 106.024 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.0 m -114.5 106.25 52.69 Favored Pre-proline 0 N--CA 1.416 -2.162 0 N-CA-C 106.503 -1.666 . . . . 74.329999999999998 106.503 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.73 132.37 9.74 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.641 1.561 . . . . 75.239999999999995 110.296 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.44 147.53 39.82 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.31 -1.367 . . . . 61.240000000000002 107.31 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.45 137.19 25.59 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.341 2.027 . . . . 61.340000000000003 108.937 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.91 132.76 35.14 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.27 -0.972 . . . . 54.530000000000001 110.092 -169.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 51.0 t -108.24 121.04 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.719 -1.585 . . . . 53.149999999999999 106.719 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' HB2' ' O2P' ' A' ' 15' ' ' TPO . 46.0 mm-40 -127.09 132.93 50.52 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.699 -1.223 . . . . 73.310000000000002 107.699 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -81.19 113.17 19.16 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.131 -1.433 . . . . 64.340000000000003 107.131 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.474 ' O ' ' HB3' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 m -92.95 152.39 19.37 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.839 -0.8 . . . . 72.010000000000005 108.839 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -83.11 115.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.453 -0.573 . . . . 62.399999999999999 109.453 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -99.54 105.35 17.23 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.603 -0.888 . . . . 70.409999999999997 108.603 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -126.96 124.92 40.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.58 0.705 . . . . 75.140000000000001 112.851 -176.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.91 -37.56 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.002 1.321 . . . . 64.099999999999994 107.885 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.74 -17.14 0.49 Allowed 'General case' 0 C--O 1.203 -1.367 0 CA-C-N 112.734 -2.03 . . . . 74.219999999999999 114.756 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.1 -41.8 88.98 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 118.156 0.434 . . . . 72.120000000000005 110.818 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.43 -36.28 45.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.569 . . . . 72.349999999999994 109.465 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -60.14 -44.09 95.22 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.11 -0.95 . . . . 51.229999999999997 108.951 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -43.12 64.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.583 -1.19 . . . . 75.019999999999996 111.149 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.15 -36.78 71.16 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.172 0.51 . . . . 60.310000000000002 110.621 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.97 -26.35 68.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.499 -0.773 . . . . 72.319999999999993 110.4 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -98.41 -36.59 9.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.557 -0.292 . . . . 54.229999999999997 111.29 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -75.33 -23.96 57.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.356 0.502 . . . . 70.030000000000001 112.356 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.1 m -66.1 114.87 5.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.332 0.587 . . . . 63.340000000000003 110.689 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.0 -70.23 0.27 Allowed Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.07 -1.612 . . . . 65.430000000000007 109.07 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -115.56 138.36 51.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.168 0.508 . . . . 65.129999999999995 111.638 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.32 154.21 37.57 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.588 -0.893 . . . . 65.0 108.588 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.2 150.97 62.65 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.512 2.141 . . . . 65.409999999999997 111.762 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.14 143.77 25.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.654 0.264 . . . . 62.030000000000001 110.517 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 p -85.15 95.16 9.05 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.865 -0.791 . . . . 52.039999999999999 108.865 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.0 p -84.77 -173.08 4.53 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.781 -0.645 . . . . 60.43 110.821 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.84 3.99 67.49 Favored Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.024 -1.231 . . . . 25.449999999999999 110.024 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 139' ' ' ALA . . . -68.57 -19.18 64.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.076 -1.062 . . . . 64.430000000000007 110.375 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.1 -5.72 37.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.395 0.617 . . . . 70.140000000000001 111.506 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.89 -12.81 23.0 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.58 -0.896 . . . . 64.120000000000005 108.58 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.87 74.07 0.56 Allowed Pre-proline 0 C--O 1.221 -0.408 0 CA-C-N 114.501 -1.227 . . . . 71.299999999999997 109.268 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.42 -57.92 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.235 1.956 . . . . 73.510000000000005 114.104 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.9 -20.21 20.88 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.961 0.726 . . . . 62.530000000000001 112.961 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.78 -4.62 83.58 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 119.978 -1.106 . . . . 53.0 111.383 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.8 m -115.48 163.74 15.31 Favored 'General case' 0 C--O 1.254 1.337 0 N-CA-C 107.9 -1.148 . . . . 71.319999999999993 107.9 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.15 158.32 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.405 -0.185 . . . . 32.340000000000003 111.176 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 48' ' ' LEU . 3.7 pp -131.08 137.19 49.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.14 0.495 . . . . 53.210000000000001 110.177 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.1 pp -117.03 136.84 52.65 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.369 -0.604 . . . . 64.420000000000002 109.369 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.75 130.92 71.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.866 -0.42 . . . . 70.400000000000006 109.866 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 t -79.37 123.12 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.913 -1.143 . . . . 61.43 107.913 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -99.24 -30.28 12.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.259 0.552 . . . . 63.350000000000001 110.033 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -136.53 127.73 28.07 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.485 -0.561 . . . . 64.329999999999998 109.485 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 136.3 175.64 13.93 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.8 -1.32 . . . . 70.219999999999999 109.8 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.57 -31.66 79.84 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 122.428 2.085 . . . . 74.239999999999995 111.817 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.29 12.78 15.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 75.519999999999996 110.897 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.54 132.18 50.45 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.928 0.394 . . . . 61.43 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -27.4 14.67 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.553 -1.019 . . . . 74.019999999999996 110.553 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.72 142.63 28.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.695 -0.483 . . . . 72.230000000000004 109.695 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 3.0 ppt_? -122.46 137.3 54.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.894 -0.594 . . . . 65.129999999999995 110.632 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.35 145.54 43.98 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.426 -0.953 . . . . 71.209999999999994 108.426 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -106.37 133.99 50.21 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.251 0.834 . . . . 62.240000000000002 113.251 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 94' ' ' ILE . 1.9 mm? -97.51 104.38 16.4 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.91 -1.885 . . . . 64.519999999999996 105.91 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.59 -0.43 2.16 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.916 0.865 . . . . 50.310000000000002 110.561 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -108.26 150.81 41.01 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.776 -0.824 . . . . 72.319999999999993 108.776 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.84 -30.17 46.28 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.417 2.745 . . . . 61.549999999999997 113.497 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -146.17 121.78 10.45 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.716 -0.615 . . . . 61.539999999999999 110.26 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 m -118.15 114.19 22.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.551 -0.295 . . . . 52.210000000000001 110.739 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m -87.32 130.18 34.72 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 110.275 -0.269 . . . . 43.240000000000002 110.275 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.63 139.68 53.67 Favored 'General case' 0 C--O 1.272 2.247 0 CA-C-O 121.609 0.719 . . . . 73.010000000000005 112.289 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.24 -160.62 31.43 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.27 -1.532 . . . . 74.5 109.27 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -118.87 116.74 27.12 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.214 -1.773 . . . . 63.140000000000001 106.214 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.642 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.7 t-160 166.87 151.0 0.08 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 104.527 -2.397 . . . . 72.099999999999994 104.527 -173.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 28.1 Cg_endo -64.52 -14.28 43.49 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.246 1.964 . . . . 74.420000000000002 112.281 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.86 -11.15 48.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 112.093 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -72.55 136.65 45.87 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.886 -0.783 . . . . 63.119999999999997 108.886 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.22 -45.07 34.78 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.716 -1.216 . . . . 64.409999999999997 107.716 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -106.32 119.27 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 107.255 -1.387 . . . . 44.329999999999998 107.255 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 81' ' ' ASP . 84.8 t80 -99.28 121.22 40.77 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.851 -0.613 . . . . 62.130000000000003 112.121 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.5 139.88 42.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.278 -2.119 . . . . 74.400000000000006 105.278 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 31.7 t70 -128.05 142.48 51.21 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 110.031 -0.359 . . . . 74.430000000000007 110.031 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -162.37 -161.42 0.73 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.613 -1.625 . . . . 75.310000000000002 106.613 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.92 -36.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.235 0.54 . . . . 73.439999999999998 109.66 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -75.71 152.45 37.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.531 -0.759 . . . . 74.219999999999999 110.521 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.26 99.09 7.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.628 -0.879 . . . . 74.239999999999995 108.628 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -99.07 85.68 3.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.126 -1.065 . . . . 63.25 108.126 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' A' ' 12' ' ' VAL . 16.4 ptt180 -55.4 -46.08 76.63 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.601 0.563 . . . . 71.349999999999994 111.933 -173.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -155.62 114.28 3.49 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.623 -1.621 . . . . 72.030000000000001 106.623 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.611 ' ND1' HG23 ' A' ' 130' ' ' ILE . 22.0 t-160 -99.74 -51.88 3.61 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.551 -0.86 . . . . 64.310000000000002 109.731 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.15 158.01 41.19 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.316 -0.554 . . . . 72.329999999999998 110.469 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' OE1' HG11 ' A' ' 104' ' ' VAL . 11.9 pt-20 -132.16 148.11 52.46 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-O 121.203 0.525 . . . . 54.340000000000003 110.021 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CD2' HG22 ' A' ' 101' ' ' VAL . 54.8 m-85 -105.14 117.01 32.92 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 75.530000000000001 108.114 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -106.29 133.63 50.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.199 -1.038 . . . . 63.130000000000003 108.199 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 63' ' ' LEU . 23.8 mt -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.563 -0.532 . . . . 73.340000000000003 109.563 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -138.87 121.02 15.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.297 -0.631 . . . . 74.120000000000005 109.297 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 55.76 38.09 29.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.223 1.009 . . . . 75.140000000000001 112.268 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.23 85.0 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.966 -0.635 . . . . 44.350000000000001 114.007 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -102.32 131.71 48.75 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 117.986 0.893 . . . . 74.439999999999998 109.788 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.99 123.62 48.11 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.936 -1.029 . . . . 65.230000000000004 109.177 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.26 137.48 54.2 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.669 -0.493 . . . . 65.340000000000003 109.669 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.451 HG22 ' CD2' ' A' ' 92' ' ' PHE . 29.2 t -103.58 122.61 56.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.212 -1.403 . . . . 65.299999999999997 107.212 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.95 133.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.923 -1.139 . . . . 63.450000000000003 107.923 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.9 148.96 36.12 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.35 0.595 . . . . 72.219999999999999 110.074 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG11 ' OE1' ' A' ' 91' ' ' GLU . 14.5 m -137.47 27.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.721 -1.214 . . . . 74.400000000000006 107.721 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 156.4 56.86 0.01 OUTLIER Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 113.796 -1.547 . . . . 73.310000000000002 110.41 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t -65.56 11.16 0.07 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.965 1.306 . . . . 61.140000000000001 111.961 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 105' ' ' GLY . 78.4 mt -65.5 -19.88 66.11 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 125.634 1.574 . . . . 64.349999999999994 110.885 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -87.09 -13.54 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.333 -0.394 . . . . 74.549999999999997 110.515 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.01 89.19 1.85 Allowed Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.729 -0.748 . . . . 70.430000000000007 111.253 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -86.6 127.9 34.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.773 -0.825 . . . . 63.310000000000002 108.773 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 81.1 m-85 -136.25 134.06 37.67 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.856 -0.794 . . . . 74.239999999999995 108.856 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.18 117.68 51.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 105.474 -2.047 . . . . 72.239999999999995 105.474 175.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.2 39.11 30.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.676 0.75 . . . . 74.430000000000007 110.172 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 mtm180 69.94 9.02 6.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.954 1.702 . . . . 65.519999999999996 114.851 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -110.24 135.89 20.55 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 110.351 -0.24 . . . . 75.040000000000006 110.351 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.02 135.9 12.69 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.728 2.285 . . . . 70.439999999999998 112.07 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -149.64 -177.62 5.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.281 0.562 . . . . 73.319999999999993 110.249 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.85 -31.02 4.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.259 -1.337 . . . . 72.340000000000003 110.057 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.7 137.31 28.1 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.277 -1.009 . . . . 32.25 108.277 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -152.44 122.63 7.14 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.277 -0.638 . . . . 55.450000000000003 109.277 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.17 117.56 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 106.963 -1.495 . . . . 71.209999999999994 106.963 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 32.6 ttm -96.87 137.81 35.39 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 114.281 1.215 . . . . 75.129999999999995 114.281 -165.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -114.14 157.25 22.86 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.473 -1.694 . . . . 54.439999999999998 107.745 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.8 t -62.59 133.94 55.63 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.414 0.626 . . . . 65.450000000000003 109.456 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.44 -0.09 56.9 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 121.107 -0.568 . . . . 74.030000000000001 111.887 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -82.38 142.2 32.18 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.932 -0.766 . . . . 72.420000000000002 108.932 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 134' ' ' ARG . 44.4 mt-10 -113.46 132.63 55.58 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.362 0.601 . . . . 75.510000000000005 110.248 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -107.39 132.82 53.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 111' ' ' TYR . 54.2 mt-30 -117.63 117.79 30.34 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.268 0.556 . . . . 61.240000000000002 109.781 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.611 HG23 ' ND1' ' A' ' 89' ' ' HIS . 48.1 mm -109.75 102.27 13.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.973 -1.491 . . . . 70.129999999999995 106.973 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.94 -78.08 0.21 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.406 -0.677 . . . . 43.140000000000001 111.406 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -141.87 5.37 1.74 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.045 0.45 . . . . 72.310000000000002 111.222 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.2 m-85 -78.9 150.44 32.14 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.223 -0.658 . . . . 54.32 109.223 176.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 127' ' ' GLU . 13.8 tpt180 -124.72 118.64 26.91 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.411 -1.7 . . . . 74.430000000000007 106.411 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.43 HD23 HD13 ' A' ' 49' ' ' LEU . 3.8 mp -122.29 140.84 52.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.337 -0.986 . . . . 74.450000000000003 108.337 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.07 122.56 65.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.201 -1.407 . . . . 73.019999999999996 107.201 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -99.31 127.29 45.31 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.077 -0.51 . . . . 75.329999999999998 109.957 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.99 155.54 50.59 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.818 -0.808 . . . . 45.539999999999999 108.818 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.489 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . . . -82.61 142.15 31.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.451 -1.685 . . . . 50.32 106.451 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.44 2.71 Favored Glycine 0 C--N 1.305 -1.192 0 C-N-CA 119.384 -1.389 . . . . 72.209999999999994 113.927 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 139' ' ' ALA . 2.9 Cg_exo -72.79 142.03 34.8 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.974 1.783 . . . . 75.0 109.769 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 179.76 73.71 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.929 0.892 . . . . 73.109999999999999 109.26 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.39 -3.448 0 CA-C-N 114.435 -1.257 . . . . 62.310000000000002 109.413 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 111.24 0.089 . . . . 64.200000000000003 111.24 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.2 t -178.07 -173.79 0.39 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.817 -1.92 . . . . 71.200000000000003 105.817 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.46 168.02 12.97 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 109.875 -0.417 . . . . 72.209999999999994 109.875 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -74.37 127.74 33.77 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.859 -0.793 . . . . 54.25 108.859 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -122.44 154.13 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.983 0.42 . . . . 75.140000000000001 112.049 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.92 -147.0 8.3 Favored Glycine 0 N--CA 1.425 -2.076 0 CA-C-N 115.115 -0.948 . . . . 31.440000000000001 111.925 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.551 ' HB ' ' NH1' ' A' ' 93' ' ' ARG . 14.9 t -125.67 151.55 70.84 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.647 -0.871 . . . . 73.120000000000005 108.647 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.49 151.18 39.0 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 122.507 2.138 . . . . 72.510000000000005 110.234 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.39 139.34 59.65 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-O 121.058 0.456 . . . . 65.219999999999999 111.629 -171.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.83 135.3 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.39 3.393 . . . . 52.329999999999998 117.3 -170.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -124.91 132.75 53.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 104.51 -2.404 . . . . 71.230000000000004 104.51 170.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.91 132.8 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.82 0.819 . . . . 72.230000000000004 110.971 -172.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.534 ' HB3' ' HG2' ' A' ' 87' ' ' ARG . 8.7 tp10 -148.02 159.99 43.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 104.898 -2.26 . . . . 63.210000000000001 104.898 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -85.97 125.33 33.3 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.669 0.618 . . . . 73.420000000000002 112.669 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.531 ' O2P' ' HG3' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -100.0 155.35 17.75 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 105.768 -1.938 . . . . 51.25 105.768 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -81.53 114.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 117.675 -1.61 . . . . 74.310000000000002 108.024 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.682 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 45.1 t80 -99.71 116.24 31.35 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.004 -0.998 . . . . 73.209999999999994 108.857 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -81.15 92.07 6.23 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.796 -0.816 . . . . 73.140000000000001 108.796 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.65 -168.41 2.08 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.975 -1.011 . . . . 73.310000000000002 110.926 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.43 -9.71 13.86 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.34 1.056 . . . . 74.5 111.28 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.86 -19.13 65.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.004 0.922 . . . . 71.450000000000003 110.365 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.0 OUTLIER -59.21 -43.71 92.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.331 -0.989 . . . . 73.430000000000007 108.331 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.536 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 7.8 tmtm? -80.47 -29.3 37.46 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.547 -0.909 . . . . 74.450000000000003 108.547 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 129' ' ' GLN . 6.6 tp10 -68.26 -33.9 75.22 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.987 -0.551 . . . . 73.510000000000005 110.705 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 27.5 ptt? -68.57 -21.02 64.55 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.778 -0.369 . . . . 52.240000000000002 110.741 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.04 -33.52 63.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.715 -1.217 . . . . 71.219999999999999 107.715 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -79.94 -14.66 58.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.769 -1.105 . . . . 63.340000000000003 110.884 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 t -67.44 -25.66 66.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.201 -0.666 . . . . 72.140000000000001 109.201 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.92 97.06 5.18 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.883 -1.525 . . . . 72.409999999999997 106.883 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.19 58.91 2.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.379 -1.088 . . . . 64.239999999999995 110.379 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -92.79 149.93 20.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.899 -0.408 . . . . 74.420000000000002 109.899 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.22 101.22 40.97 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.721 -0.474 . . . . 51.109999999999999 109.721 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.549 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 69.3 Cg_endo -75.79 143.52 26.74 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.308 2.005 . . . . 72.409999999999997 111.181 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.12 166.8 22.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.335 -0.393 . . . . 71.25 110.724 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 m -67.71 118.82 11.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.168 -0.469 . . . . 62.210000000000001 110.266 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 124' ' ' THR . 17.8 p -110.93 -161.57 0.76 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.569 0.748 . . . . 64.030000000000001 110.63 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.94 80.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.518 -0.633 . . . . 23.219999999999999 111.518 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.64 -24.51 19.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.927 0.714 . . . . 65.519999999999996 112.927 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.02 0.61 4.33 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.549 1.315 . . . . 73.019999999999996 114.549 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.3 -39.01 15.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.692 -0.855 . . . . 72.420000000000002 108.692 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 90.7 mt 53.18 80.29 0.3 Allowed Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 123.98 0.912 . . . . 72.519999999999996 111.607 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 10.8 Cg_endo -52.79 -67.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 123.649 2.9 . . . . 75.5 114.678 -173.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.38 -0.98 3.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.098 0.475 . . . . 64.510000000000005 111.317 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.6 6.98 82.6 Favored Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.384 -0.912 . . . . 63.409999999999997 112.643 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 m -129.46 158.21 39.84 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 108.118 -1.068 . . . . 71.25 108.118 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.49 41.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.254 -0.276 . . . . 73.349999999999994 110.254 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.442 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.71 139.95 53.4 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.326 0.391 . . . . 74.019999999999996 110.267 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -112.42 137.34 50.75 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.69 -0.855 . . . . 75.319999999999993 108.69 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.73 133.34 61.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.195 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.8 t -78.51 117.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 106.113 -1.81 . . . . 55.439999999999998 106.113 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -86.41 -33.99 20.3 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.545 -0.752 . . . . 73.319999999999993 110.527 -172.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 31.3 tpt180 -154.66 139.7 17.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.232 -1.025 . . . . 71.230000000000004 108.232 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.08 -178.93 20.41 Favored Glycine 0 N--CA 1.437 -1.3 0 O-C-N 123.867 0.729 . . . . 72.430000000000007 111.346 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -70.0 -37.11 9.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.341 2.027 . . . . 74.340000000000003 111.513 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 81' ' ' ASP . 5.0 p30 -90.73 18.52 6.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.352 0.596 . . . . 74.239999999999995 111.167 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.65 145.19 54.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.432 0.693 . . . . 75.040000000000006 111.034 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -14.82 37.06 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.243 -1.143 . . . . 52.240000000000002 110.243 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.86 33.56 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 121.08 -0.248 . . . . 72.150000000000006 110.359 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -134.97 139.25 44.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.816 -1.179 . . . . 73.239999999999995 107.816 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.25 123.16 26.39 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 121.311 -0.155 . . . . 72.340000000000003 110.737 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.5 tp -89.63 115.4 26.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.057 -1.461 . . . . 63.310000000000002 107.057 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.81 106.87 16.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.458 0.647 . . . . 63.310000000000002 111.744 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -102.92 15.27 29.87 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.474 -1.306 . . . . 72.310000000000002 107.474 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 15.7 mt-30 -107.31 141.85 23.83 Favored Pre-proline 0 CA--C 1.468 -2.205 0 CA-C-N 114.714 -1.13 . . . . 73.200000000000003 110.026 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 16.5 Cg_exo -72.03 -13.15 28.74 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.973 1.782 . . . . 74.329999999999998 109.375 169.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.0 m -149.29 125.37 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.281 0.563 . . . . 61.229999999999997 110.67 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.3 m -131.51 139.48 49.29 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.366 -0.976 . . . . 64.209999999999994 108.366 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.24 -0.913 . . . . 70.450000000000003 110.319 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.58 143.41 46.14 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.764 -0.828 . . . . 63.149999999999999 108.764 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.96 -147.07 6.39 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 111.361 -0.696 . . . . 73.439999999999998 111.361 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -90.91 147.9 22.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 122.591 0.357 . . . . 64.239999999999995 110.951 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.46 169.76 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.65 1.18 . . . . 75.310000000000002 112.291 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -73.2 6.66 2.48 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.246 1.964 . . . . 74.409999999999997 111.446 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.93 -37.56 67.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.319 -1.363 . . . . 53.229999999999997 107.319 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -78.74 152.82 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.758 -1.11 . . . . 73.120000000000005 108.264 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' OD2' HG23 ' A' ' 68' ' ' THR . 32.0 t70 -64.67 -41.76 95.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.892 0.377 . . . . 71.129999999999995 111.094 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.0 126.81 67.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.306 -0.998 . . . . 72.099999999999994 108.306 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -88.42 129.63 35.38 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.682 0.614 . . . . 74.310000000000002 110.737 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.7 140.3 52.82 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.39 -1.337 . . . . 75.219999999999999 107.39 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.584 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 30.7 t70 -125.4 118.42 25.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.993 -0.549 . . . . 62.149999999999999 109.611 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.34 -175.45 4.78 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.775 -2.306 . . . . 75.049999999999997 104.775 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.24 -34.84 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.368 -0.975 . . . . 74.219999999999999 108.368 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 107' ' ' LEU . 8.2 m -148.63 114.69 5.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.071 -1.085 . . . . 64.299999999999997 108.071 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.2 t -103.94 152.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.513 -0.551 . . . . 44.450000000000003 109.513 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.8 m -72.65 153.07 41.4 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.572 0.349 . . . . 52.530000000000001 110.47 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HG2' ' HB3' ' A' ' 13' ' ' GLU . 5.4 ppt_? -69.26 -29.27 67.14 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.922 0.867 . . . . 72.140000000000001 110.767 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 24.0 mtp180 -148.78 120.19 7.9 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 101.666 -3.457 . . . . 72.340000000000003 101.666 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.498 ' CE1' HG23 ' A' ' 130' ' ' ILE . 13.4 t60 -99.65 -52.69 3.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.725 -0.79 . . . . 75.420000000000002 110.483 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.01 146.52 25.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.625 -0.88 . . . . 63.350000000000001 108.625 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 11.0 pt-20 -118.36 129.75 55.61 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.816 -0.629 . . . . 74.540000000000006 109.61 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 26.7 m-85 -105.26 113.06 26.43 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.302 -2.11 . . . . 74.420000000000002 105.302 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.551 ' NH1' ' HB ' ' A' ' 7' ' ' THR . 26.2 mtp180 -115.25 127.29 55.39 Favored 'General case' 0 C--N 1.262 -3.2 0 N-CA-C 108.46 -0.941 . . . . 74.420000000000002 108.46 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.7 mp -103.67 113.02 39.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 106.894 -1.521 . . . . 63.149999999999999 106.894 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -119.65 125.06 47.81 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.812 -1.181 . . . . 70.530000000000001 107.812 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.29 34.97 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.994 0.918 . . . . 75.219999999999999 112.576 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.2 -0.15 89.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.078 -0.582 . . . . 64.519999999999996 113.401 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -102.91 150.51 23.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.28 -1.007 . . . . 74.530000000000001 108.28 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -110.1 117.65 34.29 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 121.306 -0.157 . . . . 63.130000000000003 110.745 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.618 -0.882 . . . . 63.530000000000001 108.618 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.0 123.63 68.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.743 -1.206 . . . . 42.439999999999998 107.743 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.24 130.06 73.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.664 -0.865 . . . . 62.340000000000003 108.664 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.42 130.4 37.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.482 -0.933 . . . . 71.430000000000007 108.482 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 12.85 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-N 115.675 -0.693 . . . . 63.420000000000002 109.322 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -154.83 83.01 0.16 Allowed Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.158 -0.928 . . . . 43.25 113.375 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 40.6 m -82.4 15.58 2.43 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.396 . . . . 72.230000000000004 111.176 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.7 tm? -67.2 -50.48 60.76 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 106.539 -1.652 . . . . 74.219999999999999 106.539 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 26.9 t-20 -104.46 -19.86 13.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.992 -0.744 . . . . 72.439999999999998 108.992 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . 83.99 119.32 0.76 Allowed Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.75 1.06 . . . . 52.130000000000003 115.75 168.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.9 m -87.29 128.4 35.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.793 -0.818 . . . . 74.25 108.793 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.41 142.17 51.49 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.185 -1.043 . . . . 64.099999999999994 108.185 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -124.62 117.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.389 -0.967 . . . . 74.310000000000002 108.389 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.549 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 6.8 m-80 50.93 49.03 21.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.798 0.839 . . . . 71.120000000000005 112.993 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 67.21 9.42 6.94 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.481 1.513 . . . . 75.120000000000005 112.303 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -109.97 136.31 20.43 Favored Pre-proline 0 C--N 1.313 -1.004 0 O-C-N 121.936 -0.477 . . . . 65.150000000000006 110.334 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.42 123.81 12.73 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 121.946 1.764 . . . . 40.5 108.652 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -147.41 131.98 17.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.02 -0.733 . . . . 64.549999999999997 109.02 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.79 -35.52 9.02 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.358 0.411 . . . . 75.239999999999995 111.476 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.26 135.26 53.28 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.78 -1.193 . . . . 50.43 107.78 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -146.88 143.61 28.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.513 0.197 . . . . 72.140000000000001 111.391 -175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 114.03 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 103.181 -2.896 . . . . 45.399999999999999 103.181 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.452 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 30.3 ttm -93.91 130.85 39.84 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.778 -1.169 . . . . 55.200000000000003 111.468 -170.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.41 ' OE1' ' HB ' ' A' ' 37' ' ' THR . 40.3 mt-30 -114.03 157.87 21.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 74.409999999999997 109.675 -170.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 14.8 t -63.54 126.57 27.94 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.897 -0.779 . . . . 73.140000000000001 108.897 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.0 -1.66 57.85 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 115.772 -0.649 . . . . 60.32 111.489 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.8 145.74 34.16 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 107.982 -1.118 . . . . 51.109999999999999 107.982 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' H ' ' ND2' ' A' ' 113' ' ' ASN . 36.7 mt-10 -119.93 132.86 55.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.831 -0.433 . . . . 73.019999999999996 109.831 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 mt -107.98 131.59 57.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.044 -0.724 . . . . 53.119999999999997 109.044 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.403 ' HG2' ' HG2' ' A' ' 25' ' ' GLU . 52.3 tp60 -105.53 115.43 30.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.554 -1.276 . . . . 71.140000000000001 107.554 175.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.498 HG23 ' CE1' ' A' ' 89' ' ' HIS . 63.4 mt -125.42 116.8 47.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.086 -1.449 . . . . 60.119999999999997 107.086 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.53 -104.29 0.75 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.668 -0.973 . . . . 62.32 110.668 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.503 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -124.61 5.09 8.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.195 0.522 . . . . 72.219999999999999 109.94 176.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 34.2 p90 -111.14 156.58 21.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.985 -175.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.57 136.74 54.7 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.166 0.508 . . . . 74.310000000000002 111.542 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.17 139.62 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.585 -1.265 . . . . 71.420000000000002 107.585 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.7 t -112.13 131.41 63.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.893 -1.151 . . . . 62.229999999999997 107.893 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 48.7 t80 -103.57 117.02 33.47 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.941 -0.763 . . . . 72.120000000000005 108.941 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.19 131.08 55.8 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.488 -0.56 . . . . 61.409999999999997 109.488 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -111.87 121.93 46.39 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.307 -0.997 . . . . 72.409999999999997 108.307 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.74 -104.89 0.21 Allowed Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.477 -0.868 . . . . 74.409999999999997 111.89 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.19 161.66 45.12 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.004 2.469 . . . . 61.409999999999997 113.596 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.1 24.38 5.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.309 -0.86 . . . . 63.43 109.343 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.435 -1.197 0 C-N-CA 124.961 1.305 . . . . 71.530000000000001 113.462 -176.668 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 108.0 -1.111 . . . . 70.109999999999999 108.0 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -106.17 -179.13 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.956 -1.128 . . . . 55.219999999999999 107.956 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -150.91 147.93 27.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.248 -1.019 . . . . 72.299999999999997 108.248 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -82.08 127.83 33.5 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.341 0.497 . . . . 71.109999999999999 112.341 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -85.48 109.94 18.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.397 -0.964 . . . . 75.329999999999998 108.397 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.02 -127.2 3.65 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 110.883 -0.887 . . . . 61.229999999999997 110.883 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -96.51 112.11 59.06 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.709 -0.848 . . . . 70.420000000000002 108.709 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.71 147.81 92.42 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.905 2.404 . . . . 71.219999999999999 113.051 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -79.34 131.89 64.22 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.153 -0.93 . . . . 75.230000000000004 109.878 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.89 154.9 23.16 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.996 1.798 . . . . 75.329999999999998 110.32 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -92.71 152.86 19.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.997 -0.742 . . . . 73.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.66 121.18 66.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.504 -0.554 . . . . 71.530000000000001 109.504 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -146.89 169.33 19.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.977 0.911 . . . . 62.009999999999998 110.917 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -77.49 122.22 24.93 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.596 0.591 . . . . 73.109999999999999 112.596 -174.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.499 HG22 ' HB2' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -131.94 137.53 47.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.883 -1.895 . . . . 72.150000000000006 105.883 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 t -85.9 130.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 117.8 0.273 . . . . 74.140000000000001 110.415 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -96.48 131.9 42.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.432 -0.507 . . . . 74.299999999999997 109.64 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.54 91.69 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.69 -0.485 . . . . 74.030000000000001 109.69 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.49 -84.22 0.07 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.122 0.416 . . . . 22.149999999999999 112.122 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.32 -35.48 65.18 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.497 1.119 . . . . 74.209999999999994 112.505 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.8 mt -57.85 -12.29 3.01 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.887 1.275 . . . . 74.230000000000004 113.904 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.4 tp -80.07 -16.32 55.3 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.714 0.405 . . . . 73.120000000000005 111.066 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.85 -39.65 89.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.415 1.265 . . . . 62.219999999999999 114.415 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -72.57 -14.48 61.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.239 0.829 . . . . 75.010000000000005 113.239 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.4 ttp -60.25 -30.69 69.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.367 0.603 . . . . 71.310000000000002 110.376 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.77 -16.74 63.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.367 -0.833 . . . . 53.310000000000002 111.91 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -78.38 -17.95 55.74 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.936 -0.394 . . . . 71.209999999999994 109.936 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.0 m -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.355 0.598 . . . . 73.120000000000005 110.889 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -81.79 111.44 18.03 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 115.523 -0.762 . . . . 65.329999999999998 109.757 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.0 -79.95 0.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.827 -0.701 . . . . 62.009999999999998 113.702 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -105.69 121.36 43.86 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.225 0.536 . . . . 71.129999999999995 111.707 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.61 136.12 28.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.516 -0.92 . . . . 71.239999999999995 108.516 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.42 154.55 73.85 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.319 2.012 . . . . 70.420000000000002 110.199 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.31 169.06 16.51 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 116.32 -0.4 . . . . 73.010000000000005 110.378 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 p -57.03 136.7 56.32 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.069 0.856 . . . . 71.019999999999996 110.411 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 m -118.22 1.7 11.91 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.204 0.526 . . . . 64.010000000000005 111.968 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 15.21 56.36 Favored Glycine 0 CA--C 1.488 -1.624 0 N-CA-C 108.107 -1.997 . . . . 63.109999999999999 108.107 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.13 -8.95 47.3 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.898 -1.651 . . . . 72.439999999999998 109.379 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.22 -11.4 60.77 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.627 1.571 . . . . 74.040000000000006 111.063 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.63 -22.79 43.15 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.832 -1.531 . . . . 70.439999999999998 109.425 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.66 67.58 1.51 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.255 -0.646 . . . . 54.329999999999998 109.255 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.08 -54.56 4.21 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.831 3.021 . . . . 73.430000000000007 114.914 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.14 -15.04 45.15 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.273 0.472 . . . . 64.019999999999996 112.273 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.51 -11.89 70.85 Favored Glycine 0 C--N 1.319 -0.387 0 N-CA-C 110.788 -0.925 . . . . 24.550000000000001 110.788 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.0 m -127.21 162.38 26.32 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.525 -1.658 . . . . 62.229999999999997 106.525 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -141.38 157.32 45.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.253 -0.647 . . . . 70.140000000000001 109.253 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -121.57 149.08 43.66 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.225 0.536 . . . . 74.310000000000002 111.831 -175.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -111.04 132.24 54.39 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.568 -0.901 . . . . 73.340000000000003 108.568 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.05 134.25 51.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.404 -0.591 . . . . 73.420000000000002 109.404 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.46 117.9 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.835 -1.543 . . . . 73.5 106.835 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -93.53 -30.97 14.73 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.052 -0.522 . . . . 72.420000000000002 111.46 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' CZ ' ' H ' ' A' ' 54' ' ' GLY . 2.7 tpm_? -144.52 141.19 29.34 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.583 -0.447 . . . . 73.430000000000007 109.961 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.458 ' H ' ' CZ ' ' A' ' 53' ' ' ARG . . . 128.8 168.1 12.32 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.942 -1.663 . . . . 63.32 108.942 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.4 Cg_exo -55.26 -29.58 67.78 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.46 2.107 . . . . 54.5 113.438 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -91.7 14.51 15.03 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.529 0.566 . . . . 71.219999999999999 112.529 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.51 143.07 58.18 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.191 0.52 . . . . 54.520000000000003 111.567 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.79 -23.15 34.75 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 115.408 -0.814 . . . . 72.409999999999997 111.243 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.57 149.31 22.2 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.771 0.319 . . . . 32.25 110.458 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 2.0 ppt_? -123.95 141.14 52.3 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.751 -0.463 . . . . 72.219999999999999 109.751 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -119.24 125.62 49.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.11 -0.7 . . . . 70.109999999999999 109.11 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.8 tp -93.67 136.19 34.2 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 74.0 107.809 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.84 104.7 16.6 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.937 -0.705 . . . . 71.019999999999996 110.09 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -116.46 -9.76 11.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.509 -1.223 . . . . 73.219999999999999 107.707 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 94' ' ' ILE . 15.1 pm0 -106.9 139.81 20.76 Favored Pre-proline 0 N--CA 1.425 -1.688 0 CA-C-N 114.871 -1.059 . . . . 74.010000000000005 109.728 -173.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 31.0 Cg_endo -64.18 -14.52 44.21 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.471 2.78 . . . . 73.129999999999995 114.182 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -148.02 127.55 13.23 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.216 -0.927 . . . . 74.030000000000001 112.015 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 45.7 m -124.15 113.54 18.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.312 -0.996 . . . . 73.239999999999995 108.312 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -89.43 134.89 33.89 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.329 -0.619 . . . . 64.230000000000004 109.329 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.5 147.0 44.09 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.514 0.673 . . . . 62.310000000000002 111.585 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -169.78 21.38 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 107.867 -2.093 . . . . 73.040000000000006 107.867 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -115.61 118.34 32.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.78 -1.563 . . . . 73.310000000000002 106.78 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 44.6 p-80 176.38 162.05 0.46 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 106.381 -1.711 . . . . 75.409999999999997 106.381 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 8.3 Cg_endo -48.74 -36.64 33.56 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 123.925 3.083 . . . . 74.120000000000005 115.146 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -90.81 16.2 9.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.771 1.026 . . . . 73.409999999999997 113.771 -177.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.4 p -66.05 112.28 3.78 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.167 -0.679 . . . . 62.549999999999997 109.167 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 68' ' ' THR . 27.3 t0 -77.52 -34.67 53.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.415 -0.957 . . . . 64.430000000000007 108.415 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.99 117.95 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.992 -1.484 . . . . 52.240000000000002 106.992 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -95.19 116.93 29.39 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.321 0.582 . . . . 61.140000000000001 110.959 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 2.2 mm? -123.19 139.94 53.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.032 -2.21 . . . . 74.200000000000003 105.032 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 55' ' ' PRO . 4.5 p-10 -79.68 127.15 31.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.903 0.858 . . . . 72.219999999999999 109.533 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.92 146.15 39.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.839 -1.073 . . . . 63.350000000000001 111.648 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.38 -43.27 20.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.478 -0.934 . . . . 75.150000000000006 108.478 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.405 ' HB ' ' CD2' ' A' ' 107' ' ' LEU . 45.2 m -133.53 158.0 44.23 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.517 -2.031 . . . . 63.32 105.517 176.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.97 99.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.773 0.797 . . . . 75.430000000000007 112.754 -165.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -104.14 101.76 11.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.262 -1.335 . . . . 71.109999999999999 107.584 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 6.7 ppt_? -57.16 -31.72 65.67 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.691 0.62 . . . . 75.099999999999994 112.349 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 43.6 ttm180 -159.97 132.51 6.51 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.597 -1.631 . . . . 71.510000000000005 106.597 172.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -98.67 -52.75 3.51 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.644 0.59 . . . . 74.340000000000003 110.456 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 164.6 34.45 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.335 -0.393 . . . . 71.219999999999999 110.605 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.96 130.94 54.04 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.371 -0.974 . . . . 61.450000000000003 108.371 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 9.1 m-85 -105.66 113.47 27.05 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.212 -1.773 . . . . 55.420000000000002 106.212 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -112.21 141.61 45.69 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.37 -0.532 . . . . 64.329999999999998 110.524 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.5 mp -113.78 112.72 41.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 105.117 -2.179 . . . . 65.150000000000006 105.117 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -131.48 126.55 35.29 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.939 -0.573 . . . . 72.25 109.551 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 55.67 36.21 26.76 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 125.194 1.398 . . . . 65.140000000000001 110.08 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.75 -2.0 75.76 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 115.492 -0.776 . . . . 61.32 113.685 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.22 150.33 25.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.37 0.585 . . . . 73.530000000000001 109.94 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.401 ' CD2' HG13 ' A' ' 94' ' ' ILE . 49.8 m-85 -106.43 131.51 53.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.55 -0.295 . . . . 75.400000000000006 110.612 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.42 147.21 52.1 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.754 -0.461 . . . . 71.230000000000004 109.754 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.28 123.17 64.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.388 -1.338 . . . . 50.130000000000003 107.388 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.91 122.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.346 0.593 . . . . 73.430000000000007 110.364 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -83.23 137.83 33.86 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.437 -0.801 . . . . 72.299999999999997 109.646 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.6 12.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.488 -0.778 . . . . 71.219999999999999 109.489 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.75 79.65 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.286 -0.959 . . . . 73.109999999999999 112.817 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -71.37 33.55 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 123.588 0.755 . . . . 55.420000000000002 112.209 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 15' ' ' TPO . 4.3 tt -62.81 -42.34 99.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.545 -0.909 . . . . 60.43 108.545 -176.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -86.42 -4.1 59.11 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.506 -1.225 . . . . 74.230000000000004 109.374 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 88.87 1.01 Allowed Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.992 -0.623 . . . . 71.200000000000003 112.683 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -87.51 127.71 35.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.991 -0.374 . . . . 74.200000000000003 109.991 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.8 m-85 -136.37 141.73 43.71 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 109.968 -0.382 . . . . 70.230000000000004 109.968 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.7 117.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.442 -2.059 . . . . 72.25 105.442 172.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 56.71 38.65 29.68 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.859 0.837 . . . . 71.120000000000005 110.141 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.486 HH12 ' NH2' ' A' ' 134' ' ' ARG . 75.1 mtm-85 62.79 13.02 6.13 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.339 -1.3 . . . . 74.140000000000001 114.118 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -104.06 130.3 23.64 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.735 -1.58 . . . . 73.430000000000007 106.735 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.13 123.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.586 1.524 . . . . 72.450000000000003 109.701 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -142.18 140.12 32.28 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.69 -1.226 . . . . 71.519999999999996 107.69 -172.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.2 -47.06 4.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.194 0.521 . . . . 73.310000000000002 110.189 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.14 136.47 54.6 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.775 -0.824 . . . . 73.239999999999995 108.775 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -148.49 143.88 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.737 -0.665 . . . . 74.549999999999997 110.454 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.51 114.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 102.967 -2.975 . . . . 72.319999999999993 102.967 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.6 ttp -90.03 129.39 36.35 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.482 0.658 . . . . 74.409999999999997 110.833 -169.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -129.18 157.68 41.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.86 -1.064 . . . . 62.009999999999998 108.807 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -58.92 133.7 56.29 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.883 -0.599 . . . . 61.25 109.972 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.64 -4.8 56.62 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.586 -0.734 . . . . 74.129999999999995 111.752 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -88.69 140.06 29.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.202 -0.666 . . . . 54.539999999999999 109.202 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -117.07 145.11 43.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.811 -0.811 . . . . 74.540000000000006 108.811 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.0 127.63 72.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.159 -0.682 . . . . 70.540000000000006 109.159 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 44.9 tt0 -104.86 122.08 45.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.209 -1.404 . . . . 74.140000000000001 107.209 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.74 101.75 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.091 -1.818 . . . . 62.509999999999998 106.091 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.48 -110.96 3.06 Favored Glycine 0 C--N 1.306 -1.097 0 C-N-CA 120.864 -0.684 . . . . 51.219999999999999 112.107 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -96.86 -3.52 41.88 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.981 0.513 . . . . 51.450000000000003 110.435 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.587 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.3 m-85 -95.11 139.15 31.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 109.798 -0.445 . . . . 72.109999999999999 109.798 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.486 ' NH2' HH12 ' A' ' 114' ' ' ARG . 81.1 ttt180 -124.81 119.43 28.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.446 -0.946 . . . . 74.200000000000003 108.446 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.7 mt -110.21 138.64 46.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.594 -0.891 . . . . 75.120000000000005 108.594 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.93 120.7 64.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.855 -1.165 . . . . 73.540000000000006 107.855 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 85.6 t80 -97.14 117.77 32.07 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.355 0.409 . . . . 75.329999999999998 110.29 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.16 143.76 49.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.08 0.467 . . . . 73.120000000000005 110.128 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.47 119.81 38.61 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.051 0.453 . . . . 72.409999999999997 110.244 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.46 174.44 40.5 Favored Glycine 0 C--N 1.287 -2.164 0 N-CA-C 109.436 -1.465 . . . . 34.420000000000002 109.436 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.47 141.22 38.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 119.091 1.445 . . . . 61.210000000000001 109.66 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.55 26.67 0.13 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.889 -1.152 . . . . 64.420000000000002 107.889 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.407 -2.589 0 CA-C-N 114.498 -1.228 . . . . 74.420000000000002 108.315 -177.493 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 107.176 -1.416 . . . . 75.420000000000002 107.176 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 m -70.55 137.28 49.99 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 109.311 -0.626 . . . . 72.540000000000006 109.311 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -145.7 152.89 40.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.22 -1.03 . . . . 64.409999999999997 108.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -157.69 141.86 16.08 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.885 -1.154 . . . . 63.439999999999998 107.885 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -76.69 87.17 3.33 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.891 0.853 . . . . 73.329999999999998 111.001 178.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.23 -7.67 79.55 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.107 -1.197 . . . . 41.509999999999998 110.107 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -79.59 118.6 73.33 Favored Pre-proline 0 N--CA 1.417 -2.091 0 C-N-CA 123.904 0.882 . . . . 64.129999999999995 108.903 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.9 150.85 55.97 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.453 1.435 . . . . 73.239999999999995 109.021 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -78.19 123.12 86.02 Favored Pre-proline 0 C--N 1.309 -1.162 0 C-N-CA 120.119 -0.632 . . . . 74.329999999999998 109.426 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.61 132.36 23.4 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.844 1.696 . . . . 62.530000000000001 109.958 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -91.32 145.16 24.87 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.31 132.31 55.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.372 0.605 . . . . 60.340000000000003 109.558 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -140.76 155.86 46.32 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.486 -1.672 . . . . 72.219999999999999 106.486 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -70.29 127.11 31.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.335 0.865 . . . . 74.430000000000007 113.335 -171.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -90.34 146.57 24.08 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.038 0.447 . . . . 72.010000000000005 111.997 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 115.64 26.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 72.120000000000005 108.649 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -123.12 117.79 26.21 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.637 -0.71 . . . . 74.310000000000002 110.144 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -82.76 101.24 10.78 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.691 -1.966 . . . . 72.510000000000005 105.691 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 108.75 1.71 Allowed 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.489 -0.778 . . . . 53.200000000000003 110.474 -177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 35.5 t70 -60.1 -24.16 64.41 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.659 0.742 . . . . 70.120000000000005 110.263 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -65.81 -3.81 5.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.645 -1.161 . . . . 74.310000000000002 113.142 178.114 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.83 -24.62 58.24 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.122 0.487 . . . . 65.450000000000003 111.287 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 21' ' ' ASP . 49.6 mtmt -66.82 -28.95 68.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.836 -0.62 . . . . 74.430000000000007 110.857 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -26.31 62.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.478 -0.328 . . . . 61.210000000000001 110.855 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.3 mtm -65.93 -40.35 91.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.93 -0.767 . . . . 64.439999999999998 108.93 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.91 -40.28 94.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.033 -0.985 . . . . 73.040000000000006 109.557 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 m -73.01 -27.75 61.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.536 -0.756 . . . . 61.119999999999997 111.044 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -74.05 -30.48 62.42 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 109.921 -0.4 . . . . 63.439999999999998 109.921 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 127.88 34.29 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.941 -1.027 . . . . 61.539999999999999 109.341 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.22 -42.69 1.28 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 107.674 -2.17 . . . . 63.539999999999999 107.674 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.6 m -115.77 121.95 43.99 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.474 -1.306 . . . . 72.519999999999996 107.474 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -90.39 138.52 26.95 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.008 -0.738 . . . . 74.310000000000002 109.008 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 7.9 Cg_exo -73.52 142.24 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.701 1.6 . . . . 45.039999999999999 111.468 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.13 126.48 46.38 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.081 -1.081 . . . . 73.319999999999993 108.081 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 123' ' ' GLN . 12.9 m -137.96 110.88 7.71 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.631 -0.507 . . . . 75.400000000000006 109.631 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.6 m -154.18 142.4 20.44 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.733 -1.21 . . . . 74.200000000000003 107.733 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -15.01 3.63 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.114 -1.041 . . . . 52.420000000000002 112.166 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.13 59.04 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.299 -0.63 . . . . 61.530000000000001 109.299 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -79.8 3.7 18.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.188 -0.914 . . . . 73.310000000000002 111.671 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.28 -27.89 18.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.085 -0.709 . . . . 75.310000000000002 109.085 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 46.65 77.93 0.43 Allowed Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.331 1.052 . . . . 62.539999999999999 113.665 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -70.22 -61.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.508 1.472 . . . . 71.349999999999994 111.537 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.05 -13.79 18.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 111.567 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.17 17.52 74.04 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.711 -0.955 . . . . 73.430000000000007 110.711 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -150.44 167.08 28.19 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 105.902 -1.888 . . . . 25.120000000000001 105.902 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -152.12 157.9 42.21 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 118.446 0.566 . . . . 63.420000000000002 111.278 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -121.2 154.53 36.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.129 0.49 . . . . 63.340000000000003 111.916 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.42 141.37 51.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.966 -0.753 . . . . 63.399999999999999 108.966 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.68 134.36 59.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.891 -0.411 . . . . 64.299999999999997 109.891 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 t -86.63 118.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 108.103 -1.073 . . . . 63.340000000000003 108.103 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -92.27 -32.2 15.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 111.336 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -143.47 136.73 27.97 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.422 -0.511 . . . . 75.319999999999993 110.096 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.86 174.84 13.84 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.2 -1.16 . . . . 63.340000000000003 110.2 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -55.43 -32.05 80.36 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.649 2.233 . . . . 74.200000000000003 112.793 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.44 10.48 25.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.256 0.465 . . . . 73.109999999999999 112.256 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.27 57.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.902 0.319 . . . . 70.420000000000002 111.444 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.16 -16.78 55.19 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.509 -0.636 . . . . 32.439999999999998 111.509 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.63 139.01 31.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.907 0.384 . . . . 54.200000000000003 110.324 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -122.79 134.55 54.42 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.58 118.65 30.73 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.546 -0.297 . . . . 74.319999999999993 110.338 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -87.55 111.76 21.54 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.31 -0.996 . . . . 72.140000000000001 108.31 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -95.0 117.26 29.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.342 0.591 . . . . 73.310000000000002 109.653 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -122.02 14.03 10.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.846 -1.07 . . . . 72.209999999999994 108.835 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -108.47 156.46 38.62 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 64.310000000000002 109.521 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 38.2 Cg_endo -69.18 -20.68 37.25 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.175 1.917 . . . . 65.230000000000004 114.527 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.5 m -153.53 127.17 8.74 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.29 -0.881 . . . . 75.140000000000001 111.858 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -126.25 112.86 16.23 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.979 -1.119 . . . . 74.299999999999997 107.979 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 77.7 m -89.07 139.18 30.72 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.39 -0.524 . . . . 73.400000000000006 109.624 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.01 135.61 54.85 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.358 0.599 . . . . 60.32 110.912 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.05 -160.21 33.1 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.731 -2.148 . . . . 61.229999999999997 107.731 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -115.72 116.81 28.7 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 151.43 153.23 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 127.48 2.312 . . . . 61.409999999999997 107.228 177.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.95 -9.97 25.22 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.397 2.065 . . . . 75.099999999999994 111.79 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.52 -17.84 61.17 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.746 0.818 . . . . 62.350000000000001 110.248 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 m -90.07 150.02 22.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.218 -1.401 . . . . 62.200000000000003 107.218 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.31 -45.95 24.56 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.702 -0.851 . . . . 74.430000000000007 108.702 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.8 pt -106.16 130.51 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.086 -1.079 . . . . 75.420000000000002 108.086 174.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -94.26 108.12 20.03 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.954 -0.566 . . . . 74.409999999999997 109.996 -173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.74 116.25 32.33 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.992 -1.485 . . . . 72.450000000000003 106.992 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.03 117.04 13.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.931 0.395 . . . . 73.200000000000003 110.227 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -107.62 165.97 11.03 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.815 -0.63 . . . . 65.109999999999999 109.55 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.55 -28.68 32.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.963 0.887 . . . . 73.239999999999995 108.786 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -111.03 173.93 6.1 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.588 -1.634 . . . . 54.329999999999998 106.588 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.48 96.91 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 N-CA-C 106.018 -1.845 . . . . 63.340000000000003 106.018 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 m -105.13 106.74 17.37 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.65 -0.87 . . . . 75.420000000000002 108.65 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -56.29 -42.04 76.88 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.787 1.032 . . . . 74.5 113.787 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -148.7 129.31 14.05 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.857 -1.164 . . . . 73.129999999999995 107.857 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 4.1 t60 -100.29 -52.19 3.45 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.776 -1.194 . . . . 73.030000000000001 107.776 172.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.15 163.98 38.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.147 -1.057 . . . . 71.310000000000002 108.147 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 12.7 pt-20 -138.34 148.42 44.55 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.248 0.547 . . . . 74.230000000000004 110.631 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -105.29 131.72 52.39 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.18 -1.415 . . . . 71.439999999999998 107.18 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -122.95 130.93 53.44 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 116.319 -0.401 . . . . 60.509999999999998 110.444 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 46.3 mt -116.09 112.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.553 -2.017 . . . . 33.43 105.553 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -139.83 125.71 19.59 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.731 -0.47 . . . . 73.450000000000003 109.731 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 55.87 38.02 29.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.103 0.961 . . . . 73.239999999999995 112.353 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.52 -0.31 89.26 Favored Glycine 0 C--O 1.223 -0.564 0 C-N-CA 121.16 -0.543 . . . . 30.140000000000001 113.98 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -106.47 136.86 45.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.005 0.402 . . . . 55.210000000000001 110.046 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -107.79 119.51 39.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 71.010000000000005 108.127 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.35 146.64 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.733 -0.604 . . . . 62.299999999999997 112.329 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.04 123.98 58.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.508 -1.664 . . . . 61.130000000000003 106.508 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.43 122.38 68.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.419 -0.956 . . . . 51.310000000000002 108.419 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.12 134.58 35.67 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.994 -0.743 . . . . 73.230000000000004 108.994 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.74 9.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.068 0.461 . . . . 54.439999999999998 109.867 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.63 57.19 0.39 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 108.727 -1.749 . . . . 71.310000000000002 108.727 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 p -68.7 24.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.376 1.871 . . . . 74.400000000000006 114.349 -172.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -106.35 -26.47 11.48 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 116.431 -0.349 . . . . 74.129999999999995 111.546 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.537 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 2.9 m-20 -86.48 -18.94 30.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.601 -0.84 . . . . 73.340000000000003 111.738 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.98 74.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 119.664 -1.255 . . . . 55.149999999999999 113.073 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -87.76 128.56 35.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 110.036 -0.357 . . . . 75.510000000000005 110.036 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.0 m-85 -135.53 136.06 40.87 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.658 -0.867 . . . . 72.25 108.658 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 133.19 60.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.137 -1.431 . . . . 70.319999999999993 107.137 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.52 38.59 29.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.309 1.044 . . . . 74.129999999999995 108.688 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 64.18 14.85 8.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.046 1.498 . . . . 63.119999999999997 115.046 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -124.5 148.66 59.29 Favored Pre-proline 0 C--N 1.308 -1.202 0 C-N-CA 120.204 -0.599 . . . . 63.0 109.423 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 123.43 13.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.801 1.667 . . . . 74.349999999999994 108.502 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 120' ' ' GLN . 17.4 tpp85 -151.07 135.92 17.32 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.634 -0.827 . . . . 75.109999999999999 109.728 -170.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -96.7 -57.6 2.26 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.712 0.633 . . . . 61.219999999999999 110.552 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 134.04 55.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.834 -1.173 . . . . 64.150000000000006 107.834 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HB2' ' CG ' ' A' ' 117' ' ' ARG . 27.7 tp60 -155.08 132.9 11.42 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.226 0.329 . . . . 65.099999999999994 111.228 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.58 130.71 31.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.268 -1.382 . . . . 75.340000000000003 107.268 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.8 ptm -98.87 130.24 45.26 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.103 0.478 . . . . 70.450000000000003 110.183 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 2.8 tp60 -113.53 156.16 24.09 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.861 -0.609 . . . . 45.409999999999997 110.257 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 138' ' ' LEU . 45.2 m -61.34 123.29 17.35 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 122.31 -0.244 . . . . 63.520000000000003 110.379 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.07 -2.03 56.55 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.812 -0.515 . . . . 61.329999999999998 111.812 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.49 146.0 32.94 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 108.525 -0.917 . . . . 64.109999999999999 108.525 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.45 126.69 51.06 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.915 0.864 . . . . 65.329999999999998 110.654 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.41 131.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-N 114.599 -1.182 . . . . 65.219999999999999 108.02 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.2 tt0 -120.63 112.49 18.96 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.868 -1.16 . . . . 73.450000000000003 107.868 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.2 mt -109.66 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.237 -0.892 . . . . 73.439999999999998 109.18 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.19 -89.06 0.41 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.97 -1.252 . . . . 75.420000000000002 109.97 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -134.47 6.13 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.417 -0.586 . . . . 74.409999999999997 109.417 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.1 m-85 -84.59 147.77 26.82 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -124.88 120.06 30.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.84 -0.8 . . . . 73.319999999999993 108.84 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.33 138.07 50.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.387 -1.338 . . . . 64.109999999999999 107.387 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.11 127.13 74.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 107.539 -1.282 . . . . 72.150000000000006 107.539 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -95.49 126.95 41.13 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.435 0.459 . . . . 75.209999999999994 111.062 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HA ' HG23 ' A' ' 124' ' ' THR . 2.9 mm? -127.23 159.92 32.86 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.028 -0.73 . . . . 75.400000000000006 109.028 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.41 38.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.103 -0.703 . . . . 73.420000000000002 109.103 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.93 155.26 53.55 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.172 -0.537 . . . . 63.049999999999997 112.256 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -71.18 142.85 42.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.466 2.111 . . . . 75.150000000000006 111.52 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.98 65.27 0.8 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.163 -1.421 . . . . 74.109999999999999 107.163 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.607 -1.633 . . . . 65.540000000000006 108.499 -176.82 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.682 0.277 . . . . 74.129999999999995 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -72.68 82.3 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 115.314 1.598 . . . . 74.230000000000004 115.314 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -95.48 105.66 17.65 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.554 -1.647 . . . . 64.010000000000005 106.554 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -62.96 100.47 0.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.698 0.999 . . . . 72.329999999999998 113.698 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.36 155.81 36.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.055 -0.975 . . . . 73.319999999999993 110.011 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 167.22 30.84 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.392 -1.083 . . . . 72.450000000000003 110.392 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -105.18 108.35 61.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 117.196 0.498 . . . . 53.340000000000003 110.767 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.44 150.6 52.32 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.617 2.211 . . . . 73.340000000000003 112.576 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -79.44 119.68 77.79 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.361 -0.978 . . . . 71.409999999999997 108.361 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.98 160.01 43.77 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.225 1.95 . . . . 44.520000000000003 112.287 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -91.66 162.57 14.44 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.095 -1.817 . . . . 64.329999999999998 106.095 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.6 t -108.22 121.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 119.326 -0.949 . . . . 72.420000000000002 109.694 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.65 138.42 32.5 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.319 -0.993 . . . . 71.349999999999994 108.319 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -76.48 133.31 39.83 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.83 0.706 . . . . 75.120000000000005 109.976 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.459 HG22 HG21 ' A' ' 84' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.1 m -89.41 152.92 21.23 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.602 -0.888 . . . . 72.400000000000006 108.602 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.63 115.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.746 -0.835 . . . . 64.120000000000005 108.746 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -123.82 140.78 52.65 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.697 -0.683 . . . . 75.219999999999999 110.554 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -97.53 95.58 7.73 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.1 -1.074 . . . . 72.430000000000007 108.1 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.82 38.85 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.668 -1.151 . . . . 74.120000000000005 112.069 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.86 2.18 2.16 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.536 1.135 . . . . 75.219999999999999 113.759 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -13.77 59.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 72.230000000000004 112.758 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -69.03 -19.67 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.342 0.592 . . . . 62.32 109.929 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.09 -22.52 59.47 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.077 -0.51 . . . . 74.099999999999994 110.499 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -77.09 -29.95 55.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.231 0.539 . . . . 61.539999999999999 109.939 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -65.3 -47.47 76.5 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.941 -1.133 . . . . 73.510000000000005 107.941 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.32 -39.86 94.43 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.318 -1.31 . . . . 61.009999999999998 110.251 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 t -60.84 -39.01 87.48 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.786 1.234 . . . . 63.119999999999997 110.884 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB2' ' NH1' ' A' ' 114' ' ' ARG . 31.3 t -81.71 -16.52 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.583 -0.28 . . . . 63.100000000000001 110.512 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 m 71.57 31.63 2.2 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 122.525 1.155 . . . . 71.340000000000003 108.481 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.89 -151.05 19.69 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 115.097 -0.956 . . . . 70.150000000000006 112.04 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -84.78 137.97 32.88 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.144 0.577 . . . . 42.240000000000002 110.433 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.9 115.57 59.43 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 73.140000000000001 108.304 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 142.51 25.99 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.354 2.036 . . . . 74.209999999999994 114.9 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.12 126.51 30.18 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.466 -2.049 . . . . 61.310000000000002 105.466 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' THR . 55.4 p -91.32 -98.43 0.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.253 -0.979 . . . . 63.43 113.445 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -170.34 -169.97 0.89 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.007 1.323 . . . . 71.120000000000005 108.877 -177.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.07 -161.44 31.98 Favored Glycine 1 N--CA 1.386 -4.684 0 N-CA-C 105.961 -2.856 . . . . 54.009999999999998 105.961 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.9 -20.88 20.95 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.887 -1.153 . . . . 73.329999999999998 107.887 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.62 -10.7 59.96 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.193 -1.821 . . . . 64.129999999999995 112.965 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' O ' HD13 ' A' ' 42' ' ' LEU . 32.4 p-10 -80.39 -33.72 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.377 -0.529 . . . . 73.329999999999998 110.74 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 97' ' ' GLY . 2.1 mm? -128.13 82.92 67.53 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.141 -1.059 . . . . 71.239999999999995 108.141 173.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 4.0 Cg_exo -77.24 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.173 1.915 . . . . 72.109999999999999 111.758 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 142' ' ' ALA . . . -104.48 -7.05 20.08 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.449 -0.574 . . . . 75.310000000000002 109.449 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.06 43.75 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.386 -1.086 . . . . 71.409999999999997 110.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -126.07 149.27 49.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.376 -1.342 . . . . 74.510000000000005 107.376 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.07 157.75 42.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.606 -0.516 . . . . 61.109999999999999 109.606 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.17 142.18 51.44 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 110.003 -0.369 . . . . 70.030000000000001 110.003 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.476 HD13 HD23 ' A' ' 135' ' ' LEU . 3.7 pp -110.17 139.31 45.46 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.902 -0.777 . . . . 71.319999999999993 108.902 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.56 132.59 68.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 109.538 -0.542 . . . . 73.310000000000002 109.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -81.59 117.45 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.048 -1.464 . . . . 43.240000000000002 107.048 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -85.78 -38.22 18.44 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.489 -0.778 . . . . 64.439999999999998 109.119 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 22.6 tpt180 -148.16 136.9 21.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.2 -1.407 . . . . 75.439999999999998 107.2 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.68 -176.55 26.46 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.681 -0.968 . . . . 43.530000000000001 110.681 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 -45.18 12.01 Favored 'Trans proline' 0 C--N 1.327 -0.572 0 C-N-CA 122.519 2.146 . . . . 73.230000000000004 112.145 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -95.11 23.08 5.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 111.83 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 138.77 46.98 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.32 -0.4 . . . . 71.310000000000002 111.286 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.57 -25.8 23.32 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.878 -0.889 . . . . 45.5 110.878 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 150.2 21.81 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.033 0.444 . . . . 41.530000000000001 110.19 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -126.45 153.56 44.88 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.221 -1.029 . . . . 70.310000000000002 108.221 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -128.14 130.18 47.69 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.82 -0.807 . . . . 72.439999999999998 108.82 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 tp -95.53 130.8 42.25 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.997 -0.547 . . . . 73.530000000000001 110.197 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -107.31 105.19 15.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.044 -1.095 . . . . 65.010000000000005 108.044 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.42 14.89 6.08 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.847 1.308 . . . . 63.310000000000002 107.709 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -114.43 155.01 46.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 113.825 -1.534 . . . . 61.229999999999997 108.507 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 66.5 Cg_endo -72.79 -14.64 26.9 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.734 2.289 . . . . 73.329999999999998 113.61 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 95.3 m -153.22 128.94 10.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.562 -0.711 . . . . 71.340000000000003 110.54 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 15.4 m -130.09 126.89 38.67 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.66 -0.496 . . . . 71.439999999999998 109.66 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.0 m -90.55 129.59 36.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.639 -0.874 . . . . 64.310000000000002 108.639 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.02 134.56 55.12 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.364 0.602 . . . . 55.119999999999997 110.66 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.37 -170.09 33.37 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.438 -2.665 . . . . 61.310000000000002 106.438 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -105.96 118.18 35.95 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.946 1.373 . . . . 71.340000000000003 110.396 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.414 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 17.7 m170 -172.84 152.02 2.34 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 127.184 2.194 . . . . 65.129999999999995 106.06 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.83 -17.6 28.95 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 121.627 1.552 . . . . 64.219999999999999 108.952 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 73' ' ' HIS . 8.7 mm-40 -76.81 -26.84 54.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.952 -1.476 . . . . 74.150000000000006 110.035 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 45.6 m -67.61 132.25 47.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.707 -0.849 . . . . 64.120000000000005 108.707 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.72 -41.44 95.96 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.08 -0.711 . . . . 60.420000000000002 109.08 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.6 pt -107.64 118.8 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.646 -0.872 . . . . 73.219999999999999 108.646 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.54 109.42 20.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.755 0.788 . . . . 74.430000000000007 110.512 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.16 140.37 49.6 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.438 -1.69 . . . . 71.239999999999995 106.438 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.32 117.67 34.65 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.363 -0.977 . . . . 73.510000000000005 108.363 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -102.62 173.85 6.16 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.927 -1.033 . . . . 71.209999999999994 111.956 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -66.14 -30.94 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 124.316 1.047 . . . . 71.010000000000005 108.732 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.459 HG21 HG22 ' A' ' 15' ' ' TPO . 15.0 m -117.17 163.1 16.8 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 106.899 -1.519 . . . . 52.229999999999997 106.899 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.32 96.92 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 N-CA-C 104.434 -2.432 . . . . 74.219999999999999 104.434 168.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.413 ' HA ' ' O2P' ' A' ' 15' ' ' TPO . 2.0 p -94.2 131.54 39.66 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.494 -0.775 . . . . 71.530000000000001 110.326 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 87' ' ' ARG . 36.9 mtt180 -74.23 -47.59 34.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 123.224 1.488 . . . . 72.450000000000003 107.117 -175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -149.54 115.55 5.69 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 112.557 -2.11 . . . . 72.430000000000007 107.807 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -99.22 -47.2 5.28 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.735 -0.839 . . . . 65.230000000000004 108.735 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.54 151.51 40.32 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.895 -0.78 . . . . 60.200000000000003 108.895 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.8 134.55 54.41 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.902 -1.147 . . . . 52.409999999999997 107.902 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.7 m-85 -105.2 121.43 43.83 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.257 -1.016 . . . . 74.010000000000005 108.257 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -115.85 123.74 48.93 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.171 -1.048 . . . . 63.299999999999997 108.171 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.9 mp -104.49 123.15 58.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 106.609 -1.626 . . . . 63.310000000000002 106.609 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -136.87 123.66 21.24 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.986 -1.116 . . . . 72.5 107.986 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 56.13 36.13 26.87 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.605 1.162 . . . . 71.409999999999997 111.102 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' HD12 ' A' ' 42' ' ' LEU . . . 78.97 -0.32 79.2 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 113.374 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.7 149.7 23.88 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.002 -0.74 . . . . 73.430000000000007 109.002 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.8 117.54 33.11 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.126 -0.488 . . . . 63.219999999999999 110.089 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.78 129.93 55.51 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.152 0.501 . . . . 71.120000000000005 109.658 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.49 124.6 59.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.526 -0.916 . . . . 63.509999999999998 108.526 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.22 137.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.257 -0.646 . . . . 62.030000000000001 109.257 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.81 140.94 30.02 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.64 -0.709 . . . . 64.420000000000002 110.841 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.63 14.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 122.39 1.09 . . . . 74.439999999999998 108.555 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.93 48.48 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.572 -1.411 . . . . 72.109999999999999 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -60.06 -2.6 0.45 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.876 1.67 . . . . 75.230000000000004 113.631 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.14 -26.0 17.62 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.447 -0.575 . . . . 75.430000000000007 109.447 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -94.71 -18.65 21.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 73.219999999999999 111.83 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.92 77.1 1.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.012 -1.089 . . . . 61.109999999999999 112.643 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.1 m -87.02 128.68 35.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.014 0.435 . . . . 75.109999999999999 110.388 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 35.9 m-85 -133.64 127.41 32.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.261 -0.427 . . . . 72.319999999999993 110.516 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.15 137.66 55.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 105.398 -2.075 . . . . 64.230000000000004 105.398 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 57.3 33.77 23.78 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 106.738 -1.579 . . . . 64.239999999999995 106.738 -166.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.496 ' NH1' ' HB2' ' A' ' 29' ' ' SER . 73.6 mtt180 57.94 11.43 1.43 Allowed 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 123.187 0.595 . . . . 63.340000000000003 111.655 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -107.7 144.47 29.36 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 124.388 1.075 . . . . 75.219999999999999 110.248 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.14 123.93 12.26 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.089 1.859 . . . . 64.209999999999994 108.787 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 117' ' ' ARG . 3.7 mmp_? -135.82 155.85 49.71 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.667 0.988 . . . . 73.150000000000006 113.667 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -99.2 -41.85 7.31 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.9 -1.5 . . . . 62.219999999999999 107.434 171.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.4 143.61 25.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.52 -1.218 . . . . 71.310000000000002 108.197 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 138.15 19.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.011 -1.107 . . . . 54.509999999999998 108.011 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.73 116.7 40.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 105.412 -2.07 . . . . 75.019999999999996 105.412 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 77.4 mtp -89.75 149.08 22.88 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 114.163 1.172 . . . . 64.129999999999995 114.163 -168.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -112.43 157.38 21.14 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.661 -1.609 . . . . 61.420000000000002 107.778 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.6 t -66.27 127.39 32.01 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.169 -0.613 . . . . 73.129999999999995 109.829 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 0.03 57.32 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.266 -0.734 . . . . 71.439999999999998 111.266 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -82.77 152.27 25.77 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.964 -0.384 . . . . 72.019999999999996 109.964 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -115.71 144.18 44.32 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.263 0.554 . . . . 75.420000000000002 112.237 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.6 mt -117.91 131.88 69.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.442 . . . . 74.420000000000002 107.108 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 111' ' ' TYR . 54.9 mt-30 -117.84 120.55 38.23 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.56 -0.904 . . . . 73.319999999999993 108.56 175.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.75 114.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.301 -0.863 . . . . 70.010000000000005 108.836 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.0 -80.98 0.57 Allowed Glycine 0 C--O 1.206 -1.594 0 N-CA-C 110.006 -1.238 . . . . 35.130000000000003 110.006 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -154.87 8.28 0.3 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.436 0.294 . . . . 72.299999999999997 111.112 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 31.1 p90 -107.39 160.29 15.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.881 -0.785 . . . . 62.43 108.881 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -124.76 137.82 54.31 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.234 -0.986 . . . . 64.120000000000005 112.329 -168.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.476 HD23 HD13 ' A' ' 49' ' ' LEU . 3.0 mp -122.32 139.82 53.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.698 -1.223 . . . . 75.209999999999994 107.698 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.12 124.93 69.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.768 -1.197 . . . . 55.32 107.768 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -98.28 118.26 34.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.188 -0.671 . . . . 75.25 109.188 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.4 mt -122.34 131.67 54.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.972 -0.381 . . . . 75.239999999999995 109.972 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.29 119.57 28.82 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.458 -1.682 . . . . 72.219999999999999 106.458 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.01 -70.66 0.29 Allowed Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.519 -1.324 . . . . 73.099999999999994 115.356 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 43' ' ' PRO . 25.7 Cg_exo -57.74 141.28 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.693 1.595 . . . . 71.25 114.785 -172.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . . . -161.84 29.34 0.12 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.011 -2.588 . . . . 71.540000000000006 104.011 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.416 -2.154 0 CA-C-N 112.99 -1.914 . . . . 41.140000000000001 108.31 -169.134 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 121.423 0.63 . . . . 61.420000000000002 111.543 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -92.76 11.92 25.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.672 0.749 . . . . 73.219999999999999 109.078 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.32 158.83 16.44 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 125.308 1.443 . . . . 72.230000000000004 110.823 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -79.69 -178.39 6.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.213 -0.448 . . . . 74.040000000000006 111.306 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.8 94.32 8.68 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.203 0.525 . . . . 71.219999999999999 111.092 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.51 36.31 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.967 -1.253 . . . . 72.129999999999995 109.967 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.8 p -99.38 113.22 64.69 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 119.824 -0.75 . . . . 64.209999999999994 111.551 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.16 132.63 37.25 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 N-CA-C 106.311 -2.227 . . . . 62.149999999999999 106.311 167.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.37 140.49 56.34 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 119.818 -0.753 . . . . 51.350000000000001 110.564 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -67.8 92.38 0.37 Allowed 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 121.915 1.744 . . . . 73.150000000000006 111.976 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -119.58 149.89 41.2 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.418 -1.327 . . . . 63.32 107.418 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 t -109.07 121.65 62.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.076 -1.453 . . . . 61.439999999999998 107.076 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -119.16 169.3 10.06 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.884 -1.154 . . . . 73.219999999999999 107.884 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -67.87 109.61 3.48 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.762 0.791 . . . . 61.329999999999998 111.761 -170.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -124.92 120.82 32.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.009 -0.367 . . . . 73.219999999999999 110.009 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 47.1 t -87.17 122.44 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.302 -0.629 . . . . 61.539999999999999 109.302 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -123.66 129.02 50.49 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.872 0.368 . . . . 74.530000000000001 111.855 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -96.55 116.03 28.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.266 -1.753 . . . . 75.129999999999995 106.266 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.36 -166.71 2.63 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.546 -0.862 . . . . 73.239999999999995 113.315 -171.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.16 -14.28 1.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.886 2.074 . . . . 73.040000000000006 115.059 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 22' ' ' LEU . 1.8 pt? -64.66 -23.11 67.15 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.119 -0.363 . . . . 73.439999999999998 111.744 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.19 -22.5 63.9 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.877 0.37 . . . . 72.450000000000003 111.823 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -91.8 -42.04 10.32 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.822 -1.547 . . . . 74.400000000000006 106.822 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -26.37 67.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.642 1.177 . . . . 54.32 109.397 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.6 tpp -51.75 -26.13 8.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.757 1.223 . . . . 65.209999999999994 112.167 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.49 -38.34 86.94 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 120.725 0.298 . . . . 61.340000000000003 110.472 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -72.91 -34.96 66.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.234 -0.654 . . . . 64.439999999999998 109.234 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.45 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 17.9 m -68.81 -30.5 69.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.901 -0.591 . . . . 71.120000000000005 110.065 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.4 m -81.55 107.03 13.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.18 0.514 . . . . 54.420000000000002 110.797 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 179.65 38.69 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 108.997 -1.641 . . . . 44.439999999999998 108.997 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.6 m -74.94 124.16 26.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 117.69 0.745 . . . . 72.099999999999994 109.646 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.45 150.24 38.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 N-CA-C 108.251 -1.018 . . . . 53.210000000000001 108.251 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 125' ' ' GLY . 53.4 Cg_exo -57.18 154.97 31.25 Favored 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.551 2.167 . . . . 52.310000000000002 111.876 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.07 145.67 27.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.695 -0.684 . . . . 33.310000000000002 112.335 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.426 ' HB3' HD21 ' A' ' 41' ' ' ASN . 66.1 m -116.07 148.3 40.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.122 -1.066 . . . . 75.439999999999998 108.122 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -116.74 -60.68 1.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.931 0.396 . . . . 75.140000000000001 111.384 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.83 -63.55 0.18 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.467 -0.653 . . . . 50.009999999999998 111.467 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.56 54.5 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.123 0.487 . . . . 73.409999999999997 110.95 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.52 -5.92 47.62 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.424 -0.807 . . . . 63.219999999999999 111.08 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 36' ' ' SER . 3.1 m-20 -82.09 -42.17 19.54 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.414 -0.812 . . . . 62.420000000000002 110.131 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.32 83.22 60.21 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 109.086 -0.709 . . . . 54.119999999999997 109.086 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.39 -65.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.848 2.365 . . . . 73.150000000000006 112.269 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.13 -16.19 59.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 71.230000000000004 111.012 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.97 -7.44 77.6 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 110.975 -0.85 . . . . 75.340000000000003 110.975 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -120.08 157.08 29.7 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.624 -1.621 . . . . 74.439999999999998 106.624 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.89 156.87 43.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.583 -0.525 . . . . 72.25 109.583 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.95 140.82 52.57 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.996 0.427 . . . . 72.219999999999999 110.712 -178.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.417 HD13 HD23 ' A' ' 135' ' ' LEU . 1.5 pp -112.19 140.73 46.65 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 116.288 -0.414 . . . . 74.420000000000002 110.931 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.71 128.08 71.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.45 118.92 26.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.736 -1.209 . . . . 73.409999999999997 107.736 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -83.4 -32.63 26.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.62 0.724 . . . . 74.299999999999997 110.131 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 20.2 tpp180 -154.01 148.81 26.53 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.992 -1.485 . . . . 72.439999999999998 106.992 -177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.28 -174.85 17.86 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 109.722 -1.351 . . . . 61.520000000000003 109.722 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -65.2 -37.95 29.58 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.309 2.006 . . . . 64.230000000000004 111.029 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.61 14.37 11.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.749 -1.114 . . . . 72.109999999999999 110.862 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 129.32 41.55 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.762 0.315 . . . . 63.210000000000001 111.295 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.0 -26.05 24.38 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.95 -0.568 . . . . 54.229999999999997 112.188 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.81 144.77 29.9 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.839 0.352 . . . . 53.130000000000003 110.133 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -123.69 137.54 54.69 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.992 -0.744 . . . . 73.219999999999999 108.992 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.04 130.56 52.76 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.705 -0.48 . . . . 72.140000000000001 109.705 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.75 128.4 36.67 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.644 -1.243 . . . . 75.340000000000003 107.644 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.731 HD22 HG21 ' A' ' 68' ' ' THR . 26.6 mt -106.78 123.95 48.89 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.057 -1.09 . . . . 61.409999999999997 108.057 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -136.57 1.11 2.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.688 0.996 . . . . 64.450000000000003 113.688 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.545 ' O ' HD13 ' A' ' 94' ' ' ILE . 28.1 pt20 -107.24 152.88 41.33 Favored Pre-proline 0 C--O 1.211 -0.961 0 C-N-CA 119.556 -0.857 . . . . 74.510000000000005 110.13 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 8.8 Cg_endo -52.2 -21.56 13.32 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 124.088 3.192 . . . . 74.310000000000002 114.996 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.7 m -142.51 121.66 12.97 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.723 -0.473 . . . . 71.420000000000002 109.723 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.731 HG21 HD22 ' A' ' 63' ' ' LEU . 67.9 m -129.3 113.27 14.78 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.162 -0.681 . . . . 73.409999999999997 109.162 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -94.28 143.1 26.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.707 -0.797 . . . . 74.420000000000002 109.811 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.16 135.02 54.73 Favored 'General case' 0 C--O 1.279 2.644 0 C-N-CA 122.63 0.372 . . . . 52.420000000000002 111.516 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.22 -142.12 10.24 Favored Glycine 0 N--CA 1.435 -1.401 0 O-C-N 124.759 1.287 . . . . 60.340000000000003 111.882 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 86' ' ' SER . 17.9 mmt85 -88.04 154.74 20.24 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.615 1.966 . . . . 62.299999999999997 110.272 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.433 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 22.9 m170 89.17 130.06 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.718 1.607 . . . . 63.240000000000002 111.057 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.21 -3.22 8.27 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.818 2.345 . . . . 75.230000000000004 113.283 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 13.2 pt-20 -73.56 -25.3 60.31 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.888 -0.782 . . . . 75.109999999999999 108.888 173.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.9 m -78.55 143.62 36.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.335 -1.357 . . . . 61.039999999999999 107.335 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' A' ' 68' ' ' THR . 30.0 t70 -69.44 -45.72 68.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.78 0.324 . . . . 74.010000000000005 111.142 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.3 pt -107.45 109.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 121.859 0.838 . . . . 72.120000000000005 111.032 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -87.86 115.81 25.59 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.514 -1.221 . . . . 71.329999999999998 110.652 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.21 139.98 49.79 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.1 -1.815 . . . . 72.540000000000006 106.1 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -92.2 117.05 29.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.474 -1.29 . . . . 52.240000000000002 110.197 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 171.69 7.82 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 110.24 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.93 -29.38 17.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.343 1.057 . . . . 64.109999999999999 109.76 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.3 t -131.26 -163.17 1.29 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.484 -0.932 . . . . 74.450000000000003 108.484 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -84.05 97.33 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.791 0.805 . . . . 65.450000000000003 109.008 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 16.4 t -95.9 77.83 3.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.879 -1.526 . . . . 64.329999999999998 106.879 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -56.68 -44.48 81.48 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 112.825 0.676 . . . . 74.329999999999998 112.825 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -163.42 97.3 0.88 Allowed 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.108 -1.812 . . . . 75.209999999999994 106.108 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 23.7 t-160 -92.77 -52.04 4.8 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.883 -0.727 . . . . 75.109999999999999 109.483 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -128.25 150.14 50.17 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 118.986 -1.086 . . . . 74.239999999999995 110.246 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.36 134.46 36.0 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.97 -0.752 . . . . 74.430000000000007 108.97 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 30.0 m-85 -104.27 120.31 40.89 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.43 -1.693 . . . . 54.229999999999997 106.43 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -110.19 133.75 52.91 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.61 -1.256 . . . . 72.310000000000002 107.61 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 1.9 mp -103.6 113.47 40.52 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 105.64 -1.985 . . . . 65.530000000000001 105.64 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -130.0 122.52 28.61 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.36 -1.291 . . . . 65.310000000000002 108.19 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 56.54 36.86 28.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.937 0.895 . . . . 71.349999999999994 110.786 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.44 1.69 77.01 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.218 -0.447 . . . . 71.430000000000007 113.873 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.23 152.78 29.34 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.852 0.461 . . . . 75.510000000000005 110.337 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -102.2 117.92 35.79 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.22 0.533 . . . . 73.349999999999994 110.483 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -114.89 131.85 56.72 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.078 -1.082 . . . . 72.010000000000005 108.078 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 48.0 t -103.55 124.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.817 -0.809 . . . . 65.239999999999995 108.817 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.71 129.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 115.586 -0.734 . . . . 75.329999999999998 109.247 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.0 121.9 23.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.495 -1.669 . . . . 53.229999999999997 106.495 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.43 12.42 7.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.032 0.444 . . . . 75.420000000000002 110.853 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . 169.65 83.35 0.05 OUTLIER Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.595 -1.002 . . . . 72.049999999999997 110.595 -178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.8 m -60.63 100.44 0.11 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 122.832 0.453 . . . . 64.319999999999993 110.735 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 tp -73.68 -52.31 13.72 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.988 -1.115 . . . . 74.019999999999996 107.988 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -121.44 -19.15 7.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.092 0.949 . . . . 55.130000000000003 108.613 170.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.08 130.41 3.74 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 108.446 -1.862 . . . . 72.409999999999997 108.446 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 56.3 m -81.73 130.18 34.97 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 117.13 0.465 . . . . 73.230000000000004 109.984 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 98.1 m-85 -105.43 126.24 51.89 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.29 -0.633 . . . . 70.299999999999997 109.29 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.57 122.82 67.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 105.642 -1.984 . . . . 73.420000000000002 105.642 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 56.67 39.65 29.64 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.49 1.138 . . . . 61.420000000000002 108.155 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER 62.5 8.69 3.0 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.267 1.827 . . . . 73.409999999999997 113.44 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.28 134.53 20.44 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.949 -0.76 . . . . 75.540000000000006 108.949 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.8 123.01 12.36 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 121.977 1.784 . . . . 74.400000000000006 109.737 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -145.33 148.71 33.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.959 -0.756 . . . . 63.020000000000003 108.959 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -95.1 -70.16 0.72 Allowed 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.158 -0.682 . . . . 73.340000000000003 109.158 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -124.53 134.47 52.99 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 119.715 -0.794 . . . . 32.450000000000003 109.835 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -155.19 147.04 23.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.095 -0.502 . . . . 74.239999999999995 110.832 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.24 132.12 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.698 -1.593 . . . . 74.549999999999997 106.698 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.2 tpp -90.15 148.79 22.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 112.963 0.727 . . . . 73.150000000000006 112.963 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.2 156.35 28.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.774 -1.103 . . . . 62.509999999999998 108.996 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.7 t -79.56 129.36 34.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.79 0.805 . . . . 64.329999999999998 111.252 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.546 ' O ' ' HD2' ' A' ' 34' ' ' PRO . . . 98.95 -2.84 58.37 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 115.485 -0.779 . . . . 54.030000000000001 111.82 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.97 153.25 21.18 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.403 -0.592 . . . . 70.230000000000004 109.403 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.03 132.18 56.73 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.692 0.758 . . . . 74.25 112.077 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.9 mt -111.16 126.37 68.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.444 -1.317 . . . . 51.130000000000003 107.444 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' ARG . 25.9 tt0 -106.41 114.99 29.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.53 0.681 . . . . 61.420000000000002 110.62 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mm -110.61 133.69 55.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.026 -1.443 . . . . 71.209999999999994 108.09 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.88 -93.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.375 -1.09 . . . . 65.5 110.375 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -140.03 9.06 2.32 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.563 0.345 . . . . 61.5 110.941 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.608 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.0 p90 -131.7 152.53 50.81 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.033 -0.417 . . . . 60.340000000000003 111.775 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -112.83 146.15 39.39 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 114.126 1.158 . . . . 74.439999999999998 114.126 -174.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 49' ' ' LEU . 4.4 mp -114.55 141.79 47.28 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.285 -1.78 . . . . 74.230000000000004 107.454 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -109.4 121.57 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.888 -1.523 . . . . 75.409999999999997 106.888 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -91.65 116.22 28.69 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.681 -0.69 . . . . 75.200000000000003 109.944 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.84 147.93 37.53 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.687 -0.486 . . . . 75.140000000000001 109.687 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.03 142.41 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.776 -0.453 . . . . 71.510000000000005 109.776 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.3 136.53 47.8 Favored Glycine 0 N--CA 1.441 -1.013 0 O-C-N 123.914 0.759 . . . . 63.030000000000001 112.496 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.19 162.46 35.78 Favored 'Trans proline' 0 C--O 1.251 1.156 0 C-N-CA 123.192 2.595 . . . . 61.130000000000003 112.357 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.5 46.02 0.61 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.96 0.886 . . . . 73.510000000000005 110.883 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.421 -1.326 . . . . 73.299999999999997 107.421 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 114.141 1.163 . . . . 73.209999999999994 114.141 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 p -125.98 17.0 7.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.187 -1.783 . . . . 75.340000000000003 106.187 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.75 17.12 24.72 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 112.952 -1.931 . . . . 65.430000000000007 110.267 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.36 135.88 36.84 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.86 -1.163 . . . . 74.420000000000002 107.86 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -53.49 113.37 1.14 Allowed 'General case' 0 C--O 1.248 1.016 0 O-C-N 123.9 0.75 . . . . 74.329999999999998 111.05 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.6 68.46 2.98 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.734 -0.666 . . . . 51.229999999999997 112.77 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -85.69 127.73 61.63 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 108.557 -0.905 . . . . 63.140000000000001 108.557 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.42 132.02 36.5 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.836 1.691 . . . . 63.25 108.986 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -115.62 128.83 25.63 Favored Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-N 116.233 -0.439 . . . . 74.010000000000005 111.761 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.4 108.02 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.148 1.899 . . . . 75.109999999999999 109.008 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -131.16 164.05 26.35 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.158 -1.053 . . . . 73.349999999999994 108.158 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.39 120.27 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.914 -1.884 . . . . 63.329999999999998 105.914 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -125.65 148.36 49.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.613 -1.995 . . . . 75.230000000000004 105.613 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -131.59 109.2 10.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.019 -1.073 . . . . 73.310000000000002 113.113 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -88.69 132.68 34.49 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.483 -0.932 . . . . 72.329999999999998 108.483 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 91.2 t -83.56 122.91 38.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.071 -0.344 . . . . 74.209999999999994 110.071 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -115.39 139.91 49.6 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.248 0.547 . . . . 75.420000000000002 110.369 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -88.3 118.23 27.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.421 -0.809 . . . . 74.340000000000003 109.594 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -128.84 169.81 14.13 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.547 -0.752 . . . . 52.439999999999998 110.311 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.19 8.21 24.92 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.989 1.716 . . . . 71.510000000000005 112.145 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -61.28 -4.78 1.3 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.604 1.162 . . . . 75.109999999999999 113.861 -175.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.47 -40.31 86.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.285 0.634 . . . . 64.040000000000006 109.32 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -64.97 -27.71 69.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.78 -0.645 . . . . 73.430000000000007 111.323 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -69.07 -48.73 61.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.45 -0.341 . . . . 72.019999999999996 110.931 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 ptp -68.74 -17.98 64.14 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.721 0.296 . . . . 73.230000000000004 110.996 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.97 -50.17 4.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 112.079 0.4 . . . . 61.109999999999999 112.079 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 m -102.05 -27.61 12.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.565 1.321 . . . . 74.430000000000007 114.565 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -76.2 -21.67 56.19 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.287 -1.005 . . . . 63.039999999999999 108.287 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -70.58 119.57 14.93 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.655 -1.157 . . . . 62.43 108.429 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.06 -37.25 0.53 Allowed Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 106.909 -2.476 . . . . 55.009999999999998 106.909 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -77.81 122.12 25.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.431 -0.951 . . . . 44.200000000000003 108.431 173.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.64 155.57 62.08 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 116.32 -0.4 . . . . 72.25 109.965 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.03 158.33 21.83 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.95 2.433 . . . . 72.230000000000004 111.669 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.48 156.93 25.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.811 -0.44 . . . . 74.420000000000002 109.811 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -118.26 134.56 54.92 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 108.744 -0.836 . . . . 74.230000000000004 108.744 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.2 p -144.44 162.45 36.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.793 -1.188 . . . . 75.310000000000002 107.793 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.89 18.14 56.29 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.402 -1.079 . . . . 45.420000000000002 110.402 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.1 11.3 23.57 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.396 0.679 . . . . 74.340000000000003 111.179 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.26 3.64 5.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.392 0.677 . . . . 71.420000000000002 112.279 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.04 -16.72 18.58 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.223 -1.029 . . . . 75.329999999999998 108.223 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.2 mm? 58.34 85.68 0.18 Allowed Pre-proline 0 C--O 1.222 -0.37 0 CA-C-N 115.048 -0.978 . . . . 73.409999999999997 111.101 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 18.9 Cg_endo -55.23 -54.04 4.94 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.923 2.415 . . . . 73.200000000000003 113.166 -174.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.46 0.76 51.35 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.251 -0.432 . . . . 61.25 111.108 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 10.8 70.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 116.344 -0.389 . . . . 52.439999999999998 112.928 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 m -124.13 149.45 46.23 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.476 -0.565 . . . . 71.140000000000001 109.476 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.26 157.41 44.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.802 -1.184 . . . . 71.439999999999998 107.802 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.54 155.34 50.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.43 -0.508 . . . . 75.400000000000006 111.328 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.3 pp -119.79 134.53 55.2 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.927 -0.578 . . . . 72.510000000000005 109.812 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.09 132.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.121 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG21 ' ND2' ' A' ' 56' ' ' ASN . 21.8 t -83.55 118.39 30.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.199 -1.037 . . . . 71.420000000000002 108.199 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.74 -31.62 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.554 0.693 . . . . 74.540000000000006 110.338 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 64.6 ttt180 -137.8 136.63 37.41 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.894 -1.15 . . . . 74.109999999999999 107.894 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.27 176.91 15.97 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 110.195 -1.162 . . . . 44.240000000000002 110.195 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.68 -32.89 18.0 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 122.268 1.979 . . . . 72.299999999999997 110.986 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.49 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.2 p-10 -99.67 23.32 9.71 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.959 -1.019 . . . . 71.530000000000001 110.561 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.43 57.6 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.071 -0.513 . . . . 64.120000000000005 110.718 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.94 -18.28 50.16 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.856 -0.898 . . . . 41.299999999999997 110.856 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 147.42 25.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.76 0.314 . . . . 73.349999999999994 110.328 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 60' ' ' ARG . 5.7 ptp180 -124.42 139.23 54.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.937 -1.134 . . . . 74.530000000000001 107.937 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.78 134.7 54.92 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.032 -1.099 . . . . 73.430000000000007 108.032 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tt -104.29 128.59 52.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.64 0.734 . . . . 63.130000000000003 110.703 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 76.1 mt -103.54 107.55 18.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.642 -0.708 . . . . 64.120000000000005 109.768 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -146.64 17.24 1.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.781 1.277 . . . . 60.030000000000001 107.87 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 63' ' ' LEU . 3.3 pm0 -118.12 149.87 46.44 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.294 -1.321 . . . . 74.430000000000007 109.536 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.2 Cg_exo -55.25 -30.66 72.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.148 2.566 . . . . 72.019999999999996 114.453 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 m -149.45 131.68 15.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.686 -0.805 . . . . 63.030000000000001 111.062 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 m -133.81 114.08 12.98 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.298 -0.63 . . . . 75.109999999999999 109.298 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -88.6 132.53 34.51 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.703 -0.851 . . . . 62.140000000000001 108.703 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 140.54 49.83 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 120.915 0.388 . . . . 52.219999999999999 111.257 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.45 -160.42 30.94 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 107.719 -2.152 . . . . 63.530000000000001 107.719 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 35.9 ttp180 -119.31 117.71 29.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.162 0.981 . . . . 75.340000000000003 110.348 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 0.5 OUTLIER 161.54 158.79 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 104.094 -2.558 . . . . 73.349999999999994 104.094 173.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 18.9 Cg_endo -64.54 -9.91 22.32 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 121.969 1.78 . . . . 74.140000000000001 112.229 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.51 -10.98 58.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.645 -0.707 . . . . 35.450000000000003 110.197 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 m -87.25 143.88 27.07 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 106.526 -1.657 . . . . 74.239999999999995 106.526 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.1 -42.78 36.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.849 0.833 . . . . 74.319999999999993 109.883 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.79 132.51 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 107.372 -1.344 . . . . 53.420000000000002 107.372 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -94.02 117.18 29.75 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.401 0.62 . . . . 61.039999999999999 111.913 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.4 140.28 49.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.032 -2.211 . . . . 75.239999999999995 105.032 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 26.7 t70 -91.41 116.22 28.67 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.277 -1.369 . . . . 64.209999999999994 109.17 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.454 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 15.6 t0 -96.21 167.03 11.45 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.46 -0.791 . . . . 74.430000000000007 109.244 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.76 -30.64 29.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.044 0.449 . . . . 71.239999999999995 109.934 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -137.64 -152.81 0.45 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.257 -0.645 . . . . 63.530000000000001 109.257 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.54 98.37 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.554 0.693 . . . . 74.040000000000006 109.941 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.2 m -124.07 84.87 2.33 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.316 -1.364 . . . . 64.530000000000001 107.316 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -62.28 -44.61 96.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.04 -0.982 . . . . 72.510000000000005 111.533 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -118.78 110.93 17.82 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.003 -1.11 . . . . 53.439999999999998 108.003 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.52 ' ND1' HG23 ' A' ' 130' ' ' ILE . 11.1 t-160 -100.22 -50.79 3.84 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.592 -1.262 . . . . 72.239999999999995 107.592 171.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.11 148.85 37.29 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.286 -1.005 . . . . 74.030000000000001 108.286 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -123.83 134.88 53.52 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.469 0.652 . . . . 64.530000000000001 110.043 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.26 124.73 50.03 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.836 -1.172 . . . . 74.420000000000002 107.836 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -115.22 127.58 55.6 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.477 -0.935 . . . . 65.430000000000007 108.477 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -121.35 113.19 38.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.351 -1.351 . . . . 74.25 107.351 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -136.3 131.02 33.81 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.817 -0.438 . . . . 63.399999999999999 109.817 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 55.67 37.05 28.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.059 0.944 . . . . 64.140000000000001 111.804 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.09 3.97 90.59 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.23 -0.895 . . . . 71.140000000000001 113.461 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -109.0 139.14 44.28 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.552 -0.536 . . . . 73.25 109.552 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -114.94 122.02 44.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.697 -0.683 . . . . 73.540000000000006 110.139 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.62 146.04 48.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.765 -0.457 . . . . 70.230000000000004 109.765 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.96 124.26 70.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.784 -1.191 . . . . 71.400000000000006 107.784 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.11 124.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.786 -0.82 . . . . 65.409999999999997 108.786 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -81.78 121.86 26.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.272 -1.01 . . . . 64.120000000000005 108.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 m -117.04 -11.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.955 -0.566 . . . . 62.439999999999998 110.876 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.35 46.9 1.1 Allowed Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 108.406 -1.878 . . . . 51.229999999999997 108.406 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.8 p -65.61 -3.16 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.773 1.229 . . . . 71.340000000000003 113.389 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.93 -26.65 59.77 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.045 -0.724 . . . . 40.450000000000003 109.045 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 17' ' ' VAL . 94.3 m-20 -105.62 -21.72 13.13 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.77 -0.826 . . . . 71.239999999999995 108.77 174.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.07 119.27 0.27 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.122 -0.944 . . . . 62.329999999999998 114.03 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.4 m -87.07 138.27 31.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.048 -1.093 . . . . 52.130000000000003 108.048 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 84.8 m-85 -119.13 129.16 54.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.946 -0.39 . . . . 75.430000000000007 109.946 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.9 t -114.92 120.58 64.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.532 -1.655 . . . . 72.129999999999995 106.532 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 56.27 37.96 29.33 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.564 1.146 . . . . 74.329999999999998 110.967 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 mtm-85 66.19 19.68 11.1 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 114.222 -1.354 . . . . 74.340000000000003 112.74 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.51 133.19 23.03 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.24 -1.022 . . . . 73.430000000000007 108.24 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.51 123.6 11.0 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.57 1.513 . . . . 64.430000000000007 109.401 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -144.93 138.69 27.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.199 -1.037 . . . . 75.5 108.199 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -86.3 -37.73 18.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.13 0.49 . . . . 75.239999999999995 110.422 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.63 136.28 25.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.12 -1.067 . . . . 72.120000000000005 108.12 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.19 143.09 25.71 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 63.229999999999997 108.43 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -88.23 126.18 41.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.473 -2.047 . . . . 64.340000000000003 105.473 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.41 ' HE2' HG12 ' A' ' 128' ' ' ILE . 6.6 tpt -87.99 130.71 34.88 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 113.394 0.887 . . . . 73.540000000000006 113.394 -164.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.498 ' HB3' ' OD2' ' A' ' 126' ' ' ASP . 16.3 tt0 -107.72 141.9 38.55 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.38 1.472 . . . . 65.120000000000005 109.525 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -67.03 133.53 50.1 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.046 -0.724 . . . . 75.409999999999997 109.046 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.25 -2.71 56.5 Favored Glycine 0 C--O 1.252 1.269 0 N-CA-C 111.456 -0.658 . . . . 62.43 111.456 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 123' ' ' GLN . 96.7 m-20 -82.47 151.38 26.55 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.384 0.612 . . . . 61.299999999999997 110.402 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -112.32 131.54 55.46 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.516 -0.765 . . . . 75.530000000000001 109.718 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.41 HG12 ' HE2' ' A' ' 122' ' ' MET . 21.2 mt -107.64 131.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 106.594 -1.632 . . . . 73.439999999999998 106.594 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 26.2 tt0 -112.6 118.24 34.53 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.251 -1.018 . . . . 73.140000000000001 108.251 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.52 HG23 ' ND1' ' A' ' 89' ' ' HIS . 43.7 mm -109.1 104.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.779 -1.1 . . . . 72.450000000000003 108.137 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.4 -83.95 0.64 Allowed Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.31 -0.859 . . . . 63.049999999999997 111.225 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -133.82 -12.89 2.57 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.114 0.566 . . . . 73.310000000000002 110.296 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.648 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.317 42.7 p90 -99.0 170.34 8.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 114.29 1.218 . . . . 64.099999999999994 114.29 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -118.46 126.07 51.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.604 . . . . 52.219999999999999 111.393 -164.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.09 140.23 52.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.066 -1.087 . . . . 72.010000000000005 108.066 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.3 t -115.35 127.51 72.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.253 -0.647 . . . . 72.140000000000001 109.253 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -98.33 121.28 40.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.956 -0.757 . . . . 75.450000000000003 108.956 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -140.49 160.63 39.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 110.553 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.72 127.29 32.4 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.525 -1.287 . . . . 74.450000000000003 107.525 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.13 -122.47 1.13 Allowed Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 115.423 -0.808 . . . . 70.349999999999994 113.2 -172.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 157.69 55.75 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.085 1.857 . . . . 74.420000000000002 114.273 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.75 20.97 11.62 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.408 -2.071 . . . . 71.230000000000004 105.408 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 112.803 -1.998 . . . . 75.209999999999994 108.836 -176.051 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 109.138 -0.69 . . . . 72.209999999999994 109.138 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -67.08 123.23 19.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.764 0.653 . . . . 55.119999999999997 112.764 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -109.51 160.1 16.51 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.04 -1.837 . . . . 64.200000000000003 106.04 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -57.19 118.73 5.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.087 0.858 . . . . 52.039999999999999 110.564 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -143.38 155.68 44.48 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.224 -1.399 . . . . 75.409999999999997 107.224 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.38 132.76 52.71 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.281 -1.128 . . . . 62.229999999999997 110.281 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 124.3 85.04 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 120.461 -0.496 . . . . 71.439999999999998 110.911 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.87 143.46 45.57 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.229 1.953 . . . . 70.129999999999995 109.089 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 136.65 52.31 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.601 -0.518 . . . . 74.209999999999994 109.601 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.45 142.52 95.62 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.816 2.344 . . . . 64.129999999999995 113.832 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -91.79 139.82 30.3 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.79 -1.096 . . . . 74.349999999999994 108.383 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.36 121.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.075 0.464 . . . . 75.349999999999994 110.343 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' OE2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -135.32 158.26 44.82 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.817 -1.549 . . . . 63.299999999999997 106.817 175.287 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 m -116.24 134.03 55.36 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 119.906 -0.718 . . . . 74.430000000000007 109.064 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.548 ' O2P' ' HG2' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -101.86 154.16 19.18 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.786 -1.552 . . . . 34.210000000000001 107.226 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.1 t -81.92 115.16 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.785 0.802 . . . . 73.219999999999999 108.914 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 29.8 p90 -119.43 142.18 48.46 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.83 -1.077 . . . . 75.530000000000001 110.469 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -125.93 90.62 3.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.406 0.622 . . . . 71.329999999999998 110.616 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.24 -84.42 0.15 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.723 -0.671 . . . . 75.519999999999996 110.419 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.06 -11.47 59.91 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.621 -0.718 . . . . 72.409999999999997 109.797 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 89.8 mt -64.31 -15.83 61.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.012 -0.995 . . . . 71.299999999999997 111.784 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -45.78 90.32 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.302 -0.629 . . . . 74.340000000000003 109.302 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -86.04 -33.57 20.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 109.68 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 4.6 tp10 -59.11 -33.14 70.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.418 -0.81 . . . . 73.519999999999996 110.414 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 42.3 tpp -59.47 -49.55 77.37 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.527 -0.306 . . . . 54.229999999999997 111.585 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.46 -29.49 67.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.107 0.48 . . . . 75.540000000000006 110.927 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -73.89 -25.77 60.2 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.588 0.709 . . . . 73.450000000000003 110.583 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.482 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 8.2 t -89.71 -15.73 31.9 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.468 -0.787 . . . . 73.109999999999999 110.625 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 m -62.69 101.57 0.26 Allowed 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.384 0.611 . . . . 60.009999999999998 110.59 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.69 -146.66 15.64 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.652 -1.379 . . . . 71.109999999999999 109.652 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 54.3 m -116.43 134.25 55.08 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.277 0.539 . . . . 72.450000000000003 110.686 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.18 94.65 5.81 Favored Pre-proline 0 C--O 1.246 0.872 0 N-CA-C 109.651 -0.5 . . . . 61.520000000000003 109.651 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 32' ' ' THR . 4.0 Cg_exo -76.39 160.71 35.37 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.343 2.696 . . . . 70.109999999999999 112.818 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.82 168.84 17.66 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.48 -0.934 . . . . 73.129999999999995 108.48 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 m -117.0 158.57 23.9 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.797 -0.445 . . . . 72.420000000000002 109.797 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -92.51 154.89 18.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.454 -0.943 . . . . 72.409999999999997 108.454 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.01 -29.44 1.0 Allowed Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.671 -0.776 . . . . 65.519999999999996 111.551 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.93 80.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.727 -0.472 . . . . 73.430000000000007 109.727 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.83 -6.44 41.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.613 -0.721 . . . . 74.239999999999995 111.854 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.3 -19.95 20.22 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.873 -1.158 . . . . 62.229999999999997 107.873 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.8 mt 58.91 88.0 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 113.97 -1.468 . . . . 73.140000000000001 111.391 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.44 -58.89 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.487 2.124 . . . . 74.25 110.097 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 0.89 7.59 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.585 -0.734 . . . . 43.210000000000001 109.138 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.15 85.99 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.117 -0.947 . . . . 64.140000000000001 111.419 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 15.0 m -134.85 165.56 25.02 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.082 -1.451 . . . . 65.409999999999997 107.082 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 158.87 43.1 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.256 -0.646 . . . . 62.030000000000001 109.256 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -125.41 157.8 35.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.444 -0.206 . . . . 73.310000000000002 110.444 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.15 139.01 54.25 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.204 -1.036 . . . . 75.010000000000005 108.204 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -118.65 137.26 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 120.791 0.329 . . . . 64.209999999999994 110.136 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.83 118.22 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 106.404 -1.702 . . . . 54.310000000000002 106.404 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -94.91 -31.62 13.59 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.695 -0.684 . . . . 71.25 109.918 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -145.83 137.78 25.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.933 -0.766 . . . . 54.030000000000001 108.933 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 132' ' ' LYS . . . 133.29 178.74 15.76 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.457 -1.057 . . . . 51.140000000000001 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 85.4 Cg_exo -55.3 -40.49 85.35 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.684 2.256 . . . . 73.400000000000006 112.154 177.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -90.36 16.31 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.512 -0.313 . . . . 73.019999999999996 111.593 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.96 132.7 54.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.919 0.39 . . . . 71.430000000000007 111.197 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -19.77 32.0 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.576 -0.738 . . . . 71.340000000000003 111.635 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 131.74 34.28 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.946 0.403 . . . . 71.349999999999994 110.625 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -113.3 139.15 49.08 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.107 -1.071 . . . . 51.299999999999997 108.107 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -126.68 128.07 46.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.747 -0.835 . . . . 71.120000000000005 108.747 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.4 pt? -88.23 130.03 35.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 74.129999999999995 110.528 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 103.86 12.46 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.087 -1.079 . . . . 70.450000000000003 108.087 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -121.46 -5.62 9.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.375 1.083 . . . . 72.409999999999997 108.545 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 5.9 pm0 -107.95 142.14 24.62 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 114.128 -1.396 . . . . 65.409999999999997 110.487 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' GLN . 50.2 Cg_exo -57.79 -32.0 93.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.524 2.816 . . . . 75.310000000000002 112.942 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -143.6 122.04 12.41 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 109.251 -0.648 . . . . 60.329999999999998 109.251 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.486 HG22 HG12 ' A' ' 78' ' ' ILE . 21.0 m -114.54 113.92 25.07 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.844 -1.169 . . . . 73.109999999999999 107.844 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.3 p -89.8 138.43 31.49 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 111.65 0.241 . . . . 73.129999999999995 111.65 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.51 55.75 Favored 'General case' 0 C--O 1.267 2.025 0 N-CA-C 109.14 -0.689 . . . . 74.030000000000001 109.14 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.49 -145.39 11.33 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.022 -0.99 . . . . 25.129999999999999 110.723 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.516 ' C ' ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -105.84 151.81 24.05 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 122.994 0.518 . . . . 54.240000000000002 111.909 -177.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.583 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t-80 76.75 143.39 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.93 1.292 . . . . 75.319999999999993 110.407 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 88.0 Cg_exo -48.28 -6.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 124.846 3.697 . . . . 74.209999999999994 116.688 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.83 -24.63 59.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.662 -0.866 . . . . 74.200000000000003 108.662 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.424 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 19.4 m -92.07 115.37 28.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 106.56 -1.644 . . . . 75.310000000000002 106.56 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.53 -36.25 77.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.941 -0.572 . . . . 73.030000000000001 111.409 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.486 HG12 HG22 ' A' ' 68' ' ' THR . 42.3 mm -106.7 99.56 8.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.016 -1.105 . . . . 72.109999999999999 108.016 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -93.36 110.3 21.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.727 -0.67 . . . . 63.329999999999998 109.901 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 87.0 mt -116.64 122.5 44.76 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.34 -1.356 . . . . 71.349999999999994 107.34 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.11 117.08 29.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.662 -0.815 . . . . 61.109999999999999 109.896 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.486 ' H ' HG22 ' A' ' 85' ' ' VAL . 10.0 t70 -120.62 -165.11 1.16 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.385 -0.968 . . . . 61.32 108.385 -173.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.41 -35.51 19.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.403 -0.962 . . . . 75.430000000000007 108.403 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 18' ' ' PHE . 83.2 m -145.63 99.44 3.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.261 -1.015 . . . . 74.450000000000003 108.261 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 82' ' ' ASP . 7.1 t -88.78 131.48 36.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.677 -0.49 . . . . 72.400000000000006 109.677 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -79.25 157.78 27.71 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.785 -0.643 . . . . 72.519999999999996 110.304 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.548 ' HG2' ' O2P' ' A' ' 15' ' ' TPO . 18.4 ptp180 -62.76 -45.86 90.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 72.540000000000006 109.68 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -147.25 99.55 3.16 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 103.784 -2.673 . . . . 62.409999999999997 103.784 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 5.1 t60 -79.32 -50.26 11.15 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.915 -1.513 . . . . 70.239999999999995 106.915 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.25 163.02 40.74 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.468 -1.242 . . . . 31.129999999999999 109.539 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.49 141.38 48.76 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 109.076 -0.712 . . . . 72.420000000000002 109.076 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.83 114.08 28.08 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.712 -1.959 . . . . 70.209999999999994 105.712 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 95' ' ' ASN . 35.0 mtp85 -109.95 127.5 54.8 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-N 114.736 -1.12 . . . . 74.219999999999999 110.488 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.04 112.12 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 104.099 -2.556 . . . . 50.399999999999999 104.099 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 93' ' ' ARG . 17.8 m120 -135.48 121.09 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.225 -0.657 . . . . 62.240000000000002 109.225 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 56.53 37.85 29.16 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.379 1.05 . . . . 54.409999999999997 110.687 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.47 88.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.359 -0.837 . . . . 73.019999999999996 113.469 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.48 141.31 36.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.912 -0.774 . . . . 73.450000000000003 108.912 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 84.0 m-85 -111.4 117.01 31.9 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.222 -0.658 . . . . 74.430000000000007 109.222 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 146.2 52.29 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.793 0.33 . . . . 75.230000000000004 111.775 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 23.5 t -103.79 123.37 57.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.18 -1.785 . . . . 74.439999999999998 106.18 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.1 t -119.15 126.51 75.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.103 -0.703 . . . . 45.409999999999997 109.103 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -81.05 123.54 28.45 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.197 -1.409 . . . . 73.340000000000003 107.197 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.38 14.55 7.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-O 121.049 0.452 . . . . 55.420000000000002 111.244 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.498 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . -108.9 -30.68 3.62 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.41 -1.076 . . . . 63.100000000000001 110.41 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.3 p 67.43 -52.86 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.55 2.34 . . . . 73.230000000000004 113.56 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.31 -20.43 60.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.902 0.382 . . . . 74.510000000000005 111.037 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -87.28 -20.25 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.227 1.195 . . . . 73.120000000000005 114.227 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.429 ' N ' HD22 ' A' ' 108' ' ' ASN . . . 62.06 87.0 0.04 OUTLIER Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.344 0.897 . . . . 64.109999999999999 115.344 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.9 m -79.51 137.59 37.24 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 64.140000000000001 108.787 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 30.1 m-85 -113.06 126.87 55.95 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.539 -0.465 . . . . 73.310000000000002 109.97 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.45 135.93 55.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 105.006 -2.22 . . . . 73.140000000000001 105.006 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 53.47 34.74 18.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 75.409999999999997 107.601 -165.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 29' ' ' SER . 37.9 mtm180 57.92 12.76 1.85 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.025 1.12 . . . . 74.200000000000003 114.025 -175.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -104.27 134.17 19.83 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.84 -0.8 . . . . 73.510000000000005 108.84 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.04 123.49 12.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.12 1.88 . . . . 73.129999999999995 111.657 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -140.62 165.39 27.59 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 116.079 -0.509 . . . . 64.140000000000001 110.825 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -103.91 -36.74 7.68 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.282 -1.007 . . . . 72.140000000000001 108.282 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -150.24 134.85 17.44 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.63 -1.248 . . . . 62.439999999999998 107.63 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.31 143.63 22.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.137 -0.69 . . . . 73.349999999999994 109.137 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.75 125.63 34.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.605 -0.887 . . . . 73.219999999999999 108.605 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.448 ' HE3' ' HB3' ' A' ' 99' ' ' PHE . 22.2 ptt? -90.06 130.27 36.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 62.25 110.19 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -113.79 156.41 23.9 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.128 -0.942 . . . . 74.329999999999998 109.717 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.3 t -67.53 124.64 23.79 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 121.387 0.613 . . . . 75.019999999999996 109.565 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.09 57.56 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.909 -0.877 . . . . 72.450000000000003 110.909 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -79.92 151.84 29.89 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.77 125.91 50.68 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.024 -0.732 . . . . 74.310000000000002 109.024 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -109.33 129.55 63.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 106.846 -1.538 . . . . 63.450000000000003 106.846 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 54.8 tp60 -110.05 123.22 49.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.274 -1.01 . . . . 70.209999999999994 108.274 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.4 mt -128.77 104.17 10.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.782 -1.192 . . . . 65.120000000000005 107.782 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.21 -117.21 8.25 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.4 -1.48 . . . . 55.310000000000002 109.4 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -106.46 5.75 29.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.289 0.566 . . . . 72.319999999999993 110.894 175.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.588 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 69.6 m-85 -85.37 133.21 34.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.676 -0.693 . . . . 75.129999999999995 111.091 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -110.8 119.22 38.39 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.187 -2.153 . . . . 75.219999999999999 105.187 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 mt -114.87 139.85 49.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.018 -0.734 . . . . 64.439999999999998 109.018 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.21 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.309 -0.997 . . . . 62.340000000000003 108.309 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.75 127.72 38.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.283 -0.636 . . . . 64.299999999999997 109.283 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.61 130.78 42.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.229 0.538 . . . . 74.400000000000006 110.582 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.96 122.79 44.13 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.575 -0.898 . . . . 31.440000000000001 108.575 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.0 -144.17 3.87 Favored Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.282 -1.437 . . . . 62.43 113.088 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.83 146.7 60.52 Favored 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.681 2.921 . . . . 70.209999999999994 113.157 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 46' ' ' SER . . . 179.66 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.992 1.317 . . . . 33.219999999999999 108.526 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 107.462 -1.31 . . . . 61.509999999999998 107.462 -176.065 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 C--O 1.245 0.866 0 CA-C-O 121.006 0.431 . . . . 62.530000000000001 110.008 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -63.71 127.78 32.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.174 -0.921 . . . . 73.400000000000006 111.267 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -88.0 -177.03 5.66 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.515 -0.766 . . . . 75.200000000000003 110.353 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.65 99.8 2.65 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 113.32 0.859 . . . . 75.420000000000002 113.32 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -90.0 98.4 11.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.957 -1.868 . . . . 73.329999999999998 105.957 169.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 -167.52 31.27 Favored Glycine 0 N--CA 1.416 -2.681 0 C-N-CA 120.558 -0.829 . . . . 70.120000000000005 112.266 -175.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.8 m -125.06 123.78 25.4 Favored Pre-proline 0 C--N 1.283 -2.317 0 N-CA-C 107.259 -1.386 . . . . 74.329999999999998 107.259 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.28 150.01 52.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.13 1.887 . . . . 55.049999999999997 110.939 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.64 120.5 81.65 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.883 -0.784 . . . . 61.049999999999997 108.883 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -54.05 102.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.553 2.836 . . . . 74.200000000000003 113.877 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -103.63 168.49 9.11 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.203 -2.147 . . . . 75.349999999999994 105.203 172.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.4 119.32 55.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 106.74 -1.578 . . . . 55.530000000000001 106.74 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -159.42 148.01 17.85 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 103.96 -2.608 . . . . 71.420000000000002 103.96 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -123.57 129.12 50.71 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.298 -0.63 . . . . 73.209999999999994 109.298 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -88.74 144.2 26.42 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 112.091 -172.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 58.6 t -93.85 115.7 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.553 -2.017 . . . . 52.25 105.553 170.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -108.04 127.5 53.83 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.152 -1.019 . . . . 75.0 111.544 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -106.96 101.91 11.31 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 109.468 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.56 166.21 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.928 -0.578 . . . . 64.0 111.539 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.08 -6.99 19.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.136 1.374 . . . . 74.230000000000004 112.25 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.64 -25.42 60.12 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.51 0.93 . . . . 60.149999999999999 113.51 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 88.4 mt -81.47 -28.59 34.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 111.806 0.299 . . . . 70.439999999999998 111.806 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -53.95 -45.43 71.3 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.883 0.873 . . . . 71.540000000000006 111.878 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 26' ' ' MET . 8.0 pt-20 -70.19 -37.02 75.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.823 0.344 . . . . 72.150000000000006 111.888 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.43 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 22.9 ptp -79.79 -27.36 40.36 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 112.596 0.591 . . . . 75.420000000000002 112.596 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 48.3 mt-10 -58.4 -49.46 77.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.974 0.352 . . . . 72.400000000000006 111.18 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -68.74 -26.41 65.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.632 -0.713 . . . . 74.25 110.878 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.7 t -88.17 -22.74 23.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.655 -0.702 . . . . 73.540000000000006 110.409 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.3 m -97.31 105.87 18.09 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.64 0.733 . . . . 70.239999999999995 112.097 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.9 -29.13 0.76 Allowed Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.287 -1.525 . . . . 73.049999999999997 109.287 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -116.11 148.99 39.71 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.77 -0.826 . . . . 74.310000000000002 108.77 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.47 138.92 20.68 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.652 -1.61 . . . . 64.5 106.652 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.25 142.52 91.83 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.125 1.884 . . . . 64.349999999999994 112.784 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.36 149.49 51.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.079 -0.712 . . . . 64.450000000000003 109.079 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -129.23 139.56 51.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.797 0.332 . . . . 70.420000000000002 110.624 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 m -79.34 115.07 18.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 64.109999999999999 108.036 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.16 8.2 22.05 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 110.622 -0.991 . . . . 53.140000000000001 110.622 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.09 87.67 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 123.514 0.725 . . . . 70.409999999999997 111.75 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.89 1.9 56.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.054 -0.521 . . . . 75.430000000000007 111.532 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -33.39 12.0 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.433 -1.321 . . . . 75.400000000000006 107.433 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.4 mm? 59.73 84.06 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 108.17 -1.048 . . . . 53.310000000000002 108.17 -173.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 6.8 Cg_endo -42.7 -61.85 0.5 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.593 3.529 . . . . 74.140000000000001 115.328 -168.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -13.77 40.69 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.201 -0.599 . . . . 74.209999999999994 112.151 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.22 -4.86 77.89 Favored Glycine 0 C--N 1.317 -0.5 0 C-N-CA 121.111 -0.566 . . . . 72.109999999999999 112.253 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB3' HD11 ' A' ' 62' ' ' LEU . 32.7 m -133.93 163.65 29.04 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.922 -0.769 . . . . 73.5 108.922 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.39 150.81 36.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.367 -0.605 . . . . 64.049999999999997 109.367 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.51 148.57 44.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.067 -0.515 . . . . 73.140000000000001 110.556 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.6 pt? -105.32 133.9 49.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.637 -0.875 . . . . 65.019999999999996 108.637 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.4 128.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.584 -0.895 . . . . 74.099999999999994 108.584 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.1 t -77.18 118.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.593 -1.632 . . . . 64.329999999999998 106.593 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -89.73 -33.92 16.4 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.231 0.539 . . . . 73.430000000000007 109.666 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 2.2 tpm_? -144.79 136.95 26.06 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.989 -1.115 . . . . 71.430000000000007 107.989 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.17 -171.45 25.64 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 109.442 -1.463 . . . . 15.529999999999999 109.442 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 15.6 Cg_exo -67.32 -43.64 5.81 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.522 2.148 . . . . 61.109999999999999 111.067 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.16 22.7 5.63 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.308 -0.86 . . . . 63.340000000000003 112.005 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.49 129.78 42.2 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.979 0.419 . . . . 62.100000000000001 111.069 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.97 -21.46 29.49 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.684 -0.689 . . . . 74.299999999999997 111.379 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.03 29.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.725 0.298 . . . . 72.420000000000002 110.224 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -128.8 139.05 52.36 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.721 -0.844 . . . . 61.25 108.721 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.09 131.12 53.81 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.981 -0.748 . . . . 73.310000000000002 108.981 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 46' ' ' SER . 56.3 tp -89.55 126.82 35.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.983 -0.377 . . . . 65.230000000000004 109.983 -177.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.421 HD23 HD11 ' A' ' 94' ' ' ILE . 5.2 mp -82.58 103.99 12.52 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -126.65 5.28 6.76 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 123.006 1.384 . . . . 71.140000000000001 108.061 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.81 149.75 39.4 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 114.197 -1.365 . . . . 64.25 108.792 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.99 -16.04 32.44 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.615 2.21 . . . . 71.219999999999999 113.036 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 90.3 m -154.58 128.85 9.01 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.05 -0.722 . . . . 74.299999999999997 109.05 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 20.5 m -118.58 121.38 40.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 m -96.28 130.24 43.42 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.609 -0.515 . . . . 65.540000000000006 109.609 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.04 139.4 53.35 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 116.414 -0.357 . . . . 73.120000000000005 110.19 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.37 -161.0 30.97 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.217 -1.553 . . . . 51.439999999999998 109.217 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 16.7 ttp180 -119.45 116.99 27.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 118.116 0.958 . . . . 72.030000000000001 109.544 176.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER 152.94 156.74 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 104.621 -2.363 . . . . 62.310000000000002 104.621 176.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.85 -9.29 15.98 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.443 2.096 . . . . 73.340000000000003 113.258 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.07 -18.45 60.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.461 . . . . 75.019999999999996 110.728 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 m -98.02 123.58 42.1 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 116.134 -0.485 . . . . 71.109999999999999 109.722 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.19 -42.74 96.54 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.521 -0.918 . . . . 74.519999999999996 108.521 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.52 104.74 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 106.444 -1.687 . . . . 60.219999999999999 106.444 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 72' ' ' ARG . 59.6 t80 -88.03 113.93 24.15 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.671 -0.695 . . . . 72.030000000000001 109.149 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 2.8 mm? -110.36 113.4 26.03 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.489 -0.93 . . . . 63.130000000000003 108.489 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 29.2 t70 -79.11 118.32 20.97 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.025 0.44 . . . . 72.319999999999993 110.745 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -133.08 178.0 7.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.259 -1.015 . . . . 64.549999999999997 108.259 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.07 -28.99 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 124.084 0.954 . . . . 71.200000000000003 109.247 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.441 ' HB ' HD21 ' A' ' 108' ' ' ASN . 0.7 OUTLIER -104.11 152.98 21.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.716 -0.675 . . . . 74.129999999999995 110.52 -174.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -92.19 97.46 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.698 -0.853 . . . . 73.519999999999996 108.698 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -99.81 87.83 3.63 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.595 -0.891 . . . . 63.140000000000001 108.595 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -66.92 -28.97 68.74 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.655 -0.702 . . . . 62.229999999999997 112.513 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -145.29 91.28 2.11 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.125 -1.805 . . . . 73.120000000000005 106.125 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 31.3 t60 -100.63 -52.81 3.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.053 -1.059 . . . . 71.430000000000007 112.075 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.17 141.93 46.01 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.48 -0.763 . . . . 72.510000000000005 109.158 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -122.58 129.41 51.89 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.304 -0.999 . . . . 61.210000000000001 108.304 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 67' ' ' THR . 7.7 m-85 -105.2 117.83 35.0 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.403 -1.703 . . . . 64.219999999999999 106.403 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -109.75 119.23 38.71 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.643 -0.873 . . . . 75.040000000000006 108.643 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.421 HD11 HD23 ' A' ' 63' ' ' LEU . 3.3 mp -111.96 113.29 43.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.684 -1.598 . . . . 74.329999999999998 106.684 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -138.92 123.89 18.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.943 -0.391 . . . . 62.420000000000002 109.943 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.39 36.8 26.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.413 1.085 . . . . 75.409999999999997 112.128 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 3.53 90.45 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.977 -0.63 . . . . 71.310000000000002 113.19 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -100.89 131.23 46.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.475 -0.935 . . . . 70.239999999999995 108.475 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -108.13 116.42 31.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.324 -0.991 . . . . 71.310000000000002 108.324 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 121' ' ' VAL . 41.9 mt-10 -123.6 126.16 46.14 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.335 -0.616 . . . . 73.239999999999995 109.335 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.41 123.13 56.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.511 -1.292 . . . . 72.239999999999995 107.511 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.48 138.04 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 115.586 -0.733 . . . . 54.100000000000001 110.648 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 106.141 -1.8 . . . . 73.219999999999999 106.141 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.0 m -92.41 17.07 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.756 0.65 . . . . 74.510000000000005 112.756 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.26 47.28 4.72 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 107.728 -2.149 . . . . 53.409999999999997 107.728 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.7 m -79.28 175.98 10.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.467 -0.866 . . . . 62.229999999999997 112.654 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 2.3 mm? -101.72 -28.17 12.62 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.578 0.955 . . . . 64.019999999999996 113.578 -171.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -86.61 -20.47 27.82 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 118.518 -1.273 . . . . 75.140000000000001 111.127 -173.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.79 100.13 2.29 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 119.337 -1.411 . . . . 75.209999999999994 112.615 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 m -87.41 129.13 35.15 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.52 -0.918 . . . . 53.0 108.52 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 20.4 m-85 -127.96 126.7 41.92 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.969 -1.123 . . . . 74.319999999999993 107.969 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -111.7 131.84 61.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.129 -1.434 . . . . 74.540000000000006 107.129 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.675 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 17.4 m120 57.78 38.29 27.32 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.608 0.763 . . . . 73.109999999999999 110.187 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.76 14.46 7.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.966 1.307 . . . . 64.319999999999993 113.211 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.64 145.24 37.11 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 122.351 -0.218 . . . . 73.450000000000003 110.523 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.09 123.55 13.42 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.607 1.538 . . . . 65.400000000000006 108.431 171.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -139.5 145.85 39.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.828 -1.175 . . . . 72.430000000000007 107.828 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -103.31 -44.04 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.934 -0.306 . . . . 75.209999999999994 110.85 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.14 24.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.007 -1.108 . . . . 70.219999999999999 108.007 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -150.26 134.59 17.21 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.783 -0.367 . . . . 74.200000000000003 111.264 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 100' ' ' GLU . 48.6 t -78.9 114.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 104.584 -2.376 . . . . 74.040000000000006 104.584 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.47 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 80.3 mtp -97.09 144.59 26.8 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.721 1.008 . . . . 73.25 113.721 -172.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.531 ' HG3' ' OD2' ' A' ' 126' ' ' ASP . 4.8 pp0? -119.73 157.84 27.74 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.0 -1.455 . . . . 74.120000000000005 108.328 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.3 p -58.83 126.87 29.46 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 123.508 0.723 . . . . 72.319999999999993 111.62 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.56 -5.53 54.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.927 -0.579 . . . . 71.340000000000003 113.327 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.531 ' OD2' ' HG3' ' A' ' 123' ' ' GLN . 73.3 m-20 -76.81 143.91 39.47 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 117.799 0.799 . . . . 73.129999999999995 109.337 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.675 ' OE1' ' HA ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -112.57 145.44 40.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.045 0.45 . . . . 72.310000000000002 111.412 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 41.1 mt -116.71 126.91 74.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.579 -0.897 . . . . 72.530000000000001 108.579 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 24.3 tp60 -104.81 113.45 27.05 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 104.941 -2.244 . . . . 75.420000000000002 104.941 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 62.8 mt -109.28 103.87 16.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.91 -1.144 . . . . 63.329999999999998 107.91 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.16 -98.84 0.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 CA-C-N 115.206 -0.906 . . . . 55.340000000000003 111.266 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -119.44 2.67 11.28 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.937 1.088 . . . . 53.109999999999999 113.937 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.25 25.4 p90 -131.23 168.97 16.6 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.549 -0.719 . . . . 72.340000000000003 112.19 176.251 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -129.22 138.96 52.0 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 113.037 0.754 . . . . 74.439999999999998 113.037 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.87 139.79 53.19 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.682 -1.599 . . . . 73.510000000000005 106.682 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.63 140.2 40.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 109.42 -0.585 . . . . 73.209999999999994 109.42 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -92.9 115.5 28.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.048 -0.723 . . . . 72.129999999999995 109.048 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.06 159.95 22.96 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.121 0.486 . . . . 74.010000000000005 111.691 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.77 131.46 39.81 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.84 -0.8 . . . . 74.439999999999998 108.84 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.06 143.0 15.92 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.309 -0.948 . . . . 73.340000000000003 110.922 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -59.24 156.0 37.38 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.592 2.194 . . . . 61.350000000000001 111.567 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.83 61.22 6.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.313 1.054 . . . . 63.329999999999998 109.451 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.292 -1.919 0 CA-C-N 113.107 -1.861 . . . . 74.530000000000001 109.846 -179.983 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 108.811 -0.811 . . . . 43.049999999999997 108.811 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m 76.6 4.24 3.51 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.212 1.405 . . . . 70.530000000000001 110.386 -172.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.75 121.9 44.97 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.817 -1.083 . . . . 74.310000000000002 109.504 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -147.93 179.53 7.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.37 -1.344 . . . . 73.400000000000006 107.37 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 65' ' ' GLN . 21.3 m120 -137.97 140.55 40.28 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 120.755 -0.378 . . . . 72.349999999999994 111.244 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.61 98.7 1.29 Allowed Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 107.089 -2.404 . . . . 60.539999999999999 107.089 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -78.75 144.26 64.24 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-O 120.434 0.159 . . . . 63.140000000000001 110.915 -170.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 143.09 99.6 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.528 2.152 . . . . 72.25 109.144 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.18 140.55 57.12 Favored Pre-proline 0 C--N 1.291 -1.944 0 C-N-CA 119.928 -0.709 . . . . 73.150000000000006 110.68 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.29 103.5 0.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.272 1.982 . . . . 71.099999999999994 110.178 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -92.18 156.41 17.35 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.893 -1.521 . . . . 73.530000000000001 106.893 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.2 t -108.05 121.05 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.102 -0.703 . . . . 64.030000000000001 109.102 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -158.53 132.21 7.63 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.863 -1.162 . . . . 75.420000000000002 107.863 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -75.64 134.1 40.7 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.087 -1.079 . . . . 74.420000000000002 108.087 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -88.65 120.53 30.13 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.223 -1.399 . . . . 62.200000000000003 107.223 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.61 134.56 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 120.952 0.406 . . . . 65.209999999999994 111.304 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -123.18 141.35 52.07 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.111 -1.07 . . . . 73.319999999999993 108.111 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -83.78 137.29 33.8 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.275 -0.57 . . . . 73.140000000000001 109.808 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.93 151.19 23.45 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.411 -0.588 . . . . 62.200000000000003 109.411 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.08 2.76 56.08 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.844 0.831 . . . . 73.340000000000003 110.869 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 111' ' ' TYR . 1.9 pp -58.95 -17.45 24.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.274 1.213 . . . . 74.329999999999998 114.274 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 22' ' ' LEU . 2.2 pt? -70.25 -7.71 44.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 111.765 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -80.41 -28.47 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.562 -0.903 . . . . 73.340000000000003 108.562 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.54 -22.05 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.005 -1.109 . . . . 72.209999999999994 108.005 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.5 ttp -53.95 -49.54 68.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 63.020000000000003 111.175 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -9.96 58.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.065 0.459 . . . . 72.109999999999999 111.844 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -78.64 -39.26 37.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.435 -0.802 . . . . 61.140000000000001 110.112 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -87.13 -17.79 31.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.694 0.627 . . . . 62.340000000000003 112.694 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.1 m -72.61 114.0 10.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.48 -0.563 . . . . 55.399999999999999 109.48 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.6 -59.32 0.2 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.485 -1.046 . . . . 41.530000000000001 110.485 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.7 p -114.85 121.33 42.93 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.914 -0.314 . . . . 53.020000000000003 110.509 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.86 53.0 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 109.208 -0.664 . . . . 32.020000000000003 109.208 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.64 156.56 60.82 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 121.81 1.674 . . . . 72.239999999999995 108.805 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.17 124.65 21.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.87 -1.159 . . . . 52.030000000000001 107.87 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' THR . 10.3 m -98.78 -10.84 22.49 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.879 -0.6 . . . . 55.329999999999998 112.205 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -73.47 147.48 44.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.545 -0.752 . . . . 74.450000000000003 109.987 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 -15.08 7.72 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.327 -1.109 . . . . 53.240000000000002 110.327 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.03 68.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.198 0.523 . . . . 51.109999999999999 111.322 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 41' ' ' ASN . 11.6 pt-20 -70.81 -22.13 62.38 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.255 -0.884 . . . . 74.319999999999993 112.15 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.511 ' OD1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 m-20 -96.21 -13.84 23.17 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.83 -0.433 . . . . 73.420000000000002 109.83 -175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt 55.05 66.62 3.8 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 114.98 -1.009 . . . . 72.420000000000002 110.634 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.65 -55.79 2.48 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.274 2.649 . . . . 65.239999999999995 113.569 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.72 -20.52 42.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.895 -0.593 . . . . 64.140000000000001 111.752 -176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -5.44 77.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.555 -0.831 . . . . 65.319999999999993 111.903 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -152.86 161.0 43.1 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.637 -1.246 . . . . 40.439999999999998 107.637 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.44 157.52 44.0 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.521 -0.548 . . . . 73.409999999999997 109.521 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pp -137.45 155.78 48.93 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 111.905 0.335 . . . . 75.310000000000002 111.905 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD22 HD21 ' A' ' 63' ' ' LEU . 2.4 pt? -116.22 133.67 55.77 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.001 -1.111 . . . . 71.25 108.001 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.11 133.86 51.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.57 -0.9 . . . . 73.040000000000006 108.57 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.27 118.69 31.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.765 -1.568 . . . . 75.099999999999994 106.765 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -83.26 -31.83 26.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.636 -0.711 . . . . 64.540000000000006 110.302 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -160.42 150.66 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.937 -1.505 . . . . 72.010000000000005 106.937 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.65 -167.72 17.96 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 110.217 -1.153 . . . . 62.509999999999998 110.217 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.58 -49.86 9.42 Favored 'Trans proline' 0 N--CA 1.479 0.668 0 C-N-CA 122.802 2.334 . . . . 73.239999999999995 112.257 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.6 22.54 3.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.227 -0.442 . . . . 72.150000000000006 112.045 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.23 128.73 38.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.859 0.362 . . . . 61.409999999999997 111.346 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.71 40.28 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.626 -0.715 . . . . 52.240000000000002 111.528 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 156.91 18.02 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.999 0.428 . . . . 74.209999999999994 110.155 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 139.49 30.87 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.792 -0.64 . . . . 75.310000000000002 109.564 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.39 134.05 55.46 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.2 -0.667 . . . . 73.010000000000005 109.2 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.4 pt? -90.79 143.77 26.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.024 -0.732 . . . . 64.299999999999997 109.024 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 49' ' ' LEU . 1.5 mm? -111.43 110.7 21.27 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.013 0.375 . . . . 53.020000000000003 112.013 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -138.35 59.56 1.64 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.849 -1.537 . . . . 65.340000000000003 106.849 168.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.402 ' HB2' ' OD1' ' A' ' 5' ' ' ASN . 19.7 pt20 -146.35 140.89 15.79 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 112.884 -1.962 . . . . 75.0 107.544 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.36 -22.11 71.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.271 1.98 . . . . 71.450000000000003 113.679 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -148.79 122.23 9.08 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.539 -0.726 . . . . 73.420000000000002 111.677 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 m -113.21 113.84 25.9 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.176 -1.416 . . . . 74.540000000000006 107.176 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.7 m -94.17 138.51 32.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.089 -0.645 . . . . 72.239999999999995 109.582 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 134.76 55.01 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 109.62 -0.511 . . . . 74.430000000000007 109.62 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.26 -119.1 0.9 Allowed Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.159 -0.928 . . . . 75.420000000000002 111.687 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -118.89 152.46 36.26 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.706 0.402 . . . . 72.519999999999996 110.825 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.1 m170 90.37 151.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 125.77 1.628 . . . . 71.129999999999995 111.057 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.48 -5.71 16.69 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.02 2.48 . . . . 71.319999999999993 111.799 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.68 -26.25 60.64 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.214 -1.032 . . . . 75.310000000000002 108.214 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -83.68 122.21 28.31 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.309 -1.367 . . . . 75.430000000000007 107.309 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.02 -32.38 74.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.317 0.579 . . . . 45.119999999999997 110.902 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tp -119.41 113.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-O 121.679 0.752 . . . . 33.210000000000001 109.137 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -88.01 138.18 31.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.977 -1.011 . . . . 73.239999999999995 110.542 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.5 mt -123.82 138.76 54.44 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.29 -0.633 . . . . 64.239999999999995 109.29 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.82 127.55 38.87 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.997 -1.112 . . . . 64.230000000000004 107.997 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.56 -161.4 1.34 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.839 -1.911 . . . . 72.219999999999999 105.839 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.61 -36.51 75.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.791 0.805 . . . . 72.200000000000003 109.665 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.0 m -149.51 125.78 10.78 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.93 -1.137 . . . . 75.519999999999996 107.93 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.59 135.23 43.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.825 -0.435 . . . . 74.319999999999993 109.825 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 159.84 27.95 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.793 -0.447 . . . . 72.129999999999995 109.793 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -57.66 -46.39 84.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.333 0.653 . . . . 62.140000000000001 110.534 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -146.34 109.72 4.76 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 103.755 -2.683 . . . . 71.230000000000004 103.755 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -90.25 -52.11 5.1 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.551 0.691 . . . . 73.530000000000001 109.611 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.59 156.05 41.3 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.59 -0.732 . . . . 74.120000000000005 109.049 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.492 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 10.0 pt-20 -134.59 134.19 41.02 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.306 0.574 . . . . 52.420000000000002 109.564 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -104.95 112.89 26.18 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.126 -2.175 . . . . 72.120000000000005 105.126 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 23.5 mtp180 -108.44 135.99 48.82 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.828 -0.624 . . . . 75.230000000000004 110.423 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' A' ' 99' ' ' PHE . 1.8 mp -103.59 111.68 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.664 0 N-CA-C 102.283 -3.229 . . . . 74.5 102.283 173.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -129.12 116.56 19.43 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.93 -0.767 . . . . 64.040000000000006 108.93 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 51.04 37.56 18.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.873 1.269 . . . . 73.519999999999996 111.822 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.3 -1.96 87.49 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.013 -0.54 . . . . 43.210000000000001 113.578 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.39 145.71 29.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.279 -1.008 . . . . 63.130000000000003 108.279 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 92.2 m-85 -104.7 117.94 35.33 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.223 -1.399 . . . . 64.319999999999993 107.223 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -129.49 130.75 46.24 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.319 0.58 . . . . 74.099999999999994 111.185 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.52 122.62 56.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.889 -1.152 . . . . 73.409999999999997 107.889 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.48 132.7 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 116.187 -0.461 . . . . 65.439999999999998 110.834 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -80.27 134.64 36.11 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.157 -1.423 . . . . 75.329999999999998 107.157 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.07 13.56 2.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.438 0.637 . . . . 73.019999999999996 111.226 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.89 74.85 0.09 OUTLIER Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.108 -1.197 . . . . 64.219999999999999 110.108 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 63.4 m -64.63 75.38 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.779 1.029 . . . . 73.329999999999998 113.779 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.81 -47.99 9.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.848 -1.538 . . . . 64.329999999999998 106.848 170.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -105.86 -20.0 13.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.966 -1.47 . . . . 63.409999999999997 108.631 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.72 99.33 0.04 OUTLIER Glycine 0 C--O 1.21 -1.385 0 N-CA-C 108.29 -1.924 . . . . 73.049999999999997 108.29 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.2 m -60.14 132.44 53.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.868 0.842 . . . . 61.240000000000002 112.904 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 83.4 m-85 -101.86 126.69 48.8 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 115.367 -0.833 . . . . 74.200000000000003 108.777 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.52 137.91 53.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.498 -1.667 . . . . 73.150000000000006 106.498 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 57.62 38.15 27.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.402 0.681 . . . . 64.209999999999994 109.693 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 59.4 26.13 14.98 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.825 -1.08 . . . . 75.5 111.923 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.8 153.0 71.67 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.585 0.354 . . . . 64.340000000000003 110.366 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.62 129.55 31.44 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.348 2.032 . . . . 73.340000000000003 109.671 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 20.2 tpp180 -140.42 165.5 27.24 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.768 -0.456 . . . . 73.140000000000001 109.768 -173.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.91 -41.53 1.81 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.363 -0.606 . . . . 75.299999999999997 109.363 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.29 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.655 -1.239 . . . . 73.349999999999994 107.655 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.422 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 59.4 tp60 -153.11 133.61 13.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 121.124 -0.23 . . . . 72.329999999999998 111.57 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.2 t -81.56 115.6 24.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 104.658 -2.349 . . . . 74.530000000000001 104.658 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.6 ptm -90.46 149.87 22.05 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.736 0.779 . . . . 75.439999999999998 112.694 -169.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 72.2 mt-30 -107.57 157.84 17.72 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.46 -1.246 . . . . 63.25 108.617 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 36' ' ' SER . 11.5 t -70.66 130.83 42.8 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.912 -0.715 . . . . 73.219999999999999 109.597 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.2 55.67 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 110.96 -0.856 . . . . 71.400000000000006 110.96 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 10.8 t0 -69.57 144.63 53.0 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 108.995 -0.743 . . . . 74.329999999999998 108.995 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.64 126.37 47.51 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.068 0.461 . . . . 74.239999999999995 109.875 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 70.9 mt -110.08 115.6 50.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.793 -1.094 . . . . 71.219999999999999 108.867 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.442 ' HG2' HD22 ' A' ' 22' ' ' LEU . 54.1 tt0 -105.22 123.62 48.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.584 -0.524 . . . . 65.150000000000006 109.584 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.71 129.19 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.428 0.691 . . . . 72.239999999999995 109.846 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.52 -86.4 1.46 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 109.837 -1.305 . . . . 62.009999999999998 109.837 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.94 14.32 0.34 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.288 0.635 . . . . 72.310000000000002 109.461 171.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -130.64 170.13 14.71 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.189 -0.671 . . . . 70.310000000000002 109.189 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -137.76 150.09 46.96 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.896 1.443 . . . . 72.150000000000006 114.896 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 mt -102.77 134.55 45.98 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.195 -1.78 . . . . 70.120000000000005 106.195 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.6 t -111.97 124.09 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.391 -0.966 . . . . 73.409999999999997 108.391 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -98.9 126.15 44.49 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 122.244 0.217 . . . . 74.329999999999998 110.918 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -133.81 147.48 51.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.42 -0.585 . . . . 71.510000000000005 109.42 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.59 118.69 18.7 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.621 -2.362 . . . . 73.310000000000002 104.621 169.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.04 -82.48 0.59 Allowed Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 118.502 -1.809 . . . . 43.520000000000003 113.959 -169.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.92 142.36 47.04 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 121.599 1.532 . . . . 64.140000000000001 113.859 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.48 36.7 1.67 Allowed 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 104.223 -2.51 . . . . 65.099999999999994 104.223 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.428 -1.545 0 CA-C-N 112.345 -2.207 . . . . 71.109999999999999 109.806 -171.027 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.398 -0.593 . . . . 60.420000000000002 109.398 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -64.89 140.25 58.85 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 112.287 0.477 . . . . 62.140000000000001 112.287 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -104.79 111.0 23.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.656 -0.702 . . . . 74.109999999999999 111.063 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.62 143.77 48.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.976 -1.49 . . . . 74.299999999999997 106.976 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.12 133.99 49.06 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.303 -0.258 . . . . 71.510000000000005 110.303 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.93 120.99 24.38 Favored Glycine 0 N--CA 1.44 -1.058 0 O-C-N 123.813 0.695 . . . . 71.120000000000005 111.836 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -90.85 134.82 29.68 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 109.416 -0.587 . . . . 63.409999999999997 109.416 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.54 132.52 11.11 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.054 1.836 . . . . 73.310000000000002 111.32 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -80.32 127.97 74.5 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.26 -0.644 . . . . 75.129999999999995 109.26 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.71 134.55 47.82 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.373 2.049 . . . . 74.430000000000007 110.983 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.44 132.42 36.8 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.445 -0.946 . . . . 63.109999999999999 108.445 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.9 t -108.36 120.86 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 105.915 -1.883 . . . . 73.310000000000002 105.915 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.578 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 6.0 tp10 -127.53 132.89 49.85 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 107.342 -1.355 . . . . 72.540000000000006 107.342 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.531 ' HB ' ' NH2' ' A' ' 87' ' ' ARG . 22.3 m -84.52 121.97 28.35 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.039 -1.097 . . . . 72.010000000000005 108.039 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.511 ' O2P' ' HB3' ' A' ' 13' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 20.0 m -100.21 152.3 20.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.552 -0.907 . . . . 44.329999999999998 108.552 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.27 115.57 29.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.01 -0.737 . . . . 53.5 109.01 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 62.2 t80 -111.89 127.44 55.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.177 -1.046 . . . . 70.120000000000005 108.177 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -126.44 137.06 53.37 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.158 -0.682 . . . . 75.519999999999996 109.158 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' HB3' HD23 ' A' ' 22' ' ' LEU . . . -142.65 161.75 37.25 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.039 0.447 . . . . 75.409999999999997 110.751 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.02 7.45 0.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.118 1.367 . . . . 64.049999999999997 112.893 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 20' ' ' ALA . 4.6 pp -58.05 -34.5 70.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.865 0.866 . . . . 73.549999999999997 111.284 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.53 -19.69 63.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.552 0.575 . . . . 53.210000000000001 112.552 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.11 -22.96 21.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.195 -0.668 . . . . 74.239999999999995 109.195 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -98.3 -42.9 7.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.397 -0.819 . . . . 65.349999999999994 113.045 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -68.25 -1.34 6.0 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.268 0.84 . . . . 72.120000000000005 113.268 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.65 -28.59 63.87 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.173 0.989 . . . . 61.130000000000003 111.128 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -63.56 -45.43 90.53 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.21 1.004 . . . . 71.230000000000004 111.378 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.2 p -79.39 -19.34 50.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.51 -0.768 . . . . 75.310000000000002 112.566 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -88.23 78.39 8.06 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 121.856 0.836 . . . . 71.25 110.141 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.79 -105.14 1.28 Allowed Glycine 0 CA--C 1.485 -1.825 0 N-CA-C 109.107 -1.597 . . . . 74.129999999999995 109.107 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 m -99.88 118.52 36.5 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.173 -1.417 . . . . 73.439999999999998 107.173 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.57 114.24 18.06 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.84 157.28 39.32 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.46 1.44 . . . . 62.539999999999999 110.517 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 125.72 31.12 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.927 -1.508 . . . . 71.299999999999997 106.927 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 15.8 m -71.0 113.93 8.54 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.229 0.538 . . . . 74.519999999999996 111.023 -175.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.7 p -98.7 140.69 32.53 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.337 -0.392 . . . . 71.319999999999993 110.306 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.01 -25.28 0.55 Allowed Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.694 -0.563 . . . . 53.310000000000002 111.694 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.89 58.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.989 0.423 . . . . 35.310000000000002 110.203 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -69.93 -24.66 63.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 65.340000000000003 109.202 -179.368 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.8 -13.75 47.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.776 -1.102 . . . . 71.299999999999997 109.835 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.4 mt 63.97 91.02 0.08 OUTLIER Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 115.142 -0.935 . . . . 63.439999999999998 111.174 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 10.3 Cg_endo -52.87 -69.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.147 2.565 . . . . 71.219999999999999 113.975 -176.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.07 16.38 1.07 Allowed 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.503 -0.479 . . . . 61.409999999999997 110.817 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.71 -12.4 56.77 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 120.839 -0.696 . . . . 73.439999999999998 111.617 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -137.37 151.88 49.07 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.231 -1.396 . . . . 53.329999999999998 107.231 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.44 157.19 40.85 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.072 -1.455 . . . . 31.32 107.072 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.24 156.75 38.03 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.341 0.591 . . . . 72.409999999999997 112.559 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.84 139.24 49.91 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.684 -1.228 . . . . 63.32 107.684 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 133.96 61.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.661 -0.496 . . . . 74.209999999999994 109.661 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.5 t -75.4 118.46 21.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.602 -0.888 . . . . 74.319999999999993 108.602 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -84.01 -43.4 15.19 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.034 -0.985 . . . . 73.420000000000002 108.722 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 57.4 ttt180 -144.7 133.55 22.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.468 -0.787 . . . . 73.310000000000002 109.231 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.13 174.8 23.12 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 109.109 -1.596 . . . . 63.210000000000001 109.109 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.65 -21.67 38.85 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.485 2.123 . . . . 74.519999999999996 111.187 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 80' ' ' LEU . 18.2 p-10 -100.9 21.98 12.83 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.093 0.957 . . . . 74.219999999999999 110.64 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -59.86 141.63 55.03 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.658 0.383 . . . . 62.420000000000002 111.797 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.65 -7.93 74.28 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.846 -0.692 . . . . 75.530000000000001 112.08 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.11 126.72 31.44 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 110.151 -0.314 . . . . 24.010000000000002 110.151 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -116.22 136.66 52.81 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.585 -0.895 . . . . 74.129999999999995 108.585 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -130.73 116.32 17.85 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.577 -0.527 . . . . 71.340000000000003 109.577 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.95 118.46 24.03 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.608 -0.886 . . . . 54.450000000000003 108.608 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.2 mt -87.42 125.2 34.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.83 0.348 . . . . 74.409999999999997 110.894 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -138.03 -0.61 2.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.313 -0.858 . . . . 63.119999999999997 109.825 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -107.52 150.34 39.98 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.132 -0.486 . . . . 61.530000000000001 111.085 -175.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 37.7 Cg_exo -65.17 -20.87 62.95 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.365 2.71 . . . . 61.130000000000003 114.078 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.7 m -145.68 122.54 11.28 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.272 0.558 . . . . 55.409999999999997 110.21 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.41 HG22 HG12 ' A' ' 78' ' ' ILE . 7.6 m -123.64 113.4 18.61 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.764 -1.199 . . . . 73.239999999999995 107.764 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.6 m -94.08 138.73 31.82 Favored 'General case' 0 C--O 1.255 1.393 0 O-C-N 121.594 -0.691 . . . . 71.099999999999994 111.038 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 135.39 54.63 Favored 'General case' 0 C--O 1.262 1.717 0 CA-C-O 121.655 0.741 . . . . 64.109999999999999 110.802 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.55 29.28 Favored Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 105.782 -2.927 . . . . 53.310000000000002 105.782 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 15.2 ptt180 -119.18 121.01 38.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 117.711 -1.596 . . . . 64.349999999999994 109.311 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -167.1 163.39 10.35 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 106.001 -1.851 . . . . 74.209999999999994 106.001 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.58 -46.19 34.97 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.706 2.271 . . . . 70.310000000000002 113.856 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.75 20.5 5.52 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.692 0.627 . . . . 72.329999999999998 112.692 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -58.91 116.28 3.68 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.46 -0.571 . . . . 64.450000000000003 109.46 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.27 -38.97 41.47 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.721 -1.214 . . . . 70.340000000000003 107.721 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 68' ' ' THR . 44.4 mm -105.26 121.85 57.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.126 -1.064 . . . . 74.430000000000007 108.126 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -87.95 124.76 34.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 110.065 -0.346 . . . . 73.510000000000005 110.065 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 80.0 mt -127.2 140.92 51.91 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.323 -0.991 . . . . 73.140000000000001 108.323 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -130.59 140.65 50.44 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.434 -0.58 . . . . 74.129999999999995 109.434 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -163.34 178.34 8.21 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.387 -1.709 . . . . 75.329999999999998 106.387 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 -35.19 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 107.943 -1.132 . . . . 44.0 107.943 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 m -142.0 99.84 3.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.672 0.748 . . . . 45.030000000000001 109.939 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -98.6 137.38 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.471 -1.307 . . . . 64.430000000000007 107.471 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 23.0 t -73.57 150.72 41.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.114 -1.069 . . . . 62.009999999999998 108.114 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' NH2' ' HB ' ' A' ' 14' ' ' THR . 10.1 ptt180 -61.59 -45.95 91.92 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.578 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 40.2 mtp-105 -135.21 113.86 11.75 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.413 -1.329 . . . . 75.140000000000001 107.413 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -99.29 -51.82 3.7 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.705 -0.85 . . . . 74.239999999999995 108.705 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.65 163.65 39.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.229 -0.656 . . . . 62.509999999999998 109.229 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.8 147.93 45.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.498 0.666 . . . . 64.349999999999994 109.883 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -104.76 133.31 49.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.184 -1.413 . . . . 62.140000000000001 107.184 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 8.5 mtp180 -118.1 121.78 41.44 Favored 'General case' 0 C--N 1.268 -2.964 0 CA-C-N 115.608 -0.724 . . . . 71.439999999999998 109.414 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 59.3 mt -121.14 111.39 31.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.655 -1.609 . . . . 75.120000000000005 106.655 176.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -139.24 125.7 20.42 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.643 -0.423 . . . . 71.409999999999997 110.413 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.58 40.25 31.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.015 0.926 . . . . 55.350000000000001 112.486 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 -1.67 87.53 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.032 -0.531 . . . . 32.140000000000001 113.807 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -101.04 140.97 34.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.227 -0.657 . . . . 44.340000000000003 109.227 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -119.34 117.8 29.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.112 -1.07 . . . . 62.240000000000002 108.112 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -126.45 144.89 50.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.854 -0.424 . . . . 54.329999999999998 109.854 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 122' ' ' MET . 25.1 t -112.98 122.13 66.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 105.244 -2.132 . . . . 72.549999999999997 105.244 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.61 131.88 71.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 120.652 -0.419 . . . . 73.030000000000001 110.157 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.12 140.97 36.19 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.422 -0.955 . . . . 61.329999999999998 108.422 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.2 9.89 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.637 0.256 . . . . 64.310000000000002 110.731 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.408 ' HA2' ' O3P' ' A' ' 15' ' ' TPO . . . 165.37 77.85 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.013 -0.613 . . . . 54.539999999999999 112.053 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 m -64.6 86.76 0.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.826 0.45 . . . . 62.030000000000001 111.124 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 9.8 tt -91.36 -49.91 6.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 119.137 -1.025 . . . . 75.120000000000005 108.435 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.63 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 1.0 OUTLIER -92.81 -19.02 22.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.156 -0.683 . . . . 55.119999999999997 109.156 -178.438 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.68 114.86 3.77 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.836 -0.62 . . . . 74.349999999999994 112.367 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.2 m -87.3 129.65 34.91 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 122.211 -0.582 . . . . 74.540000000000006 110.469 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.506 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 82.3 m-85 -134.9 126.0 27.84 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.077 -1.083 . . . . 74.049999999999997 108.077 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.5 t -131.14 133.98 61.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.854 -1.536 . . . . 72.519999999999996 106.854 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 54.01 40.71 31.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.306 1.051 . . . . 73.420000000000002 109.404 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 66.76 9.23 6.56 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.946 1.699 . . . . 71.400000000000006 112.424 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 49.5 mm-40 -104.57 127.66 28.5 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 112.472 0.545 . . . . 75.420000000000002 112.472 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -63.7 123.44 12.02 Favored 'Trans proline' 0 C--N 1.36 1.139 0 N-CA-C 106.242 -2.253 . . . . 74.209999999999994 106.242 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 11.8 tpt180 -146.99 154.89 41.77 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.791 -1.564 . . . . 72.409999999999997 111.797 -167.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -107.67 -37.93 6.02 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.806 -0.812 . . . . 73.230000000000004 108.806 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.2 135.21 32.16 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.265 -0.574 . . . . 64.439999999999998 109.667 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.567 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 54.3 tp60 -152.12 143.68 23.49 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.194 -0.457 . . . . 72.150000000000006 110.268 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.13 131.6 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 107.72 -1.215 . . . . 71.230000000000004 107.72 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.411 ' HB2' HG23 ' A' ' 101' ' ' VAL . 43.7 ttp -89.25 128.54 35.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.359 -0.978 . . . . 60.32 108.359 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 9.3 pt20 -130.37 142.8 50.51 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.299 -0.864 . . . . 71.349999999999994 111.382 -173.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.7 t -74.31 134.25 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 62.420000000000002 111.229 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.11 59.75 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.241 -0.89 . . . . 54.5 111.163 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -89.63 154.67 19.79 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.565 -0.318 . . . . 74.019999999999996 111.198 -177.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.3 127.86 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.663 0.744 . . . . 74.099999999999994 109.797 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.28 119.81 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 N-CA-C 107.369 -1.345 . . . . 73.409999999999997 107.369 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 47.3 tt0 -104.86 120.92 42.57 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 115.106 -0.952 . . . . 74.099999999999994 108.476 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.7 mt -109.36 102.98 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 105.914 -1.884 . . . . 72.239999999999995 105.914 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.63 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 67.45 -107.55 2.08 Favored Glycine 0 N--CA 1.411 -3.01 0 CA-C-N 114.48 -1.236 . . . . 55.299999999999997 111.639 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -118.22 11.0 13.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.408 0.521 . . . . 75.329999999999998 112.408 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 27.2 p90 -125.06 157.87 35.18 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.883 -0.414 . . . . 70.109999999999999 109.883 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -129.36 142.07 50.91 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 114.51 1.3 . . . . 75.219999999999999 114.51 -169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.35 138.52 54.37 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.591 -1.633 . . . . 75.109999999999999 106.591 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -112.48 138.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.833 -1.173 . . . . 72.120000000000005 107.833 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -101.61 116.13 32.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.175 -0.676 . . . . 72.329999999999998 109.175 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.12 154.64 48.09 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.408 0.623 . . . . 71.129999999999995 110.545 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.51 126.4 30.85 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.538 -1.653 . . . . 53.409999999999997 106.538 168.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 141' ' ' PRO . . . -103.77 -111.42 3.57 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.587 -0.816 . . . . 53.439999999999998 111.497 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 140' ' ' GLY . 10.8 Cg_exo -69.14 142.87 51.93 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.114 1.876 . . . . 62.439999999999998 111.787 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.25 18.08 19.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.648 -0.871 . . . . 53.030000000000001 108.648 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.424 -1.745 0 C-N-CA 125.305 1.442 . . . . 73.109999999999999 110.001 -179.137 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 107.11 -1.441 . . . . 55.200000000000003 107.11 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -79.02 134.99 36.76 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.124 -0.63 . . . . 55.32 110.085 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.95 100.31 12.81 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.661 -1.607 . . . . 73.349999999999994 106.661 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -89.68 113.97 25.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.965 -1.016 . . . . 64.329999999999998 113.303 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 p30 179.7 -167.89 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.688 -2.338 . . . . 71.510000000000005 104.688 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.62 -157.96 30.37 Favored Glycine 0 CA--C 1.48 -2.142 0 C-N-CA 118.967 -1.587 . . . . 73.0 112.566 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 t -112.21 108.97 54.61 Favored Pre-proline 0 N--CA 1.417 -2.116 0 N-CA-C 107.653 -1.24 . . . . 72.209999999999994 107.653 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.58 131.31 25.76 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.845 1.697 . . . . 75.329999999999998 111.371 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.74 115.51 63.2 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 106.128 -1.804 . . . . 71.019999999999996 106.128 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 24.3 Cg_endo -92.07 -161.94 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.049 2.499 . . . . 75.230000000000004 114.05 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -92.94 134.9 34.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.145 -1.428 . . . . 25.219999999999999 107.145 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.582 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 54.7 t -109.12 120.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 C-N-CA 119.035 -1.066 . . . . 74.310000000000002 110.273 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 50.1 mt-10 -128.77 140.96 51.47 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.075 -1.083 . . . . 72.25 108.075 175.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -70.35 134.36 47.83 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.877 1.271 . . . . 72.450000000000003 113.812 -168.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.3 t -125.46 155.34 40.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.671 -1.974 . . . . 65.329999999999998 105.671 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 57.8 t -81.31 114.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 119.679 -0.808 . . . . 72.409999999999997 108.854 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -118.86 140.22 50.33 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 109.241 -0.651 . . . . 74.239999999999995 109.241 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -132.75 138.66 47.27 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.953 -1.128 . . . . 74.230000000000004 107.953 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.39 172.73 12.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.075 0.768 . . . . 63.200000000000003 113.075 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.82 -3.12 26.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.905 1.282 . . . . 71.310000000000002 110.976 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 23' ' ' LEU . 4.0 pp -57.36 -25.81 60.03 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.88 0.872 . . . . 61.450000000000003 112.784 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 22' ' ' LEU . 94.7 mt -66.72 -28.36 68.36 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 121.044 0.45 . . . . 50.130000000000003 110.982 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -67.26 -44.75 78.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 74.340000000000003 109.96 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -76.1 -31.92 58.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.883 -0.599 . . . . 74.349999999999994 110.096 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.29 -30.41 64.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 75.219999999999999 110.819 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.08 -49.43 75.88 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.984 0.513 . . . . 52.219999999999999 110.633 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -77.81 -19.81 54.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.101 0.56 . . . . 72.030000000000001 111.553 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -82.97 -17.11 44.66 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.702 -0.481 . . . . 62.109999999999999 109.702 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.554 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 39.9 m -109.12 103.99 13.09 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 121.207 0.527 . . . . 60.240000000000002 111.169 -176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.88 -52.69 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 111.389 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -104.94 142.5 34.66 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.259 -0.645 . . . . 72.310000000000002 109.259 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.93 153.0 84.81 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.16 -1.052 . . . . 53.130000000000003 108.16 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.14 142.23 96.97 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.047 1.831 . . . . 71.129999999999995 112.831 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.49 131.71 41.92 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.527 -0.545 . . . . 55.219999999999999 109.527 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -125.07 -168.35 1.81 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.371 0.605 . . . . 71.319999999999993 109.969 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -106.97 5.81 28.53 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.526 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 43.48 3.79 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.22 -1.552 . . . . 62.240000000000002 109.22 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.4 -3.67 59.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.392 0.615 . . . . 64.140000000000001 110.967 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.82 2.1 3.72 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 124.167 0.987 . . . . 64.040000000000006 112.726 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -83.17 -19.59 36.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.269 -1.011 . . . . 72.329999999999998 108.269 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt 57.44 79.47 0.32 Allowed Pre-proline 0 C--N 1.345 0.394 0 CA-C-N 114.46 -1.245 . . . . 52.520000000000003 111.937 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.68 -62.48 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.483 2.122 . . . . 54.32 112.162 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.72 -2.28 35.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.953 0.406 . . . . 63.200000000000003 111.644 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.68 79.85 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.871 -0.681 . . . . 13.1 113.163 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 m -147.37 164.21 34.0 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.474 -0.565 . . . . 55.350000000000001 109.474 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.82 157.35 45.87 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.884 -1.154 . . . . 44.509999999999998 107.884 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -123.46 152.69 41.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 118.388 0.54 . . . . 72.420000000000002 111.593 -175.248 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.583 HD12 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -116.88 143.19 45.99 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.673 -1.232 . . . . 73.510000000000005 107.673 173.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.88 133.38 61.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 121.093 -0.243 . . . . 74.530000000000001 110.496 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.3 116.88 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 104.792 -2.299 . . . . 64.430000000000007 104.792 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -89.87 -31.87 17.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.752 -0.658 . . . . 54.200000000000003 109.595 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -152.89 137.0 16.42 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.924 -0.58 . . . . 74.209999999999994 109.566 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.41 172.23 13.13 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 109.21 -1.556 . . . . 74.219999999999999 109.21 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.538 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 77.9 Cg_exo -55.28 -29.67 68.36 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 122.73 2.287 . . . . 52.009999999999998 113.926 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.28 18.12 21.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 120.326 -0.549 . . . . 72.439999999999998 110.399 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.86 143.58 41.94 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.107 0.48 . . . . 63.530000000000001 112.195 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.85 -14.28 57.47 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.359 -1.096 . . . . 61.219999999999999 110.359 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.79 122.12 21.04 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.289 -0.456 . . . . 61.520000000000003 109.847 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -133.4 134.97 44.34 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.551 -1.277 . . . . 74.420000000000002 107.551 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -137.26 145.38 43.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.288 -0.634 . . . . 74.310000000000002 109.288 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.1 tp -93.17 127.23 38.64 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.493 0.496 . . . . 73.129999999999995 109.717 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.583 HD21 HD12 ' A' ' 49' ' ' LEU . 2.4 mm? -97.6 107.3 19.77 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.197 0.522 . . . . 74.049999999999997 111.368 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.24 19.19 1.09 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.054 -1.832 . . . . 73.150000000000006 106.054 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.466 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 16.0 pt20 -107.21 142.14 24.44 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 113.971 -1.468 . . . . 72.040000000000006 107.931 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 27.9 Cg_endo -64.94 -19.19 63.88 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.251 1.967 . . . . 75.219999999999999 113.955 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -149.5 129.99 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.231 -0.587 . . . . 72.510000000000005 111.58 -176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.9 m -132.9 113.51 12.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.337 -1.357 . . . . 72.209999999999994 107.337 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -92.88 138.03 31.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.757 -0.46 . . . . 73.239999999999995 109.757 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 136.93 53.33 Favored 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.329 0.393 . . . . 70.439999999999998 110.082 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.57 -153.37 24.99 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.572 -1.411 . . . . 75.230000000000004 109.572 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 64.1 ttt-85 -118.51 118.06 30.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.637 -1.986 . . . . 73.340000000000003 105.637 175.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 75' ' ' GLU . 5.2 t-160 177.92 139.25 0.24 Allowed Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.955 -1.498 . . . . 73.200000000000003 106.955 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.6 -30.53 36.69 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.529 1.486 . . . . 63.329999999999998 111.978 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 8.4 mm-40 -88.96 4.51 47.89 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.222 0.823 . . . . 54.439999999999998 113.222 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.6 p -89.99 115.84 27.58 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 119.082 -1.047 . . . . 72.230000000000004 108.879 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.9 -34.87 73.76 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.485 0.491 . . . . 75.140000000000001 110.831 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.5 pt -114.36 111.8 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.222 -1.029 . . . . 73.439999999999998 108.222 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -94.01 121.12 35.16 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.994 -1.003 . . . . 73.420000000000002 110.774 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.29 119.4 33.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.849 -1.167 . . . . 71.129999999999995 107.849 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.74 124.77 41.77 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.799 0.296 . . . . 74.329999999999998 111.799 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD2' HG23 ' A' ' 83' ' ' VAL . 16.9 t70 177.5 -145.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 103.877 -2.638 . . . . 63.0 103.877 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.424 HG23 ' OD2' ' A' ' 82' ' ' ASP . 48.5 t -57.43 -23.56 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.914 0.779 . . . . 63.219999999999999 111.004 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 m -76.59 81.59 3.26 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.688 0.756 . . . . 75.329999999999998 110.108 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.08 105.85 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.148 -1.056 . . . . 70.439999999999998 108.148 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.3 m -163.57 136.28 5.29 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.767 -1.568 . . . . 72.219999999999999 106.767 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.582 ' HD3' ' HA ' ' A' ' 12' ' ' VAL . 17.1 ptt180 -64.28 -25.56 68.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.817 0.698 . . . . 73.349999999999994 111.629 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' HG21 ' A' ' 104' ' ' VAL . 45.3 mtt-85 -145.21 128.25 16.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.776 -0.824 . . . . 73.420000000000002 108.776 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 110' ' ' THR . 30.0 t-80 -99.88 -52.78 3.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.324 -1.362 . . . . 75.150000000000006 107.324 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.01 164.91 36.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.681 -1.145 . . . . 51.409999999999997 108.271 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.85 139.45 52.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.708 -0.478 . . . . 72.049999999999997 109.708 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -108.04 125.3 51.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.946 -1.502 . . . . 71.400000000000006 106.946 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.99 131.7 56.86 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.925 -0.768 . . . . 74.420000000000002 108.925 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.8 mp -115.25 112.27 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.411 -1.329 . . . . 61.109999999999999 107.411 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -138.93 125.49 20.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 110.724 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.77 37.97 29.51 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.851 0.86 . . . . 74.150000000000006 112.677 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 1.77 90.22 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.972 -0.558 . . . . 51.329999999999998 113.544 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -110.61 131.64 54.88 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.458 -0.571 . . . . 74.409999999999997 109.458 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -104.66 117.56 34.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.869 -1.16 . . . . 64.109999999999999 107.869 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.97 130.92 56.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.183 0.516 . . . . 61.140000000000001 110.412 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.44 122.6 61.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.64 -1.245 . . . . 61.229999999999997 107.64 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.93 124.0 71.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.426 -0.583 . . . . 64.329999999999998 109.426 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.62 140.36 40.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.8 -1.185 . . . . 55.219999999999999 107.8 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 88' ' ' ARG . 18.8 m -100.41 -13.71 8.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.947 -0.701 . . . . 71.439999999999998 111.923 -175.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.65 95.29 0.1 OUTLIER Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.505 -1.038 . . . . 64.030000000000001 110.505 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -64.96 14.48 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.681 1.592 . . . . 75.430000000000007 114.291 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 6.0 mp -70.87 -37.92 73.09 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.897 -1.149 . . . . 61.409999999999997 107.897 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.3 -20.15 22.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.47 -0.786 . . . . 74.120000000000005 110.326 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.39 94.87 0.22 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.556 -0.747 . . . . 61.32 114.58 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 58.1 m -80.98 130.16 34.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.284 -0.635 . . . . 74.019999999999996 109.284 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.36 125.69 54.54 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.643 -1.243 . . . . 74.329999999999998 107.643 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.0 t -133.1 136.86 54.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.165 -1.421 . . . . 74.420000000000002 107.165 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.33 39.25 30.74 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.367 1.467 . . . . 75.209999999999994 108.257 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' A' ' 30' ' ' THR . 34.2 mtm105 63.81 20.47 12.23 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.655 -1.611 . . . . 71.5 115.279 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.513 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 41.4 mt-10 -136.02 153.42 76.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.298 -0.63 . . . . 73.420000000000002 109.298 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.2 123.72 13.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.251 1.967 . . . . 63.030000000000001 108.925 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.626 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 18.3 tpp180 -135.96 139.99 43.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.253 -0.579 . . . . 70.400000000000006 109.869 -170.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -98.84 -37.57 9.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.477 0.656 . . . . 75.120000000000005 110.525 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.04 136.96 18.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.258 -1.386 . . . . 70.040000000000006 107.258 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.626 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 55.5 tp60 -152.58 136.02 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.176 0.435 . . . . 72.519999999999996 112.176 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.35 117.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 104.676 -2.342 . . . . 72.230000000000004 104.676 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.452 ' SD ' HD11 ' A' ' 128' ' ' ILE . 43.5 ttp -88.05 130.71 34.91 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.664 0.745 . . . . 75.400000000000006 111.458 -168.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.27 156.44 16.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.081 -1.418 . . . . 74.140000000000001 109.151 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.0 t -70.56 130.81 42.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.932 -1.136 . . . . 64.329999999999998 107.932 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.3 57.73 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 120.565 -0.826 . . . . 72.319999999999993 111.158 -177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.43 141.06 50.28 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 109.326 -0.62 . . . . 54.219999999999999 109.326 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.47 125.7 54.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.496 -0.557 . . . . 72.140000000000001 109.496 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.452 HD11 ' SD ' ' A' ' 122' ' ' MET . 68.3 mt -108.21 131.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.302 -1.37 . . . . 72.219999999999999 107.302 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -119.92 123.0 42.49 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 121.378 0.609 . . . . 75.019999999999996 109.654 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.6 mt -113.9 102.31 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.301 -1.74 . . . . 74.510000000000005 106.301 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.71 -111.86 4.43 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 109.933 -1.267 . . . . 41.509999999999998 109.933 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' A' ' 82' ' ' ASP . 65.9 pttt -103.58 -4.67 23.58 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 117.406 0.603 . . . . 74.510000000000005 110.428 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.538 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.9 m-85 -73.22 130.5 40.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.401 -0.592 . . . . 73.239999999999995 109.401 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -112.01 119.41 38.37 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.628 -1.249 . . . . 75.040000000000006 107.628 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.3 134.3 54.96 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.582 -1.266 . . . . 72.519999999999996 107.582 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.71 131.53 69.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 108.746 -0.835 . . . . 73.530000000000001 108.746 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.31 122.56 43.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.572 -0.529 . . . . 73.349999999999994 109.572 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 48' ' ' LEU . 3.9 mp -128.72 137.19 51.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 110.162 -0.31 . . . . 73.310000000000002 110.162 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.57 135.48 33.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.986 -0.746 . . . . 74.230000000000004 108.986 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.2 88.07 1.81 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.788 -0.925 . . . . 74.150000000000006 110.788 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' ' 48' ' ' LEU . 21.2 Cg_exo -66.64 161.86 39.7 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.215 2.61 . . . . 64.540000000000006 112.459 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.43 53.73 0.88 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.196 -1.038 . . . . 72.310000000000002 108.196 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.026 -0.988 . . . . 72.450000000000003 109.216 -175.583 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 C--O 1.245 0.864 0 CA-C-O 121.247 0.546 . . . . 73.019999999999996 109.986 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 m -128.33 174.87 8.93 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.434 -0.803 . . . . 72.230000000000004 109.521 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -83.05 161.24 21.75 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 108.961 -0.755 . . . . 62.409999999999997 108.961 176.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -112.92 150.99 31.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.563 -0.902 . . . . 64.230000000000004 108.563 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -121.46 16.38 11.29 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.565 -1.643 . . . . 53.229999999999997 106.565 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.02 -36.18 90.47 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.036 -1.438 . . . . 71.340000000000003 109.874 177.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 m -110.02 106.73 58.46 Favored Pre-proline 0 N--CA 1.414 -2.243 0 N-CA-C 108.689 -0.856 . . . . 63.219999999999999 108.689 172.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 148.72 19.65 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.902 1.735 . . . . 73.349999999999994 108.496 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -113.88 113.76 46.95 Favored Pre-proline 0 N--CA 1.422 -1.844 0 C-N-CA 117.588 -1.645 . . . . 75.319999999999993 110.823 176.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -105.31 173.87 0.13 Allowed 'Trans proline' 0 N--CA 1.42 -2.795 0 C-N-CA 122.978 2.452 . . . . 74.340000000000003 110.313 172.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -128.88 166.19 19.57 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.576 -0.898 . . . . 71.140000000000001 108.576 175.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.24 120.07 57.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 101.361 -3.57 . . . . 71.5 101.361 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.457 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 13.0 tp10 -124.31 156.24 37.3 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.101 0.778 . . . . 72.519999999999996 113.101 -161.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.428 ' H ' ' HE ' ' A' ' 87' ' ' ARG . 22.4 m -131.07 107.29 8.95 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.9 0.857 . . . . 72.409999999999997 109.718 178.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -105.47 152.49 22.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.451 -0.574 . . . . 73.150000000000006 109.451 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 107' ' ' LEU . 93.7 t -113.64 117.45 55.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 119.63 -0.224 . . . . 62.130000000000003 110.692 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 83' ' ' VAL . 47.8 p90 -123.12 127.25 48.44 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.085 -0.646 . . . . 72.430000000000007 109.454 171.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 19' ' ' ARG . 28.5 mtp180 -106.9 92.13 3.96 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.924 -1.139 . . . . 71.25 107.924 176.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 -154.99 0.56 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.233 -0.894 . . . . 63.0 112.169 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.65 -3.21 6.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.388 1.475 . . . . 73.209999999999994 112.032 -172.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.82 -25.04 60.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.132 0.973 . . . . 74.530000000000001 111.713 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.8 pp -67.31 -24.33 65.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.302 0.572 . . . . 74.219999999999999 111.304 177.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 23' ' ' LEU . 34.9 ttmt -88.56 -29.79 19.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.839 -0.8 . . . . 75.319999999999993 108.839 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -56.57 -44.77 81.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 42.420000000000002 110.794 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.3 ptp -83.99 2.76 37.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.614 -0.721 . . . . 73.099999999999994 111.556 -179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -91.88 -49.66 6.13 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.209 -1.034 . . . . 75.219999999999999 108.209 176.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.2 m -61.0 -42.85 99.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.29 -0.868 . . . . 51.439999999999998 111.986 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -77.4 -33.56 55.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.902 0.382 . . . . 50.340000000000003 110.293 177.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m 74.44 -54.8 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.122 1.369 . . . . 64.319999999999993 111.21 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.34 -163.8 10.58 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 109.935 -1.266 . . . . 23.149999999999999 109.935 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 113' ' ' ASN . 97.8 m -104.6 138.36 41.06 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 117.054 0.427 . . . . 71.329999999999998 110.288 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.34 121.45 66.46 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 108.367 -0.975 . . . . 61.240000000000002 108.367 176.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -59.48 152.28 62.73 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 122.93 2.42 . . . . 71.140000000000001 113.02 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 166.43 16.17 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.36 -0.836 . . . . 55.399999999999999 109.127 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -66.05 122.74 18.09 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.231 0.539 . . . . 63.210000000000001 111.189 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 m -54.67 133.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.445 -1.252 . . . . 71.530000000000001 109.904 177.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 41' ' ' ASN . . . 129.78 -28.18 3.99 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 108.826 -1.71 . . . . 71.439999999999998 108.826 -174.316 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.5 65.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.695 0.76 . . . . 74.150000000000006 110.328 178.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 7.86 4.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.008 0.909 . . . . 71.5 112.576 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.7 m120 -79.54 -16.69 55.52 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.506 -1.224 . . . . 63.119999999999997 110.269 173.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 50.96 68.62 3.2 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 123.987 0.804 . . . . 71.010000000000005 112.819 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.03 -56.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.528 2.152 . . . . 74.140000000000001 113.648 -175.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -23.31 33.43 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.019 0.377 . . . . 72.540000000000006 112.019 -177.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.93 79.7 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 120.351 -0.928 . . . . 53.530000000000001 111.182 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.1 m -115.12 157.19 23.94 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.125 -1.065 . . . . 54.340000000000003 108.125 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.59 157.3 46.04 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.548 -0.538 . . . . 63.149999999999999 109.548 -177.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -134.04 160.26 38.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.744 0.652 . . . . 71.329999999999998 109.317 -177.136 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -128.69 141.22 51.4 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 120.158 -0.617 . . . . 53.329999999999998 109.846 175.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.86 139.67 38.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.432 -0.804 . . . . 62.219999999999999 109.809 -176.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 20.7 t -81.0 118.37 28.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.204 -1.036 . . . . 63.43 108.204 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -85.15 -34.79 22.05 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.169 -0.923 . . . . 75.099999999999994 109.858 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.627 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 29.2 tpt180 -151.68 144.91 24.67 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.52 -1.659 . . . . 73.109999999999999 106.52 -177.311 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.62 -171.05 22.48 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.508 -0.853 . . . . 52.229999999999997 111.551 179.219 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.67 -33.06 8.75 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.204 1.936 . . . . 72.519999999999996 109.932 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.77 11.81 21.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.058 -1.428 . . . . 74.540000000000006 110.109 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.56 42.36 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.298 0.571 . . . . 24.34 112.109 -175.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.91 -19.27 47.37 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 115.225 -0.898 . . . . 73.420000000000002 111.712 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.74 156.84 19.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.958 -0.386 . . . . 65.150000000000006 109.958 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -139.46 155.15 47.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.752 -1.203 . . . . 73.439999999999998 107.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -147.78 143.3 27.42 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.608 -0.516 . . . . 75.510000000000005 109.608 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.3 pt? -108.62 144.75 35.93 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.526 0.516 . . . . 74.430000000000007 110.285 -177.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.15 105.06 11.14 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.703 -0.681 . . . . 70.340000000000003 110.175 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.93 -15.93 11.17 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.312 1.045 . . . . 65.340000000000003 109.344 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -107.34 153.23 41.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 114.4 -1.273 . . . . 72.319999999999993 110.117 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -63.17 -29.32 73.9 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.897 2.398 . . . . 73.409999999999997 113.743 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 67.2 m -150.47 122.67 8.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.084 0.469 . . . . 70.510000000000005 111.287 -177.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.8 m -112.6 114.24 26.78 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.163 -0.68 . . . . 74.439999999999998 109.163 178.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -90.75 133.87 34.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.39 -0.967 . . . . 72.200000000000003 108.39 175.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -128.03 135.4 49.82 Favored 'General case' 0 C--O 1.267 2.019 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 111.404 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.41 -153.62 25.01 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 114.579 -1.192 . . . . 72.310000000000002 111.174 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 22.0 tpp85 -79.4 151.82 30.72 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.977 1.311 . . . . 74.219999999999999 108.676 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 14.9 m170 92.39 127.89 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 125.904 1.682 . . . . 74.420000000000002 110.619 -175.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.85 2.97 4.8 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.347 2.032 . . . . 54.25 112.522 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 12.9 pt-20 -80.2 -25.19 39.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.252 -1.018 . . . . 72.310000000000002 108.252 175.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -73.01 132.04 42.9 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.7 -1.222 . . . . 74.219999999999999 107.7 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -54.74 -39.53 68.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.698 0.629 . . . . 44.119999999999997 112.698 -174.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.4 mm -119.58 124.69 73.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.34 108.06 20.22 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.266 0.555 . . . . 60.530000000000001 110.604 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.62 117.6 32.72 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.953 -2.24 . . . . 62.420000000000002 104.953 176.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.48 116.76 18.32 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.387 -0.925 . . . . 74.329999999999998 111.954 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.73 161.4 14.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.755 -0.657 . . . . 62.020000000000003 109.457 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 18' ' ' PHE . 98.6 t -67.95 -36.25 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.328 0.585 . . . . 64.310000000000002 109.914 178.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 p -116.44 -171.29 1.98 Allowed 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.791 -0.641 . . . . 71.140000000000001 110.479 -176.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.31 96.58 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.452 -0.944 . . . . 75.230000000000004 108.452 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.9 m -129.44 85.69 2.34 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.929 -1.508 . . . . 34.100000000000001 106.929 174.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 20.0 ptt180 -77.31 -45.88 24.78 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 74.109999999999999 110.117 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -106.21 93.4 4.59 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.534 -1.284 . . . . 63.340000000000003 107.534 172.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -99.65 -53.27 3.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.094 -1.076 . . . . 75.319999999999993 108.094 174.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.9 143.76 31.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.744 -0.782 . . . . 71.549999999999997 111.474 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -122.35 135.54 54.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.29 -0.868 . . . . 64.430000000000007 109.58 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 35.6 m-85 -104.2 113.62 27.29 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.572 -1.64 . . . . 65.099999999999994 106.572 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.24 123.88 51.1 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.865 -0.791 . . . . 64.310000000000002 108.865 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 94' ' ' ILE . 2.6 mp -104.02 115.13 45.39 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 N-CA-C 106.82 -1.548 . . . . 74.329999999999998 106.82 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -131.53 120.56 23.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.58 -0.526 . . . . 50.130000000000003 109.58 -177.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 48.22 48.23 18.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.556 1.143 . . . . 73.540000000000006 113.586 -177.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.07 -6.46 62.93 Favored Glycine 0 N--CA 1.462 0.427 0 CA-C-N 116.015 -0.539 . . . . 61.240000000000002 114.414 176.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -103.05 143.56 32.43 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.276 -0.639 . . . . 71.209999999999994 109.276 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -104.8 116.76 32.57 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.871 -0.788 . . . . 72.439999999999998 108.871 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.0 126.28 55.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.434 -0.951 . . . . 73.109999999999999 108.434 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.77 123.97 63.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 118.662 -1.215 . . . . 43.409999999999997 107.787 173.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.17 123.38 67.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.044 -1.465 . . . . 71.25 107.044 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.53 136.47 47.26 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.94 -1.027 . . . . 72.430000000000007 109.991 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -116.75 0.1 8.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.946 -0.57 . . . . 64.310000000000002 110.616 177.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.08 34.64 4.86 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 121.151 -0.547 . . . . 63.140000000000001 112.049 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -51.62 -34.42 37.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.876 1.27 . . . . 61.219999999999999 111.177 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 107' ' ' LEU . 4.6 mp -67.34 -23.92 65.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.063 -0.971 . . . . 54.409999999999997 111.16 -178.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.95 -18.64 30.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.586 0.708 . . . . 75.430000000000007 109.704 -175.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.22 0.43 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 119.103 -1.522 . . . . 71.230000000000004 113.93 175.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.8 m -77.79 129.14 35.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.871 -0.789 . . . . 42.310000000000002 108.871 172.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.11 144.55 47.2 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.897 -0.321 . . . . 64.319999999999993 110.189 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.18 117.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.594 -1.632 . . . . 71.510000000000005 106.594 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.422 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 93.9 m-20 56.91 45.75 20.82 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.734 0.646 . . . . 54.32 110.062 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.04 8.95 2.81 Favored 'General case' 0 CA--C 1.569 1.701 0 C-N-CA 125.731 1.612 . . . . 73.409999999999997 113.809 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -114.11 136.85 22.24 Favored Pre-proline 0 C--N 1.31 -1.134 0 O-C-N 121.341 -0.85 . . . . 65.420000000000002 110.342 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -68.05 138.17 43.08 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 122.025 1.817 . . . . 70.420000000000002 111.211 177.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -142.19 164.6 29.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.082 -0.508 . . . . 62.310000000000002 111.025 -177.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -117.37 -37.6 3.48 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.489 1.118 . . . . 70.239999999999995 108.258 176.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.01 139.95 26.48 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.283 -1.377 . . . . 73.510000000000005 107.283 175.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 0.0 OUTLIER -152.49 130.33 11.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.432 -0.581 . . . . 64.219999999999999 109.432 -177.864 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.8 t -83.41 118.29 30.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.999 -1.482 . . . . 65.349999999999994 106.999 174.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.443 ' HE2' ' HB3' ' A' ' 120' ' ' GLN . 22.8 mmt -88.82 144.93 25.9 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.725 0.774 . . . . 63.5 112.944 -167.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.58 155.91 45.04 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.946 -1.479 . . . . 75.319999999999993 107.26 -177.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 t -62.57 134.38 56.29 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.339 0.59 . . . . 71.310000000000002 111.336 -176.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.32 -7.47 56.46 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.06 -0.973 . . . . 71.400000000000006 113.535 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.79 152.14 24.81 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 119.002 -1.079 . . . . 75.439999999999998 111.709 175.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.21 129.15 51.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.381 -1.281 . . . . 71.25 110.187 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt -108.1 131.91 57.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.198 -1.408 . . . . 74.230000000000004 107.198 -177.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -104.35 122.48 45.54 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.312 -0.996 . . . . 71.420000000000002 108.312 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 135' ' ' LEU . 2.3 mp -109.22 104.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 106.602 -1.629 . . . . 53.530000000000001 106.602 178.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.05 -107.81 2.21 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.248 -1.141 . . . . 73.120000000000005 110.248 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -110.77 6.86 21.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.849 0.325 . . . . 70.340000000000003 111.673 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.627 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 44.1 p90 -123.49 157.63 33.1 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.542 0.941 . . . . 74.219999999999999 113.542 -177.013 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -116.05 136.61 52.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.347 -0.388 . . . . 64.120000000000005 111.329 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 130' ' ' ILE . 9.6 mp -123.45 139.72 53.74 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.191 0.997 . . . . 64.230000000000004 108.337 175.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.45 126.82 69.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.574 -0.528 . . . . 62.210000000000001 109.574 -178.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -88.32 127.74 35.48 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.657 -0.868 . . . . 71.140000000000001 108.657 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.44 143.72 50.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.577 0.703 . . . . 72.120000000000005 111.238 -176.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.2 121.92 45.5 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.489 -0.93 . . . . 60.229999999999997 108.489 176.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 132.27 82.23 0.22 Allowed Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.72 -1.352 . . . . 53.219999999999999 109.72 -177.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.98 162.38 29.42 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.276 2.65 . . . . 54.219999999999999 112.719 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.89 -1.17 56.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.198 0.999 . . . . 63.240000000000002 110.929 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.271 -2.838 0 N-CA-C 103.627 -2.731 . . . . 62.009999999999998 103.627 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 109.129 -0.693 . . . . 75.129999999999995 109.129 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.7 m -130.44 134.76 47.35 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.321 -0.251 . . . . 53.43 110.321 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.18 157.89 22.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.198 -0.667 . . . . 64.049999999999997 109.198 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.57 141.18 58.52 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.919 0.488 . . . . 55.009999999999998 111.776 -175.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.16 134.67 39.87 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 122.563 0.345 . . . . 61.130000000000003 110.221 178.081 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.37 147.71 50.15 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.125 -0.79 . . . . 64.519999999999996 111.125 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 m -90.85 119.56 68.91 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 109.979 -0.378 . . . . 72.109999999999999 109.979 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.6 140.93 84.14 Favored 'Trans proline' 0 C--O 1.253 1.236 0 C-N-CA 123.011 2.474 . . . . 71.010000000000005 112.513 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -90.16 128.12 50.75 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-N 116.071 -0.513 . . . . 73.120000000000005 110.573 178.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.0 -166.37 0.19 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.053 . . . . 60.229999999999997 108.966 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 97.0 mt-30 -109.46 166.51 10.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.632 -0.877 . . . . 55.100000000000001 108.632 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.75 125.68 65.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.201 -1.037 . . . . 72.409999999999997 108.201 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' N ' ' HD3' ' A' ' 87' ' ' ARG . 37.0 tt0 -158.83 132.33 7.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.252 -0.431 . . . . 61.200000000000003 110.561 -173.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -75.59 133.13 41.0 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.733 -1.951 . . . . 71.510000000000005 105.733 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.509 ' O ' HD12 ' A' ' 107' ' ' LEU . 36.1 t -89.46 123.06 33.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.996 -1.002 . . . . 64.420000000000002 108.785 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -85.56 115.13 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.283 -1.377 . . . . 72.439999999999998 107.283 177.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.472 ' CE2' ' HG ' ' A' ' 107' ' ' LEU . 40.3 p90 -114.79 142.53 46.4 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 120.813 0.34 . . . . 74.319999999999993 110.55 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -80.78 95.93 6.81 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.74 -1.208 . . . . 73.420000000000002 107.74 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -81.3 -178.71 7.04 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.421 -0.809 . . . . 73.230000000000004 112.26 -175.187 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.42 4.44 4.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 114.326 1.232 . . . . 64.420000000000002 114.326 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 22' ' ' LEU . 2.5 pt? -82.83 -16.75 46.5 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.879 -0.513 . . . . 74.450000000000003 111.553 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 2.6 pp -70.01 -1.14 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.118 1.525 . . . . 75.140000000000001 115.118 -173.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -102.73 -22.5 13.92 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.574 -0.451 . . . . 60.229999999999997 111.257 177.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 114' ' ' ARG . 30.8 tt0 -72.68 -23.6 60.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.703 -0.399 . . . . 74.310000000000002 111.829 -172.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' SER . 52.6 ttp -62.33 -47.52 83.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.327 -0.397 . . . . 51.25 110.196 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.42 -22.58 23.66 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.505 -0.316 . . . . 70.319999999999993 110.963 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.6 t -62.29 -27.44 69.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.186 0.993 . . . . 65.540000000000006 108.532 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 26' ' ' MET . 40.0 t -65.38 -39.14 91.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.311 -1.313 . . . . 62.299999999999997 110.593 175.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 m 69.46 -7.08 0.89 Allowed 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 124.879 1.271 . . . . 71.329999999999998 111.418 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.64 96.23 0.11 Allowed Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.668 -1.773 . . . . 72.340000000000003 108.668 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 92.0 m -72.84 121.02 19.28 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.869 0.842 . . . . 62.200000000000003 110.772 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.13 106.16 19.9 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 114.803 -1.09 . . . . 73.329999999999998 109.042 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -61.16 142.96 98.38 Favored 'Trans proline' 0 C--O 1.263 1.74 0 C-N-CA 121.551 1.501 . . . . 60.240000000000002 109.202 173.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.47 125.72 27.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.939 -0.573 . . . . 63.329999999999998 110.342 -177.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.5 m -84.33 92.7 8.07 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.657 -0.868 . . . . 61.549999999999997 108.657 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 m -102.55 155.62 18.16 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.875 -1.157 . . . . 72.239999999999995 107.875 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.7 25.57 7.3 Favored Glycine 0 CA--C 1.499 -0.947 0 N-CA-C 111.05 -0.82 . . . . 74.219999999999999 111.05 -175.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.93 5.18 49.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.987 -0.607 . . . . 74.140000000000001 110.202 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.23 -3.35 13.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.373 1.069 . . . . 65.409999999999997 113.393 -175.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.86 -2.81 31.1 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.233 -1.025 . . . . 73.430000000000007 108.233 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.9 82.83 0.22 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.185 -0.916 . . . . 71.329999999999998 110.95 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.03 -59.72 0.74 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.235 2.623 . . . . 73.409999999999997 114.257 -175.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.13 -4.08 59.09 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.227 0.454 . . . . 51.229999999999997 112.227 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 9.61 86.82 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.709 -0.758 . . . . 71.0 111.478 -177.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 m -145.86 169.22 19.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.884 -1.524 . . . . 73.230000000000004 106.884 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.77 157.23 43.63 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.414 0.446 . . . . 75.409999999999997 109.916 -178.134 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -133.26 153.32 51.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.056 0.455 . . . . 72.439999999999998 110.8 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.5 pp -110.86 135.02 52.03 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.573 176.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.75 135.2 55.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.394 -0.595 . . . . 72.219999999999999 109.394 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.26 117.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.361 -1.718 . . . . 65.400000000000006 106.361 176.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.53 -31.95 16.53 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.527 -0.761 . . . . 73.200000000000003 109.683 -175.641 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -148.19 141.02 24.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.399 -0.963 . . . . 72.439999999999998 108.399 -178.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.5 174.14 13.22 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.793 -0.923 . . . . 62.420000000000002 110.793 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.592 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 76.6 Cg_exo -54.68 -43.28 60.52 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.83 2.353 . . . . 65.040000000000006 112.402 177.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -93.11 21.88 5.5 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.792 1.034 . . . . 73.439999999999998 113.792 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.75 137.26 44.9 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.735 0.302 . . . . 52.109999999999999 111.14 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.6 -18.95 40.18 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.144 -0.783 . . . . 65.319999999999993 111.144 -177.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.23 143.06 29.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.53 -0.544 . . . . 74.129999999999995 109.53 177.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -135.2 135.58 41.11 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.505 -0.924 . . . . 75.219999999999999 108.505 179.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -128.42 129.67 46.51 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.511 -0.552 . . . . 73.409999999999997 109.511 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.7 pt? -92.13 139.07 31.0 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.286 -0.635 . . . . 74.319999999999993 109.286 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.31 104.38 15.09 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.941 -0.763 . . . . 61.310000000000002 108.941 -179.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -124.37 -2.77 7.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.564 -1.198 . . . . 53.119999999999997 108.957 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 8.8 pm0 -107.73 143.76 27.93 Favored Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-N 115.184 -0.916 . . . . 74.319999999999993 109.392 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 65' ' ' GLN . 21.2 Cg_exo -68.37 -16.28 43.28 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.777 2.318 . . . . 70.319999999999993 113.445 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -150.1 128.05 11.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.727 -0.608 . . . . 74.239999999999995 109.495 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 10.6 m -123.7 119.38 29.63 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 p -87.5 137.12 32.61 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 110.208 -0.293 . . . . 70.540000000000006 110.208 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.02 148.3 51.86 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.329 0.585 . . . . 62.420000000000002 110.787 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.23 28.31 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 108.612 -1.795 . . . . 65.349999999999994 108.612 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -119.15 117.66 29.27 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.653 -1.61 . . . . 44.409999999999997 106.653 175.967 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 171.45 162.14 0.24 Allowed Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 126.077 1.751 . . . . 74.219999999999999 106.623 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.87 -28.66 75.72 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.373 2.049 . . . . 74.340000000000003 114.22 -176.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.14 4.52 48.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.719 0.637 . . . . 62.240000000000002 112.719 -174.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 m -67.9 117.54 9.92 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 73.439999999999998 109.407 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.94 -39.27 84.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.201 -1.037 . . . . 72.239999999999995 108.201 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.455 HG12 ' CG2' ' A' ' 68' ' ' THR . 47.5 mm -112.65 110.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.196 -1.779 . . . . 62.219999999999999 106.196 169.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.4 129.45 39.53 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.991 -0.549 . . . . 75.319999999999993 110.74 -176.194 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 1.7 mm? -124.58 129.78 51.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.254 -2.128 . . . . 71.019999999999996 105.254 175.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -101.31 116.66 33.31 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.589 -0.844 . . . . 54.520000000000003 109.782 177.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.03 -160.11 0.95 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.312 -1.366 . . . . 74.239999999999995 107.312 -178.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.79 -27.99 17.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.65 0.611 . . . . 55.140000000000001 112.65 -174.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.1 m -139.42 148.83 43.33 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.209 -0.932 . . . . 64.439999999999998 111.844 -175.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -74.56 148.88 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.029 . . . . 73.299999999999997 110.189 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.491 ' HB3' HD22 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -142.28 113.69 7.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.19 -1.041 . . . . 74.25 108.19 177.624 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 11' ' ' GLN . 22.3 ptt180 -56.63 -25.3 52.91 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.148 0.795 . . . . 73.329999999999998 113.148 -177.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.416 ' HG2' HG21 ' A' ' 104' ' ' VAL . 34.5 ttt180 -172.99 99.02 0.13 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.286 -1.376 . . . . 63.229999999999997 107.286 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 27.0 t-80 -84.56 -52.53 6.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.425 0.631 . . . . 72.439999999999998 109.698 -177.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.42 41.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.754 -0.832 . . . . 62.5 108.754 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.65 143.98 43.76 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.553 -0.536 . . . . 54.43 109.553 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 83.3 m-85 -104.78 125.32 50.73 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.381 -1.711 . . . . 73.319999999999993 106.381 178.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -113.43 119.11 36.48 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 106.795 -1.557 . . . . 73.439999999999998 106.795 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 3.4 mp -114.65 111.88 37.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.541 -1.651 . . . . 70.340000000000003 106.541 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -135.29 128.9 32.68 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.786 -1.19 . . . . 65.340000000000003 107.786 -177.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 55.45 37.98 29.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.882 0.873 . . . . 61.130000000000003 112.035 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.37 1.45 90.43 Favored Glycine 0 C--O 1.238 0.402 0 CA-C-N 115.974 -0.557 . . . . 52.520000000000003 113.911 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 20.2 mm-40 -102.11 131.74 48.42 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.782 -0.451 . . . . 65.239999999999995 109.782 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -107.48 118.59 37.13 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.211 -1.404 . . . . 72.439999999999998 107.211 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.17 142.79 51.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.251 -0.579 . . . . 52.329999999999998 110.303 178.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -106.63 123.61 61.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.586 -1.265 . . . . 54.420000000000002 107.586 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.3 121.21 65.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.138 -0.69 . . . . 61.340000000000003 109.138 175.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -83.14 131.65 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.459 -0.941 . . . . 74.519999999999996 108.459 173.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.416 HG21 ' HG2' ' A' ' 88' ' ' ARG . 34.6 m -124.74 -14.46 4.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 123.457 0.473 . . . . 72.209999999999994 110.645 178.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . -156.28 84.48 0.14 Allowed Glycine 0 N--CA 1.419 -2.454 0 C-N-CA 120.816 -0.707 . . . . 54.219999999999999 112.768 -178.444 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -69.7 83.09 0.44 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.11 0.481 . . . . 73.209999999999994 109.975 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 16' ' ' SER . 12.4 tp -77.17 -49.31 15.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.675 -1.232 . . . . 74.25 107.675 174.025 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -102.37 -19.17 15.08 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.296 -1.774 . . . . 52.149999999999999 110.049 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 108.82 3.31 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.873 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.6 m -87.38 130.43 34.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.464 0.174 . . . . 55.329999999999998 111.24 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 5.6 m-30 -127.97 132.24 49.21 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.147 0.979 . . . . 74.340000000000003 109.068 175.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.75 127.74 75.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.842 -1.54 . . . . 75.140000000000001 106.842 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 56.85 36.49 27.8 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.031 1.332 . . . . 73.040000000000006 109.185 -169.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.493 ' HD3' ' OE2' ' A' ' 25' ' ' GLU 0.274 44.0 ttp180 57.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.576 1.948 0 C-N-CA 125.716 1.607 . . . . 75.310000000000002 113.059 -177.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.23 147.87 36.84 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.71 -1.219 . . . . 72.450000000000003 107.71 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.72 123.16 12.14 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.703 1.602 . . . . 61.119999999999997 110.24 177.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -161.11 136.89 8.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.707 -1.22 . . . . 75.230000000000004 107.707 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -100.56 -53.75 3.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 123.364 0.415 . . . . 75.239999999999995 109.959 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.604 -0.887 . . . . 65.420000000000002 108.604 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -154.77 140.22 17.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.315 -0.402 . . . . 72.400000000000006 110.699 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.6 t -76.06 124.54 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 105.756 -1.942 . . . . 71.299999999999997 105.756 168.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.436 ' SD ' HD11 ' A' ' 128' ' ' ILE . 36.6 ttp -89.81 141.19 28.86 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.485 -169.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 11.0 pt20 -115.1 156.99 24.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 124.557 1.143 . . . . 73.099999999999994 109.815 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -69.92 130.26 41.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 74.340000000000003 107.692 173.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.02 56.5 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 119.963 -1.113 . . . . 54.340000000000003 110.351 -174.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 6.3 t70 -76.21 137.53 40.06 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.27 -1.381 . . . . 74.209999999999994 107.27 178.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.6 124.28 45.95 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.354 0.597 . . . . 73.299999999999997 109.765 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.436 HD11 ' SD ' ' A' ' 122' ' ' MET . 37.3 mt -108.16 131.69 57.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.53 -0.915 . . . . 62.210000000000001 108.53 -172.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 7.2 tp60 -115.52 119.04 34.88 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.345 -0.613 . . . . 53.140000000000001 109.345 -176.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.19 102.83 9.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 106.48 -1.674 . . . . 64.340000000000003 106.48 176.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.89 -103.66 0.06 OUTLIER Glycine 0 N--CA 1.475 1.24 0 O-C-N 123.74 0.65 . . . . 75.349999999999994 114.134 -175.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -106.59 2.03 25.73 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.106 -0.547 . . . . 73.109999999999999 111.903 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 89.3 m-85 -96.32 135.39 38.23 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.219 -1.4 . . . . 73.099999999999994 107.219 173.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -131.76 120.17 22.31 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.029 -1.1 . . . . 74.409999999999997 108.029 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.37 136.59 48.55 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.416 -0.587 . . . . 73.400000000000006 109.416 -176.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.95 120.17 64.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.219 -1.4 . . . . 72.239999999999995 107.219 175.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -98.27 117.15 32.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 110.147 -0.316 . . . . 73.510000000000005 110.147 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.37 143.88 47.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.182 0.515 . . . . 61.200000000000003 111.187 -177.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.97 119.64 34.83 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.759 -1.571 . . . . 63.210000000000001 106.759 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.39 153.24 19.81 Favored Glycine 0 N--CA 1.426 -1.969 0 C-N-CA 118.866 -1.635 . . . . 72.0 112.697 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.67 164.13 36.71 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 123.687 2.925 . . . . 72.409999999999997 111.524 175.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 84.31 69.22 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 125.213 1.405 . . . . 73.430000000000007 111.989 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 105.264 -2.125 . . . . 54.119999999999997 105.264 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 C--O 1.245 0.828 0 N-CA-C 109.471 -0.566 . . . . 70.450000000000003 109.471 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -85.33 115.83 23.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.911 -1.885 . . . . 61.409999999999997 105.911 173.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -99.38 163.5 12.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.929 0.395 . . . . 65.010000000000005 110.906 -173.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.49 124.49 21.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.641 -0.709 . . . . 73.329999999999998 110.955 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -102.74 91.45 4.18 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.65 0.738 . . . . 70.5 110.438 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.94 -46.9 4.06 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.483 -0.865 . . . . 63.399999999999999 110.982 177.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 m -104.93 109.59 63.38 Favored Pre-proline 0 C--N 1.31 -1.132 0 O-C-N 122.6 -0.353 . . . . 63.25 110.742 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.3 140.48 30.62 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 N-CA-C 107.956 -1.594 . . . . 74.109999999999999 107.956 172.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -79.13 123.06 84.97 Favored Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.97 -0.692 . . . . 62.030000000000001 109.905 -176.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.2 106.09 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.567 2.178 . . . . 42.210000000000001 112.754 -176.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.8 131.83 9.03 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.801 -1.185 . . . . 75.239999999999995 107.801 177.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.6 120.53 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.762 -1.57 . . . . 73.230000000000004 106.762 173.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.72 131.44 54.42 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 115.414 -0.812 . . . . 63.109999999999999 109.473 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.2 m -77.56 120.41 22.49 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.532 -0.758 . . . . 52.439999999999998 109.661 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.672 HG23 ' HB3' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 44.9 t -89.31 117.84 28.55 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.21 -0.306 . . . . 63.350000000000001 110.204 -177.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.38 118.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.789 -0.449 . . . . 63.340000000000003 109.789 -178.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -124.04 140.73 52.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.384 -0.371 . . . . 74.299999999999997 111.16 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -94.51 139.59 30.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.239 -0.437 . . . . 74.019999999999996 111.232 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -128.46 -164.2 1.36 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 7.6 p-10 -68.08 -3.23 9.65 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.929 0.871 . . . . 73.209999999999994 111.2 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.7 mt -57.25 -31.99 66.1 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 125.89 1.676 . . . . 73.019999999999996 111.502 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 1.6 pp -68.39 -1.38 6.32 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.224 1.564 . . . . 64.099999999999994 115.224 -175.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 63.2 pttt -81.25 -5.71 58.07 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.847 -0.533 . . . . 71.319999999999993 111.599 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -48.9 31.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 116.112 1.893 . . . . 70.430000000000007 116.112 -175.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.7 ttm -62.26 -46.86 86.93 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.942 0.401 . . . . 62.240000000000002 111.658 -176.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.28 -28.25 61.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.318 0.58 . . . . 45.409999999999997 110.303 -178.248 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -80.51 -11.63 59.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.114 -0.494 . . . . 61.439999999999998 110.924 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -71.33 -24.41 62.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.756 -0.831 . . . . 54.539999999999999 108.756 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -76.08 93.74 3.36 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.305 -1.369 . . . . 72.310000000000002 107.305 171.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.78 50.32 0.85 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 106.901 -2.48 . . . . 51.32 106.901 -169.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -67.17 148.39 51.86 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.853 1.261 . . . . 71.510000000000005 112.118 -173.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 150.38 37.8 Favored Pre-proline 0 C--N 1.312 -1.028 0 N-CA-C 108.501 -0.925 . . . . 51.009999999999998 108.501 177.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.98 146.42 96.31 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.418 2.079 . . . . 74.129999999999995 113.24 -177.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.72 159.22 17.19 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 71.219999999999999 108.484 175.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.3 t -98.92 178.12 5.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.489 -0.56 . . . . 73.040000000000006 109.489 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.506 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 12.9 t -156.4 33.56 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.792 -1.929 . . . . 72.420000000000002 105.792 176.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 124' ' ' THR . . . -103.56 35.45 5.02 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 114.827 -1.079 . . . . 62.409999999999997 113.072 -173.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 123' ' ' GLN . . . -90.82 -33.93 15.49 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.396 -0.964 . . . . 63.039999999999999 108.396 174.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.28 12.65 1.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.934 -1.485 . . . . 71.209999999999994 112.346 -177.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.08 -42.02 24.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.24 -0.282 . . . . 72.400000000000006 110.24 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt 35.94 76.07 0.46 Allowed Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 124.766 1.291 . . . . 74.530000000000001 114.241 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.35 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.437 1.425 . . . . 44.100000000000001 111.112 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.06 -8.44 20.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.147 0.499 . . . . 64.329999999999998 110.954 178.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -6.22 80.15 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.401 -0.904 . . . . 75.439999999999998 111.925 -179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -114.49 162.79 16.24 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.94 -1.874 . . . . 71.400000000000006 105.94 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -153.15 157.14 39.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 118.137 0.426 . . . . 73.519999999999996 110.51 -178.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 143.72 44.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.14 0.422 . . . . 74.140000000000001 112.14 -178.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 pt? -116.55 138.54 51.32 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.402 -0.592 . . . . 71.140000000000001 109.402 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.68 132.5 57.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 123.64 0.587 . . . . 72.329999999999998 109.573 -176.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.72 118.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.724 -1.584 . . . . 63.340000000000003 106.724 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.91 -38.96 18.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.411 0.624 . . . . 73.040000000000006 110.34 -175.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -147.54 140.7 25.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.325 -1.361 . . . . 65.019999999999996 107.325 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.94 -177.14 19.12 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 111.475 -0.65 . . . . 73.349999999999994 111.475 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.23 -36.9 86.37 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 122.772 2.315 . . . . 62.009999999999998 111.863 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.75 14.55 18.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.808 -0.633 . . . . 70.239999999999995 111.419 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.49 134.39 56.64 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.776 0.658 . . . . 61.119999999999997 112.776 -176.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -21.09 44.37 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.786 -0.643 . . . . 64.439999999999998 111.876 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 155.03 19.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.766 0.317 . . . . 73.040000000000006 110.47 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.14 144.54 51.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.107 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -117.82 138.53 52.02 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.221 -1.029 . . . . 63.219999999999999 108.221 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.11 127.01 56.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.917 0.865 . . . . 74.549999999999997 110.795 -175.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 49' ' ' LEU . 2.2 mm? -95.45 114.77 26.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.822 -1.081 . . . . 73.519999999999996 108.436 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -134.33 4.27 3.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.296 1.046 . . . . 74.349999999999994 109.193 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -121.49 143.3 37.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.978 -1.01 . . . . 72.299999999999997 110.724 -175.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 53.7 Cg_exo -55.19 -24.39 41.26 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.746 2.964 . . . . 75.420000000000002 114.699 -178.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -144.27 121.54 11.57 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.474 -0.766 . . . . 63.210000000000001 110.722 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.3 m -129.7 119.88 24.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.9 -0.778 . . . . 74.040000000000006 108.9 -178.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 140.25 29.72 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.508 0.594 . . . . 73.209999999999994 111.275 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.05 135.5 55.18 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 109.549 -0.538 . . . . 71.340000000000003 109.549 178.079 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.36 -161.34 25.69 Favored Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 115.65 -0.705 . . . . 42.130000000000003 111.385 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.541 ' HG2' ' H ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -103.83 142.16 34.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.062 -1.459 . . . . 74.239999999999995 107.062 -177.554 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.463 ' CD2' ' HD2' ' A' ' 72' ' ' ARG . 90.4 m-70 80.58 145.84 0.1 OUTLIER Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 125.414 1.486 . . . . 74.400000000000006 110.092 -176.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -66.5 17.4 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.601 2.867 . . . . 51.109999999999999 114.341 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 73' ' ' HIS . 10.4 mm-40 -77.37 -28.77 53.02 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.313 -1.366 . . . . 65.420000000000002 107.313 177.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -96.1 153.0 18.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.919 -1.037 . . . . 61.409999999999997 109.658 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.18 -47.19 78.78 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.56 0.744 . . . . 64.400000000000006 110.463 -178.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.8 mm -98.98 109.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.026 -1.102 . . . . 74.030000000000001 108.026 178.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -87.68 115.6 25.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.115 0.483 . . . . 74.420000000000002 110.577 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 70.8 mt -126.74 140.42 52.4 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.491 -1.67 . . . . 72.430000000000007 106.491 176.623 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -96.52 117.11 30.24 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.246 -0.982 . . . . 74.530000000000001 109.661 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 46.1 t0 -117.38 -179.88 3.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.779 -0.646 . . . . 70.109999999999999 109.36 -171.492 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.03 -46.44 96.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 123.757 0.823 . . . . 74.439999999999998 111.694 -176.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -128.27 -173.1 2.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.463 -0.94 . . . . 72.209999999999994 108.463 -178.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.37 97.5 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 108.825 -0.806 . . . . 54.420000000000002 108.825 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.6 m -89.74 84.89 6.31 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 108.525 -0.917 . . . . 55.210000000000001 108.525 177.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -71.82 -36.98 70.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.97 -1.468 . . . . 75.120000000000005 112.091 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.588 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 31.2 mmm180 -133.71 85.86 2.24 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.241 -1.022 . . . . 71.319999999999993 108.241 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -101.55 -55.65 2.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.193 -0.603 . . . . 61.420000000000002 110.952 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.76 164.59 31.42 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.077 0.465 . . . . 62.409999999999997 111.046 -176.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.66 141.49 37.01 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.397 0.617 . . . . 75.049999999999997 110.148 173.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -104.25 117.4 34.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.781 -1.562 . . . . 63.119999999999997 106.781 -178.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -117.37 128.46 55.05 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-N 115.445 -0.798 . . . . 74.040000000000006 109.256 -175.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -115.52 112.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 105.907 -1.886 . . . . 63.109999999999999 105.907 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -138.52 125.48 21.22 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.893 -0.323 . . . . 70.420000000000002 111.255 -175.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 51.56 49.9 19.94 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.978 1.424 . . . . 72.0 114.098 173.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 114.877 -1.056 . . . . 73.510000000000005 115.382 173.252 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -127.6 146.99 50.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 118.277 1.038 . . . . 74.230000000000004 111.026 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.33 119.6 39.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.485 -1.302 . . . . 75.5 107.485 -176.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.55 128.46 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.525 0.679 . . . . 70.549999999999997 111.353 -176.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 122' ' ' MET . 32.9 t -103.82 124.51 58.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.506 -1.294 . . . . 63.32 107.506 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 20.8 m -118.51 123.37 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 121.588 0.709 . . . . 71.140000000000001 110.836 176.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.29 121.6 25.3 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.447 -1.686 . . . . 73.209999999999994 106.447 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -111.84 -8.72 11.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.175 0.512 . . . . 72.530000000000001 111.349 -174.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -147.28 90.97 0.15 Allowed Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.17 -1.572 . . . . 51.200000000000003 109.17 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 m -79.22 74.09 5.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.559 0.695 . . . . 71.129999999999995 110.989 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.672 ' HB3' HG23 ' A' ' 15' ' ' TPO . 2.6 pt? -104.77 -44.36 4.87 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.328 -0.851 . . . . 75.200000000000003 108.786 175.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.408 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 45.7 t-20 -101.16 -21.78 14.85 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.461 -1.245 . . . . 71.510000000000005 107.897 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.49 116.41 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.309 -0.86 . . . . 73.409999999999997 111.774 -177.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 25.2 m -75.82 128.51 35.29 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.794 -0.817 . . . . 71.540000000000006 108.794 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 22' ' ' LEU . 6.4 m-85 -115.24 126.34 54.42 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.616 -0.513 . . . . 71.140000000000001 109.616 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.6 127.87 62.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.408 -1.33 . . . . 75.200000000000003 107.408 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 57.05 46.58 18.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.637 1.208 . . . . 72.120000000000005 108.385 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 62.69 8.56 3.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.534 -1.667 . . . . 75.0 114.471 -177.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.43 132.66 23.45 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 113.231 0.826 . . . . 64.219999999999999 113.231 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 52.7 Cg_endo -78.13 123.19 6.04 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.0 1.8 . . . . 73.129999999999995 108.369 173.278 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -150.34 158.05 43.73 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.173 -1.047 . . . . 71.239999999999995 108.173 -176.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 15.7 m120 -92.95 -40.8 10.37 Favored 'General case' 0 C--O 1.206 -1.192 0 C-N-CA 120.003 -0.679 . . . . 72.430000000000007 112.77 -176.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.02 134.46 55.29 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.206 -1.405 . . . . 62.200000000000003 107.206 174.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -151.92 143.44 23.49 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 120.837 -0.345 . . . . 74.430000000000007 111.309 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -82.41 124.34 39.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.15 -1.426 . . . . 61.009999999999998 107.15 173.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.438 ' HB2' HG23 ' A' ' 101' ' ' VAL . 47.3 ttp -92.5 129.25 38.49 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 62.420000000000002 108.347 -177.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' A' ' 37' ' ' THR . 26.3 mt-30 -129.8 151.02 50.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.121 -0.696 . . . . 61.030000000000001 109.121 -172.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 38' ' ' GLY . 13.7 t -62.42 132.75 53.59 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.394 0.616 . . . . 63.210000000000001 110.058 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.28 -12.08 61.82 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.774 -0.648 . . . . 72.5 112.584 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.74 151.96 25.95 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.025 0.441 . . . . 74.239999999999995 111.819 178.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -112.23 144.53 41.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.371 -0.832 . . . . 74.540000000000006 109.73 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.43 131.63 67.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.008 -1.108 . . . . 70.310000000000002 108.008 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -117.41 130.51 56.53 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.428 -0.509 . . . . 63.210000000000001 110.163 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.43 107.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 106.29 -1.744 . . . . 72.450000000000003 106.29 175.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.82 -108.53 2.27 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.127 -0.488 . . . . 70.549999999999997 113.323 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.99 -1.2 32.35 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.741 -0.23 . . . . 75.010000000000005 111.504 -175.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 38.1 p90 -124.71 146.39 49.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.992 1.108 . . . . 74.400000000000006 113.992 -173.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -118.18 132.18 56.34 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.117 -0.947 . . . . 74.25 111.288 -172.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.39 140.66 52.43 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 124.142 0.977 . . . . 73.019999999999996 108.875 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.04 130.39 67.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.705 -0.85 . . . . 73.310000000000002 108.705 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -94.06 133.07 37.91 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.976 -0.557 . . . . 63.219999999999999 111.221 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.29 155.57 39.98 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.906 -0.776 . . . . 75.319999999999993 108.906 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.42 148.66 38.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.034 -0.728 . . . . 55.109999999999999 109.034 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.5 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -75.58 136.56 20.26 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.781 -0.724 . . . . 65.129999999999995 112.019 -178.146 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.52 153.89 72.06 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.259 2.64 . . . . 53.030000000000001 112.27 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.61 65.56 0.8 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.791 -0.64 . . . . 62.439999999999998 111.516 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.414 -2.225 0 N-CA-C 107.944 -1.132 . . . . 75.349999999999994 107.944 173.183 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 108.736 -0.839 . . . . 73.209999999999994 108.736 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -84.52 136.45 33.8 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.872 -0.603 . . . . 74.049999999999997 111.678 -174.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.18 102.32 8.44 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.321 -0.854 . . . . 62.119999999999997 109.436 177.654 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -129.18 142.25 50.92 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.206 -1.776 . . . . 63.520000000000003 106.206 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -147.26 171.3 15.62 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.853 -0.425 . . . . 74.230000000000004 109.853 -177.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.97 -70.75 1.13 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.193 -0.527 . . . . 75.510000000000005 112.629 -178.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.0 m -129.32 111.07 17.99 Favored Pre-proline 0 C--N 1.287 -2.116 0 O-C-N 122.546 -0.385 . . . . 74.5 110.308 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.49 131.69 25.3 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.546 1.498 . . . . 64.430000000000007 109.148 173.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.88 149.79 40.9 Favored Pre-proline 0 C--N 1.29 -2.009 0 N-CA-C 108.803 -0.814 . . . . 75.510000000000005 108.803 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.51 122.06 7.26 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 122.174 1.916 . . . . 54.210000000000001 107.965 170.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -91.28 132.95 35.81 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.131 0.967 . . . . 74.430000000000007 112.349 -168.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.3 121.02 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.935 -1.876 . . . . 75.219999999999999 105.935 177.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.84 154.52 25.02 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 108.311 -0.996 . . . . 74.310000000000002 108.311 -177.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -70.27 113.14 7.14 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 123.623 0.769 . . . . 74.230000000000004 112.373 -173.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -96.81 152.95 18.18 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.504 -2.036 . . . . 73.439999999999998 105.504 172.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 93.4 t -82.78 114.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.853 -0.739 . . . . 73.200000000000003 109.321 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -123.3 120.41 32.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.51 -0.768 . . . . 75.329999999999998 110.778 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.92 93.02 3.04 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.155 -2.165 . . . . 71.329999999999998 105.155 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.64 9.52 22.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.467 0.914 . . . . 70.549999999999997 113.467 -168.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -107.24 8.17 29.77 Favored 'General case' 0 C--O 1.182 -2.498 0 C-N-CA 118.909 -1.116 . . . . 74.420000000000002 112.581 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.83 -32.4 63.54 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.111 -0.993 . . . . 70.430000000000007 113.374 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.1 tp -68.05 -37.69 81.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.33 0.586 . . . . 75.329999999999998 110.289 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -91.08 -25.18 19.76 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.126 -0.359 . . . . 55.200000000000003 111.343 -177.181 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -44.31 93.08 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.163 -1.421 . . . . 65.519999999999996 107.163 174.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.3 mtt -62.27 -35.4 78.86 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.33 -0.396 . . . . 65.420000000000002 111.468 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.85 -44.46 80.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.741 0.781 . . . . 75.040000000000006 109.221 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -72.92 -10.44 59.8 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.086 -178.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -65.42 -17.19 64.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.577 0.227 . . . . 32.219999999999999 110.94 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -57.43 116.95 3.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.437 -0.949 . . . . 74.25 108.437 174.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.15 119.74 18.5 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.335 -0.848 . . . . 61.310000000000002 115.079 -173.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -116.68 149.49 39.71 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.513 -1.292 . . . . 64.310000000000002 107.513 173.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.01 127.49 92.86 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.994 -0.373 . . . . 55.149999999999999 109.994 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.02 142.58 88.32 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.134 1.889 . . . . 75.239999999999995 110.61 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . . . -103.69 168.13 9.34 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.505 -0.316 . . . . 72.549999999999997 110.289 -174.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.477 ' HA ' HG23 ' A' ' 124' ' ' THR . 14.4 t -174.88 -168.28 0.34 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.903 -1.518 . . . . 72.510000000000005 106.903 177.226 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 36' ' ' SER . 15.3 t 174.45 -29.81 0.0 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.803 0.841 . . . . 71.340000000000003 109.906 178.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.34 63.3 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.901 -1.143 . . . . 64.019999999999996 112.661 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 124' ' ' THR . . . -79.34 -45.9 18.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.037 -0.727 . . . . 70.239999999999995 109.037 179.202 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.15 4.7 22.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.409 -0.814 . . . . 72.400000000000006 110.651 -178.002 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -89.88 -28.18 19.4 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.664 -1.153 . . . . 51.130000000000003 108.16 177.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.4 mt 56.34 80.05 0.31 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 114.739 -1.119 . . . . 53.530000000000001 110.626 -177.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.76 -63.71 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 122.743 2.295 . . . . 71.209999999999994 113.406 -175.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.8 14.03 7.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.212 0.529 . . . . 55.210000000000001 110.588 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.28 -9.07 62.1 Favored Glycine 0 C--O 1.215 -1.087 0 C-N-CA 121.127 -0.558 . . . . 71.019999999999996 113.378 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -115.35 153.98 30.02 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 122.351 -0.499 . . . . 51.520000000000003 109.779 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -145.91 157.51 43.89 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.073 -0.714 . . . . 42.329999999999998 109.073 -177.169 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HG ' ' HA2' ' A' ' 140' ' ' GLY . 3.9 pp -138.76 161.49 37.07 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.831 -0.347 . . . . 62.539999999999999 111.137 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.6 147.36 52.52 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.745 -0.465 . . . . 71.209999999999994 109.745 177.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.04 132.09 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.12 -0.696 . . . . 71.230000000000004 109.12 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG22 ' HG ' ' A' ' 135' ' ' LEU . 25.5 t -80.25 117.92 26.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.167 -1.42 . . . . 74.430000000000007 107.167 176.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.62 -34.0 18.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.747 -0.381 . . . . 75.209999999999994 110.636 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -146.82 133.43 19.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.431 -0.581 . . . . 70.299999999999997 109.431 -178.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.43 171.88 17.0 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 107.304 -2.318 . . . . 40.049999999999997 107.304 -177.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 52.3 Cg_exo -57.61 -31.89 92.97 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.234 1.956 . . . . 50.149999999999999 111.273 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -93.94 20.33 7.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.375 -0.829 . . . . 74.239999999999995 111.274 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 138.54 58.4 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.645 0.26 . . . . 54.109999999999999 110.654 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.92 63.16 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.737 -0.665 . . . . 73.0 111.715 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.33 135.9 33.35 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.698 0.285 . . . . 45.520000000000003 110.446 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.03 134.53 54.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.316 -1.365 . . . . 71.120000000000005 107.316 177.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -128.49 144.9 51.22 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.351 -1.352 . . . . 64.409999999999997 107.351 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.2 pt? -116.66 143.18 45.95 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.528 -0.869 . . . . 74.530000000000001 111.951 -177.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HB3' HD11 ' A' ' 94' ' ' ILE . 2.8 mm? -87.37 105.01 16.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.116 -1.809 . . . . 64.409999999999997 106.116 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -127.37 12.33 7.0 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.487 1.137 . . . . 64.340000000000003 109.761 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.66 153.81 47.38 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.029 -1.1 . . . . 71.329999999999998 108.029 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.3 -21.25 71.74 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.378 2.052 . . . . 72.150000000000006 113.713 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.7 m -136.93 121.7 18.65 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 121.893 -0.505 . . . . 64.150000000000006 110.514 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 77' ' ' ASP . 45.8 m -129.59 118.18 21.59 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.179 -0.674 . . . . 52.32 109.179 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 p -86.86 150.8 23.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.802 -0.561 . . . . 54.32 110.841 -178.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.3 135.24 48.51 Favored 'General case' 0 C--O 1.264 1.851 0 CA-C-O 121.049 0.452 . . . . 70.209999999999994 112.035 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.93 -138.66 6.35 Favored Glycine 0 N--CA 1.422 -2.3 0 CA-C-N 114.796 -1.093 . . . . 62.409999999999997 110.891 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 56.2 ttt180 -118.87 151.57 37.87 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.506 -1.294 . . . . 74.530000000000001 107.506 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 34.9 m170 89.3 164.5 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.967 0 C-N-CA 125.234 1.414 . . . . 75.230000000000004 111.323 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.15 -2.61 8.32 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.018 2.479 . . . . 71.349999999999994 111.009 174.146 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.24 -22.37 60.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.951 -1.022 . . . . 75.319999999999993 108.36 175.281 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 m -112.2 130.02 56.06 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.23 -0.895 . . . . 74.030000000000001 109.417 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.418 ' HB3' HG23 ' A' ' 68' ' ' THR . 20.0 t70 -77.37 -33.87 55.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.474 0.654 . . . . 73.329999999999998 109.652 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.9 mm -91.71 101.03 12.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 105.558 -2.016 . . . . 64.239999999999995 105.558 173.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -87.79 113.98 23.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.52 0.676 . . . . 71.230000000000004 112.237 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.0 mt -119.87 127.42 52.71 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.878 -1.897 . . . . 72.349999999999994 105.878 175.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -106.21 117.06 33.06 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.83 -0.748 . . . . 54.240000000000002 109.613 -176.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -119.85 177.56 4.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.033 -0.985 . . . . 72.530000000000001 109.071 -175.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.38 -35.76 68.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 107.913 -1.143 . . . . 74.439999999999998 107.913 176.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.9 m -97.96 151.32 20.41 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.81 -1.086 . . . . 72.129999999999995 108.778 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 81.8 t -90.51 98.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 118.686 -1.206 . . . . 73.239999999999995 110.408 175.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -87.03 78.42 8.96 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.677 -1.231 . . . . 63.109999999999999 107.677 172.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -57.43 -23.82 51.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 112.083 -176.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -172.79 97.7 0.13 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.605 -0.887 . . . . 75.129999999999995 108.605 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.503 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 2.3 t-160 -99.34 -52.12 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.942 -1.132 . . . . 72.409999999999997 107.942 176.222 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.81 155.44 41.09 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.987 -0.551 . . . . 72.519999999999996 110.844 -174.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.488 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 34.0 tt0 -131.05 129.15 41.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.566 -1.642 . . . . 74.530000000000001 106.566 176.188 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -105.27 122.2 45.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.622 -1.621 . . . . 63.509999999999998 106.622 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD3' ' OE2' ' A' ' 91' ' ' GLU . 21.3 mtm180 -125.07 145.91 49.7 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.635 0.731 . . . . 62.020000000000003 110.635 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 63' ' ' LEU . 2.1 mp -103.98 111.41 33.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 102.856 -3.016 . . . . 74.019999999999996 102.856 175.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -138.73 118.45 13.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.038 -0.528 . . . . 72.329999999999998 110.829 -169.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 53.48 37.8 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.454 1.102 . . . . 72.510000000000005 112.272 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.06 87.52 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 113.515 178.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.98 150.12 26.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.387 -0.598 . . . . 73.230000000000004 109.387 -179.44 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.415 ' CD2' HG13 ' A' ' 94' ' ' ILE . 94.1 m-85 -104.59 116.19 31.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.257 -1.757 . . . . 70.25 106.257 174.151 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.14 135.31 54.3 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.206 0.527 . . . . 55.539999999999999 111.51 -174.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.42 120.65 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 104.815 -2.291 . . . . 65.120000000000005 104.815 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.03 131.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 N-CA-C 108.35 -0.982 . . . . 72.349999999999994 108.35 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.616 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.8 p30 -97.8 157.94 15.79 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 117.65 -1.62 . . . . 74.030000000000001 112.123 176.005 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -129.96 23.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.067 -1.827 . . . . 74.349999999999994 106.067 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.99 62.92 0.52 Allowed Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.752 -1.567 . . . . 74.040000000000006 110.11 -176.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -70.97 -7.01 43.1 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 122.802 0.441 . . . . 71.099999999999994 111.485 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HB3' HG22 ' A' ' 17' ' ' VAL . 49.5 mt -75.19 -40.94 58.93 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.318 -0.253 . . . . 71.400000000000006 110.318 -178.411 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 94.3 m-20 -85.8 -20.56 29.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 119.799 -0.76 . . . . 72.25 110.25 -176.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.17 109.85 0.42 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.302 -0.951 . . . . 52.210000000000001 113.525 174.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -85.38 130.36 34.61 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.456 -0.942 . . . . 44.119999999999997 108.456 174.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 72.0 m-85 -120.0 134.31 55.28 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.076 -0.712 . . . . 74.519999999999996 109.076 179.003 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.8 t -129.87 120.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.928 -1.508 . . . . 73.129999999999995 106.928 175.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.37 39.82 28.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.645 0.736 . . . . 73.430000000000007 109.777 -173.358 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 62.07 14.87 6.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 113.589 -1.641 . . . . 73.329999999999998 113.736 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -103.53 123.41 41.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 107.684 -1.228 . . . . 72.209999999999994 107.684 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.37 123.87 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.321 2.014 . . . . 74.420000000000002 110.786 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -141.33 162.31 35.79 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 120.887 0.375 . . . . 73.140000000000001 110.593 -179.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.616 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 18.4 m120 -113.81 -29.84 6.95 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.595 -1.184 . . . . 73.409999999999997 109.533 176.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.31 134.7 36.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.617 -1.623 . . . . 71.219999999999999 106.617 172.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -153.46 138.45 17.24 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.458 -0.497 . . . . 65.450000000000003 111.826 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.6 t -84.86 122.52 38.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.401 -1.333 . . . . 75.540000000000006 107.401 171.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 ptm -90.25 130.53 36.36 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.961 -0.563 . . . . 64.439999999999998 111.099 -173.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -101.8 156.2 17.66 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.299 -0.63 . . . . 74.219999999999999 109.299 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 36' ' ' SER . 6.3 t -67.17 126.71 30.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 61.399999999999999 108.677 175.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 35' ' ' ALA . . . 99.91 -6.66 58.62 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.725 -0.67 . . . . 75.430000000000007 112.747 -175.115 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.23 151.76 29.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.27 0.535 . . . . 71.219999999999999 111.184 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -112.39 127.48 56.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.45 0.643 . . . . 75.439999999999998 110.423 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.94 122.34 68.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.041 -1.096 . . . . 72.239999999999995 108.041 -177.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 39.0 mt-30 -108.02 131.11 54.92 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 113.101 0.778 . . . . 72.230000000000004 113.101 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.477 HG23 ' ND1' ' A' ' 89' ' ' HIS . 3.3 mp -117.35 103.24 14.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.478 -1.675 . . . . 70.120000000000005 106.478 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -65.6 1.29 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-O 121.279 0.377 . . . . 64.439999999999998 112.842 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -157.72 5.71 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.151 0.98 . . . . 74.400000000000006 110.847 173.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 68.0 m-85 -91.18 124.54 35.47 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.894 -1.15 . . . . 75.120000000000005 107.894 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -111.57 118.8 36.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.927 0.87 . . . . 75.239999999999995 110.932 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' A' ' 51' ' ' VAL . 5.8 mp -108.29 133.74 52.08 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.475 -1.693 . . . . 75.409999999999997 107.413 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.25 129.09 67.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.862 -1.162 . . . . 72.519999999999996 107.862 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -88.56 134.03 33.99 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.53 -0.759 . . . . 74.450000000000003 109.484 -176.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.75 161.23 33.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.139 0.495 . . . . 75.209999999999994 109.846 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.56 132.06 43.3 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.701 -1.592 . . . . 73.430000000000007 106.701 174.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -80.11 -163.74 28.59 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 115.739 1.055 . . . . 63.299999999999997 115.739 -169.131 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.36 145.3 47.84 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 123.001 2.467 . . . . 73.409999999999997 112.424 -177.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.42 65.86 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.494 -1.298 . . . . 71.420000000000002 107.494 175.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--N 1.295 -1.782 0 CA-C-N 114.288 -1.324 . . . . 72.230000000000004 109.388 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.886 0 CA-C-O 121.42 0.629 . . . . 65.329999999999998 111.795 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -140.07 85.11 2.0 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.44 -1.318 . . . . 71.439999999999998 107.44 176.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -96.13 152.61 18.39 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.077 -0.712 . . . . 53.119999999999997 109.077 179.004 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.99 131.02 55.66 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.248 0.547 . . . . 63.130000000000003 111.775 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -150.12 154.02 37.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.592 -2.373 . . . . 71.329999999999998 104.592 174.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.77 -114.38 1.49 Allowed Glycine 0 N--CA 1.423 -2.169 0 C-N-CA 118.867 -1.635 . . . . 74.349999999999994 113.06 -176.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 m -81.22 131.77 58.13 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.308 -0.446 . . . . 70.129999999999995 111.171 -174.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.93 145.79 95.96 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.061 1.841 . . . . 71.099999999999994 108.152 169.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.87 124.22 84.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 120.279 -0.568 . . . . 75.150000000000006 110.721 -173.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.89 104.31 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.096 2.531 . . . . 60.020000000000003 110.859 177.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -100.16 154.33 18.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.292 -1.003 . . . . 65.530000000000001 108.292 178.493 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.1 t -108.22 131.57 58.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.543 0.687 . . . . 63.009999999999998 110.418 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.27 168.92 24.38 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.104 -2.924 . . . . 71.340000000000003 103.104 176.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.643 ' HB ' ' NH2' ' A' ' 87' ' ' ARG . 33.8 m -70.52 109.01 4.58 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.251 1.024 . . . . 54.119999999999997 109.854 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.4 m -117.65 143.76 45.85 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 178.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.9 t -83.72 124.57 39.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.82 -0.807 . . . . 71.400000000000006 108.82 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 43.9 t80 -81.46 105.91 13.01 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.627 -1.249 . . . . 72.209999999999994 107.627 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -89.1 95.88 10.5 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.638 -0.71 . . . . 65.450000000000003 110.203 -178.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.69 157.89 23.59 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.139 -0.937 . . . . 71.239999999999995 108.508 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.01 3.6 16.78 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.097 0.475 . . . . 71.209999999999994 112.066 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.88 -23.02 66.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.492 1.293 . . . . 64.230000000000004 114.492 -174.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.36 -26.96 63.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.913 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -66.66 -29.46 69.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 74.129999999999995 110.997 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.55 -48.64 76.66 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.535 0.522 . . . . 75.239999999999995 111.744 -175.428 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -76.78 -18.05 58.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.313 0.578 . . . . 73.310000000000002 110.868 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -81.6 -34.35 31.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.136 -1.061 . . . . 64.209999999999994 108.136 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 t -72.59 -45.24 60.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.974 -0.557 . . . . 34.32 110.21 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 p -80.75 -17.35 51.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.253 -0.43 . . . . 73.420000000000002 111.993 -177.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 67.07 73.89 0.34 Allowed 'General case' 0 C--O 1.25 1.1 0 CA-C-O 122.088 0.946 . . . . 73.310000000000002 110.228 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.62 124.68 34.34 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 113.695 -1.593 . . . . 71.25 113.926 -176.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -94.68 137.76 33.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.356 -0.609 . . . . 73.409999999999997 109.356 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.61 98.97 43.0 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 109.63 -0.507 . . . . 61.219999999999999 109.63 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 143.08 27.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.027 1.818 . . . . 73.450000000000003 110.946 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 126.0 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.944 -1.132 . . . . 71.349999999999994 107.944 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -112.28 156.83 21.76 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.288 -0.634 . . . . 75.120000000000005 109.288 -177.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.23 160.83 32.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.807 -0.812 . . . . 72.109999999999999 108.807 -177.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.53 -7.12 24.46 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.647 -1.381 . . . . 51.130000000000003 109.647 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -73.8 -39.78 63.85 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.721 -0.74 . . . . 64.040000000000006 109.979 -177.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -86.51 -5.08 59.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.466 -1.243 . . . . 75.120000000000005 110.432 -177.144 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -86.63 -29.89 22.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.931 -0.577 . . . . 72.040000000000006 110.119 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 53.41 69.21 2.38 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 124.158 0.911 . . . . 73.400000000000006 110.384 -177.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.15 -65.97 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.181 2.587 . . . . 65.200000000000003 113.819 -173.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . -102.22 -0.37 33.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.611 -0.436 . . . . 74.239999999999995 111.467 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.9 -5.14 77.14 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.079 -0.581 . . . . 53.119999999999997 113.606 178.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.1 m -115.22 157.67 23.38 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 110.0 -0.371 . . . . 61.439999999999998 110.0 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -142.59 139.93 31.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.308 -0.406 . . . . 45.25 110.161 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.46 150.61 32.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.927 0.394 . . . . 54.530000000000001 111.782 -178.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.1 pt? -124.36 134.25 53.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.262 -0.644 . . . . 74.120000000000005 109.262 177.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.7 p -111.02 133.36 56.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.042 -0.526 . . . . 62.399999999999999 110.222 -178.347 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 ' ND2' ' A' ' 56' ' ' ASN . 24.8 t -76.54 117.54 21.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.732 -1.581 . . . . 72.5 106.732 177.01 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -90.35 -31.98 16.67 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.323 0.582 . . . . 50.229999999999997 110.164 -173.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -142.5 144.27 32.91 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.91 -1.885 . . . . 61.240000000000002 105.91 -176.974 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 53' ' ' ARG . . . 134.2 169.52 12.05 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 110.175 -1.17 . . . . 72.099999999999994 110.175 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.55 -31.81 87.53 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.309 2.006 . . . . 73.209999999999994 112.042 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.548 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.5 p-10 -101.35 22.68 12.14 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.363 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.95 143.91 55.8 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.995 0.426 . . . . 72.140000000000001 111.357 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.23 -13.58 60.07 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.002 -0.839 . . . . 50.450000000000003 111.002 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 128.66 36.49 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.32 -0.622 . . . . 43.399999999999999 109.32 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 23.2 ptt180 -110.73 135.31 51.51 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.036 -0.727 . . . . 74.219999999999999 109.036 176.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' HD23 ' A' ' 49' ' ' LEU . 95.8 m-85 -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.294 -1.002 . . . . 71.120000000000005 108.294 -179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.98 144.48 26.24 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.614 -0.434 . . . . 73.340000000000003 109.846 177.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 3.4 mm? -74.77 118.4 17.69 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.91 -0.774 . . . . 62.340000000000003 108.91 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.98 -29.03 4.33 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 111.825 0.306 . . . . 71.519999999999996 111.825 -174.133 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.471 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.0 pt20 -118.69 151.96 50.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 112.97 0.73 . . . . 71.510000000000005 112.97 -177.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 76.1 Cg_exo -52.76 -25.65 27.59 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 124.306 3.337 . . . . 71.400000000000006 114.202 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.3 m -135.21 119.8 18.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.722 -1.214 . . . . 41.399999999999999 107.722 175.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.4 m -115.5 114.28 24.8 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.7 -0.852 . . . . 73.349999999999994 108.7 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.5 p -86.52 135.65 33.37 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 122.138 -0.351 . . . . 71.409999999999997 111.344 -176.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.15 134.68 55.06 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-N 116.019 -0.537 . . . . 23.440000000000001 111.492 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.43 -163.95 28.42 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 108.709 -1.756 . . . . 71.299999999999997 108.709 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -112.8 119.23 37.3 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.09 -1.818 . . . . 73.530000000000001 106.09 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.641 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 4.5 t-160 -174.33 155.29 2.18 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 104.861 -2.274 . . . . 74.219999999999999 104.861 -173.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.641 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 55.8 Cg_endo -75.66 -18.57 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-N 120.507 1.217 . . . . 53.210000000000001 110.799 175.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.21 -3.47 55.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.411 -0.813 . . . . 54.25 112.321 -176.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.468 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 56.1 p -80.38 143.09 33.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.87 -0.732 . . . . 73.120000000000005 110.24 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.64 -39.0 67.54 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.557 -0.457 . . . . 74.540000000000006 110.388 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.14 135.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.051 -0.722 . . . . 61.119999999999997 109.051 176.24 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -96.14 117.84 31.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.251 0.548 . . . . 71.409999999999997 110.152 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -125.9 140.23 52.82 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.659 -1.978 . . . . 72.409999999999997 105.659 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.12 117.29 29.9 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.056 -0.658 . . . . 43.420000000000002 109.267 -176.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.18 173.44 6.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.684 -0.858 . . . . 63.32 108.684 -174.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.32 -29.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.436 -0.95 . . . . 65.120000000000005 108.436 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -128.35 -165.26 1.47 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.591 -1.263 . . . . 74.510000000000005 107.591 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.06 98.17 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.683 -0.807 . . . . 53.140000000000001 109.896 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 107' ' ' LEU . 70.1 m -87.4 73.85 9.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 122.0 0.905 . . . . 75.239999999999995 110.275 175.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.643 ' NH2' ' HB ' ' A' ' 14' ' ' THR . 8.5 ptt180 -69.87 -40.37 75.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.198 -1.365 . . . . 73.120000000000005 112.618 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -135.65 73.76 1.48 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.47 -0.937 . . . . 72.239999999999995 108.47 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -100.45 -53.5 3.09 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.374 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.78 162.54 40.54 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 119.763 -0.775 . . . . 64.439999999999998 111.082 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.12 146.04 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.291 173.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -104.87 119.19 38.4 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.55 -2.019 . . . . 74.450000000000003 105.55 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -109.07 132.88 53.69 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.688 -0.687 . . . . 74.540000000000006 109.257 -172.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 63' ' ' LEU . 57.9 mt -125.93 123.98 65.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.393 -0.821 . . . . 64.299999999999997 108.905 -173.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.91 118.24 18.67 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.479 -0.488 . . . . 63.210000000000001 111.537 174.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.44 37.82 29.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.908 0.883 . . . . 70.430000000000007 111.905 175.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.02 82.4 Favored Glycine 0 C--O 1.222 -0.632 0 CA-C-N 115.642 -0.708 . . . . 51.329999999999998 113.859 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 35.2 mt-10 -101.53 130.58 47.85 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.048 -1.464 . . . . 74.340000000000003 107.048 175.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.2 124.47 52.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.829 -0.434 . . . . 71.420000000000002 109.829 -174.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.88 148.78 52.69 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 120.763 0.316 . . . . 71.409999999999997 111.064 177.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.48 123.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 106.681 -1.6 . . . . 74.329999999999998 106.681 177.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.36 122.97 69.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.606 -0.516 . . . . 74.319999999999993 109.606 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 6.6 t70 -80.49 129.42 34.5 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.67 -1.233 . . . . 74.319999999999993 107.67 172.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.57 23.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 120.796 -0.362 . . . . 70.299999999999997 111.369 -176.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.27 -38.07 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 118.418 -1.849 . . . . 61.020000000000003 114.218 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 61.2 30.84 19.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.931 0.872 . . . . 73.420000000000002 109.268 -174.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 86' ' ' SER . 6.4 tt -62.99 -49.21 75.59 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 113.931 -1.486 . . . . 75.209999999999994 111.083 -174.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 37.6 t-20 -106.96 -19.4 13.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.772 -1.171 . . . . 63.299999999999997 109.084 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.17 101.86 2.72 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.385 -1.086 . . . . 62.530000000000001 110.385 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 m -87.8 129.41 35.2 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.362 0.601 . . . . 72.049999999999997 110.652 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 73.3 m-85 -116.01 126.82 54.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.307 -0.997 . . . . 61.020000000000003 108.307 175.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 t -120.9 126.91 75.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 105.443 -2.058 . . . . 75.400000000000006 105.443 176.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 55.46 38.73 30.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.182 -1.414 . . . . 73.349999999999994 107.182 -169.395 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.522 ' HD3' ' NH1' ' A' ' 134' ' ' ARG . 22.1 mtm105 63.39 8.99 3.79 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 114.035 -1.439 . . . . 74.030000000000001 114.461 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.45 135.67 19.29 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.035 -0.728 . . . . 71.019999999999996 109.035 176.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.9 122.94 11.15 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 121.735 1.623 . . . . 73.200000000000003 108.651 177.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.637 ' HD2' ' HB2' ' A' ' 120' ' ' GLN . 26.1 ttm-85 -152.37 169.56 22.25 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.773 -0.771 . . . . 63.009999999999998 110.164 -170.124 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 27.3 t-20 -104.76 -68.65 0.84 Allowed 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.533 0.521 . . . . 72.129999999999995 110.458 174.579 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.69 54.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.042 -0.411 . . . . 35.399999999999999 110.68 -174.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.637 ' HB2' ' HD2' ' A' ' 117' ' ' ARG . 57.1 tp60 -153.63 137.88 16.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.944 -0.571 . . . . 63.299999999999997 111.111 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 82.8 t -65.93 133.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.379 -1.711 . . . . 62.539999999999999 106.379 169.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 42.2 ttm -87.33 129.55 34.97 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.674 -0.861 . . . . 75.129999999999995 108.674 -170.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -114.09 149.29 35.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.001 -0.74 . . . . 72.530000000000001 109.001 -177.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.476 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 14.6 t -73.52 130.58 40.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 109.272 -0.64 . . . . 75.450000000000003 109.272 -179.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.24 -0.13 57.15 Favored Glycine 0 C--O 1.241 0.535 0 N-CA-C 111.464 -0.654 . . . . 65.409999999999997 111.464 -176.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.51 148.23 35.4 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 108.953 -0.758 . . . . 74.530000000000001 108.953 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.7 124.93 53.06 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.528 -0.915 . . . . 61.039999999999999 108.528 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -108.42 113.08 42.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 106.821 -1.548 . . . . 73.319999999999993 106.821 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 64.6 tt0 -108.22 126.37 52.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.144 0.497 . . . . 72.540000000000006 109.679 -176.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.82 108.36 25.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.607 -1.257 . . . . 71.519999999999996 107.607 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.37 -105.11 1.49 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.594 -1.402 . . . . 41.200000000000003 109.594 -175.129 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -116.07 -13.64 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.197 -0.601 . . . . 60.32 111.764 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -98.92 140.75 32.61 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.386 -0.926 . . . . 70.400000000000006 110.63 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.522 ' NH1' ' HD3' ' A' ' 114' ' ' ARG . 19.5 ptp180 -112.58 144.14 42.56 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 112.667 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.63 139.76 49.37 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.983 -1.858 . . . . 74.140000000000001 105.983 174.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -111.79 128.39 68.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.127 -1.064 . . . . 72.129999999999995 108.127 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.478 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 80.4 t80 -94.41 122.11 36.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.984 0.421 . . . . 71.319999999999993 110.982 -178.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.73 159.1 26.07 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.462 0.649 . . . . 63.450000000000003 110.142 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.38 124.44 27.13 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.676 -1.231 . . . . 73.120000000000005 107.676 173.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 44' ' ' ALA . . . -75.84 142.16 28.32 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.932 -0.651 . . . . 71.230000000000004 112.19 -175.304 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.45 162.79 41.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.14 2.56 . . . . 52.32 111.991 176.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.62 44.17 0.96 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.594 0.711 . . . . 75.400000000000006 109.902 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 106.679 -1.6 . . . . 74.109999999999999 106.679 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.477 0.18 . . . . 71.329999999999998 110.991 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.8 t -112.55 116.83 30.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.808 -0.557 . . . . 74.25 110.026 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -129.11 145.54 51.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.157 -1.423 . . . . 72.340000000000003 107.157 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -138.23 152.05 48.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.133 0.492 . . . . 24.43 110.983 -178.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -98.62 22.0 10.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.645 -0.707 . . . . 70.430000000000007 110.779 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.15 -19.04 77.72 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.322 -0.711 . . . . 33.140000000000001 111.322 178.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -78.88 119.41 77.15 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 122.9 0.48 . . . . 52.310000000000002 109.771 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.24 132.54 21.15 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.379 2.053 . . . . 73.109999999999999 112.261 -177.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.81 144.87 49.01 Favored Pre-proline 0 N--CA 1.417 -2.099 0 N-CA-C 107.124 -1.436 . . . . 73.510000000000005 107.124 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.06 -179.15 0.15 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 123.054 2.503 . . . . 70.099999999999994 114.129 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -90.35 138.19 31.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.371 -1.344 . . . . 74.430000000000007 107.371 -178.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.5 t -111.4 121.5 64.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.254 -0.647 . . . . 45.409999999999997 109.254 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -114.91 168.33 10.0 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.407 -0.815 . . . . 73.439999999999998 108.99 178.304 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -68.9 127.85 34.6 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 124.059 0.849 . . . . 73.049999999999997 110.608 -174.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.423 ' H ' HD13 ' A' ' 107' ' ' LEU . 50.6 m -103.28 154.5 19.29 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.815 -1.18 . . . . 62.210000000000001 107.815 175.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.78 115.31 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.869 -1.16 . . . . 72.140000000000001 107.869 178.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.38 131.87 45.09 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.248 -1.019 . . . . 64.310000000000002 108.248 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -129.24 105.3 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.173 0.511 . . . . 74.120000000000005 110.496 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.49 140.75 48.48 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.751 -0.833 . . . . 71.510000000000005 108.751 178.502 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.52 2.04 34.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.66 0.245 . . . . 43.399999999999999 111.66 -176.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -63.92 -10.48 21.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.99 1.107 . . . . 73.310000000000002 113.99 -179.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.37 -12.76 61.93 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 122.153 0.978 . . . . 73.540000000000006 110.976 176.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 36.5 ttmt -65.5 -20.53 66.38 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 126.016 1.727 . . . . 72.439999999999998 109.813 177.196 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.525 ' HA ' ' OG ' ' A' ' 28' ' ' SER . 11.7 tp10 -59.18 -18.47 36.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.508 -0.769 . . . . 72.129999999999995 111.979 -176.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -57.84 -41.49 82.46 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.18 -0.325 . . . . 71.209999999999994 110.745 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.26 -22.16 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.992 0.368 . . . . 74.299999999999997 111.992 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 25' ' ' GLU . 6.7 p -81.02 -36.07 31.07 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.965 -0.694 . . . . 75.439999999999998 111.473 177.3 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.3 m -79.94 -48.42 13.43 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.607 -0.837 . . . . 52.399999999999999 110.757 177.069 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.1 m 47.58 -76.89 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.122 1.897 . . . . 72.450000000000003 116.122 -178.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.03 65.9 2.57 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 114.563 0.585 . . . . 74.430000000000007 114.563 -172.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.1 m -116.07 123.62 48.38 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.389 -1.338 . . . . 74.420000000000002 107.389 172.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.25 109.57 51.57 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.471 -0.491 . . . . 73.439999999999998 110.672 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.79 142.83 99.22 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.666 2.244 . . . . 72.299999999999997 110.301 174.281 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.49 126.35 32.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.25 -0.432 . . . . 54.119999999999997 111.233 -176.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 p -96.2 80.38 3.24 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.478 0.656 . . . . 71.010000000000005 110.001 178.326 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.8 t -89.51 -27.63 20.18 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.687 -0.688 . . . . 43.409999999999997 110.463 -178.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.99 55.23 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.543 -0.837 . . . . 62.32 112.55 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.91 -39.96 79.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 109.769 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.46 -11.96 60.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.92 . . . . 71.230000000000004 111.492 -178.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -97.1 -12.36 23.24 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.269 -0.641 . . . . 63.310000000000002 109.269 -175.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 mt 59.73 83.63 0.21 Allowed Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 124.722 1.264 . . . . 65.200000000000003 108.599 -176.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -33.98 -59.29 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.094 1 C-N-CA 125.703 4.269 . . . . 72.540000000000006 115.767 -166.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.58 10.71 3.72 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.743 0.782 . . . . 70.040000000000006 109.687 179.094 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.48 -12.46 46.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.1 -0.8 . . . . 75.209999999999994 111.1 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -138.9 151.52 47.01 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.056 -1.831 . . . . 61.43 106.056 177.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -152.92 158.55 42.27 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.794 -0.817 . . . . 75.239999999999995 108.794 -177.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -120.86 149.67 42.24 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.237 -0.585 . . . . 72.239999999999995 111.965 -175.225 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 49' ' ' LEU . 2.1 pt? -114.99 139.55 49.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.773 -0.825 . . . . 62.130000000000003 108.773 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.19 135.93 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.422 -0.354 . . . . 62.350000000000001 110.384 -177.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -82.79 118.12 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.026 -1.472 . . . . 63.420000000000002 107.026 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -95.96 -31.34 13.13 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.062 -0.972 . . . . 73.349999999999994 110.408 -174.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -143.12 137.68 29.29 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.153 -0.684 . . . . 73.310000000000002 109.153 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.44 175.14 13.88 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.816 -1.314 . . . . 34.229999999999997 109.816 -179.385 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 78.4 Cg_exo -55.62 -37.69 95.0 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 74.299999999999997 112.807 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -96.69 22.77 7.71 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.564 0.579 . . . . 72.209999999999994 112.564 -178.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.02 137.38 58.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.928 0.394 . . . . 63.43 110.416 177.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.55 -18.03 41.91 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 111.023 -0.831 . . . . 72.120000000000005 111.023 -178.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.29 139.6 30.33 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 110.126 -0.324 . . . . 54.520000000000003 110.126 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -128.22 137.76 52.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 73.319999999999993 108.724 178.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.41 ' O ' HD23 ' A' ' 49' ' ' LEU . 92.5 m-85 -125.18 138.39 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.999 -0.741 . . . . 72.319999999999993 108.999 -178.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -96.91 134.02 40.79 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.105 0.479 . . . . 62.420000000000002 109.713 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' HE22 ' A' ' 65' ' ' GLN . 67.6 mt -97.95 105.21 17.32 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.277 -0.42 . . . . 73.430000000000007 110.219 -178.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -130.55 5.55 4.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.774 0.797 . . . . 63.350000000000001 109.578 176.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 3.7 pm0 -107.84 141.46 23.13 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 115.109 -0.95 . . . . 74.310000000000002 110.709 -177.224 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.1 Cg_exo -57.41 -27.55 76.39 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.364 2.71 . . . . 63.520000000000003 113.745 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -137.03 123.5 20.82 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.299 -0.63 . . . . 71.200000000000003 109.299 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 26.3 m -123.47 120.76 33.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.463 -0.94 . . . . 74.010000000000005 108.463 178.285 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.519 HG23 HH11 ' A' ' 88' ' ' ARG . 74.6 m -94.49 131.06 40.59 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 112.06 0.392 . . . . 75.099999999999994 112.06 -176.353 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.89 135.49 54.89 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.292 0.568 . . . . 41.149999999999999 110.556 178.173 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.09 -159.74 25.2 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.465 -1.454 . . . . 72.109999999999999 109.465 179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -101.69 117.75 35.53 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.724 -1.213 . . . . 60.409999999999997 107.724 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -175.88 148.2 0.94 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 105.558 -2.016 . . . . 74.230000000000004 105.558 -175.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.57 -40.47 65.41 Favored 'Trans proline' 0 C--O 1.221 -0.358 0 C-N-CA 122.041 1.827 . . . . 73.120000000000005 111.801 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.07 19.37 7.97 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.514 0.931 . . . . 71.120000000000005 113.514 -178.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m -66.61 122.99 18.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.303 -0.559 . . . . 64.109999999999999 109.796 174.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.11 -38.47 66.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.289 -1.375 . . . . 62.450000000000003 107.289 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.1 mm -108.75 98.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.791 -1.929 . . . . 64.010000000000005 105.791 173.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -91.03 120.2 31.82 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.951 -0.568 . . . . 72.439999999999998 109.857 -176.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.71 138.54 52.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.4 -0.963 . . . . 73.299999999999997 108.4 -179.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.37 116.49 32.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.519 -1.66 . . . . 63.119999999999997 106.519 176.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -105.96 -173.32 2.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.182 0.438 . . . . 73.25 112.182 -171.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.72 -32.61 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.24 0.616 . . . . 75.040000000000006 111.328 -174.553 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.405 ' CG2' ' HG ' ' A' ' 107' ' ' LEU . 6.1 t -123.89 -152.81 0.53 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 105.723 -1.955 . . . . 74.109999999999999 105.723 -178.013 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.85 95.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.644 -1.623 . . . . 72.25 109.387 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -92.34 85.59 5.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.179 -1.045 . . . . 64.540000000000006 108.179 176.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.452 ' NH1' ' HB2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -57.28 -27.69 62.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.976 -1.465 . . . . 53.049999999999997 112.458 -177.644 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.588 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 20.3 mmm180 -154.87 111.33 3.24 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 104.498 -2.408 . . . . 71.319999999999993 104.498 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 12.2 t60 -100.4 -52.77 3.28 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 117.667 -1.613 . . . . 73.150000000000006 109.901 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.49 151.69 36.8 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.1 -0.704 . . . . 73.200000000000003 109.1 -177.167 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -118.42 129.43 55.4 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.694 -1.965 . . . . 62.130000000000003 105.694 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.5 m-85 -105.98 113.45 27.0 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.969 -1.493 . . . . 72.420000000000002 106.969 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -107.74 131.94 53.9 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.545 -0.539 . . . . 74.310000000000002 109.545 -177.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -118.92 113.28 41.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 106.684 -1.599 . . . . 70.109999999999999 106.684 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.93 121.41 20.49 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.129 -0.693 . . . . 75.299999999999997 109.129 -177.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 56.81 37.58 28.89 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.098 1.359 . . . . 64.439999999999998 110.244 -179.705 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.06 89.33 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.087 -0.961 . . . . 62.149999999999999 113.855 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.08 131.75 46.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.641 0.72 . . . . 72.209999999999994 109.217 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -106.2 118.1 35.74 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.857 0.723 . . . . 75.030000000000001 110.256 -174.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.87 142.48 51.09 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.569 -0.53 . . . . 54.119999999999997 109.569 177.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 122' ' ' MET . 42.0 t -114.4 123.5 70.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.74 -1.207 . . . . 74.049999999999997 107.74 177.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.07 132.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.049 0.452 . . . . 62.520000000000003 110.287 177.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -77.04 127.46 32.72 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.288 -1.004 . . . . 71.239999999999995 108.288 177.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.51 16.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.602 -0.888 . . . . 74.299999999999997 108.602 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -174.8 81.12 0.07 OUTLIER Glycine 0 N--CA 1.418 -2.556 0 CA-C-N 115.273 -0.876 . . . . 74.019999999999996 111.934 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -77.57 42.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.687 1.232 . . . . 55.109999999999999 109.053 178.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 16' ' ' SER . 23.4 tp -95.23 -28.51 14.99 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.782 -1.099 . . . . 51.240000000000002 110.627 -176.153 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 50.8 t30 -109.47 -19.82 13.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.354 -0.98 . . . . 75.120000000000005 108.354 173.197 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 109.24 3.05 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.78 -0.645 . . . . 21.23 113.39 174.452 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.0 m -87.29 128.99 35.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.464 -0.569 . . . . 61.140000000000001 109.464 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 85.3 m-85 -135.54 136.61 41.29 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.85 -0.796 . . . . 74.019999999999996 108.85 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.0 t -128.34 130.85 69.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.989 -1.856 . . . . 73.519999999999996 105.989 175.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.84 37.28 28.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.137 0.898 . . . . 74.239999999999995 108.747 -175.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 63.12 16.92 9.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 65.340000000000003 113.031 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.64 137.08 23.89 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 110.007 -0.368 . . . . 71.150000000000006 110.007 178.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.12 124.85 16.11 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.957 2.438 . . . . 75.540000000000006 112.112 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -126.66 159.29 34.06 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.24 0.543 . . . . 73.200000000000003 111.793 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.12 -29.0 3.36 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.288 -1.323 . . . . 53.299999999999997 108.145 177.118 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.65 136.91 18.6 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.515 -1.291 . . . . 52.020000000000003 107.515 174.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.38 141.94 20.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.27 -0.641 . . . . 75.420000000000002 109.27 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.65 122.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.676 -1.602 . . . . 71.230000000000004 106.676 174.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.48 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 44.3 ttp -89.6 130.44 35.91 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.328 0.585 . . . . 53.299999999999997 112.288 -168.836 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.546 ' HB2' ' OD1' ' A' ' 126' ' ' ASP . 16.7 mt-30 -120.05 152.18 37.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.053 -0.976 . . . . 74.120000000000005 108.92 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.2 p -73.21 133.81 44.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 123.522 0.729 . . . . 74.019999999999996 110.569 178.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.69 61.57 Favored Glycine 0 C--N 1.309 -0.93 0 N-CA-C 111.452 -0.659 . . . . 42.340000000000003 111.452 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 123' ' ' GLN . 3.0 m-20 -85.11 153.98 22.34 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.242 0.617 . . . . 73.099999999999994 111.437 178.41 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.02 130.67 55.5 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-N 115.256 -0.883 . . . . 71.140000000000001 109.515 -176.325 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.5 mt -114.69 132.21 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.091 -1.077 . . . . 74.120000000000005 108.091 177.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 43.9 tt0 -119.73 122.9 42.47 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 108.656 -0.868 . . . . 75.420000000000002 108.656 178.453 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 89' ' ' HIS . 66.3 mt -117.32 102.28 13.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.211 -1.403 . . . . 50.149999999999999 107.211 178.249 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.74 -108.39 1.53 Allowed Glycine 0 C--N 1.309 -0.961 0 N-CA-C 110.926 -0.87 . . . . 72.109999999999999 110.926 -173.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -103.4 4.7 36.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.644 0.259 . . . . 55.100000000000001 110.684 178.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.588 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 78.0 m-85 -87.63 158.55 18.84 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.569 0.7 . . . . 70.310000000000002 111.285 179.298 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -133.43 123.13 24.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.971 -1.013 . . . . 74.239999999999995 108.763 174.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.76 125.39 41.67 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.994 -1.484 . . . . 65.109999999999999 106.994 177.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.03 129.05 68.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.089 -1.449 . . . . 72.329999999999998 107.089 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 22.0 t80 -88.4 116.55 26.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.784 -0.821 . . . . 71.530000000000001 108.784 -178.387 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp -108.47 147.03 32.26 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.172 -0.677 . . . . 73.200000000000003 109.172 -173.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.33 131.24 40.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.474 -0.33 . . . . 62.43 111.207 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.29 132.56 11.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.602 -1.799 . . . . 74.120000000000005 108.602 175.165 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.08 148.68 92.71 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.132 1.888 . . . . 75.150000000000006 112.287 -177.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.25 69.9 10.51 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 106.775 -1.565 . . . . 63.229999999999997 106.775 178.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--N 1.266 -3.058 0 CA-C-N 112.03 -2.35 . . . . 45.520000000000003 106.338 -178.875 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 109.099 -0.704 . . . . 63.299999999999997 109.099 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -139.4 25.27 2.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.328 -1.36 . . . . 72.310000000000002 107.328 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.46 145.69 32.17 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 113.767 -1.56 . . . . 73.140000000000001 110.722 -175.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -91.41 153.34 19.93 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.037 -1.097 . . . . 71.340000000000003 108.037 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.19 47.62 1.53 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.035 0.922 . . . . 73.099999999999994 108.631 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -29.76 32.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.138 -1.185 . . . . 74.430000000000007 110.138 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.5 m -129.76 107.87 17.0 Favored Pre-proline 0 N--CA 1.419 -2.018 0 CA-C-O 121.296 0.569 . . . . 71.109999999999999 109.888 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.28 154.38 71.48 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 124.01 3.14 . . . . 71.109999999999999 111.299 176.04 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -76.14 120.62 82.45 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.39 -1.337 . . . . 64.209999999999994 107.39 178.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.15 125.47 17.64 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 123.184 2.589 . . . . 55.240000000000002 113.032 -173.545 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -92.87 132.45 37.01 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 107.181 -1.414 . . . . 73.010000000000005 107.181 176.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.38 121.81 66.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 120.096 -0.642 . . . . 51.310000000000002 109.786 -178.532 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 67.4 mm-40 -103.59 132.66 49.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.288 -1.745 . . . . 74.319999999999993 106.288 174.423 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.456 ' O ' ' HB ' ' A' ' 85' ' ' VAL . 21.5 m -80.8 126.47 31.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 120.438 0.161 . . . . 73.299999999999997 111.293 -173.39 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -99.29 152.75 19.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.121 -1.807 . . . . 75.140000000000001 106.121 170.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -82.09 122.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.985 -0.746 . . . . 55.130000000000003 108.985 -178.181 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.587 ' HD2' ' HG1' ' A' ' 84' ' ' THR . 14.8 t80 -86.95 105.41 17.09 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.097 -0.705 . . . . 64.340000000000003 109.097 -176.563 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -122.62 120.04 32.56 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.365 -0.606 . . . . 74.310000000000002 109.365 177.037 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.27 -160.68 0.86 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.188 -0.915 . . . . 62.210000000000001 108.976 -173.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -50.6 -22.16 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.266 1.426 . . . . 63.030000000000001 113.774 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 23' ' ' LEU . 3.9 pp -56.69 -30.83 63.84 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.256 0.835 . . . . 70.010000000000005 113.256 -178.024 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -89.39 0.08 57.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.469 0.914 . . . . 74.129999999999995 113.469 -177.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.23 -46.75 3.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.708 0.765 . . . . 73.329999999999998 110.45 176.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -69.36 -31.19 69.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.489 -1.232 . . . . 70.299999999999997 112.379 -174.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -56.42 -38.92 72.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.525 1.306 . . . . 74.310000000000002 114.525 -174.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.3 -35.62 35.5 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.0 0.429 . . . . 74.540000000000006 110.85 -176.318 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 m -68.1 -31.88 71.8 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.646 0.736 . . . . 54.130000000000003 110.825 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 p -83.03 -16.0 48.83 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 112.215 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 m -57.61 142.86 43.34 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.924 -0.769 . . . . 75.400000000000006 108.924 177.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.7 -52.03 0.84 Allowed Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.957 -1.257 . . . . 34.030000000000001 109.957 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 m -79.89 119.64 23.03 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.135 -1.431 . . . . 51.32 107.135 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -128.28 144.87 53.44 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 120.768 -0.373 . . . . 70.109999999999999 111.756 -174.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.608 ' HD2' ' ND2' ' A' ' 113' ' ' ASN . 42.1 Cg_exo -62.46 149.83 89.52 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.941 2.428 . . . . 54.219999999999999 110.916 172.601 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.834 0.35 . . . . 71.019999999999996 110.214 -178.141 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 m -77.55 90.08 3.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.776 -0.824 . . . . 52.310000000000002 108.776 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -94.55 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.371 0.508 . . . . 65.439999999999998 112.371 -177.04 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.34 57.88 0.64 Allowed Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.364 -0.694 . . . . 72.310000000000002 111.364 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -92.85 -47.05 7.23 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.555 0.693 . . . . 64.219999999999999 110.722 176.524 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.32 -0.49 6.34 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.361 -1.29 . . . . 70.150000000000006 114.466 -170.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -86.19 -28.47 23.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.089 -0.708 . . . . 72.310000000000002 109.089 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt 49.03 76.61 0.53 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.749 1.22 . . . . 51.5 111.747 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.512 ' HG2' ' O ' ' A' ' 140' ' ' GLY . 26.6 Cg_endo -87.41 -74.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.152 1.901 . . . . 61.439999999999998 114.344 -175.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.83 -32.63 67.73 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.151 0.501 . . . . 72.439999999999998 112.297 -176.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 7.7 82.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.183 -1.008 . . . . 64.230000000000004 110.763 -176.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 m -132.81 167.04 20.89 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.553 -1.647 . . . . 74.099999999999994 106.553 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 157.1 43.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.149 0.431 . . . . 70.140000000000001 110.127 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.16 137.51 51.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.288 0.566 . . . . 60.539999999999999 110.348 178.71 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.419 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -108.7 137.05 47.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 109.036 -0.728 . . . . 71.340000000000003 109.036 178.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -113.56 128.85 70.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 121.119 0.485 . . . . 73.140000000000001 110.03 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.468 HG21 ' ND2' ' A' ' 56' ' ' ASN . 38.4 t -83.75 118.09 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 106.99 -1.485 . . . . 73.420000000000002 106.99 178.237 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -95.05 -31.71 13.46 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.411 -0.813 . . . . 62.310000000000002 109.719 -174.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -141.35 138.41 33.05 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.753 -0.658 . . . . 72.439999999999998 109.259 176.194 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.68 169.29 13.18 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.72 -1.752 . . . . 64.519999999999996 108.72 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.98 -41.99 69.22 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.027 1.818 . . . . 72.519999999999996 111.634 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.468 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.1 p-10 -91.67 22.71 3.93 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.223 0.453 . . . . 73.010000000000005 112.223 178.518 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.21 55.57 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 123.22 0.608 . . . . 62.109999999999999 111.222 177.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.21 -19.42 43.12 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.487 -1.045 . . . . 74.530000000000001 110.487 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.36 144.37 26.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.407 -0.397 . . . . 72.340000000000003 110.28 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -119.67 134.87 55.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.273 -1.01 . . . . 71.230000000000004 108.273 176.25 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.463 ' HB3' HG21 ' A' ' 78' ' ' ILE . 93.9 m-85 -117.12 125.07 50.67 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.972 -0.381 . . . . 72.040000000000006 109.972 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.5 124.18 34.28 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.479 -0.782 . . . . 71.430000000000007 109.368 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.02 104.82 15.99 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.383 -1.71 . . . . 60.039999999999999 106.383 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.05 -21.3 12.68 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.149 -0.478 . . . . 64.109999999999999 112.157 -173.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -107.16 154.44 40.45 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 120.329 -0.548 . . . . 52.340000000000003 110.923 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 75.5 Cg_exo -52.56 -25.98 27.48 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.609 2.873 . . . . 71.409999999999997 114.021 -178.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 m -140.94 120.1 12.9 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.568 -0.853 . . . . 65.120000000000005 109.809 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 77' ' ' ASP . 49.6 m -116.43 114.39 24.17 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 109.057 -0.719 . . . . 73.049999999999997 109.057 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -87.2 136.4 32.94 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.88 -0.415 . . . . 51.539999999999999 109.88 178.163 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.58 134.71 54.89 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.34 0.59 . . . . 61.140000000000001 110.723 -177.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.37 178.01 15.39 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.284 -1.527 . . . . 43.25 109.284 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 43.6 ttt180 -85.49 117.67 24.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.222 -0.659 . . . . 74.299999999999997 109.222 178.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.75 145.9 0.31 Allowed Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 107.658 -1.238 . . . . 73.010000000000005 107.658 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -61.24 -15.72 41.93 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.236 2.624 . . . . 71.340000000000003 113.851 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.92 6.24 33.47 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.546 0.212 . . . . 74.230000000000004 111.194 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 40.9 m -100.56 125.2 46.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.625 -0.509 . . . . 74.299999999999997 109.625 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB3' HG23 ' A' ' 68' ' ' THR . 19.0 t70 -65.1 -48.54 73.32 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.046 -0.524 . . . . 73.420000000000002 110.956 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 61' ' ' PHE . 2.3 pp -116.15 130.18 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.895 -0.722 . . . . 72.540000000000006 110.715 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.02 143.0 48.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.282 0.563 . . . . 60.109999999999999 111.417 -178.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.7 mt -106.44 140.42 39.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.06 -1.459 . . . . 70.140000000000001 107.06 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HZ ' ' A' ' 133' ' ' PHE . 20.5 t70 -91.45 116.45 28.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.533 -1.654 . . . . 64.510000000000005 106.533 177.266 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' THR . 12.4 t0 -116.04 164.39 14.51 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.155 -0.683 . . . . 64.329999999999998 109.155 -169.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.26 -31.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.702 -1.222 . . . . 35.25 107.702 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.587 ' HG1' ' HD2' ' A' ' 18' ' ' PHE . 27.3 m -115.42 170.94 8.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.794 -1.558 . . . . 74.120000000000005 106.794 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 14' ' ' THR . 61.4 t -92.5 98.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.051 -1.031 . . . . 71.239999999999995 111.437 -177.574 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -97.1 91.7 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.479 -0.782 . . . . 44.420000000000002 110.227 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 13' ' ' GLU . 17.8 ptt180 -81.47 -45.22 16.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.527 0.936 . . . . 65.519999999999996 113.527 -176.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.428 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 5.6 tpt180 -126.73 87.7 2.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.712 -1.588 . . . . 75.230000000000004 106.712 -176.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -100.2 -52.36 3.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.844 -0.616 . . . . 75.450000000000003 112.253 -174.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.44 162.99 37.9 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.953 -0.699 . . . . 51.109999999999999 111.428 -175.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.44 133.78 36.99 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.361 -0.836 . . . . 65.109999999999999 109.109 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -112.28 122.3 47.33 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.939 -0.763 . . . . 63.539999999999999 108.939 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.44 119.51 39.02 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.497 -0.557 . . . . 72.329999999999998 109.497 175.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -107.1 111.77 37.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.534 -2.395 . . . . 70.409999999999997 104.534 176.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -135.74 117.66 15.24 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 120.141 -0.624 . . . . 74.230000000000004 110.258 -174.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 51.7 39.82 26.13 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.76 1.224 . . . . 74.519999999999996 111.775 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -5.61 84.33 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 115.282 -0.872 . . . . 43.329999999999998 114.677 178.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.5 150.02 23.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.907 0.854 . . . . 63.210000000000001 109.102 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.94 117.46 24.84 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.692 -0.403 . . . . 62.329999999999998 110.959 -172.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -109.6 127.13 54.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.249 -1.019 . . . . 74.140000000000001 108.249 177.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.85 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.538 -0.912 . . . . 74.510000000000005 108.538 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.01 131.39 72.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.976 -0.556 . . . . 72.239999999999995 110.444 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.46 131.11 34.45 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.394 -0.965 . . . . 54.350000000000001 108.394 174.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.35 11.38 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 116.302 -0.408 . . . . 64.510000000000005 111.074 -177.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -165.1 59.88 0.25 Allowed Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.535 -1.317 . . . . 64.5 112.954 -178.464 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.6 t -80.78 75.13 7.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.736 0.779 . . . . 71.219999999999999 109.677 177.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.86 -21.99 13.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.832 -1.544 . . . . 75.239999999999995 106.832 170.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 3.2 m-20 -102.83 3.17 36.39 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.342 -1.299 . . . . 75.230000000000004 110.868 -177.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.76 77.29 1.13 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.936 -0.575 . . . . 55.100000000000001 113.051 178.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -86.92 128.9 35.06 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.203 -0.666 . . . . 42.350000000000001 109.203 176.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -135.68 140.2 44.28 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.881 0.372 . . . . 64.019999999999996 110.245 177.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.46 119.7 60.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 105.841 -1.911 . . . . 71.519999999999996 105.841 175.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.608 ' ND2' ' HD2' ' A' ' 34' ' ' PRO . 2.9 m-20 57.38 36.82 27.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.293 -1.003 . . . . 75.109999999999999 108.293 -171.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 60.7 14.32 4.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.26 1.424 . . . . 70.430000000000007 112.979 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.06 142.48 25.12 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 124.089 0.956 . . . . 71.219999999999999 109.205 176.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.06 122.97 10.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.7 1.6 . . . . 64.239999999999995 109.569 178.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -146.36 140.04 26.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.091 -1.078 . . . . 73.400000000000006 108.091 -175.027 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.8 -41.42 8.85 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.237 -0.283 . . . . 71.099999999999994 110.237 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.39 136.84 33.53 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.822 -0.807 . . . . 75.329999999999998 108.822 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 141.91 21.9 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.731 -0.84 . . . . 61.32 108.731 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.85 114.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 106.261 -1.755 . . . . 72.430000000000007 106.261 175.139 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 38.0 ttm -94.37 148.84 21.82 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.383 0.883 . . . . 65.099999999999994 113.383 -166.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -125.66 158.34 35.0 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.829 1.252 . . . . 55.240000000000002 111.113 -172.396 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 10.6 m -58.38 124.27 18.97 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.294 0.637 . . . . 55.140000000000001 110.192 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.61 -9.45 60.53 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.908 -0.587 . . . . 71.019999999999996 112.051 178.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.52 151.21 44.09 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 108.708 -0.849 . . . . 75.120000000000005 108.708 -179.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.3 137.66 54.47 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.798 0.808 . . . . 63.119999999999997 112.124 -175.148 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.95 126.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 105.844 -1.91 . . . . 43.119999999999997 105.844 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -108.95 128.68 55.15 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.179 -1.785 . . . . 73.209999999999994 106.179 178.154 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 133' ' ' PHE . 66.6 mt -131.56 138.32 53.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 N-CA-C 103.825 -2.657 . . . . 71.150000000000006 103.825 -177.238 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -36.19 99.46 0.01 OUTLIER Glycine 0 CA--C 1.548 2.153 0 N-CA-C 115.912 1.125 . . . . 64.030000000000001 115.912 -177.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt 77.51 14.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.609 1.564 . . . . 73.319999999999993 112.929 178.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 130' ' ' ILE . 55.8 m-85 -123.56 150.64 43.81 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 125.295 1.438 . . . . 74.439999999999998 109.355 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 134' ' ' ARG . 15.6 mmm-85 -137.15 119.83 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.316 -1.735 . . . . 74.120000000000005 106.316 175.128 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 mp -122.9 136.13 54.75 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.94 -0.393 . . . . 60.530000000000001 109.94 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.68 130.16 68.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.509 -0.923 . . . . 64.420000000000002 108.509 179.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -95.93 131.88 41.83 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.106 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -131.45 136.86 48.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.88 -0.785 . . . . 64.030000000000001 108.88 177.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.05 33.04 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.433 -0.951 . . . . 63.509999999999998 108.433 175.479 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' PRO . . . -59.94 130.64 49.7 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.7 -0.96 . . . . 55.210000000000001 110.7 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.11 160.34 13.14 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.345 2.697 . . . . 71.219999999999999 113.585 -175.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.19 48.58 1.01 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.713 1.205 . . . . 71.010000000000005 111.406 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.406 -2.662 0 CA-C-N 114.643 -1.162 . . . . 62.219999999999999 108.017 176.339 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.494 -1.188 0 N-CA-C 108.697 -0.853 . . . . 74.319999999999993 108.697 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -72.85 101.97 3.29 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 123.338 0.399 . . . . 74.439999999999998 110.014 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -97.03 148.45 22.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.83 -0.433 . . . . 71.439999999999998 109.83 177.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -88.2 99.56 12.3 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.43 -0.581 . . . . 70.140000000000001 109.43 178.117 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -101.8 136.45 41.61 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.108 -0.496 . . . . 65.230000000000004 110.399 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . 121.83 -18.74 8.52 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.687 -0.768 . . . . 64.209999999999994 113.016 176.163 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 m -98.96 108.45 49.31 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 117.116 0.458 . . . . 65.319999999999993 110.742 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 2.4 Cg_endo -78.83 148.76 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.226 1.951 . . . . 51.119999999999997 109.928 176.256 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.67 133.11 63.18 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 107.883 -1.155 . . . . 72.200000000000003 107.883 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.73 136.05 44.16 Favored 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 121.96 1.773 . . . . 71.0 111.743 -179.025 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 87' ' ' ARG . 12.3 pt20 -110.51 140.93 44.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.811 0.338 . . . . 74.310000000000002 110.379 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.5 t -120.42 123.52 70.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.664 -0.865 . . . . 63.109999999999999 108.664 176.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 9.3 tp10 -148.09 148.24 30.42 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 106.476 -1.676 . . . . 64.010000000000005 106.476 -178.317 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.7 m -89.58 128.76 36.07 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 123.445 0.465 . . . . 60.130000000000003 110.674 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -87.82 138.89 31.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 108.475 -0.935 . . . . 73.420000000000002 108.475 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -83.79 117.22 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.179 -0.675 . . . . 61.149999999999999 109.179 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.72 140.18 29.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.292 0.568 . . . . 72.200000000000003 110.968 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -84.59 120.65 26.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.686 -2.338 . . . . 65.140000000000001 104.686 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.79 80.91 2.09 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.286 0.565 . . . . 73.420000000000002 111.538 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.15 -23.18 33.06 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.661 -0.866 . . . . 62.399999999999999 108.661 177.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 pp -63.33 -5.95 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.088 1.355 . . . . 71.109999999999999 113.592 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.6 -28.75 70.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.048 0.539 . . . . 72.420000000000002 109.811 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.96 -10.32 58.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.794 -0.639 . . . . 72.400000000000006 111.048 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -99.77 -41.73 7.14 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.119 0.485 . . . . 54.409999999999997 111.368 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -84.47 -3.42 58.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.931 0.396 . . . . 63.119999999999997 111.755 -176.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -61.9 -41.9 98.44 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.102 0.561 . . . . 72.530000000000001 111.57 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -78.49 -13.15 59.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.086 0.47 . . . . 75.150000000000006 111.126 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -86.59 -24.8 25.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.598 -1.26 . . . . 74.329999999999998 107.598 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.1 m -66.92 107.38 2.2 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.32 -0.855 . . . . 64.299999999999997 110.68 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.91 177.82 40.27 Favored Glycine 0 N--CA 1.404 -3.462 0 N-CA-C 107.32 -2.312 . . . . 40.100000000000001 107.32 178.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 m -75.2 120.62 20.95 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 117.686 0.743 . . . . 63.25 110.346 -177.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.21 92.01 45.01 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 106.673 -1.602 . . . . 65.439999999999998 106.673 174.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.89 142.54 69.52 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.753 2.302 . . . . 51.530000000000001 113.036 -174.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.49 162.74 18.82 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.784 -1.191 . . . . 30.329999999999998 107.784 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -77.95 126.77 31.34 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.529 -0.468 . . . . 63.130000000000003 110.342 -176.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 p -67.12 146.52 54.18 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.706 -0.679 . . . . 63.340000000000003 110.055 178.162 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 116.51 -8.75 17.36 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 108.375 -1.89 . . . . 71.030000000000001 108.375 -174.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.11 66.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.183 -1.009 . . . . 65.109999999999999 110.231 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.31 1.82 47.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.425 -0.807 . . . . 64.239999999999995 110.627 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.53 7.7 17.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.036 -0.529 . . . . 73.239999999999995 110.209 -175.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 69.74 89.91 0.09 OUTLIER Pre-proline 0 CA--C 1.512 -0.482 0 C-N-CA 124.309 1.044 . . . . 73.310000000000002 109.61 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.69 -26.3 28.06 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.674 2.25 . . . . 73.409999999999997 112.184 -175.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.39 -27.99 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.837 -1.529 . . . . 75.310000000000002 110.229 -178.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.43 69.64 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.1 -1.2 . . . . 53.310000000000002 110.1 -177.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.8 t -131.06 158.13 41.19 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.052 -1.462 . . . . 63.210000000000001 107.052 176.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.97 40.93 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.743 -0.836 . . . . 64.310000000000002 108.743 -175.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 pp -133.13 151.56 51.99 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.899 0.381 . . . . 60.149999999999999 110.385 178.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.3 pp -113.52 132.18 55.79 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.006 -1.109 . . . . 74.540000000000006 108.006 175.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.81 132.06 68.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 109.906 -178.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 15.3 t -86.64 117.86 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.363 -1.347 . . . . 63.200000000000003 107.363 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.42 -33.02 12.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.033 0.444 . . . . 72.319999999999993 110.817 -179.094 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 13.7 tpt180 -137.85 139.61 40.01 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.476 -1.305 . . . . 65.310000000000002 107.476 -176.129 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.25 176.17 14.25 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.013 -0.835 . . . . 33.119999999999997 111.013 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.5 -35.23 39.73 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.614 2.209 . . . . 62.340000000000003 112.089 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -97.49 22.31 9.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.04 0.536 . . . . 65.450000000000003 111.139 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -62.94 141.31 58.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.997 0.427 . . . . 54.25 111.793 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.99 -13.87 57.38 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.046 -0.822 . . . . 71.329999999999998 111.046 -177.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.64 142.98 27.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.898 0.38 . . . . 55.0 110.371 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -131.17 136.43 48.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.573 -0.899 . . . . 75.019999999999996 108.573 177.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -130.51 139.22 50.5 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.984 -0.747 . . . . 62.439999999999998 108.984 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.06 143.64 32.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.407 0.622 . . . . 72.019999999999996 112.114 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.436 HD23 HD11 ' A' ' 94' ' ' ILE . 5.3 mp -94.04 103.36 15.44 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.496 -0.927 . . . . 70.030000000000001 108.496 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -133.18 8.61 4.03 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.902 1.334 . . . . 62.409999999999997 107.621 178.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.458 ' O ' HD13 ' A' ' 94' ' ' ILE . 4.0 pt20 -113.23 156.93 42.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 113.437 -1.71 . . . . 62.299999999999997 109.092 -174.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.99 -32.42 94.97 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.466 2.111 . . . . 74.219999999999999 112.451 178.061 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 97.7 m -153.92 129.67 10.09 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 122.095 -0.378 . . . . 74.120000000000005 111.138 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 19.8 m -103.29 113.5 27.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.775 -1.565 . . . . 65.140000000000001 106.775 174.449 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -91.77 132.95 36.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.445 -0.576 . . . . 62.140000000000001 109.445 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.86 134.26 55.28 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 109.905 -0.405 . . . . 73.439999999999998 109.905 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.85 -132.45 2.83 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.108 -0.797 . . . . 75.329999999999998 111.108 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 86' ' ' SER . 9.9 mmm180 -118.54 151.28 38.16 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 123.029 0.532 . . . . 54.439999999999998 110.719 -175.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.8 m80 80.3 152.73 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 124.913 1.285 . . . . 72.239999999999995 112.628 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.45 -18.87 26.72 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.978 3.118 . . . . 71.310000000000002 115.6 -175.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.52 -23.2 60.98 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.236 0.471 . . . . 74.549999999999997 110.708 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m -78.18 119.72 21.97 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 105.706 -1.961 . . . . 53.020000000000003 105.706 172.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.44 -49.18 78.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.957 -0.565 . . . . 75.310000000000002 111.399 -173.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.5 pt -107.28 123.23 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 C-N-CA 120.12 -0.632 . . . . 61.130000000000003 109.685 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.89 124.02 33.24 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 109.044 -0.725 . . . . 72.0 109.044 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 mt -121.2 140.44 52.02 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.293 -2.114 . . . . 63.350000000000001 105.293 178.338 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -102.21 116.31 32.38 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.101 -1.814 . . . . 72.439999999999998 106.101 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -88.53 176.77 7.01 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.615 -1.175 . . . . 72.519999999999996 112.837 -171.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.73 -32.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.229 1.014 . . . . 70.230000000000004 108.505 -177.71 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.4 m -150.14 153.67 36.74 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.074 -2.565 . . . . 54.43 104.074 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 72' ' ' ARG . 50.0 t -70.67 112.47 5.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.655 1.217 . . . . 62.43 113.375 -162.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.557 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 23.2 m -111.27 107.18 16.38 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 113.259 -1.792 . . . . 75.219999999999999 108.0 177.294 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HB2' ' HG3' ' A' ' 11' ' ' GLN . 15.9 ptt180 -55.84 -45.69 78.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.422 -0.808 . . . . 65.120000000000005 112.03 -175.219 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -137.3 119.88 16.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.322 -2.103 . . . . 70.310000000000002 105.322 171.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -89.76 -52.91 4.75 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.205 -1.035 . . . . 73.310000000000002 108.205 178.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.2 34.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.83 -0.623 . . . . 33.450000000000003 109.567 -177.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.71 145.92 52.06 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.241 0.543 . . . . 52.020000000000003 111.04 171.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 101' ' ' VAL . 9.4 m-85 -104.45 113.22 26.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.351 -1.722 . . . . 74.329999999999998 106.351 -177.319 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -106.67 120.72 42.73 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.649 -0.871 . . . . 74.239999999999995 108.649 -176.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 65' ' ' GLN . 3.1 mp -104.42 111.58 34.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 105.109 -2.182 . . . . 74.299999999999997 105.109 179.109 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -139.38 130.56 26.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 110.083 -0.34 . . . . 73.140000000000001 110.083 -177.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 55.87 36.67 27.73 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 122.293 1.044 . . . . 73.209999999999994 110.533 175.538 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 0.86 81.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.11 -0.95 . . . . 62.240000000000002 113.652 179.057 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -101.45 133.75 45.6 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.413 -0.958 . . . . 54.340000000000003 108.413 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -104.9 116.09 31.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.521 -1.288 . . . . 73.340000000000003 107.521 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.33 134.28 48.86 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.99 0.424 . . . . 74.040000000000006 110.504 -178.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 92' ' ' PHE . 39.0 t -102.49 124.08 56.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.496 -1.298 . . . . 74.120000000000005 107.496 175.071 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.62 123.09 68.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.825 0.821 . . . . 72.25 109.325 176.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -100.48 140.63 34.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.651 -1.159 . . . . 71.510000000000005 111.952 -174.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.33 1.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.809 . . . . 72.319999999999993 109.946 171.513 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.7 40.15 2.52 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 121.358 -0.449 . . . . 63.43 113.092 -173.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.8 m -55.73 -19.62 11.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 73.450000000000003 111.903 178.491 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.448 ' H ' HD22 ' A' ' 107' ' ' LEU . 2.4 mm? -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.271 0.628 . . . . 45.329999999999998 111.293 -178.111 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -86.99 -17.91 31.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.695 0.759 . . . . 75.519999999999996 109.287 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.37 76.23 1.12 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.324 -0.853 . . . . 53.340000000000003 113.213 175.539 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 m -86.69 126.67 34.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.758 -0.46 . . . . 73.109999999999999 109.758 175.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -136.79 136.44 38.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 110.033 -0.358 . . . . 71.409999999999997 110.033 178.178 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.429 HG11 ' HG2' ' A' ' 120' ' ' GLN . 58.8 t -121.65 121.11 63.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.798 -1.556 . . . . 73.140000000000001 106.798 174.596 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.31 44.67 27.01 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.334 1.053 . . . . 71.129999999999995 110.111 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.8 9.35 5.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.375 1.47 . . . . 74.120000000000005 114.587 -177.48 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -120.07 135.54 24.42 Favored Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.982 -0.687 . . . . 73.430000000000007 109.894 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.54 137.2 67.81 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.544 2.162 . . . . 75.340000000000003 111.55 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -134.43 159.42 41.13 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.304 0.573 . . . . 74.239999999999995 111.705 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -123.65 -34.65 3.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.344 -1.298 . . . . 73.0 108.761 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.78 27.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.694 -1.595 . . . . 73.319999999999993 106.694 174.345 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.429 ' HG2' HG11 ' A' ' 112' ' ' VAL . 56.5 tp60 -147.61 122.21 9.82 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.856 -0.338 . . . . 71.430000000000007 111.214 -176.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.59 114.13 26.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.465 -2.05 . . . . 73.040000000000006 105.465 173.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.482 ' SD ' HD11 ' A' ' 128' ' ' ILE . 73.6 mtp -93.34 147.19 23.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 115.268 1.581 . . . . 60.119999999999997 115.268 -168.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -112.06 152.11 28.58 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.935 -1.484 . . . . 74.040000000000006 107.653 175.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -66.55 133.52 50.5 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.337 0.589 . . . . 63.130000000000003 111.385 -178.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.39 -2.14 56.13 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.584 -0.735 . . . . 42.329999999999998 112.392 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.94 153.52 20.97 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 117.032 0.416 . . . . 72.519999999999996 109.931 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.32 145.82 42.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.011 0.745 . . . . 63.030000000000001 113.011 -172.192 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.482 HD11 ' SD ' ' A' ' 122' ' ' MET . 60.4 mt -120.23 132.05 70.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.537 -0.912 . . . . 52.329999999999998 108.537 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -116.35 122.01 43.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.89 -1.152 . . . . 75.230000000000004 107.89 175.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.6 105.05 18.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.422 -0.955 . . . . 74.319999999999993 108.422 -178.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.25 -86.29 0.5 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 108.986 -1.646 . . . . 43.329999999999998 108.986 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -140.35 -2.86 1.39 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.535 -0.333 . . . . 75.530000000000001 111.425 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.254 50.5 p90 -95.04 164.11 13.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.202 -0.999 . . . . 74.030000000000001 111.529 -179.758 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -120.0 126.61 51.26 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 113.07 0.766 . . . . 74.219999999999999 113.07 -165.149 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.7 mt -121.96 140.13 52.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.984 -1.117 . . . . 75.140000000000001 107.984 175.149 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.05 137.46 55.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.602 -0.888 . . . . 63.049999999999997 108.602 176.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -105.69 114.83 29.23 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.146 0.579 . . . . 73.450000000000003 109.69 -177.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -127.7 159.18 35.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.817 -0.438 . . . . 71.510000000000005 109.817 -178.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.85 123.53 25.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.577 -1.638 . . . . 44.450000000000003 106.577 171.081 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.72 -89.5 1.35 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.093 -1.051 . . . . 63.340000000000003 114.934 -170.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.68 152.55 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.333 2.022 . . . . 62.119999999999997 112.821 -177.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.45 20.24 11.9 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.072 -1.085 . . . . 64.129999999999995 108.072 178.402 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-N 114.312 -1.313 . . . . 73.0 108.375 -178.425 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 108.9 -0.778 . . . . 65.5 108.9 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -116.24 132.82 56.56 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.878 -0.786 . . . . 55.039999999999999 108.878 178.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.67 88.52 3.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.153 -1.054 . . . . 75.329999999999998 108.153 177.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -87.68 83.09 7.23 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.637 -1.165 . . . . 72.340000000000003 109.036 -178.002 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -71.31 141.86 50.46 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.848 -1.069 . . . . 74.230000000000004 110.104 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.26 120.1 11.39 Favored Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.305 -0.718 . . . . 72.439999999999998 111.305 178.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.2 t -89.17 112.7 52.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 112.3 0.482 . . . . 73.400000000000006 112.3 -176.149 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 6.3 Cg_exo -79.2 149.72 22.29 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.603 2.202 . . . . 62.439999999999998 110.368 173.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -105.52 125.88 32.25 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.409 -0.589 . . . . 73.209999999999994 109.409 177.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.56 152.22 78.61 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 123.0 2.466 . . . . 64.129999999999995 114.071 -175.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.64 163.58 14.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.792 -1.095 . . . . 74.329999999999998 108.187 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.7 t -127.67 137.8 56.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.45 -0.945 . . . . 64.120000000000005 108.45 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -119.73 168.29 11.21 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 120.93 0.395 . . . . 72.430000000000007 111.319 -179.079 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 m -70.2 112.43 6.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 122.006 0.907 . . . . 74.430000000000007 110.929 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -88.97 149.72 23.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.638 -1.615 . . . . 74.420000000000002 106.638 175.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.78 115.71 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.679 -1.23 . . . . 70.340000000000003 107.679 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.18 139.81 30.1 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.427 -0.806 . . . . 62.340000000000003 109.942 -174.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -81.64 132.0 35.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.582 -0.896 . . . . 73.329999999999998 108.582 177.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.59 66.58 9.73 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.28 0.562 . . . . 64.129999999999995 112.465 -175.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.92 -18.25 58.41 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 107.841 -1.17 . . . . 64.349999999999994 107.841 174.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -62.12 -12.92 22.13 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 114.841 -1.072 . . . . 74.230000000000004 112.862 177.031 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.91 -30.54 69.89 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 121.358 0.599 . . . . 73.530000000000001 109.536 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.47 -33.74 76.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 125.008 1.323 . . . . 72.150000000000006 108.989 178.409 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 -49.0 10.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.279 -0.873 . . . . 74.530000000000001 109.081 177.31 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.3 tpp -56.88 -32.65 66.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.824 1.25 . . . . 71.409999999999997 112.031 -176.262 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 30.0 tt0 -62.78 -32.13 73.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.756 0.312 . . . . 73.120000000000005 111.554 -178.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -69.61 -32.2 70.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.097 -0.705 . . . . 73.230000000000004 109.097 179.23 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -84.26 -16.65 42.42 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.039 0.935 . . . . 71.329999999999998 111.513 -179.486 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 27' ' ' GLU . 61.6 m -59.59 124.91 21.61 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 112.615 0.598 . . . . 65.319999999999993 112.615 -175.122 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.71 -144.25 8.45 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 109.036 -1.626 . . . . 64.040000000000006 109.036 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 p -115.52 139.79 49.74 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 117.446 0.623 . . . . 73.099999999999994 109.56 174.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . . . -127.12 122.26 23.04 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 120.607 -0.437 . . . . 44.219999999999999 109.831 177.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.37 156.95 60.53 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 123.146 2.564 . . . . 71.329999999999998 112.513 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.65 158.78 35.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.567 -0.901 . . . . 73.349999999999994 108.567 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.3 m -81.26 105.62 12.6 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.382 -0.969 . . . . 62.43 108.382 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 m -70.23 78.25 0.52 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.148 0.975 . . . . 73.019999999999996 111.641 -176.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 25.98 0.14 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 109.641 -1.383 . . . . 70.400000000000006 109.641 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.1 72.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.169 -0.515 . . . . 74.099999999999994 110.134 -177.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.21 4.13 51.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.707 -0.679 . . . . 65.019999999999996 111.056 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -84.6 -42.24 15.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.964 -1.125 . . . . 75.329999999999998 107.964 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt 50.88 68.74 3.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.728 -1.124 . . . . 64.299999999999997 111.22 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.417 ' HG2' ' HA2' ' A' ' 140' ' ' GLY . 30.7 Cg_endo -65.56 -65.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.38 2.054 . . . . 73.239999999999995 113.482 -175.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -15.82 60.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.815 0.302 . . . . 54.149999999999999 111.815 -177.491 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -2.85 72.74 Favored Glycine 0 N--CA 1.46 0.271 0 N-CA-C 111.746 -0.542 . . . . 54.140000000000001 111.746 -178.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -150.77 169.59 21.29 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.616 -1.624 . . . . 73.409999999999997 106.616 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.59 44.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 118.06 0.391 . . . . 74.530000000000001 111.1 -173.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.42 157.73 36.13 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.4 0.438 . . . . 65.349999999999994 110.715 177.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.78 151.2 50.77 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.117 -0.697 . . . . 71.340000000000003 109.117 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.71 134.69 66.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 110.027 -0.36 . . . . 63.520000000000003 110.027 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.83 118.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.17 -1.419 . . . . 70.140000000000001 107.17 177.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -91.0 -32.95 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.939 0.4 . . . . 70.129999999999995 110.159 -177.162 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 tpm_? -137.81 132.63 32.92 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.647 -0.421 . . . . 73.510000000000005 110.085 -179.16 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.15 173.01 17.96 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.991 -1.644 . . . . 55.399999999999999 108.991 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -59.55 -35.42 95.64 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.584 2.189 . . . . 74.129999999999995 112.725 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -100.5 22.15 12.18 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.595 -0.442 . . . . 63.520000000000003 112.187 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.6 138.71 57.64 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.752 178.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.03 -19.24 32.89 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.268 -0.733 . . . . 74.209999999999994 111.268 -177.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.96 144.01 26.78 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 110.138 -0.319 . . . . 50.520000000000003 110.138 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.73 156.75 18.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.9 -0.778 . . . . 73.099999999999994 108.9 178.045 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.471 ' CG ' HG22 ' A' ' 78' ' ' ILE . 98.3 m-85 -138.0 144.44 41.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.335 -1.358 . . . . 75.019999999999996 107.335 175.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.7 135.1 54.97 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.156 -0.683 . . . . 74.230000000000004 109.156 -178.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.46 104.36 10.02 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.87 -0.789 . . . . 61.299999999999997 108.87 179.222 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.93 -21.37 11.61 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.827 -0.624 . . . . 72.430000000000007 111.351 -177.341 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.58 144.86 30.12 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.001 -0.545 . . . . 74.219999999999999 110.983 -173.73 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.32 -19.85 36.9 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.745 2.963 . . . . 73.129999999999995 113.901 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.8 m -141.74 121.23 13.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.997 -0.742 . . . . 71.310000000000002 108.997 175.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.8 m -120.06 133.13 55.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.253 -0.647 . . . . 55.210000000000001 109.253 -177.321 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.2 m -105.66 143.83 33.26 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.901 -0.407 . . . . 73.299999999999997 109.901 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.07 134.91 54.54 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.042 -0.725 . . . . 73.129999999999995 109.042 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . 133.79 -146.64 18.57 Favored Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 109.113 -1.595 . . . . 70.510000000000005 109.113 -179.113 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -119.67 118.65 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.614 -1.234 . . . . 53.219999999999999 111.497 174.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.581 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 47.5 m-70 -167.55 142.14 3.09 Favored Pre-proline 0 C--N 1.277 -2.557 0 C-N-CA 126.832 2.053 . . . . 73.430000000000007 105.564 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.57 -21.95 73.44 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.611 2.207 . . . . 71.439999999999998 114.733 -175.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.429 ' OE2' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -105.79 5.19 30.62 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.259 0.466 . . . . 32.219999999999999 112.259 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.581 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 73.3 m -80.98 140.27 35.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.494 -0.482 . . . . 71.219999999999999 109.826 178.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.08 -49.89 14.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 111.121 -173.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.471 HG22 ' CG ' ' A' ' 61' ' ' PHE . 43.9 pt -100.37 103.47 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.289 1.043 . . . . 75.030000000000001 111.015 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -88.1 132.44 34.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.378 -1.283 . . . . 72.340000000000003 108.965 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.48 136.36 51.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.029 -1.471 . . . . 54.43 107.029 176.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.38 139.37 50.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.235 -0.654 . . . . 75.310000000000002 109.235 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -166.4 -174.56 2.91 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.079 -2.193 . . . . 73.239999999999995 105.079 178.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.45 -24.35 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.806 -1.553 . . . . 73.209999999999994 106.806 175.055 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -78.96 96.19 5.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.505 -1.294 . . . . 72.319999999999993 107.505 176.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.56 135.59 35.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.17 0.509 . . . . 40.140000000000001 112.315 -173.023 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.9 t -134.52 142.36 46.99 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.625 -2.361 . . . . 70.120000000000005 104.625 173.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 13' ' ' GLU . 12.4 ptp180 -62.55 -46.07 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.296 0.57 . . . . 71.340000000000003 109.742 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 16.8 ptt180 -151.42 151.06 31.16 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.348 -1.352 . . . . 61.229999999999997 107.348 170.068 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -100.67 -52.33 3.36 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.613 0.571 . . . . 74.519999999999996 112.186 -176.463 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.03 164.79 36.49 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.314 -0.555 . . . . 63.140000000000001 110.462 -172.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.21 132.0 45.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.598 -0.728 . . . . 65.040000000000006 109.248 173.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.405 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 68.3 m-85 -106.11 123.76 48.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.646 -0.872 . . . . 63.399999999999999 108.646 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -106.12 127.08 52.95 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.465 -0.494 . . . . 71.310000000000002 109.728 173.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.15 114.41 46.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.563 -1.643 . . . . 72.439999999999998 106.563 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -136.84 118.93 15.41 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 120.685 -0.406 . . . . 74.5 110.205 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 55.87 40.64 30.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.602 1.161 . . . . 71.25 111.396 177.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.45 -8.53 74.29 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.464 -1.244 . . . . 35.450000000000003 114.116 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.49 135.78 42.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.882 0.841 . . . . 75.019999999999996 110.17 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 37.9 m-85 -104.94 128.35 53.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.77 -1.105 . . . . 65.310000000000002 108.183 -176.441 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.46 137.13 49.65 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.127 0.489 . . . . 75.099999999999994 110.39 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.33 125.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.729 -0.841 . . . . 71.5 108.729 -177.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -116.66 126.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.834 -1.173 . . . . 73.129999999999995 107.834 174.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.21 134.09 35.56 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.898 -0.779 . . . . 72.230000000000004 108.898 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG21 ' CZ ' ' A' ' 88' ' ' ARG . 15.5 m -138.21 15.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.862 0.839 . . . . 74.319999999999993 109.509 179.168 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -155.48 70.66 0.27 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 110.472 -1.051 . . . . 62.539999999999999 110.472 -176.28 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -72.42 27.53 0.05 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.63 0.772 . . . . 64.430000000000007 112.49 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 105' ' ' GLY . 3.0 tm? -82.96 -47.07 12.16 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 105.716 -1.957 . . . . 62.409999999999997 105.716 174.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.98 -19.93 19.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.285 -0.966 . . . . 62.43 109.55 176.709 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.77 129.7 0.12 Allowed Glycine 0 C--N 1.343 0.944 0 O-C-N 123.957 0.786 . . . . 53.43 112.352 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.2 m -82.96 127.8 33.87 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.481 -1.288 . . . . 73.319999999999993 109.116 174.301 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -130.06 126.29 37.28 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.564 -1.272 . . . . 73.010000000000005 107.564 175.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.47 119.24 59.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.097 -1.446 . . . . 72.140000000000001 107.097 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 33' ' ' ALA . 36.2 t-20 54.61 40.84 32.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.133 0.968 . . . . 71.030000000000001 109.063 -178.172 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 71.53 10.9 6.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.1 -1.409 . . . . 73.549999999999997 113.036 175.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.35 129.53 24.91 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 71.129999999999995 109.629 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.09 126.66 16.86 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.907 2.405 . . . . 61.420000000000002 110.782 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.17 162.77 23.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.958 0.885 . . . . 65.209999999999994 113.228 -176.092 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -133.0 -38.33 0.97 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.886 -1.961 . . . . 60.32 107.306 178.08 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.68 136.64 27.56 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.908 -2.256 . . . . 64.209999999999994 104.908 171.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -152.9 126.04 8.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.123 -0.631 . . . . 73.109999999999999 110.148 179.416 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.22 119.69 27.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.006 -1.479 . . . . 62.009999999999998 107.006 174.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.464 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 11.0 ttt -87.01 140.06 29.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.595 0.712 . . . . 72.530000000000001 112.032 -162.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -128.97 155.96 44.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.564 -1.198 . . . . 64.150000000000006 111.581 -176.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.5 t -80.03 135.27 36.32 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.452 1.101 . . . . 71.25 113.406 -173.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.57 -20.46 48.19 Favored Glycine 0 CA--C 1.499 -0.937 0 CA-C-N 115.851 -0.613 . . . . 54.32 112.238 177.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.76 151.95 37.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 122.903 0.481 . . . . 74.319999999999993 109.74 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 147.6 35.05 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.462 0.649 . . . . 54.140000000000001 110.896 -178.718 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -105.7 124.83 61.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 106.58 -1.637 . . . . 72.129999999999995 106.58 -176.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -110.18 126.39 54.05 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.632 -1.988 . . . . 75.120000000000005 105.632 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.31 102.49 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.15 -1.056 . . . . 63.130000000000003 108.15 -176.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.14 -84.18 0.02 OUTLIER Glycine 0 CA--C 1.536 1.38 0 CA-C-O 121.39 0.439 . . . . 53.25 113.077 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -131.82 8.91 4.52 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.491 0.716 . . . . 75.409999999999997 110.209 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -102.37 151.89 21.74 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.513 -0.767 . . . . 45.140000000000001 109.633 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 124.47 21.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.921 -0.581 . . . . 73.209999999999994 109.895 170.358 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.57 141.22 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.922 -1.14 . . . . 73.430000000000007 107.922 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.3 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.627 -0.879 . . . . 74.219999999999999 108.627 -178.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -102.23 126.95 49.36 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.732 0.645 . . . . 74.140000000000001 110.003 -176.762 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -140.0 131.06 26.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.887 0.851 . . . . 73.140000000000001 111.895 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.95 118.25 35.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.986 -1.487 . . . . 63.520000000000003 106.986 176.259 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 43' ' ' PRO . . . -177.04 -71.02 0.06 OUTLIER Glycine 0 C--N 1.295 -1.708 0 C-N-CA 118.279 -1.915 . . . . 65.340000000000003 114.639 -176.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.89 142.31 97.23 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.357 2.038 . . . . 71.540000000000006 113.179 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.83 76.51 1.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.636 -1.165 . . . . 62.350000000000001 108.166 -178.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 114.024 -1.444 . . . . 64.200000000000003 108.114 -178.592 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 109.061 -0.718 . . . . 65.219999999999999 109.061 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -110.95 156.26 21.48 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.13 -0.357 . . . . 75.430000000000007 110.174 -178.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -85.09 173.29 10.59 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 53.240000000000002 108.734 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -114.63 106.73 14.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.725 -0.472 . . . . 54.030000000000001 109.725 179.154 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -131.29 143.44 50.54 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.519 -0.919 . . . . 63.420000000000002 108.519 177.321 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.26 -69.17 1.28 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.812 -1.185 . . . . 65.040000000000006 110.216 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 p -97.87 130.77 28.09 Favored Pre-proline 0 C--N 1.291 -1.942 0 N-CA-C 109.764 -0.458 . . . . 61.119999999999997 109.764 178.163 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.24 131.32 21.71 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.104 1.202 . . . . 74.439999999999998 109.669 175.646 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -102.03 116.88 62.55 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.011 -1.107 . . . . 63.119999999999997 108.011 177.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.87 156.3 13.52 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.052 1.835 . . . . 72.120000000000005 112.483 -177.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.7 153.44 18.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.716 -1.957 . . . . 72.430000000000007 105.716 172.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.01 121.17 59.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.269 -1.382 . . . . 74.099999999999994 107.269 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.529 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 8.3 tp10 -125.85 166.19 17.31 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.98 -1.489 . . . . 75.340000000000003 106.98 -175.346 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -69.62 133.65 47.83 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 124.266 1.027 . . . . 73.319999999999993 112.888 -172.112 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' TPO . . . . . 0.457 HG22 HD13 ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.408 ' H ' HD12 ' A' ' 107' ' ' LEU . 16.7 m -107.87 108.53 19.74 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.889 -0.411 . . . . 72.219999999999999 109.889 178.63 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -97.57 114.53 35.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 107.451 -1.315 . . . . 74.409999999999997 107.451 177.097 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.456 ' CE2' HG23 ' A' ' 84' ' ' THR . 22.7 m-85 -97.45 138.6 34.65 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.033 -0.667 . . . . 63.549999999999997 112.307 -177.499 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.34 91.1 7.53 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.363 -2.458 . . . . 70.230000000000004 104.363 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . . . -101.5 168.08 9.73 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.213 -1.358 . . . . 55.020000000000003 112.779 -166.881 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.92 -1.42 56.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.235 -1.348 . . . . 61.210000000000001 109.172 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' ' 20' ' ' ALA . 3.8 pp -63.65 -14.7 54.36 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.295 -0.866 . . . . 74.239999999999995 112.478 -178.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.69 -19.61 64.38 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.897 0.38 . . . . 72.25 111.077 175.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -84.02 -38.77 20.47 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.779 -1.193 . . . . 74.5 107.779 173.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -57.47 -34.54 69.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.983 -1.008 . . . . 72.329999999999998 109.986 176.356 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.53 -49.17 70.9 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.435 1.094 . . . . 72.239999999999995 111.551 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.29 -36.05 76.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.659 0.266 . . . . 73.319999999999993 110.528 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -62.16 -37.47 85.33 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.638 -0.71 . . . . 62.509999999999998 110.8 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -86.27 -17.03 35.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.22 0.452 . . . . 63.32 112.22 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.0 m -63.71 125.34 23.98 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.345 -0.613 . . . . 71.430000000000007 109.345 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.87 3.4 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 108.311 -1.916 . . . . 74.319999999999993 108.311 -171.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.8 t -101.75 140.05 36.57 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.576 -0.812 . . . . 73.450000000000003 108.994 -179.079 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.27 80.02 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 107.418 -1.326 . . . . 74.310000000000002 107.418 174.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.487 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 38.2 Cg_exo -62.29 142.01 89.73 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.315 1.343 . . . . 53.340000000000003 109.68 176.652 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.28 124.58 44.48 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.072 -0.651 . . . . 23.420000000000002 109.459 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 124' ' ' THR . 73.4 m -165.2 143.79 6.39 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 71.209999999999994 109.531 -179.23 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -118.62 8.94 12.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.684 0.754 . . . . 62.420000000000002 109.775 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.28 65.8 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 107.008 -2.437 . . . . 73.540000000000006 107.008 -177.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' OE1' ' A' ' 123' ' ' GLN . . . -57.02 -47.56 80.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.972 -1.114 . . . . 51.130000000000003 113.151 -165.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -104.44 3.57 32.31 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 120.742 -0.383 . . . . 72.219999999999999 111.255 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.01 -44.51 9.28 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.39 -0.924 . . . . 72.319999999999993 112.03 -171.481 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 36.51 69.23 1.29 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 124.2 0.938 . . . . 75.040000000000006 111.18 -175.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.9 -70.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 125.265 3.977 . . . . 64.439999999999998 116.804 -167.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.28 -5.72 58.19 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.444 -0.502 . . . . 72.219999999999999 112.299 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -4.77 64.34 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.96 -0.638 . . . . 53.439999999999998 112.267 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.3 m -114.79 153.37 30.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.335 -1.728 . . . . 61.229999999999997 106.335 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 156.83 40.02 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.286 -0.566 . . . . 71.0 112.235 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.5 161.09 35.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.922 -1.036 . . . . 44.520000000000003 109.743 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -130.9 135.14 47.41 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.196 -0.668 . . . . 64.310000000000002 109.196 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -116.2 133.56 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.06 0.457 . . . . 74.120000000000005 110.61 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 14.0 t -78.82 118.62 26.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.667 -1.234 . . . . 33.100000000000001 107.667 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 136' ' ' VAL . 32.2 mmmt -90.86 -31.12 16.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 110.428 -176.2 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 26.2 tpt180 -143.34 145.7 32.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.109 -1.071 . . . . 74.540000000000006 108.109 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.46 178.12 15.18 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 111.305 -0.718 . . . . 42.149999999999999 111.305 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -61.42 -31.28 88.15 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.696 2.264 . . . . 73.530000000000001 112.303 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -97.09 21.22 10.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.996 0.369 . . . . 54.130000000000003 111.996 177.102 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.23 45.39 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 120.814 0.34 . . . . 54.119999999999997 110.761 179.114 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.04 -13.07 52.63 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 111.45 -0.66 . . . . 65.120000000000005 111.45 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 145.24 25.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.777 0.322 . . . . 34.329999999999998 110.197 178.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -125.62 147.54 49.28 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.08 -1.082 . . . . 70.329999999999998 108.08 177.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.85 144.89 51.79 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.749 -1.204 . . . . 64.040000000000006 107.749 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.0 pt? -111.74 134.04 53.57 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.753 0.311 . . . . 73.209999999999994 110.861 -177.107 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.4 mt -93.44 104.96 17.07 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.493 -0.558 . . . . 70.230000000000004 109.493 -178.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -121.29 -12.42 8.64 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.83 0.824 . . . . 52.329999999999998 110.809 -179.336 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -106.96 144.86 29.94 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 115.712 -0.677 . . . . 72.150000000000006 110.644 -175.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.05 -29.51 45.22 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.763 2.975 . . . . 74.129999999999995 113.434 -178.326 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -140.62 121.98 14.98 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.73 -0.606 . . . . 74.209999999999994 109.75 179.01 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -118.0 139.54 51.04 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.227 -1.397 . . . . 63.299999999999997 107.227 178.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.4 m -115.39 141.9 47.41 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.79 . . . . 65.349999999999994 110.222 -178.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.49 135.42 54.78 Favored 'General case' 0 C--O 1.256 1.446 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.761 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.01 -144.91 12.72 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.666 -1.374 . . . . 70.299999999999997 109.666 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 58.2 ttt-85 -119.95 118.29 30.32 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.663 -0.495 . . . . 65.099999999999994 109.663 176.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 75' ' ' GLU . 8.8 p80 169.74 163.02 0.2 Allowed Pre-proline 0 C--N 1.315 -0.925 0 C-N-CA 126.812 2.045 . . . . 73.230000000000004 107.811 174.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.54 -25.43 75.65 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.237 1.958 . . . . 44.210000000000001 113.043 -178.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 20.3 mp0 -86.64 -4.9 59.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.653 -0.249 . . . . 64.519999999999996 111.481 -178.397 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -71.29 107.57 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.366 -0.605 . . . . 63.549999999999997 109.366 178.035 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.0 -32.01 56.89 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.581 -1.266 . . . . 71.450000000000003 107.581 175.294 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.68 100.85 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.305 -2.109 . . . . 63.109999999999999 105.305 173.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.72 118.32 36.6 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.76 -0.376 . . . . 72.450000000000003 110.737 -175.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -123.06 122.3 38.15 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.71 -1.218 . . . . 41.350000000000001 107.71 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 55' ' ' PRO . 24.8 t70 -130.71 132.24 45.25 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.603 -0.888 . . . . 54.409999999999997 108.603 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -141.58 175.17 9.9 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.677 -1.601 . . . . 51.25 106.677 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -60.12 -32.19 49.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.577 -1.268 . . . . 64.219999999999999 107.577 174.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.456 HG23 ' CE2' ' A' ' 18' ' ' PHE . 13.1 m -74.88 114.59 13.52 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.691 -1.225 . . . . 72.0 107.691 173.282 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.57 125.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.226 0.536 . . . . 73.140000000000001 110.53 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.1 m -145.13 103.12 3.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.162 -0.681 . . . . 70.150000000000006 109.162 177.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HD3' ' H ' ' A' ' 13' ' ' GLU . 18.1 ptt180 -80.68 -45.68 16.77 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 119.604 -0.839 . . . . 73.340000000000003 111.488 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -118.88 99.67 6.9 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.313 -0.625 . . . . 74.0 109.313 177.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.442 ' CE1' HG13 ' A' ' 130' ' ' ILE . 44.4 t-80 -100.32 -52.66 3.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.301 -0.96 . . . . 73.519999999999996 111.325 177.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.59 163.57 39.2 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.03 -0.668 . . . . 45.020000000000003 111.913 -175.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.78 137.4 54.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.952 -1.129 . . . . 74.109999999999999 107.952 176.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -105.83 113.58 27.22 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.739 -1.578 . . . . 65.439999999999998 106.739 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -111.13 136.54 50.03 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.832 -0.432 . . . . 74.5 109.832 -175.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' A' ' 99' ' ' PHE . 17.9 mm -107.97 113.52 44.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.628 -1.99 . . . . 71.239999999999995 105.628 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -135.96 122.84 21.26 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.511 -0.476 . . . . 65.409999999999997 110.51 -177.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 56.37 37.16 28.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.265 1.426 . . . . 54.130000000000003 110.403 179.232 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.5 -0.72 87.53 Favored Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.13 -0.941 . . . . 31.02 113.215 177.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.85 145.72 29.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.458 -0.941 . . . . 74.150000000000006 108.458 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD2' HD12 ' A' ' 94' ' ' ILE . 50.3 m-85 -105.11 127.12 52.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.289 -1.375 . . . . 73.030000000000001 107.289 -177.503 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -130.29 147.39 52.0 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.886 -0.509 . . . . 74.129999999999995 110.23 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -113.53 123.68 69.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.636 -1.246 . . . . 53.009999999999998 107.636 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.3 121.87 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.419 0.628 . . . . 71.420000000000002 109.608 175.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.448 ' HB2' HG21 ' A' ' 110' ' ' THR . 3.5 t70 -81.84 138.21 35.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.77 -0.65 . . . . 72.430000000000007 110.612 178.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.22 12.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.679 -0.691 . . . . 72.409999999999997 109.517 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.7 -63.4 0.12 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 119.91 -1.138 . . . . 61.039999999999999 112.981 -177.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 t 62.23 9.55 3.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.723 1.209 . . . . 43.329999999999998 111.205 -177.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.6 pt? -75.98 -46.02 31.77 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 124.017 0.927 . . . . 65.230000000000004 112.577 -173.544 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.445 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 34.2 t-20 -89.74 -18.46 26.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 75.140000000000001 109.735 -171.091 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.79 86.19 1.77 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.516 -1.034 . . . . 72.230000000000004 110.516 -177.438 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 103' ' ' ASP . 8.4 m -80.63 129.81 34.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.027 0.441 . . . . 64.230000000000004 110.323 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 51.3 m-85 -131.02 136.07 48.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.741 -0.663 . . . . 71.319999999999993 110.585 178.529 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.66 123.32 49.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 105.935 -1.876 . . . . 43.310000000000002 105.935 174.135 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 57.34 37.76 28.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.44 1.096 . . . . 73.409999999999997 108.867 -176.914 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.3 mtm-85 66.68 12.29 8.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.56 -1.2 . . . . 74.140000000000001 113.702 178.142 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -114.57 142.94 29.0 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 108.871 -0.789 . . . . 71.540000000000006 108.871 174.57 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 110' ' ' THR . 26.1 Cg_exo -63.54 123.17 11.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.716 1.611 . . . . 73.200000000000003 108.73 172.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -157.3 136.89 12.18 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.166 -1.42 . . . . 73.209999999999994 107.166 -176.566 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -93.66 -49.27 5.95 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.062 -0.655 . . . . 72.109999999999999 110.56 -178.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.2 134.22 55.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.612 -0.835 . . . . 74.239999999999995 109.151 177.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -154.4 144.92 22.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.97 -0.559 . . . . 74.340000000000003 110.808 -178.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.78 125.55 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.265 -1.754 . . . . 72.420000000000002 106.265 172.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.7 ttp -98.38 129.87 45.03 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.212 0.529 . . . . 62.119999999999997 110.191 -173.218 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.492 ' OE1' ' HB1' ' A' ' 39' ' ' ALA . 69.5 mt-30 -117.7 156.23 28.6 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.8 -1.185 . . . . 62.210000000000001 107.8 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.9 t -62.62 133.74 55.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.95 0.722 . . . . 73.129999999999995 112.95 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.43 56.16 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.699 -0.682 . . . . 44.409999999999997 112.588 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -88.67 153.01 21.45 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 109.63 -0.507 . . . . 71.340000000000003 109.63 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -120.6 127.18 51.87 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.002 0.905 . . . . 53.0 111.836 -176.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.27 129.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 -177.142 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.0 tt0 -118.77 132.25 56.13 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.651 -177.425 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.442 HG13 ' CE1' ' A' ' 89' ' ' HIS . 2.9 mp -108.69 103.46 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.884 -1.895 . . . . 74.219999999999999 105.884 178.179 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.06 -93.54 0.33 Allowed Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 115.476 -0.784 . . . . 75.049999999999997 112.807 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.0 3.85 9.35 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.156 0.428 . . . . 63.5 112.156 -175.149 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.5 p90 -131.61 141.9 49.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.647 -0.658 . . . . 74.25 111.605 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 12.1 ptp180 -122.63 149.55 43.85 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 114.606 1.336 . . . . 73.409999999999997 114.606 -171.375 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 51' ' ' VAL . 6.0 mp -117.39 140.92 48.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.654 -1.612 . . . . 72.319999999999993 107.634 178.093 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.435 HG23 ' HG3' ' A' ' 52' ' ' LYS . 87.4 t -111.13 131.41 62.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.341 -0.985 . . . . 73.409999999999997 108.341 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -95.4 121.9 37.56 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.221 -0.9 . . . . 75.019999999999996 110.932 -175.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.16 133.42 51.58 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.192 0.52 . . . . 52.539999999999999 109.943 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 148.62 27.29 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.781 -0.822 . . . . 54.450000000000003 108.781 175.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 129.88 24.07 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.361 -1.096 . . . . 72.340000000000003 110.361 178.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.67 162.61 38.57 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.945 2.43 . . . . 63.130000000000003 111.459 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.34 51.96 0.9 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.028 0.918 . . . . 62.020000000000003 110.769 -178.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 105.507 -2.034 . . . . 54.210000000000001 105.507 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 106.842 -1.54 . . . . 64.340000000000003 106.842 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.89 126.29 40.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 107.507 -1.294 . . . . 73.030000000000001 107.507 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -81.42 132.74 35.34 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.366 1.079 . . . . 72.310000000000002 113.732 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -118.58 90.57 3.36 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 101.477 -3.527 . . . . 63.439999999999998 101.477 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.21 160.06 18.66 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.104 0.779 . . . . 71.099999999999994 113.104 -167.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.01 -7.16 37.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.133 -0.939 . . . . 74.299999999999997 109.647 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.32 -16.82 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.029 1.122 . . . . 75.299999999999997 114.029 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.5 pp -66.19 -26.68 67.51 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.407 0.622 . . . . 74.329999999999998 110.953 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' HD12 ' A' ' 23' ' ' LEU . 38.4 ttmt -73.97 -39.97 63.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.299 -1.0 . . . . 71.140000000000001 108.299 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.62 -35.61 80.6 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.617 -0.719 . . . . 74.140000000000001 110.076 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -42.36 98.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.983 -0.747 . . . . 71.219999999999999 108.983 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.29 -34.32 77.15 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 73.140000000000001 110.879 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.8 m -69.54 -19.06 63.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.421 0.629 . . . . 71.310000000000002 110.366 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 t -86.85 -16.71 35.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.537 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -59.52 119.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.525 0.679 . . . . 64.439999999999998 110.511 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.88 -78.38 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.167 -1.973 . . . . 61.43 108.167 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.3 t -116.76 148.41 41.17 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.463 -0.94 . . . . 74.310000000000002 108.463 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.95 116.64 26.06 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 106.893 -1.521 . . . . 45.420000000000002 106.893 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.48 140.64 82.98 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.08 1.187 . . . . 75.010000000000005 110.865 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.3 126.2 29.25 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.651 -0.87 . . . . 74.510000000000005 108.651 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 m -131.49 149.87 52.36 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.47 -0.937 . . . . 54.119999999999997 108.47 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -127.11 153.04 46.51 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.422 -0.585 . . . . 71.140000000000001 109.422 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 24.67 4.1 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 120.463 -0.875 . . . . 71.129999999999995 112.134 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.572 -0.529 . . . . 71.219999999999999 109.572 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.39 -2.31 52.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.549 -0.751 . . . . 72.409999999999997 110.998 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.43 -34.48 41.62 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.459 -0.941 . . . . 64.219999999999999 108.459 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.6 mt 56.55 90.96 0.08 OUTLIER Pre-proline 0 N--CA 1.45 -0.426 0 O-C-N 124.774 1.296 . . . . 72.519999999999996 113.006 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 8.3 Cg_endo -53.99 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.462 2.108 . . . . 71.409999999999997 111.888 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.59 15.45 8.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.0 0.429 . . . . 70.319999999999993 110.334 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.07 18.32 76.84 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.833 -0.621 . . . . 54.520000000000003 112.323 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.7 t -138.01 167.01 22.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -150.9 157.65 43.16 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.295 1.038 . . . . 73.200000000000003 108.548 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.15 160.0 39.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 121.014 -0.275 . . . . 70.310000000000002 111.458 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -127.24 134.93 50.02 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.526 -0.916 . . . . 65.439999999999998 108.526 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.51 136.75 44.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.502 -0.555 . . . . 61.539999999999999 109.502 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 17.1 t -80.59 117.42 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 106.717 -1.586 . . . . 51.130000000000003 106.717 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 51.2 tptt -90.63 -32.06 16.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.749 0.785 . . . . 64.409999999999997 109.136 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 77.8 ttt180 -151.51 142.35 22.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.52 -2.03 . . . . 61.409999999999997 105.52 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.22 -171.13 27.95 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.594 -1.002 . . . . 70.129999999999995 110.594 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 -50.15 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.386 2.057 . . . . 54.32 110.889 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 HD23 ' A' ' 80' ' ' LEU . 2.7 p30 -90.93 24.34 2.81 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.66 1.184 . . . . 44.549999999999997 112.666 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -53.45 131.78 38.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.568 0.699 . . . . 71.25 112.78 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.94 -17.31 45.28 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.359 -0.837 . . . . 74.120000000000005 111.901 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 146.53 23.98 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 122.593 -0.357 . . . . 75.439999999999998 110.435 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -120.26 135.29 55.05 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.926 -0.768 . . . . 72.010000000000005 108.926 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -118.07 140.99 48.95 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.77 -1.196 . . . . 75.219999999999999 107.77 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.1 pt? -110.7 140.96 44.59 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.256 -0.577 . . . . 64.340000000000003 111.576 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.4 HD23 HD11 ' A' ' 94' ' ' ILE . 4.6 mp -91.15 104.59 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.316 -0.994 . . . . 73.239999999999995 108.316 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -112.08 -4.86 14.35 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.965 0.888 . . . . 72.230000000000004 109.752 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -108.97 151.78 42.07 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 115.357 -0.838 . . . . 70.409999999999997 109.762 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 30.9 Cg_exo -64.98 -18.04 61.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.036 2.49 . . . . 64.239999999999995 113.948 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -144.12 122.4 12.28 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.595 -0.691 . . . . 64.150000000000006 109.522 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 77' ' ' ASP . 19.2 m -121.95 114.46 21.01 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.302 -0.629 . . . . 71.400000000000006 109.302 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -95.55 137.12 35.06 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.976 -0.452 . . . . 72.310000000000002 109.97 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 135.32 55.03 Favored 'General case' 0 C--O 1.261 1.66 0 CA-C-O 121.313 0.577 . . . . 73.25 111.228 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.04 -161.85 24.41 Favored Glycine 0 C--O 1.251 1.185 0 N-CA-C 109.07 -1.612 . . . . 60.229999999999997 109.07 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.418 ' HE ' HG11 ' A' ' 85' ' ' VAL . 3.9 tmm_? -94.07 118.75 31.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.188 -1.782 . . . . 63.119999999999997 106.188 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.552 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 11.1 t-80 -166.5 139.58 3.19 Favored Pre-proline 0 N--CA 1.401 -2.914 0 N-CA-C 103.705 -2.702 . . . . 74.209999999999994 103.705 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.552 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 17.9 Cg_endo -61.89 -29.6 82.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.115 1.21 . . . . 74.010000000000005 111.703 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -105.34 17.84 23.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.335 -0.848 . . . . 63.009999999999998 111.422 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 19.4 p -77.91 128.66 34.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 118.652 -1.219 . . . . 60.219999999999999 110.636 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' A' ' 68' ' ' THR . 12.3 t70 -77.28 -30.25 54.19 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.627 0.727 . . . . 70.5 109.109 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.04 99.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.558 -0.905 . . . . 72.030000000000001 108.558 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -92.42 120.17 32.66 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.849 -0.614 . . . . 72.319999999999993 109.9 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.405 HD23 HD21 ' A' ' 56' ' ' ASN . 77.9 mt -127.56 140.13 52.31 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.797 -1.557 . . . . 62.340000000000003 106.797 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -87.07 116.31 25.04 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.746 -0.835 . . . . 74.140000000000001 108.746 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 84' ' ' THR . 11.0 t70 -87.01 178.66 6.87 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.099 -1.074 . . . . 73.230000000000004 108.099 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.92 -34.18 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 106.873 -1.528 . . . . 72.239999999999995 106.873 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 7.0 t -114.37 -167.42 1.22 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 104.651 -2.351 . . . . 75.349999999999994 104.651 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG11 ' HE ' ' A' ' 72' ' ' ARG . 61.2 t -104.17 101.9 12.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.617 -1.233 . . . . 61.149999999999999 109.926 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.8 p -87.98 101.41 13.73 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.987 -0.551 . . . . 70.319999999999993 110.824 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 15.9 ptt180 -64.32 -34.7 78.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.751 0.786 . . . . 73.319999999999993 109.656 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -147.2 95.88 2.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.957 -1.019 . . . . 71.239999999999995 108.638 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -99.98 -52.54 3.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.769 -1.172 . . . . 73.200000000000003 109.323 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.59 156.2 34.67 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 119.925 -0.71 . . . . 70.430000000000007 111.344 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 9.7 pt-20 -137.84 142.03 40.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.943 -0.571 . . . . 64.310000000000002 109.964 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -105.69 117.48 34.14 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.928 -1.508 . . . . 73.319999999999993 106.928 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 16.3 mtp180 -109.5 127.98 54.84 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.906 -0.776 . . . . 71.140000000000001 108.906 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 mp -105.86 113.59 43.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.794 -1.188 . . . . 43.229999999999997 107.794 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -126.59 117.45 22.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.648 -0.501 . . . . 71.230000000000004 109.648 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 53.49 37.7 26.32 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.513 1.525 . . . . 72.140000000000001 112.229 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.58 87.51 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-N 115.325 -0.852 . . . . 71.400000000000006 113.02 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.49 143.06 32.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.301 -0.629 . . . . 71.219999999999999 109.301 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' CD2' HG13 ' A' ' 94' ' ' ILE . 61.9 m-85 -110.45 124.12 51.18 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.891 -0.595 . . . . 72.329999999999998 110.277 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.92 141.07 49.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.327 -0.62 . . . . 75.230000000000004 109.327 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.45 HG23 ' HG2' ' A' ' 122' ' ' MET . 17.9 t -102.95 125.36 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 107.545 -1.28 . . . . 71.420000000000002 107.545 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.79 122.12 68.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 N-CA-C 107.375 -1.343 . . . . 75.239999999999995 107.375 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 2.2 t70 -87.63 122.02 30.8 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.978 -1.01 . . . . 75.310000000000002 108.448 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.4 m -116.46 13.7 7.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 115.447 -0.797 . . . . 74.209999999999994 109.73 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.5 -66.07 0.25 Allowed Glycine 0 N--CA 1.412 -2.948 0 CA-C-N 115.084 -0.962 . . . . 72.129999999999995 112.807 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.3 t 60.66 9.61 2.23 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.974 0.91 . . . . 55.229999999999997 111.051 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 108' ' ' ASN . 3.3 pp -65.38 -46.71 79.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.724 1.21 . . . . 63.299999999999997 112.83 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.446 ' N ' HD12 ' A' ' 107' ' ' LEU . 6.8 t30 -92.77 -18.06 23.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.285 -1.006 . . . . 70.040000000000006 108.285 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.39 93.87 1.22 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 106.486 -2.646 . . . . 70.299999999999997 106.486 -169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 5.1 m -76.4 128.7 35.33 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 108.705 -0.85 . . . . 72.299999999999997 108.705 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 50.0 m-85 -112.19 126.16 54.91 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 106.888 -1.523 . . . . 73.340000000000003 106.888 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 120' ' ' GLN . 3.1 t -123.22 134.76 65.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 N-CA-C 104.358 -2.46 . . . . 73.409999999999997 104.358 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.28 38.23 29.58 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.759 -1.2 . . . . 63.149999999999999 107.759 -169.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 64.36 9.18 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.852 1.427 . . . . 70.219999999999999 114.852 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.0 148.41 67.24 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 119.03 0.832 . . . . 61.450000000000003 110.14 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 110' ' ' THR . 18.1 Cg_endo -60.83 122.68 11.6 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.563 1.509 . . . . 73.230000000000004 110.213 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -146.47 133.13 19.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.019 -0.672 . . . . 74.120000000000005 109.215 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 16.8 m120 -92.84 -28.86 16.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.568 0.699 . . . . 72.120000000000005 111.28 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.44 135.37 26.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.45 -1.685 . . . . 71.319999999999993 106.45 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.487 ' HG2' ' CG1' ' A' ' 112' ' ' VAL . 7.5 tp60 -140.54 144.68 36.05 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 111.713 0.264 . . . . 75.230000000000004 111.713 -173.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.81 124.57 52.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 103.96 -2.607 . . . . 52.399999999999999 103.96 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.45 ' HG2' HG23 ' A' ' 101' ' ' VAL . 51.4 mtp -87.94 146.33 25.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.42 -0.912 . . . . 61.450000000000003 111.946 -171.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.15 156.87 41.09 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.849 -1.537 . . . . 71.340000000000003 106.849 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -71.08 133.69 46.47 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.229 -1.397 . . . . 65.099999999999994 107.229 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.55 57.45 Favored Glycine 0 C--N 1.312 -0.785 0 C-N-CA 120.67 -0.776 . . . . 51.299999999999997 111.778 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.47 139.34 45.7 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.654 -0.869 . . . . 71.209999999999994 108.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -112.08 126.2 54.92 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.749 -1.204 . . . . 70.510000000000005 107.749 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.06 126.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.866 -0.79 . . . . 73.209999999999994 108.866 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 55.4 tp60 -105.0 111.51 24.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.222 -1.029 . . . . 72.540000000000006 108.222 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.93 112.86 42.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.614 -1.624 . . . . 74.099999999999994 106.614 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.63 -126.97 25.31 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 108.906 -1.678 . . . . 62.109999999999999 108.906 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 17.57 20.47 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.431 0.634 . . . . 71.519999999999996 109.738 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.616 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -120.62 165.62 14.79 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.078 -0.51 . . . . 72.319999999999993 110.134 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 14.7 ptm180 -137.15 146.62 45.2 Favored 'General case' 0 C--O 1.256 1.431 0 CA-C-O 121.544 0.687 . . . . 65.239999999999995 112.72 -168.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -120.48 139.88 52.23 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.548 -1.278 . . . . 53.420000000000002 107.548 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.74 120.43 62.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 107.919 -1.141 . . . . 73.109999999999999 107.919 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.03 126.61 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.261 -0.644 . . . . 61.32 109.261 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.03 162.13 30.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 123.779 0.832 . . . . 72.019999999999996 109.201 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.53 148.03 45.39 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.103 -1.443 . . . . 72.129999999999995 107.103 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.617 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -77.9 -161.43 16.48 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 121.074 -0.584 . . . . 64.200000000000003 114.356 -171.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.63 143.91 93.33 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.583 2.189 . . . . 74.430000000000007 111.897 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.48 31.93 6.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.091 -1.078 . . . . 72.310000000000002 108.091 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.524 -1.216 . . . . 63.229999999999997 109.689 -177.342 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 105.394 -2.076 . . . . 74.010000000000005 105.394 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.46 115.87 24.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.533 0.683 . . . . 73.019999999999996 109.337 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -119.94 139.86 51.79 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.287 -0.87 . . . . 75.340000000000003 110.432 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -113.22 92.18 3.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.732 -1.581 . . . . 72.319999999999993 106.732 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.21 -173.86 3.42 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.059 -0.973 . . . . 72.019999999999996 112.024 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.58 -0.55 1.42 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.117 1.767 . . . . 71.299999999999997 111.683 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.98 -17.54 63.39 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.735 1.214 . . . . 64.209999999999994 111.174 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.19 -8.95 35.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.685 0.794 . . . . 72.340000000000003 111.677 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 63.5 tttp -88.93 -23.08 22.78 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.05 -0.407 . . . . 63.229999999999997 111.246 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -59.76 -23.47 63.27 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.419 0.526 . . . . 74.019999999999996 112.419 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.57 -30.63 71.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.85 0.685 . . . . 54.450000000000003 112.85 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 13.8 pt-20 -76.56 -26.05 54.7 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.601 -0.839 . . . . 72.120000000000005 110.796 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -80.16 -26.18 39.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.029 -0.73 . . . . 74.409999999999997 109.029 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 m -77.58 -25.74 50.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.125 -0.943 . . . . 63.030000000000001 110.448 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.5 m -74.74 108.77 7.7 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.369 -0.974 . . . . 71.420000000000002 108.369 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.75 -5.23 12.82 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 109.281 -1.528 . . . . 61.0 109.281 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -113.8 121.72 44.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.012 -0.736 . . . . 73.150000000000006 109.012 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.59 45.0 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.279 -1.008 . . . . 73.310000000000002 108.279 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.15 142.08 96.89 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.162 1.908 . . . . 73.209999999999994 111.079 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.56 126.01 42.61 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.205 -0.294 . . . . 71.120000000000005 110.205 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 84.96 2.08 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.036 -1.098 . . . . 62.409999999999997 108.036 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -101.6 -36.33 8.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.251 0.548 . . . . 72.200000000000003 111.02 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.73 62.19 0.37 Allowed Glycine 0 C--N 1.305 -1.159 0 C-N-CA 121.013 -0.613 . . . . 61.340000000000003 111.991 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 123' ' ' GLN . . . -90.65 -28.52 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.591 -0.358 . . . . 61.420000000000002 111.257 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -92.75 -5.25 51.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.333 0.494 . . . . 72.420000000000002 112.333 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -80.22 -43.84 20.78 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.118 0.784 . . . . 73.030000000000001 113.118 -168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.0 mt 42.76 65.66 5.05 Favored Pre-proline 0 CA--C 1.557 1.248 0 O-C-N 124.181 0.926 . . . . 63.530000000000001 111.959 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.27 -70.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.461 2.774 . . . . 63.520000000000003 113.979 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.19 7.89 45.65 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.509 -0.476 . . . . 61.149999999999999 110.661 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.54 75.16 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.987 -0.551 . . . . 54.509999999999998 111.769 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -115.18 153.97 29.85 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 123.954 0.902 . . . . 71.239999999999995 111.012 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.34 44.3 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.459 -0.791 . . . . 74.239999999999995 109.974 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.85 160.7 38.08 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.542 -0.754 . . . . 72.430000000000007 109.196 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 pt? -121.28 131.88 54.47 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.34 -0.985 . . . . 75.0 108.34 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.57 129.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.32 -0.622 . . . . 74.310000000000002 109.32 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG21 ' ND2' ' A' ' 56' ' ' ASN . 22.4 t -80.19 118.06 27.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.529 -1.656 . . . . 70.420000000000002 106.529 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.985 0.898 . . . . 64.230000000000004 109.667 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -141.47 148.05 38.85 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.641 -1.244 . . . . 75.420000000000002 107.641 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.43 -179.7 16.85 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 111.093 -0.803 . . . . 73.239999999999995 111.093 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -67.67 -38.11 14.83 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.097 1.865 . . . . 74.430000000000007 110.943 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.452 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.7 p-10 -96.14 22.63 7.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.392 -0.822 . . . . 71.310000000000002 111.261 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.22 144.02 55.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.326 0.651 . . . . 74.030000000000001 111.342 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.46 33.23 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 111.139 -0.785 . . . . 63.149999999999999 111.139 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 141.93 29.14 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 120.765 0.317 . . . . 70.239999999999995 110.731 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -119.82 138.7 53.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.069 -0.514 . . . . 72.120000000000005 110.276 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.98 133.98 54.82 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.533 -0.543 . . . . 64.239999999999995 109.533 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.5 pt? -96.86 144.53 26.72 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.049 0.218 . . . . 60.399999999999999 110.502 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB3' HD11 ' A' ' 94' ' ' ILE . 69.3 mt -104.5 113.39 26.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -128.52 -3.1 5.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.973 0.416 . . . . 75.549999999999997 111.509 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -107.87 143.14 26.73 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 109.383 -0.599 . . . . 63.229999999999997 109.383 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.94 -25.2 27.01 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.455 2.77 . . . . 73.519999999999996 114.369 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.7 m -143.23 121.96 12.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 110.258 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 24.9 m -117.96 129.26 55.5 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.446 -0.797 . . . . 43.25 109.768 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 m -100.89 135.67 41.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.459 -0.571 . . . . 65.25 109.459 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.07 135.43 54.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.054 -0.721 . . . . 65.019999999999996 109.054 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -165.41 34.49 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.974 -1.25 . . . . 75.140000000000001 109.974 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 79.2 ttt180 -91.6 149.16 21.79 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.465 -0.568 . . . . 74.349999999999994 109.465 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 79.03 161.26 0.14 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.552 1.141 . . . . 63.350000000000001 110.519 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -72.28 13.1 0.56 Allowed 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.834 2.356 . . . . 74.310000000000002 113.156 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.62 -5.54 59.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.767 0.794 . . . . 75.540000000000006 109.6 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 m -117.57 148.74 41.62 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.75 -1.204 . . . . 70.25 107.75 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.16 -44.86 83.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.915 0.886 . . . . 40.340000000000003 109.361 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.9 mm -100.17 124.5 53.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.004 -1.11 . . . . 71.420000000000002 108.004 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -88.84 124.35 34.09 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.519 0.512 . . . . 75.420000000000002 111.229 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 6.2 mp -126.3 141.3 51.96 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.751 -1.203 . . . . 74.049999999999997 107.751 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.27 117.43 34.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.34 -1.726 . . . . 64.450000000000003 106.34 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 84' ' ' THR . 9.4 t70 -105.46 173.25 6.39 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.69 -0.687 . . . . 73.549999999999997 109.538 -168.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -82.95 -24.86 8.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.449 -1.315 . . . . 52.439999999999998 107.449 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.2 m -124.56 -173.66 2.84 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.0 -1.852 . . . . 74.209999999999994 106.0 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 84' ' ' THR . 89.3 t -102.67 99.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 120.667 -1.271 . . . . 72.129999999999995 110.157 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 p -83.87 107.47 16.28 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.434 -0.803 . . . . 73.349999999999994 109.837 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -32.36 73.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.643 0.735 . . . . 74.510000000000005 111.006 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -168.9 119.93 0.74 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.668 -2.345 . . . . 74.549999999999997 104.668 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -99.58 -52.04 3.59 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 123.375 0.422 . . . . 74.230000000000004 109.893 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.73 157.81 44.13 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.326 -0.549 . . . . 72.519999999999996 110.155 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.19 132.03 51.86 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.882 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 4.2 m-85 -105.62 113.75 27.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.72 -1.585 . . . . 73.25 106.72 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.404 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 84.8 mtt180 -104.15 133.48 49.0 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 63' ' ' LEU . 50.4 mt -104.29 113.53 41.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.063 -1.828 . . . . 62.130000000000003 106.063 176.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -134.47 118.58 17.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.447 -0.575 . . . . 70.310000000000002 109.447 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 54.22 38.04 28.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.161 0.985 . . . . 70.299999999999997 112.039 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.0 -6.92 79.84 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.092 -0.504 . . . . 61.530000000000001 113.702 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.74 149.91 23.99 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.359 -0.608 . . . . 52.240000000000002 109.359 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.97 116.9 28.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 72.129999999999995 108.794 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 93' ' ' ARG . 10.4 pt-20 -112.04 127.28 55.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.202 -0.666 . . . . 61.399999999999999 109.202 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.458 HG21 ' SD ' ' A' ' 122' ' ' MET . 43.6 t -105.5 124.32 60.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.235 -0.654 . . . . 74.219999999999999 109.235 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.4 t -115.01 122.97 70.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 115.779 -0.646 . . . . 73.310000000000002 109.639 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.05 131.4 34.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.216 -0.902 . . . . 72.030000000000001 111.351 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.37 12.74 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.905 -1.043 . . . . 53.240000000000002 108.377 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.14 34.51 5.03 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.994 -1.242 . . . . 74.510000000000005 109.994 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 m -61.9 -11.7 14.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.618 1.167 . . . . 75.219999999999999 111.315 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 107' ' ' LEU . 1.7 mm? -71.15 -26.16 62.87 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.055 0.942 . . . . 61.420000000000002 108.94 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.61 -18.68 24.74 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.106 -0.952 . . . . 75.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.94 62.71 1.65 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.702 -0.681 . . . . 72.25 112.644 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -64.5 135.5 56.11 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 124.081 0.952 . . . . 55.5 112.444 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.14 126.77 44.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.966 -1.124 . . . . 72.420000000000002 107.966 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -107.85 117.32 53.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.764 -1.569 . . . . 72.120000000000005 106.764 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 51.32 49.96 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.128 0.971 . . . . 74.340000000000003 110.276 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 70.68 7.81 6.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.273 1.429 . . . . 72.030000000000001 113.709 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.54 137.82 31.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.451 -0.9 . . . . 50.329999999999998 111.228 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.13 123.92 14.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.103 1.869 . . . . 63.140000000000001 108.793 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -151.44 138.49 19.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.124 -1.065 . . . . 64.540000000000006 108.124 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.1 -53.24 3.88 Favored 'General case' 0 C--O 1.199 -1.582 0 C-N-CA 120.73 -0.388 . . . . 64.109999999999999 110.637 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.93 136.53 54.93 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.13 -0.693 . . . . 64.299999999999997 109.13 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 140.43 20.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.383 -0.969 . . . . 75.239999999999995 108.383 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -96.42 114.57 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 105.101 -2.185 . . . . 42.140000000000001 105.101 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.458 ' SD ' HG21 ' A' ' 101' ' ' VAL . 79.1 mtp -90.22 145.32 25.1 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 114.414 1.264 . . . . 74.329999999999998 114.414 -166.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.446 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 76.1 mt-30 -111.59 158.15 19.56 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 63.43 108.677 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 138' ' ' LEU . 24.4 m -58.14 120.9 9.45 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.819 -0.437 . . . . 74.400000000000006 109.819 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.73 1.54 56.34 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.217 -0.992 . . . . 62.119999999999997 112.718 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.98 141.56 28.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.23 -1.026 . . . . 74.129999999999995 108.23 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.24 145.67 49.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.918 0.711 . . . . 74.239999999999995 112.918 -169.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.442 HD11 ' SD ' ' A' ' 122' ' ' MET . 34.5 mt -116.08 132.87 64.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.002 -0.74 . . . . 74.340000000000003 109.002 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -103.63 110.5 22.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.789 -1.93 . . . . 73.010000000000005 105.789 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.0 mt -109.67 105.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.475 -0.935 . . . . 74.040000000000006 108.475 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.51 -107.94 2.3 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.016 -1.634 . . . . 73.319999999999993 109.016 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -119.93 9.04 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 120.808 0.337 . . . . 63.310000000000002 110.12 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.4 p90 -120.28 146.26 46.26 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.802 0.668 . . . . 64.340000000000003 112.802 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 53' ' ' ARG . 47.9 ttt180 -112.58 132.28 55.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.427 -0.806 . . . . 74.140000000000001 111.467 -167.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.4 139.97 52.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.258 -0.645 . . . . 63.340000000000003 109.258 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.0 130.23 66.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.673 -0.862 . . . . 72.140000000000001 108.673 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -104.27 128.48 52.04 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.124 -0.695 . . . . 75.510000000000005 109.124 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB2' HG23 ' A' ' 124' ' ' THR 0.278 0.0 OUTLIER -140.09 135.63 32.76 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 113.109 0.781 . . . . 75.430000000000007 113.109 177.728 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.2 124.97 44.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.281 -1.748 . . . . 63.100000000000001 106.281 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 165.43 -33.7 0.24 Allowed Glycine 0 C--N 1.29 -1.976 0 C-N-CA 118.723 -1.703 . . . . 13.51 116.468 -171.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 10.2 Cg_endo -53.87 142.16 64.38 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.896 2.848 . . . . 62.32 114.653 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.49 88.92 1.23 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.831 -2.285 . . . . 73.430000000000007 104.831 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 114.803 -1.089 . . . . 73.030000000000001 108.282 -172.657 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.888 -0.412 . . . . 61.119999999999997 109.888 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.9 115.79 27.85 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 CA-C-O 120.822 0.344 . . . . 73.310000000000002 110.36 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -107.69 120.16 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.729 -0.841 . . . . 75.109999999999999 108.729 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.57 141.26 46.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.688 -0.687 . . . . 64.430000000000007 112.624 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 82.84 -20.93 0.31 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.32 1.848 . . . . 72.530000000000001 113.505 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -80.1 -38.44 31.63 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.422 -0.955 . . . . 52.009999999999998 108.422 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 23' ' ' LEU . 2.2 pp -64.73 -26.62 68.45 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.014 -0.993 . . . . 75.310000000000002 110.792 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 22' ' ' LEU . 50.9 tp -74.85 -39.96 61.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.4 -0.818 . . . . 63.240000000000002 109.232 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.8 -41.41 78.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 73.140000000000001 110.448 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.78 -39.55 80.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.706 -0.679 . . . . 62.020000000000003 110.409 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -59.43 -39.23 82.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 73.129999999999995 110.796 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -63.51 -38.51 91.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.73 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -72.06 -38.77 69.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.961 -0.563 . . . . 61.049999999999997 110.302 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -66.46 -47.01 74.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.956 -0.565 . . . . 64.340000000000003 110.242 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -83.08 98.11 9.14 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.874 0.369 . . . . 52.130000000000003 111.288 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.54 -60.51 0.74 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 108.38 -1.888 . . . . 75.540000000000006 108.38 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.514 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 38.2 m -114.37 124.77 52.78 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.866 -1.161 . . . . 73.439999999999998 107.866 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.82 94.52 6.44 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.619 -0.512 . . . . 51.420000000000002 109.619 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 32' ' ' THR . 2.7 Cg_exo -76.25 142.91 24.71 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.575 2.183 . . . . 63.399999999999999 111.962 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.1 154.74 19.93 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.156 -1.053 . . . . 54.399999999999999 108.156 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 m -114.43 144.85 42.65 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.144 0.497 . . . . 74.400000000000006 112.075 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -132.58 144.39 50.36 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.743 -1.576 . . . . 72.310000000000002 106.743 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.13 11.91 32.9 Favored Glycine 0 CA--C 1.49 -1.515 0 N-CA-C 109.891 -1.283 . . . . 73.319999999999993 109.891 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.04 -32.0 16.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.882 -0.785 . . . . 73.530000000000001 108.882 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -85.09 3.6 38.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.52 -1.218 . . . . 73.219999999999999 110.95 -177.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -80.12 -36.34 35.42 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.398 -0.819 . . . . 71.010000000000005 110.566 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 51.15 45.85 3.17 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 123.725 0.641 . . . . 71.109999999999999 112.492 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.99 -52.85 1.04 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.9 1.733 . . . . 65.209999999999994 113.929 -170.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -18.34 40.27 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.946 -0.57 . . . . 54.329999999999998 112.53 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.94 -0.49 82.7 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 120.422 -0.894 . . . . 73.319999999999993 111.814 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 t -118.62 170.02 9.32 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.347 -1.353 . . . . 63.020000000000003 107.347 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . . . -139.65 152.92 47.14 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.598 0.237 . . . . 72.239999999999995 110.463 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -130.05 155.58 45.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.925 -0.58 . . . . 75.299999999999997 109.959 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.5 pt? -119.39 125.15 48.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.911 -1.144 . . . . 65.340000000000003 107.911 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.2 135.18 53.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 115.433 -0.803 . . . . 75.200000000000003 109.791 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.11 117.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 105.171 -2.159 . . . . 50.229999999999997 105.171 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.63 -39.43 22.15 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.323 -1.362 . . . . 73.420000000000002 107.323 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 47.7 ttt180 -160.95 144.21 13.05 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.317 -1.364 . . . . 73.150000000000006 107.317 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.61 -167.69 26.54 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 108.355 -1.898 . . . . 31.140000000000001 108.355 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.1 -47.57 12.16 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.378 2.052 . . . . 73.5 112.184 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.11 22.05 3.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.662 -0.244 . . . . 72.549999999999997 111.198 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.6 134.09 46.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.723 0.638 . . . . 72.409999999999997 112.723 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.18 21.72 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.217 -0.901 . . . . 73.340000000000003 111.829 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 145.76 33.35 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.843 0.354 . . . . 73.230000000000004 110.126 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.85 136.3 22.85 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 110.991 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -121.59 145.24 48.18 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.347 -1.353 . . . . 73.409999999999997 107.347 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 1.4 pt? -110.38 145.53 37.4 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.575 0.226 . . . . 74.040000000000006 110.63 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.75 103.41 5.01 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.101 -1.444 . . . . 71.25 107.101 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -123.2 7.55 9.14 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.952 -1.499 . . . . 60.240000000000002 106.952 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -137.03 146.1 53.3 Favored Pre-proline 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 74.439999999999998 107.669 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 14.0 Cg_exo -72.06 -14.36 29.01 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.832 2.355 . . . . 74.319999999999993 114.496 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -140.14 122.37 15.88 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.293 -0.88 . . . . 73.120000000000005 109.479 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.2 m -131.02 139.08 49.91 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.523 0.729 . . . . 55.240000000000002 111.224 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.15 52.64 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.128 -1.064 . . . . 73.319999999999993 108.128 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.75 135.1 54.69 Favored 'General case' 0 C--O 1.264 1.823 0 CA-C-O 120.996 0.427 . . . . 71.239999999999995 109.94 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.74 -156.17 22.33 Favored Glycine 0 N--CA 1.417 -2.617 0 CA-C-N 115.316 -0.856 . . . . 62.130000000000003 111.119 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.505 ' NH1' ' HA ' ' A' ' 86' ' ' SER . 40.8 ttp180 -88.86 150.61 22.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.308 -0.627 . . . . 75.209999999999994 109.308 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.9 m170 81.53 150.07 0.11 Allowed Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 125.435 1.494 . . . . 64.120000000000005 111.093 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.29 0.86 6.11 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.051 2.501 . . . . 70.219999999999999 111.225 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.63 -26.53 60.82 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 124.722 1.209 . . . . 74.530000000000001 107.754 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -85.84 136.43 33.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.604 -1.258 . . . . 73.439999999999998 107.604 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.64 -46.49 73.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.369 1.068 . . . . 74.150000000000006 109.765 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 mm -102.73 109.4 26.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.588 -1.264 . . . . 72.019999999999996 107.588 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -87.61 115.77 25.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.763 -0.653 . . . . 64.219999999999999 111.196 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.23 127.83 45.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.037 -1.468 . . . . 65.319999999999993 107.037 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.07 117.9 34.98 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.113 -0.635 . . . . 71.019999999999996 110.216 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 85' ' ' VAL . 12.2 t70 -150.34 161.52 42.32 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 104.546 -2.39 . . . . 74.219999999999999 104.546 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.3 -39.3 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 118.168 0.44 . . . . 52.530000000000001 111.371 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -101.32 7.35 42.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.72 0.771 . . . . 75.109999999999999 112.308 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 82' ' ' ASP . 69.2 t -85.93 121.15 36.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.279 -1.008 . . . . 72.329999999999998 108.279 173.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.505 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 35.0 m -93.11 -164.54 1.19 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.307 0.855 . . . . 63.039999999999999 113.307 -173.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -55.07 -21.37 12.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.57 2.348 . . . . 71.439999999999998 113.499 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -170.24 116.44 0.52 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.73 -0.841 . . . . 70.530000000000001 108.73 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.491 ' ND1' HG23 ' A' ' 130' ' ' ILE . 9.4 t-160 -100.39 -51.96 3.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.984 -0.747 . . . . 74.150000000000006 108.984 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.14 43.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.454 -0.943 . . . . 44.119999999999997 108.454 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.33 149.64 50.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.536 -0.466 . . . . 72.209999999999994 110.787 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.471 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 21.9 m-85 -112.65 113.77 26.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.97 -1.122 . . . . 70.430000000000007 107.97 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -108.78 131.89 54.51 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.264 -1.013 . . . . 75.230000000000004 108.264 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -106.4 120.05 56.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.685 -1.228 . . . . 73.409999999999997 107.685 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.1 129.95 28.36 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.333 -0.617 . . . . 71.0 109.333 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.26 35.75 25.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.728 1.211 . . . . 65.200000000000003 110.71 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.17 82.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.473 -0.785 . . . . 71.209999999999994 113.839 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -100.61 141.56 33.3 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.945 -0.761 . . . . 75.239999999999995 108.945 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -106.82 117.86 35.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.091 -1.078 . . . . 72.099999999999994 108.091 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.02 141.87 51.49 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.065 -0.654 . . . . 72.549999999999997 111.674 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.05 124.82 58.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.443 -0.947 . . . . 73.019999999999996 108.443 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.84 123.38 71.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.382 -0.97 . . . . 74.230000000000004 108.382 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.98 127.64 32.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 71.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.69 -15.96 9.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.613 0.721 . . . . 75.340000000000003 109.77 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.73 57.79 0.63 Allowed Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.479 -1.448 . . . . 64.140000000000001 109.479 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -69.33 5.14 1.39 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.528 0.68 . . . . 54.240000000000002 111.56 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.89 -20.9 52.13 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.317 0.647 . . . . 70.219999999999999 109.355 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -87.83 -19.79 26.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 62.100000000000001 110.35 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.04 71.72 0.99 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 112.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 10.0 m -69.67 130.32 42.05 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.159 -1.052 . . . . 51.119999999999997 108.159 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -108.83 125.9 52.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.429 -0.908 . . . . 62.229999999999997 110.613 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.03 117.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 105.792 -1.929 . . . . 72.219999999999999 105.792 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.88 40.63 30.54 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.042 0.925 . . . . 74.099999999999994 108.849 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 71.86 7.36 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.215 1.932 . . . . 74.099999999999994 116.215 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -115.85 135.96 22.81 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 118.72 0.691 . . . . 74.230000000000004 110.519 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 110' ' ' THR . 32.1 Cg_endo -63.48 148.05 92.81 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.86 2.374 . . . . 75.540000000000006 112.62 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 51.6 mmt-85 -121.55 160.99 23.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 114.335 1.235 . . . . 75.540000000000006 114.335 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -115.8 -51.76 2.65 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 112.943 -1.935 . . . . 60.240000000000002 106.125 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.19 135.66 5.35 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.338 -1.727 . . . . 65.400000000000006 106.338 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.65 145.46 23.47 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.44 -0.504 . . . . 74.319999999999993 110.998 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.37 124.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.309 -2.108 . . . . 72.109999999999999 105.309 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 tpp -89.5 134.48 34.09 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.311 -0.955 . . . . 75.420000000000002 113.481 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -103.69 141.67 35.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.485 -1.234 . . . . 44.009999999999998 110.645 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -61.37 130.22 45.02 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.874 -1.057 . . . . 70.530000000000001 111.451 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.43 58.23 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.911 -0.586 . . . . 73.340000000000003 113.182 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -88.98 154.73 19.99 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 116.866 0.333 . . . . 62.229999999999997 110.864 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.81 133.82 53.03 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.942 0.877 . . . . 54.240000000000002 110.801 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.1 mm -113.68 123.65 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.763 -1.199 . . . . 71.099999999999994 107.763 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -104.71 113.37 26.92 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.189 -0.604 . . . . 74.519999999999996 109.562 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.491 HG23 ' ND1' ' A' ' 89' ' ' HIS . 36.9 mt -109.66 124.39 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 114.806 -1.088 . . . . 74.430000000000007 108.128 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.82 -86.36 1.35 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.866 -1.294 . . . . 62.219999999999999 109.866 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.93 25.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.364 0.602 . . . . 73.340000000000003 110.215 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.4 p90 -141.04 164.08 31.24 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.384 -0.825 . . . . 74.420000000000002 108.897 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -112.55 144.82 41.38 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 114.598 1.333 . . . . 74.129999999999995 114.598 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.06 140.64 49.72 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.22 -1.809 . . . . 72.349999999999994 106.137 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.2 t -111.3 124.76 68.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 109.067 -0.716 . . . . 72.209999999999994 109.067 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -91.46 116.03 28.52 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.614 -1.254 . . . . 70.099999999999994 107.614 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.8 tm? -128.61 132.46 48.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.931 -1.137 . . . . 63.310000000000002 107.931 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . . . -90.16 118.75 29.93 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.668 -0.813 . . . . 54.32 110.394 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 125.67 73.35 0.21 Allowed Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.763 -0.653 . . . . 34.219999999999999 112.328 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.61 162.85 40.89 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.979 2.453 . . . . 71.0 111.343 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.05 48.31 1.23 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.712 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.414 -2.239 0 CA-C-N 115.659 -0.701 . . . . 61.140000000000001 110.517 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 108.871 -0.789 . . . . 52.210000000000001 108.871 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.53 115.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 108.193 -1.04 . . . . 72.140000000000001 108.193 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -115.45 133.32 56.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.669 . . . . 74.420000000000002 109.192 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -86.78 94.41 9.53 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.02 -1.072 . . . . 62.409999999999997 110.392 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.28 -152.07 0.05 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.441 -1.254 . . . . 43.219999999999999 108.934 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.4 7.11 47.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.938 -0.476 . . . . 71.450000000000003 111.191 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.77 -50.46 72.23 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.095 1.517 . . . . 62.229999999999997 115.095 -171.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 26' ' ' MET . 7.3 tt -72.63 -39.15 67.44 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.473 0.654 . . . . 75.519999999999996 109.365 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -69.72 -32.77 71.51 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.717 -0.674 . . . . 53.329999999999998 110.314 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.51 -42.18 95.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.14 0.576 . . . . 62.329999999999998 110.151 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.01 -30.72 71.32 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 120.083 -0.647 . . . . 74.450000000000003 111.163 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.0 -49.4 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 74.120000000000005 109.785 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -69.84 -27.03 64.51 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.315 -0.857 . . . . 53.130000000000003 112.608 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.442 ' OG ' ' HD2' ' A' ' 114' ' ' ARG . 31.7 p -79.96 -16.75 54.59 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.145 0.497 . . . . 65.140000000000001 111.053 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -74.19 106.14 5.71 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 122.151 0.977 . . . . 74.540000000000006 111.095 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.78 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 104.927 -3.269 . . . . 72.439999999999998 104.927 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 m -115.5 121.39 42.55 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.729 -1.952 . . . . 64.219999999999999 105.729 168.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.37 115.46 65.47 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 106.588 -1.634 . . . . 63.310000000000002 106.588 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.84 140.03 93.4 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 121.982 1.788 . . . . 71.209999999999994 112.313 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.85 126.54 29.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.395 -0.82 . . . . 45.240000000000002 110.805 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 124' ' ' THR . 67.9 m -147.44 109.47 4.48 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.836 -1.172 . . . . 51.340000000000003 107.836 172.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -86.82 96.59 10.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 62.119999999999997 112.217 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.11 7.33 0.25 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.783 -0.644 . . . . 63.210000000000001 112.409 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.417 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -88.31 -21.17 24.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.754 0.787 . . . . 55.210000000000001 110.375 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -92.15 -6.73 50.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.711 -1.131 . . . . 71.230000000000004 109.122 178.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -100.04 -42.29 6.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.39 -1.277 . . . . 73.219999999999999 109.624 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 56.12 78.71 0.37 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.602 -0.726 . . . . 63.100000000000001 110.128 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.47 -55.5 0.91 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.131 1.888 . . . . 74.319999999999993 113.153 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.47 -7.38 26.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.932 -0.576 . . . . 73.239999999999995 111.854 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.06 -12.62 11.36 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.213 -0.449 . . . . 50.329999999999998 112.866 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m -124.68 153.42 42.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.762 -1.569 . . . . 54.43 106.762 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.28 41.13 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.905 0.128 . . . . 43.219999999999999 110.782 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.1 pp -127.6 157.01 41.36 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.803 0.668 . . . . 71.219999999999999 112.803 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 49' ' ' LEU . 3.4 pp -121.35 138.25 54.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.923 -1.14 . . . . 54.149999999999999 107.923 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.79 135.72 62.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 C-N-CA 120.534 -0.466 . . . . 71.030000000000001 109.906 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -80.81 117.09 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.774 -1.936 . . . . 63.039999999999999 105.774 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -90.21 -34.67 15.72 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.779 -0.646 . . . . 70.120000000000005 109.551 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -148.61 137.56 21.6 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.179 -0.674 . . . . 74.329999999999998 109.179 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.68 -177.86 23.8 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 108.907 -1.677 . . . . 44.310000000000002 108.907 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 72.1 Cg_exo -55.65 -51.18 10.41 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.935 2.423 . . . . 14.35 112.823 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -91.48 22.75 3.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.302 0.482 . . . . 55.509999999999998 112.302 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.85 143.07 48.71 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.087 0.47 . . . . 62.310000000000002 111.799 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.27 -23.27 32.33 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.301 -0.72 . . . . 55.329999999999998 111.301 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 134.19 34.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 120.93 0.395 . . . . 54.009999999999998 110.459 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -107.38 138.68 43.14 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.919 -1.141 . . . . 75.319999999999993 107.919 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.5 127.52 44.14 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.422 -0.584 . . . . 75.530000000000001 109.422 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 9.2 mp -93.62 137.78 32.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.39 -0.596 . . . . 74.420000000000002 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.95 103.34 13.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.013 -1.477 . . . . 62.310000000000002 107.013 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.99 -15.22 6.92 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.498 -0.774 . . . . 72.129999999999995 111.236 -175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.2 pt20 -107.32 142.47 25.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 109.648 -0.501 . . . . 74.450000000000003 109.648 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.6 -19.9 19.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.965 3.11 . . . . 72.530000000000001 113.865 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.3 m -147.18 121.66 9.72 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.814 -1.18 . . . . 71.219999999999999 107.814 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 77' ' ' ASP . 9.3 m -120.81 113.83 20.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.378 -1.341 . . . . 70.120000000000005 107.378 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.0 m -92.36 144.04 25.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.822 -0.549 . . . . 65.530000000000001 110.704 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.29 139.02 52.6 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 123.166 0.586 . . . . 62.530000000000001 109.497 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.63 -135.84 5.63 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.893 -1.283 . . . . 74.299999999999997 109.893 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 22.9 ptt85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.077 -1.083 . . . . 75.310000000000002 108.077 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER 144.77 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 127.635 2.374 . . . . 75.239999999999995 108.81 174.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.69 -15.25 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.763 1.642 . . . . 64.430000000000007 110.416 174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -78.81 -24.07 44.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.143 -0.935 . . . . 73.150000000000006 110.444 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 p -84.71 121.32 27.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.615 -0.883 . . . . 63.509999999999998 108.615 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 68' ' ' THR . 36.3 t70 -69.88 -35.8 74.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 110.677 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.4 98.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.25 -1.389 . . . . 71.120000000000005 107.25 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -92.93 115.11 27.82 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.904 -0.589 . . . . 74.109999999999999 109.632 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.6 mt -111.62 134.38 53.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.519 -1.289 . . . . 52.020000000000003 107.519 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.92 128.35 54.73 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.535 0.683 . . . . 73.200000000000003 110.413 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -148.43 -178.8 6.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.447 -2.057 . . . . 65.129999999999995 105.447 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.53 -24.84 8.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.982 -1.118 . . . . 55.149999999999999 107.982 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.2 m -137.36 90.3 2.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.968 0.89 . . . . 74.019999999999996 110.236 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -101.85 150.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.143 -1.058 . . . . 64.129999999999995 108.143 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 89' ' ' HIS . 54.2 m -92.45 146.45 23.67 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.419 -0.956 . . . . 75.150000000000006 108.419 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -17.56 53.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.725 0.774 . . . . 71.120000000000005 111.829 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -140.8 93.87 2.65 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.578 -2.379 . . . . 72.319999999999993 104.578 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 26.3 t-80 -91.96 -53.32 4.32 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.229 0.538 . . . . 71.340000000000003 111.269 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.16 155.92 37.62 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.797 -0.816 . . . . 74.430000000000007 108.797 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.24 135.1 44.76 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.894 -0.594 . . . . 70.010000000000005 109.56 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -104.92 117.22 33.47 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.534 -1.654 . . . . 74.019999999999996 106.534 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -103.67 130.78 51.2 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.588 -0.523 . . . . 64.140000000000001 109.588 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.9 mp -114.31 113.09 42.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.628 -1.619 . . . . 70.540000000000006 106.628 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -138.38 122.78 18.33 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.79 -0.448 . . . . 74.340000000000003 109.79 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 56.3 37.86 29.23 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.796 1.238 . . . . 64.329999999999998 112.891 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.45 13.68 82.34 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.223 -0.899 . . . . 45.229999999999997 113.32 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -116.04 142.38 46.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.579 -0.897 . . . . 64.120000000000005 108.579 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -115.51 117.97 31.85 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.078 -0.712 . . . . 70.400000000000006 109.078 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.03 145.22 48.35 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 111.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 37.0 t -103.51 124.71 57.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.06 -1.459 . . . . 73.329999999999998 107.06 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.95 122.86 70.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.157 -1.423 . . . . 60.310000000000002 107.157 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -104.51 134.54 47.52 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 111.787 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.8 0.5 3.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.6 -0.727 . . . . 62.229999999999997 110.297 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.32 58.9 0.4 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.124 -1.19 . . . . 44.420000000000002 110.124 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -70.33 -8.48 50.83 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.581 0.752 . . . . 72.319999999999993 112.017 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -24.05 58.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.969 0.414 . . . . 71.140000000000001 109.958 174.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -87.34 -17.93 31.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.771 -1.196 . . . . 75.549999999999997 107.771 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.62 56.06 6.27 Favored Glycine 0 CA--C 1.496 -1.128 0 CA-C-N 114.718 -1.128 . . . . 45.450000000000003 113.329 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -63.41 128.71 37.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.853 -0.425 . . . . 74.319999999999993 109.853 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 20.5 m-30 -124.28 139.89 53.48 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 110.03 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.26 121.71 66.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.32 -1.733 . . . . 61.149999999999999 106.32 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.19 39.15 31.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.037 1.335 . . . . 41.210000000000001 108.24 -169.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.442 ' HD2' ' OG ' ' A' ' 29' ' ' SER . 19.0 mtm105 62.62 20.3 11.92 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.055 -1.429 . . . . 70.019999999999996 111.519 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -111.81 136.13 21.17 Favored Pre-proline 0 C--N 1.315 -0.931 0 C-N-CA 122.875 0.47 . . . . 73.230000000000004 110.043 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.17 123.72 13.74 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.663 2.242 . . . . 72.239999999999995 108.664 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.537 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 8.9 tpp180 -143.23 142.44 31.4 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 119.167 -1.013 . . . . 73.519999999999996 112.549 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -79.05 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.614 0.766 . . . . 75.25 109.916 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -151.39 136.48 17.45 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.624 -1.25 . . . . 71.230000000000004 107.624 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.537 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 52.4 tp60 -153.22 141.68 20.74 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.023 0.202 . . . . 61.340000000000003 111.208 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 58.4 t -66.23 133.03 31.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 106.522 -1.658 . . . . 64.239999999999995 106.522 170.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -87.42 144.65 26.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.205 -1.035 . . . . 71.219999999999999 108.205 -174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.456 ' HG2' ' HB3' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -126.77 152.47 46.85 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 113.212 0.819 . . . . 70.319999999999993 113.212 -170.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 36' ' ' SER . 0.7 OUTLIER -59.46 118.15 5.69 Favored 'General case' 0 N--CA 1.403 -2.815 0 C-N-CA 124.758 1.223 . . . . 51.310000000000002 112.563 -176.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.87 -7.03 64.8 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.802 -0.713 . . . . 73.120000000000005 112.62 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -83.09 153.09 25.04 Favored 'General case' 0 C--O 1.252 1.193 0 C-N-CA 120.132 -0.627 . . . . 63.310000000000002 110.678 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.51 131.48 55.2 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.073 -0.967 . . . . 61.409999999999997 110.285 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.2 mt -105.76 115.93 48.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 104.868 -2.271 . . . . 53.43 104.868 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -104.95 131.67 52.16 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.567 -1.272 . . . . 74.409999999999997 107.567 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.408 HD13 HD13 ' A' ' 135' ' ' LEU . 4.0 mp -129.61 103.61 9.15 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 107.858 -1.164 . . . . 74.140000000000001 107.858 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.57 -78.6 0.01 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.095 0.798 . . . . 41.420000000000002 115.095 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -134.05 8.96 3.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.788 1.235 . . . . 74.530000000000001 109.981 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.603 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 49.2 m-85 -102.1 143.19 32.25 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.463 -0.569 . . . . 75.420000000000002 109.463 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -119.55 118.65 31.6 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.158 -1.423 . . . . 65.340000000000003 107.158 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 130' ' ' ILE . 9.7 mp -119.16 135.31 54.73 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.992 -0.744 . . . . 63.32 108.992 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.15 130.85 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.01 -1.107 . . . . 70.340000000000003 108.01 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -95.68 124.87 39.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.828 0.347 . . . . 53.539999999999999 110.823 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -129.71 132.34 46.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.311 0.577 . . . . 73.510000000000005 110.531 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.66 118.24 33.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.063 -1.828 . . . . 31.41 106.063 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.7 0.03 OUTLIER Glycine 0 C--N 1.296 -1.664 0 C-N-CA 118.252 -1.927 . . . . 44.329999999999998 115.428 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.76 141.55 97.06 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 119.977 1.888 . . . . 75.150000000000006 111.179 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.27 79.18 1.68 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.321 -0.992 . . . . 72.409999999999997 108.321 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.389 -3.481 0 CA-C-N 114.627 -1.17 . . . . 72.0 108.862 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 108.581 -0.896 . . . . 64.049999999999997 108.581 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.83 115.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.592 -0.522 . . . . 70.140000000000001 109.592 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -122.33 137.95 54.68 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.343 -0.614 . . . . 73.140000000000001 109.343 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.09 97.37 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.368 -1.345 . . . . 75.040000000000006 107.368 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.57 -165.84 0.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.312 -0.858 . . . . 63.039999999999999 112.821 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.09 9.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.49 2.316 . . . . 73.329999999999998 114.3 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 2.9 pp -56.37 -20.45 19.37 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.06 1.133 . . . . 73.230000000000004 114.06 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.84 -43.87 82.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.722 -0.473 . . . . 71.329999999999998 109.722 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 27' ' ' GLU . 66.0 mttm -82.51 -21.16 35.58 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.4 -0.363 . . . . 64.219999999999999 111.621 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 5.6 tp10 -56.81 -48.73 77.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.377 -1.342 . . . . 74.420000000000002 107.377 170.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.4 ttp -68.76 -47.89 65.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.555 -1.202 . . . . 65.329999999999998 110.482 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 24' ' ' LYS . 31.2 tt0 -52.53 -49.79 64.14 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.455 1.102 . . . . 41.119999999999997 111.987 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 t -84.47 -27.82 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.719 0.637 . . . . 75.430000000000007 112.719 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -82.93 -22.29 33.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.434 -0.906 . . . . 54.43 110.949 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.5 m -72.03 111.46 7.28 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.093 -0.706 . . . . 61.020000000000003 109.093 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.1 -32.89 1.26 Allowed Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 109.56 -1.416 . . . . 73.230000000000004 109.56 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -94.51 120.52 34.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 73.329999999999998 108.705 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.9 111.94 20.34 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.828 -0.804 . . . . 64.530000000000001 108.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.66 141.48 66.58 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 121.949 1.766 . . . . 51.119999999999997 113.118 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.25 162.67 31.17 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.032 -0.985 . . . . 72.25 108.607 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.2 m 61.76 20.02 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.095 0.958 . . . . 43.009999999999998 112.141 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.8 m -90.85 109.94 21.15 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.657 -1.238 . . . . 61.32 107.657 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.19 53.99 0.6 Allowed Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.051 -1.071 . . . . 52.450000000000003 113.364 -172.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 -6.94 53.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.209 1.004 . . . . 64.450000000000003 109.419 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.45 14.11 0.83 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.583 -1.19 . . . . 70.329999999999998 113.261 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.71 -5.9 23.26 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.838 -0.43 . . . . 73.109999999999999 109.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 68.38 94.82 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.606 0 O-C-N 124.691 1.244 . . . . 71.129999999999995 111.245 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.21 -74.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.672 1.582 . . . . 64.329999999999998 112.519 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.71 6.69 46.8 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.844 -0.535 . . . . 53.240000000000002 111.593 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.01 17.76 75.83 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 116.048 -0.524 . . . . 62.210000000000001 113.293 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -131.99 169.74 15.89 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.753 -1.203 . . . . 61.43 107.753 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.49 154.45 48.81 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.16 -0.616 . . . . 65.530000000000001 111.034 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.42 161.3 36.7 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 114.954 -1.021 . . . . 63.210000000000001 109.288 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.476 HD11 HG21 ' A' ' 78' ' ' ILE . 4.2 pp -127.3 139.62 52.76 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.454 -0.573 . . . . 63.0 109.454 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.8 133.65 65.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.715 -0.846 . . . . 64.340000000000003 108.715 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.55 117.12 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.003 -1.851 . . . . 64.150000000000006 106.003 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -99.86 -31.0 11.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.904 -0.589 . . . . 64.200000000000003 110.745 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -137.43 132.0 32.78 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.96 -0.696 . . . . 71.040000000000006 109.323 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.43 175.11 13.94 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.594 -1.002 . . . . 64.549999999999997 110.594 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.539 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 19.2 Cg_endo -59.82 -39.62 70.77 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.68 2.253 . . . . 71.450000000000003 112.535 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -95.29 22.22 7.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.123 -0.49 . . . . 72.409999999999997 112.087 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.77 57.53 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.037 0.535 . . . . 63.340000000000003 110.889 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.31 -18.32 36.02 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.242 -1.143 . . . . 43.049999999999997 110.242 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.66 131.95 35.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.507 -0.347 . . . . 75.450000000000003 110.281 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -125.74 136.77 53.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.99 -0.744 . . . . 73.299999999999997 108.99 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -131.14 141.14 50.07 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.074 -0.713 . . . . 70.120000000000005 109.074 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -101.95 143.92 31.22 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.446 -0.576 . . . . 71.400000000000006 109.446 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.0 mt -97.4 118.72 34.51 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.971 0.415 . . . . 62.0 111.637 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.3 2.77 7.79 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -110.32 148.94 39.42 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-N 115.007 -0.997 . . . . 61.32 110.361 -174.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 -15.86 27.6 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.981 2.454 . . . . 64.310000000000002 113.446 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 91.8 m -152.84 124.29 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 121.753 -0.592 . . . . 71.540000000000006 110.853 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 77' ' ' ASP . 25.9 m -121.41 113.98 20.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.733 -0.84 . . . . 74.349999999999994 108.733 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 88.0 m -88.51 137.77 32.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.983 -0.377 . . . . 50.310000000000002 109.983 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.04 134.89 54.55 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-O 121.415 0.626 . . . . 75.409999999999997 110.349 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.99 -135.87 6.29 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.252 -1.34 . . . . 52.520000000000003 110.019 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -117.74 124.54 48.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.977 -0.749 . . . . 63.100000000000001 108.977 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.1 151.39 0.11 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 107.801 -1.185 . . . . 74.310000000000002 107.801 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.73 -32.11 47.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.861 1.708 . . . . 55.340000000000003 111.496 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.07 -5.9 59.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.065 0.394 . . . . 74.329999999999998 112.065 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.7 m -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.119 -1.067 . . . . 62.119999999999997 108.119 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 68' ' ' THR . 10.9 t70 -54.4 -43.01 71.11 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 124.33 1.019 . . . . 61.549999999999997 110.58 -175.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.476 HG21 HD11 ' A' ' 49' ' ' LEU . 29.2 pt -106.96 107.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.992 0.901 . . . . 74.030000000000001 110.388 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -95.12 128.77 42.21 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.956 -1.02 . . . . 71.239999999999995 110.009 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.3 mt -111.44 135.43 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.847 -1.909 . . . . 75.329999999999998 105.847 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.69 137.11 52.4 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.001 -0.679 . . . . 72.200000000000003 112.472 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 83' ' ' VAL . 30.2 t70 -160.69 -162.19 0.92 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.158 -1.423 . . . . 74.25 107.158 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.515 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 48.2 t -68.54 -42.88 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 108.906 -0.775 . . . . 62.310000000000002 108.906 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.2 m -156.14 101.09 2.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.776 -0.647 . . . . 73.209999999999994 109.852 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 t -102.9 149.69 7.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 106.589 -1.634 . . . . 73.319999999999993 106.589 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.0 t -68.87 143.49 54.5 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 123.376 0.423 . . . . 52.210000000000001 111.725 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.1 ptt180 -55.86 -28.4 56.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.701 1.2 . . . . 71.430000000000007 110.389 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.95 104.72 2.86 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.805 -1.089 . . . . 74.409999999999997 109.212 169.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -86.86 -51.63 5.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.835 -1.543 . . . . 64.129999999999995 106.835 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.97 159.23 41.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.659 -1.237 . . . . 63.109999999999999 107.659 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 11.6 pt-20 -142.13 154.37 44.83 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.327 0.584 . . . . 71.409999999999997 112.186 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 67' ' ' THR . 4.8 m-85 -104.29 127.83 51.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.204 -1.406 . . . . 44.350000000000001 107.204 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -121.06 125.1 46.43 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.943 -0.762 . . . . 74.430000000000007 108.943 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.63 111.59 36.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.539 -1.652 . . . . 72.239999999999995 106.539 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -139.81 129.45 24.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.135 -0.484 . . . . 72.420000000000002 110.481 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.72 36.44 27.25 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.722 1.209 . . . . 63.109999999999999 111.888 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.82 -0.76 87.93 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 113.197 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -101.27 136.72 40.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.182 -0.673 . . . . 74.340000000000003 109.182 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.87 118.04 34.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.222 -1.029 . . . . 72.129999999999995 108.222 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -127.5 146.94 50.33 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.156 -0.617 . . . . 73.439999999999998 109.938 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.57 123.72 68.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.783 -1.192 . . . . 72.409999999999997 107.783 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.7 134.77 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.728 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.83 132.79 38.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.968 -1.864 . . . . 74.420000000000002 105.968 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.96 18.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 112.341 0.496 . . . . 54.509999999999998 112.341 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.79 42.16 0.29 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.376 -1.392 . . . . 54.020000000000003 113.344 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.8 p -87.49 143.63 27.12 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.983 -1.087 . . . . 74.049999999999997 108.365 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.94 -19.77 17.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.299 0.571 . . . . 52.329999999999998 109.475 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -87.31 -19.66 27.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.274 -0.875 . . . . 50.030000000000001 111.207 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.7 120.19 4.41 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.313 -0.946 . . . . 74.129999999999995 114.163 174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.3 m -88.04 132.04 34.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.409 -0.589 . . . . 70.510000000000005 109.409 173.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -119.8 126.42 50.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.919 -0.488 . . . . 64.329999999999998 110.004 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.3 t -111.57 117.17 54.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 106.932 -1.507 . . . . 75.540000000000006 106.932 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 55.08 37.96 29.73 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 125.452 1.501 . . . . 44.340000000000003 110.003 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 67.53 16.08 9.88 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 113.776 -1.556 . . . . 72.230000000000004 112.475 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -103.76 138.48 19.54 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 107.465 -1.309 . . . . 74.230000000000004 107.465 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.49 124.36 14.94 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.097 1.864 . . . . 75.310000000000002 109.034 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -148.17 141.89 25.62 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.915 -0.714 . . . . 74.219999999999999 110.439 -172.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.19 -58.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.129 -1.063 . . . . 75.420000000000002 108.129 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.11 139.19 42.77 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.966 -0.458 . . . . 73.340000000000003 109.784 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.92 143.79 22.91 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.073 -0.714 . . . . 74.299999999999997 109.073 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.72 131.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 107.119 -1.438 . . . . 55.299999999999997 107.119 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.4 mmt -88.97 148.49 23.76 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.889 0.852 . . . . 72.409999999999997 112.671 -170.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 126' ' ' ASP . 18.9 pt20 -119.55 157.07 29.12 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.885 -1.895 . . . . 73.549999999999997 105.885 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 133.55 54.86 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.425 -0.954 . . . . 64.519999999999996 108.425 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.93 0.49 56.22 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.589 -0.815 . . . . 64.120000000000005 112.743 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.438 ' OD2' ' HG2' ' A' ' 123' ' ' GLN . 34.0 m-20 -76.12 141.06 42.05 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.638 0.719 . . . . 74.209999999999994 111.636 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.8 127.79 55.91 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.019 -1.104 . . . . 64.230000000000004 108.019 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.9 mt -107.42 119.54 57.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.091 -1.448 . . . . 73.439999999999998 107.091 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 11.5 tm0? -106.37 117.39 33.91 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.95 -1.5 . . . . 71.540000000000006 106.95 -174.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.02 101.65 12.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.862 -1.162 . . . . 73.239999999999995 107.862 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.14 -73.52 0.13 Allowed Glycine 0 CA--C 1.536 1.405 0 CA-C-O 121.361 0.423 . . . . 63.43 113.615 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -145.44 16.53 1.49 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.452 1.101 . . . . 64.239999999999995 109.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.539 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 72.4 m-85 -109.38 148.59 30.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.145 -0.934 . . . . 74.409999999999997 109.494 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -128.53 119.78 25.48 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.168 -0.679 . . . . 54.030000000000001 109.168 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.0 mt -106.45 132.72 52.15 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.452 -1.685 . . . . 60.009999999999998 106.452 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.73 120.15 61.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.054 -1.091 . . . . 64.430000000000007 108.054 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -96.43 121.58 38.39 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.67 -0.863 . . . . 75.099999999999994 108.67 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.63 136.8 49.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.809 0.337 . . . . 61.240000000000002 110.296 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.16 119.38 29.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 105.382 -2.081 . . . . 53.450000000000003 105.382 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.26 -132.83 1.87 Allowed Glycine 0 N--CA 1.42 -2.431 0 C-N-CA 119.088 -1.53 . . . . 75.400000000000006 113.342 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.47 162.13 43.52 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.757 2.971 . . . . 64.099999999999994 114.235 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.39 69.79 1.41 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.792 -1.558 . . . . 65.430000000000007 106.792 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 . . . . . 0 N--CA 1.42 -1.974 0 CA-C-N 114.758 -1.11 . . . . 74.430000000000007 111.162 -175.231 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 105.785 -1.931 . . . . 63.329999999999998 105.785 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -89.89 112.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 107.452 -1.314 . . . . 54.119999999999997 107.452 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -125.53 141.35 52.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.616 -0.72 . . . . 74.150000000000006 109.349 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -81.5 112.85 19.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.068 -1.456 . . . . 72.019999999999996 107.068 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . -64.4 -168.44 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 115.317 1.599 . . . . 72.329999999999998 115.317 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.41 2.89 2.02 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.417 1.887 . . . . 70.109999999999999 111.536 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 3.9 pp -57.28 -21.14 32.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.476 1.51 . . . . 61.340000000000003 112.915 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.84 -34.54 78.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.349 0.26 . . . . 73.439999999999998 110.975 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.39 -40.31 8.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.112 -0.699 . . . . 74.109999999999999 109.112 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 13.1 tp10 -65.7 -24.94 67.1 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 114.34 -1.3 . . . . 74.310000000000002 114.016 -172.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.21 -50.36 69.61 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.873 0.761 . . . . 54.140000000000001 112.074 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.6 -31.92 69.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.125 0.488 . . . . 64.519999999999996 110.807 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -71.97 -26.37 62.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.656 -0.702 . . . . 74.049999999999997 110.751 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.52 -40.57 12.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.104 -0.498 . . . . 62.43 110.577 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.4 m -75.42 85.21 2.54 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.679 0.752 . . . . 61.200000000000003 112.402 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.57 26.17 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.132 -0.94 . . . . 53.299999999999997 111.194 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -83.9 123.9 30.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 123.378 0.671 . . . . 73.340000000000003 109.818 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.93 124.18 81.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 106.21 -1.774 . . . . 72.299999999999997 106.21 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.74 141.76 91.95 Favored 'Trans proline' 0 C--O 1.251 1.134 0 C-N-CA 121.939 1.759 . . . . 70.540000000000006 111.909 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.06 141.44 48.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.093 -0.958 . . . . 51.140000000000001 109.463 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.3 t -141.14 112.1 7.19 Favored 'General case' 0 N--CA 1.407 -2.61 0 CA-C-O 121.55 0.691 . . . . 73.420000000000002 109.962 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.09 36.41 0.98 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.687 -1.597 . . . . 73.450000000000003 106.687 174.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . 86.7 25.63 34.75 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.309 -2.316 . . . . 73.329999999999998 107.309 -169.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 139' ' ' ALA . . . -72.29 -47.6 48.76 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.715 -1.243 . . . . 65.319999999999993 113.618 -168.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -80.92 -2.35 47.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.614 0.721 . . . . 74.030000000000001 111.453 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.45 -25.39 20.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.868 -1.06 . . . . 74.450000000000003 108.626 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 57.37 85.49 0.19 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 114.732 -1.122 . . . . 71.400000000000006 111.284 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 45.3 Cg_endo -83.1 -73.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.443 2.095 . . . . 74.200000000000003 114.11 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.11 65.3 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.705 0.632 . . . . 63.240000000000002 112.705 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -11.85 71.02 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 111.083 -0.807 . . . . 63.109999999999999 111.083 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.3 m -114.7 169.84 8.77 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.939 -1.504 . . . . 64.400000000000006 106.939 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -149.61 157.58 43.38 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.974 -0.38 . . . . 51.240000000000002 109.974 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.404 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.19 137.65 54.51 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.366 0.603 . . . . 62.340000000000003 110.324 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.3 pp -111.11 137.02 49.3 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 109.125 -0.694 . . . . 74.230000000000004 109.125 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.8 135.62 50.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 109.613 -0.514 . . . . 64.540000000000006 109.613 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 16.1 t -80.83 118.15 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.7 -1.222 . . . . 71.109999999999999 107.7 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -88.79 -35.95 16.35 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.182 -0.673 . . . . 73.109999999999999 109.182 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HD2' ' OE1' ' A' ' 25' ' ' GLU . 39.7 ttm180 -148.1 141.93 25.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.299 -0.864 . . . . 72.530000000000001 109.282 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.79 174.78 13.57 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.397 -1.081 . . . . 64.349999999999994 110.397 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.537 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.8 Cg_exo -54.65 -44.68 47.26 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.602 2.201 . . . . 73.25 113.52 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.477 HD21 HD23 ' A' ' 80' ' ' LEU . 33.6 p30 -92.64 22.37 4.77 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.081 -1.012 . . . . 70.109999999999999 113.268 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -54.51 140.5 34.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.812 0.445 . . . . 54.119999999999997 112.036 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.37 -16.27 55.36 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.545 -0.622 . . . . 53.039999999999999 111.545 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.33 142.34 27.82 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.086 -0.246 . . . . 73.340000000000003 110.49 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -112.83 135.14 53.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.481 -0.933 . . . . 75.340000000000003 108.481 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.36 133.09 56.17 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.783 -0.451 . . . . 72.230000000000004 109.783 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.95 124.71 47.07 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.892 -0.594 . . . . 73.219999999999999 110.107 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.91 105.24 14.64 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.361 -1.348 . . . . 61.119999999999997 107.361 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -122.35 18.22 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.983 0.897 . . . . 73.319999999999993 109.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -133.17 157.67 77.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 61.130000000000003 109.516 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.59 -26.51 75.9 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.047 2.498 . . . . 62.229999999999997 114.079 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.6 m -147.55 121.8 9.58 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.329 -0.857 . . . . 75.540000000000006 111.182 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 77' ' ' ASP . 56.0 m -109.87 135.32 50.94 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.862 -0.608 . . . . 50.439999999999998 109.943 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -106.39 141.52 37.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.69 135.28 54.56 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 109.781 -0.451 . . . . 74.5 109.781 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.89 -164.19 25.52 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.792 -1.323 . . . . 70.109999999999999 109.792 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 86.1 mtt180 -101.43 117.8 35.68 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.123 -1.066 . . . . 73.109999999999999 108.123 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 176.88 153.8 0.4 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.854 -1.906 . . . . 74.409999999999997 105.854 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.07 -15.76 51.1 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.924 1.749 . . . . 74.200000000000003 113.178 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.44 -1.28 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.607 0.595 . . . . 75.219999999999999 112.607 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -85.07 112.52 20.72 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.11 -1.036 . . . . 71.230000000000004 111.154 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.453 ' HB3' HG23 ' A' ' 68' ' ' THR . 37.9 t70 -70.19 -36.95 74.98 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.133 -0.692 . . . . 70.420000000000002 109.133 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -100.66 98.73 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 122.253 1.025 . . . . 61.43 108.449 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -90.06 122.06 32.7 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.949 -1.023 . . . . 74.099999999999994 108.63 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.477 HD23 HD21 ' A' ' 56' ' ' ASN . 59.6 mt -123.87 122.18 37.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.154 -2.165 . . . . 71.319999999999993 105.154 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -130.67 117.53 19.61 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.198 -0.668 . . . . 60.130000000000003 109.198 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.0 p30 -128.78 -155.91 0.73 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.426 -0.953 . . . . 73.0 108.426 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.9 -41.74 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.24 0.616 . . . . 62.530000000000001 111.377 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -153.99 89.44 1.3 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.617 -0.677 . . . . 72.530000000000001 111.735 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 82' ' ' ASP . 85.4 t -103.54 136.29 37.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.983 -0.747 . . . . 62.439999999999998 108.983 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.526 ' HB2' HD21 ' A' ' 107' ' ' LEU . 41.2 t -71.33 161.99 30.17 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 123.843 0.715 . . . . 72.420000000000002 111.186 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 27.9 ptt180 -65.4 -38.16 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 122.127 0.965 . . . . 74.420000000000002 109.374 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -136.14 112.96 10.23 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.491 -1.3 . . . . 52.509999999999998 107.491 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t-80 -99.62 -52.93 3.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.851 -0.613 . . . . 51.420000000000002 109.847 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.69 160.44 37.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.266 -0.574 . . . . 43.340000000000003 110.537 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.0 133.97 53.56 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.307 -0.861 . . . . 72.140000000000001 110.628 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -105.69 115.54 30.42 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.417 -1.698 . . . . 61.100000000000001 106.417 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -112.65 133.92 54.44 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.032 -0.667 . . . . 70.319999999999993 110.884 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.6 mp -104.48 121.13 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.022 -1.103 . . . . 74.409999999999997 108.022 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -123.84 116.64 23.29 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.29 -1.374 . . . . 71.319999999999993 107.29 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.98 37.83 14.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.777 0.831 . . . . 71.319999999999993 112.884 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.51 -2.49 87.38 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.097 -0.501 . . . . 44.439999999999998 114.172 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.81 138.9 39.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.729 0.765 . . . . 74.420000000000002 109.148 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD2' HG13 ' A' ' 94' ' ' ILE . 31.5 m-85 -108.52 122.77 47.76 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.61 -0.268 . . . . 72.319999999999993 111.246 -172.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -114.75 139.01 50.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.667 -0.864 . . . . 55.549999999999997 108.667 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.413 HG23 ' HB2' ' A' ' 122' ' ' MET . 43.4 t -109.32 123.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.991 -1.115 . . . . 74.140000000000001 107.991 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.72 121.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.169 -1.419 . . . . 60.439999999999998 107.169 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.52 153.94 18.26 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.783 -1.191 . . . . 51.5 107.783 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 89' ' ' HIS . 18.7 m -78.79 -12.31 13.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 113.379 0.881 . . . . 65.019999999999996 113.379 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.23 17.58 0.02 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 119.086 -1.53 . . . . 54.43 116.019 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p 57.97 26.92 14.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.664 1.586 . . . . 73.450000000000003 111.496 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 86' ' ' SER . 0.0 OUTLIER -65.26 -35.31 80.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.961 -1.472 . . . . 64.439999999999998 112.926 -174.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.635 ' HB2' ' CD2' ' A' ' 89' ' ' HIS . 2.6 m120 -86.76 3.77 43.63 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 110.374 -0.232 . . . . 73.019999999999996 110.374 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.66 49.17 6.26 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.933 -1.267 . . . . 75.0 109.933 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -61.54 129.86 43.14 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 123.496 0.718 . . . . 51.219999999999999 110.977 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.406 ' CB ' ' HB3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -125.2 125.64 43.97 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.326 -1.731 . . . . 73.439999999999998 106.326 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.14 124.77 61.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 106.694 -1.595 . . . . 65.400000000000006 106.694 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.435 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 4.3 t-20 57.81 37.64 27.1 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.543 1.163 . . . . 65.310000000000002 107.884 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.15 18.62 6.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.976 -1.466 . . . . 63.350000000000001 114.23 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -125.04 147.47 57.02 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.407 -0.96 . . . . 74.329999999999998 108.407 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.57 129.43 17.78 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 N-CA-C 108.528 -1.374 . . . . 73.400000000000006 108.528 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.563 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 13.0 tpp180 -148.38 150.19 33.11 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.636 -0.826 . . . . 64.329999999999998 110.143 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -93.81 -55.46 3.23 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.558 -0.534 . . . . 60.439999999999998 109.558 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.68 34.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.808 -0.812 . . . . 61.049999999999997 108.808 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.563 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 58.1 tp60 -153.85 143.19 21.5 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 123.145 0.278 . . . . 52.229999999999997 110.71 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.95 128.11 37.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.573 -1.64 . . . . 71.329999999999998 106.573 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.413 ' HB2' HG23 ' A' ' 101' ' ' VAL . 39.4 ttp -90.26 134.88 34.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.402 0.62 . . . . 75.299999999999997 111.357 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.411 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 12.7 pt20 -104.07 152.19 22.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.23 -0.895 . . . . 72.5 110.67 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.25 130.71 41.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 C-N-CA 123.646 0.778 . . . . 54.140000000000001 111.979 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -0.44 63.0 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.099 -0.8 . . . . 73.540000000000006 111.099 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 28.3 t70 -89.44 153.65 20.66 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.45 -0.375 . . . . 74.340000000000003 111.565 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -115.92 131.19 57.01 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 121.525 0.679 . . . . 73.409999999999997 112.611 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.09 131.76 61.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 107.659 -1.237 . . . . 71.049999999999997 107.659 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 111' ' ' TYR . 16.5 tm0? -109.97 130.74 55.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.727 -1.212 . . . . 62.130000000000003 107.727 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 89' ' ' HIS . 4.1 mp -130.09 104.03 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.644 -0.873 . . . . 64.439999999999998 108.644 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.55 -96.45 0.18 Allowed Glycine 0 C--O 1.243 0.699 0 C-N-CA 121.052 -0.594 . . . . 73.409999999999997 112.565 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -113.43 -0.55 14.43 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.002 0.43 . . . . 73.409999999999997 110.219 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.537 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 87.1 m-85 -100.19 152.85 19.8 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.291 0.636 . . . . 64.140000000000001 111.479 -175.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -137.09 120.2 16.64 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.995 -1.113 . . . . 74.109999999999999 107.995 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.427 ' CD2' HG22 ' A' ' 51' ' ' VAL . 65.2 mt -105.25 140.39 38.47 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.468 0.707 . . . . 63.299999999999997 109.442 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.33 120.02 61.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.265 -1.754 . . . . 74.129999999999995 106.265 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -97.74 119.63 36.67 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 112.128 0.418 . . . . 65.239999999999995 112.128 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.422 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 95.5 mt -129.34 153.91 47.4 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.853 -0.795 . . . . 61.299999999999997 108.853 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 39' ' ' ALA . . . -75.95 162.01 28.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.869 -0.332 . . . . 55.119999999999997 110.927 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.2 168.23 41.88 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.417 -0.81 . . . . 51.229999999999997 112.108 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.522 ' HB2' ' HG2' ' A' ' 143' ' ' GLU . 12.0 Cg_endo -54.72 145.29 61.0 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 123.768 2.979 . . . . 74.530000000000001 115.455 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 43.39 1.07 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.546 -1.207 . . . . 74.549999999999997 110.384 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 141' ' ' PRO . 2.9 pt-20 . . . . . 0 N--CA 1.413 -2.307 0 C-N-CA 123.651 0.78 . . . . 75.549999999999997 109.385 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.653 -0.499 . . . . 53.229999999999997 109.653 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.482 HG22 HD12 ' A' ' 107' ' ' LEU . 57.0 t -83.24 116.57 27.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.544 -0.539 . . . . 64.349999999999994 109.544 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -123.87 140.12 53.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.73 -0.47 . . . . 72.510000000000005 109.73 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttp85 -96.21 108.53 21.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.114 -1.069 . . . . 63.229999999999997 108.114 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 -173.84 3.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.574 -0.739 . . . . 60.130000000000003 110.989 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -72.91 6.83 2.34 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.701 0.8 . . . . 64.310000000000002 111.497 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.25 -26.21 60.39 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.222 1.409 . . . . 53.310000000000002 113.942 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.4 tp -72.28 -22.52 61.2 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.87 0.843 . . . . 74.530000000000001 109.616 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.16 -32.53 12.44 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.595 -0.73 . . . . 72.420000000000002 109.572 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -56.93 -38.97 73.64 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.119 -0.492 . . . . 73.120000000000005 111.086 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 ptp -62.4 -25.94 68.21 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 120.792 -0.363 . . . . 71.420000000000002 111.558 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -87.53 -49.65 7.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.948 0.404 . . . . 75.120000000000005 110.077 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -61.21 -41.98 97.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.793 -0.64 . . . . 53.43 111.145 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -82.92 -16.98 45.31 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.881 -0.414 . . . . 74.129999999999995 109.881 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m 67.29 101.75 0.05 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.773 1.229 . . . . 53.229999999999997 113.964 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.58 -141.38 48.02 Favored Glycine 0 CA--C 1.499 -0.963 0 CA-C-N 115.485 -0.779 . . . . 33.039999999999999 112.69 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t -115.77 149.39 38.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.608 -0.516 . . . . 75.0 109.608 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 110.97 40.6 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.323 -0.992 . . . . 43.020000000000003 108.323 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.78 145.2 90.56 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.859 2.373 . . . . 70.420000000000002 113.616 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.23 162.45 13.19 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.904 -0.589 . . . . 70.450000000000003 110.102 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 123' ' ' GLN . 18.3 m -94.26 116.0 28.33 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.168 0.509 . . . . 63.109999999999999 110.551 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.2 m -69.38 100.04 1.3 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.551 -0.75 . . . . 73.120000000000005 109.403 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' OD1' ' A' ' 41' ' ' ASN . . . -152.31 43.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.273 -0.965 . . . . 55.119999999999997 112.993 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.47 -39.83 13.92 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.622 -1.251 . . . . 74.319999999999993 107.622 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.46 -1.81 25.83 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.328 -1.306 . . . . 65.109999999999999 111.387 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.443 ' OD1' ' HA2' ' A' ' 38' ' ' GLY . 11.0 m120 -82.8 -30.55 28.74 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.481 -0.782 . . . . 72.409999999999997 109.29 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt 48.06 81.33 0.26 Allowed Pre-proline 0 C--N 1.345 0.371 0 O-C-N 124.229 0.956 . . . . 42.200000000000003 112.049 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HB2' ' HA3' ' A' ' 140' ' ' GLY . 6.9 Cg_exo -68.79 -61.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 111.891 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.67 -12.97 5.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.956 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.83 1.46 85.06 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.087 -1.054 . . . . 64.329999999999998 111.176 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 6.8 m -115.02 156.56 24.9 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.23 -1.396 . . . . 61.32 107.23 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -148.11 154.53 40.31 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.708 -0.478 . . . . 71.530000000000001 109.708 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 152.37 44.5 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.92 -0.4 . . . . 54.039999999999999 109.92 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.01 132.46 52.01 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.46 -0.941 . . . . 70.530000000000001 108.46 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 p -108.82 137.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.644 -0.502 . . . . 74.129999999999995 109.644 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 135' ' ' LEU . 10.5 t -86.09 118.27 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 107.997 -1.112 . . . . 71.319999999999993 107.997 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 55.3 tttp -93.42 -31.71 14.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.356 -0.838 . . . . 64.299999999999997 109.953 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.419 ' HB3' ' HG2' ' A' ' 134' ' ' ARG . 19.5 tpp180 -147.11 138.5 24.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.988 -0.745 . . . . 71.329999999999998 108.988 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.06 171.05 12.93 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.155 -1.178 . . . . 71.219999999999999 110.155 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.67 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.1 Cg_exo -54.64 -29.99 63.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.598 2.199 . . . . 63.409999999999997 113.714 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.43 8.47 33.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.502 -0.479 . . . . 72.329999999999998 112.199 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.95 131.61 45.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.86 0.362 . . . . 62.539999999999999 111.515 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -23.94 24.44 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 115.588 -0.733 . . . . 52.509999999999998 112.295 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 152.54 20.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.754 0.277 . . . . 73.420000000000002 110.768 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.75 137.12 48.07 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.764 -0.828 . . . . 71.439999999999998 108.764 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -115.24 139.51 49.88 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.614 -0.513 . . . . 62.229999999999997 109.614 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.3 127.94 42.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.947 -1.131 . . . . 71.510000000000005 107.947 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.75 113.21 26.18 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.485 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.18 3.47 4.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.24 1.019 . . . . 74.230000000000004 108.582 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.4 pm0 -106.45 137.09 19.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-N 115.056 -0.975 . . . . 65.219999999999999 109.123 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.25 -21.58 67.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.309 2.673 . . . . 71.140000000000001 113.764 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -137.23 122.68 19.55 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.322 -0.622 . . . . 74.540000000000006 109.322 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.0 m -129.89 112.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.91 -0.774 . . . . 52.299999999999997 108.91 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 m -88.53 140.59 29.31 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.394 -0.595 . . . . 71.310000000000002 109.394 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.52 135.2 55.14 Favored 'General case' 0 C--O 1.268 2.039 0 N-CA-C 109.09 -0.707 . . . . 64.099999999999994 109.09 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -136.0 4.81 Favored Glycine 0 N--CA 1.422 -2.298 0 O-C-N 123.916 0.76 . . . . 71.120000000000005 112.833 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 24.8 mmm180 -118.67 152.94 35.17 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 125.486 1.514 . . . . 72.239999999999995 109.552 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.428 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 27.0 t-80 82.57 142.87 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 125.31 1.444 . . . . 74.319999999999993 109.209 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 9.8 Cg_endo -52.63 -6.77 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 124.14 3.227 . . . . 54.240000000000002 115.538 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.5 -12.89 59.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.353 0.597 . . . . 74.040000000000006 110.086 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -88.19 134.91 33.66 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.358 -0.979 . . . . 41.200000000000003 108.358 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -76.99 -42.2 39.8 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.169 -1.049 . . . . 74.120000000000005 108.169 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.7 mm -97.46 104.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 106.469 -1.678 . . . . 54.130000000000003 106.469 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -87.62 108.81 19.25 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.49 -0.777 . . . . 64.420000000000002 109.431 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 82.3 mt -95.7 141.05 29.65 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.742 -1.577 . . . . 73.530000000000001 106.742 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.591 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 18.3 t70 -103.94 117.46 34.36 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.152 -0.619 . . . . 75.120000000000005 110.499 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -151.22 174.98 12.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.643 -1.243 . . . . 73.409999999999997 107.643 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.48 -34.25 10.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.585 -0.894 . . . . 70.040000000000006 108.585 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.569 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 m -74.61 125.23 28.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.02 -0.991 . . . . 52.310000000000002 109.711 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.5 98.01 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 119.618 -0.833 . . . . 71.129999999999995 109.109 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 t -107.01 90.5 3.32 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.457 -1.312 . . . . 72.540000000000006 107.457 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -57.92 -31.9 67.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.544 -1.207 . . . . 74.409999999999997 111.384 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -145.12 93.43 2.39 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.411 -0.959 . . . . 71.439999999999998 108.411 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.496 ' CE1' HG23 ' A' ' 130' ' ' ILE . 39.7 t-80 -96.58 -53.58 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.704 -0.798 . . . . 73.519999999999996 109.691 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.32 160.62 38.71 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 109.194 -0.669 . . . . 63.119999999999997 109.194 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.02 143.94 36.67 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.331 0.586 . . . . 73.450000000000003 110.138 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -104.94 122.16 45.24 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.027 -2.212 . . . . 74.120000000000005 105.027 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -115.81 142.84 46.23 Favored 'General case' 0 C--N 1.273 -2.72 0 C-N-CA 119.618 -0.833 . . . . 73.340000000000003 109.256 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.7 mp -113.95 112.97 42.46 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 104.219 -2.511 . . . . 53.130000000000003 104.219 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.63 122.7 25.1 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.766 -0.457 . . . . 63.32 109.766 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 56.03 38.0 29.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.146 0.904 . . . . 72.540000000000006 111.571 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.91 -7.84 75.68 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.248 -0.887 . . . . 52.200000000000003 113.925 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -101.79 150.28 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.151 0.475 . . . . 65.25 109.844 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.29 126.4 53.31 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.774 -0.825 . . . . 73.140000000000001 108.774 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.9 147.84 52.59 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.647 0.26 . . . . 65.340000000000003 111.174 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 122' ' ' MET . 25.6 t -112.59 122.69 67.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.942 -1.503 . . . . 73.120000000000005 106.942 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.88 122.33 68.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.198 0.523 . . . . 61.219999999999999 111.147 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.9 136.93 32.75 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 123.787 0.835 . . . . 63.329999999999998 110.553 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.57 5.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.813 -0.63 . . . . 64.319999999999993 110.463 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.78 58.83 0.57 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.99 -0.624 . . . . 60.229999999999997 111.835 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -60.03 -11.65 6.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.783 1.233 . . . . 70.0 112.563 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 107' ' ' LEU . 1.2 mm? -67.4 -20.48 65.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.992 0.917 . . . . 74.420000000000002 110.847 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.66 -5.5 58.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 53.020000000000003 110.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.35 66.15 1.72 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.789 -0.641 . . . . 31.0 112.178 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 m -73.9 127.44 32.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.079 0.466 . . . . 53.32 110.844 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -136.62 141.42 43.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 109.827 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.17 119.57 58.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 106.905 -1.517 . . . . 71.140000000000001 106.905 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.457 ' OD1' ' HG2' ' A' ' 127' ' ' GLU . 87.7 m-20 56.58 39.38 29.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.792 0.837 . . . . 63.229999999999997 110.699 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 114' ' ' ARG . 0.0 OUTLIER 65.32 15.21 9.9 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 113.066 0.765 . . . . 72.530000000000001 113.066 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -112.43 133.99 21.68 Favored Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 123.062 0.545 . . . . 60.009999999999998 109.761 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.52 123.28 10.91 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 108.161 -1.515 . . . . 72.239999999999995 108.161 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -153.03 137.3 16.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.716 -1.216 . . . . 72.450000000000003 107.716 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -107.91 -56.53 2.22 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.114 -0.635 . . . . 53.119999999999997 110.657 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.7 132.72 54.38 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.127 -1.064 . . . . 72.400000000000006 108.127 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.61 150.55 26.52 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 112.682 0.623 . . . . 62.409999999999997 112.682 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.61 132.4 33.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 104.926 -2.25 . . . . 51.43 104.926 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 101' ' ' VAL . 33.1 ttp -88.97 129.12 35.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.107 -0.637 . . . . 62.530000000000001 109.938 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 36' ' ' SER . 61.9 mt-30 -118.34 156.56 28.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.738 -1.119 . . . . 63.439999999999998 109.133 -173.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -71.21 130.21 40.86 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.463 -0.94 . . . . 74.230000000000004 108.463 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.44 -4.1 56.68 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.788 -0.642 . . . . 44.43 113.057 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.27 137.33 54.63 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 117.952 0.876 . . . . 64.530000000000001 110.444 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 12.6 pt-20 -112.69 126.32 55.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.575 -1.269 . . . . 74.209999999999994 107.575 172.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.98 117.03 54.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.652 0 N-CA-C 107.878 -1.156 . . . . 74.310000000000002 107.878 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -105.33 123.87 48.58 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.553 0.692 . . . . 74.019999999999996 112.111 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.496 HG23 ' CE1' ' A' ' 89' ' ' HIS . 10.3 mm -109.87 101.95 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 105.53 -2.026 . . . . 63.539999999999999 105.53 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 56.34 -98.15 0.06 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 120.789 -0.72 . . . . 72.109999999999999 112.112 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -97.53 -24.0 15.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.808 0.443 . . . . 62.130000000000003 111.34 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.67 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 65.5 m-85 -75.31 148.47 39.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 122.769 0.428 . . . . 72.140000000000001 110.25 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 8.7 ptm180 -138.37 120.12 15.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.529 -0.915 . . . . 63.200000000000003 108.529 170.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.7 mm? -103.36 139.86 38.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.68 -0.859 . . . . 74.530000000000001 108.68 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.7 t -116.37 123.2 71.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.24 -1.022 . . . . 60.299999999999997 108.24 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.461 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 94.3 t80 -94.68 129.86 41.4 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.978 -0.555 . . . . 61.32 111.252 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.93 132.04 53.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.158 -1.053 . . . . 62.310000000000002 108.158 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.42 131.4 53.66 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.45 -0.5 . . . . 53.299999999999997 111.099 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 43' ' ' PRO . . . 97.66 46.29 2.33 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 117.506 1.762 . . . . 55.310000000000002 117.506 175.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 46' ' ' SER . 39.6 Cg_endo -72.18 155.67 56.26 Favored 'Trans proline' 0 C--N 1.363 1.336 0 CA-C-N 121.108 2.454 . . . . 43.439999999999998 109.718 169.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.69 83.59 0.96 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.253 0.549 . . . . 71.140000000000001 110.426 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.172 -1.418 . . . . 72.430000000000007 107.172 177.272 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 108' ' ' ASN . 16.2 m . . . . . 0 N--CA 1.429 -1.521 0 CA-C-O 121.136 0.493 . . . . 64.420000000000002 112.176 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.15 115.92 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 104.903 -2.258 . . . . 32.520000000000003 104.903 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -81.6 113.59 19.72 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.543 0.687 . . . . 72.530000000000001 110.802 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.92 120.63 42.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.664 -1.236 . . . . 74.120000000000005 107.664 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.49 -178.09 7.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.996 0.427 . . . . 65.0 110.009 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -83.97 -4.47 58.74 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.803 0.811 . . . . 63.0 109.862 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.34 -4.53 58.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.034 -0.985 . . . . 60.329999999999998 111.748 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.59 -33.39 68.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.111 -0.7 . . . . 71.450000000000003 109.111 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -71.81 -22.41 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.518 -0.765 . . . . 65.299999999999997 110.126 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.88 -30.85 40.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.419 -0.585 . . . . 72.150000000000006 109.419 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 30' ' ' THR . 32.7 ttm -66.95 -12.11 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.64 1.21 . . . . 71.019999999999996 108.915 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.73 -38.07 8.84 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.899 -1.046 . . . . 74.349999999999994 109.894 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -88.8 -46.38 9.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.905 1.076 . . . . 75.519999999999996 113.905 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -90.17 -20.26 23.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 119.478 -0.889 . . . . 74.349999999999994 112.006 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 115' ' ' GLU . 5.7 m -80.53 65.48 5.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.906 0.86 . . . . 64.200000000000003 109.669 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.92 5.4 2.23 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.135 -1.186 . . . . 54.43 110.135 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -110.66 121.96 46.61 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.134 -1.062 . . . . 40.240000000000002 108.134 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.16 120.96 83.98 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.979 -0.378 . . . . 55.149999999999999 109.979 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.43 150.88 87.39 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.702 2.268 . . . . 70.120000000000005 111.368 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.18 141.66 31.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.38 -0.6 . . . . 72.019999999999996 109.38 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.8 m -80.1 117.57 21.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.92 -0.4 . . . . 72.510000000000005 109.92 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.7 p -82.26 -49.85 9.63 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.903 -0.59 . . . . 72.019999999999996 110.186 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.49 114.58 2.32 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.401 -0.818 . . . . 55.509999999999998 111.894 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.85 -7.79 45.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 120.923 0.392 . . . . 62.039999999999999 110.315 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -5.3 21.11 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.678 1.362 . . . . 52.210000000000001 114.678 -168.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.03 -32.43 18.79 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.373 -0.531 . . . . 73.040000000000006 110.98 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 48.26 68.85 3.12 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 124.079 0.862 . . . . 61.119999999999997 111.069 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.44 -58.25 0.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 125.113 3.875 . . . . 74.109999999999999 114.556 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.31 17.15 4.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.329 -0.989 . . . . 54.219999999999999 108.329 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.77 -12.4 29.19 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 114.623 -1.171 . . . . 73.340000000000003 112.583 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -118.99 164.84 14.88 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.993 -0.373 . . . . 72.430000000000007 109.993 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.25 156.98 40.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.911 -1.515 . . . . 61.149999999999999 106.911 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.43 145.78 51.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.141 0.496 . . . . 73.409999999999997 111.746 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -106.32 142.68 35.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.491 -0.929 . . . . 62.32 108.491 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.66 132.24 71.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.434 -0.58 . . . . 61.229999999999997 109.434 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.56 118.3 22.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.244 -1.391 . . . . 71.230000000000004 107.244 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -89.79 -34.82 16.02 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.618 -0.719 . . . . 64.299999999999997 110.756 -174.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 43.1 ttt180 -137.96 150.95 47.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.275 -1.38 . . . . 74.120000000000005 107.275 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.96 -178.2 16.48 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.471 -0.871 . . . . 42.100000000000001 112.338 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.58 -29.08 13.6 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.889 2.393 . . . . 64.299999999999997 111.782 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -97.08 18.99 13.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.827 -0.624 . . . . 74.310000000000002 110.955 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.35 139.22 58.74 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.415 -0.357 . . . . 74.010000000000005 111.168 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.83 -18.15 50.82 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.644 -0.582 . . . . 71.140000000000001 111.644 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.12 138.78 33.54 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 120.494 0.188 . . . . 63.25 110.719 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -122.78 145.91 48.0 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.398 -0.593 . . . . 72.129999999999995 109.398 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.28 142.68 47.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.519 -0.919 . . . . 62.100000000000001 108.519 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.29 143.84 26.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.315 0.579 . . . . 51.149999999999999 112.434 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.29 104.78 12.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.451 -0.795 . . . . 53.329999999999998 108.956 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -168.59 61.1 0.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 61.310000000000002 107.473 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -146.8 157.3 47.47 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 113.126 -1.852 . . . . 74.200000000000003 107.473 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.09 -35.52 97.92 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.812 1.675 . . . . 62.32 112.614 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 m -154.53 122.44 5.89 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.195 0.522 . . . . 73.219999999999999 111.814 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -108.48 116.92 32.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.402 -0.962 . . . . 71.530000000000001 108.402 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 p -90.4 133.02 35.28 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.938 -0.476 . . . . 74.430000000000007 110.851 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.87 134.68 55.16 Favored 'General case' 0 C--O 1.253 1.259 0 N-CA-C 109.631 -0.507 . . . . 75.230000000000004 109.631 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.96 -158.72 31.83 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.733 -1.347 . . . . 52.109999999999999 109.733 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 62.1 ttt180 -95.89 150.52 20.34 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.241 -0.651 . . . . 75.530000000000001 109.241 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 85.05 151.55 0.1 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.331 1.452 . . . . 72.230000000000004 111.881 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 -0.12 3.49 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.68 2.92 . . . . 61.43 114.97 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.73 -9.93 57.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.566 0.698 . . . . 74.439999999999998 110.285 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 m -90.86 136.94 32.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.02 -1.845 . . . . 60.020000000000003 106.02 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.19 -38.57 91.67 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.892 -0.781 . . . . 62.25 108.892 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.9 mm -98.91 119.46 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.106 -1.442 . . . . 73.219999999999999 107.106 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -90.17 118.01 29.37 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.798 0.332 . . . . 61.530000000000001 111.595 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 5.2 mp -124.98 134.75 52.48 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.757 -1.572 . . . . 74.230000000000004 106.757 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -131.67 123.45 27.83 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.324 -0.551 . . . . 74.319999999999993 111.346 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -149.79 172.79 14.55 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.045 -1.465 . . . . 75.439999999999998 107.045 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.96 -31.19 52.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.165 -0.68 . . . . 75.030000000000001 109.165 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -62.29 121.12 12.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.403 0.621 . . . . 74.400000000000006 110.719 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.34 125.32 39.84 Favored 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.209 -0.905 . . . . 51.200000000000003 109.6 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 m -159.08 106.06 1.78 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.353 0.661 . . . . 70.049999999999997 110.541 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -64.38 -46.0 85.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 120.701 -0.4 . . . . 72.140000000000001 111.635 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -141.3 131.03 24.16 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.494 -1.669 . . . . 73.430000000000007 106.494 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -99.83 -52.18 3.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.806 -0.812 . . . . 71.430000000000007 108.806 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.26 155.29 36.3 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.279 -0.873 . . . . 74.209999999999994 109.167 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.5 135.55 54.68 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 116.001 -0.545 . . . . 65.019999999999996 109.591 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 33.8 m-85 -105.04 113.23 26.7 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.021 -1.844 . . . . 71.310000000000002 106.021 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.35 132.82 53.76 Favored 'General case' 0 C--N 1.269 -2.922 0 N-CA-C 108.279 -1.008 . . . . 63.350000000000001 108.279 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.7 111.9 35.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.072 -2.196 . . . . 63.210000000000001 105.072 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -124.93 118.47 26.34 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.615 -1.175 . . . . 70.400000000000006 109.752 -169.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 53.96 36.9 25.54 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.38 1.072 . . . . 50.439999999999998 111.347 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 0.58 90.27 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.68 -0.691 . . . . 62.240000000000002 113.707 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -102.49 150.27 23.55 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.691 -0.855 . . . . 73.519999999999996 108.691 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -104.51 117.01 33.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.912 -1.144 . . . . 63.5 107.912 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -124.78 134.75 52.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.5 0.667 . . . . 74.150000000000006 110.845 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 120' ' ' GLN . 24.0 t -103.03 124.98 57.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 106.735 -1.58 . . . . 64.540000000000006 106.735 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.38 122.84 70.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 107.042 -1.466 . . . . 61.130000000000003 107.042 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -96.63 144.79 26.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 115.189 -0.914 . . . . 71.239999999999995 109.741 -178.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.03 -9.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.55 -0.46 . . . . 75.109999999999999 112.037 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.45 92.52 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 119.78 -1.2 . . . . 51.409999999999997 112.367 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.1 m -58.23 -22.03 50.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.172 0.589 . . . . 63.130000000000003 111.802 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.557 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -62.12 -18.83 62.03 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.965 0.906 . . . . 73.430000000000007 112.997 177.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' SER . 6.3 t30 -85.79 -0.55 55.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.786 0.803 . . . . 70.420000000000002 108.855 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.74 44.27 1.82 Allowed Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.521 -0.763 . . . . 73.0 113.059 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m -87.02 126.93 35.06 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.26 -0.645 . . . . 41.409999999999997 109.26 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 69.7 m-85 -137.44 131.62 32.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.839 -0.43 . . . . 71.420000000000002 109.839 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.16 116.36 50.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.058 -2.201 . . . . 73.5 105.058 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 55.96 40.55 30.41 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.065 0.946 . . . . 65.540000000000006 109.729 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.0 8.55 5.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.026 1.33 . . . . 62.210000000000001 113.698 -175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 30' ' ' THR . 37.2 mt-10 -103.6 128.24 27.82 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.752 -0.593 . . . . 72.140000000000001 109.408 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.26 136.27 63.33 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.639 1.559 . . . . 63.32 108.854 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.435 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 14.2 tpp85 -151.47 131.95 13.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.461 -0.896 . . . . 74.129999999999995 109.891 -173.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 2.9 t-20 -98.91 -31.41 11.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 122.043 0.925 . . . . 50.109999999999999 109.878 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -141.14 135.69 31.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.061 -1.459 . . . . 65.099999999999994 107.061 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.435 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 8.1 tp60 -144.71 144.56 31.27 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.016 0.197 . . . . 65.140000000000001 111.492 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 80.6 t -94.49 117.53 38.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 105.092 -2.188 . . . . 60.109999999999999 105.092 171.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.423 ' HB2' HG23 ' A' ' 101' ' ' VAL . 40.6 ttp -89.85 129.27 36.24 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.415 0.626 . . . . 52.130000000000003 111.296 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.58 157.1 43.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.842 -1.072 . . . . 70.439999999999998 109.522 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -62.53 134.19 56.03 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.568 0.543 . . . . 74.109999999999999 109.805 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.05 -8.64 61.12 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.409 -0.901 . . . . 65.310000000000002 111.933 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 140.15 32.5 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.072 0.463 . . . . 71.209999999999994 110.046 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -114.12 134.78 54.65 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.446 -0.797 . . . . 73.010000000000005 109.563 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.3 mt -112.1 118.3 57.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 107.676 -1.231 . . . . 72.010000000000005 107.676 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.572 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -104.84 117.05 33.09 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.901 -1.889 . . . . 73.099999999999994 105.901 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.78 103.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.446 -0.797 . . . . 72.530000000000001 109.447 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.45 -84.44 0.44 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.107 -0.951 . . . . 40.140000000000001 112.272 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -125.35 -18.34 5.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.638 0.256 . . . . 64.129999999999995 111.192 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 48.4 p90 -121.14 150.33 41.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 112.924 0.713 . . . . 74.109999999999999 112.924 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 8.2 ptm180 -112.52 142.14 45.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.547 -0.752 . . . . 73.209999999999994 112.236 -170.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.2 139.17 54.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.911 -1.514 . . . . 63.229999999999997 106.911 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.42 134.95 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.163 -0.68 . . . . 64.140000000000001 109.163 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -97.43 119.63 36.33 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.777 -0.453 . . . . 65.230000000000004 109.777 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.42 131.14 55.59 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.651 -0.5 . . . . 74.430000000000007 109.651 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.47 135.75 33.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.751 -0.833 . . . . 70.239999999999995 108.751 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.72 163.93 15.6 Favored Glycine 0 N--CA 1.421 -2.329 0 N-CA-C 107.637 -2.185 . . . . 54.43 107.637 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.86 141.76 72.81 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 CA-C-N 119.725 1.762 . . . . 63.130000000000003 113.167 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -118.67 26.53 9.5 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.559 -1.645 . . . . 63.219999999999999 106.559 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.417 -2.099 0 CA-C-N 113.242 -1.799 . . . . 70.150000000000006 107.693 -178.152 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 108.839 -0.8 . . . . 72.010000000000005 108.839 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -83.11 115.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.453 -0.573 . . . . 62.399999999999999 109.453 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -99.54 105.35 17.23 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.603 -0.888 . . . . 70.409999999999997 108.603 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -126.96 124.92 40.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.58 0.705 . . . . 75.140000000000001 112.851 -176.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.91 -37.56 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.002 1.321 . . . . 64.099999999999994 107.885 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.74 -17.14 0.49 Allowed 'General case' 0 C--O 1.203 -1.367 0 CA-C-N 112.734 -2.03 . . . . 74.219999999999999 114.756 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.1 -41.8 88.98 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 118.156 0.434 . . . . 72.120000000000005 110.818 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.43 -36.28 45.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.569 . . . . 72.349999999999994 109.465 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -60.14 -44.09 95.22 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.11 -0.95 . . . . 51.229999999999997 108.951 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -43.12 64.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.583 -1.19 . . . . 75.019999999999996 111.149 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.15 -36.78 71.16 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.172 0.51 . . . . 60.310000000000002 110.621 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.97 -26.35 68.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.499 -0.773 . . . . 72.319999999999993 110.4 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -98.41 -36.59 9.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.557 -0.292 . . . . 54.229999999999997 111.29 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -75.33 -23.96 57.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.356 0.502 . . . . 70.030000000000001 112.356 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.1 m -66.1 114.87 5.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.332 0.587 . . . . 63.340000000000003 110.689 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.0 -70.23 0.27 Allowed Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.07 -1.612 . . . . 65.430000000000007 109.07 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -115.56 138.36 51.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.168 0.508 . . . . 65.129999999999995 111.638 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.32 154.21 37.57 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.588 -0.893 . . . . 65.0 108.588 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.2 150.97 62.65 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.512 2.141 . . . . 65.409999999999997 111.762 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.14 143.77 25.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.654 0.264 . . . . 62.030000000000001 110.517 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 p -85.15 95.16 9.05 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.865 -0.791 . . . . 52.039999999999999 108.865 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.0 p -84.77 -173.08 4.53 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.781 -0.645 . . . . 60.43 110.821 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.84 3.99 67.49 Favored Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.024 -1.231 . . . . 25.449999999999999 110.024 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 139' ' ' ALA . . . -68.57 -19.18 64.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.076 -1.062 . . . . 64.430000000000007 110.375 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.1 -5.72 37.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.395 0.617 . . . . 70.140000000000001 111.506 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.89 -12.81 23.0 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.58 -0.896 . . . . 64.120000000000005 108.58 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.87 74.07 0.56 Allowed Pre-proline 0 C--O 1.221 -0.408 0 CA-C-N 114.501 -1.227 . . . . 71.299999999999997 109.268 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.42 -57.92 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.235 1.956 . . . . 73.510000000000005 114.104 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.9 -20.21 20.88 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.961 0.726 . . . . 62.530000000000001 112.961 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.78 -4.62 83.58 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 119.978 -1.106 . . . . 53.0 111.383 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.8 m -115.48 163.74 15.31 Favored 'General case' 0 C--O 1.254 1.337 0 N-CA-C 107.9 -1.148 . . . . 71.319999999999993 107.9 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.15 158.32 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.405 -0.185 . . . . 32.340000000000003 111.176 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 48' ' ' LEU . 3.7 pp -131.08 137.19 49.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.14 0.495 . . . . 53.210000000000001 110.177 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.1 pp -117.03 136.84 52.65 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.369 -0.604 . . . . 64.420000000000002 109.369 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.75 130.92 71.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.866 -0.42 . . . . 70.400000000000006 109.866 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 t -79.37 123.12 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.913 -1.143 . . . . 61.43 107.913 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -99.24 -30.28 12.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.259 0.552 . . . . 63.350000000000001 110.033 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -136.53 127.73 28.07 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.485 -0.561 . . . . 64.329999999999998 109.485 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 136.3 175.64 13.93 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.8 -1.32 . . . . 70.219999999999999 109.8 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.57 -31.66 79.84 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 122.428 2.085 . . . . 74.239999999999995 111.817 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.29 12.78 15.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 75.519999999999996 110.897 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.54 132.18 50.45 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.928 0.394 . . . . 61.43 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -27.4 14.67 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.553 -1.019 . . . . 74.019999999999996 110.553 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.72 142.63 28.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.695 -0.483 . . . . 72.230000000000004 109.695 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.4 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 3.0 ppt_? -122.46 137.3 54.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.894 -0.594 . . . . 65.129999999999995 110.632 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.35 145.54 43.98 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.426 -0.953 . . . . 71.209999999999994 108.426 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -106.37 133.99 50.21 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.251 0.834 . . . . 62.240000000000002 113.251 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 94' ' ' ILE . 1.9 mm? -97.51 104.38 16.4 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.91 -1.885 . . . . 64.519999999999996 105.91 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.59 -0.43 2.16 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.916 0.865 . . . . 50.310000000000002 110.561 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.26 150.81 41.01 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.776 -0.824 . . . . 72.319999999999993 108.776 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.84 -30.17 46.28 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.417 2.745 . . . . 61.549999999999997 113.497 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -146.17 121.78 10.45 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.716 -0.615 . . . . 61.539999999999999 110.26 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 m -118.15 114.19 22.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.551 -0.295 . . . . 52.210000000000001 110.739 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m -87.32 130.18 34.72 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 110.275 -0.269 . . . . 43.240000000000002 110.275 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.63 139.68 53.67 Favored 'General case' 0 C--O 1.272 2.247 0 CA-C-O 121.609 0.719 . . . . 73.010000000000005 112.289 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.24 -160.62 31.43 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.27 -1.532 . . . . 74.5 109.27 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -118.87 116.74 27.12 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.214 -1.773 . . . . 63.140000000000001 106.214 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.642 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.7 t-160 166.87 151.0 0.08 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 104.527 -2.397 . . . . 72.099999999999994 104.527 -173.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 28.1 Cg_endo -64.52 -14.28 43.49 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.246 1.964 . . . . 74.420000000000002 112.281 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.86 -11.15 48.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 112.093 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -72.55 136.65 45.87 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.886 -0.783 . . . . 63.119999999999997 108.886 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.22 -45.07 34.78 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.716 -1.216 . . . . 64.409999999999997 107.716 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -106.32 119.27 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 107.255 -1.387 . . . . 44.329999999999998 107.255 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 81' ' ' ASP . 84.8 t80 -99.28 121.22 40.77 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.851 -0.613 . . . . 62.130000000000003 112.121 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.5 139.88 42.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.278 -2.119 . . . . 74.400000000000006 105.278 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 31.7 t70 -128.05 142.48 51.21 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 110.031 -0.359 . . . . 74.430000000000007 110.031 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -162.37 -161.42 0.73 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.613 -1.625 . . . . 75.310000000000002 106.613 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.92 -36.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.235 0.54 . . . . 73.439999999999998 109.66 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -75.71 152.45 37.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.531 -0.759 . . . . 74.219999999999999 110.521 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.26 99.09 7.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.628 -0.879 . . . . 74.239999999999995 108.628 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -99.07 85.68 3.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.126 -1.065 . . . . 63.25 108.126 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -55.4 -46.08 76.63 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.601 0.563 . . . . 71.349999999999994 111.933 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -155.62 114.28 3.49 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.623 -1.621 . . . . 72.030000000000001 106.623 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.611 ' ND1' HG23 ' A' ' 130' ' ' ILE . 22.0 t-160 -99.74 -51.88 3.61 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.551 -0.86 . . . . 64.310000000000002 109.731 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.15 158.01 41.19 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.316 -0.554 . . . . 72.329999999999998 110.469 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' OE1' HG11 ' A' ' 104' ' ' VAL . 11.9 pt-20 -132.16 148.11 52.46 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-O 121.203 0.525 . . . . 54.340000000000003 110.021 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CD2' HG22 ' A' ' 101' ' ' VAL . 54.8 m-85 -105.14 117.01 32.92 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 75.530000000000001 108.114 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -106.29 133.63 50.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.199 -1.038 . . . . 63.130000000000003 108.199 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 63' ' ' LEU . 23.8 mt -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.563 -0.532 . . . . 73.340000000000003 109.563 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -138.87 121.02 15.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.297 -0.631 . . . . 74.120000000000005 109.297 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 55.76 38.09 29.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.223 1.009 . . . . 75.140000000000001 112.268 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.23 85.0 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.966 -0.635 . . . . 44.350000000000001 114.007 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -102.32 131.71 48.75 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 117.986 0.893 . . . . 74.439999999999998 109.788 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.99 123.62 48.11 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.936 -1.029 . . . . 65.230000000000004 109.177 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.26 137.48 54.2 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.669 -0.493 . . . . 65.340000000000003 109.669 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.451 HG22 ' CD2' ' A' ' 92' ' ' PHE . 29.2 t -103.58 122.61 56.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.212 -1.403 . . . . 65.299999999999997 107.212 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.95 133.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.923 -1.139 . . . . 63.450000000000003 107.923 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.9 148.96 36.12 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.35 0.595 . . . . 72.219999999999999 110.074 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.445 HG11 ' OE1' ' A' ' 91' ' ' GLU . 14.5 m -137.47 27.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.721 -1.214 . . . . 74.400000000000006 107.721 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 156.4 56.86 0.01 OUTLIER Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 113.796 -1.547 . . . . 73.310000000000002 110.41 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t -65.56 11.16 0.07 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.965 1.306 . . . . 61.140000000000001 111.961 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 105' ' ' GLY . 78.4 mt -65.5 -19.88 66.11 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 125.634 1.574 . . . . 64.349999999999994 110.885 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -87.09 -13.54 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.333 -0.394 . . . . 74.549999999999997 110.515 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.01 89.19 1.85 Allowed Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.729 -0.748 . . . . 70.430000000000007 111.253 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -86.6 127.9 34.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.773 -0.825 . . . . 63.310000000000002 108.773 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 81.1 m-85 -136.25 134.06 37.67 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.856 -0.794 . . . . 74.239999999999995 108.856 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.18 117.68 51.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 105.474 -2.047 . . . . 72.239999999999995 105.474 175.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.2 39.11 30.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.676 0.75 . . . . 74.430000000000007 110.172 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 mtm180 69.94 9.02 6.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.954 1.702 . . . . 65.519999999999996 114.851 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -110.24 135.89 20.55 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 110.351 -0.24 . . . . 75.040000000000006 110.351 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.02 135.9 12.69 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.728 2.285 . . . . 70.439999999999998 112.07 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -149.64 -177.62 5.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.281 0.562 . . . . 73.319999999999993 110.249 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.85 -31.02 4.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.259 -1.337 . . . . 72.340000000000003 110.057 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.7 137.31 28.1 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.277 -1.009 . . . . 32.25 108.277 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.505 HE22 ' HA ' ' A' ' 122' ' ' MET . 0.7 OUTLIER -152.44 122.63 7.14 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.277 -0.638 . . . . 55.450000000000003 109.277 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.17 117.56 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 106.963 -1.495 . . . . 71.209999999999994 106.963 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.505 ' HA ' HE22 ' A' ' 120' ' ' GLN . 32.6 ttm -96.87 137.81 35.39 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 114.281 1.215 . . . . 75.129999999999995 114.281 -165.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -114.14 157.25 22.86 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.473 -1.694 . . . . 54.439999999999998 107.745 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.8 t -62.59 133.94 55.63 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.414 0.626 . . . . 65.450000000000003 109.456 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.44 -0.09 56.9 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 121.107 -0.568 . . . . 74.030000000000001 111.887 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -82.38 142.2 32.18 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.932 -0.766 . . . . 72.420000000000002 108.932 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 134' ' ' ARG . 44.4 mt-10 -113.46 132.63 55.58 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.362 0.601 . . . . 75.510000000000005 110.248 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -107.39 132.82 53.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 111' ' ' TYR . 54.2 mt-30 -117.63 117.79 30.34 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.268 0.556 . . . . 61.240000000000002 109.781 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.611 HG23 ' ND1' ' A' ' 89' ' ' HIS . 48.1 mm -109.75 102.27 13.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.973 -1.491 . . . . 70.129999999999995 106.973 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.94 -78.08 0.21 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.406 -0.677 . . . . 43.140000000000001 111.406 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -141.87 5.37 1.74 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.045 0.45 . . . . 72.310000000000002 111.222 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.2 m-85 -78.9 150.44 32.14 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.223 -0.658 . . . . 54.32 109.223 176.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 127' ' ' GLU . 13.8 tpt180 -124.72 118.64 26.91 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.411 -1.7 . . . . 74.430000000000007 106.411 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.43 HD23 HD13 ' A' ' 49' ' ' LEU . 3.8 mp -122.29 140.84 52.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.337 -0.986 . . . . 74.450000000000003 108.337 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.07 122.56 65.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.201 -1.407 . . . . 73.019999999999996 107.201 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -99.31 127.29 45.31 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.077 -0.51 . . . . 75.329999999999998 109.957 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.99 155.54 50.59 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.818 -0.808 . . . . 45.539999999999999 108.818 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.489 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . . . -82.61 142.15 31.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.451 -1.685 . . . . 50.32 106.451 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.44 2.71 Favored Glycine 0 C--N 1.305 -1.192 0 C-N-CA 119.384 -1.389 . . . . 72.209999999999994 113.927 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 139' ' ' ALA . 2.9 Cg_exo -72.79 142.03 34.8 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.974 1.783 . . . . 75.0 109.769 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 179.76 73.71 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.929 0.892 . . . . 73.109999999999999 109.26 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.39 -3.448 0 CA-C-N 114.435 -1.257 . . . . 62.310000000000002 109.413 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.421 -1.883 0 N-CA-C 105.768 -1.938 . . . . 51.25 105.768 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -81.53 114.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 117.675 -1.61 . . . . 74.310000000000002 108.024 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.682 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 45.1 t80 -99.71 116.24 31.35 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.004 -0.998 . . . . 73.209999999999994 108.857 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -81.15 92.07 6.23 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.796 -0.816 . . . . 73.140000000000001 108.796 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.65 -168.41 2.08 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.975 -1.011 . . . . 73.310000000000002 110.926 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.43 -9.71 13.86 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.34 1.056 . . . . 74.5 111.28 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.86 -19.13 65.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.004 0.922 . . . . 71.450000000000003 110.365 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.0 OUTLIER -59.21 -43.71 92.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.331 -0.989 . . . . 73.430000000000007 108.331 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.536 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 7.8 tmtm? -80.47 -29.3 37.46 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.547 -0.909 . . . . 74.450000000000003 108.547 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 129' ' ' GLN . 6.6 tp10 -68.26 -33.9 75.22 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.987 -0.551 . . . . 73.510000000000005 110.705 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 27.5 ptt? -68.57 -21.02 64.55 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.778 -0.369 . . . . 52.240000000000002 110.741 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.04 -33.52 63.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.715 -1.217 . . . . 71.219999999999999 107.715 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -79.94 -14.66 58.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.769 -1.105 . . . . 63.340000000000003 110.884 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 t -67.44 -25.66 66.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.201 -0.666 . . . . 72.140000000000001 109.201 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.92 97.06 5.18 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.883 -1.525 . . . . 72.409999999999997 106.883 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.19 58.91 2.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.379 -1.088 . . . . 64.239999999999995 110.379 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -92.79 149.93 20.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.899 -0.408 . . . . 74.420000000000002 109.899 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.22 101.22 40.97 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.721 -0.474 . . . . 51.109999999999999 109.721 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.549 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 69.3 Cg_endo -75.79 143.52 26.74 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.308 2.005 . . . . 72.409999999999997 111.181 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.12 166.8 22.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.335 -0.393 . . . . 71.25 110.724 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 m -67.71 118.82 11.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.168 -0.469 . . . . 62.210000000000001 110.266 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 124' ' ' THR . 17.8 p -110.93 -161.57 0.76 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.569 0.748 . . . . 64.030000000000001 110.63 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.94 80.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.518 -0.633 . . . . 23.219999999999999 111.518 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.64 -24.51 19.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.927 0.714 . . . . 65.519999999999996 112.927 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.02 0.61 4.33 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.549 1.315 . . . . 73.019999999999996 114.549 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.3 -39.01 15.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.692 -0.855 . . . . 72.420000000000002 108.692 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 90.7 mt 53.18 80.29 0.3 Allowed Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 123.98 0.912 . . . . 72.519999999999996 111.607 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 10.8 Cg_endo -52.79 -67.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 123.649 2.9 . . . . 75.5 114.678 -173.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.38 -0.98 3.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.098 0.475 . . . . 64.510000000000005 111.317 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.6 6.98 82.6 Favored Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.384 -0.912 . . . . 63.409999999999997 112.643 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 m -129.46 158.21 39.84 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 108.118 -1.068 . . . . 71.25 108.118 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.49 41.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.254 -0.276 . . . . 73.349999999999994 110.254 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.442 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.71 139.95 53.4 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.326 0.391 . . . . 74.019999999999996 110.267 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -112.42 137.34 50.75 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.69 -0.855 . . . . 75.319999999999993 108.69 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.73 133.34 61.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.195 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.8 t -78.51 117.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 106.113 -1.81 . . . . 55.439999999999998 106.113 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -86.41 -33.99 20.3 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.545 -0.752 . . . . 73.319999999999993 110.527 -172.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 31.3 tpt180 -154.66 139.7 17.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.232 -1.025 . . . . 71.230000000000004 108.232 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.08 -178.93 20.41 Favored Glycine 0 N--CA 1.437 -1.3 0 O-C-N 123.867 0.729 . . . . 72.430000000000007 111.346 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -70.0 -37.11 9.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.341 2.027 . . . . 74.340000000000003 111.513 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 81' ' ' ASP . 5.0 p30 -90.73 18.52 6.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.352 0.596 . . . . 74.239999999999995 111.167 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.65 145.19 54.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.432 0.693 . . . . 75.040000000000006 111.034 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -14.82 37.06 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.243 -1.143 . . . . 52.240000000000002 110.243 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.86 33.56 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 121.08 -0.248 . . . . 72.150000000000006 110.359 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -134.97 139.25 44.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.816 -1.179 . . . . 73.239999999999995 107.816 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.25 123.16 26.39 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 121.311 -0.155 . . . . 72.340000000000003 110.737 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.5 tp -89.63 115.4 26.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.057 -1.461 . . . . 63.310000000000002 107.057 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.81 106.87 16.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.458 0.647 . . . . 63.310000000000002 111.744 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -102.92 15.27 29.87 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.474 -1.306 . . . . 72.310000000000002 107.474 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 15.7 mt-30 -107.31 141.85 23.83 Favored Pre-proline 0 CA--C 1.468 -2.205 0 CA-C-N 114.714 -1.13 . . . . 73.200000000000003 110.026 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 16.5 Cg_exo -72.03 -13.15 28.74 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.973 1.782 . . . . 74.329999999999998 109.375 169.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.0 m -149.29 125.37 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.281 0.563 . . . . 61.229999999999997 110.67 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.3 m -131.51 139.48 49.29 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.366 -0.976 . . . . 64.209999999999994 108.366 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.24 -0.913 . . . . 70.450000000000003 110.319 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.58 143.41 46.14 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.764 -0.828 . . . . 63.149999999999999 108.764 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.96 -147.07 6.39 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 111.361 -0.696 . . . . 73.439999999999998 111.361 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -90.91 147.9 22.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 122.591 0.357 . . . . 64.239999999999995 110.951 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.46 169.76 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.65 1.18 . . . . 75.310000000000002 112.291 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -73.2 6.66 2.48 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.246 1.964 . . . . 74.409999999999997 111.446 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.93 -37.56 67.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.319 -1.363 . . . . 53.229999999999997 107.319 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -78.74 152.82 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.758 -1.11 . . . . 73.120000000000005 108.264 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' OD2' HG23 ' A' ' 68' ' ' THR . 32.0 t70 -64.67 -41.76 95.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.892 0.377 . . . . 71.129999999999995 111.094 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.0 126.81 67.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.306 -0.998 . . . . 72.099999999999994 108.306 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -88.42 129.63 35.38 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.682 0.614 . . . . 74.310000000000002 110.737 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.7 140.3 52.82 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.39 -1.337 . . . . 75.219999999999999 107.39 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.584 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 30.7 t70 -125.4 118.42 25.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.993 -0.549 . . . . 62.149999999999999 109.611 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.34 -175.45 4.78 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.775 -2.306 . . . . 75.049999999999997 104.775 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.24 -34.84 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.368 -0.975 . . . . 74.219999999999999 108.368 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 107' ' ' LEU . 8.2 m -148.63 114.69 5.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.071 -1.085 . . . . 64.299999999999997 108.071 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.2 t -103.94 152.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.513 -0.551 . . . . 44.450000000000003 109.513 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.8 m -72.65 153.07 41.4 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.572 0.349 . . . . 52.530000000000001 110.47 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -69.26 -29.27 67.14 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.922 0.867 . . . . 72.140000000000001 110.767 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 24.0 mtp180 -148.78 120.19 7.9 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 101.666 -3.457 . . . . 72.340000000000003 101.666 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.498 ' CE1' HG23 ' A' ' 130' ' ' ILE . 13.4 t60 -99.65 -52.69 3.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.725 -0.79 . . . . 75.420000000000002 110.483 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.01 146.52 25.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.625 -0.88 . . . . 63.350000000000001 108.625 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 11.0 pt-20 -118.36 129.75 55.61 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.816 -0.629 . . . . 74.540000000000006 109.61 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 26.7 m-85 -105.26 113.06 26.43 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.302 -2.11 . . . . 74.420000000000002 105.302 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 26.2 mtp180 -115.25 127.29 55.39 Favored 'General case' 0 C--N 1.262 -3.2 0 N-CA-C 108.46 -0.941 . . . . 74.420000000000002 108.46 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.7 mp -103.67 113.02 39.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 106.894 -1.521 . . . . 63.149999999999999 106.894 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -119.65 125.06 47.81 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.812 -1.181 . . . . 70.530000000000001 107.812 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.29 34.97 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.994 0.918 . . . . 75.219999999999999 112.576 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.2 -0.15 89.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.078 -0.582 . . . . 64.519999999999996 113.401 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -102.91 150.51 23.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.28 -1.007 . . . . 74.530000000000001 108.28 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -110.1 117.65 34.29 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 121.306 -0.157 . . . . 63.130000000000003 110.745 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.618 -0.882 . . . . 63.530000000000001 108.618 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.0 123.63 68.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.743 -1.206 . . . . 42.439999999999998 107.743 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.24 130.06 73.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.664 -0.865 . . . . 62.340000000000003 108.664 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.42 130.4 37.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.482 -0.933 . . . . 71.430000000000007 108.482 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 12.85 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-N 115.675 -0.693 . . . . 63.420000000000002 109.322 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -154.83 83.01 0.16 Allowed Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.158 -0.928 . . . . 43.25 113.375 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 40.6 m -82.4 15.58 2.43 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.396 . . . . 72.230000000000004 111.176 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.7 tm? -67.2 -50.48 60.76 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 106.539 -1.652 . . . . 74.219999999999999 106.539 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 26.9 t-20 -104.46 -19.86 13.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.992 -0.744 . . . . 72.439999999999998 108.992 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . 83.99 119.32 0.76 Allowed Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.75 1.06 . . . . 52.130000000000003 115.75 168.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.9 m -87.29 128.4 35.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.793 -0.818 . . . . 74.25 108.793 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.41 142.17 51.49 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.185 -1.043 . . . . 64.099999999999994 108.185 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -124.62 117.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.389 -0.967 . . . . 74.310000000000002 108.389 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.549 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 6.8 m-80 50.93 49.03 21.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.798 0.839 . . . . 71.120000000000005 112.993 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 67.21 9.42 6.94 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.481 1.513 . . . . 75.120000000000005 112.303 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -109.97 136.31 20.43 Favored Pre-proline 0 C--N 1.313 -1.004 0 O-C-N 121.936 -0.477 . . . . 65.150000000000006 110.334 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.42 123.81 12.73 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 121.946 1.764 . . . . 40.5 108.652 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -147.41 131.98 17.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.02 -0.733 . . . . 64.549999999999997 109.02 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.79 -35.52 9.02 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.358 0.411 . . . . 75.239999999999995 111.476 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.26 135.26 53.28 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.78 -1.193 . . . . 50.43 107.78 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -146.88 143.61 28.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.513 0.197 . . . . 72.140000000000001 111.391 -175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 114.03 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 103.181 -2.896 . . . . 45.399999999999999 103.181 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.452 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 30.3 ttm -93.91 130.85 39.84 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.778 -1.169 . . . . 55.200000000000003 111.468 -170.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.41 ' OE1' ' HB ' ' A' ' 37' ' ' THR . 40.3 mt-30 -114.03 157.87 21.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 74.409999999999997 109.675 -170.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 14.8 t -63.54 126.57 27.94 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.897 -0.779 . . . . 73.140000000000001 108.897 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.0 -1.66 57.85 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 115.772 -0.649 . . . . 60.32 111.489 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.8 145.74 34.16 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 107.982 -1.118 . . . . 51.109999999999999 107.982 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' H ' ' ND2' ' A' ' 113' ' ' ASN . 36.7 mt-10 -119.93 132.86 55.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.831 -0.433 . . . . 73.019999999999996 109.831 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 mt -107.98 131.59 57.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.044 -0.724 . . . . 53.119999999999997 109.044 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.403 ' HG2' ' HG2' ' A' ' 25' ' ' GLU . 52.3 tp60 -105.53 115.43 30.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.554 -1.276 . . . . 71.140000000000001 107.554 175.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.498 HG23 ' CE1' ' A' ' 89' ' ' HIS . 63.4 mt -125.42 116.8 47.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.086 -1.449 . . . . 60.119999999999997 107.086 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.53 -104.29 0.75 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.668 -0.973 . . . . 62.32 110.668 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.503 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -124.61 5.09 8.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.195 0.522 . . . . 72.219999999999999 109.94 176.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 34.2 p90 -111.14 156.58 21.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.985 -175.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.57 136.74 54.7 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.166 0.508 . . . . 74.310000000000002 111.542 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.17 139.62 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.585 -1.265 . . . . 71.420000000000002 107.585 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.7 t -112.13 131.41 63.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.893 -1.151 . . . . 62.229999999999997 107.893 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 48.7 t80 -103.57 117.02 33.47 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.941 -0.763 . . . . 72.120000000000005 108.941 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.19 131.08 55.8 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.488 -0.56 . . . . 61.409999999999997 109.488 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -111.87 121.93 46.39 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.307 -0.997 . . . . 72.409999999999997 108.307 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.74 -104.89 0.21 Allowed Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.477 -0.868 . . . . 74.409999999999997 111.89 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.19 161.66 45.12 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.004 2.469 . . . . 61.409999999999997 113.596 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.1 24.38 5.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.309 -0.86 . . . . 63.43 109.343 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.435 -1.197 0 C-N-CA 124.961 1.305 . . . . 71.530000000000001 113.462 -176.668 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 105.883 -1.895 . . . . 72.150000000000006 105.883 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 t -85.9 130.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 117.8 0.273 . . . . 74.140000000000001 110.415 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -96.48 131.9 42.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.432 -0.507 . . . . 74.299999999999997 109.64 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.54 91.69 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.69 -0.485 . . . . 74.030000000000001 109.69 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.49 -84.22 0.07 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.122 0.416 . . . . 22.149999999999999 112.122 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.32 -35.48 65.18 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.497 1.119 . . . . 74.209999999999994 112.505 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.8 mt -57.85 -12.29 3.01 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.887 1.275 . . . . 74.230000000000004 113.904 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.4 tp -80.07 -16.32 55.3 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.714 0.405 . . . . 73.120000000000005 111.066 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.85 -39.65 89.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.415 1.265 . . . . 62.219999999999999 114.415 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -72.57 -14.48 61.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.239 0.829 . . . . 75.010000000000005 113.239 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.4 ttp -60.25 -30.69 69.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.367 0.603 . . . . 71.310000000000002 110.376 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.77 -16.74 63.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.367 -0.833 . . . . 53.310000000000002 111.91 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -78.38 -17.95 55.74 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.936 -0.394 . . . . 71.209999999999994 109.936 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.0 m -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.355 0.598 . . . . 73.120000000000005 110.889 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -81.79 111.44 18.03 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 115.523 -0.762 . . . . 65.329999999999998 109.757 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.0 -79.95 0.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.827 -0.701 . . . . 62.009999999999998 113.702 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -105.69 121.36 43.86 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.225 0.536 . . . . 71.129999999999995 111.707 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.61 136.12 28.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.516 -0.92 . . . . 71.239999999999995 108.516 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.42 154.55 73.85 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.319 2.012 . . . . 70.420000000000002 110.199 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.31 169.06 16.51 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 116.32 -0.4 . . . . 73.010000000000005 110.378 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 p -57.03 136.7 56.32 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.069 0.856 . . . . 71.019999999999996 110.411 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 m -118.22 1.7 11.91 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.204 0.526 . . . . 64.010000000000005 111.968 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 15.21 56.36 Favored Glycine 0 CA--C 1.488 -1.624 0 N-CA-C 108.107 -1.997 . . . . 63.109999999999999 108.107 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.13 -8.95 47.3 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.898 -1.651 . . . . 72.439999999999998 109.379 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.22 -11.4 60.77 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.627 1.571 . . . . 74.040000000000006 111.063 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.63 -22.79 43.15 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.832 -1.531 . . . . 70.439999999999998 109.425 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.66 67.58 1.51 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.255 -0.646 . . . . 54.329999999999998 109.255 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.08 -54.56 4.21 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.831 3.021 . . . . 73.430000000000007 114.914 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.14 -15.04 45.15 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.273 0.472 . . . . 64.019999999999996 112.273 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.51 -11.89 70.85 Favored Glycine 0 C--N 1.319 -0.387 0 N-CA-C 110.788 -0.925 . . . . 24.550000000000001 110.788 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.0 m -127.21 162.38 26.32 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.525 -1.658 . . . . 62.229999999999997 106.525 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -141.38 157.32 45.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.253 -0.647 . . . . 70.140000000000001 109.253 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -121.57 149.08 43.66 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.225 0.536 . . . . 74.310000000000002 111.831 -175.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -111.04 132.24 54.39 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.568 -0.901 . . . . 73.340000000000003 108.568 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.05 134.25 51.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.404 -0.591 . . . . 73.420000000000002 109.404 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.46 117.9 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.835 -1.543 . . . . 73.5 106.835 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -93.53 -30.97 14.73 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.052 -0.522 . . . . 72.420000000000002 111.46 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' CZ ' ' H ' ' A' ' 54' ' ' GLY . 2.7 tpm_? -144.52 141.19 29.34 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.583 -0.447 . . . . 73.430000000000007 109.961 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.458 ' H ' ' CZ ' ' A' ' 53' ' ' ARG . . . 128.8 168.1 12.32 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.942 -1.663 . . . . 63.32 108.942 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.4 Cg_exo -55.26 -29.58 67.78 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.46 2.107 . . . . 54.5 113.438 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -91.7 14.51 15.03 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.529 0.566 . . . . 71.219999999999999 112.529 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.51 143.07 58.18 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.191 0.52 . . . . 54.520000000000003 111.567 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.79 -23.15 34.75 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 115.408 -0.814 . . . . 72.409999999999997 111.243 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.57 149.31 22.2 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.771 0.319 . . . . 32.25 110.458 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 2.0 ppt_? -123.95 141.14 52.3 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.751 -0.463 . . . . 72.219999999999999 109.751 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -119.24 125.62 49.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.11 -0.7 . . . . 70.109999999999999 109.11 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.8 tp -93.67 136.19 34.2 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 74.0 107.809 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.84 104.7 16.6 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.937 -0.705 . . . . 71.019999999999996 110.09 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -116.46 -9.76 11.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.509 -1.223 . . . . 73.219999999999999 107.707 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 94' ' ' ILE . 15.1 pm0 -106.9 139.81 20.76 Favored Pre-proline 0 N--CA 1.425 -1.688 0 CA-C-N 114.871 -1.059 . . . . 74.010000000000005 109.728 -173.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 31.0 Cg_endo -64.18 -14.52 44.21 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.471 2.78 . . . . 73.129999999999995 114.182 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -148.02 127.55 13.23 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.216 -0.927 . . . . 74.030000000000001 112.015 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 45.7 m -124.15 113.54 18.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.312 -0.996 . . . . 73.239999999999995 108.312 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -89.43 134.89 33.89 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.329 -0.619 . . . . 64.230000000000004 109.329 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.5 147.0 44.09 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.514 0.673 . . . . 62.310000000000002 111.585 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -169.78 21.38 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 107.867 -2.093 . . . . 73.040000000000006 107.867 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -115.61 118.34 32.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.78 -1.563 . . . . 73.310000000000002 106.78 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 44.6 p-80 176.38 162.05 0.46 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 106.381 -1.711 . . . . 75.409999999999997 106.381 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 8.3 Cg_endo -48.74 -36.64 33.56 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 123.925 3.083 . . . . 74.120000000000005 115.146 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -90.81 16.2 9.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.771 1.026 . . . . 73.409999999999997 113.771 -177.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.4 p -66.05 112.28 3.78 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.167 -0.679 . . . . 62.549999999999997 109.167 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 68' ' ' THR . 27.3 t0 -77.52 -34.67 53.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.415 -0.957 . . . . 64.430000000000007 108.415 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.99 117.95 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.992 -1.484 . . . . 52.240000000000002 106.992 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -95.19 116.93 29.39 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.321 0.582 . . . . 61.140000000000001 110.959 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 2.2 mm? -123.19 139.94 53.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.032 -2.21 . . . . 74.200000000000003 105.032 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 55' ' ' PRO . 4.5 p-10 -79.68 127.15 31.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.903 0.858 . . . . 72.219999999999999 109.533 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.92 146.15 39.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.839 -1.073 . . . . 63.350000000000001 111.648 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.38 -43.27 20.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.478 -0.934 . . . . 75.150000000000006 108.478 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.405 ' HB ' ' CD2' ' A' ' 107' ' ' LEU . 45.2 m -133.53 158.0 44.23 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.517 -2.031 . . . . 63.32 105.517 176.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.97 99.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.773 0.797 . . . . 75.430000000000007 112.754 -165.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -104.14 101.76 11.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.262 -1.335 . . . . 71.109999999999999 107.584 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 6.7 ppt_? -57.16 -31.72 65.67 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.691 0.62 . . . . 75.099999999999994 112.349 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 43.6 ttm180 -159.97 132.51 6.51 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.597 -1.631 . . . . 71.510000000000005 106.597 172.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -98.67 -52.75 3.51 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.644 0.59 . . . . 74.340000000000003 110.456 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 164.6 34.45 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.335 -0.393 . . . . 71.219999999999999 110.605 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.96 130.94 54.04 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.371 -0.974 . . . . 61.450000000000003 108.371 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 9.1 m-85 -105.66 113.47 27.05 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.212 -1.773 . . . . 55.420000000000002 106.212 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -112.21 141.61 45.69 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.37 -0.532 . . . . 64.329999999999998 110.524 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.5 mp -113.78 112.72 41.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 105.117 -2.179 . . . . 65.150000000000006 105.117 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -131.48 126.55 35.29 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.939 -0.573 . . . . 72.25 109.551 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 55.67 36.21 26.76 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 125.194 1.398 . . . . 65.140000000000001 110.08 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.75 -2.0 75.76 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 115.492 -0.776 . . . . 61.32 113.685 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.22 150.33 25.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.37 0.585 . . . . 73.530000000000001 109.94 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.401 ' CD2' HG13 ' A' ' 94' ' ' ILE . 49.8 m-85 -106.43 131.51 53.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.55 -0.295 . . . . 75.400000000000006 110.612 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.42 147.21 52.1 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.754 -0.461 . . . . 71.230000000000004 109.754 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.28 123.17 64.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.388 -1.338 . . . . 50.130000000000003 107.388 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.91 122.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.346 0.593 . . . . 73.430000000000007 110.364 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -83.23 137.83 33.86 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.437 -0.801 . . . . 72.299999999999997 109.646 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.6 12.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.488 -0.778 . . . . 71.219999999999999 109.489 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.75 79.65 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.286 -0.959 . . . . 73.109999999999999 112.817 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -71.37 33.55 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 123.588 0.755 . . . . 55.420000000000002 112.209 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.405 ' CD2' ' HB ' ' A' ' 84' ' ' THR . 4.3 tt -62.81 -42.34 99.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.545 -0.909 . . . . 60.43 108.545 -176.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -86.42 -4.1 59.11 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.506 -1.225 . . . . 74.230000000000004 109.374 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 88.87 1.01 Allowed Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.992 -0.623 . . . . 71.200000000000003 112.683 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -87.51 127.71 35.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.991 -0.374 . . . . 74.200000000000003 109.991 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.8 m-85 -136.37 141.73 43.71 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 109.968 -0.382 . . . . 70.230000000000004 109.968 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.7 117.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.442 -2.059 . . . . 72.25 105.442 172.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 56.71 38.65 29.68 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.859 0.837 . . . . 71.120000000000005 110.141 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.486 HH12 ' NH2' ' A' ' 134' ' ' ARG . 75.1 mtm-85 62.79 13.02 6.13 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.339 -1.3 . . . . 74.140000000000001 114.118 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -104.06 130.3 23.64 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.735 -1.58 . . . . 73.430000000000007 106.735 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.13 123.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.586 1.524 . . . . 72.450000000000003 109.701 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -142.18 140.12 32.28 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.69 -1.226 . . . . 71.519999999999996 107.69 -172.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.2 -47.06 4.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.194 0.521 . . . . 73.310000000000002 110.189 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.14 136.47 54.6 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.775 -0.824 . . . . 73.239999999999995 108.775 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -148.49 143.88 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.737 -0.665 . . . . 74.549999999999997 110.454 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.51 114.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 102.967 -2.975 . . . . 72.319999999999993 102.967 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.6 ttp -90.03 129.39 36.35 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.482 0.658 . . . . 74.409999999999997 110.833 -169.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -129.18 157.68 41.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.86 -1.064 . . . . 62.009999999999998 108.807 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -58.92 133.7 56.29 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.883 -0.599 . . . . 61.25 109.972 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.64 -4.8 56.62 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.586 -0.734 . . . . 74.129999999999995 111.752 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -88.69 140.06 29.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.202 -0.666 . . . . 54.539999999999999 109.202 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -117.07 145.11 43.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.811 -0.811 . . . . 74.540000000000006 108.811 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.0 127.63 72.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.159 -0.682 . . . . 70.540000000000006 109.159 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 44.9 tt0 -104.86 122.08 45.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.209 -1.404 . . . . 74.140000000000001 107.209 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.74 101.75 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.091 -1.818 . . . . 62.509999999999998 106.091 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.48 -110.96 3.06 Favored Glycine 0 C--N 1.306 -1.097 0 C-N-CA 120.864 -0.684 . . . . 51.219999999999999 112.107 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -96.86 -3.52 41.88 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.981 0.513 . . . . 51.450000000000003 110.435 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.587 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.3 m-85 -95.11 139.15 31.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 109.798 -0.445 . . . . 72.109999999999999 109.798 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.486 ' NH2' HH12 ' A' ' 114' ' ' ARG . 81.1 ttt180 -124.81 119.43 28.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.446 -0.946 . . . . 74.200000000000003 108.446 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.7 mt -110.21 138.64 46.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.594 -0.891 . . . . 75.120000000000005 108.594 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.93 120.7 64.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.855 -1.165 . . . . 73.540000000000006 107.855 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 85.6 t80 -97.14 117.77 32.07 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.355 0.409 . . . . 75.329999999999998 110.29 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.16 143.76 49.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.08 0.467 . . . . 73.120000000000005 110.128 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.47 119.81 38.61 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.051 0.453 . . . . 72.409999999999997 110.244 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.46 174.44 40.5 Favored Glycine 0 C--N 1.287 -2.164 0 N-CA-C 109.436 -1.465 . . . . 34.420000000000002 109.436 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.47 141.22 38.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 119.091 1.445 . . . . 61.210000000000001 109.66 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.55 26.67 0.13 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.889 -1.152 . . . . 64.420000000000002 107.889 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.407 -2.589 0 CA-C-N 114.498 -1.228 . . . . 74.420000000000002 108.315 -177.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 121.038 0.447 . . . . 72.010000000000005 111.997 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 115.64 26.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 72.120000000000005 108.649 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -123.12 117.79 26.21 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.637 -0.71 . . . . 74.310000000000002 110.144 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -82.76 101.24 10.78 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.691 -1.966 . . . . 72.510000000000005 105.691 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 108.75 1.71 Allowed 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.489 -0.778 . . . . 53.200000000000003 110.474 -177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 35.5 t70 -60.1 -24.16 64.41 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.659 0.742 . . . . 70.120000000000005 110.263 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -65.81 -3.81 5.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.645 -1.161 . . . . 74.310000000000002 113.142 178.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.83 -24.62 58.24 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.122 0.487 . . . . 65.450000000000003 111.287 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 21' ' ' ASP . 49.6 mtmt -66.82 -28.95 68.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.836 -0.62 . . . . 74.430000000000007 110.857 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -26.31 62.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.478 -0.328 . . . . 61.210000000000001 110.855 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.3 mtm -65.93 -40.35 91.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.93 -0.767 . . . . 64.439999999999998 108.93 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.91 -40.28 94.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.033 -0.985 . . . . 73.040000000000006 109.557 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 m -73.01 -27.75 61.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.536 -0.756 . . . . 61.119999999999997 111.044 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -74.05 -30.48 62.42 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 109.921 -0.4 . . . . 63.439999999999998 109.921 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 127.88 34.29 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.941 -1.027 . . . . 61.539999999999999 109.341 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.22 -42.69 1.28 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 107.674 -2.17 . . . . 63.539999999999999 107.674 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.6 m -115.77 121.95 43.99 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.474 -1.306 . . . . 72.519999999999996 107.474 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -90.39 138.52 26.95 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.008 -0.738 . . . . 74.310000000000002 109.008 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 7.9 Cg_exo -73.52 142.24 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.701 1.6 . . . . 45.039999999999999 111.468 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.13 126.48 46.38 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.081 -1.081 . . . . 73.319999999999993 108.081 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 123' ' ' GLN . 12.9 m -137.96 110.88 7.71 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.631 -0.507 . . . . 75.400000000000006 109.631 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.6 m -154.18 142.4 20.44 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.733 -1.21 . . . . 74.200000000000003 107.733 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -15.01 3.63 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.114 -1.041 . . . . 52.420000000000002 112.166 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.13 59.04 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.299 -0.63 . . . . 61.530000000000001 109.299 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -79.8 3.7 18.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.188 -0.914 . . . . 73.310000000000002 111.671 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.28 -27.89 18.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.085 -0.709 . . . . 75.310000000000002 109.085 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 46.65 77.93 0.43 Allowed Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.331 1.052 . . . . 62.539999999999999 113.665 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -70.22 -61.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.508 1.472 . . . . 71.349999999999994 111.537 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.05 -13.79 18.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 111.567 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.17 17.52 74.04 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.711 -0.955 . . . . 73.430000000000007 110.711 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -150.44 167.08 28.19 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 105.902 -1.888 . . . . 25.120000000000001 105.902 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -152.12 157.9 42.21 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 118.446 0.566 . . . . 63.420000000000002 111.278 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -121.2 154.53 36.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.129 0.49 . . . . 63.340000000000003 111.916 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.42 141.37 51.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.966 -0.753 . . . . 63.399999999999999 108.966 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.68 134.36 59.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.891 -0.411 . . . . 64.299999999999997 109.891 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 t -86.63 118.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 108.103 -1.073 . . . . 63.340000000000003 108.103 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -92.27 -32.2 15.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 111.336 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -143.47 136.73 27.97 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.422 -0.511 . . . . 75.319999999999993 110.096 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.86 174.84 13.84 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.2 -1.16 . . . . 63.340000000000003 110.2 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -55.43 -32.05 80.36 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.649 2.233 . . . . 74.200000000000003 112.793 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.44 10.48 25.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.256 0.465 . . . . 73.109999999999999 112.256 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.27 57.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.902 0.319 . . . . 70.420000000000002 111.444 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.16 -16.78 55.19 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.509 -0.636 . . . . 32.439999999999998 111.509 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.63 139.01 31.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.907 0.384 . . . . 54.200000000000003 110.324 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -122.79 134.55 54.42 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.58 118.65 30.73 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.546 -0.297 . . . . 74.319999999999993 110.338 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -87.55 111.76 21.54 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.31 -0.996 . . . . 72.140000000000001 108.31 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -95.0 117.26 29.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.342 0.591 . . . . 73.310000000000002 109.653 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -122.02 14.03 10.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.846 -1.07 . . . . 72.209999999999994 108.835 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -108.47 156.46 38.62 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 64.310000000000002 109.521 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 38.2 Cg_endo -69.18 -20.68 37.25 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.175 1.917 . . . . 65.230000000000004 114.527 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.5 m -153.53 127.17 8.74 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.29 -0.881 . . . . 75.140000000000001 111.858 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -126.25 112.86 16.23 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.979 -1.119 . . . . 74.299999999999997 107.979 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 77.7 m -89.07 139.18 30.72 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.39 -0.524 . . . . 73.400000000000006 109.624 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.01 135.61 54.85 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.358 0.599 . . . . 60.32 110.912 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.05 -160.21 33.1 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.731 -2.148 . . . . 61.229999999999997 107.731 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -115.72 116.81 28.7 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 151.43 153.23 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 127.48 2.312 . . . . 61.409999999999997 107.228 177.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.95 -9.97 25.22 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.397 2.065 . . . . 75.099999999999994 111.79 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.52 -17.84 61.17 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.746 0.818 . . . . 62.350000000000001 110.248 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 m -90.07 150.02 22.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.218 -1.401 . . . . 62.200000000000003 107.218 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.31 -45.95 24.56 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.702 -0.851 . . . . 74.430000000000007 108.702 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.8 pt -106.16 130.51 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.086 -1.079 . . . . 75.420000000000002 108.086 174.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -94.26 108.12 20.03 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.954 -0.566 . . . . 74.409999999999997 109.996 -173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.74 116.25 32.33 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.992 -1.485 . . . . 72.450000000000003 106.992 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.03 117.04 13.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.931 0.395 . . . . 73.200000000000003 110.227 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -107.62 165.97 11.03 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.815 -0.63 . . . . 65.109999999999999 109.55 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.55 -28.68 32.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.963 0.887 . . . . 73.239999999999995 108.786 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -111.03 173.93 6.1 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.588 -1.634 . . . . 54.329999999999998 106.588 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.48 96.91 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 N-CA-C 106.018 -1.845 . . . . 63.340000000000003 106.018 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 m -105.13 106.74 17.37 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.65 -0.87 . . . . 75.420000000000002 108.65 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -56.29 -42.04 76.88 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.787 1.032 . . . . 74.5 113.787 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -148.7 129.31 14.05 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.857 -1.164 . . . . 73.129999999999995 107.857 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 4.1 t60 -100.29 -52.19 3.45 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.776 -1.194 . . . . 73.030000000000001 107.776 172.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.15 163.98 38.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.147 -1.057 . . . . 71.310000000000002 108.147 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 12.7 pt-20 -138.34 148.42 44.55 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.248 0.547 . . . . 74.230000000000004 110.631 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -105.29 131.72 52.39 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.18 -1.415 . . . . 71.439999999999998 107.18 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -122.95 130.93 53.44 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 116.319 -0.401 . . . . 60.509999999999998 110.444 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 46.3 mt -116.09 112.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.553 -2.017 . . . . 33.43 105.553 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -139.83 125.71 19.59 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.731 -0.47 . . . . 73.450000000000003 109.731 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 55.87 38.02 29.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.103 0.961 . . . . 73.239999999999995 112.353 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.52 -0.31 89.26 Favored Glycine 0 C--O 1.223 -0.564 0 C-N-CA 121.16 -0.543 . . . . 30.140000000000001 113.98 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -106.47 136.86 45.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.005 0.402 . . . . 55.210000000000001 110.046 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -107.79 119.51 39.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 71.010000000000005 108.127 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.35 146.64 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.733 -0.604 . . . . 62.299999999999997 112.329 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.04 123.98 58.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.508 -1.664 . . . . 61.130000000000003 106.508 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.43 122.38 68.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.419 -0.956 . . . . 51.310000000000002 108.419 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.12 134.58 35.67 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.994 -0.743 . . . . 73.230000000000004 108.994 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.74 9.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.068 0.461 . . . . 54.439999999999998 109.867 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.63 57.19 0.39 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 108.727 -1.749 . . . . 71.310000000000002 108.727 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 p -68.7 24.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.376 1.871 . . . . 74.400000000000006 114.349 -172.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -106.35 -26.47 11.48 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 116.431 -0.349 . . . . 74.129999999999995 111.546 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.537 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 2.9 m-20 -86.48 -18.94 30.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.601 -0.84 . . . . 73.340000000000003 111.738 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.98 74.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 119.664 -1.255 . . . . 55.149999999999999 113.073 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -87.76 128.56 35.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 110.036 -0.357 . . . . 75.510000000000005 110.036 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.0 m-85 -135.53 136.06 40.87 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.658 -0.867 . . . . 72.25 108.658 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 133.19 60.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.137 -1.431 . . . . 70.319999999999993 107.137 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.52 38.59 29.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.309 1.044 . . . . 74.129999999999995 108.688 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 64.18 14.85 8.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.046 1.498 . . . . 63.119999999999997 115.046 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -124.5 148.66 59.29 Favored Pre-proline 0 C--N 1.308 -1.202 0 C-N-CA 120.204 -0.599 . . . . 63.0 109.423 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 123.43 13.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.801 1.667 . . . . 74.349999999999994 108.502 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 120' ' ' GLN . 17.4 tpp85 -151.07 135.92 17.32 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.634 -0.827 . . . . 75.109999999999999 109.728 -170.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -96.7 -57.6 2.26 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.712 0.633 . . . . 61.219999999999999 110.552 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 134.04 55.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.834 -1.173 . . . . 64.150000000000006 107.834 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HB2' ' CG ' ' A' ' 117' ' ' ARG . 27.7 tp60 -155.08 132.9 11.42 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.226 0.329 . . . . 65.099999999999994 111.228 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.58 130.71 31.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.268 -1.382 . . . . 75.340000000000003 107.268 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.8 ptm -98.87 130.24 45.26 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.103 0.478 . . . . 70.450000000000003 110.183 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 2.8 tp60 -113.53 156.16 24.09 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.861 -0.609 . . . . 45.409999999999997 110.257 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 138' ' ' LEU . 45.2 m -61.34 123.29 17.35 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 122.31 -0.244 . . . . 63.520000000000003 110.379 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.07 -2.03 56.55 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.812 -0.515 . . . . 61.329999999999998 111.812 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.49 146.0 32.94 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 108.525 -0.917 . . . . 64.109999999999999 108.525 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.45 126.69 51.06 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.915 0.864 . . . . 65.329999999999998 110.654 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.41 131.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-N 114.599 -1.182 . . . . 65.219999999999999 108.02 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.2 tt0 -120.63 112.49 18.96 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.868 -1.16 . . . . 73.450000000000003 107.868 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.2 mt -109.66 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.237 -0.892 . . . . 73.439999999999998 109.18 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.19 -89.06 0.41 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.97 -1.252 . . . . 75.420000000000002 109.97 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -134.47 6.13 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.417 -0.586 . . . . 74.409999999999997 109.417 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.1 m-85 -84.59 147.77 26.82 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -124.88 120.06 30.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.84 -0.8 . . . . 73.319999999999993 108.84 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.33 138.07 50.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.387 -1.338 . . . . 64.109999999999999 107.387 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.11 127.13 74.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 107.539 -1.282 . . . . 72.150000000000006 107.539 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -95.49 126.95 41.13 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.435 0.459 . . . . 75.209999999999994 111.062 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HA ' HG23 ' A' ' 124' ' ' THR . 2.9 mm? -127.23 159.92 32.86 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.028 -0.73 . . . . 75.400000000000006 109.028 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.41 38.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.103 -0.703 . . . . 73.420000000000002 109.103 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.93 155.26 53.55 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.172 -0.537 . . . . 63.049999999999997 112.256 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -71.18 142.85 42.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.466 2.111 . . . . 75.150000000000006 111.52 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.98 65.27 0.8 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.163 -1.421 . . . . 74.109999999999999 107.163 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.607 -1.633 . . . . 65.540000000000006 108.499 -176.82 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 108.602 -0.888 . . . . 72.400000000000006 108.602 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.63 115.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.746 -0.835 . . . . 64.120000000000005 108.746 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -123.82 140.78 52.65 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.697 -0.683 . . . . 75.219999999999999 110.554 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -97.53 95.58 7.73 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.1 -1.074 . . . . 72.430000000000007 108.1 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.82 38.85 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.668 -1.151 . . . . 74.120000000000005 112.069 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.86 2.18 2.16 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.536 1.135 . . . . 75.219999999999999 113.759 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -13.77 59.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 72.230000000000004 112.758 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -69.03 -19.67 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.342 0.592 . . . . 62.32 109.929 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.09 -22.52 59.47 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.077 -0.51 . . . . 74.099999999999994 110.499 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -77.09 -29.95 55.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.231 0.539 . . . . 61.539999999999999 109.939 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -65.3 -47.47 76.5 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.941 -1.133 . . . . 73.510000000000005 107.941 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.32 -39.86 94.43 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.318 -1.31 . . . . 61.009999999999998 110.251 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 t -60.84 -39.01 87.48 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.786 1.234 . . . . 63.119999999999997 110.884 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB2' ' NH1' ' A' ' 114' ' ' ARG . 31.3 t -81.71 -16.52 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.583 -0.28 . . . . 63.100000000000001 110.512 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 m 71.57 31.63 2.2 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 122.525 1.155 . . . . 71.340000000000003 108.481 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.89 -151.05 19.69 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 115.097 -0.956 . . . . 70.150000000000006 112.04 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -84.78 137.97 32.88 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.144 0.577 . . . . 42.240000000000002 110.433 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.9 115.57 59.43 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 73.140000000000001 108.304 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 142.51 25.99 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.354 2.036 . . . . 74.209999999999994 114.9 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.12 126.51 30.18 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.466 -2.049 . . . . 61.310000000000002 105.466 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' THR . 55.4 p -91.32 -98.43 0.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.253 -0.979 . . . . 63.43 113.445 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -170.34 -169.97 0.89 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.007 1.323 . . . . 71.120000000000005 108.877 -177.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.07 -161.44 31.98 Favored Glycine 1 N--CA 1.386 -4.684 0 N-CA-C 105.961 -2.856 . . . . 54.009999999999998 105.961 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.9 -20.88 20.95 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.887 -1.153 . . . . 73.329999999999998 107.887 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.62 -10.7 59.96 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.193 -1.821 . . . . 64.129999999999995 112.965 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.428 ' O ' HD13 ' A' ' 42' ' ' LEU . 32.4 p-10 -80.39 -33.72 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.377 -0.529 . . . . 73.329999999999998 110.74 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 97' ' ' GLY . 2.1 mm? -128.13 82.92 67.53 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.141 -1.059 . . . . 71.239999999999995 108.141 173.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 4.0 Cg_exo -77.24 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.173 1.915 . . . . 72.109999999999999 111.758 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 142' ' ' ALA . . . -104.48 -7.05 20.08 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.449 -0.574 . . . . 75.310000000000002 109.449 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.06 43.75 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.386 -1.086 . . . . 71.409999999999997 110.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -126.07 149.27 49.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.376 -1.342 . . . . 74.510000000000005 107.376 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.07 157.75 42.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.606 -0.516 . . . . 61.109999999999999 109.606 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.17 142.18 51.44 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 110.003 -0.369 . . . . 70.030000000000001 110.003 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.476 HD13 HD23 ' A' ' 135' ' ' LEU . 3.7 pp -110.17 139.31 45.46 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.902 -0.777 . . . . 71.319999999999993 108.902 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.56 132.59 68.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 109.538 -0.542 . . . . 73.310000000000002 109.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -81.59 117.45 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.048 -1.464 . . . . 43.240000000000002 107.048 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -85.78 -38.22 18.44 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.489 -0.778 . . . . 64.439999999999998 109.119 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 22.6 tpt180 -148.16 136.9 21.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.2 -1.407 . . . . 75.439999999999998 107.2 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.68 -176.55 26.46 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.681 -0.968 . . . . 43.530000000000001 110.681 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 -45.18 12.01 Favored 'Trans proline' 0 C--N 1.327 -0.572 0 C-N-CA 122.519 2.146 . . . . 73.230000000000004 112.145 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -95.11 23.08 5.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 111.83 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 138.77 46.98 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.32 -0.4 . . . . 71.310000000000002 111.286 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.57 -25.8 23.32 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.878 -0.889 . . . . 45.5 110.878 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 150.2 21.81 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.033 0.444 . . . . 41.530000000000001 110.19 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -126.45 153.56 44.88 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.221 -1.029 . . . . 70.310000000000002 108.221 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -128.14 130.18 47.69 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.82 -0.807 . . . . 72.439999999999998 108.82 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 tp -95.53 130.8 42.25 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.997 -0.547 . . . . 73.530000000000001 110.197 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -107.31 105.19 15.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.044 -1.095 . . . . 65.010000000000005 108.044 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.42 14.89 6.08 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.847 1.308 . . . . 63.310000000000002 107.709 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -114.43 155.01 46.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 113.825 -1.534 . . . . 61.229999999999997 108.507 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 66.5 Cg_endo -72.79 -14.64 26.9 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.734 2.289 . . . . 73.329999999999998 113.61 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 95.3 m -153.22 128.94 10.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.562 -0.711 . . . . 71.340000000000003 110.54 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 15.4 m -130.09 126.89 38.67 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.66 -0.496 . . . . 71.439999999999998 109.66 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.0 m -90.55 129.59 36.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.639 -0.874 . . . . 64.310000000000002 108.639 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.02 134.56 55.12 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.364 0.602 . . . . 55.119999999999997 110.66 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.37 -170.09 33.37 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.438 -2.665 . . . . 61.310000000000002 106.438 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -105.96 118.18 35.95 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.946 1.373 . . . . 71.340000000000003 110.396 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.414 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 17.7 m170 -172.84 152.02 2.34 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 127.184 2.194 . . . . 65.129999999999995 106.06 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.83 -17.6 28.95 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 121.627 1.552 . . . . 64.219999999999999 108.952 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 73' ' ' HIS . 8.7 mm-40 -76.81 -26.84 54.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.952 -1.476 . . . . 74.150000000000006 110.035 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 45.6 m -67.61 132.25 47.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.707 -0.849 . . . . 64.120000000000005 108.707 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.72 -41.44 95.96 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.08 -0.711 . . . . 60.420000000000002 109.08 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.6 pt -107.64 118.8 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.646 -0.872 . . . . 73.219999999999999 108.646 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.54 109.42 20.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.755 0.788 . . . . 74.430000000000007 110.512 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.16 140.37 49.6 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.438 -1.69 . . . . 71.239999999999995 106.438 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.32 117.67 34.65 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.363 -0.977 . . . . 73.510000000000005 108.363 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -102.62 173.85 6.16 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.927 -1.033 . . . . 71.209999999999994 111.956 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -66.14 -30.94 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 124.316 1.047 . . . . 71.010000000000005 108.732 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 m -117.17 163.1 16.8 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 106.899 -1.519 . . . . 52.229999999999997 106.899 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.32 96.92 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 N-CA-C 104.434 -2.432 . . . . 74.219999999999999 104.434 168.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 131.54 39.66 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.494 -0.775 . . . . 71.530000000000001 110.326 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 87' ' ' ARG . 36.9 mtt180 -74.23 -47.59 34.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 123.224 1.488 . . . . 72.450000000000003 107.117 -175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -149.54 115.55 5.69 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 112.557 -2.11 . . . . 72.430000000000007 107.807 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -99.22 -47.2 5.28 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.735 -0.839 . . . . 65.230000000000004 108.735 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.54 151.51 40.32 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.895 -0.78 . . . . 60.200000000000003 108.895 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.8 134.55 54.41 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.902 -1.147 . . . . 52.409999999999997 107.902 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.7 m-85 -105.2 121.43 43.83 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.257 -1.016 . . . . 74.010000000000005 108.257 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -115.85 123.74 48.93 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.171 -1.048 . . . . 63.299999999999997 108.171 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.9 mp -104.49 123.15 58.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 106.609 -1.626 . . . . 63.310000000000002 106.609 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -136.87 123.66 21.24 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.986 -1.116 . . . . 72.5 107.986 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 56.13 36.13 26.87 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.605 1.162 . . . . 71.409999999999997 111.102 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' HD12 ' A' ' 42' ' ' LEU . . . 78.97 -0.32 79.2 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 113.374 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.7 149.7 23.88 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.002 -0.74 . . . . 73.430000000000007 109.002 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.8 117.54 33.11 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.126 -0.488 . . . . 63.219999999999999 110.089 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.78 129.93 55.51 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.152 0.501 . . . . 71.120000000000005 109.658 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.49 124.6 59.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.526 -0.916 . . . . 63.509999999999998 108.526 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.22 137.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.257 -0.646 . . . . 62.030000000000001 109.257 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.81 140.94 30.02 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.64 -0.709 . . . . 64.420000000000002 110.841 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.63 14.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 122.39 1.09 . . . . 74.439999999999998 108.555 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.93 48.48 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.572 -1.411 . . . . 72.109999999999999 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -60.06 -2.6 0.45 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.876 1.67 . . . . 75.230000000000004 113.631 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.14 -26.0 17.62 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.447 -0.575 . . . . 75.430000000000007 109.447 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -94.71 -18.65 21.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 73.219999999999999 111.83 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.92 77.1 1.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.012 -1.089 . . . . 61.109999999999999 112.643 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.1 m -87.02 128.68 35.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.014 0.435 . . . . 75.109999999999999 110.388 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 35.9 m-85 -133.64 127.41 32.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.261 -0.427 . . . . 72.319999999999993 110.516 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.15 137.66 55.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 105.398 -2.075 . . . . 64.230000000000004 105.398 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 57.3 33.77 23.78 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 106.738 -1.579 . . . . 64.239999999999995 106.738 -166.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.496 ' NH1' ' HB2' ' A' ' 29' ' ' SER . 73.6 mtt180 57.94 11.43 1.43 Allowed 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 123.187 0.595 . . . . 63.340000000000003 111.655 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -107.7 144.47 29.36 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 124.388 1.075 . . . . 75.219999999999999 110.248 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.14 123.93 12.26 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.089 1.859 . . . . 64.209999999999994 108.787 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 117' ' ' ARG . 3.7 mmp_? -135.82 155.85 49.71 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.667 0.988 . . . . 73.150000000000006 113.667 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -99.2 -41.85 7.31 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.9 -1.5 . . . . 62.219999999999999 107.434 171.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.4 143.61 25.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.52 -1.218 . . . . 71.310000000000002 108.197 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 138.15 19.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.011 -1.107 . . . . 54.509999999999998 108.011 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.73 116.7 40.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 105.412 -2.07 . . . . 75.019999999999996 105.412 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 77.4 mtp -89.75 149.08 22.88 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 114.163 1.172 . . . . 64.129999999999995 114.163 -168.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -112.43 157.38 21.14 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.661 -1.609 . . . . 61.420000000000002 107.778 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.6 t -66.27 127.39 32.01 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.169 -0.613 . . . . 73.129999999999995 109.829 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 0.03 57.32 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.266 -0.734 . . . . 71.439999999999998 111.266 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -82.77 152.27 25.77 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.964 -0.384 . . . . 72.019999999999996 109.964 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -115.71 144.18 44.32 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.263 0.554 . . . . 75.420000000000002 112.237 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.6 mt -117.91 131.88 69.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.442 . . . . 74.420000000000002 107.108 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 111' ' ' TYR . 54.9 mt-30 -117.84 120.55 38.23 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.56 -0.904 . . . . 73.319999999999993 108.56 175.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.75 114.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.301 -0.863 . . . . 70.010000000000005 108.836 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.0 -80.98 0.57 Allowed Glycine 0 C--O 1.206 -1.594 0 N-CA-C 110.006 -1.238 . . . . 35.130000000000003 110.006 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -154.87 8.28 0.3 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.436 0.294 . . . . 72.299999999999997 111.112 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 31.1 p90 -107.39 160.29 15.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.881 -0.785 . . . . 62.43 108.881 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -124.76 137.82 54.31 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.234 -0.986 . . . . 64.120000000000005 112.329 -168.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.476 HD23 HD13 ' A' ' 49' ' ' LEU . 3.0 mp -122.32 139.82 53.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.698 -1.223 . . . . 75.209999999999994 107.698 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.12 124.93 69.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.768 -1.197 . . . . 55.32 107.768 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -98.28 118.26 34.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.188 -0.671 . . . . 75.25 109.188 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.4 mt -122.34 131.67 54.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.972 -0.381 . . . . 75.239999999999995 109.972 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.29 119.57 28.82 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.458 -1.682 . . . . 72.219999999999999 106.458 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.01 -70.66 0.29 Allowed Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.519 -1.324 . . . . 73.099999999999994 115.356 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 43' ' ' PRO . 25.7 Cg_exo -57.74 141.28 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.693 1.595 . . . . 71.25 114.785 -172.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . . . -161.84 29.34 0.12 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.011 -2.588 . . . . 71.540000000000006 104.011 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.416 -2.154 0 CA-C-N 112.99 -1.914 . . . . 41.140000000000001 108.31 -169.134 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 110.009 -0.367 . . . . 73.219999999999999 110.009 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 47.1 t -87.17 122.44 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.302 -0.629 . . . . 61.539999999999999 109.302 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -123.66 129.02 50.49 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.872 0.368 . . . . 74.530000000000001 111.855 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -96.55 116.03 28.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.266 -1.753 . . . . 75.129999999999995 106.266 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.36 -166.71 2.63 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.546 -0.862 . . . . 73.239999999999995 113.315 -171.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.16 -14.28 1.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.886 2.074 . . . . 73.040000000000006 115.059 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 22' ' ' LEU . 1.8 pt? -64.66 -23.11 67.15 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.119 -0.363 . . . . 73.439999999999998 111.744 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.19 -22.5 63.9 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.877 0.37 . . . . 72.450000000000003 111.823 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -91.8 -42.04 10.32 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.822 -1.547 . . . . 74.400000000000006 106.822 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -26.37 67.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.642 1.177 . . . . 54.32 109.397 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.6 tpp -51.75 -26.13 8.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.757 1.223 . . . . 65.209999999999994 112.167 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.49 -38.34 86.94 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 120.725 0.298 . . . . 61.340000000000003 110.472 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -72.91 -34.96 66.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.234 -0.654 . . . . 64.439999999999998 109.234 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.45 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 17.9 m -68.81 -30.5 69.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.901 -0.591 . . . . 71.120000000000005 110.065 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.4 m -81.55 107.03 13.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.18 0.514 . . . . 54.420000000000002 110.797 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 179.65 38.69 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 108.997 -1.641 . . . . 44.439999999999998 108.997 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.6 m -74.94 124.16 26.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 117.69 0.745 . . . . 72.099999999999994 109.646 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.45 150.24 38.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 N-CA-C 108.251 -1.018 . . . . 53.210000000000001 108.251 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 125' ' ' GLY . 53.4 Cg_exo -57.18 154.97 31.25 Favored 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.551 2.167 . . . . 52.310000000000002 111.876 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.07 145.67 27.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.695 -0.684 . . . . 33.310000000000002 112.335 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.426 ' HB3' HD21 ' A' ' 41' ' ' ASN . 66.1 m -116.07 148.3 40.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.122 -1.066 . . . . 75.439999999999998 108.122 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -116.74 -60.68 1.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.931 0.396 . . . . 75.140000000000001 111.384 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.83 -63.55 0.18 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.467 -0.653 . . . . 50.009999999999998 111.467 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.56 54.5 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.123 0.487 . . . . 73.409999999999997 110.95 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.52 -5.92 47.62 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.424 -0.807 . . . . 63.219999999999999 111.08 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 36' ' ' SER . 3.1 m-20 -82.09 -42.17 19.54 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.414 -0.812 . . . . 62.420000000000002 110.131 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.32 83.22 60.21 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 109.086 -0.709 . . . . 54.119999999999997 109.086 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.39 -65.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.848 2.365 . . . . 73.150000000000006 112.269 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.13 -16.19 59.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 71.230000000000004 111.012 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.97 -7.44 77.6 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 110.975 -0.85 . . . . 75.340000000000003 110.975 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -120.08 157.08 29.7 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.624 -1.621 . . . . 74.439999999999998 106.624 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.89 156.87 43.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.583 -0.525 . . . . 72.25 109.583 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.95 140.82 52.57 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.996 0.427 . . . . 72.219999999999999 110.712 -178.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.417 HD13 HD23 ' A' ' 135' ' ' LEU . 1.5 pp -112.19 140.73 46.65 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 116.288 -0.414 . . . . 74.420000000000002 110.931 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.71 128.08 71.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.45 118.92 26.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.736 -1.209 . . . . 73.409999999999997 107.736 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -83.4 -32.63 26.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.62 0.724 . . . . 74.299999999999997 110.131 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 20.2 tpp180 -154.01 148.81 26.53 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.992 -1.485 . . . . 72.439999999999998 106.992 -177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.28 -174.85 17.86 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 109.722 -1.351 . . . . 61.520000000000003 109.722 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -65.2 -37.95 29.58 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.309 2.006 . . . . 64.230000000000004 111.029 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.61 14.37 11.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.749 -1.114 . . . . 72.109999999999999 110.862 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 129.32 41.55 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.762 0.315 . . . . 63.210000000000001 111.295 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.0 -26.05 24.38 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.95 -0.568 . . . . 54.229999999999997 112.188 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.81 144.77 29.9 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.839 0.352 . . . . 53.130000000000003 110.133 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -123.69 137.54 54.69 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.992 -0.744 . . . . 73.219999999999999 108.992 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.04 130.56 52.76 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.705 -0.48 . . . . 72.140000000000001 109.705 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.75 128.4 36.67 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.644 -1.243 . . . . 75.340000000000003 107.644 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.731 HD22 HG21 ' A' ' 68' ' ' THR . 26.6 mt -106.78 123.95 48.89 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.057 -1.09 . . . . 61.409999999999997 108.057 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -136.57 1.11 2.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.688 0.996 . . . . 64.450000000000003 113.688 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.545 ' O ' HD13 ' A' ' 94' ' ' ILE . 3.8 pt20 -107.24 152.88 41.33 Favored Pre-proline 0 C--O 1.211 -0.961 0 C-N-CA 119.556 -0.857 . . . . 74.510000000000005 110.13 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 8.8 Cg_endo -52.2 -21.56 13.32 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 124.088 3.192 . . . . 74.310000000000002 114.996 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.7 m -142.51 121.66 12.97 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.723 -0.473 . . . . 71.420000000000002 109.723 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.731 HG21 HD22 ' A' ' 63' ' ' LEU . 67.9 m -129.3 113.27 14.78 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.162 -0.681 . . . . 73.409999999999997 109.162 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -94.28 143.1 26.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.707 -0.797 . . . . 74.420000000000002 109.811 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.16 135.02 54.73 Favored 'General case' 0 C--O 1.279 2.644 0 C-N-CA 122.63 0.372 . . . . 52.420000000000002 111.516 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.22 -142.12 10.24 Favored Glycine 0 N--CA 1.435 -1.401 0 O-C-N 124.759 1.287 . . . . 60.340000000000003 111.882 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 86' ' ' SER . 17.9 mmt85 -88.04 154.74 20.24 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.615 1.966 . . . . 62.299999999999997 110.272 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.433 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 22.9 m170 89.17 130.06 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.718 1.607 . . . . 63.240000000000002 111.057 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.21 -3.22 8.27 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.818 2.345 . . . . 75.230000000000004 113.283 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 13.2 pt-20 -73.56 -25.3 60.31 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.888 -0.782 . . . . 75.109999999999999 108.888 173.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.9 m -78.55 143.62 36.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.335 -1.357 . . . . 61.039999999999999 107.335 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' A' ' 68' ' ' THR . 30.0 t70 -69.44 -45.72 68.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.78 0.324 . . . . 74.010000000000005 111.142 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.3 pt -107.45 109.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 121.859 0.838 . . . . 72.120000000000005 111.032 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -87.86 115.81 25.59 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.514 -1.221 . . . . 71.329999999999998 110.652 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.21 139.98 49.79 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.1 -1.815 . . . . 72.540000000000006 106.1 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -92.2 117.05 29.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.474 -1.29 . . . . 52.240000000000002 110.197 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 171.69 7.82 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 110.24 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.93 -29.38 17.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.343 1.057 . . . . 64.109999999999999 109.76 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.3 t -131.26 -163.17 1.29 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.484 -0.932 . . . . 74.450000000000003 108.484 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -84.05 97.33 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.791 0.805 . . . . 65.450000000000003 109.008 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 16.4 t -95.9 77.83 3.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.879 -1.526 . . . . 64.329999999999998 106.879 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -56.68 -44.48 81.48 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 112.825 0.676 . . . . 74.329999999999998 112.825 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -163.42 97.3 0.88 Allowed 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.108 -1.812 . . . . 75.209999999999994 106.108 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 23.7 t-160 -92.77 -52.04 4.8 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.883 -0.727 . . . . 75.109999999999999 109.483 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -128.25 150.14 50.17 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 118.986 -1.086 . . . . 74.239999999999995 110.246 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.36 134.46 36.0 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.97 -0.752 . . . . 74.430000000000007 108.97 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 30.0 m-85 -104.27 120.31 40.89 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.43 -1.693 . . . . 54.229999999999997 106.43 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -110.19 133.75 52.91 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.61 -1.256 . . . . 72.310000000000002 107.61 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 1.9 mp -103.6 113.47 40.52 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 105.64 -1.985 . . . . 65.530000000000001 105.64 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -130.0 122.52 28.61 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.36 -1.291 . . . . 65.310000000000002 108.19 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 56.54 36.86 28.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.937 0.895 . . . . 71.349999999999994 110.786 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.44 1.69 77.01 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.218 -0.447 . . . . 71.430000000000007 113.873 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.23 152.78 29.34 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.852 0.461 . . . . 75.510000000000005 110.337 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -102.2 117.92 35.79 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.22 0.533 . . . . 73.349999999999994 110.483 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -114.89 131.85 56.72 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.078 -1.082 . . . . 72.010000000000005 108.078 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 48.0 t -103.55 124.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.817 -0.809 . . . . 65.239999999999995 108.817 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.71 129.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 115.586 -0.734 . . . . 75.329999999999998 109.247 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.0 121.9 23.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.495 -1.669 . . . . 53.229999999999997 106.495 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.43 12.42 7.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.032 0.444 . . . . 75.420000000000002 110.853 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . 169.65 83.35 0.05 OUTLIER Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.595 -1.002 . . . . 72.049999999999997 110.595 -178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.8 m -60.63 100.44 0.11 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 122.832 0.453 . . . . 64.319999999999993 110.735 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 tp -73.68 -52.31 13.72 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.988 -1.115 . . . . 74.019999999999996 107.988 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.419 HD22 HD11 ' A' ' 22' ' ' LEU . 55.9 t30 -121.44 -19.15 7.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.092 0.949 . . . . 55.130000000000003 108.613 170.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.08 130.41 3.74 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 108.446 -1.862 . . . . 72.409999999999997 108.446 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 56.3 m -81.73 130.18 34.97 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 117.13 0.465 . . . . 73.230000000000004 109.984 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 98.1 m-85 -105.43 126.24 51.89 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.29 -0.633 . . . . 70.299999999999997 109.29 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.57 122.82 67.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 105.642 -1.984 . . . . 73.420000000000002 105.642 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 56.67 39.65 29.64 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.49 1.138 . . . . 61.420000000000002 108.155 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER 62.5 8.69 3.0 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.267 1.827 . . . . 73.409999999999997 113.44 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.28 134.53 20.44 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.949 -0.76 . . . . 75.540000000000006 108.949 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.8 123.01 12.36 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 121.977 1.784 . . . . 74.400000000000006 109.737 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -145.33 148.71 33.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.959 -0.756 . . . . 63.020000000000003 108.959 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -95.1 -70.16 0.72 Allowed 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.158 -0.682 . . . . 73.340000000000003 109.158 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -124.53 134.47 52.99 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 119.715 -0.794 . . . . 32.450000000000003 109.835 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -155.19 147.04 23.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.095 -0.502 . . . . 74.239999999999995 110.832 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.24 132.12 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.698 -1.593 . . . . 74.549999999999997 106.698 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.2 tpp -90.15 148.79 22.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 112.963 0.727 . . . . 73.150000000000006 112.963 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.2 156.35 28.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.774 -1.103 . . . . 62.509999999999998 108.996 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.7 t -79.56 129.36 34.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.79 0.805 . . . . 64.329999999999998 111.252 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.546 ' O ' ' HD2' ' A' ' 34' ' ' PRO . . . 98.95 -2.84 58.37 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 115.485 -0.779 . . . . 54.030000000000001 111.82 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.97 153.25 21.18 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.403 -0.592 . . . . 70.230000000000004 109.403 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.03 132.18 56.73 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.692 0.758 . . . . 74.25 112.077 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.9 mt -111.16 126.37 68.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.444 -1.317 . . . . 51.130000000000003 107.444 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' ARG . 25.9 tt0 -106.41 114.99 29.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.53 0.681 . . . . 61.420000000000002 110.62 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mm -110.61 133.69 55.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.026 -1.443 . . . . 71.209999999999994 108.09 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.88 -93.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.375 -1.09 . . . . 65.5 110.375 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -140.03 9.06 2.32 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.563 0.345 . . . . 61.5 110.941 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.608 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.0 p90 -131.7 152.53 50.81 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.033 -0.417 . . . . 60.340000000000003 111.775 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -112.83 146.15 39.39 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 114.126 1.158 . . . . 74.439999999999998 114.126 -174.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 49' ' ' LEU . 4.4 mp -114.55 141.79 47.28 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.285 -1.78 . . . . 74.230000000000004 107.454 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -109.4 121.57 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.888 -1.523 . . . . 75.409999999999997 106.888 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -91.65 116.22 28.69 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.681 -0.69 . . . . 75.200000000000003 109.944 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.84 147.93 37.53 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.687 -0.486 . . . . 75.140000000000001 109.687 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.03 142.41 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.776 -0.453 . . . . 71.510000000000005 109.776 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.3 136.53 47.8 Favored Glycine 0 N--CA 1.441 -1.013 0 O-C-N 123.914 0.759 . . . . 63.030000000000001 112.496 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.19 162.46 35.78 Favored 'Trans proline' 0 C--O 1.251 1.156 0 C-N-CA 123.192 2.595 . . . . 61.130000000000003 112.357 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.5 46.02 0.61 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.96 0.886 . . . . 73.510000000000005 110.883 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.421 -1.326 . . . . 73.299999999999997 107.421 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 108.483 -0.932 . . . . 72.329999999999998 108.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 91.2 t -83.56 122.91 38.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.071 -0.344 . . . . 74.209999999999994 110.071 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -115.39 139.91 49.6 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.248 0.547 . . . . 75.420000000000002 110.369 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -88.3 118.23 27.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.421 -0.809 . . . . 74.340000000000003 109.594 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -128.84 169.81 14.13 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.547 -0.752 . . . . 52.439999999999998 110.311 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.19 8.21 24.92 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.989 1.716 . . . . 71.510000000000005 112.145 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -61.28 -4.78 1.3 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.604 1.162 . . . . 75.109999999999999 113.861 -175.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.47 -40.31 86.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.285 0.634 . . . . 64.040000000000006 109.32 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -64.97 -27.71 69.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.78 -0.645 . . . . 73.430000000000007 111.323 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.517 ' HB3' HE22 ' A' ' 129' ' ' GLN . 72.5 mm-40 -69.07 -48.73 61.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.45 -0.341 . . . . 72.019999999999996 110.931 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 ptp -68.74 -17.98 64.14 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.721 0.296 . . . . 73.230000000000004 110.996 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.97 -50.17 4.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 112.079 0.4 . . . . 61.109999999999999 112.079 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 m -102.05 -27.61 12.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.565 1.321 . . . . 74.430000000000007 114.565 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -76.2 -21.67 56.19 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.287 -1.005 . . . . 63.039999999999999 108.287 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -70.58 119.57 14.93 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.655 -1.157 . . . . 62.43 108.429 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.06 -37.25 0.53 Allowed Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 106.909 -2.476 . . . . 55.009999999999998 106.909 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -77.81 122.12 25.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.431 -0.951 . . . . 44.200000000000003 108.431 173.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.64 155.57 62.08 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 116.32 -0.4 . . . . 72.25 109.965 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.03 158.33 21.83 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.95 2.433 . . . . 72.230000000000004 111.669 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.48 156.93 25.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.811 -0.44 . . . . 74.420000000000002 109.811 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -118.26 134.56 54.92 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 108.744 -0.836 . . . . 74.230000000000004 108.744 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.2 p -144.44 162.45 36.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.793 -1.188 . . . . 75.310000000000002 107.793 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.89 18.14 56.29 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.402 -1.079 . . . . 45.420000000000002 110.402 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.1 11.3 23.57 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.396 0.679 . . . . 74.340000000000003 111.179 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.26 3.64 5.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.392 0.677 . . . . 71.420000000000002 112.279 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.04 -16.72 18.58 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.223 -1.029 . . . . 75.329999999999998 108.223 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.2 mm? 58.34 85.68 0.18 Allowed Pre-proline 0 C--O 1.222 -0.37 0 CA-C-N 115.048 -0.978 . . . . 73.409999999999997 111.101 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 18.9 Cg_endo -55.23 -54.04 4.94 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.923 2.415 . . . . 73.200000000000003 113.166 -174.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.46 0.76 51.35 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.251 -0.432 . . . . 61.25 111.108 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 10.8 70.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 116.344 -0.389 . . . . 52.439999999999998 112.928 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 m -124.13 149.45 46.23 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.476 -0.565 . . . . 71.140000000000001 109.476 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.26 157.41 44.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.802 -1.184 . . . . 71.439999999999998 107.802 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.54 155.34 50.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.43 -0.508 . . . . 75.400000000000006 111.328 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.3 pp -119.79 134.53 55.2 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.927 -0.578 . . . . 72.510000000000005 109.812 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.09 132.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.121 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG21 ' ND2' ' A' ' 56' ' ' ASN . 21.8 t -83.55 118.39 30.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.199 -1.037 . . . . 71.420000000000002 108.199 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.74 -31.62 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.554 0.693 . . . . 74.540000000000006 110.338 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 64.6 ttt180 -137.8 136.63 37.41 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.894 -1.15 . . . . 74.109999999999999 107.894 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.27 176.91 15.97 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 110.195 -1.162 . . . . 44.240000000000002 110.195 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.68 -32.89 18.0 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 122.268 1.979 . . . . 72.299999999999997 110.986 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.49 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.2 p-10 -99.67 23.32 9.71 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.959 -1.019 . . . . 71.530000000000001 110.561 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.43 57.6 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.071 -0.513 . . . . 64.120000000000005 110.718 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.94 -18.28 50.16 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.856 -0.898 . . . . 41.299999999999997 110.856 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 147.42 25.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.76 0.314 . . . . 73.349999999999994 110.328 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 60' ' ' ARG . 5.7 ptp180 -124.42 139.23 54.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.937 -1.134 . . . . 74.530000000000001 107.937 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.78 134.7 54.92 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.032 -1.099 . . . . 73.430000000000007 108.032 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tt -104.29 128.59 52.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.64 0.734 . . . . 63.130000000000003 110.703 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 76.1 mt -103.54 107.55 18.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.642 -0.708 . . . . 64.120000000000005 109.768 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -146.64 17.24 1.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.781 1.277 . . . . 60.030000000000001 107.87 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 63' ' ' LEU . 3.3 pm0 -118.12 149.87 46.44 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.294 -1.321 . . . . 74.430000000000007 109.536 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.2 Cg_exo -55.25 -30.66 72.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.148 2.566 . . . . 72.019999999999996 114.453 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 m -149.45 131.68 15.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.686 -0.805 . . . . 63.030000000000001 111.062 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 m -133.81 114.08 12.98 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.298 -0.63 . . . . 75.109999999999999 109.298 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -88.6 132.53 34.51 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.703 -0.851 . . . . 62.140000000000001 108.703 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 140.54 49.83 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 120.915 0.388 . . . . 52.219999999999999 111.257 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.45 -160.42 30.94 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 107.719 -2.152 . . . . 63.530000000000001 107.719 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 35.9 ttp180 -119.31 117.71 29.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.162 0.981 . . . . 75.340000000000003 110.348 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 0.5 OUTLIER 161.54 158.79 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 104.094 -2.558 . . . . 73.349999999999994 104.094 173.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 18.9 Cg_endo -64.54 -9.91 22.32 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 121.969 1.78 . . . . 74.140000000000001 112.229 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.51 -10.98 58.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.645 -0.707 . . . . 35.450000000000003 110.197 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 m -87.25 143.88 27.07 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 106.526 -1.657 . . . . 74.239999999999995 106.526 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.1 -42.78 36.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.849 0.833 . . . . 74.319999999999993 109.883 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.79 132.51 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 107.372 -1.344 . . . . 53.420000000000002 107.372 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -94.02 117.18 29.75 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.401 0.62 . . . . 61.039999999999999 111.913 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.4 140.28 49.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.032 -2.211 . . . . 75.239999999999995 105.032 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 26.7 t70 -91.41 116.22 28.67 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.277 -1.369 . . . . 64.209999999999994 109.17 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.454 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 15.6 t0 -96.21 167.03 11.45 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.46 -0.791 . . . . 74.430000000000007 109.244 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.76 -30.64 29.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.044 0.449 . . . . 71.239999999999995 109.934 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -137.64 -152.81 0.45 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.257 -0.645 . . . . 63.530000000000001 109.257 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.54 98.37 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.554 0.693 . . . . 74.040000000000006 109.941 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.2 m -124.07 84.87 2.33 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.316 -1.364 . . . . 64.530000000000001 107.316 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -62.28 -44.61 96.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.04 -0.982 . . . . 72.510000000000005 111.533 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -118.78 110.93 17.82 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.003 -1.11 . . . . 53.439999999999998 108.003 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.52 ' ND1' HG23 ' A' ' 130' ' ' ILE . 11.1 t-160 -100.22 -50.79 3.84 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.592 -1.262 . . . . 72.239999999999995 107.592 171.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.11 148.85 37.29 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.286 -1.005 . . . . 74.030000000000001 108.286 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -123.83 134.88 53.52 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.469 0.652 . . . . 64.530000000000001 110.043 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.26 124.73 50.03 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.836 -1.172 . . . . 74.420000000000002 107.836 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -115.22 127.58 55.6 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.477 -0.935 . . . . 65.430000000000007 108.477 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -121.35 113.19 38.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.351 -1.351 . . . . 74.25 107.351 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -136.3 131.02 33.81 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.817 -0.438 . . . . 63.399999999999999 109.817 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 55.67 37.05 28.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.059 0.944 . . . . 64.140000000000001 111.804 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.09 3.97 90.59 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.23 -0.895 . . . . 71.140000000000001 113.461 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -109.0 139.14 44.28 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.552 -0.536 . . . . 73.25 109.552 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -114.94 122.02 44.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.697 -0.683 . . . . 73.540000000000006 110.139 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.62 146.04 48.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.765 -0.457 . . . . 70.230000000000004 109.765 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.96 124.26 70.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.784 -1.191 . . . . 71.400000000000006 107.784 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.11 124.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.786 -0.82 . . . . 65.409999999999997 108.786 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -81.78 121.86 26.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.272 -1.01 . . . . 64.120000000000005 108.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 m -117.04 -11.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.955 -0.566 . . . . 62.439999999999998 110.876 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.35 46.9 1.1 Allowed Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 108.406 -1.878 . . . . 51.229999999999997 108.406 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.8 p -65.61 -3.16 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.773 1.229 . . . . 71.340000000000003 113.389 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.93 -26.65 59.77 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.045 -0.724 . . . . 40.450000000000003 109.045 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 17' ' ' VAL . 94.3 m-20 -105.62 -21.72 13.13 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.77 -0.826 . . . . 71.239999999999995 108.77 174.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.07 119.27 0.27 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.122 -0.944 . . . . 62.329999999999998 114.03 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.4 m -87.07 138.27 31.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.048 -1.093 . . . . 52.130000000000003 108.048 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 84.8 m-85 -119.13 129.16 54.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.946 -0.39 . . . . 75.430000000000007 109.946 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.9 t -114.92 120.58 64.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.532 -1.655 . . . . 72.129999999999995 106.532 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 56.27 37.96 29.33 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.564 1.146 . . . . 74.329999999999998 110.967 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 mtm-85 66.19 19.68 11.1 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 114.222 -1.354 . . . . 74.340000000000003 112.74 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.51 133.19 23.03 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.24 -1.022 . . . . 73.430000000000007 108.24 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.51 123.6 11.0 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.57 1.513 . . . . 64.430000000000007 109.401 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -144.93 138.69 27.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.199 -1.037 . . . . 75.5 108.199 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -86.3 -37.73 18.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.13 0.49 . . . . 75.239999999999995 110.422 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.63 136.28 25.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.12 -1.067 . . . . 72.120000000000005 108.12 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.19 143.09 25.71 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 63.229999999999997 108.43 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -88.23 126.18 41.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.473 -2.047 . . . . 64.340000000000003 105.473 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.41 ' HE2' HG12 ' A' ' 128' ' ' ILE . 6.6 tpt -87.99 130.71 34.88 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 113.394 0.887 . . . . 73.540000000000006 113.394 -164.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.498 ' HB3' ' OD2' ' A' ' 126' ' ' ASP . 16.3 tt0 -107.72 141.9 38.55 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.38 1.472 . . . . 65.120000000000005 109.525 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -67.03 133.53 50.1 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.046 -0.724 . . . . 75.409999999999997 109.046 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.25 -2.71 56.5 Favored Glycine 0 C--O 1.252 1.269 0 N-CA-C 111.456 -0.658 . . . . 62.43 111.456 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 123' ' ' GLN . 96.7 m-20 -82.47 151.38 26.55 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.384 0.612 . . . . 61.299999999999997 110.402 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -112.32 131.54 55.46 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.516 -0.765 . . . . 75.530000000000001 109.718 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.41 HG12 ' HE2' ' A' ' 122' ' ' MET . 21.2 mt -107.64 131.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 106.594 -1.632 . . . . 73.439999999999998 106.594 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.517 HE22 ' HB3' ' A' ' 25' ' ' GLU . 31.0 tt0 -112.6 118.24 34.53 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.251 -1.018 . . . . 73.140000000000001 108.251 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.52 HG23 ' ND1' ' A' ' 89' ' ' HIS . 43.7 mm -109.1 104.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.779 -1.1 . . . . 72.450000000000003 108.137 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.4 -83.95 0.64 Allowed Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.31 -0.859 . . . . 63.049999999999997 111.225 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -133.82 -12.89 2.57 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.114 0.566 . . . . 73.310000000000002 110.296 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.648 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.317 42.7 p90 -99.0 170.34 8.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 114.29 1.218 . . . . 64.099999999999994 114.29 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -118.46 126.07 51.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.604 . . . . 52.219999999999999 111.393 -164.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.09 140.23 52.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.066 -1.087 . . . . 72.010000000000005 108.066 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.3 t -115.35 127.51 72.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.253 -0.647 . . . . 72.140000000000001 109.253 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -98.33 121.28 40.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.956 -0.757 . . . . 75.450000000000003 108.956 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -140.49 160.63 39.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 110.553 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.72 127.29 32.4 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.525 -1.287 . . . . 74.450000000000003 107.525 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.13 -122.47 1.13 Allowed Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 115.423 -0.808 . . . . 70.349999999999994 113.2 -172.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 157.69 55.75 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.085 1.857 . . . . 74.420000000000002 114.273 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.75 20.97 11.62 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.408 -2.071 . . . . 71.230000000000004 105.408 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 112.803 -1.998 . . . . 75.209999999999994 108.836 -176.051 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 107.226 -1.398 . . . . 34.210000000000001 107.226 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.1 t -81.92 115.16 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.785 0.802 . . . . 73.219999999999999 108.914 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 29.8 p90 -119.43 142.18 48.46 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.83 -1.077 . . . . 75.530000000000001 110.469 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -125.93 90.62 3.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.406 0.622 . . . . 71.329999999999998 110.616 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.24 -84.42 0.15 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.723 -0.671 . . . . 75.519999999999996 110.419 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.06 -11.47 59.91 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.621 -0.718 . . . . 72.409999999999997 109.797 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 89.8 mt -64.31 -15.83 61.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.012 -0.995 . . . . 71.299999999999997 111.784 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -45.78 90.32 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.302 -0.629 . . . . 74.340000000000003 109.302 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -86.04 -33.57 20.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 109.68 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 4.6 tp10 -59.11 -33.14 70.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.418 -0.81 . . . . 73.519999999999996 110.414 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 42.3 tpp -59.47 -49.55 77.37 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.527 -0.306 . . . . 54.229999999999997 111.585 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.46 -29.49 67.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.107 0.48 . . . . 75.540000000000006 110.927 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -73.89 -25.77 60.2 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.588 0.709 . . . . 73.450000000000003 110.583 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.482 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 8.2 t -89.71 -15.73 31.9 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.468 -0.787 . . . . 73.109999999999999 110.625 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 m -62.69 101.57 0.26 Allowed 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.384 0.611 . . . . 60.009999999999998 110.59 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.69 -146.66 15.64 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.652 -1.379 . . . . 71.109999999999999 109.652 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 54.3 m -116.43 134.25 55.08 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.277 0.539 . . . . 72.450000000000003 110.686 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.18 94.65 5.81 Favored Pre-proline 0 C--O 1.246 0.872 0 N-CA-C 109.651 -0.5 . . . . 61.520000000000003 109.651 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 32' ' ' THR . 4.0 Cg_exo -76.39 160.71 35.37 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.343 2.696 . . . . 70.109999999999999 112.818 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.82 168.84 17.66 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.48 -0.934 . . . . 73.129999999999995 108.48 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 m -117.0 158.57 23.9 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.797 -0.445 . . . . 72.420000000000002 109.797 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -92.51 154.89 18.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.454 -0.943 . . . . 72.409999999999997 108.454 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.01 -29.44 1.0 Allowed Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.671 -0.776 . . . . 65.519999999999996 111.551 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.93 80.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.727 -0.472 . . . . 73.430000000000007 109.727 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.83 -6.44 41.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.613 -0.721 . . . . 74.239999999999995 111.854 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.3 -19.95 20.22 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.873 -1.158 . . . . 62.229999999999997 107.873 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.8 mt 58.91 88.0 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 113.97 -1.468 . . . . 73.140000000000001 111.391 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.44 -58.89 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.487 2.124 . . . . 74.25 110.097 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 0.89 7.59 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.585 -0.734 . . . . 43.210000000000001 109.138 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.15 85.99 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.117 -0.947 . . . . 64.140000000000001 111.419 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 15.0 m -134.85 165.56 25.02 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.082 -1.451 . . . . 65.409999999999997 107.082 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 158.87 43.1 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.256 -0.646 . . . . 62.030000000000001 109.256 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -125.41 157.8 35.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.444 -0.206 . . . . 73.310000000000002 110.444 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.15 139.01 54.25 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.204 -1.036 . . . . 75.010000000000005 108.204 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -118.65 137.26 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 120.791 0.329 . . . . 64.209999999999994 110.136 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.83 118.22 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 106.404 -1.702 . . . . 54.310000000000002 106.404 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -94.91 -31.62 13.59 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.695 -0.684 . . . . 71.25 109.918 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -145.83 137.78 25.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.933 -0.766 . . . . 54.030000000000001 108.933 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 132' ' ' LYS . . . 133.29 178.74 15.76 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.457 -1.057 . . . . 51.140000000000001 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 85.4 Cg_exo -55.3 -40.49 85.35 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.684 2.256 . . . . 73.400000000000006 112.154 177.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -90.36 16.31 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.512 -0.313 . . . . 73.019999999999996 111.593 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.96 132.7 54.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.919 0.39 . . . . 71.430000000000007 111.197 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -19.77 32.0 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.576 -0.738 . . . . 71.340000000000003 111.635 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 131.74 34.28 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.946 0.403 . . . . 71.349999999999994 110.625 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -113.3 139.15 49.08 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.107 -1.071 . . . . 51.299999999999997 108.107 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -126.68 128.07 46.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.747 -0.835 . . . . 71.120000000000005 108.747 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.4 pt? -88.23 130.03 35.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 74.129999999999995 110.528 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 103.86 12.46 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.087 -1.079 . . . . 70.450000000000003 108.087 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -121.46 -5.62 9.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.375 1.083 . . . . 72.409999999999997 108.545 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 5.9 pm0 -107.95 142.14 24.62 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 114.128 -1.396 . . . . 65.409999999999997 110.487 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' GLN . 50.2 Cg_exo -57.79 -32.0 93.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.524 2.816 . . . . 75.310000000000002 112.942 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -143.6 122.04 12.41 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 109.251 -0.648 . . . . 60.329999999999998 109.251 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.486 HG22 HG12 ' A' ' 78' ' ' ILE . 21.0 m -114.54 113.92 25.07 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.844 -1.169 . . . . 73.109999999999999 107.844 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.3 p -89.8 138.43 31.49 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 111.65 0.241 . . . . 73.129999999999995 111.65 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.51 55.75 Favored 'General case' 0 C--O 1.267 2.025 0 N-CA-C 109.14 -0.689 . . . . 74.030000000000001 109.14 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.49 -145.39 11.33 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.022 -0.99 . . . . 25.129999999999999 110.723 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.516 ' C ' ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -105.84 151.81 24.05 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 122.994 0.518 . . . . 54.240000000000002 111.909 -177.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.583 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t-80 76.75 143.39 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.93 1.292 . . . . 75.319999999999993 110.407 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 88.0 Cg_exo -48.28 -6.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 124.846 3.697 . . . . 74.209999999999994 116.688 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.83 -24.63 59.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.662 -0.866 . . . . 74.200000000000003 108.662 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.424 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 19.4 m -92.07 115.37 28.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 106.56 -1.644 . . . . 75.310000000000002 106.56 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.53 -36.25 77.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.941 -0.572 . . . . 73.030000000000001 111.409 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.486 HG12 HG22 ' A' ' 68' ' ' THR . 42.3 mm -106.7 99.56 8.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.016 -1.105 . . . . 72.109999999999999 108.016 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -93.36 110.3 21.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.727 -0.67 . . . . 63.329999999999998 109.901 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 87.0 mt -116.64 122.5 44.76 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.34 -1.356 . . . . 71.349999999999994 107.34 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.11 117.08 29.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.662 -0.815 . . . . 61.109999999999999 109.896 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.486 ' H ' HG22 ' A' ' 85' ' ' VAL . 10.0 t70 -120.62 -165.11 1.16 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.385 -0.968 . . . . 61.32 108.385 -173.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.41 -35.51 19.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.403 -0.962 . . . . 75.430000000000007 108.403 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 18' ' ' PHE . 83.2 m -145.63 99.44 3.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.261 -1.015 . . . . 74.450000000000003 108.261 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 82' ' ' ASP . 7.1 t -88.78 131.48 36.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.677 -0.49 . . . . 72.400000000000006 109.677 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -79.25 157.78 27.71 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.785 -0.643 . . . . 72.519999999999996 110.304 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -62.76 -45.86 90.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 72.540000000000006 109.68 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -147.25 99.55 3.16 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 103.784 -2.673 . . . . 62.409999999999997 103.784 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 5.1 t60 -79.32 -50.26 11.15 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.915 -1.513 . . . . 70.239999999999995 106.915 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.25 163.02 40.74 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.468 -1.242 . . . . 31.129999999999999 109.539 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.49 141.38 48.76 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 109.076 -0.712 . . . . 72.420000000000002 109.076 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.83 114.08 28.08 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.712 -1.959 . . . . 70.209999999999994 105.712 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 95' ' ' ASN . 35.0 mtp85 -109.95 127.5 54.8 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-N 114.736 -1.12 . . . . 74.219999999999999 110.488 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.04 112.12 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 104.099 -2.556 . . . . 50.399999999999999 104.099 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 93' ' ' ARG . 17.8 m120 -135.48 121.09 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.225 -0.657 . . . . 62.240000000000002 109.225 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 56.53 37.85 29.16 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.379 1.05 . . . . 54.409999999999997 110.687 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.47 88.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.359 -0.837 . . . . 73.019999999999996 113.469 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.48 141.31 36.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.912 -0.774 . . . . 73.450000000000003 108.912 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 84.0 m-85 -111.4 117.01 31.9 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.222 -0.658 . . . . 74.430000000000007 109.222 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 146.2 52.29 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.793 0.33 . . . . 75.230000000000004 111.775 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 23.5 t -103.79 123.37 57.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.18 -1.785 . . . . 74.439999999999998 106.18 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.1 t -119.15 126.51 75.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.103 -0.703 . . . . 45.409999999999997 109.103 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -81.05 123.54 28.45 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.197 -1.409 . . . . 73.340000000000003 107.197 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.38 14.55 7.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-O 121.049 0.452 . . . . 55.420000000000002 111.244 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.498 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . -108.9 -30.68 3.62 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.41 -1.076 . . . . 63.100000000000001 110.41 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.3 p 67.43 -52.86 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.55 2.34 . . . . 73.230000000000004 113.56 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.31 -20.43 60.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.902 0.382 . . . . 74.510000000000005 111.037 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -87.28 -20.25 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.227 1.195 . . . . 73.120000000000005 114.227 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.429 ' N ' HD22 ' A' ' 108' ' ' ASN . . . 62.06 87.0 0.04 OUTLIER Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.344 0.897 . . . . 64.109999999999999 115.344 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.9 m -79.51 137.59 37.24 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 64.140000000000001 108.787 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 30.1 m-85 -113.06 126.87 55.95 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.539 -0.465 . . . . 73.310000000000002 109.97 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.45 135.93 55.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 105.006 -2.22 . . . . 73.140000000000001 105.006 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m120 53.47 34.74 18.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 75.409999999999997 107.601 -165.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 29' ' ' SER . 37.9 mtm180 57.92 12.76 1.85 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.025 1.12 . . . . 74.200000000000003 114.025 -175.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -104.27 134.17 19.83 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.84 -0.8 . . . . 73.510000000000005 108.84 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.04 123.49 12.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.12 1.88 . . . . 73.129999999999995 111.657 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -140.62 165.39 27.59 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 116.079 -0.509 . . . . 64.140000000000001 110.825 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -103.91 -36.74 7.68 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.282 -1.007 . . . . 72.140000000000001 108.282 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -150.24 134.85 17.44 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.63 -1.248 . . . . 62.439999999999998 107.63 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.31 143.63 22.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.137 -0.69 . . . . 73.349999999999994 109.137 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.75 125.63 34.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.605 -0.887 . . . . 73.219999999999999 108.605 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.448 ' HE3' ' HB3' ' A' ' 99' ' ' PHE . 22.2 ptt? -90.06 130.27 36.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 62.25 110.19 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -113.79 156.41 23.9 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.128 -0.942 . . . . 74.329999999999998 109.717 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.3 t -67.53 124.64 23.79 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 121.387 0.613 . . . . 75.019999999999996 109.565 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.09 57.56 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.909 -0.877 . . . . 72.450000000000003 110.909 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -79.92 151.84 29.89 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.77 125.91 50.68 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.024 -0.732 . . . . 74.310000000000002 109.024 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -109.33 129.55 63.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 106.846 -1.538 . . . . 63.450000000000003 106.846 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 54.8 tp60 -110.05 123.22 49.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.274 -1.01 . . . . 70.209999999999994 108.274 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.4 mt -128.77 104.17 10.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.782 -1.192 . . . . 65.120000000000005 107.782 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.21 -117.21 8.25 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.4 -1.48 . . . . 55.310000000000002 109.4 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -106.46 5.75 29.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.289 0.566 . . . . 72.319999999999993 110.894 175.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.588 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 69.6 m-85 -85.37 133.21 34.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.676 -0.693 . . . . 75.129999999999995 111.091 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -110.8 119.22 38.39 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.187 -2.153 . . . . 75.219999999999999 105.187 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 mt -114.87 139.85 49.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.018 -0.734 . . . . 64.439999999999998 109.018 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.21 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.309 -0.997 . . . . 62.340000000000003 108.309 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.75 127.72 38.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.283 -0.636 . . . . 64.299999999999997 109.283 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.61 130.78 42.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.229 0.538 . . . . 74.400000000000006 110.582 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.96 122.79 44.13 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.575 -0.898 . . . . 31.440000000000001 108.575 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.0 -144.17 3.87 Favored Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.282 -1.437 . . . . 62.43 113.088 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.83 146.7 60.52 Favored 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.681 2.921 . . . . 70.209999999999994 113.157 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 46' ' ' SER . . . 179.66 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.992 1.317 . . . . 33.219999999999999 108.526 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 107.462 -1.31 . . . . 61.509999999999998 107.462 -176.065 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.434 -1.246 0 CA-C-O 121.281 0.562 . . . . 75.109999999999999 112.091 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 58.6 t -93.85 115.7 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.553 -2.017 . . . . 52.25 105.553 170.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -108.04 127.5 53.83 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.152 -1.019 . . . . 75.0 111.544 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -106.96 101.91 11.31 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 109.468 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.56 166.21 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.928 -0.578 . . . . 64.0 111.539 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.08 -6.99 19.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.136 1.374 . . . . 74.230000000000004 112.25 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.64 -25.42 60.12 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.51 0.93 . . . . 60.149999999999999 113.51 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 88.4 mt -81.47 -28.59 34.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 111.806 0.299 . . . . 70.439999999999998 111.806 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -53.95 -45.43 71.3 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.883 0.873 . . . . 71.540000000000006 111.878 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 26' ' ' MET . 8.0 pt-20 -70.19 -37.02 75.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.823 0.344 . . . . 72.150000000000006 111.888 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.43 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 22.9 ptp -79.79 -27.36 40.36 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 112.596 0.591 . . . . 75.420000000000002 112.596 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 48.3 mt-10 -58.4 -49.46 77.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.974 0.352 . . . . 72.400000000000006 111.18 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -68.74 -26.41 65.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.632 -0.713 . . . . 74.25 110.878 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.7 t -88.17 -22.74 23.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.655 -0.702 . . . . 73.540000000000006 110.409 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.3 m -97.31 105.87 18.09 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.64 0.733 . . . . 70.239999999999995 112.097 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.9 -29.13 0.76 Allowed Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.287 -1.525 . . . . 73.049999999999997 109.287 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -116.11 148.99 39.71 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.77 -0.826 . . . . 74.310000000000002 108.77 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.47 138.92 20.68 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.652 -1.61 . . . . 64.5 106.652 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.25 142.52 91.83 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.125 1.884 . . . . 64.349999999999994 112.784 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.36 149.49 51.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.079 -0.712 . . . . 64.450000000000003 109.079 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -129.23 139.56 51.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.797 0.332 . . . . 70.420000000000002 110.624 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 m -79.34 115.07 18.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 64.109999999999999 108.036 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.16 8.2 22.05 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 110.622 -0.991 . . . . 53.140000000000001 110.622 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.09 87.67 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 123.514 0.725 . . . . 70.409999999999997 111.75 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.89 1.9 56.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.054 -0.521 . . . . 75.430000000000007 111.532 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -33.39 12.0 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.433 -1.321 . . . . 75.400000000000006 107.433 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.4 mm? 59.73 84.06 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 108.17 -1.048 . . . . 53.310000000000002 108.17 -173.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 6.8 Cg_endo -42.7 -61.85 0.5 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.593 3.529 . . . . 74.140000000000001 115.328 -168.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -13.77 40.69 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.201 -0.599 . . . . 74.209999999999994 112.151 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.22 -4.86 77.89 Favored Glycine 0 C--N 1.317 -0.5 0 C-N-CA 121.111 -0.566 . . . . 72.109999999999999 112.253 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB3' HD11 ' A' ' 62' ' ' LEU . 32.7 m -133.93 163.65 29.04 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.922 -0.769 . . . . 73.5 108.922 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.39 150.81 36.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.367 -0.605 . . . . 64.049999999999997 109.367 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.51 148.57 44.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.067 -0.515 . . . . 73.140000000000001 110.556 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.6 pt? -105.32 133.9 49.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.637 -0.875 . . . . 65.019999999999996 108.637 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.4 128.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.584 -0.895 . . . . 74.099999999999994 108.584 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.1 t -77.18 118.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.593 -1.632 . . . . 64.329999999999998 106.593 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -89.73 -33.92 16.4 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.231 0.539 . . . . 73.430000000000007 109.666 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 2.2 tpm_? -144.79 136.95 26.06 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.989 -1.115 . . . . 71.430000000000007 107.989 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.17 -171.45 25.64 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 109.442 -1.463 . . . . 15.529999999999999 109.442 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 15.6 Cg_exo -67.32 -43.64 5.81 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.522 2.148 . . . . 61.109999999999999 111.067 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.16 22.7 5.63 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.308 -0.86 . . . . 63.340000000000003 112.005 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.49 129.78 42.2 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.979 0.419 . . . . 62.100000000000001 111.069 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.97 -21.46 29.49 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.684 -0.689 . . . . 74.299999999999997 111.379 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.03 29.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.725 0.298 . . . . 72.420000000000002 110.224 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -128.8 139.05 52.36 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.721 -0.844 . . . . 61.25 108.721 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.09 131.12 53.81 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.981 -0.748 . . . . 73.310000000000002 108.981 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 46' ' ' SER . 56.3 tp -89.55 126.82 35.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.983 -0.377 . . . . 65.230000000000004 109.983 -177.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.421 HD23 HD11 ' A' ' 94' ' ' ILE . 5.2 mp -82.58 103.99 12.52 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -126.65 5.28 6.76 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 123.006 1.384 . . . . 71.140000000000001 108.061 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.81 149.75 39.4 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 114.197 -1.365 . . . . 64.25 108.792 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.99 -16.04 32.44 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.615 2.21 . . . . 71.219999999999999 113.036 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 90.3 m -154.58 128.85 9.01 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.05 -0.722 . . . . 74.299999999999997 109.05 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 20.5 m -118.58 121.38 40.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 m -96.28 130.24 43.42 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.609 -0.515 . . . . 65.540000000000006 109.609 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.04 139.4 53.35 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 116.414 -0.357 . . . . 73.120000000000005 110.19 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.37 -161.0 30.97 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.217 -1.553 . . . . 51.439999999999998 109.217 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 16.7 ttp180 -119.45 116.99 27.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 118.116 0.958 . . . . 72.030000000000001 109.544 176.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER 152.94 156.74 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 104.621 -2.363 . . . . 62.310000000000002 104.621 176.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.85 -9.29 15.98 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.443 2.096 . . . . 73.340000000000003 113.258 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.07 -18.45 60.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.461 . . . . 75.019999999999996 110.728 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 m -98.02 123.58 42.1 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 116.134 -0.485 . . . . 71.109999999999999 109.722 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.19 -42.74 96.54 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.521 -0.918 . . . . 74.519999999999996 108.521 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.52 104.74 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 106.444 -1.687 . . . . 60.219999999999999 106.444 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 72' ' ' ARG . 59.6 t80 -88.03 113.93 24.15 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.671 -0.695 . . . . 72.030000000000001 109.149 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 2.8 mm? -110.36 113.4 26.03 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.489 -0.93 . . . . 63.130000000000003 108.489 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 29.2 t70 -79.11 118.32 20.97 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.025 0.44 . . . . 72.319999999999993 110.745 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -133.08 178.0 7.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.259 -1.015 . . . . 64.549999999999997 108.259 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.07 -28.99 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 124.084 0.954 . . . . 71.200000000000003 109.247 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.441 ' HB ' HD21 ' A' ' 108' ' ' ASN . 0.7 OUTLIER -104.11 152.98 21.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.716 -0.675 . . . . 74.129999999999995 110.52 -174.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -92.19 97.46 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.698 -0.853 . . . . 73.519999999999996 108.698 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -99.81 87.83 3.63 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.595 -0.891 . . . . 63.140000000000001 108.595 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -66.92 -28.97 68.74 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.655 -0.702 . . . . 62.229999999999997 112.513 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -145.29 91.28 2.11 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.125 -1.805 . . . . 73.120000000000005 106.125 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 31.3 t60 -100.63 -52.81 3.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.053 -1.059 . . . . 71.430000000000007 112.075 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.17 141.93 46.01 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.48 -0.763 . . . . 72.510000000000005 109.158 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -122.58 129.41 51.89 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.304 -0.999 . . . . 61.210000000000001 108.304 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 67' ' ' THR . 7.7 m-85 -105.2 117.83 35.0 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.403 -1.703 . . . . 64.219999999999999 106.403 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -109.75 119.23 38.71 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.643 -0.873 . . . . 75.040000000000006 108.643 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.421 HD11 HD23 ' A' ' 63' ' ' LEU . 3.3 mp -111.96 113.29 43.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.684 -1.598 . . . . 74.329999999999998 106.684 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -138.92 123.89 18.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.943 -0.391 . . . . 62.420000000000002 109.943 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.39 36.8 26.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.413 1.085 . . . . 75.409999999999997 112.128 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 3.53 90.45 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.977 -0.63 . . . . 71.310000000000002 113.19 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -100.89 131.23 46.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.475 -0.935 . . . . 70.239999999999995 108.475 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -108.13 116.42 31.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.324 -0.991 . . . . 71.310000000000002 108.324 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 121' ' ' VAL . 41.9 mt-10 -123.6 126.16 46.14 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.335 -0.616 . . . . 73.239999999999995 109.335 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.41 123.13 56.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.511 -1.292 . . . . 72.239999999999995 107.511 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.48 138.04 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 115.586 -0.733 . . . . 54.100000000000001 110.648 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 106.141 -1.8 . . . . 73.219999999999999 106.141 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.0 m -92.41 17.07 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.756 0.65 . . . . 74.510000000000005 112.756 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.26 47.28 4.72 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 107.728 -2.149 . . . . 53.409999999999997 107.728 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.7 m -79.28 175.98 10.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.467 -0.866 . . . . 62.229999999999997 112.654 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 2.3 mm? -101.72 -28.17 12.62 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.578 0.955 . . . . 64.019999999999996 113.578 -171.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -86.61 -20.47 27.82 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 118.518 -1.273 . . . . 75.140000000000001 111.127 -173.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.79 100.13 2.29 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 119.337 -1.411 . . . . 75.209999999999994 112.615 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 m -87.41 129.13 35.15 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.52 -0.918 . . . . 53.0 108.52 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 20.4 m-85 -127.96 126.7 41.92 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.969 -1.123 . . . . 74.319999999999993 107.969 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -111.7 131.84 61.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.129 -1.434 . . . . 74.540000000000006 107.129 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.675 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 17.4 m120 57.78 38.29 27.32 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.608 0.763 . . . . 73.109999999999999 110.187 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.76 14.46 7.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.966 1.307 . . . . 64.319999999999993 113.211 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.64 145.24 37.11 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 122.351 -0.218 . . . . 73.450000000000003 110.523 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.09 123.55 13.42 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.607 1.538 . . . . 65.400000000000006 108.431 171.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -139.5 145.85 39.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.828 -1.175 . . . . 72.430000000000007 107.828 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -103.31 -44.04 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.934 -0.306 . . . . 75.209999999999994 110.85 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.14 24.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.007 -1.108 . . . . 70.219999999999999 108.007 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -150.26 134.59 17.21 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.783 -0.367 . . . . 74.200000000000003 111.264 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 100' ' ' GLU . 48.6 t -78.9 114.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 104.584 -2.376 . . . . 74.040000000000006 104.584 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.47 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 80.3 mtp -97.09 144.59 26.8 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.721 1.008 . . . . 73.25 113.721 -172.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.531 ' HG3' ' OD2' ' A' ' 126' ' ' ASP . 4.8 pp0? -119.73 157.84 27.74 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.0 -1.455 . . . . 74.120000000000005 108.328 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.3 p -58.83 126.87 29.46 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 123.508 0.723 . . . . 72.319999999999993 111.62 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.56 -5.53 54.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.927 -0.579 . . . . 71.340000000000003 113.327 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.531 ' OD2' ' HG3' ' A' ' 123' ' ' GLN . 73.3 m-20 -76.81 143.91 39.47 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 117.799 0.799 . . . . 73.129999999999995 109.337 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.675 ' OE1' ' HA ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -112.57 145.44 40.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.045 0.45 . . . . 72.310000000000002 111.412 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 41.1 mt -116.71 126.91 74.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.579 -0.897 . . . . 72.530000000000001 108.579 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 24.3 tp60 -104.81 113.45 27.05 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 104.941 -2.244 . . . . 75.420000000000002 104.941 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 62.8 mt -109.28 103.87 16.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.91 -1.144 . . . . 63.329999999999998 107.91 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.16 -98.84 0.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 CA-C-N 115.206 -0.906 . . . . 55.340000000000003 111.266 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -119.44 2.67 11.28 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.937 1.088 . . . . 53.109999999999999 113.937 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.25 25.4 p90 -131.23 168.97 16.6 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.549 -0.719 . . . . 72.340000000000003 112.19 176.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -129.22 138.96 52.0 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 113.037 0.754 . . . . 74.439999999999998 113.037 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.87 139.79 53.19 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.682 -1.599 . . . . 73.510000000000005 106.682 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.63 140.2 40.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 109.42 -0.585 . . . . 73.209999999999994 109.42 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -92.9 115.5 28.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.048 -0.723 . . . . 72.129999999999995 109.048 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.06 159.95 22.96 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.121 0.486 . . . . 74.010000000000005 111.691 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.77 131.46 39.81 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.84 -0.8 . . . . 74.439999999999998 108.84 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.06 143.0 15.92 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.309 -0.948 . . . . 73.340000000000003 110.922 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -59.24 156.0 37.38 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.592 2.194 . . . . 61.350000000000001 111.567 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.83 61.22 6.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.313 1.054 . . . . 63.329999999999998 109.451 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.292 -1.919 0 CA-C-N 113.107 -1.861 . . . . 74.530000000000001 109.846 -179.983 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.223 -1.399 . . . . 62.200000000000003 107.223 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.61 134.56 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 120.952 0.406 . . . . 65.209999999999994 111.304 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -123.18 141.35 52.07 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.111 -1.07 . . . . 73.319999999999993 108.111 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -83.78 137.29 33.8 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.275 -0.57 . . . . 73.140000000000001 109.808 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.93 151.19 23.45 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.411 -0.588 . . . . 62.200000000000003 109.411 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.08 2.76 56.08 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.844 0.831 . . . . 73.340000000000003 110.869 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 111' ' ' TYR . 1.9 pp -58.95 -17.45 24.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.274 1.213 . . . . 74.329999999999998 114.274 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 22' ' ' LEU . 2.2 pt? -70.25 -7.71 44.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 111.765 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -80.41 -28.47 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.562 -0.903 . . . . 73.340000000000003 108.562 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.54 -22.05 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.005 -1.109 . . . . 72.209999999999994 108.005 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.5 ttp -53.95 -49.54 68.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 63.020000000000003 111.175 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -9.96 58.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.065 0.459 . . . . 72.109999999999999 111.844 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -78.64 -39.26 37.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.435 -0.802 . . . . 61.140000000000001 110.112 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -87.13 -17.79 31.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.694 0.627 . . . . 62.340000000000003 112.694 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.1 m -72.61 114.0 10.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.48 -0.563 . . . . 55.399999999999999 109.48 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.6 -59.32 0.2 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.485 -1.046 . . . . 41.530000000000001 110.485 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.7 p -114.85 121.33 42.93 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.914 -0.314 . . . . 53.020000000000003 110.509 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.86 53.0 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 109.208 -0.664 . . . . 32.020000000000003 109.208 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.64 156.56 60.82 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 121.81 1.674 . . . . 72.239999999999995 108.805 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.17 124.65 21.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.87 -1.159 . . . . 52.030000000000001 107.87 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' THR . 10.3 m -98.78 -10.84 22.49 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.879 -0.6 . . . . 55.329999999999998 112.205 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -73.47 147.48 44.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.545 -0.752 . . . . 74.450000000000003 109.987 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 -15.08 7.72 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.327 -1.109 . . . . 53.240000000000002 110.327 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.03 68.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.198 0.523 . . . . 51.109999999999999 111.322 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 41' ' ' ASN . 11.6 pt-20 -70.81 -22.13 62.38 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.255 -0.884 . . . . 74.319999999999993 112.15 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.511 ' OD1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 m-20 -96.21 -13.84 23.17 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.83 -0.433 . . . . 73.420000000000002 109.83 -175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt 55.05 66.62 3.8 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 114.98 -1.009 . . . . 72.420000000000002 110.634 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.65 -55.79 2.48 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.274 2.649 . . . . 65.239999999999995 113.569 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.72 -20.52 42.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.895 -0.593 . . . . 64.140000000000001 111.752 -176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -5.44 77.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.555 -0.831 . . . . 65.319999999999993 111.903 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -152.86 161.0 43.1 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.637 -1.246 . . . . 40.439999999999998 107.637 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.44 157.52 44.0 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.521 -0.548 . . . . 73.409999999999997 109.521 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pp -137.45 155.78 48.93 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 111.905 0.335 . . . . 75.310000000000002 111.905 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD22 HD21 ' A' ' 63' ' ' LEU . 2.4 pt? -116.22 133.67 55.77 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.001 -1.111 . . . . 71.25 108.001 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.11 133.86 51.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.57 -0.9 . . . . 73.040000000000006 108.57 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.27 118.69 31.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.765 -1.568 . . . . 75.099999999999994 106.765 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -83.26 -31.83 26.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.636 -0.711 . . . . 64.540000000000006 110.302 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -160.42 150.66 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.937 -1.505 . . . . 72.010000000000005 106.937 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.65 -167.72 17.96 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 110.217 -1.153 . . . . 62.509999999999998 110.217 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.58 -49.86 9.42 Favored 'Trans proline' 0 N--CA 1.479 0.668 0 C-N-CA 122.802 2.334 . . . . 73.239999999999995 112.257 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.6 22.54 3.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.227 -0.442 . . . . 72.150000000000006 112.045 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.23 128.73 38.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.859 0.362 . . . . 61.409999999999997 111.346 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.71 40.28 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.626 -0.715 . . . . 52.240000000000002 111.528 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 156.91 18.02 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.999 0.428 . . . . 74.209999999999994 110.155 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 139.49 30.87 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.792 -0.64 . . . . 75.310000000000002 109.564 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.39 134.05 55.46 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.2 -0.667 . . . . 73.010000000000005 109.2 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.4 pt? -90.79 143.77 26.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.024 -0.732 . . . . 64.299999999999997 109.024 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 49' ' ' LEU . 1.5 mm? -111.43 110.7 21.27 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.013 0.375 . . . . 53.020000000000003 112.013 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -138.35 59.56 1.64 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.849 -1.537 . . . . 65.340000000000003 106.849 168.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -146.35 140.89 15.79 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 112.884 -1.962 . . . . 75.0 107.544 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.36 -22.11 71.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.271 1.98 . . . . 71.450000000000003 113.679 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -148.79 122.23 9.08 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.539 -0.726 . . . . 73.420000000000002 111.677 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 m -113.21 113.84 25.9 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.176 -1.416 . . . . 74.540000000000006 107.176 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.7 m -94.17 138.51 32.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.089 -0.645 . . . . 72.239999999999995 109.582 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 134.76 55.01 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 109.62 -0.511 . . . . 74.430000000000007 109.62 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.26 -119.1 0.9 Allowed Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.159 -0.928 . . . . 75.420000000000002 111.687 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -118.89 152.46 36.26 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.706 0.402 . . . . 72.519999999999996 110.825 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.1 m170 90.37 151.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 125.77 1.628 . . . . 71.129999999999995 111.057 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.48 -5.71 16.69 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.02 2.48 . . . . 71.319999999999993 111.799 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.68 -26.25 60.64 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.214 -1.032 . . . . 75.310000000000002 108.214 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -83.68 122.21 28.31 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.309 -1.367 . . . . 75.430000000000007 107.309 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.02 -32.38 74.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.317 0.579 . . . . 45.119999999999997 110.902 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tp -119.41 113.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-O 121.679 0.752 . . . . 33.210000000000001 109.137 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -88.01 138.18 31.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.977 -1.011 . . . . 73.239999999999995 110.542 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.5 mt -123.82 138.76 54.44 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.29 -0.633 . . . . 64.239999999999995 109.29 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.82 127.55 38.87 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.997 -1.112 . . . . 64.230000000000004 107.997 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.56 -161.4 1.34 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.839 -1.911 . . . . 72.219999999999999 105.839 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.61 -36.51 75.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.791 0.805 . . . . 72.200000000000003 109.665 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.0 m -149.51 125.78 10.78 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.93 -1.137 . . . . 75.519999999999996 107.93 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.59 135.23 43.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.825 -0.435 . . . . 74.319999999999993 109.825 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 159.84 27.95 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.793 -0.447 . . . . 72.129999999999995 109.793 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -57.66 -46.39 84.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.333 0.653 . . . . 62.140000000000001 110.534 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -146.34 109.72 4.76 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 103.755 -2.683 . . . . 71.230000000000004 103.755 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -90.25 -52.11 5.1 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.551 0.691 . . . . 73.530000000000001 109.611 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.59 156.05 41.3 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.59 -0.732 . . . . 74.120000000000005 109.049 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.492 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 10.0 pt-20 -134.59 134.19 41.02 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.306 0.574 . . . . 52.420000000000002 109.564 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -104.95 112.89 26.18 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.126 -2.175 . . . . 72.120000000000005 105.126 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 23.5 mtp180 -108.44 135.99 48.82 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.828 -0.624 . . . . 75.230000000000004 110.423 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' A' ' 99' ' ' PHE . 1.8 mp -103.59 111.68 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.664 0 N-CA-C 102.283 -3.229 . . . . 74.5 102.283 173.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -129.12 116.56 19.43 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.93 -0.767 . . . . 64.040000000000006 108.93 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 51.04 37.56 18.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.873 1.269 . . . . 73.519999999999996 111.822 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.3 -1.96 87.49 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.013 -0.54 . . . . 43.210000000000001 113.578 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.39 145.71 29.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.279 -1.008 . . . . 63.130000000000003 108.279 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 92.2 m-85 -104.7 117.94 35.33 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.223 -1.399 . . . . 64.319999999999993 107.223 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -129.49 130.75 46.24 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.319 0.58 . . . . 74.099999999999994 111.185 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.52 122.62 56.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.889 -1.152 . . . . 73.409999999999997 107.889 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.48 132.7 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 116.187 -0.461 . . . . 65.439999999999998 110.834 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -80.27 134.64 36.11 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.157 -1.423 . . . . 75.329999999999998 107.157 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.07 13.56 2.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.438 0.637 . . . . 73.019999999999996 111.226 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.89 74.85 0.09 OUTLIER Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.108 -1.197 . . . . 64.219999999999999 110.108 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 63.4 m -64.63 75.38 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.779 1.029 . . . . 73.329999999999998 113.779 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.81 -47.99 9.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.848 -1.538 . . . . 64.329999999999998 106.848 170.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -105.86 -20.0 13.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.966 -1.47 . . . . 63.409999999999997 108.631 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.72 99.33 0.04 OUTLIER Glycine 0 C--O 1.21 -1.385 0 N-CA-C 108.29 -1.924 . . . . 73.049999999999997 108.29 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.2 m -60.14 132.44 53.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.868 0.842 . . . . 61.240000000000002 112.904 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 83.4 m-85 -101.86 126.69 48.8 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 115.367 -0.833 . . . . 74.200000000000003 108.777 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.52 137.91 53.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.498 -1.667 . . . . 73.150000000000006 106.498 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 57.62 38.15 27.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.402 0.681 . . . . 64.209999999999994 109.693 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 59.4 26.13 14.98 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.825 -1.08 . . . . 75.5 111.923 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.8 153.0 71.67 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.585 0.354 . . . . 64.340000000000003 110.366 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.62 129.55 31.44 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.348 2.032 . . . . 73.340000000000003 109.671 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 20.2 tpp180 -140.42 165.5 27.24 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.768 -0.456 . . . . 73.140000000000001 109.768 -173.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.91 -41.53 1.81 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.363 -0.606 . . . . 75.299999999999997 109.363 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.29 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.655 -1.239 . . . . 73.349999999999994 107.655 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.422 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 59.4 tp60 -153.11 133.61 13.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 121.124 -0.23 . . . . 72.329999999999998 111.57 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.2 t -81.56 115.6 24.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 104.658 -2.349 . . . . 74.530000000000001 104.658 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.6 ptm -90.46 149.87 22.05 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.736 0.779 . . . . 75.439999999999998 112.694 -169.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 72.2 mt-30 -107.57 157.84 17.72 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.46 -1.246 . . . . 63.25 108.617 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 36' ' ' SER . 11.5 t -70.66 130.83 42.8 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.912 -0.715 . . . . 73.219999999999999 109.597 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.2 55.67 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 110.96 -0.856 . . . . 71.400000000000006 110.96 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 10.8 t0 -69.57 144.63 53.0 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 108.995 -0.743 . . . . 74.329999999999998 108.995 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.64 126.37 47.51 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.068 0.461 . . . . 74.239999999999995 109.875 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 70.9 mt -110.08 115.6 50.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.793 -1.094 . . . . 71.219999999999999 108.867 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.442 ' HG2' HD22 ' A' ' 22' ' ' LEU . 54.1 tt0 -105.22 123.62 48.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.584 -0.524 . . . . 65.150000000000006 109.584 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.71 129.19 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.428 0.691 . . . . 72.239999999999995 109.846 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.52 -86.4 1.46 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 109.837 -1.305 . . . . 62.009999999999998 109.837 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.94 14.32 0.34 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.288 0.635 . . . . 72.310000000000002 109.461 171.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -130.64 170.13 14.71 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.189 -0.671 . . . . 70.310000000000002 109.189 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -137.76 150.09 46.96 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.896 1.443 . . . . 72.150000000000006 114.896 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 mt -102.77 134.55 45.98 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.195 -1.78 . . . . 70.120000000000005 106.195 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.6 t -111.97 124.09 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.391 -0.966 . . . . 73.409999999999997 108.391 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -98.9 126.15 44.49 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 122.244 0.217 . . . . 74.329999999999998 110.918 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -133.81 147.48 51.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.42 -0.585 . . . . 71.510000000000005 109.42 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.59 118.69 18.7 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.621 -2.362 . . . . 73.310000000000002 104.621 169.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.04 -82.48 0.59 Allowed Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 118.502 -1.809 . . . . 43.520000000000003 113.959 -169.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.92 142.36 47.04 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 121.599 1.532 . . . . 64.140000000000001 113.859 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.48 36.7 1.67 Allowed 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 104.223 -2.51 . . . . 65.099999999999994 104.223 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.428 -1.545 0 CA-C-N 112.345 -2.207 . . . . 71.109999999999999 109.806 -171.027 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 20.0 m . . . . . 0 N--CA 1.435 -1.208 0 N-CA-C 108.552 -0.907 . . . . 44.329999999999998 108.552 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.27 115.57 29.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.01 -0.737 . . . . 53.5 109.01 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 62.2 t80 -111.89 127.44 55.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.177 -1.046 . . . . 70.120000000000005 108.177 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -126.44 137.06 53.37 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.158 -0.682 . . . . 75.519999999999996 109.158 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' HB3' HD23 ' A' ' 22' ' ' LEU . . . -142.65 161.75 37.25 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.039 0.447 . . . . 75.409999999999997 110.751 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.02 7.45 0.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.118 1.367 . . . . 64.049999999999997 112.893 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 20' ' ' ALA . 4.6 pp -58.05 -34.5 70.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.865 0.866 . . . . 73.549999999999997 111.284 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.53 -19.69 63.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.552 0.575 . . . . 53.210000000000001 112.552 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.11 -22.96 21.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.195 -0.668 . . . . 74.239999999999995 109.195 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -98.3 -42.9 7.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.397 -0.819 . . . . 65.349999999999994 113.045 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -68.25 -1.34 6.0 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.268 0.84 . . . . 72.120000000000005 113.268 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.65 -28.59 63.87 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.173 0.989 . . . . 61.130000000000003 111.128 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -63.56 -45.43 90.53 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.21 1.004 . . . . 71.230000000000004 111.378 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.2 p -79.39 -19.34 50.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.51 -0.768 . . . . 75.310000000000002 112.566 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -88.23 78.39 8.06 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 121.856 0.836 . . . . 71.25 110.141 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.79 -105.14 1.28 Allowed Glycine 0 CA--C 1.485 -1.825 0 N-CA-C 109.107 -1.597 . . . . 74.129999999999995 109.107 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 m -99.88 118.52 36.5 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.173 -1.417 . . . . 73.439999999999998 107.173 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.57 114.24 18.06 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.84 157.28 39.32 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.46 1.44 . . . . 62.539999999999999 110.517 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 125.72 31.12 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.927 -1.508 . . . . 71.299999999999997 106.927 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 15.8 m -71.0 113.93 8.54 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.229 0.538 . . . . 74.519999999999996 111.023 -175.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.7 p -98.7 140.69 32.53 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.337 -0.392 . . . . 71.319999999999993 110.306 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.01 -25.28 0.55 Allowed Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.694 -0.563 . . . . 53.310000000000002 111.694 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.89 58.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.989 0.423 . . . . 35.310000000000002 110.203 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -69.93 -24.66 63.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 65.340000000000003 109.202 -179.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.8 -13.75 47.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.776 -1.102 . . . . 71.299999999999997 109.835 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.4 mt 63.97 91.02 0.08 OUTLIER Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 115.142 -0.935 . . . . 63.439999999999998 111.174 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 10.3 Cg_endo -52.87 -69.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.147 2.565 . . . . 71.219999999999999 113.975 -176.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.07 16.38 1.07 Allowed 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.503 -0.479 . . . . 61.409999999999997 110.817 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.71 -12.4 56.77 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 120.839 -0.696 . . . . 73.439999999999998 111.617 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -137.37 151.88 49.07 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.231 -1.396 . . . . 53.329999999999998 107.231 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.44 157.19 40.85 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.072 -1.455 . . . . 31.32 107.072 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.24 156.75 38.03 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.341 0.591 . . . . 72.409999999999997 112.559 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.84 139.24 49.91 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.684 -1.228 . . . . 63.32 107.684 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 133.96 61.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.661 -0.496 . . . . 74.209999999999994 109.661 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.5 t -75.4 118.46 21.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.602 -0.888 . . . . 74.319999999999993 108.602 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -84.01 -43.4 15.19 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.034 -0.985 . . . . 73.420000000000002 108.722 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 57.4 ttt180 -144.7 133.55 22.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.468 -0.787 . . . . 73.310000000000002 109.231 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.13 174.8 23.12 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 109.109 -1.596 . . . . 63.210000000000001 109.109 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.65 -21.67 38.85 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.485 2.123 . . . . 74.519999999999996 111.187 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 80' ' ' LEU . 18.2 p-10 -100.9 21.98 12.83 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.093 0.957 . . . . 74.219999999999999 110.64 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -59.86 141.63 55.03 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.658 0.383 . . . . 62.420000000000002 111.797 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.65 -7.93 74.28 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.846 -0.692 . . . . 75.530000000000001 112.08 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.11 126.72 31.44 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 110.151 -0.314 . . . . 24.010000000000002 110.151 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -116.22 136.66 52.81 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.585 -0.895 . . . . 74.129999999999995 108.585 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -130.73 116.32 17.85 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.577 -0.527 . . . . 71.340000000000003 109.577 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.95 118.46 24.03 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.608 -0.886 . . . . 54.450000000000003 108.608 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.2 mt -87.42 125.2 34.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.83 0.348 . . . . 74.409999999999997 110.894 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -138.03 -0.61 2.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.313 -0.858 . . . . 63.119999999999997 109.825 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -107.52 150.34 39.98 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.132 -0.486 . . . . 61.530000000000001 111.085 -175.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 37.7 Cg_exo -65.17 -20.87 62.95 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.365 2.71 . . . . 61.130000000000003 114.078 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.7 m -145.68 122.54 11.28 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.272 0.558 . . . . 55.409999999999997 110.21 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.41 HG22 HG12 ' A' ' 78' ' ' ILE . 7.6 m -123.64 113.4 18.61 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.764 -1.199 . . . . 73.239999999999995 107.764 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.6 m -94.08 138.73 31.82 Favored 'General case' 0 C--O 1.255 1.393 0 O-C-N 121.594 -0.691 . . . . 71.099999999999994 111.038 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 135.39 54.63 Favored 'General case' 0 C--O 1.262 1.717 0 CA-C-O 121.655 0.741 . . . . 64.109999999999999 110.802 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.55 29.28 Favored Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 105.782 -2.927 . . . . 53.310000000000002 105.782 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 15.2 ptt180 -119.18 121.01 38.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 117.711 -1.596 . . . . 64.349999999999994 109.311 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -167.1 163.39 10.35 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 106.001 -1.851 . . . . 74.209999999999994 106.001 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.58 -46.19 34.97 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.706 2.271 . . . . 70.310000000000002 113.856 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.75 20.5 5.52 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.692 0.627 . . . . 72.329999999999998 112.692 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -58.91 116.28 3.68 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.46 -0.571 . . . . 64.450000000000003 109.46 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.27 -38.97 41.47 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.721 -1.214 . . . . 70.340000000000003 107.721 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 68' ' ' THR . 44.4 mm -105.26 121.85 57.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.126 -1.064 . . . . 74.430000000000007 108.126 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -87.95 124.76 34.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 110.065 -0.346 . . . . 73.510000000000005 110.065 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 80.0 mt -127.2 140.92 51.91 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.323 -0.991 . . . . 73.140000000000001 108.323 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -130.59 140.65 50.44 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.434 -0.58 . . . . 74.129999999999995 109.434 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -163.34 178.34 8.21 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.387 -1.709 . . . . 75.329999999999998 106.387 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 -35.19 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 107.943 -1.132 . . . . 44.0 107.943 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 m -142.0 99.84 3.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.672 0.748 . . . . 45.030000000000001 109.939 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -98.6 137.38 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.471 -1.307 . . . . 64.430000000000007 107.471 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 23.0 t -73.57 150.72 41.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.114 -1.069 . . . . 62.009999999999998 108.114 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.1 ptt180 -61.59 -45.95 91.92 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -135.21 113.86 11.75 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.413 -1.329 . . . . 75.140000000000001 107.413 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -99.29 -51.82 3.7 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.705 -0.85 . . . . 74.239999999999995 108.705 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.65 163.65 39.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.229 -0.656 . . . . 62.509999999999998 109.229 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.8 147.93 45.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.498 0.666 . . . . 64.349999999999994 109.883 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -104.76 133.31 49.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.184 -1.413 . . . . 62.140000000000001 107.184 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 8.5 mtp180 -118.1 121.78 41.44 Favored 'General case' 0 C--N 1.268 -2.964 0 CA-C-N 115.608 -0.724 . . . . 71.439999999999998 109.414 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 59.3 mt -121.14 111.39 31.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.655 -1.609 . . . . 75.120000000000005 106.655 176.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -139.24 125.7 20.42 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.643 -0.423 . . . . 71.409999999999997 110.413 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.58 40.25 31.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.015 0.926 . . . . 55.350000000000001 112.486 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 -1.67 87.53 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.032 -0.531 . . . . 32.140000000000001 113.807 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -101.04 140.97 34.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.227 -0.657 . . . . 44.340000000000003 109.227 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -119.34 117.8 29.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.112 -1.07 . . . . 62.240000000000002 108.112 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -126.45 144.89 50.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.854 -0.424 . . . . 54.329999999999998 109.854 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 122' ' ' MET . 25.1 t -112.98 122.13 66.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 105.244 -2.132 . . . . 72.549999999999997 105.244 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.61 131.88 71.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 120.652 -0.419 . . . . 73.030000000000001 110.157 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.12 140.97 36.19 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.422 -0.955 . . . . 61.329999999999998 108.422 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.2 9.89 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.637 0.256 . . . . 64.310000000000002 110.731 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.37 77.85 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.013 -0.613 . . . . 54.539999999999999 112.053 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 m -64.6 86.76 0.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.826 0.45 . . . . 62.030000000000001 111.124 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 9.8 tt -91.36 -49.91 6.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 119.137 -1.025 . . . . 75.120000000000005 108.435 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.63 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 1.0 OUTLIER -92.81 -19.02 22.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.156 -0.683 . . . . 55.119999999999997 109.156 -178.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.68 114.86 3.77 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.836 -0.62 . . . . 74.349999999999994 112.367 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.2 m -87.3 129.65 34.91 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 122.211 -0.582 . . . . 74.540000000000006 110.469 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.506 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 82.3 m-85 -134.9 126.0 27.84 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.077 -1.083 . . . . 74.049999999999997 108.077 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.5 t -131.14 133.98 61.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.854 -1.536 . . . . 72.519999999999996 106.854 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 54.01 40.71 31.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.306 1.051 . . . . 73.420000000000002 109.404 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 66.76 9.23 6.56 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.946 1.699 . . . . 71.400000000000006 112.424 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 49.5 mm-40 -104.57 127.66 28.5 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 112.472 0.545 . . . . 75.420000000000002 112.472 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -63.7 123.44 12.02 Favored 'Trans proline' 0 C--N 1.36 1.139 0 N-CA-C 106.242 -2.253 . . . . 74.209999999999994 106.242 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 11.8 tpt180 -146.99 154.89 41.77 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.791 -1.564 . . . . 72.409999999999997 111.797 -167.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -107.67 -37.93 6.02 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.806 -0.812 . . . . 73.230000000000004 108.806 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.2 135.21 32.16 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.265 -0.574 . . . . 64.439999999999998 109.667 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.567 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 54.3 tp60 -152.12 143.68 23.49 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.194 -0.457 . . . . 72.150000000000006 110.268 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.13 131.6 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 107.72 -1.215 . . . . 71.230000000000004 107.72 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.411 ' HB2' HG23 ' A' ' 101' ' ' VAL . 43.7 ttp -89.25 128.54 35.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.359 -0.978 . . . . 60.32 108.359 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 9.3 pt20 -130.37 142.8 50.51 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.299 -0.864 . . . . 71.349999999999994 111.382 -173.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.7 t -74.31 134.25 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 62.420000000000002 111.229 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.11 59.75 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.241 -0.89 . . . . 54.5 111.163 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -89.63 154.67 19.79 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.565 -0.318 . . . . 74.019999999999996 111.198 -177.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.3 127.86 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.663 0.744 . . . . 74.099999999999994 109.797 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.28 119.81 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 N-CA-C 107.369 -1.345 . . . . 73.409999999999997 107.369 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 47.3 tt0 -104.86 120.92 42.57 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 115.106 -0.952 . . . . 74.099999999999994 108.476 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.7 mt -109.36 102.98 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 105.914 -1.884 . . . . 72.239999999999995 105.914 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.63 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 67.45 -107.55 2.08 Favored Glycine 0 N--CA 1.411 -3.01 0 CA-C-N 114.48 -1.236 . . . . 55.299999999999997 111.639 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -118.22 11.0 13.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.408 0.521 . . . . 75.329999999999998 112.408 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 27.2 p90 -125.06 157.87 35.18 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.883 -0.414 . . . . 70.109999999999999 109.883 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -129.36 142.07 50.91 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 114.51 1.3 . . . . 75.219999999999999 114.51 -169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.35 138.52 54.37 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.591 -1.633 . . . . 75.109999999999999 106.591 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -112.48 138.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.833 -1.173 . . . . 72.120000000000005 107.833 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -101.61 116.13 32.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.175 -0.676 . . . . 72.329999999999998 109.175 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.12 154.64 48.09 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.408 0.623 . . . . 71.129999999999995 110.545 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.51 126.4 30.85 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.538 -1.653 . . . . 53.409999999999997 106.538 168.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 141' ' ' PRO . . . -103.77 -111.42 3.57 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.587 -0.816 . . . . 53.439999999999998 111.497 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 140' ' ' GLY . 10.8 Cg_exo -69.14 142.87 51.93 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.114 1.876 . . . . 62.439999999999998 111.787 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.25 18.08 19.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.648 -0.871 . . . . 53.030000000000001 108.648 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.424 -1.745 0 C-N-CA 125.305 1.442 . . . . 73.109999999999999 110.001 -179.137 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 105.671 -1.974 . . . . 65.329999999999998 105.671 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 57.8 t -81.31 114.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 119.679 -0.808 . . . . 72.409999999999997 108.854 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -118.86 140.22 50.33 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 109.241 -0.651 . . . . 74.239999999999995 109.241 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -132.75 138.66 47.27 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.953 -1.128 . . . . 74.230000000000004 107.953 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.39 172.73 12.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.075 0.768 . . . . 63.200000000000003 113.075 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.82 -3.12 26.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.905 1.282 . . . . 71.310000000000002 110.976 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 23' ' ' LEU . 4.0 pp -57.36 -25.81 60.03 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.88 0.872 . . . . 61.450000000000003 112.784 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 22' ' ' LEU . 94.7 mt -66.72 -28.36 68.36 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 121.044 0.45 . . . . 50.130000000000003 110.982 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -67.26 -44.75 78.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 74.340000000000003 109.96 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -76.1 -31.92 58.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.883 -0.599 . . . . 74.349999999999994 110.096 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.29 -30.41 64.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 75.219999999999999 110.819 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.08 -49.43 75.88 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.984 0.513 . . . . 52.219999999999999 110.633 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -77.81 -19.81 54.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.101 0.56 . . . . 72.030000000000001 111.553 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -82.97 -17.11 44.66 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.702 -0.481 . . . . 62.109999999999999 109.702 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.554 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 39.9 m -109.12 103.99 13.09 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 121.207 0.527 . . . . 60.240000000000002 111.169 -176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.88 -52.69 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 111.389 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -104.94 142.5 34.66 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.259 -0.645 . . . . 72.310000000000002 109.259 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.93 153.0 84.81 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.16 -1.052 . . . . 53.130000000000003 108.16 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.14 142.23 96.97 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.047 1.831 . . . . 71.129999999999995 112.831 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.49 131.71 41.92 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.527 -0.545 . . . . 55.219999999999999 109.527 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -125.07 -168.35 1.81 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.371 0.605 . . . . 71.319999999999993 109.969 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -106.97 5.81 28.53 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.526 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 43.48 3.79 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.22 -1.552 . . . . 62.240000000000002 109.22 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.4 -3.67 59.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.392 0.615 . . . . 64.140000000000001 110.967 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.82 2.1 3.72 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 124.167 0.987 . . . . 64.040000000000006 112.726 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -83.17 -19.59 36.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.269 -1.011 . . . . 72.329999999999998 108.269 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt 57.44 79.47 0.32 Allowed Pre-proline 0 C--N 1.345 0.394 0 CA-C-N 114.46 -1.245 . . . . 52.520000000000003 111.937 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.68 -62.48 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.483 2.122 . . . . 54.32 112.162 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.72 -2.28 35.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.953 0.406 . . . . 63.200000000000003 111.644 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.68 79.85 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.871 -0.681 . . . . 13.1 113.163 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 m -147.37 164.21 34.0 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.474 -0.565 . . . . 55.350000000000001 109.474 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.82 157.35 45.87 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.884 -1.154 . . . . 44.509999999999998 107.884 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -123.46 152.69 41.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 118.388 0.54 . . . . 72.420000000000002 111.593 -175.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.583 HD12 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -116.88 143.19 45.99 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.673 -1.232 . . . . 73.510000000000005 107.673 173.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.88 133.38 61.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 121.093 -0.243 . . . . 74.530000000000001 110.496 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.3 116.88 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 104.792 -2.299 . . . . 64.430000000000007 104.792 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -89.87 -31.87 17.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.752 -0.658 . . . . 54.200000000000003 109.595 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -152.89 137.0 16.42 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.924 -0.58 . . . . 74.209999999999994 109.566 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.41 172.23 13.13 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 109.21 -1.556 . . . . 74.219999999999999 109.21 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.538 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 77.9 Cg_exo -55.28 -29.67 68.36 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 122.73 2.287 . . . . 52.009999999999998 113.926 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.28 18.12 21.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 120.326 -0.549 . . . . 72.439999999999998 110.399 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.86 143.58 41.94 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.107 0.48 . . . . 63.530000000000001 112.195 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.85 -14.28 57.47 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.359 -1.096 . . . . 61.219999999999999 110.359 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.79 122.12 21.04 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.289 -0.456 . . . . 61.520000000000003 109.847 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -133.4 134.97 44.34 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.551 -1.277 . . . . 74.420000000000002 107.551 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -137.26 145.38 43.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.288 -0.634 . . . . 74.310000000000002 109.288 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.1 tp -93.17 127.23 38.64 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.493 0.496 . . . . 73.129999999999995 109.717 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.583 HD21 HD12 ' A' ' 49' ' ' LEU . 2.4 mm? -97.6 107.3 19.77 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.197 0.522 . . . . 74.049999999999997 111.368 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.24 19.19 1.09 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.054 -1.832 . . . . 73.150000000000006 106.054 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.466 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 16.0 pt20 -107.21 142.14 24.44 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 113.971 -1.468 . . . . 72.040000000000006 107.931 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 27.9 Cg_endo -64.94 -19.19 63.88 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.251 1.967 . . . . 75.219999999999999 113.955 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -149.5 129.99 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.231 -0.587 . . . . 72.510000000000005 111.58 -176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.9 m -132.9 113.51 12.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.337 -1.357 . . . . 72.209999999999994 107.337 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -92.88 138.03 31.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.757 -0.46 . . . . 73.239999999999995 109.757 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 136.93 53.33 Favored 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.329 0.393 . . . . 70.439999999999998 110.082 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.57 -153.37 24.99 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.572 -1.411 . . . . 75.230000000000004 109.572 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 64.1 ttt-85 -118.51 118.06 30.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.637 -1.986 . . . . 73.340000000000003 105.637 175.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 75' ' ' GLU . 5.2 t-160 177.92 139.25 0.24 Allowed Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.955 -1.498 . . . . 73.200000000000003 106.955 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.6 -30.53 36.69 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.529 1.486 . . . . 63.329999999999998 111.978 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 8.4 mm-40 -88.96 4.51 47.89 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.222 0.823 . . . . 54.439999999999998 113.222 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.6 p -89.99 115.84 27.58 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 119.082 -1.047 . . . . 72.230000000000004 108.879 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.9 -34.87 73.76 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.485 0.491 . . . . 75.140000000000001 110.831 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.5 pt -114.36 111.8 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.222 -1.029 . . . . 73.439999999999998 108.222 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -94.01 121.12 35.16 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.994 -1.003 . . . . 73.420000000000002 110.774 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.29 119.4 33.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.849 -1.167 . . . . 71.129999999999995 107.849 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.74 124.77 41.77 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.799 0.296 . . . . 74.329999999999998 111.799 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD2' HG23 ' A' ' 83' ' ' VAL . 16.9 t70 177.5 -145.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 103.877 -2.638 . . . . 63.0 103.877 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.424 HG23 ' OD2' ' A' ' 82' ' ' ASP . 48.5 t -57.43 -23.56 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.914 0.779 . . . . 63.219999999999999 111.004 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 m -76.59 81.59 3.26 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.688 0.756 . . . . 75.329999999999998 110.108 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.08 105.85 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.148 -1.056 . . . . 70.439999999999998 108.148 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.3 m -163.57 136.28 5.29 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.767 -1.568 . . . . 72.219999999999999 106.767 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 17.1 ptt180 -64.28 -25.56 68.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.817 0.698 . . . . 73.349999999999994 111.629 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' HG21 ' A' ' 104' ' ' VAL . 45.3 mtt-85 -145.21 128.25 16.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.776 -0.824 . . . . 73.420000000000002 108.776 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 110' ' ' THR . 30.0 t-80 -99.88 -52.78 3.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.324 -1.362 . . . . 75.150000000000006 107.324 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.01 164.91 36.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.681 -1.145 . . . . 51.409999999999997 108.271 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.85 139.45 52.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.708 -0.478 . . . . 72.049999999999997 109.708 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -108.04 125.3 51.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.946 -1.502 . . . . 71.400000000000006 106.946 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.99 131.7 56.86 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.925 -0.768 . . . . 74.420000000000002 108.925 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.8 mp -115.25 112.27 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.411 -1.329 . . . . 61.109999999999999 107.411 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -138.93 125.49 20.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 110.724 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.77 37.97 29.51 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.851 0.86 . . . . 74.150000000000006 112.677 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 1.77 90.22 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.972 -0.558 . . . . 51.329999999999998 113.544 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -110.61 131.64 54.88 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.458 -0.571 . . . . 74.409999999999997 109.458 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -104.66 117.56 34.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.869 -1.16 . . . . 64.109999999999999 107.869 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.97 130.92 56.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.183 0.516 . . . . 61.140000000000001 110.412 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.44 122.6 61.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.64 -1.245 . . . . 61.229999999999997 107.64 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.93 124.0 71.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.426 -0.583 . . . . 64.329999999999998 109.426 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.62 140.36 40.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.8 -1.185 . . . . 55.219999999999999 107.8 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 88' ' ' ARG . 18.8 m -100.41 -13.71 8.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.947 -0.701 . . . . 71.439999999999998 111.923 -175.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.65 95.29 0.1 OUTLIER Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.505 -1.038 . . . . 64.030000000000001 110.505 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -64.96 14.48 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.681 1.592 . . . . 75.430000000000007 114.291 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 6.0 mp -70.87 -37.92 73.09 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.897 -1.149 . . . . 61.409999999999997 107.897 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.3 -20.15 22.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.47 -0.786 . . . . 74.120000000000005 110.326 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.39 94.87 0.22 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.556 -0.747 . . . . 61.32 114.58 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 58.1 m -80.98 130.16 34.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.284 -0.635 . . . . 74.019999999999996 109.284 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.36 125.69 54.54 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.643 -1.243 . . . . 74.329999999999998 107.643 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.0 t -133.1 136.86 54.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.165 -1.421 . . . . 74.420000000000002 107.165 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.33 39.25 30.74 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.367 1.467 . . . . 75.209999999999994 108.257 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' A' ' 30' ' ' THR . 34.2 mtm105 63.81 20.47 12.23 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.655 -1.611 . . . . 71.5 115.279 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.513 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 41.4 mt-10 -136.02 153.42 76.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.298 -0.63 . . . . 73.420000000000002 109.298 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.2 123.72 13.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.251 1.967 . . . . 63.030000000000001 108.925 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.626 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 18.3 tpp180 -135.96 139.99 43.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.253 -0.579 . . . . 70.400000000000006 109.869 -170.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -98.84 -37.57 9.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.477 0.656 . . . . 75.120000000000005 110.525 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.04 136.96 18.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.258 -1.386 . . . . 70.040000000000006 107.258 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.626 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 55.5 tp60 -152.58 136.02 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.176 0.435 . . . . 72.519999999999996 112.176 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.35 117.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 104.676 -2.342 . . . . 72.230000000000004 104.676 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.452 ' SD ' HD11 ' A' ' 128' ' ' ILE . 43.5 ttp -88.05 130.71 34.91 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.664 0.745 . . . . 75.400000000000006 111.458 -168.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.27 156.44 16.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.081 -1.418 . . . . 74.140000000000001 109.151 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.0 t -70.56 130.81 42.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.932 -1.136 . . . . 64.329999999999998 107.932 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.3 57.73 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 120.565 -0.826 . . . . 72.319999999999993 111.158 -177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.43 141.06 50.28 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 109.326 -0.62 . . . . 54.219999999999999 109.326 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.47 125.7 54.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.496 -0.557 . . . . 72.140000000000001 109.496 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.452 HD11 ' SD ' ' A' ' 122' ' ' MET . 68.3 mt -108.21 131.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.302 -1.37 . . . . 72.219999999999999 107.302 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -119.92 123.0 42.49 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 121.378 0.609 . . . . 75.019999999999996 109.654 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.6 mt -113.9 102.31 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.301 -1.74 . . . . 74.510000000000005 106.301 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.71 -111.86 4.43 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 109.933 -1.267 . . . . 41.509999999999998 109.933 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' A' ' 82' ' ' ASP . 65.9 pttt -103.58 -4.67 23.58 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 117.406 0.603 . . . . 74.510000000000005 110.428 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.538 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.9 m-85 -73.22 130.5 40.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.401 -0.592 . . . . 73.239999999999995 109.401 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -112.01 119.41 38.37 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.628 -1.249 . . . . 75.040000000000006 107.628 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.3 134.3 54.96 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.582 -1.266 . . . . 72.519999999999996 107.582 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.71 131.53 69.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 108.746 -0.835 . . . . 73.530000000000001 108.746 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.31 122.56 43.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.572 -0.529 . . . . 73.349999999999994 109.572 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 48' ' ' LEU . 3.9 mp -128.72 137.19 51.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 110.162 -0.31 . . . . 73.310000000000002 110.162 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.57 135.48 33.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.986 -0.746 . . . . 74.230000000000004 108.986 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.2 88.07 1.81 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.788 -0.925 . . . . 74.150000000000006 110.788 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' ' 48' ' ' LEU . 21.2 Cg_exo -66.64 161.86 39.7 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.215 2.61 . . . . 64.540000000000006 112.459 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.43 53.73 0.88 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.196 -1.038 . . . . 72.310000000000002 108.196 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.026 -0.988 . . . . 72.450000000000003 109.216 -175.583 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 109.451 -0.574 . . . . 73.150000000000006 109.451 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 107' ' ' LEU . 93.7 t -113.64 117.45 55.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 119.63 -0.224 . . . . 62.130000000000003 110.692 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 83' ' ' VAL . 47.8 p90 -123.12 127.25 48.44 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.085 -0.646 . . . . 72.430000000000007 109.454 171.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 19' ' ' ARG . 28.5 mtp180 -106.9 92.13 3.96 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.924 -1.139 . . . . 71.25 107.924 176.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 -154.99 0.56 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.233 -0.894 . . . . 63.0 112.169 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.65 -3.21 6.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.388 1.475 . . . . 73.209999999999994 112.032 -172.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.82 -25.04 60.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.132 0.973 . . . . 74.530000000000001 111.713 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.8 pp -67.31 -24.33 65.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.302 0.572 . . . . 74.219999999999999 111.304 177.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 23' ' ' LEU . 34.9 ttmt -88.56 -29.79 19.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.839 -0.8 . . . . 75.319999999999993 108.839 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -56.57 -44.77 81.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 42.420000000000002 110.794 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.3 ptp -83.99 2.76 37.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.614 -0.721 . . . . 73.099999999999994 111.556 -179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -91.88 -49.66 6.13 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.209 -1.034 . . . . 75.219999999999999 108.209 176.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.2 m -61.0 -42.85 99.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.29 -0.868 . . . . 51.439999999999998 111.986 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -77.4 -33.56 55.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.902 0.382 . . . . 50.340000000000003 110.293 177.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m 74.44 -54.8 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.122 1.369 . . . . 64.319999999999993 111.21 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.34 -163.8 10.58 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 109.935 -1.266 . . . . 23.149999999999999 109.935 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 113' ' ' ASN . 97.8 m -104.6 138.36 41.06 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 117.054 0.427 . . . . 71.329999999999998 110.288 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.34 121.45 66.46 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 108.367 -0.975 . . . . 61.240000000000002 108.367 176.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -59.48 152.28 62.73 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 122.93 2.42 . . . . 71.140000000000001 113.02 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 166.43 16.17 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.36 -0.836 . . . . 55.399999999999999 109.127 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -66.05 122.74 18.09 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.231 0.539 . . . . 63.210000000000001 111.189 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 m -54.67 133.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.445 -1.252 . . . . 71.530000000000001 109.904 177.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 41' ' ' ASN . . . 129.78 -28.18 3.99 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 108.826 -1.71 . . . . 71.439999999999998 108.826 -174.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.5 65.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.695 0.76 . . . . 74.150000000000006 110.328 178.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 7.86 4.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.008 0.909 . . . . 71.5 112.576 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.7 m120 -79.54 -16.69 55.52 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.506 -1.224 . . . . 63.119999999999997 110.269 173.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 50.96 68.62 3.2 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 123.987 0.804 . . . . 71.010000000000005 112.819 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.03 -56.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.528 2.152 . . . . 74.140000000000001 113.648 -175.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -23.31 33.43 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.019 0.377 . . . . 72.540000000000006 112.019 -177.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.93 79.7 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 120.351 -0.928 . . . . 53.530000000000001 111.182 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.1 m -115.12 157.19 23.94 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.125 -1.065 . . . . 54.340000000000003 108.125 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.59 157.3 46.04 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.548 -0.538 . . . . 63.149999999999999 109.548 -177.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -134.04 160.26 38.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.744 0.652 . . . . 71.329999999999998 109.317 -177.136 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -128.69 141.22 51.4 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 120.158 -0.617 . . . . 53.329999999999998 109.846 175.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.86 139.67 38.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.432 -0.804 . . . . 62.219999999999999 109.809 -176.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 20.7 t -81.0 118.37 28.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.204 -1.036 . . . . 63.43 108.204 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -85.15 -34.79 22.05 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.169 -0.923 . . . . 75.099999999999994 109.858 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.627 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 29.2 tpt180 -151.68 144.91 24.67 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.52 -1.659 . . . . 73.109999999999999 106.52 -177.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.62 -171.05 22.48 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.508 -0.853 . . . . 52.229999999999997 111.551 179.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.67 -33.06 8.75 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.204 1.936 . . . . 72.519999999999996 109.932 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.77 11.81 21.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.058 -1.428 . . . . 74.540000000000006 110.109 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.56 42.36 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.298 0.571 . . . . 24.34 112.109 -175.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.91 -19.27 47.37 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 115.225 -0.898 . . . . 73.420000000000002 111.712 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.74 156.84 19.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.958 -0.386 . . . . 65.150000000000006 109.958 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -139.46 155.15 47.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.752 -1.203 . . . . 73.439999999999998 107.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -147.78 143.3 27.42 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.608 -0.516 . . . . 75.510000000000005 109.608 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.3 pt? -108.62 144.75 35.93 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.526 0.516 . . . . 74.430000000000007 110.285 -177.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.15 105.06 11.14 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.703 -0.681 . . . . 70.340000000000003 110.175 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.93 -15.93 11.17 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.312 1.045 . . . . 65.340000000000003 109.344 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -107.34 153.23 41.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 114.4 -1.273 . . . . 72.319999999999993 110.117 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -63.17 -29.32 73.9 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.897 2.398 . . . . 73.409999999999997 113.743 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 67.2 m -150.47 122.67 8.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.084 0.469 . . . . 70.510000000000005 111.287 -177.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.8 m -112.6 114.24 26.78 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.163 -0.68 . . . . 74.439999999999998 109.163 178.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -90.75 133.87 34.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.39 -0.967 . . . . 72.200000000000003 108.39 175.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -128.03 135.4 49.82 Favored 'General case' 0 C--O 1.267 2.019 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 111.404 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.41 -153.62 25.01 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 114.579 -1.192 . . . . 72.310000000000002 111.174 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 22.0 tpp85 -79.4 151.82 30.72 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.977 1.311 . . . . 74.219999999999999 108.676 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 14.9 m170 92.39 127.89 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 125.904 1.682 . . . . 74.420000000000002 110.619 -175.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.85 2.97 4.8 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.347 2.032 . . . . 54.25 112.522 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 12.9 pt-20 -80.2 -25.19 39.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.252 -1.018 . . . . 72.310000000000002 108.252 175.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -73.01 132.04 42.9 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.7 -1.222 . . . . 74.219999999999999 107.7 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -54.74 -39.53 68.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.698 0.629 . . . . 44.119999999999997 112.698 -174.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.4 mm -119.58 124.69 73.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.34 108.06 20.22 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.266 0.555 . . . . 60.530000000000001 110.604 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.62 117.6 32.72 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.953 -2.24 . . . . 62.420000000000002 104.953 176.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.48 116.76 18.32 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.387 -0.925 . . . . 74.329999999999998 111.954 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.73 161.4 14.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.755 -0.657 . . . . 62.020000000000003 109.457 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 18' ' ' PHE . 98.6 t -67.95 -36.25 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.328 0.585 . . . . 64.310000000000002 109.914 178.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 p -116.44 -171.29 1.98 Allowed 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.791 -0.641 . . . . 71.140000000000001 110.479 -176.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.31 96.58 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.452 -0.944 . . . . 75.230000000000004 108.452 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.9 m -129.44 85.69 2.34 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.929 -1.508 . . . . 34.100000000000001 106.929 174.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 20.0 ptt180 -77.31 -45.88 24.78 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 74.109999999999999 110.117 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -106.21 93.4 4.59 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.534 -1.284 . . . . 63.340000000000003 107.534 172.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -99.65 -53.27 3.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.094 -1.076 . . . . 75.319999999999993 108.094 174.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.9 143.76 31.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.744 -0.782 . . . . 71.549999999999997 111.474 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -122.35 135.54 54.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.29 -0.868 . . . . 64.430000000000007 109.58 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 35.6 m-85 -104.2 113.62 27.29 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.572 -1.64 . . . . 65.099999999999994 106.572 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.24 123.88 51.1 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.865 -0.791 . . . . 64.310000000000002 108.865 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 94' ' ' ILE . 2.6 mp -104.02 115.13 45.39 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 N-CA-C 106.82 -1.548 . . . . 74.329999999999998 106.82 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -131.53 120.56 23.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.58 -0.526 . . . . 50.130000000000003 109.58 -177.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 48.22 48.23 18.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.556 1.143 . . . . 73.540000000000006 113.586 -177.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.07 -6.46 62.93 Favored Glycine 0 N--CA 1.462 0.427 0 CA-C-N 116.015 -0.539 . . . . 61.240000000000002 114.414 176.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -103.05 143.56 32.43 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.276 -0.639 . . . . 71.209999999999994 109.276 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -104.8 116.76 32.57 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.871 -0.788 . . . . 72.439999999999998 108.871 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.0 126.28 55.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.434 -0.951 . . . . 73.109999999999999 108.434 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.77 123.97 63.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 118.662 -1.215 . . . . 43.409999999999997 107.787 173.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.17 123.38 67.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.044 -1.465 . . . . 71.25 107.044 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.53 136.47 47.26 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.94 -1.027 . . . . 72.430000000000007 109.991 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -116.75 0.1 8.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.946 -0.57 . . . . 64.310000000000002 110.616 177.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.08 34.64 4.86 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 121.151 -0.547 . . . . 63.140000000000001 112.049 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -51.62 -34.42 37.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.876 1.27 . . . . 61.219999999999999 111.177 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 107' ' ' LEU . 4.6 mp -67.34 -23.92 65.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.063 -0.971 . . . . 54.409999999999997 111.16 -178.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.95 -18.64 30.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.586 0.708 . . . . 75.430000000000007 109.704 -175.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.22 0.43 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 119.103 -1.522 . . . . 71.230000000000004 113.93 175.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.8 m -77.79 129.14 35.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.871 -0.789 . . . . 42.310000000000002 108.871 172.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.11 144.55 47.2 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.897 -0.321 . . . . 64.319999999999993 110.189 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.18 117.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.594 -1.632 . . . . 71.510000000000005 106.594 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.422 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 93.9 m-20 56.91 45.75 20.82 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.734 0.646 . . . . 54.32 110.062 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.04 8.95 2.81 Favored 'General case' 0 CA--C 1.569 1.701 0 C-N-CA 125.731 1.612 . . . . 73.409999999999997 113.809 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -114.11 136.85 22.24 Favored Pre-proline 0 C--N 1.31 -1.134 0 O-C-N 121.341 -0.85 . . . . 65.420000000000002 110.342 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -68.05 138.17 43.08 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 122.025 1.817 . . . . 70.420000000000002 111.211 177.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -142.19 164.6 29.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.082 -0.508 . . . . 62.310000000000002 111.025 -177.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -117.37 -37.6 3.48 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.489 1.118 . . . . 70.239999999999995 108.258 176.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.01 139.95 26.48 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.283 -1.377 . . . . 73.510000000000005 107.283 175.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 0.0 OUTLIER -152.49 130.33 11.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.432 -0.581 . . . . 64.219999999999999 109.432 -177.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.8 t -83.41 118.29 30.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.999 -1.482 . . . . 65.349999999999994 106.999 174.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.443 ' HE2' ' HB3' ' A' ' 120' ' ' GLN . 22.8 mmt -88.82 144.93 25.9 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.725 0.774 . . . . 63.5 112.944 -167.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.58 155.91 45.04 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.946 -1.479 . . . . 75.319999999999993 107.26 -177.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 t -62.57 134.38 56.29 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.339 0.59 . . . . 71.310000000000002 111.336 -176.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.32 -7.47 56.46 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.06 -0.973 . . . . 71.400000000000006 113.535 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.79 152.14 24.81 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 119.002 -1.079 . . . . 75.439999999999998 111.709 175.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.21 129.15 51.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.381 -1.281 . . . . 71.25 110.187 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt -108.1 131.91 57.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.198 -1.408 . . . . 74.230000000000004 107.198 -177.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -104.35 122.48 45.54 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.312 -0.996 . . . . 71.420000000000002 108.312 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 135' ' ' LEU . 2.3 mp -109.22 104.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 106.602 -1.629 . . . . 53.530000000000001 106.602 178.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.05 -107.81 2.21 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.248 -1.141 . . . . 73.120000000000005 110.248 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -110.77 6.86 21.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.849 0.325 . . . . 70.340000000000003 111.673 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.627 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 44.1 p90 -123.49 157.63 33.1 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.542 0.941 . . . . 74.219999999999999 113.542 -177.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -116.05 136.61 52.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.347 -0.388 . . . . 64.120000000000005 111.329 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 130' ' ' ILE . 9.6 mp -123.45 139.72 53.74 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.191 0.997 . . . . 64.230000000000004 108.337 175.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.45 126.82 69.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.574 -0.528 . . . . 62.210000000000001 109.574 -178.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -88.32 127.74 35.48 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.657 -0.868 . . . . 71.140000000000001 108.657 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.44 143.72 50.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.577 0.703 . . . . 72.120000000000005 111.238 -176.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.2 121.92 45.5 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.489 -0.93 . . . . 60.229999999999997 108.489 176.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 132.27 82.23 0.22 Allowed Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.72 -1.352 . . . . 53.219999999999999 109.72 -177.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.98 162.38 29.42 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.276 2.65 . . . . 54.219999999999999 112.719 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.89 -1.17 56.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.198 0.999 . . . . 63.240000000000002 110.929 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.271 -2.838 0 N-CA-C 103.627 -2.731 . . . . 62.009999999999998 103.627 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.509 ' O ' HD12 ' A' ' 107' ' ' LEU . 36.1 t . . . . . 0 N--CA 1.424 -1.773 0 N-CA-C 108.785 -0.82 . . . . 64.420000000000002 108.785 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -85.56 115.13 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.283 -1.377 . . . . 72.439999999999998 107.283 177.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.472 ' CE2' ' HG ' ' A' ' 107' ' ' LEU . 40.3 p90 -114.79 142.53 46.4 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 120.813 0.34 . . . . 74.319999999999993 110.55 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -80.78 95.93 6.81 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.74 -1.208 . . . . 73.420000000000002 107.74 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -81.3 -178.71 7.04 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.421 -0.809 . . . . 73.230000000000004 112.26 -175.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.42 4.44 4.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 114.326 1.232 . . . . 64.420000000000002 114.326 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 22' ' ' LEU . 2.5 pt? -82.83 -16.75 46.5 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.879 -0.513 . . . . 74.450000000000003 111.553 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 2.6 pp -70.01 -1.14 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.118 1.525 . . . . 75.140000000000001 115.118 -173.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -102.73 -22.5 13.92 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.574 -0.451 . . . . 60.229999999999997 111.257 177.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 114' ' ' ARG . 30.8 tt0 -72.68 -23.6 60.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.703 -0.399 . . . . 74.310000000000002 111.829 -172.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' SER . 52.6 ttp -62.33 -47.52 83.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.327 -0.397 . . . . 51.25 110.196 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.42 -22.58 23.66 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.505 -0.316 . . . . 70.319999999999993 110.963 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.6 t -62.29 -27.44 69.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.186 0.993 . . . . 65.540000000000006 108.532 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 26' ' ' MET . 40.0 t -65.38 -39.14 91.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.311 -1.313 . . . . 62.299999999999997 110.593 175.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 m 69.46 -7.08 0.89 Allowed 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 124.879 1.271 . . . . 71.329999999999998 111.418 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.64 96.23 0.11 Allowed Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.668 -1.773 . . . . 72.340000000000003 108.668 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 92.0 m -72.84 121.02 19.28 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.869 0.842 . . . . 62.200000000000003 110.772 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.13 106.16 19.9 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 114.803 -1.09 . . . . 73.329999999999998 109.042 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -61.16 142.96 98.38 Favored 'Trans proline' 0 C--O 1.263 1.74 0 C-N-CA 121.551 1.501 . . . . 60.240000000000002 109.202 173.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.47 125.72 27.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.939 -0.573 . . . . 63.329999999999998 110.342 -177.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.5 m -84.33 92.7 8.07 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.657 -0.868 . . . . 61.549999999999997 108.657 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 m -102.55 155.62 18.16 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.875 -1.157 . . . . 72.239999999999995 107.875 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.7 25.57 7.3 Favored Glycine 0 CA--C 1.499 -0.947 0 N-CA-C 111.05 -0.82 . . . . 74.219999999999999 111.05 -175.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.93 5.18 49.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.987 -0.607 . . . . 74.140000000000001 110.202 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.23 -3.35 13.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.373 1.069 . . . . 65.409999999999997 113.393 -175.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.86 -2.81 31.1 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.233 -1.025 . . . . 73.430000000000007 108.233 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.9 82.83 0.22 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.185 -0.916 . . . . 71.329999999999998 110.95 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.03 -59.72 0.74 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.235 2.623 . . . . 73.409999999999997 114.257 -175.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.13 -4.08 59.09 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.227 0.454 . . . . 51.229999999999997 112.227 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 9.61 86.82 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.709 -0.758 . . . . 71.0 111.478 -177.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 m -145.86 169.22 19.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.884 -1.524 . . . . 73.230000000000004 106.884 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.77 157.23 43.63 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.414 0.446 . . . . 75.409999999999997 109.916 -178.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -133.26 153.32 51.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.056 0.455 . . . . 72.439999999999998 110.8 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.5 pp -110.86 135.02 52.03 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.573 176.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.75 135.2 55.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.394 -0.595 . . . . 72.219999999999999 109.394 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.26 117.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.361 -1.718 . . . . 65.400000000000006 106.361 176.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.53 -31.95 16.53 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.527 -0.761 . . . . 73.200000000000003 109.683 -175.641 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -148.19 141.02 24.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.399 -0.963 . . . . 72.439999999999998 108.399 -178.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.5 174.14 13.22 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.793 -0.923 . . . . 62.420000000000002 110.793 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.592 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 76.6 Cg_exo -54.68 -43.28 60.52 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.83 2.353 . . . . 65.040000000000006 112.402 177.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -93.11 21.88 5.5 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.792 1.034 . . . . 73.439999999999998 113.792 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.75 137.26 44.9 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.735 0.302 . . . . 52.109999999999999 111.14 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.6 -18.95 40.18 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.144 -0.783 . . . . 65.319999999999993 111.144 -177.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.23 143.06 29.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.53 -0.544 . . . . 74.129999999999995 109.53 177.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -135.2 135.58 41.11 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.505 -0.924 . . . . 75.219999999999999 108.505 179.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -128.42 129.67 46.51 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.511 -0.552 . . . . 73.409999999999997 109.511 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.7 pt? -92.13 139.07 31.0 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.286 -0.635 . . . . 74.319999999999993 109.286 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.31 104.38 15.09 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.941 -0.763 . . . . 61.310000000000002 108.941 -179.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -124.37 -2.77 7.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.564 -1.198 . . . . 53.119999999999997 108.957 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 8.8 pm0 -107.73 143.76 27.93 Favored Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-N 115.184 -0.916 . . . . 74.319999999999993 109.392 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 65' ' ' GLN . 21.2 Cg_exo -68.37 -16.28 43.28 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.777 2.318 . . . . 70.319999999999993 113.445 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -150.1 128.05 11.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.727 -0.608 . . . . 74.239999999999995 109.495 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 10.6 m -123.7 119.38 29.63 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 p -87.5 137.12 32.61 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 110.208 -0.293 . . . . 70.540000000000006 110.208 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.02 148.3 51.86 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.329 0.585 . . . . 62.420000000000002 110.787 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.23 28.31 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 108.612 -1.795 . . . . 65.349999999999994 108.612 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -119.15 117.66 29.27 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.653 -1.61 . . . . 44.409999999999997 106.653 175.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 171.45 162.14 0.24 Allowed Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 126.077 1.751 . . . . 74.219999999999999 106.623 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.87 -28.66 75.72 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.373 2.049 . . . . 74.340000000000003 114.22 -176.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.14 4.52 48.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.719 0.637 . . . . 62.240000000000002 112.719 -174.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 m -67.9 117.54 9.92 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 73.439999999999998 109.407 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.94 -39.27 84.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.201 -1.037 . . . . 72.239999999999995 108.201 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.455 HG12 ' CG2' ' A' ' 68' ' ' THR . 47.5 mm -112.65 110.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.196 -1.779 . . . . 62.219999999999999 106.196 169.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.4 129.45 39.53 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.991 -0.549 . . . . 75.319999999999993 110.74 -176.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 1.7 mm? -124.58 129.78 51.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.254 -2.128 . . . . 71.019999999999996 105.254 175.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -101.31 116.66 33.31 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.589 -0.844 . . . . 54.520000000000003 109.782 177.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.03 -160.11 0.95 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.312 -1.366 . . . . 74.239999999999995 107.312 -178.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.79 -27.99 17.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.65 0.611 . . . . 55.140000000000001 112.65 -174.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.1 m -139.42 148.83 43.33 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.209 -0.932 . . . . 64.439999999999998 111.844 -175.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -74.56 148.88 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.029 . . . . 73.299999999999997 110.189 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.491 ' HB3' HD22 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -142.28 113.69 7.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.19 -1.041 . . . . 74.25 108.19 177.624 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -56.63 -25.3 52.91 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.148 0.795 . . . . 73.329999999999998 113.148 -177.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.416 ' HG2' HG21 ' A' ' 104' ' ' VAL . 34.5 ttt180 -172.99 99.02 0.13 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.286 -1.376 . . . . 63.229999999999997 107.286 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 27.0 t-80 -84.56 -52.53 6.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.425 0.631 . . . . 72.439999999999998 109.698 -177.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.42 41.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.754 -0.832 . . . . 62.5 108.754 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.65 143.98 43.76 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.553 -0.536 . . . . 54.43 109.553 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 83.3 m-85 -104.78 125.32 50.73 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.381 -1.711 . . . . 73.319999999999993 106.381 178.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -113.43 119.11 36.48 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 106.795 -1.557 . . . . 73.439999999999998 106.795 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 3.4 mp -114.65 111.88 37.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.541 -1.651 . . . . 70.340000000000003 106.541 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -135.29 128.9 32.68 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.786 -1.19 . . . . 65.340000000000003 107.786 -177.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 55.45 37.98 29.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.882 0.873 . . . . 61.130000000000003 112.035 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.37 1.45 90.43 Favored Glycine 0 C--O 1.238 0.402 0 CA-C-N 115.974 -0.557 . . . . 52.520000000000003 113.911 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 20.2 mm-40 -102.11 131.74 48.42 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.782 -0.451 . . . . 65.239999999999995 109.782 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -107.48 118.59 37.13 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.211 -1.404 . . . . 72.439999999999998 107.211 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.17 142.79 51.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.251 -0.579 . . . . 52.329999999999998 110.303 178.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -106.63 123.61 61.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.586 -1.265 . . . . 54.420000000000002 107.586 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.3 121.21 65.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.138 -0.69 . . . . 61.340000000000003 109.138 175.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -83.14 131.65 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.459 -0.941 . . . . 74.519999999999996 108.459 173.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.416 HG21 ' HG2' ' A' ' 88' ' ' ARG . 34.6 m -124.74 -14.46 4.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 123.457 0.473 . . . . 72.209999999999994 110.645 178.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . -156.28 84.48 0.14 Allowed Glycine 0 N--CA 1.419 -2.454 0 C-N-CA 120.816 -0.707 . . . . 54.219999999999999 112.768 -178.444 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -69.7 83.09 0.44 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.11 0.481 . . . . 73.209999999999994 109.975 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 16' ' ' SER . 12.4 tp -77.17 -49.31 15.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.675 -1.232 . . . . 74.25 107.675 174.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -102.37 -19.17 15.08 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.296 -1.774 . . . . 52.149999999999999 110.049 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 108.82 3.31 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.873 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.6 m -87.38 130.43 34.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.464 0.174 . . . . 55.329999999999998 111.24 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 5.6 m-30 -127.97 132.24 49.21 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.147 0.979 . . . . 74.340000000000003 109.068 175.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.75 127.74 75.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.842 -1.54 . . . . 75.140000000000001 106.842 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 56.85 36.49 27.8 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.031 1.332 . . . . 73.040000000000006 109.185 -169.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.493 ' HD3' ' OE2' ' A' ' 25' ' ' GLU 0.274 44.0 ttp180 57.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.576 1.948 0 C-N-CA 125.716 1.607 . . . . 75.310000000000002 113.059 -177.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.23 147.87 36.84 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.71 -1.219 . . . . 72.450000000000003 107.71 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.72 123.16 12.14 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.703 1.602 . . . . 61.119999999999997 110.24 177.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -161.11 136.89 8.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.707 -1.22 . . . . 75.230000000000004 107.707 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -100.56 -53.75 3.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 123.364 0.415 . . . . 75.239999999999995 109.959 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.604 -0.887 . . . . 65.420000000000002 108.604 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -154.77 140.22 17.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.315 -0.402 . . . . 72.400000000000006 110.699 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.6 t -76.06 124.54 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 105.756 -1.942 . . . . 71.299999999999997 105.756 168.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.436 ' SD ' HD11 ' A' ' 128' ' ' ILE . 36.6 ttp -89.81 141.19 28.86 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.485 -169.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 11.0 pt20 -115.1 156.99 24.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 124.557 1.143 . . . . 73.099999999999994 109.815 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -69.92 130.26 41.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 74.340000000000003 107.692 173.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.02 56.5 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 119.963 -1.113 . . . . 54.340000000000003 110.351 -174.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 6.3 t70 -76.21 137.53 40.06 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.27 -1.381 . . . . 74.209999999999994 107.27 178.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.6 124.28 45.95 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.354 0.597 . . . . 73.299999999999997 109.765 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.436 HD11 ' SD ' ' A' ' 122' ' ' MET . 37.3 mt -108.16 131.69 57.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.53 -0.915 . . . . 62.210000000000001 108.53 -172.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 7.2 tp60 -115.52 119.04 34.88 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.345 -0.613 . . . . 53.140000000000001 109.345 -176.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.19 102.83 9.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 106.48 -1.674 . . . . 64.340000000000003 106.48 176.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.89 -103.66 0.06 OUTLIER Glycine 0 N--CA 1.475 1.24 0 O-C-N 123.74 0.65 . . . . 75.349999999999994 114.134 -175.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -106.59 2.03 25.73 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.106 -0.547 . . . . 73.109999999999999 111.903 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 89.3 m-85 -96.32 135.39 38.23 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.219 -1.4 . . . . 73.099999999999994 107.219 173.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -131.76 120.17 22.31 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.029 -1.1 . . . . 74.409999999999997 108.029 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.37 136.59 48.55 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.416 -0.587 . . . . 73.400000000000006 109.416 -176.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.95 120.17 64.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.219 -1.4 . . . . 72.239999999999995 107.219 175.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -98.27 117.15 32.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 110.147 -0.316 . . . . 73.510000000000005 110.147 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.37 143.88 47.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.182 0.515 . . . . 61.200000000000003 111.187 -177.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.97 119.64 34.83 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.759 -1.571 . . . . 63.210000000000001 106.759 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.39 153.24 19.81 Favored Glycine 0 N--CA 1.426 -1.969 0 C-N-CA 118.866 -1.635 . . . . 72.0 112.697 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.67 164.13 36.71 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 123.687 2.925 . . . . 72.409999999999997 111.524 175.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 84.31 69.22 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 125.213 1.405 . . . . 73.430000000000007 111.989 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 105.264 -2.125 . . . . 54.119999999999997 105.264 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 44.9 t . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.204 -0.295 . . . . 63.350000000000001 110.204 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.38 118.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.789 -0.449 . . . . 63.340000000000003 109.789 -178.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -124.04 140.73 52.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.384 -0.371 . . . . 74.299999999999997 111.16 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -94.51 139.59 30.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.239 -0.437 . . . . 74.019999999999996 111.232 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -128.46 -164.2 1.36 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 7.6 p-10 -68.08 -3.23 9.65 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.929 0.871 . . . . 73.209999999999994 111.2 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.7 mt -57.25 -31.99 66.1 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 125.89 1.676 . . . . 73.019999999999996 111.502 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 1.6 pp -68.39 -1.38 6.32 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.224 1.564 . . . . 64.099999999999994 115.224 -175.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 63.2 pttt -81.25 -5.71 58.07 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.847 -0.533 . . . . 71.319999999999993 111.599 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -48.9 31.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 116.112 1.893 . . . . 70.430000000000007 116.112 -175.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.7 ttm -62.26 -46.86 86.93 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.942 0.401 . . . . 62.240000000000002 111.658 -176.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.28 -28.25 61.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.318 0.58 . . . . 45.409999999999997 110.303 -178.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -80.51 -11.63 59.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.114 -0.494 . . . . 61.439999999999998 110.924 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -71.33 -24.41 62.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.756 -0.831 . . . . 54.539999999999999 108.756 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -76.08 93.74 3.36 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.305 -1.369 . . . . 72.310000000000002 107.305 171.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.78 50.32 0.85 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 106.901 -2.48 . . . . 51.32 106.901 -169.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -67.17 148.39 51.86 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.853 1.261 . . . . 71.510000000000005 112.118 -173.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 150.38 37.8 Favored Pre-proline 0 C--N 1.312 -1.028 0 N-CA-C 108.501 -0.925 . . . . 51.009999999999998 108.501 177.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.98 146.42 96.31 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.418 2.079 . . . . 74.129999999999995 113.24 -177.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.72 159.22 17.19 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 71.219999999999999 108.484 175.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.3 t -98.92 178.12 5.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.489 -0.56 . . . . 73.040000000000006 109.489 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.506 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 12.9 t -156.4 33.56 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.792 -1.929 . . . . 72.420000000000002 105.792 176.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 124' ' ' THR . . . -103.56 35.45 5.02 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 114.827 -1.079 . . . . 62.409999999999997 113.072 -173.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 123' ' ' GLN . . . -90.82 -33.93 15.49 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.396 -0.964 . . . . 63.039999999999999 108.396 174.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.28 12.65 1.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.934 -1.485 . . . . 71.209999999999994 112.346 -177.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.08 -42.02 24.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.24 -0.282 . . . . 72.400000000000006 110.24 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt 35.94 76.07 0.46 Allowed Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 124.766 1.291 . . . . 74.530000000000001 114.241 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.35 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.437 1.425 . . . . 44.100000000000001 111.112 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.06 -8.44 20.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.147 0.499 . . . . 64.329999999999998 110.954 178.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -6.22 80.15 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.401 -0.904 . . . . 75.439999999999998 111.925 -179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -114.49 162.79 16.24 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.94 -1.874 . . . . 71.400000000000006 105.94 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -153.15 157.14 39.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 118.137 0.426 . . . . 73.519999999999996 110.51 -178.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 143.72 44.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.14 0.422 . . . . 74.140000000000001 112.14 -178.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 pt? -116.55 138.54 51.32 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.402 -0.592 . . . . 71.140000000000001 109.402 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.68 132.5 57.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 123.64 0.587 . . . . 72.329999999999998 109.573 -176.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.72 118.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.724 -1.584 . . . . 63.340000000000003 106.724 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.91 -38.96 18.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.411 0.624 . . . . 73.040000000000006 110.34 -175.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -147.54 140.7 25.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.325 -1.361 . . . . 65.019999999999996 107.325 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.94 -177.14 19.12 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 111.475 -0.65 . . . . 73.349999999999994 111.475 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.23 -36.9 86.37 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 122.772 2.315 . . . . 62.009999999999998 111.863 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.75 14.55 18.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.808 -0.633 . . . . 70.239999999999995 111.419 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.49 134.39 56.64 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.776 0.658 . . . . 61.119999999999997 112.776 -176.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -21.09 44.37 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.786 -0.643 . . . . 64.439999999999998 111.876 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 155.03 19.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.766 0.317 . . . . 73.040000000000006 110.47 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.14 144.54 51.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.107 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -117.82 138.53 52.02 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.221 -1.029 . . . . 63.219999999999999 108.221 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.11 127.01 56.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.917 0.865 . . . . 74.549999999999997 110.795 -175.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 49' ' ' LEU . 2.2 mm? -95.45 114.77 26.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.822 -1.081 . . . . 73.519999999999996 108.436 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -134.33 4.27 3.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.296 1.046 . . . . 74.349999999999994 109.193 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -121.49 143.3 37.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.978 -1.01 . . . . 72.299999999999997 110.724 -175.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 53.7 Cg_exo -55.19 -24.39 41.26 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.746 2.964 . . . . 75.420000000000002 114.699 -178.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -144.27 121.54 11.57 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.474 -0.766 . . . . 63.210000000000001 110.722 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.3 m -129.7 119.88 24.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.9 -0.778 . . . . 74.040000000000006 108.9 -178.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 140.25 29.72 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.508 0.594 . . . . 73.209999999999994 111.275 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.05 135.5 55.18 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 109.549 -0.538 . . . . 71.340000000000003 109.549 178.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.36 -161.34 25.69 Favored Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 115.65 -0.705 . . . . 42.130000000000003 111.385 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.541 ' HG2' ' H ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -103.83 142.16 34.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.062 -1.459 . . . . 74.239999999999995 107.062 -177.554 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.463 ' CD2' ' HD2' ' A' ' 72' ' ' ARG . 90.4 m-70 80.58 145.84 0.1 OUTLIER Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 125.414 1.486 . . . . 74.400000000000006 110.092 -176.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -66.5 17.4 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.601 2.867 . . . . 51.109999999999999 114.341 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 73' ' ' HIS . 10.4 mm-40 -77.37 -28.77 53.02 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.313 -1.366 . . . . 65.420000000000002 107.313 177.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -96.1 153.0 18.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.919 -1.037 . . . . 61.409999999999997 109.658 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.18 -47.19 78.78 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.56 0.744 . . . . 64.400000000000006 110.463 -178.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.8 mm -98.98 109.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.026 -1.102 . . . . 74.030000000000001 108.026 178.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -87.68 115.6 25.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.115 0.483 . . . . 74.420000000000002 110.577 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 70.8 mt -126.74 140.42 52.4 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.491 -1.67 . . . . 72.430000000000007 106.491 176.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -96.52 117.11 30.24 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.246 -0.982 . . . . 74.530000000000001 109.661 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.541 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 46.1 t0 -117.38 -179.88 3.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.779 -0.646 . . . . 70.109999999999999 109.36 -171.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.03 -46.44 96.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 123.757 0.823 . . . . 74.439999999999998 111.694 -176.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -128.27 -173.1 2.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.463 -0.94 . . . . 72.209999999999994 108.463 -178.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.37 97.5 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 108.825 -0.806 . . . . 54.420000000000002 108.825 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.6 m -89.74 84.89 6.31 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 108.525 -0.917 . . . . 55.210000000000001 108.525 177.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -71.82 -36.98 70.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.97 -1.468 . . . . 75.120000000000005 112.091 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.588 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 31.2 mmm180 -133.71 85.86 2.24 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.241 -1.022 . . . . 71.319999999999993 108.241 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -101.55 -55.65 2.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.193 -0.603 . . . . 61.420000000000002 110.952 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.76 164.59 31.42 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.077 0.465 . . . . 62.409999999999997 111.046 -176.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.66 141.49 37.01 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.397 0.617 . . . . 75.049999999999997 110.148 173.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -104.25 117.4 34.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.781 -1.562 . . . . 63.119999999999997 106.781 -178.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -117.37 128.46 55.05 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-N 115.445 -0.798 . . . . 74.040000000000006 109.256 -175.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -115.52 112.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 105.907 -1.886 . . . . 63.109999999999999 105.907 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -138.52 125.48 21.22 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.893 -0.323 . . . . 70.420000000000002 111.255 -175.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 51.56 49.9 19.94 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.978 1.424 . . . . 72.0 114.098 173.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 114.877 -1.056 . . . . 73.510000000000005 115.382 173.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -127.6 146.99 50.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 118.277 1.038 . . . . 74.230000000000004 111.026 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.33 119.6 39.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.485 -1.302 . . . . 75.5 107.485 -176.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.55 128.46 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.525 0.679 . . . . 70.549999999999997 111.353 -176.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 122' ' ' MET . 32.9 t -103.82 124.51 58.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.506 -1.294 . . . . 63.32 107.506 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 20.8 m -118.51 123.37 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 121.588 0.709 . . . . 71.140000000000001 110.836 176.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.29 121.6 25.3 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.447 -1.686 . . . . 73.209999999999994 106.447 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -111.84 -8.72 11.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.175 0.512 . . . . 72.530000000000001 111.349 -174.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -147.28 90.97 0.15 Allowed Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.17 -1.572 . . . . 51.200000000000003 109.17 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 m -79.22 74.09 5.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.559 0.695 . . . . 71.129999999999995 110.989 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.6 pt? -104.77 -44.36 4.87 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.328 -0.851 . . . . 75.200000000000003 108.786 175.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.408 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 45.7 t-20 -101.16 -21.78 14.85 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.461 -1.245 . . . . 71.510000000000005 107.897 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.49 116.41 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.309 -0.86 . . . . 73.409999999999997 111.774 -177.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 25.2 m -75.82 128.51 35.29 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.794 -0.817 . . . . 71.540000000000006 108.794 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 22' ' ' LEU . 6.4 m-85 -115.24 126.34 54.42 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.616 -0.513 . . . . 71.140000000000001 109.616 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.6 127.87 62.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.408 -1.33 . . . . 75.200000000000003 107.408 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 57.05 46.58 18.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.637 1.208 . . . . 72.120000000000005 108.385 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 62.69 8.56 3.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.534 -1.667 . . . . 75.0 114.471 -177.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.43 132.66 23.45 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 113.231 0.826 . . . . 64.219999999999999 113.231 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 52.7 Cg_endo -78.13 123.19 6.04 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.0 1.8 . . . . 73.129999999999995 108.369 173.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -150.34 158.05 43.73 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.173 -1.047 . . . . 71.239999999999995 108.173 -176.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 15.7 m120 -92.95 -40.8 10.37 Favored 'General case' 0 C--O 1.206 -1.192 0 C-N-CA 120.003 -0.679 . . . . 72.430000000000007 112.77 -176.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.02 134.46 55.29 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.206 -1.405 . . . . 62.200000000000003 107.206 174.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -151.92 143.44 23.49 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 120.837 -0.345 . . . . 74.430000000000007 111.309 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -82.41 124.34 39.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.15 -1.426 . . . . 61.009999999999998 107.15 173.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.438 ' HB2' HG23 ' A' ' 101' ' ' VAL . 47.3 ttp -92.5 129.25 38.49 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 62.420000000000002 108.347 -177.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' A' ' 37' ' ' THR . 26.3 mt-30 -129.8 151.02 50.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.121 -0.696 . . . . 61.030000000000001 109.121 -172.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 38' ' ' GLY . 13.7 t -62.42 132.75 53.59 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.394 0.616 . . . . 63.210000000000001 110.058 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.28 -12.08 61.82 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.774 -0.648 . . . . 72.5 112.584 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.74 151.96 25.95 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.025 0.441 . . . . 74.239999999999995 111.819 178.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -112.23 144.53 41.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.371 -0.832 . . . . 74.540000000000006 109.73 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.43 131.63 67.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.008 -1.108 . . . . 70.310000000000002 108.008 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -117.41 130.51 56.53 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.428 -0.509 . . . . 63.210000000000001 110.163 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.43 107.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 106.29 -1.744 . . . . 72.450000000000003 106.29 175.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.82 -108.53 2.27 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.127 -0.488 . . . . 70.549999999999997 113.323 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.99 -1.2 32.35 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.741 -0.23 . . . . 75.010000000000005 111.504 -175.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 38.1 p90 -124.71 146.39 49.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.992 1.108 . . . . 74.400000000000006 113.992 -173.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -118.18 132.18 56.34 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.117 -0.947 . . . . 74.25 111.288 -172.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.39 140.66 52.43 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 124.142 0.977 . . . . 73.019999999999996 108.875 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.04 130.39 67.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.705 -0.85 . . . . 73.310000000000002 108.705 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -94.06 133.07 37.91 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.976 -0.557 . . . . 63.219999999999999 111.221 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.29 155.57 39.98 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.906 -0.776 . . . . 75.319999999999993 108.906 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.42 148.66 38.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.034 -0.728 . . . . 55.109999999999999 109.034 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.5 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -75.58 136.56 20.26 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.781 -0.724 . . . . 65.129999999999995 112.019 -178.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.52 153.89 72.06 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.259 2.64 . . . . 53.030000000000001 112.27 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.61 65.56 0.8 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.791 -0.64 . . . . 62.439999999999998 111.516 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.414 -2.225 0 N-CA-C 107.944 -1.132 . . . . 75.349999999999994 107.944 173.183 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.423 -1.817 0 N-CA-C 105.504 -2.036 . . . . 73.439999999999998 105.504 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.467 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 93.4 t -82.78 114.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.853 -0.739 . . . . 73.200000000000003 109.321 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -123.3 120.41 32.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.51 -0.768 . . . . 75.329999999999998 110.778 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.92 93.02 3.04 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.155 -2.165 . . . . 71.329999999999998 105.155 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.64 9.52 22.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.467 0.914 . . . . 70.549999999999997 113.467 -168.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -107.24 8.17 29.77 Favored 'General case' 0 C--O 1.182 -2.498 0 C-N-CA 118.909 -1.116 . . . . 74.420000000000002 112.581 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.83 -32.4 63.54 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.111 -0.993 . . . . 70.430000000000007 113.374 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.1 tp -68.05 -37.69 81.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.33 0.586 . . . . 75.329999999999998 110.289 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -91.08 -25.18 19.76 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.126 -0.359 . . . . 55.200000000000003 111.343 -177.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -44.31 93.08 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.163 -1.421 . . . . 65.519999999999996 107.163 174.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.3 mtt -62.27 -35.4 78.86 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.33 -0.396 . . . . 65.420000000000002 111.468 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.85 -44.46 80.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.741 0.781 . . . . 75.040000000000006 109.221 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -72.92 -10.44 59.8 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.086 -178.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -65.42 -17.19 64.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.577 0.227 . . . . 32.219999999999999 110.94 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -57.43 116.95 3.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.437 -0.949 . . . . 74.25 108.437 174.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.15 119.74 18.5 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.335 -0.848 . . . . 61.310000000000002 115.079 -173.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -116.68 149.49 39.71 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.513 -1.292 . . . . 64.310000000000002 107.513 173.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.01 127.49 92.86 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.994 -0.373 . . . . 55.149999999999999 109.994 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.02 142.58 88.32 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.134 1.889 . . . . 75.239999999999995 110.61 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . . . -103.69 168.13 9.34 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.505 -0.316 . . . . 72.549999999999997 110.289 -174.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.477 ' HA ' HG23 ' A' ' 124' ' ' THR . 14.4 t -174.88 -168.28 0.34 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.903 -1.518 . . . . 72.510000000000005 106.903 177.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 36' ' ' SER . 15.3 t 174.45 -29.81 0.0 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.803 0.841 . . . . 71.340000000000003 109.906 178.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.34 63.3 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.901 -1.143 . . . . 64.019999999999996 112.661 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 124' ' ' THR . . . -79.34 -45.9 18.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.037 -0.727 . . . . 70.239999999999995 109.037 179.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.15 4.7 22.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.409 -0.814 . . . . 72.400000000000006 110.651 -178.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -89.88 -28.18 19.4 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.664 -1.153 . . . . 51.130000000000003 108.16 177.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.4 mt 56.34 80.05 0.31 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 114.739 -1.119 . . . . 53.530000000000001 110.626 -177.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.76 -63.71 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 122.743 2.295 . . . . 71.209999999999994 113.406 -175.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.8 14.03 7.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.212 0.529 . . . . 55.210000000000001 110.588 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.28 -9.07 62.1 Favored Glycine 0 C--O 1.215 -1.087 0 C-N-CA 121.127 -0.558 . . . . 71.019999999999996 113.378 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -115.35 153.98 30.02 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 122.351 -0.499 . . . . 51.520000000000003 109.779 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -145.91 157.51 43.89 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.073 -0.714 . . . . 42.329999999999998 109.073 -177.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HG ' ' HA2' ' A' ' 140' ' ' GLY . 3.9 pp -138.76 161.49 37.07 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.831 -0.347 . . . . 62.539999999999999 111.137 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.6 147.36 52.52 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.745 -0.465 . . . . 71.209999999999994 109.745 177.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.04 132.09 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.12 -0.696 . . . . 71.230000000000004 109.12 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG22 ' HG ' ' A' ' 135' ' ' LEU . 25.5 t -80.25 117.92 26.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.167 -1.42 . . . . 74.430000000000007 107.167 176.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.62 -34.0 18.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.747 -0.381 . . . . 75.209999999999994 110.636 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -146.82 133.43 19.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.431 -0.581 . . . . 70.299999999999997 109.431 -178.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.43 171.88 17.0 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 107.304 -2.318 . . . . 40.049999999999997 107.304 -177.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 52.3 Cg_exo -57.61 -31.89 92.97 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.234 1.956 . . . . 50.149999999999999 111.273 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -93.94 20.33 7.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.375 -0.829 . . . . 74.239999999999995 111.274 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 138.54 58.4 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.645 0.26 . . . . 54.109999999999999 110.654 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.92 63.16 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.737 -0.665 . . . . 73.0 111.715 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.33 135.9 33.35 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.698 0.285 . . . . 45.520000000000003 110.446 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.03 134.53 54.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.316 -1.365 . . . . 71.120000000000005 107.316 177.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -128.49 144.9 51.22 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.351 -1.352 . . . . 64.409999999999997 107.351 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.2 pt? -116.66 143.18 45.95 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.528 -0.869 . . . . 74.530000000000001 111.951 -177.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HB3' HD11 ' A' ' 94' ' ' ILE . 2.8 mm? -87.37 105.01 16.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.116 -1.809 . . . . 64.409999999999997 106.116 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -127.37 12.33 7.0 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.487 1.137 . . . . 64.340000000000003 109.761 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.66 153.81 47.38 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.029 -1.1 . . . . 71.329999999999998 108.029 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.3 -21.25 71.74 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.378 2.052 . . . . 72.150000000000006 113.713 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.7 m -136.93 121.7 18.65 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 121.893 -0.505 . . . . 64.150000000000006 110.514 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 77' ' ' ASP . 45.8 m -129.59 118.18 21.59 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.179 -0.674 . . . . 52.32 109.179 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 p -86.86 150.8 23.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.802 -0.561 . . . . 54.32 110.841 -178.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.3 135.24 48.51 Favored 'General case' 0 C--O 1.264 1.851 0 CA-C-O 121.049 0.452 . . . . 70.209999999999994 112.035 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.93 -138.66 6.35 Favored Glycine 0 N--CA 1.422 -2.3 0 CA-C-N 114.796 -1.093 . . . . 62.409999999999997 110.891 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 56.2 ttt180 -118.87 151.57 37.87 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.506 -1.294 . . . . 74.530000000000001 107.506 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 34.9 m170 89.3 164.5 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.967 0 C-N-CA 125.234 1.414 . . . . 75.230000000000004 111.323 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.15 -2.61 8.32 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.018 2.479 . . . . 71.349999999999994 111.009 174.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.24 -22.37 60.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.951 -1.022 . . . . 75.319999999999993 108.36 175.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 m -112.2 130.02 56.06 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.23 -0.895 . . . . 74.030000000000001 109.417 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.418 ' HB3' HG23 ' A' ' 68' ' ' THR . 20.0 t70 -77.37 -33.87 55.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.474 0.654 . . . . 73.329999999999998 109.652 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.9 mm -91.71 101.03 12.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 105.558 -2.016 . . . . 64.239999999999995 105.558 173.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -87.79 113.98 23.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.52 0.676 . . . . 71.230000000000004 112.237 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.0 mt -119.87 127.42 52.71 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.878 -1.897 . . . . 72.349999999999994 105.878 175.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -106.21 117.06 33.06 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.83 -0.748 . . . . 54.240000000000002 109.613 -176.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -119.85 177.56 4.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.033 -0.985 . . . . 72.530000000000001 109.071 -175.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.38 -35.76 68.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 107.913 -1.143 . . . . 74.439999999999998 107.913 176.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.9 m -97.96 151.32 20.41 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.81 -1.086 . . . . 72.129999999999995 108.778 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 81.8 t -90.51 98.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 118.686 -1.206 . . . . 73.239999999999995 110.408 175.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -87.03 78.42 8.96 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.677 -1.231 . . . . 63.109999999999999 107.677 172.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -57.43 -23.82 51.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 112.083 -176.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -172.79 97.7 0.13 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.605 -0.887 . . . . 75.129999999999995 108.605 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.503 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 2.3 t-160 -99.34 -52.12 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.942 -1.132 . . . . 72.409999999999997 107.942 176.222 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.81 155.44 41.09 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.987 -0.551 . . . . 72.519999999999996 110.844 -174.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.488 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 34.0 tt0 -131.05 129.15 41.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.566 -1.642 . . . . 74.530000000000001 106.566 176.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -105.27 122.2 45.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.622 -1.621 . . . . 63.509999999999998 106.622 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD3' ' OE2' ' A' ' 91' ' ' GLU . 21.3 mtm180 -125.07 145.91 49.7 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.635 0.731 . . . . 62.020000000000003 110.635 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 63' ' ' LEU . 2.1 mp -103.98 111.41 33.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 102.856 -3.016 . . . . 74.019999999999996 102.856 175.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -138.73 118.45 13.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.038 -0.528 . . . . 72.329999999999998 110.829 -169.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 53.48 37.8 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.454 1.102 . . . . 72.510000000000005 112.272 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.06 87.52 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 113.515 178.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.98 150.12 26.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.387 -0.598 . . . . 73.230000000000004 109.387 -179.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.415 ' CD2' HG13 ' A' ' 94' ' ' ILE . 94.1 m-85 -104.59 116.19 31.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.257 -1.757 . . . . 70.25 106.257 174.151 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.14 135.31 54.3 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.206 0.527 . . . . 55.539999999999999 111.51 -174.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.42 120.65 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 104.815 -2.291 . . . . 65.120000000000005 104.815 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.03 131.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 N-CA-C 108.35 -0.982 . . . . 72.349999999999994 108.35 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.616 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.8 p30 -97.8 157.94 15.79 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 117.65 -1.62 . . . . 74.030000000000001 112.123 176.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -129.96 23.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.067 -1.827 . . . . 74.349999999999994 106.067 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.99 62.92 0.52 Allowed Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.752 -1.567 . . . . 74.040000000000006 110.11 -176.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -70.97 -7.01 43.1 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 122.802 0.441 . . . . 71.099999999999994 111.485 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HB3' HG22 ' A' ' 17' ' ' VAL . 49.5 mt -75.19 -40.94 58.93 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.318 -0.253 . . . . 71.400000000000006 110.318 -178.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 94.3 m-20 -85.8 -20.56 29.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 119.799 -0.76 . . . . 72.25 110.25 -176.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.17 109.85 0.42 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.302 -0.951 . . . . 52.210000000000001 113.525 174.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -85.38 130.36 34.61 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.456 -0.942 . . . . 44.119999999999997 108.456 174.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 72.0 m-85 -120.0 134.31 55.28 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.076 -0.712 . . . . 74.519999999999996 109.076 179.003 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.8 t -129.87 120.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.928 -1.508 . . . . 73.129999999999995 106.928 175.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.37 39.82 28.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.645 0.736 . . . . 73.430000000000007 109.777 -173.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 62.07 14.87 6.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 113.589 -1.641 . . . . 73.329999999999998 113.736 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -103.53 123.41 41.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 107.684 -1.228 . . . . 72.209999999999994 107.684 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.37 123.87 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.321 2.014 . . . . 74.420000000000002 110.786 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -141.33 162.31 35.79 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 120.887 0.375 . . . . 73.140000000000001 110.593 -179.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.616 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 18.4 m120 -113.81 -29.84 6.95 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.595 -1.184 . . . . 73.409999999999997 109.533 176.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.31 134.7 36.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.617 -1.623 . . . . 71.219999999999999 106.617 172.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -153.46 138.45 17.24 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.458 -0.497 . . . . 65.450000000000003 111.826 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.6 t -84.86 122.52 38.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.401 -1.333 . . . . 75.540000000000006 107.401 171.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 ptm -90.25 130.53 36.36 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.961 -0.563 . . . . 64.439999999999998 111.099 -173.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -101.8 156.2 17.66 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.299 -0.63 . . . . 74.219999999999999 109.299 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 36' ' ' SER . 6.3 t -67.17 126.71 30.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 61.399999999999999 108.677 175.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 35' ' ' ALA . . . 99.91 -6.66 58.62 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.725 -0.67 . . . . 75.430000000000007 112.747 -175.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.23 151.76 29.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.27 0.535 . . . . 71.219999999999999 111.184 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -112.39 127.48 56.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.45 0.643 . . . . 75.439999999999998 110.423 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.94 122.34 68.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.041 -1.096 . . . . 72.239999999999995 108.041 -177.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 39.0 mt-30 -108.02 131.11 54.92 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 113.101 0.778 . . . . 72.230000000000004 113.101 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.477 HG23 ' ND1' ' A' ' 89' ' ' HIS . 3.3 mp -117.35 103.24 14.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.478 -1.675 . . . . 70.120000000000005 106.478 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -65.6 1.29 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-O 121.279 0.377 . . . . 64.439999999999998 112.842 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -157.72 5.71 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.151 0.98 . . . . 74.400000000000006 110.847 173.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 68.0 m-85 -91.18 124.54 35.47 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.894 -1.15 . . . . 75.120000000000005 107.894 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -111.57 118.8 36.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.927 0.87 . . . . 75.239999999999995 110.932 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' A' ' 51' ' ' VAL . 5.8 mp -108.29 133.74 52.08 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.475 -1.693 . . . . 75.409999999999997 107.413 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.25 129.09 67.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.862 -1.162 . . . . 72.519999999999996 107.862 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -88.56 134.03 33.99 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.53 -0.759 . . . . 74.450000000000003 109.484 -176.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.75 161.23 33.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.139 0.495 . . . . 75.209999999999994 109.846 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.56 132.06 43.3 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.701 -1.592 . . . . 73.430000000000007 106.701 174.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -80.11 -163.74 28.59 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 115.739 1.055 . . . . 63.299999999999997 115.739 -169.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.36 145.3 47.84 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 123.001 2.467 . . . . 73.409999999999997 112.424 -177.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.42 65.86 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.494 -1.298 . . . . 71.420000000000002 107.494 175.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--N 1.295 -1.782 0 CA-C-N 114.288 -1.324 . . . . 72.230000000000004 109.388 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.9 t -83.72 124.57 39.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.82 -0.807 . . . . 71.400000000000006 108.82 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 43.9 t80 -81.46 105.91 13.01 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.627 -1.249 . . . . 72.209999999999994 107.627 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -89.1 95.88 10.5 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.638 -0.71 . . . . 65.450000000000003 110.203 -178.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.69 157.89 23.59 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.139 -0.937 . . . . 71.239999999999995 108.508 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.01 3.6 16.78 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.097 0.475 . . . . 71.209999999999994 112.066 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.88 -23.02 66.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.492 1.293 . . . . 64.230000000000004 114.492 -174.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.36 -26.96 63.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.913 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -66.66 -29.46 69.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 74.129999999999995 110.997 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.55 -48.64 76.66 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.535 0.522 . . . . 75.239999999999995 111.744 -175.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -76.78 -18.05 58.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.313 0.578 . . . . 73.310000000000002 110.868 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -81.6 -34.35 31.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.136 -1.061 . . . . 64.209999999999994 108.136 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 t -72.59 -45.24 60.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.974 -0.557 . . . . 34.32 110.21 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 p -80.75 -17.35 51.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.253 -0.43 . . . . 73.420000000000002 111.993 -177.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 67.07 73.89 0.34 Allowed 'General case' 0 C--O 1.25 1.1 0 CA-C-O 122.088 0.946 . . . . 73.310000000000002 110.228 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.62 124.68 34.34 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 113.695 -1.593 . . . . 71.25 113.926 -176.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -94.68 137.76 33.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.356 -0.609 . . . . 73.409999999999997 109.356 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.61 98.97 43.0 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 109.63 -0.507 . . . . 61.219999999999999 109.63 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 143.08 27.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.027 1.818 . . . . 73.450000000000003 110.946 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 126.0 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.944 -1.132 . . . . 71.349999999999994 107.944 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -112.28 156.83 21.76 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.288 -0.634 . . . . 75.120000000000005 109.288 -177.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.23 160.83 32.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.807 -0.812 . . . . 72.109999999999999 108.807 -177.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.53 -7.12 24.46 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.647 -1.381 . . . . 51.130000000000003 109.647 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -73.8 -39.78 63.85 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.721 -0.74 . . . . 64.040000000000006 109.979 -177.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -86.51 -5.08 59.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.466 -1.243 . . . . 75.120000000000005 110.432 -177.144 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -86.63 -29.89 22.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.931 -0.577 . . . . 72.040000000000006 110.119 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 53.41 69.21 2.38 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 124.158 0.911 . . . . 73.400000000000006 110.384 -177.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.15 -65.97 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.181 2.587 . . . . 65.200000000000003 113.819 -173.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . -102.22 -0.37 33.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.611 -0.436 . . . . 74.239999999999995 111.467 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.9 -5.14 77.14 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.079 -0.581 . . . . 53.119999999999997 113.606 178.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.1 m -115.22 157.67 23.38 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 110.0 -0.371 . . . . 61.439999999999998 110.0 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -142.59 139.93 31.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.308 -0.406 . . . . 45.25 110.161 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.46 150.61 32.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.927 0.394 . . . . 54.530000000000001 111.782 -178.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.1 pt? -124.36 134.25 53.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.262 -0.644 . . . . 74.120000000000005 109.262 177.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.7 p -111.02 133.36 56.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.042 -0.526 . . . . 62.399999999999999 110.222 -178.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 ' ND2' ' A' ' 56' ' ' ASN . 24.8 t -76.54 117.54 21.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.732 -1.581 . . . . 72.5 106.732 177.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -90.35 -31.98 16.67 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.323 0.582 . . . . 50.229999999999997 110.164 -173.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -142.5 144.27 32.91 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.91 -1.885 . . . . 61.240000000000002 105.91 -176.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 53' ' ' ARG . . . 134.2 169.52 12.05 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 110.175 -1.17 . . . . 72.099999999999994 110.175 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.55 -31.81 87.53 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.309 2.006 . . . . 73.209999999999994 112.042 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.548 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.5 p-10 -101.35 22.68 12.14 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.363 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.95 143.91 55.8 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.995 0.426 . . . . 72.140000000000001 111.357 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.23 -13.58 60.07 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.002 -0.839 . . . . 50.450000000000003 111.002 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 128.66 36.49 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.32 -0.622 . . . . 43.399999999999999 109.32 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 23.2 ptt180 -110.73 135.31 51.51 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.036 -0.727 . . . . 74.219999999999999 109.036 176.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' HD23 ' A' ' 49' ' ' LEU . 95.8 m-85 -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.294 -1.002 . . . . 71.120000000000005 108.294 -179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.98 144.48 26.24 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.614 -0.434 . . . . 73.340000000000003 109.846 177.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 3.4 mm? -74.77 118.4 17.69 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.91 -0.774 . . . . 62.340000000000003 108.91 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.98 -29.03 4.33 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 111.825 0.306 . . . . 71.519999999999996 111.825 -174.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.471 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.0 pt20 -118.69 151.96 50.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 112.97 0.73 . . . . 71.510000000000005 112.97 -177.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 76.1 Cg_exo -52.76 -25.65 27.59 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 124.306 3.337 . . . . 71.400000000000006 114.202 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.3 m -135.21 119.8 18.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.722 -1.214 . . . . 41.399999999999999 107.722 175.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.4 m -115.5 114.28 24.8 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.7 -0.852 . . . . 73.349999999999994 108.7 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.5 p -86.52 135.65 33.37 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 122.138 -0.351 . . . . 71.409999999999997 111.344 -176.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.15 134.68 55.06 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-N 116.019 -0.537 . . . . 23.440000000000001 111.492 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.43 -163.95 28.42 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 108.709 -1.756 . . . . 71.299999999999997 108.709 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -112.8 119.23 37.3 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.09 -1.818 . . . . 73.530000000000001 106.09 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.641 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 4.5 t-160 -174.33 155.29 2.18 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 104.861 -2.274 . . . . 74.219999999999999 104.861 -173.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.641 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 55.8 Cg_endo -75.66 -18.57 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-N 120.507 1.217 . . . . 53.210000000000001 110.799 175.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.21 -3.47 55.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.411 -0.813 . . . . 54.25 112.321 -176.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.468 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 56.1 p -80.38 143.09 33.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.87 -0.732 . . . . 73.120000000000005 110.24 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.64 -39.0 67.54 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.557 -0.457 . . . . 74.540000000000006 110.388 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.14 135.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.051 -0.722 . . . . 61.119999999999997 109.051 176.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -96.14 117.84 31.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.251 0.548 . . . . 71.409999999999997 110.152 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -125.9 140.23 52.82 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.659 -1.978 . . . . 72.409999999999997 105.659 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.12 117.29 29.9 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.056 -0.658 . . . . 43.420000000000002 109.267 -176.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.18 173.44 6.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.684 -0.858 . . . . 63.32 108.684 -174.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.32 -29.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.436 -0.95 . . . . 65.120000000000005 108.436 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -128.35 -165.26 1.47 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.591 -1.263 . . . . 74.510000000000005 107.591 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.06 98.17 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.683 -0.807 . . . . 53.140000000000001 109.896 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 107' ' ' LEU . 70.1 m -87.4 73.85 9.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 122.0 0.905 . . . . 75.239999999999995 110.275 175.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -69.87 -40.37 75.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.198 -1.365 . . . . 73.120000000000005 112.618 -179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -135.65 73.76 1.48 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.47 -0.937 . . . . 72.239999999999995 108.47 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -100.45 -53.5 3.09 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.374 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.78 162.54 40.54 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 119.763 -0.775 . . . . 64.439999999999998 111.082 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.12 146.04 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.291 173.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -104.87 119.19 38.4 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.55 -2.019 . . . . 74.450000000000003 105.55 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -109.07 132.88 53.69 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.688 -0.687 . . . . 74.540000000000006 109.257 -172.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 63' ' ' LEU . 57.9 mt -125.93 123.98 65.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.393 -0.821 . . . . 64.299999999999997 108.905 -173.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.91 118.24 18.67 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.479 -0.488 . . . . 63.210000000000001 111.537 174.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.44 37.82 29.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.908 0.883 . . . . 70.430000000000007 111.905 175.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.02 82.4 Favored Glycine 0 C--O 1.222 -0.632 0 CA-C-N 115.642 -0.708 . . . . 51.329999999999998 113.859 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 35.2 mt-10 -101.53 130.58 47.85 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.048 -1.464 . . . . 74.340000000000003 107.048 175.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.2 124.47 52.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.829 -0.434 . . . . 71.420000000000002 109.829 -174.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.88 148.78 52.69 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 120.763 0.316 . . . . 71.409999999999997 111.064 177.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.48 123.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 106.681 -1.6 . . . . 74.329999999999998 106.681 177.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.36 122.97 69.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.606 -0.516 . . . . 74.319999999999993 109.606 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 6.6 t70 -80.49 129.42 34.5 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.67 -1.233 . . . . 74.319999999999993 107.67 172.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.57 23.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 120.796 -0.362 . . . . 70.299999999999997 111.369 -176.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.27 -38.07 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 118.418 -1.849 . . . . 61.020000000000003 114.218 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 61.2 30.84 19.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.931 0.872 . . . . 73.420000000000002 109.268 -174.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 86' ' ' SER . 6.4 tt -62.99 -49.21 75.59 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 113.931 -1.486 . . . . 75.209999999999994 111.083 -174.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 37.6 t-20 -106.96 -19.4 13.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.772 -1.171 . . . . 63.299999999999997 109.084 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.17 101.86 2.72 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.385 -1.086 . . . . 62.530000000000001 110.385 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 m -87.8 129.41 35.2 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.362 0.601 . . . . 72.049999999999997 110.652 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 73.3 m-85 -116.01 126.82 54.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.307 -0.997 . . . . 61.020000000000003 108.307 175.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 t -120.9 126.91 75.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 105.443 -2.058 . . . . 75.400000000000006 105.443 176.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 55.46 38.73 30.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.182 -1.414 . . . . 73.349999999999994 107.182 -169.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.522 ' HD3' ' NH1' ' A' ' 134' ' ' ARG . 22.1 mtm105 63.39 8.99 3.79 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 114.035 -1.439 . . . . 74.030000000000001 114.461 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.45 135.67 19.29 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.035 -0.728 . . . . 71.019999999999996 109.035 176.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.9 122.94 11.15 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 121.735 1.623 . . . . 73.200000000000003 108.651 177.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.637 ' HD2' ' HB2' ' A' ' 120' ' ' GLN . 26.1 ttm-85 -152.37 169.56 22.25 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.773 -0.771 . . . . 63.009999999999998 110.164 -170.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 27.3 t-20 -104.76 -68.65 0.84 Allowed 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.533 0.521 . . . . 72.129999999999995 110.458 174.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.69 54.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.042 -0.411 . . . . 35.399999999999999 110.68 -174.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.637 ' HB2' ' HD2' ' A' ' 117' ' ' ARG . 57.1 tp60 -153.63 137.88 16.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.944 -0.571 . . . . 63.299999999999997 111.111 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 82.8 t -65.93 133.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.379 -1.711 . . . . 62.539999999999999 106.379 169.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 42.2 ttm -87.33 129.55 34.97 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.674 -0.861 . . . . 75.129999999999995 108.674 -170.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -114.09 149.29 35.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.001 -0.74 . . . . 72.530000000000001 109.001 -177.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.476 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 14.6 t -73.52 130.58 40.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 109.272 -0.64 . . . . 75.450000000000003 109.272 -179.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.24 -0.13 57.15 Favored Glycine 0 C--O 1.241 0.535 0 N-CA-C 111.464 -0.654 . . . . 65.409999999999997 111.464 -176.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.51 148.23 35.4 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 108.953 -0.758 . . . . 74.530000000000001 108.953 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.7 124.93 53.06 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.528 -0.915 . . . . 61.039999999999999 108.528 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -108.42 113.08 42.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 106.821 -1.548 . . . . 73.319999999999993 106.821 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 64.6 tt0 -108.22 126.37 52.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.144 0.497 . . . . 72.540000000000006 109.679 -176.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.82 108.36 25.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.607 -1.257 . . . . 71.519999999999996 107.607 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.37 -105.11 1.49 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.594 -1.402 . . . . 41.200000000000003 109.594 -175.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -116.07 -13.64 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.197 -0.601 . . . . 60.32 111.764 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -98.92 140.75 32.61 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.386 -0.926 . . . . 70.400000000000006 110.63 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.522 ' NH1' ' HD3' ' A' ' 114' ' ' ARG . 19.5 ptp180 -112.58 144.14 42.56 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 112.667 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.63 139.76 49.37 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.983 -1.858 . . . . 74.140000000000001 105.983 174.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -111.79 128.39 68.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.127 -1.064 . . . . 72.129999999999995 108.127 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.478 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 80.4 t80 -94.41 122.11 36.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.984 0.421 . . . . 71.319999999999993 110.982 -178.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.73 159.1 26.07 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.462 0.649 . . . . 63.450000000000003 110.142 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.38 124.44 27.13 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.676 -1.231 . . . . 73.120000000000005 107.676 173.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 44' ' ' ALA . . . -75.84 142.16 28.32 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.932 -0.651 . . . . 71.230000000000004 112.19 -175.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.45 162.79 41.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.14 2.56 . . . . 52.32 111.991 176.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.62 44.17 0.96 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.594 0.711 . . . . 75.400000000000006 109.902 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 106.679 -1.6 . . . . 74.109999999999999 106.679 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.427 -1.595 0 N-CA-C 107.815 -1.18 . . . . 62.210000000000001 107.815 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.78 115.31 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.869 -1.16 . . . . 72.140000000000001 107.869 178.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.38 131.87 45.09 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.248 -1.019 . . . . 64.310000000000002 108.248 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -129.24 105.3 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.173 0.511 . . . . 74.120000000000005 110.496 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.49 140.75 48.48 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.751 -0.833 . . . . 71.510000000000005 108.751 178.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.52 2.04 34.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.66 0.245 . . . . 43.399999999999999 111.66 -176.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -63.92 -10.48 21.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.99 1.107 . . . . 73.310000000000002 113.99 -179.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.37 -12.76 61.93 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 122.153 0.978 . . . . 73.540000000000006 110.976 176.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 36.5 ttmt -65.5 -20.53 66.38 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 126.016 1.727 . . . . 72.439999999999998 109.813 177.196 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.525 ' HA ' ' OG ' ' A' ' 28' ' ' SER . 11.7 tp10 -59.18 -18.47 36.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.508 -0.769 . . . . 72.129999999999995 111.979 -176.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -57.84 -41.49 82.46 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.18 -0.325 . . . . 71.209999999999994 110.745 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.26 -22.16 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.992 0.368 . . . . 74.299999999999997 111.992 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 25' ' ' GLU . 6.7 p -81.02 -36.07 31.07 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.965 -0.694 . . . . 75.439999999999998 111.473 177.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.3 m -79.94 -48.42 13.43 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.607 -0.837 . . . . 52.399999999999999 110.757 177.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.1 m 47.58 -76.89 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.122 1.897 . . . . 72.450000000000003 116.122 -178.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.03 65.9 2.57 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 114.563 0.585 . . . . 74.430000000000007 114.563 -172.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.1 m -116.07 123.62 48.38 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.389 -1.338 . . . . 74.420000000000002 107.389 172.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.25 109.57 51.57 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.471 -0.491 . . . . 73.439999999999998 110.672 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.79 142.83 99.22 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.666 2.244 . . . . 72.299999999999997 110.301 174.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.49 126.35 32.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.25 -0.432 . . . . 54.119999999999997 111.233 -176.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 p -96.2 80.38 3.24 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.478 0.656 . . . . 71.010000000000005 110.001 178.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.8 t -89.51 -27.63 20.18 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.687 -0.688 . . . . 43.409999999999997 110.463 -178.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.99 55.23 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.543 -0.837 . . . . 62.32 112.55 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.91 -39.96 79.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 109.769 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.46 -11.96 60.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.92 . . . . 71.230000000000004 111.492 -178.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -97.1 -12.36 23.24 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.269 -0.641 . . . . 63.310000000000002 109.269 -175.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 mt 59.73 83.63 0.21 Allowed Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 124.722 1.264 . . . . 65.200000000000003 108.599 -176.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -33.98 -59.29 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.094 1 C-N-CA 125.703 4.269 . . . . 72.540000000000006 115.767 -166.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.58 10.71 3.72 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.743 0.782 . . . . 70.040000000000006 109.687 179.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.48 -12.46 46.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.1 -0.8 . . . . 75.209999999999994 111.1 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -138.9 151.52 47.01 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.056 -1.831 . . . . 61.43 106.056 177.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -152.92 158.55 42.27 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.794 -0.817 . . . . 75.239999999999995 108.794 -177.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -120.86 149.67 42.24 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.237 -0.585 . . . . 72.239999999999995 111.965 -175.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 49' ' ' LEU . 2.1 pt? -114.99 139.55 49.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.773 -0.825 . . . . 62.130000000000003 108.773 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.19 135.93 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.422 -0.354 . . . . 62.350000000000001 110.384 -177.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -82.79 118.12 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.026 -1.472 . . . . 63.420000000000002 107.026 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -95.96 -31.34 13.13 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.062 -0.972 . . . . 73.349999999999994 110.408 -174.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -143.12 137.68 29.29 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.153 -0.684 . . . . 73.310000000000002 109.153 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.44 175.14 13.88 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.816 -1.314 . . . . 34.229999999999997 109.816 -179.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 78.4 Cg_exo -55.62 -37.69 95.0 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 74.299999999999997 112.807 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -96.69 22.77 7.71 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.564 0.579 . . . . 72.209999999999994 112.564 -178.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.02 137.38 58.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.928 0.394 . . . . 63.43 110.416 177.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.55 -18.03 41.91 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 111.023 -0.831 . . . . 72.120000000000005 111.023 -178.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.29 139.6 30.33 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 110.126 -0.324 . . . . 54.520000000000003 110.126 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -128.22 137.76 52.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 73.319999999999993 108.724 178.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.41 ' O ' HD23 ' A' ' 49' ' ' LEU . 92.5 m-85 -125.18 138.39 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.999 -0.741 . . . . 72.319999999999993 108.999 -178.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -96.91 134.02 40.79 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.105 0.479 . . . . 62.420000000000002 109.713 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' HE22 ' A' ' 65' ' ' GLN . 67.6 mt -97.95 105.21 17.32 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.277 -0.42 . . . . 73.430000000000007 110.219 -178.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -130.55 5.55 4.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.774 0.797 . . . . 63.350000000000001 109.578 176.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 3.7 pm0 -107.84 141.46 23.13 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 115.109 -0.95 . . . . 74.310000000000002 110.709 -177.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.1 Cg_exo -57.41 -27.55 76.39 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.364 2.71 . . . . 63.520000000000003 113.745 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -137.03 123.5 20.82 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.299 -0.63 . . . . 71.200000000000003 109.299 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 26.3 m -123.47 120.76 33.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.463 -0.94 . . . . 74.010000000000005 108.463 178.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.519 HG23 HH11 ' A' ' 88' ' ' ARG . 74.6 m -94.49 131.06 40.59 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 112.06 0.392 . . . . 75.099999999999994 112.06 -176.353 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.89 135.49 54.89 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.292 0.568 . . . . 41.149999999999999 110.556 178.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.09 -159.74 25.2 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.465 -1.454 . . . . 72.109999999999999 109.465 179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -101.69 117.75 35.53 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.724 -1.213 . . . . 60.409999999999997 107.724 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -175.88 148.2 0.94 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 105.558 -2.016 . . . . 74.230000000000004 105.558 -175.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.57 -40.47 65.41 Favored 'Trans proline' 0 C--O 1.221 -0.358 0 C-N-CA 122.041 1.827 . . . . 73.120000000000005 111.801 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.07 19.37 7.97 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.514 0.931 . . . . 71.120000000000005 113.514 -178.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m -66.61 122.99 18.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.303 -0.559 . . . . 64.109999999999999 109.796 174.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.11 -38.47 66.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.289 -1.375 . . . . 62.450000000000003 107.289 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.1 mm -108.75 98.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.791 -1.929 . . . . 64.010000000000005 105.791 173.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -91.03 120.2 31.82 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.951 -0.568 . . . . 72.439999999999998 109.857 -176.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.71 138.54 52.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.4 -0.963 . . . . 73.299999999999997 108.4 -179.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.37 116.49 32.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.519 -1.66 . . . . 63.119999999999997 106.519 176.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -105.96 -173.32 2.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.182 0.438 . . . . 73.25 112.182 -171.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.72 -32.61 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.24 0.616 . . . . 75.040000000000006 111.328 -174.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.405 ' CG2' ' HG ' ' A' ' 107' ' ' LEU . 6.1 t -123.89 -152.81 0.53 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 105.723 -1.955 . . . . 74.109999999999999 105.723 -178.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.85 95.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.644 -1.623 . . . . 72.25 109.387 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -92.34 85.59 5.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.179 -1.045 . . . . 64.540000000000006 108.179 176.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.452 ' NH1' ' HB2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -57.28 -27.69 62.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.976 -1.465 . . . . 53.049999999999997 112.458 -177.644 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.588 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 20.3 mmm180 -154.87 111.33 3.24 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 104.498 -2.408 . . . . 71.319999999999993 104.498 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 12.2 t60 -100.4 -52.77 3.28 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 117.667 -1.613 . . . . 73.150000000000006 109.901 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.49 151.69 36.8 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.1 -0.704 . . . . 73.200000000000003 109.1 -177.167 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -118.42 129.43 55.4 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.694 -1.965 . . . . 62.130000000000003 105.694 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.5 m-85 -105.98 113.45 27.0 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.969 -1.493 . . . . 72.420000000000002 106.969 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -107.74 131.94 53.9 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.545 -0.539 . . . . 74.310000000000002 109.545 -177.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -118.92 113.28 41.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 106.684 -1.599 . . . . 70.109999999999999 106.684 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.93 121.41 20.49 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.129 -0.693 . . . . 75.299999999999997 109.129 -177.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 56.81 37.58 28.89 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.098 1.359 . . . . 64.439999999999998 110.244 -179.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.06 89.33 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.087 -0.961 . . . . 62.149999999999999 113.855 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.08 131.75 46.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.641 0.72 . . . . 72.209999999999994 109.217 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -106.2 118.1 35.74 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.857 0.723 . . . . 75.030000000000001 110.256 -174.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.87 142.48 51.09 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.569 -0.53 . . . . 54.119999999999997 109.569 177.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 122' ' ' MET . 42.0 t -114.4 123.5 70.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.74 -1.207 . . . . 74.049999999999997 107.74 177.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.07 132.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.049 0.452 . . . . 62.520000000000003 110.287 177.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -77.04 127.46 32.72 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.288 -1.004 . . . . 71.239999999999995 108.288 177.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.51 16.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.602 -0.888 . . . . 74.299999999999997 108.602 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -174.8 81.12 0.07 OUTLIER Glycine 0 N--CA 1.418 -2.556 0 CA-C-N 115.273 -0.876 . . . . 74.019999999999996 111.934 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -77.57 42.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.687 1.232 . . . . 55.109999999999999 109.053 178.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.405 ' HG ' ' CG2' ' A' ' 84' ' ' THR . 23.4 tp -95.23 -28.51 14.99 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.782 -1.099 . . . . 51.240000000000002 110.627 -176.153 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 50.8 t30 -109.47 -19.82 13.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.354 -0.98 . . . . 75.120000000000005 108.354 173.197 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 109.24 3.05 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.78 -0.645 . . . . 21.23 113.39 174.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.0 m -87.29 128.99 35.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.464 -0.569 . . . . 61.140000000000001 109.464 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 85.3 m-85 -135.54 136.61 41.29 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.85 -0.796 . . . . 74.019999999999996 108.85 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.0 t -128.34 130.85 69.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.989 -1.856 . . . . 73.519999999999996 105.989 175.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.84 37.28 28.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.137 0.898 . . . . 74.239999999999995 108.747 -175.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 63.12 16.92 9.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 65.340000000000003 113.031 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.64 137.08 23.89 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 110.007 -0.368 . . . . 71.150000000000006 110.007 178.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.12 124.85 16.11 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.957 2.438 . . . . 75.540000000000006 112.112 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -126.66 159.29 34.06 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.24 0.543 . . . . 73.200000000000003 111.793 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.12 -29.0 3.36 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.288 -1.323 . . . . 53.299999999999997 108.145 177.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.65 136.91 18.6 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.515 -1.291 . . . . 52.020000000000003 107.515 174.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.38 141.94 20.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.27 -0.641 . . . . 75.420000000000002 109.27 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.65 122.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.676 -1.602 . . . . 71.230000000000004 106.676 174.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.48 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 44.3 ttp -89.6 130.44 35.91 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.328 0.585 . . . . 53.299999999999997 112.288 -168.836 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.546 ' HB2' ' OD1' ' A' ' 126' ' ' ASP . 16.7 mt-30 -120.05 152.18 37.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.053 -0.976 . . . . 74.120000000000005 108.92 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.2 p -73.21 133.81 44.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 123.522 0.729 . . . . 74.019999999999996 110.569 178.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.69 61.57 Favored Glycine 0 C--N 1.309 -0.93 0 N-CA-C 111.452 -0.659 . . . . 42.340000000000003 111.452 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 123' ' ' GLN . 3.0 m-20 -85.11 153.98 22.34 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.242 0.617 . . . . 73.099999999999994 111.437 178.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.02 130.67 55.5 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-N 115.256 -0.883 . . . . 71.140000000000001 109.515 -176.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.5 mt -114.69 132.21 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.091 -1.077 . . . . 74.120000000000005 108.091 177.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 43.9 tt0 -119.73 122.9 42.47 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 108.656 -0.868 . . . . 75.420000000000002 108.656 178.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 89' ' ' HIS . 66.3 mt -117.32 102.28 13.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.211 -1.403 . . . . 50.149999999999999 107.211 178.249 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.74 -108.39 1.53 Allowed Glycine 0 C--N 1.309 -0.961 0 N-CA-C 110.926 -0.87 . . . . 72.109999999999999 110.926 -173.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -103.4 4.7 36.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.644 0.259 . . . . 55.100000000000001 110.684 178.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.588 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 78.0 m-85 -87.63 158.55 18.84 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.569 0.7 . . . . 70.310000000000002 111.285 179.298 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -133.43 123.13 24.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.971 -1.013 . . . . 74.239999999999995 108.763 174.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.76 125.39 41.67 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.994 -1.484 . . . . 65.109999999999999 106.994 177.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.03 129.05 68.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.089 -1.449 . . . . 72.329999999999998 107.089 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 22.0 t80 -88.4 116.55 26.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.784 -0.821 . . . . 71.530000000000001 108.784 -178.387 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp -108.47 147.03 32.26 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.172 -0.677 . . . . 73.200000000000003 109.172 -173.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.33 131.24 40.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.474 -0.33 . . . . 62.43 111.207 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.29 132.56 11.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.602 -1.799 . . . . 74.120000000000005 108.602 175.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.08 148.68 92.71 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.132 1.888 . . . . 75.150000000000006 112.287 -177.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.25 69.9 10.51 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 106.775 -1.565 . . . . 63.229999999999997 106.775 178.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--N 1.266 -3.058 0 CA-C-N 112.03 -2.35 . . . . 45.520000000000003 106.338 -178.875 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.424 -1.752 0 N-CA-C 106.121 -1.807 . . . . 75.140000000000001 106.121 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -82.09 122.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.985 -0.746 . . . . 55.130000000000003 108.985 -178.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.587 ' HD2' ' HG1' ' A' ' 84' ' ' THR . 14.8 t80 -86.95 105.41 17.09 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.097 -0.705 . . . . 64.340000000000003 109.097 -176.563 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -122.62 120.04 32.56 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.365 -0.606 . . . . 74.310000000000002 109.365 177.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.27 -160.68 0.86 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.188 -0.915 . . . . 62.210000000000001 108.976 -173.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -50.6 -22.16 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.266 1.426 . . . . 63.030000000000001 113.774 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 23' ' ' LEU . 3.9 pp -56.69 -30.83 63.84 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.256 0.835 . . . . 70.010000000000005 113.256 -178.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -89.39 0.08 57.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.469 0.914 . . . . 74.129999999999995 113.469 -177.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.23 -46.75 3.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.708 0.765 . . . . 73.329999999999998 110.45 176.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -69.36 -31.19 69.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.489 -1.232 . . . . 70.299999999999997 112.379 -174.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -56.42 -38.92 72.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.525 1.306 . . . . 74.310000000000002 114.525 -174.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.3 -35.62 35.5 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.0 0.429 . . . . 74.540000000000006 110.85 -176.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 m -68.1 -31.88 71.8 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.646 0.736 . . . . 54.130000000000003 110.825 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 p -83.03 -16.0 48.83 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 112.215 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 m -57.61 142.86 43.34 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.924 -0.769 . . . . 75.400000000000006 108.924 177.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.7 -52.03 0.84 Allowed Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.957 -1.257 . . . . 34.030000000000001 109.957 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 m -79.89 119.64 23.03 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.135 -1.431 . . . . 51.32 107.135 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -128.28 144.87 53.44 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 120.768 -0.373 . . . . 70.109999999999999 111.756 -174.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' OD1' ' A' ' 113' ' ' ASN . 42.1 Cg_exo -62.46 149.83 89.52 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.941 2.428 . . . . 54.219999999999999 110.916 172.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.834 0.35 . . . . 71.019999999999996 110.214 -178.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 m -77.55 90.08 3.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.776 -0.824 . . . . 52.310000000000002 108.776 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -94.55 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.371 0.508 . . . . 65.439999999999998 112.371 -177.04 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.34 57.88 0.64 Allowed Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.364 -0.694 . . . . 72.310000000000002 111.364 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -92.85 -47.05 7.23 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.555 0.693 . . . . 64.219999999999999 110.722 176.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.32 -0.49 6.34 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.361 -1.29 . . . . 70.150000000000006 114.466 -170.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -86.19 -28.47 23.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.089 -0.708 . . . . 72.310000000000002 109.089 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt 49.03 76.61 0.53 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.749 1.22 . . . . 51.5 111.747 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.512 ' HG2' ' O ' ' A' ' 140' ' ' GLY . 26.6 Cg_endo -87.41 -74.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.152 1.901 . . . . 61.439999999999998 114.344 -175.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.83 -32.63 67.73 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.151 0.501 . . . . 72.439999999999998 112.297 -176.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 7.7 82.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.183 -1.008 . . . . 64.230000000000004 110.763 -176.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 m -132.81 167.04 20.89 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.553 -1.647 . . . . 74.099999999999994 106.553 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 157.1 43.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.149 0.431 . . . . 70.140000000000001 110.127 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.16 137.51 51.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.288 0.566 . . . . 60.539999999999999 110.348 178.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.419 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -108.7 137.05 47.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 109.036 -0.728 . . . . 71.340000000000003 109.036 178.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -113.56 128.85 70.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 121.119 0.485 . . . . 73.140000000000001 110.03 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.468 HG21 ' ND2' ' A' ' 56' ' ' ASN . 38.4 t -83.75 118.09 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 106.99 -1.485 . . . . 73.420000000000002 106.99 178.237 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -95.05 -31.71 13.46 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.411 -0.813 . . . . 62.310000000000002 109.719 -174.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -141.35 138.41 33.05 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.753 -0.658 . . . . 72.439999999999998 109.259 176.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.68 169.29 13.18 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.72 -1.752 . . . . 64.519999999999996 108.72 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.98 -41.99 69.22 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.027 1.818 . . . . 72.519999999999996 111.634 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.468 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.1 p-10 -91.67 22.71 3.93 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.223 0.453 . . . . 73.010000000000005 112.223 178.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.21 55.57 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 123.22 0.608 . . . . 62.109999999999999 111.222 177.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.21 -19.42 43.12 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.487 -1.045 . . . . 74.530000000000001 110.487 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.36 144.37 26.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.407 -0.397 . . . . 72.340000000000003 110.28 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -119.67 134.87 55.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.273 -1.01 . . . . 71.230000000000004 108.273 176.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.463 ' HB3' HG21 ' A' ' 78' ' ' ILE . 93.9 m-85 -117.12 125.07 50.67 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.972 -0.381 . . . . 72.040000000000006 109.972 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.5 124.18 34.28 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.479 -0.782 . . . . 71.430000000000007 109.368 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.02 104.82 15.99 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.383 -1.71 . . . . 60.039999999999999 106.383 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.05 -21.3 12.68 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.149 -0.478 . . . . 64.109999999999999 112.157 -173.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.16 154.44 40.45 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 120.329 -0.548 . . . . 52.340000000000003 110.923 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 75.5 Cg_exo -52.56 -25.98 27.48 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.609 2.873 . . . . 71.409999999999997 114.021 -178.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 m -140.94 120.1 12.9 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.568 -0.853 . . . . 65.120000000000005 109.809 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 77' ' ' ASP . 49.6 m -116.43 114.39 24.17 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 109.057 -0.719 . . . . 73.049999999999997 109.057 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -87.2 136.4 32.94 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.88 -0.415 . . . . 51.539999999999999 109.88 178.163 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.58 134.71 54.89 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.34 0.59 . . . . 61.140000000000001 110.723 -177.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.37 178.01 15.39 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.284 -1.527 . . . . 43.25 109.284 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 43.6 ttt180 -85.49 117.67 24.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.222 -0.659 . . . . 74.299999999999997 109.222 178.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.75 145.9 0.31 Allowed Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 107.658 -1.238 . . . . 73.010000000000005 107.658 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -61.24 -15.72 41.93 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.236 2.624 . . . . 71.340000000000003 113.851 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.92 6.24 33.47 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.546 0.212 . . . . 74.230000000000004 111.194 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 40.9 m -100.56 125.2 46.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.625 -0.509 . . . . 74.299999999999997 109.625 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB3' HG23 ' A' ' 68' ' ' THR . 19.0 t70 -65.1 -48.54 73.32 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.046 -0.524 . . . . 73.420000000000002 110.956 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 61' ' ' PHE . 2.3 pp -116.15 130.18 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.895 -0.722 . . . . 72.540000000000006 110.715 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.02 143.0 48.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.282 0.563 . . . . 60.109999999999999 111.417 -178.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.7 mt -106.44 140.42 39.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.06 -1.459 . . . . 70.140000000000001 107.06 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HZ ' ' A' ' 133' ' ' PHE . 20.5 t70 -91.45 116.45 28.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.533 -1.654 . . . . 64.510000000000005 106.533 177.266 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' THR . 12.4 t0 -116.04 164.39 14.51 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.155 -0.683 . . . . 64.329999999999998 109.155 -169.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.26 -31.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.702 -1.222 . . . . 35.25 107.702 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.587 ' HG1' ' HD2' ' A' ' 18' ' ' PHE . 27.3 m -115.42 170.94 8.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.794 -1.558 . . . . 74.120000000000005 106.794 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.5 98.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.051 -1.031 . . . . 71.239999999999995 111.437 -177.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -97.1 91.7 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.479 -0.782 . . . . 44.420000000000002 110.227 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 17.8 ptt180 -81.47 -45.22 16.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.527 0.936 . . . . 65.519999999999996 113.527 -176.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.428 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 5.6 tpt180 -126.73 87.7 2.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.712 -1.588 . . . . 75.230000000000004 106.712 -176.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -100.2 -52.36 3.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.844 -0.616 . . . . 75.450000000000003 112.253 -174.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.44 162.99 37.9 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.953 -0.699 . . . . 51.109999999999999 111.428 -175.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.44 133.78 36.99 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.361 -0.836 . . . . 65.109999999999999 109.109 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -112.28 122.3 47.33 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.939 -0.763 . . . . 63.539999999999999 108.939 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.44 119.51 39.02 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.497 -0.557 . . . . 72.329999999999998 109.497 175.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -107.1 111.77 37.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.534 -2.395 . . . . 70.409999999999997 104.534 176.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -135.74 117.66 15.24 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 120.141 -0.624 . . . . 74.230000000000004 110.258 -174.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 51.7 39.82 26.13 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.76 1.224 . . . . 74.519999999999996 111.775 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -5.61 84.33 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 115.282 -0.872 . . . . 43.329999999999998 114.677 178.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.5 150.02 23.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.907 0.854 . . . . 63.210000000000001 109.102 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.94 117.46 24.84 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.692 -0.403 . . . . 62.329999999999998 110.959 -172.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -109.6 127.13 54.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.249 -1.019 . . . . 74.140000000000001 108.249 177.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.85 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.538 -0.912 . . . . 74.510000000000005 108.538 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.01 131.39 72.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.976 -0.556 . . . . 72.239999999999995 110.444 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.46 131.11 34.45 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.394 -0.965 . . . . 54.350000000000001 108.394 174.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.35 11.38 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 116.302 -0.408 . . . . 64.510000000000005 111.074 -177.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -165.1 59.88 0.25 Allowed Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.535 -1.317 . . . . 64.5 112.954 -178.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.6 t -80.78 75.13 7.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.736 0.779 . . . . 71.219999999999999 109.677 177.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.86 -21.99 13.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.832 -1.544 . . . . 75.239999999999995 106.832 170.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 3.2 m-20 -102.83 3.17 36.39 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.342 -1.299 . . . . 75.230000000000004 110.868 -177.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.76 77.29 1.13 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.936 -0.575 . . . . 55.100000000000001 113.051 178.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -86.92 128.9 35.06 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.203 -0.666 . . . . 42.350000000000001 109.203 176.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -135.68 140.2 44.28 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.881 0.372 . . . . 64.019999999999996 110.245 177.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.46 119.7 60.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 105.841 -1.911 . . . . 71.519999999999996 105.841 175.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.486 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.7 OUTLIER 57.38 36.82 27.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.293 -1.003 . . . . 75.109999999999999 108.293 -171.896 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 60.7 14.32 4.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.26 1.424 . . . . 70.430000000000007 112.979 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.06 142.48 25.12 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 124.089 0.956 . . . . 71.219999999999999 109.205 176.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.06 122.97 10.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.7 1.6 . . . . 64.239999999999995 109.569 178.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -146.36 140.04 26.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.091 -1.078 . . . . 73.400000000000006 108.091 -175.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.8 -41.42 8.85 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.237 -0.283 . . . . 71.099999999999994 110.237 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.39 136.84 33.53 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.822 -0.807 . . . . 75.329999999999998 108.822 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 141.91 21.9 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.731 -0.84 . . . . 61.32 108.731 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.85 114.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 106.261 -1.755 . . . . 72.430000000000007 106.261 175.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 38.0 ttm -94.37 148.84 21.82 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.383 0.883 . . . . 65.099999999999994 113.383 -166.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -125.66 158.34 35.0 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.829 1.252 . . . . 55.240000000000002 111.113 -172.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 10.6 m -58.38 124.27 18.97 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.294 0.637 . . . . 55.140000000000001 110.192 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.61 -9.45 60.53 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.908 -0.587 . . . . 71.019999999999996 112.051 178.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.52 151.21 44.09 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 108.708 -0.849 . . . . 75.120000000000005 108.708 -179.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.3 137.66 54.47 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.798 0.808 . . . . 63.119999999999997 112.124 -175.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.95 126.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 105.844 -1.91 . . . . 43.119999999999997 105.844 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -108.95 128.68 55.15 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.179 -1.785 . . . . 73.209999999999994 106.179 178.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 133' ' ' PHE . 66.6 mt -131.56 138.32 53.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 N-CA-C 103.825 -2.657 . . . . 71.150000000000006 103.825 -177.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -36.19 99.46 0.01 OUTLIER Glycine 0 CA--C 1.548 2.153 0 N-CA-C 115.912 1.125 . . . . 64.030000000000001 115.912 -177.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt 77.51 14.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.609 1.564 . . . . 73.319999999999993 112.929 178.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 130' ' ' ILE . 55.8 m-85 -123.56 150.64 43.81 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 125.295 1.438 . . . . 74.439999999999998 109.355 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 134' ' ' ARG . 15.6 mmm-85 -137.15 119.83 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.316 -1.735 . . . . 74.120000000000005 106.316 175.128 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 mp -122.9 136.13 54.75 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.94 -0.393 . . . . 60.530000000000001 109.94 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.68 130.16 68.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.509 -0.923 . . . . 64.420000000000002 108.509 179.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -95.93 131.88 41.83 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.106 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -131.45 136.86 48.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.88 -0.785 . . . . 64.030000000000001 108.88 177.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.05 33.04 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.433 -0.951 . . . . 63.509999999999998 108.433 175.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' PRO . . . -59.94 130.64 49.7 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.7 -0.96 . . . . 55.210000000000001 110.7 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.11 160.34 13.14 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.345 2.697 . . . . 71.219999999999999 113.585 -175.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.19 48.58 1.01 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.713 1.205 . . . . 71.010000000000005 111.406 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.406 -2.662 0 CA-C-N 114.643 -1.162 . . . . 62.219999999999999 108.017 176.339 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 108.475 -0.935 . . . . 73.420000000000002 108.475 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -83.79 117.22 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.179 -0.675 . . . . 61.149999999999999 109.179 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.72 140.18 29.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.292 0.568 . . . . 72.200000000000003 110.968 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -84.59 120.65 26.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.686 -2.338 . . . . 65.140000000000001 104.686 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.79 80.91 2.09 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.286 0.565 . . . . 73.420000000000002 111.538 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.15 -23.18 33.06 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.661 -0.866 . . . . 62.399999999999999 108.661 177.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 pp -63.33 -5.95 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.088 1.355 . . . . 71.109999999999999 113.592 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.6 -28.75 70.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.048 0.539 . . . . 72.420000000000002 109.811 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.96 -10.32 58.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.794 -0.639 . . . . 72.400000000000006 111.048 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -99.77 -41.73 7.14 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.119 0.485 . . . . 54.409999999999997 111.368 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -84.47 -3.42 58.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.931 0.396 . . . . 63.119999999999997 111.755 -176.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -61.9 -41.9 98.44 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.102 0.561 . . . . 72.530000000000001 111.57 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -78.49 -13.15 59.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.086 0.47 . . . . 75.150000000000006 111.126 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -86.59 -24.8 25.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.598 -1.26 . . . . 74.329999999999998 107.598 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.1 m -66.92 107.38 2.2 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.32 -0.855 . . . . 64.299999999999997 110.68 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.91 177.82 40.27 Favored Glycine 0 N--CA 1.404 -3.462 0 N-CA-C 107.32 -2.312 . . . . 40.100000000000001 107.32 178.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 m -75.2 120.62 20.95 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 117.686 0.743 . . . . 63.25 110.346 -177.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.21 92.01 45.01 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 106.673 -1.602 . . . . 65.439999999999998 106.673 174.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.89 142.54 69.52 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.753 2.302 . . . . 51.530000000000001 113.036 -174.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.49 162.74 18.82 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.784 -1.191 . . . . 30.329999999999998 107.784 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -77.95 126.77 31.34 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.529 -0.468 . . . . 63.130000000000003 110.342 -176.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 p -67.12 146.52 54.18 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.706 -0.679 . . . . 63.340000000000003 110.055 178.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 116.51 -8.75 17.36 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 108.375 -1.89 . . . . 71.030000000000001 108.375 -174.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.11 66.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.183 -1.009 . . . . 65.109999999999999 110.231 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.31 1.82 47.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.425 -0.807 . . . . 64.239999999999995 110.627 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.53 7.7 17.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.036 -0.529 . . . . 73.239999999999995 110.209 -175.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 69.74 89.91 0.09 OUTLIER Pre-proline 0 CA--C 1.512 -0.482 0 C-N-CA 124.309 1.044 . . . . 73.310000000000002 109.61 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.69 -26.3 28.06 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.674 2.25 . . . . 73.409999999999997 112.184 -175.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.39 -27.99 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.837 -1.529 . . . . 75.310000000000002 110.229 -178.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.43 69.64 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.1 -1.2 . . . . 53.310000000000002 110.1 -177.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.8 t -131.06 158.13 41.19 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.052 -1.462 . . . . 63.210000000000001 107.052 176.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.97 40.93 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.743 -0.836 . . . . 64.310000000000002 108.743 -175.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 pp -133.13 151.56 51.99 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.899 0.381 . . . . 60.149999999999999 110.385 178.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.3 pp -113.52 132.18 55.79 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.006 -1.109 . . . . 74.540000000000006 108.006 175.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.81 132.06 68.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 109.906 -178.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 15.3 t -86.64 117.86 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.363 -1.347 . . . . 63.200000000000003 107.363 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.42 -33.02 12.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.033 0.444 . . . . 72.319999999999993 110.817 -179.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 13.7 tpt180 -137.85 139.61 40.01 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.476 -1.305 . . . . 65.310000000000002 107.476 -176.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.25 176.17 14.25 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.013 -0.835 . . . . 33.119999999999997 111.013 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.5 -35.23 39.73 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.614 2.209 . . . . 62.340000000000003 112.089 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -97.49 22.31 9.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.04 0.536 . . . . 65.450000000000003 111.139 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -62.94 141.31 58.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.997 0.427 . . . . 54.25 111.793 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.99 -13.87 57.38 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.046 -0.822 . . . . 71.329999999999998 111.046 -177.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.64 142.98 27.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.898 0.38 . . . . 55.0 110.371 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -131.17 136.43 48.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.573 -0.899 . . . . 75.019999999999996 108.573 177.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -130.51 139.22 50.5 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.984 -0.747 . . . . 62.439999999999998 108.984 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.06 143.64 32.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.407 0.622 . . . . 72.019999999999996 112.114 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.436 HD23 HD11 ' A' ' 94' ' ' ILE . 5.3 mp -94.04 103.36 15.44 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.496 -0.927 . . . . 70.030000000000001 108.496 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -133.18 8.61 4.03 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.902 1.334 . . . . 62.409999999999997 107.621 178.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.458 ' O ' HD13 ' A' ' 94' ' ' ILE . 4.0 pt20 -113.23 156.93 42.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 113.437 -1.71 . . . . 62.299999999999997 109.092 -174.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.99 -32.42 94.97 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.466 2.111 . . . . 74.219999999999999 112.451 178.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 97.7 m -153.92 129.67 10.09 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 122.095 -0.378 . . . . 74.120000000000005 111.138 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 19.8 m -103.29 113.5 27.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.775 -1.565 . . . . 65.140000000000001 106.775 174.449 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -91.77 132.95 36.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.445 -0.576 . . . . 62.140000000000001 109.445 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.86 134.26 55.28 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 109.905 -0.405 . . . . 73.439999999999998 109.905 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.85 -132.45 2.83 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.108 -0.797 . . . . 75.329999999999998 111.108 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 86' ' ' SER . 9.9 mmm180 -118.54 151.28 38.16 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 123.029 0.532 . . . . 54.439999999999998 110.719 -175.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.8 m80 80.3 152.73 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 124.913 1.285 . . . . 72.239999999999995 112.628 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.45 -18.87 26.72 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.978 3.118 . . . . 71.310000000000002 115.6 -175.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.52 -23.2 60.98 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.236 0.471 . . . . 74.549999999999997 110.708 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m -78.18 119.72 21.97 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 105.706 -1.961 . . . . 53.020000000000003 105.706 172.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.44 -49.18 78.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.957 -0.565 . . . . 75.310000000000002 111.399 -173.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.5 pt -107.28 123.23 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 C-N-CA 120.12 -0.632 . . . . 61.130000000000003 109.685 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.89 124.02 33.24 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 109.044 -0.725 . . . . 72.0 109.044 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 mt -121.2 140.44 52.02 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.293 -2.114 . . . . 63.350000000000001 105.293 178.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -102.21 116.31 32.38 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.101 -1.814 . . . . 72.439999999999998 106.101 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -88.53 176.77 7.01 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.615 -1.175 . . . . 72.519999999999996 112.837 -171.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.73 -32.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.229 1.014 . . . . 70.230000000000004 108.505 -177.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.4 m -150.14 153.67 36.74 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.074 -2.565 . . . . 54.43 104.074 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 72' ' ' ARG . 50.0 t -70.67 112.47 5.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.655 1.217 . . . . 62.43 113.375 -162.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.557 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 23.2 m -111.27 107.18 16.38 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 113.259 -1.792 . . . . 75.219999999999999 108.0 177.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -55.84 -45.69 78.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.422 -0.808 . . . . 65.120000000000005 112.03 -175.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -137.3 119.88 16.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.322 -2.103 . . . . 70.310000000000002 105.322 171.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -89.76 -52.91 4.75 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.205 -1.035 . . . . 73.310000000000002 108.205 178.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.2 34.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.83 -0.623 . . . . 33.450000000000003 109.567 -177.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.71 145.92 52.06 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.241 0.543 . . . . 52.020000000000003 111.04 171.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 101' ' ' VAL . 9.4 m-85 -104.45 113.22 26.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.351 -1.722 . . . . 74.329999999999998 106.351 -177.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -106.67 120.72 42.73 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.649 -0.871 . . . . 74.239999999999995 108.649 -176.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 65' ' ' GLN . 3.1 mp -104.42 111.58 34.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 105.109 -2.182 . . . . 74.299999999999997 105.109 179.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -139.38 130.56 26.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 110.083 -0.34 . . . . 73.140000000000001 110.083 -177.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 55.87 36.67 27.73 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 122.293 1.044 . . . . 73.209999999999994 110.533 175.538 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 0.86 81.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.11 -0.95 . . . . 62.240000000000002 113.652 179.057 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -101.45 133.75 45.6 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.413 -0.958 . . . . 54.340000000000003 108.413 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -104.9 116.09 31.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.521 -1.288 . . . . 73.340000000000003 107.521 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.33 134.28 48.86 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.99 0.424 . . . . 74.040000000000006 110.504 -178.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 92' ' ' PHE . 39.0 t -102.49 124.08 56.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.496 -1.298 . . . . 74.120000000000005 107.496 175.071 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.62 123.09 68.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.825 0.821 . . . . 72.25 109.325 176.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -100.48 140.63 34.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.651 -1.159 . . . . 71.510000000000005 111.952 -174.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.33 1.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.809 . . . . 72.319999999999993 109.946 171.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.7 40.15 2.52 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 121.358 -0.449 . . . . 63.43 113.092 -173.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.8 m -55.73 -19.62 11.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 73.450000000000003 111.903 178.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.448 ' H ' HD22 ' A' ' 107' ' ' LEU . 2.4 mm? -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.271 0.628 . . . . 45.329999999999998 111.293 -178.111 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -86.99 -17.91 31.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.695 0.759 . . . . 75.519999999999996 109.287 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.37 76.23 1.12 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.324 -0.853 . . . . 53.340000000000003 113.213 175.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 m -86.69 126.67 34.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.758 -0.46 . . . . 73.109999999999999 109.758 175.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -136.79 136.44 38.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 110.033 -0.358 . . . . 71.409999999999997 110.033 178.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.429 HG11 ' HG2' ' A' ' 120' ' ' GLN . 58.8 t -121.65 121.11 63.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.798 -1.556 . . . . 73.140000000000001 106.798 174.596 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.31 44.67 27.01 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.334 1.053 . . . . 71.129999999999995 110.111 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.8 9.35 5.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.375 1.47 . . . . 74.120000000000005 114.587 -177.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -120.07 135.54 24.42 Favored Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.982 -0.687 . . . . 73.430000000000007 109.894 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.54 137.2 67.81 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.544 2.162 . . . . 75.340000000000003 111.55 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -134.43 159.42 41.13 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.304 0.573 . . . . 74.239999999999995 111.705 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.65 -34.65 3.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.344 -1.298 . . . . 73.0 108.761 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.78 27.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.694 -1.595 . . . . 73.319999999999993 106.694 174.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.429 ' HG2' HG11 ' A' ' 112' ' ' VAL . 56.5 tp60 -147.61 122.21 9.82 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.856 -0.338 . . . . 71.430000000000007 111.214 -176.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.59 114.13 26.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.465 -2.05 . . . . 73.040000000000006 105.465 173.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.482 ' SD ' HD11 ' A' ' 128' ' ' ILE . 73.6 mtp -93.34 147.19 23.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 115.268 1.581 . . . . 60.119999999999997 115.268 -168.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -112.06 152.11 28.58 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.935 -1.484 . . . . 74.040000000000006 107.653 175.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -66.55 133.52 50.5 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.337 0.589 . . . . 63.130000000000003 111.385 -178.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.39 -2.14 56.13 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.584 -0.735 . . . . 42.329999999999998 112.392 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.94 153.52 20.97 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 117.032 0.416 . . . . 72.519999999999996 109.931 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.32 145.82 42.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.011 0.745 . . . . 63.030000000000001 113.011 -172.192 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.482 HD11 ' SD ' ' A' ' 122' ' ' MET . 60.4 mt -120.23 132.05 70.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.537 -0.912 . . . . 52.329999999999998 108.537 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -116.35 122.01 43.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.89 -1.152 . . . . 75.230000000000004 107.89 175.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.6 105.05 18.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.422 -0.955 . . . . 74.319999999999993 108.422 -178.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.25 -86.29 0.5 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 108.986 -1.646 . . . . 43.329999999999998 108.986 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -140.35 -2.86 1.39 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.535 -0.333 . . . . 75.530000000000001 111.425 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.254 50.5 p90 -95.04 164.11 13.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.202 -0.999 . . . . 74.030000000000001 111.529 -179.758 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -120.0 126.61 51.26 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 113.07 0.766 . . . . 74.219999999999999 113.07 -165.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.7 mt -121.96 140.13 52.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.984 -1.117 . . . . 75.140000000000001 107.984 175.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.05 137.46 55.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.602 -0.888 . . . . 63.049999999999997 108.602 176.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -105.69 114.83 29.23 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.146 0.579 . . . . 73.450000000000003 109.69 -177.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -127.7 159.18 35.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.817 -0.438 . . . . 71.510000000000005 109.817 -178.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.85 123.53 25.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.577 -1.638 . . . . 44.450000000000003 106.577 171.081 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.72 -89.5 1.35 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.093 -1.051 . . . . 63.340000000000003 114.934 -170.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.68 152.55 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.333 2.022 . . . . 62.119999999999997 112.821 -177.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.45 20.24 11.9 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.072 -1.085 . . . . 64.129999999999995 108.072 178.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-N 114.312 -1.313 . . . . 73.0 108.375 -178.425 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 106.638 -1.615 . . . . 74.420000000000002 106.638 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.78 115.71 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.679 -1.23 . . . . 70.340000000000003 107.679 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.18 139.81 30.1 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.427 -0.806 . . . . 62.340000000000003 109.942 -174.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -81.64 132.0 35.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.582 -0.896 . . . . 73.329999999999998 108.582 177.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.59 66.58 9.73 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.28 0.562 . . . . 64.129999999999995 112.465 -175.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.92 -18.25 58.41 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 107.841 -1.17 . . . . 64.349999999999994 107.841 174.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -62.12 -12.92 22.13 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 114.841 -1.072 . . . . 74.230000000000004 112.862 177.031 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.91 -30.54 69.89 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 121.358 0.599 . . . . 73.530000000000001 109.536 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.47 -33.74 76.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 125.008 1.323 . . . . 72.150000000000006 108.989 178.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 -49.0 10.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.279 -0.873 . . . . 74.530000000000001 109.081 177.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.3 tpp -56.88 -32.65 66.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.824 1.25 . . . . 71.409999999999997 112.031 -176.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 30.0 tt0 -62.78 -32.13 73.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.756 0.312 . . . . 73.120000000000005 111.554 -178.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -69.61 -32.2 70.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.097 -0.705 . . . . 73.230000000000004 109.097 179.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -84.26 -16.65 42.42 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.039 0.935 . . . . 71.329999999999998 111.513 -179.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 27' ' ' GLU . 61.6 m -59.59 124.91 21.61 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 112.615 0.598 . . . . 65.319999999999993 112.615 -175.122 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.71 -144.25 8.45 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 109.036 -1.626 . . . . 64.040000000000006 109.036 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 p -115.52 139.79 49.74 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 117.446 0.623 . . . . 73.099999999999994 109.56 174.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . . . -127.12 122.26 23.04 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 120.607 -0.437 . . . . 44.219999999999999 109.831 177.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.37 156.95 60.53 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 123.146 2.564 . . . . 71.329999999999998 112.513 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.65 158.78 35.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.567 -0.901 . . . . 73.349999999999994 108.567 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.3 m -81.26 105.62 12.6 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.382 -0.969 . . . . 62.43 108.382 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 m -70.23 78.25 0.52 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.148 0.975 . . . . 73.019999999999996 111.641 -176.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 25.98 0.14 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 109.641 -1.383 . . . . 70.400000000000006 109.641 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.1 72.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.169 -0.515 . . . . 74.099999999999994 110.134 -177.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.21 4.13 51.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.707 -0.679 . . . . 65.019999999999996 111.056 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -84.6 -42.24 15.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.964 -1.125 . . . . 75.329999999999998 107.964 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt 50.88 68.74 3.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.728 -1.124 . . . . 64.299999999999997 111.22 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.417 ' HG2' ' HA2' ' A' ' 140' ' ' GLY . 30.7 Cg_endo -65.56 -65.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.38 2.054 . . . . 73.239999999999995 113.482 -175.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -15.82 60.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.815 0.302 . . . . 54.149999999999999 111.815 -177.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -2.85 72.74 Favored Glycine 0 N--CA 1.46 0.271 0 N-CA-C 111.746 -0.542 . . . . 54.140000000000001 111.746 -178.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -150.77 169.59 21.29 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.616 -1.624 . . . . 73.409999999999997 106.616 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.59 44.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 118.06 0.391 . . . . 74.530000000000001 111.1 -173.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.42 157.73 36.13 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.4 0.438 . . . . 65.349999999999994 110.715 177.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.78 151.2 50.77 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.117 -0.697 . . . . 71.340000000000003 109.117 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.71 134.69 66.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 110.027 -0.36 . . . . 63.520000000000003 110.027 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.83 118.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.17 -1.419 . . . . 70.140000000000001 107.17 177.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -91.0 -32.95 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.939 0.4 . . . . 70.129999999999995 110.159 -177.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 tpm_? -137.81 132.63 32.92 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.647 -0.421 . . . . 73.510000000000005 110.085 -179.16 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.15 173.01 17.96 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.991 -1.644 . . . . 55.399999999999999 108.991 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -59.55 -35.42 95.64 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.584 2.189 . . . . 74.129999999999995 112.725 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -100.5 22.15 12.18 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.595 -0.442 . . . . 63.520000000000003 112.187 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.6 138.71 57.64 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.752 178.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.03 -19.24 32.89 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.268 -0.733 . . . . 74.209999999999994 111.268 -177.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.96 144.01 26.78 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 110.138 -0.319 . . . . 50.520000000000003 110.138 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.73 156.75 18.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.9 -0.778 . . . . 73.099999999999994 108.9 178.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.471 ' CG ' HG22 ' A' ' 78' ' ' ILE . 98.3 m-85 -138.0 144.44 41.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.335 -1.358 . . . . 75.019999999999996 107.335 175.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.7 135.1 54.97 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.156 -0.683 . . . . 74.230000000000004 109.156 -178.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.46 104.36 10.02 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.87 -0.789 . . . . 61.299999999999997 108.87 179.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.93 -21.37 11.61 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.827 -0.624 . . . . 72.430000000000007 111.351 -177.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.58 144.86 30.12 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.001 -0.545 . . . . 74.219999999999999 110.983 -173.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.32 -19.85 36.9 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.745 2.963 . . . . 73.129999999999995 113.901 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.8 m -141.74 121.23 13.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.997 -0.742 . . . . 71.310000000000002 108.997 175.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.8 m -120.06 133.13 55.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.253 -0.647 . . . . 55.210000000000001 109.253 -177.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.2 m -105.66 143.83 33.26 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.901 -0.407 . . . . 73.299999999999997 109.901 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.07 134.91 54.54 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.042 -0.725 . . . . 73.129999999999995 109.042 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . 133.79 -146.64 18.57 Favored Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 109.113 -1.595 . . . . 70.510000000000005 109.113 -179.113 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -119.67 118.65 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.614 -1.234 . . . . 53.219999999999999 111.497 174.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.581 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 47.5 m-70 -167.55 142.14 3.09 Favored Pre-proline 0 C--N 1.277 -2.557 0 C-N-CA 126.832 2.053 . . . . 73.430000000000007 105.564 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.57 -21.95 73.44 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.611 2.207 . . . . 71.439999999999998 114.733 -175.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.429 ' OE2' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -105.79 5.19 30.62 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.259 0.466 . . . . 32.219999999999999 112.259 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.581 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 73.3 m -80.98 140.27 35.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.494 -0.482 . . . . 71.219999999999999 109.826 178.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.08 -49.89 14.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 111.121 -173.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.471 HG22 ' CG ' ' A' ' 61' ' ' PHE . 43.9 pt -100.37 103.47 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.289 1.043 . . . . 75.030000000000001 111.015 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -88.1 132.44 34.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.378 -1.283 . . . . 72.340000000000003 108.965 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.48 136.36 51.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.029 -1.471 . . . . 54.43 107.029 176.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.38 139.37 50.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.235 -0.654 . . . . 75.310000000000002 109.235 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -166.4 -174.56 2.91 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.079 -2.193 . . . . 73.239999999999995 105.079 178.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.45 -24.35 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.806 -1.553 . . . . 73.209999999999994 106.806 175.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -78.96 96.19 5.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.505 -1.294 . . . . 72.319999999999993 107.505 176.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.56 135.59 35.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.17 0.509 . . . . 40.140000000000001 112.315 -173.023 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.9 t -134.52 142.36 46.99 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.625 -2.361 . . . . 70.120000000000005 104.625 173.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -62.55 -46.07 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.296 0.57 . . . . 71.340000000000003 109.742 -178.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 16.8 ptt180 -151.42 151.06 31.16 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.348 -1.352 . . . . 61.229999999999997 107.348 170.068 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -100.67 -52.33 3.36 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.613 0.571 . . . . 74.519999999999996 112.186 -176.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.03 164.79 36.49 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.314 -0.555 . . . . 63.140000000000001 110.462 -172.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.21 132.0 45.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.598 -0.728 . . . . 65.040000000000006 109.248 173.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.405 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 68.3 m-85 -106.11 123.76 48.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.646 -0.872 . . . . 63.399999999999999 108.646 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -106.12 127.08 52.95 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.465 -0.494 . . . . 71.310000000000002 109.728 173.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.15 114.41 46.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.563 -1.643 . . . . 72.439999999999998 106.563 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -136.84 118.93 15.41 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 120.685 -0.406 . . . . 74.5 110.205 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 55.87 40.64 30.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.602 1.161 . . . . 71.25 111.396 177.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.45 -8.53 74.29 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.464 -1.244 . . . . 35.450000000000003 114.116 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.49 135.78 42.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.882 0.841 . . . . 75.019999999999996 110.17 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 37.9 m-85 -104.94 128.35 53.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.77 -1.105 . . . . 65.310000000000002 108.183 -176.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.46 137.13 49.65 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.127 0.489 . . . . 75.099999999999994 110.39 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.33 125.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.729 -0.841 . . . . 71.5 108.729 -177.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -116.66 126.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.834 -1.173 . . . . 73.129999999999995 107.834 174.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.21 134.09 35.56 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.898 -0.779 . . . . 72.230000000000004 108.898 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG21 ' CZ ' ' A' ' 88' ' ' ARG . 15.5 m -138.21 15.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.862 0.839 . . . . 74.319999999999993 109.509 179.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -155.48 70.66 0.27 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 110.472 -1.051 . . . . 62.539999999999999 110.472 -176.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -72.42 27.53 0.05 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.63 0.772 . . . . 64.430000000000007 112.49 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 105' ' ' GLY . 3.0 tm? -82.96 -47.07 12.16 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 105.716 -1.957 . . . . 62.409999999999997 105.716 174.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.98 -19.93 19.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.285 -0.966 . . . . 62.43 109.55 176.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.77 129.7 0.12 Allowed Glycine 0 C--N 1.343 0.944 0 O-C-N 123.957 0.786 . . . . 53.43 112.352 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.2 m -82.96 127.8 33.87 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.481 -1.288 . . . . 73.319999999999993 109.116 174.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -130.06 126.29 37.28 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.564 -1.272 . . . . 73.010000000000005 107.564 175.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.47 119.24 59.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.097 -1.446 . . . . 72.140000000000001 107.097 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 33' ' ' ALA . 36.2 t-20 54.61 40.84 32.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.133 0.968 . . . . 71.030000000000001 109.063 -178.172 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 71.53 10.9 6.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.1 -1.409 . . . . 73.549999999999997 113.036 175.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.35 129.53 24.91 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 71.129999999999995 109.629 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.09 126.66 16.86 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.907 2.405 . . . . 61.420000000000002 110.782 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.17 162.77 23.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.958 0.885 . . . . 65.209999999999994 113.228 -176.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -133.0 -38.33 0.97 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.886 -1.961 . . . . 60.32 107.306 178.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.68 136.64 27.56 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.908 -2.256 . . . . 64.209999999999994 104.908 171.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -152.9 126.04 8.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.123 -0.631 . . . . 73.109999999999999 110.148 179.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.22 119.69 27.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.006 -1.479 . . . . 62.009999999999998 107.006 174.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.464 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 11.0 ttt -87.01 140.06 29.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.595 0.712 . . . . 72.530000000000001 112.032 -162.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -128.97 155.96 44.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.564 -1.198 . . . . 64.150000000000006 111.581 -176.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.5 t -80.03 135.27 36.32 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.452 1.101 . . . . 71.25 113.406 -173.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.57 -20.46 48.19 Favored Glycine 0 CA--C 1.499 -0.937 0 CA-C-N 115.851 -0.613 . . . . 54.32 112.238 177.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.76 151.95 37.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 122.903 0.481 . . . . 74.319999999999993 109.74 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 147.6 35.05 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.462 0.649 . . . . 54.140000000000001 110.896 -178.718 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -105.7 124.83 61.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 106.58 -1.637 . . . . 72.129999999999995 106.58 -176.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -110.18 126.39 54.05 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.632 -1.988 . . . . 75.120000000000005 105.632 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.31 102.49 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.15 -1.056 . . . . 63.130000000000003 108.15 -176.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.14 -84.18 0.02 OUTLIER Glycine 0 CA--C 1.536 1.38 0 CA-C-O 121.39 0.439 . . . . 53.25 113.077 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -131.82 8.91 4.52 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.491 0.716 . . . . 75.409999999999997 110.209 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -102.37 151.89 21.74 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.513 -0.767 . . . . 45.140000000000001 109.633 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 124.47 21.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.921 -0.581 . . . . 73.209999999999994 109.895 170.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.57 141.22 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.922 -1.14 . . . . 73.430000000000007 107.922 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.3 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.627 -0.879 . . . . 74.219999999999999 108.627 -178.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -102.23 126.95 49.36 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.732 0.645 . . . . 74.140000000000001 110.003 -176.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -140.0 131.06 26.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.887 0.851 . . . . 73.140000000000001 111.895 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.95 118.25 35.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.986 -1.487 . . . . 63.520000000000003 106.986 176.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 43' ' ' PRO . . . -177.04 -71.02 0.06 OUTLIER Glycine 0 C--N 1.295 -1.708 0 C-N-CA 118.279 -1.915 . . . . 65.340000000000003 114.639 -176.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.89 142.31 97.23 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.357 2.038 . . . . 71.540000000000006 113.179 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.83 76.51 1.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.636 -1.165 . . . . 62.350000000000001 108.166 -178.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 114.024 -1.444 . . . . 64.200000000000003 108.114 -178.592 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.435 -1.201 0 N-CA-C 109.889 -0.411 . . . . 72.219999999999999 109.889 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -97.57 114.53 35.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 107.451 -1.315 . . . . 74.409999999999997 107.451 177.097 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.456 ' CE2' HG23 ' A' ' 84' ' ' THR . 22.7 m-85 -97.45 138.6 34.65 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.033 -0.667 . . . . 63.549999999999997 112.307 -177.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.34 91.1 7.53 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.363 -2.458 . . . . 70.230000000000004 104.363 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . . . -101.5 168.08 9.73 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.213 -1.358 . . . . 55.020000000000003 112.779 -166.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.92 -1.42 56.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.235 -1.348 . . . . 61.210000000000001 109.172 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' ' 20' ' ' ALA . 3.8 pp -63.65 -14.7 54.36 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.295 -0.866 . . . . 74.239999999999995 112.478 -178.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.69 -19.61 64.38 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.897 0.38 . . . . 72.25 111.077 175.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -84.02 -38.77 20.47 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.779 -1.193 . . . . 74.5 107.779 173.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -57.47 -34.54 69.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.983 -1.008 . . . . 72.329999999999998 109.986 176.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.53 -49.17 70.9 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.435 1.094 . . . . 72.239999999999995 111.551 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.29 -36.05 76.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.659 0.266 . . . . 73.319999999999993 110.528 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -62.16 -37.47 85.33 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.638 -0.71 . . . . 62.509999999999998 110.8 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -86.27 -17.03 35.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.22 0.452 . . . . 63.32 112.22 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.0 m -63.71 125.34 23.98 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.345 -0.613 . . . . 71.430000000000007 109.345 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.87 3.4 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 108.311 -1.916 . . . . 74.319999999999993 108.311 -171.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.8 t -101.75 140.05 36.57 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.576 -0.812 . . . . 73.450000000000003 108.994 -179.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.27 80.02 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 107.418 -1.326 . . . . 74.310000000000002 107.418 174.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.487 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 38.2 Cg_exo -62.29 142.01 89.73 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.315 1.343 . . . . 53.340000000000003 109.68 176.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.28 124.58 44.48 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.072 -0.651 . . . . 23.420000000000002 109.459 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 124' ' ' THR . 73.4 m -165.2 143.79 6.39 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 71.209999999999994 109.531 -179.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -118.62 8.94 12.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.684 0.754 . . . . 62.420000000000002 109.775 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.28 65.8 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 107.008 -2.437 . . . . 73.540000000000006 107.008 -177.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' OE1' ' A' ' 123' ' ' GLN . . . -57.02 -47.56 80.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.972 -1.114 . . . . 51.130000000000003 113.151 -165.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -104.44 3.57 32.31 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 120.742 -0.383 . . . . 72.219999999999999 111.255 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.01 -44.51 9.28 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.39 -0.924 . . . . 72.319999999999993 112.03 -171.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 36.51 69.23 1.29 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 124.2 0.938 . . . . 75.040000000000006 111.18 -175.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.9 -70.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 125.265 3.977 . . . . 64.439999999999998 116.804 -167.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.28 -5.72 58.19 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.444 -0.502 . . . . 72.219999999999999 112.299 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -4.77 64.34 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.96 -0.638 . . . . 53.439999999999998 112.267 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.3 m -114.79 153.37 30.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.335 -1.728 . . . . 61.229999999999997 106.335 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 156.83 40.02 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.286 -0.566 . . . . 71.0 112.235 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.5 161.09 35.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.922 -1.036 . . . . 44.520000000000003 109.743 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -130.9 135.14 47.41 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.196 -0.668 . . . . 64.310000000000002 109.196 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -116.2 133.56 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.06 0.457 . . . . 74.120000000000005 110.61 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 14.0 t -78.82 118.62 26.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.667 -1.234 . . . . 33.100000000000001 107.667 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 136' ' ' VAL . 32.2 mmmt -90.86 -31.12 16.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 110.428 -176.2 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 26.2 tpt180 -143.34 145.7 32.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.109 -1.071 . . . . 74.540000000000006 108.109 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.46 178.12 15.18 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 111.305 -0.718 . . . . 42.149999999999999 111.305 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -61.42 -31.28 88.15 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.696 2.264 . . . . 73.530000000000001 112.303 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -97.09 21.22 10.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.996 0.369 . . . . 54.130000000000003 111.996 177.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.23 45.39 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 120.814 0.34 . . . . 54.119999999999997 110.761 179.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.04 -13.07 52.63 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 111.45 -0.66 . . . . 65.120000000000005 111.45 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 145.24 25.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.777 0.322 . . . . 34.329999999999998 110.197 178.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -125.62 147.54 49.28 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.08 -1.082 . . . . 70.329999999999998 108.08 177.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.85 144.89 51.79 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.749 -1.204 . . . . 64.040000000000006 107.749 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.0 pt? -111.74 134.04 53.57 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.753 0.311 . . . . 73.209999999999994 110.861 -177.107 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.4 mt -93.44 104.96 17.07 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.493 -0.558 . . . . 70.230000000000004 109.493 -178.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -121.29 -12.42 8.64 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.83 0.824 . . . . 52.329999999999998 110.809 -179.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -106.96 144.86 29.94 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 115.712 -0.677 . . . . 72.150000000000006 110.644 -175.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.05 -29.51 45.22 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.763 2.975 . . . . 74.129999999999995 113.434 -178.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -140.62 121.98 14.98 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.73 -0.606 . . . . 74.209999999999994 109.75 179.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -118.0 139.54 51.04 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.227 -1.397 . . . . 63.299999999999997 107.227 178.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.4 m -115.39 141.9 47.41 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.79 . . . . 65.349999999999994 110.222 -178.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.49 135.42 54.78 Favored 'General case' 0 C--O 1.256 1.446 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.761 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.01 -144.91 12.72 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.666 -1.374 . . . . 70.299999999999997 109.666 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 58.2 ttt-85 -119.95 118.29 30.32 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.663 -0.495 . . . . 65.099999999999994 109.663 176.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 75' ' ' GLU . 8.8 p80 169.74 163.02 0.2 Allowed Pre-proline 0 C--N 1.315 -0.925 0 C-N-CA 126.812 2.045 . . . . 73.230000000000004 107.811 174.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.54 -25.43 75.65 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.237 1.958 . . . . 44.210000000000001 113.043 -178.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 20.3 mp0 -86.64 -4.9 59.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.653 -0.249 . . . . 64.519999999999996 111.481 -178.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -71.29 107.57 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.366 -0.605 . . . . 63.549999999999997 109.366 178.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.0 -32.01 56.89 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.581 -1.266 . . . . 71.450000000000003 107.581 175.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.68 100.85 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.305 -2.109 . . . . 63.109999999999999 105.305 173.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.72 118.32 36.6 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.76 -0.376 . . . . 72.450000000000003 110.737 -175.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -123.06 122.3 38.15 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.71 -1.218 . . . . 41.350000000000001 107.71 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 55' ' ' PRO . 24.8 t70 -130.71 132.24 45.25 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.603 -0.888 . . . . 54.409999999999997 108.603 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -141.58 175.17 9.9 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.677 -1.601 . . . . 51.25 106.677 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -60.12 -32.19 49.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.577 -1.268 . . . . 64.219999999999999 107.577 174.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.456 HG23 ' CE2' ' A' ' 18' ' ' PHE . 13.1 m -74.88 114.59 13.52 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.691 -1.225 . . . . 72.0 107.691 173.282 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.57 125.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.226 0.536 . . . . 73.140000000000001 110.53 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.1 m -145.13 103.12 3.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.162 -0.681 . . . . 70.150000000000006 109.162 177.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 72' ' ' ARG . 18.1 ptt180 -80.68 -45.68 16.77 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 119.604 -0.839 . . . . 73.340000000000003 111.488 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -118.88 99.67 6.9 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.313 -0.625 . . . . 74.0 109.313 177.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.442 ' CE1' HG13 ' A' ' 130' ' ' ILE . 44.4 t-80 -100.32 -52.66 3.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.301 -0.96 . . . . 73.519999999999996 111.325 177.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.59 163.57 39.2 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.03 -0.668 . . . . 45.020000000000003 111.913 -175.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.78 137.4 54.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.952 -1.129 . . . . 74.109999999999999 107.952 176.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -105.83 113.58 27.22 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.739 -1.578 . . . . 65.439999999999998 106.739 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -111.13 136.54 50.03 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.832 -0.432 . . . . 74.5 109.832 -175.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' A' ' 99' ' ' PHE . 17.9 mm -107.97 113.52 44.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.628 -1.99 . . . . 71.239999999999995 105.628 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -135.96 122.84 21.26 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.511 -0.476 . . . . 65.409999999999997 110.51 -177.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 56.37 37.16 28.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.265 1.426 . . . . 54.130000000000003 110.403 179.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.5 -0.72 87.53 Favored Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.13 -0.941 . . . . 31.02 113.215 177.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.85 145.72 29.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.458 -0.941 . . . . 74.150000000000006 108.458 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD2' HD12 ' A' ' 94' ' ' ILE . 50.3 m-85 -105.11 127.12 52.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.289 -1.375 . . . . 73.030000000000001 107.289 -177.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -130.29 147.39 52.0 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.886 -0.509 . . . . 74.129999999999995 110.23 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -113.53 123.68 69.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.636 -1.246 . . . . 53.009999999999998 107.636 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.3 121.87 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.419 0.628 . . . . 71.420000000000002 109.608 175.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.448 ' HB2' HG21 ' A' ' 110' ' ' THR . 3.5 t70 -81.84 138.21 35.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.77 -0.65 . . . . 72.430000000000007 110.612 178.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.22 12.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.679 -0.691 . . . . 72.409999999999997 109.517 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.7 -63.4 0.12 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 119.91 -1.138 . . . . 61.039999999999999 112.981 -177.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 t 62.23 9.55 3.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.723 1.209 . . . . 43.329999999999998 111.205 -177.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.6 pt? -75.98 -46.02 31.77 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 124.017 0.927 . . . . 65.230000000000004 112.577 -173.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.445 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 34.2 t-20 -89.74 -18.46 26.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 75.140000000000001 109.735 -171.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.79 86.19 1.77 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.516 -1.034 . . . . 72.230000000000004 110.516 -177.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 103' ' ' ASP . 8.4 m -80.63 129.81 34.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.027 0.441 . . . . 64.230000000000004 110.323 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 51.3 m-85 -131.02 136.07 48.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.741 -0.663 . . . . 71.319999999999993 110.585 178.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.66 123.32 49.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 105.935 -1.876 . . . . 43.310000000000002 105.935 174.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 57.34 37.76 28.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.44 1.096 . . . . 73.409999999999997 108.867 -176.914 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.3 mtm-85 66.68 12.29 8.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.56 -1.2 . . . . 74.140000000000001 113.702 178.142 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -114.57 142.94 29.0 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 108.871 -0.789 . . . . 71.540000000000006 108.871 174.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 110' ' ' THR . 26.1 Cg_exo -63.54 123.17 11.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.716 1.611 . . . . 73.200000000000003 108.73 172.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -157.3 136.89 12.18 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.166 -1.42 . . . . 73.209999999999994 107.166 -176.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -93.66 -49.27 5.95 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.062 -0.655 . . . . 72.109999999999999 110.56 -178.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.2 134.22 55.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.612 -0.835 . . . . 74.239999999999995 109.151 177.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -154.4 144.92 22.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.97 -0.559 . . . . 74.340000000000003 110.808 -178.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.78 125.55 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.265 -1.754 . . . . 72.420000000000002 106.265 172.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.7 ttp -98.38 129.87 45.03 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.212 0.529 . . . . 62.119999999999997 110.191 -173.218 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.492 ' OE1' ' HB1' ' A' ' 39' ' ' ALA . 69.5 mt-30 -117.7 156.23 28.6 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.8 -1.185 . . . . 62.210000000000001 107.8 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.9 t -62.62 133.74 55.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.95 0.722 . . . . 73.129999999999995 112.95 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.43 56.16 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.699 -0.682 . . . . 44.409999999999997 112.588 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -88.67 153.01 21.45 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 109.63 -0.507 . . . . 71.340000000000003 109.63 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -120.6 127.18 51.87 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.002 0.905 . . . . 53.0 111.836 -176.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.27 129.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 -177.142 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.0 tt0 -118.77 132.25 56.13 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.651 -177.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.442 HG13 ' CE1' ' A' ' 89' ' ' HIS . 2.9 mp -108.69 103.46 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.884 -1.895 . . . . 74.219999999999999 105.884 178.179 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.06 -93.54 0.33 Allowed Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 115.476 -0.784 . . . . 75.049999999999997 112.807 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.0 3.85 9.35 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.156 0.428 . . . . 63.5 112.156 -175.149 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.5 p90 -131.61 141.9 49.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.647 -0.658 . . . . 74.25 111.605 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 12.1 ptp180 -122.63 149.55 43.85 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 114.606 1.336 . . . . 73.409999999999997 114.606 -171.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 51' ' ' VAL . 6.0 mp -117.39 140.92 48.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.654 -1.612 . . . . 72.319999999999993 107.634 178.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.435 HG23 ' HG3' ' A' ' 52' ' ' LYS . 87.4 t -111.13 131.41 62.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.341 -0.985 . . . . 73.409999999999997 108.341 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -95.4 121.9 37.56 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.221 -0.9 . . . . 75.019999999999996 110.932 -175.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.16 133.42 51.58 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.192 0.52 . . . . 52.539999999999999 109.943 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 148.62 27.29 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.781 -0.822 . . . . 54.450000000000003 108.781 175.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 129.88 24.07 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.361 -1.096 . . . . 72.340000000000003 110.361 178.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.67 162.61 38.57 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.945 2.43 . . . . 63.130000000000003 111.459 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.34 51.96 0.9 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.028 0.918 . . . . 62.020000000000003 110.769 -178.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 105.507 -2.034 . . . . 54.210000000000001 105.507 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 108.424 -0.954 . . . . 45.149999999999999 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -150.1 -43.92 0.13 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.86 0.362 . . . . 64.299999999999997 110.365 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -78.72 165.25 23.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.365 -0.38 . . . . 72.400000000000006 110.433 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -72.27 114.44 10.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.449 -0.945 . . . . 74.319999999999993 108.449 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.83 100.12 3.38 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.785 0.802 . . . . 75.200000000000003 111.252 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.21 -150.62 22.6 Favored Glycine 0 N--CA 1.426 -2.009 0 N-CA-C 107.847 -2.101 . . . . 72.5 107.847 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -122.75 108.57 32.91 Favored Pre-proline 0 C--N 1.293 -1.882 0 CA-C-N 118.22 1.01 . . . . 72.430000000000007 111.738 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.33 131.41 20.38 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 107.426 -1.798 . . . . 65.310000000000002 107.426 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -79.5 123.12 84.42 Favored Pre-proline 0 C--N 1.301 -1.534 0 C-N-CA 121.185 -0.206 . . . . 64.439999999999998 111.221 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.11 135.39 34.5 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.372 2.048 . . . . 71.510000000000005 110.115 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -125.69 137.7 53.85 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t -110.1 121.64 63.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.13 -1.433 . . . . 75.019999999999996 107.13 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -158.98 157.94 32.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.613 -1.254 . . . . 74.349999999999994 107.613 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 m -104.46 115.87 31.12 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 120.408 -0.517 . . . . 73.019999999999996 110.847 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.602 ' O2P' ' HG2' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.4 t -89.17 135.55 33.5 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 106.842 -1.54 . . . . 64.340000000000003 106.842 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.89 126.29 40.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 107.507 -1.294 . . . . 73.030000000000001 107.507 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -81.42 132.74 35.34 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.366 1.079 . . . . 72.310000000000002 113.732 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -118.58 90.57 3.36 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 101.477 -3.527 . . . . 63.439999999999998 101.477 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.21 160.06 18.66 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.104 0.779 . . . . 71.099999999999994 113.104 -167.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.01 -7.16 37.1 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.133 -0.939 . . . . 74.299999999999997 109.647 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.32 -16.82 9.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.029 1.122 . . . . 75.299999999999997 114.029 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.5 pp -66.19 -26.68 67.51 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.407 0.622 . . . . 74.329999999999998 110.953 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' HD12 ' A' ' 23' ' ' LEU . 38.4 ttmt -73.97 -39.97 63.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.299 -1.0 . . . . 71.140000000000001 108.299 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -66.62 -35.61 80.6 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.617 -0.719 . . . . 74.140000000000001 110.076 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -42.36 98.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.983 -0.747 . . . . 71.219999999999999 108.983 174.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.29 -34.32 77.15 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 73.140000000000001 110.879 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.8 m -69.54 -19.06 63.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.421 0.629 . . . . 71.310000000000002 110.366 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.9 t -86.85 -16.71 35.3 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.537 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -59.52 119.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.525 0.679 . . . . 64.439999999999998 110.511 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.88 -78.38 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.139 0 N-CA-C 108.167 -1.973 . . . . 61.43 108.167 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.3 t -116.76 148.41 41.17 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.463 -0.94 . . . . 74.310000000000002 108.463 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.95 116.64 26.06 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 106.893 -1.521 . . . . 45.420000000000002 106.893 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.48 140.64 82.98 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.08 1.187 . . . . 75.010000000000005 110.865 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.3 126.2 29.25 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.651 -0.87 . . . . 74.510000000000005 108.651 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 m -131.49 149.87 52.36 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.47 -0.937 . . . . 54.119999999999997 108.47 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -127.11 153.04 46.51 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.422 -0.585 . . . . 71.140000000000001 109.422 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.17 24.67 4.1 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 120.463 -0.875 . . . . 71.129999999999995 112.134 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.02 -32.8 61.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.572 -0.529 . . . . 71.219999999999999 109.572 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.39 -2.31 52.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.549 -0.751 . . . . 72.409999999999997 110.998 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.43 -34.48 41.62 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.459 -0.941 . . . . 64.219999999999999 108.459 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.6 mt 56.55 90.96 0.08 OUTLIER Pre-proline 0 N--CA 1.45 -0.426 0 O-C-N 124.774 1.296 . . . . 72.519999999999996 113.006 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 8.3 Cg_endo -53.99 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.462 2.108 . . . . 71.409999999999997 111.888 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.59 15.45 8.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.0 0.429 . . . . 70.319999999999993 110.334 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.07 18.32 76.84 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.833 -0.621 . . . . 54.520000000000003 112.323 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.7 t -138.01 167.01 22.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.859 -0.793 . . . . 73.019999999999996 108.859 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -150.9 157.65 43.16 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.295 1.038 . . . . 73.200000000000003 108.548 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 pp -135.15 160.0 39.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 121.014 -0.275 . . . . 70.310000000000002 111.458 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -127.24 134.93 50.02 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.526 -0.916 . . . . 65.439999999999998 108.526 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.51 136.75 44.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.502 -0.555 . . . . 61.539999999999999 109.502 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 17.1 t -80.59 117.42 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 106.717 -1.586 . . . . 51.130000000000003 106.717 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 51.2 tptt -90.63 -32.06 16.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.749 0.785 . . . . 64.409999999999997 109.136 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.616 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 77.8 ttt180 -151.51 142.35 22.91 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.52 -2.03 . . . . 61.409999999999997 105.52 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.22 -171.13 27.95 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.594 -1.002 . . . . 70.129999999999995 110.594 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.59 -50.15 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.386 2.057 . . . . 54.32 110.889 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 HD23 ' A' ' 80' ' ' LEU . 2.7 p30 -90.93 24.34 2.81 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.66 1.184 . . . . 44.549999999999997 112.666 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -53.45 131.78 38.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.568 0.699 . . . . 71.25 112.78 -176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.94 -17.31 45.28 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.359 -0.837 . . . . 74.120000000000005 111.901 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 146.53 23.98 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 122.593 -0.357 . . . . 75.439999999999998 110.435 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -120.26 135.29 55.05 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.926 -0.768 . . . . 72.010000000000005 108.926 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -118.07 140.99 48.95 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.77 -1.196 . . . . 75.219999999999999 107.77 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.1 pt? -110.7 140.96 44.59 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.256 -0.577 . . . . 64.340000000000003 111.576 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.4 HD23 HD11 ' A' ' 94' ' ' ILE . 4.6 mp -91.15 104.59 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.316 -0.994 . . . . 73.239999999999995 108.316 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -112.08 -4.86 14.35 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.965 0.888 . . . . 72.230000000000004 109.752 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -108.97 151.78 42.07 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-N 115.357 -0.838 . . . . 70.409999999999997 109.762 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 30.9 Cg_exo -64.98 -18.04 61.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.036 2.49 . . . . 64.239999999999995 113.948 -177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -144.12 122.4 12.28 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.595 -0.691 . . . . 64.150000000000006 109.522 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 77' ' ' ASP . 19.2 m -121.95 114.46 21.01 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.302 -0.629 . . . . 71.400000000000006 109.302 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.4 m -95.55 137.12 35.06 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.976 -0.452 . . . . 72.310000000000002 109.97 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 135.32 55.03 Favored 'General case' 0 C--O 1.261 1.66 0 CA-C-O 121.313 0.577 . . . . 73.25 111.228 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.04 -161.85 24.41 Favored Glycine 0 C--O 1.251 1.185 0 N-CA-C 109.07 -1.612 . . . . 60.229999999999997 109.07 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.418 ' HE ' HG11 ' A' ' 85' ' ' VAL . 3.9 tmm_? -94.07 118.75 31.96 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.188 -1.782 . . . . 63.119999999999997 106.188 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.552 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 11.1 t-80 -166.5 139.58 3.19 Favored Pre-proline 0 N--CA 1.401 -2.914 0 N-CA-C 103.705 -2.702 . . . . 74.209999999999994 103.705 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.552 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 17.9 Cg_endo -61.89 -29.6 82.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 121.115 1.21 . . . . 74.010000000000005 111.703 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -105.34 17.84 23.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.335 -0.848 . . . . 63.009999999999998 111.422 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 73' ' ' HIS . 19.4 p -77.91 128.66 34.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 118.652 -1.219 . . . . 60.219999999999999 110.636 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' A' ' 68' ' ' THR . 12.3 t70 -77.28 -30.25 54.19 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.627 0.727 . . . . 70.5 109.109 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.04 99.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 108.558 -0.905 . . . . 72.030000000000001 108.558 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -92.42 120.17 32.66 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.849 -0.614 . . . . 72.319999999999993 109.9 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.405 HD23 HD21 ' A' ' 56' ' ' ASN . 77.9 mt -127.56 140.13 52.31 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.797 -1.557 . . . . 62.340000000000003 106.797 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -87.07 116.31 25.04 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.746 -0.835 . . . . 74.140000000000001 108.746 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 84' ' ' THR . 11.0 t70 -87.01 178.66 6.87 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.099 -1.074 . . . . 73.230000000000004 108.099 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.92 -34.18 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 106.873 -1.528 . . . . 72.239999999999995 106.873 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.551 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 7.0 t -114.37 -167.42 1.22 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 104.651 -2.351 . . . . 75.349999999999994 104.651 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG11 ' HE ' ' A' ' 72' ' ' ARG . 61.2 t -104.17 101.9 12.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.617 -1.233 . . . . 61.149999999999999 109.926 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.8 p -87.98 101.41 13.73 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.987 -0.551 . . . . 70.319999999999993 110.824 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.602 ' HG2' ' O2P' ' A' ' 15' ' ' TPO . 15.9 ptt180 -64.32 -34.7 78.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.751 0.786 . . . . 73.319999999999993 109.656 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -147.2 95.88 2.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.957 -1.019 . . . . 71.239999999999995 108.638 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -99.98 -52.54 3.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.769 -1.172 . . . . 73.200000000000003 109.323 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.59 156.2 34.67 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 119.925 -0.71 . . . . 70.430000000000007 111.344 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 9.7 pt-20 -137.84 142.03 40.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.943 -0.571 . . . . 64.310000000000002 109.964 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -105.69 117.48 34.14 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.928 -1.508 . . . . 73.319999999999993 106.928 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 16.3 mtp180 -109.5 127.98 54.84 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.906 -0.776 . . . . 71.140000000000001 108.906 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 mp -105.86 113.59 43.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.794 -1.188 . . . . 43.229999999999997 107.794 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -126.59 117.45 22.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.648 -0.501 . . . . 71.230000000000004 109.648 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 53.49 37.7 26.32 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.513 1.525 . . . . 72.140000000000001 112.229 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 -2.58 87.51 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-N 115.325 -0.852 . . . . 71.400000000000006 113.02 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -102.49 143.06 32.69 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.301 -0.629 . . . . 71.219999999999999 109.301 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' CD2' HG13 ' A' ' 94' ' ' ILE . 61.9 m-85 -110.45 124.12 51.18 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.891 -0.595 . . . . 72.329999999999998 110.277 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.92 141.07 49.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.327 -0.62 . . . . 75.230000000000004 109.327 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.45 HG23 ' HG2' ' A' ' 122' ' ' MET . 17.9 t -102.95 125.36 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 107.545 -1.28 . . . . 71.420000000000002 107.545 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.79 122.12 68.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 N-CA-C 107.375 -1.343 . . . . 75.239999999999995 107.375 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 2.2 t70 -87.63 122.02 30.8 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.978 -1.01 . . . . 75.310000000000002 108.448 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.4 m -116.46 13.7 7.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 115.447 -0.797 . . . . 74.209999999999994 109.73 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.5 -66.07 0.25 Allowed Glycine 0 N--CA 1.412 -2.948 0 CA-C-N 115.084 -0.962 . . . . 72.129999999999995 112.807 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.3 t 60.66 9.61 2.23 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.974 0.91 . . . . 55.229999999999997 111.051 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 108' ' ' ASN . 3.3 pp -65.38 -46.71 79.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.724 1.21 . . . . 63.299999999999997 112.83 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.446 ' N ' HD12 ' A' ' 107' ' ' LEU . 6.8 t30 -92.77 -18.06 23.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.285 -1.006 . . . . 70.040000000000006 108.285 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.39 93.87 1.22 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 106.486 -2.646 . . . . 70.299999999999997 106.486 -169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 5.1 m -76.4 128.7 35.33 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 108.705 -0.85 . . . . 72.299999999999997 108.705 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 50.0 m-85 -112.19 126.16 54.91 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 106.888 -1.523 . . . . 73.340000000000003 106.888 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 120' ' ' GLN . 3.1 t -123.22 134.76 65.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 N-CA-C 104.358 -2.46 . . . . 73.409999999999997 104.358 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.28 38.23 29.58 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.759 -1.2 . . . . 63.149999999999999 107.759 -169.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 64.36 9.18 4.71 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.852 1.427 . . . . 70.219999999999999 114.852 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.0 148.41 67.24 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 119.03 0.832 . . . . 61.450000000000003 110.14 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 110' ' ' THR . 18.1 Cg_endo -60.83 122.68 11.6 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.563 1.509 . . . . 73.230000000000004 110.213 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -146.47 133.13 19.9 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.019 -0.672 . . . . 74.120000000000005 109.215 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 16.8 m120 -92.84 -28.86 16.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.568 0.699 . . . . 72.120000000000005 111.28 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.44 135.37 26.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.45 -1.685 . . . . 71.319999999999993 106.45 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.487 ' HG2' ' CG1' ' A' ' 112' ' ' VAL . 7.5 tp60 -140.54 144.68 36.05 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 111.713 0.264 . . . . 75.230000000000004 111.713 -173.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.81 124.57 52.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 103.96 -2.607 . . . . 52.399999999999999 103.96 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.45 ' HG2' HG23 ' A' ' 101' ' ' VAL . 51.4 mtp -87.94 146.33 25.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.42 -0.912 . . . . 61.450000000000003 111.946 -171.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.15 156.87 41.09 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.849 -1.537 . . . . 71.340000000000003 106.849 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.0 t -71.08 133.69 46.47 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.229 -1.397 . . . . 65.099999999999994 107.229 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.55 57.45 Favored Glycine 0 C--N 1.312 -0.785 0 C-N-CA 120.67 -0.776 . . . . 51.299999999999997 111.778 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.47 139.34 45.7 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.654 -0.869 . . . . 71.209999999999994 108.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -112.08 126.2 54.92 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 107.749 -1.204 . . . . 70.510000000000005 107.749 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.06 126.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.866 -0.79 . . . . 73.209999999999994 108.866 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 55.4 tp60 -105.0 111.51 24.32 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.222 -1.029 . . . . 72.540000000000006 108.222 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.93 112.86 42.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.614 -1.624 . . . . 74.099999999999994 106.614 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.63 -126.97 25.31 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 108.906 -1.678 . . . . 62.109999999999999 108.906 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 17.57 20.47 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.431 0.634 . . . . 71.519999999999996 109.738 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.616 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -120.62 165.62 14.79 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.078 -0.51 . . . . 72.319999999999993 110.134 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.466 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 14.7 ptm180 -137.15 146.62 45.2 Favored 'General case' 0 C--O 1.256 1.431 0 CA-C-O 121.544 0.687 . . . . 65.239999999999995 112.72 -168.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -120.48 139.88 52.23 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.548 -1.278 . . . . 53.420000000000002 107.548 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.74 120.43 62.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 107.919 -1.141 . . . . 73.109999999999999 107.919 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.03 126.61 35.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.261 -0.644 . . . . 61.32 109.261 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.03 162.13 30.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 123.779 0.832 . . . . 72.019999999999996 109.201 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.53 148.03 45.39 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.103 -1.443 . . . . 72.129999999999995 107.103 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.617 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -77.9 -161.43 16.48 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 121.074 -0.584 . . . . 64.200000000000003 114.356 -171.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.63 143.91 93.33 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.583 2.189 . . . . 74.430000000000007 111.897 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.48 31.93 6.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.091 -1.078 . . . . 72.310000000000002 108.091 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.524 -1.216 . . . . 63.229999999999997 109.689 -177.342 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 108.399 -0.963 . . . . 73.219999999999999 108.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.2 t -168.59 171.51 8.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.319 -1.363 . . . . 74.409999999999997 107.319 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.92 114.26 13.18 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.108 -0.701 . . . . 64.439999999999998 109.108 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -87.05 151.86 22.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.044 -0.526 . . . . 74.040000000000006 109.942 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -108.23 167.15 10.22 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.54 -0.541 . . . . 63.340000000000003 109.54 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.53 -162.72 26.19 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 109.684 -1.366 . . . . 63.43 109.684 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 23.8 m -79.75 128.26 75.01 Favored Pre-proline 0 C--N 1.284 -2.251 0 N-CA-C 109.553 -0.536 . . . . 71.150000000000006 109.553 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 7' ' ' THR . 18.9 Cg_endo -58.9 154.18 46.05 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 123.591 2.861 . . . . 54.420000000000002 111.356 175.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -78.19 119.35 77.02 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 116.405 -0.362 . . . . 63.409999999999997 110.61 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.45 140.59 82.82 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.478 2.785 . . . . 72.340000000000003 113.201 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' A' ' 11' ' ' GLN . 19.6 pt20 -94.09 161.11 14.41 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.853 -1.536 . . . . 75.310000000000002 106.853 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.74 123.72 70.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 120.058 -0.657 . . . . 70.299999999999997 110.023 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -151.29 138.39 19.19 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.914 -1.884 . . . . 74.349999999999994 105.914 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.7 m -94.97 128.72 42.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.612 0.244 . . . . 71.109999999999999 110.86 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.565 ' O2P' ' HA ' ' A' ' 86' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -88.2 152.58 21.88 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.394 -2.076 . . . . 74.010000000000005 105.394 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.46 115.87 24.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.533 0.683 . . . . 73.019999999999996 109.337 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -119.94 139.86 51.79 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.287 -0.87 . . . . 75.340000000000003 110.432 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -113.22 92.18 3.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.732 -1.581 . . . . 72.319999999999993 106.732 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.21 -173.86 3.42 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.059 -0.973 . . . . 72.019999999999996 112.024 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.58 -0.55 1.42 Allowed 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 126.117 1.767 . . . . 71.299999999999997 111.683 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.98 -17.54 63.39 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.735 1.214 . . . . 64.209999999999994 111.174 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.19 -8.95 35.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.685 0.794 . . . . 72.340000000000003 111.677 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 63.5 tttp -88.93 -23.08 22.78 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 122.05 -0.407 . . . . 63.229999999999997 111.246 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -59.76 -23.47 63.27 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.419 0.526 . . . . 74.019999999999996 112.419 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.57 -30.63 71.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.85 0.685 . . . . 54.450000000000003 112.85 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 13.8 pt-20 -76.56 -26.05 54.7 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.601 -0.839 . . . . 72.120000000000005 110.796 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -80.16 -26.18 39.46 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.029 -0.73 . . . . 74.409999999999997 109.029 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.7 m -77.58 -25.74 50.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.125 -0.943 . . . . 63.030000000000001 110.448 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.5 m -74.74 108.77 7.7 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.369 -0.974 . . . . 71.420000000000002 108.369 174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.75 -5.23 12.82 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 109.281 -1.528 . . . . 61.0 109.281 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -113.8 121.72 44.88 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 109.012 -0.736 . . . . 73.150000000000006 109.012 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.48 114.59 45.0 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.279 -1.008 . . . . 73.310000000000002 108.279 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.15 142.08 96.89 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 122.162 1.908 . . . . 73.209999999999994 111.079 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.56 126.01 42.61 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 110.205 -0.294 . . . . 71.120000000000005 110.205 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 84.96 2.08 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.036 -1.098 . . . . 62.409999999999997 108.036 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -101.6 -36.33 8.8 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.251 0.548 . . . . 72.200000000000003 111.02 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.73 62.19 0.37 Allowed Glycine 0 C--N 1.305 -1.159 0 C-N-CA 121.013 -0.613 . . . . 61.340000000000003 111.991 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 123' ' ' GLN . . . -90.65 -28.52 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.591 -0.358 . . . . 61.420000000000002 111.257 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -92.75 -5.25 51.61 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.333 0.494 . . . . 72.420000000000002 112.333 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -80.22 -43.84 20.78 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.118 0.784 . . . . 73.030000000000001 113.118 -168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.0 mt 42.76 65.66 5.05 Favored Pre-proline 0 CA--C 1.557 1.248 0 O-C-N 124.181 0.926 . . . . 63.530000000000001 111.959 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.27 -70.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.593 0 C-N-CA 123.461 2.774 . . . . 63.520000000000003 113.979 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.19 7.89 45.65 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.509 -0.476 . . . . 61.149999999999999 110.661 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.54 75.16 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.987 -0.551 . . . . 54.509999999999998 111.769 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.7 p -115.18 153.97 29.85 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 123.954 0.902 . . . . 71.239999999999995 111.012 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.34 44.3 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.459 -0.791 . . . . 74.239999999999995 109.974 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.85 160.7 38.08 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.542 -0.754 . . . . 72.430000000000007 109.196 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 pt? -121.28 131.88 54.47 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.34 -0.985 . . . . 75.0 108.34 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.57 129.83 68.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.32 -0.622 . . . . 74.310000000000002 109.32 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG21 ' ND2' ' A' ' 56' ' ' ASN . 22.4 t -80.19 118.06 27.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.529 -1.656 . . . . 70.420000000000002 106.529 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.985 0.898 . . . . 64.230000000000004 109.667 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -141.47 148.05 38.85 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.641 -1.244 . . . . 75.420000000000002 107.641 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.43 -179.7 16.85 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 111.093 -0.803 . . . . 73.239999999999995 111.093 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -67.67 -38.11 14.83 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.097 1.865 . . . . 74.430000000000007 110.943 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.7 p-10 -96.14 22.63 7.38 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.392 -0.822 . . . . 71.310000000000002 111.261 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.22 144.02 55.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 123.326 0.651 . . . . 74.030000000000001 111.342 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.46 33.23 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 111.139 -0.785 . . . . 63.149999999999999 111.139 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.0 141.93 29.14 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 120.765 0.317 . . . . 70.239999999999995 110.731 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -119.82 138.7 53.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.069 -0.514 . . . . 72.120000000000005 110.276 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.98 133.98 54.82 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.533 -0.543 . . . . 64.239999999999995 109.533 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.5 pt? -96.86 144.53 26.72 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.049 0.218 . . . . 60.399999999999999 110.502 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB3' HD11 ' A' ' 94' ' ' ILE . 69.3 mt -104.5 113.39 26.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -128.52 -3.1 5.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.973 0.416 . . . . 75.549999999999997 111.509 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -107.87 143.14 26.73 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 109.383 -0.599 . . . . 63.229999999999997 109.383 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.94 -25.2 27.01 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.455 2.77 . . . . 73.519999999999996 114.369 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.7 m -143.23 121.96 12.62 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.353 0.597 . . . . 74.200000000000003 110.258 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 24.9 m -117.96 129.26 55.5 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.446 -0.797 . . . . 43.25 109.768 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 m -100.89 135.67 41.97 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.459 -0.571 . . . . 65.25 109.459 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.07 135.43 54.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.054 -0.721 . . . . 65.019999999999996 109.054 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.73 -165.41 34.49 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.974 -1.25 . . . . 75.140000000000001 109.974 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 79.2 ttt180 -91.6 149.16 21.79 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.465 -0.568 . . . . 74.349999999999994 109.465 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.5 m170 79.03 161.26 0.14 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.552 1.141 . . . . 63.350000000000001 110.519 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -72.28 13.1 0.56 Allowed 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.834 2.356 . . . . 74.310000000000002 113.156 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -83.62 -5.54 59.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.767 0.794 . . . . 75.540000000000006 109.6 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.5 m -117.57 148.74 41.62 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.75 -1.204 . . . . 70.25 107.75 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.16 -44.86 83.86 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.915 0.886 . . . . 40.340000000000003 109.361 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.9 mm -100.17 124.5 53.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.004 -1.11 . . . . 71.420000000000002 108.004 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -88.84 124.35 34.09 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.519 0.512 . . . . 75.420000000000002 111.229 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 6.2 mp -126.3 141.3 51.96 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.751 -1.203 . . . . 74.049999999999997 107.751 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.27 117.43 34.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.34 -1.726 . . . . 64.450000000000003 106.34 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 84' ' ' THR . 9.4 t70 -105.46 173.25 6.39 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.69 -0.687 . . . . 73.549999999999997 109.538 -168.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -82.95 -24.86 8.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.449 -1.315 . . . . 52.439999999999998 107.449 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.2 m -124.56 -173.66 2.84 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.0 -1.852 . . . . 74.209999999999994 106.0 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 84' ' ' THR . 89.3 t -102.67 99.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 120.667 -1.271 . . . . 72.129999999999995 110.157 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.565 ' HA ' ' O2P' ' A' ' 15' ' ' TPO . 1.9 p -83.87 107.47 16.28 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.434 -0.803 . . . . 73.349999999999994 109.837 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.404 ' HD2' ' O2P' ' A' ' 15' ' ' TPO . 0.1 OUTLIER -64.43 -32.36 73.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.643 0.735 . . . . 74.510000000000005 111.006 -176.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -168.9 119.93 0.74 Allowed 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.668 -2.345 . . . . 74.549999999999997 104.668 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -99.58 -52.04 3.59 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 123.375 0.422 . . . . 74.230000000000004 109.893 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.73 157.81 44.13 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.326 -0.549 . . . . 72.519999999999996 110.155 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.19 132.03 51.86 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.882 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 4.2 m-85 -105.62 113.75 27.5 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.72 -1.585 . . . . 73.25 106.72 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.404 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 84.8 mtt180 -104.15 133.48 49.0 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 63' ' ' LEU . 50.4 mt -104.29 113.53 41.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.063 -1.828 . . . . 62.130000000000003 106.063 176.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -134.47 118.58 17.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.447 -0.575 . . . . 70.310000000000002 109.447 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 54.22 38.04 28.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.161 0.985 . . . . 70.299999999999997 112.039 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.0 -6.92 79.84 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 116.092 -0.504 . . . . 61.530000000000001 113.702 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.74 149.91 23.99 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.359 -0.608 . . . . 52.240000000000002 109.359 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.97 116.9 28.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 72.129999999999995 108.794 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 93' ' ' ARG . 10.4 pt-20 -112.04 127.28 55.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.202 -0.666 . . . . 61.399999999999999 109.202 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.458 HG21 ' SD ' ' A' ' 122' ' ' MET . 43.6 t -105.5 124.32 60.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.235 -0.654 . . . . 74.219999999999999 109.235 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.4 t -115.01 122.97 70.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 115.779 -0.646 . . . . 73.310000000000002 109.639 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -88.05 131.4 34.67 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.216 -0.902 . . . . 72.030000000000001 111.351 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.37 12.74 2.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.905 -1.043 . . . . 53.240000000000002 108.377 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.14 34.51 5.03 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.994 -1.242 . . . . 74.510000000000005 109.994 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 m -61.9 -11.7 14.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.618 1.167 . . . . 75.219999999999999 111.315 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 107' ' ' LEU . 1.7 mm? -71.15 -26.16 62.87 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.055 0.942 . . . . 61.420000000000002 108.94 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.61 -18.68 24.74 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.106 -0.952 . . . . 75.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.94 62.71 1.65 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.702 -0.681 . . . . 72.25 112.644 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 m -64.5 135.5 56.11 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 124.081 0.952 . . . . 55.5 112.444 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.14 126.77 44.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.966 -1.124 . . . . 72.420000000000002 107.966 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -107.85 117.32 53.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.764 -1.569 . . . . 72.120000000000005 106.764 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 51.32 49.96 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.128 0.971 . . . . 74.340000000000003 110.276 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 70.68 7.81 6.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.273 1.429 . . . . 72.030000000000001 113.709 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.54 137.82 31.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.451 -0.9 . . . . 50.329999999999998 111.228 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.13 123.92 14.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.103 1.869 . . . . 63.140000000000001 108.793 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -151.44 138.49 19.14 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.124 -1.065 . . . . 64.540000000000006 108.124 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.1 -53.24 3.88 Favored 'General case' 0 C--O 1.199 -1.582 0 C-N-CA 120.73 -0.388 . . . . 64.109999999999999 110.637 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.93 136.53 54.93 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.13 -0.693 . . . . 64.299999999999997 109.13 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 140.43 20.67 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.383 -0.969 . . . . 75.239999999999995 108.383 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 51.4 t -96.42 114.57 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 105.101 -2.185 . . . . 42.140000000000001 105.101 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.458 ' SD ' HG21 ' A' ' 101' ' ' VAL . 79.1 mtp -90.22 145.32 25.1 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 114.414 1.264 . . . . 74.329999999999998 114.414 -166.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.446 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 76.1 mt-30 -111.59 158.15 19.56 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 63.43 108.677 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 138' ' ' LEU . 24.4 m -58.14 120.9 9.45 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.819 -0.437 . . . . 74.400000000000006 109.819 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.73 1.54 56.34 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.217 -0.992 . . . . 62.119999999999997 112.718 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.98 141.56 28.48 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.23 -1.026 . . . . 74.129999999999995 108.23 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.24 145.67 49.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.918 0.711 . . . . 74.239999999999995 112.918 -169.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.442 HD11 ' SD ' ' A' ' 122' ' ' MET . 34.5 mt -116.08 132.87 64.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.002 -0.74 . . . . 74.340000000000003 109.002 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -103.63 110.5 22.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.789 -1.93 . . . . 73.010000000000005 105.789 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.0 mt -109.67 105.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.475 -0.935 . . . . 74.040000000000006 108.475 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.51 -107.94 2.3 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.016 -1.634 . . . . 73.319999999999993 109.016 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -119.93 9.04 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 120.808 0.337 . . . . 63.310000000000002 110.12 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.4 p90 -120.28 146.26 46.26 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.802 0.668 . . . . 64.340000000000003 112.802 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 53' ' ' ARG . 47.9 ttt180 -112.58 132.28 55.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.427 -0.806 . . . . 74.140000000000001 111.467 -167.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.4 139.97 52.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.258 -0.645 . . . . 63.340000000000003 109.258 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.0 130.23 66.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.673 -0.862 . . . . 72.140000000000001 108.673 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -104.27 128.48 52.04 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.124 -0.695 . . . . 75.510000000000005 109.124 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB2' HG23 ' A' ' 124' ' ' THR 0.278 0.0 OUTLIER -140.09 135.63 32.76 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 113.109 0.781 . . . . 75.430000000000007 113.109 177.728 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.2 124.97 44.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.281 -1.748 . . . . 63.100000000000001 106.281 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.519 ' N ' ' HD2' ' A' ' 141' ' ' PRO . . . 165.43 -33.7 0.24 Allowed Glycine 0 C--N 1.29 -1.976 0 C-N-CA 118.723 -1.703 . . . . 13.51 116.468 -171.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 140' ' ' GLY . 10.2 Cg_endo -53.87 142.16 64.38 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.896 2.848 . . . . 62.32 114.653 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.49 88.92 1.23 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.831 -2.285 . . . . 73.430000000000007 104.831 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 114.803 -1.089 . . . . 73.030000000000001 108.282 -172.657 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' H3 ' HD11 ' A' ' 62' ' ' LEU . 65.2 mtt . . . . . 0 CA--C 1.503 -0.862 0 N-CA-C 108.828 -0.804 . . . . 60.030000000000001 108.828 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 6.2 p -154.98 132.4 11.17 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.581 -0.896 . . . . 72.120000000000005 108.581 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.2 -70.73 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.441 -0.578 . . . . 72.519999999999996 109.441 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -147.47 130.4 16.23 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 107.568 -1.271 . . . . 42.049999999999997 107.568 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.432 ' HA ' ' OD1' ' A' ' 77' ' ' ASP . 3.5 t-20 -65.31 115.23 5.38 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.115 0.884 . . . . 73.439999999999998 109.257 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.13 98.97 2.28 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 115.663 -0.698 . . . . 61.450000000000003 114.296 -174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -114.61 107.98 50.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 107.479 -1.304 . . . . 73.340000000000003 107.479 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.75 144.09 99.51 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.825 2.35 . . . . 74.450000000000003 113.272 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.51 149.46 71.79 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 115.114 -0.948 . . . . 72.310000000000002 109.39 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -50.84 112.05 0.68 Allowed 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.61 2.873 . . . . 62.43 113.133 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -147.78 144.58 28.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.027 -1.101 . . . . 44.43 108.027 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 41.8 t -111.82 127.38 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 120.976 0.417 . . . . 71.319999999999993 111.378 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.0 164.42 28.03 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.52 -0.919 . . . . 73.209999999999994 108.52 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -99.54 126.96 45.6 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.644 -0.873 . . . . 71.219999999999999 108.644 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -93.49 149.17 21.44 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.098 -0.501 . . . . 61.119999999999997 109.888 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.9 115.79 27.85 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 CA-C-O 120.822 0.344 . . . . 73.310000000000002 110.36 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -107.69 120.16 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.729 -0.841 . . . . 75.109999999999999 108.729 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.57 141.26 46.61 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.688 -0.687 . . . . 64.430000000000007 112.624 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 82.84 -20.93 0.31 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.32 1.848 . . . . 72.530000000000001 113.505 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -80.1 -38.44 31.63 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.422 -0.955 . . . . 52.009999999999998 108.422 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 23' ' ' LEU . 2.2 pp -64.73 -26.62 68.45 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.014 -0.993 . . . . 75.310000000000002 110.792 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 22' ' ' LEU . 50.9 tp -74.85 -39.96 61.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.4 -0.818 . . . . 63.240000000000002 109.232 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.8 -41.41 78.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 73.140000000000001 110.448 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -68.78 -39.55 80.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.706 -0.679 . . . . 62.020000000000003 110.409 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -59.43 -39.23 82.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 73.129999999999995 110.796 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -63.51 -38.51 91.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.066 0.46 . . . . 74.239999999999995 110.73 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -72.06 -38.77 69.38 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.961 -0.563 . . . . 61.049999999999997 110.302 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -66.46 -47.01 74.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.956 -0.565 . . . . 64.340000000000003 110.242 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -83.08 98.11 9.14 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 120.874 0.369 . . . . 52.130000000000003 111.288 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.54 -60.51 0.74 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 108.38 -1.888 . . . . 75.540000000000006 108.38 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.514 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 38.2 m -114.37 124.77 52.78 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 107.866 -1.161 . . . . 73.439999999999998 107.866 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.82 94.52 6.44 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.619 -0.512 . . . . 51.420000000000002 109.619 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 32' ' ' THR . 2.7 Cg_exo -76.25 142.91 24.71 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.575 2.183 . . . . 63.399999999999999 111.962 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.1 154.74 19.93 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.156 -1.053 . . . . 54.399999999999999 108.156 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 m -114.43 144.85 42.65 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.144 0.497 . . . . 74.400000000000006 112.075 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -132.58 144.39 50.36 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.743 -1.576 . . . . 72.310000000000002 106.743 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.13 11.91 32.9 Favored Glycine 0 CA--C 1.49 -1.515 0 N-CA-C 109.891 -1.283 . . . . 73.319999999999993 109.891 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.04 -32.0 16.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.882 -0.785 . . . . 73.530000000000001 108.882 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -85.09 3.6 38.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.52 -1.218 . . . . 73.219999999999999 110.95 -177.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -80.12 -36.34 35.42 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.398 -0.819 . . . . 71.010000000000005 110.566 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 51.15 45.85 3.17 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 123.725 0.641 . . . . 71.109999999999999 112.492 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.99 -52.85 1.04 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.9 1.733 . . . . 65.209999999999994 113.929 -170.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -18.34 40.27 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.946 -0.57 . . . . 54.329999999999998 112.53 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.94 -0.49 82.7 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 120.422 -0.894 . . . . 73.319999999999993 111.814 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.0 t -118.62 170.02 9.32 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.347 -1.353 . . . . 63.020000000000003 107.347 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . . . -139.65 152.92 47.14 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 120.598 0.237 . . . . 72.239999999999995 110.463 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -130.05 155.58 45.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.925 -0.58 . . . . 75.299999999999997 109.959 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 49' ' ' LEU . 1.5 pt? -119.39 125.15 48.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.911 -1.144 . . . . 65.340000000000003 107.911 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.2 135.18 53.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 115.433 -0.803 . . . . 75.200000000000003 109.791 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.11 117.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 105.171 -2.159 . . . . 50.229999999999997 105.171 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.63 -39.43 22.15 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.323 -1.362 . . . . 73.420000000000002 107.323 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 47.7 ttt180 -160.95 144.21 13.05 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.317 -1.364 . . . . 73.150000000000006 107.317 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.61 -167.69 26.54 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 108.355 -1.898 . . . . 31.140000000000001 108.355 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.1 -47.57 12.16 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.378 2.052 . . . . 73.5 112.184 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.11 22.05 3.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.662 -0.244 . . . . 72.549999999999997 111.198 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.6 134.09 46.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.723 0.638 . . . . 72.409999999999997 112.723 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.18 21.72 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 115.217 -0.901 . . . . 73.340000000000003 111.829 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.28 145.76 33.35 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.843 0.354 . . . . 73.230000000000004 110.126 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.85 136.3 22.85 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 110.991 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -121.59 145.24 48.18 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.347 -1.353 . . . . 73.409999999999997 107.347 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 1.4 pt? -110.38 145.53 37.4 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.575 0.226 . . . . 74.040000000000006 110.63 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.75 103.41 5.01 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.101 -1.444 . . . . 71.25 107.101 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 16.0 t70 -123.2 7.55 9.14 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.952 -1.499 . . . . 60.240000000000002 106.952 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -137.03 146.1 53.3 Favored Pre-proline 0 N--CA 1.419 -2.003 0 CA-C-N 113.495 -1.684 . . . . 74.439999999999998 107.669 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 14.0 Cg_exo -72.06 -14.36 29.01 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.832 2.355 . . . . 74.319999999999993 114.496 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -140.14 122.37 15.88 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.293 -0.88 . . . . 73.120000000000005 109.479 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 4.2 m -131.02 139.08 49.91 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.523 0.729 . . . . 55.240000000000002 111.224 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.4 m -121.64 140.15 52.64 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.128 -1.064 . . . . 73.319999999999993 108.128 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.75 135.1 54.69 Favored 'General case' 0 C--O 1.264 1.823 0 CA-C-O 120.996 0.427 . . . . 71.239999999999995 109.94 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.74 -156.17 22.33 Favored Glycine 0 N--CA 1.417 -2.617 0 CA-C-N 115.316 -0.856 . . . . 62.130000000000003 111.119 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.505 ' NH1' ' HA ' ' A' ' 86' ' ' SER . 40.8 ttp180 -88.86 150.61 22.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.308 -0.627 . . . . 75.209999999999994 109.308 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 37.9 m170 81.53 150.07 0.11 Allowed Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 125.435 1.494 . . . . 64.120000000000005 111.093 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.29 0.86 6.11 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.051 2.501 . . . . 70.219999999999999 111.225 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.63 -26.53 60.82 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 124.722 1.209 . . . . 74.530000000000001 107.754 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -85.84 136.43 33.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.604 -1.258 . . . . 73.439999999999998 107.604 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' A' ' 5' ' ' ASN . 17.0 t70 -54.64 -46.49 73.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.369 1.068 . . . . 74.150000000000006 109.765 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.0 mm -102.73 109.4 26.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 107.588 -1.264 . . . . 72.019999999999996 107.588 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -87.61 115.77 25.28 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.763 -0.653 . . . . 64.219999999999999 111.196 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.6 mt -127.23 127.83 45.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.037 -1.468 . . . . 65.319999999999993 107.037 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.07 117.9 34.98 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.113 -0.635 . . . . 71.019999999999996 110.216 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 85' ' ' VAL . 12.2 t70 -150.34 161.52 42.32 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 104.546 -2.39 . . . . 74.219999999999999 104.546 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.9 t -70.3 -39.3 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 118.168 0.44 . . . . 52.530000000000001 111.371 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -101.32 7.35 42.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.72 0.771 . . . . 75.109999999999999 112.308 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 82' ' ' ASP . 69.2 t -85.93 121.15 36.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.279 -1.008 . . . . 72.329999999999998 108.279 173.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.505 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 35.0 m -93.11 -164.54 1.19 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.307 0.855 . . . . 63.039999999999999 113.307 -173.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.471 ' NH1' ' HA ' ' A' ' 12' ' ' VAL . 21.3 ptt180 -55.07 -21.37 12.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.57 2.348 . . . . 71.439999999999998 113.499 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -170.24 116.44 0.52 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.73 -0.841 . . . . 70.530000000000001 108.73 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.491 ' ND1' HG23 ' A' ' 130' ' ' ILE . 9.4 t-160 -100.39 -51.96 3.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.984 -0.747 . . . . 74.150000000000006 108.984 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.87 160.14 43.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.454 -0.943 . . . . 44.119999999999997 108.454 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.33 149.64 50.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.536 -0.466 . . . . 72.209999999999994 110.787 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.471 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 21.9 m-85 -112.65 113.77 26.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.97 -1.122 . . . . 70.430000000000007 107.97 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -108.78 131.89 54.51 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.264 -1.013 . . . . 75.230000000000004 108.264 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -106.4 120.05 56.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 107.685 -1.228 . . . . 73.409999999999997 107.685 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.1 129.95 28.36 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.333 -0.617 . . . . 71.0 109.333 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.26 35.75 25.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.728 1.211 . . . . 65.200000000000003 110.71 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.17 82.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.473 -0.785 . . . . 71.209999999999994 113.839 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -100.61 141.56 33.3 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.945 -0.761 . . . . 75.239999999999995 108.945 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -106.82 117.86 35.16 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.091 -1.078 . . . . 72.099999999999994 108.091 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -123.02 141.87 51.49 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.065 -0.654 . . . . 72.549999999999997 111.674 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.05 124.82 58.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.443 -0.947 . . . . 73.019999999999996 108.443 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.84 123.38 71.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.382 -0.97 . . . . 74.230000000000004 108.382 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.98 127.64 32.8 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 71.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.69 -15.96 9.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.613 0.721 . . . . 75.340000000000003 109.77 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.73 57.79 0.63 Allowed Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.479 -1.448 . . . . 64.140000000000001 109.479 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -69.33 5.14 1.39 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.528 0.68 . . . . 54.240000000000002 111.56 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.89 -20.9 52.13 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.317 0.647 . . . . 70.219999999999999 109.355 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -87.83 -19.79 26.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 62.100000000000001 110.35 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.04 71.72 0.99 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.934 -0.575 . . . . 71.140000000000001 112.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 10.0 m -69.67 130.32 42.05 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.159 -1.052 . . . . 51.119999999999997 108.159 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -108.83 125.9 52.46 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.429 -0.908 . . . . 62.229999999999997 110.613 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.8 t -111.03 117.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 105.792 -1.929 . . . . 72.219999999999999 105.792 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.88 40.63 30.54 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.042 0.925 . . . . 74.099999999999994 108.849 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 71.86 7.36 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.215 1.932 . . . . 74.099999999999994 116.215 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -115.85 135.96 22.81 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 118.72 0.691 . . . . 74.230000000000004 110.519 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 110' ' ' THR . 32.1 Cg_endo -63.48 148.05 92.81 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.86 2.374 . . . . 75.540000000000006 112.62 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 51.6 mmt-85 -121.55 160.99 23.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 114.335 1.235 . . . . 75.540000000000006 114.335 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -115.8 -51.76 2.65 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 112.943 -1.935 . . . . 60.240000000000002 106.125 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -163.19 135.66 5.35 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 106.338 -1.727 . . . . 65.400000000000006 106.338 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.65 145.46 23.47 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.44 -0.504 . . . . 74.319999999999993 110.998 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.37 124.79 41.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.309 -2.108 . . . . 72.109999999999999 105.309 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.0 tpp -89.5 134.48 34.09 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.311 -0.955 . . . . 75.420000000000002 113.481 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -103.69 141.67 35.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.485 -1.234 . . . . 44.009999999999998 110.645 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -61.37 130.22 45.02 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.874 -1.057 . . . . 70.530000000000001 111.451 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.5 -4.43 58.23 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.911 -0.586 . . . . 73.340000000000003 113.182 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -88.98 154.73 19.99 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-N 116.866 0.333 . . . . 62.229999999999997 110.864 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.81 133.82 53.03 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.942 0.877 . . . . 54.240000000000002 110.801 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.1 mm -113.68 123.65 69.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.763 -1.199 . . . . 71.099999999999994 107.763 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -104.71 113.37 26.92 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.189 -0.604 . . . . 74.519999999999996 109.562 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.491 HG23 ' ND1' ' A' ' 89' ' ' HIS . 36.9 mt -109.66 124.39 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 114.806 -1.088 . . . . 74.430000000000007 108.128 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.82 -86.36 1.35 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.866 -1.294 . . . . 62.219999999999999 109.866 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.93 25.94 0.08 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.364 0.602 . . . . 73.340000000000003 110.215 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.4 p90 -141.04 164.08 31.24 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.384 -0.825 . . . . 74.420000000000002 108.897 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -112.55 144.82 41.38 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 114.598 1.333 . . . . 74.129999999999995 114.598 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.06 140.64 49.72 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.22 -1.809 . . . . 72.349999999999994 106.137 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.2 t -111.3 124.76 68.37 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 109.067 -0.716 . . . . 72.209999999999994 109.067 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -91.46 116.03 28.52 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.614 -1.254 . . . . 70.099999999999994 107.614 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.8 tm? -128.61 132.46 48.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.931 -1.137 . . . . 63.310000000000002 107.931 -174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . . . -90.16 118.75 29.93 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.668 -0.813 . . . . 54.32 110.394 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 125.67 73.35 0.21 Allowed Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.763 -0.653 . . . . 34.219999999999999 112.328 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.61 162.85 40.89 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.979 2.453 . . . . 71.0 111.343 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.05 48.31 1.23 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.53 0.681 . . . . 73.439999999999998 110.712 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.414 -2.239 0 CA-C-N 115.659 -0.701 . . . . 61.140000000000001 110.517 178.362 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.498 -1.02 0 N-CA-C 108.016 -1.105 . . . . 71.230000000000004 108.016 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p 50.88 27.33 3.08 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.753 0.821 . . . . 63.340000000000003 112.895 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -107.71 121.12 44.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.786 -1.19 . . . . 75.239999999999995 107.786 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -98.88 132.12 44.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.357 -0.838 . . . . 72.439999999999998 109.783 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -71.05 129.96 40.32 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.26 -0.645 . . . . 64.319999999999993 109.26 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.08 40.75 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 116.021 -0.536 . . . . 53.539999999999999 112.074 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.0 m -79.83 118.08 70.63 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 109.561 -0.533 . . . . 73.349999999999994 109.561 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.31 132.11 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.146 1.897 . . . . 65.430000000000007 111.029 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.08 118.07 59.98 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 109.608 -0.515 . . . . 53.229999999999997 109.608 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.04 157.11 30.51 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.664 2.243 . . . . 74.010000000000005 112.178 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -122.21 132.2 54.32 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.051 -0.722 . . . . 61.229999999999997 109.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.19 121.64 23.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.713 -0.847 . . . . 73.209999999999994 108.713 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' OE1' ' HD3' ' A' ' 87' ' ' ARG . 43.2 mt-10 -130.21 167.98 17.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.662 -1.977 . . . . 73.420000000000002 105.662 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.0 m -70.4 108.63 4.34 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.737 0.78 . . . . 72.230000000000004 111.854 -173.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.3 t -89.41 146.49 24.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.871 -0.789 . . . . 52.210000000000001 108.871 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.53 115.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 108.193 -1.04 . . . . 72.140000000000001 108.193 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -115.45 133.32 56.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.669 . . . . 74.420000000000002 109.192 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -86.78 94.41 9.53 Favored 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 119.02 -1.072 . . . . 62.409999999999997 110.392 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.28 -152.07 0.05 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.441 -1.254 . . . . 43.219999999999999 108.934 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.4 7.11 47.29 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.938 -0.476 . . . . 71.450000000000003 111.191 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.77 -50.46 72.23 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.095 1.517 . . . . 62.229999999999997 115.095 -171.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 26' ' ' MET . 7.3 tt -72.63 -39.15 67.44 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.473 0.654 . . . . 75.519999999999996 109.365 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -69.72 -32.77 71.51 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.717 -0.674 . . . . 53.329999999999998 110.314 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.51 -42.18 95.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.14 0.576 . . . . 62.329999999999998 110.151 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.01 -30.72 71.32 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 120.083 -0.647 . . . . 74.450000000000003 111.163 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.0 -49.4 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.337 0.589 . . . . 74.120000000000005 109.785 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -69.84 -27.03 64.51 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.315 -0.857 . . . . 53.130000000000003 112.608 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.442 ' OG ' ' HD2' ' A' ' 114' ' ' ARG . 31.7 p -79.96 -16.75 54.59 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.145 0.497 . . . . 65.140000000000001 111.053 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -74.19 106.14 5.71 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 122.151 0.977 . . . . 74.540000000000006 111.095 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.78 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.479 -2.182 0 N-CA-C 104.927 -3.269 . . . . 72.439999999999998 104.927 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 m -115.5 121.39 42.55 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.729 -1.952 . . . . 64.219999999999999 105.729 168.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.37 115.46 65.47 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 106.588 -1.634 . . . . 63.310000000000002 106.588 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.84 140.03 93.4 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 121.982 1.788 . . . . 71.209999999999994 112.313 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.85 126.54 29.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.395 -0.82 . . . . 45.240000000000002 110.805 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 124' ' ' THR . 67.9 m -147.44 109.47 4.48 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.836 -1.172 . . . . 51.340000000000003 107.836 172.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -86.82 96.59 10.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.411 -0.516 . . . . 62.119999999999997 112.217 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.11 7.33 0.25 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.783 -0.644 . . . . 63.210000000000001 112.409 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.417 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -88.31 -21.17 24.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.754 0.787 . . . . 55.210000000000001 110.375 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -92.15 -6.73 50.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.711 -1.131 . . . . 71.230000000000004 109.122 178.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -100.04 -42.29 6.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.39 -1.277 . . . . 73.219999999999999 109.624 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 56.12 78.71 0.37 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.602 -0.726 . . . . 63.100000000000001 110.128 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.47 -55.5 0.91 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.131 1.888 . . . . 74.319999999999993 113.153 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.47 -7.38 26.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.932 -0.576 . . . . 73.239999999999995 111.854 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.06 -12.62 11.36 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.213 -0.449 . . . . 50.329999999999998 112.866 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m -124.68 153.42 42.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.762 -1.569 . . . . 54.43 106.762 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.32 157.28 41.13 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.905 0.128 . . . . 43.219999999999999 110.782 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 3.1 pp -127.6 157.01 41.36 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.803 0.668 . . . . 71.219999999999999 112.803 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 49' ' ' LEU . 3.4 pp -121.35 138.25 54.34 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.923 -1.14 . . . . 54.149999999999999 107.923 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.79 135.72 62.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 C-N-CA 120.534 -0.466 . . . . 71.030000000000001 109.906 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.3 t -80.81 117.09 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.774 -1.936 . . . . 63.039999999999999 105.774 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -90.21 -34.67 15.72 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.779 -0.646 . . . . 70.120000000000005 109.551 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -148.61 137.56 21.6 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.179 -0.674 . . . . 74.329999999999998 109.179 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.68 -177.86 23.8 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 108.907 -1.677 . . . . 44.310000000000002 108.907 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 72.1 Cg_exo -55.65 -51.18 10.41 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.935 2.423 . . . . 14.35 112.823 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -91.48 22.75 3.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.302 0.482 . . . . 55.509999999999998 112.302 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.85 143.07 48.71 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.087 0.47 . . . . 62.310000000000002 111.799 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.27 -23.27 32.33 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.301 -0.72 . . . . 55.329999999999998 111.301 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.28 134.19 34.94 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 120.93 0.395 . . . . 54.009999999999998 110.459 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -107.38 138.68 43.14 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.919 -1.141 . . . . 75.319999999999993 107.919 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.5 127.52 44.14 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.422 -0.584 . . . . 75.530000000000001 109.422 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 48' ' ' LEU . 9.2 mp -93.62 137.78 32.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.39 -0.596 . . . . 74.420000000000002 109.39 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.95 103.34 13.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.013 -1.477 . . . . 62.310000000000002 107.013 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.99 -15.22 6.92 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.498 -0.774 . . . . 72.129999999999995 111.236 -175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.2 pt20 -107.32 142.47 25.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 109.648 -0.501 . . . . 74.450000000000003 109.648 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.6 -19.9 19.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.965 3.11 . . . . 72.530000000000001 113.865 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.3 m -147.18 121.66 9.72 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.814 -1.18 . . . . 71.219999999999999 107.814 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 77' ' ' ASP . 9.3 m -120.81 113.83 20.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.378 -1.341 . . . . 70.120000000000005 107.378 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.0 m -92.36 144.04 25.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.822 -0.549 . . . . 65.530000000000001 110.704 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.29 139.02 52.6 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 123.166 0.586 . . . . 62.530000000000001 109.497 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.63 -135.84 5.63 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.893 -1.283 . . . . 74.299999999999997 109.893 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 22.9 ptt85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.077 -1.083 . . . . 75.310000000000002 108.077 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.3 OUTLIER 144.77 156.54 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 127.635 2.374 . . . . 75.239999999999995 108.81 174.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.69 -15.25 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.763 1.642 . . . . 64.430000000000007 110.416 174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -78.81 -24.07 44.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.143 -0.935 . . . . 73.150000000000006 110.444 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 p -84.71 121.32 27.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.615 -0.883 . . . . 63.509999999999998 108.615 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 68' ' ' THR . 36.3 t70 -69.88 -35.8 74.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 110.677 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.4 98.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.25 -1.389 . . . . 71.120000000000005 107.25 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -92.93 115.11 27.82 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.904 -0.589 . . . . 74.109999999999999 109.632 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.6 mt -111.62 134.38 53.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.519 -1.289 . . . . 52.020000000000003 107.519 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -117.92 128.35 54.73 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.535 0.683 . . . . 73.200000000000003 110.413 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -148.43 -178.8 6.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.447 -2.057 . . . . 65.129999999999995 105.447 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.53 -24.84 8.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.982 -1.118 . . . . 55.149999999999999 107.982 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.2 m -137.36 90.3 2.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.968 0.89 . . . . 74.019999999999996 110.236 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 t -101.85 150.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.143 -1.058 . . . . 64.129999999999995 108.143 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 89' ' ' HIS . 54.2 m -92.45 146.45 23.67 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.419 -0.956 . . . . 75.150000000000006 108.419 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -79.61 -17.56 53.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.725 0.774 . . . . 71.120000000000005 111.829 -177.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -140.8 93.87 2.65 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.578 -2.379 . . . . 72.319999999999993 104.578 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 26.3 t-80 -91.96 -53.32 4.32 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.229 0.538 . . . . 71.340000000000003 111.269 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.16 155.92 37.62 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.797 -0.816 . . . . 74.430000000000007 108.797 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.24 135.1 44.76 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.894 -0.594 . . . . 70.010000000000005 109.56 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -104.92 117.22 33.47 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.534 -1.654 . . . . 74.019999999999996 106.534 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -103.67 130.78 51.2 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.588 -0.523 . . . . 64.140000000000001 109.588 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.9 mp -114.31 113.09 42.78 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.628 -1.619 . . . . 70.540000000000006 106.628 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -138.38 122.78 18.33 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.79 -0.448 . . . . 74.340000000000003 109.79 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 56.3 37.86 29.23 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.796 1.238 . . . . 64.329999999999998 112.891 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.45 13.68 82.34 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.223 -0.899 . . . . 45.229999999999997 113.32 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -116.04 142.38 46.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.579 -0.897 . . . . 64.120000000000005 108.579 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -115.51 117.97 31.85 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.078 -0.712 . . . . 70.400000000000006 109.078 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.03 145.22 48.35 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.112 0.482 . . . . 73.439999999999998 111.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 37.0 t -103.51 124.71 57.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.06 -1.459 . . . . 73.329999999999998 107.06 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.95 122.86 70.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.157 -1.423 . . . . 60.310000000000002 107.157 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -104.51 134.54 47.52 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 111.787 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.1 m -128.8 0.5 3.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.6 -0.727 . . . . 62.229999999999997 110.297 173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.32 58.9 0.4 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.124 -1.19 . . . . 44.420000000000002 110.124 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -70.33 -8.48 50.83 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.581 0.752 . . . . 72.319999999999993 112.017 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -24.05 58.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.969 0.414 . . . . 71.140000000000001 109.958 174.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -87.34 -17.93 31.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.771 -1.196 . . . . 75.549999999999997 107.771 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.62 56.06 6.27 Favored Glycine 0 CA--C 1.496 -1.128 0 CA-C-N 114.718 -1.128 . . . . 45.450000000000003 113.329 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -63.41 128.71 37.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.853 -0.425 . . . . 74.319999999999993 109.853 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 20.5 m-30 -124.28 139.89 53.48 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 110.03 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.26 121.71 66.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.32 -1.733 . . . . 61.149999999999999 106.32 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.19 39.15 31.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.037 1.335 . . . . 41.210000000000001 108.24 -169.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.442 ' HD2' ' OG ' ' A' ' 29' ' ' SER . 19.0 mtm105 62.62 20.3 11.92 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.055 -1.429 . . . . 70.019999999999996 111.519 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -111.81 136.13 21.17 Favored Pre-proline 0 C--N 1.315 -0.931 0 C-N-CA 122.875 0.47 . . . . 73.230000000000004 110.043 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.17 123.72 13.74 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 C-N-CA 122.663 2.242 . . . . 72.239999999999995 108.664 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.537 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 8.9 tpp180 -143.23 142.44 31.4 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 119.167 -1.013 . . . . 73.519999999999996 112.549 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -79.05 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.614 0.766 . . . . 75.25 109.916 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -151.39 136.48 17.45 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.624 -1.25 . . . . 71.230000000000004 107.624 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.537 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 52.4 tp60 -153.22 141.68 20.74 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.023 0.202 . . . . 61.340000000000003 111.208 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 58.4 t -66.23 133.03 31.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 106.522 -1.658 . . . . 64.239999999999995 106.522 170.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -87.42 144.65 26.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.205 -1.035 . . . . 71.219999999999999 108.205 -174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.456 ' HG2' ' HB3' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -126.77 152.47 46.85 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 113.212 0.819 . . . . 70.319999999999993 113.212 -170.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 36' ' ' SER . 0.7 OUTLIER -59.46 118.15 5.69 Favored 'General case' 0 N--CA 1.403 -2.815 0 C-N-CA 124.758 1.223 . . . . 51.310000000000002 112.563 -176.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.87 -7.03 64.8 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.802 -0.713 . . . . 73.120000000000005 112.62 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -83.09 153.09 25.04 Favored 'General case' 0 C--O 1.252 1.193 0 C-N-CA 120.132 -0.627 . . . . 63.310000000000002 110.678 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.51 131.48 55.2 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.073 -0.967 . . . . 61.409999999999997 110.285 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 57.2 mt -105.76 115.93 48.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 104.868 -2.271 . . . . 53.43 104.868 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -104.95 131.67 52.16 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.567 -1.272 . . . . 74.409999999999997 107.567 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.408 HD13 HD13 ' A' ' 135' ' ' LEU . 4.0 mp -129.61 103.61 9.15 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 107.858 -1.164 . . . . 74.140000000000001 107.858 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.57 -78.6 0.01 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.095 0.798 . . . . 41.420000000000002 115.095 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -134.05 8.96 3.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.788 1.235 . . . . 74.530000000000001 109.981 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.603 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 49.2 m-85 -102.1 143.19 32.25 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.463 -0.569 . . . . 75.420000000000002 109.463 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -119.55 118.65 31.6 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.158 -1.423 . . . . 65.340000000000003 107.158 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 130' ' ' ILE . 9.7 mp -119.16 135.31 54.73 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.992 -0.744 . . . . 63.32 108.992 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.15 130.85 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.01 -1.107 . . . . 70.340000000000003 108.01 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -95.68 124.87 39.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.828 0.347 . . . . 53.539999999999999 110.823 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -129.71 132.34 46.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.311 0.577 . . . . 73.510000000000005 110.531 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.66 118.24 33.09 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.063 -1.828 . . . . 31.41 106.063 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -168.96 -54.7 0.03 OUTLIER Glycine 0 C--N 1.296 -1.664 0 C-N-CA 118.252 -1.927 . . . . 44.329999999999998 115.428 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.76 141.55 97.06 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 119.977 1.888 . . . . 75.150000000000006 111.179 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.27 79.18 1.68 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.321 -0.992 . . . . 72.409999999999997 108.321 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 N--CA 1.389 -3.481 0 CA-C-N 114.627 -1.17 . . . . 72.0 108.862 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 CA--C 1.504 -0.813 0 N-CA-C 108.957 -0.757 . . . . 60.439999999999998 108.957 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -84.99 78.5 9.9 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.457 0.646 . . . . 75.200000000000003 109.416 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -80.72 -55.75 4.62 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.794 -1.187 . . . . 74.219999999999999 107.794 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 58.1 t30 64.7 94.77 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.446 1.498 . . . . 74.230000000000004 111.721 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -140.81 -53.23 0.48 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.469 0.652 . . . . 62.549999999999997 109.324 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.26 59.33 0.1 Allowed Glycine 0 N--CA 1.421 -2.307 0 N-CA-C 110.804 -0.918 . . . . 74.329999999999998 110.804 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 m -79.68 111.31 20.22 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.234 -1.395 . . . . 72.109999999999999 107.234 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.6 131.56 10.46 Favored 'Trans proline' 0 N--CA 1.428 -2.355 0 C-N-CA 121.22 1.28 . . . . 65.25 112.076 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -117.99 141.02 28.59 Favored Pre-proline 0 C--N 1.283 -2.305 0 N-CA-C 107.497 -1.298 . . . . 72.510000000000005 107.497 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.24 143.97 79.29 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.931 1.754 . . . . 71.409999999999997 110.993 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -91.95 144.68 25.22 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.873 -1.529 . . . . 73.219999999999999 106.873 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.09 133.27 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.697 -0.853 . . . . 73.439999999999998 108.697 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.34 146.96 33.98 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.803 -1.09 . . . . 64.230000000000004 108.526 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 m -105.57 124.8 50.16 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 105.802 -1.925 . . . . 42.340000000000003 105.802 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.5 m -88.91 133.23 34.37 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.581 -0.896 . . . . 64.049999999999997 108.581 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.83 115.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.592 -0.522 . . . . 70.140000000000001 109.592 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -122.33 137.95 54.68 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.343 -0.614 . . . . 73.140000000000001 109.343 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -117.09 97.37 5.9 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.368 -1.345 . . . . 75.040000000000006 107.368 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.57 -165.84 0.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.312 -0.858 . . . . 63.039999999999999 112.821 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.09 9.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.49 2.316 . . . . 73.329999999999998 114.3 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 2.9 pp -56.37 -20.45 19.37 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.06 1.133 . . . . 73.230000000000004 114.06 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.84 -43.87 82.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.722 -0.473 . . . . 71.329999999999998 109.722 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 27' ' ' GLU . 66.0 mttm -82.51 -21.16 35.58 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 116.4 -0.363 . . . . 64.219999999999999 111.621 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 5.6 tp10 -56.81 -48.73 77.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.377 -1.342 . . . . 74.420000000000002 107.377 170.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.4 ttp -68.76 -47.89 65.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.555 -1.202 . . . . 65.329999999999998 110.482 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 24' ' ' LYS . 31.2 tt0 -52.53 -49.79 64.14 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.455 1.102 . . . . 41.119999999999997 111.987 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.7 t -84.47 -27.82 27.21 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.719 0.637 . . . . 75.430000000000007 112.719 -174.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -82.93 -22.29 33.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.434 -0.906 . . . . 54.43 110.949 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.5 m -72.03 111.46 7.28 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.093 -0.706 . . . . 61.020000000000003 109.093 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.1 -32.89 1.26 Allowed Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 109.56 -1.416 . . . . 73.230000000000004 109.56 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -94.51 120.52 34.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 73.329999999999998 108.705 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.9 111.94 20.34 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.828 -0.804 . . . . 64.530000000000001 108.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.66 141.48 66.58 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 121.949 1.766 . . . . 51.119999999999997 113.118 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.25 162.67 31.17 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.032 -0.985 . . . . 72.25 108.607 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.2 m 61.76 20.02 11.04 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.095 0.958 . . . . 43.009999999999998 112.141 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.8 m -90.85 109.94 21.15 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.657 -1.238 . . . . 61.32 107.657 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.19 53.99 0.6 Allowed Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.051 -1.071 . . . . 52.450000000000003 113.364 -172.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.06 -6.94 53.09 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.209 1.004 . . . . 64.450000000000003 109.419 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.45 14.11 0.83 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.583 -1.19 . . . . 70.329999999999998 113.261 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -102.71 -5.9 23.26 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.838 -0.43 . . . . 73.109999999999999 109.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 68.38 94.82 0.05 OUTLIER Pre-proline 0 C--N 1.35 0.606 0 O-C-N 124.691 1.244 . . . . 71.129999999999995 111.245 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.21 -74.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.672 1.582 . . . . 64.329999999999998 112.519 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.71 6.69 46.8 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.844 -0.535 . . . . 53.240000000000002 111.593 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.01 17.76 75.83 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 116.048 -0.524 . . . . 62.210000000000001 113.293 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -131.99 169.74 15.89 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.753 -1.203 . . . . 61.43 107.753 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.49 154.45 48.81 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.16 -0.616 . . . . 65.530000000000001 111.034 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.42 161.3 36.7 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 114.954 -1.021 . . . . 63.210000000000001 109.288 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.476 HD11 HG21 ' A' ' 78' ' ' ILE . 4.2 pp -127.3 139.62 52.76 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.454 -0.573 . . . . 63.0 109.454 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.8 133.65 65.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.715 -0.846 . . . . 64.340000000000003 108.715 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.55 117.12 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 106.003 -1.851 . . . . 64.150000000000006 106.003 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -99.86 -31.0 11.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.904 -0.589 . . . . 64.200000000000003 110.745 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -137.43 132.0 32.78 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.96 -0.696 . . . . 71.040000000000006 109.323 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 139.43 175.11 13.94 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.594 -1.002 . . . . 64.549999999999997 110.594 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.539 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 19.2 Cg_endo -59.82 -39.62 70.77 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.68 2.253 . . . . 71.450000000000003 112.535 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -95.29 22.22 7.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.123 -0.49 . . . . 72.409999999999997 112.087 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 143.77 57.53 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.037 0.535 . . . . 63.340000000000003 110.889 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.31 -18.32 36.02 Favored Glycine 0 N--CA 1.433 -1.548 0 N-CA-C 110.242 -1.143 . . . . 43.049999999999997 110.242 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.66 131.95 35.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.507 -0.347 . . . . 75.450000000000003 110.281 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -125.74 136.77 53.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.99 -0.744 . . . . 73.299999999999997 108.99 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -131.14 141.14 50.07 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.074 -0.713 . . . . 70.120000000000005 109.074 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -101.95 143.92 31.22 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.446 -0.576 . . . . 71.400000000000006 109.446 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.0 mt -97.4 118.72 34.51 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.971 0.415 . . . . 62.0 111.637 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -125.3 2.77 7.79 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -110.32 148.94 39.42 Favored Pre-proline 0 C--N 1.301 -1.541 0 CA-C-N 115.007 -0.997 . . . . 61.32 110.361 -174.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 -15.86 27.6 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.981 2.454 . . . . 64.310000000000002 113.446 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 91.8 m -152.84 124.29 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 121.753 -0.592 . . . . 71.540000000000006 110.853 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 77' ' ' ASP . 25.9 m -121.41 113.98 20.64 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.733 -0.84 . . . . 74.349999999999994 108.733 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 88.0 m -88.51 137.77 32.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.983 -0.377 . . . . 50.310000000000002 109.983 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.04 134.89 54.55 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-O 121.415 0.626 . . . . 75.409999999999997 110.349 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.99 -135.87 6.29 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.252 -1.34 . . . . 52.520000000000003 110.019 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -117.74 124.54 48.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.977 -0.749 . . . . 63.100000000000001 108.977 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.1 151.39 0.11 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 107.801 -1.185 . . . . 74.310000000000002 107.801 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -65.73 -32.11 47.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.861 1.708 . . . . 55.340000000000003 111.496 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.07 -5.9 59.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.065 0.394 . . . . 74.329999999999998 112.065 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.7 m -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.119 -1.067 . . . . 62.119999999999997 108.119 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 68' ' ' THR . 10.9 t70 -54.4 -43.01 71.11 Favored 'General case' 0 C--O 1.249 1.059 0 O-C-N 124.33 1.019 . . . . 61.549999999999997 110.58 -175.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.476 HG21 HD11 ' A' ' 49' ' ' LEU . 29.2 pt -106.96 107.33 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-O 121.992 0.901 . . . . 74.030000000000001 110.388 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -95.12 128.77 42.21 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.956 -1.02 . . . . 71.239999999999995 110.009 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.3 mt -111.44 135.43 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 105.847 -1.909 . . . . 75.329999999999998 105.847 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.69 137.11 52.4 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.001 -0.679 . . . . 72.200000000000003 112.472 -174.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 83' ' ' VAL . 30.2 t70 -160.69 -162.19 0.92 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.158 -1.423 . . . . 74.25 107.158 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.515 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 48.2 t -68.54 -42.88 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 108.906 -0.775 . . . . 62.310000000000002 108.906 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.2 m -156.14 101.09 2.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.776 -0.647 . . . . 73.209999999999994 109.852 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 t -102.9 149.69 7.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 106.589 -1.634 . . . . 73.319999999999993 106.589 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.0 t -68.87 143.49 54.5 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 123.376 0.423 . . . . 52.210000000000001 111.725 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 12.1 ptt180 -55.86 -28.4 56.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.701 1.2 . . . . 71.430000000000007 110.389 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.95 104.72 2.86 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.805 -1.089 . . . . 74.409999999999997 109.212 169.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -86.86 -51.63 5.95 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.835 -1.543 . . . . 64.129999999999995 106.835 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.97 159.23 41.58 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.659 -1.237 . . . . 63.109999999999999 107.659 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 11.6 pt-20 -142.13 154.37 44.83 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.327 0.584 . . . . 71.409999999999997 112.186 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 67' ' ' THR . 4.8 m-85 -104.29 127.83 51.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.204 -1.406 . . . . 44.350000000000001 107.204 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -121.06 125.1 46.43 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.943 -0.762 . . . . 74.430000000000007 108.943 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.63 111.59 36.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 106.539 -1.652 . . . . 72.239999999999995 106.539 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -139.81 129.45 24.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 116.135 -0.484 . . . . 72.420000000000002 110.481 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.72 36.44 27.25 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.722 1.209 . . . . 63.109999999999999 111.888 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.82 -0.76 87.93 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.73 -0.668 . . . . 75.109999999999999 113.197 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -101.27 136.72 40.66 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.182 -0.673 . . . . 74.340000000000003 109.182 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.87 118.04 34.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.222 -1.029 . . . . 72.129999999999995 108.222 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -127.5 146.94 50.33 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.156 -0.617 . . . . 73.439999999999998 109.938 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.57 123.72 68.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.783 -1.192 . . . . 72.409999999999997 107.783 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.7 134.77 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.728 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -77.83 132.79 38.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.968 -1.864 . . . . 74.420000000000002 105.968 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -118.96 18.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 N-CA-C 112.341 0.496 . . . . 54.509999999999998 112.341 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.79 42.16 0.29 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 119.376 -1.392 . . . . 54.020000000000003 113.344 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 55.8 p -87.49 143.63 27.12 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 118.983 -1.087 . . . . 74.049999999999997 108.365 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.94 -19.77 17.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.299 0.571 . . . . 52.329999999999998 109.475 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -87.31 -19.66 27.92 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.274 -0.875 . . . . 50.030000000000001 111.207 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.7 120.19 4.41 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.313 -0.946 . . . . 74.129999999999995 114.163 174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.3 m -88.04 132.04 34.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.409 -0.589 . . . . 70.510000000000005 109.409 173.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -119.8 126.42 50.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.919 -0.488 . . . . 64.329999999999998 110.004 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.3 t -111.57 117.17 54.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 106.932 -1.507 . . . . 75.540000000000006 106.932 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 55.08 37.96 29.73 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 125.452 1.501 . . . . 44.340000000000003 110.003 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 67.53 16.08 9.88 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 113.776 -1.556 . . . . 72.230000000000004 112.475 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -103.76 138.48 19.54 Favored Pre-proline 0 C--O 1.243 0.726 0 N-CA-C 107.465 -1.309 . . . . 74.230000000000004 107.465 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.49 124.36 14.94 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.097 1.864 . . . . 75.310000000000002 109.034 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -148.17 141.89 25.62 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.915 -0.714 . . . . 74.219999999999999 110.439 -172.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.19 -58.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.129 -1.063 . . . . 75.420000000000002 108.129 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.11 139.19 42.77 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.966 -0.458 . . . . 73.340000000000003 109.784 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.92 143.79 22.91 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.073 -0.714 . . . . 74.299999999999997 109.073 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.72 131.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 107.119 -1.438 . . . . 55.299999999999997 107.119 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.4 mmt -88.97 148.49 23.76 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.889 0.852 . . . . 72.409999999999997 112.671 -170.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 126' ' ' ASP . 18.9 pt20 -119.55 157.07 29.12 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.885 -1.895 . . . . 73.549999999999997 105.885 172.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.2 t -62.88 133.55 54.86 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.425 -0.954 . . . . 64.519999999999996 108.425 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.93 0.49 56.22 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 120.589 -0.815 . . . . 64.120000000000005 112.743 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.438 ' OD2' ' HG2' ' A' ' 123' ' ' GLN . 34.0 m-20 -76.12 141.06 42.05 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.638 0.719 . . . . 74.209999999999994 111.636 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.8 127.79 55.91 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.019 -1.104 . . . . 64.230000000000004 108.019 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.9 mt -107.42 119.54 57.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.091 -1.448 . . . . 73.439999999999998 107.091 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 11.5 tm0? -106.37 117.39 33.91 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.95 -1.5 . . . . 71.540000000000006 106.95 -174.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.02 101.65 12.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.862 -1.162 . . . . 73.239999999999995 107.862 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.14 -73.52 0.13 Allowed Glycine 0 CA--C 1.536 1.405 0 CA-C-O 121.361 0.423 . . . . 63.43 113.615 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -145.44 16.53 1.49 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 124.452 1.101 . . . . 64.239999999999995 109.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.539 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 72.4 m-85 -109.38 148.59 30.84 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.145 -0.934 . . . . 74.409999999999997 109.494 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -128.53 119.78 25.48 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.168 -0.679 . . . . 54.030000000000001 109.168 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.0 mt -106.45 132.72 52.15 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.452 -1.685 . . . . 60.009999999999998 106.452 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.73 120.15 61.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.054 -1.091 . . . . 64.430000000000007 108.054 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -96.43 121.58 38.39 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.67 -0.863 . . . . 75.099999999999994 108.67 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.63 136.8 49.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.809 0.337 . . . . 61.240000000000002 110.296 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.16 119.38 29.61 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 105.382 -2.081 . . . . 53.450000000000003 105.382 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.26 -132.83 1.87 Allowed Glycine 0 N--CA 1.42 -2.431 0 C-N-CA 119.088 -1.53 . . . . 75.400000000000006 113.342 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.47 162.13 43.52 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.757 2.971 . . . . 64.099999999999994 114.235 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.39 69.79 1.41 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.792 -1.558 . . . . 65.430000000000007 106.792 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 . . . . . 0 N--CA 1.42 -1.974 0 CA-C-N 114.758 -1.11 . . . . 74.430000000000007 111.162 -175.231 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 CA--C 1.512 -0.483 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 110.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 t -144.73 90.94 2.11 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.232 -1.766 . . . . 64.540000000000006 106.232 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -147.03 136.26 22.58 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.374 -0.972 . . . . 52.009999999999998 108.374 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -88.2 169.41 11.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.861 0.362 . . . . 74.219999999999999 110.727 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -90.08 114.47 26.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.854 -0.795 . . . . 74.019999999999996 108.854 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.35 -49.04 54.77 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 109.402 -1.479 . . . . 63.020000000000003 109.402 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 m -116.12 108.5 45.97 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 107.312 -1.366 . . . . 62.32 107.312 173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.75 143.32 73.6 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.487 2.124 . . . . 62.399999999999999 112.787 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.29 127.69 60.33 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.642 -0.708 . . . . 75.019999999999996 111.481 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.92 91.9 1.07 Allowed 'Trans proline' 0 N--CA 1.427 -2.415 0 C-N-CA 121.711 1.607 . . . . 73.0 110.446 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -91.75 143.79 26.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.232 -1.349 . . . . 75.439999999999998 107.703 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -107.99 137.47 39.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.434 0.635 . . . . 72.239999999999995 110.57 -172.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.28 155.88 41.24 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 105.129 -2.174 . . . . 72.430000000000007 105.129 175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -70.51 109.85 5.05 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 113.292 0.849 . . . . 45.340000000000003 113.292 -172.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.49 HG22 ' HG ' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -135.87 147.9 48.4 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 105.785 -1.931 . . . . 63.329999999999998 105.785 172.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -89.89 112.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 107.452 -1.314 . . . . 54.119999999999997 107.452 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -125.53 141.35 52.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.616 -0.72 . . . . 74.150000000000006 109.349 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -81.5 112.85 19.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.068 -1.456 . . . . 72.019999999999996 107.068 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . -64.4 -168.44 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 115.317 1.599 . . . . 72.329999999999998 115.317 -171.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.41 2.89 2.02 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.417 1.887 . . . . 70.109999999999999 111.536 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 3.9 pp -57.28 -21.14 32.6 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.476 1.51 . . . . 61.340000000000003 112.915 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.84 -34.54 78.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.349 0.26 . . . . 73.439999999999998 110.975 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.39 -40.31 8.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.112 -0.699 . . . . 74.109999999999999 109.112 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 13.1 tp10 -65.7 -24.94 67.1 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 114.34 -1.3 . . . . 74.310000000000002 114.016 -172.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.21 -50.36 69.61 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.873 0.761 . . . . 54.140000000000001 112.074 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.6 -31.92 69.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.125 0.488 . . . . 64.519999999999996 110.807 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.9 m -71.97 -26.37 62.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.656 -0.702 . . . . 74.049999999999997 110.751 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.4 m -89.52 -40.57 12.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.104 -0.498 . . . . 62.43 110.577 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.4 m -75.42 85.21 2.54 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.679 0.752 . . . . 61.200000000000003 112.402 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.57 26.17 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.132 -0.94 . . . . 53.299999999999997 111.194 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -83.9 123.9 30.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 123.378 0.671 . . . . 73.340000000000003 109.818 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.93 124.18 81.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 106.21 -1.774 . . . . 72.299999999999997 106.21 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.74 141.76 91.95 Favored 'Trans proline' 0 C--O 1.251 1.134 0 C-N-CA 121.939 1.759 . . . . 70.540000000000006 111.909 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.06 141.44 48.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.093 -0.958 . . . . 51.140000000000001 109.463 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.3 t -141.14 112.1 7.19 Favored 'General case' 0 N--CA 1.407 -2.61 0 CA-C-O 121.55 0.691 . . . . 73.420000000000002 109.962 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.09 36.41 0.98 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.687 -1.597 . . . . 73.450000000000003 106.687 174.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 43' ' ' PRO . . . 86.7 25.63 34.75 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.309 -2.316 . . . . 73.329999999999998 107.309 -169.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 139' ' ' ALA . . . -72.29 -47.6 48.76 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.715 -1.243 . . . . 65.319999999999993 113.618 -168.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -80.92 -2.35 47.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.614 0.721 . . . . 74.030000000000001 111.453 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.45 -25.39 20.36 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.868 -1.06 . . . . 74.450000000000003 108.626 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 57.37 85.49 0.19 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 114.732 -1.122 . . . . 71.400000000000006 111.284 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 45.3 Cg_endo -83.1 -73.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.443 2.095 . . . . 74.200000000000003 114.11 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.11 65.3 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.705 0.632 . . . . 63.240000000000002 112.705 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.85 -11.85 71.02 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 111.083 -0.807 . . . . 63.109999999999999 111.083 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.3 m -114.7 169.84 8.77 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.939 -1.504 . . . . 64.400000000000006 106.939 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 138' ' ' LEU . . . -149.61 157.58 43.38 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.974 -0.38 . . . . 51.240000000000002 109.974 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.404 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.19 137.65 54.51 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.366 0.603 . . . . 62.340000000000003 110.324 178.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.3 pp -111.11 137.02 49.3 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 109.125 -0.694 . . . . 74.230000000000004 109.125 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.8 135.62 50.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 109.613 -0.514 . . . . 64.540000000000006 109.613 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 16.1 t -80.83 118.15 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.7 -1.222 . . . . 71.109999999999999 107.7 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -88.79 -35.95 16.35 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.182 -0.673 . . . . 73.109999999999999 109.182 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HD2' ' OE1' ' A' ' 25' ' ' GLU . 39.7 ttm180 -148.1 141.93 25.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.299 -0.864 . . . . 72.530000000000001 109.282 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.79 174.78 13.57 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.397 -1.081 . . . . 64.349999999999994 110.397 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.537 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.8 Cg_exo -54.65 -44.68 47.26 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.602 2.201 . . . . 73.25 113.52 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.477 HD21 HD23 ' A' ' 80' ' ' LEU . 33.6 p30 -92.64 22.37 4.77 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.081 -1.012 . . . . 70.109999999999999 113.268 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -54.51 140.5 34.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.812 0.445 . . . . 54.119999999999997 112.036 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.37 -16.27 55.36 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.545 -0.622 . . . . 53.039999999999999 111.545 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.33 142.34 27.82 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 121.086 -0.246 . . . . 73.340000000000003 110.49 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -112.83 135.14 53.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.481 -0.933 . . . . 75.340000000000003 108.481 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -118.36 133.09 56.17 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.783 -0.451 . . . . 72.230000000000004 109.783 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.95 124.71 47.07 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.892 -0.594 . . . . 73.219999999999999 110.107 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.91 105.24 14.64 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.361 -1.348 . . . . 61.119999999999997 107.361 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -122.35 18.22 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.983 0.897 . . . . 73.319999999999993 109.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -133.17 157.67 77.69 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.72 -0.673 . . . . 61.130000000000003 109.516 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.59 -26.51 75.9 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.047 2.498 . . . . 62.229999999999997 114.079 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.6 m -147.55 121.8 9.58 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.329 -0.857 . . . . 75.540000000000006 111.182 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 77' ' ' ASP . 56.0 m -109.87 135.32 50.94 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.862 -0.608 . . . . 50.439999999999998 109.943 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -106.39 141.52 37.57 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.69 135.28 54.56 Favored 'General case' 0 C--O 1.252 1.214 0 N-CA-C 109.781 -0.451 . . . . 74.5 109.781 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.89 -164.19 25.52 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.792 -1.323 . . . . 70.109999999999999 109.792 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 86.1 mtt180 -101.43 117.8 35.68 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.123 -1.066 . . . . 73.109999999999999 108.123 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 176.88 153.8 0.4 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.854 -1.906 . . . . 74.409999999999997 105.854 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -64.07 -15.76 51.1 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.924 1.749 . . . . 74.200000000000003 113.178 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -95.44 -1.28 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.607 0.595 . . . . 75.219999999999999 112.607 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 p -85.07 112.52 20.72 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.11 -1.036 . . . . 71.230000000000004 111.154 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.453 ' HB3' HG23 ' A' ' 68' ' ' THR . 37.9 t70 -70.19 -36.95 74.98 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.133 -0.692 . . . . 70.420000000000002 109.133 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -100.66 98.73 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 122.253 1.025 . . . . 61.43 108.449 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -90.06 122.06 32.7 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.949 -1.023 . . . . 74.099999999999994 108.63 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.477 HD23 HD21 ' A' ' 56' ' ' ASN . 59.6 mt -123.87 122.18 37.32 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.154 -2.165 . . . . 71.319999999999993 105.154 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -130.67 117.53 19.61 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.198 -0.668 . . . . 60.130000000000003 109.198 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.0 p30 -128.78 -155.91 0.73 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.426 -0.953 . . . . 73.0 108.426 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.9 -41.74 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.24 0.616 . . . . 62.530000000000001 111.377 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.2 m -153.99 89.44 1.3 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.617 -0.677 . . . . 72.530000000000001 111.735 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 82' ' ' ASP . 85.4 t -103.54 136.29 37.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.983 -0.747 . . . . 62.439999999999998 108.983 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.526 ' HB2' HD21 ' A' ' 107' ' ' LEU . 41.2 t -71.33 161.99 30.17 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 123.843 0.715 . . . . 72.420000000000002 111.186 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 27.9 ptt180 -65.4 -38.16 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 122.127 0.965 . . . . 74.420000000000002 109.374 175.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -136.14 112.96 10.23 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.491 -1.3 . . . . 52.509999999999998 107.491 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t-80 -99.62 -52.93 3.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.851 -0.613 . . . . 51.420000000000002 109.847 178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.69 160.44 37.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.266 -0.574 . . . . 43.340000000000003 110.537 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.0 133.97 53.56 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.307 -0.861 . . . . 72.140000000000001 110.628 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -105.69 115.54 30.42 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.417 -1.698 . . . . 61.100000000000001 106.417 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm-85 -112.65 133.92 54.44 Favored 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.032 -0.667 . . . . 70.319999999999993 110.884 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.6 mp -104.48 121.13 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.022 -1.103 . . . . 74.409999999999997 108.022 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -123.84 116.64 23.29 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.29 -1.374 . . . . 71.319999999999993 107.29 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 49.98 37.83 14.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.777 0.831 . . . . 71.319999999999993 112.884 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.51 -2.49 87.38 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.097 -0.501 . . . . 44.439999999999998 114.172 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.81 138.9 39.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.729 0.765 . . . . 74.420000000000002 109.148 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD2' HG13 ' A' ' 94' ' ' ILE . 31.5 m-85 -108.52 122.77 47.76 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.61 -0.268 . . . . 72.319999999999993 111.246 -172.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -114.75 139.01 50.05 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.667 -0.864 . . . . 55.549999999999997 108.667 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.413 HG23 ' HB2' ' A' ' 122' ' ' MET . 43.4 t -109.32 123.14 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.991 -1.115 . . . . 74.140000000000001 107.991 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.72 121.83 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.169 -1.419 . . . . 60.439999999999998 107.169 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.52 153.94 18.26 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.783 -1.191 . . . . 51.5 107.783 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 89' ' ' HIS . 18.7 m -78.79 -12.31 13.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 113.379 0.881 . . . . 65.019999999999996 113.379 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.23 17.58 0.02 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 119.086 -1.53 . . . . 54.43 116.019 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 p 57.97 26.92 14.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.664 1.586 . . . . 73.450000000000003 111.496 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 86' ' ' SER . 0.0 OUTLIER -65.26 -35.31 80.64 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.961 -1.472 . . . . 64.439999999999998 112.926 -174.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.635 ' HB2' ' CD2' ' A' ' 89' ' ' HIS . 2.6 m120 -86.76 3.77 43.63 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 110.374 -0.232 . . . . 73.019999999999996 110.374 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.66 49.17 6.26 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.933 -1.267 . . . . 75.0 109.933 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -61.54 129.86 43.14 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 123.496 0.718 . . . . 51.219999999999999 110.977 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.406 ' CB ' ' HB3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -125.2 125.64 43.97 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 106.326 -1.731 . . . . 73.439999999999998 106.326 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.14 124.77 61.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 106.694 -1.595 . . . . 65.400000000000006 106.694 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.435 ' HA ' ' OD1' ' A' ' 126' ' ' ASP . 4.3 t-20 57.81 37.64 27.1 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.543 1.163 . . . . 65.310000000000002 107.884 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.15 18.62 6.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.976 -1.466 . . . . 63.350000000000001 114.23 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -125.04 147.47 57.02 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.407 -0.96 . . . . 74.329999999999998 108.407 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -69.57 129.43 17.78 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 N-CA-C 108.528 -1.374 . . . . 73.400000000000006 108.528 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.563 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 13.0 tpp180 -148.38 150.19 33.11 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.636 -0.826 . . . . 64.329999999999998 110.143 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -93.81 -55.46 3.23 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.558 -0.534 . . . . 60.439999999999998 109.558 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.68 34.73 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.808 -0.812 . . . . 61.049999999999997 108.808 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.563 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 58.1 tp60 -153.85 143.19 21.5 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 123.145 0.278 . . . . 52.229999999999997 110.71 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.95 128.11 37.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.573 -1.64 . . . . 71.329999999999998 106.573 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.413 ' HB2' HG23 ' A' ' 101' ' ' VAL . 39.4 ttp -90.26 134.88 34.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.402 0.62 . . . . 75.299999999999997 111.357 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.411 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 12.7 pt20 -104.07 152.19 22.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.23 -0.895 . . . . 72.5 110.67 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.25 130.71 41.46 Favored 'General case' 0 N--CA 1.409 -2.482 0 C-N-CA 123.646 0.778 . . . . 54.140000000000001 111.979 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -0.44 63.0 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.099 -0.8 . . . . 73.540000000000006 111.099 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 113' ' ' ASN . 28.3 t70 -89.44 153.65 20.66 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.45 -0.375 . . . . 74.340000000000003 111.565 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -115.92 131.19 57.01 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 121.525 0.679 . . . . 73.409999999999997 112.611 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.09 131.76 61.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 107.659 -1.237 . . . . 71.049999999999997 107.659 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 111' ' ' TYR . 16.5 tm0? -109.97 130.74 55.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.727 -1.212 . . . . 62.130000000000003 107.727 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 89' ' ' HIS . 4.1 mp -130.09 104.03 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.644 -0.873 . . . . 64.439999999999998 108.644 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.55 -96.45 0.18 Allowed Glycine 0 C--O 1.243 0.699 0 C-N-CA 121.052 -0.594 . . . . 73.409999999999997 112.565 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -113.43 -0.55 14.43 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.002 0.43 . . . . 73.409999999999997 110.219 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.537 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 87.1 m-85 -100.19 152.85 19.8 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 123.291 0.636 . . . . 64.140000000000001 111.479 -175.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -137.09 120.2 16.64 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.995 -1.113 . . . . 74.109999999999999 107.995 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.427 ' CD2' HG22 ' A' ' 51' ' ' VAL . 65.2 mt -105.25 140.39 38.47 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 123.468 0.707 . . . . 63.299999999999997 109.442 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.33 120.02 61.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.265 -1.754 . . . . 74.129999999999995 106.265 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -97.74 119.63 36.67 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 112.128 0.418 . . . . 65.239999999999995 112.128 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.422 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 95.5 mt -129.34 153.91 47.4 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.853 -0.795 . . . . 61.299999999999997 108.853 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 39' ' ' ALA . . . -75.95 162.01 28.45 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.869 -0.332 . . . . 55.119999999999997 110.927 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.2 168.23 41.88 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 115.417 -0.81 . . . . 51.229999999999997 112.108 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.522 ' HB2' ' HG2' ' A' ' 143' ' ' GLU . 12.0 Cg_endo -54.72 145.29 61.0 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 123.768 2.979 . . . . 74.530000000000001 115.455 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 43.39 1.07 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.546 -1.207 . . . . 74.549999999999997 110.384 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 141' ' ' PRO . 2.9 pt-20 . . . . . 0 N--CA 1.413 -2.307 0 C-N-CA 123.651 0.78 . . . . 75.549999999999997 109.385 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.5 -0.966 0 N-CA-C 107.938 -1.134 . . . . 71.040000000000006 107.938 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.1 m 70.66 -64.36 0.37 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 124.153 0.981 . . . . 65.420000000000002 110.368 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 56.2 29.95 15.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.363 1.465 . . . . 63.009999999999998 113.577 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -150.28 137.48 19.52 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.451 -0.795 . . . . 65.200000000000003 109.15 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -88.26 94.68 9.91 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.72 -0.844 . . . . 51.520000000000003 108.72 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.47 -58.11 2.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.083 -1.207 . . . . 71.310000000000002 110.083 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.5 m -111.9 108.5 55.6 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-N 115.393 -0.404 . . . . 52.119999999999997 110.867 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.08 136.77 18.65 Favored 'Trans proline' 0 C--O 1.256 1.386 0 N-CA-C 108.157 -1.516 . . . . 73.109999999999999 108.157 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.84 133.46 62.01 Favored Pre-proline 0 C--N 1.315 -0.896 0 C-N-CA 120.482 -0.487 . . . . 63.229999999999997 111.39 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.48 118.6 5.71 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 122.243 1.962 . . . . 73.019999999999996 112.433 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.475 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 26.5 mm-40 -112.69 139.87 47.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.406 -2.072 . . . . 61.310000000000002 105.406 174.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.24 133.54 54.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 119.819 -0.752 . . . . 72.109999999999999 112.764 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.11 150.22 21.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.384 -1.339 . . . . 54.210000000000001 107.384 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -90.35 130.3 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.023 0.439 . . . . 61.039999999999999 110.92 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.5 m -89.92 152.6 21.15 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.653 -0.499 . . . . 53.229999999999997 109.653 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG22 HD12 ' A' ' 107' ' ' LEU . 57.0 t -83.24 116.57 27.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.544 -0.539 . . . . 64.349999999999994 109.544 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -123.87 140.12 53.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.73 -0.47 . . . . 72.510000000000005 109.73 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttp85 -96.21 108.53 21.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.114 -1.069 . . . . 63.229999999999997 108.114 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 -173.84 3.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.574 -0.739 . . . . 60.130000000000003 110.989 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -72.91 6.83 2.34 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.701 0.8 . . . . 64.310000000000002 111.497 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pp -57.25 -26.21 60.39 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.222 1.409 . . . . 53.310000000000002 113.942 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.4 tp -72.28 -22.52 61.2 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.87 0.843 . . . . 74.530000000000001 109.616 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -96.16 -32.53 12.44 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.595 -0.73 . . . . 72.420000000000002 109.572 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -56.93 -38.97 73.64 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.119 -0.492 . . . . 73.120000000000005 111.086 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.8 ptp -62.4 -25.94 68.21 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 120.792 -0.363 . . . . 71.420000000000002 111.558 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -87.53 -49.65 7.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.948 0.404 . . . . 75.120000000000005 110.077 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -61.21 -41.98 97.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.793 -0.64 . . . . 53.43 111.145 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -82.92 -16.98 45.31 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.881 -0.414 . . . . 74.129999999999995 109.881 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m 67.29 101.75 0.05 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.773 1.229 . . . . 53.229999999999997 113.964 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.58 -141.38 48.02 Favored Glycine 0 CA--C 1.499 -0.963 0 CA-C-N 115.485 -0.779 . . . . 33.039999999999999 112.69 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t -115.77 149.39 38.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.608 -0.516 . . . . 75.0 109.608 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 110.97 40.6 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.323 -0.992 . . . . 43.020000000000003 108.323 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.78 145.2 90.56 Favored 'Trans proline' 0 C--O 1.246 0.921 0 C-N-CA 122.859 2.373 . . . . 70.420000000000002 113.616 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.23 162.45 13.19 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.904 -0.589 . . . . 70.450000000000003 110.102 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 123' ' ' GLN . 18.3 m -94.26 116.0 28.33 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.168 0.509 . . . . 63.109999999999999 110.551 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.2 m -69.38 100.04 1.3 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.551 -0.75 . . . . 73.120000000000005 109.403 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' OD1' ' A' ' 41' ' ' ASN . . . -152.31 43.59 0.65 Allowed Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.273 -0.965 . . . . 55.119999999999997 112.993 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.47 -39.83 13.92 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.622 -1.251 . . . . 74.319999999999993 107.622 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.46 -1.81 25.83 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.328 -1.306 . . . . 65.109999999999999 111.387 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.443 ' OD1' ' HA2' ' A' ' 38' ' ' GLY . 11.0 m120 -82.8 -30.55 28.74 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 115.481 -0.782 . . . . 72.409999999999997 109.29 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt 48.06 81.33 0.26 Allowed Pre-proline 0 C--N 1.345 0.371 0 O-C-N 124.229 0.956 . . . . 42.200000000000003 112.049 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HB2' ' HA3' ' A' ' 140' ' ' GLY . 6.9 Cg_exo -68.79 -61.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 111.891 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.67 -12.97 5.41 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.956 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.83 1.46 85.06 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.087 -1.054 . . . . 64.329999999999998 111.176 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 6.8 m -115.02 156.56 24.9 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.23 -1.396 . . . . 61.32 107.23 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -148.11 154.53 40.31 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.708 -0.478 . . . . 71.530000000000001 109.708 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.24 152.37 44.5 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 109.92 -0.4 . . . . 54.039999999999999 109.92 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.01 132.46 52.01 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.46 -0.941 . . . . 70.530000000000001 108.46 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 p -108.82 137.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.644 -0.502 . . . . 74.129999999999995 109.644 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 135' ' ' LEU . 10.5 t -86.09 118.27 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 107.997 -1.112 . . . . 71.319999999999993 107.997 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' A' ' 134' ' ' ARG . 55.3 tttp -93.42 -31.71 14.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.356 -0.838 . . . . 64.299999999999997 109.953 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.419 ' HB3' ' HG2' ' A' ' 134' ' ' ARG . 19.5 tpp180 -147.11 138.5 24.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.988 -0.745 . . . . 71.329999999999998 108.988 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.06 171.05 12.93 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.155 -1.178 . . . . 71.219999999999999 110.155 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.67 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 80.1 Cg_exo -54.64 -29.99 63.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.598 2.199 . . . . 63.409999999999997 113.714 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -90.43 8.47 33.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.502 -0.479 . . . . 72.329999999999998 112.199 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.95 131.61 45.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.86 0.362 . . . . 62.539999999999999 111.515 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -23.94 24.44 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 115.588 -0.733 . . . . 52.509999999999998 112.295 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 152.54 20.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.754 0.277 . . . . 73.420000000000002 110.768 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.75 137.12 48.07 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.764 -0.828 . . . . 71.439999999999998 108.764 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -115.24 139.51 49.88 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.614 -0.513 . . . . 62.229999999999997 109.614 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.3 127.94 42.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.947 -1.131 . . . . 71.510000000000005 107.947 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.75 113.21 26.18 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.485 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.18 3.47 4.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.24 1.019 . . . . 74.230000000000004 108.582 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' HD13 ' A' ' 94' ' ' ILE . 14.4 pm0 -106.45 137.09 19.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-N 115.056 -0.975 . . . . 65.219999999999999 109.123 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.25 -21.58 67.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.309 2.673 . . . . 71.140000000000001 113.764 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -137.23 122.68 19.55 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.322 -0.622 . . . . 74.540000000000006 109.322 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.0 m -129.89 112.3 13.41 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.91 -0.774 . . . . 52.299999999999997 108.91 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.6 m -88.53 140.59 29.31 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.394 -0.595 . . . . 71.310000000000002 109.394 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.52 135.2 55.14 Favored 'General case' 0 C--O 1.268 2.039 0 N-CA-C 109.09 -0.707 . . . . 64.099999999999994 109.09 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.13 -136.0 4.81 Favored Glycine 0 N--CA 1.422 -2.298 0 O-C-N 123.916 0.76 . . . . 71.120000000000005 112.833 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' NH1' ' HA ' ' A' ' 81' ' ' ASP . 24.8 mmm180 -118.67 152.94 35.17 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 125.486 1.514 . . . . 72.239999999999995 109.552 -175.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.428 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 27.0 t-80 82.57 142.87 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 125.31 1.444 . . . . 74.319999999999993 109.209 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 9.8 Cg_endo -52.63 -6.77 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 124.14 3.227 . . . . 54.240000000000002 115.538 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.5 -12.89 59.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.353 0.597 . . . . 74.040000000000006 110.086 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -88.19 134.91 33.66 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.358 -0.979 . . . . 41.200000000000003 108.358 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -76.99 -42.2 39.8 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.169 -1.049 . . . . 74.120000000000005 108.169 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 51.7 mm -97.46 104.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 106.469 -1.678 . . . . 54.130000000000003 106.469 172.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -87.62 108.81 19.25 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.49 -0.777 . . . . 64.420000000000002 109.431 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 82.3 mt -95.7 141.05 29.65 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.742 -1.577 . . . . 73.530000000000001 106.742 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.591 ' HA ' ' NH1' ' A' ' 72' ' ' ARG . 18.3 t70 -103.94 117.46 34.36 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.152 -0.619 . . . . 75.120000000000005 110.499 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -151.22 174.98 12.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.643 -1.243 . . . . 73.409999999999997 107.643 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.48 -34.25 10.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.585 -0.894 . . . . 70.040000000000006 108.585 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.569 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 3.4 m -74.61 125.23 28.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.02 -0.991 . . . . 52.310000000000002 109.711 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.5 98.01 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 119.618 -0.833 . . . . 71.129999999999995 109.109 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 t -107.01 90.5 3.32 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.457 -1.312 . . . . 72.540000000000006 107.457 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 11' ' ' GLN . 20.7 ptt180 -57.92 -31.9 67.24 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.544 -1.207 . . . . 74.409999999999997 111.384 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -145.12 93.43 2.39 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.411 -0.959 . . . . 71.439999999999998 108.411 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.496 ' CE1' HG23 ' A' ' 130' ' ' ILE . 39.7 t-80 -96.58 -53.58 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.704 -0.798 . . . . 73.519999999999996 109.691 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.32 160.62 38.71 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 109.194 -0.669 . . . . 63.119999999999997 109.194 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.02 143.94 36.67 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.331 0.586 . . . . 73.450000000000003 110.138 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -104.94 122.16 45.24 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.027 -2.212 . . . . 74.120000000000005 105.027 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -115.81 142.84 46.23 Favored 'General case' 0 C--N 1.273 -2.72 0 C-N-CA 119.618 -0.833 . . . . 73.340000000000003 109.256 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 65' ' ' GLN . 2.7 mp -113.95 112.97 42.46 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 104.219 -2.511 . . . . 53.130000000000003 104.219 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.63 122.7 25.1 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.766 -0.457 . . . . 63.32 109.766 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 56.03 38.0 29.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 124.146 0.904 . . . . 72.540000000000006 111.571 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.91 -7.84 75.68 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.248 -0.887 . . . . 52.200000000000003 113.925 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -101.79 150.28 23.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 117.151 0.475 . . . . 65.25 109.844 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.29 126.4 53.31 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.774 -0.825 . . . . 73.140000000000001 108.774 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -130.9 147.84 52.59 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.647 0.26 . . . . 65.340000000000003 111.174 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 122' ' ' MET . 25.6 t -112.59 122.69 67.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.942 -1.503 . . . . 73.120000000000005 106.942 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.88 122.33 68.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.198 0.523 . . . . 61.219999999999999 111.147 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.9 136.93 32.75 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 123.787 0.835 . . . . 63.329999999999998 110.553 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -132.57 5.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.813 -0.63 . . . . 64.319999999999993 110.463 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.78 58.83 0.57 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.99 -0.624 . . . . 60.229999999999997 111.835 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -60.03 -11.65 6.34 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.783 1.233 . . . . 70.0 112.563 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 107' ' ' LEU . 1.2 mm? -67.4 -20.48 65.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.992 0.917 . . . . 74.420000000000002 110.847 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.66 -5.5 58.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 53.020000000000003 110.168 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.35 66.15 1.72 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.789 -0.641 . . . . 31.0 112.178 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 m -73.9 127.44 32.86 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.079 0.466 . . . . 53.32 110.844 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -136.62 141.42 43.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 109.827 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -123.17 119.57 58.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 106.905 -1.517 . . . . 71.140000000000001 106.905 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.457 ' OD1' ' HG2' ' A' ' 127' ' ' GLU . 87.7 m-20 56.58 39.38 29.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.792 0.837 . . . . 63.229999999999997 110.699 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 114' ' ' ARG . 0.0 OUTLIER 65.32 15.21 9.9 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 113.066 0.765 . . . . 72.530000000000001 113.066 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -112.43 133.99 21.68 Favored Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 123.062 0.545 . . . . 60.009999999999998 109.761 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.52 123.28 10.91 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 N-CA-C 108.161 -1.515 . . . . 72.239999999999995 108.161 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -153.03 137.3 16.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.716 -1.216 . . . . 72.450000000000003 107.716 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -107.91 -56.53 2.22 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.114 -0.635 . . . . 53.119999999999997 110.657 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.7 132.72 54.38 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.127 -1.064 . . . . 72.400000000000006 108.127 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.61 150.55 26.52 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 112.682 0.623 . . . . 62.409999999999997 112.682 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.61 132.4 33.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 104.926 -2.25 . . . . 51.43 104.926 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 101' ' ' VAL . 33.1 ttp -88.97 129.12 35.69 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.107 -0.637 . . . . 62.530000000000001 109.938 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 36' ' ' SER . 61.9 mt-30 -118.34 156.56 28.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.738 -1.119 . . . . 63.439999999999998 109.133 -173.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -71.21 130.21 40.86 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.463 -0.94 . . . . 74.230000000000004 108.463 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.44 -4.1 56.68 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.788 -0.642 . . . . 44.43 113.057 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.27 137.33 54.63 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 117.952 0.876 . . . . 64.530000000000001 110.444 175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 12.6 pt-20 -112.69 126.32 55.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.575 -1.269 . . . . 74.209999999999994 107.575 172.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.98 117.03 54.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.652 0 N-CA-C 107.878 -1.156 . . . . 74.310000000000002 107.878 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -105.33 123.87 48.58 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.553 0.692 . . . . 74.019999999999996 112.111 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.496 HG23 ' CE1' ' A' ' 89' ' ' HIS . 10.3 mm -109.87 101.95 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 105.53 -2.026 . . . . 63.539999999999999 105.53 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 56.34 -98.15 0.06 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 120.789 -0.72 . . . . 72.109999999999999 112.112 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -97.53 -24.0 15.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.808 0.443 . . . . 62.130000000000003 111.34 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.67 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 65.5 m-85 -75.31 148.47 39.3 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 122.769 0.428 . . . . 72.140000000000001 110.25 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 52' ' ' LYS . 8.7 ptm180 -138.37 120.12 15.24 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.529 -0.915 . . . . 63.200000000000003 108.529 170.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.7 mm? -103.36 139.86 38.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.68 -0.859 . . . . 74.530000000000001 108.68 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.7 t -116.37 123.2 71.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.24 -1.022 . . . . 60.299999999999997 108.24 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.461 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 94.3 t80 -94.68 129.86 41.4 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.978 -0.555 . . . . 61.32 111.252 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.93 132.04 53.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.158 -1.053 . . . . 62.310000000000002 108.158 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.42 131.4 53.66 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 120.45 -0.5 . . . . 53.299999999999997 111.099 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 43' ' ' PRO . . . 97.66 46.29 2.33 Favored Glycine 0 CA--C 1.539 1.554 0 N-CA-C 117.506 1.762 . . . . 55.310000000000002 117.506 175.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 46' ' ' SER . 39.6 Cg_endo -72.18 155.67 56.26 Favored 'Trans proline' 0 C--N 1.363 1.336 0 CA-C-N 121.108 2.454 . . . . 43.439999999999998 109.718 169.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.69 83.59 0.96 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.253 0.549 . . . . 71.140000000000001 110.426 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.172 -1.418 . . . . 72.430000000000007 107.172 177.272 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 108.489 -0.93 . . . . 74.129999999999995 108.489 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.3 m -150.17 160.74 43.45 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.475 -0.565 . . . . 74.340000000000003 109.475 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.72 99.71 11.02 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.583 0.552 . . . . 61.340000000000003 110.32 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.78 91.61 7.56 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.798 0.809 . . . . 72.519999999999996 108.936 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -118.68 152.12 36.7 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.411 -1.268 . . . . 72.530000000000001 108.575 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.52 98.88 0.3 Allowed Glycine 0 N--CA 1.437 -1.292 0 O-C-N 123.649 0.593 . . . . 71.340000000000003 111.863 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.9 m -82.48 128.82 65.42 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.089 -0.708 . . . . 70.239999999999995 109.089 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 132.28 50.84 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.288 1.992 . . . . 64.109999999999999 110.696 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -89.93 148.61 40.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 109.427 -0.582 . . . . 73.299999999999997 109.427 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.91 153.67 49.45 Favored 'Trans proline' 0 C--O 1.246 0.899 0 C-N-CA 122.364 2.043 . . . . 64.400000000000006 111.025 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -91.84 167.53 12.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.43 -0.952 . . . . 65.140000000000001 108.43 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.92 132.83 54.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.432 0.634 . . . . 72.129999999999995 111.239 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 10.0 tp10 -158.18 154.36 27.23 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.274 -2.121 . . . . 64.329999999999998 105.274 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -70.66 134.75 47.82 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.784 1.031 . . . . 70.120000000000005 113.784 -174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 108' ' ' ASN . 16.2 m -99.04 152.39 19.88 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.136 0.493 . . . . 64.420000000000002 112.176 -168.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.15 115.92 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 104.903 -2.258 . . . . 32.520000000000003 104.903 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -81.6 113.59 19.72 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.543 0.687 . . . . 72.530000000000001 110.802 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.92 120.63 42.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.664 -1.236 . . . . 74.120000000000005 107.664 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.49 -178.09 7.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.996 0.427 . . . . 65.0 110.009 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -83.97 -4.47 58.74 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.803 0.811 . . . . 63.0 109.862 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.34 -4.53 58.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.034 -0.985 . . . . 60.329999999999998 111.748 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.59 -33.39 68.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.111 -0.7 . . . . 71.450000000000003 109.111 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -71.81 -22.41 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.518 -0.765 . . . . 65.299999999999997 110.126 173.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -79.88 -30.85 40.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.419 -0.585 . . . . 72.150000000000006 109.419 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 30' ' ' THR . 32.7 ttm -66.95 -12.11 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.64 1.21 . . . . 71.019999999999996 108.915 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.73 -38.07 8.84 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.899 -1.046 . . . . 74.349999999999994 109.894 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -88.8 -46.38 9.01 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.905 1.076 . . . . 75.519999999999996 113.905 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -90.17 -20.26 23.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 119.478 -0.889 . . . . 74.349999999999994 112.006 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 115' ' ' GLU . 5.7 m -80.53 65.48 5.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.906 0.86 . . . . 64.200000000000003 109.669 177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.92 5.4 2.23 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.135 -1.186 . . . . 54.43 110.135 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -110.66 121.96 46.61 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.134 -1.062 . . . . 40.240000000000002 108.134 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.16 120.96 83.98 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.979 -0.378 . . . . 55.149999999999999 109.979 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.43 150.88 87.39 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.702 2.268 . . . . 70.120000000000005 111.368 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.18 141.66 31.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.38 -0.6 . . . . 72.019999999999996 109.38 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.8 m -80.1 117.57 21.03 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.92 -0.4 . . . . 72.510000000000005 109.92 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.7 p -82.26 -49.85 9.63 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.903 -0.59 . . . . 72.019999999999996 110.186 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.49 114.58 2.32 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.401 -0.818 . . . . 55.509999999999998 111.894 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.85 -7.79 45.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 120.923 0.392 . . . . 62.039999999999999 110.315 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -5.3 21.11 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.678 1.362 . . . . 52.210000000000001 114.678 -168.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.03 -32.43 18.79 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.373 -0.531 . . . . 73.040000000000006 110.98 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 48.26 68.85 3.12 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 124.079 0.862 . . . . 61.119999999999997 111.069 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.44 -58.25 0.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 125.113 3.875 . . . . 74.109999999999999 114.556 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.31 17.15 4.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.329 -0.989 . . . . 54.219999999999999 108.329 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.77 -12.4 29.19 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 114.623 -1.171 . . . . 73.340000000000003 112.583 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 p -118.99 164.84 14.88 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 109.993 -0.373 . . . . 72.430000000000007 109.993 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.25 156.98 40.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.911 -1.515 . . . . 61.149999999999999 106.911 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.43 145.78 51.95 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.141 0.496 . . . . 73.409999999999997 111.746 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -106.32 142.68 35.59 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.491 -0.929 . . . . 62.32 108.491 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.66 132.24 71.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.434 -0.58 . . . . 61.229999999999997 109.434 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.56 118.3 22.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.244 -1.391 . . . . 71.230000000000004 107.244 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -89.79 -34.82 16.02 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.618 -0.719 . . . . 64.299999999999997 110.756 -174.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 43.1 ttt180 -137.96 150.95 47.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.275 -1.38 . . . . 74.120000000000005 107.275 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.96 -178.2 16.48 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.471 -0.871 . . . . 42.100000000000001 112.338 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.58 -29.08 13.6 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.889 2.393 . . . . 64.299999999999997 111.782 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -97.08 18.99 13.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.827 -0.624 . . . . 74.310000000000002 110.955 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.35 139.22 58.74 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.415 -0.357 . . . . 74.010000000000005 111.168 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.83 -18.15 50.82 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.644 -0.582 . . . . 71.140000000000001 111.644 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.12 138.78 33.54 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 120.494 0.188 . . . . 63.25 110.719 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -122.78 145.91 48.0 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.398 -0.593 . . . . 72.129999999999995 109.398 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.28 142.68 47.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.519 -0.919 . . . . 62.100000000000001 108.519 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.29 143.84 26.22 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.315 0.579 . . . . 51.149999999999999 112.434 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -112.29 104.78 12.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.451 -0.795 . . . . 53.329999999999998 108.956 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -168.59 61.1 0.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 61.310000000000002 107.473 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -146.8 157.3 47.47 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 113.126 -1.852 . . . . 74.200000000000003 107.473 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.09 -35.52 97.92 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.812 1.675 . . . . 62.32 112.614 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 m -154.53 122.44 5.89 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.195 0.522 . . . . 73.219999999999999 111.814 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.9 m -108.48 116.92 32.88 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.402 -0.962 . . . . 71.530000000000001 108.402 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 p -90.4 133.02 35.28 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.938 -0.476 . . . . 74.430000000000007 110.851 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.87 134.68 55.16 Favored 'General case' 0 C--O 1.253 1.259 0 N-CA-C 109.631 -0.507 . . . . 75.230000000000004 109.631 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.96 -158.72 31.83 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 109.733 -1.347 . . . . 52.109999999999999 109.733 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 62.1 ttt180 -95.89 150.52 20.34 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.241 -0.651 . . . . 75.530000000000001 109.241 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 85.05 151.55 0.1 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.331 1.452 . . . . 72.230000000000004 111.881 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 -0.12 3.49 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.68 2.92 . . . . 61.43 114.97 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.73 -9.93 57.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.566 0.698 . . . . 74.439999999999998 110.285 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 m -90.86 136.94 32.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.02 -1.845 . . . . 60.020000000000003 106.02 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.19 -38.57 91.67 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.892 -0.781 . . . . 62.25 108.892 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.9 mm -98.91 119.46 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.106 -1.442 . . . . 73.219999999999999 107.106 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -90.17 118.01 29.37 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 120.798 0.332 . . . . 61.530000000000001 111.595 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 5.2 mp -124.98 134.75 52.48 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.757 -1.572 . . . . 74.230000000000004 106.757 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -131.67 123.45 27.83 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.324 -0.551 . . . . 74.319999999999993 111.346 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -149.79 172.79 14.55 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.045 -1.465 . . . . 75.439999999999998 107.045 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.96 -31.19 52.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.165 -0.68 . . . . 75.030000000000001 109.165 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -62.29 121.12 12.36 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.403 0.621 . . . . 74.400000000000006 110.719 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.34 125.32 39.84 Favored 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.209 -0.905 . . . . 51.200000000000003 109.6 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.0 m -159.08 106.06 1.78 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.353 0.661 . . . . 70.049999999999997 110.541 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' A' ' 13' ' ' GLU . 27.7 ptt180 -64.38 -46.0 85.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 120.701 -0.4 . . . . 72.140000000000001 111.635 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -141.3 131.03 24.16 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.494 -1.669 . . . . 73.430000000000007 106.494 173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -99.83 -52.18 3.51 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.806 -0.812 . . . . 71.430000000000007 108.806 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.26 155.29 36.3 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.279 -0.873 . . . . 74.209999999999994 109.167 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.5 135.55 54.68 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 116.001 -0.545 . . . . 65.019999999999996 109.591 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 33.8 m-85 -105.04 113.23 26.7 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.021 -1.844 . . . . 71.310000000000002 106.021 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.35 132.82 53.76 Favored 'General case' 0 C--N 1.269 -2.922 0 N-CA-C 108.279 -1.008 . . . . 63.350000000000001 108.279 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.7 111.9 35.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.072 -2.196 . . . . 63.210000000000001 105.072 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -124.93 118.47 26.34 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.615 -1.175 . . . . 70.400000000000006 109.752 -169.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 53.96 36.9 25.54 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.38 1.072 . . . . 50.439999999999998 111.347 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 0.58 90.27 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.68 -0.691 . . . . 62.240000000000002 113.707 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -102.49 150.27 23.55 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.691 -0.855 . . . . 73.519999999999996 108.691 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -104.51 117.01 33.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.912 -1.144 . . . . 63.5 107.912 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -124.78 134.75 52.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.5 0.667 . . . . 74.150000000000006 110.845 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 120' ' ' GLN . 24.0 t -103.03 124.98 57.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 106.735 -1.58 . . . . 64.540000000000006 106.735 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.38 122.84 70.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 107.042 -1.466 . . . . 61.130000000000003 107.042 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -96.63 144.79 26.35 Favored 'General case' 0 C--N 1.266 -3.035 0 CA-C-N 115.189 -0.914 . . . . 71.239999999999995 109.741 -178.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.03 -9.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.55 -0.46 . . . . 75.109999999999999 112.037 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.45 92.52 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 119.78 -1.2 . . . . 51.409999999999997 112.367 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.1 m -58.23 -22.03 50.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.172 0.589 . . . . 63.130000000000003 111.802 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.557 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -62.12 -18.83 62.03 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.965 0.906 . . . . 73.430000000000007 112.997 177.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' SER . 6.3 t30 -85.79 -0.55 55.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.786 0.803 . . . . 70.420000000000002 108.855 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.74 44.27 1.82 Allowed Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.521 -0.763 . . . . 73.0 113.059 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m -87.02 126.93 35.06 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.26 -0.645 . . . . 41.409999999999997 109.26 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 69.7 m-85 -137.44 131.62 32.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.839 -0.43 . . . . 71.420000000000002 109.839 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.16 116.36 50.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 105.058 -2.201 . . . . 73.5 105.058 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 55.96 40.55 30.41 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.065 0.946 . . . . 65.540000000000006 109.729 -173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.0 8.55 5.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.026 1.33 . . . . 62.210000000000001 113.698 -175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 30' ' ' THR . 37.2 mt-10 -103.6 128.24 27.82 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 121.752 -0.593 . . . . 72.140000000000001 109.408 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -61.26 136.27 63.33 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.639 1.559 . . . . 63.32 108.854 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.435 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 14.2 tpp85 -151.47 131.95 13.82 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.461 -0.896 . . . . 74.129999999999995 109.891 -173.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 2.9 t-20 -98.91 -31.41 11.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 122.043 0.925 . . . . 50.109999999999999 109.878 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -141.14 135.69 31.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.061 -1.459 . . . . 65.099999999999994 107.061 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.435 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 8.1 tp60 -144.71 144.56 31.27 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.016 0.197 . . . . 65.140000000000001 111.492 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 80.6 t -94.49 117.53 38.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 105.092 -2.188 . . . . 60.109999999999999 105.092 171.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.423 ' HB2' HG23 ' A' ' 101' ' ' VAL . 40.6 ttp -89.85 129.27 36.24 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.415 0.626 . . . . 52.130000000000003 111.296 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.58 157.1 43.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.842 -1.072 . . . . 70.439999999999998 109.522 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 t -62.53 134.19 56.03 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 123.568 0.543 . . . . 74.109999999999999 109.805 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.05 -8.64 61.12 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 120.409 -0.901 . . . . 65.310000000000002 111.933 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.47 140.15 32.5 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.072 0.463 . . . . 71.209999999999994 110.046 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -114.12 134.78 54.65 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.446 -0.797 . . . . 73.010000000000005 109.563 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.3 mt -112.1 118.3 57.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 107.676 -1.231 . . . . 72.010000000000005 107.676 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.572 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -104.84 117.05 33.09 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 105.901 -1.889 . . . . 73.099999999999994 105.901 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.78 103.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.446 -0.797 . . . . 72.530000000000001 109.447 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.45 -84.44 0.44 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.107 -0.951 . . . . 40.140000000000001 112.272 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -125.35 -18.34 5.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.638 0.256 . . . . 64.129999999999995 111.192 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 48.4 p90 -121.14 150.33 41.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 112.924 0.713 . . . . 74.109999999999999 112.924 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 8.2 ptm180 -112.52 142.14 45.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.547 -0.752 . . . . 73.209999999999994 112.236 -170.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.2 139.17 54.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.911 -1.514 . . . . 63.229999999999997 106.911 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.42 134.95 53.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.163 -0.68 . . . . 64.140000000000001 109.163 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -97.43 119.63 36.33 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.777 -0.453 . . . . 65.230000000000004 109.777 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.42 131.14 55.59 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.651 -0.5 . . . . 74.430000000000007 109.651 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.47 135.75 33.33 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.751 -0.833 . . . . 70.239999999999995 108.751 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.72 163.93 15.6 Favored Glycine 0 N--CA 1.421 -2.329 0 N-CA-C 107.637 -2.185 . . . . 54.43 107.637 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.86 141.76 72.81 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 CA-C-N 119.725 1.762 . . . . 63.130000000000003 113.167 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -118.67 26.53 9.5 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.559 -1.645 . . . . 63.219999999999999 106.559 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.417 -2.099 0 CA-C-N 113.242 -1.799 . . . . 70.150000000000006 107.693 -178.152 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 109.945 -0.391 . . . . 72.099999999999994 109.945 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -120.95 94.28 4.3 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.687 -0.633 . . . . 54.140000000000001 111.564 -173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -89.47 68.78 7.9 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.577 1.18 . . . . 73.129999999999995 108.051 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -129.59 156.04 44.85 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.127 -1.397 . . . . 65.420000000000002 108.336 -174.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -82.77 82.59 8.03 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.844 0.831 . . . . 52.420000000000002 108.82 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.39 -71.57 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.393 0 N-CA-C 106.024 -2.83 . . . . 75.430000000000007 106.024 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.0 m -114.5 106.25 52.69 Favored Pre-proline 0 N--CA 1.416 -2.162 0 N-CA-C 106.503 -1.666 . . . . 74.329999999999998 106.503 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.73 132.37 9.74 Favored 'Trans proline' 0 N--CA 1.436 -1.859 0 C-N-CA 121.641 1.561 . . . . 75.239999999999995 110.296 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.44 147.53 39.82 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.31 -1.367 . . . . 61.240000000000002 107.31 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.45 137.19 25.59 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 122.341 2.027 . . . . 61.340000000000003 108.937 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.91 132.76 35.14 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.27 -0.972 . . . . 54.530000000000001 110.092 -169.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' HA ' ' NH1' ' A' ' 87' ' ' ARG . 51.0 t -108.24 121.04 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.719 -1.585 . . . . 53.149999999999999 106.719 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' HB2' ' O2P' ' A' ' 15' ' ' TPO . 46.0 mm-40 -127.09 132.93 50.52 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.699 -1.223 . . . . 73.310000000000002 107.699 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 m -81.19 113.17 19.16 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.131 -1.433 . . . . 64.340000000000003 107.131 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.474 ' O ' ' HB3' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 m -92.95 152.39 19.37 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.839 -0.8 . . . . 72.010000000000005 108.839 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -83.11 115.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.453 -0.573 . . . . 62.399999999999999 109.453 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -99.54 105.35 17.23 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.603 -0.888 . . . . 70.409999999999997 108.603 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -126.96 124.92 40.58 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.58 0.705 . . . . 75.140000000000001 112.851 -176.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.91 -37.56 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.002 1.321 . . . . 64.099999999999994 107.885 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.74 -17.14 0.49 Allowed 'General case' 0 C--O 1.203 -1.367 0 CA-C-N 112.734 -2.03 . . . . 74.219999999999999 114.756 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -59.1 -41.8 88.98 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 118.156 0.434 . . . . 72.120000000000005 110.818 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.43 -36.28 45.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.465 -0.569 . . . . 72.349999999999994 109.465 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -60.14 -44.09 95.22 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.11 -0.95 . . . . 51.229999999999997 108.951 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.2 -43.12 64.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.583 -1.19 . . . . 75.019999999999996 111.149 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.15 -36.78 71.16 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.172 0.51 . . . . 60.310000000000002 110.621 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.97 -26.35 68.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.499 -0.773 . . . . 72.319999999999993 110.4 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -98.41 -36.59 9.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.557 -0.292 . . . . 54.229999999999997 111.29 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -75.33 -23.96 57.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.356 0.502 . . . . 70.030000000000001 112.356 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.1 m -66.1 114.87 5.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.332 0.587 . . . . 63.340000000000003 110.689 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.0 -70.23 0.27 Allowed Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 109.07 -1.612 . . . . 65.430000000000007 109.07 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 p -115.56 138.36 51.14 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.168 0.508 . . . . 65.129999999999995 111.638 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.32 154.21 37.57 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.588 -0.893 . . . . 65.0 108.588 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.2 150.97 62.65 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 122.512 2.141 . . . . 65.409999999999997 111.762 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.14 143.77 25.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.654 0.264 . . . . 62.030000000000001 110.517 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 p -85.15 95.16 9.05 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.865 -0.791 . . . . 52.039999999999999 108.865 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.0 p -84.77 -173.08 4.53 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.781 -0.645 . . . . 60.43 110.821 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.84 3.99 67.49 Favored Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.024 -1.231 . . . . 25.449999999999999 110.024 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' A' ' 139' ' ' ALA . . . -68.57 -19.18 64.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 114.076 -1.062 . . . . 64.430000000000007 110.375 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.1 -5.72 37.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.395 0.617 . . . . 70.140000000000001 111.506 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.89 -12.81 23.0 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.58 -0.896 . . . . 64.120000000000005 108.58 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.87 74.07 0.56 Allowed Pre-proline 0 C--O 1.221 -0.408 0 CA-C-N 114.501 -1.227 . . . . 71.299999999999997 109.268 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.42 -57.92 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.235 1.956 . . . . 73.510000000000005 114.104 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.9 -20.21 20.88 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.961 0.726 . . . . 62.530000000000001 112.961 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.78 -4.62 83.58 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 119.978 -1.106 . . . . 53.0 111.383 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.8 m -115.48 163.74 15.31 Favored 'General case' 0 C--O 1.254 1.337 0 N-CA-C 107.9 -1.148 . . . . 71.319999999999993 107.9 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.15 158.32 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.405 -0.185 . . . . 32.340000000000003 111.176 -174.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 48' ' ' LEU . 3.7 pp -131.08 137.19 49.01 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.14 0.495 . . . . 53.210000000000001 110.177 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.1 pp -117.03 136.84 52.65 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.369 -0.604 . . . . 64.420000000000002 109.369 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.0 p -117.75 130.92 71.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.866 -0.42 . . . . 70.400000000000006 109.866 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 t -79.37 123.12 35.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.913 -1.143 . . . . 61.43 107.913 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -99.24 -30.28 12.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.259 0.552 . . . . 63.350000000000001 110.033 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -136.53 127.73 28.07 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.485 -0.561 . . . . 64.329999999999998 109.485 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 136.3 175.64 13.93 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.8 -1.32 . . . . 70.219999999999999 109.8 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.57 -31.66 79.84 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 C-N-CA 122.428 2.085 . . . . 74.239999999999995 111.817 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -89.29 12.78 15.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.538 -0.301 . . . . 75.519999999999996 110.897 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.54 132.18 50.45 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.928 0.394 . . . . 61.43 110.528 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.94 -27.4 14.67 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.553 -1.019 . . . . 74.019999999999996 110.553 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.72 142.63 28.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.695 -0.483 . . . . 72.230000000000004 109.695 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 3.0 ppt_? -122.46 137.3 54.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.894 -0.594 . . . . 65.129999999999995 110.632 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -117.35 145.54 43.98 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.426 -0.953 . . . . 71.209999999999994 108.426 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -106.37 133.99 50.21 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 113.251 0.834 . . . . 62.240000000000002 113.251 -176.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 94' ' ' ILE . 1.9 mm? -97.51 104.38 16.4 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.91 -1.885 . . . . 64.519999999999996 105.91 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.59 -0.43 2.16 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.916 0.865 . . . . 50.310000000000002 110.561 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.26 150.81 41.01 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.776 -0.824 . . . . 72.319999999999993 108.776 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.84 -30.17 46.28 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.417 2.745 . . . . 61.549999999999997 113.497 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -146.17 121.78 10.45 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 121.716 -0.615 . . . . 61.539999999999999 110.26 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 m -118.15 114.19 22.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.551 -0.295 . . . . 52.210000000000001 110.739 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.7 m -87.32 130.18 34.72 Favored 'General case' 0 C--O 1.252 1.219 0 N-CA-C 110.275 -0.269 . . . . 43.240000000000002 110.275 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.63 139.68 53.67 Favored 'General case' 0 C--O 1.272 2.247 0 CA-C-O 121.609 0.719 . . . . 73.010000000000005 112.289 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.24 -160.62 31.43 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.27 -1.532 . . . . 74.5 109.27 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -118.87 116.74 27.12 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.214 -1.773 . . . . 63.140000000000001 106.214 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.642 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.7 t-160 166.87 151.0 0.08 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 104.527 -2.397 . . . . 72.099999999999994 104.527 -173.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 28.1 Cg_endo -64.52 -14.28 43.49 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.246 1.964 . . . . 74.420000000000002 112.281 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -87.86 -11.15 48.62 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 112.093 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -72.55 136.65 45.87 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.886 -0.783 . . . . 63.119999999999997 108.886 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.22 -45.07 34.78 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.716 -1.216 . . . . 64.409999999999997 107.716 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.5 pt -106.32 119.27 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 107.255 -1.387 . . . . 44.329999999999998 107.255 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 81' ' ' ASP . 84.8 t80 -99.28 121.22 40.77 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.851 -0.613 . . . . 62.130000000000003 112.121 -171.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.5 139.88 42.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 105.278 -2.119 . . . . 74.400000000000006 105.278 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 31.7 t70 -128.05 142.48 51.21 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 110.031 -0.359 . . . . 74.430000000000007 110.031 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -162.37 -161.42 0.73 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 106.613 -1.625 . . . . 75.310000000000002 106.613 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.92 -36.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-O 121.235 0.54 . . . . 73.439999999999998 109.66 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.0 t -75.71 152.45 37.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.531 -0.759 . . . . 74.219999999999999 110.521 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.26 99.09 7.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.628 -0.879 . . . . 74.239999999999995 108.628 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -99.07 85.68 3.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.126 -1.065 . . . . 63.25 108.126 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' A' ' 12' ' ' VAL . 16.4 ptt180 -55.4 -46.08 76.63 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.601 0.563 . . . . 71.349999999999994 111.933 -173.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -155.62 114.28 3.49 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.623 -1.621 . . . . 72.030000000000001 106.623 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.611 ' ND1' HG23 ' A' ' 130' ' ' ILE . 22.0 t-160 -99.74 -51.88 3.61 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.551 -0.86 . . . . 64.310000000000002 109.731 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.15 158.01 41.19 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.316 -0.554 . . . . 72.329999999999998 110.469 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' OE1' HG11 ' A' ' 104' ' ' VAL . 11.9 pt-20 -132.16 148.11 52.46 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-O 121.203 0.525 . . . . 54.340000000000003 110.021 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CD2' HG22 ' A' ' 101' ' ' VAL . 54.8 m-85 -105.14 117.01 32.92 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 75.530000000000001 108.114 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -106.29 133.63 50.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.199 -1.038 . . . . 63.130000000000003 108.199 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 63' ' ' LEU . 23.8 mt -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.563 -0.532 . . . . 73.340000000000003 109.563 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -138.87 121.02 15.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.297 -0.631 . . . . 74.120000000000005 109.297 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 55.76 38.09 29.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.223 1.009 . . . . 75.140000000000001 112.268 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.23 85.0 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.966 -0.635 . . . . 44.350000000000001 114.007 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -102.32 131.71 48.75 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 117.986 0.893 . . . . 74.439999999999998 109.788 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.99 123.62 48.11 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.936 -1.029 . . . . 65.230000000000004 109.177 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -120.26 137.48 54.2 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.669 -0.493 . . . . 65.340000000000003 109.669 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.451 HG22 ' CD2' ' A' ' 92' ' ' PHE . 29.2 t -103.58 122.61 56.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.212 -1.403 . . . . 65.299999999999997 107.212 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.95 133.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.923 -1.139 . . . . 63.450000000000003 107.923 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.9 148.96 36.12 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.35 0.595 . . . . 72.219999999999999 110.074 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG11 ' OE1' ' A' ' 91' ' ' GLU . 14.5 m -137.47 27.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.721 -1.214 . . . . 74.400000000000006 107.721 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . 156.4 56.86 0.01 OUTLIER Glycine 0 N--CA 1.41 -3.04 0 CA-C-N 113.796 -1.547 . . . . 73.310000000000002 110.41 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t -65.56 11.16 0.07 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.965 1.306 . . . . 61.140000000000001 111.961 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 105' ' ' GLY . 78.4 mt -65.5 -19.88 66.11 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 125.634 1.574 . . . . 64.349999999999994 110.885 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -87.09 -13.54 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.333 -0.394 . . . . 74.549999999999997 110.515 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.01 89.19 1.85 Allowed Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.729 -0.748 . . . . 70.430000000000007 111.253 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -86.6 127.9 34.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.773 -0.825 . . . . 63.310000000000002 108.773 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 81.1 m-85 -136.25 134.06 37.67 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.856 -0.794 . . . . 74.239999999999995 108.856 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.8 t -124.18 117.68 51.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 105.474 -2.047 . . . . 72.239999999999995 105.474 175.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.2 39.11 30.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.676 0.75 . . . . 74.430000000000007 110.172 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 22.7 mtm180 69.94 9.02 6.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.954 1.702 . . . . 65.519999999999996 114.851 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -110.24 135.89 20.55 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 110.351 -0.24 . . . . 75.040000000000006 110.351 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.02 135.9 12.69 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.728 2.285 . . . . 70.439999999999998 112.07 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -149.64 -177.62 5.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.281 0.562 . . . . 73.319999999999993 110.249 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -121.85 -31.02 4.02 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.259 -1.337 . . . . 72.340000000000003 110.057 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.7 137.31 28.1 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.277 -1.009 . . . . 32.25 108.277 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.505 HE22 ' HA ' ' A' ' 122' ' ' MET . 0.7 OUTLIER -152.44 122.63 7.14 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.277 -0.638 . . . . 55.450000000000003 109.277 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.1 t -81.17 117.56 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 106.963 -1.495 . . . . 71.209999999999994 106.963 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.505 ' HA ' HE22 ' A' ' 120' ' ' GLN . 32.6 ttm -96.87 137.81 35.39 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 114.281 1.215 . . . . 75.129999999999995 114.281 -165.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -114.14 157.25 22.86 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.473 -1.694 . . . . 54.439999999999998 107.745 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 14.8 t -62.59 133.94 55.63 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.414 0.626 . . . . 65.450000000000003 109.456 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.44 -0.09 56.9 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 121.107 -0.568 . . . . 74.030000000000001 111.887 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -82.38 142.2 32.18 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.932 -0.766 . . . . 72.420000000000002 108.932 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 134' ' ' ARG . 44.4 mt-10 -113.46 132.63 55.58 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.362 0.601 . . . . 75.510000000000005 110.248 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -107.39 132.82 53.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.707 -1.22 . . . . 74.109999999999999 107.707 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 111' ' ' TYR . 54.2 mt-30 -117.63 117.79 30.34 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.268 0.556 . . . . 61.240000000000002 109.781 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.611 HG23 ' ND1' ' A' ' 89' ' ' HIS . 48.1 mm -109.75 102.27 13.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.973 -1.491 . . . . 70.129999999999995 106.973 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.94 -78.08 0.21 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.406 -0.677 . . . . 43.140000000000001 111.406 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -141.87 5.37 1.74 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.045 0.45 . . . . 72.310000000000002 111.222 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.2 m-85 -78.9 150.44 32.14 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 109.223 -0.658 . . . . 54.32 109.223 176.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 127' ' ' GLU . 13.8 tpt180 -124.72 118.64 26.91 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.411 -1.7 . . . . 74.430000000000007 106.411 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.43 HD23 HD13 ' A' ' 49' ' ' LEU . 3.8 mp -122.29 140.84 52.17 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.337 -0.986 . . . . 74.450000000000003 108.337 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.07 122.56 65.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 107.201 -1.407 . . . . 73.019999999999996 107.201 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -99.31 127.29 45.31 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.077 -0.51 . . . . 75.329999999999998 109.957 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.99 155.54 50.59 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.818 -0.808 . . . . 45.539999999999999 108.818 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.489 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . . . -82.61 142.15 31.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.451 -1.685 . . . . 50.32 106.451 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.44 2.71 Favored Glycine 0 C--N 1.305 -1.192 0 C-N-CA 119.384 -1.389 . . . . 72.209999999999994 113.927 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 139' ' ' ALA . 2.9 Cg_exo -72.79 142.03 34.8 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.974 1.783 . . . . 75.0 109.769 172.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 179.76 73.71 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.929 0.892 . . . . 73.109999999999999 109.26 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.39 -3.448 0 CA-C-N 114.435 -1.257 . . . . 62.310000000000002 109.413 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 111.24 0.089 . . . . 64.200000000000003 111.24 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.2 t -178.07 -173.79 0.39 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.817 -1.92 . . . . 71.200000000000003 105.817 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -88.46 168.02 12.97 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 109.875 -0.417 . . . . 72.209999999999994 109.875 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -74.37 127.74 33.77 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.859 -0.793 . . . . 54.25 108.859 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -122.44 154.13 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.983 0.42 . . . . 75.140000000000001 112.049 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.92 -147.0 8.3 Favored Glycine 0 N--CA 1.425 -2.076 0 CA-C-N 115.115 -0.948 . . . . 31.440000000000001 111.925 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.551 ' HB ' ' NH1' ' A' ' 93' ' ' ARG . 14.9 t -125.67 151.55 70.84 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.647 -0.871 . . . . 73.120000000000005 108.647 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.49 151.18 39.0 Favored 'Trans proline' 0 C--N 1.364 1.369 0 C-N-CA 122.507 2.138 . . . . 72.510000000000005 110.234 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.39 139.34 59.65 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-O 121.058 0.456 . . . . 65.219999999999999 111.629 -171.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.83 135.3 68.9 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.39 3.393 . . . . 52.329999999999998 117.3 -170.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -124.91 132.75 53.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 104.51 -2.404 . . . . 71.230000000000004 104.51 170.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.91 132.8 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.82 0.819 . . . . 72.230000000000004 110.971 -172.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.534 ' HB3' ' HG2' ' A' ' 87' ' ' ARG . 8.7 tp10 -148.02 159.99 43.32 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 104.898 -2.26 . . . . 63.210000000000001 104.898 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -85.97 125.33 33.3 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.669 0.618 . . . . 73.420000000000002 112.669 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.531 ' O2P' ' HG3' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -100.0 155.35 17.75 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 105.768 -1.938 . . . . 51.25 105.768 172.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -81.53 114.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 117.675 -1.61 . . . . 74.310000000000002 108.024 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.682 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 45.1 t80 -99.71 116.24 31.35 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.004 -0.998 . . . . 73.209999999999994 108.857 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -81.15 92.07 6.23 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.796 -0.816 . . . . 73.140000000000001 108.796 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.65 -168.41 2.08 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.975 -1.011 . . . . 73.310000000000002 110.926 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.43 -9.71 13.86 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.34 1.056 . . . . 74.5 111.28 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.86 -19.13 65.77 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 124.004 0.922 . . . . 71.450000000000003 110.365 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.0 OUTLIER -59.21 -43.71 92.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.331 -0.989 . . . . 73.430000000000007 108.331 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.536 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 7.8 tmtm? -80.47 -29.3 37.46 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.547 -0.909 . . . . 74.450000000000003 108.547 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG2' ' HG2' ' A' ' 129' ' ' GLN . 6.6 tp10 -68.26 -33.9 75.22 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.987 -0.551 . . . . 73.510000000000005 110.705 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 27.5 ptt? -68.57 -21.02 64.55 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.778 -0.369 . . . . 52.240000000000002 110.741 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.04 -33.52 63.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.715 -1.217 . . . . 71.219999999999999 107.715 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -79.94 -14.66 58.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.769 -1.105 . . . . 63.340000000000003 110.884 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 t -67.44 -25.66 66.02 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.201 -0.666 . . . . 72.140000000000001 109.201 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.92 97.06 5.18 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.883 -1.525 . . . . 72.409999999999997 106.883 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.19 58.91 2.51 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.379 -1.088 . . . . 64.239999999999995 110.379 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 t -92.79 149.93 20.97 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.899 -0.408 . . . . 74.420000000000002 109.899 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.22 101.22 40.97 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 109.721 -0.474 . . . . 51.109999999999999 109.721 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.549 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 69.3 Cg_endo -75.79 143.52 26.74 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.308 2.005 . . . . 72.409999999999997 111.181 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.12 166.8 22.42 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.335 -0.393 . . . . 71.25 110.724 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 m -67.71 118.82 11.49 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.168 -0.469 . . . . 62.210000000000001 110.266 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 124' ' ' THR . 17.8 p -110.93 -161.57 0.76 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.569 0.748 . . . . 64.030000000000001 110.63 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.94 80.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.518 -0.633 . . . . 23.219999999999999 111.518 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.64 -24.51 19.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.927 0.714 . . . . 65.519999999999996 112.927 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.02 0.61 4.33 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.549 1.315 . . . . 73.019999999999996 114.549 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.3 -39.01 15.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.692 -0.855 . . . . 72.420000000000002 108.692 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 90.7 mt 53.18 80.29 0.3 Allowed Pre-proline 0 N--CA 1.466 0.345 0 C-N-CA 123.98 0.912 . . . . 72.519999999999996 111.607 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 10.8 Cg_endo -52.79 -67.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 123.649 2.9 . . . . 75.5 114.678 -173.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.38 -0.98 3.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.098 0.475 . . . . 64.510000000000005 111.317 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.6 6.98 82.6 Favored Glycine 0 C--N 1.322 -0.215 0 C-N-CA 120.384 -0.912 . . . . 63.409999999999997 112.643 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 m -129.46 158.21 39.84 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 108.118 -1.068 . . . . 71.25 108.118 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.49 41.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 110.254 -0.276 . . . . 73.349999999999994 110.254 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.442 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.71 139.95 53.4 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.326 0.391 . . . . 74.019999999999996 110.267 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -112.42 137.34 50.75 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.69 -0.855 . . . . 75.319999999999993 108.69 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.73 133.34 61.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-O 120.728 0.299 . . . . 72.019999999999996 110.195 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.8 t -78.51 117.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 106.113 -1.81 . . . . 55.439999999999998 106.113 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -86.41 -33.99 20.3 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.545 -0.752 . . . . 73.319999999999993 110.527 -172.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 31.3 tpt180 -154.66 139.7 17.37 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.232 -1.025 . . . . 71.230000000000004 108.232 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.08 -178.93 20.41 Favored Glycine 0 N--CA 1.437 -1.3 0 O-C-N 123.867 0.729 . . . . 72.430000000000007 111.346 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -70.0 -37.11 9.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.341 2.027 . . . . 74.340000000000003 111.513 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 81' ' ' ASP . 5.0 p30 -90.73 18.52 6.36 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.352 0.596 . . . . 74.239999999999995 111.167 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.65 145.19 54.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.432 0.693 . . . . 75.040000000000006 111.034 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -14.82 37.06 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.243 -1.143 . . . . 52.240000000000002 110.243 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.57 134.86 33.56 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 121.08 -0.248 . . . . 72.150000000000006 110.359 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -134.97 139.25 44.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.816 -1.179 . . . . 73.239999999999995 107.816 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.25 123.16 26.39 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 121.311 -0.155 . . . . 72.340000000000003 110.737 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.5 tp -89.63 115.4 26.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.057 -1.461 . . . . 63.310000000000002 107.057 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.81 106.87 16.66 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.458 0.647 . . . . 63.310000000000002 111.744 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -102.92 15.27 29.87 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.474 -1.306 . . . . 72.310000000000002 107.474 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 15.7 mt-30 -107.31 141.85 23.83 Favored Pre-proline 0 CA--C 1.468 -2.205 0 CA-C-N 114.714 -1.13 . . . . 73.200000000000003 110.026 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 16.5 Cg_exo -72.03 -13.15 28.74 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.973 1.782 . . . . 74.329999999999998 109.375 169.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.0 m -149.29 125.37 10.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.281 0.563 . . . . 61.229999999999997 110.67 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 90.3 m -131.51 139.48 49.29 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.366 -0.976 . . . . 64.209999999999994 108.366 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 m -132.57 139.07 47.67 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.24 -0.913 . . . . 70.450000000000003 110.319 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.58 143.41 46.14 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.764 -0.828 . . . . 63.149999999999999 108.764 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.96 -147.07 6.39 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 111.361 -0.696 . . . . 73.439999999999998 111.361 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -90.91 147.9 22.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 122.591 0.357 . . . . 64.239999999999995 110.951 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.46 169.76 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.65 1.18 . . . . 75.310000000000002 112.291 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -73.2 6.66 2.48 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.246 1.964 . . . . 74.409999999999997 111.446 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.93 -37.56 67.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.319 -1.363 . . . . 53.229999999999997 107.319 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -78.74 152.82 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.758 -1.11 . . . . 73.120000000000005 108.264 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' OD2' HG23 ' A' ' 68' ' ' THR . 32.0 t70 -64.67 -41.76 95.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.892 0.377 . . . . 71.129999999999995 111.094 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.0 126.81 67.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.306 -0.998 . . . . 72.099999999999994 108.306 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -88.42 129.63 35.38 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.682 0.614 . . . . 74.310000000000002 110.737 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.7 140.3 52.82 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.39 -1.337 . . . . 75.219999999999999 107.39 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.584 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 30.7 t70 -125.4 118.42 25.83 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.993 -0.549 . . . . 62.149999999999999 109.611 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -146.34 -175.45 4.78 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 104.775 -2.306 . . . . 75.049999999999997 104.775 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.24 -34.84 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.368 -0.975 . . . . 74.219999999999999 108.368 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 107' ' ' LEU . 8.2 m -148.63 114.69 5.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.071 -1.085 . . . . 64.299999999999997 108.071 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.2 t -103.94 152.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.513 -0.551 . . . . 44.450000000000003 109.513 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.8 m -72.65 153.07 41.4 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.572 0.349 . . . . 52.530000000000001 110.47 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HG2' ' HB3' ' A' ' 13' ' ' GLU . 5.4 ppt_? -69.26 -29.27 67.14 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.922 0.867 . . . . 72.140000000000001 110.767 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 24.0 mtp180 -148.78 120.19 7.9 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 101.666 -3.457 . . . . 72.340000000000003 101.666 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.498 ' CE1' HG23 ' A' ' 130' ' ' ILE . 13.4 t60 -99.65 -52.69 3.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.725 -0.79 . . . . 75.420000000000002 110.483 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.01 146.52 25.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.625 -0.88 . . . . 63.350000000000001 108.625 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 11.0 pt-20 -118.36 129.75 55.61 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.816 -0.629 . . . . 74.540000000000006 109.61 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 26.7 m-85 -105.26 113.06 26.43 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.302 -2.11 . . . . 74.420000000000002 105.302 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.551 ' NH1' ' HB ' ' A' ' 7' ' ' THR . 26.2 mtp180 -115.25 127.29 55.39 Favored 'General case' 0 C--N 1.262 -3.2 0 N-CA-C 108.46 -0.941 . . . . 74.420000000000002 108.46 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.7 mp -103.67 113.02 39.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 106.894 -1.521 . . . . 63.149999999999999 106.894 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -119.65 125.06 47.81 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.812 -1.181 . . . . 70.530000000000001 107.812 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.29 34.97 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.994 0.918 . . . . 75.219999999999999 112.576 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.2 -0.15 89.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.078 -0.582 . . . . 64.519999999999996 113.401 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -102.91 150.51 23.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.28 -1.007 . . . . 74.530000000000001 108.28 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -110.1 117.65 34.29 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 121.306 -0.157 . . . . 63.130000000000003 110.745 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.618 -0.882 . . . . 63.530000000000001 108.618 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.0 123.63 68.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 107.743 -1.206 . . . . 42.439999999999998 107.743 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.24 130.06 73.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.664 -0.865 . . . . 62.340000000000003 108.664 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.42 130.4 37.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.482 -0.933 . . . . 71.430000000000007 108.482 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.26 12.85 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-N 115.675 -0.693 . . . . 63.420000000000002 109.322 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -154.83 83.01 0.16 Allowed Glycine 0 N--CA 1.413 -2.876 0 CA-C-N 115.158 -0.928 . . . . 43.25 113.375 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 40.6 m -82.4 15.58 2.43 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.396 . . . . 72.230000000000004 111.176 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.7 tm? -67.2 -50.48 60.76 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 106.539 -1.652 . . . . 74.219999999999999 106.539 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 26.9 t-20 -104.46 -19.86 13.9 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.992 -0.744 . . . . 72.439999999999998 108.992 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . 83.99 119.32 0.76 Allowed Glycine 0 C--N 1.355 1.608 0 N-CA-C 115.75 1.06 . . . . 52.130000000000003 115.75 168.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.9 m -87.29 128.4 35.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.793 -0.818 . . . . 74.25 108.793 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.41 142.17 51.49 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.185 -1.043 . . . . 64.099999999999994 108.185 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -124.62 117.76 51.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.389 -0.967 . . . . 74.310000000000002 108.389 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.549 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 6.8 m-80 50.93 49.03 21.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.798 0.839 . . . . 71.120000000000005 112.993 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 67.21 9.42 6.94 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.481 1.513 . . . . 75.120000000000005 112.303 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -109.97 136.31 20.43 Favored Pre-proline 0 C--N 1.313 -1.004 0 O-C-N 121.936 -0.477 . . . . 65.150000000000006 110.334 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.42 123.81 12.73 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 121.946 1.764 . . . . 40.5 108.652 172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -147.41 131.98 17.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.02 -0.733 . . . . 64.549999999999997 109.02 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -101.79 -35.52 9.02 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.358 0.411 . . . . 75.239999999999995 111.476 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.26 135.26 53.28 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.78 -1.193 . . . . 50.43 107.78 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -146.88 143.61 28.67 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.513 0.197 . . . . 72.140000000000001 111.391 -175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 114.03 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 103.181 -2.896 . . . . 45.399999999999999 103.181 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.452 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 30.3 ttm -93.91 130.85 39.84 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 118.778 -1.169 . . . . 55.200000000000003 111.468 -170.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.41 ' OE1' ' HB ' ' A' ' 37' ' ' THR . 40.3 mt-30 -114.03 157.87 21.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.263 -1.335 . . . . 74.409999999999997 109.675 -170.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 14.8 t -63.54 126.57 27.94 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.897 -0.779 . . . . 73.140000000000001 108.897 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.0 -1.66 57.85 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 115.772 -0.649 . . . . 60.32 111.489 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.8 145.74 34.16 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 107.982 -1.118 . . . . 51.109999999999999 107.982 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' H ' ' ND2' ' A' ' 113' ' ' ASN . 36.7 mt-10 -119.93 132.86 55.66 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.831 -0.433 . . . . 73.019999999999996 109.831 -172.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.1 mt -107.98 131.59 57.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.044 -0.724 . . . . 53.119999999999997 109.044 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.403 ' HG2' ' HG2' ' A' ' 25' ' ' GLU . 52.3 tp60 -105.53 115.43 30.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.554 -1.276 . . . . 71.140000000000001 107.554 175.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.498 HG23 ' CE1' ' A' ' 89' ' ' HIS . 63.4 mt -125.42 116.8 47.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.086 -1.449 . . . . 60.119999999999997 107.086 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.53 -104.29 0.75 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.668 -0.973 . . . . 62.32 110.668 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.503 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -124.61 5.09 8.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.195 0.522 . . . . 72.219999999999999 109.94 176.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 34.2 p90 -111.14 156.58 21.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.985 -175.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.57 136.74 54.7 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.166 0.508 . . . . 74.310000000000002 111.542 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.17 139.62 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.585 -1.265 . . . . 71.420000000000002 107.585 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.7 t -112.13 131.41 63.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.893 -1.151 . . . . 62.229999999999997 107.893 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 48.7 t80 -103.57 117.02 33.47 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.941 -0.763 . . . . 72.120000000000005 108.941 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.19 131.08 55.8 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.488 -0.56 . . . . 61.409999999999997 109.488 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -111.87 121.93 46.39 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.307 -0.997 . . . . 72.409999999999997 108.307 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -157.74 -104.89 0.21 Allowed Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.477 -0.868 . . . . 74.409999999999997 111.89 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.19 161.66 45.12 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.004 2.469 . . . . 61.409999999999997 113.596 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.1 24.38 5.25 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.309 -0.86 . . . . 63.43 109.343 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.435 -1.197 0 C-N-CA 124.961 1.305 . . . . 71.530000000000001 113.462 -176.668 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 108.0 -1.111 . . . . 70.109999999999999 108.0 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -106.17 -179.13 3.85 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.956 -1.128 . . . . 55.219999999999999 107.956 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -150.91 147.93 27.81 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.248 -1.019 . . . . 72.299999999999997 108.248 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -82.08 127.83 33.5 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.341 0.497 . . . . 71.109999999999999 112.341 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -85.48 109.94 18.83 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.397 -0.964 . . . . 75.329999999999998 108.397 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.02 -127.2 3.65 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 110.883 -0.887 . . . . 61.229999999999997 110.883 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.4 m -96.51 112.11 59.06 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.709 -0.848 . . . . 70.420000000000002 108.709 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.71 147.81 92.42 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.905 2.404 . . . . 71.219999999999999 113.051 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -79.34 131.89 64.22 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.153 -0.93 . . . . 75.230000000000004 109.878 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -79.89 154.9 23.16 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.996 1.798 . . . . 75.329999999999998 110.32 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -92.71 152.86 19.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.997 -0.742 . . . . 73.0 108.997 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.66 121.18 66.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.504 -0.554 . . . . 71.530000000000001 109.504 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -146.89 169.33 19.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.977 0.911 . . . . 62.009999999999998 110.917 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -77.49 122.22 24.93 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 112.596 0.591 . . . . 73.109999999999999 112.596 -174.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.499 HG22 ' HB2' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -131.94 137.53 47.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 105.883 -1.895 . . . . 72.150000000000006 105.883 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 t -85.9 130.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 117.8 0.273 . . . . 74.140000000000001 110.415 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -96.48 131.9 42.59 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.432 -0.507 . . . . 74.299999999999997 109.64 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.54 91.69 3.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.69 -0.485 . . . . 74.030000000000001 109.69 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.49 -84.22 0.07 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.122 0.416 . . . . 22.149999999999999 112.122 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -55.32 -35.48 65.18 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 124.497 1.119 . . . . 74.209999999999994 112.505 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.8 mt -57.85 -12.29 3.01 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.887 1.275 . . . . 74.230000000000004 113.904 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.4 tp -80.07 -16.32 55.3 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.714 0.405 . . . . 73.120000000000005 111.066 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -60.85 -39.65 89.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.415 1.265 . . . . 62.219999999999999 114.415 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -72.57 -14.48 61.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.239 0.829 . . . . 75.010000000000005 113.239 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.4 ttp -60.25 -30.69 69.59 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.367 0.603 . . . . 71.310000000000002 110.376 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.77 -16.74 63.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.367 -0.833 . . . . 53.310000000000002 111.91 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.3 t -78.38 -17.95 55.74 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.936 -0.394 . . . . 71.209999999999994 109.936 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.0 m -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.355 0.598 . . . . 73.120000000000005 110.889 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -81.79 111.44 18.03 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 115.523 -0.762 . . . . 65.329999999999998 109.757 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.0 -79.95 0.28 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.827 -0.701 . . . . 62.009999999999998 113.702 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -105.69 121.36 43.86 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.225 0.536 . . . . 71.129999999999995 111.707 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.61 136.12 28.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.516 -0.92 . . . . 71.239999999999995 108.516 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.42 154.55 73.85 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.319 2.012 . . . . 70.420000000000002 110.199 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.31 169.06 16.51 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 116.32 -0.4 . . . . 73.010000000000005 110.378 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 p -57.03 136.7 56.32 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.069 0.856 . . . . 71.019999999999996 110.411 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 m -118.22 1.7 11.91 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.204 0.526 . . . . 64.010000000000005 111.968 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 15.21 56.36 Favored Glycine 0 CA--C 1.488 -1.624 0 N-CA-C 108.107 -1.997 . . . . 63.109999999999999 108.107 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.13 -8.95 47.3 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 112.898 -1.651 . . . . 72.439999999999998 109.379 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.22 -11.4 60.77 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.627 1.571 . . . . 74.040000000000006 111.063 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.63 -22.79 43.15 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.832 -1.531 . . . . 70.439999999999998 109.425 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.66 67.58 1.51 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.255 -0.646 . . . . 54.329999999999998 109.255 -174.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.08 -54.56 4.21 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.831 3.021 . . . . 73.430000000000007 114.914 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.14 -15.04 45.15 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.273 0.472 . . . . 64.019999999999996 112.273 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.51 -11.89 70.85 Favored Glycine 0 C--N 1.319 -0.387 0 N-CA-C 110.788 -0.925 . . . . 24.550000000000001 110.788 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.0 m -127.21 162.38 26.32 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.525 -1.658 . . . . 62.229999999999997 106.525 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -141.38 157.32 45.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.253 -0.647 . . . . 70.140000000000001 109.253 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -121.57 149.08 43.66 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.225 0.536 . . . . 74.310000000000002 111.831 -175.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -111.04 132.24 54.39 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.568 -0.901 . . . . 73.340000000000003 108.568 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 p -109.05 134.25 51.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.404 -0.591 . . . . 73.420000000000002 109.404 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.46 117.9 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.835 -1.543 . . . . 73.5 106.835 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -93.53 -30.97 14.73 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.052 -0.522 . . . . 72.420000000000002 111.46 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' CZ ' ' H ' ' A' ' 54' ' ' GLY . 2.7 tpm_? -144.52 141.19 29.34 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.583 -0.447 . . . . 73.430000000000007 109.961 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.458 ' H ' ' CZ ' ' A' ' 53' ' ' ARG . . . 128.8 168.1 12.32 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.942 -1.663 . . . . 63.32 108.942 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 88.4 Cg_exo -55.26 -29.58 67.78 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 122.46 2.107 . . . . 54.5 113.438 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -91.7 14.51 15.03 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.529 0.566 . . . . 71.219999999999999 112.529 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.51 143.07 58.18 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.191 0.52 . . . . 54.520000000000003 111.567 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.79 -23.15 34.75 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 115.408 -0.814 . . . . 72.409999999999997 111.243 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.57 149.31 22.2 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.771 0.319 . . . . 32.25 110.458 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 2.0 ppt_? -123.95 141.14 52.3 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.751 -0.463 . . . . 72.219999999999999 109.751 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -119.24 125.62 49.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.11 -0.7 . . . . 70.109999999999999 109.11 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.8 tp -93.67 136.19 34.2 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.809 -1.182 . . . . 74.0 107.809 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.84 104.7 16.6 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.937 -0.705 . . . . 71.019999999999996 110.09 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -116.46 -9.76 11.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.509 -1.223 . . . . 73.219999999999999 107.707 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 94' ' ' ILE . 15.1 pm0 -106.9 139.81 20.76 Favored Pre-proline 0 N--CA 1.425 -1.688 0 CA-C-N 114.871 -1.059 . . . . 74.010000000000005 109.728 -173.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 31.0 Cg_endo -64.18 -14.52 44.21 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.471 2.78 . . . . 73.129999999999995 114.182 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -148.02 127.55 13.23 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.216 -0.927 . . . . 74.030000000000001 112.015 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 45.7 m -124.15 113.54 18.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.312 -0.996 . . . . 73.239999999999995 108.312 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -89.43 134.89 33.89 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.329 -0.619 . . . . 64.230000000000004 109.329 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.5 147.0 44.09 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.514 0.673 . . . . 62.310000000000002 111.585 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.78 -169.78 21.38 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 107.867 -2.093 . . . . 73.040000000000006 107.867 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -115.61 118.34 32.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.78 -1.563 . . . . 73.310000000000002 106.78 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 44.6 p-80 176.38 162.05 0.46 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 106.381 -1.711 . . . . 75.409999999999997 106.381 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 8.3 Cg_endo -48.74 -36.64 33.56 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 123.925 3.083 . . . . 74.120000000000005 115.146 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -90.81 16.2 9.79 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.771 1.026 . . . . 73.409999999999997 113.771 -177.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.4 p -66.05 112.28 3.78 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.167 -0.679 . . . . 62.549999999999997 109.167 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 68' ' ' THR . 27.3 t0 -77.52 -34.67 53.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.415 -0.957 . . . . 64.430000000000007 108.415 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.99 117.95 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 106.992 -1.484 . . . . 52.240000000000002 106.992 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -95.19 116.93 29.39 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.321 0.582 . . . . 61.140000000000001 110.959 -175.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 2.2 mm? -123.19 139.94 53.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 105.032 -2.21 . . . . 74.200000000000003 105.032 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 55' ' ' PRO . 4.5 p-10 -79.68 127.15 31.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.903 0.858 . . . . 72.219999999999999 109.533 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -75.92 146.15 39.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.839 -1.073 . . . . 63.350000000000001 111.648 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.0 t -81.38 -43.27 20.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.478 -0.934 . . . . 75.150000000000006 108.478 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.405 ' HB ' ' CD2' ' A' ' 107' ' ' LEU . 45.2 m -133.53 158.0 44.23 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 105.517 -2.031 . . . . 63.32 105.517 176.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.97 99.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.773 0.797 . . . . 75.430000000000007 112.754 -165.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -104.14 101.76 11.5 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 114.262 -1.335 . . . . 71.109999999999999 107.584 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 6.7 ppt_? -57.16 -31.72 65.67 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.691 0.62 . . . . 75.099999999999994 112.349 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 43.6 ttm180 -159.97 132.51 6.51 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.597 -1.631 . . . . 71.510000000000005 106.597 172.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -98.67 -52.75 3.51 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.644 0.59 . . . . 74.340000000000003 110.456 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 164.6 34.45 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.335 -0.393 . . . . 71.219999999999999 110.605 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.96 130.94 54.04 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.371 -0.974 . . . . 61.450000000000003 108.371 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 9.1 m-85 -105.66 113.47 27.05 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 106.212 -1.773 . . . . 55.420000000000002 106.212 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -112.21 141.61 45.69 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.37 -0.532 . . . . 64.329999999999998 110.524 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.5 mp -113.78 112.72 41.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 105.117 -2.179 . . . . 65.150000000000006 105.117 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -131.48 126.55 35.29 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.939 -0.573 . . . . 72.25 109.551 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 55.67 36.21 26.76 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 125.194 1.398 . . . . 65.140000000000001 110.08 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.75 -2.0 75.76 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 115.492 -0.776 . . . . 61.32 113.685 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.22 150.33 25.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.37 0.585 . . . . 73.530000000000001 109.94 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.401 ' CD2' HG13 ' A' ' 94' ' ' ILE . 49.8 m-85 -106.43 131.51 53.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.55 -0.295 . . . . 75.400000000000006 110.612 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.42 147.21 52.1 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.754 -0.461 . . . . 71.230000000000004 109.754 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.28 123.17 64.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.388 -1.338 . . . . 50.130000000000003 107.388 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.6 m -118.91 122.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.346 0.593 . . . . 73.430000000000007 110.364 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -83.23 137.83 33.86 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.437 -0.801 . . . . 72.299999999999997 109.646 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.6 12.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.488 -0.778 . . . . 71.219999999999999 109.489 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.75 79.65 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.305 0 C-N-CA 120.286 -0.959 . . . . 73.109999999999999 112.817 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -71.37 33.55 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 123.588 0.755 . . . . 55.420000000000002 112.209 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 15' ' ' TPO . 4.3 tt -62.81 -42.34 99.68 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.545 -0.909 . . . . 60.43 108.545 -176.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -86.42 -4.1 59.11 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.506 -1.225 . . . . 74.230000000000004 109.374 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 88.87 1.01 Allowed Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.992 -0.623 . . . . 71.200000000000003 112.683 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -87.51 127.71 35.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.991 -0.374 . . . . 74.200000000000003 109.991 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.8 m-85 -136.37 141.73 43.71 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 109.968 -0.382 . . . . 70.230000000000004 109.968 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.7 117.66 53.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.442 -2.059 . . . . 72.25 105.442 172.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 56.71 38.65 29.68 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.859 0.837 . . . . 71.120000000000005 110.141 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.486 HH12 ' NH2' ' A' ' 134' ' ' ARG . 75.1 mtm-85 62.79 13.02 6.13 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.339 -1.3 . . . . 74.140000000000001 114.118 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -104.06 130.3 23.64 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.735 -1.58 . . . . 73.430000000000007 106.735 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.13 123.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.586 1.524 . . . . 72.450000000000003 109.701 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -142.18 140.12 32.28 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.69 -1.226 . . . . 71.519999999999996 107.69 -172.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.2 -47.06 4.07 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.194 0.521 . . . . 73.310000000000002 110.189 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.14 136.47 54.6 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.775 -0.824 . . . . 73.239999999999995 108.775 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -148.49 143.88 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.737 -0.665 . . . . 74.549999999999997 110.454 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.51 114.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 102.967 -2.975 . . . . 72.319999999999993 102.967 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.6 ttp -90.03 129.39 36.35 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.482 0.658 . . . . 74.409999999999997 110.833 -169.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -129.18 157.68 41.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.86 -1.064 . . . . 62.009999999999998 108.807 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -58.92 133.7 56.29 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.883 -0.599 . . . . 61.25 109.972 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.64 -4.8 56.62 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.586 -0.734 . . . . 74.129999999999995 111.752 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -88.69 140.06 29.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.202 -0.666 . . . . 54.539999999999999 109.202 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -117.07 145.11 43.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.811 -0.811 . . . . 74.540000000000006 108.811 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.8 mt -125.0 127.63 72.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.159 -0.682 . . . . 70.540000000000006 109.159 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 44.9 tt0 -104.86 122.08 45.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.209 -1.404 . . . . 74.140000000000001 107.209 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.74 101.75 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.091 -1.818 . . . . 62.509999999999998 106.091 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.48 -110.96 3.06 Favored Glycine 0 C--N 1.306 -1.097 0 C-N-CA 120.864 -0.684 . . . . 51.219999999999999 112.107 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -96.86 -3.52 41.88 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 122.981 0.513 . . . . 51.450000000000003 110.435 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.587 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.3 m-85 -95.11 139.15 31.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 109.798 -0.445 . . . . 72.109999999999999 109.798 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.486 ' NH2' HH12 ' A' ' 114' ' ' ARG . 81.1 ttt180 -124.81 119.43 28.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.446 -0.946 . . . . 74.200000000000003 108.446 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.7 mt -110.21 138.64 46.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.594 -0.891 . . . . 75.120000000000005 108.594 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -118.93 120.7 64.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.855 -1.165 . . . . 73.540000000000006 107.855 175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 85.6 t80 -97.14 117.77 32.07 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.355 0.409 . . . . 75.329999999999998 110.29 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -133.16 143.76 49.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.08 0.467 . . . . 73.120000000000005 110.128 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.47 119.81 38.61 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.051 0.453 . . . . 72.409999999999997 110.244 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.46 174.44 40.5 Favored Glycine 0 C--N 1.287 -2.164 0 N-CA-C 109.436 -1.465 . . . . 34.420000000000002 109.436 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.47 141.22 38.07 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 119.091 1.445 . . . . 61.210000000000001 109.66 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.55 26.67 0.13 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.889 -1.152 . . . . 64.420000000000002 107.889 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.407 -2.589 0 CA-C-N 114.498 -1.228 . . . . 74.420000000000002 108.315 -177.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 107.176 -1.416 . . . . 75.420000000000002 107.176 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 m -70.55 137.28 49.99 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 109.311 -0.626 . . . . 72.540000000000006 109.311 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -145.7 152.89 40.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.22 -1.03 . . . . 64.409999999999997 108.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -157.69 141.86 16.08 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.885 -1.154 . . . . 63.439999999999998 107.885 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -76.69 87.17 3.33 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.891 0.853 . . . . 73.329999999999998 111.001 178.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.23 -7.67 79.55 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.107 -1.197 . . . . 41.509999999999998 110.107 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -79.59 118.6 73.33 Favored Pre-proline 0 N--CA 1.417 -2.091 0 C-N-CA 123.904 0.882 . . . . 64.129999999999995 108.903 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.9 150.85 55.97 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.453 1.435 . . . . 73.239999999999995 109.021 176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -78.19 123.12 86.02 Favored Pre-proline 0 C--N 1.309 -1.162 0 C-N-CA 120.119 -0.632 . . . . 74.329999999999998 109.426 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.61 132.36 23.4 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.844 1.696 . . . . 62.530000000000001 109.958 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -91.32 145.16 24.87 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.31 132.31 55.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 121.372 0.605 . . . . 60.340000000000003 109.558 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -140.76 155.86 46.32 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 106.486 -1.672 . . . . 72.219999999999999 106.486 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -70.29 127.11 31.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.335 0.865 . . . . 74.430000000000007 113.335 -171.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.8 m -90.34 146.57 24.08 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.038 0.447 . . . . 72.010000000000005 111.997 -169.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 115.64 26.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 72.120000000000005 108.649 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -123.12 117.79 26.21 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.637 -0.71 . . . . 74.310000000000002 110.144 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -82.76 101.24 10.78 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.691 -1.966 . . . . 72.510000000000005 105.691 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 108.75 1.71 Allowed 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.489 -0.778 . . . . 53.200000000000003 110.474 -177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 35.5 t70 -60.1 -24.16 64.41 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.659 0.742 . . . . 70.120000000000005 110.263 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -65.81 -3.81 5.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.645 -1.161 . . . . 74.310000000000002 113.142 178.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 pp -57.83 -24.62 58.24 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.122 0.487 . . . . 65.450000000000003 111.287 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 21' ' ' ASP . 49.6 mtmt -66.82 -28.95 68.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.836 -0.62 . . . . 74.430000000000007 110.857 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.69 -26.31 62.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.478 -0.328 . . . . 61.210000000000001 110.855 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.3 mtm -65.93 -40.35 91.32 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.93 -0.767 . . . . 64.439999999999998 108.93 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.91 -40.28 94.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.033 -0.985 . . . . 73.040000000000006 109.557 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 m -73.01 -27.75 61.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.536 -0.756 . . . . 61.119999999999997 111.044 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.1 m -74.05 -30.48 62.42 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 109.921 -0.4 . . . . 63.439999999999998 109.921 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 127.88 34.29 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.941 -1.027 . . . . 61.539999999999999 109.341 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.22 -42.69 1.28 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 107.674 -2.17 . . . . 63.539999999999999 107.674 -175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.6 m -115.77 121.95 43.99 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 107.474 -1.306 . . . . 72.519999999999996 107.474 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -90.39 138.52 26.95 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.008 -0.738 . . . . 74.310000000000002 109.008 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' ALA . 7.9 Cg_exo -73.52 142.24 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.701 1.6 . . . . 45.039999999999999 111.468 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.13 126.48 46.38 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.081 -1.081 . . . . 73.319999999999993 108.081 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 123' ' ' GLN . 12.9 m -137.96 110.88 7.71 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.631 -0.507 . . . . 75.400000000000006 109.631 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.6 m -154.18 142.4 20.44 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.733 -1.21 . . . . 74.200000000000003 107.733 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -15.01 3.63 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.114 -1.041 . . . . 52.420000000000002 112.166 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.13 59.04 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.299 -0.63 . . . . 61.530000000000001 109.299 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -79.8 3.7 18.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.188 -0.914 . . . . 73.310000000000002 111.671 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.28 -27.89 18.13 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.085 -0.709 . . . . 75.310000000000002 109.085 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 46.65 77.93 0.43 Allowed Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.331 1.052 . . . . 62.539999999999999 113.665 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -70.22 -61.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.508 1.472 . . . . 71.349999999999994 111.537 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.05 -13.79 18.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 111.567 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.17 17.52 74.04 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.711 -0.955 . . . . 73.430000000000007 110.711 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -150.44 167.08 28.19 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 105.902 -1.888 . . . . 25.120000000000001 105.902 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -152.12 157.9 42.21 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 118.446 0.566 . . . . 63.420000000000002 111.278 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.1 pp -121.2 154.53 36.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.129 0.49 . . . . 63.340000000000003 111.916 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.42 141.37 51.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.966 -0.753 . . . . 63.399999999999999 108.966 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.68 134.36 59.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 109.891 -0.411 . . . . 64.299999999999997 109.891 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 t -86.63 118.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 108.103 -1.073 . . . . 63.340000000000003 108.103 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -92.27 -32.2 15.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 111.336 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -143.47 136.73 27.97 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 120.422 -0.511 . . . . 75.319999999999993 110.096 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.86 174.84 13.84 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.2 -1.16 . . . . 63.340000000000003 110.2 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -55.43 -32.05 80.36 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.649 2.233 . . . . 74.200000000000003 112.793 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -90.44 10.48 25.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.256 0.465 . . . . 73.109999999999999 112.256 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.39 136.27 57.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.902 0.319 . . . . 70.420000000000002 111.444 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.16 -16.78 55.19 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.509 -0.636 . . . . 32.439999999999998 111.509 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.63 139.01 31.12 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.907 0.384 . . . . 54.200000000000003 110.324 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -122.79 134.55 54.42 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.146 -1.057 . . . . 74.530000000000001 108.146 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -120.58 118.65 30.73 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.546 -0.297 . . . . 74.319999999999993 110.338 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.3 tp -87.55 111.76 21.54 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.31 -0.996 . . . . 72.140000000000001 108.31 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -95.0 117.26 29.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.342 0.591 . . . . 73.310000000000002 109.653 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -122.02 14.03 10.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.846 -1.07 . . . . 72.209999999999994 108.835 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -108.47 156.46 38.62 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.304 -0.862 . . . . 64.310000000000002 109.521 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 38.2 Cg_endo -69.18 -20.68 37.25 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.175 1.917 . . . . 65.230000000000004 114.527 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.5 m -153.53 127.17 8.74 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.29 -0.881 . . . . 75.140000000000001 111.858 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -126.25 112.86 16.23 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.979 -1.119 . . . . 74.299999999999997 107.979 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 77.7 m -89.07 139.18 30.72 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.39 -0.524 . . . . 73.400000000000006 109.624 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.01 135.61 54.85 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.358 0.599 . . . . 60.32 110.912 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.05 -160.21 33.1 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.731 -2.148 . . . . 61.229999999999997 107.731 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -115.72 116.81 28.7 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 151.43 153.23 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 127.48 2.312 . . . . 61.409999999999997 107.228 177.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.95 -9.97 25.22 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.397 2.065 . . . . 75.099999999999994 111.79 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.52 -17.84 61.17 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.746 0.818 . . . . 62.350000000000001 110.248 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 m -90.07 150.02 22.25 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.218 -1.401 . . . . 62.200000000000003 107.218 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.31 -45.95 24.56 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.702 -0.851 . . . . 74.430000000000007 108.702 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.8 pt -106.16 130.51 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.086 -1.079 . . . . 75.420000000000002 108.086 174.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -94.26 108.12 20.03 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.954 -0.566 . . . . 74.409999999999997 109.996 -173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -101.74 116.25 32.33 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.992 -1.485 . . . . 72.450000000000003 106.992 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.03 117.04 13.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.931 0.395 . . . . 73.200000000000003 110.227 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -107.62 165.97 11.03 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.815 -0.63 . . . . 65.109999999999999 109.55 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.55 -28.68 32.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.963 0.887 . . . . 73.239999999999995 108.786 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -111.03 173.93 6.1 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.588 -1.634 . . . . 54.329999999999998 106.588 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.48 96.91 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 N-CA-C 106.018 -1.845 . . . . 63.340000000000003 106.018 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 m -105.13 106.74 17.37 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.65 -0.87 . . . . 75.420000000000002 108.65 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -56.29 -42.04 76.88 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.787 1.032 . . . . 74.5 113.787 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -148.7 129.31 14.05 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.857 -1.164 . . . . 73.129999999999995 107.857 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 4.1 t60 -100.29 -52.19 3.45 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.776 -1.194 . . . . 73.030000000000001 107.776 172.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.15 163.98 38.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.147 -1.057 . . . . 71.310000000000002 108.147 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 69' ' ' THR . 12.7 pt-20 -138.34 148.42 44.55 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.248 0.547 . . . . 74.230000000000004 110.631 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -105.29 131.72 52.39 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.18 -1.415 . . . . 71.439999999999998 107.18 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -122.95 130.93 53.44 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 116.319 -0.401 . . . . 60.509999999999998 110.444 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 46.3 mt -116.09 112.08 38.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 105.553 -2.017 . . . . 33.43 105.553 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -139.83 125.71 19.59 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.731 -0.47 . . . . 73.450000000000003 109.731 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 55.87 38.02 29.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.103 0.961 . . . . 73.239999999999995 112.353 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.52 -0.31 89.26 Favored Glycine 0 C--O 1.223 -0.564 0 C-N-CA 121.16 -0.543 . . . . 30.140000000000001 113.98 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -106.47 136.86 45.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.005 0.402 . . . . 55.210000000000001 110.046 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -107.79 119.51 39.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.127 -1.064 . . . . 71.010000000000005 108.127 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.35 146.64 51.96 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 121.733 -0.604 . . . . 62.299999999999997 112.329 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.04 123.98 58.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 106.508 -1.664 . . . . 61.130000000000003 106.508 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.43 122.38 68.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.419 -0.956 . . . . 51.310000000000002 108.419 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.12 134.58 35.67 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.994 -0.743 . . . . 73.230000000000004 108.994 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.74 9.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.068 0.461 . . . . 54.439999999999998 109.867 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.63 57.19 0.39 Allowed Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 108.727 -1.749 . . . . 71.310000000000002 108.727 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 p -68.7 24.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.376 1.871 . . . . 74.400000000000006 114.349 -172.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 78.3 mt -106.35 -26.47 11.48 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 116.431 -0.349 . . . . 74.129999999999995 111.546 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.537 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 2.9 m-20 -86.48 -18.94 30.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.601 -0.84 . . . . 73.340000000000003 111.738 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.98 74.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.814 0 C-N-CA 119.664 -1.255 . . . . 55.149999999999999 113.073 175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -87.76 128.56 35.32 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 110.036 -0.357 . . . . 75.510000000000005 110.036 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 89.0 m-85 -135.53 136.06 40.87 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.658 -0.867 . . . . 72.25 108.658 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.45 133.19 60.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.137 -1.431 . . . . 70.319999999999993 107.137 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.52 38.59 29.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.309 1.044 . . . . 74.129999999999995 108.688 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 64.18 14.85 8.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.046 1.498 . . . . 63.119999999999997 115.046 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -124.5 148.66 59.29 Favored Pre-proline 0 C--N 1.308 -1.202 0 C-N-CA 120.204 -0.599 . . . . 63.0 109.423 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.39 123.43 13.07 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.801 1.667 . . . . 74.349999999999994 108.502 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 120' ' ' GLN . 17.4 tpp85 -151.07 135.92 17.32 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.634 -0.827 . . . . 75.109999999999999 109.728 -170.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -96.7 -57.6 2.26 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.712 0.633 . . . . 61.219999999999999 110.552 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.85 134.04 55.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.834 -1.173 . . . . 64.150000000000006 107.834 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.468 ' HB2' ' CG ' ' A' ' 117' ' ' ARG . 27.7 tp60 -155.08 132.9 11.42 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 123.226 0.329 . . . . 65.099999999999994 111.228 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.58 130.71 31.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.268 -1.382 . . . . 75.340000000000003 107.268 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.8 ptm -98.87 130.24 45.26 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.103 0.478 . . . . 70.450000000000003 110.183 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 2.8 tp60 -113.53 156.16 24.09 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.861 -0.609 . . . . 45.409999999999997 110.257 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 138' ' ' LEU . 45.2 m -61.34 123.29 17.35 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 122.31 -0.244 . . . . 63.520000000000003 110.379 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.07 -2.03 56.55 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.812 -0.515 . . . . 61.329999999999998 111.812 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.49 146.0 32.94 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 108.525 -0.917 . . . . 64.109999999999999 108.525 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.45 126.69 51.06 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-O 121.915 0.864 . . . . 65.329999999999998 110.654 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.41 131.65 60.92 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-N 114.599 -1.182 . . . . 65.219999999999999 108.02 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.2 tt0 -120.63 112.49 18.96 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.868 -1.16 . . . . 73.450000000000003 107.868 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.2 mt -109.66 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.237 -0.892 . . . . 73.439999999999998 109.18 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.19 -89.06 0.41 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.97 -1.252 . . . . 75.420000000000002 109.97 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -134.47 6.13 3.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.417 -0.586 . . . . 74.409999999999997 109.417 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 65.1 m-85 -84.59 147.77 26.82 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.018 -0.734 . . . . 64.340000000000003 109.018 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -124.88 120.06 30.58 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.84 -0.8 . . . . 73.319999999999993 108.84 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.33 138.07 50.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.387 -1.338 . . . . 64.109999999999999 107.387 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.6 t -117.11 127.13 74.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 107.539 -1.282 . . . . 72.150000000000006 107.539 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -95.49 126.95 41.13 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.435 0.459 . . . . 75.209999999999994 111.062 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.414 ' HA ' HG23 ' A' ' 124' ' ' THR . 2.9 mm? -127.23 159.92 32.86 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.028 -0.73 . . . . 75.400000000000006 109.028 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.89 151.41 38.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.103 -0.703 . . . . 73.420000000000002 109.103 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -68.93 155.26 53.55 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.172 -0.537 . . . . 63.049999999999997 112.256 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -71.18 142.85 42.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.466 2.111 . . . . 75.150000000000006 111.52 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.98 65.27 0.8 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.163 -1.421 . . . . 74.109999999999999 107.163 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.607 -1.633 . . . . 65.540000000000006 108.499 -176.82 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.682 0.277 . . . . 74.129999999999995 111.178 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -72.68 82.3 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 115.314 1.598 . . . . 74.230000000000004 115.314 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -95.48 105.66 17.65 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.554 -1.647 . . . . 64.010000000000005 106.554 170.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -62.96 100.47 0.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.698 0.999 . . . . 72.329999999999998 113.698 -172.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.36 155.81 36.11 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.055 -0.975 . . . . 73.319999999999993 110.011 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.64 167.22 30.84 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 110.392 -1.083 . . . . 72.450000000000003 110.392 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -105.18 108.35 61.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 117.196 0.498 . . . . 53.340000000000003 110.767 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.44 150.6 52.32 Favored 'Trans proline' 0 C--O 1.25 1.118 0 C-N-CA 122.617 2.211 . . . . 73.340000000000003 112.576 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -79.44 119.68 77.79 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.361 -0.978 . . . . 71.409999999999997 108.361 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.98 160.01 43.77 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.225 1.95 . . . . 44.520000000000003 112.287 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -91.66 162.57 14.44 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.095 -1.817 . . . . 64.329999999999998 106.095 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.6 t -108.22 121.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 119.326 -0.949 . . . . 72.420000000000002 109.694 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.65 138.42 32.5 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.319 -0.993 . . . . 71.349999999999994 108.319 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -76.48 133.31 39.83 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.83 0.706 . . . . 75.120000000000005 109.976 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.459 HG22 HG21 ' A' ' 84' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.1 m -89.41 152.92 21.23 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.602 -0.888 . . . . 72.400000000000006 108.602 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -82.63 115.28 24.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.746 -0.835 . . . . 64.120000000000005 108.746 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -123.82 140.78 52.65 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.697 -0.683 . . . . 75.219999999999999 110.554 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -97.53 95.58 7.73 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.1 -1.074 . . . . 72.430000000000007 108.1 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.82 38.85 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.668 -1.151 . . . . 74.120000000000005 112.069 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.86 2.18 2.16 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.536 1.135 . . . . 75.219999999999999 113.759 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.66 -13.77 59.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.758 0.651 . . . . 72.230000000000004 112.758 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -69.03 -19.67 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.342 0.592 . . . . 62.32 109.929 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.09 -22.52 59.47 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.077 -0.51 . . . . 74.099999999999994 110.499 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -77.09 -29.95 55.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.231 0.539 . . . . 61.539999999999999 109.939 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -65.3 -47.47 76.5 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.941 -1.133 . . . . 73.510000000000005 107.941 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.32 -39.86 94.43 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.318 -1.31 . . . . 61.009999999999998 110.251 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 t -60.84 -39.01 87.48 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.786 1.234 . . . . 63.119999999999997 110.884 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.496 ' HB2' ' NH1' ' A' ' 114' ' ' ARG . 31.3 t -81.71 -16.52 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.583 -0.28 . . . . 63.100000000000001 110.512 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 m 71.57 31.63 2.2 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 122.525 1.155 . . . . 71.340000000000003 108.481 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.89 -151.05 19.69 Favored Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 115.097 -0.956 . . . . 70.150000000000006 112.04 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 t -84.78 137.97 32.88 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.144 0.577 . . . . 42.240000000000002 110.433 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.9 115.57 59.43 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 73.140000000000001 108.304 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 142.51 25.99 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.354 2.036 . . . . 74.209999999999994 114.9 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.12 126.51 30.18 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.466 -2.049 . . . . 61.310000000000002 105.466 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' THR . 55.4 p -91.32 -98.43 0.11 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.253 -0.979 . . . . 63.43 113.445 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 36' ' ' SER . 1.0 OUTLIER -170.34 -169.97 0.89 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.007 1.323 . . . . 71.120000000000005 108.877 -177.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.07 -161.44 31.98 Favored Glycine 1 N--CA 1.386 -4.684 0 N-CA-C 105.961 -2.856 . . . . 54.009999999999998 105.961 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.9 -20.88 20.95 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.887 -1.153 . . . . 73.329999999999998 107.887 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.62 -10.7 59.96 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.193 -1.821 . . . . 64.129999999999995 112.965 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' O ' HD13 ' A' ' 42' ' ' LEU . 32.4 p-10 -80.39 -33.72 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.377 -0.529 . . . . 73.329999999999998 110.74 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 97' ' ' GLY . 2.1 mm? -128.13 82.92 67.53 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.141 -1.059 . . . . 71.239999999999995 108.141 173.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' A' ' 141' ' ' PRO . 4.0 Cg_exo -77.24 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.173 1.915 . . . . 72.109999999999999 111.758 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 142' ' ' ALA . . . -104.48 -7.05 20.08 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.449 -0.574 . . . . 75.310000000000002 109.449 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.06 43.75 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.386 -1.086 . . . . 71.409999999999997 110.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 m -126.07 149.27 49.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.376 -1.342 . . . . 74.510000000000005 107.376 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.07 157.75 42.06 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.606 -0.516 . . . . 61.109999999999999 109.606 -175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.17 142.18 51.44 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 110.003 -0.369 . . . . 70.030000000000001 110.003 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.476 HD13 HD23 ' A' ' 135' ' ' LEU . 3.7 pp -110.17 139.31 45.46 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.902 -0.777 . . . . 71.319999999999993 108.902 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.56 132.59 68.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 N-CA-C 109.538 -0.542 . . . . 73.310000000000002 109.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.5 t -81.59 117.45 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.048 -1.464 . . . . 43.240000000000002 107.048 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -85.78 -38.22 18.44 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.489 -0.778 . . . . 64.439999999999998 109.119 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 22.6 tpt180 -148.16 136.9 21.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.2 -1.407 . . . . 75.439999999999998 107.2 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.68 -176.55 26.46 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.681 -0.968 . . . . 43.530000000000001 110.681 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.54 -45.18 12.01 Favored 'Trans proline' 0 C--N 1.327 -0.572 0 C-N-CA 122.519 2.146 . . . . 73.230000000000004 112.145 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -95.11 23.08 5.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 111.83 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 138.77 46.98 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.32 -0.4 . . . . 71.310000000000002 111.286 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.57 -25.8 23.32 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.878 -0.889 . . . . 45.5 110.878 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.61 150.2 21.81 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.033 0.444 . . . . 41.530000000000001 110.19 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -126.45 153.56 44.88 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.221 -1.029 . . . . 70.310000000000002 108.221 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -128.14 130.18 47.69 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.82 -0.807 . . . . 72.439999999999998 108.82 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 tp -95.53 130.8 42.25 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.997 -0.547 . . . . 73.530000000000001 110.197 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -107.31 105.19 15.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.044 -1.095 . . . . 65.010000000000005 108.044 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -129.42 14.89 6.08 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.847 1.308 . . . . 63.310000000000002 107.709 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -114.43 155.01 46.44 Favored Pre-proline 0 C--N 1.303 -1.437 0 CA-C-N 113.825 -1.534 . . . . 61.229999999999997 108.507 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 66.5 Cg_endo -72.79 -14.64 26.9 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.734 2.289 . . . . 73.329999999999998 113.61 -178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 95.3 m -153.22 128.94 10.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.562 -0.711 . . . . 71.340000000000003 110.54 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 15.4 m -130.09 126.89 38.67 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.66 -0.496 . . . . 71.439999999999998 109.66 177.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.0 m -90.55 129.59 36.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.639 -0.874 . . . . 64.310000000000002 108.639 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.02 134.56 55.12 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.364 0.602 . . . . 55.119999999999997 110.66 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.37 -170.09 33.37 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.438 -2.665 . . . . 61.310000000000002 106.438 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -105.96 118.18 35.95 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.946 1.373 . . . . 71.340000000000003 110.396 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.414 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 17.7 m170 -172.84 152.02 2.34 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 127.184 2.194 . . . . 65.129999999999995 106.06 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.83 -17.6 28.95 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 121.627 1.552 . . . . 64.219999999999999 108.952 169.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 73' ' ' HIS . 8.7 mm-40 -76.81 -26.84 54.87 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.952 -1.476 . . . . 74.150000000000006 110.035 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 45.6 m -67.61 132.25 47.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.707 -0.849 . . . . 64.120000000000005 108.707 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.72 -41.44 95.96 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.08 -0.711 . . . . 60.420000000000002 109.08 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.6 pt -107.64 118.8 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.646 -0.872 . . . . 73.219999999999999 108.646 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.54 109.42 20.57 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.755 0.788 . . . . 74.430000000000007 110.512 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.16 140.37 49.6 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.438 -1.69 . . . . 71.239999999999995 106.438 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.32 117.67 34.65 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.363 -0.977 . . . . 73.510000000000005 108.363 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -102.62 173.85 6.16 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.927 -1.033 . . . . 71.209999999999994 111.956 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -66.14 -30.94 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 124.316 1.047 . . . . 71.010000000000005 108.732 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.459 HG21 HG22 ' A' ' 15' ' ' TPO . 15.0 m -117.17 163.1 16.8 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 106.899 -1.519 . . . . 52.229999999999997 106.899 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.32 96.92 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 N-CA-C 104.434 -2.432 . . . . 74.219999999999999 104.434 168.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.413 ' HA ' ' O2P' ' A' ' 15' ' ' TPO . 2.0 p -94.2 131.54 39.66 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-N 115.494 -0.775 . . . . 71.530000000000001 110.326 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 87' ' ' ARG . 36.9 mtt180 -74.23 -47.59 34.32 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 123.224 1.488 . . . . 72.450000000000003 107.117 -175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -149.54 115.55 5.69 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 112.557 -2.11 . . . . 72.430000000000007 107.807 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -99.22 -47.2 5.28 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.735 -0.839 . . . . 65.230000000000004 108.735 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.54 151.51 40.32 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.895 -0.78 . . . . 60.200000000000003 108.895 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.8 134.55 54.41 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.902 -1.147 . . . . 52.409999999999997 107.902 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.7 m-85 -105.2 121.43 43.83 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.257 -1.016 . . . . 74.010000000000005 108.257 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -115.85 123.74 48.93 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.171 -1.048 . . . . 63.299999999999997 108.171 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 2.9 mp -104.49 123.15 58.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 106.609 -1.626 . . . . 63.310000000000002 106.609 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -136.87 123.66 21.24 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.986 -1.116 . . . . 72.5 107.986 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 56.13 36.13 26.87 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.605 1.162 . . . . 71.409999999999997 111.102 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' HD12 ' A' ' 42' ' ' LEU . . . 78.97 -0.32 79.2 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 113.374 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.7 149.7 23.88 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 109.002 -0.74 . . . . 73.430000000000007 109.002 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.8 117.54 33.11 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.126 -0.488 . . . . 63.219999999999999 110.089 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.78 129.93 55.51 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.152 0.501 . . . . 71.120000000000005 109.658 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.49 124.6 59.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.526 -0.916 . . . . 63.509999999999998 108.526 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.22 137.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.257 -0.646 . . . . 62.030000000000001 109.257 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -85.81 140.94 30.02 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.64 -0.709 . . . . 64.420000000000002 110.841 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.63 14.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 122.39 1.09 . . . . 74.439999999999998 108.555 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.93 48.48 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.572 -1.411 . . . . 72.109999999999999 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 m -60.06 -2.6 0.45 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.876 1.67 . . . . 75.230000000000004 113.631 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.14 -26.0 17.62 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.447 -0.575 . . . . 75.430000000000007 109.447 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -94.71 -18.65 21.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.623 -0.717 . . . . 73.219999999999999 111.83 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.92 77.1 1.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.012 -1.089 . . . . 61.109999999999999 112.643 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.1 m -87.02 128.68 35.08 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.014 0.435 . . . . 75.109999999999999 110.388 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 35.9 m-85 -133.64 127.41 32.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.261 -0.427 . . . . 72.319999999999993 110.516 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.15 137.66 55.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 105.398 -2.075 . . . . 64.230000000000004 105.398 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 57.3 33.77 23.78 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 106.738 -1.579 . . . . 64.239999999999995 106.738 -166.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.496 ' NH1' ' HB2' ' A' ' 29' ' ' SER . 73.6 mtt180 57.94 11.43 1.43 Allowed 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 123.187 0.595 . . . . 63.340000000000003 111.655 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -107.7 144.47 29.36 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 124.388 1.075 . . . . 75.219999999999999 110.248 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.14 123.93 12.26 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.089 1.859 . . . . 64.209999999999994 108.787 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 117' ' ' ARG . 3.7 mmp_? -135.82 155.85 49.71 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.667 0.988 . . . . 73.150000000000006 113.667 -176.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -99.2 -41.85 7.31 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.9 -1.5 . . . . 62.219999999999999 107.434 171.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.4 143.61 25.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.52 -1.218 . . . . 71.310000000000002 108.197 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 138.15 19.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.011 -1.107 . . . . 54.509999999999998 108.011 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.73 116.7 40.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 105.412 -2.07 . . . . 75.019999999999996 105.412 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 77.4 mtp -89.75 149.08 22.88 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 114.163 1.172 . . . . 64.129999999999995 114.163 -168.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -112.43 157.38 21.14 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.661 -1.609 . . . . 61.420000000000002 107.778 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.6 t -66.27 127.39 32.01 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.169 -0.613 . . . . 73.129999999999995 109.829 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 0.03 57.32 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.266 -0.734 . . . . 71.439999999999998 111.266 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -82.77 152.27 25.77 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.964 -0.384 . . . . 72.019999999999996 109.964 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -115.71 144.18 44.32 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.263 0.554 . . . . 75.420000000000002 112.237 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.6 mt -117.91 131.88 69.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.442 . . . . 74.420000000000002 107.108 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 111' ' ' TYR . 54.9 mt-30 -117.84 120.55 38.23 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.56 -0.904 . . . . 73.319999999999993 108.56 175.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.75 114.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.301 -0.863 . . . . 70.010000000000005 108.836 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.0 -80.98 0.57 Allowed Glycine 0 C--O 1.206 -1.594 0 N-CA-C 110.006 -1.238 . . . . 35.130000000000003 110.006 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -154.87 8.28 0.3 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 122.436 0.294 . . . . 72.299999999999997 111.112 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 31.1 p90 -107.39 160.29 15.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.881 -0.785 . . . . 62.43 108.881 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -124.76 137.82 54.31 Favored 'General case' 0 C--O 1.253 1.288 0 C-N-CA 119.234 -0.986 . . . . 64.120000000000005 112.329 -168.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.476 HD23 HD13 ' A' ' 49' ' ' LEU . 3.0 mp -122.32 139.82 53.37 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.698 -1.223 . . . . 75.209999999999994 107.698 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.12 124.93 69.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.768 -1.197 . . . . 55.32 107.768 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -98.28 118.26 34.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.188 -0.671 . . . . 75.25 109.188 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.4 mt -122.34 131.67 54.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.972 -0.381 . . . . 75.239999999999995 109.972 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.29 119.57 28.82 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.458 -1.682 . . . . 72.219999999999999 106.458 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.01 -70.66 0.29 Allowed Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.519 -1.324 . . . . 73.099999999999994 115.356 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 43' ' ' PRO . 25.7 Cg_exo -57.74 141.28 95.57 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.693 1.595 . . . . 71.25 114.785 -172.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . . . -161.84 29.34 0.12 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 104.011 -2.588 . . . . 71.540000000000006 104.011 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.416 -2.154 0 CA-C-N 112.99 -1.914 . . . . 41.140000000000001 108.31 -169.134 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 CA--C 1.508 -0.656 0 CA-C-O 121.423 0.63 . . . . 61.420000000000002 111.543 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -92.76 11.92 25.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.672 0.749 . . . . 73.219999999999999 109.078 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.32 158.83 16.44 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 125.308 1.443 . . . . 72.230000000000004 110.823 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -79.69 -178.39 6.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.213 -0.448 . . . . 74.040000000000006 111.306 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -84.8 94.32 8.68 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.203 0.525 . . . . 71.219999999999999 111.092 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.51 36.31 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.967 -1.253 . . . . 72.129999999999995 109.967 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.8 p -99.38 113.22 64.69 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 119.824 -0.75 . . . . 64.209999999999994 111.551 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.16 132.63 37.25 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 N-CA-C 106.311 -2.227 . . . . 62.149999999999999 106.311 167.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.37 140.49 56.34 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 119.818 -0.753 . . . . 51.350000000000001 110.564 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -67.8 92.38 0.37 Allowed 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 121.915 1.744 . . . . 73.150000000000006 111.976 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -119.58 149.89 41.2 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 107.418 -1.327 . . . . 63.32 107.418 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 t -109.07 121.65 62.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 107.076 -1.453 . . . . 61.439999999999998 107.076 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -119.16 169.3 10.06 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.884 -1.154 . . . . 73.219999999999999 107.884 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -67.87 109.61 3.48 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-O 121.762 0.791 . . . . 61.329999999999998 111.761 -170.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -124.92 120.82 32.7 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.009 -0.367 . . . . 73.219999999999999 110.009 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 47.1 t -87.17 122.44 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.302 -0.629 . . . . 61.539999999999999 109.302 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -123.66 129.02 50.49 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.872 0.368 . . . . 74.530000000000001 111.855 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -96.55 116.03 28.41 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.266 -1.753 . . . . 75.129999999999995 106.266 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.36 -166.71 2.63 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.546 -0.862 . . . . 73.239999999999995 113.315 -171.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.16 -14.28 1.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.886 2.074 . . . . 73.040000000000006 115.059 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 22' ' ' LEU . 1.8 pt? -64.66 -23.11 67.15 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.119 -0.363 . . . . 73.439999999999998 111.744 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.19 -22.5 63.9 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.877 0.37 . . . . 72.450000000000003 111.823 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -91.8 -42.04 10.32 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.822 -1.547 . . . . 74.400000000000006 106.822 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -26.37 67.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.642 1.177 . . . . 54.32 109.397 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.6 tpp -51.75 -26.13 8.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.757 1.223 . . . . 65.209999999999994 112.167 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.49 -38.34 86.94 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 120.725 0.298 . . . . 61.340000000000003 110.472 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -72.91 -34.96 66.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.234 -0.654 . . . . 64.439999999999998 109.234 -177.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.45 ' O ' ' HD2' ' A' ' 114' ' ' ARG . 17.9 m -68.81 -30.5 69.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.901 -0.591 . . . . 71.120000000000005 110.065 176.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.4 m -81.55 107.03 13.98 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.18 0.514 . . . . 54.420000000000002 110.797 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 179.65 38.69 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 108.997 -1.641 . . . . 44.439999999999998 108.997 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.6 m -74.94 124.16 26.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 117.69 0.745 . . . . 72.099999999999994 109.646 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.45 150.24 38.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 N-CA-C 108.251 -1.018 . . . . 53.210000000000001 108.251 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 125' ' ' GLY . 53.4 Cg_exo -57.18 154.97 31.25 Favored 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.551 2.167 . . . . 52.310000000000002 111.876 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.07 145.67 27.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.695 -0.684 . . . . 33.310000000000002 112.335 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.426 ' HB3' HD21 ' A' ' 41' ' ' ASN . 66.1 m -116.07 148.3 40.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.122 -1.066 . . . . 75.439999999999998 108.122 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 p -116.74 -60.68 1.82 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.931 0.396 . . . . 75.140000000000001 111.384 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.83 -63.55 0.18 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.467 -0.653 . . . . 50.009999999999998 111.467 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.56 54.5 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.123 0.487 . . . . 73.409999999999997 110.95 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.52 -5.92 47.62 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.424 -0.807 . . . . 63.219999999999999 111.08 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 36' ' ' SER . 3.1 m-20 -82.09 -42.17 19.54 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.414 -0.812 . . . . 62.420000000000002 110.131 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -131.32 83.22 60.21 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 109.086 -0.709 . . . . 54.119999999999997 109.086 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.39 -65.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.848 2.365 . . . . 73.150000000000006 112.269 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.13 -16.19 59.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.286 0.565 . . . . 71.230000000000004 111.012 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.97 -7.44 77.6 Favored Glycine 0 C--O 1.222 -0.63 0 N-CA-C 110.975 -0.85 . . . . 75.340000000000003 110.975 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -120.08 157.08 29.7 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.624 -1.621 . . . . 74.439999999999998 106.624 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.89 156.87 43.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.583 -0.525 . . . . 72.25 109.583 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.95 140.82 52.57 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.996 0.427 . . . . 72.219999999999999 110.712 -178.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.417 HD13 HD23 ' A' ' 135' ' ' LEU . 1.5 pp -112.19 140.73 46.65 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 116.288 -0.414 . . . . 74.420000000000002 110.931 177.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -114.71 128.08 71.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 107.638 -1.245 . . . . 74.430000000000007 107.638 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.3 t -78.45 118.92 26.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.736 -1.209 . . . . 73.409999999999997 107.736 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -83.4 -32.63 26.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.62 0.724 . . . . 74.299999999999997 110.131 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 20.2 tpp180 -154.01 148.81 26.53 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.992 -1.485 . . . . 72.439999999999998 106.992 -177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.28 -174.85 17.86 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 109.722 -1.351 . . . . 61.520000000000003 109.722 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -65.2 -37.95 29.58 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.309 2.006 . . . . 64.230000000000004 111.029 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -89.61 14.37 11.77 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.749 -1.114 . . . . 72.109999999999999 110.862 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.65 129.32 41.55 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.762 0.315 . . . . 63.210000000000001 111.295 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.0 -26.05 24.38 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.95 -0.568 . . . . 54.229999999999997 112.188 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.81 144.77 29.9 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.839 0.352 . . . . 53.130000000000003 110.133 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -123.69 137.54 54.69 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.992 -0.744 . . . . 73.219999999999999 108.992 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.04 130.56 52.76 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.705 -0.48 . . . . 72.140000000000001 109.705 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.75 128.4 36.67 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.644 -1.243 . . . . 75.340000000000003 107.644 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.731 HD22 HG21 ' A' ' 68' ' ' THR . 26.6 mt -106.78 123.95 48.89 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.057 -1.09 . . . . 61.409999999999997 108.057 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -136.57 1.11 2.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.688 0.996 . . . . 64.450000000000003 113.688 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.545 ' O ' HD13 ' A' ' 94' ' ' ILE . 3.8 pt20 -107.24 152.88 41.33 Favored Pre-proline 0 C--O 1.211 -0.961 0 C-N-CA 119.556 -0.857 . . . . 74.510000000000005 110.13 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 8.8 Cg_endo -52.2 -21.56 13.32 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 124.088 3.192 . . . . 74.310000000000002 114.996 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.7 m -142.51 121.66 12.97 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.723 -0.473 . . . . 71.420000000000002 109.723 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.731 HG21 HD22 ' A' ' 63' ' ' LEU . 67.9 m -129.3 113.27 14.78 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.162 -0.681 . . . . 73.409999999999997 109.162 178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -94.28 143.1 26.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.707 -0.797 . . . . 74.420000000000002 109.811 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.16 135.02 54.73 Favored 'General case' 0 C--O 1.279 2.644 0 C-N-CA 122.63 0.372 . . . . 52.420000000000002 111.516 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.22 -142.12 10.24 Favored Glycine 0 N--CA 1.435 -1.401 0 O-C-N 124.759 1.287 . . . . 60.340000000000003 111.882 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 86' ' ' SER . 17.9 mmt85 -88.04 154.74 20.24 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.615 1.966 . . . . 62.299999999999997 110.272 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.433 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 22.9 m170 89.17 130.06 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.718 1.607 . . . . 63.240000000000002 111.057 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.21 -3.22 8.27 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.818 2.345 . . . . 75.230000000000004 113.283 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 13.2 pt-20 -73.56 -25.3 60.31 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.888 -0.782 . . . . 75.109999999999999 108.888 173.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.9 m -78.55 143.62 36.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.335 -1.357 . . . . 61.039999999999999 107.335 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' A' ' 68' ' ' THR . 30.0 t70 -69.44 -45.72 68.43 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.78 0.324 . . . . 74.010000000000005 111.142 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.3 pt -107.45 109.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 121.859 0.838 . . . . 72.120000000000005 111.032 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -87.86 115.81 25.59 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.514 -1.221 . . . . 71.329999999999998 110.652 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.21 139.98 49.79 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.1 -1.815 . . . . 72.540000000000006 106.1 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -92.2 117.05 29.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.474 -1.29 . . . . 52.240000000000002 110.197 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.29 171.69 7.82 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.693 -0.685 . . . . 74.310000000000002 110.24 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.93 -29.38 17.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.343 1.057 . . . . 64.109999999999999 109.76 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.3 t -131.26 -163.17 1.29 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.484 -0.932 . . . . 74.450000000000003 108.484 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.4 t -84.05 97.33 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-O 121.791 0.805 . . . . 65.450000000000003 109.008 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 16.4 t -95.9 77.83 3.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.879 -1.526 . . . . 64.329999999999998 106.879 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -56.68 -44.48 81.48 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 112.825 0.676 . . . . 74.329999999999998 112.825 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -163.42 97.3 0.88 Allowed 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.108 -1.812 . . . . 75.209999999999994 106.108 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 23.7 t-160 -92.77 -52.04 4.8 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.883 -0.727 . . . . 75.109999999999999 109.483 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -128.25 150.14 50.17 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 118.986 -1.086 . . . . 74.239999999999995 110.246 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.36 134.46 36.0 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.97 -0.752 . . . . 74.430000000000007 108.97 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 30.0 m-85 -104.27 120.31 40.89 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.43 -1.693 . . . . 54.229999999999997 106.43 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -110.19 133.75 52.91 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.61 -1.256 . . . . 72.310000000000002 107.61 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' A' ' 66' ' ' PRO . 1.9 mp -103.6 113.47 40.52 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 105.64 -1.985 . . . . 65.530000000000001 105.64 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -130.0 122.52 28.61 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.36 -1.291 . . . . 65.310000000000002 108.19 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 56.54 36.86 28.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.937 0.895 . . . . 71.349999999999994 110.786 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.44 1.69 77.01 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.218 -0.447 . . . . 71.430000000000007 113.873 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -113.23 152.78 29.34 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.852 0.461 . . . . 75.510000000000005 110.337 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -102.2 117.92 35.79 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.22 0.533 . . . . 73.349999999999994 110.483 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -114.89 131.85 56.72 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.078 -1.082 . . . . 72.010000000000005 108.078 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 48.0 t -103.55 124.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.817 -0.809 . . . . 65.239999999999995 108.817 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.71 129.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 115.586 -0.734 . . . . 75.329999999999998 109.247 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -76.0 121.9 23.42 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.495 -1.669 . . . . 53.229999999999997 106.495 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.43 12.42 7.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.032 0.444 . . . . 75.420000000000002 110.853 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . 169.65 83.35 0.05 OUTLIER Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.595 -1.002 . . . . 72.049999999999997 110.595 -178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.8 m -60.63 100.44 0.11 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 122.832 0.453 . . . . 64.319999999999993 110.735 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 tp -73.68 -52.31 13.72 Favored 'General case' 0 C--O 1.202 -1.44 0 N-CA-C 107.988 -1.115 . . . . 74.019999999999996 107.988 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.419 HD22 HD11 ' A' ' 22' ' ' LEU . 55.9 t30 -121.44 -19.15 7.06 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 122.092 0.949 . . . . 55.130000000000003 108.613 170.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.08 130.41 3.74 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 108.446 -1.862 . . . . 72.409999999999997 108.446 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 56.3 m -81.73 130.18 34.97 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 117.13 0.465 . . . . 73.230000000000004 109.984 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 98.1 m-85 -105.43 126.24 51.89 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.29 -0.633 . . . . 70.299999999999997 109.29 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.57 122.82 67.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 105.642 -1.984 . . . . 73.420000000000002 105.642 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 56.67 39.65 29.64 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.49 1.138 . . . . 61.420000000000002 108.155 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER 62.5 8.69 3.0 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.267 1.827 . . . . 73.409999999999997 113.44 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -109.28 134.53 20.44 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.949 -0.76 . . . . 75.540000000000006 108.949 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.8 123.01 12.36 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 121.977 1.784 . . . . 74.400000000000006 109.737 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -145.33 148.71 33.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.959 -0.756 . . . . 63.020000000000003 108.959 -174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -95.1 -70.16 0.72 Allowed 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.158 -0.682 . . . . 73.340000000000003 109.158 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -124.53 134.47 52.99 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 119.715 -0.794 . . . . 32.450000000000003 109.835 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -155.19 147.04 23.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.095 -0.502 . . . . 74.239999999999995 110.832 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.24 132.12 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.698 -1.593 . . . . 74.549999999999997 106.698 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.2 tpp -90.15 148.79 22.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 112.963 0.727 . . . . 73.150000000000006 112.963 -169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.2 156.35 28.91 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.774 -1.103 . . . . 62.509999999999998 108.996 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.7 t -79.56 129.36 34.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.79 0.805 . . . . 64.329999999999998 111.252 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.546 ' O ' ' HD2' ' A' ' 34' ' ' PRO . . . 98.95 -2.84 58.37 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 115.485 -0.779 . . . . 54.030000000000001 111.82 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.97 153.25 21.18 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.403 -0.592 . . . . 70.230000000000004 109.403 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.03 132.18 56.73 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.692 0.758 . . . . 74.25 112.077 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 43.9 mt -111.16 126.37 68.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.444 -1.317 . . . . 51.130000000000003 107.444 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' ARG . 25.9 tt0 -106.41 114.99 29.44 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.53 0.681 . . . . 61.420000000000002 110.62 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mm -110.61 133.69 55.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 114.026 -1.443 . . . . 71.209999999999994 108.09 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.88 -93.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.375 -1.09 . . . . 65.5 110.375 -176.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -140.03 9.06 2.32 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.563 0.345 . . . . 61.5 110.941 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.608 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 41.0 p90 -131.7 152.53 50.81 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.033 -0.417 . . . . 60.340000000000003 111.775 -174.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -112.83 146.15 39.39 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 114.126 1.158 . . . . 74.439999999999998 114.126 -174.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 49' ' ' LEU . 4.4 mp -114.55 141.79 47.28 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.285 -1.78 . . . . 74.230000000000004 107.454 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -109.4 121.57 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.888 -1.523 . . . . 75.409999999999997 106.888 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -91.65 116.22 28.69 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.681 -0.69 . . . . 75.200000000000003 109.944 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.84 147.93 37.53 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.687 -0.486 . . . . 75.140000000000001 109.687 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.03 142.41 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.776 -0.453 . . . . 71.510000000000005 109.776 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.3 136.53 47.8 Favored Glycine 0 N--CA 1.441 -1.013 0 O-C-N 123.914 0.759 . . . . 63.030000000000001 112.496 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.19 162.46 35.78 Favored 'Trans proline' 0 C--O 1.251 1.156 0 C-N-CA 123.192 2.595 . . . . 61.130000000000003 112.357 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.5 46.02 0.61 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.96 0.886 . . . . 73.510000000000005 110.883 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 107.421 -1.326 . . . . 73.299999999999997 107.421 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 114.141 1.163 . . . . 73.209999999999994 114.141 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 p -125.98 17.0 7.93 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.187 -1.783 . . . . 75.340000000000003 106.187 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.75 17.12 24.72 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 112.952 -1.931 . . . . 65.430000000000007 110.267 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.36 135.88 36.84 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.86 -1.163 . . . . 74.420000000000002 107.86 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -53.49 113.37 1.14 Allowed 'General case' 0 C--O 1.248 1.016 0 O-C-N 123.9 0.75 . . . . 74.329999999999998 111.05 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.6 68.46 2.98 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.734 -0.666 . . . . 51.229999999999997 112.77 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -85.69 127.73 61.63 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 108.557 -0.905 . . . . 63.140000000000001 108.557 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.42 132.02 36.5 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.836 1.691 . . . . 63.25 108.986 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -115.62 128.83 25.63 Favored Pre-proline 0 N--CA 1.419 -2.017 0 CA-C-N 116.233 -0.439 . . . . 74.010000000000005 111.761 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.4 108.02 1.31 Allowed 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.148 1.899 . . . . 75.109999999999999 109.008 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -131.16 164.05 26.35 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.158 -1.053 . . . . 73.349999999999994 108.158 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.39 120.27 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.914 -1.884 . . . . 63.329999999999998 105.914 175.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -125.65 148.36 49.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.613 -1.995 . . . . 75.230000000000004 105.613 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -131.59 109.2 10.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.019 -1.073 . . . . 73.310000000000002 113.113 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -88.69 132.68 34.49 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.483 -0.932 . . . . 72.329999999999998 108.483 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 91.2 t -83.56 122.91 38.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.071 -0.344 . . . . 74.209999999999994 110.071 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -115.39 139.91 49.6 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.248 0.547 . . . . 75.420000000000002 110.369 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -88.3 118.23 27.76 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.421 -0.809 . . . . 74.340000000000003 109.594 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' HD12 ' A' ' 22' ' ' LEU . . . -128.84 169.81 14.13 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.547 -0.752 . . . . 52.439999999999998 110.311 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.19 8.21 24.92 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.989 1.716 . . . . 71.510000000000005 112.145 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -61.28 -4.78 1.3 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.604 1.162 . . . . 75.109999999999999 113.861 -175.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.47 -40.31 86.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.285 0.634 . . . . 64.040000000000006 109.32 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -64.97 -27.71 69.02 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.78 -0.645 . . . . 73.430000000000007 111.323 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.517 ' HB3' HE22 ' A' ' 129' ' ' GLN . 72.5 mm-40 -69.07 -48.73 61.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.45 -0.341 . . . . 72.019999999999996 110.931 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 ptp -68.74 -17.98 64.14 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.721 0.296 . . . . 73.230000000000004 110.996 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.97 -50.17 4.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 112.079 0.4 . . . . 61.109999999999999 112.079 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 m -102.05 -27.61 12.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.565 1.321 . . . . 74.430000000000007 114.565 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.1 m -76.2 -21.67 56.19 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.287 -1.005 . . . . 63.039999999999999 108.287 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -70.58 119.57 14.93 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.655 -1.157 . . . . 62.43 108.429 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.06 -37.25 0.53 Allowed Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 106.909 -2.476 . . . . 55.009999999999998 106.909 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -77.81 122.12 25.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.431 -0.951 . . . . 44.200000000000003 108.431 173.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.64 155.57 62.08 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 116.32 -0.4 . . . . 72.25 109.965 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.03 158.33 21.83 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.95 2.433 . . . . 72.230000000000004 111.669 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.48 156.93 25.07 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.811 -0.44 . . . . 74.420000000000002 109.811 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -118.26 134.56 54.92 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 108.744 -0.836 . . . . 74.230000000000004 108.744 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.2 p -144.44 162.45 36.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.793 -1.188 . . . . 75.310000000000002 107.793 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.89 18.14 56.29 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.402 -1.079 . . . . 45.420000000000002 110.402 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.1 11.3 23.57 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.396 0.679 . . . . 74.340000000000003 111.179 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.26 3.64 5.52 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.392 0.677 . . . . 71.420000000000002 112.279 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.04 -16.72 18.58 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.223 -1.029 . . . . 75.329999999999998 108.223 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.2 mm? 58.34 85.68 0.18 Allowed Pre-proline 0 C--O 1.222 -0.37 0 CA-C-N 115.048 -0.978 . . . . 73.409999999999997 111.101 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 18.9 Cg_endo -55.23 -54.04 4.94 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.923 2.415 . . . . 73.200000000000003 113.166 -174.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.46 0.76 51.35 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.251 -0.432 . . . . 61.25 111.108 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 10.8 70.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 116.344 -0.389 . . . . 52.439999999999998 112.928 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 m -124.13 149.45 46.23 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.476 -0.565 . . . . 71.140000000000001 109.476 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.26 157.41 44.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.802 -1.184 . . . . 71.439999999999998 107.802 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.54 155.34 50.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 120.43 -0.508 . . . . 75.400000000000006 111.328 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.3 pp -119.79 134.53 55.2 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.927 -0.578 . . . . 72.510000000000005 109.812 177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.09 132.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.23 0.538 . . . . 63.310000000000002 110.121 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG21 ' ND2' ' A' ' 56' ' ' ASN . 21.8 t -83.55 118.39 30.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.199 -1.037 . . . . 71.420000000000002 108.199 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.74 -31.62 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.554 0.693 . . . . 74.540000000000006 110.338 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 64.6 ttt180 -137.8 136.63 37.41 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.894 -1.15 . . . . 74.109999999999999 107.894 -177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.27 176.91 15.97 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 110.195 -1.162 . . . . 44.240000000000002 110.195 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.68 -32.89 18.0 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 122.268 1.979 . . . . 72.299999999999997 110.986 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.49 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.2 p-10 -99.67 23.32 9.71 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.959 -1.019 . . . . 71.530000000000001 110.561 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.43 57.6 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.071 -0.513 . . . . 64.120000000000005 110.718 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.94 -18.28 50.16 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.856 -0.898 . . . . 41.299999999999997 110.856 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 147.42 25.82 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.76 0.314 . . . . 73.349999999999994 110.328 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 60' ' ' ARG . 5.7 ptp180 -124.42 139.23 54.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.937 -1.134 . . . . 74.530000000000001 107.937 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.78 134.7 54.92 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.032 -1.099 . . . . 73.430000000000007 108.032 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tt -104.29 128.59 52.1 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.64 0.734 . . . . 63.130000000000003 110.703 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HA ' ' NE2' ' A' ' 65' ' ' GLN . 76.1 mt -103.54 107.55 18.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.642 -0.708 . . . . 64.120000000000005 109.768 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -146.64 17.24 1.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.781 1.277 . . . . 60.030000000000001 107.87 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 63' ' ' LEU . 3.3 pm0 -118.12 149.87 46.44 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.294 -1.321 . . . . 74.430000000000007 109.536 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.2 Cg_exo -55.25 -30.66 72.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.148 2.566 . . . . 72.019999999999996 114.453 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 m -149.45 131.68 15.48 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.686 -0.805 . . . . 63.030000000000001 111.062 -176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 m -133.81 114.08 12.98 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.298 -0.63 . . . . 75.109999999999999 109.298 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -88.6 132.53 34.51 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.703 -0.851 . . . . 62.140000000000001 108.703 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 140.54 49.83 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 120.915 0.388 . . . . 52.219999999999999 111.257 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.45 -160.42 30.94 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 107.719 -2.152 . . . . 63.530000000000001 107.719 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 35.9 ttp180 -119.31 117.71 29.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.162 0.981 . . . . 75.340000000000003 110.348 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 74' ' ' PRO . 0.5 OUTLIER 161.54 158.79 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 104.094 -2.558 . . . . 73.349999999999994 104.094 173.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 73' ' ' HIS . 18.9 Cg_endo -64.54 -9.91 22.32 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 121.969 1.78 . . . . 74.140000000000001 112.229 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.51 -10.98 58.78 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.645 -0.707 . . . . 35.450000000000003 110.197 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 m -87.25 143.88 27.07 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 106.526 -1.657 . . . . 74.239999999999995 106.526 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.1 -42.78 36.74 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.849 0.833 . . . . 74.319999999999993 109.883 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.79 132.51 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 107.372 -1.344 . . . . 53.420000000000002 107.372 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -94.02 117.18 29.75 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.401 0.62 . . . . 61.039999999999999 111.913 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.4 140.28 49.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.032 -2.211 . . . . 75.239999999999995 105.032 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 26.7 t70 -91.41 116.22 28.67 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.277 -1.369 . . . . 64.209999999999994 109.17 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.454 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 15.6 t0 -96.21 167.03 11.45 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.46 -0.791 . . . . 74.430000000000007 109.244 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.76 -30.64 29.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.044 0.449 . . . . 71.239999999999995 109.934 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.9 t -137.64 -152.81 0.45 Allowed 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.257 -0.645 . . . . 63.530000000000001 109.257 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.54 98.37 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.554 0.693 . . . . 74.040000000000006 109.941 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.2 m -124.07 84.87 2.33 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.316 -1.364 . . . . 64.530000000000001 107.316 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -62.28 -44.61 96.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.04 -0.982 . . . . 72.510000000000005 111.533 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -118.78 110.93 17.82 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.003 -1.11 . . . . 53.439999999999998 108.003 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.52 ' ND1' HG23 ' A' ' 130' ' ' ILE . 11.1 t-160 -100.22 -50.79 3.84 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.592 -1.262 . . . . 72.239999999999995 107.592 171.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.11 148.85 37.29 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.286 -1.005 . . . . 74.030000000000001 108.286 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -123.83 134.88 53.52 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 121.469 0.652 . . . . 64.530000000000001 110.043 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.26 124.73 50.03 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.836 -1.172 . . . . 74.420000000000002 107.836 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -115.22 127.58 55.6 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.477 -0.935 . . . . 65.430000000000007 108.477 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -121.35 113.19 38.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.351 -1.351 . . . . 74.25 107.351 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -136.3 131.02 33.81 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.817 -0.438 . . . . 63.399999999999999 109.817 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 55.67 37.05 28.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.059 0.944 . . . . 64.140000000000001 111.804 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.09 3.97 90.59 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.23 -0.895 . . . . 71.140000000000001 113.461 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -109.0 139.14 44.28 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.552 -0.536 . . . . 73.25 109.552 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -114.94 122.02 44.98 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.697 -0.683 . . . . 73.540000000000006 110.139 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.62 146.04 48.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.765 -0.457 . . . . 70.230000000000004 109.765 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.96 124.26 70.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.784 -1.191 . . . . 71.400000000000006 107.784 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -117.11 124.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.786 -0.82 . . . . 65.409999999999997 108.786 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -81.78 121.86 26.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.272 -1.01 . . . . 64.120000000000005 108.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 m -117.04 -11.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.955 -0.566 . . . . 62.439999999999998 110.876 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -108.35 46.9 1.1 Allowed Glycine 0 N--CA 1.424 -2.113 0 N-CA-C 108.406 -1.878 . . . . 51.229999999999997 108.406 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.8 p -65.61 -3.16 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.773 1.229 . . . . 71.340000000000003 113.389 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.93 -26.65 59.77 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.045 -0.724 . . . . 40.450000000000003 109.045 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 17' ' ' VAL . 94.3 m-20 -105.62 -21.72 13.13 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.77 -0.826 . . . . 71.239999999999995 108.77 174.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.07 119.27 0.27 Allowed Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.122 -0.944 . . . . 62.329999999999998 114.03 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.4 m -87.07 138.27 31.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.048 -1.093 . . . . 52.130000000000003 108.048 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 84.8 m-85 -119.13 129.16 54.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.946 -0.39 . . . . 75.430000000000007 109.946 -176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.9 t -114.92 120.58 64.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.532 -1.655 . . . . 72.129999999999995 106.532 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 56.27 37.96 29.33 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.564 1.146 . . . . 74.329999999999998 110.967 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 mtm-85 66.19 19.68 11.1 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 114.222 -1.354 . . . . 74.340000000000003 112.74 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.51 133.19 23.03 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.24 -1.022 . . . . 73.430000000000007 108.24 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.51 123.6 11.0 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.57 1.513 . . . . 64.430000000000007 109.401 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -144.93 138.69 27.06 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.199 -1.037 . . . . 75.5 108.199 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -86.3 -37.73 18.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.13 0.49 . . . . 75.239999999999995 110.422 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.63 136.28 25.66 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.12 -1.067 . . . . 72.120000000000005 108.12 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.19 143.09 25.71 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.43 -0.952 . . . . 63.229999999999997 108.43 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -88.23 126.18 41.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 105.473 -2.047 . . . . 64.340000000000003 105.473 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.41 ' HE2' HG12 ' A' ' 128' ' ' ILE . 6.6 tpt -87.99 130.71 34.88 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 113.394 0.887 . . . . 73.540000000000006 113.394 -164.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.498 ' HB3' ' OD2' ' A' ' 126' ' ' ASP . 16.3 tt0 -107.72 141.9 38.55 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.38 1.472 . . . . 65.120000000000005 109.525 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -67.03 133.53 50.1 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.046 -0.724 . . . . 75.409999999999997 109.046 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.25 -2.71 56.5 Favored Glycine 0 C--O 1.252 1.269 0 N-CA-C 111.456 -0.658 . . . . 62.43 111.456 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 123' ' ' GLN . 96.7 m-20 -82.47 151.38 26.55 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.384 0.612 . . . . 61.299999999999997 110.402 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -112.32 131.54 55.46 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.516 -0.765 . . . . 75.530000000000001 109.718 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.41 HG12 ' HE2' ' A' ' 122' ' ' MET . 21.2 mt -107.64 131.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 106.594 -1.632 . . . . 73.439999999999998 106.594 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.517 HE22 ' HB3' ' A' ' 25' ' ' GLU . 31.0 tt0 -112.6 118.24 34.53 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.251 -1.018 . . . . 73.140000000000001 108.251 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.52 HG23 ' ND1' ' A' ' 89' ' ' HIS . 43.7 mm -109.1 104.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.779 -1.1 . . . . 72.450000000000003 108.137 -176.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.4 -83.95 0.64 Allowed Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.31 -0.859 . . . . 63.049999999999997 111.225 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -133.82 -12.89 2.57 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.114 0.566 . . . . 73.310000000000002 110.296 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.648 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.317 42.7 p90 -99.0 170.34 8.79 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 114.29 1.218 . . . . 64.099999999999994 114.29 -172.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -118.46 126.07 51.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.872 -0.604 . . . . 52.219999999999999 111.393 -164.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.09 140.23 52.42 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.066 -1.087 . . . . 72.010000000000005 108.066 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.3 t -115.35 127.51 72.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.253 -0.647 . . . . 72.140000000000001 109.253 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -98.33 121.28 40.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.956 -0.757 . . . . 75.450000000000003 108.956 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -140.49 160.63 39.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 110.553 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.72 127.29 32.4 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.525 -1.287 . . . . 74.450000000000003 107.525 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.13 -122.47 1.13 Allowed Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 115.423 -0.808 . . . . 70.349999999999994 113.2 -172.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.48 157.69 55.75 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.085 1.857 . . . . 74.420000000000002 114.273 -176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.75 20.97 11.62 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.408 -2.071 . . . . 71.230000000000004 105.408 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 112.803 -1.998 . . . . 75.209999999999994 108.836 -176.051 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 109.138 -0.69 . . . . 72.209999999999994 109.138 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -67.08 123.23 19.66 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.764 0.653 . . . . 55.119999999999997 112.764 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -109.51 160.1 16.51 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.04 -1.837 . . . . 64.200000000000003 106.04 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -57.19 118.73 5.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.087 0.858 . . . . 52.039999999999999 110.564 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -143.38 155.68 44.48 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.224 -1.399 . . . . 75.409999999999997 107.224 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.38 132.76 52.71 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.281 -1.128 . . . . 62.229999999999997 110.281 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -78.81 124.3 85.04 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 120.461 -0.496 . . . . 71.439999999999998 110.911 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.87 143.46 45.57 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.229 1.953 . . . . 70.129999999999995 109.089 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -80.46 136.65 52.31 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.601 -0.518 . . . . 74.209999999999994 109.601 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.45 142.52 95.62 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.816 2.344 . . . . 64.129999999999995 113.832 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -91.79 139.82 30.3 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.79 -1.096 . . . . 74.349999999999994 108.383 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.36 121.87 68.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.075 0.464 . . . . 75.349999999999994 110.343 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' OE2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -135.32 158.26 44.82 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.817 -1.549 . . . . 63.299999999999997 106.817 175.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 m -116.24 134.03 55.36 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 119.906 -0.718 . . . . 74.430000000000007 109.064 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.548 ' O2P' ' HG2' ' A' ' 87' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 m -101.86 154.16 19.18 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.786 -1.552 . . . . 34.210000000000001 107.226 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.1 t -81.92 115.16 24.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.785 0.802 . . . . 73.219999999999999 108.914 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 84' ' ' THR . 29.8 p90 -119.43 142.18 48.46 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.83 -1.077 . . . . 75.530000000000001 110.469 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -125.93 90.62 3.23 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.406 0.622 . . . . 71.329999999999998 110.616 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.24 -84.42 0.15 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.723 -0.671 . . . . 75.519999999999996 110.419 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.06 -11.47 59.91 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.621 -0.718 . . . . 72.409999999999997 109.797 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 25' ' ' GLU . 89.8 mt -64.31 -15.83 61.0 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.012 -0.995 . . . . 71.299999999999997 111.784 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.14 -45.78 90.32 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 109.302 -0.629 . . . . 74.340000000000003 109.302 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -86.04 -33.57 20.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 109.68 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 4.6 tp10 -59.11 -33.14 70.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.418 -0.81 . . . . 73.519999999999996 110.414 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 42.3 tpp -59.47 -49.55 77.37 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.527 -0.306 . . . . 54.229999999999997 111.585 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.46 -29.49 67.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.107 0.48 . . . . 75.540000000000006 110.927 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -73.89 -25.77 60.2 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.588 0.709 . . . . 73.450000000000003 110.583 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.482 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 8.2 t -89.71 -15.73 31.9 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.468 -0.787 . . . . 73.109999999999999 110.625 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.0 m -62.69 101.57 0.26 Allowed 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.384 0.611 . . . . 60.009999999999998 110.59 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.69 -146.66 15.64 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.652 -1.379 . . . . 71.109999999999999 109.652 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 54.3 m -116.43 134.25 55.08 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.277 0.539 . . . . 72.450000000000003 110.686 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.18 94.65 5.81 Favored Pre-proline 0 C--O 1.246 0.872 0 N-CA-C 109.651 -0.5 . . . . 61.520000000000003 109.651 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 32' ' ' THR . 4.0 Cg_exo -76.39 160.71 35.37 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 123.343 2.696 . . . . 70.109999999999999 112.818 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.82 168.84 17.66 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.48 -0.934 . . . . 73.129999999999995 108.48 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 m -117.0 158.57 23.9 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.797 -0.445 . . . . 72.420000000000002 109.797 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -92.51 154.89 18.17 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.454 -0.943 . . . . 72.409999999999997 108.454 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.01 -29.44 1.0 Allowed Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.671 -0.776 . . . . 65.519999999999996 111.551 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.93 80.84 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.727 -0.472 . . . . 73.430000000000007 109.727 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.83 -6.44 41.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.613 -0.721 . . . . 74.239999999999995 111.854 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -94.3 -19.95 20.22 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.873 -1.158 . . . . 62.229999999999997 107.873 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.8 mt 58.91 88.0 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 113.97 -1.468 . . . . 73.140000000000001 111.391 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.44 -58.89 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.487 2.124 . . . . 74.25 110.097 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 0.89 7.59 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.585 -0.734 . . . . 43.210000000000001 109.138 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.15 85.99 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.117 -0.947 . . . . 64.140000000000001 111.419 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 15.0 m -134.85 165.56 25.02 Favored 'General case' 0 N--CA 1.42 -1.925 0 N-CA-C 107.082 -1.451 . . . . 65.409999999999997 107.082 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 158.87 43.1 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.256 -0.646 . . . . 62.030000000000001 109.256 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -125.41 157.8 35.95 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 110.444 -0.206 . . . . 73.310000000000002 110.444 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.15 139.01 54.25 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.204 -1.036 . . . . 75.010000000000005 108.204 174.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.9 p -118.65 137.26 53.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 120.791 0.329 . . . . 64.209999999999994 110.136 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.83 118.22 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 106.404 -1.702 . . . . 54.310000000000002 106.404 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -94.91 -31.62 13.59 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.695 -0.684 . . . . 71.25 109.918 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -145.83 137.78 25.25 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.933 -0.766 . . . . 54.030000000000001 108.933 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 132' ' ' LYS . . . 133.29 178.74 15.76 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 110.457 -1.057 . . . . 51.140000000000001 110.457 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 133' ' ' PHE . 85.4 Cg_exo -55.3 -40.49 85.35 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.684 2.256 . . . . 73.400000000000006 112.154 177.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -90.36 16.31 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.512 -0.313 . . . . 73.019999999999996 111.593 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.96 132.7 54.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.919 0.39 . . . . 71.430000000000007 111.197 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.06 -19.77 32.0 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.576 -0.738 . . . . 71.340000000000003 111.635 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 131.74 34.28 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.946 0.403 . . . . 71.349999999999994 110.625 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -113.3 139.15 49.08 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.107 -1.071 . . . . 51.299999999999997 108.107 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -126.68 128.07 46.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.747 -0.835 . . . . 71.120000000000005 108.747 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.4 pt? -88.23 130.03 35.19 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 74.129999999999995 110.528 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 103.86 12.46 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.087 -1.079 . . . . 70.450000000000003 108.087 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -121.46 -5.62 9.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.375 1.083 . . . . 72.409999999999997 108.545 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 5.9 pm0 -107.95 142.14 24.62 Favored Pre-proline 0 N--CA 1.431 -1.406 0 CA-C-N 114.128 -1.396 . . . . 65.409999999999997 110.487 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' GLN . 50.2 Cg_exo -57.79 -32.0 93.72 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.524 2.816 . . . . 75.310000000000002 112.942 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.5 m -143.6 122.04 12.41 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 109.251 -0.648 . . . . 60.329999999999998 109.251 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.486 HG22 HG12 ' A' ' 78' ' ' ILE . 21.0 m -114.54 113.92 25.07 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.844 -1.169 . . . . 73.109999999999999 107.844 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.3 p -89.8 138.43 31.49 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 111.65 0.241 . . . . 73.129999999999995 111.65 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.51 55.75 Favored 'General case' 0 C--O 1.267 2.025 0 N-CA-C 109.14 -0.689 . . . . 74.030000000000001 109.14 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.49 -145.39 11.33 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.022 -0.99 . . . . 25.129999999999999 110.723 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.516 ' C ' ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -105.84 151.81 24.05 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 122.994 0.518 . . . . 54.240000000000002 111.909 -177.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.583 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 14.9 t-80 76.75 143.39 0.1 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.93 1.292 . . . . 75.319999999999993 110.407 175.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 88.0 Cg_exo -48.28 -6.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 124.846 3.697 . . . . 74.209999999999994 116.688 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.83 -24.63 59.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.662 -0.866 . . . . 74.200000000000003 108.662 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.424 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 19.4 m -92.07 115.37 28.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 106.56 -1.644 . . . . 75.310000000000002 106.56 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.53 -36.25 77.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.941 -0.572 . . . . 73.030000000000001 111.409 -176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.486 HG12 HG22 ' A' ' 68' ' ' THR . 42.3 mm -106.7 99.56 8.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.016 -1.105 . . . . 72.109999999999999 108.016 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -93.36 110.3 21.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.727 -0.67 . . . . 63.329999999999998 109.901 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 87.0 mt -116.64 122.5 44.76 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.34 -1.356 . . . . 71.349999999999994 107.34 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.11 117.08 29.66 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.662 -0.815 . . . . 61.109999999999999 109.896 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.486 ' H ' HG22 ' A' ' 85' ' ' VAL . 10.0 t70 -120.62 -165.11 1.16 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.385 -0.968 . . . . 61.32 108.385 -173.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.41 -35.51 19.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.403 -0.962 . . . . 75.430000000000007 108.403 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 18' ' ' PHE . 83.2 m -145.63 99.44 3.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.261 -1.015 . . . . 74.450000000000003 108.261 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 82' ' ' ASP . 7.1 t -88.78 131.48 36.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.677 -0.49 . . . . 72.400000000000006 109.677 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -79.25 157.78 27.71 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.785 -0.643 . . . . 72.519999999999996 110.304 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.548 ' HG2' ' O2P' ' A' ' 15' ' ' TPO . 18.4 ptp180 -62.76 -45.86 90.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 72.540000000000006 109.68 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -147.25 99.55 3.16 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 103.784 -2.673 . . . . 62.409999999999997 103.784 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 5.1 t60 -79.32 -50.26 11.15 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.915 -1.513 . . . . 70.239999999999995 106.915 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.25 163.02 40.74 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.468 -1.242 . . . . 31.129999999999999 109.539 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.49 141.38 48.76 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 109.076 -0.712 . . . . 72.420000000000002 109.076 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -103.83 114.08 28.08 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 105.712 -1.959 . . . . 70.209999999999994 105.712 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 95' ' ' ASN . 35.0 mtp85 -109.95 127.5 54.8 Favored 'General case' 0 C--N 1.275 -2.674 0 CA-C-N 114.736 -1.12 . . . . 74.219999999999999 110.488 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.04 112.12 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 N-CA-C 104.099 -2.556 . . . . 50.399999999999999 104.099 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 93' ' ' ARG . 17.8 m120 -135.48 121.09 19.43 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.225 -0.657 . . . . 62.240000000000002 109.225 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 56.53 37.85 29.16 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.379 1.05 . . . . 54.409999999999997 110.687 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.46 3.47 88.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.359 -0.837 . . . . 73.019999999999996 113.469 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.48 141.31 36.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.912 -0.774 . . . . 73.450000000000003 108.912 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB3' ' HE3' ' A' ' 122' ' ' MET . 84.0 m-85 -111.4 117.01 31.9 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.222 -0.658 . . . . 74.430000000000007 109.222 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -131.05 146.2 52.29 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.793 0.33 . . . . 75.230000000000004 111.775 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 23.5 t -103.79 123.37 57.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.18 -1.785 . . . . 74.439999999999998 106.18 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.1 t -119.15 126.51 75.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.103 -0.703 . . . . 45.409999999999997 109.103 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -81.05 123.54 28.45 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.197 -1.409 . . . . 73.340000000000003 107.197 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.38 14.55 7.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-O 121.049 0.452 . . . . 55.420000000000002 111.244 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.498 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . -108.9 -30.68 3.62 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.41 -1.076 . . . . 63.100000000000001 110.41 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.3 p 67.43 -52.86 0.49 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.55 2.34 . . . . 73.230000000000004 113.56 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.31 -20.43 60.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.902 0.382 . . . . 74.510000000000005 111.037 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -87.28 -20.25 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 114.227 1.195 . . . . 73.120000000000005 114.227 -173.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.429 ' N ' HD22 ' A' ' 108' ' ' ASN . . . 62.06 87.0 0.04 OUTLIER Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.344 0.897 . . . . 64.109999999999999 115.344 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.9 m -79.51 137.59 37.24 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.787 -0.82 . . . . 64.140000000000001 108.787 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 30.1 m-85 -113.06 126.87 55.95 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.539 -0.465 . . . . 73.310000000000002 109.97 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.45 135.93 55.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 105.006 -2.22 . . . . 73.140000000000001 105.006 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m120 53.47 34.74 18.97 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 75.409999999999997 107.601 -165.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 29' ' ' SER . 37.9 mtm180 57.92 12.76 1.85 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 114.025 1.12 . . . . 74.200000000000003 114.025 -175.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -104.27 134.17 19.83 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.84 -0.8 . . . . 73.510000000000005 108.84 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.04 123.49 12.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.12 1.88 . . . . 73.129999999999995 111.657 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -140.62 165.39 27.59 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 116.079 -0.509 . . . . 64.140000000000001 110.825 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -103.91 -36.74 7.68 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.282 -1.007 . . . . 72.140000000000001 108.282 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 101' ' ' VAL . . . -150.24 134.85 17.44 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.63 -1.248 . . . . 62.439999999999998 107.63 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.31 143.63 22.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.137 -0.69 . . . . 73.349999999999994 109.137 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.75 125.63 34.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.605 -0.887 . . . . 73.219999999999999 108.605 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.448 ' HE3' ' HB3' ' A' ' 99' ' ' PHE . 22.2 ptt? -90.06 130.27 36.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.202 0.525 . . . . 62.25 110.19 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -113.79 156.41 23.9 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.128 -0.942 . . . . 74.329999999999998 109.717 -174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.3 t -67.53 124.64 23.79 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-O 121.387 0.613 . . . . 75.019999999999996 109.565 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.89 0.09 57.56 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.909 -0.877 . . . . 72.450000000000003 110.909 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -79.92 151.84 29.89 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.77 125.91 50.68 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.024 -0.732 . . . . 74.310000000000002 109.024 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -109.33 129.55 63.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 N-CA-C 106.846 -1.538 . . . . 63.450000000000003 106.846 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 54.8 tp60 -110.05 123.22 49.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.274 -1.01 . . . . 70.209999999999994 108.274 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.4 mt -128.77 104.17 10.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.782 -1.192 . . . . 65.120000000000005 107.782 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.21 -117.21 8.25 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.4 -1.48 . . . . 55.310000000000002 109.4 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -106.46 5.75 29.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.289 0.566 . . . . 72.319999999999993 110.894 175.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.588 ' CZ ' ' HD2' ' A' ' 55' ' ' PRO . 69.6 m-85 -85.37 133.21 34.14 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.676 -0.693 . . . . 75.129999999999995 111.091 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -110.8 119.22 38.39 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.187 -2.153 . . . . 75.219999999999999 105.187 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 mt -114.87 139.85 49.44 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.018 -0.734 . . . . 64.439999999999998 109.018 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.21 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.309 -0.997 . . . . 62.340000000000003 108.309 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -92.75 127.72 38.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.283 -0.636 . . . . 64.299999999999997 109.283 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.61 130.78 42.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.229 0.538 . . . . 74.400000000000006 110.582 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.96 122.79 44.13 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.575 -0.898 . . . . 31.440000000000001 108.575 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.0 -144.17 3.87 Favored Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.282 -1.437 . . . . 62.43 113.088 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.83 146.7 60.52 Favored 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 123.681 2.921 . . . . 70.209999999999994 113.157 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 46' ' ' SER . . . 179.66 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.992 1.317 . . . . 33.219999999999999 108.526 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 107.462 -1.31 . . . . 61.509999999999998 107.462 -176.065 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 C--O 1.245 0.866 0 CA-C-O 121.006 0.431 . . . . 62.530000000000001 110.008 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -63.71 127.78 32.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.174 -0.921 . . . . 73.400000000000006 111.267 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -88.0 -177.03 5.66 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.515 -0.766 . . . . 75.200000000000003 110.353 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.65 99.8 2.65 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 113.32 0.859 . . . . 75.420000000000002 113.32 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -90.0 98.4 11.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 105.957 -1.868 . . . . 73.329999999999998 105.957 169.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 -167.52 31.27 Favored Glycine 0 N--CA 1.416 -2.681 0 C-N-CA 120.558 -0.829 . . . . 70.120000000000005 112.266 -175.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.8 m -125.06 123.78 25.4 Favored Pre-proline 0 C--N 1.283 -2.317 0 N-CA-C 107.259 -1.386 . . . . 74.329999999999998 107.259 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.28 150.01 52.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.13 1.887 . . . . 55.049999999999997 110.939 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.64 120.5 81.65 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.883 -0.784 . . . . 61.049999999999997 108.883 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -54.05 102.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.553 2.836 . . . . 74.200000000000003 113.877 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -103.63 168.49 9.11 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.203 -2.147 . . . . 75.349999999999994 105.203 172.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.4 119.32 55.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 106.74 -1.578 . . . . 55.530000000000001 106.74 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -159.42 148.01 17.85 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 103.96 -2.608 . . . . 71.420000000000002 103.96 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -123.57 129.12 50.71 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 109.298 -0.63 . . . . 73.209999999999994 109.298 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -88.74 144.2 26.42 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 112.091 -172.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 58.6 t -93.85 115.7 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.553 -2.017 . . . . 52.25 105.553 170.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -108.04 127.5 53.83 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.152 -1.019 . . . . 75.0 111.544 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -106.96 101.91 11.31 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 109.468 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.56 166.21 11.35 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.928 -0.578 . . . . 64.0 111.539 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.08 -6.99 19.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.136 1.374 . . . . 74.230000000000004 112.25 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.64 -25.42 60.12 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.51 0.93 . . . . 60.149999999999999 113.51 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 88.4 mt -81.47 -28.59 34.05 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 111.806 0.299 . . . . 70.439999999999998 111.806 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -53.95 -45.43 71.3 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.883 0.873 . . . . 71.540000000000006 111.878 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 26' ' ' MET . 8.0 pt-20 -70.19 -37.02 75.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.823 0.344 . . . . 72.150000000000006 111.888 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.43 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 22.9 ptp -79.79 -27.36 40.36 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 112.596 0.591 . . . . 75.420000000000002 112.596 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 23' ' ' LEU . 48.3 mt-10 -58.4 -49.46 77.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.974 0.352 . . . . 72.400000000000006 111.18 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -68.74 -26.41 65.23 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.632 -0.713 . . . . 74.25 110.878 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.7 t -88.17 -22.74 23.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.655 -0.702 . . . . 73.540000000000006 110.409 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.3 m -97.31 105.87 18.09 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.64 0.733 . . . . 70.239999999999995 112.097 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.9 -29.13 0.76 Allowed Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.287 -1.525 . . . . 73.049999999999997 109.287 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.3 m -116.11 148.99 39.71 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.77 -0.826 . . . . 74.310000000000002 108.77 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.47 138.92 20.68 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.652 -1.61 . . . . 64.5 106.652 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.25 142.52 91.83 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.125 1.884 . . . . 64.349999999999994 112.784 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.36 149.49 51.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.079 -0.712 . . . . 64.450000000000003 109.079 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.2 m -129.23 139.56 51.79 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.797 0.332 . . . . 70.420000000000002 110.624 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 m -79.34 115.07 18.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 64.109999999999999 108.036 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.16 8.2 22.05 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 110.622 -0.991 . . . . 53.140000000000001 110.622 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.09 87.67 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 123.514 0.725 . . . . 70.409999999999997 111.75 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.89 1.9 56.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.054 -0.521 . . . . 75.430000000000007 111.532 -177.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -33.39 12.0 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.433 -1.321 . . . . 75.400000000000006 107.433 176.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.4 mm? 59.73 84.06 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.247 0 N-CA-C 108.17 -1.048 . . . . 53.310000000000002 108.17 -173.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 6.8 Cg_endo -42.7 -61.85 0.5 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 124.593 3.529 . . . . 74.140000000000001 115.328 -168.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -13.77 40.69 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.201 -0.599 . . . . 74.209999999999994 112.151 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.22 -4.86 77.89 Favored Glycine 0 C--N 1.317 -0.5 0 C-N-CA 121.111 -0.566 . . . . 72.109999999999999 112.253 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB3' HD11 ' A' ' 62' ' ' LEU . 32.7 m -133.93 163.65 29.04 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.922 -0.769 . . . . 73.5 108.922 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.39 150.81 36.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.367 -0.605 . . . . 64.049999999999997 109.367 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.51 148.57 44.43 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.067 -0.515 . . . . 73.140000000000001 110.556 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.6 pt? -105.32 133.9 49.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.637 -0.875 . . . . 65.019999999999996 108.637 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.4 128.21 70.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.584 -0.895 . . . . 74.099999999999994 108.584 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.1 t -77.18 118.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.593 -1.632 . . . . 64.329999999999998 106.593 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -89.73 -33.92 16.4 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.231 0.539 . . . . 73.430000000000007 109.666 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 2.2 tpm_? -144.79 136.95 26.06 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.989 -1.115 . . . . 71.430000000000007 107.989 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.17 -171.45 25.64 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 109.442 -1.463 . . . . 15.529999999999999 109.442 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 15.6 Cg_exo -67.32 -43.64 5.81 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.522 2.148 . . . . 61.109999999999999 111.067 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.16 22.7 5.63 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.308 -0.86 . . . . 63.340000000000003 112.005 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.49 129.78 42.2 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.979 0.419 . . . . 62.100000000000001 111.069 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.97 -21.46 29.49 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.684 -0.689 . . . . 74.299999999999997 111.379 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.83 147.03 29.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.725 0.298 . . . . 72.420000000000002 110.224 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -128.8 139.05 52.36 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.721 -0.844 . . . . 61.25 108.721 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.09 131.12 53.81 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.981 -0.748 . . . . 73.310000000000002 108.981 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 46' ' ' SER . 56.3 tp -89.55 126.82 35.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.983 -0.377 . . . . 65.230000000000004 109.983 -177.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.421 HD23 HD11 ' A' ' 94' ' ' ILE . 5.2 mp -82.58 103.99 12.52 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -126.65 5.28 6.76 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 123.006 1.384 . . . . 71.140000000000001 108.061 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.81 149.75 39.4 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 114.197 -1.365 . . . . 64.25 108.792 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.99 -16.04 32.44 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 122.615 2.21 . . . . 71.219999999999999 113.036 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 90.3 m -154.58 128.85 9.01 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.05 -0.722 . . . . 74.299999999999997 109.05 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 20.5 m -118.58 121.38 40.07 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.1 m -96.28 130.24 43.42 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.609 -0.515 . . . . 65.540000000000006 109.609 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.04 139.4 53.35 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 116.414 -0.357 . . . . 73.120000000000005 110.19 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.37 -161.0 30.97 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.217 -1.553 . . . . 51.439999999999998 109.217 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 16.7 ttp180 -119.45 116.99 27.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 118.116 0.958 . . . . 72.030000000000001 109.544 176.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER 152.94 156.74 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 104.621 -2.363 . . . . 62.310000000000002 104.621 176.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.85 -9.29 15.98 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.443 2.096 . . . . 73.340000000000003 113.258 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.07 -18.45 60.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.067 0.461 . . . . 75.019999999999996 110.728 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 m -98.02 123.58 42.1 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 116.134 -0.485 . . . . 71.109999999999999 109.722 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -64.19 -42.74 96.54 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.521 -0.918 . . . . 74.519999999999996 108.521 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.52 104.74 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 106.444 -1.687 . . . . 60.219999999999999 106.444 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 72' ' ' ARG . 59.6 t80 -88.03 113.93 24.15 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.671 -0.695 . . . . 72.030000000000001 109.149 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 72' ' ' ARG . 2.8 mm? -110.36 113.4 26.03 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.489 -0.93 . . . . 63.130000000000003 108.489 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 29.2 t70 -79.11 118.32 20.97 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.025 0.44 . . . . 72.319999999999993 110.745 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -133.08 178.0 7.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.259 -1.015 . . . . 64.549999999999997 108.259 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.07 -28.99 38.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 124.084 0.954 . . . . 71.200000000000003 109.247 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.441 ' HB ' HD21 ' A' ' 108' ' ' ASN . 0.7 OUTLIER -104.11 152.98 21.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.716 -0.675 . . . . 74.129999999999995 110.52 -174.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -92.19 97.46 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.698 -0.853 . . . . 73.519999999999996 108.698 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -99.81 87.83 3.63 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.595 -0.891 . . . . 63.140000000000001 108.595 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -66.92 -28.97 68.74 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.655 -0.702 . . . . 62.229999999999997 112.513 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -145.29 91.28 2.11 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.125 -1.805 . . . . 73.120000000000005 106.125 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 31.3 t60 -100.63 -52.81 3.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.053 -1.059 . . . . 71.430000000000007 112.075 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.17 141.93 46.01 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.48 -0.763 . . . . 72.510000000000005 109.158 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -122.58 129.41 51.89 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.304 -0.999 . . . . 61.210000000000001 108.304 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 67' ' ' THR . 7.7 m-85 -105.2 117.83 35.0 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.403 -1.703 . . . . 64.219999999999999 106.403 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -109.75 119.23 38.71 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.643 -0.873 . . . . 75.040000000000006 108.643 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.421 HD11 HD23 ' A' ' 63' ' ' LEU . 3.3 mp -111.96 113.29 43.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.684 -1.598 . . . . 74.329999999999998 106.684 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -138.92 123.89 18.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.943 -0.391 . . . . 62.420000000000002 109.943 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.39 36.8 26.31 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.413 1.085 . . . . 75.409999999999997 112.128 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 3.53 90.45 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.977 -0.63 . . . . 71.310000000000002 113.19 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -100.89 131.23 46.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.475 -0.935 . . . . 70.239999999999995 108.475 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -108.13 116.42 31.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.324 -0.991 . . . . 71.310000000000002 108.324 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 121' ' ' VAL . 41.9 mt-10 -123.6 126.16 46.14 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.335 -0.616 . . . . 73.239999999999995 109.335 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.41 123.13 56.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.511 -1.292 . . . . 72.239999999999995 107.511 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.48 138.04 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-N 115.586 -0.733 . . . . 54.100000000000001 110.648 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 106.141 -1.8 . . . . 73.219999999999999 106.141 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.0 m -92.41 17.07 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.756 0.65 . . . . 74.510000000000005 112.756 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.26 47.28 4.72 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 107.728 -2.149 . . . . 53.409999999999997 107.728 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.7 m -79.28 175.98 10.1 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.467 -0.866 . . . . 62.229999999999997 112.654 -172.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 2.3 mm? -101.72 -28.17 12.62 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.578 0.955 . . . . 64.019999999999996 113.578 -171.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -86.61 -20.47 27.82 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 118.518 -1.273 . . . . 75.140000000000001 111.127 -173.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.79 100.13 2.29 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 119.337 -1.411 . . . . 75.209999999999994 112.615 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 m -87.41 129.13 35.15 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.52 -0.918 . . . . 53.0 108.52 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 20.4 m-85 -127.96 126.7 41.92 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.969 -1.123 . . . . 74.319999999999993 107.969 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.6 t -111.7 131.84 61.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.129 -1.434 . . . . 74.540000000000006 107.129 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.675 ' HA ' ' OE1' ' A' ' 127' ' ' GLU . 17.4 m120 57.78 38.29 27.32 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.608 0.763 . . . . 73.109999999999999 110.187 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.76 14.46 7.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.966 1.307 . . . . 64.319999999999993 113.211 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.64 145.24 37.11 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 122.351 -0.218 . . . . 73.450000000000003 110.523 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.09 123.55 13.42 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.607 1.538 . . . . 65.400000000000006 108.431 171.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -139.5 145.85 39.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.828 -1.175 . . . . 72.430000000000007 107.828 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -103.31 -44.04 5.27 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.934 -0.306 . . . . 75.209999999999994 110.85 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.14 24.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.007 -1.108 . . . . 70.219999999999999 108.007 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -150.26 134.59 17.21 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.783 -0.367 . . . . 74.200000000000003 111.264 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 100' ' ' GLU . 48.6 t -78.9 114.73 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 104.584 -2.376 . . . . 74.040000000000006 104.584 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.47 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 80.3 mtp -97.09 144.59 26.8 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 113.721 1.008 . . . . 73.25 113.721 -172.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.531 ' HG3' ' OD2' ' A' ' 126' ' ' ASP . 4.8 pp0? -119.73 157.84 27.74 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.0 -1.455 . . . . 74.120000000000005 108.328 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.3 p -58.83 126.87 29.46 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 123.508 0.723 . . . . 72.319999999999993 111.62 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.56 -5.53 54.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.927 -0.579 . . . . 71.340000000000003 113.327 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.531 ' OD2' ' HG3' ' A' ' 123' ' ' GLN . 73.3 m-20 -76.81 143.91 39.47 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 117.799 0.799 . . . . 73.129999999999995 109.337 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.675 ' OE1' ' HA ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -112.57 145.44 40.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.045 0.45 . . . . 72.310000000000002 111.412 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 41.1 mt -116.71 126.91 74.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.579 -0.897 . . . . 72.530000000000001 108.579 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 24.3 tp60 -104.81 113.45 27.05 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 104.941 -2.244 . . . . 75.420000000000002 104.941 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 62.8 mt -109.28 103.87 16.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.91 -1.144 . . . . 63.329999999999998 107.91 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.16 -98.84 0.46 Allowed Glycine 0 N--CA 1.427 -1.911 0 CA-C-N 115.206 -0.906 . . . . 55.340000000000003 111.266 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -119.44 2.67 11.28 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.937 1.088 . . . . 53.109999999999999 113.937 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.25 25.4 p90 -131.23 168.97 16.6 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.549 -0.719 . . . . 72.340000000000003 112.19 176.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -129.22 138.96 52.0 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 113.037 0.754 . . . . 74.439999999999998 113.037 -168.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.87 139.79 53.19 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.682 -1.599 . . . . 73.510000000000005 106.682 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.63 140.2 40.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 109.42 -0.585 . . . . 73.209999999999994 109.42 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -92.9 115.5 28.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.048 -0.723 . . . . 72.129999999999995 109.048 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.06 159.95 22.96 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.121 0.486 . . . . 74.010000000000005 111.691 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.77 131.46 39.81 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.84 -0.8 . . . . 74.439999999999998 108.84 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.06 143.0 15.92 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.309 -0.948 . . . . 73.340000000000003 110.922 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -59.24 156.0 37.38 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.592 2.194 . . . . 61.350000000000001 111.567 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.83 61.22 6.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.313 1.054 . . . . 63.329999999999998 109.451 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.292 -1.919 0 CA-C-N 113.107 -1.861 . . . . 74.530000000000001 109.846 -179.983 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 108.811 -0.811 . . . . 43.049999999999997 108.811 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m 76.6 4.24 3.51 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.212 1.405 . . . . 70.530000000000001 110.386 -172.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.75 121.9 44.97 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.817 -1.083 . . . . 74.310000000000002 109.504 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -147.93 179.53 7.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.37 -1.344 . . . . 73.400000000000006 107.37 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 65' ' ' GLN . 21.3 m120 -137.97 140.55 40.28 Favored 'General case' 0 CA--C 1.481 -1.701 0 C-N-CA 120.755 -0.378 . . . . 72.349999999999994 111.244 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.61 98.7 1.29 Allowed Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 107.089 -2.404 . . . . 60.539999999999999 107.089 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -78.75 144.26 64.24 Favored Pre-proline 0 C--N 1.294 -1.825 0 CA-C-O 120.434 0.159 . . . . 63.140000000000001 110.915 -170.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.88 143.09 99.6 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.528 2.152 . . . . 72.25 109.144 174.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.18 140.55 57.12 Favored Pre-proline 0 C--N 1.291 -1.944 0 C-N-CA 119.928 -0.709 . . . . 73.150000000000006 110.68 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.29 103.5 0.25 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 122.272 1.982 . . . . 71.099999999999994 110.178 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -92.18 156.41 17.35 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.893 -1.521 . . . . 73.530000000000001 106.893 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.2 t -108.05 121.05 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.102 -0.703 . . . . 64.030000000000001 109.102 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -158.53 132.21 7.63 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.863 -1.162 . . . . 75.420000000000002 107.863 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 m -75.64 134.1 40.7 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 108.087 -1.079 . . . . 74.420000000000002 108.087 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -88.65 120.53 30.13 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 107.223 -1.399 . . . . 62.200000000000003 107.223 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.61 134.56 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 120.952 0.406 . . . . 65.209999999999994 111.304 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -123.18 141.35 52.07 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.111 -1.07 . . . . 73.319999999999993 108.111 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -83.78 137.29 33.8 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.275 -0.57 . . . . 73.140000000000001 109.808 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.93 151.19 23.45 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.411 -0.588 . . . . 62.200000000000003 109.411 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.08 2.76 56.08 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.844 0.831 . . . . 73.340000000000003 110.869 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 111' ' ' TYR . 1.9 pp -58.95 -17.45 24.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.274 1.213 . . . . 74.329999999999998 114.274 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 22' ' ' LEU . 2.2 pt? -70.25 -7.71 44.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 111.765 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -80.41 -28.47 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.562 -0.903 . . . . 73.340000000000003 108.562 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.54 -22.05 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.005 -1.109 . . . . 72.209999999999994 108.005 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.5 ttp -53.95 -49.54 68.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.977 -1.011 . . . . 63.020000000000003 111.175 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -9.96 58.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.065 0.459 . . . . 72.109999999999999 111.844 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -78.64 -39.26 37.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.435 -0.802 . . . . 61.140000000000001 110.112 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.7 m -87.13 -17.79 31.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.694 0.627 . . . . 62.340000000000003 112.694 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.1 m -72.61 114.0 10.26 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.48 -0.563 . . . . 55.399999999999999 109.48 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.6 -59.32 0.2 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.485 -1.046 . . . . 41.530000000000001 110.485 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.7 p -114.85 121.33 42.93 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.914 -0.314 . . . . 53.020000000000003 110.509 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.86 53.0 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 109.208 -0.664 . . . . 32.020000000000003 109.208 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.64 156.56 60.82 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 121.81 1.674 . . . . 72.239999999999995 108.805 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.17 124.65 21.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.87 -1.159 . . . . 52.030000000000001 107.87 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' THR . 10.3 m -98.78 -10.84 22.49 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.879 -0.6 . . . . 55.329999999999998 112.205 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -73.47 147.48 44.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.545 -0.752 . . . . 74.450000000000003 109.987 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 -15.08 7.72 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.327 -1.109 . . . . 53.240000000000002 110.327 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.17 -26.03 68.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.198 0.523 . . . . 51.109999999999999 111.322 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 41' ' ' ASN . 11.6 pt-20 -70.81 -22.13 62.38 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.255 -0.884 . . . . 74.319999999999993 112.15 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.511 ' OD1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 m-20 -96.21 -13.84 23.17 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.83 -0.433 . . . . 73.420000000000002 109.83 -175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt 55.05 66.62 3.8 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 114.98 -1.009 . . . . 72.420000000000002 110.634 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.65 -55.79 2.48 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 123.274 2.649 . . . . 65.239999999999995 113.569 -172.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.72 -20.52 42.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.895 -0.593 . . . . 64.140000000000001 111.752 -176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.38 -5.44 77.39 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.555 -0.831 . . . . 65.319999999999993 111.903 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -152.86 161.0 43.1 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.637 -1.246 . . . . 40.439999999999998 107.637 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.44 157.52 44.0 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.521 -0.548 . . . . 73.409999999999997 109.521 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pp -137.45 155.78 48.93 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 111.905 0.335 . . . . 75.310000000000002 111.905 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD22 HD21 ' A' ' 63' ' ' LEU . 2.4 pt? -116.22 133.67 55.77 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.001 -1.111 . . . . 71.25 108.001 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.11 133.86 51.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.57 -0.9 . . . . 73.040000000000006 108.57 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.27 118.69 31.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.765 -1.568 . . . . 75.099999999999994 106.765 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -83.26 -31.83 26.74 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.636 -0.711 . . . . 64.540000000000006 110.302 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -160.42 150.66 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.937 -1.505 . . . . 72.010000000000005 106.937 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.65 -167.72 17.96 Favored Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 110.217 -1.153 . . . . 62.509999999999998 110.217 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.58 -49.86 9.42 Favored 'Trans proline' 0 N--CA 1.479 0.668 0 C-N-CA 122.802 2.334 . . . . 73.239999999999995 112.257 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.6 22.54 3.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.227 -0.442 . . . . 72.150000000000006 112.045 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.23 128.73 38.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.859 0.362 . . . . 61.409999999999997 111.346 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.71 40.28 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.626 -0.715 . . . . 52.240000000000002 111.528 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 156.91 18.02 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.999 0.428 . . . . 74.209999999999994 110.155 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 139.49 30.87 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.792 -0.64 . . . . 75.310000000000002 109.564 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.39 134.05 55.46 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.2 -0.667 . . . . 73.010000000000005 109.2 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.4 pt? -90.79 143.77 26.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.024 -0.732 . . . . 64.299999999999997 109.024 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 49' ' ' LEU . 1.5 mm? -111.43 110.7 21.27 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.013 0.375 . . . . 53.020000000000003 112.013 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -138.35 59.56 1.64 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.849 -1.537 . . . . 65.340000000000003 106.849 168.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.402 ' HB2' ' OD1' ' A' ' 5' ' ' ASN . 19.7 pt20 -146.35 140.89 15.79 Favored Pre-proline 0 C--N 1.295 -1.802 0 CA-C-N 112.884 -1.962 . . . . 75.0 107.544 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -63.36 -22.11 71.68 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.271 1.98 . . . . 71.450000000000003 113.679 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -148.79 122.23 9.08 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.539 -0.726 . . . . 73.420000000000002 111.677 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 m -113.21 113.84 25.9 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.176 -1.416 . . . . 74.540000000000006 107.176 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.7 m -94.17 138.51 32.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.089 -0.645 . . . . 72.239999999999995 109.582 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.09 134.76 55.01 Favored 'General case' 0 C--O 1.268 2.065 0 N-CA-C 109.62 -0.511 . . . . 74.430000000000007 109.62 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.26 -119.1 0.9 Allowed Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.159 -0.928 . . . . 75.420000000000002 111.687 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -118.89 152.46 36.26 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.706 0.402 . . . . 72.519999999999996 110.825 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.1 m170 90.37 151.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 125.77 1.628 . . . . 71.129999999999995 111.057 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.48 -5.71 16.69 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.02 2.48 . . . . 71.319999999999993 111.799 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.68 -26.25 60.64 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.214 -1.032 . . . . 75.310000000000002 108.214 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -83.68 122.21 28.31 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.309 -1.367 . . . . 75.430000000000007 107.309 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.02 -32.38 74.07 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.317 0.579 . . . . 45.119999999999997 110.902 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tp -119.41 113.22 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-O 121.679 0.752 . . . . 33.210000000000001 109.137 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -88.01 138.18 31.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.977 -1.011 . . . . 73.239999999999995 110.542 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.5 mt -123.82 138.76 54.44 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.29 -0.633 . . . . 64.239999999999995 109.29 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.82 127.55 38.87 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.997 -1.112 . . . . 64.230000000000004 107.997 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.56 -161.4 1.34 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.839 -1.911 . . . . 72.219999999999999 105.839 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.61 -36.51 75.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.791 0.805 . . . . 72.200000000000003 109.665 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.0 m -149.51 125.78 10.78 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.93 -1.137 . . . . 75.519999999999996 107.93 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.59 135.23 43.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.825 -0.435 . . . . 74.319999999999993 109.825 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 159.84 27.95 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.793 -0.447 . . . . 72.129999999999995 109.793 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -57.66 -46.39 84.28 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.333 0.653 . . . . 62.140000000000001 110.534 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -146.34 109.72 4.76 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 103.755 -2.683 . . . . 71.230000000000004 103.755 171.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -90.25 -52.11 5.1 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.551 0.691 . . . . 73.530000000000001 109.611 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.59 156.05 41.3 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.59 -0.732 . . . . 74.120000000000005 109.049 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.492 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 10.0 pt-20 -134.59 134.19 41.02 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.306 0.574 . . . . 52.420000000000002 109.564 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -104.95 112.89 26.18 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.126 -2.175 . . . . 72.120000000000005 105.126 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 91' ' ' GLU . 23.5 mtp180 -108.44 135.99 48.82 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 115.828 -0.624 . . . . 75.230000000000004 110.423 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' A' ' 99' ' ' PHE . 1.8 mp -103.59 111.68 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.664 0 N-CA-C 102.283 -3.229 . . . . 74.5 102.283 173.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -129.12 116.56 19.43 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.93 -0.767 . . . . 64.040000000000006 108.93 -172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 51.04 37.56 18.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.873 1.269 . . . . 73.519999999999996 111.822 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.3 -1.96 87.49 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.013 -0.54 . . . . 43.210000000000001 113.578 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.39 145.71 29.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.279 -1.008 . . . . 63.130000000000003 108.279 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CD1' HG13 ' A' ' 94' ' ' ILE . 92.2 m-85 -104.7 117.94 35.33 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.223 -1.399 . . . . 64.319999999999993 107.223 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -129.49 130.75 46.24 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.319 0.58 . . . . 74.099999999999994 111.185 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.52 122.62 56.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.889 -1.152 . . . . 73.409999999999997 107.889 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.48 132.7 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 116.187 -0.461 . . . . 65.439999999999998 110.834 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -80.27 134.64 36.11 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.157 -1.423 . . . . 75.329999999999998 107.157 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.07 13.56 2.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 121.438 0.637 . . . . 73.019999999999996 111.226 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.89 74.85 0.09 OUTLIER Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.108 -1.197 . . . . 64.219999999999999 110.108 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 63.4 m -64.63 75.38 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.779 1.029 . . . . 73.329999999999998 113.779 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.81 -47.99 9.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.848 -1.538 . . . . 64.329999999999998 106.848 170.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -105.86 -20.0 13.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.966 -1.47 . . . . 63.409999999999997 108.631 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.72 99.33 0.04 OUTLIER Glycine 0 C--O 1.21 -1.385 0 N-CA-C 108.29 -1.924 . . . . 73.049999999999997 108.29 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.2 m -60.14 132.44 53.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.868 0.842 . . . . 61.240000000000002 112.904 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 83.4 m-85 -101.86 126.69 48.8 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 115.367 -0.833 . . . . 74.200000000000003 108.777 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.52 137.91 53.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.498 -1.667 . . . . 73.150000000000006 106.498 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 57.62 38.15 27.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.402 0.681 . . . . 64.209999999999994 109.693 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 59.4 26.13 14.98 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.825 -1.08 . . . . 75.5 111.923 177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.8 153.0 71.67 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.585 0.354 . . . . 64.340000000000003 110.366 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.62 129.55 31.44 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.348 2.032 . . . . 73.340000000000003 109.671 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 20.2 tpp180 -140.42 165.5 27.24 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.768 -0.456 . . . . 73.140000000000001 109.768 -173.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.91 -41.53 1.81 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.363 -0.606 . . . . 75.299999999999997 109.363 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.35 135.29 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.655 -1.239 . . . . 73.349999999999994 107.655 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.422 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 59.4 tp60 -153.11 133.61 13.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 121.124 -0.23 . . . . 72.329999999999998 111.57 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.2 t -81.56 115.6 24.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 104.658 -2.349 . . . . 74.530000000000001 104.658 168.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.6 ptm -90.46 149.87 22.05 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.736 0.779 . . . . 75.439999999999998 112.694 -169.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 72.2 mt-30 -107.57 157.84 17.72 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.46 -1.246 . . . . 63.25 108.617 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 36' ' ' SER . 11.5 t -70.66 130.83 42.8 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.912 -0.715 . . . . 73.219999999999999 109.597 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.35 1.2 55.67 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 110.96 -0.856 . . . . 71.400000000000006 110.96 -172.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 10.8 t0 -69.57 144.63 53.0 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 108.995 -0.743 . . . . 74.329999999999998 108.995 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.64 126.37 47.51 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.068 0.461 . . . . 74.239999999999995 109.875 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 70.9 mt -110.08 115.6 50.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 114.793 -1.094 . . . . 71.219999999999999 108.867 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.442 ' HG2' HD22 ' A' ' 22' ' ' LEU . 54.1 tt0 -105.22 123.62 48.15 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.584 -0.524 . . . . 65.150000000000006 109.584 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.71 129.19 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.428 0.691 . . . . 72.239999999999995 109.846 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 82.52 -86.4 1.46 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 109.837 -1.305 . . . . 62.009999999999998 109.837 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.94 14.32 0.34 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.288 0.635 . . . . 72.310000000000002 109.461 171.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -130.64 170.13 14.71 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.189 -0.671 . . . . 70.310000000000002 109.189 -178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -137.76 150.09 46.96 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.896 1.443 . . . . 72.150000000000006 114.896 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 mt -102.77 134.55 45.98 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.195 -1.78 . . . . 70.120000000000005 106.195 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.6 t -111.97 124.09 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.391 -0.966 . . . . 73.409999999999997 108.391 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -98.9 126.15 44.49 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 122.244 0.217 . . . . 74.329999999999998 110.918 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -133.81 147.48 51.24 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.42 -0.585 . . . . 71.510000000000005 109.42 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.59 118.69 18.7 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 104.621 -2.362 . . . . 73.310000000000002 104.621 169.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.04 -82.48 0.59 Allowed Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 118.502 -1.809 . . . . 43.520000000000003 113.959 -169.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -69.92 142.36 47.04 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 121.599 1.532 . . . . 64.140000000000001 113.859 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.48 36.7 1.67 Allowed 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 104.223 -2.51 . . . . 65.099999999999994 104.223 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.428 -1.545 0 CA-C-N 112.345 -2.207 . . . . 71.109999999999999 109.806 -171.027 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.398 -0.593 . . . . 60.420000000000002 109.398 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -64.89 140.25 58.85 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 112.287 0.477 . . . . 62.140000000000001 112.287 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -104.79 111.0 23.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.656 -0.702 . . . . 74.109999999999999 111.063 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.62 143.77 48.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.976 -1.49 . . . . 74.299999999999997 106.976 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -128.12 133.99 49.06 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.303 -0.258 . . . . 71.510000000000005 110.303 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.93 120.99 24.38 Favored Glycine 0 N--CA 1.44 -1.058 0 O-C-N 123.813 0.695 . . . . 71.120000000000005 111.836 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -90.85 134.82 29.68 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 109.416 -0.587 . . . . 63.409999999999997 109.416 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.54 132.52 11.11 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.054 1.836 . . . . 73.310000000000002 111.32 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -80.32 127.97 74.5 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 109.26 -0.644 . . . . 75.129999999999995 109.26 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.71 134.55 47.82 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.373 2.049 . . . . 74.430000000000007 110.983 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.44 132.42 36.8 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.445 -0.946 . . . . 63.109999999999999 108.445 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.9 t -108.36 120.86 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 105.915 -1.883 . . . . 73.310000000000002 105.915 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.578 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 6.0 tp10 -127.53 132.89 49.85 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 107.342 -1.355 . . . . 72.540000000000006 107.342 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.531 ' HB ' ' NH2' ' A' ' 87' ' ' ARG . 22.3 m -84.52 121.97 28.35 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.039 -1.097 . . . . 72.010000000000005 108.039 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.511 ' O2P' ' HB3' ' A' ' 13' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 20.0 m -100.21 152.3 20.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.552 -0.907 . . . . 44.329999999999998 108.552 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.8 t -89.27 115.57 29.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.01 -0.737 . . . . 53.5 109.01 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' A' ' 107' ' ' LEU . 62.2 t80 -111.89 127.44 55.84 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.177 -1.046 . . . . 70.120000000000005 108.177 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -126.44 137.06 53.37 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.158 -0.682 . . . . 75.519999999999996 109.158 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' HB3' HD23 ' A' ' 22' ' ' LEU . . . -142.65 161.75 37.25 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.039 0.447 . . . . 75.409999999999997 110.751 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.02 7.45 0.55 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.118 1.367 . . . . 64.049999999999997 112.893 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 20' ' ' ALA . 4.6 pp -58.05 -34.5 70.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.865 0.866 . . . . 73.549999999999997 111.284 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.53 -19.69 63.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.552 0.575 . . . . 53.210000000000001 112.552 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.11 -22.96 21.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.195 -0.668 . . . . 74.239999999999995 109.195 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -98.3 -42.9 7.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.397 -0.819 . . . . 65.349999999999994 113.045 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -68.25 -1.34 6.0 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 113.268 0.84 . . . . 72.120000000000005 113.268 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.65 -28.59 63.87 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.173 0.989 . . . . 61.130000000000003 111.128 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 p -63.56 -45.43 90.53 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.21 1.004 . . . . 71.230000000000004 111.378 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.2 p -79.39 -19.34 50.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.51 -0.768 . . . . 75.310000000000002 112.566 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -88.23 78.39 8.06 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 121.856 0.836 . . . . 71.25 110.141 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.79 -105.14 1.28 Allowed Glycine 0 CA--C 1.485 -1.825 0 N-CA-C 109.107 -1.597 . . . . 74.129999999999995 109.107 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.9 m -99.88 118.52 36.5 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.173 -1.417 . . . . 73.439999999999998 107.173 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.57 114.24 18.06 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.998 -0.741 . . . . 74.140000000000001 108.998 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -75.84 157.28 39.32 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.46 1.44 . . . . 62.539999999999999 110.517 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 125.72 31.12 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.927 -1.508 . . . . 71.299999999999997 106.927 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' GLN . 15.8 m -71.0 113.93 8.54 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.229 0.538 . . . . 74.519999999999996 111.023 -175.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.7 p -98.7 140.69 32.53 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.337 -0.392 . . . . 71.319999999999993 110.306 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.01 -25.28 0.55 Allowed Glycine 0 C--N 1.308 -0.982 0 N-CA-C 111.694 -0.563 . . . . 53.310000000000002 111.694 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.89 58.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.989 0.423 . . . . 35.310000000000002 110.203 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 1.0 OUTLIER -69.93 -24.66 63.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 65.340000000000003 109.202 -179.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.8 -13.75 47.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.776 -1.102 . . . . 71.299999999999997 109.835 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 93.4 mt 63.97 91.02 0.08 OUTLIER Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 115.142 -0.935 . . . . 63.439999999999998 111.174 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 10.3 Cg_endo -52.87 -69.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.147 2.565 . . . . 71.219999999999999 113.975 -176.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.07 16.38 1.07 Allowed 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.503 -0.479 . . . . 61.409999999999997 110.817 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.71 -12.4 56.77 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 120.839 -0.696 . . . . 73.439999999999998 111.617 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -137.37 151.88 49.07 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.231 -1.396 . . . . 53.329999999999998 107.231 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.44 157.19 40.85 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.072 -1.455 . . . . 31.32 107.072 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.24 156.75 38.03 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.341 0.591 . . . . 72.409999999999997 112.559 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.84 139.24 49.91 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 107.684 -1.228 . . . . 63.32 107.684 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 133.96 61.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 109.661 -0.496 . . . . 74.209999999999994 109.661 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 20.5 t -75.4 118.46 21.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.602 -0.888 . . . . 74.319999999999993 108.602 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -84.01 -43.4 15.19 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.034 -0.985 . . . . 73.420000000000002 108.722 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 57.4 ttt180 -144.7 133.55 22.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.468 -0.787 . . . . 73.310000000000002 109.231 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.13 174.8 23.12 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 109.109 -1.596 . . . . 63.210000000000001 109.109 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.65 -21.67 38.85 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.485 2.123 . . . . 74.519999999999996 111.187 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 80' ' ' LEU . 18.2 p-10 -100.9 21.98 12.83 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.093 0.957 . . . . 74.219999999999999 110.64 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -59.86 141.63 55.03 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.658 0.383 . . . . 62.420000000000002 111.797 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.65 -7.93 74.28 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.846 -0.692 . . . . 75.530000000000001 112.08 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.11 126.72 31.44 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 110.151 -0.314 . . . . 24.010000000000002 110.151 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -116.22 136.66 52.81 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.585 -0.895 . . . . 74.129999999999995 108.585 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -130.73 116.32 17.85 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.577 -0.527 . . . . 71.340000000000003 109.577 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.95 118.46 24.03 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.608 -0.886 . . . . 54.450000000000003 108.608 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.2 mt -87.42 125.2 34.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.83 0.348 . . . . 74.409999999999997 110.894 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -138.03 -0.61 2.05 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.313 -0.858 . . . . 63.119999999999997 109.825 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -107.52 150.34 39.98 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.132 -0.486 . . . . 61.530000000000001 111.085 -175.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 37.7 Cg_exo -65.17 -20.87 62.95 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 123.365 2.71 . . . . 61.130000000000003 114.078 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.7 m -145.68 122.54 11.28 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.272 0.558 . . . . 55.409999999999997 110.21 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.41 HG22 HG12 ' A' ' 78' ' ' ILE . 7.6 m -123.64 113.4 18.61 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.764 -1.199 . . . . 73.239999999999995 107.764 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.6 m -94.08 138.73 31.82 Favored 'General case' 0 C--O 1.255 1.393 0 O-C-N 121.594 -0.691 . . . . 71.099999999999994 111.038 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.96 135.39 54.63 Favored 'General case' 0 C--O 1.262 1.717 0 CA-C-O 121.655 0.741 . . . . 64.109999999999999 110.802 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.55 29.28 Favored Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 105.782 -2.927 . . . . 53.310000000000002 105.782 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 15.2 ptt180 -119.18 121.01 38.76 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 117.711 -1.596 . . . . 64.349999999999994 109.311 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -167.1 163.39 10.35 Favored Pre-proline 0 C--N 1.283 -2.299 0 N-CA-C 106.001 -1.851 . . . . 74.209999999999994 106.001 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.58 -46.19 34.97 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.706 2.271 . . . . 70.310000000000002 113.856 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.75 20.5 5.52 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.692 0.627 . . . . 72.329999999999998 112.692 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -58.91 116.28 3.68 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.46 -0.571 . . . . 64.450000000000003 109.46 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.27 -38.97 41.47 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.721 -1.214 . . . . 70.340000000000003 107.721 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 68' ' ' THR . 44.4 mm -105.26 121.85 57.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.126 -1.064 . . . . 74.430000000000007 108.126 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -87.95 124.76 34.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 110.065 -0.346 . . . . 73.510000000000005 110.065 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 80.0 mt -127.2 140.92 51.91 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.323 -0.991 . . . . 73.140000000000001 108.323 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -130.59 140.65 50.44 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.434 -0.58 . . . . 74.129999999999995 109.434 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -163.34 178.34 8.21 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.387 -1.709 . . . . 75.329999999999998 106.387 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.29 -35.19 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 107.943 -1.132 . . . . 44.0 107.943 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 m -142.0 99.84 3.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.672 0.748 . . . . 45.030000000000001 109.939 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 t -98.6 137.38 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.471 -1.307 . . . . 64.430000000000007 107.471 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 23.0 t -73.57 150.72 41.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.114 -1.069 . . . . 62.009999999999998 108.114 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' NH2' ' HB ' ' A' ' 14' ' ' THR . 10.1 ptt180 -61.59 -45.95 91.92 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.578 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 40.2 mtp-105 -135.21 113.86 11.75 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.413 -1.329 . . . . 75.140000000000001 107.413 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -99.29 -51.82 3.7 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.705 -0.85 . . . . 74.239999999999995 108.705 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.65 163.65 39.63 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.229 -0.656 . . . . 62.509999999999998 109.229 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.8 147.93 45.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.498 0.666 . . . . 64.349999999999994 109.883 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -104.76 133.31 49.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.184 -1.413 . . . . 62.140000000000001 107.184 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 8.5 mtp180 -118.1 121.78 41.44 Favored 'General case' 0 C--N 1.268 -2.964 0 CA-C-N 115.608 -0.724 . . . . 71.439999999999998 109.414 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 59.3 mt -121.14 111.39 31.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.655 -1.609 . . . . 75.120000000000005 106.655 176.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -139.24 125.7 20.42 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.643 -0.423 . . . . 71.409999999999997 110.413 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.58 40.25 31.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.015 0.926 . . . . 55.350000000000001 112.486 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 -1.67 87.53 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.032 -0.531 . . . . 32.140000000000001 113.807 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -101.04 140.97 34.59 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.227 -0.657 . . . . 44.340000000000003 109.227 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -119.34 117.8 29.52 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.112 -1.07 . . . . 62.240000000000002 108.112 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -126.45 144.89 50.69 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.854 -0.424 . . . . 54.329999999999998 109.854 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 122' ' ' MET . 25.1 t -112.98 122.13 66.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 105.244 -2.132 . . . . 72.549999999999997 105.244 171.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.61 131.88 71.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 120.652 -0.419 . . . . 73.030000000000001 110.157 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.12 140.97 36.19 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.422 -0.955 . . . . 61.329999999999998 108.422 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.2 9.89 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.637 0.256 . . . . 64.310000000000002 110.731 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.408 ' HA2' ' O3P' ' A' ' 15' ' ' TPO . . . 165.37 77.85 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.013 -0.613 . . . . 54.539999999999999 112.053 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 m -64.6 86.76 0.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.826 0.45 . . . . 62.030000000000001 111.124 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 9.8 tt -91.36 -49.91 6.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 119.137 -1.025 . . . . 75.120000000000005 108.435 175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.63 ' OD1' ' HA3' ' A' ' 131' ' ' GLY . 1.0 OUTLIER -92.81 -19.02 22.16 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.156 -0.683 . . . . 55.119999999999997 109.156 -178.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.68 114.86 3.77 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.836 -0.62 . . . . 74.349999999999994 112.367 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.2 m -87.3 129.65 34.91 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 122.211 -0.582 . . . . 74.540000000000006 110.469 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.506 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 82.3 m-85 -134.9 126.0 27.84 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.077 -1.083 . . . . 74.049999999999997 108.077 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.5 t -131.14 133.98 61.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 106.854 -1.536 . . . . 72.519999999999996 106.854 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 54.01 40.71 31.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.306 1.051 . . . . 73.420000000000002 109.404 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 66.76 9.23 6.56 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.946 1.699 . . . . 71.400000000000006 112.424 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 111' ' ' TYR . 49.5 mm-40 -104.57 127.66 28.5 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 112.472 0.545 . . . . 75.420000000000002 112.472 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -63.7 123.44 12.02 Favored 'Trans proline' 0 C--N 1.36 1.139 0 N-CA-C 106.242 -2.253 . . . . 74.209999999999994 106.242 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 11.8 tpt180 -146.99 154.89 41.77 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.791 -1.564 . . . . 72.409999999999997 111.797 -167.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -107.67 -37.93 6.02 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.806 -0.812 . . . . 73.230000000000004 108.806 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.2 135.21 32.16 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.265 -0.574 . . . . 64.439999999999998 109.667 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.567 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 54.3 tp60 -152.12 143.68 23.49 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.194 -0.457 . . . . 72.150000000000006 110.268 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.13 131.6 34.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 107.72 -1.215 . . . . 71.230000000000004 107.72 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.411 ' HB2' HG23 ' A' ' 101' ' ' VAL . 43.7 ttp -89.25 128.54 35.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.359 -0.978 . . . . 60.32 108.359 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 126' ' ' ASP . 9.3 pt20 -130.37 142.8 50.51 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.299 -0.864 . . . . 71.349999999999994 111.382 -173.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.7 t -74.31 134.25 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 62.420000000000002 111.229 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.11 59.75 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.241 -0.89 . . . . 54.5 111.163 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' HG3' ' A' ' 123' ' ' GLN . 0.8 OUTLIER -89.63 154.67 19.79 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.565 -0.318 . . . . 74.019999999999996 111.198 -177.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.3 127.86 55.24 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 121.663 0.744 . . . . 74.099999999999994 109.797 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.28 119.81 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 N-CA-C 107.369 -1.345 . . . . 73.409999999999997 107.369 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 47.3 tt0 -104.86 120.92 42.57 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 115.106 -0.952 . . . . 74.099999999999994 108.476 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 66.7 mt -109.36 102.98 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 105.914 -1.884 . . . . 72.239999999999995 105.914 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.63 ' HA3' ' OD1' ' A' ' 108' ' ' ASN . . . 67.45 -107.55 2.08 Favored Glycine 0 N--CA 1.411 -3.01 0 CA-C-N 114.48 -1.236 . . . . 55.299999999999997 111.639 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -118.22 11.0 13.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 112.408 0.521 . . . . 75.329999999999998 112.408 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 27.2 p90 -125.06 157.87 35.18 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.883 -0.414 . . . . 70.109999999999999 109.883 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -129.36 142.07 50.91 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 114.51 1.3 . . . . 75.219999999999999 114.51 -169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mp -124.35 138.52 54.37 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.591 -1.633 . . . . 75.109999999999999 106.591 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -112.48 138.36 41.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.833 -1.173 . . . . 72.120000000000005 107.833 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -101.61 116.13 32.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.175 -0.676 . . . . 72.329999999999998 109.175 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -131.12 154.64 48.09 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.408 0.623 . . . . 71.129999999999995 110.545 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.51 126.4 30.85 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.538 -1.653 . . . . 53.409999999999997 106.538 168.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 141' ' ' PRO . . . -103.77 -111.42 3.57 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.587 -0.816 . . . . 53.439999999999998 111.497 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 140' ' ' GLY . 10.8 Cg_exo -69.14 142.87 51.93 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.114 1.876 . . . . 62.439999999999998 111.787 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.25 18.08 19.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.648 -0.871 . . . . 53.030000000000001 108.648 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.424 -1.745 0 C-N-CA 125.305 1.442 . . . . 73.109999999999999 110.001 -179.137 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 107.11 -1.441 . . . . 55.200000000000003 107.11 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -79.02 134.99 36.76 Favored 'General case' 0 N--CA 1.426 -1.659 0 C-N-CA 120.124 -0.63 . . . . 55.32 110.085 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.95 100.31 12.81 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.661 -1.607 . . . . 73.349999999999994 106.661 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -89.68 113.97 25.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.965 -1.016 . . . . 64.329999999999998 113.303 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 p30 179.7 -167.89 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.688 -2.338 . . . . 71.510000000000005 104.688 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.62 -157.96 30.37 Favored Glycine 0 CA--C 1.48 -2.142 0 C-N-CA 118.967 -1.587 . . . . 73.0 112.566 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 t -112.21 108.97 54.61 Favored Pre-proline 0 N--CA 1.417 -2.116 0 N-CA-C 107.653 -1.24 . . . . 72.209999999999994 107.653 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.58 131.31 25.76 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.845 1.697 . . . . 75.329999999999998 111.371 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.74 115.51 63.2 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 106.128 -1.804 . . . . 71.019999999999996 106.128 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 24.3 Cg_endo -92.07 -161.94 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.049 2.499 . . . . 75.230000000000004 114.05 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -92.94 134.9 34.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.145 -1.428 . . . . 25.219999999999999 107.145 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.582 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 54.7 t -109.12 120.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 C-N-CA 119.035 -1.066 . . . . 74.310000000000002 110.273 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 50.1 mt-10 -128.77 140.96 51.47 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.075 -1.083 . . . . 72.25 108.075 175.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -70.35 134.36 47.83 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.877 1.271 . . . . 72.450000000000003 113.812 -168.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.3 t -125.46 155.34 40.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.671 -1.974 . . . . 65.329999999999998 105.671 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 57.8 t -81.31 114.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 119.679 -0.808 . . . . 72.409999999999997 108.854 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -118.86 140.22 50.33 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 109.241 -0.651 . . . . 74.239999999999995 109.241 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -132.75 138.66 47.27 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 107.953 -1.128 . . . . 74.230000000000004 107.953 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.39 172.73 12.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.075 0.768 . . . . 63.200000000000003 113.075 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.82 -3.12 26.69 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.905 1.282 . . . . 71.310000000000002 110.976 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 23' ' ' LEU . 4.0 pp -57.36 -25.81 60.03 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.88 0.872 . . . . 61.450000000000003 112.784 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 22' ' ' LEU . 94.7 mt -66.72 -28.36 68.36 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-O 121.044 0.45 . . . . 50.130000000000003 110.982 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -67.26 -44.75 78.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.772 -0.649 . . . . 74.340000000000003 109.96 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -76.1 -31.92 58.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.883 -0.599 . . . . 74.349999999999994 110.096 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 52.3 ttm -57.29 -30.41 64.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 75.219999999999999 110.819 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.08 -49.43 75.88 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 122.984 0.513 . . . . 52.219999999999999 110.633 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -77.81 -19.81 54.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.101 0.56 . . . . 72.030000000000001 111.553 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -82.97 -17.11 44.66 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.702 -0.481 . . . . 62.109999999999999 109.702 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.554 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 39.9 m -109.12 103.99 13.09 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 121.207 0.527 . . . . 60.240000000000002 111.169 -176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.88 -52.69 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 111.389 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.4 m -104.94 142.5 34.66 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.259 -0.645 . . . . 72.310000000000002 109.259 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.93 153.0 84.81 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.16 -1.052 . . . . 53.130000000000003 108.16 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.14 142.23 96.97 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.047 1.831 . . . . 71.129999999999995 112.831 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.49 131.71 41.92 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.527 -0.545 . . . . 55.219999999999999 109.527 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -125.07 -168.35 1.81 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.371 0.605 . . . . 71.319999999999993 109.969 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -106.97 5.81 28.53 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 123.995 0.918 . . . . 74.549999999999997 109.526 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 43.48 3.79 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.22 -1.552 . . . . 62.240000000000002 109.22 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.4 -3.67 59.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.392 0.615 . . . . 64.140000000000001 110.967 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.82 2.1 3.72 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 124.167 0.987 . . . . 64.040000000000006 112.726 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -83.17 -19.59 36.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.269 -1.011 . . . . 72.329999999999998 108.269 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt 57.44 79.47 0.32 Allowed Pre-proline 0 C--N 1.345 0.394 0 CA-C-N 114.46 -1.245 . . . . 52.520000000000003 111.937 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.68 -62.48 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.483 2.122 . . . . 54.32 112.162 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.72 -2.28 35.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.953 0.406 . . . . 63.200000000000003 111.644 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.4 18.68 79.85 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.871 -0.681 . . . . 13.1 113.163 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 m -147.37 164.21 34.0 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.474 -0.565 . . . . 55.350000000000001 109.474 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.82 157.35 45.87 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.884 -1.154 . . . . 44.509999999999998 107.884 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -123.46 152.69 41.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 118.388 0.54 . . . . 72.420000000000002 111.593 -175.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.583 HD12 HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -116.88 143.19 45.99 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.673 -1.232 . . . . 73.510000000000005 107.673 173.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.88 133.38 61.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 121.093 -0.243 . . . . 74.530000000000001 110.496 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.3 116.88 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 104.792 -2.299 . . . . 64.430000000000007 104.792 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -89.87 -31.87 17.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.752 -0.658 . . . . 54.200000000000003 109.595 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -152.89 137.0 16.42 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.924 -0.58 . . . . 74.209999999999994 109.566 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.41 172.23 13.13 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 109.21 -1.556 . . . . 74.219999999999999 109.21 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.538 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 77.9 Cg_exo -55.28 -29.67 68.36 Favored 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 122.73 2.287 . . . . 52.009999999999998 113.926 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.28 18.12 21.74 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 120.326 -0.549 . . . . 72.439999999999998 110.399 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.86 143.58 41.94 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.107 0.48 . . . . 63.530000000000001 112.195 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.85 -14.28 57.47 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.359 -1.096 . . . . 61.219999999999999 110.359 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.79 122.12 21.04 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.289 -0.456 . . . . 61.520000000000003 109.847 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -133.4 134.97 44.34 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.551 -1.277 . . . . 74.420000000000002 107.551 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -137.26 145.38 43.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.288 -0.634 . . . . 74.310000000000002 109.288 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.1 tp -93.17 127.23 38.64 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.493 0.496 . . . . 73.129999999999995 109.717 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.583 HD21 HD12 ' A' ' 49' ' ' LEU . 2.4 mm? -97.6 107.3 19.77 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.197 0.522 . . . . 74.049999999999997 111.368 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -148.24 19.19 1.09 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.054 -1.832 . . . . 73.150000000000006 106.054 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.466 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 16.0 pt20 -107.21 142.14 24.44 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 113.971 -1.468 . . . . 72.040000000000006 107.931 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 27.9 Cg_endo -64.94 -19.19 63.88 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.251 1.967 . . . . 75.219999999999999 113.955 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.7 m -149.5 129.99 13.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.231 -0.587 . . . . 72.510000000000005 111.58 -176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.9 m -132.9 113.51 12.95 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.337 -1.357 . . . . 72.209999999999994 107.337 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -92.88 138.03 31.84 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.757 -0.46 . . . . 73.239999999999995 109.757 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 136.93 53.33 Favored 'General case' 0 C--O 1.246 0.905 0 O-C-N 123.329 0.393 . . . . 70.439999999999998 110.082 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.57 -153.37 24.99 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 109.572 -1.411 . . . . 75.230000000000004 109.572 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 64.1 ttt-85 -118.51 118.06 30.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.637 -1.986 . . . . 73.340000000000003 105.637 175.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 75' ' ' GLU . 5.2 t-160 177.92 139.25 0.24 Allowed Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 106.955 -1.498 . . . . 73.200000000000003 106.955 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.6 -30.53 36.69 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 121.529 1.486 . . . . 63.329999999999998 111.978 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 8.4 mm-40 -88.96 4.51 47.89 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.222 0.823 . . . . 54.439999999999998 113.222 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.6 p -89.99 115.84 27.58 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 119.082 -1.047 . . . . 72.230000000000004 108.879 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.9 -34.87 73.76 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.485 0.491 . . . . 75.140000000000001 110.831 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.5 pt -114.36 111.8 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.222 -1.029 . . . . 73.439999999999998 108.222 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -94.01 121.12 35.16 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.994 -1.003 . . . . 73.420000000000002 110.774 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.29 119.4 33.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.849 -1.167 . . . . 71.129999999999995 107.849 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.74 124.77 41.77 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.799 0.296 . . . . 74.329999999999998 111.799 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD2' HG23 ' A' ' 83' ' ' VAL . 16.9 t70 177.5 -145.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 103.877 -2.638 . . . . 63.0 103.877 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.424 HG23 ' OD2' ' A' ' 82' ' ' ASP . 48.5 t -57.43 -23.56 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.914 0.779 . . . . 63.219999999999999 111.004 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.4 m -76.59 81.59 3.26 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.688 0.756 . . . . 75.329999999999998 110.108 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.08 105.85 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.148 -1.056 . . . . 70.439999999999998 108.148 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.3 m -163.57 136.28 5.29 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.767 -1.568 . . . . 72.219999999999999 106.767 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.582 ' HD3' ' HA ' ' A' ' 12' ' ' VAL . 17.1 ptt180 -64.28 -25.56 68.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.817 0.698 . . . . 73.349999999999994 111.629 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' HG21 ' A' ' 104' ' ' VAL . 45.3 mtt-85 -145.21 128.25 16.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.776 -0.824 . . . . 73.420000000000002 108.776 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 110' ' ' THR . 30.0 t-80 -99.88 -52.78 3.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.324 -1.362 . . . . 75.150000000000006 107.324 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.01 164.91 36.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.681 -1.145 . . . . 51.409999999999997 108.271 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.85 139.45 52.15 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.708 -0.478 . . . . 72.049999999999997 109.708 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -108.04 125.3 51.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.946 -1.502 . . . . 71.400000000000006 106.946 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.99 131.7 56.86 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.925 -0.768 . . . . 74.420000000000002 108.925 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.8 mp -115.25 112.27 39.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.411 -1.329 . . . . 61.109999999999999 107.411 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -138.93 125.49 20.62 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.842 -0.617 . . . . 75.349999999999994 110.724 -175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.77 37.97 29.51 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.851 0.86 . . . . 74.150000000000006 112.677 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 1.77 90.22 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.972 -0.558 . . . . 51.329999999999998 113.544 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -110.61 131.64 54.88 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.458 -0.571 . . . . 74.409999999999997 109.458 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -104.66 117.56 34.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.869 -1.16 . . . . 64.109999999999999 107.869 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -117.97 130.92 56.49 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.183 0.516 . . . . 61.140000000000001 110.412 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.44 122.6 61.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.64 -1.245 . . . . 61.229999999999997 107.64 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.93 124.0 71.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 109.426 -0.583 . . . . 64.329999999999998 109.426 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.62 140.36 40.96 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.8 -1.185 . . . . 55.219999999999999 107.8 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 88' ' ' ARG . 18.8 m -100.41 -13.71 8.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.947 -0.701 . . . . 71.439999999999998 111.923 -175.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.65 95.29 0.1 OUTLIER Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.505 -1.038 . . . . 64.030000000000001 110.505 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -64.96 14.48 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.681 1.592 . . . . 75.430000000000007 114.291 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 6.0 mp -70.87 -37.92 73.09 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.897 -1.149 . . . . 61.409999999999997 107.897 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.3 -20.15 22.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.47 -0.786 . . . . 74.120000000000005 110.326 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.39 94.87 0.22 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.556 -0.747 . . . . 61.32 114.58 172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.482 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 58.1 m -80.98 130.16 34.88 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.284 -0.635 . . . . 74.019999999999996 109.284 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.36 125.69 54.54 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 107.643 -1.243 . . . . 74.329999999999998 107.643 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.0 t -133.1 136.86 54.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.165 -1.421 . . . . 74.420000000000002 107.165 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 54.33 39.25 30.74 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.367 1.467 . . . . 75.209999999999994 108.257 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' A' ' 30' ' ' THR . 34.2 mtm105 63.81 20.47 12.23 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.655 -1.611 . . . . 71.5 115.279 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.513 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 41.4 mt-10 -136.02 153.42 76.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.298 -0.63 . . . . 73.420000000000002 109.298 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.2 123.72 13.73 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.251 1.967 . . . . 63.030000000000001 108.925 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.626 ' HG2' ' HB2' ' A' ' 120' ' ' GLN . 18.3 tpp180 -135.96 139.99 43.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.253 -0.579 . . . . 70.400000000000006 109.869 -170.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -98.84 -37.57 9.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.477 0.656 . . . . 75.120000000000005 110.525 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.04 136.96 18.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.258 -1.386 . . . . 70.040000000000006 107.258 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.626 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 55.5 tp60 -152.58 136.02 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.176 0.435 . . . . 72.519999999999996 112.176 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.35 117.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 104.676 -2.342 . . . . 72.230000000000004 104.676 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.452 ' SD ' HD11 ' A' ' 128' ' ' ILE . 43.5 ttp -88.05 130.71 34.91 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.664 0.745 . . . . 75.400000000000006 111.458 -168.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.27 156.44 16.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.081 -1.418 . . . . 74.140000000000001 109.151 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.0 t -70.56 130.81 42.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.932 -1.136 . . . . 64.329999999999998 107.932 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 98.73 0.3 57.73 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 120.565 -0.826 . . . . 72.319999999999993 111.158 -177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.43 141.06 50.28 Favored 'General case' 0 C--O 1.251 1.166 0 N-CA-C 109.326 -0.62 . . . . 54.219999999999999 109.326 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.47 125.7 54.51 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.496 -0.557 . . . . 72.140000000000001 109.496 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.452 HD11 ' SD ' ' A' ' 122' ' ' MET . 68.3 mt -108.21 131.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.302 -1.37 . . . . 72.219999999999999 107.302 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -119.92 123.0 42.49 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 121.378 0.609 . . . . 75.019999999999996 109.654 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.6 mt -113.9 102.31 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.301 -1.74 . . . . 74.510000000000005 106.301 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.71 -111.86 4.43 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 109.933 -1.267 . . . . 41.509999999999998 109.933 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HE2' ' CG ' ' A' ' 82' ' ' ASP . 65.9 pttt -103.58 -4.67 23.58 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 117.406 0.603 . . . . 74.510000000000005 110.428 176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.538 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 83.9 m-85 -73.22 130.5 40.36 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.401 -0.592 . . . . 73.239999999999995 109.401 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -112.01 119.41 38.37 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.628 -1.249 . . . . 75.040000000000006 107.628 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.3 134.3 54.96 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.582 -1.266 . . . . 72.519999999999996 107.582 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.71 131.53 69.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 108.746 -0.835 . . . . 73.530000000000001 108.746 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.31 122.56 43.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.572 -0.529 . . . . 73.349999999999994 109.572 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 48' ' ' LEU . 3.9 mp -128.72 137.19 51.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 110.162 -0.31 . . . . 73.310000000000002 110.162 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.57 135.48 33.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.986 -0.746 . . . . 74.230000000000004 108.986 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.2 88.07 1.81 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.788 -0.925 . . . . 74.150000000000006 110.788 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.468 ' HA ' HD12 ' A' ' 48' ' ' LEU . 21.2 Cg_exo -66.64 161.86 39.7 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.215 2.61 . . . . 64.540000000000006 112.459 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.43 53.73 0.88 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.196 -1.038 . . . . 72.310000000000002 108.196 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.026 -0.988 . . . . 72.450000000000003 109.216 -175.583 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 C--O 1.245 0.864 0 CA-C-O 121.247 0.546 . . . . 73.019999999999996 109.986 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 m -128.33 174.87 8.93 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.434 -0.803 . . . . 72.230000000000004 109.521 -178.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -83.05 161.24 21.75 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 108.961 -0.755 . . . . 62.409999999999997 108.961 176.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -112.92 150.99 31.04 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.563 -0.902 . . . . 64.230000000000004 108.563 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -121.46 16.38 11.29 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.565 -1.643 . . . . 53.229999999999997 106.565 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.02 -36.18 90.47 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.036 -1.438 . . . . 71.340000000000003 109.874 177.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 m -110.02 106.73 58.46 Favored Pre-proline 0 N--CA 1.414 -2.243 0 N-CA-C 108.689 -0.856 . . . . 63.219999999999999 108.689 172.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 148.72 19.65 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.902 1.735 . . . . 73.349999999999994 108.496 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -113.88 113.76 46.95 Favored Pre-proline 0 N--CA 1.422 -1.844 0 C-N-CA 117.588 -1.645 . . . . 75.319999999999993 110.823 176.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -105.31 173.87 0.13 Allowed 'Trans proline' 0 N--CA 1.42 -2.795 0 C-N-CA 122.978 2.452 . . . . 74.340000000000003 110.313 172.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -128.88 166.19 19.57 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.576 -0.898 . . . . 71.140000000000001 108.576 175.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.24 120.07 57.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 101.361 -3.57 . . . . 71.5 101.361 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.457 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 13.0 tp10 -124.31 156.24 37.3 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.101 0.778 . . . . 72.519999999999996 113.101 -161.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.428 ' H ' ' HE ' ' A' ' 87' ' ' ARG . 22.4 m -131.07 107.29 8.95 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.9 0.857 . . . . 72.409999999999997 109.718 178.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -105.47 152.49 22.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.451 -0.574 . . . . 73.150000000000006 109.451 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 107' ' ' LEU . 93.7 t -113.64 117.45 55.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 119.63 -0.224 . . . . 62.130000000000003 110.692 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 83' ' ' VAL . 47.8 p90 -123.12 127.25 48.44 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.085 -0.646 . . . . 72.430000000000007 109.454 171.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 19' ' ' ARG . 28.5 mtp180 -106.9 92.13 3.96 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.924 -1.139 . . . . 71.25 107.924 176.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 -154.99 0.56 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.233 -0.894 . . . . 63.0 112.169 -173.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.65 -3.21 6.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.388 1.475 . . . . 73.209999999999994 112.032 -172.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.82 -25.04 60.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.132 0.973 . . . . 74.530000000000001 111.713 176.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 24' ' ' LYS . 2.8 pp -67.31 -24.33 65.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.302 0.572 . . . . 74.219999999999999 111.304 177.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 23' ' ' LEU . 34.9 ttmt -88.56 -29.79 19.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.839 -0.8 . . . . 75.319999999999993 108.839 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -56.57 -44.77 81.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.949 -0.569 . . . . 42.420000000000002 110.794 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.3 ptp -83.99 2.76 37.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.614 -0.721 . . . . 73.099999999999994 111.556 -179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -91.88 -49.66 6.13 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.209 -1.034 . . . . 75.219999999999999 108.209 176.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.2 m -61.0 -42.85 99.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.29 -0.868 . . . . 51.439999999999998 111.986 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 p -77.4 -33.56 55.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.902 0.382 . . . . 50.340000000000003 110.293 177.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m 74.44 -54.8 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.122 1.369 . . . . 64.319999999999993 111.21 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.34 -163.8 10.58 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 109.935 -1.266 . . . . 23.149999999999999 109.935 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 113' ' ' ASN . 97.8 m -104.6 138.36 41.06 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 117.054 0.427 . . . . 71.329999999999998 110.288 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.34 121.45 66.46 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 108.367 -0.975 . . . . 61.240000000000002 108.367 176.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -59.48 152.28 62.73 Favored 'Trans proline' 0 C--O 1.255 1.356 0 C-N-CA 122.93 2.42 . . . . 71.140000000000001 113.02 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 166.43 16.17 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.36 -0.836 . . . . 55.399999999999999 109.127 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -66.05 122.74 18.09 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.231 0.539 . . . . 63.210000000000001 111.189 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 m -54.67 133.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.445 -1.252 . . . . 71.530000000000001 109.904 177.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 41' ' ' ASN . . . 129.78 -28.18 3.99 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 108.826 -1.71 . . . . 71.439999999999998 108.826 -174.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.5 65.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.695 0.76 . . . . 74.150000000000006 110.328 178.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 7.86 4.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.008 0.909 . . . . 71.5 112.576 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 1.7 m120 -79.54 -16.69 55.52 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.506 -1.224 . . . . 63.119999999999997 110.269 173.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 50.96 68.62 3.2 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 123.987 0.804 . . . . 71.010000000000005 112.819 178.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.03 -56.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.528 2.152 . . . . 74.140000000000001 113.648 -175.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.97 -23.31 33.43 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.019 0.377 . . . . 72.540000000000006 112.019 -177.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.93 79.7 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 120.351 -0.928 . . . . 53.530000000000001 111.182 -176.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.1 m -115.12 157.19 23.94 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.125 -1.065 . . . . 54.340000000000003 108.125 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.59 157.3 46.04 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.548 -0.538 . . . . 63.149999999999999 109.548 -177.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD13 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -134.04 160.26 38.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.744 0.652 . . . . 71.329999999999998 109.317 -177.136 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -128.69 141.22 51.4 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 120.158 -0.617 . . . . 53.329999999999998 109.846 175.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.86 139.67 38.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.432 -0.804 . . . . 62.219999999999999 109.809 -176.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 20.7 t -81.0 118.37 28.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.204 -1.036 . . . . 63.43 108.204 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -85.15 -34.79 22.05 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.169 -0.923 . . . . 75.099999999999994 109.858 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.627 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 29.2 tpt180 -151.68 144.91 24.67 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.52 -1.659 . . . . 73.109999999999999 106.52 -177.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.62 -171.05 22.48 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.508 -0.853 . . . . 52.229999999999997 111.551 179.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.67 -33.06 8.75 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.204 1.936 . . . . 72.519999999999996 109.932 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.77 11.81 21.2 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.058 -1.428 . . . . 74.540000000000006 110.109 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.56 42.36 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.298 0.571 . . . . 24.34 112.109 -175.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.91 -19.27 47.37 Favored Glycine 0 N--CA 1.427 -1.956 0 CA-C-N 115.225 -0.898 . . . . 73.420000000000002 111.712 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.74 156.84 19.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.958 -0.386 . . . . 65.150000000000006 109.958 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -139.46 155.15 47.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.752 -1.203 . . . . 73.439999999999998 107.752 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -147.78 143.3 27.42 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.608 -0.516 . . . . 75.510000000000005 109.608 175.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.3 pt? -108.62 144.75 35.93 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.526 0.516 . . . . 74.430000000000007 110.285 -177.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.15 105.06 11.14 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.703 -0.681 . . . . 70.340000000000003 110.175 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.93 -15.93 11.17 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.312 1.045 . . . . 65.340000000000003 109.344 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -107.34 153.23 41.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 114.4 -1.273 . . . . 72.319999999999993 110.117 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -63.17 -29.32 73.9 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.897 2.398 . . . . 73.409999999999997 113.743 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 67.2 m -150.47 122.67 8.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.084 0.469 . . . . 70.510000000000005 111.287 -177.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 11.8 m -112.6 114.24 26.78 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.163 -0.68 . . . . 74.439999999999998 109.163 178.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -90.75 133.87 34.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.39 -0.967 . . . . 72.200000000000003 108.39 175.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 78' ' ' ILE . . . -128.03 135.4 49.82 Favored 'General case' 0 C--O 1.267 2.019 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 111.404 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.41 -153.62 25.01 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-N 114.579 -1.192 . . . . 72.310000000000002 111.174 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 22.0 tpp85 -79.4 151.82 30.72 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.977 1.311 . . . . 74.219999999999999 108.676 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 75' ' ' GLU . 14.9 m170 92.39 127.89 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 125.904 1.682 . . . . 74.420000000000002 110.619 -175.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.85 2.97 4.8 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.347 2.032 . . . . 54.25 112.522 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 73' ' ' HIS . 12.9 pt-20 -80.2 -25.19 39.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.252 -1.018 . . . . 72.310000000000002 108.252 175.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -73.01 132.04 42.9 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.7 -1.222 . . . . 74.219999999999999 107.7 177.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -54.74 -39.53 68.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.698 0.629 . . . . 44.119999999999997 112.698 -174.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 46.4 mm -119.58 124.69 73.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.594 -0.891 . . . . 71.340000000000003 108.594 175.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -95.34 108.06 20.22 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.266 0.555 . . . . 60.530000000000001 110.604 -177.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.62 117.6 32.72 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 104.953 -2.24 . . . . 62.420000000000002 104.953 176.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.48 116.76 18.32 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.387 -0.925 . . . . 74.329999999999998 111.954 -173.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.73 161.4 14.9 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.755 -0.657 . . . . 62.020000000000003 109.457 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 18' ' ' PHE . 98.6 t -67.95 -36.25 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.328 0.585 . . . . 64.310000000000002 109.914 178.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 p -116.44 -171.29 1.98 Allowed 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.791 -0.641 . . . . 71.140000000000001 110.479 -176.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.31 96.58 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 108.452 -0.944 . . . . 75.230000000000004 108.452 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.9 m -129.44 85.69 2.34 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.929 -1.508 . . . . 34.100000000000001 106.929 174.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 20.0 ptt180 -77.31 -45.88 24.78 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 74.109999999999999 110.117 -175.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -106.21 93.4 4.59 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.534 -1.284 . . . . 63.340000000000003 107.534 172.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -99.65 -53.27 3.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.094 -1.076 . . . . 75.319999999999993 108.094 174.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.9 143.76 31.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.744 -0.782 . . . . 71.549999999999997 111.474 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -122.35 135.54 54.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.29 -0.868 . . . . 64.430000000000007 109.58 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 35.6 m-85 -104.2 113.62 27.29 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.572 -1.64 . . . . 65.099999999999994 106.572 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.24 123.88 51.1 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.865 -0.791 . . . . 64.310000000000002 108.865 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 94' ' ' ILE . 2.6 mp -104.02 115.13 45.39 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 N-CA-C 106.82 -1.548 . . . . 74.329999999999998 106.82 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -131.53 120.56 23.1 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.58 -0.526 . . . . 50.130000000000003 109.58 -177.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 48.22 48.23 18.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.556 1.143 . . . . 73.540000000000006 113.586 -177.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.07 -6.46 62.93 Favored Glycine 0 N--CA 1.462 0.427 0 CA-C-N 116.015 -0.539 . . . . 61.240000000000002 114.414 176.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -103.05 143.56 32.43 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.276 -0.639 . . . . 71.209999999999994 109.276 -179.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -104.8 116.76 32.57 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.871 -0.788 . . . . 72.439999999999998 108.871 -176.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.0 126.28 55.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.434 -0.951 . . . . 73.109999999999999 108.434 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.77 123.97 63.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 118.662 -1.215 . . . . 43.409999999999997 107.787 173.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.17 123.38 67.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.044 -1.465 . . . . 71.25 107.044 179.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.53 136.47 47.26 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.94 -1.027 . . . . 72.430000000000007 109.991 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.8 m -116.75 0.1 8.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.946 -0.57 . . . . 64.310000000000002 110.616 177.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.08 34.64 4.86 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 121.151 -0.547 . . . . 63.140000000000001 112.049 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -51.62 -34.42 37.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.876 1.27 . . . . 61.219999999999999 111.177 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 107' ' ' LEU . 4.6 mp -67.34 -23.92 65.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.063 -0.971 . . . . 54.409999999999997 111.16 -178.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.95 -18.64 30.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.586 0.708 . . . . 75.430000000000007 109.704 -175.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.03 46.22 0.43 Allowed Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 119.103 -1.522 . . . . 71.230000000000004 113.93 175.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.8 m -77.79 129.14 35.09 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.871 -0.789 . . . . 42.310000000000002 108.871 172.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.11 144.55 47.2 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.897 -0.321 . . . . 64.319999999999993 110.189 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.18 117.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.594 -1.632 . . . . 71.510000000000005 106.594 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.422 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 93.9 m-20 56.91 45.75 20.82 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.734 0.646 . . . . 54.32 110.062 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.04 8.95 2.81 Favored 'General case' 0 CA--C 1.569 1.701 0 C-N-CA 125.731 1.612 . . . . 73.409999999999997 113.809 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -114.11 136.85 22.24 Favored Pre-proline 0 C--N 1.31 -1.134 0 O-C-N 121.341 -0.85 . . . . 65.420000000000002 110.342 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -68.05 138.17 43.08 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 122.025 1.817 . . . . 70.420000000000002 111.211 177.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -142.19 164.6 29.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.082 -0.508 . . . . 62.310000000000002 111.025 -177.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -117.37 -37.6 3.48 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.489 1.118 . . . . 70.239999999999995 108.258 176.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.01 139.95 26.48 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.283 -1.377 . . . . 73.510000000000005 107.283 175.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HB3' ' HE2' ' A' ' 122' ' ' MET . 0.0 OUTLIER -152.49 130.33 11.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.432 -0.581 . . . . 64.219999999999999 109.432 -177.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 83.8 t -83.41 118.29 30.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.999 -1.482 . . . . 65.349999999999994 106.999 174.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.443 ' HE2' ' HB3' ' A' ' 120' ' ' GLN . 22.8 mmt -88.82 144.93 25.9 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.725 0.774 . . . . 63.5 112.944 -167.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.58 155.91 45.04 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.946 -1.479 . . . . 75.319999999999993 107.26 -177.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 t -62.57 134.38 56.29 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.339 0.59 . . . . 71.310000000000002 111.336 -176.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.32 -7.47 56.46 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.06 -0.973 . . . . 71.400000000000006 113.535 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -83.79 152.14 24.81 Favored 'General case' 0 CA--C 1.487 -1.468 0 C-N-CA 119.002 -1.079 . . . . 75.439999999999998 111.709 175.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.21 129.15 51.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.381 -1.281 . . . . 71.25 110.187 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.8 mt -108.1 131.91 57.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 107.198 -1.408 . . . . 74.230000000000004 107.198 -177.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -104.35 122.48 45.54 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.312 -0.996 . . . . 71.420000000000002 108.312 177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 135' ' ' LEU . 2.3 mp -109.22 104.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 106.602 -1.629 . . . . 53.530000000000001 106.602 178.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.05 -107.81 2.21 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.248 -1.141 . . . . 73.120000000000005 110.248 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -110.77 6.86 21.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.849 0.325 . . . . 70.340000000000003 111.673 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.627 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 44.1 p90 -123.49 157.63 33.1 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.542 0.941 . . . . 74.219999999999999 113.542 -177.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -116.05 136.61 52.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.347 -0.388 . . . . 64.120000000000005 111.329 -169.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 130' ' ' ILE . 9.6 mp -123.45 139.72 53.74 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.191 0.997 . . . . 64.230000000000004 108.337 175.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.45 126.82 69.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.574 -0.528 . . . . 62.210000000000001 109.574 -178.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -88.32 127.74 35.48 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.657 -0.868 . . . . 71.140000000000001 108.657 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.44 143.72 50.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.577 0.703 . . . . 72.120000000000005 111.238 -176.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.2 121.92 45.5 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.489 -0.93 . . . . 60.229999999999997 108.489 176.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 132.27 82.23 0.22 Allowed Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.72 -1.352 . . . . 53.219999999999999 109.72 -177.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.98 162.38 29.42 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.276 2.65 . . . . 54.219999999999999 112.719 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.89 -1.17 56.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.198 0.999 . . . . 63.240000000000002 110.929 -178.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.271 -2.838 0 N-CA-C 103.627 -2.731 . . . . 62.009999999999998 103.627 176.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 109.129 -0.693 . . . . 75.129999999999995 109.129 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.7 m -130.44 134.76 47.35 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.321 -0.251 . . . . 53.43 110.321 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.18 157.89 22.06 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.198 -0.667 . . . . 64.049999999999997 109.198 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.57 141.18 58.52 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.919 0.488 . . . . 55.009999999999998 111.776 -175.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.16 134.67 39.87 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 122.563 0.345 . . . . 61.130000000000003 110.221 178.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.37 147.71 50.15 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.125 -0.79 . . . . 64.519999999999996 111.125 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 m -90.85 119.56 68.91 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 109.979 -0.378 . . . . 72.109999999999999 109.979 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.6 140.93 84.14 Favored 'Trans proline' 0 C--O 1.253 1.236 0 C-N-CA 123.011 2.474 . . . . 71.010000000000005 112.513 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -90.16 128.12 50.75 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-N 116.071 -0.513 . . . . 73.120000000000005 110.573 178.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.0 -166.37 0.19 Allowed 'Trans proline' 0 N--CA 1.436 -1.861 0 C-N-CA 122.38 2.053 . . . . 60.229999999999997 108.966 171.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.459 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 97.0 mt-30 -109.46 166.51 10.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.632 -0.877 . . . . 55.100000000000001 108.632 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.75 125.68 65.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 108.201 -1.037 . . . . 72.409999999999997 108.201 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' N ' ' HD3' ' A' ' 87' ' ' ARG . 37.0 tt0 -158.83 132.33 7.41 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 116.252 -0.431 . . . . 61.200000000000003 110.561 -173.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.9 m -75.59 133.13 41.0 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 105.733 -1.951 . . . . 71.510000000000005 105.733 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.509 ' O ' HD12 ' A' ' 107' ' ' LEU . 36.1 t -89.46 123.06 33.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.996 -1.002 . . . . 64.420000000000002 108.785 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -85.56 115.13 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.283 -1.377 . . . . 72.439999999999998 107.283 177.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.472 ' CE2' ' HG ' ' A' ' 107' ' ' LEU . 40.3 p90 -114.79 142.53 46.4 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 120.813 0.34 . . . . 74.319999999999993 110.55 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -80.78 95.93 6.81 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.74 -1.208 . . . . 73.420000000000002 107.74 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -81.3 -178.71 7.04 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.421 -0.809 . . . . 73.230000000000004 112.26 -175.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.42 4.44 4.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 114.326 1.232 . . . . 64.420000000000002 114.326 -172.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 22' ' ' LEU . 2.5 pt? -82.83 -16.75 46.5 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.879 -0.513 . . . . 74.450000000000003 111.553 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 2.6 pp -70.01 -1.14 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.118 1.525 . . . . 75.140000000000001 115.118 -173.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -102.73 -22.5 13.92 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.574 -0.451 . . . . 60.229999999999997 111.257 177.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 114' ' ' ARG . 30.8 tt0 -72.68 -23.6 60.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.703 -0.399 . . . . 74.310000000000002 111.829 -172.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' SER . 52.6 ttp -62.33 -47.52 83.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.327 -0.397 . . . . 51.25 110.196 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.42 -22.58 23.66 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.505 -0.316 . . . . 70.319999999999993 110.963 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.6 t -62.29 -27.44 69.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.186 0.993 . . . . 65.540000000000006 108.532 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 26' ' ' MET . 40.0 t -65.38 -39.14 91.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.311 -1.313 . . . . 62.299999999999997 110.593 175.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 m 69.46 -7.08 0.89 Allowed 'General case' 0 CA--C 1.571 1.752 0 C-N-CA 124.879 1.271 . . . . 71.329999999999998 111.418 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.64 96.23 0.11 Allowed Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.668 -1.773 . . . . 72.340000000000003 108.668 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 92.0 m -72.84 121.02 19.28 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.869 0.842 . . . . 62.200000000000003 110.772 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.13 106.16 19.9 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 114.803 -1.09 . . . . 73.329999999999998 109.042 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -61.16 142.96 98.38 Favored 'Trans proline' 0 C--O 1.263 1.74 0 C-N-CA 121.551 1.501 . . . . 60.240000000000002 109.202 173.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.47 125.72 27.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.939 -0.573 . . . . 63.329999999999998 110.342 -177.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.5 m -84.33 92.7 8.07 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.657 -0.868 . . . . 61.549999999999997 108.657 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 m -102.55 155.62 18.16 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.875 -1.157 . . . . 72.239999999999995 107.875 -178.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.7 25.57 7.3 Favored Glycine 0 CA--C 1.499 -0.947 0 N-CA-C 111.05 -0.82 . . . . 74.219999999999999 111.05 -175.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.93 5.18 49.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.987 -0.607 . . . . 74.140000000000001 110.202 -178.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.23 -3.35 13.39 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.373 1.069 . . . . 65.409999999999997 113.393 -175.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -100.86 -2.81 31.1 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.233 -1.025 . . . . 73.430000000000007 108.233 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.9 82.83 0.22 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.185 -0.916 . . . . 71.329999999999998 110.95 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.03 -59.72 0.74 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.235 2.623 . . . . 73.409999999999997 114.257 -175.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.13 -4.08 59.09 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.227 0.454 . . . . 51.229999999999997 112.227 -177.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 9.61 86.82 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.709 -0.758 . . . . 71.0 111.478 -177.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 m -145.86 169.22 19.01 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.884 -1.524 . . . . 73.230000000000004 106.884 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.77 157.23 43.63 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.414 0.446 . . . . 75.409999999999997 109.916 -178.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -133.26 153.32 51.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.056 0.455 . . . . 72.439999999999998 110.8 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.5 pp -110.86 135.02 52.03 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.573 176.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.75 135.2 55.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 109.394 -0.595 . . . . 72.219999999999999 109.394 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.26 117.46 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 N-CA-C 106.361 -1.718 . . . . 65.400000000000006 106.361 176.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.53 -31.95 16.53 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.527 -0.761 . . . . 73.200000000000003 109.683 -175.641 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -148.19 141.02 24.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.399 -0.963 . . . . 72.439999999999998 108.399 -178.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.5 174.14 13.22 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 110.793 -0.923 . . . . 62.420000000000002 110.793 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.592 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 76.6 Cg_exo -54.68 -43.28 60.52 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.83 2.353 . . . . 65.040000000000006 112.402 177.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -93.11 21.88 5.5 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.792 1.034 . . . . 73.439999999999998 113.792 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.75 137.26 44.9 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.735 0.302 . . . . 52.109999999999999 111.14 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.6 -18.95 40.18 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.144 -0.783 . . . . 65.319999999999993 111.144 -177.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.23 143.06 29.84 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.53 -0.544 . . . . 74.129999999999995 109.53 177.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -135.2 135.58 41.11 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.505 -0.924 . . . . 75.219999999999999 108.505 179.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -128.42 129.67 46.51 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.511 -0.552 . . . . 73.409999999999997 109.511 -176.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.7 pt? -92.13 139.07 31.0 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.286 -0.635 . . . . 74.319999999999993 109.286 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.31 104.38 15.09 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.941 -0.763 . . . . 61.310000000000002 108.941 -179.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -124.37 -2.77 7.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.564 -1.198 . . . . 53.119999999999997 108.957 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 8.8 pm0 -107.73 143.76 27.93 Favored Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-N 115.184 -0.916 . . . . 74.319999999999993 109.392 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 65' ' ' GLN . 21.2 Cg_exo -68.37 -16.28 43.28 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.777 2.318 . . . . 70.319999999999993 113.445 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.8 m -150.1 128.05 11.85 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.727 -0.608 . . . . 74.239999999999995 109.495 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 10.6 m -123.7 119.38 29.63 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 p -87.5 137.12 32.61 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 110.208 -0.293 . . . . 70.540000000000006 110.208 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.02 148.3 51.86 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.329 0.585 . . . . 62.420000000000002 110.787 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.28 -161.23 28.31 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 108.612 -1.795 . . . . 65.349999999999994 108.612 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -119.15 117.66 29.27 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.653 -1.61 . . . . 44.409999999999997 106.653 175.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 171.45 162.14 0.24 Allowed Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 126.077 1.751 . . . . 74.219999999999999 106.623 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.87 -28.66 75.72 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.373 2.049 . . . . 74.340000000000003 114.22 -176.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.14 4.52 48.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.719 0.637 . . . . 62.240000000000002 112.719 -174.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 m -67.9 117.54 9.92 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 73.439999999999998 109.407 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.94 -39.27 84.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.201 -1.037 . . . . 72.239999999999995 108.201 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.455 HG12 ' CG2' ' A' ' 68' ' ' THR . 47.5 mm -112.65 110.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.196 -1.779 . . . . 62.219999999999999 106.196 169.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.4 129.45 39.53 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.991 -0.549 . . . . 75.319999999999993 110.74 -176.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 1.7 mm? -124.58 129.78 51.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.254 -2.128 . . . . 71.019999999999996 105.254 175.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -101.31 116.66 33.31 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.589 -0.844 . . . . 54.520000000000003 109.782 177.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -126.03 -160.11 0.95 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.312 -1.366 . . . . 74.239999999999995 107.312 -178.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.79 -27.99 17.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.65 0.611 . . . . 55.140000000000001 112.65 -174.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.1 m -139.42 148.83 43.33 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 121.209 -0.932 . . . . 64.439999999999998 111.844 -175.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -74.56 148.88 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.029 . . . . 73.299999999999997 110.189 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.491 ' HB3' HD22 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -142.28 113.69 7.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.19 -1.041 . . . . 74.25 108.19 177.624 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 11' ' ' GLN . 22.3 ptt180 -56.63 -25.3 52.91 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.148 0.795 . . . . 73.329999999999998 113.148 -177.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.416 ' HG2' HG21 ' A' ' 104' ' ' VAL . 34.5 ttt180 -172.99 99.02 0.13 Allowed 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.286 -1.376 . . . . 63.229999999999997 107.286 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 27.0 t-80 -84.56 -52.53 6.06 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.425 0.631 . . . . 72.439999999999998 109.698 -177.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.42 41.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.754 -0.832 . . . . 62.5 108.754 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.65 143.98 43.76 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.553 -0.536 . . . . 54.43 109.553 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.505 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 83.3 m-85 -104.78 125.32 50.73 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.381 -1.711 . . . . 73.319999999999993 106.381 178.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -113.43 119.11 36.48 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 106.795 -1.557 . . . . 73.439999999999998 106.795 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 3.4 mp -114.65 111.88 37.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 106.541 -1.651 . . . . 70.340000000000003 106.541 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -135.29 128.9 32.68 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 107.786 -1.19 . . . . 65.340000000000003 107.786 -177.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 55.45 37.98 29.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.882 0.873 . . . . 61.130000000000003 112.035 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.37 1.45 90.43 Favored Glycine 0 C--O 1.238 0.402 0 CA-C-N 115.974 -0.557 . . . . 52.520000000000003 113.911 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 20.2 mm-40 -102.11 131.74 48.42 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.782 -0.451 . . . . 65.239999999999995 109.782 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -107.48 118.59 37.13 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.211 -1.404 . . . . 72.439999999999998 107.211 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.17 142.79 51.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.251 -0.579 . . . . 52.329999999999998 110.303 178.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -106.63 123.61 61.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.586 -1.265 . . . . 54.420000000000002 107.586 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.3 121.21 65.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.138 -0.69 . . . . 61.340000000000003 109.138 175.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -83.14 131.65 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.459 -0.941 . . . . 74.519999999999996 108.459 173.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.416 HG21 ' HG2' ' A' ' 88' ' ' ARG . 34.6 m -124.74 -14.46 4.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 O-C-N 123.457 0.473 . . . . 72.209999999999994 110.645 178.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' HIS . . . -156.28 84.48 0.14 Allowed Glycine 0 N--CA 1.419 -2.454 0 C-N-CA 120.816 -0.707 . . . . 54.219999999999999 112.768 -178.444 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -69.7 83.09 0.44 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 121.11 0.481 . . . . 73.209999999999994 109.975 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 16' ' ' SER . 12.4 tp -77.17 -49.31 15.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.675 -1.232 . . . . 74.25 107.675 174.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -102.37 -19.17 15.08 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.296 -1.774 . . . . 52.149999999999999 110.049 -174.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 108.82 3.31 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.873 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.6 m -87.38 130.43 34.65 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 120.464 0.174 . . . . 55.329999999999998 111.24 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 5.6 m-30 -127.97 132.24 49.21 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.147 0.979 . . . . 74.340000000000003 109.068 175.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.75 127.74 75.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.842 -1.54 . . . . 75.140000000000001 106.842 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 56.85 36.49 27.8 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.031 1.332 . . . . 73.040000000000006 109.185 -169.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.493 ' HD3' ' OE2' ' A' ' 25' ' ' GLU 0.274 44.0 ttp180 57.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.576 1.948 0 C-N-CA 125.716 1.607 . . . . 75.310000000000002 113.059 -177.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -109.23 147.87 36.84 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.71 -1.219 . . . . 72.450000000000003 107.71 177.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.72 123.16 12.14 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.703 1.602 . . . . 61.119999999999997 110.24 177.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -161.11 136.89 8.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.707 -1.22 . . . . 75.230000000000004 107.707 -174.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -100.56 -53.75 3.01 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 123.364 0.415 . . . . 75.239999999999995 109.959 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.92 134.51 55.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.604 -0.887 . . . . 65.420000000000002 108.604 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -154.77 140.22 17.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.315 -0.402 . . . . 72.400000000000006 110.699 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.6 t -76.06 124.54 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 105.756 -1.942 . . . . 71.299999999999997 105.756 168.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.436 ' SD ' HD11 ' A' ' 128' ' ' ILE . 36.6 ttp -89.81 141.19 28.86 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.485 -169.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 126' ' ' ASP . 11.0 pt20 -115.1 156.99 24.18 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 124.557 1.143 . . . . 73.099999999999994 109.815 -175.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -69.92 130.26 41.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 74.340000000000003 107.692 173.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.62 1.02 56.5 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 119.963 -1.113 . . . . 54.340000000000003 110.351 -174.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 123' ' ' GLN . 6.3 t70 -76.21 137.53 40.06 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.27 -1.381 . . . . 74.209999999999994 107.27 178.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.6 124.28 45.95 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.354 0.597 . . . . 73.299999999999997 109.765 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.436 HD11 ' SD ' ' A' ' 122' ' ' MET . 37.3 mt -108.16 131.69 57.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.53 -0.915 . . . . 62.210000000000001 108.53 -172.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 7.2 tp60 -115.52 119.04 34.88 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 109.345 -0.613 . . . . 53.140000000000001 109.345 -176.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.19 102.83 9.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 106.48 -1.674 . . . . 64.340000000000003 106.48 176.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.89 -103.66 0.06 OUTLIER Glycine 0 N--CA 1.475 1.24 0 O-C-N 123.74 0.65 . . . . 75.349999999999994 114.134 -175.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -106.59 2.03 25.73 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.106 -0.547 . . . . 73.109999999999999 111.903 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 89.3 m-85 -96.32 135.39 38.23 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.219 -1.4 . . . . 73.099999999999994 107.219 173.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -131.76 120.17 22.31 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.029 -1.1 . . . . 74.409999999999997 108.029 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.37 136.59 48.55 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.416 -0.587 . . . . 73.400000000000006 109.416 -176.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.95 120.17 64.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.219 -1.4 . . . . 72.239999999999995 107.219 175.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -98.27 117.15 32.01 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 110.147 -0.316 . . . . 73.510000000000005 110.147 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.37 143.88 47.89 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.182 0.515 . . . . 61.200000000000003 111.187 -177.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.97 119.64 34.83 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.759 -1.571 . . . . 63.210000000000001 106.759 172.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -129.39 153.24 19.81 Favored Glycine 0 N--CA 1.426 -1.969 0 C-N-CA 118.866 -1.635 . . . . 72.0 112.697 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.67 164.13 36.71 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 123.687 2.925 . . . . 72.409999999999997 111.524 175.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 84.31 69.22 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 125.213 1.405 . . . . 73.430000000000007 111.989 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 N-CA-C 105.264 -2.125 . . . . 54.119999999999997 105.264 177.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 C--O 1.245 0.828 0 N-CA-C 109.471 -0.566 . . . . 70.450000000000003 109.471 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -85.33 115.83 23.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.911 -1.885 . . . . 61.409999999999997 105.911 173.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -99.38 163.5 12.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.929 0.395 . . . . 65.010000000000005 110.906 -173.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.49 124.49 21.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.641 -0.709 . . . . 73.329999999999998 110.955 -177.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -102.74 91.45 4.18 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.65 0.738 . . . . 70.5 110.438 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.94 -46.9 4.06 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.483 -0.865 . . . . 63.399999999999999 110.982 177.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 m -104.93 109.59 63.38 Favored Pre-proline 0 C--N 1.31 -1.132 0 O-C-N 122.6 -0.353 . . . . 63.25 110.742 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -73.3 140.48 30.62 Favored 'Trans proline' 0 N--CA 1.445 -1.344 0 N-CA-C 107.956 -1.594 . . . . 74.109999999999999 107.956 172.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -79.13 123.06 84.97 Favored Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.97 -0.692 . . . . 62.030000000000001 109.905 -176.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.2 106.09 1.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.567 2.178 . . . . 42.210000000000001 112.754 -176.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -156.8 131.83 9.03 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.801 -1.185 . . . . 75.239999999999995 107.801 177.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.6 120.53 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.235 0 N-CA-C 106.762 -1.57 . . . . 73.230000000000004 106.762 173.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.72 131.44 54.42 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 115.414 -0.812 . . . . 63.109999999999999 109.473 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.2 m -77.56 120.41 22.49 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.532 -0.758 . . . . 52.439999999999998 109.661 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.672 HG23 ' HB3' ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 44.9 t -89.31 117.84 28.55 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 122.21 -0.306 . . . . 63.350000000000001 110.204 -177.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.38 118.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.789 -0.449 . . . . 63.340000000000003 109.789 -178.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -124.04 140.73 52.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.384 -0.371 . . . . 74.299999999999997 111.16 -179.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -94.51 139.59 30.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.239 -0.437 . . . . 74.019999999999996 111.232 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -128.46 -164.2 1.36 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 7.6 p-10 -68.08 -3.23 9.65 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.929 0.871 . . . . 73.209999999999994 111.2 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.7 mt -57.25 -31.99 66.1 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 125.89 1.676 . . . . 73.019999999999996 111.502 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 20' ' ' ALA . 1.6 pp -68.39 -1.38 6.32 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.224 1.564 . . . . 64.099999999999994 115.224 -175.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 63.2 pttt -81.25 -5.71 58.07 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.847 -0.533 . . . . 71.319999999999993 111.599 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -48.9 31.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 116.112 1.893 . . . . 70.430000000000007 116.112 -175.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 46.7 ttm -62.26 -46.86 86.93 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.942 0.401 . . . . 62.240000000000002 111.658 -176.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.28 -28.25 61.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.318 0.58 . . . . 45.409999999999997 110.303 -178.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -80.51 -11.63 59.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.114 -0.494 . . . . 61.439999999999998 110.924 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 t -71.33 -24.41 62.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.756 -0.831 . . . . 54.539999999999999 108.756 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -76.08 93.74 3.36 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.305 -1.369 . . . . 72.310000000000002 107.305 171.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.78 50.32 0.85 Allowed Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 106.901 -2.48 . . . . 51.32 106.901 -169.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -67.17 148.39 51.86 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.853 1.261 . . . . 71.510000000000005 112.118 -173.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 150.38 37.8 Favored Pre-proline 0 C--N 1.312 -1.028 0 N-CA-C 108.501 -0.925 . . . . 51.009999999999998 108.501 177.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.98 146.42 96.31 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.418 2.079 . . . . 74.129999999999995 113.24 -177.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.72 159.22 17.19 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 71.219999999999999 108.484 175.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.3 t -98.92 178.12 5.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.489 -0.56 . . . . 73.040000000000006 109.489 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.506 ' HA ' ' OE1' ' A' ' 123' ' ' GLN . 12.9 t -156.4 33.56 0.32 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.792 -1.929 . . . . 72.420000000000002 105.792 176.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 124' ' ' THR . . . -103.56 35.45 5.02 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 114.827 -1.079 . . . . 62.409999999999997 113.072 -173.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 123' ' ' GLN . . . -90.82 -33.93 15.49 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.396 -0.964 . . . . 63.039999999999999 108.396 174.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.28 12.65 1.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.934 -1.485 . . . . 71.209999999999994 112.346 -177.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -80.08 -42.02 24.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.24 -0.282 . . . . 72.400000000000006 110.24 -177.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.5 mt 35.94 76.07 0.46 Allowed Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 124.766 1.291 . . . . 74.530000000000001 114.241 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.35 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.437 1.425 . . . . 44.100000000000001 111.112 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.06 -8.44 20.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.147 0.499 . . . . 64.329999999999998 110.954 178.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -6.22 80.15 Favored Glycine 0 C--O 1.216 -0.978 0 C-N-CA 120.401 -0.904 . . . . 75.439999999999998 111.925 -179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -114.49 162.79 16.24 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 105.94 -1.874 . . . . 71.400000000000006 105.94 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -153.15 157.14 39.89 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 118.137 0.426 . . . . 73.519999999999996 110.51 -178.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 143.72 44.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.14 0.422 . . . . 74.140000000000001 112.14 -178.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 49' ' ' LEU . 1.9 pt? -116.55 138.54 51.32 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.402 -0.592 . . . . 71.140000000000001 109.402 176.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.68 132.5 57.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 123.64 0.587 . . . . 72.329999999999998 109.573 -176.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.72 118.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 106.724 -1.584 . . . . 63.340000000000003 106.724 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.91 -38.96 18.77 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.411 0.624 . . . . 73.040000000000006 110.34 -175.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -147.54 140.7 25.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.325 -1.361 . . . . 65.019999999999996 107.325 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.94 -177.14 19.12 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 111.475 -0.65 . . . . 73.349999999999994 111.475 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.23 -36.9 86.37 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 122.772 2.315 . . . . 62.009999999999998 111.863 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.75 14.55 18.9 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.808 -0.633 . . . . 70.239999999999995 111.419 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.49 134.39 56.64 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.776 0.658 . . . . 61.119999999999997 112.776 -176.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -21.09 44.37 Favored Glycine 0 N--CA 1.437 -1.274 0 CA-C-N 115.786 -0.643 . . . . 64.439999999999998 111.876 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 155.03 19.27 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.766 0.317 . . . . 73.040000000000006 110.47 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.14 144.54 51.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.992 -0.744 . . . . 75.310000000000002 108.992 178.107 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -117.82 138.53 52.02 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.221 -1.029 . . . . 63.219999999999999 108.221 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.11 127.01 56.08 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.917 0.865 . . . . 74.549999999999997 110.795 -175.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 49' ' ' LEU . 2.2 mm? -95.45 114.77 26.57 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.822 -1.081 . . . . 73.519999999999996 108.436 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -134.33 4.27 3.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 122.296 1.046 . . . . 74.349999999999994 109.193 177.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -121.49 143.3 37.47 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.978 -1.01 . . . . 72.299999999999997 110.724 -175.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 53.7 Cg_exo -55.19 -24.39 41.26 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.746 2.964 . . . . 75.420000000000002 114.699 -178.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.4 m -144.27 121.54 11.57 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.474 -0.766 . . . . 63.210000000000001 110.722 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.3 m -129.7 119.88 24.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.9 -0.778 . . . . 74.040000000000006 108.9 -178.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 140.25 29.72 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.508 0.594 . . . . 73.209999999999994 111.275 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.05 135.5 55.18 Favored 'General case' 0 C--O 1.259 1.592 0 N-CA-C 109.549 -0.538 . . . . 71.340000000000003 109.549 178.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.36 -161.34 25.69 Favored Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 115.65 -0.705 . . . . 42.130000000000003 111.385 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.541 ' HG2' ' H ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -103.83 142.16 34.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.062 -1.459 . . . . 74.239999999999995 107.062 -177.554 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.463 ' CD2' ' HD2' ' A' ' 72' ' ' ARG . 90.4 m-70 80.58 145.84 0.1 OUTLIER Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 125.414 1.486 . . . . 74.400000000000006 110.092 -176.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -66.5 17.4 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.601 2.867 . . . . 51.109999999999999 114.341 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 73' ' ' HIS . 10.4 mm-40 -77.37 -28.77 53.02 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.313 -1.366 . . . . 65.420000000000002 107.313 177.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -96.1 153.0 18.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.919 -1.037 . . . . 61.409999999999997 109.658 177.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.18 -47.19 78.78 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.56 0.744 . . . . 64.400000000000006 110.463 -178.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.8 mm -98.98 109.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.026 -1.102 . . . . 74.030000000000001 108.026 178.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -87.68 115.6 25.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.115 0.483 . . . . 74.420000000000002 110.577 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 70.8 mt -126.74 140.42 52.4 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.491 -1.67 . . . . 72.430000000000007 106.491 176.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -96.52 117.11 30.24 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.246 -0.982 . . . . 74.530000000000001 109.661 -179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 46.1 t0 -117.38 -179.88 3.85 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.779 -0.646 . . . . 70.109999999999999 109.36 -171.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.03 -46.44 96.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 123.757 0.823 . . . . 74.439999999999998 111.694 -176.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 t -128.27 -173.1 2.86 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.463 -0.94 . . . . 72.209999999999994 108.463 -178.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.37 97.5 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 108.825 -0.806 . . . . 54.420000000000002 108.825 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.6 m -89.74 84.89 6.31 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 108.525 -0.917 . . . . 55.210000000000001 108.525 177.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -71.82 -36.98 70.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.97 -1.468 . . . . 75.120000000000005 112.091 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.588 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 31.2 mmm180 -133.71 85.86 2.24 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.241 -1.022 . . . . 71.319999999999993 108.241 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -101.55 -55.65 2.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.193 -0.603 . . . . 61.420000000000002 110.952 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.76 164.59 31.42 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.077 0.465 . . . . 62.409999999999997 111.046 -176.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.66 141.49 37.01 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.397 0.617 . . . . 75.049999999999997 110.148 173.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -104.25 117.4 34.13 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.781 -1.562 . . . . 63.119999999999997 106.781 -178.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -117.37 128.46 55.05 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-N 115.445 -0.798 . . . . 74.040000000000006 109.256 -175.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.4 mp -115.52 112.3 39.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 105.907 -1.886 . . . . 63.109999999999999 105.907 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -138.52 125.48 21.22 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.893 -0.323 . . . . 70.420000000000002 111.255 -175.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 51.56 49.9 19.94 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.978 1.424 . . . . 72.0 114.098 173.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.33 0.58 86.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 114.877 -1.056 . . . . 73.510000000000005 115.382 173.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -127.6 146.99 50.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 118.277 1.038 . . . . 74.230000000000004 111.026 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.33 119.6 39.32 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.485 -1.302 . . . . 75.5 107.485 -176.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -129.55 128.46 42.81 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.525 0.679 . . . . 70.549999999999997 111.353 -176.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 122' ' ' MET . 32.9 t -103.82 124.51 58.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.506 -1.294 . . . . 63.32 107.506 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 20.8 m -118.51 123.37 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 CA-C-O 121.588 0.709 . . . . 71.140000000000001 110.836 176.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.29 121.6 25.3 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.447 -1.686 . . . . 73.209999999999994 106.447 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -111.84 -8.72 11.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.175 0.512 . . . . 72.530000000000001 111.349 -174.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -147.28 90.97 0.15 Allowed Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.17 -1.572 . . . . 51.200000000000003 109.17 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 m -79.22 74.09 5.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.559 0.695 . . . . 71.129999999999995 110.989 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.672 ' HB3' HG23 ' A' ' 15' ' ' TPO . 2.6 pt? -104.77 -44.36 4.87 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.328 -0.851 . . . . 75.200000000000003 108.786 175.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.408 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 45.7 t-20 -101.16 -21.78 14.85 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.461 -1.245 . . . . 71.510000000000005 107.897 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.49 116.41 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.309 -0.86 . . . . 73.409999999999997 111.774 -177.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 25.2 m -75.82 128.51 35.29 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.794 -0.817 . . . . 71.540000000000006 108.794 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 22' ' ' LEU . 6.4 m-85 -115.24 126.34 54.42 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.616 -0.513 . . . . 71.140000000000001 109.616 178.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.6 127.87 62.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.408 -1.33 . . . . 75.200000000000003 107.408 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 57.05 46.58 18.99 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.637 1.208 . . . . 72.120000000000005 108.385 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 62.69 8.56 3.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.534 -1.667 . . . . 75.0 114.471 -177.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.43 132.66 23.45 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 113.231 0.826 . . . . 64.219999999999999 113.231 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 52.7 Cg_endo -78.13 123.19 6.04 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.0 1.8 . . . . 73.129999999999995 108.369 173.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -150.34 158.05 43.73 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.173 -1.047 . . . . 71.239999999999995 108.173 -176.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 15.7 m120 -92.95 -40.8 10.37 Favored 'General case' 0 C--O 1.206 -1.192 0 C-N-CA 120.003 -0.679 . . . . 72.430000000000007 112.77 -176.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.02 134.46 55.29 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.206 -1.405 . . . . 62.200000000000003 107.206 174.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -151.92 143.44 23.49 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 120.837 -0.345 . . . . 74.430000000000007 111.309 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -82.41 124.34 39.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.15 -1.426 . . . . 61.009999999999998 107.15 173.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.438 ' HB2' HG23 ' A' ' 101' ' ' VAL . 47.3 ttp -92.5 129.25 38.49 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 62.420000000000002 108.347 -177.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' A' ' 37' ' ' THR . 26.3 mt-30 -129.8 151.02 50.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.121 -0.696 . . . . 61.030000000000001 109.121 -172.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 38' ' ' GLY . 13.7 t -62.42 132.75 53.59 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 121.394 0.616 . . . . 63.210000000000001 110.058 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.28 -12.08 61.82 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 115.774 -0.648 . . . . 72.5 112.584 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.74 151.96 25.95 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-O 121.025 0.441 . . . . 74.239999999999995 111.819 178.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -112.23 144.53 41.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.371 -0.832 . . . . 74.540000000000006 109.73 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.43 131.63 67.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.008 -1.108 . . . . 70.310000000000002 108.008 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -117.41 130.51 56.53 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.428 -0.509 . . . . 63.210000000000001 110.163 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.43 107.81 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 106.29 -1.744 . . . . 72.450000000000003 106.29 175.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 63.82 -108.53 2.27 Favored Glycine 0 C--N 1.299 -1.516 0 CA-C-N 116.127 -0.488 . . . . 70.549999999999997 113.323 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.99 -1.2 32.35 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.741 -0.23 . . . . 75.010000000000005 111.504 -175.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 38.1 p90 -124.71 146.39 49.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.992 1.108 . . . . 74.400000000000006 113.992 -173.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -118.18 132.18 56.34 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.117 -0.947 . . . . 74.25 111.288 -172.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.39 140.66 52.43 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 124.142 0.977 . . . . 73.019999999999996 108.875 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.04 130.39 67.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.705 -0.85 . . . . 73.310000000000002 108.705 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -94.06 133.07 37.91 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.976 -0.557 . . . . 63.219999999999999 111.221 -177.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.29 155.57 39.98 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.906 -0.776 . . . . 75.319999999999993 108.906 176.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.42 148.66 38.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.034 -0.728 . . . . 55.109999999999999 109.034 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.5 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -75.58 136.56 20.26 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.781 -0.724 . . . . 65.129999999999995 112.019 -178.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.52 153.89 72.06 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.259 2.64 . . . . 53.030000000000001 112.27 -177.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.61 65.56 0.8 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.791 -0.64 . . . . 62.439999999999998 111.516 -175.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.414 -2.225 0 N-CA-C 107.944 -1.132 . . . . 75.349999999999994 107.944 173.183 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.513 -0.455 0 N-CA-C 108.736 -0.839 . . . . 73.209999999999994 108.736 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -84.52 136.45 33.8 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.872 -0.603 . . . . 74.049999999999997 111.678 -174.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.18 102.32 8.44 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.321 -0.854 . . . . 62.119999999999997 109.436 177.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -129.18 142.25 50.92 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.206 -1.776 . . . . 63.520000000000003 106.206 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.26 171.3 15.62 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.853 -0.425 . . . . 74.230000000000004 109.853 -177.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.97 -70.75 1.13 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 121.193 -0.527 . . . . 75.510000000000005 112.629 -178.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.0 m -129.32 111.07 17.99 Favored Pre-proline 0 C--N 1.287 -2.116 0 O-C-N 122.546 -0.385 . . . . 74.5 110.308 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.49 131.69 25.3 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.546 1.498 . . . . 64.430000000000007 109.148 173.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.88 149.79 40.9 Favored Pre-proline 0 C--N 1.29 -2.009 0 N-CA-C 108.803 -0.814 . . . . 75.510000000000005 108.803 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.51 122.06 7.26 Favored 'Trans proline' 0 C--O 1.252 1.175 0 C-N-CA 122.174 1.916 . . . . 54.210000000000001 107.965 170.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -91.28 132.95 35.81 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.131 0.967 . . . . 74.430000000000007 112.349 -168.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -108.3 121.02 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 105.935 -1.876 . . . . 75.219999999999999 105.935 177.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.84 154.52 25.02 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 108.311 -0.996 . . . . 74.310000000000002 108.311 -177.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -70.27 113.14 7.14 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 123.623 0.769 . . . . 74.230000000000004 112.373 -173.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -96.81 152.95 18.18 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 105.504 -2.036 . . . . 73.439999999999998 105.504 172.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 93.4 t -82.78 114.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.853 -0.739 . . . . 73.200000000000003 109.321 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -123.3 120.41 32.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.51 -0.768 . . . . 75.329999999999998 110.778 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.92 93.02 3.04 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.155 -2.165 . . . . 71.329999999999998 105.155 174.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.64 9.52 22.92 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.467 0.914 . . . . 70.549999999999997 113.467 -168.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -107.24 8.17 29.77 Favored 'General case' 0 C--O 1.182 -2.498 0 C-N-CA 118.909 -1.116 . . . . 74.420000000000002 112.581 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.83 -32.4 63.54 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.111 -0.993 . . . . 70.430000000000007 113.374 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.1 tp -68.05 -37.69 81.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.33 0.586 . . . . 75.329999999999998 110.289 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -91.08 -25.18 19.76 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 122.126 -0.359 . . . . 55.200000000000003 111.343 -177.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -44.31 93.08 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.163 -1.421 . . . . 65.519999999999996 107.163 174.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 60.3 mtt -62.27 -35.4 78.86 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.33 -0.396 . . . . 65.420000000000002 111.468 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.85 -44.46 80.99 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.741 0.781 . . . . 75.040000000000006 109.221 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -72.92 -10.44 59.8 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.676 1.19 . . . . 75.510000000000005 112.086 -178.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -65.42 -17.19 64.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.577 0.227 . . . . 32.219999999999999 110.94 176.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -57.43 116.95 3.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.437 -0.949 . . . . 74.25 108.437 174.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.15 119.74 18.5 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.335 -0.848 . . . . 61.310000000000002 115.079 -173.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -116.68 149.49 39.71 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 107.513 -1.292 . . . . 64.310000000000002 107.513 173.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.01 127.49 92.86 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.994 -0.373 . . . . 55.149999999999999 109.994 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.02 142.58 88.32 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.134 1.889 . . . . 75.239999999999995 110.61 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . . . -103.69 168.13 9.34 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.505 -0.316 . . . . 72.549999999999997 110.289 -174.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.477 ' HA ' HG23 ' A' ' 124' ' ' THR . 14.4 t -174.88 -168.28 0.34 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.903 -1.518 . . . . 72.510000000000005 106.903 177.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 36' ' ' SER . 15.3 t 174.45 -29.81 0.0 OUTLIER 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.803 0.841 . . . . 71.340000000000003 109.906 178.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.34 63.3 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.901 -1.143 . . . . 64.019999999999996 112.661 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 124' ' ' THR . . . -79.34 -45.9 18.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.037 -0.727 . . . . 70.239999999999995 109.037 179.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.15 4.7 22.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.409 -0.814 . . . . 72.400000000000006 110.651 -178.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -89.88 -28.18 19.4 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.664 -1.153 . . . . 51.130000000000003 108.16 177.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.4 mt 56.34 80.05 0.31 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 114.739 -1.119 . . . . 53.530000000000001 110.626 -177.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.76 -63.71 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 122.743 2.295 . . . . 71.209999999999994 113.406 -175.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.8 14.03 7.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.212 0.529 . . . . 55.210000000000001 110.588 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.28 -9.07 62.1 Favored Glycine 0 C--O 1.215 -1.087 0 C-N-CA 121.127 -0.558 . . . . 71.019999999999996 113.378 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -115.35 153.98 30.02 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 122.351 -0.499 . . . . 51.520000000000003 109.779 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HA ' ' N ' ' A' ' 140' ' ' GLY . . . -145.91 157.51 43.89 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.073 -0.714 . . . . 42.329999999999998 109.073 -177.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HG ' ' HA2' ' A' ' 140' ' ' GLY . 3.9 pp -138.76 161.49 37.07 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.831 -0.347 . . . . 62.539999999999999 111.137 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.6 147.36 52.52 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.745 -0.465 . . . . 71.209999999999994 109.745 177.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.04 132.09 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.12 -0.696 . . . . 71.230000000000004 109.12 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG22 ' HG ' ' A' ' 135' ' ' LEU . 25.5 t -80.25 117.92 26.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.167 -1.42 . . . . 74.430000000000007 107.167 176.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.62 -34.0 18.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.747 -0.381 . . . . 75.209999999999994 110.636 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -146.82 133.43 19.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.431 -0.581 . . . . 70.299999999999997 109.431 -178.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.43 171.88 17.0 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 107.304 -2.318 . . . . 40.049999999999997 107.304 -177.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 52.3 Cg_exo -57.61 -31.89 92.97 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.234 1.956 . . . . 50.149999999999999 111.273 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -93.94 20.33 7.91 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.375 -0.829 . . . . 74.239999999999995 111.274 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 138.54 58.4 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.645 0.26 . . . . 54.109999999999999 110.654 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.92 63.16 Favored Glycine 0 N--CA 1.438 -1.168 0 CA-C-N 115.737 -0.665 . . . . 73.0 111.715 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.33 135.9 33.35 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.698 0.285 . . . . 45.520000000000003 110.446 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.03 134.53 54.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.316 -1.365 . . . . 71.120000000000005 107.316 177.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -128.49 144.9 51.22 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.351 -1.352 . . . . 64.409999999999997 107.351 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.2 pt? -116.66 143.18 45.95 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.528 -0.869 . . . . 74.530000000000001 111.951 -177.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HB3' HD11 ' A' ' 94' ' ' ILE . 2.8 mm? -87.37 105.01 16.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.116 -1.809 . . . . 64.409999999999997 106.116 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -127.37 12.33 7.0 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 122.487 1.137 . . . . 64.340000000000003 109.761 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.66 153.81 47.38 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.029 -1.1 . . . . 71.329999999999998 108.029 -176.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.3 -21.25 71.74 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.378 2.052 . . . . 72.150000000000006 113.713 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.7 m -136.93 121.7 18.65 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 121.893 -0.505 . . . . 64.150000000000006 110.514 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 77' ' ' ASP . 45.8 m -129.59 118.18 21.59 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.179 -0.674 . . . . 52.32 109.179 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 p -86.86 150.8 23.86 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.802 -0.561 . . . . 54.32 110.841 -178.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.3 135.24 48.51 Favored 'General case' 0 C--O 1.264 1.851 0 CA-C-O 121.049 0.452 . . . . 70.209999999999994 112.035 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.93 -138.66 6.35 Favored Glycine 0 N--CA 1.422 -2.3 0 CA-C-N 114.796 -1.093 . . . . 62.409999999999997 110.891 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 73' ' ' HIS . 56.2 ttt180 -118.87 151.57 37.87 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.506 -1.294 . . . . 74.530000000000001 107.506 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 34.9 m170 89.3 164.5 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.967 0 C-N-CA 125.234 1.414 . . . . 75.230000000000004 111.323 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.15 -2.61 8.32 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.018 2.479 . . . . 71.349999999999994 111.009 174.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.24 -22.37 60.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.951 -1.022 . . . . 75.319999999999993 108.36 175.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 m -112.2 130.02 56.06 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.23 -0.895 . . . . 74.030000000000001 109.417 178.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.418 ' HB3' HG23 ' A' ' 68' ' ' THR . 20.0 t70 -77.37 -33.87 55.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.474 0.654 . . . . 73.329999999999998 109.652 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.9 mm -91.71 101.03 12.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 105.558 -2.016 . . . . 64.239999999999995 105.558 173.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -87.79 113.98 23.97 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.52 0.676 . . . . 71.230000000000004 112.237 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.0 mt -119.87 127.42 52.71 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 105.878 -1.897 . . . . 72.349999999999994 105.878 175.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -106.21 117.06 33.06 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.83 -0.748 . . . . 54.240000000000002 109.613 -176.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -119.85 177.56 4.92 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.033 -0.985 . . . . 72.530000000000001 109.071 -175.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.38 -35.76 68.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 107.913 -1.143 . . . . 74.439999999999998 107.913 176.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.9 m -97.96 151.32 20.41 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.81 -1.086 . . . . 72.129999999999995 108.778 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 81.8 t -90.51 98.41 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 118.686 -1.206 . . . . 73.239999999999995 110.408 175.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -87.03 78.42 8.96 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.677 -1.231 . . . . 63.109999999999999 107.677 172.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -57.43 -23.82 51.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 112.083 -176.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -172.79 97.7 0.13 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.605 -0.887 . . . . 75.129999999999995 108.605 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.503 ' CE1' ' HB2' ' A' ' 108' ' ' ASN . 2.3 t-160 -99.34 -52.12 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.942 -1.132 . . . . 72.409999999999997 107.942 176.222 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.81 155.44 41.09 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.987 -0.551 . . . . 72.519999999999996 110.844 -174.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.488 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 34.0 tt0 -131.05 129.15 41.6 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.566 -1.642 . . . . 74.530000000000001 106.566 176.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -105.27 122.2 45.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.622 -1.621 . . . . 63.509999999999998 106.622 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD3' ' OE2' ' A' ' 91' ' ' GLU . 21.3 mtm180 -125.07 145.91 49.7 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.635 0.731 . . . . 62.020000000000003 110.635 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 63' ' ' LEU . 2.1 mp -103.98 111.41 33.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 102.856 -3.016 . . . . 74.019999999999996 102.856 175.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -138.73 118.45 13.12 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.038 -0.528 . . . . 72.329999999999998 110.829 -169.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 53.48 37.8 26.55 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.454 1.102 . . . . 72.510000000000005 112.272 177.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.06 87.52 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 113.515 178.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.98 150.12 26.0 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.387 -0.598 . . . . 73.230000000000004 109.387 -179.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.415 ' CD2' HG13 ' A' ' 94' ' ' ILE . 94.1 m-85 -104.59 116.19 31.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.257 -1.757 . . . . 70.25 106.257 174.151 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.14 135.31 54.3 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.206 0.527 . . . . 55.539999999999999 111.51 -174.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.42 120.65 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.991 0 N-CA-C 104.815 -2.291 . . . . 65.120000000000005 104.815 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.03 131.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 N-CA-C 108.35 -0.982 . . . . 72.349999999999994 108.35 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.616 ' OD2' ' HA ' ' A' ' 118' ' ' ASN . 1.8 p30 -97.8 157.94 15.79 Favored 'General case' 0 C--N 1.28 -2.434 0 C-N-CA 117.65 -1.62 . . . . 74.030000000000001 112.123 176.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -129.96 23.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.067 -1.827 . . . . 74.349999999999994 106.067 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.99 62.92 0.52 Allowed Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.752 -1.567 . . . . 74.040000000000006 110.11 -176.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -70.97 -7.01 43.1 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 122.802 0.441 . . . . 71.099999999999994 111.485 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HB3' HG22 ' A' ' 17' ' ' VAL . 49.5 mt -75.19 -40.94 58.93 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.318 -0.253 . . . . 71.400000000000006 110.318 -178.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 94.3 m-20 -85.8 -20.56 29.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 119.799 -0.76 . . . . 72.25 110.25 -176.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.17 109.85 0.42 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.302 -0.951 . . . . 52.210000000000001 113.525 174.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -85.38 130.36 34.61 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.456 -0.942 . . . . 44.119999999999997 108.456 174.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 129' ' ' GLN . 72.0 m-85 -120.0 134.31 55.28 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.076 -0.712 . . . . 74.519999999999996 109.076 179.003 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.8 t -129.87 120.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 106.928 -1.508 . . . . 73.129999999999995 106.928 175.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.37 39.82 28.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.645 0.736 . . . . 73.430000000000007 109.777 -173.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 62.07 14.87 6.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 113.589 -1.641 . . . . 73.329999999999998 113.736 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -103.53 123.41 41.56 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 107.684 -1.228 . . . . 72.209999999999994 107.684 177.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.37 123.87 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.321 2.014 . . . . 74.420000000000002 110.786 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -141.33 162.31 35.79 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 120.887 0.375 . . . . 73.140000000000001 110.593 -179.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.616 ' HA ' ' OD2' ' A' ' 103' ' ' ASP . 18.4 m120 -113.81 -29.84 6.95 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.595 -1.184 . . . . 73.409999999999997 109.533 176.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.31 134.7 36.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.617 -1.623 . . . . 71.219999999999999 106.617 172.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -153.46 138.45 17.24 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.458 -0.497 . . . . 65.450000000000003 111.826 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.6 t -84.86 122.52 38.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 107.401 -1.333 . . . . 75.540000000000006 107.401 171.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 ptm -90.25 130.53 36.36 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.961 -0.563 . . . . 64.439999999999998 111.099 -173.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -101.8 156.2 17.66 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.299 -0.63 . . . . 74.219999999999999 109.299 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 36' ' ' SER . 6.3 t -67.17 126.71 30.06 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.677 -0.86 . . . . 61.399999999999999 108.677 175.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 35' ' ' ALA . . . 99.91 -6.66 58.62 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.725 -0.67 . . . . 75.430000000000007 112.747 -175.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -80.23 151.76 29.46 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.27 0.535 . . . . 71.219999999999999 111.184 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -112.39 127.48 56.03 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.45 0.643 . . . . 75.439999999999998 110.423 175.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.94 122.34 68.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.041 -1.096 . . . . 72.239999999999995 108.041 -177.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 133' ' ' PHE . 39.0 mt-30 -108.02 131.11 54.92 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 113.101 0.778 . . . . 72.230000000000004 113.101 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.477 HG23 ' ND1' ' A' ' 89' ' ' HIS . 3.3 mp -117.35 103.24 14.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 106.478 -1.675 . . . . 70.120000000000005 106.478 174.187 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.28 -65.6 1.29 Allowed Glycine 0 N--CA 1.477 1.38 0 CA-C-O 121.279 0.377 . . . . 64.439999999999998 112.842 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -157.72 5.71 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.151 0.98 . . . . 74.400000000000006 110.847 173.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 68.0 m-85 -91.18 124.54 35.47 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.894 -1.15 . . . . 75.120000000000005 107.894 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -111.57 118.8 36.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.927 0.87 . . . . 75.239999999999995 110.932 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' A' ' 51' ' ' VAL . 5.8 mp -108.29 133.74 52.08 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.475 -1.693 . . . . 75.409999999999997 107.413 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.25 129.09 67.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.862 -1.162 . . . . 72.519999999999996 107.862 177.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -88.56 134.03 33.99 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.53 -0.759 . . . . 74.450000000000003 109.484 -176.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.75 161.23 33.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.139 0.495 . . . . 75.209999999999994 109.846 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.56 132.06 43.3 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.701 -1.592 . . . . 73.430000000000007 106.701 174.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 47' ' ' ALA . . . -80.11 -163.74 28.59 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 115.739 1.055 . . . . 63.299999999999997 115.739 -169.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.36 145.3 47.84 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 123.001 2.467 . . . . 73.409999999999997 112.424 -177.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.42 65.86 0.67 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.494 -1.298 . . . . 71.420000000000002 107.494 175.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--N 1.295 -1.782 0 CA-C-N 114.288 -1.324 . . . . 72.230000000000004 109.388 -176.987 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.886 0 CA-C-O 121.42 0.629 . . . . 65.329999999999998 111.795 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -140.07 85.11 2.0 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 107.44 -1.318 . . . . 71.439999999999998 107.44 176.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -96.13 152.61 18.39 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.077 -0.712 . . . . 53.119999999999997 109.077 179.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.99 131.02 55.66 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.248 0.547 . . . . 63.130000000000003 111.775 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -150.12 154.02 37.35 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.592 -2.373 . . . . 71.329999999999998 104.592 174.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.77 -114.38 1.49 Allowed Glycine 0 N--CA 1.423 -2.169 0 C-N-CA 118.867 -1.635 . . . . 74.349999999999994 113.06 -176.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 m -81.22 131.77 58.13 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.308 -0.446 . . . . 70.129999999999995 111.171 -174.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.93 145.79 95.96 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.061 1.841 . . . . 71.099999999999994 108.152 169.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.87 124.22 84.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 120.279 -0.568 . . . . 75.150000000000006 110.721 -173.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.89 104.31 0.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.096 2.531 . . . . 60.020000000000003 110.859 177.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -100.16 154.33 18.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.292 -1.003 . . . . 65.530000000000001 108.292 178.493 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.1 t -108.22 131.57 58.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.543 0.687 . . . . 63.009999999999998 110.418 -175.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.27 168.92 24.38 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 103.104 -2.924 . . . . 71.340000000000003 103.104 176.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.643 ' HB ' ' NH2' ' A' ' 87' ' ' ARG . 33.8 m -70.52 109.01 4.58 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.251 1.024 . . . . 54.119999999999997 109.854 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.4 m -117.65 143.76 45.85 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 178.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.9 t -83.72 124.57 39.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.82 -0.807 . . . . 71.400000000000006 108.82 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 43.9 t80 -81.46 105.91 13.01 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.627 -1.249 . . . . 72.209999999999994 107.627 -178.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -89.1 95.88 10.5 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.638 -0.71 . . . . 65.450000000000003 110.203 -178.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.69 157.89 23.59 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.139 -0.937 . . . . 71.239999999999995 108.508 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.01 3.6 16.78 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.097 0.475 . . . . 71.209999999999994 112.066 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.88 -23.02 66.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.492 1.293 . . . . 64.230000000000004 114.492 -174.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.36 -26.96 63.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.913 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -66.66 -29.46 69.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 74.129999999999995 110.997 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -63.55 -48.64 76.66 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.535 0.522 . . . . 75.239999999999995 111.744 -175.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -76.78 -18.05 58.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.313 0.578 . . . . 73.310000000000002 110.868 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -81.6 -34.35 31.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.136 -1.061 . . . . 64.209999999999994 108.136 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 t -72.59 -45.24 60.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.974 -0.557 . . . . 34.32 110.21 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 p -80.75 -17.35 51.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.253 -0.43 . . . . 73.420000000000002 111.993 -177.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m 67.07 73.89 0.34 Allowed 'General case' 0 C--O 1.25 1.1 0 CA-C-O 122.088 0.946 . . . . 73.310000000000002 110.228 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.62 124.68 34.34 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 113.695 -1.593 . . . . 71.25 113.926 -176.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.5 t -94.68 137.76 33.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.356 -0.609 . . . . 73.409999999999997 109.356 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.61 98.97 43.0 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 109.63 -0.507 . . . . 61.219999999999999 109.63 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 143.08 27.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.027 1.818 . . . . 73.450000000000003 110.946 178.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 126.0 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.944 -1.132 . . . . 71.349999999999994 107.944 178.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -112.28 156.83 21.76 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.288 -0.634 . . . . 75.120000000000005 109.288 -177.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.23 160.83 32.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.807 -0.812 . . . . 72.109999999999999 108.807 -177.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.53 -7.12 24.46 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.647 -1.381 . . . . 51.130000000000003 109.647 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -73.8 -39.78 63.85 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.721 -0.74 . . . . 64.040000000000006 109.979 -177.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -86.51 -5.08 59.24 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.466 -1.243 . . . . 75.120000000000005 110.432 -177.144 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -86.63 -29.89 22.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.931 -0.577 . . . . 72.040000000000006 110.119 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 53.41 69.21 2.38 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 124.158 0.911 . . . . 73.400000000000006 110.384 -177.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.15 -65.97 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.181 2.587 . . . . 65.200000000000003 113.819 -173.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . -102.22 -0.37 33.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.611 -0.436 . . . . 74.239999999999995 111.467 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.9 -5.14 77.14 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.079 -0.581 . . . . 53.119999999999997 113.606 178.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.1 m -115.22 157.67 23.38 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 110.0 -0.371 . . . . 61.439999999999998 110.0 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 137' ' ' PHE . . . -142.59 139.93 31.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.308 -0.406 . . . . 45.25 110.161 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.46 150.61 32.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.927 0.394 . . . . 54.530000000000001 111.782 -178.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.1 pt? -124.36 134.25 53.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.262 -0.644 . . . . 74.120000000000005 109.262 177.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.7 p -111.02 133.36 56.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.042 -0.526 . . . . 62.399999999999999 110.222 -178.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG21 ' ND2' ' A' ' 56' ' ' ASN . 24.8 t -76.54 117.54 21.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.732 -1.581 . . . . 72.5 106.732 177.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -90.35 -31.98 16.67 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.323 0.582 . . . . 50.229999999999997 110.164 -173.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -142.5 144.27 32.91 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.91 -1.885 . . . . 61.240000000000002 105.91 -176.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 53' ' ' ARG . . . 134.2 169.52 12.05 Favored Glycine 0 C--N 1.29 -1.972 0 N-CA-C 110.175 -1.17 . . . . 72.099999999999994 110.175 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.55 -31.81 87.53 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.309 2.006 . . . . 73.209999999999994 112.042 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.548 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.5 p-10 -101.35 22.68 12.14 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.363 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.95 143.91 55.8 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.995 0.426 . . . . 72.140000000000001 111.357 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.23 -13.58 60.07 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.002 -0.839 . . . . 50.450000000000003 111.002 -178.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.3 128.66 36.49 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.32 -0.622 . . . . 43.399999999999999 109.32 177.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 23.2 ptt180 -110.73 135.31 51.51 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.036 -0.727 . . . . 74.219999999999999 109.036 176.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' HD23 ' A' ' 49' ' ' LEU . 95.8 m-85 -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.294 -1.002 . . . . 71.120000000000005 108.294 -179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.98 144.48 26.24 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 120.614 -0.434 . . . . 73.340000000000003 109.846 177.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 3.4 mm? -74.77 118.4 17.69 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.91 -0.774 . . . . 62.340000000000003 108.91 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.98 -29.03 4.33 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 111.825 0.306 . . . . 71.519999999999996 111.825 -174.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.471 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.0 pt20 -118.69 151.96 50.69 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 112.97 0.73 . . . . 71.510000000000005 112.97 -177.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 76.1 Cg_exo -52.76 -25.65 27.59 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 124.306 3.337 . . . . 71.400000000000006 114.202 -179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.3 m -135.21 119.8 18.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.722 -1.214 . . . . 41.399999999999999 107.722 175.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.4 m -115.5 114.28 24.8 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.7 -0.852 . . . . 73.349999999999994 108.7 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 4.5 p -86.52 135.65 33.37 Favored 'General case' 0 C--N 1.289 -2.06 0 O-C-N 122.138 -0.351 . . . . 71.409999999999997 111.344 -176.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.15 134.68 55.06 Favored 'General case' 0 C--O 1.274 2.346 0 CA-C-N 116.019 -0.537 . . . . 23.440000000000001 111.492 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.43 -163.95 28.42 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 108.709 -1.756 . . . . 71.299999999999997 108.709 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -112.8 119.23 37.3 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.09 -1.818 . . . . 73.530000000000001 106.09 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.641 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 4.5 t-160 -174.33 155.29 2.18 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 104.861 -2.274 . . . . 74.219999999999999 104.861 -173.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.641 ' HD2' ' CD2' ' A' ' 73' ' ' HIS . 55.8 Cg_endo -75.66 -18.57 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-N 120.507 1.217 . . . . 53.210000000000001 110.799 175.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.21 -3.47 55.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.411 -0.813 . . . . 54.25 112.321 -176.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.468 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 56.1 p -80.38 143.09 33.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.87 -0.732 . . . . 73.120000000000005 110.24 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -72.64 -39.0 67.54 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.557 -0.457 . . . . 74.540000000000006 110.388 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.14 135.47 45.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.051 -0.722 . . . . 61.119999999999997 109.051 176.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -96.14 117.84 31.53 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.251 0.548 . . . . 71.409999999999997 110.152 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -125.9 140.23 52.82 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.659 -1.978 . . . . 72.409999999999997 105.659 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -94.12 117.29 29.9 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.056 -0.658 . . . . 43.420000000000002 109.267 -176.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.18 173.44 6.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.684 -0.858 . . . . 63.32 108.684 -174.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.32 -29.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.436 -0.95 . . . . 65.120000000000005 108.436 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -128.35 -165.26 1.47 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.591 -1.263 . . . . 74.510000000000005 107.591 179.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.06 98.17 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.683 -0.807 . . . . 53.140000000000001 109.896 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.591 ' HA ' HD13 ' A' ' 107' ' ' LEU . 70.1 m -87.4 73.85 9.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 122.0 0.905 . . . . 75.239999999999995 110.275 175.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.643 ' NH2' ' HB ' ' A' ' 14' ' ' THR . 8.5 ptt180 -69.87 -40.37 75.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.198 -1.365 . . . . 73.120000000000005 112.618 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -135.65 73.76 1.48 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.47 -0.937 . . . . 72.239999999999995 108.47 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -100.45 -53.5 3.09 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.49 -0.777 . . . . 75.319999999999993 110.374 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.78 162.54 40.54 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 119.763 -0.775 . . . . 64.439999999999998 111.082 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.12 146.04 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.291 173.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -104.87 119.19 38.4 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 105.55 -2.019 . . . . 74.450000000000003 105.55 177.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -109.07 132.88 53.69 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.688 -0.687 . . . . 74.540000000000006 109.257 -172.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 63' ' ' LEU . 57.9 mt -125.93 123.98 65.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.393 -0.821 . . . . 64.299999999999997 108.905 -173.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.91 118.24 18.67 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.479 -0.488 . . . . 63.210000000000001 111.537 174.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 55.44 37.82 29.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.908 0.883 . . . . 70.430000000000007 111.905 175.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.02 82.4 Favored Glycine 0 C--O 1.222 -0.632 0 CA-C-N 115.642 -0.708 . . . . 51.329999999999998 113.859 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 35.2 mt-10 -101.53 130.58 47.85 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.048 -1.464 . . . . 74.340000000000003 107.048 175.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.2 124.47 52.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.829 -0.434 . . . . 71.420000000000002 109.829 -174.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.88 148.78 52.69 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 120.763 0.316 . . . . 71.409999999999997 111.064 177.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.48 123.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 106.681 -1.6 . . . . 74.329999999999998 106.681 177.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.36 122.97 69.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.606 -0.516 . . . . 74.319999999999993 109.606 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 118' ' ' ASN . 6.6 t70 -80.49 129.42 34.5 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.67 -1.233 . . . . 74.319999999999993 107.67 172.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.57 23.77 4.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 120.796 -0.362 . . . . 70.299999999999997 111.369 -176.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.27 -38.07 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 118.418 -1.849 . . . . 61.020000000000003 114.218 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m 61.2 30.84 19.49 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.931 0.872 . . . . 73.420000000000002 109.268 -174.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 86' ' ' SER . 6.4 tt -62.99 -49.21 75.59 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 113.931 -1.486 . . . . 75.209999999999994 111.083 -174.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 37.6 t-20 -106.96 -19.4 13.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.772 -1.171 . . . . 63.299999999999997 109.084 178.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 109.17 101.86 2.72 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 110.385 -1.086 . . . . 62.530000000000001 110.385 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 m -87.8 129.41 35.2 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.362 0.601 . . . . 72.049999999999997 110.652 -179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 73.3 m-85 -116.01 126.82 54.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.307 -0.997 . . . . 61.020000000000003 108.307 175.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 t -120.9 126.91 75.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 105.443 -2.058 . . . . 75.400000000000006 105.443 176.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 55.46 38.73 30.67 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.182 -1.414 . . . . 73.349999999999994 107.182 -169.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.522 ' HD3' ' NH1' ' A' ' 134' ' ' ARG . 22.1 mtm105 63.39 8.99 3.79 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 114.035 -1.439 . . . . 74.030000000000001 114.461 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.45 135.67 19.29 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.035 -0.728 . . . . 71.019999999999996 109.035 176.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.9 122.94 11.15 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 121.735 1.623 . . . . 73.200000000000003 108.651 177.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.637 ' HD2' ' HB2' ' A' ' 120' ' ' GLN . 26.1 ttm-85 -152.37 169.56 22.25 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.773 -0.771 . . . . 63.009999999999998 110.164 -170.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 103' ' ' ASP . 27.3 t-20 -104.76 -68.65 0.84 Allowed 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.533 0.521 . . . . 72.129999999999995 110.458 174.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.69 54.84 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.042 -0.411 . . . . 35.399999999999999 110.68 -174.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.637 ' HB2' ' HD2' ' A' ' 117' ' ' ARG . 57.1 tp60 -153.63 137.88 16.58 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.944 -0.571 . . . . 63.299999999999997 111.111 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 82.8 t -65.93 133.85 30.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.379 -1.711 . . . . 62.539999999999999 106.379 169.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 42.2 ttm -87.33 129.55 34.97 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.674 -0.861 . . . . 75.129999999999995 108.674 -170.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -114.09 149.29 35.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.001 -0.74 . . . . 72.530000000000001 109.001 -177.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.476 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 14.6 t -73.52 130.58 40.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 109.272 -0.64 . . . . 75.450000000000003 109.272 -179.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.24 -0.13 57.15 Favored Glycine 0 C--O 1.241 0.535 0 N-CA-C 111.464 -0.654 . . . . 65.409999999999997 111.464 -176.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.51 148.23 35.4 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 108.953 -0.758 . . . . 74.530000000000001 108.953 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.7 124.93 53.06 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.528 -0.915 . . . . 61.039999999999999 108.528 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -108.42 113.08 42.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 106.821 -1.548 . . . . 73.319999999999993 106.821 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 64.6 tt0 -108.22 126.37 52.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.144 0.497 . . . . 72.540000000000006 109.679 -176.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.2 mt -109.82 108.36 25.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.607 -1.257 . . . . 71.519999999999996 107.607 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.37 -105.11 1.49 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.594 -1.402 . . . . 41.200000000000003 109.594 -175.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -116.07 -13.64 11.21 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.197 -0.601 . . . . 60.32 111.764 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 52.3 p90 -98.92 140.75 32.61 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.386 -0.926 . . . . 70.400000000000006 110.63 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.522 ' NH1' ' HD3' ' A' ' 114' ' ' ARG . 19.5 ptp180 -112.58 144.14 42.56 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 112.667 -173.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.63 139.76 49.37 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.983 -1.858 . . . . 74.140000000000001 105.983 174.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -111.79 128.39 68.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.127 -1.064 . . . . 72.129999999999995 108.127 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.478 ' CE1' ' HB1' ' A' ' 47' ' ' ALA . 80.4 t80 -94.41 122.11 36.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.984 0.421 . . . . 71.319999999999993 110.982 -178.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.73 159.1 26.07 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.462 0.649 . . . . 63.450000000000003 110.142 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.38 124.44 27.13 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.676 -1.231 . . . . 73.120000000000005 107.676 173.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 44' ' ' ALA . . . -75.84 142.16 28.32 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.932 -0.651 . . . . 71.230000000000004 112.19 -175.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.45 162.79 41.19 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.14 2.56 . . . . 52.32 111.991 176.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.62 44.17 0.96 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.594 0.711 . . . . 75.400000000000006 109.902 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.535 0 N-CA-C 106.679 -1.6 . . . . 74.109999999999999 106.679 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.477 0.18 . . . . 71.329999999999998 110.991 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.8 t -112.55 116.83 30.84 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.808 -0.557 . . . . 74.25 110.026 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -129.11 145.54 51.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.157 -1.423 . . . . 72.340000000000003 107.157 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -138.23 152.05 48.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.133 0.492 . . . . 24.43 110.983 -178.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.62 22.0 10.53 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.645 -0.707 . . . . 70.430000000000007 110.779 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.15 -19.04 77.72 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 111.322 -0.711 . . . . 33.140000000000001 111.322 178.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -78.88 119.41 77.15 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 122.9 0.48 . . . . 52.310000000000002 109.771 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.24 132.54 21.15 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.379 2.053 . . . . 73.109999999999999 112.261 -177.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.81 144.87 49.01 Favored Pre-proline 0 N--CA 1.417 -2.099 0 N-CA-C 107.124 -1.436 . . . . 73.510000000000005 107.124 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.06 -179.15 0.15 Allowed 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 123.054 2.503 . . . . 70.099999999999994 114.129 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -90.35 138.19 31.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.371 -1.344 . . . . 74.430000000000007 107.371 -178.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.5 t -111.4 121.5 64.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.254 -0.647 . . . . 45.409999999999997 109.254 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -114.91 168.33 10.0 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.407 -0.815 . . . . 73.439999999999998 108.99 178.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -68.9 127.85 34.6 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 124.059 0.849 . . . . 73.049999999999997 110.608 -174.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.423 ' H ' HD13 ' A' ' 107' ' ' LEU . 50.6 m -103.28 154.5 19.29 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.815 -1.18 . . . . 62.210000000000001 107.815 175.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.78 115.31 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.869 -1.16 . . . . 72.140000000000001 107.869 178.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.38 131.87 45.09 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.248 -1.019 . . . . 64.310000000000002 108.248 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -129.24 105.3 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.173 0.511 . . . . 74.120000000000005 110.496 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.49 140.75 48.48 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.751 -0.833 . . . . 71.510000000000005 108.751 178.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.52 2.04 34.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 111.66 0.245 . . . . 43.399999999999999 111.66 -176.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pp -63.92 -10.48 21.23 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.99 1.107 . . . . 73.310000000000002 113.99 -179.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.37 -12.76 61.93 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 122.153 0.978 . . . . 73.540000000000006 110.976 176.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 36.5 ttmt -65.5 -20.53 66.38 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 126.016 1.727 . . . . 72.439999999999998 109.813 177.196 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.525 ' HA ' ' OG ' ' A' ' 28' ' ' SER . 11.7 tp10 -59.18 -18.47 36.65 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.508 -0.769 . . . . 72.129999999999995 111.979 -176.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -57.84 -41.49 82.46 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.18 -0.325 . . . . 71.209999999999994 110.745 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.26 -22.16 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.992 0.368 . . . . 74.299999999999997 111.992 -175.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 25' ' ' GLU . 6.7 p -81.02 -36.07 31.07 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.965 -0.694 . . . . 75.439999999999998 111.473 177.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.3 m -79.94 -48.42 13.43 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.607 -0.837 . . . . 52.399999999999999 110.757 177.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.1 m 47.58 -76.89 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.122 1.897 . . . . 72.450000000000003 116.122 -178.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.03 65.9 2.57 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 114.563 0.585 . . . . 74.430000000000007 114.563 -172.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.1 m -116.07 123.62 48.38 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.389 -1.338 . . . . 74.420000000000002 107.389 172.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.25 109.57 51.57 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 120.471 -0.491 . . . . 73.439999999999998 110.672 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.79 142.83 99.22 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.666 2.244 . . . . 72.299999999999997 110.301 174.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.49 126.35 32.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.25 -0.432 . . . . 54.119999999999997 111.233 -176.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 p -96.2 80.38 3.24 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.478 0.656 . . . . 71.010000000000005 110.001 178.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.8 t -89.51 -27.63 20.18 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.687 -0.688 . . . . 43.409999999999997 110.463 -178.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.99 55.23 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.543 -0.837 . . . . 62.32 112.55 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.91 -39.96 79.37 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.213 0.53 . . . . 74.200000000000003 109.769 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.46 -11.96 60.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.92 . . . . 71.230000000000004 111.492 -178.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -97.1 -12.36 23.24 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.269 -0.641 . . . . 63.310000000000002 109.269 -175.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 mt 59.73 83.63 0.21 Allowed Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 124.722 1.264 . . . . 65.200000000000003 108.599 -176.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -33.98 -59.29 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.094 1 C-N-CA 125.703 4.269 . . . . 72.540000000000006 115.767 -166.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.58 10.71 3.72 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.743 0.782 . . . . 70.040000000000006 109.687 179.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.48 -12.46 46.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.1 -0.8 . . . . 75.209999999999994 111.1 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.3 m -138.9 151.52 47.01 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.056 -1.831 . . . . 61.43 106.056 177.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . . . -152.92 158.55 42.27 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.794 -0.817 . . . . 75.239999999999995 108.794 -177.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 pp -120.86 149.67 42.24 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.237 -0.585 . . . . 72.239999999999995 111.965 -175.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 49' ' ' LEU . 2.1 pt? -114.99 139.55 49.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.773 -0.825 . . . . 62.130000000000003 108.773 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.19 135.93 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.422 -0.354 . . . . 62.350000000000001 110.384 -177.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.0 t -82.79 118.12 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.026 -1.472 . . . . 63.420000000000002 107.026 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -95.96 -31.34 13.13 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.062 -0.972 . . . . 73.349999999999994 110.408 -174.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -143.12 137.68 29.29 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.153 -0.684 . . . . 73.310000000000002 109.153 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.44 175.14 13.88 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.816 -1.314 . . . . 34.229999999999997 109.816 -179.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' CE2' ' A' ' 133' ' ' PHE . 78.4 Cg_exo -55.62 -37.69 95.0 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 74.299999999999997 112.807 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -96.69 22.77 7.71 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.564 0.579 . . . . 72.209999999999994 112.564 -178.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.02 137.38 58.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.928 0.394 . . . . 63.43 110.416 177.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.55 -18.03 41.91 Favored Glycine 0 C--N 1.304 -1.236 0 N-CA-C 111.023 -0.831 . . . . 72.120000000000005 111.023 -178.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.29 139.6 30.33 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 110.126 -0.324 . . . . 54.520000000000003 110.126 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -128.22 137.76 52.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 73.319999999999993 108.724 178.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.41 ' O ' HD23 ' A' ' 49' ' ' LEU . 92.5 m-85 -125.18 138.39 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.999 -0.741 . . . . 72.319999999999993 108.999 -178.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 tt -96.91 134.02 40.79 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.105 0.479 . . . . 62.420000000000002 109.713 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' HE22 ' A' ' 65' ' ' GLN . 67.6 mt -97.95 105.21 17.32 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.277 -0.42 . . . . 73.430000000000007 110.219 -178.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -130.55 5.55 4.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.774 0.797 . . . . 63.350000000000001 109.578 176.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 3.7 pm0 -107.84 141.46 23.13 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 115.109 -0.95 . . . . 74.310000000000002 110.709 -177.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 52.1 Cg_exo -57.41 -27.55 76.39 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.364 2.71 . . . . 63.520000000000003 113.745 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.3 m -137.03 123.5 20.82 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.299 -0.63 . . . . 71.200000000000003 109.299 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 26.3 m -123.47 120.76 33.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.463 -0.94 . . . . 74.010000000000005 108.463 178.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.519 HG23 HH11 ' A' ' 88' ' ' ARG . 74.6 m -94.49 131.06 40.59 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 112.06 0.392 . . . . 75.099999999999994 112.06 -176.353 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.89 135.49 54.89 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.292 0.568 . . . . 41.149999999999999 110.556 178.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.09 -159.74 25.2 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 109.465 -1.454 . . . . 72.109999999999999 109.465 179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -101.69 117.75 35.53 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.724 -1.213 . . . . 60.409999999999997 107.724 178.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -175.88 148.2 0.94 Allowed Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 105.558 -2.016 . . . . 74.230000000000004 105.558 -175.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.57 -40.47 65.41 Favored 'Trans proline' 0 C--O 1.221 -0.358 0 C-N-CA 122.041 1.827 . . . . 73.120000000000005 111.801 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -93.07 19.37 7.97 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.514 0.931 . . . . 71.120000000000005 113.514 -178.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.4 m -66.61 122.99 18.83 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.303 -0.559 . . . . 64.109999999999999 109.796 174.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.11 -38.47 66.33 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.289 -1.375 . . . . 62.450000000000003 107.289 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.1 mm -108.75 98.68 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.791 -1.929 . . . . 64.010000000000005 105.791 173.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -91.03 120.2 31.82 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.951 -0.568 . . . . 72.439999999999998 109.857 -176.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.9 mt -127.71 138.54 52.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.4 -0.963 . . . . 73.299999999999997 108.4 -179.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.37 116.49 32.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.519 -1.66 . . . . 63.119999999999997 106.519 176.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -105.96 -173.32 2.27 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.182 0.438 . . . . 73.25 112.182 -171.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.72 -32.61 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.24 0.616 . . . . 75.040000000000006 111.328 -174.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.405 ' CG2' ' HG ' ' A' ' 107' ' ' LEU . 6.1 t -123.89 -152.81 0.53 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 105.723 -1.955 . . . . 74.109999999999999 105.723 -178.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.4 t -104.85 95.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 117.644 -1.623 . . . . 72.25 109.387 173.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -92.34 85.59 5.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.179 -1.045 . . . . 64.540000000000006 108.179 176.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.452 ' NH1' ' HB2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -57.28 -27.69 62.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.976 -1.465 . . . . 53.049999999999997 112.458 -177.644 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.588 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 20.3 mmm180 -154.87 111.33 3.24 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 104.498 -2.408 . . . . 71.319999999999993 104.498 -177.028 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 12.2 t60 -100.4 -52.77 3.28 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 117.667 -1.613 . . . . 73.150000000000006 109.901 179.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.49 151.69 36.8 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.1 -0.704 . . . . 73.200000000000003 109.1 -177.167 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -118.42 129.43 55.4 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.694 -1.965 . . . . 62.130000000000003 105.694 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 14.5 m-85 -105.98 113.45 27.0 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.969 -1.493 . . . . 72.420000000000002 106.969 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -107.74 131.94 53.9 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.545 -0.539 . . . . 74.310000000000002 109.545 -177.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -118.92 113.28 41.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 106.684 -1.599 . . . . 70.109999999999999 106.684 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.93 121.41 20.49 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.129 -0.693 . . . . 75.299999999999997 109.129 -177.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 56.81 37.58 28.89 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.098 1.359 . . . . 64.439999999999998 110.244 -179.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.06 89.33 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.087 -0.961 . . . . 62.149999999999999 113.855 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -101.08 131.75 46.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.641 0.72 . . . . 72.209999999999994 109.217 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -106.2 118.1 35.74 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.857 0.723 . . . . 75.030000000000001 110.256 -174.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.87 142.48 51.09 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.569 -0.53 . . . . 54.119999999999997 109.569 177.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 122' ' ' MET . 42.0 t -114.4 123.5 70.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.74 -1.207 . . . . 74.049999999999997 107.74 177.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.07 132.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.049 0.452 . . . . 62.520000000000003 110.287 177.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -77.04 127.46 32.72 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.288 -1.004 . . . . 71.239999999999995 108.288 177.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.51 16.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.602 -0.888 . . . . 74.299999999999997 108.602 178.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -174.8 81.12 0.07 OUTLIER Glycine 0 N--CA 1.418 -2.556 0 CA-C-N 115.273 -0.876 . . . . 74.019999999999996 111.934 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -77.57 42.41 0.36 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.687 1.232 . . . . 55.109999999999999 109.053 178.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 16' ' ' SER . 23.4 tp -95.23 -28.51 14.99 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.782 -1.099 . . . . 51.240000000000002 110.627 -176.153 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 50.8 t30 -109.47 -19.82 13.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.354 -0.98 . . . . 75.120000000000005 108.354 173.197 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 109.24 3.05 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.78 -0.645 . . . . 21.23 113.39 174.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.0 m -87.29 128.99 35.16 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.464 -0.569 . . . . 61.140000000000001 109.464 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 85.3 m-85 -135.54 136.61 41.29 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.85 -0.796 . . . . 74.019999999999996 108.85 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.0 t -128.34 130.85 69.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.989 -1.856 . . . . 73.519999999999996 105.989 175.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.84 37.28 28.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.137 0.898 . . . . 74.239999999999995 108.747 -175.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 63.12 16.92 9.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.649 0.78 . . . . 65.340000000000003 113.031 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.64 137.08 23.89 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 110.007 -0.368 . . . . 71.150000000000006 110.007 178.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.12 124.85 16.11 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.957 2.438 . . . . 75.540000000000006 112.112 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -126.66 159.29 34.06 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.24 0.543 . . . . 73.200000000000003 111.793 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.12 -29.0 3.36 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.288 -1.323 . . . . 53.299999999999997 108.145 177.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.65 136.91 18.6 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.515 -1.291 . . . . 52.020000000000003 107.515 174.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.38 141.94 20.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.27 -0.641 . . . . 75.420000000000002 109.27 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.65 122.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 106.676 -1.602 . . . . 71.230000000000004 106.676 174.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.48 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 44.3 ttp -89.6 130.44 35.91 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.328 0.585 . . . . 53.299999999999997 112.288 -168.836 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.546 ' HB2' ' OD1' ' A' ' 126' ' ' ASP . 16.7 mt-30 -120.05 152.18 37.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.053 -0.976 . . . . 74.120000000000005 108.92 -177.149 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.2 p -73.21 133.81 44.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 123.522 0.729 . . . . 74.019999999999996 110.569 178.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.69 61.57 Favored Glycine 0 C--N 1.309 -0.93 0 N-CA-C 111.452 -0.659 . . . . 42.340000000000003 111.452 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 123' ' ' GLN . 3.0 m-20 -85.11 153.98 22.34 Favored 'General case' 0 C--O 1.248 0.977 0 C-N-CA 123.242 0.617 . . . . 73.099999999999994 111.437 178.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.02 130.67 55.5 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-N 115.256 -0.883 . . . . 71.140000000000001 109.515 -176.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.5 mt -114.69 132.21 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.091 -1.077 . . . . 74.120000000000005 108.091 177.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 43.9 tt0 -119.73 122.9 42.47 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 108.656 -0.868 . . . . 75.420000000000002 108.656 178.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 89' ' ' HIS . 66.3 mt -117.32 102.28 13.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.211 -1.403 . . . . 50.149999999999999 107.211 178.249 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.74 -108.39 1.53 Allowed Glycine 0 C--N 1.309 -0.961 0 N-CA-C 110.926 -0.87 . . . . 72.109999999999999 110.926 -173.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -103.4 4.7 36.51 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.644 0.259 . . . . 55.100000000000001 110.684 178.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.588 ' CE2' ' HD2' ' A' ' 55' ' ' PRO . 78.0 m-85 -87.63 158.55 18.84 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.569 0.7 . . . . 70.310000000000002 111.285 179.298 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -133.43 123.13 24.76 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.971 -1.013 . . . . 74.239999999999995 108.763 174.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.76 125.39 41.67 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 106.994 -1.484 . . . . 65.109999999999999 106.994 177.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -112.03 129.05 68.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 107.089 -1.449 . . . . 72.329999999999998 107.089 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 122' ' ' MET . 22.0 t80 -88.4 116.55 26.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.784 -0.821 . . . . 71.530000000000001 108.784 -178.387 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.6 tp -108.47 147.03 32.26 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.172 -0.677 . . . . 73.200000000000003 109.172 -173.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.33 131.24 40.14 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.474 -0.33 . . . . 62.43 111.207 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.29 132.56 11.85 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.602 -1.799 . . . . 74.120000000000005 108.602 175.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.08 148.68 92.71 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 122.132 1.888 . . . . 75.150000000000006 112.287 -177.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -84.25 69.9 10.51 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 106.775 -1.565 . . . . 63.229999999999997 106.775 178.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--N 1.266 -3.058 0 CA-C-N 112.03 -2.35 . . . . 45.520000000000003 106.338 -178.875 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 109.099 -0.704 . . . . 63.299999999999997 109.099 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -139.4 25.27 2.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.328 -1.36 . . . . 72.310000000000002 107.328 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.46 145.69 32.17 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 113.767 -1.56 . . . . 73.140000000000001 110.722 -175.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -91.41 153.34 19.93 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.037 -1.097 . . . . 71.340000000000003 108.037 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.19 47.62 1.53 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.035 0.922 . . . . 73.099999999999994 108.631 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -29.76 32.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.138 -1.185 . . . . 74.430000000000007 110.138 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.5 m -129.76 107.87 17.0 Favored Pre-proline 0 N--CA 1.419 -2.018 0 CA-C-O 121.296 0.569 . . . . 71.109999999999999 109.888 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.28 154.38 71.48 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 124.01 3.14 . . . . 71.109999999999999 111.299 176.04 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -76.14 120.62 82.45 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.39 -1.337 . . . . 64.209999999999994 107.39 178.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.15 125.47 17.64 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 123.184 2.589 . . . . 55.240000000000002 113.032 -173.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -92.87 132.45 37.01 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 107.181 -1.414 . . . . 73.010000000000005 107.181 176.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.38 121.81 66.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 C-N-CA 120.096 -0.642 . . . . 51.310000000000002 109.786 -178.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 67.4 mm-40 -103.59 132.66 49.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.288 -1.745 . . . . 74.319999999999993 106.288 174.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.456 ' O ' ' HB ' ' A' ' 85' ' ' VAL . 21.5 m -80.8 126.47 31.36 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 120.438 0.161 . . . . 73.299999999999997 111.293 -173.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -99.29 152.75 19.57 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.121 -1.807 . . . . 75.140000000000001 106.121 170.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -82.09 122.19 36.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.985 -0.746 . . . . 55.130000000000003 108.985 -178.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.587 ' HD2' ' HG1' ' A' ' 84' ' ' THR . 14.8 t80 -86.95 105.41 17.09 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.097 -0.705 . . . . 64.340000000000003 109.097 -176.563 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -122.62 120.04 32.56 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.365 -0.606 . . . . 74.310000000000002 109.365 177.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.27 -160.68 0.86 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.188 -0.915 . . . . 62.210000000000001 108.976 -173.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -50.6 -22.16 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.266 1.426 . . . . 63.030000000000001 113.774 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 23' ' ' LEU . 3.9 pp -56.69 -30.83 63.84 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.256 0.835 . . . . 70.010000000000005 113.256 -178.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -89.39 0.08 57.1 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.469 0.914 . . . . 74.129999999999995 113.469 -177.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.23 -46.75 3.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.708 0.765 . . . . 73.329999999999998 110.45 176.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -69.36 -31.19 69.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.489 -1.232 . . . . 70.299999999999997 112.379 -174.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -56.42 -38.92 72.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.525 1.306 . . . . 74.310000000000002 114.525 -174.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.3 -35.62 35.5 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.0 0.429 . . . . 74.540000000000006 110.85 -176.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 m -68.1 -31.88 71.8 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.646 0.736 . . . . 54.130000000000003 110.825 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 p -83.03 -16.0 48.83 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.657 -0.701 . . . . 61.229999999999997 112.215 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.1 m -57.61 142.86 43.34 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.924 -0.769 . . . . 75.400000000000006 108.924 177.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.7 -52.03 0.84 Allowed Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.957 -1.257 . . . . 34.030000000000001 109.957 -176.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 m -79.89 119.64 23.03 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.135 -1.431 . . . . 51.32 107.135 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . . . -128.28 144.87 53.44 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 120.768 -0.373 . . . . 70.109999999999999 111.756 -174.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' OD1' ' A' ' 113' ' ' ASN . 42.1 Cg_exo -62.46 149.83 89.52 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.941 2.428 . . . . 54.219999999999999 110.916 172.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.834 0.35 . . . . 71.019999999999996 110.214 -178.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 m -77.55 90.08 3.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.776 -0.824 . . . . 52.310000000000002 108.776 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -94.55 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.371 0.508 . . . . 65.439999999999998 112.371 -177.04 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.34 57.88 0.64 Allowed Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.364 -0.694 . . . . 72.310000000000002 111.364 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 124' ' ' THR . . . -92.85 -47.05 7.23 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.555 0.693 . . . . 64.219999999999999 110.722 176.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.32 -0.49 6.34 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.361 -1.29 . . . . 70.150000000000006 114.466 -170.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -86.19 -28.47 23.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.089 -0.708 . . . . 72.310000000000002 109.089 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt 49.03 76.61 0.53 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.749 1.22 . . . . 51.5 111.747 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.512 ' HG2' ' O ' ' A' ' 140' ' ' GLY . 26.6 Cg_endo -87.41 -74.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.152 1.901 . . . . 61.439999999999998 114.344 -175.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.83 -32.63 67.73 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.151 0.501 . . . . 72.439999999999998 112.297 -176.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.43 7.7 82.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.183 -1.008 . . . . 64.230000000000004 110.763 -176.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 m -132.81 167.04 20.89 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.553 -1.647 . . . . 74.099999999999994 106.553 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.23 157.1 43.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 118.149 0.431 . . . . 70.140000000000001 110.127 -176.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.16 137.51 51.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.288 0.566 . . . . 60.539999999999999 110.348 178.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.419 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.2 pp -108.7 137.05 47.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 109.036 -0.728 . . . . 71.340000000000003 109.036 178.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -113.56 128.85 70.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 121.119 0.485 . . . . 73.140000000000001 110.03 -179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.468 HG21 ' ND2' ' A' ' 56' ' ' ASN . 38.4 t -83.75 118.09 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 106.99 -1.485 . . . . 73.420000000000002 106.99 178.237 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -95.05 -31.71 13.46 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.411 -0.813 . . . . 62.310000000000002 109.719 -174.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -141.35 138.41 33.05 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.753 -0.658 . . . . 72.439999999999998 109.259 176.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.68 169.29 13.18 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 108.72 -1.752 . . . . 64.519999999999996 108.72 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.98 -41.99 69.22 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.027 1.818 . . . . 72.519999999999996 111.634 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.468 ' ND2' HG21 ' A' ' 51' ' ' VAL . 4.1 p-10 -91.67 22.71 3.93 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.223 0.453 . . . . 73.010000000000005 112.223 178.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.21 55.57 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 123.22 0.608 . . . . 62.109999999999999 111.222 177.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.21 -19.42 43.12 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 110.487 -1.045 . . . . 74.530000000000001 110.487 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.36 144.37 26.12 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.407 -0.397 . . . . 72.340000000000003 110.28 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -119.67 134.87 55.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.273 -1.01 . . . . 71.230000000000004 108.273 176.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.463 ' HB3' HG21 ' A' ' 78' ' ' ILE . 93.9 m-85 -117.12 125.07 50.67 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.972 -0.381 . . . . 72.040000000000006 109.972 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.5 124.18 34.28 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.479 -0.782 . . . . 71.430000000000007 109.368 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.02 104.82 15.99 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.383 -1.71 . . . . 60.039999999999999 106.383 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -109.05 -21.3 12.68 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.149 -0.478 . . . . 64.109999999999999 112.157 -173.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.16 154.44 40.45 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 120.329 -0.548 . . . . 52.340000000000003 110.923 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 75.5 Cg_exo -52.56 -25.98 27.48 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 123.609 2.873 . . . . 71.409999999999997 114.021 -178.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 m -140.94 120.1 12.9 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.568 -0.853 . . . . 65.120000000000005 109.809 176.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 77' ' ' ASP . 49.6 m -116.43 114.39 24.17 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 109.057 -0.719 . . . . 73.049999999999997 109.057 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -87.2 136.4 32.94 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 109.88 -0.415 . . . . 51.539999999999999 109.88 178.163 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.58 134.71 54.89 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 121.34 0.59 . . . . 61.140000000000001 110.723 -177.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.37 178.01 15.39 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 109.284 -1.527 . . . . 43.25 109.284 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 43.6 ttt180 -85.49 117.67 24.54 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.222 -0.659 . . . . 74.299999999999997 109.222 178.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.75 145.9 0.31 Allowed Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 107.658 -1.238 . . . . 73.010000000000005 107.658 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -61.24 -15.72 41.93 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.236 2.624 . . . . 71.340000000000003 113.851 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.92 6.24 33.47 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.546 0.212 . . . . 74.230000000000004 111.194 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.405 ' HA ' ' OG1' ' A' ' 69' ' ' THR . 40.9 m -100.56 125.2 46.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.625 -0.509 . . . . 74.299999999999997 109.625 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB3' HG23 ' A' ' 68' ' ' THR . 19.0 t70 -65.1 -48.54 73.32 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.046 -0.524 . . . . 73.420000000000002 110.956 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 61' ' ' PHE . 2.3 pp -116.15 130.18 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 119.895 -0.722 . . . . 72.540000000000006 110.715 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.02 143.0 48.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.282 0.563 . . . . 60.109999999999999 111.417 -178.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.7 mt -106.44 140.42 39.38 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.06 -1.459 . . . . 70.140000000000001 107.06 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HZ ' ' A' ' 133' ' ' PHE . 20.5 t70 -91.45 116.45 28.86 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.533 -1.654 . . . . 64.510000000000005 106.533 177.266 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' THR . 12.4 t0 -116.04 164.39 14.51 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.155 -0.683 . . . . 64.329999999999998 109.155 -169.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.26 -31.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.702 -1.222 . . . . 35.25 107.702 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.587 ' HG1' ' HD2' ' A' ' 18' ' ' PHE . 27.3 m -115.42 170.94 8.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.794 -1.558 . . . . 74.120000000000005 106.794 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 14' ' ' THR . 61.4 t -92.5 98.52 8.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.051 -1.031 . . . . 71.239999999999995 111.437 -177.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -97.1 91.7 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.479 -0.782 . . . . 44.420000000000002 110.227 177.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 13' ' ' GLU . 17.8 ptt180 -81.47 -45.22 16.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.527 0.936 . . . . 65.519999999999996 113.527 -176.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.428 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 5.6 tpt180 -126.73 87.7 2.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.712 -1.588 . . . . 75.230000000000004 106.712 -176.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -100.2 -52.36 3.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.844 -0.616 . . . . 75.450000000000003 112.253 -174.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.44 162.99 37.9 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.953 -0.699 . . . . 51.109999999999999 111.428 -175.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.44 133.78 36.99 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.361 -0.836 . . . . 65.109999999999999 109.109 176.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -112.28 122.3 47.33 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.939 -0.763 . . . . 63.539999999999999 108.939 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.44 119.51 39.02 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.497 -0.557 . . . . 72.329999999999998 109.497 175.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.2 mp -107.1 111.77 37.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.534 -2.395 . . . . 70.409999999999997 104.534 176.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -135.74 117.66 15.24 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 120.141 -0.624 . . . . 74.230000000000004 110.258 -174.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 51.7 39.82 26.13 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.76 1.224 . . . . 74.519999999999996 111.775 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.59 -5.61 84.33 Favored Glycine 0 C--O 1.216 -1.012 0 CA-C-N 115.282 -0.872 . . . . 43.329999999999998 114.677 178.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.5 150.02 23.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.907 0.854 . . . . 63.210000000000001 109.102 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.94 117.46 24.84 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.692 -0.403 . . . . 62.329999999999998 110.959 -172.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -109.6 127.13 54.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.249 -1.019 . . . . 74.140000000000001 108.249 177.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.85 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.538 -0.912 . . . . 74.510000000000005 108.538 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.01 131.39 72.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.976 -0.556 . . . . 72.239999999999995 110.444 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.46 131.11 34.45 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.394 -0.965 . . . . 54.350000000000001 108.394 174.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.35 11.38 2.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 116.302 -0.408 . . . . 64.510000000000005 111.074 -177.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 88' ' ' ARG . . . -165.1 59.88 0.25 Allowed Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.535 -1.317 . . . . 64.5 112.954 -178.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.6 t -80.78 75.13 7.71 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.736 0.779 . . . . 71.219999999999999 109.677 177.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -105.86 -21.99 13.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.832 -1.544 . . . . 75.239999999999995 106.832 170.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 3.2 m-20 -102.83 3.17 36.39 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.342 -1.299 . . . . 75.230000000000004 110.868 -177.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.76 77.29 1.13 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.936 -0.575 . . . . 55.100000000000001 113.051 178.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.5 m -86.92 128.9 35.06 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.203 -0.666 . . . . 42.350000000000001 109.203 176.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -135.68 140.2 44.28 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.881 0.372 . . . . 64.019999999999996 110.245 177.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.46 119.7 60.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 105.841 -1.911 . . . . 71.519999999999996 105.841 175.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.486 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.7 OUTLIER 57.38 36.82 27.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.293 -1.003 . . . . 75.109999999999999 108.293 -171.896 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 60.7 14.32 4.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.26 1.424 . . . . 70.430000000000007 112.979 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -107.06 142.48 25.12 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 124.089 0.956 . . . . 71.219999999999999 109.205 176.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.06 122.97 10.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.7 1.6 . . . . 64.239999999999995 109.569 178.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -146.36 140.04 26.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.091 -1.078 . . . . 73.400000000000006 108.091 -175.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.8 -41.42 8.85 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 110.237 -0.283 . . . . 71.099999999999994 110.237 179.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.39 136.84 33.53 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.822 -0.807 . . . . 75.329999999999998 108.822 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 141.91 21.9 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.731 -0.84 . . . . 61.32 108.731 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.85 114.74 26.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 106.261 -1.755 . . . . 72.430000000000007 106.261 175.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 38.0 ttm -94.37 148.84 21.82 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 113.383 0.883 . . . . 65.099999999999994 113.383 -166.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -125.66 158.34 35.0 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.829 1.252 . . . . 55.240000000000002 111.113 -172.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.528 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 10.6 m -58.38 124.27 18.97 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.294 0.637 . . . . 55.140000000000001 110.192 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.61 -9.45 60.53 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.908 -0.587 . . . . 71.019999999999996 112.051 178.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.52 151.21 44.09 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 108.708 -0.849 . . . . 75.120000000000005 108.708 -179.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -124.3 137.66 54.47 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.798 0.808 . . . . 63.119999999999997 112.124 -175.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.95 126.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 105.844 -1.91 . . . . 43.119999999999997 105.844 177.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -108.95 128.68 55.15 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.179 -1.785 . . . . 73.209999999999994 106.179 178.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 133' ' ' PHE . 66.6 mt -131.56 138.32 53.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 N-CA-C 103.825 -2.657 . . . . 71.150000000000006 103.825 -177.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -36.19 99.46 0.01 OUTLIER Glycine 0 CA--C 1.548 2.153 0 N-CA-C 115.912 1.125 . . . . 64.030000000000001 115.912 -177.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt 77.51 14.03 1.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.609 1.564 . . . . 73.319999999999993 112.929 178.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 130' ' ' ILE . 55.8 m-85 -123.56 150.64 43.81 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 125.295 1.438 . . . . 74.439999999999998 109.355 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 134' ' ' ARG . 15.6 mmm-85 -137.15 119.83 16.14 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.316 -1.735 . . . . 74.120000000000005 106.316 175.128 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 mp -122.9 136.13 54.75 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.94 -0.393 . . . . 60.530000000000001 109.94 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.68 130.16 68.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 108.509 -0.923 . . . . 64.420000000000002 108.509 179.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -95.93 131.88 41.83 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.106 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.2 mt -131.45 136.86 48.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.88 -0.785 . . . . 64.030000000000001 108.88 177.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.87 153.05 33.04 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.433 -0.951 . . . . 63.509999999999998 108.433 175.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' PRO . . . -59.94 130.64 49.7 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.7 -0.96 . . . . 55.210000000000001 110.7 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.11 160.34 13.14 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.345 2.697 . . . . 71.219999999999999 113.585 -175.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.19 48.58 1.01 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.713 1.205 . . . . 71.010000000000005 111.406 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.406 -2.662 0 CA-C-N 114.643 -1.162 . . . . 62.219999999999999 108.017 176.339 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.494 -1.188 0 N-CA-C 108.697 -0.853 . . . . 74.319999999999993 108.697 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m -72.85 101.97 3.29 Favored 'General case' 0 N--CA 1.428 -1.543 0 O-C-N 123.338 0.399 . . . . 74.439999999999998 110.014 178.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -97.03 148.45 22.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.83 -0.433 . . . . 71.439999999999998 109.83 177.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -88.2 99.56 12.3 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.43 -0.581 . . . . 70.140000000000001 109.43 178.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -101.8 136.45 41.61 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.108 -0.496 . . . . 65.230000000000004 110.399 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . 121.83 -18.74 8.52 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 120.687 -0.768 . . . . 64.209999999999994 113.016 176.163 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 m -98.96 108.45 49.31 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 117.116 0.458 . . . . 65.319999999999993 110.742 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 2.4 Cg_endo -78.83 148.76 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.226 1.951 . . . . 51.119999999999997 109.928 176.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.67 133.11 63.18 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 107.883 -1.155 . . . . 72.200000000000003 107.883 -179.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.73 136.05 44.16 Favored 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 121.96 1.773 . . . . 71.0 111.743 -179.025 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 87' ' ' ARG . 12.3 pt20 -110.51 140.93 44.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.811 0.338 . . . . 74.310000000000002 110.379 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.5 t -120.42 123.52 70.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.664 -0.865 . . . . 63.109999999999999 108.664 176.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 9.3 tp10 -148.09 148.24 30.42 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 106.476 -1.676 . . . . 64.010000000000005 106.476 -178.317 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.7 m -89.58 128.76 36.07 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 123.445 0.465 . . . . 60.130000000000003 110.674 -176.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -87.82 138.89 31.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 108.475 -0.935 . . . . 73.420000000000002 108.475 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -83.79 117.22 29.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.179 -0.675 . . . . 61.149999999999999 109.179 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -87.72 140.18 29.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.292 0.568 . . . . 72.200000000000003 110.968 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -84.59 120.65 26.6 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.686 -2.338 . . . . 65.140000000000001 104.686 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.79 80.91 2.09 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.286 0.565 . . . . 73.420000000000002 111.538 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.15 -23.18 33.06 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.661 -0.866 . . . . 62.399999999999999 108.661 177.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 pp -63.33 -5.95 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.088 1.355 . . . . 71.109999999999999 113.592 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.6 -28.75 70.14 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.048 0.539 . . . . 72.420000000000002 109.811 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -82.96 -10.32 58.85 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.794 -0.639 . . . . 72.400000000000006 111.048 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -99.77 -41.73 7.14 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.119 0.485 . . . . 54.409999999999997 111.368 179.435 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -84.47 -3.42 58.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.931 0.396 . . . . 63.119999999999997 111.755 -176.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -61.9 -41.9 98.44 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.102 0.561 . . . . 72.530000000000001 111.57 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -78.49 -13.15 59.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.086 0.47 . . . . 75.150000000000006 111.126 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -86.59 -24.8 25.26 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.598 -1.26 . . . . 74.329999999999998 107.598 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.1 m -66.92 107.38 2.2 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.32 -0.855 . . . . 64.299999999999997 110.68 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.91 177.82 40.27 Favored Glycine 0 N--CA 1.404 -3.462 0 N-CA-C 107.32 -2.312 . . . . 40.100000000000001 107.32 178.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 m -75.2 120.62 20.95 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 117.686 0.743 . . . . 63.25 110.346 -177.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.21 92.01 45.01 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 106.673 -1.602 . . . . 65.439999999999998 106.673 174.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.89 142.54 69.52 Favored 'Trans proline' 0 C--O 1.24 0.613 0 C-N-CA 122.753 2.302 . . . . 51.530000000000001 113.036 -174.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.49 162.74 18.82 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 107.784 -1.191 . . . . 30.329999999999998 107.784 177.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -77.95 126.77 31.34 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.529 -0.468 . . . . 63.130000000000003 110.342 -176.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 p -67.12 146.52 54.18 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.706 -0.679 . . . . 63.340000000000003 110.055 178.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 116.51 -8.75 17.36 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 108.375 -1.89 . . . . 71.030000000000001 108.375 -174.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.47 -27.11 66.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.183 -1.009 . . . . 65.109999999999999 110.231 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.31 1.82 47.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.425 -0.807 . . . . 64.239999999999995 110.627 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.53 7.7 17.52 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.036 -0.529 . . . . 73.239999999999995 110.209 -175.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 69.74 89.91 0.09 OUTLIER Pre-proline 0 CA--C 1.512 -0.482 0 C-N-CA 124.309 1.044 . . . . 73.310000000000002 109.61 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.69 -26.3 28.06 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.674 2.25 . . . . 73.409999999999997 112.184 -175.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.39 -27.99 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.837 -1.529 . . . . 75.310000000000002 110.229 -178.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.43 69.64 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 110.1 -1.2 . . . . 53.310000000000002 110.1 -177.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.8 t -131.06 158.13 41.19 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.052 -1.462 . . . . 63.210000000000001 107.052 176.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.1 156.97 40.93 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 108.743 -0.836 . . . . 64.310000000000002 108.743 -175.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 pp -133.13 151.56 51.99 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.899 0.381 . . . . 60.149999999999999 110.385 178.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.3 pp -113.52 132.18 55.79 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 108.006 -1.109 . . . . 74.540000000000006 108.006 175.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.81 132.06 68.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 109.906 -178.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 15.3 t -86.64 117.86 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.363 -1.347 . . . . 63.200000000000003 107.363 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.42 -33.02 12.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.033 0.444 . . . . 72.319999999999993 110.817 -179.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 13.7 tpt180 -137.85 139.61 40.01 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.476 -1.305 . . . . 65.310000000000002 107.476 -176.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.25 176.17 14.25 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.013 -0.835 . . . . 33.119999999999997 111.013 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.5 -35.23 39.73 Favored 'Trans proline' 0 C--N 1.331 -0.372 0 C-N-CA 122.614 2.209 . . . . 62.340000000000003 112.089 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -97.49 22.31 9.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.04 0.536 . . . . 65.450000000000003 111.139 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . . . -62.94 141.31 58.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.997 0.427 . . . . 54.25 111.793 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.99 -13.87 57.38 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.046 -0.822 . . . . 71.329999999999998 111.046 -177.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.64 142.98 27.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 120.898 0.38 . . . . 55.0 110.371 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -131.17 136.43 48.3 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.573 -0.899 . . . . 75.019999999999996 108.573 177.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -130.51 139.22 50.5 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.984 -0.747 . . . . 62.439999999999998 108.984 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.06 143.64 32.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.407 0.622 . . . . 72.019999999999996 112.114 -177.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.436 HD23 HD11 ' A' ' 94' ' ' ILE . 5.3 mp -94.04 103.36 15.44 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.496 -0.927 . . . . 70.030000000000001 108.496 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -133.18 8.61 4.03 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.902 1.334 . . . . 62.409999999999997 107.621 178.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.458 ' O ' HD13 ' A' ' 94' ' ' ILE . 4.0 pt20 -113.23 156.93 42.34 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 113.437 -1.71 . . . . 62.299999999999997 109.092 -174.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.99 -32.42 94.97 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.466 2.111 . . . . 74.219999999999999 112.451 178.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' PHE . 97.7 m -153.92 129.67 10.09 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 122.095 -0.378 . . . . 74.120000000000005 111.138 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 19.8 m -103.29 113.5 27.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.775 -1.565 . . . . 65.140000000000001 106.775 174.449 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -91.77 132.95 36.04 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.445 -0.576 . . . . 62.140000000000001 109.445 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.86 134.26 55.28 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 109.905 -0.405 . . . . 73.439999999999998 109.905 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.85 -132.45 2.83 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.108 -0.797 . . . . 75.329999999999998 111.108 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 86' ' ' SER . 9.9 mmm180 -118.54 151.28 38.16 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 123.029 0.532 . . . . 54.439999999999998 110.719 -175.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 61.8 m80 80.3 152.73 0.12 Allowed Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 124.913 1.285 . . . . 72.239999999999995 112.628 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.45 -18.87 26.72 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.978 3.118 . . . . 71.310000000000002 115.6 -175.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.52 -23.2 60.98 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.236 0.471 . . . . 74.549999999999997 110.708 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m -78.18 119.72 21.97 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 105.706 -1.961 . . . . 53.020000000000003 105.706 172.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.44 -49.18 78.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.957 -0.565 . . . . 75.310000000000002 111.399 -173.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.5 pt -107.28 123.23 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 C-N-CA 120.12 -0.632 . . . . 61.130000000000003 109.685 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.89 124.02 33.24 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 109.044 -0.725 . . . . 72.0 109.044 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 mt -121.2 140.44 52.02 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.293 -2.114 . . . . 63.350000000000001 105.293 178.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -102.21 116.31 32.38 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.101 -1.814 . . . . 72.439999999999998 106.101 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -88.53 176.77 7.01 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.615 -1.175 . . . . 72.519999999999996 112.837 -171.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.73 -32.91 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.229 1.014 . . . . 70.230000000000004 108.505 -177.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.4 m -150.14 153.67 36.74 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 104.074 -2.565 . . . . 54.43 104.074 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 72' ' ' ARG . 50.0 t -70.67 112.47 5.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.655 1.217 . . . . 62.43 113.375 -162.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.557 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 23.2 m -111.27 107.18 16.38 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-N 113.259 -1.792 . . . . 75.219999999999999 108.0 177.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HB2' ' HG3' ' A' ' 11' ' ' GLN . 15.9 ptt180 -55.84 -45.69 78.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.422 -0.808 . . . . 65.120000000000005 112.03 -175.219 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -137.3 119.88 16.06 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 105.322 -2.103 . . . . 70.310000000000002 105.322 171.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -89.76 -52.91 4.75 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.205 -1.035 . . . . 73.310000000000002 108.205 178.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.2 34.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.83 -0.623 . . . . 33.450000000000003 109.567 -177.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.71 145.92 52.06 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.241 0.543 . . . . 52.020000000000003 111.04 171.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 101' ' ' VAL . 9.4 m-85 -104.45 113.22 26.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.351 -1.722 . . . . 74.329999999999998 106.351 -177.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -106.67 120.72 42.73 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.649 -0.871 . . . . 74.239999999999995 108.649 -176.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 65' ' ' GLN . 3.1 mp -104.42 111.58 34.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 105.109 -2.182 . . . . 74.299999999999997 105.109 179.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -139.38 130.56 26.64 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 110.083 -0.34 . . . . 73.140000000000001 110.083 -177.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 55.87 36.67 27.73 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 122.293 1.044 . . . . 73.209999999999994 110.533 175.538 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 0.86 81.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.11 -0.95 . . . . 62.240000000000002 113.652 179.057 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -101.45 133.75 45.6 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.413 -0.958 . . . . 54.340000000000003 108.413 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -104.9 116.09 31.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.521 -1.288 . . . . 73.340000000000003 107.521 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.33 134.28 48.86 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.99 0.424 . . . . 74.040000000000006 110.504 -178.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 92' ' ' PHE . 39.0 t -102.49 124.08 56.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 107.496 -1.298 . . . . 74.120000000000005 107.496 175.071 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.62 123.09 68.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.825 0.821 . . . . 72.25 109.325 176.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -100.48 140.63 34.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.651 -1.159 . . . . 71.510000000000005 111.952 -174.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.33 1.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.809 . . . . 72.319999999999993 109.946 171.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.7 40.15 2.52 Favored Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 121.358 -0.449 . . . . 63.43 113.092 -173.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.8 m -55.73 -19.62 11.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.015 0.526 . . . . 73.450000000000003 111.903 178.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.448 ' H ' HD22 ' A' ' 107' ' ' LEU . 2.4 mm? -66.17 -29.73 70.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.271 0.628 . . . . 45.329999999999998 111.293 -178.111 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -86.99 -17.91 31.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.695 0.759 . . . . 75.519999999999996 109.287 179.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.37 76.23 1.12 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.324 -0.853 . . . . 53.340000000000003 113.213 175.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.9 m -86.69 126.67 34.72 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.758 -0.46 . . . . 73.109999999999999 109.758 175.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -136.79 136.44 38.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 110.033 -0.358 . . . . 71.409999999999997 110.033 178.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.429 HG11 ' HG2' ' A' ' 120' ' ' GLN . 58.8 t -121.65 121.11 63.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.798 -1.556 . . . . 73.140000000000001 106.798 174.596 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.31 44.67 27.01 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.334 1.053 . . . . 71.129999999999995 110.111 -178.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.8 9.35 5.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.375 1.47 . . . . 74.120000000000005 114.587 -177.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -120.07 135.54 24.42 Favored Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.982 -0.687 . . . . 73.430000000000007 109.894 178.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.54 137.2 67.81 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.544 2.162 . . . . 75.340000000000003 111.55 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -134.43 159.42 41.13 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.304 0.573 . . . . 74.239999999999995 111.705 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.65 -34.65 3.01 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.344 -1.298 . . . . 73.0 108.761 177.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.78 27.76 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.694 -1.595 . . . . 73.319999999999993 106.694 174.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.429 ' HG2' HG11 ' A' ' 112' ' ' VAL . 56.5 tp60 -147.61 122.21 9.82 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.856 -0.338 . . . . 71.430000000000007 111.214 -176.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.59 114.13 26.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.465 -2.05 . . . . 73.040000000000006 105.465 173.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.482 ' SD ' HD11 ' A' ' 128' ' ' ILE . 73.6 mtp -93.34 147.19 23.15 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 115.268 1.581 . . . . 60.119999999999997 115.268 -168.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -112.06 152.11 28.58 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.935 -1.484 . . . . 74.040000000000006 107.653 175.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -66.55 133.52 50.5 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.337 0.589 . . . . 63.130000000000003 111.385 -178.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.39 -2.14 56.13 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.584 -0.735 . . . . 42.329999999999998 112.392 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.94 153.52 20.97 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 117.032 0.416 . . . . 72.519999999999996 109.931 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.32 145.82 42.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.011 0.745 . . . . 63.030000000000001 113.011 -172.192 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.482 HD11 ' SD ' ' A' ' 122' ' ' MET . 60.4 mt -120.23 132.05 70.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.537 -0.912 . . . . 52.329999999999998 108.537 177.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -116.35 122.01 43.63 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.89 -1.152 . . . . 75.230000000000004 107.89 175.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.6 105.05 18.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.422 -0.955 . . . . 74.319999999999993 108.422 -178.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.25 -86.29 0.5 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 108.986 -1.646 . . . . 43.329999999999998 108.986 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -140.35 -2.86 1.39 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.535 -0.333 . . . . 75.530000000000001 111.425 177.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' ARG 0.254 50.5 p90 -95.04 164.11 13.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 119.202 -0.999 . . . . 74.030000000000001 111.529 -179.758 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -120.0 126.61 51.26 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 113.07 0.766 . . . . 74.219999999999999 113.07 -165.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.7 mt -121.96 140.13 52.83 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.984 -1.117 . . . . 75.140000000000001 107.984 175.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.05 137.46 55.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.602 -0.888 . . . . 63.049999999999997 108.602 176.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -105.69 114.83 29.23 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 123.146 0.579 . . . . 73.450000000000003 109.69 -177.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -127.7 159.18 35.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.817 -0.438 . . . . 71.510000000000005 109.817 -178.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.85 123.53 25.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.577 -1.638 . . . . 44.450000000000003 106.577 171.081 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.72 -89.5 1.35 Allowed Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.093 -1.051 . . . . 63.340000000000003 114.934 -170.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.68 152.55 77.5 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.333 2.022 . . . . 62.119999999999997 112.821 -177.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.45 20.24 11.9 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.072 -1.085 . . . . 64.129999999999995 108.072 178.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.426 -1.643 0 CA-C-N 114.312 -1.313 . . . . 73.0 108.375 -178.425 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 108.9 -0.778 . . . . 65.5 108.9 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -116.24 132.82 56.56 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.878 -0.786 . . . . 55.039999999999999 108.878 178.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.67 88.52 3.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.153 -1.054 . . . . 75.329999999999998 108.153 177.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -87.68 83.09 7.23 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.637 -1.165 . . . . 72.340000000000003 109.036 -178.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -71.31 141.86 50.46 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.848 -1.069 . . . . 74.230000000000004 110.104 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.26 120.1 11.39 Favored Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.305 -0.718 . . . . 72.439999999999998 111.305 178.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.2 t -89.17 112.7 52.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 112.3 0.482 . . . . 73.400000000000006 112.3 -176.149 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 6.3 Cg_exo -79.2 149.72 22.29 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.603 2.202 . . . . 62.439999999999998 110.368 173.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -105.52 125.88 32.25 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.409 -0.589 . . . . 73.209999999999994 109.409 177.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.56 152.22 78.61 Favored 'Trans proline' 0 C--O 1.242 0.718 0 C-N-CA 123.0 2.466 . . . . 64.129999999999995 114.071 -175.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.64 163.58 14.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.792 -1.095 . . . . 74.329999999999998 108.187 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.7 t -127.67 137.8 56.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.45 -0.945 . . . . 64.120000000000005 108.45 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -119.73 168.29 11.21 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 120.93 0.395 . . . . 72.430000000000007 111.319 -179.079 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.5 m -70.2 112.43 6.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 122.006 0.907 . . . . 74.430000000000007 110.929 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -88.97 149.72 23.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.638 -1.615 . . . . 74.420000000000002 106.638 175.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.78 115.71 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.679 -1.23 . . . . 70.340000000000003 107.679 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.18 139.81 30.1 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.427 -0.806 . . . . 62.340000000000003 109.942 -174.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -81.64 132.0 35.29 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.582 -0.896 . . . . 73.329999999999998 108.582 177.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.59 66.58 9.73 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.28 0.562 . . . . 64.129999999999995 112.465 -175.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.92 -18.25 58.41 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 107.841 -1.17 . . . . 64.349999999999994 107.841 174.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pp -62.12 -12.92 22.13 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 114.841 -1.072 . . . . 74.230000000000004 112.862 177.031 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.91 -30.54 69.89 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 121.358 0.599 . . . . 73.530000000000001 109.536 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.47 -33.74 76.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 125.008 1.323 . . . . 72.150000000000006 108.989 178.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 -49.0 10.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.279 -0.873 . . . . 74.530000000000001 109.081 177.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.3 tpp -56.88 -32.65 66.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.824 1.25 . . . . 71.409999999999997 112.031 -176.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 30.0 tt0 -62.78 -32.13 73.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.756 0.312 . . . . 73.120000000000005 111.554 -178.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -69.61 -32.2 70.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.097 -0.705 . . . . 73.230000000000004 109.097 179.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 m -84.26 -16.65 42.42 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.039 0.935 . . . . 71.329999999999998 111.513 -179.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 27' ' ' GLU . 61.6 m -59.59 124.91 21.61 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 112.615 0.598 . . . . 65.319999999999993 112.615 -175.122 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.71 -144.25 8.45 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 109.036 -1.626 . . . . 64.040000000000006 109.036 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 p -115.52 139.79 49.74 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 117.446 0.623 . . . . 73.099999999999994 109.56 174.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . . . -127.12 122.26 23.04 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 120.607 -0.437 . . . . 44.219999999999999 109.831 177.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.37 156.95 60.53 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 123.146 2.564 . . . . 71.329999999999998 112.513 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.65 158.78 35.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.567 -0.901 . . . . 73.349999999999994 108.567 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.3 m -81.26 105.62 12.6 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.382 -0.969 . . . . 62.43 108.382 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 m -70.23 78.25 0.52 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.148 0.975 . . . . 73.019999999999996 111.641 -176.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 25.98 0.14 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 109.641 -1.383 . . . . 70.400000000000006 109.641 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.1 72.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.169 -0.515 . . . . 74.099999999999994 110.134 -177.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.21 4.13 51.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.707 -0.679 . . . . 65.019999999999996 111.056 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -84.6 -42.24 15.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.964 -1.125 . . . . 75.329999999999998 107.964 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.9 mt 50.88 68.74 3.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 114.728 -1.124 . . . . 64.299999999999997 111.22 -177.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.417 ' HG2' ' HA2' ' A' ' 140' ' ' GLY . 30.7 Cg_endo -65.56 -65.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.38 2.054 . . . . 73.239999999999995 113.482 -175.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -15.82 60.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.815 0.302 . . . . 54.149999999999999 111.815 -177.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -2.85 72.74 Favored Glycine 0 N--CA 1.46 0.271 0 N-CA-C 111.746 -0.542 . . . . 54.140000000000001 111.746 -178.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -150.77 169.59 21.29 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.616 -1.624 . . . . 73.409999999999997 106.616 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.59 44.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 118.06 0.391 . . . . 74.530000000000001 111.1 -173.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.42 157.73 36.13 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.4 0.438 . . . . 65.349999999999994 110.715 177.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.78 151.2 50.77 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.117 -0.697 . . . . 71.340000000000003 109.117 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.71 134.69 66.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 110.027 -0.36 . . . . 63.520000000000003 110.027 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -79.83 118.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.17 -1.419 . . . . 70.140000000000001 107.17 177.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -91.0 -32.95 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.939 0.4 . . . . 70.129999999999995 110.159 -177.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 tpm_? -137.81 132.63 32.92 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.647 -0.421 . . . . 73.510000000000005 110.085 -179.16 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.15 173.01 17.96 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 108.991 -1.644 . . . . 55.399999999999999 108.991 -179.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -59.55 -35.42 95.64 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.584 2.189 . . . . 74.129999999999995 112.725 177.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -100.5 22.15 12.18 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.595 -0.442 . . . . 63.520000000000003 112.187 177.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.6 138.71 57.64 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.752 178.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.03 -19.24 32.89 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.268 -0.733 . . . . 74.209999999999994 111.268 -177.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.96 144.01 26.78 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 110.138 -0.319 . . . . 50.520000000000003 110.138 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.73 156.75 18.75 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.9 -0.778 . . . . 73.099999999999994 108.9 178.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.471 ' CG ' HG22 ' A' ' 78' ' ' ILE . 98.3 m-85 -138.0 144.44 41.1 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.335 -1.358 . . . . 75.019999999999996 107.335 175.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.7 135.1 54.97 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.156 -0.683 . . . . 74.230000000000004 109.156 -178.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.46 104.36 10.02 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.87 -0.789 . . . . 61.299999999999997 108.87 179.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.93 -21.37 11.61 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.827 -0.624 . . . . 72.430000000000007 111.351 -177.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.58 144.86 30.12 Favored Pre-proline 0 C--N 1.295 -1.784 0 CA-C-N 116.001 -0.545 . . . . 74.219999999999999 110.983 -173.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.32 -19.85 36.9 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 123.745 2.963 . . . . 73.129999999999995 113.901 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.8 m -141.74 121.23 13.26 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.997 -0.742 . . . . 71.310000000000002 108.997 175.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 92' ' ' PHE . 31.8 m -120.06 133.13 55.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.253 -0.647 . . . . 55.210000000000001 109.253 -177.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.2 m -105.66 143.83 33.26 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.901 -0.407 . . . . 73.299999999999997 109.901 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.07 134.91 54.54 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.042 -0.725 . . . . 73.129999999999995 109.042 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . 133.79 -146.64 18.57 Favored Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 109.113 -1.595 . . . . 70.510000000000005 109.113 -179.113 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -119.67 118.65 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.614 -1.234 . . . . 53.219999999999999 111.497 174.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.581 ' HB2' ' OG ' ' A' ' 76' ' ' SER . 47.5 m-70 -167.55 142.14 3.09 Favored Pre-proline 0 C--N 1.277 -2.557 0 C-N-CA 126.832 2.053 . . . . 73.430000000000007 105.564 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.57 -21.95 73.44 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.611 2.207 . . . . 71.439999999999998 114.733 -175.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.429 ' OE2' ' HB3' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -105.79 5.19 30.62 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.259 0.466 . . . . 32.219999999999999 112.259 179.379 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.581 ' OG ' ' HB2' ' A' ' 73' ' ' HIS . 73.3 m -80.98 140.27 35.31 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 120.494 -0.482 . . . . 71.219999999999999 109.826 178.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.08 -49.89 14.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.153 -0.476 . . . . 72.400000000000006 111.121 -173.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.471 HG22 ' CG ' ' A' ' 61' ' ' PHE . 43.9 pt -100.37 103.47 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.289 1.043 . . . . 75.030000000000001 111.015 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -88.1 132.44 34.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.378 -1.283 . . . . 72.340000000000003 108.965 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.6 mt -127.48 136.36 51.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.029 -1.471 . . . . 54.43 107.029 176.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.38 139.37 50.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.235 -0.654 . . . . 75.310000000000002 109.235 -178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -166.4 -174.56 2.91 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.079 -2.193 . . . . 73.239999999999995 105.079 178.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.45 -24.35 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.806 -1.553 . . . . 73.209999999999994 106.806 175.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -78.96 96.19 5.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.505 -1.294 . . . . 72.319999999999993 107.505 176.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.56 135.59 35.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.17 0.509 . . . . 40.140000000000001 112.315 -173.023 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.9 t -134.52 142.36 46.99 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.625 -2.361 . . . . 70.120000000000005 104.625 173.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 13' ' ' GLU . 12.4 ptp180 -62.55 -46.07 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.296 0.57 . . . . 71.340000000000003 109.742 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 16.8 ptt180 -151.42 151.06 31.16 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.348 -1.352 . . . . 61.229999999999997 107.348 170.068 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -100.67 -52.33 3.36 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.613 0.571 . . . . 74.519999999999996 112.186 -176.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -152.03 164.79 36.49 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.314 -0.555 . . . . 63.140000000000001 110.462 -172.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.21 132.0 45.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.598 -0.728 . . . . 65.040000000000006 109.248 173.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.405 ' HB2' ' HB ' ' A' ' 68' ' ' THR . 68.3 m-85 -106.11 123.76 48.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.646 -0.872 . . . . 63.399999999999999 108.646 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -106.12 127.08 52.95 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.465 -0.494 . . . . 71.310000000000002 109.728 173.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.15 114.41 46.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.563 -1.643 . . . . 72.439999999999998 106.563 178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -136.84 118.93 15.41 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 120.685 -0.406 . . . . 74.5 110.205 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 55.87 40.64 30.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.602 1.161 . . . . 71.25 111.396 177.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.45 -8.53 74.29 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.464 -1.244 . . . . 35.450000000000003 114.116 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.49 135.78 42.42 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.882 0.841 . . . . 75.019999999999996 110.17 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 122' ' ' MET . 37.9 m-85 -104.94 128.35 53.17 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.77 -1.105 . . . . 65.310000000000002 108.183 -176.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.46 137.13 49.65 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.127 0.489 . . . . 75.099999999999994 110.39 175.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 t -103.33 125.8 57.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.729 -0.841 . . . . 71.5 108.729 -177.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -116.66 126.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.834 -1.173 . . . . 73.129999999999995 107.834 174.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.21 134.09 35.56 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.898 -0.779 . . . . 72.230000000000004 108.898 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG21 ' CZ ' ' A' ' 88' ' ' ARG . 15.5 m -138.21 15.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.862 0.839 . . . . 74.319999999999993 109.509 179.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 107' ' ' LEU . . . -155.48 70.66 0.27 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 110.472 -1.051 . . . . 62.539999999999999 110.472 -176.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -72.42 27.53 0.05 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.63 0.772 . . . . 64.430000000000007 112.49 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 105' ' ' GLY . 3.0 tm? -82.96 -47.07 12.16 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 105.716 -1.957 . . . . 62.409999999999997 105.716 174.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.98 -19.93 19.12 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.285 -0.966 . . . . 62.43 109.55 176.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.77 129.7 0.12 Allowed Glycine 0 C--N 1.343 0.944 0 O-C-N 123.957 0.786 . . . . 53.43 112.352 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.2 m -82.96 127.8 33.87 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.481 -1.288 . . . . 73.319999999999993 109.116 174.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -130.06 126.29 37.28 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.564 -1.272 . . . . 73.010000000000005 107.564 175.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.47 119.24 59.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.097 -1.446 . . . . 72.140000000000001 107.097 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 33' ' ' ALA . 36.2 t-20 54.61 40.84 32.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.133 0.968 . . . . 71.030000000000001 109.063 -178.172 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 71.53 10.9 6.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.1 -1.409 . . . . 73.549999999999997 113.036 175.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.35 129.53 24.91 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 71.129999999999995 109.629 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.09 126.66 16.86 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.907 2.405 . . . . 61.420000000000002 110.782 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.17 162.77 23.91 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.958 0.885 . . . . 65.209999999999994 113.228 -176.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -133.0 -38.33 0.97 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.886 -1.961 . . . . 60.32 107.306 178.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -143.68 136.64 27.56 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.908 -2.256 . . . . 64.209999999999994 104.908 171.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -152.9 126.04 8.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.123 -0.631 . . . . 73.109999999999999 110.148 179.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.22 119.69 27.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.006 -1.479 . . . . 62.009999999999998 107.006 174.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.464 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 11.0 ttt -87.01 140.06 29.94 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.595 0.712 . . . . 72.530000000000001 112.032 -162.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -128.97 155.96 44.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.564 -1.198 . . . . 64.150000000000006 111.581 -176.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.5 t -80.03 135.27 36.32 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.452 1.101 . . . . 71.25 113.406 -173.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.57 -20.46 48.19 Favored Glycine 0 CA--C 1.499 -0.937 0 CA-C-N 115.851 -0.613 . . . . 54.32 112.238 177.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.76 151.95 37.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 122.903 0.481 . . . . 74.319999999999993 109.74 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 147.6 35.05 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.462 0.649 . . . . 54.140000000000001 110.896 -178.718 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -105.7 124.83 61.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 106.58 -1.637 . . . . 72.129999999999995 106.58 -176.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -110.18 126.39 54.05 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.632 -1.988 . . . . 75.120000000000005 105.632 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.31 102.49 6.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.15 -1.056 . . . . 63.130000000000003 108.15 -176.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.14 -84.18 0.02 OUTLIER Glycine 0 CA--C 1.536 1.38 0 CA-C-O 121.39 0.439 . . . . 53.25 113.077 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -131.82 8.91 4.52 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 123.491 0.716 . . . . 75.409999999999997 110.209 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -102.37 151.89 21.74 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.513 -0.767 . . . . 45.140000000000001 109.633 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 124.47 21.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.921 -0.581 . . . . 73.209999999999994 109.895 170.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.0 mp -120.57 141.22 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.922 -1.14 . . . . 73.430000000000007 107.922 -178.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.4 t -110.3 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.627 -0.879 . . . . 74.219999999999999 108.627 -178.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -102.23 126.95 49.36 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.732 0.645 . . . . 74.140000000000001 110.003 -176.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -140.0 131.06 26.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.887 0.851 . . . . 73.140000000000001 111.895 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.95 118.25 35.96 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.986 -1.487 . . . . 63.520000000000003 106.986 176.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 43' ' ' PRO . . . -177.04 -71.02 0.06 OUTLIER Glycine 0 C--N 1.295 -1.708 0 C-N-CA 118.279 -1.915 . . . . 65.340000000000003 114.639 -176.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.89 142.31 97.23 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.357 2.038 . . . . 71.540000000000006 113.179 -174.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.83 76.51 1.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.636 -1.165 . . . . 62.350000000000001 108.166 -178.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 114.024 -1.444 . . . . 64.200000000000003 108.114 -178.592 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 109.061 -0.718 . . . . 65.219999999999999 109.061 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -110.95 156.26 21.48 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 122.13 -0.357 . . . . 75.430000000000007 110.174 -178.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -85.09 173.29 10.59 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.734 -0.839 . . . . 53.240000000000002 108.734 179.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -114.63 106.73 14.58 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.725 -0.472 . . . . 54.030000000000001 109.725 179.154 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -131.29 143.44 50.54 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.519 -0.919 . . . . 63.420000000000002 108.519 177.321 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.26 -69.17 1.28 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.812 -1.185 . . . . 65.040000000000006 110.216 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 p -97.87 130.77 28.09 Favored Pre-proline 0 C--N 1.291 -1.942 0 N-CA-C 109.764 -0.458 . . . . 61.119999999999997 109.764 178.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.24 131.32 21.71 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.104 1.202 . . . . 74.439999999999998 109.669 175.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -102.03 116.88 62.55 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.011 -1.107 . . . . 63.119999999999997 108.011 177.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.87 156.3 13.52 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.052 1.835 . . . . 72.120000000000005 112.483 -177.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -92.7 153.44 18.94 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.716 -1.957 . . . . 72.430000000000007 105.716 172.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.01 121.17 59.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.269 -1.382 . . . . 74.099999999999994 107.269 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.529 ' H ' ' HD3' ' A' ' 87' ' ' ARG . 8.3 tp10 -125.85 166.19 17.31 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.98 -1.489 . . . . 75.340000000000003 106.98 -175.346 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -69.62 133.65 47.83 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 124.266 1.027 . . . . 73.319999999999993 112.888 -172.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' TPO . . . . . 0.457 HG22 HD13 ' A' ' 107' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.408 ' H ' HD12 ' A' ' 107' ' ' LEU . 16.7 m -107.87 108.53 19.74 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.889 -0.411 . . . . 72.219999999999999 109.889 178.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -97.57 114.53 35.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 107.451 -1.315 . . . . 74.409999999999997 107.451 177.097 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.456 ' CE2' HG23 ' A' ' 84' ' ' THR . 22.7 m-85 -97.45 138.6 34.65 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.033 -0.667 . . . . 63.549999999999997 112.307 -177.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -92.34 91.1 7.53 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.363 -2.458 . . . . 70.230000000000004 104.363 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . . . -101.5 168.08 9.73 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.213 -1.358 . . . . 55.020000000000003 112.779 -166.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.92 -1.42 56.61 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.235 -1.348 . . . . 61.210000000000001 109.172 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' ' 20' ' ' ALA . 3.8 pp -63.65 -14.7 54.36 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.295 -0.866 . . . . 74.239999999999995 112.478 -178.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.69 -19.61 64.38 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.897 0.38 . . . . 72.25 111.077 175.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -84.02 -38.77 20.47 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.779 -1.193 . . . . 74.5 107.779 173.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -57.47 -34.54 69.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.983 -1.008 . . . . 72.329999999999998 109.986 176.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.53 -49.17 70.9 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.435 1.094 . . . . 72.239999999999995 111.551 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.29 -36.05 76.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.659 0.266 . . . . 73.319999999999993 110.528 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -62.16 -37.47 85.33 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.638 -0.71 . . . . 62.509999999999998 110.8 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -86.27 -17.03 35.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.22 0.452 . . . . 63.32 112.22 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.0 m -63.71 125.34 23.98 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.345 -0.613 . . . . 71.430000000000007 109.345 177.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.29 28.87 3.4 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 108.311 -1.916 . . . . 74.319999999999993 108.311 -171.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.8 t -101.75 140.05 36.57 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 114.576 -0.812 . . . . 73.450000000000003 108.994 -179.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.45 148.27 80.02 Favored Pre-proline 0 C--N 1.293 -1.877 0 N-CA-C 107.418 -1.326 . . . . 74.310000000000002 107.418 174.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.487 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 38.2 Cg_exo -62.29 142.01 89.73 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.315 1.343 . . . . 53.340000000000003 109.68 176.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.28 124.58 44.48 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 120.072 -0.651 . . . . 23.420000000000002 109.459 -176.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 124' ' ' THR . 73.4 m -165.2 143.79 6.39 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 124.025 0.93 . . . . 71.209999999999994 109.531 -179.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -118.62 8.94 12.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.684 0.754 . . . . 62.420000000000002 109.775 177.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.28 65.8 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 107.008 -2.437 . . . . 73.540000000000006 107.008 -177.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' OE1' ' A' ' 123' ' ' GLN . . . -57.02 -47.56 80.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.972 -1.114 . . . . 51.130000000000003 113.151 -165.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -104.44 3.57 32.31 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 120.742 -0.383 . . . . 72.219999999999999 111.255 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -91.01 -44.51 9.28 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.39 -0.924 . . . . 72.319999999999993 112.03 -171.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 36.51 69.23 1.29 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 124.2 0.938 . . . . 75.040000000000006 111.18 -175.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.9 -70.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 125.265 3.977 . . . . 64.439999999999998 116.804 -167.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.28 -5.72 58.19 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.444 -0.502 . . . . 72.219999999999999 112.299 -176.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.89 -4.77 64.34 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.96 -0.638 . . . . 53.439999999999998 112.267 -178.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.3 m -114.79 153.37 30.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.335 -1.728 . . . . 61.229999999999997 106.335 179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 156.83 40.02 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.286 -0.566 . . . . 71.0 112.235 -175.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.5 161.09 35.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.922 -1.036 . . . . 44.520000000000003 109.743 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -130.9 135.14 47.41 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.196 -0.668 . . . . 64.310000000000002 109.196 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.8 p -116.2 133.56 62.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.06 0.457 . . . . 74.120000000000005 110.61 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' HG ' ' A' ' 135' ' ' LEU . 14.0 t -78.82 118.62 26.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.667 -1.234 . . . . 33.100000000000001 107.667 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 136' ' ' VAL . 32.2 mmmt -90.86 -31.12 16.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 110.428 -176.2 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 26.2 tpt180 -143.34 145.7 32.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.109 -1.071 . . . . 74.540000000000006 108.109 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.46 178.12 15.18 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 111.305 -0.718 . . . . 42.149999999999999 111.305 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HG2' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -61.42 -31.28 88.15 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.696 2.264 . . . . 73.530000000000001 112.303 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -97.09 21.22 10.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.996 0.369 . . . . 54.130000000000003 111.996 177.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.23 45.39 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 120.814 0.34 . . . . 54.119999999999997 110.761 179.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.04 -13.07 52.63 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 111.45 -0.66 . . . . 65.120000000000005 111.45 -178.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.13 145.24 25.19 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.777 0.322 . . . . 34.329999999999998 110.197 178.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -125.62 147.54 49.28 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.08 -1.082 . . . . 70.329999999999998 108.08 177.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.85 144.89 51.79 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.749 -1.204 . . . . 64.040000000000006 107.749 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 62' ' ' LEU . 2.0 pt? -111.74 134.04 53.57 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.753 0.311 . . . . 73.209999999999994 110.861 -177.107 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 84.4 mt -93.44 104.96 17.07 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.493 -0.558 . . . . 70.230000000000004 109.493 -178.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -121.29 -12.42 8.64 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.83 0.824 . . . . 52.329999999999998 110.809 -179.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -106.96 144.86 29.94 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 115.712 -0.677 . . . . 72.150000000000006 110.644 -175.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.05 -29.51 45.22 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.763 2.975 . . . . 74.129999999999995 113.434 -178.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -140.62 121.98 14.98 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.73 -0.606 . . . . 74.209999999999994 109.75 179.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.9 m -118.0 139.54 51.04 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.227 -1.397 . . . . 63.299999999999997 107.227 178.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.4 m -115.39 141.9 47.41 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.79 . . . . 65.349999999999994 110.222 -178.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.49 135.42 54.78 Favored 'General case' 0 C--O 1.256 1.446 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.761 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 149.01 -144.91 12.72 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.666 -1.374 . . . . 70.299999999999997 109.666 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 58.2 ttt-85 -119.95 118.29 30.32 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.663 -0.495 . . . . 65.099999999999994 109.663 176.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 75' ' ' GLU . 8.8 p80 169.74 163.02 0.2 Allowed Pre-proline 0 C--N 1.315 -0.925 0 C-N-CA 126.812 2.045 . . . . 73.230000000000004 107.811 174.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.54 -25.43 75.65 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.237 1.958 . . . . 44.210000000000001 113.043 -178.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 20.3 mp0 -86.64 -4.9 59.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.653 -0.249 . . . . 64.519999999999996 111.481 -178.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -71.29 107.57 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.366 -0.605 . . . . 63.549999999999997 109.366 178.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.0 -32.01 56.89 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.581 -1.266 . . . . 71.450000000000003 107.581 175.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mm -100.68 100.85 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 105.305 -2.109 . . . . 63.109999999999999 105.305 173.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.72 118.32 36.6 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.76 -0.376 . . . . 72.450000000000003 110.737 -175.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -123.06 122.3 38.15 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.71 -1.218 . . . . 41.350000000000001 107.71 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 55' ' ' PRO . 24.8 t70 -130.71 132.24 45.25 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.603 -0.888 . . . . 54.409999999999997 108.603 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -141.58 175.17 9.9 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.677 -1.601 . . . . 51.25 106.677 -179.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.8 t -60.12 -32.19 49.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.577 -1.268 . . . . 64.219999999999999 107.577 174.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.456 HG23 ' CE2' ' A' ' 18' ' ' PHE . 13.1 m -74.88 114.59 13.52 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.691 -1.225 . . . . 72.0 107.691 173.282 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.57 125.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.226 0.536 . . . . 73.140000000000001 110.53 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.1 m -145.13 103.12 3.83 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.162 -0.681 . . . . 70.150000000000006 109.162 177.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HD3' ' H ' ' A' ' 13' ' ' GLU . 18.1 ptt180 -80.68 -45.68 16.77 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 119.604 -0.839 . . . . 73.340000000000003 111.488 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -118.88 99.67 6.9 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.313 -0.625 . . . . 74.0 109.313 177.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.442 ' CE1' HG13 ' A' ' 130' ' ' ILE . 44.4 t-80 -100.32 -52.66 3.32 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.301 -0.96 . . . . 73.519999999999996 111.325 177.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.59 163.57 39.2 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.03 -0.668 . . . . 45.020000000000003 111.913 -175.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.78 137.4 54.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.952 -1.129 . . . . 74.109999999999999 107.952 176.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -105.83 113.58 27.22 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.739 -1.578 . . . . 65.439999999999998 106.739 176.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -111.13 136.54 50.03 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.832 -0.432 . . . . 74.5 109.832 -175.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' A' ' 99' ' ' PHE . 17.9 mm -107.97 113.52 44.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.628 -1.99 . . . . 71.239999999999995 105.628 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -135.96 122.84 21.26 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.511 -0.476 . . . . 65.409999999999997 110.51 -177.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 56.37 37.16 28.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.265 1.426 . . . . 54.130000000000003 110.403 179.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.5 -0.72 87.53 Favored Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.13 -0.941 . . . . 31.02 113.215 177.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.85 145.72 29.35 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.458 -0.941 . . . . 74.150000000000006 108.458 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CD2' HD12 ' A' ' 94' ' ' ILE . 50.3 m-85 -105.11 127.12 52.75 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.289 -1.375 . . . . 73.030000000000001 107.289 -177.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -130.29 147.39 52.0 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.886 -0.509 . . . . 74.129999999999995 110.23 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -113.53 123.68 69.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.636 -1.246 . . . . 53.009999999999998 107.636 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.0 m -119.3 121.87 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.419 0.628 . . . . 71.420000000000002 109.608 175.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.448 ' HB2' HG21 ' A' ' 110' ' ' THR . 3.5 t70 -81.84 138.21 35.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.77 -0.65 . . . . 72.430000000000007 110.612 178.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.22 12.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.679 -0.691 . . . . 72.409999999999997 109.517 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.7 -63.4 0.12 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 119.91 -1.138 . . . . 61.039999999999999 112.981 -177.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 t 62.23 9.55 3.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.723 1.209 . . . . 43.329999999999998 111.205 -177.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.6 pt? -75.98 -46.02 31.77 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 124.017 0.927 . . . . 65.230000000000004 112.577 -173.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.445 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 34.2 t-20 -89.74 -18.46 26.32 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.09 -0.959 . . . . 75.140000000000001 109.735 -171.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.79 86.19 1.77 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.516 -1.034 . . . . 72.230000000000004 110.516 -177.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 103' ' ' ASP . 8.4 m -80.63 129.81 34.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.027 0.441 . . . . 64.230000000000004 110.323 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.62 ' HB2' ' HB3' ' A' ' 129' ' ' GLN . 51.3 m-85 -131.02 136.07 48.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.741 -0.663 . . . . 71.319999999999993 110.585 178.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.66 123.32 49.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 105.935 -1.876 . . . . 43.310000000000002 105.935 174.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 57.34 37.76 28.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.44 1.096 . . . . 73.409999999999997 108.867 -176.914 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.3 mtm-85 66.68 12.29 8.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.56 -1.2 . . . . 74.140000000000001 113.702 178.142 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -114.57 142.94 29.0 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 108.871 -0.789 . . . . 71.540000000000006 108.871 174.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 110' ' ' THR . 26.1 Cg_exo -63.54 123.17 11.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.716 1.611 . . . . 73.200000000000003 108.73 172.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -157.3 136.89 12.18 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.166 -1.42 . . . . 73.209999999999994 107.166 -176.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -93.66 -49.27 5.95 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.062 -0.655 . . . . 72.109999999999999 110.56 -178.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.2 134.22 55.2 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.612 -0.835 . . . . 74.239999999999995 109.151 177.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -154.4 144.92 22.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.97 -0.559 . . . . 74.340000000000003 110.808 -178.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.9 t -81.78 125.55 39.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.265 -1.754 . . . . 72.420000000000002 106.265 172.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 47.7 ttp -98.38 129.87 45.03 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.212 0.529 . . . . 62.119999999999997 110.191 -173.218 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.492 ' OE1' ' HB1' ' A' ' 39' ' ' ALA . 69.5 mt-30 -117.7 156.23 28.6 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.8 -1.185 . . . . 62.210000000000001 107.8 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.9 t -62.62 133.74 55.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.95 0.722 . . . . 73.129999999999995 112.95 -175.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.43 56.16 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.699 -0.682 . . . . 44.409999999999997 112.588 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -88.67 153.01 21.45 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 109.63 -0.507 . . . . 71.340000000000003 109.63 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -120.6 127.18 51.87 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.002 0.905 . . . . 53.0 111.836 -176.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.27 129.23 65.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 -177.142 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 111' ' ' TYR . 45.0 tt0 -118.77 132.25 56.13 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.651 -177.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.442 HG13 ' CE1' ' A' ' 89' ' ' HIS . 2.9 mp -108.69 103.46 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 105.884 -1.895 . . . . 74.219999999999999 105.884 178.179 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.06 -93.54 0.33 Allowed Glycine 0 N--CA 1.422 -2.252 0 CA-C-N 115.476 -0.784 . . . . 75.049999999999997 112.807 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.0 3.85 9.35 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.156 0.428 . . . . 63.5 112.156 -175.149 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.5 p90 -131.61 141.9 49.76 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.647 -0.658 . . . . 74.25 111.605 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 12.1 ptp180 -122.63 149.55 43.85 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 114.606 1.336 . . . . 73.409999999999997 114.606 -171.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 51' ' ' VAL . 6.0 mp -117.39 140.92 48.95 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.654 -1.612 . . . . 72.319999999999993 107.634 178.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.435 HG23 ' HG3' ' A' ' 52' ' ' LYS . 87.4 t -111.13 131.41 62.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.341 -0.985 . . . . 73.409999999999997 108.341 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -95.4 121.9 37.56 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.221 -0.9 . . . . 75.019999999999996 110.932 -175.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.16 133.42 51.58 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.192 0.52 . . . . 52.539999999999999 109.943 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 148.62 27.29 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.781 -0.822 . . . . 54.450000000000003 108.781 175.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 129.88 24.07 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.361 -1.096 . . . . 72.340000000000003 110.361 178.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.67 162.61 38.57 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.945 2.43 . . . . 63.130000000000003 111.459 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.34 51.96 0.9 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.028 0.918 . . . . 62.020000000000003 110.769 -178.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 . . . . . 0 C--N 1.288 -2.097 0 N-CA-C 105.507 -2.034 . . . . 54.210000000000001 105.507 -179.972 . . . . . . . . 0 0 . 1 stop_ save_